data_5lw4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 5lw4 _Structure_validation_residue.Date_analyzed 2017-10-20 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.24 0.479 0 N-CA-C 108.905 -1.678 . . . . 25.0 108.905 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.31 166.08 34.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.953 0.877 . . . . 25.0 112.696 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.65 122.08 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.752 -1.573 . . . . 25.0 106.752 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -85.75 -42.54 14.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.233 -0.44 . . . . 50.0 111.024 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -143.23 158.6 57.87 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.53 116.13 3.93 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 131.403 1.835 . . . . 25.0 116.823 2.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.2 148.64 7.12 Favored Glycine 0 C--O 1.221 -0.682 0 CA-C-N 114.947 -1.024 . . . . 50.0 113.039 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -94.13 119.87 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.514 . . . . 25.0 109.611 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -21.18 64.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.436 -0.347 . . . . 50.0 111.481 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.38 72.39 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.031 0.382 . . . . 25.0 112.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.59 -27.57 69.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.985 0.422 . . . . 25.0 111.075 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 mt -94.69 -4.09 48.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 50.0 110.901 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.6 t . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.849 -0.614 . . . . 50.0 109.478 -177.192 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 121.674 0.75 . . . . 50.0 111.112 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -15.23 61.96 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.92 1.452 . . . . 25.0 114.92 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -76.19 -30.17 57.94 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.745 1.017 . . . . 50.0 113.745 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.98 44.75 0.46 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 116.805 2.15 . . . . 25.0 116.805 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.06 -22.58 25.99 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 114.543 -3.171 . . . . 50.0 113.786 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -83.68 -34.85 24.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.177 0.513 . . . . 50.0 109.896 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.7 m -111.39 69.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.645 -0.422 . . . . 50.0 111.645 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 tp -81.85 123.34 28.73 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 104.979 -2.23 . . . . 50.0 104.979 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -83.95 132.2 34.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.335 . . . . 50.0 110.868 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.64 28.65 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.82 -1.178 . . . . 25.0 107.82 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 109.855 -0.424 . . . . 50.0 109.855 -173.107 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -1.011 0 N-CA-C 111.366 -0.693 . . . . 50.0 111.366 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.6 -48.18 73.18 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.174 -0.603 . . . . 25.0 110.98 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -73.68 -22.24 60.0 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.781 -0.575 . . . . 25.0 109.494 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -20.64 74.93 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 121.059 -0.591 . . . . 50.0 111.883 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.25 -21.35 70.11 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-N 117.786 0.793 . . . . 50.0 112.409 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.79 -39.17 77.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.343 -0.984 . . . . 50.0 108.343 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.57 -25.78 45.43 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.029 -0.532 . . . . 50.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -67.74 -27.32 66.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.789 0.804 . . . . 50.0 109.852 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -73.1 2.28 7.45 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.847 -0.533 . . . . 25.0 111.534 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -129.61 18.58 5.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.197 0.599 . . . . 25.0 110.036 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.7 t -86.18 156.13 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 25.0 111.897 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -66.75 -31.46 72.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.642 0.734 . . . . 50.0 109.057 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -88.07 1.9 53.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 50.0 112.658 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -56.87 134.95 55.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.533 -0.914 . . . . 50.0 108.533 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.39 165.79 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.666 0.746 . . . . 50.0 109.969 -174.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -79.56 106.13 11.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.088 0.47 . . . . 25.0 110.561 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -65.22 146.8 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.93 -1.106 . . . . 25.0 111.133 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.91 130.06 55.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 25.0 110.906 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.2 135.63 24.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.701 -0.681 . . . . 25.0 109.677 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.1 mtp -134.19 142.27 47.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.626 -1.25 . . . . 50.0 107.626 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -89.47 172.96 8.62 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.09 -177.4 6.1 Favored Glycine 0 C--O 1.24 0.531 0 N-CA-C 115.801 1.08 . . . . 25.0 115.801 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.63 -178.72 36.78 Favored Glycine 0 CA--C 1.517 0.181 0 N-CA-C 110.833 -0.907 . . . . 50.0 110.833 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 147.04 34.84 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.452 -1.028 . . . . 25.0 108.596 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -141.86 153.82 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.328 -0.99 . . . . 50.0 108.328 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.9 m -117.03 128.26 54.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.303 -0.408 . . . . 25.0 110.241 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -104.11 136.14 44.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.38 0.672 . . . . 50.0 109.285 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.1 m -132.59 130.01 39.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -122.05 152.6 39.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.698 -1.593 . . . . 50.0 106.698 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -143.47 153.17 42.35 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.762 -1.199 . . . . 25.0 107.762 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -121.64 138.49 54.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.742 0.306 . . . . 25.0 110.746 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -92.71 0.41 57.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 25.0 110.526 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.41 129.82 41.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.109 -0.7 . . . . 25.0 109.109 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.11 1.3 9.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 O-C-N 121.983 0.464 . . . . 25.0 112.98 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -73.73 149.36 41.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 50.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.14 155.81 39.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 50.0 112.19 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.2 m -123.48 130.32 52.52 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -90.76 -43.8 9.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 50.0 111.654 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -160.9 152.48 19.41 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 110.259 -0.275 . . . . 50.0 110.259 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -147.32 144.05 28.49 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 25.0 109.132 169.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -152.73 156.71 39.65 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.17 -0.307 . . . . 50.0 110.17 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -149.69 152.97 36.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.116 0.784 . . . . 50.0 113.116 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -134.38 167.43 20.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.617 -1.253 . . . . 50.0 107.617 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 pt -133.14 152.22 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.5 p -89.87 145.75 24.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 112.472 0.545 . . . . 25.0 112.472 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -117.49 115.26 24.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.836 0.827 . . . . 25.0 109.966 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -76.23 146.9 38.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.279 -1.748 . . . . 25.0 106.279 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.68 18.47 9.48 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 120.608 -0.806 . . . . 25.0 114.46 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -58.62 149.15 26.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.365 0.582 . . . . 50.0 111.105 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -76.13 146.77 79.04 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 107.472 -1.307 . . . . 50.0 107.472 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.79 -19.97 26.77 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 117.288 -1.341 . . . . 50.0 112.896 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.78 -22.59 61.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.816 0.817 . . . . 50.0 111.756 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -95.92 146.41 31.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.94 -0.475 . . . . 50.0 110.091 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.39 111.52 2.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 117.377 -1.282 . . . . 50.0 113.091 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -38.59 63.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.398 0.679 . . . . 50.0 112.741 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -54.57 -33.03 59.59 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -92.73 -45.06 8.22 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.496 0.554 . . . . 50.0 112.496 175.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.96 -17.19 64.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.67 -39.64 84.5 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.175 1.176 . . . . 50.0 114.175 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.47 155.08 49.19 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 114.231 1.197 . . . . 25.0 114.231 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -129.29 147.0 51.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.97 0.508 . . . . 25.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.5 tp -78.26 128.69 34.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.092 -0.336 . . . . 50.0 110.092 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.0 pt -119.85 1.93 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.95 0.405 . . . . 25.0 111.53 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.64 141.08 3.32 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.179 -1.01 . . . . 50.0 114.513 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.4 131.17 24.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.91 94.88 23.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.206 0.526 . . . . 25.0 110.126 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.17 162.98 37.64 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 116.235 -2.043 . . . . 50.0 110.733 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -103.17 115.67 31.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.79 -1.559 . . . . 50.0 106.79 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.868 ' H ' ' HG ' ' A' ' 129' ' ' SER . 11.5 t0 -127.42 -97.81 0.4 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.498 -1.668 . . . . 50.0 106.498 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -159.35 -167.06 19.49 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.161 -0.776 . . . . 25.0 111.161 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 p 61.41 169.71 0.08 OUTLIER Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 124.365 1.066 . . . . 25.0 111.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.36 -4.47 15.47 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 113.18 -4.08 . . . . 50.0 114.729 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.07 69.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.083 -0.508 . . . . 25.0 109.994 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.868 ' HG ' ' H ' ' A' ' 124' ' ' ASP . 29.0 t -76.62 -20.43 56.74 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.564 0.697 . . . . 25.0 110.544 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -67.27 -16.79 64.49 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.828 -0.624 . . . . 50.0 111.635 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -71.86 105.02 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.205 0.526 . . . . 50.0 111.992 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.48 -21.24 28.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.944 -0.571 . . . . 50.0 109.726 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.1 t -95.28 138.54 32.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.929 -0.397 . . . . 50.0 109.929 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -141.7 151.15 42.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.279 -0.419 . . . . 25.0 111.925 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -101.35 133.83 45.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.818 -0.628 . . . . 50.0 109.948 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.0 mm -131.86 132.61 61.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.78 136.8 32.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.606 -0.516 . . . . 50.0 109.606 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.05 134.18 20.48 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.37 144.15 84.87 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 117.17 -1.42 . . . . 25.0 113.886 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -96.8 -7.56 33.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.449 -0.796 . . . . 50.0 110.095 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -112.42 -3.15 14.54 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.164 1.542 . . . . 50.0 115.164 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -136.54 156.63 48.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.635 0.605 . . . . 50.0 112.635 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.6 mp -127.85 152.48 47.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.006 -0.997 . . . . 50.0 108.888 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.67 154.49 6.15 Favored Glycine 0 C--O 1.237 0.308 0 CA-C-O 121.671 0.595 . . . . 25.0 113.933 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -86.97 148.9 25.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.643 0.735 . . . . 50.0 111.859 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -139.04 149.05 44.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.525 -1.657 . . . . 25.0 106.525 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.5 t -103.4 131.6 51.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.343 -2.095 . . . . 50.0 105.343 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.7 mt -95.92 123.51 48.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.233 -2.136 . . . . 25.0 105.233 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 mp -99.99 127.9 46.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 103.683 -2.71 . . . . 50.0 103.683 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.72 144.08 35.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.819 0.736 . . . . 25.0 111.762 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.56 132.94 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.141 -0.936 . . . . 50.0 109.215 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -124.31 112.63 17.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -97.26 121.65 39.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.008 -0.542 . . . . 50.0 111.784 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.43 115.84 39.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 108.892 -0.781 . . . . 50.0 108.892 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.74 63.44 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.43 -0.77 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.751 0.649 . . . . 50.0 112.751 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.2 t -154.83 166.27 34.02 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.35 -2.66 46.38 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 109.957 -0.386 . . . . 50.0 109.957 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.47 152.99 20.49 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.698 -0.626 . . . . 50.0 109.775 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.36 171.91 13.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.452 -0.573 . . . . 25.0 109.452 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.59 128.33 47.9 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.818 -0.808 . . . . 50.0 108.818 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -126.07 126.55 44.41 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 103.876 -2.639 . . . . 50.0 103.876 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.59 155.78 44.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.376 0.535 . . . . 50.0 111.318 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.49 136.7 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.893 -1.521 . . . . 50.0 106.893 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.4 mt -137.69 122.15 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.745 0.307 . . . . 25.0 110.822 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -77.72 130.94 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.168 0.509 . . . . 25.0 112.065 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.83 156.02 41.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -123.24 113.84 19.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.884 -2.265 . . . . 50.0 104.884 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.7 mt -108.4 121.59 45.24 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.333 -1.358 . . . . 50.0 107.333 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.97 170.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.055 0.455 . . . . 50.0 111.505 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -70.38 176.61 3.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.363 -0.835 . . . . 50.0 111.524 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.8 pttt . . . . . 0 C--O 1.244 0.789 0 CA-C-O 117.511 -1.233 . . . . 50.0 111.23 177.755 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 0.086 0 CA-C-O 119.065 -0.853 . . . . 25.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -144.18 166.79 24.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.296 0.548 . . . . 25.0 109.976 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.1 120.99 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.415 -1.698 . . . . 25.0 106.415 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -87.01 -40.2 14.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.893 0.378 . . . . 50.0 111.542 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -145.52 153.7 51.75 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 116.271 -0.422 . . . . 25.0 109.876 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.24 130.98 21.52 Favored 'Cis proline' 0 C--N 1.351 0.709 0 C-N-CA 129.625 1.094 . . . . 25.0 113.432 -3.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.95 -172.55 40.11 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 110.493 -1.043 . . . . 50.0 110.493 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -141.74 134.76 28.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -68.32 -21.15 64.77 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.563 -0.29 . . . . 50.0 111.46 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.68 72.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.81 0.338 . . . . 25.0 111.332 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -29.4 68.75 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 116.538 -0.301 . . . . 25.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 mt -88.25 -26.53 22.28 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.118 0.485 . . . . 50.0 110.263 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.051 -0.977 . . . . 50.0 110.991 -178.361 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.951 0.405 . . . . 50.0 111.744 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -11.17 23.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.841 1.793 . . . . 25.0 115.841 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -73.69 -36.61 65.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.542 0.61 . . . . 50.0 112.516 -173.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.94 59.09 2.19 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.6 -11.59 28.24 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.437 -1.242 . . . . 50.0 113.809 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -97.48 7.16 47.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 50.0 111.013 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -100.3 89.0 3.83 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 120.794 -1.191 . . . . 50.0 109.847 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.64 129.04 49.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.157 -0.683 . . . . 50.0 109.157 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.99 148.97 51.9 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.467 -0.568 . . . . 50.0 109.467 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.22 127.7 34.31 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.3 tttt . . . . . 0 C--N 1.324 -0.518 0 N-CA-C 107.647 -1.242 . . . . 50.0 107.647 176.452 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.486 0 N-CA-C 107.871 -2.092 . . . . 50.0 107.871 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.92 -11.04 15.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.804 0.842 . . . . 25.0 112.26 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -52.04 -33.63 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.005 0.743 . . . . 25.0 113.005 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.8 -29.59 59.06 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 119.835 -1.174 . . . . 50.0 112.805 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.29 0.71 87.34 Favored Glycine 0 C--O 1.219 -0.801 0 N-CA-C 116.124 1.21 . . . . 50.0 116.124 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.2 mm -54.6 -34.57 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 118.463 1.132 . . . . 50.0 112.846 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.08 -31.8 72.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.687 -0.633 . . . . 50.0 112.212 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.83 -12.13 57.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.587 0.708 . . . . 50.0 112.218 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -71.59 8.37 1.14 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -63.33 85.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.86 1.059 . . . . 25.0 113.86 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t -151.85 -170.97 3.8 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.486 -2.413 . . . . 25.0 104.486 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -62.92 -25.14 68.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.593 . . . . 50.0 110.547 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -89.26 19.31 4.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.322 0.86 . . . . 50.0 113.322 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -66.64 165.42 14.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.689 -0.856 . . . . 50.0 108.689 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -84.56 151.2 24.7 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.532 -1.284 . . . . 50.0 107.532 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.54 126.59 27.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.791 -0.64 . . . . 25.0 109.917 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -133.95 128.35 34.29 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.084 -0.962 . . . . 25.0 110.554 -175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -123.07 149.96 43.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.929 -0.308 . . . . 25.0 111.213 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -94.04 134.96 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.8 ttt -150.38 163.41 38.42 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.238 -1.393 . . . . 50.0 107.238 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.7 p -94.98 168.09 10.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.28 177.87 23.81 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.301 -0.476 . . . . 25.0 112.563 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.09 -174.1 15.14 Favored Glycine 0 N--CA 1.459 0.182 0 N-CA-C 109.573 -1.411 . . . . 50.0 109.573 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.16 141.78 39.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.577 1.188 . . . . 25.0 109.259 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -123.03 134.61 54.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.627 -1.62 . . . . 50.0 106.627 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -108.96 118.9 38.01 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -108.42 139.39 43.22 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.34 -1.356 . . . . 50.0 107.34 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.5 m -133.07 123.33 25.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.056 -1.461 . . . . 25.0 107.056 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -111.99 140.06 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 104.512 -2.403 . . . . 50.0 104.512 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 140.86 51.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.003 0.906 . . . . 25.0 113.131 -173.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -125.87 148.34 49.21 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.96 -2.978 . . . . 25.0 102.96 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -71.47 -18.93 62.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.344 0.52 . . . . 25.0 112.333 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.29 152.15 63.41 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.9 157.09 61.28 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 116.817 -1.656 . . . . 25.0 110.335 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -130.98 149.42 52.61 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.526 -0.546 . . . . 50.0 109.526 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.55 141.09 53.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.596 -1.631 . . . . 50.0 106.596 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.0 m -150.92 146.58 26.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.423 ' HG ' ' HB1' ' A' ' 155' ' ' ALA . 17.0 m -109.62 -41.87 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.669 0.271 . . . . 50.0 110.633 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.9 153.32 26.07 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.429 -0.582 . . . . 50.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -145.83 148.55 33.01 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.402 -0.962 . . . . 25.0 108.402 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.37 159.17 43.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 50.0 111.079 -172.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -130.52 142.5 50.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.128 -1.064 . . . . 50.0 108.128 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -132.88 164.44 26.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.714 -1.587 . . . . 50.0 106.714 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.1 pt -129.19 145.77 35.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.983 -1.488 . . . . 25.0 106.983 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.7 p -83.54 136.18 34.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.458 -1.312 . . . . 25.0 107.458 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -80.79 116.98 21.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.602 -0.888 . . . . 25.0 108.602 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -76.0 125.29 28.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.88 19.91 49.18 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 119.183 -1.484 . . . . 25.0 114.208 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -51.31 149.89 3.77 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 117.95 0.875 . . . . 50.0 112.029 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -70.93 129.59 89.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.081 -0.509 . . . . 50.0 111.135 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.98 -15.26 26.23 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 117.314 -1.324 . . . . 50.0 111.877 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.11 -14.99 61.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.159 0.984 . . . . 50.0 111.462 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -110.15 155.51 41.67 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.135 -1.061 . . . . 50.0 108.135 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.78 113.45 1.72 Allowed 'Trans proline' 0 C--O 1.24 0.593 0 N-CA-C 113.519 0.546 . . . . 50.0 113.519 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 2.5 0.63 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 118.404 2.742 . . . . 50.0 118.404 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.12 2.75 7.93 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.103 -0.373 . . . . 25.0 111.695 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -105.96 -54.71 2.44 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 116.166 -0.47 . . . . 50.0 112.027 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.0 0.51 55.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.688 0.996 . . . . 25.0 113.688 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -80.65 -21.6 41.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.096 0.406 . . . . 50.0 112.096 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -126.19 152.02 46.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -128.15 141.47 51.47 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.2 tp -77.09 118.62 19.81 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.022 -0.733 . . . . 50.0 109.022 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.03 -8.34 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.652 0.739 . . . . 25.0 110.253 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.36 155.8 9.81 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.638 -0.792 . . . . 50.0 113.289 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.57 147.07 29.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.223 -1.029 . . . . 25.0 108.223 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.62 104.48 14.47 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.97 160.99 30.19 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 115.372 -2.619 . . . . 50.0 110.884 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.04 120.96 42.2 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.161 -1.052 . . . . 50.0 108.161 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -140.25 -96.79 0.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.087 -2.19 . . . . 50.0 105.087 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.23 -144.16 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.529 ' HG ' HH11 ' A' ' 130' ' ' ARG . 22.8 t -118.3 70.54 8.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.492 0.923 . . . . 25.0 113.492 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.44 171.76 17.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 118.106 -0.796 . . . . 50.0 111.255 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.33 68.44 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.906 -0.496 . . . . 25.0 111.175 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.7 p -73.21 -2.39 21.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.529 HH11 ' HG ' ' A' ' 126' ' ' SER . 80.2 ttt180 -64.37 -22.35 66.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.716 -0.846 . . . . 50.0 108.716 173.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -62.43 131.55 49.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.398 -0.593 . . . . 50.0 109.398 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.45 -10.2 56.98 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.348 0.659 . . . . 50.0 112.692 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.2 t -97.21 120.4 37.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.522 -1.288 . . . . 50.0 107.522 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -125.66 135.19 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 25.0 111.482 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -90.93 136.67 32.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.722 -1.214 . . . . 50.0 107.722 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.7 mp -132.12 119.85 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 106.197 -1.779 . . . . 25.0 106.197 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -85.26 126.88 34.06 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.357 -0.979 . . . . 50.0 108.357 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -125.86 101.73 29.22 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 109.964 -0.384 . . . . 25.0 109.964 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.0 145.6 40.13 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 114.447 -3.236 . . . . 25.0 108.273 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.76 96.71 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.576 0.703 . . . . 50.0 109.476 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.86 10.29 31.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.386 -0.824 . . . . 50.0 108.974 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -130.1 -179.47 5.25 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.451 -0.795 . . . . 50.0 109.991 -170.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.8 mp -132.11 128.48 38.24 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.348 -1.353 . . . . 50.0 107.348 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 151.16 164.21 11.92 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-O 122.285 0.936 . . . . 25.0 115.042 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -94.77 144.94 25.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.207 1.558 . . . . 50.0 115.207 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -148.93 158.34 44.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.249 -1.76 . . . . 25.0 106.249 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.07 139.73 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 50.0 110.704 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.7 mt -96.25 128.16 47.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.855 -2.276 . . . . 25.0 104.855 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.09 144.46 35.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.079 -1.452 . . . . 50.0 107.079 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.04 135.51 41.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.607 -0.516 . . . . 25.0 109.607 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.3 t -128.95 131.12 68.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 50.0 107.897 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -126.58 109.49 12.18 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.867 -0.79 . . . . 50.0 108.867 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.04 131.98 43.99 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.756 0.789 . . . . 50.0 111.976 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.1 t -128.65 122.45 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.673 -1.602 . . . . 50.0 106.673 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB1' ' HG ' ' A' ' 93' ' ' SER . . . -72.0 -33.25 67.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.598 0.713 . . . . 25.0 109.404 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -7.08 28.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 115.343 1.609 . . . . 50.0 115.343 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.1 p -130.33 156.32 44.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.69 -21.49 60.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.744 0.783 . . . . 50.0 111.068 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -109.82 165.11 11.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.549 -0.751 . . . . 50.0 109.762 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 159.77 26.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -109.29 137.01 47.81 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 50.0 109.032 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -139.0 154.09 48.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.251 -0.281 . . . . 50.0 110.62 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -145.86 155.15 42.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.252 -0.647 . . . . 50.0 109.252 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.3 140.51 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.329 -0.989 . . . . 50.0 108.329 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.85 122.04 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.028 -1.101 . . . . 25.0 108.028 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -85.1 134.23 34.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.98 -1.119 . . . . 25.0 107.98 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.88 125.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.469 -0.567 . . . . 25.0 109.469 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -93.84 107.94 19.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.403 -2.073 . . . . 50.0 105.403 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.5 mt -109.55 133.14 53.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.188 0.518 . . . . 50.0 109.674 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.71 159.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.123 -0.944 . . . . 50.0 110.712 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -76.06 155.93 34.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 105.285 -2.117 . . . . 50.0 105.285 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-O 117.413 -1.279 . . . . 50.0 110.931 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.18 0 N-CA-C 104.336 -3.506 . . . . 25.0 104.336 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -154.18 169.66 23.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.085 1.942 . . . . 25.0 113.015 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.3 mm -93.52 127.1 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.515 -0.766 . . . . 25.0 108.975 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -87.63 13.16 10.89 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.818 0.673 . . . . 50.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.5 mttt 80.92 156.57 0.13 Allowed Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 126.142 1.777 . . . . 25.0 107.348 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.79 151.37 75.15 Favored 'Cis proline' 0 C--N 1.346 0.401 0 C-N-CA 129.311 0.963 . . . . 25.0 112.502 -4.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.08 9.34 63.78 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 116.297 1.279 . . . . 50.0 116.297 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -62.05 132.4 52.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 25.0 111.751 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -70.53 -26.44 63.57 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.069 -0.514 . . . . 50.0 111.298 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.15 70.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.503 -0.317 . . . . 25.0 111.629 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.39 75.81 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 120.798 0.332 . . . . 25.0 110.675 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.91 -8.04 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.353 -0.385 . . . . 50.0 111.308 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 t . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 120.739 0.304 . . . . 50.0 110.449 -177.271 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 113.09 0.774 . . . . 50.0 113.09 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.9 ptm -56.32 -10.98 1.02 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.499 1.666 . . . . 25.0 115.499 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -76.43 -35.98 58.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.9 0.381 . . . . 50.0 110.779 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -147.14 50.22 0.91 Allowed Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.824 1.046 . . . . 25.0 113.824 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.58 -17.15 23.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 115.114 -2.791 . . . . 50.0 114.634 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.07 4.99 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.073 0.768 . . . . 50.0 113.073 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 94.06 4.85 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 113.067 0.766 . . . . 50.0 113.067 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.98 132.78 51.97 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 105.602 -1.999 . . . . 50.0 105.602 168.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -129.94 149.06 51.83 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.265 0.839 . . . . 50.0 113.265 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.68 49.32 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt . . . . . 0 C--N 1.324 -0.502 0 N-CA-C 109.089 -0.708 . . . . 50.0 109.089 178.208 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.557 0 CA-C-O 120.195 -0.225 . . . . 50.0 113.494 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.38 -36.97 85.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.779 0.799 . . . . 25.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -71.18 -12.7 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.549 -0.751 . . . . 25.0 111.745 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.38 -23.2 53.22 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 121.325 -0.464 . . . . 50.0 113.524 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.12 73.71 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 117.961 0.88 . . . . 50.0 112.49 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.62 -38.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.922 -1.14 . . . . 50.0 107.922 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.61 -29.12 69.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 50.0 110.087 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.69 -7.81 36.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.646 0.61 . . . . 50.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -68.93 -41.04 78.65 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -159.89 110.19 1.88 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 120.848 0.356 . . . . 25.0 110.646 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.91 163.55 39.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -72.47 -26.41 61.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.165 -0.309 . . . . 50.0 110.165 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.01 20.5 15.42 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.76 0.281 . . . . 50.0 111.76 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -54.81 147.56 14.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.861 -0.608 . . . . 50.0 110.624 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -90.84 151.69 21.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.215 -0.661 . . . . 50.0 109.215 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -77.51 136.15 38.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -106.12 144.81 32.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.133 -0.485 . . . . 25.0 110.105 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.05 142.25 48.02 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -100.71 136.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.76 151.57 45.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.288 0.477 . . . . 50.0 112.288 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p -96.14 172.05 8.22 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 106.863 -1.532 . . . . 25.0 106.863 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.46 -172.69 15.37 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 117.814 1.886 . . . . 25.0 117.814 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.86 172.04 25.46 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 113.799 -1.2 . . . . 50.0 111.622 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.06 139.23 41.31 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.935 -1.135 . . . . 25.0 107.935 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -137.3 157.12 47.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.901 -1.148 . . . . 50.0 107.901 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.1 m -125.61 127.33 46.16 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -115.03 140.77 48.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.898 -0.779 . . . . 50.0 108.898 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -127.2 133.07 50.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.357 -0.609 . . . . 25.0 109.357 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.97 150.06 45.24 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.041 -2.207 . . . . 50.0 105.041 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 161.95 37.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.755 0.707 . . . . 25.0 111.121 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.1 151.83 39.4 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -71.85 -14.3 61.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.612 0.597 . . . . 25.0 112.612 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.88 160.4 58.6 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 104.094 -2.558 . . . . 25.0 104.094 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.84 145.89 94.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 115.479 -2.547 . . . . 25.0 111.092 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -108.16 118.18 36.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.222 -0.445 . . . . 50.0 110.735 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.03 129.56 41.45 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.598 -1.63 . . . . 50.0 106.598 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.615 ' HG1' ' HE1' ' A' ' 152' ' ' TRP . 62.2 m -145.64 133.58 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.745 -0.207 . . . . 25.0 110.834 -170.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -104.92 -33.62 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.438 -0.579 . . . . 50.0 109.438 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -163.02 148.55 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.089 -1.078 . . . . 50.0 108.089 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -142.69 139.07 31.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.868 -0.79 . . . . 25.0 108.868 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.05 159.05 44.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 50.0 110.817 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.57 145.34 33.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.699 0.762 . . . . 50.0 111.286 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -127.52 167.45 16.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.794 -1.093 . . . . 50.0 109.211 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.56 156.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.396 -0.964 . . . . 25.0 108.396 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 p -95.48 145.44 25.18 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.862 -0.422 . . . . 25.0 109.862 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -88.68 113.59 24.41 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.275 -0.57 . . . . 25.0 111.563 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -77.2 147.93 36.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.669 -1.975 . . . . 25.0 105.669 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.97 59.79 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 118.076 1.991 . . . . 25.0 118.076 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -54.89 147.13 15.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.68 1.24 . . . . 50.0 113.409 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 146.69 72.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.051 -0.722 . . . . 50.0 109.051 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.65 -18.4 25.39 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 118.031 -0.846 . . . . 50.0 113.917 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.05 -22.29 62.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.183 0.992 . . . . 50.0 110.915 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.84 147.11 32.98 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.624 -0.716 . . . . 50.0 109.733 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 93.94 0.65 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 118.463 -0.558 . . . . 50.0 111.799 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . 0.403 ' H ' HD22 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -52.99 -41.31 64.49 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 114.36 1.244 . . . . 50.0 114.36 -173.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -70.66 -16.41 62.81 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.057 0.762 . . . . 25.0 113.057 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -85.69 -41.38 15.2 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.356 0.598 . . . . 50.0 109.622 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.79 7.85 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.654 -1.157 . . . . 25.0 111.943 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.2 -29.03 70.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.917 0.71 . . . . 50.0 112.917 -169.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -126.04 144.98 50.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.018 0.748 . . . . 25.0 113.018 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -127.96 144.64 51.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.697 -0.853 . . . . 25.0 108.697 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -82.58 113.69 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.521 -0.918 . . . . 50.0 108.521 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -97.34 -8.62 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.345 0.593 . . . . 25.0 110.275 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.93 149.94 8.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.198 -1.001 . . . . 50.0 114.061 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.59 146.86 28.44 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.417 -0.957 . . . . 25.0 108.417 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.1 90.11 6.89 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-O 121.23 0.538 . . . . 25.0 110.299 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.39 162.59 38.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 117.751 -1.033 . . . . 50.0 109.752 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -96.9 91.98 5.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.334 -1.728 . . . . 50.0 106.334 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -100.38 2.75 42.68 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 113.976 -1.465 . . . . 50.0 109.167 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.17 -11.42 65.33 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.068 -1.213 . . . . 25.0 110.068 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.4 t -59.34 141.1 87.8 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.659 -0.497 . . . . 25.0 109.659 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.05 -6.63 19.49 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 C-N-CA 116.94 -1.573 . . . . 50.0 115.295 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.17 83.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.182 -0.917 . . . . 25.0 109.657 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.2 t -85.57 -27.87 25.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 25.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -69.4 -35.15 75.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.465 -0.568 . . . . 50.0 109.465 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.36 111.23 12.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.027 -0.533 . . . . 50.0 110.058 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.25 -13.06 60.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.507 -0.77 . . . . 50.0 112.906 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -96.98 121.31 38.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.846 -0.798 . . . . 50.0 108.846 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -133.05 149.42 52.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.461 . . . . 25.0 111.925 -172.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -84.78 135.17 34.23 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.839 -0.619 . . . . 50.0 109.917 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 73.2 mt -134.51 120.62 33.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 106.783 -1.562 . . . . 25.0 106.783 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -73.39 140.99 46.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.643 0.259 . . . . 50.0 110.724 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.04 129.89 25.15 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 106.731 -1.581 . . . . 25.0 106.731 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.1 148.78 63.62 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 117.355 -1.297 . . . . 25.0 113.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -100.82 -9.4 21.71 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.654 0.74 . . . . 50.0 109.217 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.09 10.56 20.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.862 1.06 . . . . 50.0 113.862 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -132.15 141.61 49.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 110.072 -0.344 . . . . 50.0 110.072 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 mp -113.13 153.87 27.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 50.0 109.307 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 116.74 154.21 10.06 Favored Glycine 0 C--O 1.24 0.5 0 CA-C-O 122.192 0.885 . . . . 25.0 114.97 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -87.01 146.27 26.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.226 0.824 . . . . 50.0 113.226 -177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -148.95 158.96 44.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.965 -1.495 . . . . 25.0 106.965 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.03 143.61 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.901 0.381 . . . . 50.0 111.81 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.93 131.26 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.601 -2.0 . . . . 25.0 105.601 172.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.45 140.22 49.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.216 -1.401 . . . . 50.0 107.216 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -130.09 133.82 46.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.9 130.29 68.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.73 -1.211 . . . . 50.0 107.73 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . 0.615 ' HE1' ' HG1' ' A' ' 92' ' ' THR . 6.2 t-105 -117.85 116.27 26.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.55 -0.75 . . . . 50.0 110.584 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.63 131.9 42.81 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 122.123 0.963 . . . . 50.0 110.484 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.12 124.2 65.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 106.937 -1.505 . . . . 50.0 106.937 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.03 -31.31 64.36 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.192 0.52 . . . . 25.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -67.41 -14.93 63.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.557 2.058 . . . . 50.0 116.557 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -129.2 160.42 32.96 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 122.098 -0.376 . . . . 25.0 110.747 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.46 -12.2 59.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.148 0.499 . . . . 50.0 110.591 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -110.2 160.59 16.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.741 0.781 . . . . 50.0 111.121 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -121.94 156.54 33.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 103.355 -2.831 . . . . 25.0 103.355 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -123.81 143.91 50.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.806 -0.813 . . . . 50.0 108.806 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.01 153.97 48.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.056 0.455 . . . . 50.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -134.75 143.68 47.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.322 -1.733 . . . . 50.0 106.322 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.04 129.14 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.603 -0.518 . . . . 50.0 109.603 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.2 mt -140.21 125.74 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.088 -1.078 . . . . 25.0 108.088 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -87.73 141.63 28.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.605 -0.887 . . . . 25.0 108.605 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.45 143.75 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.098 0.475 . . . . 25.0 109.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -97.94 122.15 40.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.032 -1.47 . . . . 50.0 107.032 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.1 mt -115.71 119.4 35.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.878 -1.897 . . . . 50.0 105.878 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.17 162.19 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.685 0.994 . . . . 50.0 113.685 -170.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.64 161.22 30.53 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.443 -1.688 . . . . 50.0 106.443 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt . . . . . 0 C--O 1.246 0.909 0 CA-C-O 117.841 -1.076 . . . . 50.0 109.214 172.544 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.479 1 N-CA-C 101.837 -4.505 . . . . 25.0 101.837 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -158.2 163.65 37.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.374 1.587 . . . . 25.0 111.046 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -92.36 114.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 105.569 -2.011 . . . . 25.0 105.569 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -72.81 -40.92 65.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.533 -0.914 . . . . 50.0 108.533 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -153.35 131.59 6.44 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.152 -0.476 . . . . 25.0 109.744 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.47 140.81 46.59 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 118.62 0.543 . . . . 25.0 112.476 0.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 154.51 18.29 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 116.019 -0.537 . . . . 50.0 113.767 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p -61.91 152.88 30.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.598 0.713 . . . . 25.0 112.744 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -65.1 -17.08 64.16 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.964 -0.562 . . . . 50.0 112.078 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.34 68.14 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 122.617 0.367 . . . . 25.0 111.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.3 77.84 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.972 0.415 . . . . 25.0 111.275 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.02 -4.04 55.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 50.0 110.941 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t . . . . . 0 C--N 1.325 -0.457 0 N-CA-C 108.369 -0.975 . . . . 50.0 108.369 179.334 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 112.658 0.614 . . . . 50.0 112.658 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm -65.31 -19.94 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.419 0.896 . . . . 25.0 113.419 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -75.53 -45.77 36.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.239 0.472 . . . . 50.0 111.018 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -154.97 89.79 3.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 113.1 0.778 . . . . 25.0 113.1 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.61 1.46 4.97 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 N-CA-C 113.22 0.431 . . . . 50.0 113.22 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.14 -7.87 24.32 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.252 1.205 . . . . 50.0 114.252 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -132.99 129.94 38.84 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.924 1.824 . . . . 75.0 115.924 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -120.62 140.47 51.5 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.069 -2.197 . . . . 50.0 105.069 161.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -84.03 118.33 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.555 0.616 . . . . 50.0 109.858 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.86 158.1 43.95 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 107.75 -1.204 . . . . 25.0 107.75 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tttt . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.4 0.619 . . . . 50.0 110.223 178.056 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.531 0 N-CA-C 115.611 1.005 . . . . 50.0 115.611 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.37 -26.94 68.69 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.234 1.017 . . . . 25.0 112.099 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.19 -23.69 67.4 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.536 -0.466 . . . . 25.0 111.262 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.18 -26.05 71.67 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.771 -0.728 . . . . 50.0 111.852 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.7 73.48 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 121.025 -0.607 . . . . 50.0 112.008 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.25 -28.22 41.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.29 -0.633 . . . . 50.0 109.29 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -88.05 -38.6 15.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.725 -0.472 . . . . 50.0 109.725 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.64 -38.27 84.26 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.91 0.386 . . . . 50.0 112.005 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -64.68 -0.19 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.052 1.13 . . . . 25.0 114.052 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -143.65 34.85 1.28 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.766 0.426 . . . . 25.0 110.157 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 t -115.94 172.29 7.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.979 0.418 . . . . 25.0 111.804 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.46 -38.35 74.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.555 0.693 . . . . 50.0 110.557 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -79.99 5.44 14.03 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.751 0.649 . . . . 50.0 112.751 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -52.74 149.87 5.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.044 1.128 . . . . 50.0 114.044 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -70.28 158.51 35.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 50.0 110.92 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -84.33 151.51 24.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.825 -0.547 . . . . 25.0 111.155 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -120.52 143.29 48.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.313 -0.403 . . . . 25.0 111.2 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -121.1 150.97 40.41 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 106.612 -1.625 . . . . 25.0 106.612 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -96.2 143.0 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.178 -2.156 . . . . 25.0 105.178 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.6 ttt -150.7 164.31 36.45 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 110.421 -0.215 . . . . 50.0 110.421 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 p -110.2 172.48 6.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.775 -1.935 . . . . 25.0 105.775 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.97 -168.67 6.9 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.318 1.287 . . . . 25.0 116.318 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.68 -179.14 26.45 Favored Glycine 0 CA--C 1.521 0.417 0 O-C-N 122.519 -0.401 . . . . 50.0 113.371 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -73.08 133.65 44.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.748 -0.854 . . . . 25.0 109.615 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -125.77 137.79 53.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 50.0 110.047 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.7 m -102.56 125.54 49.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.492 -0.559 . . . . 25.0 109.492 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -112.83 130.12 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.01 -1.478 . . . . 50.0 107.01 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -137.98 135.1 35.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.78 -0.191 . . . . 25.0 110.565 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -122.42 150.08 42.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.47 -1.678 . . . . 50.0 106.47 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -144.96 158.58 43.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.644 -0.872 . . . . 25.0 108.644 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.66 151.04 47.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.656 -0.868 . . . . 25.0 108.656 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -72.4 -16.87 61.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.992 0.425 . . . . 25.0 111.347 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.87 141.1 23.13 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 174.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.07 146.88 47.65 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 117.167 -1.422 . . . . 25.0 112.896 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -131.12 157.08 44.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.185 -0.672 . . . . 50.0 109.185 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -76.99 144.67 38.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.312 -0.625 . . . . 50.0 109.312 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -128.28 130.11 47.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.415 -0.957 . . . . 25.0 108.415 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 t -89.75 -44.29 10.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.681 0.753 . . . . 50.0 109.771 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -158.13 155.69 29.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -146.86 141.23 26.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 168.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -148.4 159.75 43.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 50.0 111.368 -170.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -130.1 141.0 50.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.7 0.625 . . . . 50.0 110.444 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -126.68 162.87 24.76 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.035 -1.839 . . . . 50.0 106.035 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 pt -132.4 139.43 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.271 -0.27 . . . . 25.0 110.271 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -85.01 130.75 34.57 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 120.903 0.382 . . . . 25.0 110.339 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -88.08 125.02 34.35 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.817 0.673 . . . . 25.0 112.817 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -75.1 140.21 43.29 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.21 21.32 55.22 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.06 1.184 . . . . 25.0 116.06 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -57.09 154.18 10.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.226 1.013 . . . . 50.0 111.777 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.08 119.24 65.82 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.94 -15.84 18.52 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 117.163 -1.425 . . . . 50.0 113.51 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -75.72 -15.62 60.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.393 1.092 . . . . 50.0 110.744 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -105.01 153.79 39.17 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 106.606 -1.627 . . . . 50.0 106.606 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.98 128.44 21.87 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 115.058 -2.828 . . . . 50.0 112.215 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 tt -53.67 -38.01 63.73 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.402 -0.817 . . . . 50.0 111.895 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -58.18 -18.81 28.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.036 1.125 . . . . 25.0 114.036 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -101.61 -42.99 6.02 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 122.098 -0.376 . . . . 50.0 111.735 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.04 59.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.92 1.082 . . . . 25.0 113.92 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.95 -38.69 83.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.848 1.425 . . . . 50.0 114.848 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -130.46 161.97 30.22 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 116.413 2.005 . . . . 25.0 116.413 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -128.51 149.68 50.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.0 tp -85.56 112.93 21.4 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.169 -1.419 . . . . 50.0 107.169 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.16 -12.07 9.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.204 0.526 . . . . 25.0 110.327 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.22 158.72 12.61 Favored Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.832 -1.175 . . . . 50.0 114.707 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.93 146.58 31.11 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.496 -1.298 . . . . 25.0 107.496 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.26 107.75 4.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.619 -0.512 . . . . 25.0 109.619 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -86.64 177.26 4.32 Favored 'Trans proline' 0 C--O 1.24 0.575 0 N-CA-C 114.066 0.756 . . . . 50.0 114.066 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -104.08 91.53 3.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.812 -2.292 . . . . 50.0 104.812 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -156.44 71.42 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.062 0.458 . . . . 50.0 110.675 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.76 13.35 39.09 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.037 -0.529 . . . . 25.0 114.204 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.97 145.73 97.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.568 -0.372 . . . . 25.0 111.135 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.55 -175.63 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.784 1.656 . . . . 50.0 113.897 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.47 -26.2 12.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -57.36 -8.9 0.86 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.145 1.165 . . . . 25.0 114.145 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -76.27 3.63 10.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.729 -0.607 . . . . 50.0 111.707 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -58.7 150.45 23.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.95 -7.02 19.18 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.687 0.995 . . . . 50.0 113.687 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.3 t -97.94 122.65 41.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.141 -1.8 . . . . 50.0 106.141 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.4 151.06 51.88 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.207 0.527 . . . . 25.0 110.958 -175.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -105.92 138.51 41.97 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.67 -1.233 . . . . 50.0 107.67 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.5 mm -127.01 123.0 61.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.29 -2.115 . . . . 25.0 105.29 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.56 133.98 35.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.694 -1.224 . . . . 50.0 107.694 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.9 mm -125.88 118.6 24.06 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.03 155.29 61.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 115.736 -2.376 . . . . 25.0 110.715 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -104.79 55.03 0.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.463 -1.31 . . . . 50.0 107.463 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.73 -36.31 21.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.743 -0.662 . . . . 50.0 112.367 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -151.7 159.21 44.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.259 0.552 . . . . 50.0 110.786 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.62 143.87 26.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.987 -1.006 . . . . 50.0 110.25 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.31 152.0 6.04 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-O 121.839 0.688 . . . . 25.0 113.739 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -80.04 146.3 32.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.597 0.713 . . . . 50.0 111.984 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -136.27 128.52 29.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.766 -1.939 . . . . 25.0 105.766 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.01 125.57 47.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 105.675 -1.972 . . . . 50.0 105.675 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 76.7 mt -96.21 119.73 44.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.98 109.01 20.61 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.549 -1.648 . . . . 50.0 106.549 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -113.04 146.77 38.54 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.03 -0.419 . . . . 25.0 110.507 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.14 134.25 65.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.955 -0.566 . . . . 50.0 109.652 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -121.24 106.42 11.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.34 -0.985 . . . . 50.0 108.34 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.01 88.04 7.61 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.904 -0.776 . . . . 50.0 108.904 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.71 138.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.286 -1.376 . . . . 50.0 107.286 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -94.53 -13.69 25.82 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 122.068 -0.395 . . . . 25.0 111.274 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -77.26 -12.24 59.92 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.385 0.883 . . . . 50.0 113.385 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.0 p -140.18 170.59 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.89 0.7 . . . . 25.0 112.89 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -85.04 13.49 6.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.567 0.747 . . . . 50.0 110.317 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -109.91 163.51 13.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.741 -0.837 . . . . 50.0 108.741 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.95 139.35 32.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 100.376 -3.935 . . . . 25.0 100.376 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -117.99 152.01 36.33 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.276 0.56 . . . . 50.0 110.921 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.68 140.81 51.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.565 -1.198 . . . . 50.0 108.381 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -128.23 126.2 40.46 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.651 -2.351 . . . . 50.0 104.651 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.13 131.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.485 -0.561 . . . . 50.0 109.485 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.38 123.73 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.41 138.65 31.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.517 -1.29 . . . . 25.0 107.517 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.87 126.07 46.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -93.29 95.84 9.6 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.331 -0.989 . . . . 50.0 108.331 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.46 124.75 31.01 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.291 -1.374 . . . . 50.0 107.291 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.0 158.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 112.68 0.622 . . . . 50.0 112.68 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.92 161.72 14.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.773 -1.565 . . . . 50.0 106.773 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.35 -0.833 . . . . 50.0 109.138 172.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.119 0 N-CA-C 110.699 -0.96 . . . . 25.0 110.699 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -166.32 164.17 17.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.127 0.571 . . . . 25.0 110.427 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.91 128.12 45.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.284 -2.117 . . . . 25.0 105.284 170.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -94.6 -46.56 6.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.086 0.47 . . . . 50.0 110.238 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -145.97 157.1 51.02 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.909 -0.587 . . . . 25.0 109.5 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.53 132.38 26.12 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 130.312 1.38 . . . . 25.0 115.647 -0.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.51 -172.19 35.74 Favored Glycine 0 C--O 1.221 -0.695 0 CA-C-N 115.636 -0.711 . . . . 50.0 113.713 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -150.92 150.34 30.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.931 -1.137 . . . . 25.0 107.931 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.74 -21.02 59.58 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 111.907 0.336 . . . . 50.0 111.907 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.3 -31.17 68.89 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 113.043 0.757 . . . . 25.0 113.043 -173.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -27.81 68.95 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.634 0.605 . . . . 25.0 112.634 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.82 -10.5 39.61 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 120.809 0.338 . . . . 50.0 111.273 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.515 0.674 . . . . 50.0 110.044 -177.95 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 114.394 1.257 . . . . 50.0 114.394 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -72.15 -27.42 62.59 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.43 -0.794 . . . . 25.0 110.691 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -92.51 -36.18 13.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 50.0 109.976 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -118.88 72.39 11.33 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 121.427 0.632 . . . . 25.0 111.375 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.98 -26.87 21.37 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.159 -2.094 . . . . 50.0 115.021 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -8.76 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.798 1.777 . . . . 50.0 115.798 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 t -86.36 94.05 9.26 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 121.543 -0.723 . . . . 50.0 111.06 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mp -117.1 80.02 1.42 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.492 -0.322 . . . . 50.0 111.365 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -142.38 126.55 17.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.796 -0.446 . . . . 50.0 109.796 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 134.59 38.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.657 -0.498 . . . . 25.0 109.657 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt . . . . . 0 C--N 1.325 -0.494 0 O-C-N 121.448 -0.782 . . . . 50.0 109.232 177.652 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.404 0 CA-C-O 121.295 0.386 . . . . 50.0 113.254 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.03 -28.3 68.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.958 0.409 . . . . 25.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -68.46 -24.0 64.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.218 -0.301 . . . . 25.0 111.538 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -30.26 59.93 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 110.205 -1.158 . . . . 50.0 110.205 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.69 -20.63 74.26 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 121.272 -0.489 . . . . 50.0 112.409 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -66.13 -42.86 92.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.192 -1.04 . . . . 50.0 108.192 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.64 -32.05 63.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 50.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.37 -26.89 68.96 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.802 -0.359 . . . . 50.0 111.785 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -64.16 -7.59 9.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -132.07 27.22 4.54 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.055 0.455 . . . . 25.0 110.606 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.7 t -87.99 157.85 18.8 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.119 0.485 . . . . 25.0 111.748 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.97 -41.71 95.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 50.0 110.012 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -102.73 24.39 10.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.671 0.748 . . . . 50.0 111.161 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -55.08 154.57 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.655 -1.157 . . . . 50.0 110.053 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -80.11 156.15 27.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.826 0.822 . . . . 50.0 109.961 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -62.1 141.0 58.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.664 -0.698 . . . . 25.0 111.412 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -112.93 134.59 54.37 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.022 -0.536 . . . . 25.0 110.69 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.23 149.36 50.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.55 137.58 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.2 ttt -150.97 167.0 28.95 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.7 p -101.45 170.86 7.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.39 -166.08 11.0 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.066 -0.588 . . . . 25.0 113.321 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.94 179.47 25.39 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 112.16 -0.376 . . . . 50.0 112.16 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -73.79 133.03 43.19 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.759 -0.848 . . . . 25.0 109.365 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -125.33 155.2 40.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.538 -1.282 . . . . 50.0 107.538 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -106.25 125.23 50.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.106 -1.072 . . . . 25.0 108.106 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -105.68 122.14 45.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.219 -2.141 . . . . 50.0 105.219 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -126.07 109.24 12.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.73 -0.47 . . . . 25.0 109.73 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -122.93 140.85 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.767 -3.049 . . . . 50.0 102.767 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 123.58 12.44 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -126.69 118.99 25.88 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.747 -0.835 . . . . 25.0 108.747 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -88.36 -6.37 57.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.821 -1.081 . . . . 25.0 111.922 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.73 130.7 54.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.87 119.61 6.45 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 115.903 -2.265 . . . . 25.0 112.794 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.04 136.06 48.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 50.0 109.821 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -84.24 149.93 25.78 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.317 -2.105 . . . . 50.0 105.317 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 m -137.11 152.55 50.12 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 104.645 -2.354 . . . . 25.0 104.645 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.6 p -93.03 -41.57 9.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.847 -1.168 . . . . 50.0 107.847 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -167.57 169.3 12.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.518 -0.31 . . . . 50.0 110.44 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.4 p90 -144.85 146.99 32.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.121 -1.437 . . . . 25.0 107.121 163.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.08 159.2 44.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 50.0 109.267 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.46 151.35 47.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.533 0.683 . . . . 50.0 112.604 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.35 163.95 27.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.883 -1.053 . . . . 50.0 108.533 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.52 152.43 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.6 p -80.84 126.13 30.95 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 120.906 0.384 . . . . 25.0 110.403 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -87.99 115.73 25.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.755 -1.202 . . . . 25.0 107.755 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -81.28 154.03 26.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.33 10.98 34.84 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 116.863 1.505 . . . . 25.0 116.863 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -62.56 155.02 27.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.263 1.031 . . . . 50.0 109.717 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -127.79 158.46 70.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 104.185 -2.524 . . . . 50.0 104.185 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.21 -14.9 35.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 117.646 -1.102 . . . . 50.0 113.508 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -65.58 -29.22 69.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.866 1.317 . . . . 50.0 108.801 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -96.03 145.25 29.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 106.797 -1.557 . . . . 50.0 106.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.37 104.6 1.11 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.325 -1.983 . . . . 50.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.99 -42.62 65.75 Favored 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 113.386 0.884 . . . . 50.0 113.386 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -59.88 -35.28 74.49 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -77.19 -38.75 50.91 Favored 'General case' 0 C--O 1.213 -0.865 0 O-C-N 122.074 -0.391 . . . . 50.0 111.25 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.6 -8.69 58.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.842 1.053 . . . . 25.0 113.842 -172.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.83 -36.79 75.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.959 1.096 . . . . 50.0 113.959 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -128.73 162.06 28.28 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.171 1.174 . . . . 25.0 114.171 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -130.07 146.38 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 172.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.8 115.14 20.14 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.916 -1.513 . . . . 50.0 106.916 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -95.12 -6.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.498 0.666 . . . . 25.0 109.966 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.82 159.53 11.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.771 . . . . 50.0 113.568 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.17 143.76 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.0 t -134.27 98.78 13.76 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 108.061 -1.088 . . . . 25.0 108.061 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.25 159.99 39.82 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 115.45 -2.567 . . . . 50.0 110.475 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -104.05 91.2 3.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.574 -2.38 . . . . 50.0 104.574 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -104.49 -25.01 12.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.245 -0.889 . . . . 50.0 109.827 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.17 -151.24 20.21 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 107.709 -2.157 . . . . 25.0 107.709 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.6 m 61.71 168.44 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.873 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.71 0.18 8.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 114.288 -3.341 . . . . 50.0 114.262 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.46 87.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.405 -0.816 . . . . 25.0 108.892 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.1 t -67.58 -26.42 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.917 -0.583 . . . . 25.0 112.022 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -68.43 -27.22 66.0 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.889 0.376 . . . . 50.0 110.517 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.38 104.84 11.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.329 -0.619 . . . . 50.0 109.329 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.03 -28.41 17.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.578 0.704 . . . . 50.0 109.941 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.0 t -93.2 139.46 30.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.802 -1.185 . . . . 50.0 107.802 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -139.93 150.9 45.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.028 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.53 132.49 36.78 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.297 -2.112 . . . . 50.0 105.297 172.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.97 128.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.636 -1.987 . . . . 25.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -78.5 125.01 28.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.923 -1.14 . . . . 50.0 107.923 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.61 108.73 59.81 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.701 -0.851 . . . . 25.0 108.701 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.89 163.92 34.53 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 117.09 -1.473 . . . . 25.0 111.496 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.88 113.05 13.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.604 -2.369 . . . . 50.0 104.604 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -90.19 -33.27 16.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 50.0 110.139 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -155.08 162.04 41.14 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 104.206 -2.516 . . . . 50.0 104.206 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -85.92 136.42 33.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.452 -1.314 . . . . 50.0 107.452 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.76 -176.83 25.45 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-O 121.593 0.551 . . . . 25.0 111.727 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -82.82 137.08 34.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.564 1.173 . . . . 50.0 111.901 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -133.33 158.99 41.59 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.294 -3.224 . . . . 25.0 102.294 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.64 137.35 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.791 -1.189 . . . . 50.0 107.791 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.92 129.08 59.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.409 -2.441 . . . . 25.0 104.409 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.02 134.23 55.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.905 -1.146 . . . . 50.0 107.905 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.11 48.83 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.3 t -129.03 132.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.076 -0.713 . . . . 50.0 109.076 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -116.38 111.67 20.39 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 92.49 5.77 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.821 0.343 . . . . 50.0 111.208 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.98 144.2 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.29 -0.633 . . . . 50.0 109.29 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -102.95 -21.7 13.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.309 0.485 . . . . 25.0 112.309 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -73.7 -21.67 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.336 0.495 . . . . 50.0 112.336 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 159' ' ' ASN . 68.0 p -135.92 168.57 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 25.0 110.724 -172.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -79.3 13.61 1.84 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.979 0.895 . . . . 50.0 110.734 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 157' ' ' THR . 69.0 m-20 -110.03 157.8 18.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 50.0 111.294 -172.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.93 171.9 18.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -141.01 143.45 34.45 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.52 -0.872 . . . . 50.0 111.849 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.55 119.93 37.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.386 -2.45 . . . . 50.0 104.386 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -122.69 132.41 54.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.022 -1.844 . . . . 50.0 106.022 -173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.33 147.48 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 50.0 110.275 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.53 120.68 48.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.43 125.04 28.7 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.624 -1.25 . . . . 25.0 107.624 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.33 126.02 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.951 0.881 . . . . 25.0 108.682 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -89.02 96.09 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 103.474 -2.787 . . . . 50.0 103.474 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.11 119.63 31.4 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.339 -1.726 . . . . 50.0 106.339 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.18 161.91 39.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 O-C-N 123.592 0.558 . . . . 50.0 111.788 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -79.35 159.08 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.314 -1.365 . . . . 50.0 107.314 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.863 -1.065 . . . . 50.0 109.84 178.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.141 0 CA-C-O 120.197 -0.224 . . . . 25.0 113.566 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -135.62 139.74 44.03 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.3 mt -96.67 111.96 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.337 -0.616 . . . . 25.0 109.337 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -93.56 39.95 1.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.321 0.649 . . . . 50.0 110.326 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 79.81 156.35 0.13 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 126.317 1.847 . . . . 25.0 111.629 171.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.89 147.86 90.62 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 129.622 1.093 . . . . 25.0 113.928 -0.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.58 152.14 29.03 Favored Glycine 0 C--O 1.223 -0.55 0 CA-C-N 114.964 -1.016 . . . . 50.0 113.854 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -161.63 142.94 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.91 -1.515 . . . . 25.0 106.91 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -77.97 -28.92 49.51 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.477 -0.489 . . . . 50.0 110.081 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.2 71.85 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.713 0.292 . . . . 25.0 111.013 -177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.44 89.57 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.596 -0.275 . . . . 25.0 111.135 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.08 -16.52 35.32 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 120.679 0.276 . . . . 50.0 111.183 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.976 -0.556 . . . . 50.0 110.906 179.563 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 113.693 0.997 . . . . 50.0 113.693 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -16.81 23.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.668 1.359 . . . . 25.0 114.668 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -73.04 -36.49 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.997 0.74 . . . . 50.0 112.997 -173.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.05 45.61 0.42 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 118.69 2.848 . . . . 25.0 118.69 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.28 -22.68 33.92 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 113.778 -3.681 . . . . 50.0 112.582 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -77.76 3.23 14.68 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.841 0.682 . . . . 50.0 112.841 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -110.87 66.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.103 -0.702 . . . . 50.0 109.103 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 tt -118.96 111.28 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.438 -0.801 . . . . 50.0 109.414 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -130.03 142.24 50.64 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.317 -1.735 . . . . 50.0 106.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.99 144.84 51.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.9 tttt . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.103 0.478 . . . . 50.0 110.972 -178.421 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.591 0 N-CA-C 111.483 -0.647 . . . . 50.0 111.483 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.26 -30.07 68.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.502 -0.411 . . . . 25.0 111.584 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -66.31 -22.44 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.863 -0.335 . . . . 25.0 111.36 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.07 -22.52 77.27 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.775 -0.726 . . . . 50.0 111.48 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.73 -18.02 71.77 Favored Glycine 0 C--O 1.223 -0.555 0 C-N-CA 121.332 -0.461 . . . . 50.0 112.815 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.09 -38.18 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.461 -0.94 . . . . 50.0 108.461 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.53 -38.05 62.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 50.0 109.794 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -64.21 -41.86 96.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.378 0.608 . . . . 50.0 111.505 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -78.64 -1.82 36.1 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.723 -0.611 . . . . 25.0 112.268 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -134.15 55.08 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.862 0.839 . . . . 25.0 110.177 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -135.79 163.91 29.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 25.0 108.687 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -68.84 -27.71 66.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.245 -1.021 . . . . 50.0 108.245 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -96.49 22.82 7.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.3 -0.864 . . . . 50.0 110.933 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -56.91 145.62 29.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 50.0 108.552 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -81.63 160.2 23.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 50.0 109.908 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -61.71 149.27 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.326 -0.852 . . . . 25.0 111.798 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -121.65 143.24 49.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -124.85 140.01 53.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 25.0 109.846 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.15 131.55 34.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.566 -2.012 . . . . 25.0 105.566 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.0 mtp -138.74 167.88 21.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.961 -1.496 . . . . 50.0 106.961 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -101.33 174.53 5.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.798 -0.183 . . . . 25.0 110.647 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.76 -170.99 13.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.488 -1.445 . . . . 25.0 109.488 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.51 -176.13 44.58 Favored Glycine 0 C--O 1.236 0.236 0 N-CA-C 111.702 -0.559 . . . . 50.0 111.702 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -87.75 144.9 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.981 -0.717 . . . . 25.0 111.508 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -136.21 161.46 35.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.576 -2.009 . . . . 50.0 105.576 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.5 m -122.85 125.45 45.42 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -108.93 137.96 46.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.059 -1.089 . . . . 50.0 108.059 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 m -124.1 123.35 40.13 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -123.91 149.96 45.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 103.698 -2.705 . . . . 50.0 103.698 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.7 p -138.12 159.86 40.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.186 0.517 . . . . 25.0 110.507 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -133.13 123.92 26.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 103.571 -2.752 . . . . 25.0 103.571 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -84.21 -20.76 31.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.448 0.536 . . . . 25.0 112.448 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.19 127.26 69.67 Favored Pre-proline 0 C--O 1.244 0.78 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -67.0 129.89 21.71 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.782 -1.012 . . . . 25.0 113.067 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -136.07 158.93 43.22 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.649 -0.705 . . . . 50.0 110.395 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.18 86.98 6.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.081 -1.451 . . . . 50.0 107.081 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -76.99 129.28 35.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.04 -0.527 . . . . 25.0 110.002 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.9 m -92.73 -42.71 9.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.588 0.588 . . . . 50.0 112.588 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -166.85 173.66 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.897 0.379 . . . . 50.0 111.222 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -147.76 145.62 28.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 165.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -147.93 154.1 39.91 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.716 -0.846 . . . . 50.0 108.716 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -149.84 148.93 29.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.142 0.496 . . . . 50.0 110.537 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.94 156.97 44.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.79 161.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 110.252 -0.277 . . . . 25.0 110.252 -176.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 p -70.61 140.09 51.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.042 0.448 . . . . 25.0 110.938 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -87.94 120.49 29.33 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.921 0.712 . . . . 25.0 112.921 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -77.04 133.16 39.19 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.95 62.12 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 119.47 -1.347 . . . . 25.0 115.109 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.08 142.59 24.83 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.437 1.118 . . . . 50.0 113.173 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.47 128.04 92.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.405 -1.271 . . . . 50.0 109.338 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.44 -13.18 27.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 117.875 -0.95 . . . . 50.0 112.839 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -66.08 -29.48 69.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.884 0.85 . . . . 50.0 110.886 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -96.01 141.03 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.056 -0.72 . . . . 50.0 109.056 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.62 128.57 18.32 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 115.085 -2.81 . . . . 50.0 111.53 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -25.41 60.35 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.997 -0.547 . . . . 50.0 111.993 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.37 -34.26 46.98 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.63 -0.714 . . . . 25.0 111.963 176.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.5 mpt_? -96.81 -42.92 7.73 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.195 -0.457 . . . . 50.0 110.96 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.08 1.99 11.79 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.48 2.03 . . . . 25.0 116.48 -170.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.69 -34.95 79.52 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.059 -0.719 . . . . 50.0 109.059 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -127.16 146.6 50.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.081 0.552 . . . . 25.0 109.985 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.58 144.67 50.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.418 -0.586 . . . . 25.0 109.418 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.74 124.83 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.526 . . . . 50.0 109.905 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.7 tt -111.49 -12.17 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.291 0.567 . . . . 25.0 109.986 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.39 147.76 8.41 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.489 -1.339 . . . . 50.0 116.092 174.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.82 131.03 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.104 -2.184 . . . . 25.0 105.104 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.99 129.71 9.08 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 118.089 0.404 . . . . 25.0 109.99 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -86.62 177.08 4.41 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 117.289 -1.341 . . . . 50.0 114.718 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -137.73 120.95 16.86 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 106.598 -1.63 . . . . 50.0 106.598 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.45 7.12 10.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 50.0 112.005 -176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.14 -99.43 0.21 Allowed Glycine 0 N--CA 1.454 -0.104 0 N-CA-C 111.469 -0.652 . . . . 25.0 111.469 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.644 ' HG ' HH11 ' A' ' 130' ' ' ARG . 22.9 t -124.45 53.56 7.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.751 1.389 . . . . 25.0 114.751 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.07 -177.18 3.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 117.563 -1.158 . . . . 50.0 110.479 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.15 -30.69 70.54 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.56 -0.713 . . . . 25.0 109.662 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 78.3 p -80.19 8.02 8.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.509 0.929 . . . . 25.0 113.509 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . 0.644 HH11 ' HG ' ' A' ' 126' ' ' SER . 33.2 ptt180 -60.35 -23.59 64.38 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.514 -0.741 . . . . 50.0 111.965 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -81.3 129.85 34.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 50.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.67 -9.29 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.411 0.624 . . . . 50.0 112.145 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.8 t -82.26 137.98 34.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.126 -1.064 . . . . 50.0 108.126 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -144.01 143.18 31.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.427 0.529 . . . . 25.0 112.427 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -77.63 139.51 39.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.153 -1.425 . . . . 50.0 107.153 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -131.88 120.73 45.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -98.62 136.07 39.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.312 -0.255 . . . . 50.0 110.312 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.4 mm -117.32 123.78 29.65 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.135 -1.432 . . . . 25.0 107.135 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.78 143.09 49.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 115.549 -2.501 . . . . 25.0 112.012 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.72 12.18 30.83 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.134 -0.939 . . . . 50.0 112.602 -171.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -58.85 -38.33 78.49 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.854 1.057 . . . . 50.0 113.854 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -151.82 157.24 41.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.817 0.342 . . . . 50.0 110.938 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -88.45 152.74 21.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 50.0 109.067 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.88 154.94 8.99 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 115.497 0.959 . . . . 25.0 115.497 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -78.82 145.03 34.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.65 -0.87 . . . . 50.0 108.65 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.21 159.0 43.09 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.117 -0.492 . . . . 25.0 110.004 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.3 t -118.7 133.65 64.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 104.942 -2.244 . . . . 50.0 104.942 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.4 mt -114.65 127.83 71.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.404 -1.702 . . . . 25.0 106.404 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.0 tp -124.65 120.85 33.06 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.387 -0.968 . . . . 50.0 108.387 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.52 42.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 25.0 109.424 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.01 140.05 50.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.465 -0.939 . . . . 50.0 108.465 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -126.96 113.92 17.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 50.0 107.709 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -105.85 131.99 52.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.843 -0.617 . . . . 50.0 111.317 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.04 136.13 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.153 -1.054 . . . . 50.0 108.153 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.34 54.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 115.083 1.512 . . . . 25.0 115.083 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -87.18 10.77 15.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.405 1.261 . . . . 50.0 114.405 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.487 ' HG1' ' N ' ' A' ' 158' ' ' GLU . 5.3 t -145.28 161.77 38.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.231 0.538 . . . . 25.0 110.879 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.487 ' N ' ' HG1' ' A' ' 157' ' ' THR . 21.9 tt0 -88.33 0.92 55.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.347 0.594 . . . . 50.0 110.264 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -110.08 160.84 16.11 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.914 -0.585 . . . . 50.0 110.216 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.03 154.45 41.27 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.559 -1.645 . . . . 25.0 106.559 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -105.08 137.05 43.45 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.493 -0.928 . . . . 50.0 108.493 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.67 150.1 50.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.991 -1.114 . . . . 50.0 107.991 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.06 129.7 17.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.357 -0.979 . . . . 50.0 108.357 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.96 137.94 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.295 -1.372 . . . . 50.0 107.295 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.0 mt -138.41 120.46 17.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.38 -0.97 . . . . 25.0 108.38 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.87 134.07 35.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.47 166.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.263 0.554 . . . . 25.0 110.419 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -124.54 106.69 10.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.435 -1.691 . . . . 50.0 106.435 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.2 103.96 14.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.851 -1.166 . . . . 50.0 107.851 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.07 160.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.831 1.419 . . . . 50.0 114.831 -172.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -95.11 162.2 13.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.323 -2.102 . . . . 50.0 105.323 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt . . . . . 0 C--O 1.244 0.779 0 N-CA-C 107.456 -1.313 . . . . 50.0 107.456 173.231 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 CA-C-O 120.341 -0.144 . . . . 25.0 112.948 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -112.4 158.22 20.09 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.758 0.779 . . . . 25.0 112.273 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.4 mt -103.86 121.3 55.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.561 -1.274 . . . . 25.0 107.561 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -91.34 -36.61 13.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.352 0.596 . . . . 50.0 111.441 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -140.47 146.04 43.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.18 109.27 1.35 Allowed 'Cis proline' 0 CA--C 1.539 0.749 0 C-N-CA 130.874 1.614 . . . . 25.0 115.562 -0.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.47 173.23 9.91 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 115.562 0.985 . . . . 50.0 115.562 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -86.67 131.48 34.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.619 -0.342 . . . . 25.0 111.033 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -69.76 -37.32 76.36 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.417 -0.586 . . . . 50.0 109.417 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.85 72.55 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 112.592 0.59 . . . . 25.0 112.592 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.73 85.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 25.0 110.904 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.76 -10.31 51.41 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.036 0.446 . . . . 50.0 111.558 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 109.221 -0.659 . . . . 50.0 109.221 178.954 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.194 0.521 . . . . 50.0 111.814 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -66.66 -12.4 58.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -78.35 -37.44 44.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.543 0.61 . . . . 50.0 111.507 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -149.43 70.05 9.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.656 0.741 . . . . 25.0 112.964 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.61 -6.75 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 N-CA-C 113.792 0.651 . . . . 50.0 113.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -87.28 -7.61 57.66 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.102 0.779 . . . . 50.0 113.102 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 t -108.58 95.43 5.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.861 1.06 . . . . 75.0 113.861 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 tt -125.21 81.38 1.96 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.101 0.477 . . . . 50.0 110.06 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -100.22 137.63 38.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.384 0.513 . . . . 50.0 112.384 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.77 114.96 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.075 -0.343 . . . . 25.0 110.075 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 112.7 0.63 . . . . 50.0 112.7 -176.682 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.542 0 N-CA-C 114.552 0.581 . . . . 50.0 114.552 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -67.31 -27.79 67.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.419 0.526 . . . . 25.0 112.419 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -71.45 -21.68 61.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.246 0.462 . . . . 25.0 112.246 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.03 90.83 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.904 -0.665 . . . . 50.0 112.473 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.28 68.22 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.784 -0.722 . . . . 50.0 113.541 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.58 -46.22 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.084 0.469 . . . . 50.0 109.989 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.16 -24.08 62.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.933 1.086 . . . . 50.0 113.933 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.41 -25.68 59.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 50.0 114.254 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -57.16 -21.6 34.17 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.532 0.938 . . . . 25.0 113.532 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -138.87 38.84 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.41 0.624 . . . . 25.0 109.788 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.5 t -85.98 146.75 26.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 25.0 110.715 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -63.26 -25.11 68.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.135 0.969 . . . . 50.0 109.881 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -118.77 28.19 8.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.993 -1.003 . . . . 50.0 108.733 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -47.65 140.78 5.88 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.245 -0.889 . . . . 50.0 112.982 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -79.05 146.15 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.968 0.889 . . . . 50.0 109.65 -171.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -68.82 134.68 50.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.361 -0.836 . . . . 25.0 109.388 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -121.01 139.99 52.54 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 113.453 0.908 . . . . 25.0 113.453 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -119.42 143.21 47.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.69 -1.226 . . . . 25.0 107.69 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.9 mt -94.06 128.27 45.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 102.928 -2.99 . . . . 25.0 102.928 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 89.8 mtp -140.88 164.29 30.63 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 107.554 -1.276 . . . . 50.0 107.554 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.0 p -92.44 174.06 7.48 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 104.494 -2.409 . . . . 25.0 104.494 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.52 -162.27 8.9 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.846 -0.902 . . . . 25.0 110.846 173.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.6 -178.13 27.33 Favored Glycine 0 C--N 1.323 -0.173 0 CA-C-O 121.452 0.473 . . . . 50.0 112.392 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.4 131.35 43.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.948 -0.736 . . . . 25.0 109.222 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.12 158.55 37.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.853 -1.166 . . . . 50.0 107.853 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 m -120.38 126.68 51.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.11 0.481 . . . . 25.0 109.73 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.62 135.77 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.526 -2.027 . . . . 50.0 105.526 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.1 m -138.07 128.52 26.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.036 0.384 . . . . 25.0 112.036 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -117.96 149.98 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.023 -1.843 . . . . 50.0 106.023 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.5 t -137.85 160.12 40.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.9 143.87 38.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 p -80.78 -16.82 52.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.0 151.81 63.4 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.83 144.99 61.08 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 116.54 -1.84 . . . . 25.0 111.521 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -131.16 148.58 52.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 50.0 109.262 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.08 157.34 33.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.414 -1.328 . . . . 50.0 107.414 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.9 m -160.07 148.31 16.94 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 104.093 -2.558 . . . . 25.0 104.093 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -92.1 -51.63 5.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.386 -0.968 . . . . 50.0 108.386 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -156.12 170.61 21.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.309 -0.626 . . . . 50.0 109.309 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -149.56 142.52 24.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.915 -1.143 . . . . 25.0 107.915 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -148.04 154.55 40.4 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.226 -0.296 . . . . 50.0 111.162 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -120.02 133.81 55.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.368 -0.833 . . . . 50.0 109.391 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -121.62 163.67 18.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.383 -1.71 . . . . 50.0 106.383 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.37 165.18 29.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 t -126.12 135.71 52.02 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-O 121.435 0.636 . . . . 25.0 111.452 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -109.06 118.78 37.67 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.838 -0.619 . . . . 25.0 112.323 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -75.98 156.02 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.416 -1.327 . . . . 25.0 107.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.97 10.55 15.76 Favored Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.955 -0.64 . . . . 25.0 114.24 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -60.69 162.88 6.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.306 0.574 . . . . 50.0 112.439 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.55 144.98 92.16 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.785 -1.561 . . . . 50.0 106.785 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.7 -23.11 14.81 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 116.638 -1.774 . . . . 50.0 115.001 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -104.64 24.93 10.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.093 0.949 . . . . 50.0 112.721 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -122.97 160.47 49.29 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 105.752 -1.944 . . . . 50.0 105.752 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.64 83.46 1.74 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 116.14 -2.107 . . . . 50.0 112.868 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.27 -39.19 72.24 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 121.511 0.672 . . . . 50.0 110.019 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -16.61 6.58 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.475 1.287 . . . . 25.0 114.475 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -93.81 -46.76 7.07 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 112.447 0.536 . . . . 50.0 112.447 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.97 -17.17 41.44 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.898 1.814 . . . . 25.0 115.898 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.93 -26.32 65.91 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.325 1.232 . . . . 50.0 114.325 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -103.32 125.17 49.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.464 0.65 . . . . 25.0 111.257 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.74 141.0 52.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.782 -0.644 . . . . 25.0 109.695 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.41 128.15 32.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.513 -0.551 . . . . 50.0 109.513 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.6 tt -111.0 -3.65 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.609 0.719 . . . . 25.0 110.33 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.26 150.96 6.68 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.749 -0.739 . . . . 50.0 113.42 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.54 140.68 31.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.958 -0.756 . . . . 25.0 108.958 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.38 112.36 8.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 123.326 0.391 . . . . 25.0 109.989 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.73 158.86 28.18 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 114.877 -2.949 . . . . 50.0 111.326 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -105.83 91.9 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 103.154 -2.906 . . . . 50.0 103.154 175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -156.6 56.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.663 0.744 . . . . 50.0 110.973 -172.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.62 12.97 43.35 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.062 -0.589 . . . . 25.0 113.839 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.27 156.85 7.22 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.271 1.212 . . . . 25.0 114.271 -173.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.08 -163.8 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.369 1.379 . . . . 50.0 112.146 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.07 -25.57 0.6 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 117.21 2.3 . . . . 25.0 117.21 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' SER . . . . . 0.513 ' HG ' ' HE2' ' A' ' 134' ' ' HIS . 14.8 t -62.39 -18.34 61.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.616 0.598 . . . . 25.0 112.616 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -58.88 -25.13 63.07 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.249 1.02 . . . . 50.0 112.547 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -59.0 135.61 57.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.882 0.697 . . . . 50.0 112.882 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.57 -7.78 51.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.124 -0.944 . . . . 50.0 111.527 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -100.0 120.02 39.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.123 -2.547 . . . . 50.0 104.123 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.513 ' HE2' ' HG ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -136.5 136.26 39.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 -171.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -83.27 136.75 34.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.31 -1.737 . . . . 50.0 106.31 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.0 mm -131.96 131.19 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 105.971 -1.862 . . . . 25.0 105.971 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -93.34 130.87 38.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.603 -0.518 . . . . 50.0 109.603 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.6 mt -126.1 136.47 28.56 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.047 -1.464 . . . . 25.0 107.047 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.3 168.1 24.37 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 117.22 -1.386 . . . . 25.0 113.015 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -127.24 35.98 4.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.854 -1.165 . . . . 50.0 107.854 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -86.18 -31.4 21.8 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.986 1.106 . . . . 50.0 113.986 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -146.22 169.66 18.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.114 -0.328 . . . . 50.0 110.114 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -107.68 152.02 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.874 0.694 . . . . 50.0 112.874 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.29 157.75 7.33 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.721 -0.672 . . . . 25.0 112.078 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -84.03 144.94 28.77 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.732 0.777 . . . . 50.0 113.042 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -138.06 135.01 35.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.7 t -98.0 134.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.263 -1.754 . . . . 50.0 106.263 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.02 125.31 61.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -104.69 109.68 21.7 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.401 -1.333 . . . . 50.0 107.401 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -108.09 123.8 49.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.63 133.1 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.663 -0.865 . . . . 50.0 108.663 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -121.25 107.58 12.72 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.537 -1.283 . . . . 50.0 107.537 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -82.67 90.69 6.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 50.0 109.98 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.59 119.32 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.043 -1.095 . . . . 50.0 108.043 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.32 11.89 22.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 25.0 112.101 -174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.96 -2.97 30.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.046 0.387 . . . . 50.0 112.046 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.7 p -143.83 168.5 19.8 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.671 0.272 . . . . 25.0 111.512 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.26 1.07 34.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.957 0.884 . . . . 50.0 109.371 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.14 155.04 18.69 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.843 -1.169 . . . . 50.0 107.843 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 150.86 41.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 103.197 -2.89 . . . . 25.0 103.197 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.33 138.57 47.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.593 -0.521 . . . . 50.0 109.593 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -138.97 154.02 48.25 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.135 -1.061 . . . . 50.0 108.135 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.16 152.3 45.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.467 -1.679 . . . . 50.0 106.467 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.97 145.46 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.538 -0.542 . . . . 50.0 109.538 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.2 mt -136.24 125.19 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.086 -2.561 . . . . 25.0 104.086 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -111.15 130.63 55.57 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.31 -1.367 . . . . 25.0 107.31 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.73 134.93 58.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.17 100.52 12.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.55 -2.018 . . . . 50.0 105.55 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.0 mt -92.88 130.21 38.54 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.915 -1.513 . . . . 50.0 106.915 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.1 m -127.04 158.01 38.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 113.871 1.063 . . . . 50.0 113.871 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -93.82 161.47 14.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.299 -1.371 . . . . 50.0 107.299 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt . . . . . 0 C--O 1.243 0.723 0 CA-C-O 118.472 -0.775 . . . . 50.0 109.409 175.293 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.32 0 N-CA-C 107.906 -2.078 . . . . 25.0 107.906 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -134.06 161.7 34.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.015 0.908 . . . . 25.0 108.907 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.98 121.77 66.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.938 -1.505 . . . . 25.0 106.938 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -12.27 60.58 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.95 1.092 . . . . 50.0 113.95 -174.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt 79.68 149.69 0.12 Allowed Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 126.195 1.798 . . . . 25.0 108.161 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.31 156.72 91.42 Favored 'Cis proline' 0 C--N 1.346 0.425 0 CA-C-O 121.181 0.409 . . . . 25.0 112.371 -0.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.7 10.53 30.63 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 116.262 1.265 . . . . 50.0 116.262 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -64.5 126.93 29.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.945 0.872 . . . . 25.0 111.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -77.95 -19.12 55.16 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 116.345 -0.389 . . . . 50.0 110.231 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.79 69.64 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.75 -0.205 . . . . 25.0 111.191 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -25.12 65.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 25.0 110.811 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.28 0.56 51.03 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 122.915 0.486 . . . . 50.0 110.567 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 111.997 0.369 . . . . 50.0 111.997 -176.775 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 121.021 0.439 . . . . 50.0 110.559 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.6 ptm -60.32 -10.44 4.72 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.53 -46.61 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.576 0.625 . . . . 50.0 109.983 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.02 69.41 5.61 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 113.185 0.809 . . . . 25.0 113.185 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.32 3.12 6.06 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 N-CA-C 113.71 0.619 . . . . 50.0 113.71 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -101.32 -2.44 31.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.497 0.555 . . . . 50.0 112.497 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.94 97.4 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.662 0.986 . . . . 50.0 113.662 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.96 112.29 24.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.504 -1.665 . . . . 50.0 106.504 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -89.03 110.19 20.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.977 0.732 . . . . 50.0 112.977 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.55 152.42 20.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.084 -1.821 . . . . 25.0 106.084 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.1 tttt . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 112.171 0.434 . . . . 50.0 112.171 -179.192 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.523 0 N-CA-C 112.305 -0.318 . . . . 50.0 112.305 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.3 mt -72.26 -25.97 61.81 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.704 . . . . 25.0 110.291 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.561 -0.533 . . . . 25.0 109.561 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -24.99 69.5 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.926 -0.869 . . . . 50.0 110.926 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.86 -16.9 68.81 Favored Glycine 0 C--O 1.228 -0.26 0 O-C-N 122.774 -0.251 . . . . 50.0 112.536 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mm -66.16 -40.1 86.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.943 -1.132 . . . . 50.0 107.943 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mp -75.81 -26.89 57.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 50.0 111.15 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.78 -22.01 66.7 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.149 0.5 . . . . 50.0 111.589 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.73 -5.93 18.48 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.865 -0.522 . . . . 25.0 112.156 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -130.65 35.15 4.04 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -106.62 156.54 18.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 25.0 111.101 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -68.66 -31.02 69.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.811 -0.811 . . . . 50.0 108.811 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -97.48 21.39 10.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.564 -0.744 . . . . 50.0 110.409 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -52.31 136.1 31.51 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.057 0.456 . . . . 50.0 111.5 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 146.03 46.44 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 122.686 1.231 . . . . 50.0 112.33 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -75.7 148.78 38.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.383 -1.28 . . . . 25.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -103.03 126.87 50.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -100.1 108.79 21.03 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.182 -0.607 . . . . 25.0 109.658 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.55 138.6 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.67 -0.863 . . . . 25.0 108.67 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.4 tpt -151.04 154.09 36.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.202 -0.666 . . . . 50.0 109.202 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.2 p -91.16 -179.48 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.838 -1.171 . . . . 25.0 107.838 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.45 -168.88 31.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 116.445 1.338 . . . . 25.0 116.445 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.92 170.72 36.92 Favored Glycine 0 C--N 1.329 0.162 0 N-CA-C 108.864 -1.694 . . . . 50.0 108.864 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.77 148.3 28.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 119.309 1.555 . . . . 25.0 108.477 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -134.19 157.96 44.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.611 -1.255 . . . . 50.0 107.611 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -124.95 125.74 44.39 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.46 140.89 48.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.189 -1.041 . . . . 50.0 108.189 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -132.58 132.42 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.608 0.568 . . . . 25.0 111.993 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -118.47 150.06 40.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.714 -1.217 . . . . 50.0 107.714 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.0 p -133.84 161.71 34.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.99 158.11 42.32 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.867 -1.531 . . . . 25.0 106.867 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 t -69.83 -27.02 64.51 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.347 0.499 . . . . 25.0 112.347 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.13 61.17 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 106.684 -1.598 . . . . 25.0 106.684 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.39 152.03 65.82 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 115.956 -2.229 . . . . 25.0 110.038 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.15 147.57 52.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.268 -0.641 . . . . 50.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -61.03 137.01 58.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.277 -1.749 . . . . 50.0 106.277 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 m -146.16 144.66 30.09 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.9 t -91.56 -48.03 7.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.487 -0.56 . . . . 50.0 109.487 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -166.2 169.65 14.11 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.298 -0.251 . . . . 50.0 111.369 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -141.9 141.0 32.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 166.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.8 156.42 42.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.605 -0.27 . . . . 50.0 110.84 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -130.67 142.94 50.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.809 -0.632 . . . . 50.0 111.535 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -132.3 164.96 25.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.622 -0.881 . . . . 50.0 108.622 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.9 pt -130.31 157.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.9 p -96.71 133.63 41.0 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-O 121.148 0.499 . . . . 25.0 111.273 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -92.22 99.57 12.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.627 0.727 . . . . 25.0 111.98 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -76.16 148.14 38.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.407 -1.331 . . . . 25.0 107.407 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 22.19 40.32 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 115.579 0.992 . . . . 25.0 115.579 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -56.93 148.74 20.31 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.686 0.743 . . . . 50.0 111.705 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.96 138.79 46.2 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.204 -1.036 . . . . 50.0 108.204 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.98 -15.91 29.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 117.617 -1.122 . . . . 50.0 112.261 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.15 -22.06 64.88 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.023 0.929 . . . . 50.0 111.577 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -113.75 153.79 45.89 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.944 -0.571 . . . . 50.0 109.55 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.08 107.03 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 117.987 -0.876 . . . . 50.0 113.633 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -52.72 -46.87 67.57 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.193 -0.912 . . . . 50.0 112.742 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -54.35 -38.48 66.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.184 -0.462 . . . . 25.0 112.094 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.71 -44.28 23.88 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.894 -0.594 . . . . 50.0 111.944 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.43 -24.69 62.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.765 1.394 . . . . 25.0 114.765 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -68.07 -23.81 65.0 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.812 1.412 . . . . 50.0 114.812 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -123.02 135.18 54.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.003 -1.061 . . . . 25.0 112.508 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -128.15 133.11 48.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.464 -0.939 . . . . 25.0 108.464 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.11 120.56 23.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.708 -0.849 . . . . 50.0 108.708 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.2 tt -96.3 -10.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.478 0.656 . . . . 25.0 110.094 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.05 160.27 13.1 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.323 -0.942 . . . . 50.0 113.935 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.69 146.71 29.38 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.096 -1.075 . . . . 25.0 108.096 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -135.25 106.84 10.23 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.09 160.57 39.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 114.902 -2.932 . . . . 50.0 110.743 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -118.51 94.19 4.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.395 1.093 . . . . 50.0 108.804 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.17 -94.71 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.033 -2.951 . . . . 50.0 103.033 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.26 128.54 9.6 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.3 t -163.49 145.07 7.44 Favored Pre-proline 0 C--O 1.242 0.708 0 CA-C-N 117.159 0.48 . . . . 25.0 109.959 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -76.08 -154.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.516 1.477 . . . . 50.0 110.744 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -18.84 4.47 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.129 1.529 . . . . 25.0 115.129 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.6 t -66.87 -6.73 17.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.825 0.676 . . . . 25.0 112.825 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.92 -14.87 63.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.423 0.689 . . . . 50.0 110.807 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -66.59 150.66 48.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.495 0.664 . . . . 50.0 112.205 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.06 -12.51 60.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.182 -0.917 . . . . 50.0 110.209 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -89.68 120.81 31.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.231 -1.766 . . . . 50.0 106.231 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -135.07 134.15 40.05 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.277 0.473 . . . . 25.0 112.277 -173.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -82.28 139.31 34.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.812 -0.631 . . . . 50.0 109.973 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.19 121.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 106.395 -1.706 . . . . 25.0 106.395 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -80.65 135.36 36.02 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.036 -0.728 . . . . 50.0 109.036 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.0 mm -122.94 117.85 28.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.47 158.05 51.85 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 115.947 -2.235 . . . . 25.0 110.577 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -112.35 51.65 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.948 -1.501 . . . . 50.0 106.948 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.29 -26.01 16.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.039 -0.982 . . . . 50.0 111.731 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -158.09 160.13 37.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.301 . . . . 50.0 110.782 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.13 137.54 38.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.178 -1.045 . . . . 50.0 108.178 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 172.26 144.53 4.57 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 122.348 0.971 . . . . 25.0 115.453 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -95.72 144.96 25.67 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 112.664 0.616 . . . . 50.0 112.664 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -148.95 163.57 37.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.369 -0.974 . . . . 25.0 108.369 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.1 t -93.43 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.384 -0.969 . . . . 50.0 108.384 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.04 129.22 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 105.893 -1.892 . . . . 25.0 105.893 171.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.32 141.86 45.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.001 -1.852 . . . . 50.0 106.001 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.36 143.99 40.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.716 -0.475 . . . . 25.0 109.716 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.07 135.11 62.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.442 -0.948 . . . . 50.0 108.442 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -126.08 118.5 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 50.0 108.059 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -111.76 134.62 53.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.949 0.351 . . . . 50.0 111.949 -173.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.28 128.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.781 -1.563 . . . . 50.0 106.781 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -31.17 65.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 25.0 111.533 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -75.26 -2.03 26.19 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.901 1.074 . . . . 50.0 113.901 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.0 p -123.01 155.01 37.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.748 0.785 . . . . 25.0 112.699 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -83.24 -6.36 59.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.124 -0.695 . . . . 50.0 109.124 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -109.25 153.83 23.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.2 -0.909 . . . . 50.0 109.544 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.86 150.63 51.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -119.66 135.81 54.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.037 0.446 . . . . 50.0 111.239 -168.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -127.09 153.88 45.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.753 -0.832 . . . . 50.0 108.753 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -146.19 156.18 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.132 -1.062 . . . . 50.0 108.132 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.69 138.78 48.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.585 . . . . 50.0 109.422 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.5 mt -140.04 121.43 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.66 140.52 29.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.703 -0.851 . . . . 25.0 108.703 174.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.78 157.56 42.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -128.81 118.58 23.0 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 104.293 -2.484 . . . . 50.0 104.293 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.7 mt -108.25 121.91 45.86 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 104.627 -2.36 . . . . 50.0 104.627 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.86 160.4 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.12 1.155 . . . . 50.0 114.12 -171.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -95.13 157.51 15.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.307 -1.738 . . . . 50.0 106.307 174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.9 tptt . . . . . 0 C--O 1.251 1.139 0 O-C-N 124.297 0.998 . . . . 50.0 110.83 174.601 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.853 0 CA-C-O 119.632 -0.538 . . . . 25.0 113.911 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -150.96 170.96 18.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.173 0.589 . . . . 25.0 109.431 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 tt -106.86 131.86 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.074 0.464 . . . . 25.0 110.245 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -85.15 -47.94 9.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.266 1.031 . . . . 50.0 111.054 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.21 149.69 56.04 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.771 -1.104 . . . . 25.0 108.552 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.17 98.59 0.23 Allowed 'Cis proline' 0 CA--C 1.545 1.041 0 C-N-CA 131.498 1.874 . . . . 25.0 114.52 -1.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.9 138.82 7.26 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 121.657 0.587 . . . . 50.0 113.593 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.402 ' HG ' ' H ' ' A' ' 11' ' ' ALA . 42.2 t -68.21 145.53 54.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.612 0.72 . . . . 25.0 112.71 -176.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.385 -0.825 . . . . 50.0 110.248 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.402 ' H ' ' HG ' ' A' ' 9' ' ' SER . . . -64.94 -26.43 68.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.291 0.848 . . . . 25.0 113.291 -175.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.76 88.71 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 112.079 0.4 . . . . 25.0 112.079 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.92 -3.92 55.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.579 0.704 . . . . 50.0 111.605 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.218 -0.597 0 CA-C-N 115.335 -0.848 . . . . 50.0 109.84 179.479 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.943 0.401 . . . . 50.0 110.695 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.33 -14.21 10.82 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 115.3 1.593 . . . . 25.0 115.3 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -71.47 -37.72 71.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.427 0.558 . . . . 50.0 110.111 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.81 68.26 10.62 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 121.64 0.733 . . . . 25.0 111.797 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.91 -8.97 23.14 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 117.541 -1.173 . . . . 50.0 112.829 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -83.77 -9.9 58.47 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.718 -0.475 . . . . 50.0 109.718 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 t -81.37 104.15 11.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.462 0.649 . . . . 50.0 110.037 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.6 mt -122.91 74.02 1.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.494 -0.775 . . . . 50.0 109.325 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -142.02 135.68 29.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.664 0.386 . . . . 50.0 111.142 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.51 32.54 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt . . . . . 0 C--N 1.322 -0.609 0 O-C-N 122.047 -0.408 . . . . 50.0 109.954 -178.874 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.663 0 N-CA-C 114.092 0.397 . . . . 50.0 114.092 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.13 -37.99 13.03 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.137 -0.625 . . . . 25.0 111.897 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -84.77 -13.72 50.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.692 0.997 . . . . 25.0 113.692 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.4 -15.92 64.32 Favored Glycine 0 C--O 1.216 -1.024 0 C-N-CA 121.496 -0.383 . . . . 50.0 112.87 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.15 -24.34 68.71 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.654 -0.784 . . . . 50.0 112.843 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -66.67 -41.54 88.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.904 -0.776 . . . . 50.0 108.904 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -72.15 -29.37 63.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.041 -0.527 . . . . 50.0 110.537 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.44 -19.78 65.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.282 0.475 . . . . 50.0 112.282 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -66.29 -11.8 52.68 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.046 -0.409 . . . . 25.0 111.082 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -137.86 64.91 1.5 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.582 -1.266 . . . . 25.0 107.582 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.5 t -135.75 159.58 41.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.318 -0.401 . . . . 25.0 110.742 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.75 -32.33 72.86 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.984 0.897 . . . . 50.0 109.488 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -96.88 22.04 8.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.438 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -49.59 134.5 19.68 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.946 0.879 . . . . 50.0 112.916 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.12 154.81 38.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.906 -1.043 . . . . 50.0 112.678 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -80.49 129.53 34.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.792 -0.818 . . . . 25.0 108.792 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 152.79 21.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.929 0.395 . . . . 25.0 111.746 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.78 100.35 6.14 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.534 0.334 . . . . 25.0 110.694 174.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.9 mt -78.52 131.02 35.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.149 -1.056 . . . . 25.0 108.149 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.3 mtm -143.32 163.81 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.263 0.625 . . . . 50.0 110.309 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.3 p -93.14 -179.46 5.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.958 -1.867 . . . . 25.0 105.958 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.9 30.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.778 -0.725 . . . . 25.0 111.319 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.73 -160.76 16.99 Favored Glycine 0 CA--C 1.517 0.171 0 O-C-N 122.269 -0.548 . . . . 50.0 114.053 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.59 137.56 38.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.946 0.403 . . . . 25.0 111.425 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -132.6 139.95 48.02 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.013 -0.736 . . . . 50.0 109.013 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.2 m -120.35 111.43 17.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -93.15 116.37 28.97 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.008 -1.849 . . . . 50.0 106.008 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.0 m -119.28 93.47 4.09 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.149 -0.686 . . . . 25.0 109.149 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -89.06 133.59 34.3 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.884 -1.525 . . . . 50.0 106.884 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -123.77 136.62 54.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -126.4 148.57 49.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 120.985 0.422 . . . . 25.0 110.308 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -120.64 31.35 6.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.623 -1.992 . . . . 25.0 105.623 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.66 125.08 91.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 114.619 -1.173 . . . . 25.0 109.43 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.08 26.39 0.65 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 120.227 0.618 . . . . 25.0 112.615 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -130.9 149.48 52.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 50.0 111.495 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -69.78 156.42 39.05 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.21 -0.663 . . . . 50.0 109.21 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -123.03 149.53 44.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.049 -1.834 . . . . 25.0 106.049 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -93.95 -56.85 2.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.074 0.464 . . . . 50.0 110.501 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -161.63 173.77 14.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.815 -0.439 . . . . 50.0 109.815 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.32 152.69 39.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.735 -0.666 . . . . 25.0 109.698 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -146.73 141.82 27.17 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.335 -1.357 . . . . 50.0 107.335 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -140.83 149.12 41.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.836 0.827 . . . . 50.0 112.53 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.07 160.51 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.617 -1.174 . . . . 50.0 109.397 -172.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.5 158.88 42.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.314 -0.995 . . . . 25.0 108.314 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 t -96.86 126.96 42.38 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 113.227 0.825 . . . . 25.0 113.227 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -99.47 103.33 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.644 -1.243 . . . . 25.0 107.644 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -70.91 152.36 43.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.13 10.08 24.8 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.731 -0.483 . . . . 25.0 113.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -62.02 153.81 28.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.76 0.79 . . . . 50.0 109.817 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.54 151.29 85.03 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.361 -0.977 . . . . 50.0 108.361 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.03 -11.35 27.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 113.499 0.538 . . . . 50.0 113.499 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -74.46 -6.16 46.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.544 0.687 . . . . 50.0 111.511 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -105.07 135.82 19.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 121.812 -0.555 . . . . 50.0 111.161 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.89 123.21 10.42 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.588 -1.141 . . . . 50.0 113.002 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -52.62 -49.41 65.16 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 114.415 1.265 . . . . 50.0 114.415 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -64.72 -11.05 31.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.746 1.017 . . . . 25.0 113.746 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -104.69 -48.96 3.64 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 112.231 0.456 . . . . 50.0 112.231 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.81 -22.46 58.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 -170.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.16 -28.77 67.58 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.535 -0.466 . . . . 50.0 111.895 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -124.6 144.89 49.91 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -126.7 144.29 50.97 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.998 0.428 . . . . 25.0 110.516 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.39 126.79 30.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.074 -0.713 . . . . 50.0 109.074 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.6 tp -115.21 1.82 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 121.997 0.904 . . . . 25.0 109.027 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.55 156.08 9.03 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 115.838 1.095 . . . . 50.0 115.838 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.62 128.04 16.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.1 t -140.5 123.09 9.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.568 0.347 . . . . 25.0 110.336 -170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.7 168.58 20.9 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 117.191 -1.406 . . . . 50.0 111.973 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -82.65 121.0 26.28 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.891 -0.723 . . . . 50.0 111.987 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.77 33.14 22.86 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.92 1.822 . . . . 50.0 115.92 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.43 165.12 44.11 Favored Glycine 0 C--O 1.219 -0.84 0 N-CA-C 110.968 -0.853 . . . . 25.0 110.968 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.3 t -54.9 -47.41 98.42 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 117.3 2.333 . . . . 25.0 117.3 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.08 159.82 49.03 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 114.17 -3.42 . . . . 50.0 114.648 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.75 -14.23 20.02 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.817 1.043 . . . . 25.0 113.817 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.7 p -68.88 -10.47 57.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.802 0.297 . . . . 25.0 111.802 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.64 -16.89 29.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.424 1.268 . . . . 50.0 114.424 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.55 141.51 58.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.334 0.587 . . . . 50.0 111.625 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 tp -72.21 -25.42 61.64 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.439 -0.948 . . . . 50.0 108.439 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.9 t -89.23 134.04 34.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.438 -0.949 . . . . 50.0 108.438 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -138.86 150.92 46.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.619 0.723 . . . . 25.0 112.658 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -92.53 132.89 36.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.239 -1.022 . . . . 50.0 108.239 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.1 mm -132.62 119.15 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.242 -1.021 . . . . 25.0 108.242 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -82.27 139.47 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.253 -1.017 . . . . 50.0 108.253 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -125.93 128.22 24.58 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.64 167.33 26.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 CA-C-N 118.566 0.524 . . . . 25.0 111.592 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -122.91 30.51 6.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.655 0.741 . . . . 50.0 111.523 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -78.37 -20.72 50.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.993 -0.548 . . . . 50.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -143.35 169.84 16.91 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.665 -0.495 . . . . 50.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 150.41 47.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.832 -0.622 . . . . 50.0 109.545 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.08 165.5 12.62 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.469 0.547 . . . . 25.0 114.469 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -86.94 147.21 25.86 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.744 1.016 . . . . 50.0 113.744 -176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -139.65 158.92 43.31 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.525 -1.216 . . . . 25.0 108.001 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 52.8 t -116.41 136.54 53.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.045 -1.094 . . . . 50.0 108.045 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.3 mt -106.49 129.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.001 -1.851 . . . . 25.0 106.001 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.25 135.58 50.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.926 -0.398 . . . . 50.0 109.926 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.0 130.18 31.07 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.614 -0.266 . . . . 25.0 110.721 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.79 128.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 106.299 -1.741 . . . . 50.0 106.299 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -125.64 108.67 11.78 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 50.0 108.619 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -96.17 107.72 20.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.978 -0.556 . . . . 50.0 112.327 -171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.47 135.46 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.514 -1.291 . . . . 50.0 107.514 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.01 -32.23 27.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 25.0 111.849 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -79.28 -12.68 59.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.733 1.383 . . . . 50.0 114.733 -170.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.0 p -139.21 165.8 26.22 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.166 0.802 . . . . 25.0 113.166 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.61 5.2 16.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.546 0.689 . . . . 50.0 110.756 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -102.79 150.08 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.908 -1.145 . . . . 50.0 107.908 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.23 170.55 21.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 102.544 -3.132 . . . . 25.0 102.544 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -143.48 151.83 40.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.765 1.166 . . . . 50.0 113.411 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.93 120.5 41.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.681 -1.6 . . . . 50.0 106.681 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -94.53 130.82 40.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.99 -2.226 . . . . 50.0 104.99 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.5 p -133.11 133.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.824 -0.806 . . . . 50.0 108.824 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.35 128.69 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -85.3 133.03 34.17 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.789 -0.819 . . . . 25.0 108.789 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 149.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -120.41 111.11 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.625 -1.991 . . . . 50.0 105.625 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.0 mt -109.18 104.63 13.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.037 -1.468 . . . . 50.0 107.037 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.72 168.02 19.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.129 -0.487 . . . . 50.0 111.92 -173.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -80.78 135.97 36.05 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.878 -0.786 . . . . 50.0 108.878 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.9 pttm . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.344 -1.313 . . . . 50.0 111.287 176.112 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.294 0 N-CA-C 110.529 -1.029 . . . . 25.0 110.529 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -98.24 149.77 22.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.798 -0.816 . . . . 25.0 108.798 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -102.32 126.77 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 122.427 0.291 . . . . 25.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -103.47 -34.3 8.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.684 0.754 . . . . 50.0 111.054 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.27 143.01 16.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.0 137.63 50.79 Favored 'Cis proline' 0 C--N 1.352 0.736 0 N-CA-C 117.863 2.216 . . . . 25.0 117.863 2.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 137.12 2.94 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 117.388 1.715 . . . . 50.0 117.388 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -76.17 147.98 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.116 0.484 . . . . 25.0 111.249 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -68.22 -37.96 81.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.669 . . . . 50.0 111.602 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.83 66.42 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.67 -28.02 69.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.255 0.465 . . . . 25.0 112.255 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.94 -9.16 44.11 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 111.85 0.315 . . . . 50.0 111.85 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 C--O 1.217 -0.641 0 CA-C-O 121.251 0.548 . . . . 50.0 110.839 -177.033 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 113.749 1.018 . . . . 50.0 113.749 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -68.63 -14.26 62.9 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.156 -0.965 . . . . 25.0 112.957 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.64 -37.64 49.58 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.87 -0.332 . . . . 50.0 111.68 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -149.63 63.58 6.54 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.115 1.154 . . . . 25.0 114.115 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.28 -9.15 25.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 118.096 -0.803 . . . . 50.0 114.083 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -97.82 -0.19 45.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.241 0.46 . . . . 50.0 112.241 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -87.3 94.13 9.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.764 -1.199 . . . . 50.0 107.764 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -129.78 133.43 46.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.042 -1.095 . . . . 50.0 108.042 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -125.9 131.89 52.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.444 0.566 . . . . 50.0 109.731 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.01 163.53 32.45 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.98 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.8 mttt . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 112.973 0.731 . . . . 50.0 112.973 -176.567 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.535 0 CA-C-O 120.139 -0.256 . . . . 50.0 113.588 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -62.1 -45.9 91.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.925 0.869 . . . . 25.0 109.534 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -84.87 -13.19 51.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.49 -0.777 . . . . 25.0 110.598 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.34 86.18 Favored Glycine 0 C--O 1.216 -0.989 0 CA-C-N 116.072 -0.513 . . . . 50.0 112.475 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.64 77.63 Favored Glycine 0 C--O 1.222 -0.607 0 C-N-CA 120.358 -0.925 . . . . 50.0 112.493 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.51 -43.82 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.286 -1.005 . . . . 50.0 108.286 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.54 -34.42 75.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.722 -0.672 . . . . 50.0 110.689 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.42 -30.66 70.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.394 0.516 . . . . 50.0 112.394 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -68.04 -6.05 20.62 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.604 -0.685 . . . . 25.0 111.921 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -130.3 37.5 3.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.34 -0.615 . . . . 25.0 109.34 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -120.42 169.54 10.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 25.0 109.794 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.99 -28.1 68.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.495 0.664 . . . . 50.0 109.983 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -96.18 19.99 10.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.621 -0.718 . . . . 50.0 111.438 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -49.75 135.58 18.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.602 0.715 . . . . 50.0 111.536 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -87.76 154.75 20.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.057 0.932 . . . . 50.0 110.428 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -66.41 147.14 53.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 25.0 110.152 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -116.22 132.32 56.7 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.468 -0.938 . . . . 25.0 108.468 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -119.9 135.89 54.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.99 136.29 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.29 -1.745 . . . . 25.0 106.29 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.1 ttt -150.59 168.14 25.17 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.236 -1.765 . . . . 50.0 106.236 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.8 p -90.52 166.7 13.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.79 -1.93 . . . . 25.0 105.79 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.25 -164.28 10.65 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 117.925 0.33 . . . . 25.0 113.667 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.06 -175.77 31.24 Favored Glycine 0 N--CA 1.458 0.114 0 O-C-N 122.348 -0.501 . . . . 50.0 112.2 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -69.73 134.65 48.86 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.754 -0.85 . . . . 25.0 109.444 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -125.59 158.23 35.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.561 -0.903 . . . . 50.0 108.561 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.0 m -117.63 116.28 26.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.898 -1.89 . . . . 25.0 105.898 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -93.01 136.87 32.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 105.901 -1.889 . . . . 50.0 105.901 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -127.62 115.53 18.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 25.0 110.469 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -122.3 145.2 48.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.387 -2.449 . . . . 50.0 104.387 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -145.02 156.74 44.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 25.0 109.622 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -139.82 154.45 47.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -71.42 -13.25 61.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.398 0.888 . . . . 25.0 113.398 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.12 158.34 64.72 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.275 -1.009 . . . . 25.0 108.275 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.16 150.86 72.36 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 114.581 -3.146 . . . . 25.0 109.594 170.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -130.98 132.81 45.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.361 -0.978 . . . . 50.0 108.361 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -66.05 144.89 56.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 50.0 109.689 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -162.92 152.07 15.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.368 -3.197 . . . . 25.0 102.368 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 -40.13 10.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.715 0.769 . . . . 50.0 108.946 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -156.1 148.96 24.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.799 -0.815 . . . . 50.0 108.799 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.59 142.31 39.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.32 -1.363 . . . . 25.0 107.32 170.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 156.33 42.69 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.394 -0.191 . . . . 50.0 110.723 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -130.52 144.94 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.642 0.589 . . . . 50.0 111.3 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -131.96 159.7 37.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.021 -1.844 . . . . 50.0 106.021 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.96 158.1 38.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.423 -0.954 . . . . 25.0 108.423 175.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.9 p -103.23 138.69 39.69 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.489 0.661 . . . . 25.0 110.942 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.0 117.72 27.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.98 128.36 34.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 102.575 -3.121 . . . . 25.0 102.575 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.67 30.67 12.75 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 118.856 -1.64 . . . . 25.0 113.611 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -51.77 148.16 5.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.688 0.744 . . . . 50.0 110.172 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -68.97 129.43 92.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.998 -0.547 . . . . 50.0 110.22 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.22 -14.03 25.7 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 118.484 -0.544 . . . . 50.0 113.451 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.5 -10.23 59.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.778 0.799 . . . . 50.0 110.808 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -116.55 148.99 43.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.558 -0.534 . . . . 50.0 109.558 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.2 125.93 15.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 116.616 -1.79 . . . . 50.0 112.059 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 tt -52.99 -50.43 64.16 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.079 -0.964 . . . . 50.0 113.158 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -68.55 -2.96 10.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.748 1.388 . . . . 25.0 114.748 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.86 -49.33 3.53 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.138 0.494 . . . . 50.0 111.703 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.06 50.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.186 1.55 . . . . 25.0 115.186 -170.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -77.63 -29.05 51.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.479 0.548 . . . . 50.0 112.479 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -126.01 151.12 47.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.694 0.628 . . . . 25.0 112.694 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.11 154.66 47.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.71 128.04 33.98 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.0 tt -104.25 -9.47 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.297 0.57 . . . . 25.0 111.609 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.92 160.12 21.62 Favored Glycine 0 CA--C 1.511 -0.197 0 C-N-CA 119.86 -1.162 . . . . 50.0 114.33 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.55 142.03 25.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.779 -1.193 . . . . 25.0 107.779 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.32 111.62 10.84 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.78 163.96 25.85 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 116.013 -2.192 . . . . 50.0 111.299 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -138.45 113.88 9.6 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.219 1.009 . . . . 50.0 109.276 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -172.44 -107.2 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 99.111 -4.403 . . . . 50.0 99.111 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.53 54.19 4.9 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.377 -1.089 . . . . 25.0 110.377 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 t -81.99 132.88 52.57 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 122.382 -0.481 . . . . 25.0 110.245 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.08 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 121.691 1.594 . . . . 50.0 111.423 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -21.06 8.42 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.9 t -64.71 -8.0 12.99 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -62.56 -14.16 39.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.282 1.215 . . . . 50.0 114.282 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.17 137.8 58.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.512 -0.551 . . . . 50.0 109.512 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -20.33 63.75 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.153 1.168 . . . . 50.0 114.153 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -99.97 132.99 44.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.357 -1.349 . . . . 50.0 107.357 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -137.43 149.82 47.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -81.66 133.31 35.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.408 -1.701 . . . . 50.0 106.408 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.98 118.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.552 -2.018 . . . . 25.0 105.552 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -84.57 125.67 32.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 50.0 108.842 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.14 104.28 25.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 120.508 0.194 . . . . 25.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.63 150.9 51.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 116.027 -2.182 . . . . 25.0 109.486 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.2 102.75 3.26 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.496 -0.557 . . . . 50.0 109.496 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -91.73 -17.93 24.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.489 0.552 . . . . 50.0 112.489 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -140.93 169.91 16.74 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 107.62 -1.252 . . . . 50.0 107.62 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.41 128.97 36.64 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.751 -1.203 . . . . 50.0 107.751 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -179.36 163.37 30.77 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.202 2.041 . . . . 25.0 118.202 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -87.09 147.04 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.64 -1.28 . . . . 50.0 110.384 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -134.94 150.41 50.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.06 127.97 67.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.038 -2.208 . . . . 50.0 105.038 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.96 116.85 53.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.487 -1.672 . . . . 25.0 106.487 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.1 tt -99.09 133.63 43.08 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.665 -1.235 . . . . 50.0 107.665 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -122.85 145.77 48.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.89 0.376 . . . . 25.0 110.069 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.7 t -126.57 134.05 67.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.013 -1.106 . . . . 50.0 108.013 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -129.18 99.0 5.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.419 -1.326 . . . . 50.0 107.419 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.83 106.79 17.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.084 -0.507 . . . . 50.0 111.891 -173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.4 t -92.48 126.69 44.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.14 -2.17 . . . . 50.0 105.14 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.35 -13.52 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.419 -0.956 . . . . 25.0 108.419 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.43 -1.39 29.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.288 -1.324 . . . . 50.0 112.035 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.9 t -152.95 165.87 34.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.13 -25.02 67.58 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.764 1.024 . . . . 50.0 113.764 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -110.07 159.1 17.62 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.183 0.809 . . . . 50.0 113.183 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 163.86 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 104.639 -2.356 . . . . 25.0 104.639 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -108.94 127.93 54.49 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.774 -0.37 . . . . 50.0 111.047 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.95 137.76 53.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.833 -1.543 . . . . 50.0 106.833 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -148.96 166.05 29.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.74 -0.467 . . . . 50.0 109.74 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.97 150.98 31.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.339 -0.986 . . . . 50.0 108.339 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.09 118.44 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.905 -1.887 . . . . 25.0 105.905 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -92.21 134.2 35.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.473 0.654 . . . . 25.0 110.577 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.58 157.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.25 119.21 25.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.234 -2.136 . . . . 50.0 105.234 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.7 mt -119.86 132.38 55.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.097 0.475 . . . . 50.0 110.208 -170.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.91 163.57 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.904 -0.589 . . . . 50.0 110.969 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -78.08 158.28 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.325 -1.361 . . . . 50.0 107.325 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.48 ' HZ3' ' C ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 116.609 -1.662 . . . . 50.0 107.799 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.261 1 N-CA-C 102.497 -4.241 . . . . 25.0 102.497 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.46 149.15 35.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 120.093 1.946 . . . . 25.0 113.103 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -94.84 120.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.143 -0.935 . . . . 25.0 109.996 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.92 -13.09 20.14 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.527 0.566 . . . . 50.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -162.7 142.81 7.29 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.84 126.61 12.95 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 130.373 1.406 . . . . 25.0 113.999 -1.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.81 51.21 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 111.276 -0.73 . . . . 50.0 111.276 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.2 t -141.29 136.47 31.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.634 -1.246 . . . . 25.0 107.634 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -67.28 -21.12 65.72 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.43 0.53 . . . . 50.0 112.43 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.14 80.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.132 0.492 . . . . 25.0 110.641 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.56 65.07 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 120.876 0.37 . . . . 25.0 110.639 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.92 -4.25 59.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.219 -0.446 . . . . 50.0 110.825 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 50.0 110.078 -176.554 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.329 0.862 . . . . 50.0 113.329 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -50.35 -22.05 1.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 117.742 2.497 . . . . 25.0 117.742 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -79.91 -35.96 37.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.459 -0.776 . . . . 50.0 112.045 -172.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.88 63.31 5.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.173 0.805 . . . . 25.0 113.173 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.28 -6.46 18.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 117.411 -1.26 . . . . 50.0 112.296 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -93.68 4.97 53.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 50.0 112.115 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -92.34 93.94 8.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.219 -1.03 . . . . 50.0 108.219 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.0 mt -116.47 104.95 11.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.686 -0.857 . . . . 50.0 108.686 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -129.9 146.17 51.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.947 0.404 . . . . 50.0 110.628 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.5 145.53 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.995 -0.743 . . . . 25.0 108.995 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.686 0.279 . . . . 50.0 110.417 179.693 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.47 0 CA-C-O 120.222 -0.21 . . . . 50.0 113.085 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.81 -43.89 94.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.532 0.682 . . . . 25.0 109.948 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -69.51 -25.52 64.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.626 -0.715 . . . . 25.0 111.468 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -31.83 72.64 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.836 -0.697 . . . . 50.0 111.52 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.53 72.17 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 120.952 -0.642 . . . . 50.0 112.891 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.95 -38.21 71.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.731 -0.84 . . . . 50.0 108.731 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.25 -43.89 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.997 0.427 . . . . 50.0 111.308 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.73 -4.44 37.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.863 1.06 . . . . 50.0 113.863 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -62.1 -13.4 26.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -133.88 82.8 2.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 171.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.4 t -145.74 152.22 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.344 -0.614 . . . . 25.0 109.344 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.03 -25.76 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.392 0.615 . . . . 50.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -97.18 7.34 46.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.973 -0.558 . . . . 50.0 111.424 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -65.43 169.37 6.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.471 1.129 . . . . 50.0 110.219 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -91.37 165.94 13.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.103 -1.443 . . . . 50.0 107.103 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -76.12 151.87 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -121.14 123.21 41.75 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 106.078 -1.823 . . . . 25.0 106.078 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -118.82 126.09 51.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.315 0.487 . . . . 25.0 112.315 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.5 132.2 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.682 -0.858 . . . . 25.0 108.682 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttp -150.69 157.56 43.11 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 107.809 -1.182 . . . . 50.0 107.809 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.0 p -95.01 163.79 13.16 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.081 -0.387 . . . . 25.0 110.143 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.23 172.23 50.25 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.937 -0.649 . . . . 25.0 112.815 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.57 -166.2 12.36 Favored Glycine 0 C--O 1.228 -0.258 0 O-C-N 122.516 -0.402 . . . . 50.0 112.367 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -76.84 140.54 40.67 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.058 -0.672 . . . . 25.0 111.417 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -136.02 158.54 44.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.391 -1.337 . . . . 50.0 107.391 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.8 m -126.07 123.77 39.12 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -116.23 139.58 50.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.003 -1.11 . . . . 50.0 108.003 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 t -137.96 145.99 42.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.3 -1.37 . . . . 25.0 107.3 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -121.42 145.18 48.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.777 -1.564 . . . . 50.0 106.777 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -131.47 161.96 31.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.41 153.65 48.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.597 -1.26 . . . . 25.0 107.597 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.1 p -81.02 -11.89 59.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.934 0.346 . . . . 25.0 111.934 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.92 20.75 Favored Pre-proline 0 C--O 1.25 1.112 0 N-CA-C 110.371 -0.233 . . . . 25.0 110.371 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.07 129.54 14.29 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.725 -1.05 . . . . 25.0 110.959 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -131.14 158.69 39.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.97 -0.382 . . . . 50.0 109.97 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -81.74 157.48 24.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.039 -1.097 . . . . 50.0 108.039 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.3 m -139.31 140.17 37.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.1 t -88.5 -48.64 7.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.238 -1.393 . . . . 50.0 107.238 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.23 166.36 18.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.265 -0.642 . . . . 50.0 109.265 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -146.79 138.68 24.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.456 -1.683 . . . . 25.0 106.456 167.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.84 148.91 31.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 50.0 109.297 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -145.32 148.25 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.23 1.014 . . . . 50.0 113.289 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.77 168.94 17.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.384 -1.28 . . . . 50.0 107.734 -170.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.54 159.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 166.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -95.35 135.86 36.43 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -87.7 124.9 34.05 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.336 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -88.6 153.94 20.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.49 15.17 58.91 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.147 -1.502 . . . . 25.0 113.059 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -52.75 153.47 3.22 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.597 0.962 . . . . 50.0 113.597 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -75.79 130.59 78.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.78 -0.646 . . . . 50.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.92 -15.7 29.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 117.174 -1.417 . . . . 50.0 111.777 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.61 -21.77 65.39 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.309 1.043 . . . . 50.0 111.718 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -120.2 141.97 32.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 O-C-N 121.978 -0.451 . . . . 50.0 110.444 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.55 134.42 30.61 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 115.34 -2.64 . . . . 50.0 112.554 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.5 mt -57.81 -33.84 69.01 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.39 -0.823 . . . . 50.0 111.939 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -53.2 -39.23 63.55 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.609 -0.723 . . . . 25.0 111.286 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.28 -51.8 7.56 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.738 0.644 . . . . 50.0 112.738 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.87 -27.45 61.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 116.855 2.169 . . . . 25.0 116.855 -166.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -71.1 -17.3 62.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.784 1.402 . . . . 50.0 114.784 -170.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -96.74 121.39 38.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -118.65 112.03 19.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.422 -0.585 . . . . 25.0 109.422 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.8 124.24 23.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.866 -1.531 . . . . 50.0 106.866 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.0 tt -115.8 1.82 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.919 0.866 . . . . 25.0 109.834 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.51 145.8 4.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 50.0 114.004 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.73 137.91 31.99 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.723 -1.584 . . . . 25.0 106.723 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 t -132.48 89.27 36.75 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 108.636 -0.876 . . . . 25.0 108.636 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.41 163.49 37.6 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 116.073 -2.151 . . . . 50.0 110.54 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -128.22 120.99 28.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.434 0.635 . . . . 50.0 109.578 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -127.07 -76.7 0.57 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.002 -2.592 . . . . 50.0 104.002 172.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -147.97 -150.09 5.12 Favored Glycine 0 C--O 1.242 0.603 0 N-CA-C 108.6 -1.8 . . . . 25.0 108.6 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.2 m 62.59 157.17 0.12 Allowed Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 114.474 1.287 . . . . 25.0 114.474 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.11 0.15 9.3 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 115.781 -2.346 . . . . 50.0 114.799 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.42 91.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.443 -0.799 . . . . 25.0 109.486 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.3 p -79.74 -11.24 59.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.117 0.484 . . . . 25.0 111.626 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -76.97 -21.0 55.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.191 -0.459 . . . . 50.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -74.34 104.93 5.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.885 0.374 . . . . 50.0 111.172 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -16.06 24.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.019 0.748 . . . . 50.0 113.019 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -100.22 126.51 46.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.301 -1.37 . . . . 50.0 107.301 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -131.07 150.5 52.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.559 0.695 . . . . 25.0 111.826 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -94.73 136.08 35.45 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 105.602 -1.999 . . . . 50.0 105.602 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.0 118.97 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -80.61 130.58 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.169 -2.16 . . . . 50.0 105.169 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.7 mt -122.43 111.57 31.64 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 107.265 -1.383 . . . . 25.0 107.265 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.74 162.0 40.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 116.949 -1.567 . . . . 25.0 112.406 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -111.24 91.03 3.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.517 -2.401 . . . . 50.0 104.517 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -79.42 -29.77 42.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.155 -0.683 . . . . 50.0 109.155 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mtt-85 -155.27 170.0 22.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 103.535 -2.765 . . . . 50.0 103.535 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.89 112.68 24.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.987 -2.968 . . . . 50.0 102.987 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 168.27 166.7 27.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.229 -0.51 . . . . 25.0 112.497 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -87.08 142.35 27.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.778 1.399 . . . . 50.0 114.778 -172.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -129.4 136.85 50.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.182 -1.784 . . . . 25.0 106.182 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.91 133.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.89 -1.152 . . . . 50.0 107.89 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.8 mt -96.08 126.27 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.6 mt -111.6 127.05 55.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.038 -1.467 . . . . 50.0 107.038 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.34 145.84 52.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.51 0.596 . . . . 25.0 111.022 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.07 138.15 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.668 -1.234 . . . . 50.0 107.668 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -129.19 120.63 26.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.783 -0.821 . . . . 50.0 108.783 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -101.45 97.0 7.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.327 0.585 . . . . 50.0 109.955 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.62 123.03 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.218 -1.03 . . . . 50.0 108.218 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.17 -22.97 59.19 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.95 -7.61 55.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.578 0.955 . . . . 50.0 113.578 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -132.16 158.03 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.24 13.07 3.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.628 -1.169 . . . . 50.0 109.285 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -109.92 162.21 14.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 50.0 109.93 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.88 150.28 50.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.381 -2.452 . . . . 25.0 104.381 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -122.65 143.11 49.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.794 -1.188 . . . . 50.0 107.794 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -138.93 156.38 47.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.384 -0.599 . . . . 50.0 109.384 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.71 149.67 36.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 50.0 109.88 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.35 141.98 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.72 -0.474 . . . . 50.0 109.72 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.4 mt -139.02 128.53 30.6 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 105.396 -2.076 . . . . 25.0 105.396 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -112.15 126.9 55.7 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.4 m -125.52 126.12 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.576 0.703 . . . . 25.0 109.92 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -87.58 96.05 10.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.196 -1.779 . . . . 50.0 106.196 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.2 112.14 22.42 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.356 -0.838 . . . . 50.0 109.86 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.6 m -136.32 173.75 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.171 -0.468 . . . . 50.0 111.245 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -63.05 159.37 17.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.695 0.76 . . . . 50.0 112.678 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.59 -1.187 . . . . 50.0 110.861 178.144 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.163 0 N-CA-C 107.801 -2.119 . . . . 25.0 107.801 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.24 165.76 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.824 1.312 . . . . 25.0 110.57 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.1 mm -93.98 124.55 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 25.0 109.78 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -87.9 22.11 2.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.386 0.675 . . . . 50.0 111.7 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.3 mttt 77.05 153.27 0.14 Allowed Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 125.975 1.71 . . . . 25.0 111.955 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.97 151.98 68.7 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 129.031 0.846 . . . . 25.0 111.158 -7.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.91 21.73 15.21 Favored Glycine 0 C--O 1.211 -1.288 0 N-CA-C 117.714 1.846 . . . . 50.0 117.714 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -76.5 128.37 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 119.23 1.515 . . . . 25.0 110.041 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -73.33 -27.13 61.34 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.988 -0.375 . . . . 50.0 109.988 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.22 -33.63 69.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.526 0.565 . . . . 25.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.21 69.6 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 120.826 0.346 . . . . 25.0 111.55 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.95 -8.33 46.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.583 0.706 . . . . 50.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.8 t . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.133 -0.939 . . . . 50.0 113.24 -171.729 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.551 0.983 0 N-CA-C 112.592 0.59 . . . . 50.0 112.592 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.3 ptm -56.46 -10.92 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 116.678 2.103 . . . . 25.0 116.678 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.19 -35.9 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 118.163 0.438 . . . . 50.0 111.985 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.05 46.02 0.39 Allowed Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 117.042 2.238 . . . . 25.0 117.042 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.45 -14.28 36.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 115.797 -2.335 . . . . 50.0 114.648 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.06 5.01 49.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.367 0.506 . . . . 50.0 112.367 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.4 t -106.39 89.69 3.12 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.588 -1.264 . . . . 75.0 107.588 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.36 124.68 45.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.0 -1.852 . . . . 50.0 106.0 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -127.45 145.82 50.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 50.0 110.883 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 158.02 45.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.902 -1.888 . . . . 25.0 105.902 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 tttt . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 108.805 -0.813 . . . . 50.0 108.805 178.406 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.427 0 N-CA-C 114.839 0.695 . . . . 50.0 114.839 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.62 -25.41 66.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 25.0 111.14 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -84.9 0.57 50.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.817 0.342 . . . . 25.0 111.77 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.68 -19.49 58.33 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 121.129 -0.558 . . . . 50.0 112.98 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.97 -20.75 67.08 Favored Glycine 0 C--O 1.222 -0.617 0 C-N-CA 121.079 -0.582 . . . . 50.0 113.228 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.59 -39.4 80.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.415 -0.957 . . . . 50.0 108.415 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.03 -26.86 61.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.538 -0.541 . . . . 50.0 109.538 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.52 7.56 4.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.485 0.66 . . . . 50.0 112.221 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.49 -28.02 15.1 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.45 -0.781 . . . . 25.0 109.037 171.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -150.72 96.73 2.4 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.836 0.351 . . . . 25.0 111.394 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.6 t -152.87 154.37 34.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -69.55 -32.8 71.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.177 0.989 . . . . 50.0 109.802 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.32 28.13 8.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.2 -0.909 . . . . 50.0 110.037 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -53.68 154.31 3.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.273 -0.876 . . . . 50.0 109.992 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -84.78 165.26 17.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.28 -1.378 . . . . 50.0 107.28 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -74.8 139.02 42.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -127.5 133.98 49.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -119.63 146.94 45.1 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.366 -1.346 . . . . 25.0 107.366 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -96.7 133.03 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 25.0 108.199 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 93.7 mtp -135.06 158.42 44.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.65 -0.87 . . . . 50.0 108.65 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -104.47 172.04 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.14 -175.93 7.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 114.495 0.558 . . . . 25.0 114.495 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.14 -173.37 20.56 Favored Glycine 0 CA--C 1.518 0.221 0 O-C-N 122.525 -0.397 . . . . 50.0 112.755 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.14 141.13 33.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -141.91 160.75 39.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.349 -0.612 . . . . 50.0 109.349 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -126.75 129.49 48.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.39 -1.708 . . . . 25.0 106.39 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.43 139.05 49.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.08 -1.081 . . . . 50.0 108.08 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -130.82 133.41 45.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.495 0.497 . . . . 25.0 110.16 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -124.08 151.71 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.839 -1.911 . . . . 50.0 105.839 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -138.07 161.95 35.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 119.037 0.835 . . . . 25.0 110.656 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.14 150.65 39.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.488 -1.671 . . . . 25.0 106.488 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -68.63 -22.39 64.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.384 0.513 . . . . 25.0 112.384 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.04 151.97 63.72 Favored Pre-proline 0 C--O 1.242 0.693 0 N-CA-C 105.719 -1.956 . . . . 25.0 105.719 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.38 145.93 73.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 115.587 -2.475 . . . . 25.0 109.515 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -130.88 140.49 50.22 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.994 -0.441 . . . . 50.0 111.491 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.62 141.52 57.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.406 -1.331 . . . . 50.0 107.406 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 m -150.02 151.9 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.746 -1.946 . . . . 25.0 105.746 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.0 p -108.01 -34.05 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 118.256 0.48 . . . . 50.0 110.618 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.76 145.29 18.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.971 -0.456 . . . . 50.0 109.835 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -141.2 139.43 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.035 -0.666 . . . . 25.0 109.543 163.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -148.09 159.64 43.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.89 -0.596 . . . . 50.0 109.532 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -145.04 150.24 36.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.915 1.08 . . . . 50.0 113.915 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.74 164.6 17.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.035 -1.438 . . . . 50.0 107.522 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.66 155.73 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.6 p -96.02 144.19 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.424 -0.584 . . . . 25.0 109.424 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -87.99 129.82 35.14 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 110.163 -0.31 . . . . 25.0 110.163 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -81.53 156.21 25.36 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.054 0.542 . . . . 25.0 109.671 172.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.8 10.12 73.2 Favored Glycine 0 N--CA 1.462 0.419 0 N-CA-C 118.59 2.196 . . . . 25.0 118.59 166.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -59.26 161.35 5.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.032 1.123 . . . . 50.0 114.032 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.24 156.02 36.28 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 106.646 -1.613 . . . . 50.0 106.646 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.45 -8.62 18.48 Favored 'Trans proline' 0 C--N 1.345 0.389 0 N-CA-C 116.663 1.755 . . . . 50.0 116.663 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -82.33 0.72 40.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.912 0.863 . . . . 50.0 111.77 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -95.97 148.43 34.53 Favored Pre-proline 0 C--N 1.322 -0.616 0 O-C-N 121.734 -0.604 . . . . 50.0 110.412 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.04 83.4 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 N-CA-C 110.329 -0.681 . . . . 50.0 110.329 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.7 mt -53.15 -39.53 63.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.912 1.449 . . . . 50.0 114.912 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -63.07 -21.98 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.797 0.666 . . . . 25.0 112.797 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -94.76 -48.55 5.99 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 112.344 0.498 . . . . 50.0 112.344 169.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.79 64.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 115.708 1.744 . . . . 25.0 115.708 -166.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -69.31 -28.88 66.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.247 -0.581 . . . . 50.0 111.633 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -97.66 113.92 25.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.116 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -121.86 136.67 54.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.235 0.541 . . . . 25.0 111.469 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.4 tp -75.61 123.93 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.459 -1.682 . . . . 50.0 106.459 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.2 tp -121.75 -5.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.564 0.697 . . . . 25.0 111.185 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -161.21 140.15 6.47 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.395 -0.907 . . . . 50.0 112.243 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 134.21 16.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.401 -1.333 . . . . 25.0 107.401 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.74 103.2 7.65 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.92 148.73 76.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 116.013 -2.191 . . . . 50.0 109.69 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -106.14 92.2 4.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.364 -1.346 . . . . 50.0 107.364 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -119.17 1.15 11.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.373 -1.739 . . . . 50.0 109.782 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.62 -18.75 9.93 Favored Glycine 0 C--O 1.236 0.24 0 CA-C-N 115.303 -0.862 . . . . 25.0 111.905 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.6 t -54.71 136.99 63.89 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 117.116 0.458 . . . . 25.0 110.465 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.75 -11.67 28.03 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 117.029 -1.514 . . . . 50.0 114.753 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.78 -34.67 78.89 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.375 -1.284 . . . . 25.0 109.143 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -84.4 -10.05 57.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.202 0.525 . . . . 25.0 112.044 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -86.48 -22.78 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.643 -1.243 . . . . 50.0 107.643 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.04 104.84 17.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 50.0 110.402 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.65 -10.87 59.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.667 -0.697 . . . . 50.0 112.321 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -91.31 121.98 33.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.928 -1.138 . . . . 50.0 107.928 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -137.26 147.83 46.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 25.0 111.426 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -79.23 137.89 37.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.726 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.0 mt -132.68 106.02 9.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.744 -1.206 . . . . 25.0 107.744 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -78.12 140.85 39.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.574 -0.899 . . . . 50.0 108.574 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.9 mm -124.63 123.36 25.72 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.61 158.44 53.59 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 117.289 -1.341 . . . . 25.0 111.52 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -106.97 52.83 0.71 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.512 1.149 . . . . 50.0 110.037 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.75 -37.5 24.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 115.477 1.658 . . . . 50.0 115.477 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -152.87 172.23 17.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.19 0.596 . . . . 50.0 109.738 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.0 mp -99.95 142.77 30.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.678 -2.342 . . . . 50.0 104.678 167.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.41 150.07 5.88 Favored Glycine 0 C--O 1.234 0.117 0 C-N-CA 120.588 -0.815 . . . . 25.0 114.078 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -86.01 145.11 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 50.0 110.049 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 153.02 40.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.842 -0.617 . . . . 25.0 110.184 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.65 143.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.046 -0.524 . . . . 50.0 110.644 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.08 128.85 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.341 -2.466 . . . . 25.0 104.341 172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.72 137.43 53.93 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.842 -1.54 . . . . 50.0 106.842 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.82 151.15 42.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 118.958 0.799 . . . . 25.0 110.971 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.04 134.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.124 -1.435 . . . . 50.0 107.124 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -124.78 98.98 5.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.586 -1.265 . . . . 50.0 107.586 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -84.79 117.81 24.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.037 0.446 . . . . 50.0 110.554 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.03 133.75 28.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.331 -0.989 . . . . 50.0 108.331 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.76 -42.47 58.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.119 0.485 . . . . 25.0 111.194 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.66 -24.07 64.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.812 1.782 . . . . 50.0 115.812 -168.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 66.3 p -135.62 162.55 32.39 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 122.381 -0.199 . . . . 25.0 110.701 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 11.32 2.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 50.0 112.587 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.11 160.0 16.85 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.168 -1.419 . . . . 50.0 107.168 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.52 170.7 15.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.04 -2.207 . . . . 25.0 105.04 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -120.32 158.37 27.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.1 -1.074 . . . . 50.0 108.1 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -138.7 154.63 48.6 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.442 -1.318 . . . . 50.0 107.442 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -132.7 142.06 48.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.304 -0.999 . . . . 50.0 108.304 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.11 129.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.73 -0.841 . . . . 50.0 108.73 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.3 mt -140.66 126.56 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.47 137.09 37.66 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.624 -0.51 . . . . 25.0 109.624 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.58 137.51 43.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -82.03 136.14 35.26 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.687 -1.598 . . . . 50.0 106.687 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.14 104.24 9.94 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.489 -0.93 . . . . 50.0 108.489 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.03 166.95 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.239 0.543 . . . . 50.0 111.824 -176.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.21 158.7 32.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.535 -1.654 . . . . 50.0 106.535 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 117.285 -1.34 . . . . 50.0 110.365 178.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 CA-C-O 118.428 -1.207 . . . . 25.0 110.714 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -156.64 164.73 37.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.226 1.013 . . . . 25.0 112.864 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.4 mt -90.73 122.74 42.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -77.72 -41.38 38.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.382 0.61 . . . . 50.0 109.537 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.32 117.08 8.73 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.182 -0.463 . . . . 25.0 109.836 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.36 122.61 7.83 Favored 'Cis proline' 0 C--N 1.357 1.002 0 C-N-CA 130.412 1.422 . . . . 25.0 113.454 -3.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.1 -22.58 57.07 Favored Glycine 0 CA--C 1.508 -0.36 0 N-CA-C 116.051 1.18 . . . . 50.0 116.051 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 t -91.18 97.18 10.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.601 -0.941 . . . . 25.0 110.73 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -83.96 -32.34 25.08 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.727 -0.471 . . . . 50.0 109.727 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -36.67 71.13 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.203 1.186 . . . . 25.0 114.203 -173.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.81 -32.43 71.8 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.282 0.364 . . . . 25.0 110.957 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.9 mp -92.93 -19.93 21.14 Favored 'General case' 0 C--O 1.211 -0.931 0 N-CA-C 112.708 0.632 . . . . 50.0 112.708 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.7 t . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 109.303 -0.628 . . . . 50.0 109.303 179.046 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.546 0.812 0 CA-C-O 121.597 0.713 . . . . 50.0 111.024 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -26.26 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 117.933 2.568 . . . . 25.0 117.933 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -75.97 -43.4 44.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.882 0.764 . . . . 50.0 112.816 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.9 71.93 19.03 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 122.009 0.909 . . . . 25.0 112.928 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.66 2.0 5.09 Favored 'Trans proline' 0 C--O 1.221 -0.346 0 N-CA-C 114.606 0.964 . . . . 50.0 114.606 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 3.17 33.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.654 -0.498 . . . . 50.0 109.654 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -134.15 84.03 2.08 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 115.771 1.767 . . . . 75.0 115.771 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.0 131.19 55.31 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 103.525 -2.769 . . . . 50.0 103.525 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -114.37 143.54 44.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.191 1.182 . . . . 50.0 114.191 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.28 155.97 49.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.456 -2.424 . . . . 25.0 104.456 167.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.7 tttt . . . . . 0 C--N 1.327 -0.392 0 O-C-N 121.572 -0.705 . . . . 50.0 110.483 -178.306 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.561 0 N-CA-C 113.495 0.158 . . . . 50.0 113.495 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 mt -59.32 -10.68 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.606 1.706 . . . . 25.0 115.606 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -61.04 -19.96 61.98 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.21 -16.15 77.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.35 -0.844 . . . . 50.0 111.709 177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.71 -4.58 66.49 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 115.421 0.928 . . . . 50.0 115.421 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.48 -32.76 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.352 1.076 . . . . 50.0 110.077 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.52 -25.37 65.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.513 -0.312 . . . . 50.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -106.15 15.44 26.32 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.783 0.801 . . . . 50.0 110.041 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -70.59 14.75 0.12 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.37 1.248 . . . . 25.0 114.37 -174.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.51 52.91 1.69 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -131.91 178.69 6.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -64.64 -21.15 66.65 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.805 -0.559 . . . . 50.0 112.413 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -95.57 14.38 23.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.555 0.693 . . . . 50.0 112.098 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 ttt85 -58.18 128.32 36.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.867 -0.606 . . . . 50.0 111.129 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -106.14 168.18 9.31 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.921 0.867 . . . . 50.0 112.203 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -63.86 149.58 46.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.613 -0.721 . . . . 25.0 112.123 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -130.5 146.5 52.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.74 -1.207 . . . . 25.0 107.74 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -113.34 138.49 49.97 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.38 129.19 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 94.3 mmm -137.88 166.51 23.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.521 -0.548 . . . . 50.0 109.521 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.3 p -107.46 -173.72 2.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.256 -2.128 . . . . 25.0 105.256 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -161.54 21.56 Favored Glycine 0 C--O 1.242 0.605 0 CA-C-O 121.676 0.598 . . . . 25.0 113.744 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.79 176.61 42.65 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.73 -0.948 . . . . 50.0 110.73 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 141.48 31.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.139 1.469 . . . . 25.0 109.849 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -129.39 139.16 51.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.714 -0.847 . . . . 50.0 108.714 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -85.57 128.84 34.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 25.0 109.946 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.03 127.43 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.962 -1.866 . . . . 50.0 105.962 174.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -128.85 120.47 26.33 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.1 -0.333 . . . . 25.0 110.1 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -124.08 150.1 45.4 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.45 -1.685 . . . . 50.0 106.45 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.1 t -145.21 158.78 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.465 -0.569 . . . . 25.0 109.465 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.01 133.45 52.97 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 108.997 -0.742 . . . . 25.0 108.997 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -77.03 -6.63 53.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.686 0.625 . . . . 25.0 112.686 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.95 145.04 37.65 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 106.907 -1.516 . . . . 25.0 106.907 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.32 142.87 38.1 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 117.239 -1.374 . . . . 25.0 111.804 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -136.27 140.22 43.27 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.935 -0.765 . . . . 50.0 108.935 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -81.51 152.97 27.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.097 -1.816 . . . . 50.0 106.097 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.1 m -138.79 148.49 43.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 105.855 -1.905 . . . . 25.0 105.855 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 t -102.71 -43.36 5.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 50.0 110.59 173.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.82 143.46 20.67 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.947 -0.76 . . . . 50.0 108.947 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -144.5 134.8 24.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.78 0.324 . . . . 25.0 110.192 170.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -154.18 162.22 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.407 0.521 . . . . 50.0 112.407 -172.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.25 146.01 51.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.458 0.647 . . . . 50.0 112.107 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -124.0 163.79 20.66 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.539 -1.282 . . . . 50.0 107.539 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -131.34 152.98 38.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.6 p -80.48 144.69 32.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.884 -1.154 . . . . 25.0 107.884 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -88.42 124.77 34.28 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 25.0 110.295 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -73.51 126.22 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.007 -1.109 . . . . 25.0 108.007 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.63 35.82 31.23 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 119.041 -1.552 . . . . 25.0 113.931 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -54.9 149.19 11.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.241 1.02 . . . . 50.0 110.713 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -75.6 139.68 71.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.13 -0.693 . . . . 50.0 109.13 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.44 -22.47 16.11 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 118.549 -0.5 . . . . 50.0 113.179 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.8 -27.55 64.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.877 0.846 . . . . 50.0 111.956 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -91.67 143.86 28.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.934 -1.136 . . . . 50.0 107.934 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.19 115.67 3.28 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 117.555 -1.163 . . . . 50.0 112.019 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tt -52.36 -54.35 32.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.851 1.426 . . . . 50.0 114.851 -166.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -69.57 -4.03 17.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.114 1.153 . . . . 25.0 114.114 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.63 -46.58 5.96 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.503 -0.748 . . . . 50.0 109.483 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.5 -19.99 51.79 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.545 1.313 . . . . 25.0 114.545 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -72.67 -33.69 66.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.08 1.141 . . . . 50.0 114.08 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -91.7 100.01 12.8 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.623 -0.831 . . . . 25.0 112.593 -173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -97.37 125.06 41.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 25.0 110.011 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 tp -71.4 116.98 12.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.976 -0.749 . . . . 50.0 108.976 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -96.88 -4.46 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.876 0.846 . . . . 25.0 109.898 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.35 159.72 11.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.602 -0.808 . . . . 50.0 113.016 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.0 147.07 28.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.769 -0.826 . . . . 25.0 108.769 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -133.67 111.8 12.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.223 -1.028 . . . . 25.0 108.223 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.72 168.92 18.89 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 115.796 -2.336 . . . . 50.0 111.071 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -145.18 120.04 9.94 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 120.568 -0.453 . . . . 50.0 110.505 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -91.57 -39.94 11.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.953 0.882 . . . . 50.0 110.04 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.08 -26.04 0.42 Allowed Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.125 -1.99 . . . . 25.0 108.125 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 t -51.76 141.42 26.55 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.771 0.656 . . . . 25.0 112.771 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.29 23.77 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.805 1.67 . . . . 50.0 114.343 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.28 -25.91 66.07 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.282 -0.886 . . . . 25.0 110.688 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 54.6 p -71.71 0.95 7.58 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.955 0.724 . . . . 25.0 112.955 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -62.1 -35.28 78.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.373 -0.973 . . . . 50.0 108.373 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -94.41 82.82 4.08 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.003 -1.851 . . . . 50.0 106.003 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.87 -19.84 58.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.345 -0.843 . . . . 50.0 111.653 -175.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 t -72.65 138.69 46.85 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.623 -0.673 . . . . 50.0 109.858 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -135.57 143.16 45.51 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.711 -0.477 . . . . 25.0 109.711 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -96.29 139.39 32.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.431 -1.692 . . . . 50.0 106.431 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.9 mm -133.28 130.19 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -80.71 132.17 35.53 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.0 mm -112.06 126.39 28.54 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.604 -0.888 . . . . 25.0 108.604 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.85 169.49 22.48 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 118.19 -0.74 . . . . 25.0 111.758 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -130.18 51.26 2.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.084 -1.45 . . . . 50.0 107.084 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -78.52 -32.03 47.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.123 1.157 . . . . 50.0 114.123 -172.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -152.2 165.83 33.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.975 -1.491 . . . . 50.0 106.975 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.89 142.91 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.271 -2.492 . . . . 50.0 104.271 167.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.29 165.39 10.27 Favored Glycine 0 C--O 1.237 0.318 0 N-CA-C 114.24 0.456 . . . . 25.0 114.24 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -81.45 149.69 28.66 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.086 0.772 . . . . 50.0 113.086 -176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.86 159.39 43.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.137 -1.801 . . . . 25.0 106.137 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.1 149.68 11.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 118.517 0.599 . . . . 50.0 111.158 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.7 128.44 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.94 139.21 52.04 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.362 -0.977 . . . . 50.0 108.362 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.69 144.32 41.73 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.87 -0.419 . . . . 25.0 109.87 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.85 135.28 61.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.417 -0.957 . . . . 50.0 108.417 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -128.38 112.14 14.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.261 0.624 . . . . 50.0 111.466 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -88.7 88.42 7.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.887 -0.783 . . . . 50.0 108.887 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.42 126.81 33.66 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 105.267 -2.123 . . . . 50.0 105.267 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.09 -23.52 54.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.261 0.553 . . . . 25.0 110.222 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.5 -11.85 61.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.686 -0.688 . . . . 50.0 112.481 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -127.61 161.4 28.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.952 0.406 . . . . 25.0 110.641 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -88.38 3.27 50.49 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.635 1.207 . . . . 50.0 108.054 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -108.83 157.34 18.68 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.702 -1.136 . . . . 50.0 108.945 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.69 141.77 49.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.785 -2.672 . . . . 25.0 103.785 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.03 144.69 32.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.066 -0.516 . . . . 50.0 111.14 -172.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -124.57 145.84 49.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.402 -0.817 . . . . 50.0 109.282 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -138.77 129.5 26.29 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.048 -1.834 . . . . 50.0 106.048 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.14 130.4 34.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.615 -0.883 . . . . 50.0 108.615 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.5 mt -140.37 130.87 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 120.486 0.184 . . . . 25.0 110.645 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.18 138.61 39.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.807 0.813 . . . . 25.0 111.282 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.61 160.81 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 25.0 109.07 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -117.29 132.1 56.68 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.216 -1.772 . . . . 50.0 106.216 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.07 121.99 40.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.833 -1.543 . . . . 50.0 106.833 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.54 167.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 123.532 0.52 . . . . 50.0 110.059 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -77.58 158.1 29.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.839 -0.8 . . . . 50.0 108.839 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 117.317 -1.325 . . . . 50.0 110.466 176.541 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.344 0 N-CA-C 108.548 -1.821 . . . . 25.0 108.548 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -80.27 136.33 36.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.11 106.85 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -77.26 -41.13 42.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.794 0.807 . . . . 50.0 110.94 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -152.84 143.76 15.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.036 -0.506 . . . . 25.0 109.669 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 137.39 47.96 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 118.99 0.675 . . . . 25.0 112.126 -5.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.68 168.06 38.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.817 -1.182 . . . . 50.0 113.665 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -161.93 121.36 2.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.339 -2.467 . . . . 25.0 104.339 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -83.4 -38.54 21.82 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 112.149 0.426 . . . . 50.0 112.149 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.21 74.14 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 25.0 112.559 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.77 70.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 112.08 0.4 . . . . 25.0 112.08 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 mt -92.0 -35.39 13.99 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 121.363 0.601 . . . . 50.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-N 114.809 -1.087 . . . . 50.0 110.917 -174.985 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.202 0.815 . . . . 50.0 113.202 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -67.08 -10.4 49.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.24 -41.09 70.57 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.888 1.07 . . . . 50.0 113.888 -171.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -142.59 43.28 0.47 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 117.377 2.362 . . . . 25.0 117.377 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.95 -21.1 28.4 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 113.236 -4.042 . . . . 50.0 112.259 176.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -79.03 -18.74 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 50.0 111.599 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -132.87 78.99 1.82 Allowed 'General case' 0 C--O 1.206 -1.229 0 N-CA-C 113.039 0.755 . . . . 75.0 113.039 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.2 mt -104.33 141.57 36.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.23 -0.656 . . . . 50.0 109.23 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -105.43 141.67 36.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 50.0 109.495 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 167.37 21.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 25.0 110.766 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 113.286 0.847 . . . . 50.0 113.286 -179.011 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.842 0 N-CA-C 111.79 -0.524 . . . . 50.0 111.79 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.95 -61.24 1.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.461 0.648 . . . . 25.0 111.309 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -85.02 -13.03 51.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.31 0.856 . . . . 25.0 113.31 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.38 72.26 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.804 -0.713 . . . . 50.0 113.058 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.89 -31.49 80.99 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 120.495 -0.86 . . . . 50.0 111.948 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mm -65.5 -37.36 79.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.385 0.612 . . . . 50.0 109.527 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.14 -33.63 59.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.531 . . . . 50.0 110.33 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -67.39 -31.74 72.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.451 0.643 . . . . 50.0 111.231 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.96 -5.06 23.67 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -130.11 41.94 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 25.0 109.044 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -125.16 167.63 14.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.25 -26.11 67.2 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.572 -0.899 . . . . 50.0 108.572 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -88.08 12.67 12.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.601 -0.727 . . . . 50.0 112.203 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -53.42 139.66 29.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.563 0.697 . . . . 50.0 109.702 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -81.93 142.32 32.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.52 1.153 . . . . 50.0 111.577 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -71.14 152.13 43.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.939 -1.482 . . . . 25.0 112.01 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -110.9 140.97 44.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.793 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -119.01 133.43 55.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.98 131.0 41.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.4 ttt -151.03 168.18 25.38 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 106.862 -1.533 . . . . 50.0 106.862 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.7 p -88.21 165.97 14.68 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.805 -1.924 . . . . 25.0 105.805 173.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.8 -158.2 5.23 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.396 -0.431 . . . . 25.0 112.583 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.52 -163.89 25.23 Favored Glycine 0 CA--C 1.512 -0.099 0 O-C-N 122.347 -0.502 . . . . 50.0 112.908 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -74.71 129.14 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.008 -0.701 . . . . 25.0 110.906 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -122.5 136.21 54.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.218 -1.03 . . . . 50.0 108.218 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.5 m -99.94 118.15 35.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.896 -1.52 . . . . 25.0 106.896 175.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.65 134.78 42.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.131 -1.433 . . . . 50.0 107.131 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -133.11 130.91 39.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -114.61 150.04 35.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.558 -0.905 . . . . 50.0 108.558 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -143.31 154.92 44.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.164 -0.68 . . . . 25.0 109.164 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -140.13 159.07 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -67.48 -30.55 70.28 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.84 151.18 62.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.65 134.32 27.93 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 115.475 -2.55 . . . . 25.0 111.217 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -131.0 154.47 48.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.129 -0.693 . . . . 50.0 109.129 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -68.54 160.34 30.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.842 0.83 . . . . 50.0 109.717 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -154.46 161.64 41.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.692 -3.818 . . . . 25.0 100.692 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 p -110.7 -39.13 4.96 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.997 -0.742 . . . . 50.0 108.997 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -159.75 143.59 14.53 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.557 -0.905 . . . . 50.0 108.557 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.81 138.47 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.18 -1.415 . . . . 25.0 107.18 169.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -140.83 152.81 45.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.399 . . . . 50.0 111.527 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -117.28 139.11 51.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.934 -1.03 . . . . 50.0 109.081 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.99 165.77 25.23 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.168 -1.419 . . . . 50.0 107.168 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.97 153.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.1 p -85.78 147.87 26.11 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.169 -0.678 . . . . 25.0 109.169 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -86.45 100.85 12.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.996 0.903 . . . . 25.0 110.095 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -76.08 126.72 31.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.761 -1.2 . . . . 25.0 107.761 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 20.92 34.75 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 119.701 -1.238 . . . . 25.0 114.053 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.06 141.1 19.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.492 0.663 . . . . 50.0 111.837 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.85 134.86 81.0 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.38 -0.6 . . . . 50.0 109.38 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.8 -16.73 23.35 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 117.703 -1.065 . . . . 50.0 113.344 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.44 -29.32 68.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.061 0.934 . . . . 50.0 110.339 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -100.76 152.31 37.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 107.973 -1.121 . . . . 50.0 107.973 -174.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.52 105.99 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 117.449 -1.234 . . . . 50.0 113.885 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.14 -42.18 69.26 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.459 -0.792 . . . . 50.0 112.075 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.74 -6.55 27.12 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.267 1.21 . . . . 25.0 114.267 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.3 -44.02 6.07 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.535 0.683 . . . . 50.0 111.281 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.45 28.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.333 -1.303 . . . . 25.0 114.489 -170.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -69.13 -29.09 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.9 1.074 . . . . 50.0 113.9 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -127.36 159.15 35.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.332 0.514 . . . . 25.0 112.228 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -133.48 147.68 51.67 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.203 -1.406 . . . . 25.0 107.203 173.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 tt -87.02 133.79 33.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.893 -0.504 . . . . 50.0 110.277 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 tt -121.34 1.87 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.847 0.832 . . . . 25.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.81 156.91 14.17 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.175 -1.012 . . . . 50.0 113.408 172.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.92 139.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.989 -1.115 . . . . 25.0 107.989 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.76 102.13 13.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.3 169.77 16.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 117.353 -1.298 . . . . 50.0 112.044 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -132.24 113.49 13.31 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.721 -1.215 . . . . 50.0 107.721 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -164.59 -104.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 102.009 -3.33 . . . . 50.0 102.009 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.7 40.4 2.93 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 111.152 -0.779 . . . . 25.0 111.152 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -76.28 132.73 72.63 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 122.244 -0.562 . . . . 25.0 111.597 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.2 -178.45 3.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 O-C-N 121.719 0.326 . . . . 50.0 111.955 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -13.9 6.35 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.396 1.258 . . . . 25.0 114.396 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -59.66 -13.24 8.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.583 0.957 . . . . 25.0 113.583 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -67.0 16.24 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.63 1.715 . . . . 50.0 115.63 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -58.09 143.13 44.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.553 0.692 . . . . 50.0 110.679 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.49 -10.79 60.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.139 -0.937 . . . . 50.0 112.21 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.5 t -100.06 122.67 43.29 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 106.936 -1.505 . . . . 50.0 106.936 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -133.83 141.31 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.08 0.467 . . . . 25.0 110.326 -175.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -91.97 132.88 36.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.932 -1.136 . . . . 50.0 107.932 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -131.92 129.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.903 -1.888 . . . . 25.0 105.903 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -96.73 132.08 42.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.008 -1.108 . . . . 50.0 108.008 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.16 106.31 36.17 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.42 151.13 65.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 116.145 -2.103 . . . . 25.0 109.242 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -139.04 95.31 2.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.64 0.733 . . . . 50.0 111.028 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.87 4.68 53.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.933 -1.03 . . . . 50.0 110.721 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -140.8 -179.34 6.0 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.57 130.48 51.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 104.432 -2.433 . . . . 50.0 104.432 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.01 -177.36 24.42 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-O 122.848 1.249 . . . . 25.0 115.973 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -79.02 146.54 33.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.354 1.242 . . . . 50.0 114.354 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -136.39 158.81 43.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.376 -2.453 . . . . 25.0 104.376 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.88 132.91 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.681 -0.859 . . . . 50.0 108.681 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.6 mt -108.51 134.85 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 tt -118.4 137.82 52.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.428 -0.953 . . . . 50.0 108.428 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.48 144.52 51.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.532 0.682 . . . . 25.0 110.9 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.98 133.64 68.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.012 -1.107 . . . . 50.0 108.012 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -129.43 100.79 5.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 50.0 108.952 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.1 131.97 34.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.006 -0.543 . . . . 50.0 109.562 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -89.05 160.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.957 -1.127 . . . . 50.0 107.957 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.99 -27.65 12.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.984 -0.747 . . . . 25.0 108.984 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.65 -2.42 58.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.729 1.011 . . . . 50.0 113.729 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.407 ' HG1' ' H ' ' A' ' 158' ' ' GLU . 11.4 t -152.95 162.78 40.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 25.0 111.469 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.407 ' H ' ' HG1' ' A' ' 157' ' ' THR . 38.3 tp10 -67.74 -26.17 66.01 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.496 1.119 . . . . 50.0 111.855 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.74 167.31 14.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 50.0 110.592 -173.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.43 -179.56 5.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -128.36 140.46 51.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.538 -0.912 . . . . 50.0 108.538 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -131.76 137.83 48.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.688 -1.227 . . . . 50.0 107.688 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -149.18 155.36 40.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.527 -0.545 . . . . 50.0 109.527 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.6 151.0 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.699 -0.852 . . . . 50.0 108.699 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.5 mm -134.58 113.01 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.993 -1.114 . . . . 25.0 107.993 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.8 141.27 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.783 -1.192 . . . . 25.0 107.783 175.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.0 m -135.51 161.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.71 117.59 23.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.955 -1.868 . . . . 50.0 105.955 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.97 135.12 55.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.868 -0.606 . . . . 50.0 110.937 -169.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.35 165.83 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.525 -0.762 . . . . 50.0 109.774 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -91.47 157.71 16.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.198 -1.779 . . . . 50.0 106.198 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.437 ' HZ3' ' C ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.593 -1.194 . . . . 50.0 108.602 175.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.569 0 N-CA-C 104.769 -3.333 . . . . 25.0 104.769 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.54 161.38 41.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.587 2.193 . . . . 25.0 113.244 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 mt -93.97 126.47 46.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.432 -1.321 . . . . 25.0 107.432 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.27 -47.59 14.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.189 -0.671 . . . . 50.0 109.189 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.676 ' HE2' ' HG1' ' A' ' 83' ' ' THR . 47.5 pttt -163.15 165.59 14.38 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.076 -1.083 . . . . 25.0 108.076 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -70.32 124.78 8.18 Favored 'Cis proline' 0 C--N 1.353 0.805 0 C-N-CA 131.392 1.83 . . . . 25.0 114.987 1.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.07 175.4 39.14 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.484 -0.78 . . . . 50.0 112.731 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -139.61 152.83 47.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.407 -0.96 . . . . 25.0 108.407 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -75.29 -21.01 58.81 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.815 -0.439 . . . . 50.0 109.815 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -33.58 66.57 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.006 0.373 . . . . 25.0 112.006 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.51 70.76 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 112.446 0.536 . . . . 25.0 112.446 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.04 -32.07 15.33 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.254 0.549 . . . . 50.0 109.86 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 50.0 111.526 -176.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 112.955 0.724 . . . . 50.0 112.955 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -22.6 15.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 116.539 2.051 . . . . 25.0 116.539 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.67 -37.88 62.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.582 0.628 . . . . 50.0 111.777 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.74 68.29 8.23 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 115.358 1.614 . . . . 25.0 115.358 174.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.8 -6.49 19.11 Favored 'Trans proline' 0 C--O 1.222 -0.309 0 N-CA-C 113.14 0.4 . . . . 50.0 113.14 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -97.92 4.85 49.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.855 0.687 . . . . 50.0 112.855 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -107.81 88.08 2.65 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.666 -0.813 . . . . 50.0 110.603 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.95 140.18 42.79 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 103.891 -2.633 . . . . 50.0 103.891 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -107.51 144.05 35.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.666 0.746 . . . . 50.0 112.198 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 162.78 31.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.606 -1.998 . . . . 25.0 105.606 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 tttt . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 118.228 0.467 . . . . 50.0 109.816 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 112.527 -0.229 . . . . 50.0 112.527 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.73 -10.88 6.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.262 0.838 . . . . 25.0 113.262 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -57.86 -21.22 41.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.364 0.876 . . . . 25.0 113.364 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.86 -26.32 72.16 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.252 -0.975 . . . . 50.0 111.136 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.44 -14.7 72.22 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-O 119.589 -0.562 . . . . 50.0 114.028 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.86 -33.08 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.072 0.936 . . . . 50.0 110.146 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.5 -39.51 91.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 50.0 110.65 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -88.82 -2.97 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.996 0.903 . . . . 50.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.57 23.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.438 1.273 . . . . 25.0 114.438 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -70.57 74.33 0.56 Allowed 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.615 -0.678 . . . . 25.0 111.882 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t -151.59 171.2 17.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.877 -1.898 . . . . 25.0 105.877 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -64.76 -17.03 63.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.885 0.874 . . . . 50.0 112.025 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -74.26 -9.96 59.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.214 0.45 . . . . 50.0 112.214 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -71.04 160.38 33.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.407 0.622 . . . . 50.0 110.216 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -85.06 163.65 18.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.328 -0.99 . . . . 50.0 108.328 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -62.73 146.78 51.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.938 0.875 . . . . 25.0 112.525 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -114.4 143.59 44.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.188 -1.412 . . . . 25.0 107.188 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -118.89 118.16 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.392 -0.596 . . . . 25.0 109.392 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.7 mt -76.13 135.87 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.89 165.97 30.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.995 -1.483 . . . . 50.0 106.995 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 p -108.49 170.19 8.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.926 -1.879 . . . . 25.0 105.926 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.54 179.21 26.36 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 115.076 0.791 . . . . 25.0 115.076 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.13 172.99 21.04 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.593 -1.003 . . . . 50.0 110.593 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 144.99 54.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.786 -0.832 . . . . 25.0 109.345 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -133.32 157.18 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.389 -0.597 . . . . 50.0 109.389 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.3 m -115.91 127.89 55.35 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.517 -0.549 . . . . 25.0 109.517 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.18 132.77 53.29 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.188 -1.041 . . . . 50.0 108.188 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.676 ' HG1' ' HE2' ' A' ' 6' ' ' LYS . 46.3 m -137.84 130.05 29.06 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -124.07 155.74 37.81 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.686 -1.598 . . . . 50.0 106.686 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.9 t -142.24 162.01 36.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.466 -0.568 . . . . 25.0 109.466 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -125.42 142.8 51.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.703 -1.221 . . . . 25.0 107.703 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -83.52 -0.56 50.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.27 0.557 . . . . 25.0 111.617 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 160.4 58.42 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.18 147.82 94.33 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.286 -2.01 . . . . 25.0 110.411 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -130.74 109.5 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.081 0.771 . . . . 50.0 113.081 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.29 144.5 53.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.062 -0.972 . . . . 50.0 108.85 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.4 m -133.34 132.81 41.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 25.0 109.976 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -106.54 -47.28 3.8 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.693 -1.225 . . . . 50.0 107.693 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -162.47 145.32 11.2 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.582 -1.636 . . . . 50.0 106.582 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -137.96 136.16 36.71 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -148.06 158.58 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.741 -0.837 . . . . 50.0 108.741 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . 0.424 ' HH ' ' CG ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -140.49 154.89 46.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.163 0.506 . . . . 50.0 111.878 -175.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -135.44 163.2 30.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.255 -0.884 . . . . 50.0 109.936 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.7 pt -129.36 152.56 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 168.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.6 p -84.87 141.92 30.09 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -74.22 114.82 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.809 0.814 . . . . 25.0 110.605 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -76.22 122.76 24.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 105.598 -2.001 . . . . 25.0 105.598 172.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.28 44.92 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.885 -1.15 . . . . 25.0 115.416 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.02 150.41 17.04 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.898 0.849 . . . . 50.0 112.552 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.83 118.63 72.41 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.099 -0.5 . . . . 50.0 110.789 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.27 -15.95 22.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 N-CA-C 114.725 1.01 . . . . 50.0 114.725 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.77 -3.85 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.174 0.987 . . . . 50.0 111.071 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -113.79 159.26 36.49 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 105.358 -2.09 . . . . 50.0 105.358 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.28 99.32 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 117.454 -1.23 . . . . 50.0 112.829 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.08 -36.57 60.8 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 113.634 0.975 . . . . 50.0 113.634 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.46 -15.27 6.42 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -85.99 -43.62 13.02 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.238 0.472 . . . . 50.0 111.439 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.82 -3.89 59.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.78 1.03 . . . . 25.0 113.78 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -67.87 -31.46 71.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.103 -0.239 . . . . 50.0 110.862 -174.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -127.15 132.41 50.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.772 0.656 . . . . 25.0 112.772 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -118.35 124.8 48.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.148 -1.056 . . . . 25.0 108.148 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.29 119.98 15.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.208 -1.034 . . . . 50.0 108.208 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -103.13 -2.13 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.913 0.863 . . . . 25.0 109.668 -176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.97 160.54 11.06 Favored Glycine 0 CA--C 1.512 -0.143 0 C-N-CA 120.769 -0.729 . . . . 50.0 113.242 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.2 144.84 26.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.678 -0.86 . . . . 25.0 108.678 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.6 104.76 10.0 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 107.159 -1.423 . . . . 25.0 107.159 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.52 172.21 12.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 116.902 -1.599 . . . . 50.0 112.662 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -134.65 91.45 2.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.303 -2.48 . . . . 50.0 104.303 170.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -106.14 29.95 6.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.166 0.984 . . . . 50.0 108.997 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.72 -37.29 3.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 109.336 -1.506 . . . . 25.0 109.336 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.412 ' HG ' ' HD2' ' A' ' 127' ' ' PRO . 41.3 t -59.38 138.1 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 176.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.412 ' HD2' ' HG ' ' A' ' 126' ' ' SER . 59.3 Cg_endo -77.1 46.78 2.05 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.991 1.794 . . . . 50.0 114.496 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.85 -21.79 61.42 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.828 0.677 . . . . 25.0 112.828 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.0 m -61.84 -13.16 21.65 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 113.834 1.05 . . . . 25.0 113.834 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -61.14 -35.92 78.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.884 0.374 . . . . 50.0 110.394 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -106.56 105.02 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 50.0 110.425 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.12 -13.81 30.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.274 0.842 . . . . 50.0 113.274 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.4 t -100.03 140.95 33.51 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.184 -0.323 . . . . 50.0 110.748 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . 0.424 ' CG ' ' HH ' ' A' ' 97' ' ' TYR . 14.9 t-80 -139.15 139.52 37.63 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.019 0.437 . . . . 25.0 111.904 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -86.75 137.53 32.36 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.013 -0.736 . . . . 50.0 109.013 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.14 124.97 53.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.289 -1.375 . . . . 25.0 107.289 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -77.0 135.56 38.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.016 -0.735 . . . . 50.0 109.016 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.9 mm -126.08 129.21 24.31 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.78 172.64 14.89 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 117.941 -0.906 . . . . 25.0 112.87 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -129.83 45.58 2.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.271 -1.381 . . . . 50.0 107.271 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.45 -37.72 15.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.657 -1.156 . . . . 50.0 113.364 -174.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -147.77 156.95 43.28 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 110.175 -0.306 . . . . 50.0 110.175 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.0 mp -95.56 145.73 25.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.199 0.6 . . . . 50.0 110.431 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.55 163.85 9.82 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 114.558 0.583 . . . . 25.0 114.558 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -94.37 145.75 24.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.895 1.443 . . . . 50.0 114.895 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -148.99 163.32 37.84 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.04 149.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.14 0.495 . . . . 50.0 112.029 -175.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.8 mt -120.59 133.22 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.426 -2.065 . . . . 25.0 105.426 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 mp -121.52 149.06 43.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.282 -1.007 . . . . 50.0 108.282 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -136.68 144.13 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.91 131.14 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.951 -1.129 . . . . 50.0 107.951 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -122.33 101.84 7.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.362 0.601 . . . . 50.0 109.959 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -79.97 131.87 35.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.369 -0.975 . . . . 50.0 108.369 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.58 128.96 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.218 -1.771 . . . . 50.0 106.218 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.99 44.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.94 0.4 . . . . 25.0 109.99 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -24.95 66.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 115.6 1.704 . . . . 50.0 115.6 -175.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 p -123.27 161.69 24.1 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.241 -0.287 . . . . 25.0 110.331 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.67 -19.12 62.12 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.181 0.991 . . . . 50.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -108.92 161.81 14.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.886 -1.052 . . . . 50.0 111.249 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.18 16.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.73 -2.693 . . . . 25.0 103.73 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -114.97 144.36 43.71 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.036 0.446 . . . . 50.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -113.28 146.53 39.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.416 -1.698 . . . . 50.0 106.416 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -133.55 141.17 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 104.813 -2.291 . . . . 50.0 104.813 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.07 136.61 47.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.502 -0.555 . . . . 50.0 109.502 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.3 mt -137.89 125.39 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.88 142.89 27.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.16 142.51 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.947 -0.471 . . . . 25.0 109.967 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -109.67 120.88 43.86 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.935 -2.246 . . . . 50.0 104.935 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 mt -120.02 128.22 53.32 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.713 -0.477 . . . . 50.0 109.713 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.73 170.06 18.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.774 -0.454 . . . . 50.0 109.774 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -77.56 157.94 30.08 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.898 -0.778 . . . . 50.0 108.898 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.6 mttt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 117.793 -1.098 . . . . 50.0 109.787 178.353 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.332 0 N-CA-C 106.26 -2.736 . . . . 25.0 106.26 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -125.77 156.72 39.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.642 1.221 . . . . 25.0 111.372 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.6 mt -97.66 119.44 45.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.637 -2.727 . . . . 25.0 103.637 170.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -77.5 5.67 8.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.654 0.613 . . . . 50.0 112.654 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttt 79.26 152.43 0.13 Allowed Pre-proline 0 N--CA 1.489 1.509 0 C-N-CA 126.021 1.729 . . . . 25.0 108.322 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 152.4 90.71 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 128.547 0.645 . . . . 25.0 112.023 -2.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.15 26.01 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 118.177 2.031 . . . . 50.0 118.177 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -65.04 131.29 46.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.896 1.348 . . . . 25.0 111.762 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -78.84 -15.93 57.75 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 113.459 0.911 . . . . 50.0 113.459 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.78 74.78 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 112.222 0.453 . . . . 25.0 112.222 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.73 -23.66 62.48 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.841 -0.537 . . . . 25.0 110.908 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.18 -4.03 54.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 50.0 110.279 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.219 -0.515 0 N-CA-C 108.822 -0.806 . . . . 50.0 108.822 179.384 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 113.071 0.767 . . . . 50.0 113.071 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.3 ptm -57.83 -11.09 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 118.121 2.637 . . . . 25.0 118.121 -174.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -69.94 -38.7 76.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.521 0.601 . . . . 50.0 110.462 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.95 63.74 3.16 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.174 1.176 . . . . 25.0 114.174 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.97 -8.12 22.35 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.122 -0.785 . . . . 50.0 113.856 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -97.19 5.12 50.66 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 122.056 -0.403 . . . . 50.0 111.878 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -121.21 130.4 53.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.739 0.644 . . . . 75.0 112.739 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.0 137.3 52.23 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.947 -1.501 . . . . 50.0 106.947 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -110.36 140.52 44.49 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.932 0.145 . . . . 50.0 111.132 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.93 158.08 45.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.396 -0.594 . . . . 25.0 109.396 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 tttt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 112.939 0.718 . . . . 50.0 112.939 179.812 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.463 0 N-CA-C 114.24 0.456 . . . . 50.0 114.24 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.68 -24.53 67.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.319 0.56 . . . . 25.0 111.151 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -66.49 -19.39 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.955 0.354 . . . . 25.0 111.955 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.76 -26.85 74.28 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.46 -1.056 . . . . 50.0 110.46 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.64 78.35 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.235 -0.507 . . . . 50.0 112.189 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.38 -42.59 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.377 -1.342 . . . . 50.0 107.377 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.39 -32.57 72.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.526 . . . . 50.0 109.914 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.11 -23.21 66.4 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.628 0.603 . . . . 50.0 112.628 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -68.94 -7.27 33.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.439 -0.788 . . . . 25.0 112.171 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -131.0 40.79 3.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -112.43 158.29 20.03 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.19 -30.78 63.79 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.582 -0.895 . . . . 50.0 108.582 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -96.64 21.26 9.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.416 -0.811 . . . . 50.0 110.329 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -50.24 148.29 3.63 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.127 -0.942 . . . . 50.0 111.64 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -67.37 138.15 56.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.766 1.269 . . . . 50.0 110.03 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -82.06 140.08 34.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.911 -1.495 . . . . 25.0 109.551 -172.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -108.72 138.68 44.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 25.0 111.485 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -124.39 135.25 53.15 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.835 -0.431 . . . . 25.0 109.835 168.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -79.66 138.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.1 tpt -139.51 156.11 47.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.349 -1.352 . . . . 50.0 107.349 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.9 p -101.43 -179.34 4.0 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.6 -178.77 30.3 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.275 -0.488 . . . . 25.0 112.355 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.26 -177.89 32.64 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 122.439 -0.448 . . . . 50.0 113.575 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.2 142.31 29.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -139.62 158.5 44.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.14 0.495 . . . . 50.0 110.206 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m -110.18 129.15 55.76 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.393 -0.966 . . . . 25.0 108.393 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.6 138.21 53.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.518 -1.289 . . . . 50.0 107.518 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -136.38 144.07 44.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.903 0.382 . . . . 25.0 111.113 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -121.02 149.98 41.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.634 -1.617 . . . . 50.0 106.634 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.83 156.44 48.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.296 0.57 . . . . 25.0 110.282 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -139.03 145.56 39.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.544 -2.021 . . . . 25.0 105.544 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -75.03 -14.15 60.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.495 0.554 . . . . 25.0 112.495 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.98 149.25 55.32 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.588 -1.264 . . . . 25.0 107.588 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -71.05 153.15 63.06 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 117.267 -1.356 . . . . 25.0 111.062 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -131.0 140.18 50.09 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.729 -0.471 . . . . 50.0 109.729 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.74 145.81 51.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.51 -1.663 . . . . 50.0 106.51 174.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.8 m -152.11 142.65 22.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.1 p -101.88 -37.37 8.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.477 -0.564 . . . . 50.0 109.477 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -165.13 167.11 18.51 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.239 -0.288 . . . . 50.0 111.119 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -141.25 141.17 34.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.625 -0.88 . . . . 25.0 108.625 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -147.94 155.68 41.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.377 -0.374 . . . . 50.0 110.265 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 150.03 46.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.39 0.614 . . . . 50.0 111.918 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -131.5 165.06 24.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.435 -1.32 . . . . 50.0 107.435 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -132.47 148.91 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 106.839 -1.541 . . . . 25.0 106.839 173.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 p -83.93 121.78 27.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -99.88 104.29 15.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.686 0.755 . . . . 25.0 109.06 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -75.99 153.96 36.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.61 23.95 17.24 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 119.779 -1.201 . . . . 25.0 114.606 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -66.7 161.62 23.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.667 0.734 . . . . 50.0 109.546 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.83 155.7 47.58 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 107.485 -1.302 . . . . 50.0 107.485 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.73 -14.54 33.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.777 -1.015 . . . . 50.0 113.261 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.07 -20.6 64.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.703 0.801 . . . . 50.0 111.468 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -96.04 147.16 32.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.494 -0.558 . . . . 50.0 109.494 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -61.82 119.71 6.96 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.285 -0.677 . . . . 50.0 111.609 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.58 -49.97 61.06 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 115.533 1.679 . . . . 50.0 115.533 -167.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.91 -36.67 36.09 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.902 0.858 . . . . 25.0 111.797 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -75.85 -32.67 59.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.492 -0.776 . . . . 50.0 112.983 -172.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.62 1.9 47.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.624 -0.262 . . . . 25.0 111.157 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.91 -29.59 68.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.195 -0.202 . . . . 50.0 111.135 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -125.88 150.14 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.91 0.708 . . . . 25.0 112.91 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -127.75 145.76 50.8 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.073 -1.084 . . . . 25.0 108.073 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.12 124.68 28.34 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.257 -0.645 . . . . 50.0 109.257 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.1 tt -98.36 -12.21 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.375 0.607 . . . . 25.0 110.137 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.46 160.19 14.42 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.311 -0.947 . . . . 50.0 114.206 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.54 139.06 23.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.706 -1.591 . . . . 25.0 106.706 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.0 t -137.09 116.49 10.4 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.85 167.53 22.09 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 115.329 -2.648 . . . . 50.0 111.904 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -126.64 96.25 4.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.348 1.071 . . . . 50.0 108.554 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -165.72 -98.15 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 100.527 -3.879 . . . . 50.0 100.527 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -93.69 134.93 12.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 105.843 -2.903 . . . . 25.0 105.843 168.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 t -164.58 146.2 6.76 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 117.48 0.64 . . . . 25.0 109.442 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.2 -162.43 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 120.747 0.964 . . . . 50.0 110.184 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.76 -14.07 2.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.381 1.252 . . . . 25.0 114.381 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.5 m -60.48 -16.05 32.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.079 0.77 . . . . 25.0 113.079 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -67.36 -10.44 51.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.467 0.544 . . . . 50.0 112.467 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -65.97 147.7 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 50.0 109.935 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.57 -9.7 58.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.568 0.699 . . . . 50.0 111.258 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.0 t -100.03 121.04 40.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.313 -1.736 . . . . 50.0 106.313 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -124.61 132.28 53.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 25.0 110.49 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -87.21 137.03 32.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.019 -0.537 . . . . 50.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.03 124.6 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.315 -0.994 . . . . 25.0 108.315 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -90.87 140.97 29.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.261 -0.644 . . . . 50.0 109.261 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -122.3 128.93 25.29 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 107.587 -1.264 . . . . 25.0 107.587 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.27 166.45 29.48 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 117.892 -0.939 . . . . 25.0 112.444 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -111.02 14.27 21.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.617 0.722 . . . . 50.0 111.076 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.34 -18.18 46.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.938 1.458 . . . . 50.0 114.938 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -155.18 170.01 22.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.19 0.811 . . . . 50.0 113.19 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.8 144.81 51.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.994 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.29 151.67 5.47 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.138 0.815 . . . . 25.0 115.138 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.03 146.89 25.94 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 114.943 1.46 . . . . 50.0 114.943 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -149.01 163.54 37.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -96.96 150.03 4.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.592 -0.522 . . . . 50.0 109.592 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.49 132.58 62.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.9 mt -119.05 139.84 51.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.876 -1.898 . . . . 50.0 105.876 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.79 151.52 47.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.114 0.87 . . . . 25.0 110.31 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.0 133.61 65.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.995 -1.002 . . . . 50.0 109.035 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -117.39 113.73 22.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.801 -1.185 . . . . 50.0 107.801 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -103.25 133.54 48.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.401 0.62 . . . . 50.0 111.358 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.86 132.26 70.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.468 -1.679 . . . . 50.0 106.468 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.73 -43.61 30.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 25.0 110.925 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 10.14 3.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.502 2.038 . . . . 50.0 116.502 -169.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -131.55 155.02 48.21 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.915 -0.49 . . . . 25.0 110.867 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -73.7 -7.85 53.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 50.0 110.959 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -115.22 163.83 15.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 50.0 112.14 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.88 163.22 33.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 103.453 -2.795 . . . . 25.0 103.453 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -130.45 152.39 49.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.548 0.573 . . . . 50.0 112.548 -172.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -130.96 157.58 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.594 -0.891 . . . . 50.0 108.594 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.5 154.62 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.862 -0.792 . . . . 50.0 108.862 171.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.1 137.22 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.934 0.397 . . . . 50.0 110.853 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 60.6 mt -141.71 135.0 29.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.55 141.74 37.34 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.242 1.383 . . . . 25.0 108.961 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.41 134.52 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.447 0.641 . . . . 25.0 109.657 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -101.73 96.02 6.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.782 . . . . 50.0 106.187 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.66 105.86 17.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.824 -1.176 . . . . 50.0 107.824 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.04 158.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.451 1.278 . . . . 50.0 114.451 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -99.66 164.99 11.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.632 -1.167 . . . . 50.0 107.897 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 C--O 1.253 1.264 0 CA-C-O 116.544 -1.693 . . . . 50.0 113.051 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.137 0 N-CA-C 111.423 -0.671 . . . . 25.0 111.423 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -108.88 135.99 49.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.38 0.272 . . . . 25.0 111.247 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.6 mt -93.98 114.38 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.27 -1.381 . . . . 25.0 107.27 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.12 -43.37 9.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.86 -0.792 . . . . 50.0 108.86 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -137.47 149.4 65.18 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 107.763 -1.199 . . . . 25.0 107.763 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.81 105.07 0.64 Allowed 'Cis proline' 0 CA--C 1.539 0.757 0 C-N-CA 131.102 1.709 . . . . 25.0 113.143 -3.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.71 -166.41 46.52 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.776 -0.726 . . . . 50.0 111.873 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 t -139.95 154.54 47.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.565 -0.531 . . . . 25.0 109.565 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.1 -20.85 57.3 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 116.391 -0.368 . . . . 50.0 111.701 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.52 66.53 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.914 0.709 . . . . 25.0 112.914 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.33 70.63 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.96 -11.36 39.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.036 0.446 . . . . 50.0 110.615 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.8 t . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 120.884 0.373 . . . . 50.0 111.373 -177.921 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 121.045 0.45 . . . . 50.0 110.772 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.5 ptm -62.69 -27.01 68.95 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.391 -0.818 . . . . 25.0 111.31 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.21 -28.87 31.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.542 0.687 . . . . 50.0 110.03 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -115.95 61.51 1.97 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.749 -0.659 . . . . 25.0 112.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.61 -38.62 3.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 114.169 -3.421 . . . . 50.0 113.335 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -105.69 -32.55 8.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.391 0.885 . . . . 50.0 113.391 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 m -102.14 78.26 1.75 Allowed 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 109.133 -0.692 . . . . 50.0 109.133 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -107.58 109.97 21.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.228 -1.027 . . . . 50.0 108.228 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.913 0.708 . . . . 50.0 112.913 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.35 103.91 4.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.565 0.58 . . . . 25.0 112.565 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 107.068 -1.456 . . . . 50.0 107.068 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.65 0 N-CA-C 113.478 0.151 . . . . 50.0 113.478 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.04 -21.46 66.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.522 0.329 . . . . 25.0 111.712 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -63.98 -13.0 42.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.117 0.414 . . . . 25.0 112.117 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.89 -14.64 56.25 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.432 -0.413 . . . . 50.0 113.732 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.86 -21.72 65.73 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 117.773 0.787 . . . . 50.0 112.796 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -66.44 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.887 -0.783 . . . . 50.0 108.887 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.39 -31.71 58.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 50.0 111.061 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.79 -49.89 76.01 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.32 0.581 . . . . 50.0 110.4 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -75.27 2.11 11.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -119.92 19.15 12.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.91 0.862 . . . . 25.0 109.61 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.0 t -107.47 177.18 4.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 25.0 110.614 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -80.95 -18.05 48.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.101 -1.074 . . . . 50.0 108.101 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -95.38 14.84 21.18 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.166 -0.925 . . . . 50.0 109.651 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.86 146.05 33.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.047 -1.094 . . . . 50.0 108.047 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -80.69 140.84 35.41 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.55 -0.907 . . . . 50.0 108.55 -176.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -58.33 142.45 48.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 25.0 112.645 -171.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -126.23 147.89 49.58 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.365 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -126.28 151.04 48.02 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.153 -0.684 . . . . 25.0 109.153 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -94.76 143.01 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.841 -1.911 . . . . 25.0 105.841 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.6 ttp -151.0 166.89 29.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.205 -0.295 . . . . 50.0 110.205 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.1 p -103.96 171.96 7.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.38 -2.081 . . . . 25.0 105.38 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.04 -169.41 7.52 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.361 0.423 . . . . 25.0 114.117 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.92 -172.74 20.21 Favored Glycine 0 N--CA 1.459 0.222 0 O-C-N 122.405 -0.467 . . . . 50.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -75.82 135.66 40.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.952 -0.734 . . . . 25.0 109.424 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -129.24 152.11 49.17 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.26 -1.015 . . . . 50.0 108.26 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.8 m -117.7 134.84 54.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.455 . . . . 25.0 110.136 -174.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.73 111.99 23.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.781 -1.933 . . . . 50.0 105.781 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.4 m -120.37 110.78 16.93 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.99 141.38 52.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 104.699 -2.334 . . . . 50.0 104.699 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.6 t -145.01 161.97 38.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.553 0.216 . . . . 25.0 110.657 -173.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -125.43 150.73 47.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -72.39 -17.41 61.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 159.69 61.09 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.0 140.49 60.49 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 114.553 -3.165 . . . . 25.0 110.355 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -130.91 147.17 52.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.547 -1.279 . . . . 50.0 107.547 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -68.01 146.9 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.455 -1.313 . . . . 50.0 107.455 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.4 p -140.37 146.71 38.76 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.322 -1.362 . . . . 25.0 107.322 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -110.23 -50.16 2.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.905 0.383 . . . . 50.0 110.082 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -158.95 147.59 18.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.03 -0.419 . . . . 50.0 109.927 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -135.18 144.29 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 166.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -148.04 159.13 44.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.472 -0.566 . . . . 50.0 109.472 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.35 149.91 47.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.653 0.74 . . . . 50.0 112.08 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.74 165.95 20.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.051 -1.463 . . . . 50.0 107.051 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 pt -130.03 159.1 42.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.598 -0.89 . . . . 25.0 108.598 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.9 m -111.72 115.95 29.94 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -89.99 112.02 23.29 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -76.11 153.96 35.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.014 -1.106 . . . . 25.0 108.014 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.33 31.95 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 116.011 1.164 . . . . 25.0 116.011 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -60.2 153.74 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.765 0.783 . . . . 50.0 110.102 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.52 147.1 98.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 50.0 107.767 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.91 -20.0 34.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 117.828 -0.982 . . . . 50.0 114.468 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.11 -23.71 63.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.027 0.918 . . . . 50.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -96.04 136.19 22.29 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.901 -1.148 . . . . 50.0 107.901 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.49 126.56 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 116.726 -1.716 . . . . 50.0 114.372 -172.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 tt -52.76 -39.44 62.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.421 -1.263 . . . . 50.0 111.726 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.04 -16.06 63.04 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -83.06 -41.72 18.29 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.965 -0.459 . . . . 50.0 110.831 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.84 60.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -31.51 71.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.164 -0.471 . . . . 50.0 112.041 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -125.98 111.67 15.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.784 0.661 . . . . 25.0 112.784 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -128.18 121.14 28.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.52 124.26 23.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.227 -0.296 . . . . 50.0 110.746 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -14.96 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.985 -0.746 . . . . 25.0 108.985 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.51 154.43 10.22 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.298 -0.953 . . . . 50.0 113.965 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.66 137.25 36.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.88 87.47 48.98 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.0 157.65 46.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.275 -1.35 . . . . 50.0 111.339 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -112.21 99.11 7.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.195 -1.039 . . . . 50.0 108.195 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.29 4.21 9.15 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.552 -1.647 . . . . 50.0 106.552 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.52 -179.1 45.13 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 103.401 -3.88 . . . . 25.0 103.401 -175.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -139.51 65.58 33.76 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 116.12 1.896 . . . . 25.0 116.12 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 175.71 9.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 116.884 -1.611 . . . . 50.0 109.565 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.87 56.2 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.045 0.757 . . . . 25.0 113.045 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.3 t -60.36 -24.55 65.17 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.193 0.52 . . . . 25.0 112.28 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.97 7.1 47.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.384 0.673 . . . . 50.0 112.532 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -58.37 141.28 51.78 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.542 -1.651 . . . . 50.0 106.542 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -35.6 80.81 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.376 0.534 . . . . 50.0 111.883 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.4 t -86.09 124.84 32.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.769 -0.826 . . . . 50.0 108.769 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -120.58 149.76 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.735 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -112.35 131.72 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.119 -1.808 . . . . 50.0 106.119 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.2 mm -132.0 128.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -79.79 132.81 36.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.954 -1.128 . . . . 50.0 107.954 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.6 mm -119.42 123.07 28.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.09 162.97 39.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 117.355 -1.296 . . . . 25.0 112.523 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.91 28.71 8.18 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.919 -1.511 . . . . 50.0 106.919 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.15 -18.63 63.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.852 -1.067 . . . . 50.0 113.566 -172.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -156.81 150.29 24.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.258 0.552 . . . . 50.0 109.959 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.83 154.18 19.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.898 -1.046 . . . . 50.0 108.718 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.27 -176.33 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 121.509 0.505 . . . . 25.0 112.105 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -80.74 145.02 31.74 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.78 0.659 . . . . 50.0 112.78 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -132.66 116.05 16.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 t -93.28 138.12 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.996 -0.742 . . . . 50.0 108.996 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 120.69 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 mp -104.51 141.08 37.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.804 -1.184 . . . . 50.0 107.804 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.67 132.92 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.827 0.739 . . . . 25.0 112.206 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.33 137.41 57.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 50.0 109.012 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -120.65 112.54 19.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.763 -1.569 . . . . 50.0 106.763 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.78 133.1 34.36 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.553 -1.203 . . . . 50.0 109.444 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.24 121.96 68.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.542 -0.91 . . . . 50.0 108.542 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -13.6 61.58 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.747 0.647 . . . . 25.0 112.747 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -81.31 -13.64 58.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.702 0.63 . . . . 50.0 112.702 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.3 p -144.31 159.77 42.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.33 0.863 . . . . 25.0 113.33 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -79.45 3.82 17.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 50.0 110.722 171.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -110.13 171.04 7.69 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.742 -0.836 . . . . 50.0 108.742 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.47 161.29 40.06 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.421 0.629 . . . . 25.0 109.925 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -96.45 130.39 43.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.545 -0.909 . . . . 50.0 108.545 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -132.31 139.13 48.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.694 0.627 . . . . 50.0 112.694 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.71 154.24 39.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.119 -0.697 . . . . 50.0 109.119 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.2 p -136.98 137.25 47.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.374 -2.454 . . . . 50.0 104.374 171.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.6 mt -132.2 130.73 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -111.97 139.12 47.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.65 -1.241 . . . . 25.0 107.65 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.81 126.91 60.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.442 0.639 . . . . 25.0 109.921 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -85.97 102.04 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.778 -1.564 . . . . 50.0 106.778 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.21 117.33 33.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.537 -0.912 . . . . 50.0 108.537 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 25.7 m -136.45 163.19 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.017 -0.538 . . . . 50.0 111.023 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -89.99 155.27 19.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.007 -1.849 . . . . 50.0 106.007 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . 0.456 ' HZ3' ' C ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.991 -1.004 . . . . 50.0 110.095 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.267 0 N-CA-C 106.147 -2.781 . . . . 25.0 106.147 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.19 148.12 36.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.441 1.121 . . . . 25.0 111.021 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.23 112.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 104.025 -2.583 . . . . 25.0 104.025 170.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.48 2.69 13.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.709 0.633 . . . . 50.0 112.709 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 74.15 151.66 0.14 Allowed Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 125.752 1.621 . . . . 25.0 110.003 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.53 153.78 89.52 Favored 'Cis proline' 0 C--O 1.222 -0.283 0 CA-C-O 121.733 0.639 . . . . 25.0 112.203 -1.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.56 14.8 13.37 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 117.081 1.592 . . . . 50.0 117.081 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -65.86 125.36 25.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.632 1.216 . . . . 25.0 111.431 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -78.51 -19.64 52.54 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.441 0.534 . . . . 50.0 112.441 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.66 67.93 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.146 0.278 . . . . 25.0 111.091 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.02 -31.52 72.67 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 120.693 0.283 . . . . 25.0 111.315 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.98 -3.88 55.3 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 116.43 -0.35 . . . . 50.0 111.164 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.487 . . . . 50.0 109.684 179.464 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 120.861 0.362 . . . . 50.0 111.167 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.7 ptm -58.6 -10.88 2.5 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 117.77 2.507 . . . . 25.0 117.77 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -69.4 -39.84 77.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.43 0.559 . . . . 50.0 110.85 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.37 64.59 2.52 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 113.571 0.952 . . . . 25.0 113.571 173.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.37 -8.87 24.63 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 118.185 -0.743 . . . . 50.0 113.754 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 pm0 -97.85 4.37 49.68 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.823 0.675 . . . . 50.0 112.823 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -100.74 98.73 9.23 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 118.573 0.624 . . . . 75.0 111.16 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.7 mt -90.47 117.7 29.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.978 -2.23 . . . . 50.0 104.978 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -84.21 141.31 31.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.725 0.297 . . . . 50.0 110.632 -175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.96 157.71 46.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.012 -1.477 . . . . 25.0 107.012 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttm . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.498 0.666 . . . . 50.0 111.703 178.379 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.4 0 N-CA-C 112.35 -0.3 . . . . 50.0 112.35 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.24 -24.94 63.17 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.401 -0.47 . . . . 25.0 111.493 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.01 -26.64 67.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.91 0.386 . . . . 25.0 111.349 175.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.25 -25.68 75.05 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 110.673 -0.971 . . . . 50.0 110.673 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.49 71.62 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 121.25 -0.5 . . . . 50.0 112.846 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.42 -42.61 84.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.929 -1.137 . . . . 50.0 107.929 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.06 -26.42 56.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 50.0 111.227 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -21.65 64.87 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.425 0.631 . . . . 50.0 111.674 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -68.84 -3.78 13.79 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.816 -0.553 . . . . 25.0 112.41 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -132.69 55.68 1.88 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -135.71 157.8 45.98 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.979 -0.378 . . . . 25.0 109.979 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -71.95 -25.11 61.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.688 0.756 . . . . 50.0 109.138 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -97.55 18.84 14.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.711 . . . . 50.0 110.492 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -52.71 142.22 19.13 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.564 0.697 . . . . 50.0 111.634 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -69.02 143.82 54.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.555 1.169 . . . . 50.0 109.778 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -75.36 131.29 40.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.587 -0.733 . . . . 25.0 111.562 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -91.62 146.34 23.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.813 -0.63 . . . . 25.0 111.121 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -131.76 114.32 14.59 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.173 -0.306 . . . . 25.0 110.173 168.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -73.47 135.54 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.063 -2.199 . . . . 25.0 105.063 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.1 tpt -150.42 154.15 37.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.253 -0.647 . . . . 50.0 109.253 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 p -93.0 -177.17 4.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.189 -1.411 . . . . 25.0 107.189 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -166.53 31.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.87 -0.492 . . . . 25.0 111.87 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.78 -178.94 30.05 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 112.16 -0.376 . . . . 50.0 112.16 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.99 133.89 36.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -126.03 121.81 34.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.414 0.626 . . . . 50.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.3 m -91.75 126.92 37.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.982 -1.118 . . . . 25.0 107.982 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -119.06 125.91 50.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.172 -0.677 . . . . 50.0 109.172 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -123.54 130.76 53.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 25.0 111.347 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.1 m0 -123.66 147.91 46.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.628 -2.73 . . . . 50.0 103.628 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -136.54 161.06 36.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.16 0.505 . . . . 25.0 109.723 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.05 137.88 47.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.7 t -79.32 -9.13 59.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.93 60.85 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 106.268 -1.752 . . . . 25.0 106.268 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.26 144.75 47.0 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 116.203 -2.065 . . . . 25.0 111.92 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -131.07 139.74 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.197 -1.409 . . . . 50.0 107.197 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -71.26 148.39 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.231 -1.396 . . . . 50.0 107.231 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -149.95 141.89 23.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.7 t -92.44 -47.26 7.25 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.756 0.422 . . . . 50.0 109.998 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -165.61 168.65 16.15 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.162 -0.336 . . . . 50.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -139.58 140.19 36.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 167.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -145.86 156.37 43.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.389 -0.369 . . . . 50.0 110.748 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -133.14 144.78 50.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.874 -0.603 . . . . 50.0 111.02 -167.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -137.12 165.53 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.325 -0.991 . . . . 50.0 108.325 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 28.2 pt -134.74 152.2 32.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.686 -1.227 . . . . 25.0 107.686 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 p -85.13 141.95 29.84 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -88.33 121.31 30.58 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 113.255 0.835 . . . . 25.0 113.255 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -86.5 150.78 24.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.443 -1.317 . . . . 25.0 107.443 169.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.29 64.1 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.072 1.589 . . . . 25.0 117.072 173.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -61.19 154.32 23.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.678 1.239 . . . . 50.0 110.735 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.63 154.43 44.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 50.0 109.907 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.62 -7.39 16.7 Favored 'Trans proline' 0 C--N 1.351 0.707 0 N-CA-C 116.084 1.532 . . . . 50.0 116.084 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.16 -8.1 55.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.141 0.972 . . . . 50.0 110.096 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -123.74 150.14 61.12 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.192 -0.67 . . . . 50.0 109.192 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.7 111.36 1.88 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 117.321 -1.319 . . . . 50.0 111.797 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.84 -44.06 66.48 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.226 -0.897 . . . . 50.0 113.23 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.68 -27.22 68.54 Favored 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.92 -41.78 50.79 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.337 0.589 . . . . 50.0 110.209 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.46 6.37 23.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.943 -1.026 . . . . 25.0 112.953 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.07 -38.83 82.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.848 0.684 . . . . 50.0 112.848 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -133.62 156.77 47.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.957 -0.464 . . . . 25.0 111.605 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -133.53 146.31 50.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.033 -0.728 . . . . 25.0 109.033 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.4 tp -77.59 127.18 32.07 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 50.0 109.277 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 tt -106.08 -3.37 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.693 0.759 . . . . 25.0 110.984 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.23 156.12 8.29 Favored Glycine 0 C--O 1.229 -0.175 0 C-N-CA 120.469 -0.872 . . . . 50.0 113.948 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.35 137.18 22.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.681 -1.229 . . . . 25.0 107.681 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.19 109.45 10.55 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.69 161.7 36.38 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 116.228 -2.048 . . . . 50.0 111.965 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -122.96 92.66 3.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.383 -0.969 . . . . 50.0 108.383 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -175.62 -94.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 N-CA-C 99.897 -4.112 . . . . 50.0 99.897 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -97.87 143.27 16.59 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 105.32 -3.112 . . . . 25.0 105.32 167.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.6 155.82 13.35 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.67 -167.3 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 O-C-N 122.265 0.613 . . . . 50.0 111.017 174.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.75 24.2 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.662 0.616 . . . . 25.0 112.662 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.8 1.07 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.927 1.454 . . . . 25.0 114.927 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -58.66 -13.84 6.91 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.421 1.267 . . . . 50.0 114.421 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -59.12 144.12 46.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.686 0.755 . . . . 50.0 112.714 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.6 tp -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.983 -1.008 . . . . 50.0 112.395 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.6 t -94.45 123.37 37.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.282 -1.007 . . . . 50.0 108.282 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -103.99 133.72 48.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 25.0 110.742 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -99.82 134.1 43.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 50.0 109.563 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.9 mt -132.95 119.67 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -85.82 138.01 32.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.785 -0.45 . . . . 50.0 109.785 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.45 124.87 26.21 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.46 153.57 50.02 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 116.381 -1.946 . . . . 25.0 111.403 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -108.1 51.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.66 1.219 . . . . 50.0 109.302 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -103.72 -6.2 21.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.639 -1.164 . . . . 50.0 111.2 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -161.0 157.74 26.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.283 0.563 . . . . 50.0 112.41 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -116.72 153.87 31.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.584 -0.735 . . . . 50.0 110.334 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 133.31 140.26 4.35 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 113.851 0.3 . . . . 25.0 113.851 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -85.83 145.95 26.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 116.272 1.953 . . . . 50.0 116.272 -173.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -149.55 167.05 27.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -98.06 150.51 4.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.894 0.854 . . . . 50.0 111.965 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.7 mt -106.94 131.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.311 -2.848 . . . . 25.0 103.311 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.0 mt -110.12 143.97 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.468 -1.679 . . . . 50.0 106.468 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.63 148.49 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.612 -0.885 . . . . 25.0 108.612 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.14 139.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.622 -0.717 . . . . 50.0 109.563 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -126.5 103.23 7.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.596 -0.89 . . . . 50.0 108.596 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -94.15 138.19 32.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.238 -0.289 . . . . 50.0 110.8 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.5 t -117.6 132.01 68.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.056 -1.461 . . . . 50.0 107.056 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.54 -41.42 46.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 25.0 110.524 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -10.92 60.37 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.12 1.896 . . . . 50.0 116.12 -170.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.8 p -126.37 158.25 36.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.966 -0.459 . . . . 25.0 110.519 -176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -74.44 -10.17 59.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 50.0 111.588 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -103.76 158.67 16.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.412 0.625 . . . . 50.0 110.451 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.83 162.92 34.2 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.465 -3.161 . . . . 25.0 102.465 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.31 150.59 45.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.516 0.562 . . . . 50.0 112.516 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.65 153.92 41.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.29 -1.374 . . . . 50.0 107.29 174.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.95 154.21 41.67 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.334 -1.358 . . . . 50.0 107.334 176.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.83 141.86 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.886 0.374 . . . . 50.0 110.324 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 62.9 mt -133.58 122.6 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.28 -1.378 . . . . 25.0 107.28 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -87.81 131.6 34.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.549 -1.649 . . . . 25.0 106.549 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.38 132.59 70.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.827 -0.805 . . . . 25.0 108.827 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.9 95.76 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 104.929 -2.248 . . . . 50.0 104.929 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.58 121.8 32.12 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.254 -1.758 . . . . 50.0 106.254 -173.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.0 m -135.19 166.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 123.231 0.332 . . . . 50.0 111.448 -175.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.38 141.11 28.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.249 -1.389 . . . . 50.0 107.249 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.8 tptt . . . . . 0 C--O 1.246 0.917 0 N-CA-C 115.564 1.69 . . . . 50.0 115.564 177.38 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.555 0 N-CA-C 117.364 1.706 . . . . 25.0 117.364 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -128.02 153.0 47.26 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.602 0.761 . . . . 25.0 111.956 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 93.7 mt -93.83 119.34 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 103.665 -2.717 . . . . 25.0 103.665 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -90.08 -43.33 10.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.535 -0.543 . . . . 50.0 109.535 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -138.79 149.68 62.9 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 109.8 1.48 Allowed 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 132.306 2.211 . . . . 25.0 115.299 -1.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.38 -176.76 26.81 Favored Glycine 0 C--O 1.226 -0.405 0 N-CA-C 114.631 0.612 . . . . 50.0 114.631 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.483 ' HG ' ' H ' ' A' ' 11' ' ' ALA . 45.7 t -82.97 134.77 35.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.485 -0.421 . . . . 25.0 111.065 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -78.11 -26.32 47.94 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.919 0.39 . . . . 50.0 111.051 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.483 ' H ' ' HG ' ' A' ' 9' ' ' SER . . . -72.91 -33.34 65.92 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.873 0.694 . . . . 25.0 112.873 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.07 71.9 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 120.785 0.326 . . . . 25.0 111.184 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.47 -4.38 55.6 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.054 -0.521 . . . . 50.0 111.743 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 50.0 111.577 -175.325 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.843 0.354 . . . . 50.0 110.36 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -63.94 -11.06 24.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -79.04 -35.98 41.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.659 -0.496 . . . . 50.0 109.659 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.66 79.25 9.56 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 175.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.53 -15.89 46.01 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 115.938 -2.241 . . . . 50.0 112.44 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -85.4 -22.08 28.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.718 -0.658 . . . . 50.0 112.437 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -132.99 94.02 3.29 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 114.732 1.382 . . . . 75.0 114.732 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.15 114.79 28.82 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.165 -1.05 . . . . 50.0 108.165 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -114.5 142.21 46.7 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.427 0.454 . . . . 50.0 110.358 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 104.16 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.475 -0.565 . . . . 25.0 109.475 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.969 0.89 . . . . 50.0 112.933 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.687 0 N-CA-C 113.833 0.293 . . . . 50.0 113.833 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.2 mt -61.89 -23.28 66.21 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 112.585 0.587 . . . . 25.0 112.585 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -71.06 -13.12 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.205 -0.309 . . . . 25.0 111.692 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.25 -16.65 60.53 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.114 0.805 . . . . 50.0 115.114 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.3 -26.14 69.12 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-N 118.121 0.961 . . . . 50.0 112.389 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.2 mm -68.03 -33.91 63.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.112 -0.64 . . . . 50.0 110.007 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -77.53 -19.3 55.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.206 -0.309 . . . . 50.0 111.256 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.96 -21.56 64.91 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.625 0.602 . . . . 50.0 112.625 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -56.03 -21.4 21.36 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.678 0.622 . . . . 25.0 112.678 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -138.75 51.73 1.81 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.174 0.511 . . . . 25.0 109.751 177.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 t -118.78 162.83 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 25.0 111.255 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.87 -32.48 74.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.827 0.822 . . . . 50.0 110.283 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -94.48 16.43 15.34 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.659 -0.701 . . . . 50.0 112.633 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -61.07 150.25 34.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.961 -1.496 . . . . 50.0 106.961 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -97.02 156.4 16.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.042 -1.096 . . . . 50.0 108.042 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.06 121.93 3.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -76.24 108.08 8.92 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.799 -0.445 . . . . 25.0 109.799 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 105.93 16.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.362 0.601 . . . . 25.0 112.117 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -64.18 142.86 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.028 -0.731 . . . . 25.0 109.028 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 tpt -146.82 151.87 37.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.849 -1.167 . . . . 50.0 107.849 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -101.95 171.99 7.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.455 -1.313 . . . . 25.0 107.455 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.08 177.57 19.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.81 0.684 . . . . 25.0 114.81 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.16 177.1 31.79 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 112.399 -0.281 . . . . 50.0 112.399 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.06 132.73 36.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.942 -0.74 . . . . 25.0 109.733 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -135.33 141.78 45.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.888 0.375 . . . . 50.0 110.448 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.9 m -84.34 118.75 24.42 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -93.03 111.92 23.71 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.443 -2.058 . . . . 50.0 105.443 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -90.67 118.74 30.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.93 -0.577 . . . . 25.0 111.192 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -122.92 139.49 53.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.757 -2.312 . . . . 50.0 104.757 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -145.01 161.84 38.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 25.0 111.95 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.87 136.87 52.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.076 -2.564 . . . . 25.0 104.076 173.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.7 t -72.82 -15.91 61.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.382 0.882 . . . . 25.0 113.382 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 153.81 67.74 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 104.752 -2.314 . . . . 25.0 104.752 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 130.73 25.24 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 115.525 -2.517 . . . . 25.0 111.574 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -130.93 153.34 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.02 -1.104 . . . . 50.0 108.02 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -65.08 143.2 58.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.563 -1.643 . . . . 50.0 106.563 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -144.78 147.26 32.69 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.378 -2.453 . . . . 25.0 104.378 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -116.99 -47.15 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.099 0.777 . . . . 50.0 113.099 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -159.12 153.29 23.7 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.518 -0.739 . . . . 50.0 112.388 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.39 132.34 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.161 0.505 . . . . 25.0 109.73 167.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -136.89 142.57 42.75 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.864 -1.532 . . . . 50.0 106.864 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.85 151.52 39.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.774 0.797 . . . . 50.0 111.614 -166.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.48 168.94 18.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.61 -1.177 . . . . 50.0 109.064 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.78 149.11 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.115 -0.328 . . . . 25.0 110.115 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.5 m -88.5 117.19 27.28 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.192 -0.458 . . . . 25.0 110.025 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.18 125.16 34.47 Favored 'General case' 0 C--O 1.209 -1.057 0 O-C-N 121.334 -0.854 . . . . 25.0 110.949 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -76.86 154.08 34.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 106.531 -1.655 . . . . 25.0 106.531 168.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.01 10.21 56.45 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 119.349 2.499 . . . . 25.0 119.349 170.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -61.02 153.33 25.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.958 1.379 . . . . 50.0 110.699 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.51 152.05 95.46 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.337 -1.357 . . . . 50.0 107.337 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 -19.8 47.3 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 117.646 -1.102 . . . . 50.0 114.868 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.18 -18.62 62.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.822 0.82 . . . . 50.0 111.67 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -96.13 128.86 35.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.483 -0.761 . . . . 50.0 109.866 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.14 126.28 16.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.588 -1.141 . . . . 50.0 114.223 -173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.12 -42.94 66.51 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.525 -1.216 . . . . 50.0 113.213 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -69.01 -17.35 63.9 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 113.046 0.758 . . . . 25.0 113.046 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -77.15 -45.63 26.12 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 109.335 -0.617 . . . . 50.0 109.335 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.64 67.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.364 0.602 . . . . 25.0 112.216 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -71.04 -29.03 64.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 50.0 110.538 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.46 92.12 3.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.259 0.552 . . . . 25.0 109.712 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -99.75 110.13 22.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -62.82 117.25 6.09 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.857 -0.423 . . . . 50.0 109.857 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -2.53 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 107.382 -1.34 . . . . 25.0 107.382 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.22 151.05 6.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.778 . . . . 50.0 114.639 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -143.04 122.66 13.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.057 -1.831 . . . . 25.0 106.057 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.09 117.95 11.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.35 175.38 11.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 115.962 -2.225 . . . . 50.0 110.259 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -128.56 92.36 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.253 -2.128 . . . . 50.0 105.253 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.0 -19.94 13.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.681 -1.6 . . . . 50.0 107.711 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.76 -179.35 30.78 Favored Glycine 0 N--CA 1.445 -0.764 1 N-CA-C 103.013 -4.035 . . . . 25.0 103.013 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -116.65 36.75 0.22 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 117.16 2.281 . . . . 25.0 117.16 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.88 170.57 18.5 Favored 'Trans proline' 0 C--N 1.355 0.876 1 C-N-CA 113.225 -4.05 . . . . 50.0 110.333 171.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.11 55.43 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.294 1.22 . . . . 25.0 114.294 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.8 p -70.51 -19.81 62.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.1 mmt-85 -100.96 10.72 40.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.274 0.63 . . . . 50.0 112.478 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -58.05 156.8 8.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.028 1.862 . . . . 50.0 116.028 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.73 -22.4 59.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.344 -1.298 . . . . 50.0 111.662 176.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 65.1 m -100.04 140.55 34.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.55 -1.278 . . . . 50.0 107.55 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -129.57 136.86 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.339 0.866 . . . . 25.0 113.339 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -79.37 126.8 31.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.543 -1.651 . . . . 50.0 106.543 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -131.91 125.81 55.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.705 -1.221 . . . . 25.0 107.705 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -85.85 133.33 33.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.791 -0.818 . . . . 50.0 108.791 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -108.84 129.67 23.65 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.844 -1.539 . . . . 25.0 106.844 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -66.27 146.58 81.47 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 117.127 -1.449 . . . . 25.0 111.92 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -110.57 -12.54 14.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.055 0.931 . . . . 50.0 110.857 -173.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.0 4.22 45.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.839 1.052 . . . . 50.0 113.839 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -151.78 151.65 31.65 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 121.844 -0.535 . . . . 50.0 112.145 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.32 141.57 47.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.286 -0.87 . . . . 50.0 109.49 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.74 163.49 10.49 Favored Glycine 0 CA--C 1.517 0.178 0 N-CA-C 115.11 0.804 . . . . 25.0 115.11 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -86.92 145.04 26.69 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.504 0.927 . . . . 50.0 113.504 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -144.5 159.09 43.35 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 105.861 -1.904 . . . . 25.0 105.861 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.83 136.31 50.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 106.894 -1.521 . . . . 50.0 106.894 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.7 mt -96.04 120.16 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.155 -2.535 . . . . 25.0 104.155 174.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.5 mt -105.5 137.48 43.26 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.31 146.64 32.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.101 0.864 . . . . 25.0 112.321 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.03 135.43 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.64 -1.615 . . . . 50.0 106.64 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -130.06 117.45 20.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.606 0.717 . . . . 50.0 110.01 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.7 132.0 38.49 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.865 -1.061 . . . . 50.0 109.998 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.0 t -135.18 134.74 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.732 -1.951 . . . . 50.0 105.732 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.0 -10.04 19.29 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.204 1.557 . . . . 25.0 115.204 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -102.29 18.22 21.52 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 50.0 110.457 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.2 p -133.0 151.16 52.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -70.22 -18.13 63.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.665 0.269 . . . . 50.0 111.656 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.16 171.93 7.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.061 -0.518 . . . . 50.0 111.87 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 159.53 26.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.683 -1.969 . . . . 25.0 105.683 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -111.35 145.59 38.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.302 1.223 . . . . 50.0 114.302 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -123.5 139.7 53.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.204 -0.907 . . . . 50.0 108.734 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -149.57 142.1 24.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.417 -1.327 . . . . 50.0 107.417 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 m -135.59 151.06 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.305 -1.369 . . . . 50.0 107.305 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.08 110.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.006 -1.479 . . . . 25.0 107.006 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -77.53 131.74 38.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.321 -1.733 . . . . 25.0 106.321 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.0 157.93 41.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.789 -0.569 . . . . 25.0 110.605 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -123.58 108.29 12.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.344 -1.724 . . . . 50.0 106.344 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.77 103.99 16.0 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.81 -1.552 . . . . 50.0 106.81 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.45 171.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.825 0.345 . . . . 50.0 111.319 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.02 152.67 32.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.9 -1.148 . . . . 50.0 107.9 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.896 0 CA-C-O 117.844 -1.074 . . . . 50.0 109.599 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.285 0 N-CA-C 110.559 -1.016 . . . . 25.0 110.559 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.08 133.24 36.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.995 0.398 . . . . 25.0 110.347 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.68 112.32 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 106.498 -1.668 . . . . 25.0 106.498 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.61 -43.5 10.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.95 -0.568 . . . . 50.0 110.798 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -140.55 158.09 66.71 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 107.862 -1.162 . . . . 25.0 107.862 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.14 116.57 4.53 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 131.672 1.947 . . . . 25.0 113.955 -2.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.23 -149.48 45.27 Favored Glycine 0 C--O 1.226 -0.367 0 N-CA-C 110.201 -1.16 . . . . 50.0 110.201 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -131.43 110.77 11.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.239 0.542 . . . . 25.0 110.553 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -20.73 65.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.994 -0.548 . . . . 50.0 111.004 176.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -24.13 67.7 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.104 0.253 . . . . 25.0 111.577 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.65 93.89 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 120.852 -0.339 . . . . 25.0 110.281 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.53 -16.8 61.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.269 0.557 . . . . 50.0 111.147 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.547 -0.751 . . . . 50.0 110.099 -177.693 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 t . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 112.482 0.549 . . . . 50.0 112.482 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -70.34 -27.95 64.76 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.763 -0.586 . . . . 25.0 112.542 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.17 -16.28 25.03 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.378 1.085 . . . . 50.0 108.541 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.66 60.09 0.84 Allowed Pre-proline 0 C--O 1.245 0.86 0 CA-C-N 115.176 -0.92 . . . . 25.0 111.733 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.71 -39.86 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 113.558 -3.828 . . . . 50.0 114.348 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -104.24 -23.44 13.24 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.476 1.288 . . . . 50.0 114.476 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.49 114.16 21.86 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 104.567 -2.383 . . . . 75.0 104.567 173.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -133.38 105.05 6.72 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 106.487 -1.671 . . . . 50.0 106.487 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -128.62 141.01 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.22 0.533 . . . . 50.0 112.18 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.07 102.86 5.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm . . . . . 0 C--N 1.327 -0.401 0 N-CA-C 105.037 -2.208 . . . . 50.0 105.037 -174.312 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.709 0 N-CA-C 115.079 0.791 . . . . 50.0 115.079 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -59.84 -35.94 75.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.573 0.953 . . . . 25.0 113.573 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -65.03 -11.82 43.54 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.841 0.682 . . . . 25.0 112.841 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.94 48.34 Favored Glycine 0 C--O 1.22 -0.74 0 CA-C-O 119.713 -0.493 . . . . 50.0 113.663 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.55 -22.9 73.56 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 117.962 0.881 . . . . 50.0 112.673 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -86.31 -36.98 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.325 -0.991 . . . . 50.0 108.325 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.31 -10.86 60.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 50.0 111.9 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -30.57 64.55 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 111.654 0.242 . . . . 50.0 111.654 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.92 -8.64 11.84 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.259 1.207 . . . . 25.0 114.259 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -127.8 24.25 6.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.418 0.628 . . . . 25.0 109.867 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 t -98.5 164.96 12.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.244 -0.435 . . . . 25.0 110.983 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.67 -33.38 74.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.61 0.719 . . . . 50.0 109.148 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -94.89 19.03 10.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.002 -0.545 . . . . 50.0 112.053 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -47.63 136.37 10.41 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.345 0.869 . . . . 50.0 113.345 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -89.68 159.06 17.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.788 . . . . 50.0 109.227 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -65.52 132.91 50.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -80.78 143.24 33.01 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.47 -0.787 . . . . 25.0 109.717 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 96.57 4.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.898 0.703 . . . . 25.0 112.898 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -69.25 138.43 22.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.152 -2.536 . . . . 25.0 104.152 168.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.5 tpt -145.42 146.55 31.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.23 -0.655 . . . . 50.0 109.23 -176.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p -95.0 172.04 8.39 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.81 -174.97 5.48 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 116.648 1.419 . . . . 25.0 116.648 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.84 177.08 35.18 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 115.035 -0.583 . . . . 50.0 113.031 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.97 132.63 34.17 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.034 -0.686 . . . . 25.0 110.86 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -132.61 137.92 47.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 50.0 109.515 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 m -101.97 137.49 40.19 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.596 0.961 . . . . 25.0 113.596 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.29 129.73 55.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.901 -1.518 . . . . 50.0 106.901 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -137.77 129.56 28.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.993 -0.373 . . . . 25.0 109.993 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -124.01 143.36 50.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.035 -1.839 . . . . 50.0 106.035 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -145.01 156.92 44.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.7 0.286 . . . . 25.0 111.168 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -139.78 163.98 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -71.28 -19.38 62.35 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.501 0.926 . . . . 25.0 113.501 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.77 147.34 48.11 Favored Pre-proline 0 C--O 1.238 0.468 0 O-C-N 121.943 -0.473 . . . . 25.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.86 149.71 37.79 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 117.689 -1.074 . . . . 25.0 111.734 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -130.94 161.65 31.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 50.0 109.199 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -65.86 131.09 45.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.563 -1.273 . . . . 50.0 107.563 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.4 p -143.63 152.22 41.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.256 -1.387 . . . . 25.0 107.256 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.2 t -103.3 -56.84 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.494 0.924 . . . . 50.0 113.494 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -159.01 150.43 20.45 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.849 -0.532 . . . . 50.0 110.644 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 131.12 52.4 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.008 -1.478 . . . . 25.0 107.008 169.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -147.84 158.96 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.528 -0.305 . . . . 50.0 110.729 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -145.32 150.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.705 0.764 . . . . 50.0 112.239 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -128.36 154.8 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.606 -1.179 . . . . 50.0 108.12 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.01 149.36 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.907 0.706 . . . . 25.0 112.907 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.1 m -86.79 121.82 29.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -108.05 125.53 51.67 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 121.74 -0.6 . . . . 25.0 111.759 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -75.9 148.29 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.202 -1.777 . . . . 25.0 106.202 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.58 9.91 34.47 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 117.229 1.652 . . . . 25.0 117.229 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -83.05 161.5 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.615 1.208 . . . . 50.0 110.56 175.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.63 140.35 78.38 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.048 -0.723 . . . . 50.0 109.048 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.26 -13.51 20.87 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 114.492 0.92 . . . . 50.0 114.492 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.44 -13.97 61.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.114 0.959 . . . . 50.0 111.621 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.22 148.21 52.47 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.102 -1.814 . . . . 50.0 106.102 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.96 93.82 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-O 121.55 0.562 . . . . 50.0 112.717 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -36.35 61.13 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 114.367 1.247 . . . . 50.0 114.367 -174.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -61.39 -28.04 68.96 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.186 -0.606 . . . . 25.0 112.305 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -84.65 -46.02 11.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.043 0.449 . . . . 50.0 110.946 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.38 57.54 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 115.705 1.743 . . . . 25.0 115.705 -169.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -64.99 -30.71 71.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 50.0 111.335 -172.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -126.15 108.88 11.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.787 -0.82 . . . . 25.0 108.787 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -103.1 132.19 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.525 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.51 127.94 33.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.037 -0.727 . . . . 50.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.92 0.74 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.944 0.878 . . . . 25.0 110.031 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.46 140.8 4.72 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.363 -0.922 . . . . 50.0 112.863 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 132.86 15.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.67 109.6 12.14 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.069 -1.086 . . . . 25.0 108.069 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.0 164.69 22.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.482 -1.879 . . . . 50.0 111.72 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -103.84 106.86 17.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.025 -1.472 . . . . 50.0 107.025 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -114.53 -22.7 9.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.578 -1.192 . . . . 50.0 109.515 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -173.86 -161.58 24.19 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 103.78 -3.728 . . . . 25.0 103.78 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.3 t -123.7 50.44 3.36 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.301 1.593 . . . . 25.0 115.301 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.77 170.55 17.52 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 114.047 -3.502 . . . . 50.0 109.769 170.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.62 58.67 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.077 1.14 . . . . 25.0 114.077 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 53.3 p -70.87 -16.0 62.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.892 0.701 . . . . 25.0 112.892 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -99.16 7.01 46.19 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.742 0.275 . . . . 50.0 111.742 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -61.19 152.29 29.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.885 -1.154 . . . . 50.0 107.885 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -11.49 60.77 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.618 0.599 . . . . 50.0 112.618 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.2 t -90.98 124.47 35.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 50.0 108.059 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -128.86 140.39 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.049 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -100.83 137.22 39.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.235 -1.024 . . . . 50.0 108.235 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.3 mm -130.85 123.74 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -93.35 134.34 35.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.649 -0.5 . . . . 50.0 109.649 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.72 129.86 23.45 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.7 150.0 73.91 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 117.951 -0.9 . . . . 25.0 112.275 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.36 -4.93 11.3 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 122.115 0.96 . . . . 50.0 110.663 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.87 6.61 27.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.698 -0.683 . . . . 50.0 112.796 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -155.95 170.09 22.93 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.991 -0.443 . . . . 50.0 111.852 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.82 153.56 45.47 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 105.766 -1.939 . . . . 50.0 105.766 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 153.02 144.87 4.01 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-O 122.075 0.819 . . . . 25.0 115.091 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -81.48 146.12 30.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.439 -0.88 . . . . 50.0 112.425 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -146.33 158.95 43.94 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 105.512 -2.033 . . . . 25.0 105.512 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.6 t -121.36 130.26 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.05 -2.574 . . . . 50.0 104.05 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.48 119.34 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.204 -1.036 . . . . 25.0 108.204 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.48 131.43 54.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.419 -1.697 . . . . 50.0 106.419 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.49 133.82 45.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.2 t -129.01 132.92 66.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 50.0 109.246 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -119.47 108.31 14.39 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.447 -1.686 . . . . 50.0 106.447 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.29 132.0 34.06 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.872 -1.058 . . . . 50.0 111.259 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.28 129.5 66.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.559 -2.015 . . . . 50.0 105.559 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.94 -28.3 63.37 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 -167.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -110.0 22.66 15.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.929 1.085 . . . . 50.0 113.929 -172.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.6 p -137.98 153.1 49.46 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.867 0.365 . . . . 25.0 111.685 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -78.8 -7.81 58.19 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.601 0.715 . . . . 50.0 110.333 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -110.11 161.31 15.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.02 -0.991 . . . . 50.0 109.081 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.11 39.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.785 -2.302 . . . . 25.0 104.785 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -90.86 131.25 36.61 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.836 -1.172 . . . . 50.0 107.836 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -128.73 134.47 48.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.149 -0.478 . . . . 50.0 110.216 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.97 140.15 26.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.36 -1.348 . . . . 50.0 107.36 176.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.02 139.82 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.79 -1.559 . . . . 50.0 106.79 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.9 mt -135.31 118.55 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -80.16 131.42 35.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.96 -1.866 . . . . 25.0 105.96 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.12 162.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.345 0.593 . . . . 25.0 111.767 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -129.58 120.99 26.22 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.242 -2.873 . . . . 50.0 103.242 170.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.74 111.41 24.12 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.858 -1.534 . . . . 50.0 106.858 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.75 166.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 114.48 1.289 . . . . 50.0 114.48 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -72.08 154.35 41.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.085 -1.45 . . . . 50.0 107.085 173.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.659 0 CA-C-O 118.255 -0.879 . . . . 50.0 110.106 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 59.0 m80 . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.017 -0.364 . . . . 25.0 110.017 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.9 -177.02 47.93 Favored Glycine 0 C--O 1.24 0.479 0 N-CA-C 108.905 -1.678 . . . . 25.0 108.905 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.31 166.08 34.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.953 0.877 . . . . 25.0 112.696 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.65 122.08 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.752 -1.573 . . . . 25.0 106.752 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -85.75 -42.54 14.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.233 -0.44 . . . . 50.0 111.024 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -143.23 158.6 57.87 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.53 116.13 3.93 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 131.403 1.835 . . . . 25.0 116.823 2.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.2 148.64 7.12 Favored Glycine 0 C--O 1.221 -0.682 0 CA-C-N 114.947 -1.024 . . . . 50.0 113.039 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -94.13 119.87 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.514 . . . . 25.0 109.611 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -21.18 64.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.436 -0.347 . . . . 50.0 111.481 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.38 72.39 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.031 0.382 . . . . 25.0 112.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.59 -27.57 69.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.985 0.422 . . . . 25.0 111.075 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 mt -94.69 -4.09 48.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 50.0 110.901 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.6 t -90.94 -36.49 14.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.849 -0.614 . . . . 50.0 109.478 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -60.05 142.86 53.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.67 -0.695 . . . . 50.0 111.442 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -68.17 -14.97 63.38 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 116.465 -0.334 . . . . 50.0 110.606 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.92 -13.0 29.1 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.003 0.372 . . . . 25.0 112.003 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -83.02 -5.05 58.95 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.311 0.485 . . . . 50.0 112.311 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.68 -29.97 0.1 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 116.904 1.522 . . . . 50.0 116.904 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 t80 63.66 -59.51 0.18 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.602 1.961 . . . . 50.0 114.805 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.55 -20.82 62.77 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.844 -1.169 . . . . 25.0 107.844 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -134.3 117.0 15.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.959 -1.018 . . . . 25.0 108.721 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.94 157.0 43.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.794 -1.928 . . . . 50.0 105.794 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -149.78 77.9 1.34 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.878 0.371 . . . . 50.0 110.028 -173.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.9 t -132.12 -74.7 0.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.713 -0.676 . . . . 50.0 112.794 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.59 177.8 42.08 Favored Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.48 -0.867 . . . . 50.0 112.883 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.7 t -75.18 -16.72 60.49 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.996 0.739 . . . . 25.0 112.996 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.92 -12.5 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.674 0.75 . . . . 50.0 111.112 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -15.23 61.96 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.92 1.452 . . . . 25.0 114.92 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -76.19 -30.17 57.94 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.745 1.017 . . . . 50.0 113.745 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.98 44.75 0.46 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 116.805 2.15 . . . . 25.0 116.805 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.06 -22.58 25.99 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 114.543 -3.171 . . . . 50.0 113.786 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -83.68 -34.85 24.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.177 0.513 . . . . 50.0 109.896 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.7 m -111.39 69.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.645 -0.422 . . . . 50.0 111.645 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 tp -81.85 123.34 28.73 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 104.979 -2.23 . . . . 50.0 104.979 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -83.95 132.2 34.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.335 . . . . 50.0 110.868 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.64 28.65 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.82 -1.178 . . . . 25.0 107.82 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -139.7 143.63 37.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.855 -0.424 . . . . 50.0 109.855 -173.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -69.96 142.52 52.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.139 -1.06 . . . . 50.0 108.139 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.76 -152.37 47.4 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.252 -0.975 . . . . 25.0 114.744 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -104.69 153.9 38.91 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.18 150.46 88.72 Favored 'Cis proline' 0 C--N 1.349 0.594 0 C-N-CA 128.856 0.773 . . . . 25.0 112.64 -1.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -68.69 -46.17 69.76 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.287 -0.635 . . . . 25.0 109.287 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t 64.6 -46.27 0.32 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.012 1.856 . . . . 25.0 116.012 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.34 -155.31 31.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.581 -0.608 . . . . 50.0 111.581 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.52 173.72 9.42 Favored 'Trans proline' 0 C--O 1.237 0.452 0 CA-C-N 118.541 1.171 . . . . 25.0 113.741 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 105.06 2.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.586 . . . . 25.0 110.941 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -143.78 173.97 11.22 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.233 -1.025 . . . . 25.0 108.233 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 11.0 81.32 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 108.437 -1.865 . . . . 25.0 108.437 -172.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -126.75 35.47 4.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.619 0.368 . . . . 25.0 111.273 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.8 mt -67.83 -42.66 86.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.099 0.476 . . . . 25.0 110.16 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.04 82.78 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.431 0.53 . . . . 25.0 112.431 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 p -90.41 -4.67 56.87 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.192 -0.458 . . . . 25.0 110.681 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.79 19.83 4.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.904 1.282 . . . . 25.0 114.286 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.47 -36.08 92.12 Favored Glycine 0 CA--C 1.512 -0.125 0 N-CA-C 109.375 -1.49 . . . . 25.0 109.375 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.2 -36.33 24.6 Favored Glycine 0 C--O 1.216 -1.011 0 N-CA-C 111.366 -0.693 . . . . 50.0 111.366 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.6 -48.18 73.18 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.174 -0.603 . . . . 25.0 110.98 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -73.68 -22.24 60.0 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.781 -0.575 . . . . 25.0 109.494 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -20.64 74.93 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 121.059 -0.591 . . . . 50.0 111.883 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.25 -21.35 70.11 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-N 117.786 0.793 . . . . 50.0 112.409 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.79 -39.17 77.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.343 -0.984 . . . . 50.0 108.343 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.57 -25.78 45.43 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.029 -0.532 . . . . 50.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -67.74 -27.32 66.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.789 0.804 . . . . 50.0 109.852 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -73.1 2.28 7.45 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.847 -0.533 . . . . 25.0 111.534 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -129.61 18.58 5.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.197 0.599 . . . . 25.0 110.036 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.7 t -86.18 156.13 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 25.0 111.897 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -66.75 -31.46 72.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.642 0.734 . . . . 50.0 109.057 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -88.07 1.9 53.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 50.0 112.658 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -56.87 134.95 55.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.533 -0.914 . . . . 50.0 108.533 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.39 165.79 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.666 0.746 . . . . 50.0 109.969 -174.028 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -79.56 106.13 11.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.088 0.47 . . . . 25.0 110.561 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -65.22 146.8 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.93 -1.106 . . . . 25.0 111.133 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.91 130.06 55.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 25.0 110.906 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.2 135.63 24.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.701 -0.681 . . . . 25.0 109.677 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.1 mtp -134.19 142.27 47.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.626 -1.25 . . . . 50.0 107.626 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -89.47 172.96 8.62 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.09 -177.4 6.1 Favored Glycine 0 C--O 1.24 0.531 0 N-CA-C 115.801 1.08 . . . . 25.0 115.801 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.63 -178.72 36.78 Favored Glycine 0 CA--C 1.517 0.181 0 N-CA-C 110.833 -0.907 . . . . 50.0 110.833 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 147.04 34.84 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.452 -1.028 . . . . 25.0 108.596 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -141.86 153.82 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.328 -0.99 . . . . 50.0 108.328 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.9 m -117.03 128.26 54.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.303 -0.408 . . . . 25.0 110.241 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -104.11 136.14 44.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.38 0.672 . . . . 50.0 109.285 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.1 m -132.59 130.01 39.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -122.05 152.6 39.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.698 -1.593 . . . . 50.0 106.698 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -143.47 153.17 42.35 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.762 -1.199 . . . . 25.0 107.762 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -121.64 138.49 54.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.742 0.306 . . . . 25.0 110.746 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -92.71 0.41 57.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 25.0 110.526 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.41 129.82 41.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.109 -0.7 . . . . 25.0 109.109 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.11 1.3 9.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 O-C-N 121.983 0.464 . . . . 25.0 112.98 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -73.73 149.36 41.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 50.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.14 155.81 39.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 50.0 112.19 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.2 m -123.48 130.32 52.52 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -90.76 -43.8 9.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 50.0 111.654 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -160.9 152.48 19.41 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 110.259 -0.275 . . . . 50.0 110.259 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -147.32 144.05 28.49 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 25.0 109.132 169.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -152.73 156.71 39.65 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.17 -0.307 . . . . 50.0 110.17 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -149.69 152.97 36.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.116 0.784 . . . . 50.0 113.116 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -134.38 167.43 20.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.617 -1.253 . . . . 50.0 107.617 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 pt -133.14 152.22 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.5 p -89.87 145.75 24.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 112.472 0.545 . . . . 25.0 112.472 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -117.49 115.26 24.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.836 0.827 . . . . 25.0 109.966 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -76.23 146.9 38.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.279 -1.748 . . . . 25.0 106.279 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.68 18.47 9.48 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 120.608 -0.806 . . . . 25.0 114.46 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -58.62 149.15 26.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.365 0.582 . . . . 50.0 111.105 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -76.13 146.77 79.04 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 107.472 -1.307 . . . . 50.0 107.472 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.79 -19.97 26.77 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 117.288 -1.341 . . . . 50.0 112.896 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.78 -22.59 61.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.816 0.817 . . . . 50.0 111.756 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -95.92 146.41 31.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.94 -0.475 . . . . 50.0 110.091 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.39 111.52 2.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 117.377 -1.282 . . . . 50.0 113.091 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -38.59 63.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.398 0.679 . . . . 50.0 112.741 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -54.57 -33.03 59.59 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -92.73 -45.06 8.22 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.496 0.554 . . . . 50.0 112.496 175.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.96 -17.19 64.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.67 -39.64 84.5 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.175 1.176 . . . . 50.0 114.175 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.47 155.08 49.19 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 114.231 1.197 . . . . 25.0 114.231 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -129.29 147.0 51.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.97 0.508 . . . . 25.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.5 tp -78.26 128.69 34.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.092 -0.336 . . . . 50.0 110.092 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.0 pt -119.85 1.93 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.95 0.405 . . . . 25.0 111.53 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.64 141.08 3.32 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.179 -1.01 . . . . 50.0 114.513 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.4 131.17 24.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.91 94.88 23.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.206 0.526 . . . . 25.0 110.126 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.17 162.98 37.64 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 116.235 -2.043 . . . . 50.0 110.733 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -103.17 115.67 31.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.79 -1.559 . . . . 50.0 106.79 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.868 ' H ' ' HG ' ' A' ' 129' ' ' SER . 11.5 t0 -127.42 -97.81 0.4 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.498 -1.668 . . . . 50.0 106.498 -179.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -159.35 -167.06 19.49 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.161 -0.776 . . . . 25.0 111.161 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 p 61.41 169.71 0.08 OUTLIER Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 124.365 1.066 . . . . 25.0 111.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.36 -4.47 15.47 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 113.18 -4.08 . . . . 50.0 114.729 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.07 69.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.083 -0.508 . . . . 25.0 109.994 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.868 ' HG ' ' H ' ' A' ' 124' ' ' ASP . 29.0 t -76.62 -20.43 56.74 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.564 0.697 . . . . 25.0 110.544 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -67.27 -16.79 64.49 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.828 -0.624 . . . . 50.0 111.635 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -71.86 105.02 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.205 0.526 . . . . 50.0 111.992 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.48 -21.24 28.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.944 -0.571 . . . . 50.0 109.726 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.1 t -95.28 138.54 32.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.929 -0.397 . . . . 50.0 109.929 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -141.7 151.15 42.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.279 -0.419 . . . . 25.0 111.925 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -101.35 133.83 45.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.818 -0.628 . . . . 50.0 109.948 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.0 mm -131.86 132.61 61.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.78 136.8 32.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.606 -0.516 . . . . 50.0 109.606 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.05 134.18 20.48 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.37 144.15 84.87 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 117.17 -1.42 . . . . 25.0 113.886 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -96.8 -7.56 33.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.449 -0.796 . . . . 50.0 110.095 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -112.42 -3.15 14.54 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.164 1.542 . . . . 50.0 115.164 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -136.54 156.63 48.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.635 0.605 . . . . 50.0 112.635 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.6 mp -127.85 152.48 47.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.006 -0.997 . . . . 50.0 108.888 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.67 154.49 6.15 Favored Glycine 0 C--O 1.237 0.308 0 CA-C-O 121.671 0.595 . . . . 25.0 113.933 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -86.97 148.9 25.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.643 0.735 . . . . 50.0 111.859 -178.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -139.04 149.05 44.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.525 -1.657 . . . . 25.0 106.525 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.5 t -103.4 131.6 51.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.343 -2.095 . . . . 50.0 105.343 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.7 mt -95.92 123.51 48.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.233 -2.136 . . . . 25.0 105.233 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 mp -99.99 127.9 46.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 103.683 -2.71 . . . . 50.0 103.683 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.72 144.08 35.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.819 0.736 . . . . 25.0 111.762 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.56 132.94 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.141 -0.936 . . . . 50.0 109.215 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -124.31 112.63 17.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.906 -1.516 . . . . 50.0 106.906 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -97.26 121.65 39.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.008 -0.542 . . . . 50.0 111.784 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.43 115.84 39.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 108.892 -0.781 . . . . 50.0 108.892 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.74 63.44 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.43 -0.77 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.751 0.649 . . . . 50.0 112.751 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.2 t -154.83 166.27 34.02 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.35 -2.66 46.38 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 109.957 -0.386 . . . . 50.0 109.957 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.47 152.99 20.49 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.698 -0.626 . . . . 50.0 109.775 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.36 171.91 13.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.452 -0.573 . . . . 25.0 109.452 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.59 128.33 47.9 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.818 -0.808 . . . . 50.0 108.818 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -126.07 126.55 44.41 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 103.876 -2.639 . . . . 50.0 103.876 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.59 155.78 44.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.376 0.535 . . . . 50.0 111.318 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.49 136.7 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.893 -1.521 . . . . 50.0 106.893 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.4 mt -137.69 122.15 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.745 0.307 . . . . 25.0 110.822 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -77.72 130.94 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.168 0.509 . . . . 25.0 112.065 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.83 156.02 41.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -123.24 113.84 19.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.884 -2.265 . . . . 50.0 104.884 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.7 mt -108.4 121.59 45.24 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.333 -1.358 . . . . 50.0 107.333 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 32.7 m -127.97 170.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.055 0.455 . . . . 50.0 111.505 -174.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -70.38 176.61 3.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.363 -0.835 . . . . 50.0 111.524 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.8 pttt . . . . . 0 C--O 1.244 0.789 0 CA-C-O 117.511 -1.233 . . . . 50.0 111.23 177.755 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 110.811 -0.07 . . . . 25.0 110.811 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.74 -173.66 52.65 Favored Glycine 0 C--N 1.329 0.175 0 CA-C-O 119.065 -0.853 . . . . 25.0 111.206 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -144.18 166.79 24.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.296 0.548 . . . . 25.0 109.976 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.1 120.99 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.415 -1.698 . . . . 25.0 106.415 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -87.01 -40.2 14.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.893 0.378 . . . . 50.0 111.542 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -145.52 153.7 51.75 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 116.271 -0.422 . . . . 25.0 109.876 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.24 130.98 21.52 Favored 'Cis proline' 0 C--N 1.351 0.709 0 C-N-CA 129.625 1.094 . . . . 25.0 113.432 -3.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.95 -172.55 40.11 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 110.493 -1.043 . . . . 50.0 110.493 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -141.74 134.76 28.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -68.32 -21.15 64.77 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.563 -0.29 . . . . 50.0 111.46 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.68 72.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.81 0.338 . . . . 25.0 111.332 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -29.4 68.75 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 116.538 -0.301 . . . . 25.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 mt -88.25 -26.53 22.28 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.118 0.485 . . . . 50.0 110.263 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.44 -42.59 92.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.051 -0.977 . . . . 50.0 110.991 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.7 t -69.05 142.11 54.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.691 -0.686 . . . . 50.0 112.064 -176.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -64.42 -16.32 62.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.465 -0.789 . . . . 50.0 110.321 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.3 -12.92 15.51 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.398 0.518 . . . . 25.0 112.398 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -83.01 -2.01 54.14 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.043 0.386 . . . . 50.0 112.043 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.77 -31.26 0.05 OUTLIER Glycine 0 C--O 1.223 -0.553 0 N-CA-C 116.591 1.396 . . . . 50.0 116.591 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.9 t80 61.13 1.77 0.52 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.882 1.808 . . . . 50.0 115.882 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.65 -24.63 45.08 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.6 -0.687 . . . . 25.0 110.188 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -164.98 164.82 20.56 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.179 -1.415 . . . . 25.0 107.179 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.2 154.69 37.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.922 -1.51 . . . . 50.0 106.922 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -142.33 48.97 1.54 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.55 0.944 . . . . 50.0 113.55 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -151.57 -44.65 0.11 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.119 1.526 . . . . 50.0 115.119 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.73 170.86 35.86 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.072 -0.585 . . . . 50.0 112.926 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -70.93 -14.02 62.22 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.05 -0.676 . . . . 25.0 112.657 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -10.09 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.951 0.405 . . . . 50.0 111.744 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -11.17 23.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.841 1.793 . . . . 25.0 115.841 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -73.69 -36.61 65.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.542 0.61 . . . . 50.0 112.516 -173.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.94 59.09 2.19 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.6 -11.59 28.24 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.437 -1.242 . . . . 50.0 113.809 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -97.48 7.16 47.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 50.0 111.013 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -100.3 89.0 3.83 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 120.794 -1.191 . . . . 50.0 109.847 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.64 129.04 49.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.157 -0.683 . . . . 50.0 109.157 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.99 148.97 51.9 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.467 -0.568 . . . . 50.0 109.467 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.22 127.7 34.31 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -64.95 142.04 58.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.647 -1.242 . . . . 50.0 107.647 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.03 129.5 41.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.024 -0.732 . . . . 50.0 109.024 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.22 68.27 2.91 Favored Glycine 0 C--O 1.227 -0.297 0 N-CA-C 116.597 1.399 . . . . 25.0 116.597 -171.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -102.76 118.43 58.42 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 109.035 -0.728 . . . . 25.0 109.035 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.32 155.51 99.87 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 131.499 1.875 . . . . 25.0 112.292 -2.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.79 -34.53 78.1 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 113.835 1.05 . . . . 25.0 113.835 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.0 t 53.34 -107.3 0.35 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 122.641 0.376 . . . . 25.0 111.772 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.75 157.47 50.68 Favored Glycine 0 C--O 1.219 -0.805 0 N-CA-C 111.483 -0.647 . . . . 50.0 111.483 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.69 -28.05 12.08 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 116.711 -1.726 . . . . 25.0 116.397 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.19 121.11 17.78 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.684 0.624 . . . . 25.0 112.684 -174.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.47 142.33 58.43 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.213 0.82 . . . . 25.0 113.213 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.0 -31.64 1.77 Allowed Glycine 0 N--CA 1.461 0.327 0 CA-C-N 115.759 -0.655 . . . . 25.0 114.359 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -69.5 -10.22 57.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.273 0.842 . . . . 25.0 113.273 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 5.3 mp -62.71 -54.31 35.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.461 179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.84 -25.22 26.39 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.737 0.643 . . . . 25.0 112.737 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.5 p -86.58 4.93 38.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.408 0.522 . . . . 25.0 112.408 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.65 45.8 27.31 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.814 0.816 . . . . 25.0 109.774 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 22.05 0.49 Allowed Glycine 0 C--O 1.225 -0.464 0 N-CA-C 117.705 1.842 . . . . 25.0 117.705 -174.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.26 -17.85 79.01 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 107.871 -2.092 . . . . 50.0 107.871 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.92 -11.04 15.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.804 0.842 . . . . 25.0 112.26 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -52.04 -33.63 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.005 0.743 . . . . 25.0 113.005 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.8 -29.59 59.06 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 119.835 -1.174 . . . . 50.0 112.805 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.29 0.71 87.34 Favored Glycine 0 C--O 1.219 -0.801 0 N-CA-C 116.124 1.21 . . . . 50.0 116.124 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.2 mm -54.6 -34.57 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 118.463 1.132 . . . . 50.0 112.846 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.08 -31.8 72.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.687 -0.633 . . . . 50.0 112.212 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.83 -12.13 57.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.587 0.708 . . . . 50.0 112.218 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -71.59 8.37 1.14 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -63.33 85.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.86 1.059 . . . . 25.0 113.86 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t -151.85 -170.97 3.8 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.486 -2.413 . . . . 25.0 104.486 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -62.92 -25.14 68.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.593 . . . . 50.0 110.547 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -89.26 19.31 4.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.322 0.86 . . . . 50.0 113.322 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -66.64 165.42 14.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.689 -0.856 . . . . 50.0 108.689 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -84.56 151.2 24.7 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.532 -1.284 . . . . 50.0 107.532 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.54 126.59 27.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.791 -0.64 . . . . 25.0 109.917 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -133.95 128.35 34.29 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.084 -0.962 . . . . 25.0 110.554 -175.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -123.07 149.96 43.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.929 -0.308 . . . . 25.0 111.213 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -94.04 134.96 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.8 ttt -150.38 163.41 38.42 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.238 -1.393 . . . . 50.0 107.238 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.7 p -94.98 168.09 10.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.28 177.87 23.81 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.301 -0.476 . . . . 25.0 112.563 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.09 -174.1 15.14 Favored Glycine 0 N--CA 1.459 0.182 0 N-CA-C 109.573 -1.411 . . . . 50.0 109.573 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.16 141.78 39.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.577 1.188 . . . . 25.0 109.259 178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -123.03 134.61 54.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.627 -1.62 . . . . 50.0 106.627 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -108.96 118.9 38.01 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -108.42 139.39 43.22 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.34 -1.356 . . . . 50.0 107.34 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.5 m -133.07 123.33 25.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.056 -1.461 . . . . 25.0 107.056 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -111.99 140.06 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 104.512 -2.403 . . . . 50.0 104.512 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 140.86 51.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.003 0.906 . . . . 25.0 113.131 -173.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -125.87 148.34 49.21 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.96 -2.978 . . . . 25.0 102.96 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -71.47 -18.93 62.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.344 0.52 . . . . 25.0 112.333 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.29 152.15 63.41 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.9 157.09 61.28 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 116.817 -1.656 . . . . 25.0 110.335 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -130.98 149.42 52.61 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.526 -0.546 . . . . 50.0 109.526 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.55 141.09 53.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.596 -1.631 . . . . 50.0 106.596 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.0 m -150.92 146.58 26.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.423 ' HG ' ' HB1' ' A' ' 155' ' ' ALA . 17.0 m -109.62 -41.87 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.669 0.271 . . . . 50.0 110.633 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.9 153.32 26.07 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.429 -0.582 . . . . 50.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -145.83 148.55 33.01 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.402 -0.962 . . . . 25.0 108.402 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.37 159.17 43.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 50.0 111.079 -172.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -130.52 142.5 50.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.128 -1.064 . . . . 50.0 108.128 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -132.88 164.44 26.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.714 -1.587 . . . . 50.0 106.714 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.1 pt -129.19 145.77 35.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.983 -1.488 . . . . 25.0 106.983 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.7 p -83.54 136.18 34.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.458 -1.312 . . . . 25.0 107.458 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -80.79 116.98 21.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.602 -0.888 . . . . 25.0 108.602 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -76.0 125.29 28.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.88 19.91 49.18 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 119.183 -1.484 . . . . 25.0 114.208 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -51.31 149.89 3.77 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 117.95 0.875 . . . . 50.0 112.029 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -70.93 129.59 89.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.081 -0.509 . . . . 50.0 111.135 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.98 -15.26 26.23 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 117.314 -1.324 . . . . 50.0 111.877 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.11 -14.99 61.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.159 0.984 . . . . 50.0 111.462 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -110.15 155.51 41.67 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.135 -1.061 . . . . 50.0 108.135 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.78 113.45 1.72 Allowed 'Trans proline' 0 C--O 1.24 0.593 0 N-CA-C 113.519 0.546 . . . . 50.0 113.519 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 2.5 0.63 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 118.404 2.742 . . . . 50.0 118.404 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.12 2.75 7.93 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.103 -0.373 . . . . 25.0 111.695 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -105.96 -54.71 2.44 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 116.166 -0.47 . . . . 50.0 112.027 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.0 0.51 55.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.688 0.996 . . . . 25.0 113.688 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -80.65 -21.6 41.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.096 0.406 . . . . 50.0 112.096 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -126.19 152.02 46.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -128.15 141.47 51.47 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.2 tp -77.09 118.62 19.81 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.022 -0.733 . . . . 50.0 109.022 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.03 -8.34 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.652 0.739 . . . . 25.0 110.253 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.36 155.8 9.81 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.638 -0.792 . . . . 50.0 113.289 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.57 147.07 29.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.223 -1.029 . . . . 25.0 108.223 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.62 104.48 14.47 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.97 160.99 30.19 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 115.372 -2.619 . . . . 50.0 110.884 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.04 120.96 42.2 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.161 -1.052 . . . . 50.0 108.161 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -140.25 -96.79 0.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.087 -2.19 . . . . 50.0 105.087 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.23 -144.16 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.529 ' HG ' HH11 ' A' ' 130' ' ' ARG . 22.8 t -118.3 70.54 8.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.492 0.923 . . . . 25.0 113.492 -179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.44 171.76 17.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 118.106 -0.796 . . . . 50.0 111.255 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.33 68.44 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.906 -0.496 . . . . 25.0 111.175 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.7 p -73.21 -2.39 21.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.529 HH11 ' HG ' ' A' ' 126' ' ' SER . 80.2 ttt180 -64.37 -22.35 66.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.716 -0.846 . . . . 50.0 108.716 173.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -62.43 131.55 49.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.398 -0.593 . . . . 50.0 109.398 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.45 -10.2 56.98 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.348 0.659 . . . . 50.0 112.692 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.2 t -97.21 120.4 37.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.522 -1.288 . . . . 50.0 107.522 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -125.66 135.19 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 25.0 111.482 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -90.93 136.67 32.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.722 -1.214 . . . . 50.0 107.722 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.7 mp -132.12 119.85 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 106.197 -1.779 . . . . 25.0 106.197 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.9 t80 -85.26 126.88 34.06 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.357 -0.979 . . . . 50.0 108.357 177.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -125.86 101.73 29.22 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 109.964 -0.384 . . . . 25.0 109.964 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.0 145.6 40.13 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 114.447 -3.236 . . . . 25.0 108.273 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.76 96.71 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.576 0.703 . . . . 50.0 109.476 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.86 10.29 31.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.386 -0.824 . . . . 50.0 108.974 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -130.1 -179.47 5.25 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.451 -0.795 . . . . 50.0 109.991 -170.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.8 mp -132.11 128.48 38.24 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.348 -1.353 . . . . 50.0 107.348 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 151.16 164.21 11.92 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-O 122.285 0.936 . . . . 25.0 115.042 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -94.77 144.94 25.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.207 1.558 . . . . 50.0 115.207 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -148.93 158.34 44.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.249 -1.76 . . . . 25.0 106.249 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.07 139.73 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 50.0 110.704 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.7 mt -96.25 128.16 47.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.855 -2.276 . . . . 25.0 104.855 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.09 144.46 35.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.079 -1.452 . . . . 50.0 107.079 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.04 135.51 41.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.607 -0.516 . . . . 25.0 109.607 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.3 t -128.95 131.12 68.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 50.0 107.897 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -126.58 109.49 12.18 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.867 -0.79 . . . . 50.0 108.867 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.04 131.98 43.99 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.756 0.789 . . . . 50.0 111.976 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.1 t -128.65 122.45 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.673 -1.602 . . . . 50.0 106.673 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.423 ' HB1' ' HG ' ' A' ' 93' ' ' SER . . . -72.0 -33.25 67.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.598 0.713 . . . . 25.0 109.404 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -7.08 28.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 115.343 1.609 . . . . 50.0 115.343 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.1 p -130.33 156.32 44.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.69 -21.49 60.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.744 0.783 . . . . 50.0 111.068 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -109.82 165.11 11.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.549 -0.751 . . . . 50.0 109.762 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 159.77 26.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -109.29 137.01 47.81 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 50.0 109.032 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -139.0 154.09 48.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.251 -0.281 . . . . 50.0 110.62 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -145.86 155.15 42.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.252 -0.647 . . . . 50.0 109.252 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.3 140.51 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.329 -0.989 . . . . 50.0 108.329 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.85 122.04 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.028 -1.101 . . . . 25.0 108.028 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -85.1 134.23 34.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.98 -1.119 . . . . 25.0 107.98 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.88 125.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.469 -0.567 . . . . 25.0 109.469 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -93.84 107.94 19.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.403 -2.073 . . . . 50.0 105.403 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.5 mt -109.55 133.14 53.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.188 0.518 . . . . 50.0 109.674 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.71 159.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.123 -0.944 . . . . 50.0 110.712 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -76.06 155.93 34.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 105.285 -2.117 . . . . 50.0 105.285 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-O 117.413 -1.279 . . . . 50.0 110.931 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.88 0.371 . . . . 25.0 110.991 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.43 173.88 46.59 Favored Glycine 0 C--O 1.235 0.18 0 N-CA-C 104.336 -3.506 . . . . 25.0 104.336 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -154.18 169.66 23.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.085 1.942 . . . . 25.0 113.015 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.3 mm -93.52 127.1 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.515 -0.766 . . . . 25.0 108.975 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -87.63 13.16 10.89 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.818 0.673 . . . . 50.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 53.5 mttt 80.92 156.57 0.13 Allowed Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 126.142 1.777 . . . . 25.0 107.348 -177.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.79 151.37 75.15 Favored 'Cis proline' 0 C--N 1.346 0.401 0 C-N-CA 129.311 0.963 . . . . 25.0 112.502 -4.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.08 9.34 63.78 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 116.297 1.279 . . . . 50.0 116.297 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -62.05 132.4 52.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 25.0 111.751 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -70.53 -26.44 63.57 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.069 -0.514 . . . . 50.0 111.298 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.15 70.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.503 -0.317 . . . . 25.0 111.629 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.39 75.81 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 120.798 0.332 . . . . 25.0 110.675 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.91 -8.04 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.353 -0.385 . . . . 50.0 111.308 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 t -81.16 -14.21 57.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.739 0.304 . . . . 50.0 110.449 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.5 t -99.97 139.69 35.27 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.643 -0.502 . . . . 50.0 109.643 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.07 -16.87 63.79 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 120.901 0.381 . . . . 50.0 110.144 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.53 -12.85 17.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -79.9 -10.89 59.82 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.245 -0.284 . . . . 50.0 111.596 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.21 -12.81 0.02 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 117.588 1.795 . . . . 50.0 117.588 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.9 t80 64.02 -32.47 0.13 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.368 2.359 . . . . 50.0 117.368 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.68 -25.66 65.81 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.931 -0.481 . . . . 25.0 111.112 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -167.72 171.99 9.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.27 150.68 44.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.769 -1.937 . . . . 50.0 105.769 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -129.28 47.87 2.43 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.556 0.947 . . . . 50.0 113.556 -170.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -66.92 -61.97 1.67 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 120.684 -0.406 . . . . 50.0 111.895 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.1 147.11 18.84 Favored Glycine 0 C--O 1.219 -0.825 0 CA-C-N 116.463 -0.335 . . . . 50.0 113.704 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -63.71 -29.9 71.06 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.062 1.134 . . . . 25.0 114.062 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.28 0.39 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 113.09 0.774 . . . . 50.0 113.09 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.9 ptm -56.32 -10.98 1.02 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.499 1.666 . . . . 25.0 115.499 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -76.43 -35.98 58.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.9 0.381 . . . . 50.0 110.779 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -147.14 50.22 0.91 Allowed Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.824 1.046 . . . . 25.0 113.824 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.58 -17.15 23.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 115.114 -2.791 . . . . 50.0 114.634 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.07 4.99 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.073 0.768 . . . . 50.0 113.073 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 94.06 4.85 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 113.067 0.766 . . . . 50.0 113.067 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.98 132.78 51.97 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 105.602 -1.999 . . . . 50.0 105.602 168.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -129.94 149.06 51.83 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.265 0.839 . . . . 50.0 113.265 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.68 49.32 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -80.9 138.15 36.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.089 -0.708 . . . . 50.0 109.089 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -65.51 136.75 56.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.939 0.4 . . . . 50.0 110.077 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.34 179.72 48.84 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 109.567 -1.413 . . . . 25.0 109.567 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.96 145.27 32.82 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.978 -0.749 . . . . 25.0 108.978 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.59 163.76 83.28 Favored 'Cis proline' 0 C--N 1.348 0.517 0 C-N-CA 130.666 1.527 . . . . 25.0 111.664 -5.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -146.52 27.75 1.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.908 0.707 . . . . 25.0 112.908 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.8 t -89.93 -25.69 20.81 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.868 0.692 . . . . 25.0 112.868 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -114.01 172.44 14.34 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 110.338 -1.105 . . . . 50.0 110.338 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.81 -17.71 10.8 Favored 'Trans proline' 0 C--N 1.346 0.444 0 CA-C-N 119.329 1.564 . . . . 25.0 114.429 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.82 129.53 38.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.733 -0.84 . . . . 25.0 108.733 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -148.07 170.13 18.45 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.865 -1.532 . . . . 25.0 106.865 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.44 -32.02 1.17 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 116.253 1.261 . . . . 25.0 116.253 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -124.91 44.04 2.88 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.049 -0.677 . . . . 25.0 109.766 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.2 mm -58.14 -45.09 88.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.131 -0.486 . . . . 25.0 112.216 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.74 -36.86 83.44 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.874 1.064 . . . . 25.0 113.874 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.1 p -96.79 -20.88 17.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.914 0.709 . . . . 25.0 112.914 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.08 28.33 10.71 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.666 0.786 . . . . 25.0 109.877 -170.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -20.08 76.15 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-N 116.009 -0.541 . . . . 25.0 114.304 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.98 -21.14 67.49 Favored Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.867 -0.682 . . . . 50.0 113.494 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.38 -36.97 85.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.779 0.799 . . . . 25.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -71.18 -12.7 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.549 -0.751 . . . . 25.0 111.745 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.38 -23.2 53.22 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 121.325 -0.464 . . . . 50.0 113.524 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.12 73.71 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 117.961 0.88 . . . . 50.0 112.49 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.62 -38.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.922 -1.14 . . . . 50.0 107.922 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.61 -29.12 69.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 50.0 110.087 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.69 -7.81 36.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.646 0.61 . . . . 50.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -68.93 -41.04 78.65 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -159.89 110.19 1.88 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 120.848 0.356 . . . . 25.0 110.646 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.91 163.55 39.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -72.47 -26.41 61.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.165 -0.309 . . . . 50.0 110.165 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.01 20.5 15.42 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.76 0.281 . . . . 50.0 111.76 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -54.81 147.56 14.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.861 -0.608 . . . . 50.0 110.624 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -90.84 151.69 21.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.215 -0.661 . . . . 50.0 109.215 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -77.51 136.15 38.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -106.12 144.81 32.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.133 -0.485 . . . . 25.0 110.105 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.05 142.25 48.02 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -100.71 136.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.76 151.57 45.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.288 0.477 . . . . 50.0 112.288 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p -96.14 172.05 8.22 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 106.863 -1.532 . . . . 25.0 106.863 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.46 -172.69 15.37 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 117.814 1.886 . . . . 25.0 117.814 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.86 172.04 25.46 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 113.799 -1.2 . . . . 50.0 111.622 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.06 139.23 41.31 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.935 -1.135 . . . . 25.0 107.935 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -137.3 157.12 47.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.901 -1.148 . . . . 50.0 107.901 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.1 m -125.61 127.33 46.16 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -115.03 140.77 48.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.898 -0.779 . . . . 50.0 108.898 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -127.2 133.07 50.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.357 -0.609 . . . . 25.0 109.357 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.97 150.06 45.24 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.041 -2.207 . . . . 50.0 105.041 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 161.95 37.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.755 0.707 . . . . 25.0 111.121 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.1 151.83 39.4 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -71.85 -14.3 61.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.612 0.597 . . . . 25.0 112.612 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.88 160.4 58.6 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 104.094 -2.558 . . . . 25.0 104.094 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.84 145.89 94.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 115.479 -2.547 . . . . 25.0 111.092 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -108.16 118.18 36.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.222 -0.445 . . . . 50.0 110.735 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.03 129.56 41.45 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.598 -1.63 . . . . 50.0 106.598 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.615 ' HG1' ' HE1' ' A' ' 152' ' ' TRP . 62.2 m -145.64 133.58 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.745 -0.207 . . . . 25.0 110.834 -170.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -104.92 -33.62 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.438 -0.579 . . . . 50.0 109.438 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -163.02 148.55 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.089 -1.078 . . . . 50.0 108.089 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -142.69 139.07 31.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.868 -0.79 . . . . 25.0 108.868 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.05 159.05 44.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 50.0 110.817 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.57 145.34 33.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.699 0.762 . . . . 50.0 111.286 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -127.52 167.45 16.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.794 -1.093 . . . . 50.0 109.211 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.56 156.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.396 -0.964 . . . . 25.0 108.396 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 p -95.48 145.44 25.18 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.862 -0.422 . . . . 25.0 109.862 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -88.68 113.59 24.41 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.275 -0.57 . . . . 25.0 111.563 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -77.2 147.93 36.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.669 -1.975 . . . . 25.0 105.669 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.97 59.79 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 118.076 1.991 . . . . 25.0 118.076 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -54.89 147.13 15.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.68 1.24 . . . . 50.0 113.409 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 146.69 72.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.051 -0.722 . . . . 50.0 109.051 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.65 -18.4 25.39 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 118.031 -0.846 . . . . 50.0 113.917 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.05 -22.29 62.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.183 0.992 . . . . 50.0 110.915 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.84 147.11 32.98 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.624 -0.716 . . . . 50.0 109.733 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 93.94 0.65 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 118.463 -0.558 . . . . 50.0 111.799 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . 0.403 ' H ' HD22 ' A' ' 110' ' ' LEU . 0.9 OUTLIER -52.99 -41.31 64.49 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 114.36 1.244 . . . . 50.0 114.36 -173.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -70.66 -16.41 62.81 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.057 0.762 . . . . 25.0 113.057 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -85.69 -41.38 15.2 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.356 0.598 . . . . 50.0 109.622 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.79 7.85 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.654 -1.157 . . . . 25.0 111.943 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.2 -29.03 70.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.917 0.71 . . . . 50.0 112.917 -169.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -126.04 144.98 50.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.018 0.748 . . . . 25.0 113.018 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -127.96 144.64 51.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.697 -0.853 . . . . 25.0 108.697 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -82.58 113.69 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.521 -0.918 . . . . 50.0 108.521 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -97.34 -8.62 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.345 0.593 . . . . 25.0 110.275 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.93 149.94 8.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.198 -1.001 . . . . 50.0 114.061 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.59 146.86 28.44 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.417 -0.957 . . . . 25.0 108.417 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.1 90.11 6.89 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-O 121.23 0.538 . . . . 25.0 110.299 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.39 162.59 38.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 117.751 -1.033 . . . . 50.0 109.752 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -96.9 91.98 5.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.334 -1.728 . . . . 50.0 106.334 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -100.38 2.75 42.68 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 113.976 -1.465 . . . . 50.0 109.167 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.17 -11.42 65.33 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.068 -1.213 . . . . 25.0 110.068 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.4 t -59.34 141.1 87.8 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.659 -0.497 . . . . 25.0 109.659 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.05 -6.63 19.49 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 C-N-CA 116.94 -1.573 . . . . 50.0 115.295 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.17 83.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.182 -0.917 . . . . 25.0 109.657 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.2 t -85.57 -27.87 25.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 25.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -69.4 -35.15 75.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.465 -0.568 . . . . 50.0 109.465 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.36 111.23 12.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.027 -0.533 . . . . 50.0 110.058 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.25 -13.06 60.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.507 -0.77 . . . . 50.0 112.906 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -96.98 121.31 38.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.846 -0.798 . . . . 50.0 108.846 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -133.05 149.42 52.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.461 . . . . 25.0 111.925 -172.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -84.78 135.17 34.23 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.839 -0.619 . . . . 50.0 109.917 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 73.2 mt -134.51 120.62 33.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 106.783 -1.562 . . . . 25.0 106.783 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -73.39 140.99 46.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.643 0.259 . . . . 50.0 110.724 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.04 129.89 25.15 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 106.731 -1.581 . . . . 25.0 106.731 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.1 148.78 63.62 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 117.355 -1.297 . . . . 25.0 113.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -100.82 -9.4 21.71 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.654 0.74 . . . . 50.0 109.217 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.09 10.56 20.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.862 1.06 . . . . 50.0 113.862 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -132.15 141.61 49.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 110.072 -0.344 . . . . 50.0 110.072 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 mp -113.13 153.87 27.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 50.0 109.307 176.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 116.74 154.21 10.06 Favored Glycine 0 C--O 1.24 0.5 0 CA-C-O 122.192 0.885 . . . . 25.0 114.97 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 42.4 p90 -87.01 146.27 26.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.226 0.824 . . . . 50.0 113.226 -177.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -148.95 158.96 44.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.965 -1.495 . . . . 25.0 106.965 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.0 t -98.03 143.61 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.901 0.381 . . . . 50.0 111.81 -175.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.93 131.26 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.601 -2.0 . . . . 25.0 105.601 172.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.45 140.22 49.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.216 -1.401 . . . . 50.0 107.216 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -130.09 133.82 46.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.9 130.29 68.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.73 -1.211 . . . . 50.0 107.73 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . 0.615 ' HE1' ' HG1' ' A' ' 92' ' ' THR . 6.2 t-105 -117.85 116.27 26.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.55 -0.75 . . . . 50.0 110.584 -175.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.63 131.9 42.81 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 122.123 0.963 . . . . 50.0 110.484 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.12 124.2 65.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 106.937 -1.505 . . . . 50.0 106.937 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.03 -31.31 64.36 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.192 0.52 . . . . 25.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -67.41 -14.93 63.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.557 2.058 . . . . 50.0 116.557 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -129.2 160.42 32.96 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 122.098 -0.376 . . . . 25.0 110.747 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.46 -12.2 59.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.148 0.499 . . . . 50.0 110.591 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -110.2 160.59 16.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.741 0.781 . . . . 50.0 111.121 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -121.94 156.54 33.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 103.355 -2.831 . . . . 25.0 103.355 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -123.81 143.91 50.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.806 -0.813 . . . . 50.0 108.806 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.01 153.97 48.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.056 0.455 . . . . 50.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -134.75 143.68 47.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.322 -1.733 . . . . 50.0 106.322 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.04 129.14 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.603 -0.518 . . . . 50.0 109.603 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.2 mt -140.21 125.74 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.088 -1.078 . . . . 25.0 108.088 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -87.73 141.63 28.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.605 -0.887 . . . . 25.0 108.605 173.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.45 143.75 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.098 0.475 . . . . 25.0 109.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -97.94 122.15 40.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.032 -1.47 . . . . 50.0 107.032 179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.1 mt -115.71 119.4 35.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.878 -1.897 . . . . 50.0 105.878 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 27.7 m -134.17 162.19 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.685 0.994 . . . . 50.0 113.685 -170.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.64 161.22 30.53 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.443 -1.688 . . . . 50.0 106.443 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt . . . . . 0 C--O 1.246 0.909 0 CA-C-O 117.841 -1.076 . . . . 50.0 109.214 172.544 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 28.4 m170 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.576 0.227 . . . . 25.0 110.493 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.68 -165.96 37.53 Favored Glycine 0 CA--C 1.506 -0.479 1 N-CA-C 101.837 -4.505 . . . . 25.0 101.837 -175.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -158.2 163.65 37.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.374 1.587 . . . . 25.0 111.046 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -92.36 114.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 105.569 -2.011 . . . . 25.0 105.569 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -72.81 -40.92 65.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.533 -0.914 . . . . 50.0 108.533 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -153.35 131.59 6.44 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.152 -0.476 . . . . 25.0 109.744 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.47 140.81 46.59 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 118.62 0.543 . . . . 25.0 112.476 0.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 154.51 18.29 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 116.019 -0.537 . . . . 50.0 113.767 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p -61.91 152.88 30.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.598 0.713 . . . . 25.0 112.744 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -65.1 -17.08 64.16 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.964 -0.562 . . . . 50.0 112.078 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.34 68.14 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 122.617 0.367 . . . . 25.0 111.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.3 77.84 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.972 0.415 . . . . 25.0 111.275 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.02 -4.04 55.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 50.0 110.941 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -91.8 -16.03 27.4 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.369 -0.975 . . . . 50.0 108.369 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 t -63.87 145.52 55.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.861 -0.609 . . . . 50.0 109.695 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mp0 -63.79 -19.48 65.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.599 . . . . 50.0 110.251 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.46 -22.19 63.2 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.798 -0.564 . . . . 25.0 111.759 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -91.96 -1.73 57.12 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.619 0.97 . . . . 50.0 113.619 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.3 -30.11 0.05 OUTLIER Glycine 0 N--CA 1.461 0.326 0 N-CA-C 116.286 1.274 . . . . 50.0 116.286 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 65.35 -45.16 0.36 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 118.027 2.603 . . . . 50.0 118.027 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 87.1 mt -78.01 -21.12 51.28 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.898 -0.502 . . . . 25.0 112.347 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -149.06 153.17 37.45 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.822 -0.807 . . . . 25.0 108.822 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.07 156.95 42.58 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.953 -1.128 . . . . 50.0 107.953 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -153.37 83.07 1.18 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.743 0.782 . . . . 50.0 110.68 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 m -75.76 -39.08 57.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.456 -0.793 . . . . 50.0 112.608 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.28 172.65 8.79 Favored Glycine 0 C--O 1.221 -0.715 0 C-N-CA 121.611 -0.328 . . . . 50.0 112.927 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 t -63.69 -27.96 69.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.259 1.028 . . . . 25.0 110.704 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 t -60.16 -13.03 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 114.748 -1.115 . . . . 50.0 112.658 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm -65.31 -19.94 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.419 0.896 . . . . 25.0 113.419 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -75.53 -45.77 36.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.239 0.472 . . . . 50.0 111.018 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -154.97 89.79 3.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 113.1 0.778 . . . . 25.0 113.1 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.61 1.46 4.97 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 N-CA-C 113.22 0.431 . . . . 50.0 113.22 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.14 -7.87 24.32 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.252 1.205 . . . . 50.0 114.252 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -132.99 129.94 38.84 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.924 1.824 . . . . 75.0 115.924 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -120.62 140.47 51.5 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.069 -2.197 . . . . 50.0 105.069 161.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -84.03 118.33 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.555 0.616 . . . . 50.0 109.858 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.86 158.1 43.95 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 107.75 -1.204 . . . . 25.0 107.75 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -130.53 169.01 16.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.4 0.619 . . . . 50.0 110.223 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -73.9 164.08 27.09 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 104.023 -2.584 . . . . 50.0 104.023 172.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.95 23.77 0.7 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 116.664 1.426 . . . . 25.0 116.664 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -107.58 134.23 20.1 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 109.07 -0.715 . . . . 25.0 109.07 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -79.58 145.09 73.05 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 129.731 1.138 . . . . 25.0 112.472 -4.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -74.16 2.8 8.22 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.651 0.612 . . . . 25.0 112.651 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -92.27 -9.5 41.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.881 -0.6 . . . . 25.0 111.543 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.32 -164.37 32.08 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 109.834 -1.306 . . . . 50.0 109.834 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -69.21 165.53 30.02 Favored 'Trans proline' 0 C--N 1.345 0.368 0 CA-C-N 118.959 1.379 . . . . 25.0 110.804 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 131.59 46.86 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.731 -0.387 . . . . 25.0 110.665 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -145.03 157.2 44.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 104.574 -2.38 . . . . 25.0 104.574 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.83 10.12 54.55 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.68 -0.295 . . . . 25.0 113.528 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -68.49 -8.96 45.68 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.106 0.78 . . . . 25.0 113.106 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -66.81 -29.52 46.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 175.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.26 69.57 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.982 -0.449 . . . . 25.0 111.847 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.0 p -101.09 12.51 37.49 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.291 0.567 . . . . 25.0 109.953 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.14 15.99 3.61 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.592 1.557 . . . . 25.0 114.095 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.29 -37.21 42.67 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 120.62 -0.8 . . . . 25.0 111.921 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.32 -2.8 68.57 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 115.611 1.005 . . . . 50.0 115.611 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.37 -26.94 68.69 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.234 1.017 . . . . 25.0 112.099 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.19 -23.69 67.4 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.536 -0.466 . . . . 25.0 111.262 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.18 -26.05 71.67 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.771 -0.728 . . . . 50.0 111.852 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.7 73.48 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 121.025 -0.607 . . . . 50.0 112.008 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.25 -28.22 41.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.29 -0.633 . . . . 50.0 109.29 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -88.05 -38.6 15.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.725 -0.472 . . . . 50.0 109.725 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.64 -38.27 84.26 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.91 0.386 . . . . 50.0 112.005 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -64.68 -0.19 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.052 1.13 . . . . 25.0 114.052 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -143.65 34.85 1.28 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.766 0.426 . . . . 25.0 110.157 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 t -115.94 172.29 7.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.979 0.418 . . . . 25.0 111.804 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.46 -38.35 74.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.555 0.693 . . . . 50.0 110.557 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -79.99 5.44 14.03 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.751 0.649 . . . . 50.0 112.751 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -52.74 149.87 5.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.044 1.128 . . . . 50.0 114.044 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -70.28 158.51 35.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 50.0 110.92 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -84.33 151.51 24.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.825 -0.547 . . . . 25.0 111.155 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -120.52 143.29 48.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.313 -0.403 . . . . 25.0 111.2 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -121.1 150.97 40.41 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 106.612 -1.625 . . . . 25.0 106.612 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -96.2 143.0 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.178 -2.156 . . . . 25.0 105.178 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.6 ttt -150.7 164.31 36.45 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 110.421 -0.215 . . . . 50.0 110.421 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 p -110.2 172.48 6.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.775 -1.935 . . . . 25.0 105.775 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.97 -168.67 6.9 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.318 1.287 . . . . 25.0 116.318 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.68 -179.14 26.45 Favored Glycine 0 CA--C 1.521 0.417 0 O-C-N 122.519 -0.401 . . . . 50.0 113.371 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -73.08 133.65 44.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.748 -0.854 . . . . 25.0 109.615 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -125.77 137.79 53.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 50.0 110.047 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.7 m -102.56 125.54 49.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.492 -0.559 . . . . 25.0 109.492 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -112.83 130.12 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.01 -1.478 . . . . 50.0 107.01 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -137.98 135.1 35.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.78 -0.191 . . . . 25.0 110.565 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -122.42 150.08 42.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.47 -1.678 . . . . 50.0 106.47 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -144.96 158.58 43.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.644 -0.872 . . . . 25.0 108.644 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.66 151.04 47.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.656 -0.868 . . . . 25.0 108.656 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -72.4 -16.87 61.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.992 0.425 . . . . 25.0 111.347 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.87 141.1 23.13 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 174.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.07 146.88 47.65 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 117.167 -1.422 . . . . 25.0 112.896 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -131.12 157.08 44.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.185 -0.672 . . . . 50.0 109.185 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -76.99 144.67 38.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.312 -0.625 . . . . 50.0 109.312 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -128.28 130.11 47.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.415 -0.957 . . . . 25.0 108.415 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 t -89.75 -44.29 10.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.681 0.753 . . . . 50.0 109.771 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -158.13 155.69 29.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -146.86 141.23 26.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 168.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -148.4 159.75 43.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 50.0 111.368 -170.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -130.1 141.0 50.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.7 0.625 . . . . 50.0 110.444 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -126.68 162.87 24.76 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.035 -1.839 . . . . 50.0 106.035 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 pt -132.4 139.43 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.271 -0.27 . . . . 25.0 110.271 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -85.01 130.75 34.57 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 120.903 0.382 . . . . 25.0 110.339 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -88.08 125.02 34.35 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.817 0.673 . . . . 25.0 112.817 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -75.1 140.21 43.29 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.21 21.32 55.22 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.06 1.184 . . . . 25.0 116.06 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -57.09 154.18 10.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.226 1.013 . . . . 50.0 111.777 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.08 119.24 65.82 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.566 -0.531 . . . . 50.0 109.566 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.94 -15.84 18.52 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 117.163 -1.425 . . . . 50.0 113.51 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -75.72 -15.62 60.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.393 1.092 . . . . 50.0 110.744 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -105.01 153.79 39.17 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 106.606 -1.627 . . . . 50.0 106.606 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.98 128.44 21.87 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 115.058 -2.828 . . . . 50.0 112.215 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 tt -53.67 -38.01 63.73 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.402 -0.817 . . . . 50.0 111.895 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -58.18 -18.81 28.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.036 1.125 . . . . 25.0 114.036 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -101.61 -42.99 6.02 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 122.098 -0.376 . . . . 50.0 111.735 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.04 59.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.92 1.082 . . . . 25.0 113.92 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.95 -38.69 83.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.848 1.425 . . . . 50.0 114.848 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -130.46 161.97 30.22 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 116.413 2.005 . . . . 25.0 116.413 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -128.51 149.68 50.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.0 tp -85.56 112.93 21.4 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.169 -1.419 . . . . 50.0 107.169 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.16 -12.07 9.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.204 0.526 . . . . 25.0 110.327 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.22 158.72 12.61 Favored Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.832 -1.175 . . . . 50.0 114.707 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.93 146.58 31.11 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.496 -1.298 . . . . 25.0 107.496 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.26 107.75 4.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.619 -0.512 . . . . 25.0 109.619 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -86.64 177.26 4.32 Favored 'Trans proline' 0 C--O 1.24 0.575 0 N-CA-C 114.066 0.756 . . . . 50.0 114.066 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -104.08 91.53 3.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.812 -2.292 . . . . 50.0 104.812 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -156.44 71.42 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.062 0.458 . . . . 50.0 110.675 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.76 13.35 39.09 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.037 -0.529 . . . . 25.0 114.204 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.97 145.73 97.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.568 -0.372 . . . . 25.0 111.135 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.55 -175.63 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.784 1.656 . . . . 50.0 113.897 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.47 -26.2 12.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -57.36 -8.9 0.86 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.145 1.165 . . . . 25.0 114.145 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -76.27 3.63 10.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.729 -0.607 . . . . 50.0 111.707 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -58.7 150.45 23.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.949 -0.76 . . . . 50.0 108.949 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.95 -7.02 19.18 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.687 0.995 . . . . 50.0 113.687 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.3 t -97.94 122.65 41.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.141 -1.8 . . . . 50.0 106.141 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.4 151.06 51.88 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.207 0.527 . . . . 25.0 110.958 -175.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -105.92 138.51 41.97 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.67 -1.233 . . . . 50.0 107.67 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.5 mm -127.01 123.0 61.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.29 -2.115 . . . . 25.0 105.29 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.56 133.98 35.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.694 -1.224 . . . . 50.0 107.694 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.9 mm -125.88 118.6 24.06 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.03 155.29 61.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 115.736 -2.376 . . . . 25.0 110.715 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -104.79 55.03 0.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.463 -1.31 . . . . 50.0 107.463 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.73 -36.31 21.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.743 -0.662 . . . . 50.0 112.367 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -151.7 159.21 44.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.259 0.552 . . . . 50.0 110.786 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -91.62 143.87 26.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.987 -1.006 . . . . 50.0 110.25 178.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.31 152.0 6.04 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-O 121.839 0.688 . . . . 25.0 113.739 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -80.04 146.3 32.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.597 0.713 . . . . 50.0 111.984 -179.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -136.27 128.52 29.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.766 -1.939 . . . . 25.0 105.766 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.01 125.57 47.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 105.675 -1.972 . . . . 50.0 105.675 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 76.7 mt -96.21 119.73 44.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.98 109.01 20.61 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.549 -1.648 . . . . 50.0 106.549 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -113.04 146.77 38.54 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.03 -0.419 . . . . 25.0 110.507 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.14 134.25 65.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.955 -0.566 . . . . 50.0 109.652 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -121.24 106.42 11.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.34 -0.985 . . . . 50.0 108.34 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.01 88.04 7.61 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.904 -0.776 . . . . 50.0 108.904 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.71 138.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.286 -1.376 . . . . 50.0 107.286 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -94.53 -13.69 25.82 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 122.068 -0.395 . . . . 25.0 111.274 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -77.26 -12.24 59.92 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.385 0.883 . . . . 50.0 113.385 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.0 p -140.18 170.59 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.89 0.7 . . . . 25.0 112.89 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -85.04 13.49 6.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.567 0.747 . . . . 50.0 110.317 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -109.91 163.51 13.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.741 -0.837 . . . . 50.0 108.741 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.95 139.35 32.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 100.376 -3.935 . . . . 25.0 100.376 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -117.99 152.01 36.33 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.276 0.56 . . . . 50.0 110.921 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.68 140.81 51.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.565 -1.198 . . . . 50.0 108.381 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -128.23 126.2 40.46 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.651 -2.351 . . . . 50.0 104.651 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.13 131.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.485 -0.561 . . . . 50.0 109.485 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.38 123.73 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.41 138.65 31.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.517 -1.29 . . . . 25.0 107.517 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.87 126.07 46.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -93.29 95.84 9.6 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.331 -0.989 . . . . 50.0 108.331 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.46 124.75 31.01 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.291 -1.374 . . . . 50.0 107.291 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.0 158.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 112.68 0.622 . . . . 50.0 112.68 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.92 161.72 14.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.773 -1.565 . . . . 50.0 106.773 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.35 -0.833 . . . . 50.0 109.138 172.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 110.249 -0.278 . . . . 25.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.67 157.33 33.14 Favored Glycine 0 C--O 1.234 0.119 0 N-CA-C 110.699 -0.96 . . . . 25.0 110.699 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -166.32 164.17 17.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.127 0.571 . . . . 25.0 110.427 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.91 128.12 45.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.284 -2.117 . . . . 25.0 105.284 170.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -94.6 -46.56 6.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.086 0.47 . . . . 50.0 110.238 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -145.97 157.1 51.02 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.909 -0.587 . . . . 25.0 109.5 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.53 132.38 26.12 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 130.312 1.38 . . . . 25.0 115.647 -0.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.51 -172.19 35.74 Favored Glycine 0 C--O 1.221 -0.695 0 CA-C-N 115.636 -0.711 . . . . 50.0 113.713 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -150.92 150.34 30.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.931 -1.137 . . . . 25.0 107.931 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.74 -21.02 59.58 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 111.907 0.336 . . . . 50.0 111.907 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.3 -31.17 68.89 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 113.043 0.757 . . . . 25.0 113.043 -173.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -27.81 68.95 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.634 0.605 . . . . 25.0 112.634 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.82 -10.5 39.61 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 120.809 0.338 . . . . 50.0 111.273 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t -99.2 -11.49 21.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.515 0.674 . . . . 50.0 110.044 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.425 ' HG ' ' H ' ' A' ' 17' ' ' ALA . 47.4 t -67.79 151.95 46.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.329 0.585 . . . . 50.0 110.553 -178.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.6 mp0 -63.74 -28.45 69.89 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.529 -0.915 . . . . 50.0 108.529 177.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.425 ' H ' ' HG ' ' A' ' 15' ' ' SER . . . -66.19 -12.98 59.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.578 -0.737 . . . . 25.0 112.655 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -83.03 2.1 36.71 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.918 0.34 . . . . 50.0 111.918 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.52 5.7 1.07 Allowed Glycine 0 N--CA 1.463 0.497 0 N-CA-C 116.033 1.173 . . . . 50.0 116.033 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 t80 55.87 25.61 8.75 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.123 1.157 . . . . 50.0 114.123 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.96 -39.47 79.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.738 -1.208 . . . . 25.0 107.738 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 57.84 25.16 11.67 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.658 -1.156 . . . . 25.0 113.636 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.25 157.0 46.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.7 -0.682 . . . . 50.0 110.239 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.9 t30 51.3 77.01 0.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.602 2.075 . . . . 50.0 116.602 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.6 m -92.19 17.67 9.28 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.513 -0.767 . . . . 50.0 110.877 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.71 161.09 11.56 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.305 -0.407 . . . . 50.0 113.595 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.6 t -57.55 -29.01 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.361 0.6 . . . . 25.0 110.756 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -12.08 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 114.394 1.257 . . . . 50.0 114.394 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -72.15 -27.42 62.59 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.43 -0.794 . . . . 25.0 110.691 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -92.51 -36.18 13.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 50.0 109.976 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -118.88 72.39 11.33 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 121.427 0.632 . . . . 25.0 111.375 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.98 -26.87 21.37 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.159 -2.094 . . . . 50.0 115.021 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -8.76 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.798 1.777 . . . . 50.0 115.798 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 t -86.36 94.05 9.26 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 121.543 -0.723 . . . . 50.0 111.06 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mp -117.1 80.02 1.42 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.492 -0.322 . . . . 50.0 111.365 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -142.38 126.55 17.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.796 -0.446 . . . . 50.0 109.796 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 134.59 38.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.657 -0.498 . . . . 25.0 109.657 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -63.79 137.09 57.91 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.448 -0.782 . . . . 50.0 109.232 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.53 135.51 54.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.267 -0.424 . . . . 50.0 110.451 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.21 157.85 22.99 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 117.618 1.807 . . . . 25.0 117.618 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -94.67 156.52 38.24 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.42 147.99 85.05 Favored 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 130.39 1.412 . . . . 25.0 112.624 1.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -144.56 12.09 1.49 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.994 0.739 . . . . 25.0 112.994 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.63 -54.06 0.55 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.216 1.406 . . . . 25.0 112.196 -173.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.19 -176.62 51.06 Favored Glycine 0 C--O 1.243 0.714 0 N-CA-C 110.147 -1.181 . . . . 50.0 110.147 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.86 159.38 54.06 Favored 'Trans proline' 0 C--N 1.344 0.33 0 CA-C-N 118.503 1.152 . . . . 25.0 112.895 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.89 120.12 21.59 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.912 -0.773 . . . . 25.0 108.912 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.455 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 41.5 t0 -135.82 -179.41 5.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.648 -0.501 . . . . 25.0 109.648 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.455 ' H ' ' CG ' ' A' ' 48' ' ' ASP . . . 89.94 -9.52 76.99 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 108.602 -1.799 . . . . 25.0 108.602 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -86.59 42.79 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.647 0.779 . . . . 25.0 110.267 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.8 mt -65.28 -39.71 86.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.591 -0.731 . . . . 25.0 109.232 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.0 -31.22 72.3 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.055 0.455 . . . . 25.0 111.758 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 m -91.11 -3.51 57.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.466 -0.334 . . . . 25.0 110.881 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.76 37.52 24.05 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.31 1.044 . . . . 25.0 111.414 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.31 -42.07 2.1 Favored Glycine 0 C--O 1.223 -0.554 0 CA-C-N 115.804 -0.634 . . . . 25.0 113.458 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.17 -15.82 80.92 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.942 -0.647 . . . . 50.0 113.254 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.03 -28.3 68.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.958 0.409 . . . . 25.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -68.46 -24.0 64.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.218 -0.301 . . . . 25.0 111.538 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -30.26 59.93 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 110.205 -1.158 . . . . 50.0 110.205 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.69 -20.63 74.26 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 121.272 -0.489 . . . . 50.0 112.409 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -66.13 -42.86 92.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.192 -1.04 . . . . 50.0 108.192 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.64 -32.05 63.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 50.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.37 -26.89 68.96 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.802 -0.359 . . . . 50.0 111.785 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -64.16 -7.59 9.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -132.07 27.22 4.54 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.055 0.455 . . . . 25.0 110.606 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.7 t -87.99 157.85 18.8 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.119 0.485 . . . . 25.0 111.748 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.97 -41.71 95.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 50.0 110.012 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -102.73 24.39 10.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.671 0.748 . . . . 50.0 111.161 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -55.08 154.57 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.655 -1.157 . . . . 50.0 110.053 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -80.11 156.15 27.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.826 0.822 . . . . 50.0 109.961 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -62.1 141.0 58.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.664 -0.698 . . . . 25.0 111.412 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -112.93 134.59 54.37 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.022 -0.536 . . . . 25.0 110.69 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.23 149.36 50.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.55 137.58 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.2 ttt -150.97 167.0 28.95 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.389 -0.967 . . . . 50.0 108.389 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.7 p -101.45 170.86 7.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.39 -166.08 11.0 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.066 -0.588 . . . . 25.0 113.321 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.94 179.47 25.39 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 112.16 -0.376 . . . . 50.0 112.16 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -73.79 133.03 43.19 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.759 -0.848 . . . . 25.0 109.365 178.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -125.33 155.2 40.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.538 -1.282 . . . . 50.0 107.538 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -106.25 125.23 50.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.106 -1.072 . . . . 25.0 108.106 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -105.68 122.14 45.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.219 -2.141 . . . . 50.0 105.219 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -126.07 109.24 12.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.73 -0.47 . . . . 25.0 109.73 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -122.93 140.85 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.767 -3.049 . . . . 50.0 102.767 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 123.58 12.44 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -126.69 118.99 25.88 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.747 -0.835 . . . . 25.0 108.747 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -88.36 -6.37 57.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.821 -1.081 . . . . 25.0 111.922 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.73 130.7 54.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.87 119.61 6.45 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 115.903 -2.265 . . . . 25.0 112.794 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.04 136.06 48.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 50.0 109.821 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -84.24 149.93 25.78 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.317 -2.105 . . . . 50.0 105.317 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 m -137.11 152.55 50.12 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 104.645 -2.354 . . . . 25.0 104.645 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.6 p -93.03 -41.57 9.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.847 -1.168 . . . . 50.0 107.847 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -167.57 169.3 12.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.518 -0.31 . . . . 50.0 110.44 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.4 p90 -144.85 146.99 32.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.121 -1.437 . . . . 25.0 107.121 163.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.08 159.2 44.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 50.0 109.267 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.46 151.35 47.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.533 0.683 . . . . 50.0 112.604 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.35 163.95 27.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.883 -1.053 . . . . 50.0 108.533 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.52 152.43 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.6 p -80.84 126.13 30.95 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 120.906 0.384 . . . . 25.0 110.403 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -87.99 115.73 25.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.755 -1.202 . . . . 25.0 107.755 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -81.28 154.03 26.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.33 10.98 34.84 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 116.863 1.505 . . . . 25.0 116.863 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -62.56 155.02 27.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.263 1.031 . . . . 50.0 109.717 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -127.79 158.46 70.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 104.185 -2.524 . . . . 50.0 104.185 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.21 -14.9 35.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 117.646 -1.102 . . . . 50.0 113.508 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -65.58 -29.22 69.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.866 1.317 . . . . 50.0 108.801 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -96.03 145.25 29.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 106.797 -1.557 . . . . 50.0 106.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.37 104.6 1.11 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.325 -1.983 . . . . 50.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.99 -42.62 65.75 Favored 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 113.386 0.884 . . . . 50.0 113.386 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -59.88 -35.28 74.49 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -77.19 -38.75 50.91 Favored 'General case' 0 C--O 1.213 -0.865 0 O-C-N 122.074 -0.391 . . . . 50.0 111.25 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.6 -8.69 58.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.842 1.053 . . . . 25.0 113.842 -172.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.83 -36.79 75.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.959 1.096 . . . . 50.0 113.959 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -128.73 162.06 28.28 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.171 1.174 . . . . 25.0 114.171 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -130.07 146.38 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 172.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.8 115.14 20.14 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.916 -1.513 . . . . 50.0 106.916 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -95.12 -6.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.498 0.666 . . . . 25.0 109.966 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.82 159.53 11.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.771 . . . . 50.0 113.568 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.17 143.76 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.0 t -134.27 98.78 13.76 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 108.061 -1.088 . . . . 25.0 108.061 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.25 159.99 39.82 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 115.45 -2.567 . . . . 50.0 110.475 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -104.05 91.2 3.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.574 -2.38 . . . . 50.0 104.574 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -104.49 -25.01 12.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.245 -0.889 . . . . 50.0 109.827 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.17 -151.24 20.21 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 107.709 -2.157 . . . . 25.0 107.709 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.6 m 61.71 168.44 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.873 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.71 0.18 8.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 114.288 -3.341 . . . . 50.0 114.262 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.46 87.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.405 -0.816 . . . . 25.0 108.892 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.1 t -67.58 -26.42 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.917 -0.583 . . . . 25.0 112.022 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -68.43 -27.22 66.0 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.889 0.376 . . . . 50.0 110.517 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.38 104.84 11.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.329 -0.619 . . . . 50.0 109.329 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.03 -28.41 17.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.578 0.704 . . . . 50.0 109.941 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.0 t -93.2 139.46 30.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.802 -1.185 . . . . 50.0 107.802 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -139.93 150.9 45.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.028 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.53 132.49 36.78 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.297 -2.112 . . . . 50.0 105.297 172.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.97 128.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.636 -1.987 . . . . 25.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -78.5 125.01 28.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.923 -1.14 . . . . 50.0 107.923 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.61 108.73 59.81 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.701 -0.851 . . . . 25.0 108.701 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.89 163.92 34.53 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 117.09 -1.473 . . . . 25.0 111.496 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.88 113.05 13.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.604 -2.369 . . . . 50.0 104.604 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -90.19 -33.27 16.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 50.0 110.139 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -155.08 162.04 41.14 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 104.206 -2.516 . . . . 50.0 104.206 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -85.92 136.42 33.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.452 -1.314 . . . . 50.0 107.452 177.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.76 -176.83 25.45 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-O 121.593 0.551 . . . . 25.0 111.727 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -82.82 137.08 34.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.564 1.173 . . . . 50.0 111.901 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -133.33 158.99 41.59 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.294 -3.224 . . . . 25.0 102.294 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.64 137.35 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.791 -1.189 . . . . 50.0 107.791 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.92 129.08 59.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.409 -2.441 . . . . 25.0 104.409 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.02 134.23 55.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.905 -1.146 . . . . 50.0 107.905 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.11 48.83 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.3 t -129.03 132.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.076 -0.713 . . . . 50.0 109.076 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -116.38 111.67 20.39 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 50.0 108.6 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 92.49 5.77 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.821 0.343 . . . . 50.0 111.208 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.98 144.2 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.29 -0.633 . . . . 50.0 109.29 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -102.95 -21.7 13.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.309 0.485 . . . . 25.0 112.309 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -73.7 -21.67 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.336 0.495 . . . . 50.0 112.336 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.42 ' C ' ' H ' ' A' ' 159' ' ' ASN . 68.0 p -135.92 168.57 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 25.0 110.724 -172.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -79.3 13.61 1.84 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.979 0.895 . . . . 50.0 110.734 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . 0.42 ' H ' ' C ' ' A' ' 157' ' ' THR . 69.0 m-20 -110.03 157.8 18.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 50.0 111.294 -172.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.93 171.9 18.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -141.01 143.45 34.45 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.52 -0.872 . . . . 50.0 111.849 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.55 119.93 37.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.386 -2.45 . . . . 50.0 104.386 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -122.69 132.41 54.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.022 -1.844 . . . . 50.0 106.022 -173.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.33 147.48 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 50.0 110.275 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.53 120.68 48.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.43 125.04 28.7 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.624 -1.25 . . . . 25.0 107.624 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.33 126.02 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.951 0.881 . . . . 25.0 108.682 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -89.02 96.09 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 103.474 -2.787 . . . . 50.0 103.474 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.11 119.63 31.4 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.339 -1.726 . . . . 50.0 106.339 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.18 161.91 39.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 O-C-N 123.592 0.558 . . . . 50.0 111.788 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -79.35 159.08 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.314 -1.365 . . . . 50.0 107.314 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.863 -1.065 . . . . 50.0 109.84 178.589 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.8 m170 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 118.864 -0.589 . . . . 25.0 109.762 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.6 168.91 32.25 Favored Glycine 0 C--O 1.23 -0.141 0 C-N-CA 121.251 -0.5 . . . . 25.0 113.566 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -135.62 139.74 44.03 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 84.3 mt -96.67 111.96 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.337 -0.616 . . . . 25.0 109.337 179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -93.56 39.95 1.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.321 0.649 . . . . 50.0 110.326 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 74.5 mttt 79.81 156.35 0.13 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 126.317 1.847 . . . . 25.0 111.629 171.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.89 147.86 90.62 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 129.622 1.093 . . . . 25.0 113.928 -0.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.58 152.14 29.03 Favored Glycine 0 C--O 1.223 -0.55 0 CA-C-N 114.964 -1.016 . . . . 50.0 113.854 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -161.63 142.94 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.91 -1.515 . . . . 25.0 106.91 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -77.97 -28.92 49.51 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.477 -0.489 . . . . 50.0 110.081 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.2 71.85 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.713 0.292 . . . . 25.0 111.013 -177.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.44 89.57 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.596 -0.275 . . . . 25.0 111.135 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.08 -16.52 35.32 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 120.679 0.276 . . . . 50.0 111.183 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t -73.28 -17.97 61.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.976 -0.556 . . . . 50.0 110.906 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.435 ' HG ' ' H ' ' A' ' 17' ' ' ALA . 46.2 t -66.19 140.63 58.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.965 -0.561 . . . . 50.0 111.822 -175.583 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -64.35 -13.38 50.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.406 -0.815 . . . . 50.0 111.152 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.435 ' H ' ' HG ' ' A' ' 15' ' ' SER . . . -58.62 -27.52 64.79 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.978 -0.451 . . . . 25.0 110.247 172.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -111.28 -13.08 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 50.0 110.47 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.47 52.63 0.62 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 108.954 -1.658 . . . . 50.0 108.954 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -69.41 -27.0 64.91 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.321 1.23 . . . . 50.0 114.321 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.6 mt -100.93 -24.7 14.3 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.85 0.357 . . . . 25.0 111.848 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -161.21 155.87 23.4 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.444 -2.428 . . . . 25.0 104.444 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.89 121.68 22.25 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.731 -1.211 . . . . 50.0 107.731 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -101.89 11.26 38.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.792 -1.095 . . . . 50.0 112.682 -170.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -67.45 -28.61 68.02 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.195 0.813 . . . . 50.0 113.195 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.94 164.88 24.92 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 121.591 -0.338 . . . . 50.0 112.602 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -79.07 -35.79 41.9 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.76 -0.847 . . . . 25.0 111.027 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.66 -15.93 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.693 0.997 . . . . 50.0 113.693 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -16.81 23.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.668 1.359 . . . . 25.0 114.668 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -73.04 -36.49 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.997 0.74 . . . . 50.0 112.997 -173.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.05 45.61 0.42 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 118.69 2.848 . . . . 25.0 118.69 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.28 -22.68 33.92 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 113.778 -3.681 . . . . 50.0 112.582 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -77.76 3.23 14.68 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.841 0.682 . . . . 50.0 112.841 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -110.87 66.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.103 -0.702 . . . . 50.0 109.103 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 tt -118.96 111.28 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.438 -0.801 . . . . 50.0 109.414 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -130.03 142.24 50.64 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.317 -1.735 . . . . 50.0 106.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.99 144.84 51.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -106.8 136.94 45.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.103 0.478 . . . . 50.0 110.972 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -71.71 134.69 46.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.882 -1.155 . . . . 50.0 107.882 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.51 -144.57 25.67 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.44 -0.886 . . . . 25.0 113.754 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -109.75 154.62 42.41 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.134 0.574 . . . . 25.0 111.059 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.44 137.34 34.08 Favored 'Cis proline' 0 C--N 1.354 0.847 0 C-N-CA 129.403 1.001 . . . . 25.0 110.789 -0.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -80.14 -47.67 14.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.551 1.315 . . . . 25.0 114.551 -168.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.8 t 62.11 -63.48 0.1 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 117.855 2.539 . . . . 25.0 117.855 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.64 -154.98 30.46 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 117.416 1.726 . . . . 50.0 117.416 -171.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.05 -177.97 2.58 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.973 2.449 . . . . 25.0 111.221 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.79 86.47 1.71 Allowed 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.354 -0.841 . . . . 25.0 111.362 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -74.7 146.7 42.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.04 -0.982 . . . . 25.0 109.765 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.08 -31.98 1.53 Allowed Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.664 -0.698 . . . . 25.0 113.472 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -85.49 38.79 0.75 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.715 0.769 . . . . 25.0 110.024 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.2 mm -59.06 -32.79 48.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.435 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.74 -11.37 35.61 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.293 1.22 . . . . 25.0 114.293 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -91.51 -10.09 42.04 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.006 -0.434 . . . . 25.0 110.382 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.47 13.76 1.97 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.321 1.448 . . . . 25.0 113.243 -171.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.0 -42.57 99.64 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 121.087 -0.578 . . . . 25.0 111.97 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.75 -29.07 61.82 Favored Glycine 0 C--O 1.223 -0.591 0 C-N-CA 120.574 -0.822 . . . . 50.0 111.483 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.26 -30.07 68.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.502 -0.411 . . . . 25.0 111.584 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -66.31 -22.44 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.863 -0.335 . . . . 25.0 111.36 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.07 -22.52 77.27 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.775 -0.726 . . . . 50.0 111.48 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.73 -18.02 71.77 Favored Glycine 0 C--O 1.223 -0.555 0 C-N-CA 121.332 -0.461 . . . . 50.0 112.815 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.09 -38.18 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.461 -0.94 . . . . 50.0 108.461 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.53 -38.05 62.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 50.0 109.794 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -64.21 -41.86 96.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.378 0.608 . . . . 50.0 111.505 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -78.64 -1.82 36.1 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.723 -0.611 . . . . 25.0 112.268 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -134.15 55.08 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.862 0.839 . . . . 25.0 110.177 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -135.79 163.91 29.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 25.0 108.687 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -68.84 -27.71 66.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.245 -1.021 . . . . 50.0 108.245 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -96.49 22.82 7.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.3 -0.864 . . . . 50.0 110.933 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -56.91 145.62 29.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 50.0 108.552 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -81.63 160.2 23.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 50.0 109.908 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -61.71 149.27 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.326 -0.852 . . . . 25.0 111.798 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -121.65 143.24 49.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -124.85 140.01 53.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 25.0 109.846 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.15 131.55 34.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.566 -2.012 . . . . 25.0 105.566 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.0 mtp -138.74 167.88 21.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.961 -1.496 . . . . 50.0 106.961 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -101.33 174.53 5.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.798 -0.183 . . . . 25.0 110.647 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.76 -170.99 13.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.488 -1.445 . . . . 25.0 109.488 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.51 -176.13 44.58 Favored Glycine 0 C--O 1.236 0.236 0 N-CA-C 111.702 -0.559 . . . . 50.0 111.702 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -87.75 144.9 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.981 -0.717 . . . . 25.0 111.508 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -136.21 161.46 35.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.576 -2.009 . . . . 50.0 105.576 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.5 m -122.85 125.45 45.42 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -108.93 137.96 46.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.059 -1.089 . . . . 50.0 108.059 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 m -124.1 123.35 40.13 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -123.91 149.96 45.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 103.698 -2.705 . . . . 50.0 103.698 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.7 p -138.12 159.86 40.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.186 0.517 . . . . 25.0 110.507 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -133.13 123.92 26.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 103.571 -2.752 . . . . 25.0 103.571 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -84.21 -20.76 31.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.448 0.536 . . . . 25.0 112.448 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.19 127.26 69.67 Favored Pre-proline 0 C--O 1.244 0.78 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -67.0 129.89 21.71 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.782 -1.012 . . . . 25.0 113.067 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -136.07 158.93 43.22 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.649 -0.705 . . . . 50.0 110.395 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.18 86.98 6.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.081 -1.451 . . . . 50.0 107.081 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -76.99 129.28 35.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.04 -0.527 . . . . 25.0 110.002 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.9 m -92.73 -42.71 9.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.588 0.588 . . . . 50.0 112.588 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -166.85 173.66 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.897 0.379 . . . . 50.0 111.222 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -147.76 145.62 28.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 165.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -147.93 154.1 39.91 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.716 -0.846 . . . . 50.0 108.716 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -149.84 148.93 29.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.142 0.496 . . . . 50.0 110.537 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.94 156.97 44.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.435 -0.95 . . . . 50.0 108.435 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.79 161.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 110.252 -0.277 . . . . 25.0 110.252 -176.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 p -70.61 140.09 51.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.042 0.448 . . . . 25.0 110.938 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -87.94 120.49 29.33 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.921 0.712 . . . . 25.0 112.921 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -77.04 133.16 39.19 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.95 62.12 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 119.47 -1.347 . . . . 25.0 115.109 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.08 142.59 24.83 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.437 1.118 . . . . 50.0 113.173 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.47 128.04 92.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.405 -1.271 . . . . 50.0 109.338 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.44 -13.18 27.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 117.875 -0.95 . . . . 50.0 112.839 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -66.08 -29.48 69.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.884 0.85 . . . . 50.0 110.886 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -96.01 141.03 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.056 -0.72 . . . . 50.0 109.056 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.62 128.57 18.32 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 115.085 -2.81 . . . . 50.0 111.53 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -25.41 60.35 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.997 -0.547 . . . . 50.0 111.993 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.37 -34.26 46.98 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.63 -0.714 . . . . 25.0 111.963 176.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.5 mpt_? -96.81 -42.92 7.73 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.195 -0.457 . . . . 50.0 110.96 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.08 1.99 11.79 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.48 2.03 . . . . 25.0 116.48 -170.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.69 -34.95 79.52 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.059 -0.719 . . . . 50.0 109.059 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -127.16 146.6 50.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.081 0.552 . . . . 25.0 109.985 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.58 144.67 50.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.418 -0.586 . . . . 25.0 109.418 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.74 124.83 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.526 . . . . 50.0 109.905 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.7 tt -111.49 -12.17 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.291 0.567 . . . . 25.0 109.986 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.39 147.76 8.41 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.489 -1.339 . . . . 50.0 116.092 174.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.82 131.03 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.104 -2.184 . . . . 25.0 105.104 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.99 129.71 9.08 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 118.089 0.404 . . . . 25.0 109.99 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -86.62 177.08 4.41 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 117.289 -1.341 . . . . 50.0 114.718 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -137.73 120.95 16.86 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 106.598 -1.63 . . . . 50.0 106.598 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.45 7.12 10.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 50.0 112.005 -176.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.14 -99.43 0.21 Allowed Glycine 0 N--CA 1.454 -0.104 0 N-CA-C 111.469 -0.652 . . . . 25.0 111.469 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.644 ' HG ' HH11 ' A' ' 130' ' ' ARG . 22.9 t -124.45 53.56 7.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.751 1.389 . . . . 25.0 114.751 178.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.07 -177.18 3.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 117.563 -1.158 . . . . 50.0 110.479 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.15 -30.69 70.54 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.56 -0.713 . . . . 25.0 109.662 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 78.3 p -80.19 8.02 8.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.509 0.929 . . . . 25.0 113.509 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . 0.644 HH11 ' HG ' ' A' ' 126' ' ' SER . 33.2 ptt180 -60.35 -23.59 64.38 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.514 -0.741 . . . . 50.0 111.965 -178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -81.3 129.85 34.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 50.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.67 -9.29 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.411 0.624 . . . . 50.0 112.145 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.8 t -82.26 137.98 34.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.126 -1.064 . . . . 50.0 108.126 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -144.01 143.18 31.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.427 0.529 . . . . 25.0 112.427 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -77.63 139.51 39.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.153 -1.425 . . . . 50.0 107.153 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -131.88 120.73 45.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -98.62 136.07 39.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.312 -0.255 . . . . 50.0 110.312 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.4 mm -117.32 123.78 29.65 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.135 -1.432 . . . . 25.0 107.135 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.78 143.09 49.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 115.549 -2.501 . . . . 25.0 112.012 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.72 12.18 30.83 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.134 -0.939 . . . . 50.0 112.602 -171.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -58.85 -38.33 78.49 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.854 1.057 . . . . 50.0 113.854 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -151.82 157.24 41.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.817 0.342 . . . . 50.0 110.938 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -88.45 152.74 21.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 50.0 109.067 176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.88 154.94 8.99 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 115.497 0.959 . . . . 25.0 115.497 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -78.82 145.03 34.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.65 -0.87 . . . . 50.0 108.65 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.21 159.0 43.09 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.117 -0.492 . . . . 25.0 110.004 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.3 t -118.7 133.65 64.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 104.942 -2.244 . . . . 50.0 104.942 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.4 mt -114.65 127.83 71.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.404 -1.702 . . . . 25.0 106.404 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.0 tp -124.65 120.85 33.06 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.387 -0.968 . . . . 50.0 108.387 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.52 42.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 25.0 109.424 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.01 140.05 50.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.465 -0.939 . . . . 50.0 108.465 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -126.96 113.92 17.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 50.0 107.709 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -105.85 131.99 52.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.843 -0.617 . . . . 50.0 111.317 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.04 136.13 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.153 -1.054 . . . . 50.0 108.153 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.34 54.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 115.083 1.512 . . . . 25.0 115.083 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -87.18 10.77 15.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.405 1.261 . . . . 50.0 114.405 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.487 ' HG1' ' N ' ' A' ' 158' ' ' GLU . 5.3 t -145.28 161.77 38.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.231 0.538 . . . . 25.0 110.879 179.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.487 ' N ' ' HG1' ' A' ' 157' ' ' THR . 21.9 tt0 -88.33 0.92 55.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.347 0.594 . . . . 50.0 110.264 179.575 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -110.08 160.84 16.11 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.914 -0.585 . . . . 50.0 110.216 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.03 154.45 41.27 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.559 -1.645 . . . . 25.0 106.559 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -105.08 137.05 43.45 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.493 -0.928 . . . . 50.0 108.493 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.67 150.1 50.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.991 -1.114 . . . . 50.0 107.991 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.06 129.7 17.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.357 -0.979 . . . . 50.0 108.357 173.018 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.96 137.94 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.295 -1.372 . . . . 50.0 107.295 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.0 mt -138.41 120.46 17.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.38 -0.97 . . . . 25.0 108.38 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.87 134.07 35.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.47 166.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.263 0.554 . . . . 25.0 110.419 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -124.54 106.69 10.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.435 -1.691 . . . . 50.0 106.435 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.2 103.96 14.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.851 -1.166 . . . . 50.0 107.851 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.07 160.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.831 1.419 . . . . 50.0 114.831 -172.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -95.11 162.2 13.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.323 -2.102 . . . . 50.0 105.323 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt . . . . . 0 C--O 1.244 0.779 0 N-CA-C 107.456 -1.313 . . . . 50.0 107.456 173.231 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 119.209 -0.424 . . . . 25.0 110.439 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.42 -138.61 4.02 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 118.046 0.384 . . . . 25.0 112.948 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -112.4 158.22 20.09 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.758 0.779 . . . . 25.0 112.273 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.4 mt -103.86 121.3 55.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.561 -1.274 . . . . 25.0 107.561 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -91.34 -36.61 13.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.352 0.596 . . . . 50.0 111.441 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -140.47 146.04 43.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.18 109.27 1.35 Allowed 'Cis proline' 0 CA--C 1.539 0.749 0 C-N-CA 130.874 1.614 . . . . 25.0 115.562 -0.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.47 173.23 9.91 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 115.562 0.985 . . . . 50.0 115.562 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -86.67 131.48 34.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.619 -0.342 . . . . 25.0 111.033 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -69.76 -37.32 76.36 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.417 -0.586 . . . . 50.0 109.417 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.85 72.55 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 112.592 0.59 . . . . 25.0 112.592 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.73 85.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 25.0 110.904 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.76 -10.31 51.41 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.036 0.446 . . . . 50.0 111.558 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t -84.54 -23.26 29.81 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.221 -0.659 . . . . 50.0 109.221 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -72.75 146.71 46.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.314 0.578 . . . . 50.0 111.714 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -67.79 -16.63 64.2 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.847 -0.615 . . . . 50.0 110.674 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.84 -18.68 57.26 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.71 0.263 . . . . 25.0 111.71 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -83.08 -1.19 52.15 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.42 0.896 . . . . 50.0 113.42 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.92 -34.68 0.08 OUTLIER Glycine 0 CA--C 1.522 0.522 0 N-CA-C 117.384 1.713 . . . . 50.0 117.384 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.3 t80 62.14 -40.35 0.15 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 118.392 2.738 . . . . 50.0 118.392 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.92 -20.09 66.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.772 -0.58 . . . . 25.0 112.304 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -146.26 151.14 37.08 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.283 -1.747 . . . . 25.0 106.283 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.14 138.24 25.15 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.302 -0.999 . . . . 50.0 108.302 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -130.6 44.14 3.01 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.035 -0.728 . . . . 50.0 109.035 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.73 10.72 1.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.219 0.822 . . . . 50.0 113.219 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.49 -61.7 7.11 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 115.673 1.029 . . . . 50.0 115.673 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.4 t -78.98 -14.1 59.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.807 0.803 . . . . 25.0 111.281 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.1 t -75.95 -33.39 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 50.0 111.814 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -66.66 -12.4 58.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -78.35 -37.44 44.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.543 0.61 . . . . 50.0 111.507 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -149.43 70.05 9.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.656 0.741 . . . . 25.0 112.964 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.61 -6.75 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 N-CA-C 113.792 0.651 . . . . 50.0 113.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -87.28 -7.61 57.66 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.102 0.779 . . . . 50.0 113.102 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 t -108.58 95.43 5.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.861 1.06 . . . . 75.0 113.861 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 tt -125.21 81.38 1.96 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.101 0.477 . . . . 50.0 110.06 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -100.22 137.63 38.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.384 0.513 . . . . 50.0 112.384 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.77 114.96 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.075 -0.343 . . . . 25.0 110.075 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -76.54 140.33 41.08 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.7 0.63 . . . . 50.0 112.7 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -69.15 153.61 43.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.631 -0.713 . . . . 50.0 111.673 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.43 -167.72 47.23 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 115.108 0.803 . . . . 25.0 115.108 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -98.09 153.69 38.02 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.359 -0.608 . . . . 25.0 109.359 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.66 159.11 98.37 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 129.406 1.003 . . . . 25.0 111.839 -3.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -65.6 -23.96 66.95 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.946 -0.301 . . . . 25.0 111.31 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t 60.59 -89.42 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.25 1.02 . . . . 25.0 113.305 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.3 -176.99 39.8 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.403 -0.427 . . . . 50.0 112.938 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.47 171.02 18.57 Favored 'Trans proline' 0 C--O 1.235 0.371 0 CA-C-N 118.591 1.195 . . . . 25.0 112.867 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.79 113.33 25.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.863 -1.532 . . . . 25.0 106.863 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' A' ' 50' ' ' GLN . 44.3 t0 -150.81 144.73 25.25 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.51 -1.293 . . . . 25.0 107.51 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.14 -13.8 3.24 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 122.69 1.161 . . . . 25.0 112.291 -173.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.485 ' H ' ' C ' ' A' ' 48' ' ' ASP . 29.3 mt-30 -89.68 46.76 1.39 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.805 1.242 . . . . 25.0 109.31 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.8 mt -60.79 -39.54 82.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.717 -1.129 . . . . 25.0 108.078 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.73 -23.07 67.13 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.5 t -89.84 7.27 37.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.001 -0.37 . . . . 25.0 110.001 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.86 23.98 11.93 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.418 1.087 . . . . 25.0 113.817 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.55 -34.96 0.72 Allowed Glycine 0 C--O 1.22 -0.734 0 C-N-CA 121.361 -0.447 . . . . 25.0 113.466 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.0 15.74 60.21 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 114.552 0.581 . . . . 50.0 114.552 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -67.31 -27.79 67.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.419 0.526 . . . . 25.0 112.419 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -71.45 -21.68 61.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.246 0.462 . . . . 25.0 112.246 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.03 90.83 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.904 -0.665 . . . . 50.0 112.473 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.28 68.22 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.784 -0.722 . . . . 50.0 113.541 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.58 -46.22 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.084 0.469 . . . . 50.0 109.989 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.16 -24.08 62.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.933 1.086 . . . . 50.0 113.933 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.41 -25.68 59.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 50.0 114.254 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -57.16 -21.6 34.17 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.532 0.938 . . . . 25.0 113.532 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -138.87 38.84 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.41 0.624 . . . . 25.0 109.788 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.5 t -85.98 146.75 26.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 25.0 110.715 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -63.26 -25.11 68.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.135 0.969 . . . . 50.0 109.881 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -118.77 28.19 8.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.993 -1.003 . . . . 50.0 108.733 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -47.65 140.78 5.88 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.245 -0.889 . . . . 50.0 112.982 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -79.05 146.15 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.968 0.889 . . . . 50.0 109.65 -171.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -68.82 134.68 50.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.361 -0.836 . . . . 25.0 109.388 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -121.01 139.99 52.54 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 113.453 0.908 . . . . 25.0 113.453 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -119.42 143.21 47.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.69 -1.226 . . . . 25.0 107.69 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.9 mt -94.06 128.27 45.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 102.928 -2.99 . . . . 25.0 102.928 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 89.8 mtp -140.88 164.29 30.63 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 107.554 -1.276 . . . . 50.0 107.554 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.0 p -92.44 174.06 7.48 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 104.494 -2.409 . . . . 25.0 104.494 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.52 -162.27 8.9 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.846 -0.902 . . . . 25.0 110.846 173.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.6 -178.13 27.33 Favored Glycine 0 C--N 1.323 -0.173 0 CA-C-O 121.452 0.473 . . . . 50.0 112.392 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.4 131.35 43.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.948 -0.736 . . . . 25.0 109.222 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.12 158.55 37.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.853 -1.166 . . . . 50.0 107.853 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 m -120.38 126.68 51.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.11 0.481 . . . . 25.0 109.73 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.62 135.77 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.526 -2.027 . . . . 50.0 105.526 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.1 m -138.07 128.52 26.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.036 0.384 . . . . 25.0 112.036 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -117.96 149.98 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.023 -1.843 . . . . 50.0 106.023 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.5 t -137.85 160.12 40.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.9 143.87 38.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 p -80.78 -16.82 52.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.0 151.81 63.4 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.83 144.99 61.08 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 116.54 -1.84 . . . . 25.0 111.521 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -131.16 148.58 52.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 50.0 109.262 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.08 157.34 33.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.414 -1.328 . . . . 50.0 107.414 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.9 m -160.07 148.31 16.94 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 104.093 -2.558 . . . . 25.0 104.093 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -92.1 -51.63 5.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.386 -0.968 . . . . 50.0 108.386 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -156.12 170.61 21.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.309 -0.626 . . . . 50.0 109.309 178.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -149.56 142.52 24.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.915 -1.143 . . . . 25.0 107.915 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -148.04 154.55 40.4 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.226 -0.296 . . . . 50.0 111.162 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -120.02 133.81 55.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.368 -0.833 . . . . 50.0 109.391 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -121.62 163.67 18.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.383 -1.71 . . . . 50.0 106.383 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.37 165.18 29.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 t -126.12 135.71 52.02 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-O 121.435 0.636 . . . . 25.0 111.452 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -109.06 118.78 37.67 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.838 -0.619 . . . . 25.0 112.323 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -75.98 156.02 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.416 -1.327 . . . . 25.0 107.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.97 10.55 15.76 Favored Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.955 -0.64 . . . . 25.0 114.24 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -60.69 162.88 6.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.306 0.574 . . . . 50.0 112.439 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.55 144.98 92.16 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.785 -1.561 . . . . 50.0 106.785 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.7 -23.11 14.81 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 116.638 -1.774 . . . . 50.0 115.001 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -104.64 24.93 10.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.093 0.949 . . . . 50.0 112.721 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -122.97 160.47 49.29 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 105.752 -1.944 . . . . 50.0 105.752 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.64 83.46 1.74 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 116.14 -2.107 . . . . 50.0 112.868 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.27 -39.19 72.24 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 121.511 0.672 . . . . 50.0 110.019 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -16.61 6.58 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.475 1.287 . . . . 25.0 114.475 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -93.81 -46.76 7.07 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 112.447 0.536 . . . . 50.0 112.447 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.97 -17.17 41.44 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.898 1.814 . . . . 25.0 115.898 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.93 -26.32 65.91 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.325 1.232 . . . . 50.0 114.325 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -103.32 125.17 49.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.464 0.65 . . . . 25.0 111.257 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.74 141.0 52.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.782 -0.644 . . . . 25.0 109.695 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.41 128.15 32.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.513 -0.551 . . . . 50.0 109.513 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.6 tt -111.0 -3.65 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.609 0.719 . . . . 25.0 110.33 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.26 150.96 6.68 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.749 -0.739 . . . . 50.0 113.42 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.54 140.68 31.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.958 -0.756 . . . . 25.0 108.958 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.38 112.36 8.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 123.326 0.391 . . . . 25.0 109.989 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.73 158.86 28.18 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 114.877 -2.949 . . . . 50.0 111.326 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -105.83 91.9 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 103.154 -2.906 . . . . 50.0 103.154 175.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -156.6 56.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.663 0.744 . . . . 50.0 110.973 -172.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.62 12.97 43.35 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.062 -0.589 . . . . 25.0 113.839 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.27 156.85 7.22 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.271 1.212 . . . . 25.0 114.271 -173.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.08 -163.8 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.369 1.379 . . . . 50.0 112.146 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.07 -25.57 0.6 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 117.21 2.3 . . . . 25.0 117.21 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . 0.513 ' HG ' ' HE2' ' A' ' 134' ' ' HIS . 14.8 t -62.39 -18.34 61.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.616 0.598 . . . . 25.0 112.616 176.042 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -58.88 -25.13 63.07 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.249 1.02 . . . . 50.0 112.547 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -59.0 135.61 57.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.882 0.697 . . . . 50.0 112.882 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.57 -7.78 51.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.124 -0.944 . . . . 50.0 111.527 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -100.0 120.02 39.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.123 -2.547 . . . . 50.0 104.123 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.513 ' HE2' ' HG ' ' A' ' 129' ' ' SER . 0.3 OUTLIER -136.5 136.26 39.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 -171.892 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -83.27 136.75 34.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.31 -1.737 . . . . 50.0 106.31 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.0 mm -131.96 131.19 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 105.971 -1.862 . . . . 25.0 105.971 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -93.34 130.87 38.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.603 -0.518 . . . . 50.0 109.603 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.6 mt -126.1 136.47 28.56 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.047 -1.464 . . . . 25.0 107.047 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.3 168.1 24.37 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 117.22 -1.386 . . . . 25.0 113.015 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -127.24 35.98 4.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.854 -1.165 . . . . 50.0 107.854 -178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -86.18 -31.4 21.8 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.986 1.106 . . . . 50.0 113.986 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -146.22 169.66 18.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.114 -0.328 . . . . 50.0 110.114 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -107.68 152.02 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.874 0.694 . . . . 50.0 112.874 178.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.29 157.75 7.33 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.721 -0.672 . . . . 25.0 112.078 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 15.8 p90 -84.03 144.94 28.77 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.732 0.777 . . . . 50.0 113.042 -175.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -138.06 135.01 35.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.7 t -98.0 134.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.263 -1.754 . . . . 50.0 106.263 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.02 125.31 61.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -104.69 109.68 21.7 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.401 -1.333 . . . . 50.0 107.401 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -108.09 123.8 49.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.63 133.1 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.663 -0.865 . . . . 50.0 108.663 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -121.25 107.58 12.72 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.537 -1.283 . . . . 50.0 107.537 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.2 t0 -82.67 90.69 6.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 50.0 109.98 -174.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.59 119.32 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.043 -1.095 . . . . 50.0 108.043 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.32 11.89 22.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 25.0 112.101 -174.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.96 -2.97 30.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.046 0.387 . . . . 50.0 112.046 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.7 p -143.83 168.5 19.8 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.671 0.272 . . . . 25.0 111.512 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.26 1.07 34.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.957 0.884 . . . . 50.0 109.371 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.14 155.04 18.69 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.843 -1.169 . . . . 50.0 107.843 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 150.86 41.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 103.197 -2.89 . . . . 25.0 103.197 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.33 138.57 47.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.593 -0.521 . . . . 50.0 109.593 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -138.97 154.02 48.25 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.135 -1.061 . . . . 50.0 108.135 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.16 152.3 45.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.467 -1.679 . . . . 50.0 106.467 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.97 145.46 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.538 -0.542 . . . . 50.0 109.538 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.2 mt -136.24 125.19 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.086 -2.561 . . . . 25.0 104.086 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -111.15 130.63 55.57 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.31 -1.367 . . . . 25.0 107.31 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.73 134.93 58.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -93.17 100.52 12.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.55 -2.018 . . . . 50.0 105.55 176.288 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.0 mt -92.88 130.21 38.54 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.915 -1.513 . . . . 50.0 106.915 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 10.1 m -127.04 158.01 38.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 113.871 1.063 . . . . 50.0 113.871 -176.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -93.82 161.47 14.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.299 -1.371 . . . . 50.0 107.299 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt . . . . . 0 C--O 1.243 0.723 0 CA-C-O 118.472 -0.775 . . . . 50.0 109.409 175.293 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.444 ' HD1' ' HH ' ' A' ' 30' ' ' TYR . 45.2 p-80 . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 110.299 -0.26 . . . . 25.0 110.299 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.96 179.75 29.15 Favored Glycine 0 CA--C 1.509 -0.32 0 N-CA-C 107.906 -2.078 . . . . 25.0 107.906 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -134.06 161.7 34.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.015 0.908 . . . . 25.0 108.907 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.98 121.77 66.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.938 -1.505 . . . . 25.0 106.938 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -12.27 60.58 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.95 1.092 . . . . 50.0 113.95 -174.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt 79.68 149.69 0.12 Allowed Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 126.195 1.798 . . . . 25.0 108.161 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.31 156.72 91.42 Favored 'Cis proline' 0 C--N 1.346 0.425 0 CA-C-O 121.181 0.409 . . . . 25.0 112.371 -0.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.7 10.53 30.63 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 116.262 1.265 . . . . 50.0 116.262 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -64.5 126.93 29.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.945 0.872 . . . . 25.0 111.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -77.95 -19.12 55.16 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 116.345 -0.389 . . . . 50.0 110.231 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.79 69.64 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.75 -0.205 . . . . 25.0 111.191 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -25.12 65.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 25.0 110.811 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.28 0.56 51.03 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 122.915 0.486 . . . . 50.0 110.567 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 t -80.12 -8.7 59.53 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.997 0.369 . . . . 50.0 111.997 -176.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.667 ' HG ' ' H ' ' A' ' 17' ' ' ALA . 30.5 t -56.99 143.69 37.08 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.487 0.921 . . . . 50.0 113.487 -174.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -17.19 54.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.625 -1.17 . . . . 50.0 112.026 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.667 ' H ' ' HG ' ' A' ' 15' ' ' SER . . . -59.89 -12.96 8.8 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.069 0.766 . . . . 25.0 113.069 177.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -75.22 -12.97 60.4 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.024 0.379 . . . . 50.0 112.024 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.43 -8.02 0.03 OUTLIER Glycine 0 N--CA 1.464 0.519 0 N-CA-C 118.037 1.975 . . . . 50.0 118.037 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.5 t80 57.2 27.83 14.15 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.727 1.38 . . . . 50.0 114.727 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.0 mt -101.05 -2.94 30.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.337 0.589 . . . . 25.0 109.438 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -133.53 167.58 20.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.624 -0.716 . . . . 25.0 110.432 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mp -74.9 164.26 26.75 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.835 -1.913 . . . . 50.0 105.835 172.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -45.67 -20.06 0.07 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.888 2.181 . . . . 50.0 116.888 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.9 t -164.27 -16.55 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.708 0.766 . . . . 50.0 109.966 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.07 167.72 38.46 Favored Glycine 0 C--O 1.222 -0.644 0 C-N-CA 121.251 -0.499 . . . . 50.0 113.08 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.3 t -76.47 -13.97 60.07 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.869 -0.783 . . . . 25.0 111.441 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -69.84 -11.92 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 122.801 0.441 . . . . 50.0 110.559 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.6 ptm -60.32 -10.44 4.72 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.444 ' HH ' ' HD1' ' A' ' 1' ' ' HIS . 80.9 t80 -65.53 -46.61 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.576 0.625 . . . . 50.0 109.983 -177.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.02 69.41 5.61 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 113.185 0.809 . . . . 25.0 113.185 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.32 3.12 6.06 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 N-CA-C 113.71 0.619 . . . . 50.0 113.71 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -101.32 -2.44 31.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.497 0.555 . . . . 50.0 112.497 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.94 97.4 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.662 0.986 . . . . 50.0 113.662 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.96 112.29 24.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.504 -1.665 . . . . 50.0 106.504 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -89.03 110.19 20.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.977 0.732 . . . . 50.0 112.977 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.55 152.42 20.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.084 -1.821 . . . . 25.0 106.084 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -141.49 149.37 40.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.171 0.434 . . . . 50.0 112.171 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -66.01 146.24 54.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.37 -1.344 . . . . 50.0 107.37 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.58 108.95 0.56 Allowed Glycine 0 C--O 1.219 -0.803 0 C-N-CA 120.691 -0.766 . . . . 25.0 114.462 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.35 152.54 38.0 Favored Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 122.286 -0.537 . . . . 25.0 111.4 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.05 -17.65 16.92 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 128.824 0.76 . . . . 25.0 113.188 -1.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -162.27 -33.1 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 116.238 -0.437 . . . . 25.0 111.537 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 t 59.51 -85.69 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.073 0.949 . . . . 25.0 111.829 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.62 -154.99 19.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.449 -0.661 . . . . 50.0 111.449 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.21 167.1 26.0 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.19 1.495 . . . . 25.0 111.583 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.02 115.83 16.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.491 -0.559 . . . . 25.0 109.491 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -146.58 179.47 7.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 105.857 -1.905 . . . . 25.0 105.857 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.74 -2.09 69.96 Favored Glycine 0 C--N 1.324 -0.135 0 CA-C-O 121.951 0.75 . . . . 25.0 111.252 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -73.54 -1.93 20.64 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.158 0.504 . . . . 25.0 111.885 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.92 -38.61 82.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.243 -1.021 . . . . 25.0 108.243 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.67 -23.96 60.96 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.604 0.594 . . . . 25.0 112.604 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.7 p -95.39 2.48 54.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.612 0.244 . . . . 25.0 111.062 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.18 -0.56 0.84 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.238 1.415 . . . . 25.0 113.336 -173.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.33 -31.54 71.57 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 121.06 -0.591 . . . . 25.0 111.724 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.5 -17.2 80.23 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 121.047 -0.597 . . . . 50.0 112.305 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.3 mt -72.26 -25.97 61.81 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.704 . . . . 25.0 110.291 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.561 -0.533 . . . . 25.0 109.561 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -24.99 69.5 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.926 -0.869 . . . . 50.0 110.926 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.86 -16.9 68.81 Favored Glycine 0 C--O 1.228 -0.26 0 O-C-N 122.774 -0.251 . . . . 50.0 112.536 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mm -66.16 -40.1 86.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.943 -1.132 . . . . 50.0 107.943 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mp -75.81 -26.89 57.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 50.0 111.15 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.78 -22.01 66.7 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.149 0.5 . . . . 50.0 111.589 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.73 -5.93 18.48 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.865 -0.522 . . . . 25.0 112.156 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -130.65 35.15 4.04 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -106.62 156.54 18.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 25.0 111.101 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -68.66 -31.02 69.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.811 -0.811 . . . . 50.0 108.811 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -97.48 21.39 10.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.564 -0.744 . . . . 50.0 110.409 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -52.31 136.1 31.51 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.057 0.456 . . . . 50.0 111.5 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 146.03 46.44 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 122.686 1.231 . . . . 50.0 112.33 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -75.7 148.78 38.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.383 -1.28 . . . . 25.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -103.03 126.87 50.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -100.1 108.79 21.03 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.182 -0.607 . . . . 25.0 109.658 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.55 138.6 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.67 -0.863 . . . . 25.0 108.67 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.4 tpt -151.04 154.09 36.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.202 -0.666 . . . . 50.0 109.202 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.2 p -91.16 -179.48 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.838 -1.171 . . . . 25.0 107.838 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.45 -168.88 31.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 116.445 1.338 . . . . 25.0 116.445 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.92 170.72 36.92 Favored Glycine 0 C--N 1.329 0.162 0 N-CA-C 108.864 -1.694 . . . . 50.0 108.864 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.77 148.3 28.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 119.309 1.555 . . . . 25.0 108.477 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -134.19 157.96 44.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.611 -1.255 . . . . 50.0 107.611 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -124.95 125.74 44.39 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.46 140.89 48.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.189 -1.041 . . . . 50.0 108.189 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -132.58 132.42 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.608 0.568 . . . . 25.0 111.993 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -118.47 150.06 40.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.714 -1.217 . . . . 50.0 107.714 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.0 p -133.84 161.71 34.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.99 158.11 42.32 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.867 -1.531 . . . . 25.0 106.867 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 t -69.83 -27.02 64.51 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.347 0.499 . . . . 25.0 112.347 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.13 61.17 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 106.684 -1.598 . . . . 25.0 106.684 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.39 152.03 65.82 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 115.956 -2.229 . . . . 25.0 110.038 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.15 147.57 52.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.268 -0.641 . . . . 50.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -61.03 137.01 58.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.277 -1.749 . . . . 50.0 106.277 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 m -146.16 144.66 30.09 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.9 t -91.56 -48.03 7.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.487 -0.56 . . . . 50.0 109.487 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -166.2 169.65 14.11 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.298 -0.251 . . . . 50.0 111.369 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -141.9 141.0 32.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 166.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.8 156.42 42.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.605 -0.27 . . . . 50.0 110.84 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -130.67 142.94 50.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.809 -0.632 . . . . 50.0 111.535 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -132.3 164.96 25.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.622 -0.881 . . . . 50.0 108.622 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.9 pt -130.31 157.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.9 p -96.71 133.63 41.0 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-O 121.148 0.499 . . . . 25.0 111.273 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -92.22 99.57 12.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.627 0.727 . . . . 25.0 111.98 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -76.16 148.14 38.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.407 -1.331 . . . . 25.0 107.407 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 22.19 40.32 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 115.579 0.992 . . . . 25.0 115.579 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -56.93 148.74 20.31 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.686 0.743 . . . . 50.0 111.705 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.96 138.79 46.2 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.204 -1.036 . . . . 50.0 108.204 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.98 -15.91 29.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 117.617 -1.122 . . . . 50.0 112.261 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.15 -22.06 64.88 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.023 0.929 . . . . 50.0 111.577 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -113.75 153.79 45.89 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.944 -0.571 . . . . 50.0 109.55 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.08 107.03 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 117.987 -0.876 . . . . 50.0 113.633 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -52.72 -46.87 67.57 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.193 -0.912 . . . . 50.0 112.742 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -54.35 -38.48 66.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.184 -0.462 . . . . 25.0 112.094 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.71 -44.28 23.88 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.894 -0.594 . . . . 50.0 111.944 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.43 -24.69 62.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.765 1.394 . . . . 25.0 114.765 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -68.07 -23.81 65.0 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.812 1.412 . . . . 50.0 114.812 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -123.02 135.18 54.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.003 -1.061 . . . . 25.0 112.508 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -128.15 133.11 48.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.464 -0.939 . . . . 25.0 108.464 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.11 120.56 23.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.708 -0.849 . . . . 50.0 108.708 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.2 tt -96.3 -10.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.478 0.656 . . . . 25.0 110.094 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.05 160.27 13.1 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.323 -0.942 . . . . 50.0 113.935 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.69 146.71 29.38 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.096 -1.075 . . . . 25.0 108.096 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -135.25 106.84 10.23 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.09 160.57 39.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 114.902 -2.932 . . . . 50.0 110.743 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -118.51 94.19 4.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.395 1.093 . . . . 50.0 108.804 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.17 -94.71 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.033 -2.951 . . . . 50.0 103.033 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.26 128.54 9.6 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.3 t -163.49 145.07 7.44 Favored Pre-proline 0 C--O 1.242 0.708 0 CA-C-N 117.159 0.48 . . . . 25.0 109.959 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -76.08 -154.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.516 1.477 . . . . 50.0 110.744 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -18.84 4.47 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.129 1.529 . . . . 25.0 115.129 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.6 t -66.87 -6.73 17.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.825 0.676 . . . . 25.0 112.825 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.92 -14.87 63.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.423 0.689 . . . . 50.0 110.807 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -66.59 150.66 48.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.495 0.664 . . . . 50.0 112.205 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.06 -12.51 60.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.182 -0.917 . . . . 50.0 110.209 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -89.68 120.81 31.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.231 -1.766 . . . . 50.0 106.231 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -135.07 134.15 40.05 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.277 0.473 . . . . 25.0 112.277 -173.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -82.28 139.31 34.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.812 -0.631 . . . . 50.0 109.973 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.19 121.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 106.395 -1.706 . . . . 25.0 106.395 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -80.65 135.36 36.02 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.036 -0.728 . . . . 50.0 109.036 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.0 mm -122.94 117.85 28.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.47 158.05 51.85 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 115.947 -2.235 . . . . 25.0 110.577 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -112.35 51.65 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.948 -1.501 . . . . 50.0 106.948 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.29 -26.01 16.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.039 -0.982 . . . . 50.0 111.731 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -158.09 160.13 37.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.301 . . . . 50.0 110.782 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -100.13 137.54 38.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.178 -1.045 . . . . 50.0 108.178 175.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 172.26 144.53 4.57 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 122.348 0.971 . . . . 25.0 115.453 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -95.72 144.96 25.67 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 112.664 0.616 . . . . 50.0 112.664 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -148.95 163.57 37.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.369 -0.974 . . . . 25.0 108.369 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.1 t -93.43 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.384 -0.969 . . . . 50.0 108.384 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.04 129.22 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 105.893 -1.892 . . . . 25.0 105.893 171.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.32 141.86 45.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.001 -1.852 . . . . 50.0 106.001 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.36 143.99 40.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.716 -0.475 . . . . 25.0 109.716 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.07 135.11 62.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.442 -0.948 . . . . 50.0 108.442 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -126.08 118.5 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 50.0 108.059 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -111.76 134.62 53.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.949 0.351 . . . . 50.0 111.949 -173.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.28 128.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.781 -1.563 . . . . 50.0 106.781 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -31.17 65.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 25.0 111.533 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -75.26 -2.03 26.19 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.901 1.074 . . . . 50.0 113.901 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.0 p -123.01 155.01 37.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.748 0.785 . . . . 25.0 112.699 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -83.24 -6.36 59.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.124 -0.695 . . . . 50.0 109.124 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -109.25 153.83 23.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.2 -0.909 . . . . 50.0 109.544 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.86 150.63 51.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -119.66 135.81 54.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.037 0.446 . . . . 50.0 111.239 -168.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -127.09 153.88 45.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.753 -0.832 . . . . 50.0 108.753 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -146.19 156.18 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.132 -1.062 . . . . 50.0 108.132 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.69 138.78 48.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.585 . . . . 50.0 109.422 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.5 mt -140.04 121.43 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.66 140.52 29.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.703 -0.851 . . . . 25.0 108.703 174.561 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.78 157.56 42.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -128.81 118.58 23.0 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 104.293 -2.484 . . . . 50.0 104.293 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.7 mt -108.25 121.91 45.86 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 104.627 -2.36 . . . . 50.0 104.627 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.7 m -130.86 160.4 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.12 1.155 . . . . 50.0 114.12 -171.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -95.13 157.51 15.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.307 -1.738 . . . . 50.0 106.307 174.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.9 tptt . . . . . 0 C--O 1.251 1.139 0 O-C-N 124.297 0.998 . . . . 50.0 110.83 174.601 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 51.6 m80 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 119.605 -0.236 . . . . 25.0 110.894 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.83 -169.28 40.08 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.13 -0.557 . . . . 25.0 113.911 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -150.96 170.96 18.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.173 0.589 . . . . 25.0 109.431 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 tt -106.86 131.86 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.074 0.464 . . . . 25.0 110.245 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -85.15 -47.94 9.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.266 1.031 . . . . 50.0 111.054 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.21 149.69 56.04 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.771 -1.104 . . . . 25.0 108.552 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.17 98.59 0.23 Allowed 'Cis proline' 0 CA--C 1.545 1.041 0 C-N-CA 131.498 1.874 . . . . 25.0 114.52 -1.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.9 138.82 7.26 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 121.657 0.587 . . . . 50.0 113.593 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.402 ' HG ' ' H ' ' A' ' 11' ' ' ALA . 42.2 t -68.21 145.53 54.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.612 0.72 . . . . 25.0 112.71 -176.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.385 -0.825 . . . . 50.0 110.248 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.402 ' H ' ' HG ' ' A' ' 9' ' ' SER . . . -64.94 -26.43 68.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.291 0.848 . . . . 25.0 113.291 -175.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.76 88.71 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 112.079 0.4 . . . . 25.0 112.079 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.92 -3.92 55.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.579 0.704 . . . . 50.0 111.605 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 t -87.31 -21.69 25.58 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.335 -0.848 . . . . 50.0 109.84 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.2 t -73.47 133.0 43.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.669 -0.493 . . . . 50.0 109.669 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -65.48 -30.15 70.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.379 0.609 . . . . 50.0 110.432 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.48 -17.39 63.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.005 -0.543 . . . . 25.0 112.179 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -79.95 -15.84 56.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.776 -0.577 . . . . 50.0 110.935 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.51 7.34 10.45 Favored Glycine 0 C--N 1.328 0.102 0 N-CA-C 110.02 -1.232 . . . . 50.0 110.02 174.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.0 t80 61.96 -60.95 0.11 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.775 2.03 . . . . 50.0 114.803 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.9 mt -108.5 -4.22 17.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.691 0.396 . . . . 25.0 111.582 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -137.57 159.46 41.91 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.236 0.458 . . . . 25.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.1 157.62 45.64 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.517 -1.66 . . . . 50.0 106.517 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.41 26.53 9.53 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.125 0.488 . . . . 50.0 111.02 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.99 -21.23 31.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.694 0.628 . . . . 50.0 112.694 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.86 -179.59 30.74 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.747 -0.66 . . . . 50.0 112.636 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.491 ' H ' ' HG ' ' A' ' 27' ' ' SER . 2.6 p -66.24 -14.01 61.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.301 0.572 . . . . 25.0 110.919 176.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t -61.17 -18.44 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.286 0.634 . . . . 50.0 110.695 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.33 -14.21 10.82 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 115.3 1.593 . . . . 25.0 115.3 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -71.47 -37.72 71.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.427 0.558 . . . . 50.0 110.111 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.81 68.26 10.62 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 121.64 0.733 . . . . 25.0 111.797 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.91 -8.97 23.14 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 117.541 -1.173 . . . . 50.0 112.829 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -83.77 -9.9 58.47 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.718 -0.475 . . . . 50.0 109.718 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 t -81.37 104.15 11.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.462 0.649 . . . . 50.0 110.037 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.6 mt -122.91 74.02 1.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.494 -0.775 . . . . 50.0 109.325 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -142.02 135.68 29.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.664 0.386 . . . . 50.0 111.142 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.51 32.54 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -103.53 147.37 27.26 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.047 -0.408 . . . . 50.0 109.954 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -60.25 153.43 22.38 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.876 0.369 . . . . 50.0 111.791 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.79 -158.03 9.06 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.707 -0.957 . . . . 25.0 110.707 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -88.53 144.18 33.26 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.422 ' C ' ' H ' ' A' ' 44' ' ' SER . 23.2 Cg_endo -96.37 -2.37 34.39 Favored 'Cis proline' 0 CA--C 1.534 0.498 0 C-N-CA 130.681 1.534 . . . . 25.0 115.264 -0.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.4 t60 67.1 -32.59 0.19 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.807 1.643 . . . . 25.0 114.188 -172.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.422 ' H ' ' C ' ' A' ' 42' ' ' PRO . 9.7 m -83.6 -14.13 52.76 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.515 1.302 . . . . 25.0 114.515 -177.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.2 165.62 12.85 Favored Glycine 0 N--CA 1.46 0.254 0 C-N-CA 121.161 -0.543 . . . . 50.0 112.427 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.41 -27.11 13.59 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 118.737 1.268 . . . . 25.0 113.262 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.9 132.83 42.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.367 -1.716 . . . . 25.0 106.367 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -135.86 142.17 44.74 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.19 -1.041 . . . . 25.0 108.19 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.45 -32.38 3.11 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.911 1.125 . . . . 25.0 115.911 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -105.16 34.16 3.34 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.787 1.294 . . . . 25.0 112.726 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mm -63.39 -36.9 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.666 0.617 . . . . 25.0 112.666 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.03 -38.27 72.92 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.32 0.859 . . . . 25.0 113.32 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.9 p -102.47 -8.54 20.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.432 -0.168 . . . . 25.0 110.963 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.27 19.98 3.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.622 1.169 . . . . 25.0 112.107 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.8 1.93 84.8 Favored Glycine 0 C--O 1.217 -0.934 0 N-CA-C 115.745 1.058 . . . . 25.0 115.745 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.68 -35.13 84.99 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 117.92 0.86 . . . . 50.0 114.092 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.13 -37.99 13.03 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.137 -0.625 . . . . 25.0 111.897 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -84.77 -13.72 50.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.692 0.997 . . . . 25.0 113.692 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.4 -15.92 64.32 Favored Glycine 0 C--O 1.216 -1.024 0 C-N-CA 121.496 -0.383 . . . . 50.0 112.87 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.15 -24.34 68.71 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.654 -0.784 . . . . 50.0 112.843 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -66.67 -41.54 88.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.904 -0.776 . . . . 50.0 108.904 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -72.15 -29.37 63.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.041 -0.527 . . . . 50.0 110.537 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.44 -19.78 65.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.282 0.475 . . . . 50.0 112.282 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -66.29 -11.8 52.68 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.046 -0.409 . . . . 25.0 111.082 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -137.86 64.91 1.5 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.582 -1.266 . . . . 25.0 107.582 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.5 t -135.75 159.58 41.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.318 -0.401 . . . . 25.0 110.742 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.75 -32.33 72.86 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.984 0.897 . . . . 50.0 109.488 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -96.88 22.04 8.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.762 -0.654 . . . . 50.0 110.438 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -49.59 134.5 19.68 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.946 0.879 . . . . 50.0 112.916 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.12 154.81 38.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.906 -1.043 . . . . 50.0 112.678 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -80.49 129.53 34.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.792 -0.818 . . . . 25.0 108.792 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 152.79 21.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.929 0.395 . . . . 25.0 111.746 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.78 100.35 6.14 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.534 0.334 . . . . 25.0 110.694 174.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.9 mt -78.52 131.02 35.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.149 -1.056 . . . . 25.0 108.149 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.3 mtm -143.32 163.81 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.263 0.625 . . . . 50.0 110.309 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.3 p -93.14 -179.46 5.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.958 -1.867 . . . . 25.0 105.958 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.9 30.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.778 -0.725 . . . . 25.0 111.319 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.73 -160.76 16.99 Favored Glycine 0 CA--C 1.517 0.171 0 O-C-N 122.269 -0.548 . . . . 50.0 114.053 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.59 137.56 38.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.946 0.403 . . . . 25.0 111.425 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -132.6 139.95 48.02 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.013 -0.736 . . . . 50.0 109.013 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.2 m -120.35 111.43 17.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -93.15 116.37 28.97 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.008 -1.849 . . . . 50.0 106.008 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.0 m -119.28 93.47 4.09 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.149 -0.686 . . . . 25.0 109.149 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -89.06 133.59 34.3 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.884 -1.525 . . . . 50.0 106.884 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -123.77 136.62 54.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -126.4 148.57 49.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 120.985 0.422 . . . . 25.0 110.308 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -120.64 31.35 6.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.623 -1.992 . . . . 25.0 105.623 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.66 125.08 91.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 114.619 -1.173 . . . . 25.0 109.43 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.08 26.39 0.65 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 120.227 0.618 . . . . 25.0 112.615 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -130.9 149.48 52.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 50.0 111.495 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -69.78 156.42 39.05 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.21 -0.663 . . . . 50.0 109.21 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -123.03 149.53 44.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.049 -1.834 . . . . 25.0 106.049 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -93.95 -56.85 2.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.074 0.464 . . . . 50.0 110.501 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -161.63 173.77 14.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.815 -0.439 . . . . 50.0 109.815 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.32 152.69 39.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.735 -0.666 . . . . 25.0 109.698 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -146.73 141.82 27.17 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.335 -1.357 . . . . 50.0 107.335 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -140.83 149.12 41.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.836 0.827 . . . . 50.0 112.53 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.07 160.51 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.617 -1.174 . . . . 50.0 109.397 -172.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.5 158.88 42.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.314 -0.995 . . . . 25.0 108.314 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 1.1 t -96.86 126.96 42.38 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 113.227 0.825 . . . . 25.0 113.227 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -99.47 103.33 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.644 -1.243 . . . . 25.0 107.644 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -70.91 152.36 43.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.13 10.08 24.8 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.731 -0.483 . . . . 25.0 113.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -62.02 153.81 28.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.76 0.79 . . . . 50.0 109.817 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.54 151.29 85.03 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.361 -0.977 . . . . 50.0 108.361 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.03 -11.35 27.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 113.499 0.538 . . . . 50.0 113.499 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -74.46 -6.16 46.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.544 0.687 . . . . 50.0 111.511 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -105.07 135.82 19.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 121.812 -0.555 . . . . 50.0 111.161 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.89 123.21 10.42 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.588 -1.141 . . . . 50.0 113.002 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -52.62 -49.41 65.16 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 114.415 1.265 . . . . 50.0 114.415 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -64.72 -11.05 31.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.746 1.017 . . . . 25.0 113.746 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -104.69 -48.96 3.64 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 112.231 0.456 . . . . 50.0 112.231 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.81 -22.46 58.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 -170.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.16 -28.77 67.58 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.535 -0.466 . . . . 50.0 111.895 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -124.6 144.89 49.91 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -126.7 144.29 50.97 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.998 0.428 . . . . 25.0 110.516 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.39 126.79 30.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.074 -0.713 . . . . 50.0 109.074 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.6 tp -115.21 1.82 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 121.997 0.904 . . . . 25.0 109.027 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.55 156.08 9.03 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 115.838 1.095 . . . . 50.0 115.838 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.62 128.04 16.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.1 t -140.5 123.09 9.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.568 0.347 . . . . 25.0 110.336 -170.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.7 168.58 20.9 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 117.191 -1.406 . . . . 50.0 111.973 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -82.65 121.0 26.28 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.891 -0.723 . . . . 50.0 111.987 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.77 33.14 22.86 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.92 1.822 . . . . 50.0 115.92 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.43 165.12 44.11 Favored Glycine 0 C--O 1.219 -0.84 0 N-CA-C 110.968 -0.853 . . . . 25.0 110.968 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.3 t -54.9 -47.41 98.42 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 117.3 2.333 . . . . 25.0 117.3 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.08 159.82 49.03 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 114.17 -3.42 . . . . 50.0 114.648 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.75 -14.23 20.02 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.817 1.043 . . . . 25.0 113.817 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.7 p -68.88 -10.47 57.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.802 0.297 . . . . 25.0 111.802 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.64 -16.89 29.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.424 1.268 . . . . 50.0 114.424 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.55 141.51 58.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.334 0.587 . . . . 50.0 111.625 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 tp -72.21 -25.42 61.64 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.439 -0.948 . . . . 50.0 108.439 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.9 t -89.23 134.04 34.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.438 -0.949 . . . . 50.0 108.438 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -138.86 150.92 46.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.619 0.723 . . . . 25.0 112.658 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -92.53 132.89 36.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.239 -1.022 . . . . 50.0 108.239 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.1 mm -132.62 119.15 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.242 -1.021 . . . . 25.0 108.242 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -82.27 139.47 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.253 -1.017 . . . . 50.0 108.253 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -125.93 128.22 24.58 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.64 167.33 26.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 CA-C-N 118.566 0.524 . . . . 25.0 111.592 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -122.91 30.51 6.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.655 0.741 . . . . 50.0 111.523 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -78.37 -20.72 50.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.993 -0.548 . . . . 50.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -143.35 169.84 16.91 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.665 -0.495 . . . . 50.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 150.41 47.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.832 -0.622 . . . . 50.0 109.545 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.08 165.5 12.62 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.469 0.547 . . . . 25.0 114.469 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -86.94 147.21 25.86 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.744 1.016 . . . . 50.0 113.744 -176.512 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -139.65 158.92 43.31 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.525 -1.216 . . . . 25.0 108.001 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 52.8 t -116.41 136.54 53.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.045 -1.094 . . . . 50.0 108.045 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.3 mt -106.49 129.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.001 -1.851 . . . . 25.0 106.001 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.25 135.58 50.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.926 -0.398 . . . . 50.0 109.926 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.0 130.18 31.07 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.614 -0.266 . . . . 25.0 110.721 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.79 128.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 106.299 -1.741 . . . . 50.0 106.299 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -125.64 108.67 11.78 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 50.0 108.619 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -96.17 107.72 20.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.978 -0.556 . . . . 50.0 112.327 -171.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.47 135.46 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.514 -1.291 . . . . 50.0 107.514 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.01 -32.23 27.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 25.0 111.849 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -79.28 -12.68 59.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.733 1.383 . . . . 50.0 114.733 -170.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.0 p -139.21 165.8 26.22 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.166 0.802 . . . . 25.0 113.166 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.61 5.2 16.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.546 0.689 . . . . 50.0 110.756 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -102.79 150.08 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.908 -1.145 . . . . 50.0 107.908 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.23 170.55 21.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 102.544 -3.132 . . . . 25.0 102.544 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 23.7 t80 -143.48 151.83 40.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.765 1.166 . . . . 50.0 113.411 178.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.93 120.5 41.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.681 -1.6 . . . . 50.0 106.681 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.9 mm-40 -94.53 130.82 40.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.99 -2.226 . . . . 50.0 104.99 -178.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.5 p -133.11 133.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.824 -0.806 . . . . 50.0 108.824 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.35 128.69 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -85.3 133.03 34.17 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.789 -0.819 . . . . 25.0 108.789 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 149.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -120.41 111.11 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.625 -1.991 . . . . 50.0 105.625 178.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.0 mt -109.18 104.63 13.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.037 -1.468 . . . . 50.0 107.037 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.72 168.02 19.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.129 -0.487 . . . . 50.0 111.92 -173.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -80.78 135.97 36.05 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.878 -0.786 . . . . 50.0 108.878 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.9 pttm . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.344 -1.313 . . . . 50.0 111.287 176.112 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 119.225 -0.417 . . . . 25.0 111.031 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.33 -163.36 15.72 Favored Glycine 0 N--CA 1.46 0.294 0 N-CA-C 110.529 -1.029 . . . . 25.0 110.529 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -98.24 149.77 22.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.798 -0.816 . . . . 25.0 108.798 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -102.32 126.77 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 122.427 0.291 . . . . 25.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -103.47 -34.3 8.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.684 0.754 . . . . 50.0 111.054 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.27 143.01 16.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.0 137.63 50.79 Favored 'Cis proline' 0 C--N 1.352 0.736 0 N-CA-C 117.863 2.216 . . . . 25.0 117.863 2.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 137.12 2.94 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 117.388 1.715 . . . . 50.0 117.388 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -76.17 147.98 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.116 0.484 . . . . 25.0 111.249 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -68.22 -37.96 81.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.669 . . . . 50.0 111.602 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.83 66.42 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.67 -28.02 69.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.255 0.465 . . . . 25.0 112.255 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.94 -9.16 44.11 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 111.85 0.315 . . . . 50.0 111.85 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.4 t -78.84 -16.15 57.45 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.251 0.548 . . . . 50.0 110.839 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.502 ' HG ' ' H ' ' A' ' 17' ' ' ALA . 45.0 t -77.74 144.29 37.33 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 121.885 -0.509 . . . . 50.0 109.916 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -64.1 -20.3 65.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.188 0.518 . . . . 50.0 109.738 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.502 ' H ' ' HG ' ' A' ' 15' ' ' SER . . . -61.5 -13.11 18.33 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.475 0.546 . . . . 25.0 112.475 176.134 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -78.62 -8.94 59.16 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.225 -0.297 . . . . 50.0 111.157 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.36 -4.8 0.02 OUTLIER Glycine 0 CA--C 1.521 0.423 0 N-CA-C 120.067 2.787 . . . . 50.0 120.067 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.6 t80 64.11 -40.64 0.24 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 117.558 2.429 . . . . 50.0 117.558 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.3 mt -103.77 0.61 30.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.254 0.55 . . . . 25.0 111.002 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -80.91 177.23 9.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.757 -0.656 . . . . 25.0 109.419 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.04 155.56 37.13 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.512 -1.662 . . . . 50.0 106.512 175.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.14 15.45 0.07 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.725 1.75 . . . . 50.0 115.725 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.3 t -176.63 -34.21 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.081 0.952 . . . . 50.0 110.019 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.1 132.37 7.38 Favored Glycine 0 C--O 1.221 -0.659 0 CA-C-N 115.444 -0.798 . . . . 50.0 112.514 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.6 t -67.73 -28.65 67.83 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.403 0.62 . . . . 25.0 112.484 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -57.54 -15.38 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.749 1.018 . . . . 50.0 113.749 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -68.63 -14.26 62.9 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.156 -0.965 . . . . 25.0 112.957 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.64 -37.64 49.58 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.87 -0.332 . . . . 50.0 111.68 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -149.63 63.58 6.54 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.115 1.154 . . . . 25.0 114.115 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.28 -9.15 25.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 118.096 -0.803 . . . . 50.0 114.083 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -97.82 -0.19 45.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.241 0.46 . . . . 50.0 112.241 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -87.3 94.13 9.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.764 -1.199 . . . . 50.0 107.764 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -129.78 133.43 46.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.042 -1.095 . . . . 50.0 108.042 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -125.9 131.89 52.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.444 0.566 . . . . 50.0 109.731 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.01 163.53 32.45 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.98 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -73.95 175.14 7.64 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.973 0.731 . . . . 50.0 112.973 -176.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.92 141.34 22.18 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.99 0.737 . . . . 50.0 112.99 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.59 18.66 15.03 Favored Glycine 0 C--O 1.225 -0.451 0 CA-C-N 115.651 -0.704 . . . . 25.0 113.539 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -89.93 132.29 36.78 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.599 -0.889 . . . . 25.0 108.599 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.99 143.48 73.54 Favored 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 130.825 1.594 . . . . 25.0 113.747 -2.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -68.09 -14.24 62.83 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.891 1.071 . . . . 25.0 113.891 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -80.99 -12.28 59.41 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.131 -0.486 . . . . 25.0 111.222 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.35 179.0 43.37 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 120.885 -0.674 . . . . 50.0 114.48 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.11 -173.38 1.76 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.726 2.284 . . . . 25.0 110.29 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.18 123.58 19.0 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.737 -0.385 . . . . 25.0 110.24 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -100.05 -178.85 3.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.14 0.495 . . . . 25.0 111.011 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.82 3.04 87.27 Favored Glycine 0 C--N 1.328 0.108 0 CA-C-O 121.122 0.29 . . . . 25.0 112.636 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -142.71 4.51 1.52 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.367 0.506 . . . . 25.0 112.367 -173.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.01 -36.01 59.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.968 0.729 . . . . 25.0 112.968 -170.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.3 -39.71 64.21 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.878 1.066 . . . . 25.0 113.878 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 m -112.88 -16.65 12.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.675 0.991 . . . . 25.0 113.675 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 54.86 36.04 25.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.627 0.771 . . . . 25.0 109.864 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.06 -16.67 80.51 Favored Glycine 0 C--O 1.222 -0.632 0 N-CA-C 115.526 0.971 . . . . 25.0 115.526 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.45 -21.14 70.34 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 118.014 0.907 . . . . 50.0 113.588 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -62.1 -45.9 91.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.925 0.869 . . . . 25.0 109.534 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -84.87 -13.19 51.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.49 -0.777 . . . . 25.0 110.598 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.34 86.18 Favored Glycine 0 C--O 1.216 -0.989 0 CA-C-N 116.072 -0.513 . . . . 50.0 112.475 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.64 77.63 Favored Glycine 0 C--O 1.222 -0.607 0 C-N-CA 120.358 -0.925 . . . . 50.0 112.493 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.51 -43.82 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.286 -1.005 . . . . 50.0 108.286 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.54 -34.42 75.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.722 -0.672 . . . . 50.0 110.689 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.42 -30.66 70.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.394 0.516 . . . . 50.0 112.394 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -68.04 -6.05 20.62 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.604 -0.685 . . . . 25.0 111.921 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -130.3 37.5 3.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.34 -0.615 . . . . 25.0 109.34 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -120.42 169.54 10.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 25.0 109.794 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.99 -28.1 68.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.495 0.664 . . . . 50.0 109.983 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -96.18 19.99 10.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.621 -0.718 . . . . 50.0 111.438 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -49.75 135.58 18.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.602 0.715 . . . . 50.0 111.536 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -87.76 154.75 20.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.057 0.932 . . . . 50.0 110.428 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -66.41 147.14 53.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 25.0 110.152 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -116.22 132.32 56.7 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.468 -0.938 . . . . 25.0 108.468 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -119.9 135.89 54.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.99 136.29 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.29 -1.745 . . . . 25.0 106.29 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.1 ttt -150.59 168.14 25.17 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.236 -1.765 . . . . 50.0 106.236 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.8 p -90.52 166.7 13.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.79 -1.93 . . . . 25.0 105.79 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.25 -164.28 10.65 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 117.925 0.33 . . . . 25.0 113.667 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.06 -175.77 31.24 Favored Glycine 0 N--CA 1.458 0.114 0 O-C-N 122.348 -0.501 . . . . 50.0 112.2 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -69.73 134.65 48.86 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.754 -0.85 . . . . 25.0 109.444 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -125.59 158.23 35.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.561 -0.903 . . . . 50.0 108.561 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.0 m -117.63 116.28 26.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.898 -1.89 . . . . 25.0 105.898 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -93.01 136.87 32.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 105.901 -1.889 . . . . 50.0 105.901 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -127.62 115.53 18.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 25.0 110.469 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -122.3 145.2 48.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.387 -2.449 . . . . 50.0 104.387 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -145.02 156.74 44.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 25.0 109.622 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -139.82 154.45 47.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -71.42 -13.25 61.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.398 0.888 . . . . 25.0 113.398 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.12 158.34 64.72 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.275 -1.009 . . . . 25.0 108.275 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.16 150.86 72.36 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 114.581 -3.146 . . . . 25.0 109.594 170.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -130.98 132.81 45.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.361 -0.978 . . . . 50.0 108.361 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -66.05 144.89 56.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 50.0 109.689 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -162.92 152.07 15.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.368 -3.197 . . . . 25.0 102.368 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 -40.13 10.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.715 0.769 . . . . 50.0 108.946 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -156.1 148.96 24.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.799 -0.815 . . . . 50.0 108.799 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.59 142.31 39.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.32 -1.363 . . . . 25.0 107.32 170.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 156.33 42.69 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.394 -0.191 . . . . 50.0 110.723 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -130.52 144.94 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.642 0.589 . . . . 50.0 111.3 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -131.96 159.7 37.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.021 -1.844 . . . . 50.0 106.021 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -135.96 158.1 38.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.423 -0.954 . . . . 25.0 108.423 175.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.9 p -103.23 138.69 39.69 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.489 0.661 . . . . 25.0 110.942 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.0 117.72 27.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.98 128.36 34.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 102.575 -3.121 . . . . 25.0 102.575 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.67 30.67 12.75 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 118.856 -1.64 . . . . 25.0 113.611 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -51.77 148.16 5.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.688 0.744 . . . . 50.0 110.172 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -68.97 129.43 92.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.998 -0.547 . . . . 50.0 110.22 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.22 -14.03 25.7 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 118.484 -0.544 . . . . 50.0 113.451 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.5 -10.23 59.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.778 0.799 . . . . 50.0 110.808 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -116.55 148.99 43.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.558 -0.534 . . . . 50.0 109.558 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.2 125.93 15.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 116.616 -1.79 . . . . 50.0 112.059 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 tt -52.99 -50.43 64.16 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.079 -0.964 . . . . 50.0 113.158 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -68.55 -2.96 10.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.748 1.388 . . . . 25.0 114.748 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.86 -49.33 3.53 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.138 0.494 . . . . 50.0 111.703 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.06 50.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.186 1.55 . . . . 25.0 115.186 -170.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -77.63 -29.05 51.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.479 0.548 . . . . 50.0 112.479 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -126.01 151.12 47.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.694 0.628 . . . . 25.0 112.694 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.11 154.66 47.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.71 128.04 33.98 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.098 -0.704 . . . . 50.0 109.098 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 10.0 tt -104.25 -9.47 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.297 0.57 . . . . 25.0 111.609 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.92 160.12 21.62 Favored Glycine 0 CA--C 1.511 -0.197 0 C-N-CA 119.86 -1.162 . . . . 50.0 114.33 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.55 142.03 25.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.779 -1.193 . . . . 25.0 107.779 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.32 111.62 10.84 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.78 163.96 25.85 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 116.013 -2.192 . . . . 50.0 111.299 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -138.45 113.88 9.6 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.219 1.009 . . . . 50.0 109.276 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -172.44 -107.2 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 99.111 -4.403 . . . . 50.0 99.111 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.53 54.19 4.9 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.377 -1.089 . . . . 25.0 110.377 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 t -81.99 132.88 52.57 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 122.382 -0.481 . . . . 25.0 110.245 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.08 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 121.691 1.594 . . . . 50.0 111.423 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -21.06 8.42 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.9 t -64.71 -8.0 12.99 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -62.56 -14.16 39.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.282 1.215 . . . . 50.0 114.282 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.17 137.8 58.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.512 -0.551 . . . . 50.0 109.512 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -20.33 63.75 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.153 1.168 . . . . 50.0 114.153 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -99.97 132.99 44.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.357 -1.349 . . . . 50.0 107.357 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -137.43 149.82 47.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -81.66 133.31 35.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.408 -1.701 . . . . 50.0 106.408 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.98 118.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.552 -2.018 . . . . 25.0 105.552 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 49.6 t80 -84.57 125.67 32.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 50.0 108.842 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.14 104.28 25.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 120.508 0.194 . . . . 25.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.63 150.9 51.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 116.027 -2.182 . . . . 25.0 109.486 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.2 102.75 3.26 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.496 -0.557 . . . . 50.0 109.496 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -91.73 -17.93 24.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.489 0.552 . . . . 50.0 112.489 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -140.93 169.91 16.74 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 107.62 -1.252 . . . . 50.0 107.62 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.41 128.97 36.64 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.751 -1.203 . . . . 50.0 107.751 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -179.36 163.37 30.77 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.202 2.041 . . . . 25.0 118.202 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -87.09 147.04 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.64 -1.28 . . . . 50.0 110.384 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -134.94 150.41 50.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.06 127.97 67.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.038 -2.208 . . . . 50.0 105.038 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.96 116.85 53.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.487 -1.672 . . . . 25.0 106.487 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.1 tt -99.09 133.63 43.08 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.665 -1.235 . . . . 50.0 107.665 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -122.85 145.77 48.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.89 0.376 . . . . 25.0 110.069 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.7 t -126.57 134.05 67.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.013 -1.106 . . . . 50.0 108.013 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -129.18 99.0 5.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.419 -1.326 . . . . 50.0 107.419 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.83 106.79 17.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.084 -0.507 . . . . 50.0 111.891 -173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.4 t -92.48 126.69 44.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.14 -2.17 . . . . 50.0 105.14 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.35 -13.52 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.419 -0.956 . . . . 25.0 108.419 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.43 -1.39 29.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.288 -1.324 . . . . 50.0 112.035 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.9 t -152.95 165.87 34.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.13 -25.02 67.58 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.764 1.024 . . . . 50.0 113.764 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -110.07 159.1 17.62 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.183 0.809 . . . . 50.0 113.183 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 163.86 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 104.639 -2.356 . . . . 25.0 104.639 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -108.94 127.93 54.49 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.774 -0.37 . . . . 50.0 111.047 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.95 137.76 53.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.833 -1.543 . . . . 50.0 106.833 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -148.96 166.05 29.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.74 -0.467 . . . . 50.0 109.74 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.97 150.98 31.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.339 -0.986 . . . . 50.0 108.339 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.09 118.44 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.905 -1.887 . . . . 25.0 105.905 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -92.21 134.2 35.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.473 0.654 . . . . 25.0 110.577 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.58 157.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.25 119.21 25.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.234 -2.136 . . . . 50.0 105.234 174.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.7 mt -119.86 132.38 55.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.097 0.475 . . . . 50.0 110.208 -170.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.91 163.57 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.904 -0.589 . . . . 50.0 110.969 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -78.08 158.28 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.325 -1.361 . . . . 50.0 107.325 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.48 ' HZ3' ' C ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 116.609 -1.662 . . . . 50.0 107.799 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 121.559 0.695 . . . . 25.0 112.081 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.71 -179.0 27.91 Favored Glycine 0 C--O 1.236 0.261 1 N-CA-C 102.497 -4.241 . . . . 25.0 102.497 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.46 149.15 35.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 120.093 1.946 . . . . 25.0 113.103 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -94.84 120.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.143 -0.935 . . . . 25.0 109.996 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.92 -13.09 20.14 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.527 0.566 . . . . 50.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -162.7 142.81 7.29 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.84 126.61 12.95 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 130.373 1.406 . . . . 25.0 113.999 -1.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.81 51.21 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 111.276 -0.73 . . . . 50.0 111.276 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.2 t -141.29 136.47 31.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.634 -1.246 . . . . 25.0 107.634 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -67.28 -21.12 65.72 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.43 0.53 . . . . 50.0 112.43 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.14 80.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.132 0.492 . . . . 25.0 110.641 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.56 65.07 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 120.876 0.37 . . . . 25.0 110.639 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.92 -4.25 59.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.219 -0.446 . . . . 50.0 110.825 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -111.75 -11.52 13.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 50.0 110.078 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -77.42 134.98 38.27 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.124 -1.065 . . . . 50.0 108.124 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -78.55 -74.08 0.29 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 120.033 -0.667 . . . . 50.0 111.958 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.49 -53.02 2.45 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.554 1.687 . . . . 25.0 115.554 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -110.99 26.03 11.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.772 -1.104 . . . . 50.0 113.449 -166.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.76 34.5 9.06 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.022 -1.085 . . . . 50.0 111.231 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 t80 63.45 38.32 10.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.162 1.541 . . . . 50.0 115.162 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.14 -16.32 63.08 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.774 -0.825 . . . . 25.0 108.774 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -120.62 137.76 54.26 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.548 -1.649 . . . . 25.0 106.548 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.21 111.24 19.65 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.1 0.407 . . . . 50.0 112.1 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -148.45 46.59 1.05 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.487 -0.779 . . . . 50.0 111.931 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.8 t -145.32 7.03 1.14 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.475 0.655 . . . . 50.0 112.671 -175.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.29 172.49 37.56 Favored Glycine 0 C--O 1.217 -0.92 0 C-N-CA 120.95 -0.643 . . . . 50.0 113.082 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -78.99 -33.5 44.96 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -9.94 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 113.329 0.862 . . . . 50.0 113.329 -174.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -50.35 -22.05 1.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 117.742 2.497 . . . . 25.0 117.742 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -79.91 -35.96 37.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.459 -0.776 . . . . 50.0 112.045 -172.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.88 63.31 5.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.173 0.805 . . . . 25.0 113.173 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.28 -6.46 18.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 117.411 -1.26 . . . . 50.0 112.296 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -93.68 4.97 53.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 50.0 112.115 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -92.34 93.94 8.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.219 -1.03 . . . . 50.0 108.219 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.0 mt -116.47 104.95 11.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.686 -0.857 . . . . 50.0 108.686 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -129.9 146.17 51.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.947 0.404 . . . . 50.0 110.628 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.5 145.53 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.995 -0.743 . . . . 25.0 108.995 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -93.02 142.21 27.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.686 0.279 . . . . 50.0 110.417 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -71.47 135.51 47.19 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.246 -1.02 . . . . 50.0 108.246 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.73 143.4 3.72 Favored Glycine 0 C--O 1.225 -0.462 0 C-N-CA 121.065 -0.588 . . . . 25.0 112.987 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -90.05 151.92 45.6 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 122.573 -0.369 . . . . 25.0 110.574 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.88 -27.86 7.6 Favored 'Cis proline' 0 C--N 1.352 0.749 0 N-CA-C 113.463 0.524 . . . . 25.0 113.463 -1.179 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.3 p80 160.85 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 127.117 2.167 . . . . 25.0 106.759 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 m 64.65 -42.77 0.3 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.529 2.048 . . . . 25.0 116.529 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.01 -154.89 17.37 Favored Glycine 0 C--O 1.239 0.414 0 N-CA-C 109.192 -1.563 . . . . 50.0 109.192 172.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -67.18 -177.29 1.01 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 CA-C-N 119.787 1.793 . . . . 25.0 110.751 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.98 101.44 8.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.169 -1.789 . . . . 25.0 106.169 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -99.06 158.84 15.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.663 -0.698 . . . . 25.0 109.596 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.52 61.93 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.772 -0.728 . . . . 25.0 114.005 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -66.94 -9.36 37.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.0 -39.4 83.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 172.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.74 -32.26 67.55 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.166 0.508 . . . . 25.0 110.038 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -74.03 -6.39 47.18 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.089 -0.505 . . . . 25.0 110.597 175.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.51 20.0 7.12 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.202 1.401 . . . . 25.0 112.546 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.04 -24.71 28.84 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 109.771 -1.331 . . . . 25.0 109.771 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.52 -14.01 68.97 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 121.272 -0.49 . . . . 50.0 113.085 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.81 -43.89 94.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.532 0.682 . . . . 25.0 109.948 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -69.51 -25.52 64.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.626 -0.715 . . . . 25.0 111.468 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -31.83 72.64 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.836 -0.697 . . . . 50.0 111.52 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.53 72.17 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 120.952 -0.642 . . . . 50.0 112.891 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.95 -38.21 71.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.731 -0.84 . . . . 50.0 108.731 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.25 -43.89 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.997 0.427 . . . . 50.0 111.308 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.73 -4.44 37.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.863 1.06 . . . . 50.0 113.863 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -62.1 -13.4 26.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -133.88 82.8 2.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 171.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.4 t -145.74 152.22 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.344 -0.614 . . . . 25.0 109.344 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.03 -25.76 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.392 0.615 . . . . 50.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -97.18 7.34 46.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.973 -0.558 . . . . 50.0 111.424 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 44.7 ttp180 -65.43 169.37 6.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.471 1.129 . . . . 50.0 110.219 -178.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 20.7 p90 -91.37 165.94 13.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.103 -1.443 . . . . 50.0 107.103 177.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -76.12 151.87 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -121.14 123.21 41.75 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 106.078 -1.823 . . . . 25.0 106.078 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -118.82 126.09 51.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.315 0.487 . . . . 25.0 112.315 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.5 132.2 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.682 -0.858 . . . . 25.0 108.682 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttp -150.69 157.56 43.11 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 107.809 -1.182 . . . . 50.0 107.809 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.0 p -95.01 163.79 13.16 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.081 -0.387 . . . . 25.0 110.143 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.23 172.23 50.25 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.937 -0.649 . . . . 25.0 112.815 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.57 -166.2 12.36 Favored Glycine 0 C--O 1.228 -0.258 0 O-C-N 122.516 -0.402 . . . . 50.0 112.367 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -76.84 140.54 40.67 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.058 -0.672 . . . . 25.0 111.417 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -136.02 158.54 44.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.391 -1.337 . . . . 50.0 107.391 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.8 m -126.07 123.77 39.12 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -116.23 139.58 50.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.003 -1.11 . . . . 50.0 108.003 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 t -137.96 145.99 42.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.3 -1.37 . . . . 25.0 107.3 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -121.42 145.18 48.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.777 -1.564 . . . . 50.0 106.777 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -131.47 161.96 31.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.41 153.65 48.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.597 -1.26 . . . . 25.0 107.597 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.1 p -81.02 -11.89 59.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.934 0.346 . . . . 25.0 111.934 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.92 20.75 Favored Pre-proline 0 C--O 1.25 1.112 0 N-CA-C 110.371 -0.233 . . . . 25.0 110.371 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.07 129.54 14.29 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.725 -1.05 . . . . 25.0 110.959 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -131.14 158.69 39.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.97 -0.382 . . . . 50.0 109.97 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -81.74 157.48 24.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.039 -1.097 . . . . 50.0 108.039 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.3 m -139.31 140.17 37.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.1 t -88.5 -48.64 7.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.238 -1.393 . . . . 50.0 107.238 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.23 166.36 18.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.265 -0.642 . . . . 50.0 109.265 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -146.79 138.68 24.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.456 -1.683 . . . . 25.0 106.456 167.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.84 148.91 31.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 50.0 109.297 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -145.32 148.25 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.23 1.014 . . . . 50.0 113.289 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.77 168.94 17.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.384 -1.28 . . . . 50.0 107.734 -170.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.54 159.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 166.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -95.35 135.86 36.43 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -87.7 124.9 34.05 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.336 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -88.6 153.94 20.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.49 15.17 58.91 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.147 -1.502 . . . . 25.0 113.059 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -52.75 153.47 3.22 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.597 0.962 . . . . 50.0 113.597 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -75.79 130.59 78.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.78 -0.646 . . . . 50.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.92 -15.7 29.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 117.174 -1.417 . . . . 50.0 111.777 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.61 -21.77 65.39 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.309 1.043 . . . . 50.0 111.718 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -120.2 141.97 32.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 O-C-N 121.978 -0.451 . . . . 50.0 110.444 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.55 134.42 30.61 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 115.34 -2.64 . . . . 50.0 112.554 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.5 mt -57.81 -33.84 69.01 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.39 -0.823 . . . . 50.0 111.939 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -53.2 -39.23 63.55 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.609 -0.723 . . . . 25.0 111.286 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.28 -51.8 7.56 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.738 0.644 . . . . 50.0 112.738 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.87 -27.45 61.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 116.855 2.169 . . . . 25.0 116.855 -166.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -71.1 -17.3 62.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.784 1.402 . . . . 50.0 114.784 -170.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -96.74 121.39 38.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -118.65 112.03 19.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.422 -0.585 . . . . 25.0 109.422 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.8 124.24 23.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.866 -1.531 . . . . 50.0 106.866 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.0 tt -115.8 1.82 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.919 0.866 . . . . 25.0 109.834 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.51 145.8 4.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 50.0 114.004 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.73 137.91 31.99 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.723 -1.584 . . . . 25.0 106.723 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 t -132.48 89.27 36.75 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 108.636 -0.876 . . . . 25.0 108.636 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.41 163.49 37.6 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 116.073 -2.151 . . . . 50.0 110.54 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -128.22 120.99 28.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.434 0.635 . . . . 50.0 109.578 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -127.07 -76.7 0.57 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.002 -2.592 . . . . 50.0 104.002 172.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -147.97 -150.09 5.12 Favored Glycine 0 C--O 1.242 0.603 0 N-CA-C 108.6 -1.8 . . . . 25.0 108.6 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.2 m 62.59 157.17 0.12 Allowed Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 114.474 1.287 . . . . 25.0 114.474 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.11 0.15 9.3 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 115.781 -2.346 . . . . 50.0 114.799 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.42 91.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.443 -0.799 . . . . 25.0 109.486 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.3 p -79.74 -11.24 59.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.117 0.484 . . . . 25.0 111.626 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -76.97 -21.0 55.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.191 -0.459 . . . . 50.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -74.34 104.93 5.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.885 0.374 . . . . 50.0 111.172 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -16.06 24.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.019 0.748 . . . . 50.0 113.019 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -100.22 126.51 46.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.301 -1.37 . . . . 50.0 107.301 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -131.07 150.5 52.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.559 0.695 . . . . 25.0 111.826 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -94.73 136.08 35.45 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 105.602 -1.999 . . . . 50.0 105.602 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.0 118.97 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -80.61 130.58 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.169 -2.16 . . . . 50.0 105.169 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.7 mt -122.43 111.57 31.64 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 107.265 -1.383 . . . . 25.0 107.265 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.74 162.0 40.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 116.949 -1.567 . . . . 25.0 112.406 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -111.24 91.03 3.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.517 -2.401 . . . . 50.0 104.517 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -79.42 -29.77 42.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.155 -0.683 . . . . 50.0 109.155 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mtt-85 -155.27 170.0 22.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 103.535 -2.765 . . . . 50.0 103.535 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.89 112.68 24.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.987 -2.968 . . . . 50.0 102.987 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 168.27 166.7 27.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.229 -0.51 . . . . 25.0 112.497 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 49.9 p90 -87.08 142.35 27.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.778 1.399 . . . . 50.0 114.778 -172.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -129.4 136.85 50.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.182 -1.784 . . . . 25.0 106.182 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.91 133.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.89 -1.152 . . . . 50.0 107.89 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.8 mt -96.08 126.27 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.6 mt -111.6 127.05 55.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.038 -1.467 . . . . 50.0 107.038 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.34 145.84 52.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.51 0.596 . . . . 25.0 111.022 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.07 138.15 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.668 -1.234 . . . . 50.0 107.668 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -129.19 120.63 26.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.783 -0.821 . . . . 50.0 108.783 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -101.45 97.0 7.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.327 0.585 . . . . 50.0 109.955 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.62 123.03 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.218 -1.03 . . . . 50.0 108.218 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.17 -22.97 59.19 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.95 -7.61 55.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.578 0.955 . . . . 50.0 113.578 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -132.16 158.03 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.24 13.07 3.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.628 -1.169 . . . . 50.0 109.285 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -109.92 162.21 14.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 50.0 109.93 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.88 150.28 50.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.381 -2.452 . . . . 25.0 104.381 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -122.65 143.11 49.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.794 -1.188 . . . . 50.0 107.794 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -138.93 156.38 47.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.384 -0.599 . . . . 50.0 109.384 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.71 149.67 36.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 50.0 109.88 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.35 141.98 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.72 -0.474 . . . . 50.0 109.72 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.4 mt -139.02 128.53 30.6 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 105.396 -2.076 . . . . 25.0 105.396 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -112.15 126.9 55.7 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.4 m -125.52 126.12 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.576 0.703 . . . . 25.0 109.92 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -87.58 96.05 10.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.196 -1.779 . . . . 50.0 106.196 178.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.2 112.14 22.42 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.356 -0.838 . . . . 50.0 109.86 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.6 m -136.32 173.75 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.171 -0.468 . . . . 50.0 111.245 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -63.05 159.37 17.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.695 0.76 . . . . 50.0 112.678 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.59 -1.187 . . . . 50.0 110.861 178.144 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 110.43 -0.211 . . . . 25.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.69 -158.84 22.92 Favored Glycine 0 CA--C 1.511 -0.163 0 N-CA-C 107.801 -2.119 . . . . 25.0 107.801 -177.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.24 165.76 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.824 1.312 . . . . 25.0 110.57 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.1 mm -93.98 124.55 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 25.0 109.78 -174.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -87.9 22.11 2.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.386 0.675 . . . . 50.0 111.7 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 42.3 mttt 77.05 153.27 0.14 Allowed Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 125.975 1.71 . . . . 25.0 111.955 175.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.97 151.98 68.7 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 129.031 0.846 . . . . 25.0 111.158 -7.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.91 21.73 15.21 Favored Glycine 0 C--O 1.211 -1.288 0 N-CA-C 117.714 1.846 . . . . 50.0 117.714 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -76.5 128.37 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 119.23 1.515 . . . . 25.0 110.041 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -73.33 -27.13 61.34 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.988 -0.375 . . . . 50.0 109.988 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.22 -33.63 69.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.526 0.565 . . . . 25.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.21 69.6 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 120.826 0.346 . . . . 25.0 111.55 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.95 -8.33 46.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.583 0.706 . . . . 50.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.8 t -89.73 -44.3 10.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.133 -0.939 . . . . 50.0 113.24 -171.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.8 t -67.36 129.06 38.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.992 0.425 . . . . 50.0 110.854 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.53 -23.66 63.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.666 . . . . 50.0 110.203 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.63 -20.31 66.2 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.039 -0.413 . . . . 25.0 111.68 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -83.06 -13.21 56.25 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.373 0.508 . . . . 50.0 112.373 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.47 -8.23 2.91 Favored Glycine 0 N--CA 1.46 0.269 0 N-CA-C 115.003 0.761 . . . . 50.0 115.003 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 61.96 -59.91 0.11 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.775 2.03 . . . . 50.0 114.85 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.9 mt -103.97 -3.17 25.02 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.705 0.402 . . . . 25.0 110.695 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -134.35 137.38 44.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.397 0.888 . . . . 25.0 113.397 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.95 157.06 42.78 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.237 -2.135 . . . . 50.0 105.237 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -138.86 33.06 2.19 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.682 0.753 . . . . 50.0 111.063 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.7 t -62.73 -50.31 71.59 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.264 1.209 . . . . 50.0 114.264 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.89 154.38 10.63 Favored Glycine 0 C--O 1.217 -0.908 0 N-CA-C 112.504 -0.238 . . . . 50.0 112.504 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 t -65.64 -25.41 67.35 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.638 0.719 . . . . 25.0 112.278 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -61.03 -10.05 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.701 0.8 . . . . 50.0 112.592 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.3 ptm -56.46 -10.92 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 116.678 2.103 . . . . 25.0 116.678 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.19 -35.9 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 118.163 0.438 . . . . 50.0 111.985 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.05 46.02 0.39 Allowed Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 117.042 2.238 . . . . 25.0 117.042 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.45 -14.28 36.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 115.797 -2.335 . . . . 50.0 114.648 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.06 5.01 49.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.367 0.506 . . . . 50.0 112.367 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.4 t -106.39 89.69 3.12 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.588 -1.264 . . . . 75.0 107.588 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.36 124.68 45.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.0 -1.852 . . . . 50.0 106.0 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -127.45 145.82 50.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 50.0 110.883 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 158.02 45.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.902 -1.888 . . . . 25.0 105.902 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -100.14 141.71 32.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.805 -0.813 . . . . 50.0 108.805 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -69.94 135.21 49.21 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.192 -0.67 . . . . 50.0 109.192 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.83 163.03 28.87 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 107.024 -2.43 . . . . 25.0 107.024 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -92.28 146.92 33.53 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 117.641 0.721 . . . . 25.0 110.32 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.4 149.64 91.76 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 129.321 0.967 . . . . 25.0 113.048 -2.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.38 16.06 1.85 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.324 0.861 . . . . 25.0 113.324 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -88.77 -33.8 17.33 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.391 0.515 . . . . 25.0 112.391 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.76 175.35 38.59 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-O 119.463 -0.631 . . . . 50.0 111.873 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.79 -14.8 21.59 Favored 'Trans proline' 0 C--N 1.346 0.422 0 CA-C-N 118.858 1.329 . . . . 25.0 114.167 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.82 126.8 32.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.041 -0.725 . . . . 25.0 109.041 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -149.34 157.45 43.33 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.853 -1.536 . . . . 25.0 106.853 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.76 -31.86 0.38 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 118.148 2.019 . . . . 25.0 118.148 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -115.6 35.07 4.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.958 0.879 . . . . 25.0 109.989 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.4 mm -61.22 -38.36 79.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.559 -0.746 . . . . 25.0 110.468 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.3 87.9 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.9 p -93.86 -21.08 19.48 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.181 -0.324 . . . . 25.0 111.344 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.23 19.98 1.7 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.264 1.026 . . . . 25.0 112.726 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.33 -6.07 45.25 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 114.653 0.621 . . . . 25.0 114.653 -174.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.33 -24.67 61.66 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 114.839 0.695 . . . . 50.0 114.839 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.62 -25.41 66.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 25.0 111.14 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -84.9 0.57 50.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.817 0.342 . . . . 25.0 111.77 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.68 -19.49 58.33 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 121.129 -0.558 . . . . 50.0 112.98 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.97 -20.75 67.08 Favored Glycine 0 C--O 1.222 -0.617 0 C-N-CA 121.079 -0.582 . . . . 50.0 113.228 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.59 -39.4 80.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.415 -0.957 . . . . 50.0 108.415 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.03 -26.86 61.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.538 -0.541 . . . . 50.0 109.538 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.52 7.56 4.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.485 0.66 . . . . 50.0 112.221 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.49 -28.02 15.1 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.45 -0.781 . . . . 25.0 109.037 171.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -150.72 96.73 2.4 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.836 0.351 . . . . 25.0 111.394 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.6 t -152.87 154.37 34.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -69.55 -32.8 71.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.177 0.989 . . . . 50.0 109.802 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.32 28.13 8.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.2 -0.909 . . . . 50.0 110.037 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -53.68 154.31 3.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.273 -0.876 . . . . 50.0 109.992 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -84.78 165.26 17.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.28 -1.378 . . . . 50.0 107.28 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -74.8 139.02 42.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -127.5 133.98 49.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -119.63 146.94 45.1 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.366 -1.346 . . . . 25.0 107.366 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -96.7 133.03 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 25.0 108.199 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 93.7 mtp -135.06 158.42 44.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.65 -0.87 . . . . 50.0 108.65 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -104.47 172.04 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.14 -175.93 7.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 114.495 0.558 . . . . 25.0 114.495 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.14 -173.37 20.56 Favored Glycine 0 CA--C 1.518 0.221 0 O-C-N 122.525 -0.397 . . . . 50.0 112.755 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.14 141.13 33.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -141.91 160.75 39.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.349 -0.612 . . . . 50.0 109.349 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -126.75 129.49 48.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.39 -1.708 . . . . 25.0 106.39 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.43 139.05 49.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.08 -1.081 . . . . 50.0 108.08 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -130.82 133.41 45.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.495 0.497 . . . . 25.0 110.16 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -124.08 151.71 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.839 -1.911 . . . . 50.0 105.839 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -138.07 161.95 35.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 119.037 0.835 . . . . 25.0 110.656 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.14 150.65 39.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.488 -1.671 . . . . 25.0 106.488 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -68.63 -22.39 64.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.384 0.513 . . . . 25.0 112.384 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.04 151.97 63.72 Favored Pre-proline 0 C--O 1.242 0.693 0 N-CA-C 105.719 -1.956 . . . . 25.0 105.719 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.38 145.93 73.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 115.587 -2.475 . . . . 25.0 109.515 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -130.88 140.49 50.22 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.994 -0.441 . . . . 50.0 111.491 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.62 141.52 57.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.406 -1.331 . . . . 50.0 107.406 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 m -150.02 151.9 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.746 -1.946 . . . . 25.0 105.746 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.0 p -108.01 -34.05 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 118.256 0.48 . . . . 50.0 110.618 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.76 145.29 18.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.971 -0.456 . . . . 50.0 109.835 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -141.2 139.43 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.035 -0.666 . . . . 25.0 109.543 163.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -148.09 159.64 43.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.89 -0.596 . . . . 50.0 109.532 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -145.04 150.24 36.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.915 1.08 . . . . 50.0 113.915 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.74 164.6 17.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.035 -1.438 . . . . 50.0 107.522 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.66 155.73 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.6 p -96.02 144.19 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.424 -0.584 . . . . 25.0 109.424 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -87.99 129.82 35.14 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 110.163 -0.31 . . . . 25.0 110.163 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -81.53 156.21 25.36 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.054 0.542 . . . . 25.0 109.671 172.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.8 10.12 73.2 Favored Glycine 0 N--CA 1.462 0.419 0 N-CA-C 118.59 2.196 . . . . 25.0 118.59 166.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -59.26 161.35 5.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.032 1.123 . . . . 50.0 114.032 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.24 156.02 36.28 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 106.646 -1.613 . . . . 50.0 106.646 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.45 -8.62 18.48 Favored 'Trans proline' 0 C--N 1.345 0.389 0 N-CA-C 116.663 1.755 . . . . 50.0 116.663 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -82.33 0.72 40.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.912 0.863 . . . . 50.0 111.77 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -95.97 148.43 34.53 Favored Pre-proline 0 C--N 1.322 -0.616 0 O-C-N 121.734 -0.604 . . . . 50.0 110.412 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.04 83.4 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 N-CA-C 110.329 -0.681 . . . . 50.0 110.329 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.7 mt -53.15 -39.53 63.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.912 1.449 . . . . 50.0 114.912 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -63.07 -21.98 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.797 0.666 . . . . 25.0 112.797 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -94.76 -48.55 5.99 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 112.344 0.498 . . . . 50.0 112.344 169.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.79 64.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 115.708 1.744 . . . . 25.0 115.708 -166.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -69.31 -28.88 66.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.247 -0.581 . . . . 50.0 111.633 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -97.66 113.92 25.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.116 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -121.86 136.67 54.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.235 0.541 . . . . 25.0 111.469 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.4 tp -75.61 123.93 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.459 -1.682 . . . . 50.0 106.459 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.2 tp -121.75 -5.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.564 0.697 . . . . 25.0 111.185 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -161.21 140.15 6.47 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.395 -0.907 . . . . 50.0 112.243 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 134.21 16.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.401 -1.333 . . . . 25.0 107.401 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.74 103.2 7.65 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.92 148.73 76.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 116.013 -2.191 . . . . 50.0 109.69 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -106.14 92.2 4.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.364 -1.346 . . . . 50.0 107.364 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -119.17 1.15 11.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.373 -1.739 . . . . 50.0 109.782 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.62 -18.75 9.93 Favored Glycine 0 C--O 1.236 0.24 0 CA-C-N 115.303 -0.862 . . . . 25.0 111.905 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.6 t -54.71 136.99 63.89 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 117.116 0.458 . . . . 25.0 110.465 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.75 -11.67 28.03 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 117.029 -1.514 . . . . 50.0 114.753 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.78 -34.67 78.89 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.375 -1.284 . . . . 25.0 109.143 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -84.4 -10.05 57.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.202 0.525 . . . . 25.0 112.044 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -86.48 -22.78 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.643 -1.243 . . . . 50.0 107.643 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.04 104.84 17.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 50.0 110.402 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.65 -10.87 59.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.667 -0.697 . . . . 50.0 112.321 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -91.31 121.98 33.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.928 -1.138 . . . . 50.0 107.928 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -137.26 147.83 46.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 25.0 111.426 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -79.23 137.89 37.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.726 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.0 mt -132.68 106.02 9.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.744 -1.206 . . . . 25.0 107.744 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -78.12 140.85 39.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.574 -0.899 . . . . 50.0 108.574 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.9 mm -124.63 123.36 25.72 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.61 158.44 53.59 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 117.289 -1.341 . . . . 25.0 111.52 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -106.97 52.83 0.71 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.512 1.149 . . . . 50.0 110.037 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.75 -37.5 24.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 115.477 1.658 . . . . 50.0 115.477 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -152.87 172.23 17.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.19 0.596 . . . . 50.0 109.738 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.0 mp -99.95 142.77 30.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.678 -2.342 . . . . 50.0 104.678 167.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.41 150.07 5.88 Favored Glycine 0 C--O 1.234 0.117 0 C-N-CA 120.588 -0.815 . . . . 25.0 114.078 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 27.4 p90 -86.01 145.11 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 50.0 110.049 -177.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 153.02 40.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.842 -0.617 . . . . 25.0 110.184 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.65 143.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.046 -0.524 . . . . 50.0 110.644 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.08 128.85 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.341 -2.466 . . . . 25.0 104.341 172.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.72 137.43 53.93 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.842 -1.54 . . . . 50.0 106.842 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.82 151.15 42.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 118.958 0.799 . . . . 25.0 110.971 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.04 134.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.124 -1.435 . . . . 50.0 107.124 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -124.78 98.98 5.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.586 -1.265 . . . . 50.0 107.586 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -84.79 117.81 24.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.037 0.446 . . . . 50.0 110.554 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.03 133.75 28.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.331 -0.989 . . . . 50.0 108.331 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.76 -42.47 58.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.119 0.485 . . . . 25.0 111.194 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.66 -24.07 64.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.812 1.782 . . . . 50.0 115.812 -168.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 66.3 p -135.62 162.55 32.39 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 122.381 -0.199 . . . . 25.0 110.701 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 11.32 2.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 50.0 112.587 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.11 160.0 16.85 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.168 -1.419 . . . . 50.0 107.168 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.52 170.7 15.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.04 -2.207 . . . . 25.0 105.04 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -120.32 158.37 27.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.1 -1.074 . . . . 50.0 108.1 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -138.7 154.63 48.6 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.442 -1.318 . . . . 50.0 107.442 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -132.7 142.06 48.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.304 -0.999 . . . . 50.0 108.304 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.11 129.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.73 -0.841 . . . . 50.0 108.73 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.3 mt -140.66 126.56 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.47 137.09 37.66 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.624 -0.51 . . . . 25.0 109.624 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.58 137.51 43.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -82.03 136.14 35.26 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.687 -1.598 . . . . 50.0 106.687 179.434 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.14 104.24 9.94 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.489 -0.93 . . . . 50.0 108.489 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.1 m -113.03 166.95 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.239 0.543 . . . . 50.0 111.824 -176.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.21 158.7 32.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.535 -1.654 . . . . 50.0 106.535 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 117.285 -1.34 . . . . 50.0 110.365 178.975 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.1 m80 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 119.77 -0.157 . . . . 25.0 111.041 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.48 -177.83 51.53 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-O 118.428 -1.207 . . . . 25.0 110.714 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -156.64 164.73 37.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.226 1.013 . . . . 25.0 112.864 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.4 mt -90.73 122.74 42.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -77.72 -41.38 38.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.382 0.61 . . . . 50.0 109.537 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.32 117.08 8.73 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.182 -0.463 . . . . 25.0 109.836 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.36 122.61 7.83 Favored 'Cis proline' 0 C--N 1.357 1.002 0 C-N-CA 130.412 1.422 . . . . 25.0 113.454 -3.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.1 -22.58 57.07 Favored Glycine 0 CA--C 1.508 -0.36 0 N-CA-C 116.051 1.18 . . . . 50.0 116.051 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 t -91.18 97.18 10.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.601 -0.941 . . . . 25.0 110.73 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -83.96 -32.34 25.08 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.727 -0.471 . . . . 50.0 109.727 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -36.67 71.13 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.203 1.186 . . . . 25.0 114.203 -173.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.81 -32.43 71.8 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.282 0.364 . . . . 25.0 110.957 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.9 mp -92.93 -19.93 21.14 Favored 'General case' 0 C--O 1.211 -0.931 0 N-CA-C 112.708 0.632 . . . . 50.0 112.708 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.7 t -70.16 -30.47 67.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.303 -0.628 . . . . 50.0 109.303 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.2 t -55.88 138.47 48.38 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.93 1.085 . . . . 50.0 113.93 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -69.33 -11.05 60.48 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 114.217 -1.356 . . . . 50.0 110.36 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.83 -10.94 0.34 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.035 1.124 . . . . 25.0 114.035 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -68.71 -14.01 62.75 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.843 -0.536 . . . . 50.0 110.97 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.31 -24.1 0.02 OUTLIER Glycine 0 C--O 1.222 -0.64 0 C-N-CA 120.197 -1.001 . . . . 50.0 115.454 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 t80 65.56 -21.86 0.09 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.881 1.808 . . . . 50.0 115.881 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.34 -15.85 59.2 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.968 -0.457 . . . . 25.0 110.533 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -154.64 163.39 40.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.894 0.378 . . . . 25.0 110.481 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.86 155.06 35.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 50.0 111.72 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -127.17 11.75 7.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.131 0.967 . . . . 50.0 111.229 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.3 t -110.73 -35.46 5.98 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 115.384 1.624 . . . . 50.0 115.384 -172.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.42 150.98 6.06 Favored Glycine 0 CA--C 1.517 0.182 0 CA-C-O 121.252 0.362 . . . . 50.0 112.82 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.6 t -66.39 -14.32 61.96 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.583 -0.951 . . . . 25.0 112.817 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.69 0.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.597 0.713 . . . . 50.0 111.024 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -26.26 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 117.933 2.568 . . . . 25.0 117.933 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -75.97 -43.4 44.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.882 0.764 . . . . 50.0 112.816 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.9 71.93 19.03 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 122.009 0.909 . . . . 25.0 112.928 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.66 2.0 5.09 Favored 'Trans proline' 0 C--O 1.221 -0.346 0 N-CA-C 114.606 0.964 . . . . 50.0 114.606 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 3.17 33.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.654 -0.498 . . . . 50.0 109.654 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -134.15 84.03 2.08 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 115.771 1.767 . . . . 75.0 115.771 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.0 131.19 55.31 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 103.525 -2.769 . . . . 50.0 103.525 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -114.37 143.54 44.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.191 1.182 . . . . 50.0 114.191 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.28 155.97 49.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.456 -2.424 . . . . 25.0 104.456 167.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -83.42 146.4 28.45 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.572 -0.705 . . . . 50.0 110.483 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -70.84 145.73 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.548 -0.538 . . . . 50.0 109.548 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.96 -177.65 44.59 Favored Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 103.527 -3.829 . . . . 25.0 103.527 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -112.93 147.56 37.48 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 107.006 -1.479 . . . . 25.0 107.006 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.84 148.65 75.82 Favored 'Cis proline' 0 C--O 1.212 -0.793 0 C-N-CA 129.556 1.065 . . . . 25.0 113.329 0.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -138.54 -48.51 0.52 Allowed 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.657 -0.701 . . . . 25.0 111.051 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 t -91.84 1.83 56.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.138 0.971 . . . . 25.0 108.746 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.9 -154.65 30.16 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 113.625 -1.625 . . . . 50.0 109.492 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.28 154.45 73.53 Favored 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 118.712 1.256 . . . . 25.0 112.291 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.14 106.98 10.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.276 -0.875 . . . . 25.0 111.915 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -114.99 158.88 21.45 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 104.159 -2.534 . . . . 25.0 104.159 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.45 -31.94 3.17 Favored Glycine 0 C--O 1.215 -1.09 0 C-N-CA 120.611 -0.804 . . . . 25.0 112.733 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.18 -21.96 62.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.962 1.468 . . . . 25.0 114.962 -176.67 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.3 mt -69.29 -42.42 81.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 N-CA-C 108.768 -0.827 . . . . 25.0 108.768 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.72 -31.12 66.38 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 112.094 0.405 . . . . 25.0 112.094 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -85.85 2.95 43.82 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.205 0.817 . . . . 25.0 113.205 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.16 24.35 11.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.832 0.853 . . . . 25.0 112.001 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.9 -13.89 75.69 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 110.33 -1.108 . . . . 25.0 110.33 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.46 17.94 31.69 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.755 -0.223 . . . . 50.0 113.495 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 mt -59.32 -10.68 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.606 1.706 . . . . 25.0 115.606 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -61.04 -19.96 61.98 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.21 -16.15 77.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.35 -0.844 . . . . 50.0 111.709 177.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.71 -4.58 66.49 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 115.421 0.928 . . . . 50.0 115.421 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.48 -32.76 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.352 1.076 . . . . 50.0 110.077 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.52 -25.37 65.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.513 -0.312 . . . . 50.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -106.15 15.44 26.32 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.783 0.801 . . . . 50.0 110.041 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -70.59 14.75 0.12 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.37 1.248 . . . . 25.0 114.37 -174.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.51 52.91 1.69 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -131.91 178.69 6.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -64.64 -21.15 66.65 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.805 -0.559 . . . . 50.0 112.413 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -95.57 14.38 23.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.555 0.693 . . . . 50.0 112.098 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 ttt85 -58.18 128.32 36.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.867 -0.606 . . . . 50.0 111.129 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -106.14 168.18 9.31 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.921 0.867 . . . . 50.0 112.203 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -63.86 149.58 46.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.613 -0.721 . . . . 25.0 112.123 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -130.5 146.5 52.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.74 -1.207 . . . . 25.0 107.74 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -113.34 138.49 49.97 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.38 129.19 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 94.3 mmm -137.88 166.51 23.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.521 -0.548 . . . . 50.0 109.521 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.3 p -107.46 -173.72 2.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.256 -2.128 . . . . 25.0 105.256 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -161.54 21.56 Favored Glycine 0 C--O 1.242 0.605 0 CA-C-O 121.676 0.598 . . . . 25.0 113.744 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.79 176.61 42.65 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.73 -0.948 . . . . 50.0 110.73 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.29 141.48 31.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.139 1.469 . . . . 25.0 109.849 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -129.39 139.16 51.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.714 -0.847 . . . . 50.0 108.714 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -85.57 128.84 34.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 25.0 109.946 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.03 127.43 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.962 -1.866 . . . . 50.0 105.962 174.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -128.85 120.47 26.33 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.1 -0.333 . . . . 25.0 110.1 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -124.08 150.1 45.4 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.45 -1.685 . . . . 50.0 106.45 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.1 t -145.21 158.78 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.465 -0.569 . . . . 25.0 109.465 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.01 133.45 52.97 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 108.997 -0.742 . . . . 25.0 108.997 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -77.03 -6.63 53.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.686 0.625 . . . . 25.0 112.686 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.95 145.04 37.65 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 106.907 -1.516 . . . . 25.0 106.907 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.32 142.87 38.1 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 117.239 -1.374 . . . . 25.0 111.804 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -136.27 140.22 43.27 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.935 -0.765 . . . . 50.0 108.935 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -81.51 152.97 27.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.097 -1.816 . . . . 50.0 106.097 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.1 m -138.79 148.49 43.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 105.855 -1.905 . . . . 25.0 105.855 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 t -102.71 -43.36 5.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 50.0 110.59 173.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.82 143.46 20.67 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.947 -0.76 . . . . 50.0 108.947 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -144.5 134.8 24.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.78 0.324 . . . . 25.0 110.192 170.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -154.18 162.22 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.407 0.521 . . . . 50.0 112.407 -172.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.25 146.01 51.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.458 0.647 . . . . 50.0 112.107 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -124.0 163.79 20.66 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.539 -1.282 . . . . 50.0 107.539 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -131.34 152.98 38.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.6 p -80.48 144.69 32.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.884 -1.154 . . . . 25.0 107.884 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -88.42 124.77 34.28 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 25.0 110.295 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -73.51 126.22 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.007 -1.109 . . . . 25.0 108.007 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.63 35.82 31.23 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 119.041 -1.552 . . . . 25.0 113.931 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -54.9 149.19 11.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.241 1.02 . . . . 50.0 110.713 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -75.6 139.68 71.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.13 -0.693 . . . . 50.0 109.13 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.44 -22.47 16.11 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 118.549 -0.5 . . . . 50.0 113.179 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.8 -27.55 64.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.877 0.846 . . . . 50.0 111.956 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -91.67 143.86 28.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.934 -1.136 . . . . 50.0 107.934 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.19 115.67 3.28 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 117.555 -1.163 . . . . 50.0 112.019 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tt -52.36 -54.35 32.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.851 1.426 . . . . 50.0 114.851 -166.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -69.57 -4.03 17.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.114 1.153 . . . . 25.0 114.114 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.63 -46.58 5.96 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.503 -0.748 . . . . 50.0 109.483 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.5 -19.99 51.79 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.545 1.313 . . . . 25.0 114.545 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -72.67 -33.69 66.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.08 1.141 . . . . 50.0 114.08 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -91.7 100.01 12.8 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.623 -0.831 . . . . 25.0 112.593 -173.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -97.37 125.06 41.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 25.0 110.011 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 tp -71.4 116.98 12.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.976 -0.749 . . . . 50.0 108.976 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -96.88 -4.46 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.876 0.846 . . . . 25.0 109.898 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.35 159.72 11.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.602 -0.808 . . . . 50.0 113.016 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.0 147.07 28.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.769 -0.826 . . . . 25.0 108.769 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -133.67 111.8 12.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.223 -1.028 . . . . 25.0 108.223 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.72 168.92 18.89 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 115.796 -2.336 . . . . 50.0 111.071 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -145.18 120.04 9.94 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 120.568 -0.453 . . . . 50.0 110.505 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -91.57 -39.94 11.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.953 0.882 . . . . 50.0 110.04 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.08 -26.04 0.42 Allowed Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.125 -1.99 . . . . 25.0 108.125 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 t -51.76 141.42 26.55 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.771 0.656 . . . . 25.0 112.771 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.29 23.77 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.805 1.67 . . . . 50.0 114.343 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.28 -25.91 66.07 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.282 -0.886 . . . . 25.0 110.688 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 54.6 p -71.71 0.95 7.58 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.955 0.724 . . . . 25.0 112.955 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -62.1 -35.28 78.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.373 -0.973 . . . . 50.0 108.373 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -94.41 82.82 4.08 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.003 -1.851 . . . . 50.0 106.003 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.87 -19.84 58.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.345 -0.843 . . . . 50.0 111.653 -175.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 t -72.65 138.69 46.85 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.623 -0.673 . . . . 50.0 109.858 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -135.57 143.16 45.51 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.711 -0.477 . . . . 25.0 109.711 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -96.29 139.39 32.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.431 -1.692 . . . . 50.0 106.431 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.9 mm -133.28 130.19 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -80.71 132.17 35.53 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 175.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.0 mm -112.06 126.39 28.54 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.604 -0.888 . . . . 25.0 108.604 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.85 169.49 22.48 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 118.19 -0.74 . . . . 25.0 111.758 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -130.18 51.26 2.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.084 -1.45 . . . . 50.0 107.084 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -78.52 -32.03 47.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.123 1.157 . . . . 50.0 114.123 -172.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -152.2 165.83 33.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.975 -1.491 . . . . 50.0 106.975 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.4 mp -92.89 142.91 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.271 -2.492 . . . . 50.0 104.271 167.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.29 165.39 10.27 Favored Glycine 0 C--O 1.237 0.318 0 N-CA-C 114.24 0.456 . . . . 25.0 114.24 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -81.45 149.69 28.66 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.086 0.772 . . . . 50.0 113.086 -176.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.86 159.39 43.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.137 -1.801 . . . . 25.0 106.137 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.1 149.68 11.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 118.517 0.599 . . . . 50.0 111.158 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.7 128.44 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.94 139.21 52.04 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.362 -0.977 . . . . 50.0 108.362 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.69 144.32 41.73 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.87 -0.419 . . . . 25.0 109.87 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.85 135.28 61.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.417 -0.957 . . . . 50.0 108.417 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -128.38 112.14 14.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.261 0.624 . . . . 50.0 111.466 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -88.7 88.42 7.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.887 -0.783 . . . . 50.0 108.887 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.42 126.81 33.66 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 105.267 -2.123 . . . . 50.0 105.267 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.09 -23.52 54.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.261 0.553 . . . . 25.0 110.222 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.5 -11.85 61.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.686 -0.688 . . . . 50.0 112.481 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -127.61 161.4 28.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.952 0.406 . . . . 25.0 110.641 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -88.38 3.27 50.49 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.635 1.207 . . . . 50.0 108.054 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -108.83 157.34 18.68 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.702 -1.136 . . . . 50.0 108.945 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.69 141.77 49.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.785 -2.672 . . . . 25.0 103.785 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.03 144.69 32.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.066 -0.516 . . . . 50.0 111.14 -172.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -124.57 145.84 49.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.402 -0.817 . . . . 50.0 109.282 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -138.77 129.5 26.29 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.048 -1.834 . . . . 50.0 106.048 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.14 130.4 34.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.615 -0.883 . . . . 50.0 108.615 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.5 mt -140.37 130.87 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 120.486 0.184 . . . . 25.0 110.645 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.18 138.61 39.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.807 0.813 . . . . 25.0 111.282 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.61 160.81 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 25.0 109.07 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -117.29 132.1 56.68 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.216 -1.772 . . . . 50.0 106.216 179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.07 121.99 40.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.833 -1.543 . . . . 50.0 106.833 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 33.8 m -130.54 167.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 123.532 0.52 . . . . 50.0 110.059 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -77.58 158.1 29.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.839 -0.8 . . . . 50.0 108.839 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 117.317 -1.325 . . . . 50.0 110.466 176.541 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.85 179.58 48.79 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 108.548 -1.821 . . . . 25.0 108.548 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -80.27 136.33 36.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.11 106.85 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -77.26 -41.13 42.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.794 0.807 . . . . 50.0 110.94 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -152.84 143.76 15.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.036 -0.506 . . . . 25.0 109.669 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 137.39 47.96 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 118.99 0.675 . . . . 25.0 112.126 -5.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.68 168.06 38.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.817 -1.182 . . . . 50.0 113.665 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -161.93 121.36 2.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.339 -2.467 . . . . 25.0 104.339 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -83.4 -38.54 21.82 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 112.149 0.426 . . . . 50.0 112.149 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.21 74.14 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 25.0 112.559 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.77 70.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 112.08 0.4 . . . . 25.0 112.08 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 mt -92.0 -35.39 13.99 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 121.363 0.601 . . . . 50.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.7 t -66.07 -39.95 90.49 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 114.809 -1.087 . . . . 50.0 110.917 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.7 t -61.47 134.16 56.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.076 0.465 . . . . 50.0 110.147 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -64.57 -15.01 60.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.171 -0.468 . . . . 50.0 110.959 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.19 -12.91 14.58 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 122.055 -0.403 . . . . 25.0 111.831 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.73 -3.82 54.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.834 0.309 . . . . 50.0 111.834 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.58 -9.64 0.03 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 119.604 2.602 . . . . 50.0 119.604 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 63.68 -41.6 0.23 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.704 2.113 . . . . 50.0 116.704 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 80.0 mt -80.08 -3.01 46.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.594 0.711 . . . . 25.0 109.241 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -73.85 153.9 39.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.341 -0.845 . . . . 25.0 109.398 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 mp -75.08 163.82 27.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 105.722 -1.955 . . . . 50.0 105.722 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -49.82 -10.1 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.778 2.14 . . . . 50.0 116.778 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -163.9 -17.85 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.024 0.53 . . . . 50.0 112.158 171.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.68 142.79 13.38 Favored Glycine 0 C--O 1.222 -0.64 0 N-CA-C 112.187 -0.365 . . . . 50.0 112.187 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 m -76.24 -30.8 58.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.816 0.808 . . . . 25.0 112.953 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.28 -12.27 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.202 0.815 . . . . 50.0 113.202 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -67.08 -10.4 49.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.24 -41.09 70.57 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.888 1.07 . . . . 50.0 113.888 -171.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -142.59 43.28 0.47 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 117.377 2.362 . . . . 25.0 117.377 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.95 -21.1 28.4 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 113.236 -4.042 . . . . 50.0 112.259 176.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -79.03 -18.74 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 50.0 111.599 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -132.87 78.99 1.82 Allowed 'General case' 0 C--O 1.206 -1.229 0 N-CA-C 113.039 0.755 . . . . 75.0 113.039 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.2 mt -104.33 141.57 36.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.23 -0.656 . . . . 50.0 109.23 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -105.43 141.67 36.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 50.0 109.495 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 167.37 21.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 25.0 110.766 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -63.15 -178.15 0.22 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.286 0.847 . . . . 50.0 113.286 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 14.4 pttp -53.32 138.71 31.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.833 -1.076 . . . . 50.0 112.302 178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.34 -7.37 32.58 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 115.097 -0.956 . . . . 25.0 114.833 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -73.27 133.34 81.08 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 118.259 1.03 . . . . 25.0 108.526 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.1 116.35 4.16 Favored 'Cis proline' 0 CA--C 1.545 1.053 0 C-N-CA 130.748 1.562 . . . . 25.0 115.077 -0.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.2 m170 -60.32 -19.79 56.71 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.808 1.41 . . . . 25.0 114.808 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 t -69.94 -28.29 65.45 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.135 -0.353 . . . . 25.0 111.461 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.32 -159.61 31.14 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 114.914 0.726 . . . . 50.0 114.914 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.3 -178.82 4.71 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.637 1.558 . . . . 25.0 111.511 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.79 133.01 55.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.37 -0.377 . . . . 25.0 111.169 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -104.79 175.14 5.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.116 0.484 . . . . 25.0 111.212 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.81 0.93 57.53 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 114.528 0.571 . . . . 25.0 114.528 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -144.49 -31.12 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 116.067 1.877 . . . . 25.0 116.067 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.5 mm -68.18 -33.83 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 118.489 0.586 . . . . 25.0 109.671 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.6 -28.61 70.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.87 0.367 . . . . 25.0 111.478 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.7 m -94.26 3.09 55.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.268 -0.424 . . . . 25.0 110.77 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.64 15.07 1.97 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.441 1.497 . . . . 25.0 113.627 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.96 -29.75 50.11 Favored Glycine 0 C--O 1.215 -1.09 0 N-CA-C 110.446 -1.062 . . . . 25.0 110.446 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.41 -16.7 77.4 Favored Glycine 0 C--O 1.219 -0.842 0 C-N-CA 120.38 -0.914 . . . . 50.0 111.79 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.95 -61.24 1.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.461 0.648 . . . . 25.0 111.309 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -85.02 -13.03 51.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.31 0.856 . . . . 25.0 113.31 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.38 72.26 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.804 -0.713 . . . . 50.0 113.058 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.89 -31.49 80.99 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 120.495 -0.86 . . . . 50.0 111.948 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mm -65.5 -37.36 79.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.385 0.612 . . . . 50.0 109.527 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.14 -33.63 59.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.531 . . . . 50.0 110.33 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -67.39 -31.74 72.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.451 0.643 . . . . 50.0 111.231 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.96 -5.06 23.67 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -130.11 41.94 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 25.0 109.044 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -125.16 167.63 14.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.25 -26.11 67.2 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.572 -0.899 . . . . 50.0 108.572 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -88.08 12.67 12.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.601 -0.727 . . . . 50.0 112.203 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -53.42 139.66 29.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.563 0.697 . . . . 50.0 109.702 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -81.93 142.32 32.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.52 1.153 . . . . 50.0 111.577 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -71.14 152.13 43.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.939 -1.482 . . . . 25.0 112.01 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -110.9 140.97 44.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.793 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -119.01 133.43 55.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.98 131.0 41.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.4 ttt -151.03 168.18 25.38 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 106.862 -1.533 . . . . 50.0 106.862 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.7 p -88.21 165.97 14.68 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.805 -1.924 . . . . 25.0 105.805 173.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.8 -158.2 5.23 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.396 -0.431 . . . . 25.0 112.583 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.52 -163.89 25.23 Favored Glycine 0 CA--C 1.512 -0.099 0 O-C-N 122.347 -0.502 . . . . 50.0 112.908 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -74.71 129.14 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.008 -0.701 . . . . 25.0 110.906 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -122.5 136.21 54.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.218 -1.03 . . . . 50.0 108.218 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.5 m -99.94 118.15 35.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.896 -1.52 . . . . 25.0 106.896 175.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.65 134.78 42.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.131 -1.433 . . . . 50.0 107.131 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -133.11 130.91 39.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -114.61 150.04 35.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.558 -0.905 . . . . 50.0 108.558 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -143.31 154.92 44.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.164 -0.68 . . . . 25.0 109.164 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -140.13 159.07 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -67.48 -30.55 70.28 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.84 151.18 62.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.65 134.32 27.93 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 115.475 -2.55 . . . . 25.0 111.217 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -131.0 154.47 48.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.129 -0.693 . . . . 50.0 109.129 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -68.54 160.34 30.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.842 0.83 . . . . 50.0 109.717 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -154.46 161.64 41.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.692 -3.818 . . . . 25.0 100.692 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 p -110.7 -39.13 4.96 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.997 -0.742 . . . . 50.0 108.997 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -159.75 143.59 14.53 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.557 -0.905 . . . . 50.0 108.557 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.81 138.47 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.18 -1.415 . . . . 25.0 107.18 169.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -140.83 152.81 45.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.399 . . . . 50.0 111.527 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -117.28 139.11 51.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.934 -1.03 . . . . 50.0 109.081 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.99 165.77 25.23 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.168 -1.419 . . . . 50.0 107.168 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.97 153.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.1 p -85.78 147.87 26.11 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.169 -0.678 . . . . 25.0 109.169 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -86.45 100.85 12.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.996 0.903 . . . . 25.0 110.095 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -76.08 126.72 31.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.761 -1.2 . . . . 25.0 107.761 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 20.92 34.75 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 119.701 -1.238 . . . . 25.0 114.053 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.06 141.1 19.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.492 0.663 . . . . 50.0 111.837 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.85 134.86 81.0 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.38 -0.6 . . . . 50.0 109.38 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.8 -16.73 23.35 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 117.703 -1.065 . . . . 50.0 113.344 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.44 -29.32 68.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.061 0.934 . . . . 50.0 110.339 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -100.76 152.31 37.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 107.973 -1.121 . . . . 50.0 107.973 -174.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.52 105.99 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 117.449 -1.234 . . . . 50.0 113.885 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.14 -42.18 69.26 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.459 -0.792 . . . . 50.0 112.075 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.74 -6.55 27.12 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.267 1.21 . . . . 25.0 114.267 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.3 -44.02 6.07 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.535 0.683 . . . . 50.0 111.281 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.45 28.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.333 -1.303 . . . . 25.0 114.489 -170.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -69.13 -29.09 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.9 1.074 . . . . 50.0 113.9 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -127.36 159.15 35.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.332 0.514 . . . . 25.0 112.228 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -133.48 147.68 51.67 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.203 -1.406 . . . . 25.0 107.203 173.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 tt -87.02 133.79 33.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.893 -0.504 . . . . 50.0 110.277 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 tt -121.34 1.87 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.847 0.832 . . . . 25.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.81 156.91 14.17 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.175 -1.012 . . . . 50.0 113.408 172.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.92 139.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.989 -1.115 . . . . 25.0 107.989 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.76 102.13 13.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.3 169.77 16.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 117.353 -1.298 . . . . 50.0 112.044 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -132.24 113.49 13.31 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.721 -1.215 . . . . 50.0 107.721 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -164.59 -104.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 102.009 -3.33 . . . . 50.0 102.009 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.7 40.4 2.93 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 111.152 -0.779 . . . . 25.0 111.152 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -76.28 132.73 72.63 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 122.244 -0.562 . . . . 25.0 111.597 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.2 -178.45 3.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 O-C-N 121.719 0.326 . . . . 50.0 111.955 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -13.9 6.35 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.396 1.258 . . . . 25.0 114.396 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -59.66 -13.24 8.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.583 0.957 . . . . 25.0 113.583 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -67.0 16.24 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.63 1.715 . . . . 50.0 115.63 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -58.09 143.13 44.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.553 0.692 . . . . 50.0 110.679 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.49 -10.79 60.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.139 -0.937 . . . . 50.0 112.21 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.5 t -100.06 122.67 43.29 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 106.936 -1.505 . . . . 50.0 106.936 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -133.83 141.31 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.08 0.467 . . . . 25.0 110.326 -175.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -91.97 132.88 36.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.932 -1.136 . . . . 50.0 107.932 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -131.92 129.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.903 -1.888 . . . . 25.0 105.903 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -96.73 132.08 42.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.008 -1.108 . . . . 50.0 108.008 176.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.16 106.31 36.17 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.42 151.13 65.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 116.145 -2.103 . . . . 25.0 109.242 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -139.04 95.31 2.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.64 0.733 . . . . 50.0 111.028 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.87 4.68 53.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.933 -1.03 . . . . 50.0 110.721 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -140.8 -179.34 6.0 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 109.046 -0.724 . . . . 50.0 109.046 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.57 130.48 51.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 104.432 -2.433 . . . . 50.0 104.432 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.01 -177.36 24.42 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-O 122.848 1.249 . . . . 25.0 115.973 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -79.02 146.54 33.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.354 1.242 . . . . 50.0 114.354 -173.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -136.39 158.81 43.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.376 -2.453 . . . . 25.0 104.376 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.88 132.91 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.681 -0.859 . . . . 50.0 108.681 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.6 mt -108.51 134.85 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 tt -118.4 137.82 52.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.428 -0.953 . . . . 50.0 108.428 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.48 144.52 51.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.532 0.682 . . . . 25.0 110.9 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.98 133.64 68.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.012 -1.107 . . . . 50.0 108.012 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -129.43 100.79 5.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 50.0 108.952 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.1 131.97 34.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.006 -0.543 . . . . 50.0 109.562 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -89.05 160.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.957 -1.127 . . . . 50.0 107.957 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.99 -27.65 12.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.984 -0.747 . . . . 25.0 108.984 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.65 -2.42 58.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.729 1.011 . . . . 50.0 113.729 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.407 ' HG1' ' H ' ' A' ' 158' ' ' GLU . 11.4 t -152.95 162.78 40.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 25.0 111.469 -179.073 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.407 ' H ' ' HG1' ' A' ' 157' ' ' THR . 38.3 tp10 -67.74 -26.17 66.01 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.496 1.119 . . . . 50.0 111.855 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.74 167.31 14.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 50.0 110.592 -173.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.43 -179.56 5.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -128.36 140.46 51.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.538 -0.912 . . . . 50.0 108.538 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -131.76 137.83 48.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.688 -1.227 . . . . 50.0 107.688 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -149.18 155.36 40.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.527 -0.545 . . . . 50.0 109.527 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.6 151.0 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.699 -0.852 . . . . 50.0 108.699 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.5 mm -134.58 113.01 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.993 -1.114 . . . . 25.0 107.993 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.8 141.27 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.783 -1.192 . . . . 25.0 107.783 175.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.0 m -135.51 161.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -126.71 117.59 23.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.955 -1.868 . . . . 50.0 105.955 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.97 135.12 55.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.868 -0.606 . . . . 50.0 110.937 -169.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.35 165.83 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.525 -0.762 . . . . 50.0 109.774 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -91.47 157.71 16.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.198 -1.779 . . . . 50.0 106.198 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.437 ' HZ3' ' C ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.593 -1.194 . . . . 50.0 108.602 175.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.0 m80 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 109.999 -0.371 . . . . 25.0 109.999 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.68 -168.17 21.25 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 104.769 -3.333 . . . . 25.0 104.769 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.54 161.38 41.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.587 2.193 . . . . 25.0 113.244 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 mt -93.97 126.47 46.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.432 -1.321 . . . . 25.0 107.432 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.27 -47.59 14.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.189 -0.671 . . . . 50.0 109.189 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.676 ' HE2' ' HG1' ' A' ' 83' ' ' THR . 47.5 pttt -163.15 165.59 14.38 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.076 -1.083 . . . . 25.0 108.076 -176.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -70.32 124.78 8.18 Favored 'Cis proline' 0 C--N 1.353 0.805 0 C-N-CA 131.392 1.83 . . . . 25.0 114.987 1.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.07 175.4 39.14 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.484 -0.78 . . . . 50.0 112.731 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -139.61 152.83 47.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.407 -0.96 . . . . 25.0 108.407 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -75.29 -21.01 58.81 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.815 -0.439 . . . . 50.0 109.815 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -33.58 66.57 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.006 0.373 . . . . 25.0 112.006 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.51 70.76 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 112.446 0.536 . . . . 25.0 112.446 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.04 -32.07 15.33 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.254 0.549 . . . . 50.0 109.86 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -39.71 75.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 50.0 111.526 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.2 t -63.37 129.04 38.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.191 0.811 . . . . 50.0 113.191 -174.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -65.6 -15.01 62.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.763 -1.108 . . . . 50.0 111.747 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 -13.01 8.63 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.431 0.53 . . . . 25.0 112.431 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -77.83 -7.17 56.27 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 111.983 0.364 . . . . 50.0 111.983 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.47 -29.89 0.05 OUTLIER Glycine 0 C--O 1.223 -0.573 0 N-CA-C 115.999 1.16 . . . . 50.0 115.999 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 61.5 3.26 0.78 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.094 1.887 . . . . 50.0 116.094 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.5 mt -71.6 -27.53 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.977 -0.452 . . . . 25.0 111.162 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -160.9 161.94 31.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.1 138.83 38.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.958 -1.127 . . . . 50.0 107.958 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -125.45 -3.28 7.36 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.043 1.127 . . . . 50.0 114.043 -174.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 t -66.08 -45.1 82.45 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.215 1.191 . . . . 50.0 114.215 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.85 156.32 6.12 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 114.766 0.667 . . . . 50.0 114.766 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 t -66.25 -33.46 75.8 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.595 0.961 . . . . 25.0 113.595 -176.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.21 -10.01 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.955 0.724 . . . . 50.0 112.955 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -22.6 15.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 116.539 2.051 . . . . 25.0 116.539 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.67 -37.88 62.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.582 0.628 . . . . 50.0 111.777 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.74 68.29 8.23 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 115.358 1.614 . . . . 25.0 115.358 174.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.8 -6.49 19.11 Favored 'Trans proline' 0 C--O 1.222 -0.309 0 N-CA-C 113.14 0.4 . . . . 50.0 113.14 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -97.92 4.85 49.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.855 0.687 . . . . 50.0 112.855 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -107.81 88.08 2.65 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.666 -0.813 . . . . 50.0 110.603 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.95 140.18 42.79 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 103.891 -2.633 . . . . 50.0 103.891 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -107.51 144.05 35.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.666 0.746 . . . . 50.0 112.198 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 162.78 31.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.606 -1.998 . . . . 25.0 105.606 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -109.4 154.0 23.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.228 0.467 . . . . 50.0 109.816 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -61.54 142.1 57.3 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.223 -0.658 . . . . 50.0 109.223 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.57 93.28 0.09 OUTLIER Glycine 0 C--O 1.22 -0.719 0 N-CA-C 110.111 -1.196 . . . . 25.0 110.111 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.94 148.65 94.67 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.278 -1.008 . . . . 25.0 108.278 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.9 153.03 93.17 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 129.937 1.224 . . . . 25.0 114.024 0.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 -36.19 0.67 Allowed 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 114.24 1.2 . . . . 25.0 114.24 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 t -83.14 -12.97 56.5 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.831 0.741 . . . . 25.0 109.765 173.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.08 -148.52 18.28 Favored Glycine 0 C--O 1.236 0.258 0 N-CA-C 108.51 -1.836 . . . . 50.0 108.51 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -61.96 156.24 50.47 Favored 'Trans proline' 0 C--N 1.346 0.396 0 CA-C-N 119.113 1.457 . . . . 25.0 111.321 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.86 123.85 20.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.033 -0.53 . . . . 25.0 111.167 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -146.36 174.88 10.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.797 -2.668 . . . . 25.0 103.797 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.5 -32.02 4.33 Favored Glycine 0 C--O 1.223 -0.579 0 CA-C-N 118.309 0.504 . . . . 25.0 112.73 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -100.72 12.47 37.4 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.426 -0.455 . . . . 25.0 111.676 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.11 -40.01 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.12 -24.59 66.71 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.492 0.552 . . . . 25.0 112.492 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.0 p -101.18 23.18 11.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.305 0.242 . . . . 25.0 110.886 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.32 46.22 26.84 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.996 0.739 . . . . 25.0 112.996 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 -10.18 9.63 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 116.166 1.226 . . . . 25.0 116.166 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.84 -7.32 58.7 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 117.783 0.792 . . . . 50.0 112.527 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.73 -10.88 6.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.262 0.838 . . . . 25.0 113.262 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -57.86 -21.22 41.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.364 0.876 . . . . 25.0 113.364 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.86 -26.32 72.16 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.252 -0.975 . . . . 50.0 111.136 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.44 -14.7 72.22 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-O 119.589 -0.562 . . . . 50.0 114.028 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.86 -33.08 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.072 0.936 . . . . 50.0 110.146 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.5 -39.51 91.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 50.0 110.65 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -88.82 -2.97 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.996 0.903 . . . . 50.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.57 23.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.438 1.273 . . . . 25.0 114.438 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -70.57 74.33 0.56 Allowed 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.615 -0.678 . . . . 25.0 111.882 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t -151.59 171.2 17.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.877 -1.898 . . . . 25.0 105.877 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -64.76 -17.03 63.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.885 0.874 . . . . 50.0 112.025 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -74.26 -9.96 59.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.214 0.45 . . . . 50.0 112.214 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -71.04 160.38 33.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.407 0.622 . . . . 50.0 110.216 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -85.06 163.65 18.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.328 -0.99 . . . . 50.0 108.328 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -62.73 146.78 51.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.938 0.875 . . . . 25.0 112.525 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -114.4 143.59 44.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.188 -1.412 . . . . 25.0 107.188 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -118.89 118.16 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.392 -0.596 . . . . 25.0 109.392 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.7 mt -76.13 135.87 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.89 165.97 30.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.995 -1.483 . . . . 50.0 106.995 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 p -108.49 170.19 8.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.926 -1.879 . . . . 25.0 105.926 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.54 179.21 26.36 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 115.076 0.791 . . . . 25.0 115.076 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.13 172.99 21.04 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.593 -1.003 . . . . 50.0 110.593 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 144.99 54.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.786 -0.832 . . . . 25.0 109.345 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -133.32 157.18 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.389 -0.597 . . . . 50.0 109.389 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.3 m -115.91 127.89 55.35 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.517 -0.549 . . . . 25.0 109.517 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.18 132.77 53.29 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.188 -1.041 . . . . 50.0 108.188 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.676 ' HG1' ' HE2' ' A' ' 6' ' ' LYS . 46.3 m -137.84 130.05 29.06 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 178.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -124.07 155.74 37.81 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.686 -1.598 . . . . 50.0 106.686 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.9 t -142.24 162.01 36.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.466 -0.568 . . . . 25.0 109.466 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -125.42 142.8 51.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.703 -1.221 . . . . 25.0 107.703 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -83.52 -0.56 50.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.27 0.557 . . . . 25.0 111.617 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 160.4 58.42 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.18 147.82 94.33 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.286 -2.01 . . . . 25.0 110.411 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -130.74 109.5 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.081 0.771 . . . . 50.0 113.081 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.29 144.5 53.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.062 -0.972 . . . . 50.0 108.85 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.4 m -133.34 132.81 41.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 25.0 109.976 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -106.54 -47.28 3.8 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.693 -1.225 . . . . 50.0 107.693 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -162.47 145.32 11.2 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.582 -1.636 . . . . 50.0 106.582 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -137.96 136.16 36.71 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -148.06 158.58 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.741 -0.837 . . . . 50.0 108.741 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . 0.424 ' HH ' ' CG ' ' A' ' 134' ' ' HIS . 0.1 OUTLIER -140.49 154.89 46.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.163 0.506 . . . . 50.0 111.878 -175.65 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -135.44 163.2 30.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.255 -0.884 . . . . 50.0 109.936 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.7 pt -129.36 152.56 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 168.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.6 p -84.87 141.92 30.09 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -74.22 114.82 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.809 0.814 . . . . 25.0 110.605 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -76.22 122.76 24.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 105.598 -2.001 . . . . 25.0 105.598 172.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.28 44.92 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.885 -1.15 . . . . 25.0 115.416 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.02 150.41 17.04 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.898 0.849 . . . . 50.0 112.552 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.83 118.63 72.41 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.099 -0.5 . . . . 50.0 110.789 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.27 -15.95 22.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 N-CA-C 114.725 1.01 . . . . 50.0 114.725 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.77 -3.85 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.174 0.987 . . . . 50.0 111.071 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -113.79 159.26 36.49 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 105.358 -2.09 . . . . 50.0 105.358 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.28 99.32 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 117.454 -1.23 . . . . 50.0 112.829 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.08 -36.57 60.8 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 113.634 0.975 . . . . 50.0 113.634 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.46 -15.27 6.42 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -85.99 -43.62 13.02 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.238 0.472 . . . . 50.0 111.439 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.82 -3.89 59.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.78 1.03 . . . . 25.0 113.78 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -67.87 -31.46 71.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.103 -0.239 . . . . 50.0 110.862 -174.28 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -127.15 132.41 50.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.772 0.656 . . . . 25.0 112.772 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -118.35 124.8 48.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.148 -1.056 . . . . 25.0 108.148 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.29 119.98 15.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.208 -1.034 . . . . 50.0 108.208 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -103.13 -2.13 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.913 0.863 . . . . 25.0 109.668 -176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.97 160.54 11.06 Favored Glycine 0 CA--C 1.512 -0.143 0 C-N-CA 120.769 -0.729 . . . . 50.0 113.242 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.2 144.84 26.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.678 -0.86 . . . . 25.0 108.678 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.6 104.76 10.0 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 107.159 -1.423 . . . . 25.0 107.159 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.52 172.21 12.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 116.902 -1.599 . . . . 50.0 112.662 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -134.65 91.45 2.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.303 -2.48 . . . . 50.0 104.303 170.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -106.14 29.95 6.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.166 0.984 . . . . 50.0 108.997 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.72 -37.29 3.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 109.336 -1.506 . . . . 25.0 109.336 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.412 ' HG ' ' HD2' ' A' ' 127' ' ' PRO . 41.3 t -59.38 138.1 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 176.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.412 ' HD2' ' HG ' ' A' ' 126' ' ' SER . 59.3 Cg_endo -77.1 46.78 2.05 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.991 1.794 . . . . 50.0 114.496 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.85 -21.79 61.42 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.828 0.677 . . . . 25.0 112.828 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.0 m -61.84 -13.16 21.65 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 113.834 1.05 . . . . 25.0 113.834 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -61.14 -35.92 78.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.884 0.374 . . . . 50.0 110.394 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -106.56 105.02 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 50.0 110.425 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.12 -13.81 30.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.274 0.842 . . . . 50.0 113.274 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.4 t -100.03 140.95 33.51 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.184 -0.323 . . . . 50.0 110.748 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.424 ' CG ' ' HH ' ' A' ' 97' ' ' TYR . 14.9 t-80 -139.15 139.52 37.63 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.019 0.437 . . . . 25.0 111.904 -179.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -86.75 137.53 32.36 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.013 -0.736 . . . . 50.0 109.013 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.14 124.97 53.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.289 -1.375 . . . . 25.0 107.289 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -77.0 135.56 38.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.016 -0.735 . . . . 50.0 109.016 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.9 mm -126.08 129.21 24.31 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.78 172.64 14.89 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 117.941 -0.906 . . . . 25.0 112.87 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -129.83 45.58 2.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.271 -1.381 . . . . 50.0 107.271 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.45 -37.72 15.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.657 -1.156 . . . . 50.0 113.364 -174.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -147.77 156.95 43.28 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 110.175 -0.306 . . . . 50.0 110.175 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.0 mp -95.56 145.73 25.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.199 0.6 . . . . 50.0 110.431 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.55 163.85 9.82 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 114.558 0.583 . . . . 25.0 114.558 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -94.37 145.75 24.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.895 1.443 . . . . 50.0 114.895 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -148.99 163.32 37.84 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.04 149.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.14 0.495 . . . . 50.0 112.029 -175.466 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.8 mt -120.59 133.22 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.426 -2.065 . . . . 25.0 105.426 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 mp -121.52 149.06 43.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.282 -1.007 . . . . 50.0 108.282 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -136.68 144.13 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.91 131.14 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.951 -1.129 . . . . 50.0 107.951 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -122.33 101.84 7.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.362 0.601 . . . . 50.0 109.959 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -79.97 131.87 35.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.369 -0.975 . . . . 50.0 108.369 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.58 128.96 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.218 -1.771 . . . . 50.0 106.218 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.99 44.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.94 0.4 . . . . 25.0 109.99 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -24.95 66.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 115.6 1.704 . . . . 50.0 115.6 -175.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 p -123.27 161.69 24.1 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.241 -0.287 . . . . 25.0 110.331 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.67 -19.12 62.12 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.181 0.991 . . . . 50.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -108.92 161.81 14.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.886 -1.052 . . . . 50.0 111.249 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.18 16.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.73 -2.693 . . . . 25.0 103.73 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -114.97 144.36 43.71 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.036 0.446 . . . . 50.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -113.28 146.53 39.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.416 -1.698 . . . . 50.0 106.416 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -133.55 141.17 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 104.813 -2.291 . . . . 50.0 104.813 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.07 136.61 47.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.502 -0.555 . . . . 50.0 109.502 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.3 mt -137.89 125.39 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.88 142.89 27.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.16 142.51 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.947 -0.471 . . . . 25.0 109.967 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -109.67 120.88 43.86 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.935 -2.246 . . . . 50.0 104.935 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 mt -120.02 128.22 53.32 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.713 -0.477 . . . . 50.0 109.713 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.73 170.06 18.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.774 -0.454 . . . . 50.0 109.774 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -77.56 157.94 30.08 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.898 -0.778 . . . . 50.0 108.898 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.6 mttt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 117.793 -1.098 . . . . 50.0 109.787 178.353 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . 0.441 ' CE1' ' HH ' ' A' ' 30' ' ' TYR . 1.9 p-80 . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 110.582 -0.155 . . . . 25.0 110.582 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.03 178.28 47.52 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 106.26 -2.736 . . . . 25.0 106.26 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -125.77 156.72 39.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.642 1.221 . . . . 25.0 111.372 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.6 mt -97.66 119.44 45.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.637 -2.727 . . . . 25.0 103.637 170.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -77.5 5.67 8.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.654 0.613 . . . . 50.0 112.654 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttt 79.26 152.43 0.13 Allowed Pre-proline 0 N--CA 1.489 1.509 0 C-N-CA 126.021 1.729 . . . . 25.0 108.322 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 152.4 90.71 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 128.547 0.645 . . . . 25.0 112.023 -2.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.15 26.01 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 118.177 2.031 . . . . 50.0 118.177 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -65.04 131.29 46.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.896 1.348 . . . . 25.0 111.762 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -78.84 -15.93 57.75 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 113.459 0.911 . . . . 50.0 113.459 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.78 74.78 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 112.222 0.453 . . . . 25.0 112.222 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.73 -23.66 62.48 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.841 -0.537 . . . . 25.0 110.908 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.18 -4.03 54.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 50.0 110.279 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 t -88.02 -15.33 36.67 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.822 -0.806 . . . . 50.0 108.822 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.89 162.06 3.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.391 0.886 . . . . 50.0 113.391 -176.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -18.79 7.05 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.125 0.97 . . . . 50.0 113.282 176.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.4 -12.93 2.87 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.731 0.813 . . . . 25.0 112.737 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -71.44 -11.2 60.76 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.175 0.59 . . . . 50.0 111.196 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.41 -0.56 0.58 Allowed Glycine 0 C--O 1.223 -0.573 0 N-CA-C 116.785 1.474 . . . . 50.0 116.785 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 56.49 22.59 6.66 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.472 1.286 . . . . 50.0 114.472 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.8 mt -84.58 -7.87 59.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.586 0.708 . . . . 25.0 109.541 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -135.39 -174.89 3.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.009 -0.996 . . . . 25.0 110.461 -172.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 mp -74.89 168.56 19.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.977 -1.49 . . . . 50.0 106.977 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -42.15 -24.48 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.404 2.002 . . . . 50.0 116.404 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.19 -13.05 0.26 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.48 0.657 . . . . 50.0 111.763 171.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.44 167.5 42.8 Favored Glycine 0 CA--C 1.524 0.62 0 O-C-N 121.628 -0.67 . . . . 50.0 112.875 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -65.72 -30.24 70.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.473 0.654 . . . . 25.0 112.545 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p -66.84 -10.27 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.071 0.767 . . . . 50.0 113.071 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.3 ptm -57.83 -11.09 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 118.121 2.637 . . . . 25.0 118.121 -174.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . 0.441 ' HH ' ' CE1' ' A' ' 1' ' ' HIS . 92.7 t80 -69.94 -38.7 76.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.521 0.601 . . . . 50.0 110.462 -177.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.95 63.74 3.16 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.174 1.176 . . . . 25.0 114.174 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.97 -8.12 22.35 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.122 -0.785 . . . . 50.0 113.856 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -97.19 5.12 50.66 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 122.056 -0.403 . . . . 50.0 111.878 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -121.21 130.4 53.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.739 0.644 . . . . 75.0 112.739 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.0 137.3 52.23 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.947 -1.501 . . . . 50.0 106.947 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -110.36 140.52 44.49 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.932 0.145 . . . . 50.0 111.132 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.93 158.08 45.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.396 -0.594 . . . . 25.0 109.396 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -127.22 159.25 34.89 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.939 0.718 . . . . 50.0 112.939 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.03 169.53 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.395 1.078 . . . . 50.0 109.521 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.94 108.5 2.55 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 116.405 -0.361 . . . . 25.0 112.509 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -62.13 147.12 91.29 Favored Pre-proline 0 CA--C 1.539 0.528 0 O-C-N 122.014 -0.698 . . . . 25.0 110.871 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.48 -16.98 16.46 Favored 'Cis proline' 0 C--N 1.349 0.597 0 N-CA-C 114.83 1.05 . . . . 25.0 114.83 1.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -177.31 -34.71 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.697 0.799 . . . . 25.0 110.652 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.9 t 68.7 -37.88 0.37 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.11 1.364 . . . . 25.0 114.434 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.8 -146.61 21.02 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 108.294 -1.922 . . . . 50.0 108.294 173.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -67.85 -163.27 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.831 0 CA-C-N 119.557 1.679 . . . . 25.0 110.067 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.08 88.72 1.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.853 -1.154 . . . . 25.0 108.912 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -88.79 162.62 16.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.011 -0.995 . . . . 25.0 111.533 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.07 -6.96 31.87 Favored Glycine 0 C--O 1.227 -0.296 0 N-CA-C 114.958 0.743 . . . . 25.0 114.958 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.453 ' HA ' ' HG ' ' A' ' 53' ' ' SER . 92.8 mm-40 -68.21 -25.48 65.24 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.947 -0.737 . . . . 25.0 112.176 -175.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.46 -39.46 78.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.611 -0.885 . . . . 25.0 108.611 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.04 -31.99 69.89 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.907 0.336 . . . . 25.0 111.907 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.453 ' HG ' ' HA ' ' A' ' 50' ' ' GLN . 95.5 p -81.62 -0.71 43.69 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.873 0.368 . . . . 25.0 110.215 176.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.29 19.9 9.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.933 1.293 . . . . 25.0 112.678 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.93 -32.27 10.12 Favored Glycine 0 C--O 1.226 -0.397 0 N-CA-C 111.02 -0.832 . . . . 25.0 111.02 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.71 -5.32 88.37 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 114.24 0.456 . . . . 50.0 114.24 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.68 -24.53 67.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.319 0.56 . . . . 25.0 111.151 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -66.49 -19.39 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.955 0.354 . . . . 25.0 111.955 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.76 -26.85 74.28 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.46 -1.056 . . . . 50.0 110.46 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.64 78.35 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.235 -0.507 . . . . 50.0 112.189 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.38 -42.59 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.377 -1.342 . . . . 50.0 107.377 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.39 -32.57 72.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.526 . . . . 50.0 109.914 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.11 -23.21 66.4 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.628 0.603 . . . . 50.0 112.628 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -68.94 -7.27 33.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.439 -0.788 . . . . 25.0 112.171 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -131.0 40.79 3.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -112.43 158.29 20.03 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.19 -30.78 63.79 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.582 -0.895 . . . . 50.0 108.582 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -96.64 21.26 9.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.416 -0.811 . . . . 50.0 110.329 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -50.24 148.29 3.63 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.127 -0.942 . . . . 50.0 111.64 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -67.37 138.15 56.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.766 1.269 . . . . 50.0 110.03 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -82.06 140.08 34.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.911 -1.495 . . . . 25.0 109.551 -172.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -108.72 138.68 44.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 25.0 111.485 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -124.39 135.25 53.15 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.835 -0.431 . . . . 25.0 109.835 168.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -79.66 138.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.1 tpt -139.51 156.11 47.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.349 -1.352 . . . . 50.0 107.349 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.9 p -101.43 -179.34 4.0 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.6 -178.77 30.3 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.275 -0.488 . . . . 25.0 112.355 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.26 -177.89 32.64 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 122.439 -0.448 . . . . 50.0 113.575 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.2 142.31 29.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 178.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -139.62 158.5 44.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.14 0.495 . . . . 50.0 110.206 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m -110.18 129.15 55.76 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.393 -0.966 . . . . 25.0 108.393 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.6 138.21 53.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.518 -1.289 . . . . 50.0 107.518 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -136.38 144.07 44.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.903 0.382 . . . . 25.0 111.113 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -121.02 149.98 41.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.634 -1.617 . . . . 50.0 106.634 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.83 156.44 48.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.296 0.57 . . . . 25.0 110.282 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -139.03 145.56 39.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.544 -2.021 . . . . 25.0 105.544 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -75.03 -14.15 60.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.495 0.554 . . . . 25.0 112.495 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.98 149.25 55.32 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.588 -1.264 . . . . 25.0 107.588 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -71.05 153.15 63.06 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 117.267 -1.356 . . . . 25.0 111.062 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -131.0 140.18 50.09 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.729 -0.471 . . . . 50.0 109.729 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.74 145.81 51.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.51 -1.663 . . . . 50.0 106.51 174.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.8 m -152.11 142.65 22.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.1 p -101.88 -37.37 8.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.477 -0.564 . . . . 50.0 109.477 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -165.13 167.11 18.51 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.239 -0.288 . . . . 50.0 111.119 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -141.25 141.17 34.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.625 -0.88 . . . . 25.0 108.625 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -147.94 155.68 41.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.377 -0.374 . . . . 50.0 110.265 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 150.03 46.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.39 0.614 . . . . 50.0 111.918 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -131.5 165.06 24.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.435 -1.32 . . . . 50.0 107.435 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -132.47 148.91 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 106.839 -1.541 . . . . 25.0 106.839 173.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 p -83.93 121.78 27.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -99.88 104.29 15.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.686 0.755 . . . . 25.0 109.06 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -75.99 153.96 36.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.61 23.95 17.24 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 119.779 -1.201 . . . . 25.0 114.606 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -66.7 161.62 23.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.667 0.734 . . . . 50.0 109.546 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.83 155.7 47.58 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 107.485 -1.302 . . . . 50.0 107.485 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.73 -14.54 33.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.777 -1.015 . . . . 50.0 113.261 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.07 -20.6 64.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.703 0.801 . . . . 50.0 111.468 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -96.04 147.16 32.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.494 -0.558 . . . . 50.0 109.494 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -61.82 119.71 6.96 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.285 -0.677 . . . . 50.0 111.609 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.58 -49.97 61.06 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 115.533 1.679 . . . . 50.0 115.533 -167.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.91 -36.67 36.09 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.902 0.858 . . . . 25.0 111.797 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -75.85 -32.67 59.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.492 -0.776 . . . . 50.0 112.983 -172.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.62 1.9 47.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.624 -0.262 . . . . 25.0 111.157 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.91 -29.59 68.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.195 -0.202 . . . . 50.0 111.135 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -125.88 150.14 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.91 0.708 . . . . 25.0 112.91 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -127.75 145.76 50.8 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.073 -1.084 . . . . 25.0 108.073 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.12 124.68 28.34 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.257 -0.645 . . . . 50.0 109.257 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.1 tt -98.36 -12.21 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.375 0.607 . . . . 25.0 110.137 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.46 160.19 14.42 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.311 -0.947 . . . . 50.0 114.206 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.54 139.06 23.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.706 -1.591 . . . . 25.0 106.706 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.0 t -137.09 116.49 10.4 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.85 167.53 22.09 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 115.329 -2.648 . . . . 50.0 111.904 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -126.64 96.25 4.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.348 1.071 . . . . 50.0 108.554 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -165.72 -98.15 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 100.527 -3.879 . . . . 50.0 100.527 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -93.69 134.93 12.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 105.843 -2.903 . . . . 25.0 105.843 168.103 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 t -164.58 146.2 6.76 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 117.48 0.64 . . . . 25.0 109.442 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.2 -162.43 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 120.747 0.964 . . . . 50.0 110.184 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.76 -14.07 2.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.381 1.252 . . . . 25.0 114.381 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.5 m -60.48 -16.05 32.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.079 0.77 . . . . 25.0 113.079 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -67.36 -10.44 51.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.467 0.544 . . . . 50.0 112.467 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -65.97 147.7 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 50.0 109.935 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.57 -9.7 58.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.568 0.699 . . . . 50.0 111.258 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.0 t -100.03 121.04 40.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.313 -1.736 . . . . 50.0 106.313 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -124.61 132.28 53.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 25.0 110.49 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -87.21 137.03 32.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.019 -0.537 . . . . 50.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.03 124.6 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.315 -0.994 . . . . 25.0 108.315 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 82.3 t80 -90.87 140.97 29.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.261 -0.644 . . . . 50.0 109.261 176.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -122.3 128.93 25.29 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 107.587 -1.264 . . . . 25.0 107.587 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.27 166.45 29.48 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 117.892 -0.939 . . . . 25.0 112.444 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -111.02 14.27 21.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.617 0.722 . . . . 50.0 111.076 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.34 -18.18 46.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.938 1.458 . . . . 50.0 114.938 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -155.18 170.01 22.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.19 0.811 . . . . 50.0 113.19 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.8 144.81 51.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.709 -0.678 . . . . 50.0 109.994 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.29 151.67 5.47 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.138 0.815 . . . . 25.0 115.138 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.03 146.89 25.94 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 114.943 1.46 . . . . 50.0 114.943 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -149.01 163.54 37.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -96.96 150.03 4.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.592 -0.522 . . . . 50.0 109.592 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.49 132.58 62.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.9 mt -119.05 139.84 51.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.876 -1.898 . . . . 50.0 105.876 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.79 151.52 47.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.114 0.87 . . . . 25.0 110.31 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.0 133.61 65.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.995 -1.002 . . . . 50.0 109.035 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -117.39 113.73 22.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.801 -1.185 . . . . 50.0 107.801 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -103.25 133.54 48.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.401 0.62 . . . . 50.0 111.358 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.86 132.26 70.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.468 -1.679 . . . . 50.0 106.468 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.73 -43.61 30.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 25.0 110.925 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 10.14 3.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.502 2.038 . . . . 50.0 116.502 -169.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -131.55 155.02 48.21 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.915 -0.49 . . . . 25.0 110.867 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -73.7 -7.85 53.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 50.0 110.959 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -115.22 163.83 15.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 50.0 112.14 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.88 163.22 33.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 103.453 -2.795 . . . . 25.0 103.453 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -130.45 152.39 49.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.548 0.573 . . . . 50.0 112.548 -172.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -130.96 157.58 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.594 -0.891 . . . . 50.0 108.594 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.5 154.62 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.862 -0.792 . . . . 50.0 108.862 171.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.1 137.22 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.934 0.397 . . . . 50.0 110.853 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 60.6 mt -141.71 135.0 29.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.55 141.74 37.34 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.242 1.383 . . . . 25.0 108.961 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.41 134.52 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.447 0.641 . . . . 25.0 109.657 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -101.73 96.02 6.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.782 . . . . 50.0 106.187 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.66 105.86 17.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.824 -1.176 . . . . 50.0 107.824 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.04 158.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.451 1.278 . . . . 50.0 114.451 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -99.66 164.99 11.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.632 -1.167 . . . . 50.0 107.897 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 C--O 1.253 1.264 0 CA-C-O 116.544 -1.693 . . . . 50.0 113.051 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 119.512 -0.28 . . . . 25.0 111.524 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.92 -159.87 34.75 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.184 -1.008 . . . . 25.0 111.423 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -108.88 135.99 49.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.38 0.272 . . . . 25.0 111.247 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.6 mt -93.98 114.38 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.27 -1.381 . . . . 25.0 107.27 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.12 -43.37 9.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.86 -0.792 . . . . 50.0 108.86 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -137.47 149.4 65.18 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 107.763 -1.199 . . . . 25.0 107.763 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.81 105.07 0.64 Allowed 'Cis proline' 0 CA--C 1.539 0.757 0 C-N-CA 131.102 1.709 . . . . 25.0 113.143 -3.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.71 -166.41 46.52 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.776 -0.726 . . . . 50.0 111.873 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 t -139.95 154.54 47.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.565 -0.531 . . . . 25.0 109.565 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.1 -20.85 57.3 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 116.391 -0.368 . . . . 50.0 111.701 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.52 66.53 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.914 0.709 . . . . 25.0 112.914 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.33 70.63 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.96 -11.36 39.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.036 0.446 . . . . 50.0 110.615 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.8 t -80.13 -43.4 21.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.884 0.373 . . . . 50.0 111.373 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -71.89 129.53 38.81 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.203 0.445 . . . . 50.0 112.203 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.9 -24.05 67.64 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.262 0.553 . . . . 50.0 110.041 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.08 -13.09 2.54 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.496 0.924 . . . . 25.0 113.496 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -78.67 -10.83 59.89 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.231 0.212 . . . . 50.0 111.431 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.96 -14.84 0.04 OUTLIER Glycine 0 C--O 1.222 -0.603 0 N-CA-C 117.461 1.744 . . . . 50.0 117.461 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.9 t80 62.12 -7.95 0.11 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 116.773 2.138 . . . . 50.0 116.773 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.78 -38.62 83.63 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.757 -0.589 . . . . 25.0 109.895 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -169.31 177.26 4.8 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -136.81 157.04 47.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.587 -1.264 . . . . 50.0 107.587 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.87 54.94 1.67 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.745 -1.205 . . . . 50.0 107.745 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.5 t -91.21 -48.29 7.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.383 -0.527 . . . . 50.0 110.566 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.74 -176.78 35.43 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 116.182 -0.463 . . . . 50.0 112.894 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 t -64.94 -13.96 58.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.679 0.752 . . . . 25.0 110.886 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t -62.51 -9.75 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.665 -0.698 . . . . 50.0 110.772 175.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.5 ptm -62.69 -27.01 68.95 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.391 -0.818 . . . . 25.0 111.31 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.21 -28.87 31.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.542 0.687 . . . . 50.0 110.03 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -115.95 61.51 1.97 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.749 -0.659 . . . . 25.0 112.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.61 -38.62 3.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 114.169 -3.421 . . . . 50.0 113.335 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -105.69 -32.55 8.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.391 0.885 . . . . 50.0 113.391 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 m -102.14 78.26 1.75 Allowed 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 109.133 -0.692 . . . . 50.0 109.133 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -107.58 109.97 21.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.228 -1.027 . . . . 50.0 108.228 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.913 0.708 . . . . 50.0 112.913 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.35 103.91 4.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.565 0.58 . . . . 25.0 112.565 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.95 -164.8 0.17 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.068 -1.456 . . . . 50.0 107.068 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -60.63 151.28 29.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.302 0.641 . . . . 50.0 111.146 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.87 140.19 3.51 Favored Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 109.255 -1.538 . . . . 25.0 109.255 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -112.26 125.46 30.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 117.288 0.544 . . . . 25.0 110.264 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.0 152.56 98.43 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 129.72 1.134 . . . . 25.0 111.041 -3.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -98.15 -42.85 7.26 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 112.696 0.628 . . . . 25.0 112.696 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t 63.67 -52.51 0.23 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.143 1.534 . . . . 25.0 115.143 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.37 172.42 53.67 Favored Glycine 0 C--O 1.244 0.736 0 N-CA-C 111.37 -0.692 . . . . 50.0 111.37 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.428 ' HB2' HE21 ' A' ' 50' ' ' GLN . 67.5 Cg_endo -74.51 -170.57 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.8 2.333 . . . . 25.0 113.684 -177.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.35 141.63 19.08 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.819 0.674 . . . . 25.0 112.819 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -55.51 113.68 1.53 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.769 -0.65 . . . . 25.0 112.534 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.52 17.19 25.24 Favored Glycine 0 C--O 1.222 -0.601 0 CA-C-N 115.503 -0.771 . . . . 25.0 114.242 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.428 HE21 ' HB2' ' A' ' 46' ' ' PRO . 1.6 mp0 57.2 13.86 1.83 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.837 0.855 . . . . 25.0 113.234 -174.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.09 -39.21 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 25.0 110.096 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.19 -27.26 69.24 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.287 0.847 . . . . 25.0 113.287 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.3 p -94.16 -19.47 20.75 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.64 -0.424 . . . . 25.0 110.715 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.19 -0.54 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 116.324 1.972 . . . . 25.0 116.324 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 -23.62 4.37 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 112.016 -0.434 . . . . 25.0 112.016 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.64 2.89 65.81 Favored Glycine 0 C--O 1.222 -0.65 0 C-N-CA 120.912 -0.661 . . . . 50.0 113.478 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.04 -21.46 66.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.522 0.329 . . . . 25.0 111.712 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -63.98 -13.0 42.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.117 0.414 . . . . 25.0 112.117 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.89 -14.64 56.25 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.432 -0.413 . . . . 50.0 113.732 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.86 -21.72 65.73 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 117.773 0.787 . . . . 50.0 112.796 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -66.44 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.887 -0.783 . . . . 50.0 108.887 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.39 -31.71 58.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 50.0 111.061 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.79 -49.89 76.01 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.32 0.581 . . . . 50.0 110.4 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -75.27 2.11 11.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -119.92 19.15 12.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.91 0.862 . . . . 25.0 109.61 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.0 t -107.47 177.18 4.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 25.0 110.614 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -80.95 -18.05 48.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.101 -1.074 . . . . 50.0 108.101 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -95.38 14.84 21.18 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.166 -0.925 . . . . 50.0 109.651 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.86 146.05 33.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.047 -1.094 . . . . 50.0 108.047 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -80.69 140.84 35.41 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.55 -0.907 . . . . 50.0 108.55 -176.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -58.33 142.45 48.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 25.0 112.645 -171.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -126.23 147.89 49.58 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.365 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -126.28 151.04 48.02 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.153 -0.684 . . . . 25.0 109.153 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -94.76 143.01 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.841 -1.911 . . . . 25.0 105.841 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.6 ttp -151.0 166.89 29.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.205 -0.295 . . . . 50.0 110.205 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.1 p -103.96 171.96 7.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.38 -2.081 . . . . 25.0 105.38 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.04 -169.41 7.52 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.361 0.423 . . . . 25.0 114.117 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.92 -172.74 20.21 Favored Glycine 0 N--CA 1.459 0.222 0 O-C-N 122.405 -0.467 . . . . 50.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -75.82 135.66 40.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.952 -0.734 . . . . 25.0 109.424 178.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -129.24 152.11 49.17 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.26 -1.015 . . . . 50.0 108.26 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.8 m -117.7 134.84 54.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.455 . . . . 25.0 110.136 -174.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.73 111.99 23.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.781 -1.933 . . . . 50.0 105.781 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.4 m -120.37 110.78 16.93 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.99 141.38 52.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 104.699 -2.334 . . . . 50.0 104.699 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.6 t -145.01 161.97 38.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.553 0.216 . . . . 25.0 110.657 -173.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -125.43 150.73 47.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -72.39 -17.41 61.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 159.69 61.09 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.0 140.49 60.49 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 114.553 -3.165 . . . . 25.0 110.355 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -130.91 147.17 52.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.547 -1.279 . . . . 50.0 107.547 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -68.01 146.9 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.455 -1.313 . . . . 50.0 107.455 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.4 p -140.37 146.71 38.76 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.322 -1.362 . . . . 25.0 107.322 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -110.23 -50.16 2.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.905 0.383 . . . . 50.0 110.082 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -158.95 147.59 18.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.03 -0.419 . . . . 50.0 109.927 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -135.18 144.29 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 166.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -148.04 159.13 44.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.472 -0.566 . . . . 50.0 109.472 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.35 149.91 47.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.653 0.74 . . . . 50.0 112.08 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.74 165.95 20.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.051 -1.463 . . . . 50.0 107.051 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 pt -130.03 159.1 42.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.598 -0.89 . . . . 25.0 108.598 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 58.9 m -111.72 115.95 29.94 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 173.791 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -89.99 112.02 23.29 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -76.11 153.96 35.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.014 -1.106 . . . . 25.0 108.014 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.33 31.95 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 116.011 1.164 . . . . 25.0 116.011 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -60.2 153.74 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.765 0.783 . . . . 50.0 110.102 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.52 147.1 98.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 50.0 107.767 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.91 -20.0 34.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 117.828 -0.982 . . . . 50.0 114.468 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.11 -23.71 63.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.027 0.918 . . . . 50.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -96.04 136.19 22.29 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.901 -1.148 . . . . 50.0 107.901 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.49 126.56 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 116.726 -1.716 . . . . 50.0 114.372 -172.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 tt -52.76 -39.44 62.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.421 -1.263 . . . . 50.0 111.726 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.04 -16.06 63.04 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -83.06 -41.72 18.29 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.965 -0.459 . . . . 50.0 110.831 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.84 60.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.87 -31.51 71.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.164 -0.471 . . . . 50.0 112.041 -176.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -125.98 111.67 15.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.784 0.661 . . . . 25.0 112.784 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -128.18 121.14 28.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.52 124.26 23.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.227 -0.296 . . . . 50.0 110.746 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -14.96 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.985 -0.746 . . . . 25.0 108.985 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.51 154.43 10.22 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.298 -0.953 . . . . 50.0 113.965 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.66 137.25 36.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.88 87.47 48.98 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.0 157.65 46.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.275 -1.35 . . . . 50.0 111.339 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -112.21 99.11 7.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.195 -1.039 . . . . 50.0 108.195 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.29 4.21 9.15 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.552 -1.647 . . . . 50.0 106.552 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.52 -179.1 45.13 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 103.401 -3.88 . . . . 25.0 103.401 -175.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -139.51 65.58 33.76 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 116.12 1.896 . . . . 25.0 116.12 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 175.71 9.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 116.884 -1.611 . . . . 50.0 109.565 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.87 56.2 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.045 0.757 . . . . 25.0 113.045 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.3 t -60.36 -24.55 65.17 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.193 0.52 . . . . 25.0 112.28 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.97 7.1 47.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.384 0.673 . . . . 50.0 112.532 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -58.37 141.28 51.78 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.542 -1.651 . . . . 50.0 106.542 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -35.6 80.81 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.376 0.534 . . . . 50.0 111.883 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.4 t -86.09 124.84 32.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.769 -0.826 . . . . 50.0 108.769 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -120.58 149.76 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.735 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -112.35 131.72 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.119 -1.808 . . . . 50.0 106.119 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.2 mm -132.0 128.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 63.0 t80 -79.79 132.81 36.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.954 -1.128 . . . . 50.0 107.954 173.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.6 mm -119.42 123.07 28.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.09 162.97 39.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 117.355 -1.296 . . . . 25.0 112.523 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.91 28.71 8.18 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.919 -1.511 . . . . 50.0 106.919 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.15 -18.63 63.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.852 -1.067 . . . . 50.0 113.566 -172.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -156.81 150.29 24.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.258 0.552 . . . . 50.0 109.959 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.83 154.18 19.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.898 -1.046 . . . . 50.0 108.718 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.27 -176.33 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 121.509 0.505 . . . . 25.0 112.105 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -80.74 145.02 31.74 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.78 0.659 . . . . 50.0 112.78 -174.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -132.66 116.05 16.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 t -93.28 138.12 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.996 -0.742 . . . . 50.0 108.996 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 120.69 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 mp -104.51 141.08 37.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.804 -1.184 . . . . 50.0 107.804 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.67 132.92 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.827 0.739 . . . . 25.0 112.206 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.33 137.41 57.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 50.0 109.012 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -120.65 112.54 19.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.763 -1.569 . . . . 50.0 106.763 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.78 133.1 34.36 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.553 -1.203 . . . . 50.0 109.444 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 58.1 t -117.24 121.96 68.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.542 -0.91 . . . . 50.0 108.542 -174.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -13.6 61.58 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.747 0.647 . . . . 25.0 112.747 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -81.31 -13.64 58.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.702 0.63 . . . . 50.0 112.702 -176.512 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.3 p -144.31 159.77 42.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.33 0.863 . . . . 25.0 113.33 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -79.45 3.82 17.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 50.0 110.722 171.143 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -110.13 171.04 7.69 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.742 -0.836 . . . . 50.0 108.742 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.47 161.29 40.06 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.421 0.629 . . . . 25.0 109.925 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -96.45 130.39 43.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.545 -0.909 . . . . 50.0 108.545 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -132.31 139.13 48.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.694 0.627 . . . . 50.0 112.694 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.71 154.24 39.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.119 -0.697 . . . . 50.0 109.119 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.2 p -136.98 137.25 47.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.374 -2.454 . . . . 50.0 104.374 171.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.6 mt -132.2 130.73 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -111.97 139.12 47.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.65 -1.241 . . . . 25.0 107.65 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.81 126.91 60.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.442 0.639 . . . . 25.0 109.921 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 42.3 t0 -85.97 102.04 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.778 -1.564 . . . . 50.0 106.778 178.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.21 117.33 33.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.537 -0.912 . . . . 50.0 108.537 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 25.7 m -136.45 163.19 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.017 -0.538 . . . . 50.0 111.023 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -89.99 155.27 19.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.007 -1.849 . . . . 50.0 106.007 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . 0.456 ' HZ3' ' C ' ' A' ' 172' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.991 -1.004 . . . . 50.0 110.095 176.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 109.896 -0.409 . . . . 25.0 109.896 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.89 -175.84 47.79 Favored Glycine 0 CA--C 1.51 -0.267 0 N-CA-C 106.147 -2.781 . . . . 25.0 106.147 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.19 148.12 36.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.441 1.121 . . . . 25.0 111.021 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.23 112.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 104.025 -2.583 . . . . 25.0 104.025 170.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.48 2.69 13.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.709 0.633 . . . . 50.0 112.709 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 74.15 151.66 0.14 Allowed Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 125.752 1.621 . . . . 25.0 110.003 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.53 153.78 89.52 Favored 'Cis proline' 0 C--O 1.222 -0.283 0 CA-C-O 121.733 0.639 . . . . 25.0 112.203 -1.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.56 14.8 13.37 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 117.081 1.592 . . . . 50.0 117.081 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -65.86 125.36 25.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.632 1.216 . . . . 25.0 111.431 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -78.51 -19.64 52.54 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.441 0.534 . . . . 50.0 112.441 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.66 67.93 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.146 0.278 . . . . 25.0 111.091 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.02 -31.52 72.67 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 120.693 0.283 . . . . 25.0 111.315 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.98 -3.88 55.3 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 116.43 -0.35 . . . . 50.0 111.164 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -80.88 -6.27 58.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.487 . . . . 50.0 109.684 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.466 ' HG ' ' N ' ' A' ' 16' ' ' GLU . 12.9 t -56.56 160.37 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.013 -0.994 . . . . 50.0 111.212 179.221 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.466 ' N ' ' HG ' ' A' ' 15' ' ' SER . 4.8 pm0 -55.46 -17.26 4.81 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.959 0.904 . . . . 50.0 113.1 177.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.96 -20.99 57.67 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 121.83 -0.544 . . . . 25.0 112.378 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -83.09 -1.98 54.21 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.347 0.869 . . . . 50.0 113.347 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.5 -31.28 0.06 OUTLIER Glycine 0 C--O 1.222 -0.644 0 N-CA-C 117.191 1.637 . . . . 50.0 117.191 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 63.54 -27.86 0.08 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 118.545 2.795 . . . . 50.0 118.545 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.5 mt -80.02 -3.02 46.7 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.815 -0.553 . . . . 25.0 111.792 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -119.21 -178.21 3.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.91 -0.586 . . . . 25.0 110.503 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.03 158.17 33.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.168 -1.79 . . . . 50.0 106.168 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -63.1 12.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.779 2.14 . . . . 50.0 116.779 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.7 t 178.91 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.089 1.756 . . . . 50.0 108.236 170.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.29 177.65 51.16 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 121.196 -0.526 . . . . 50.0 113.584 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.6 t -70.02 -14.19 62.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.894 0.702 . . . . 25.0 112.894 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -70.33 -12.82 16.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.861 0.362 . . . . 50.0 111.167 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.7 ptm -58.6 -10.88 2.5 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 117.77 2.507 . . . . 25.0 117.77 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -69.4 -39.84 77.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.43 0.559 . . . . 50.0 110.85 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.37 64.59 2.52 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 113.571 0.952 . . . . 25.0 113.571 173.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.37 -8.87 24.63 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 118.185 -0.743 . . . . 50.0 113.754 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 pm0 -97.85 4.37 49.68 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.823 0.675 . . . . 50.0 112.823 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -100.74 98.73 9.23 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 118.573 0.624 . . . . 75.0 111.16 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.7 mt -90.47 117.7 29.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.978 -2.23 . . . . 50.0 104.978 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -84.21 141.31 31.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.725 0.297 . . . . 50.0 110.632 -175.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.96 157.71 46.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.012 -1.477 . . . . 25.0 107.012 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -127.47 143.52 51.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.498 0.666 . . . . 50.0 111.703 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -71.36 155.47 40.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.685 -0.689 . . . . 50.0 110.421 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.64 154.82 27.62 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 116.261 1.264 . . . . 25.0 116.261 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -90.42 153.88 46.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.247 -0.476 . . . . 25.0 110.046 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.6 -26.17 8.0 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 128.618 0.674 . . . . 25.0 112.787 0.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.8 p80 163.56 -46.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.933 2.093 . . . . 25.0 106.588 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 m 64.0 -39.94 0.22 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.723 1.609 . . . . 25.0 115.169 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.45 -146.53 6.89 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.815 -1.714 . . . . 50.0 108.815 171.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -67.65 -178.97 1.75 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 CA-C-N 119.998 1.899 . . . . 25.0 111.3 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 100.54 3.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.096 -1.075 . . . . 25.0 108.096 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -93.73 165.24 12.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.41 -0.814 . . . . 25.0 112.07 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.53 -3.64 58.78 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.468 -0.787 . . . . 25.0 113.736 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.403 ' HA ' ' HG ' ' A' ' 53' ' ' SER . 94.0 mm-40 -70.41 -18.23 63.03 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.129 -0.63 . . . . 25.0 112.399 -176.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -71.27 -40.49 74.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.148 -1.056 . . . . 25.0 108.148 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.81 -30.51 68.05 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.026 0.38 . . . . 25.0 112.026 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.403 ' HG ' ' HA ' ' A' ' 50' ' ' GLN . 93.8 p -87.83 -2.88 58.9 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.375 -0.375 . . . . 25.0 110.731 178.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.23 17.28 3.51 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 125.243 1.417 . . . . 25.0 113.144 -173.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.94 -33.14 46.89 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.641 -0.984 . . . . 25.0 110.641 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.37 -18.7 65.98 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.6 -0.81 . . . . 50.0 112.35 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.24 -24.94 63.17 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.401 -0.47 . . . . 25.0 111.493 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.01 -26.64 67.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.91 0.386 . . . . 25.0 111.349 175.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.25 -25.68 75.05 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 110.673 -0.971 . . . . 50.0 110.673 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.49 71.62 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 121.25 -0.5 . . . . 50.0 112.846 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.42 -42.61 84.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.929 -1.137 . . . . 50.0 107.929 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.06 -26.42 56.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 50.0 111.227 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -21.65 64.87 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.425 0.631 . . . . 50.0 111.674 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -68.84 -3.78 13.79 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.816 -0.553 . . . . 25.0 112.41 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -132.69 55.68 1.88 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -135.71 157.8 45.98 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.979 -0.378 . . . . 25.0 109.979 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -71.95 -25.11 61.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.688 0.756 . . . . 50.0 109.138 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -97.55 18.84 14.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.711 . . . . 50.0 110.492 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -52.71 142.22 19.13 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.564 0.697 . . . . 50.0 111.634 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -69.02 143.82 54.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.555 1.169 . . . . 50.0 109.778 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -75.36 131.29 40.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.587 -0.733 . . . . 25.0 111.562 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -91.62 146.34 23.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.813 -0.63 . . . . 25.0 111.121 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -131.76 114.32 14.59 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.173 -0.306 . . . . 25.0 110.173 168.095 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -73.47 135.54 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.063 -2.199 . . . . 25.0 105.063 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.1 tpt -150.42 154.15 37.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.253 -0.647 . . . . 50.0 109.253 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 p -93.0 -177.17 4.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.189 -1.411 . . . . 25.0 107.189 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -166.53 31.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.87 -0.492 . . . . 25.0 111.87 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.78 -178.94 30.05 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 112.16 -0.376 . . . . 50.0 112.16 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -79.99 133.89 36.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -126.03 121.81 34.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.414 0.626 . . . . 50.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.3 m -91.75 126.92 37.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.982 -1.118 . . . . 25.0 107.982 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -119.06 125.91 50.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.172 -0.677 . . . . 50.0 109.172 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -123.54 130.76 53.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 25.0 111.347 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.1 m0 -123.66 147.91 46.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.628 -2.73 . . . . 50.0 103.628 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -136.54 161.06 36.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.16 0.505 . . . . 25.0 109.723 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.05 137.88 47.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.7 t -79.32 -9.13 59.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.93 60.85 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 106.268 -1.752 . . . . 25.0 106.268 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.26 144.75 47.0 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 116.203 -2.065 . . . . 25.0 111.92 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -131.07 139.74 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.197 -1.409 . . . . 50.0 107.197 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -71.26 148.39 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.231 -1.396 . . . . 50.0 107.231 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -149.95 141.89 23.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.7 t -92.44 -47.26 7.25 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.756 0.422 . . . . 50.0 109.998 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -165.61 168.65 16.15 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.162 -0.336 . . . . 50.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -139.58 140.19 36.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 167.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -145.86 156.37 43.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.389 -0.369 . . . . 50.0 110.748 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -133.14 144.78 50.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.874 -0.603 . . . . 50.0 111.02 -167.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -137.12 165.53 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.325 -0.991 . . . . 50.0 108.325 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 28.2 pt -134.74 152.2 32.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.686 -1.227 . . . . 25.0 107.686 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 p -85.13 141.95 29.84 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -88.33 121.31 30.58 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 113.255 0.835 . . . . 25.0 113.255 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -86.5 150.78 24.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.443 -1.317 . . . . 25.0 107.443 169.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.29 64.1 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.072 1.589 . . . . 25.0 117.072 173.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -61.19 154.32 23.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.678 1.239 . . . . 50.0 110.735 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.63 154.43 44.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 50.0 109.907 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.62 -7.39 16.7 Favored 'Trans proline' 0 C--N 1.351 0.707 0 N-CA-C 116.084 1.532 . . . . 50.0 116.084 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.16 -8.1 55.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.141 0.972 . . . . 50.0 110.096 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -123.74 150.14 61.12 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.192 -0.67 . . . . 50.0 109.192 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.7 111.36 1.88 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 117.321 -1.319 . . . . 50.0 111.797 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.84 -44.06 66.48 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.226 -0.897 . . . . 50.0 113.23 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.68 -27.22 68.54 Favored 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.92 -41.78 50.79 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.337 0.589 . . . . 50.0 110.209 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.46 6.37 23.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.943 -1.026 . . . . 25.0 112.953 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.07 -38.83 82.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.848 0.684 . . . . 50.0 112.848 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -133.62 156.77 47.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.957 -0.464 . . . . 25.0 111.605 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -133.53 146.31 50.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.033 -0.728 . . . . 25.0 109.033 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.4 tp -77.59 127.18 32.07 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 50.0 109.277 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 tt -106.08 -3.37 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.693 0.759 . . . . 25.0 110.984 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.23 156.12 8.29 Favored Glycine 0 C--O 1.229 -0.175 0 C-N-CA 120.469 -0.872 . . . . 50.0 113.948 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.35 137.18 22.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.681 -1.229 . . . . 25.0 107.681 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.19 109.45 10.55 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.69 161.7 36.38 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 116.228 -2.048 . . . . 50.0 111.965 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -122.96 92.66 3.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.383 -0.969 . . . . 50.0 108.383 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -175.62 -94.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 N-CA-C 99.897 -4.112 . . . . 50.0 99.897 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -97.87 143.27 16.59 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 105.32 -3.112 . . . . 25.0 105.32 167.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.6 155.82 13.35 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.67 -167.3 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 O-C-N 122.265 0.613 . . . . 50.0 111.017 174.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.75 24.2 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.662 0.616 . . . . 25.0 112.662 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.8 1.07 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.927 1.454 . . . . 25.0 114.927 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -58.66 -13.84 6.91 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.421 1.267 . . . . 50.0 114.421 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -59.12 144.12 46.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.686 0.755 . . . . 50.0 112.714 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.6 tp -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.983 -1.008 . . . . 50.0 112.395 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.6 t -94.45 123.37 37.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.282 -1.007 . . . . 50.0 108.282 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -103.99 133.72 48.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 25.0 110.742 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -99.82 134.1 43.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 50.0 109.563 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.9 mt -132.95 119.67 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 87.9 t80 -85.82 138.01 32.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.785 -0.45 . . . . 50.0 109.785 173.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.45 124.87 26.21 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.46 153.57 50.02 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 116.381 -1.946 . . . . 25.0 111.403 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -108.1 51.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.66 1.219 . . . . 50.0 109.302 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -103.72 -6.2 21.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.639 -1.164 . . . . 50.0 111.2 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -161.0 157.74 26.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.283 0.563 . . . . 50.0 112.41 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -116.72 153.87 31.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.584 -0.735 . . . . 50.0 110.334 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 133.31 140.26 4.35 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 113.851 0.3 . . . . 25.0 113.851 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -85.83 145.95 26.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 116.272 1.953 . . . . 50.0 116.272 -173.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -149.55 167.05 27.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -98.06 150.51 4.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.894 0.854 . . . . 50.0 111.965 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.7 mt -106.94 131.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.311 -2.848 . . . . 25.0 103.311 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.0 mt -110.12 143.97 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.468 -1.679 . . . . 50.0 106.468 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.63 148.49 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.612 -0.885 . . . . 25.0 108.612 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.14 139.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.622 -0.717 . . . . 50.0 109.563 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -126.5 103.23 7.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.596 -0.89 . . . . 50.0 108.596 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -94.15 138.19 32.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.238 -0.289 . . . . 50.0 110.8 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.5 t -117.6 132.01 68.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.056 -1.461 . . . . 50.0 107.056 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.54 -41.42 46.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 25.0 110.524 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -10.92 60.37 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.12 1.896 . . . . 50.0 116.12 -170.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.8 p -126.37 158.25 36.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.966 -0.459 . . . . 25.0 110.519 -176.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -74.44 -10.17 59.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 50.0 111.588 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -103.76 158.67 16.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.412 0.625 . . . . 50.0 110.451 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.83 162.92 34.2 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.465 -3.161 . . . . 25.0 102.465 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.31 150.59 45.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.516 0.562 . . . . 50.0 112.516 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.65 153.92 41.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.29 -1.374 . . . . 50.0 107.29 174.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.95 154.21 41.67 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.334 -1.358 . . . . 50.0 107.334 176.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.83 141.86 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.886 0.374 . . . . 50.0 110.324 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 62.9 mt -133.58 122.6 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.28 -1.378 . . . . 25.0 107.28 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -87.81 131.6 34.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.549 -1.649 . . . . 25.0 106.549 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.38 132.59 70.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.827 -0.805 . . . . 25.0 108.827 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.9 95.76 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 104.929 -2.248 . . . . 50.0 104.929 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.58 121.8 32.12 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.254 -1.758 . . . . 50.0 106.254 -173.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.0 m -135.19 166.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 123.231 0.332 . . . . 50.0 111.448 -175.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.38 141.11 28.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.249 -1.389 . . . . 50.0 107.249 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.8 tptt . . . . . 0 C--O 1.246 0.917 0 N-CA-C 115.564 1.69 . . . . 50.0 115.564 177.38 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 112.149 0.426 . . . . 25.0 112.149 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.24 -153.37 27.23 Favored Glycine 0 C--O 1.241 0.555 0 N-CA-C 117.364 1.706 . . . . 25.0 117.364 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -128.02 153.0 47.26 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.602 0.761 . . . . 25.0 111.956 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 93.7 mt -93.83 119.34 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 103.665 -2.717 . . . . 25.0 103.665 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -90.08 -43.33 10.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.535 -0.543 . . . . 50.0 109.535 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -138.79 149.68 62.9 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 109.8 1.48 Allowed 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 132.306 2.211 . . . . 25.0 115.299 -1.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.38 -176.76 26.81 Favored Glycine 0 C--O 1.226 -0.405 0 N-CA-C 114.631 0.612 . . . . 50.0 114.631 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.483 ' HG ' ' H ' ' A' ' 11' ' ' ALA . 45.7 t -82.97 134.77 35.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.485 -0.421 . . . . 25.0 111.065 -179.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -78.11 -26.32 47.94 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.919 0.39 . . . . 50.0 111.051 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.483 ' H ' ' HG ' ' A' ' 9' ' ' SER . . . -72.91 -33.34 65.92 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.873 0.694 . . . . 25.0 112.873 -172.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.07 71.9 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 120.785 0.326 . . . . 25.0 111.184 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.47 -4.38 55.6 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.054 -0.521 . . . . 50.0 111.743 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.93 -33.04 24.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 50.0 111.577 -175.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -71.6 153.85 41.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.014 0.746 . . . . 50.0 113.014 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.04 -31.49 67.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.629 -0.714 . . . . 50.0 110.679 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.17 -29.23 65.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.468 0.544 . . . . 25.0 112.468 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -83.28 -13.26 55.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.066 0.395 . . . . 50.0 112.066 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.99 -6.28 26.32 Favored Glycine 0 CA--C 1.513 -0.086 0 N-CA-C 111.411 -0.675 . . . . 50.0 111.411 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.6 t80 63.69 -46.66 0.26 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.448 1.899 . . . . 50.0 115.528 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -103.89 -22.15 13.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.768 0.655 . . . . 25.0 112.768 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -151.91 159.8 43.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.559 0.219 . . . . 25.0 111.173 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -81.32 156.95 25.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.495 . . . . 50.0 109.752 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.84 59.38 0.99 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.956 -1.498 . . . . 50.0 106.956 176.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.21 -36.63 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.227 1.195 . . . . 50.0 114.227 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.95 -154.44 51.18 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.158 -1.177 . . . . 50.0 110.158 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.3 t -61.2 -13.86 21.23 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.334 1.235 . . . . 25.0 114.334 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.2 t -62.54 -20.99 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.868 -0.52 . . . . 50.0 110.36 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -63.94 -11.06 24.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -79.04 -35.98 41.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.659 -0.496 . . . . 50.0 109.659 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.66 79.25 9.56 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 175.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.53 -15.89 46.01 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 115.938 -2.241 . . . . 50.0 112.44 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -85.4 -22.08 28.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.718 -0.658 . . . . 50.0 112.437 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -132.99 94.02 3.29 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 114.732 1.382 . . . . 75.0 114.732 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.15 114.79 28.82 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.165 -1.05 . . . . 50.0 108.165 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -114.5 142.21 46.7 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.427 0.454 . . . . 50.0 110.358 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 104.16 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.475 -0.565 . . . . 25.0 109.475 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.0 -72.28 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.969 0.89 . . . . 50.0 112.933 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -112.27 -163.99 0.89 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 106.558 -1.645 . . . . 50.0 106.558 -176.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.8 53.09 0.67 Allowed Glycine 0 C--O 1.218 -0.888 0 C-N-CA 121.277 -0.487 . . . . 25.0 111.946 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -89.97 138.36 27.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.58 -0.896 . . . . 25.0 108.58 177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.21 128.13 15.41 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 128.957 0.815 . . . . 25.0 112.346 -3.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -67.91 -36.25 79.85 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.561 -0.456 . . . . 25.0 110.693 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m 64.25 -38.32 0.21 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.636 2.088 . . . . 25.0 116.636 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.19 -155.06 28.73 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.654 -0.578 . . . . 50.0 111.654 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.26 161.46 40.36 Favored 'Trans proline' 0 C--N 1.346 0.437 0 CA-C-N 118.668 1.234 . . . . 25.0 114.181 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.58 13.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.081 -0.963 . . . . 25.0 112.451 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.62 134.55 56.51 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.025 -1.102 . . . . 25.0 108.025 173.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.11 6.99 35.2 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.347 -0.454 . . . . 25.0 113.476 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 57.7 20.78 6.68 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.259 1.024 . . . . 25.0 113.438 -176.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.6 mt -50.87 -37.92 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 114.338 1.236 . . . . 25.0 114.338 -171.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.62 -45.44 89.21 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.257 1.206 . . . . 25.0 114.257 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 m -120.47 -20.86 7.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 117.006 2.224 . . . . 25.0 117.006 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.01 19.87 0.52 Allowed 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 115.281 1.586 . . . . 25.0 115.281 -171.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -108.99 -25.8 5.49 Favored Glycine 0 C--O 1.221 -0.682 0 O-C-N 122.221 -0.3 . . . . 25.0 113.362 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.87 -6.08 42.61 Favored Glycine 0 C--O 1.221 -0.687 0 O-C-N 122.45 -0.441 . . . . 50.0 113.833 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.2 mt -61.89 -23.28 66.21 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 112.585 0.587 . . . . 25.0 112.585 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -71.06 -13.12 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.205 -0.309 . . . . 25.0 111.692 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.25 -16.65 60.53 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.114 0.805 . . . . 50.0 115.114 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.3 -26.14 69.12 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-N 118.121 0.961 . . . . 50.0 112.389 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.2 mm -68.03 -33.91 63.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.112 -0.64 . . . . 50.0 110.007 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -77.53 -19.3 55.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.206 -0.309 . . . . 50.0 111.256 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.96 -21.56 64.91 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.625 0.602 . . . . 50.0 112.625 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -56.03 -21.4 21.36 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.678 0.622 . . . . 25.0 112.678 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -138.75 51.73 1.81 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.174 0.511 . . . . 25.0 109.751 177.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 t -118.78 162.83 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 25.0 111.255 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.87 -32.48 74.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.827 0.822 . . . . 50.0 110.283 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -94.48 16.43 15.34 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.659 -0.701 . . . . 50.0 112.633 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -61.07 150.25 34.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.961 -1.496 . . . . 50.0 106.961 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -97.02 156.4 16.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.042 -1.096 . . . . 50.0 108.042 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.06 121.93 3.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -76.24 108.08 8.92 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.799 -0.445 . . . . 25.0 109.799 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 105.93 16.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.362 0.601 . . . . 25.0 112.117 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -64.18 142.86 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.028 -0.731 . . . . 25.0 109.028 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 tpt -146.82 151.87 37.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.849 -1.167 . . . . 50.0 107.849 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -101.95 171.99 7.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.455 -1.313 . . . . 25.0 107.455 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.08 177.57 19.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.81 0.684 . . . . 25.0 114.81 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.16 177.1 31.79 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 112.399 -0.281 . . . . 50.0 112.399 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -92.06 132.73 36.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.942 -0.74 . . . . 25.0 109.733 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -135.33 141.78 45.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.888 0.375 . . . . 50.0 110.448 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.9 m -84.34 118.75 24.42 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -93.03 111.92 23.71 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.443 -2.058 . . . . 50.0 105.443 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -90.67 118.74 30.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.93 -0.577 . . . . 25.0 111.192 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -122.92 139.49 53.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.757 -2.312 . . . . 50.0 104.757 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -145.01 161.84 38.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 25.0 111.95 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.87 136.87 52.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.076 -2.564 . . . . 25.0 104.076 173.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.7 t -72.82 -15.91 61.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.382 0.882 . . . . 25.0 113.382 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 153.81 67.74 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 104.752 -2.314 . . . . 25.0 104.752 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 130.73 25.24 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 115.525 -2.517 . . . . 25.0 111.574 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -130.93 153.34 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.02 -1.104 . . . . 50.0 108.02 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -65.08 143.2 58.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.563 -1.643 . . . . 50.0 106.563 171.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -144.78 147.26 32.69 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.378 -2.453 . . . . 25.0 104.378 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -116.99 -47.15 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.099 0.777 . . . . 50.0 113.099 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -159.12 153.29 23.7 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.518 -0.739 . . . . 50.0 112.388 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.39 132.34 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.161 0.505 . . . . 25.0 109.73 167.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -136.89 142.57 42.75 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.864 -1.532 . . . . 50.0 106.864 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.85 151.52 39.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.774 0.797 . . . . 50.0 111.614 -166.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.48 168.94 18.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.61 -1.177 . . . . 50.0 109.064 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.78 149.11 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.115 -0.328 . . . . 25.0 110.115 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.5 m -88.5 117.19 27.28 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.192 -0.458 . . . . 25.0 110.025 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.18 125.16 34.47 Favored 'General case' 0 C--O 1.209 -1.057 0 O-C-N 121.334 -0.854 . . . . 25.0 110.949 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -76.86 154.08 34.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 106.531 -1.655 . . . . 25.0 106.531 168.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.01 10.21 56.45 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 119.349 2.499 . . . . 25.0 119.349 170.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -61.02 153.33 25.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.958 1.379 . . . . 50.0 110.699 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.51 152.05 95.46 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.337 -1.357 . . . . 50.0 107.337 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 -19.8 47.3 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 117.646 -1.102 . . . . 50.0 114.868 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.18 -18.62 62.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.822 0.82 . . . . 50.0 111.67 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -96.13 128.86 35.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.483 -0.761 . . . . 50.0 109.866 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.14 126.28 16.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.588 -1.141 . . . . 50.0 114.223 -173.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.12 -42.94 66.51 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.525 -1.216 . . . . 50.0 113.213 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -69.01 -17.35 63.9 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 113.046 0.758 . . . . 25.0 113.046 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -77.15 -45.63 26.12 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 109.335 -0.617 . . . . 50.0 109.335 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.64 67.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.364 0.602 . . . . 25.0 112.216 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -71.04 -29.03 64.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 50.0 110.538 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.46 92.12 3.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.259 0.552 . . . . 25.0 109.712 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -99.75 110.13 22.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -62.82 117.25 6.09 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.857 -0.423 . . . . 50.0 109.857 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -2.53 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 107.382 -1.34 . . . . 25.0 107.382 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.22 151.05 6.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.778 . . . . 50.0 114.639 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -143.04 122.66 13.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.057 -1.831 . . . . 25.0 106.057 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.09 117.95 11.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.35 175.38 11.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 115.962 -2.225 . . . . 50.0 110.259 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -128.56 92.36 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.253 -2.128 . . . . 50.0 105.253 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.0 -19.94 13.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.681 -1.6 . . . . 50.0 107.711 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.76 -179.35 30.78 Favored Glycine 0 N--CA 1.445 -0.764 1 N-CA-C 103.013 -4.035 . . . . 25.0 103.013 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -116.65 36.75 0.22 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 117.16 2.281 . . . . 25.0 117.16 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.88 170.57 18.5 Favored 'Trans proline' 0 C--N 1.355 0.876 1 C-N-CA 113.225 -4.05 . . . . 50.0 110.333 171.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.11 55.43 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.294 1.22 . . . . 25.0 114.294 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.8 p -70.51 -19.81 62.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.1 mmt-85 -100.96 10.72 40.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.274 0.63 . . . . 50.0 112.478 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -58.05 156.8 8.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.028 1.862 . . . . 50.0 116.028 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.73 -22.4 59.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.344 -1.298 . . . . 50.0 111.662 176.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 65.1 m -100.04 140.55 34.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.55 -1.278 . . . . 50.0 107.55 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -129.57 136.86 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.339 0.866 . . . . 25.0 113.339 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -79.37 126.8 31.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.543 -1.651 . . . . 50.0 106.543 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -131.91 125.81 55.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.705 -1.221 . . . . 25.0 107.705 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -85.85 133.33 33.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.791 -0.818 . . . . 50.0 108.791 174.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -108.84 129.67 23.65 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.844 -1.539 . . . . 25.0 106.844 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -66.27 146.58 81.47 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 117.127 -1.449 . . . . 25.0 111.92 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -110.57 -12.54 14.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.055 0.931 . . . . 50.0 110.857 -173.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.0 4.22 45.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.839 1.052 . . . . 50.0 113.839 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -151.78 151.65 31.65 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 121.844 -0.535 . . . . 50.0 112.145 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.32 141.57 47.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.286 -0.87 . . . . 50.0 109.49 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.74 163.49 10.49 Favored Glycine 0 CA--C 1.517 0.178 0 N-CA-C 115.11 0.804 . . . . 25.0 115.11 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -86.92 145.04 26.69 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.504 0.927 . . . . 50.0 113.504 -176.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -144.5 159.09 43.35 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 105.861 -1.904 . . . . 25.0 105.861 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.83 136.31 50.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 106.894 -1.521 . . . . 50.0 106.894 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.7 mt -96.04 120.16 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.155 -2.535 . . . . 25.0 104.155 174.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.5 mt -105.5 137.48 43.26 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.933 -1.136 . . . . 50.0 107.933 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.31 146.64 32.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.101 0.864 . . . . 25.0 112.321 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.03 135.43 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.64 -1.615 . . . . 50.0 106.64 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -130.06 117.45 20.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.606 0.717 . . . . 50.0 110.01 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.7 132.0 38.49 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.865 -1.061 . . . . 50.0 109.998 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.0 t -135.18 134.74 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.732 -1.951 . . . . 50.0 105.732 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.0 -10.04 19.29 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.204 1.557 . . . . 25.0 115.204 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 41.9 p-10 -102.29 18.22 21.52 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 50.0 110.457 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.2 p -133.0 151.16 52.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -70.22 -18.13 63.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.665 0.269 . . . . 50.0 111.656 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.16 171.93 7.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.061 -0.518 . . . . 50.0 111.87 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 159.53 26.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.683 -1.969 . . . . 25.0 105.683 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -111.35 145.59 38.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.302 1.223 . . . . 50.0 114.302 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -123.5 139.7 53.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.204 -0.907 . . . . 50.0 108.734 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -149.57 142.1 24.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.417 -1.327 . . . . 50.0 107.417 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 m -135.59 151.06 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.305 -1.369 . . . . 50.0 107.305 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.08 110.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.006 -1.479 . . . . 25.0 107.006 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -77.53 131.74 38.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.321 -1.733 . . . . 25.0 106.321 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.0 157.93 41.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.789 -0.569 . . . . 25.0 110.605 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -123.58 108.29 12.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.344 -1.724 . . . . 50.0 106.344 176.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.77 103.99 16.0 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.81 -1.552 . . . . 50.0 106.81 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.45 171.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.825 0.345 . . . . 50.0 111.319 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.02 152.67 32.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.9 -1.148 . . . . 50.0 107.9 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.896 0 CA-C-O 117.844 -1.074 . . . . 50.0 109.599 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 112.374 0.509 . . . . 25.0 112.374 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.42 -156.75 48.79 Favored Glycine 0 C--O 1.227 -0.285 0 C-N-CA 119.731 -1.223 . . . . 25.0 110.559 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.08 133.24 36.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.995 0.398 . . . . 25.0 110.347 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.68 112.32 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 106.498 -1.668 . . . . 25.0 106.498 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.61 -43.5 10.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.95 -0.568 . . . . 50.0 110.798 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -140.55 158.09 66.71 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 107.862 -1.162 . . . . 25.0 107.862 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.14 116.57 4.53 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 131.672 1.947 . . . . 25.0 113.955 -2.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.23 -149.48 45.27 Favored Glycine 0 C--O 1.226 -0.367 0 N-CA-C 110.201 -1.16 . . . . 50.0 110.201 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -131.43 110.77 11.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.239 0.542 . . . . 25.0 110.553 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -20.73 65.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.994 -0.548 . . . . 50.0 111.004 176.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -24.13 67.7 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.104 0.253 . . . . 25.0 111.577 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.65 93.89 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 120.852 -0.339 . . . . 25.0 110.281 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.53 -16.8 61.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.269 0.557 . . . . 50.0 111.147 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 t -83.49 -20.44 33.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.547 -0.751 . . . . 50.0 110.099 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.3 p -96.21 157.25 15.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.976 -0.556 . . . . 50.0 111.282 -177.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.29 -16.23 64.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.225 -0.443 . . . . 50.0 111.318 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.45 -13.47 30.38 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.184 0.438 . . . . 25.0 112.184 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -83.28 2.22 37.07 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.429 0.9 . . . . 50.0 113.429 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.81 -29.38 0.17 Allowed Glycine 0 C--O 1.224 -0.503 0 N-CA-C 116.317 1.287 . . . . 50.0 116.317 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.76 4.16 0.73 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.34 1.978 . . . . 50.0 116.34 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.19 -30.74 38.8 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.761 -0.587 . . . . 25.0 110.459 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -169.0 157.21 7.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.423 -1.695 . . . . 25.0 106.423 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.08 144.4 40.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.307 -1.738 . . . . 50.0 106.307 170.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.26 63.33 0.49 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.712 -1.218 . . . . 50.0 107.712 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.5 t -92.33 -10.34 38.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.247 0.546 . . . . 50.0 111.314 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.83 -160.66 53.94 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.733 -1.347 . . . . 50.0 109.733 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -64.9 -13.86 58.01 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.614 0.598 . . . . 25.0 112.614 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 t -58.09 -23.73 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.482 0.549 . . . . 50.0 112.482 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -70.34 -27.95 64.76 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.763 -0.586 . . . . 25.0 112.542 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.17 -16.28 25.03 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.378 1.085 . . . . 50.0 108.541 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.66 60.09 0.84 Allowed Pre-proline 0 C--O 1.245 0.86 0 CA-C-N 115.176 -0.92 . . . . 25.0 111.733 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.71 -39.86 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 113.558 -3.828 . . . . 50.0 114.348 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -104.24 -23.44 13.24 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.476 1.288 . . . . 50.0 114.476 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.49 114.16 21.86 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 104.567 -2.383 . . . . 75.0 104.567 173.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -133.38 105.05 6.72 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 106.487 -1.671 . . . . 50.0 106.487 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -128.62 141.01 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.22 0.533 . . . . 50.0 112.18 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.07 102.86 5.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -170.94 -168.42 0.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.037 -2.208 . . . . 50.0 105.037 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.58 122.21 23.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.663 0.986 . . . . 50.0 113.663 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.63 156.68 15.42 Favored Glycine 0 C--N 1.322 -0.198 0 N-CA-C 104.026 -3.629 . . . . 25.0 104.026 164.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -112.08 125.78 29.59 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 118.749 1.274 . . . . 25.0 111.061 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.1 149.99 92.66 Favored 'Cis proline' 0 C--N 1.353 0.785 0 C-N-CA 130.461 1.442 . . . . 25.0 110.983 -3.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -68.72 -47.41 66.41 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 -172.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.6 t 61.31 -62.98 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.415 2.006 . . . . 25.0 116.415 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.15 -179.18 29.51 Favored Glycine 0 C--O 1.242 0.599 0 N-CA-C 116.015 1.166 . . . . 50.0 116.015 -175.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.68 170.29 16.83 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.261 2.64 . . . . 25.0 113.758 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.99 132.66 47.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.541 0.571 . . . . 25.0 112.541 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.12 125.22 24.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.047 -0.723 . . . . 25.0 109.047 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.22 9.51 42.48 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.175 -0.535 . . . . 25.0 111.885 -176.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 55.96 19.21 3.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.713 1.205 . . . . 25.0 112.68 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.3 -44.84 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.62 -26.7 68.51 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.419 1.266 . . . . 25.0 114.419 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -112.95 -21.11 11.29 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.79 0.663 . . . . 25.0 112.79 -178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 48.19 26.62 1.09 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.719 1.378 . . . . 25.0 114.719 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.95 -41.28 1.2 Allowed Glycine 0 C--O 1.221 -0.69 0 C-N-CA 121.306 -0.473 . . . . 25.0 113.485 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.46 18.38 33.78 Favored Glycine 0 C--O 1.221 -0.709 0 N-CA-C 115.079 0.791 . . . . 50.0 115.079 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -59.84 -35.94 75.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.573 0.953 . . . . 25.0 113.573 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -65.03 -11.82 43.54 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.841 0.682 . . . . 25.0 112.841 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.94 48.34 Favored Glycine 0 C--O 1.22 -0.74 0 CA-C-O 119.713 -0.493 . . . . 50.0 113.663 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.55 -22.9 73.56 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 117.962 0.881 . . . . 50.0 112.673 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -86.31 -36.98 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.325 -0.991 . . . . 50.0 108.325 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.31 -10.86 60.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 50.0 111.9 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -30.57 64.55 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 111.654 0.242 . . . . 50.0 111.654 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.92 -8.64 11.84 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.259 1.207 . . . . 25.0 114.259 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -127.8 24.25 6.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.418 0.628 . . . . 25.0 109.867 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 t -98.5 164.96 12.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.244 -0.435 . . . . 25.0 110.983 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.67 -33.38 74.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.61 0.719 . . . . 50.0 109.148 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -94.89 19.03 10.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.002 -0.545 . . . . 50.0 112.053 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -47.63 136.37 10.41 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.345 0.869 . . . . 50.0 113.345 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -89.68 159.06 17.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.788 . . . . 50.0 109.227 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -65.52 132.91 50.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -80.78 143.24 33.01 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.47 -0.787 . . . . 25.0 109.717 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 96.57 4.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.898 0.703 . . . . 25.0 112.898 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -69.25 138.43 22.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.152 -2.536 . . . . 25.0 104.152 168.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.5 tpt -145.42 146.55 31.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.23 -0.655 . . . . 50.0 109.23 -176.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p -95.0 172.04 8.39 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.81 -174.97 5.48 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 116.648 1.419 . . . . 25.0 116.648 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.84 177.08 35.18 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 115.035 -0.583 . . . . 50.0 113.031 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.97 132.63 34.17 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.034 -0.686 . . . . 25.0 110.86 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -132.61 137.92 47.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 50.0 109.515 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 m -101.97 137.49 40.19 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.596 0.961 . . . . 25.0 113.596 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.29 129.73 55.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.901 -1.518 . . . . 50.0 106.901 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -137.77 129.56 28.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.993 -0.373 . . . . 25.0 109.993 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -124.01 143.36 50.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.035 -1.839 . . . . 50.0 106.035 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -145.01 156.92 44.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.7 0.286 . . . . 25.0 111.168 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -139.78 163.98 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -71.28 -19.38 62.35 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.501 0.926 . . . . 25.0 113.501 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.77 147.34 48.11 Favored Pre-proline 0 C--O 1.238 0.468 0 O-C-N 121.943 -0.473 . . . . 25.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.86 149.71 37.79 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 117.689 -1.074 . . . . 25.0 111.734 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -130.94 161.65 31.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 50.0 109.199 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -65.86 131.09 45.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.563 -1.273 . . . . 50.0 107.563 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.4 p -143.63 152.22 41.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.256 -1.387 . . . . 25.0 107.256 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.2 t -103.3 -56.84 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.494 0.924 . . . . 50.0 113.494 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -159.01 150.43 20.45 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.849 -0.532 . . . . 50.0 110.644 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 131.12 52.4 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.008 -1.478 . . . . 25.0 107.008 169.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -147.84 158.96 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.528 -0.305 . . . . 50.0 110.729 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -145.32 150.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.705 0.764 . . . . 50.0 112.239 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -128.36 154.8 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.606 -1.179 . . . . 50.0 108.12 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.01 149.36 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.907 0.706 . . . . 25.0 112.907 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.1 m -86.79 121.82 29.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -108.05 125.53 51.67 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 121.74 -0.6 . . . . 25.0 111.759 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -75.9 148.29 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.202 -1.777 . . . . 25.0 106.202 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.58 9.91 34.47 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 117.229 1.652 . . . . 25.0 117.229 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -83.05 161.5 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.615 1.208 . . . . 50.0 110.56 175.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.63 140.35 78.38 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.048 -0.723 . . . . 50.0 109.048 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.26 -13.51 20.87 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 114.492 0.92 . . . . 50.0 114.492 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.44 -13.97 61.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.114 0.959 . . . . 50.0 111.621 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.22 148.21 52.47 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.102 -1.814 . . . . 50.0 106.102 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.96 93.82 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-O 121.55 0.562 . . . . 50.0 112.717 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -36.35 61.13 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 114.367 1.247 . . . . 50.0 114.367 -174.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -61.39 -28.04 68.96 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.186 -0.606 . . . . 25.0 112.305 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -84.65 -46.02 11.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.043 0.449 . . . . 50.0 110.946 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.38 57.54 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 115.705 1.743 . . . . 25.0 115.705 -169.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 42.7 t0 -64.99 -30.71 71.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 50.0 111.335 -172.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -126.15 108.88 11.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.787 -0.82 . . . . 25.0 108.787 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -103.1 132.19 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.525 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.51 127.94 33.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.037 -0.727 . . . . 50.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.92 0.74 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.944 0.878 . . . . 25.0 110.031 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.46 140.8 4.72 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.363 -0.922 . . . . 50.0 112.863 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 132.86 15.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.67 109.6 12.14 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.069 -1.086 . . . . 25.0 108.069 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.0 164.69 22.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.482 -1.879 . . . . 50.0 111.72 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -103.84 106.86 17.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.025 -1.472 . . . . 50.0 107.025 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -114.53 -22.7 9.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.578 -1.192 . . . . 50.0 109.515 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -173.86 -161.58 24.19 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 103.78 -3.728 . . . . 25.0 103.78 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.3 t -123.7 50.44 3.36 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.301 1.593 . . . . 25.0 115.301 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.77 170.55 17.52 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 114.047 -3.502 . . . . 50.0 109.769 170.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.62 58.67 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.077 1.14 . . . . 25.0 114.077 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 53.3 p -70.87 -16.0 62.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.892 0.701 . . . . 25.0 112.892 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -99.16 7.01 46.19 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.742 0.275 . . . . 50.0 111.742 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -61.19 152.29 29.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.885 -1.154 . . . . 50.0 107.885 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -11.49 60.77 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.618 0.599 . . . . 50.0 112.618 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.2 t -90.98 124.47 35.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 50.0 108.059 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -128.86 140.39 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.049 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -100.83 137.22 39.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.235 -1.024 . . . . 50.0 108.235 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.3 mm -130.85 123.74 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -93.35 134.34 35.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.649 -0.5 . . . . 50.0 109.649 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.72 129.86 23.45 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.7 150.0 73.91 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 117.951 -0.9 . . . . 25.0 112.275 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.36 -4.93 11.3 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 122.115 0.96 . . . . 50.0 110.663 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.87 6.61 27.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.698 -0.683 . . . . 50.0 112.796 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -155.95 170.09 22.93 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.991 -0.443 . . . . 50.0 111.852 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.82 153.56 45.47 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 105.766 -1.939 . . . . 50.0 105.766 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 153.02 144.87 4.01 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-O 122.075 0.819 . . . . 25.0 115.091 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.8 p90 -81.48 146.12 30.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.439 -0.88 . . . . 50.0 112.425 -177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -146.33 158.95 43.94 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 105.512 -2.033 . . . . 25.0 105.512 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.6 t -121.36 130.26 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.05 -2.574 . . . . 50.0 104.05 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.48 119.34 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.204 -1.036 . . . . 25.0 108.204 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.48 131.43 54.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.419 -1.697 . . . . 50.0 106.419 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.49 133.82 45.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.2 t -129.01 132.92 66.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 50.0 109.246 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -119.47 108.31 14.39 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.447 -1.686 . . . . 50.0 106.447 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.29 132.0 34.06 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.872 -1.058 . . . . 50.0 111.259 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.28 129.5 66.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.559 -2.015 . . . . 50.0 105.559 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.94 -28.3 63.37 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 -167.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -110.0 22.66 15.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.929 1.085 . . . . 50.0 113.929 -172.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.6 p -137.98 153.1 49.46 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.867 0.365 . . . . 25.0 111.685 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -78.8 -7.81 58.19 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.601 0.715 . . . . 50.0 110.333 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -110.11 161.31 15.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.02 -0.991 . . . . 50.0 109.081 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.11 39.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.785 -2.302 . . . . 25.0 104.785 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -90.86 131.25 36.61 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.836 -1.172 . . . . 50.0 107.836 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -128.73 134.47 48.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.149 -0.478 . . . . 50.0 110.216 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.97 140.15 26.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.36 -1.348 . . . . 50.0 107.36 176.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.02 139.82 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.79 -1.559 . . . . 50.0 106.79 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.9 mt -135.31 118.55 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -80.16 131.42 35.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.96 -1.866 . . . . 25.0 105.96 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.12 162.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.345 0.593 . . . . 25.0 111.767 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -129.58 120.99 26.22 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.242 -2.873 . . . . 50.0 103.242 170.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.74 111.41 24.12 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.858 -1.534 . . . . 50.0 106.858 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.75 166.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 114.48 1.289 . . . . 50.0 114.48 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -72.08 154.35 41.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.085 -1.45 . . . . 50.0 107.085 173.293 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.659 0 CA-C-O 118.255 -0.879 . . . . 50.0 110.106 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . 0.641 ' N ' ' HG ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--O 1.24 0.479 0 N-CA-C 108.905 -1.678 . . . . 25.0 108.905 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.31 166.08 34.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.953 0.877 . . . . 25.0 112.696 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.65 122.08 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.752 -1.573 . . . . 25.0 106.752 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -85.75 -42.54 14.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.233 -0.44 . . . . 25.0 111.024 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -143.23 158.6 57.87 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.53 116.13 3.93 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 131.403 1.835 . . . . 25.0 116.823 2.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.2 148.64 7.12 Favored Glycine 0 C--O 1.221 -0.682 0 CA-C-N 114.947 -1.024 . . . . 25.0 113.039 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -94.13 119.87 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.514 . . . . 25.0 109.611 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -21.18 64.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.436 -0.347 . . . . 25.0 111.481 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.38 72.39 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.031 0.382 . . . . 25.0 112.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.59 -27.57 69.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.985 0.422 . . . . 25.0 111.075 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 mt -94.69 -4.09 48.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 25.0 110.901 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.6 t . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.849 -0.614 . . . . 25.0 109.478 -177.192 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 121.674 0.75 . . . . 25.0 111.112 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -15.23 61.96 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.92 1.452 . . . . 25.0 114.92 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -76.19 -30.17 57.94 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.745 1.017 . . . . 25.0 113.745 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.98 44.75 0.46 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 116.805 2.15 . . . . 25.0 116.805 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.06 -22.58 25.99 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 114.543 -3.171 . . . . 25.0 113.786 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -83.68 -34.85 24.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.177 0.513 . . . . 25.0 109.896 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.641 ' HG ' ' N ' ' A' ' 2' ' ' GLY . 60.7 m -111.39 69.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.645 -0.422 . . . . 25.0 111.645 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 tp -81.85 123.34 28.73 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 104.979 -2.23 . . . . 25.0 104.979 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -83.95 132.2 34.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.335 . . . . 25.0 110.868 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.64 28.65 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.82 -1.178 . . . . 25.0 107.82 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 109.855 -0.424 . . . . 25.0 109.855 -173.107 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -1.011 0 N-CA-C 111.366 -0.693 . . . . 25.0 111.366 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.6 -48.18 73.18 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.174 -0.603 . . . . 25.0 110.98 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -73.68 -22.24 60.0 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.781 -0.575 . . . . 25.0 109.494 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -20.64 74.93 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 121.059 -0.591 . . . . 25.0 111.883 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.25 -21.35 70.11 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-N 117.786 0.793 . . . . 25.0 112.409 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.79 -39.17 77.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.343 -0.984 . . . . 25.0 108.343 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.57 -25.78 45.43 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.029 -0.532 . . . . 25.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -67.74 -27.32 66.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.789 0.804 . . . . 25.0 109.852 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -73.1 2.28 7.45 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.847 -0.533 . . . . 25.0 111.534 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -129.61 18.58 5.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.197 0.599 . . . . 25.0 110.036 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.7 t -86.18 156.13 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 25.0 111.897 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -66.75 -31.46 72.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.642 0.734 . . . . 25.0 109.057 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -88.07 1.9 53.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 25.0 112.658 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -56.87 134.95 55.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.39 165.79 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.666 0.746 . . . . 25.0 109.969 -174.028 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -79.56 106.13 11.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.088 0.47 . . . . 25.0 110.561 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -65.22 146.8 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.93 -1.106 . . . . 25.0 111.133 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.91 130.06 55.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 25.0 110.906 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.2 135.63 24.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.701 -0.681 . . . . 25.0 109.677 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.1 mtp -134.19 142.27 47.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.626 -1.25 . . . . 25.0 107.626 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -89.47 172.96 8.62 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.09 -177.4 6.1 Favored Glycine 0 C--O 1.24 0.531 0 N-CA-C 115.801 1.08 . . . . 25.0 115.801 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.63 -178.72 36.78 Favored Glycine 0 CA--C 1.517 0.181 0 N-CA-C 110.833 -0.907 . . . . 25.0 110.833 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 147.04 34.84 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.452 -1.028 . . . . 25.0 108.596 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -141.86 153.82 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.9 m -117.03 128.26 54.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.303 -0.408 . . . . 25.0 110.241 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -104.11 136.14 44.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.38 0.672 . . . . 25.0 109.285 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.1 m -132.59 130.01 39.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -122.05 152.6 39.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.698 -1.593 . . . . 25.0 106.698 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -143.47 153.17 42.35 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.762 -1.199 . . . . 25.0 107.762 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -121.64 138.49 54.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.742 0.306 . . . . 25.0 110.746 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -92.71 0.41 57.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 25.0 110.526 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.41 129.82 41.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.109 -0.7 . . . . 25.0 109.109 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.11 1.3 9.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 O-C-N 121.983 0.464 . . . . 25.0 112.98 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -73.73 149.36 41.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 25.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.14 155.81 39.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 25.0 112.19 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.2 m -123.48 130.32 52.52 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -90.76 -43.8 9.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 25.0 111.654 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -160.9 152.48 19.41 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 110.259 -0.275 . . . . 25.0 110.259 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -147.32 144.05 28.49 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 25.0 109.132 169.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -152.73 156.71 39.65 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.17 -0.307 . . . . 25.0 110.17 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -149.69 152.97 36.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.116 0.784 . . . . 25.0 113.116 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -134.38 167.43 20.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 pt -133.14 152.22 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.5 p -89.87 145.75 24.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 112.472 0.545 . . . . 25.0 112.472 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -117.49 115.26 24.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.836 0.827 . . . . 25.0 109.966 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -76.23 146.9 38.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.279 -1.748 . . . . 25.0 106.279 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.68 18.47 9.48 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 120.608 -0.806 . . . . 25.0 114.46 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -58.62 149.15 26.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.365 0.582 . . . . 25.0 111.105 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -76.13 146.77 79.04 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 107.472 -1.307 . . . . 25.0 107.472 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.79 -19.97 26.77 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 117.288 -1.341 . . . . 25.0 112.896 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.78 -22.59 61.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.816 0.817 . . . . 25.0 111.756 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -95.92 146.41 31.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.94 -0.475 . . . . 25.0 110.091 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.39 111.52 2.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 117.377 -1.282 . . . . 25.0 113.091 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -38.59 63.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.398 0.679 . . . . 25.0 112.741 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -54.57 -33.03 59.59 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -92.73 -45.06 8.22 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.496 0.554 . . . . 25.0 112.496 175.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.96 -17.19 64.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.67 -39.64 84.5 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.175 1.176 . . . . 25.0 114.175 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.47 155.08 49.19 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 114.231 1.197 . . . . 25.0 114.231 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -129.29 147.0 51.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.97 0.508 . . . . 25.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.5 tp -78.26 128.69 34.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.092 -0.336 . . . . 25.0 110.092 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.0 pt -119.85 1.93 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.95 0.405 . . . . 25.0 111.53 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.64 141.08 3.32 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.179 -1.01 . . . . 25.0 114.513 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.4 131.17 24.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.91 94.88 23.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.206 0.526 . . . . 25.0 110.126 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.17 162.98 37.64 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 116.235 -2.043 . . . . 25.0 110.733 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -103.17 115.67 31.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -127.42 -97.81 0.4 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.498 -1.668 . . . . 25.0 106.498 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -159.35 -167.06 19.49 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.161 -0.776 . . . . 25.0 111.161 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 p 61.41 169.71 0.08 OUTLIER Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 124.365 1.066 . . . . 25.0 111.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.36 -4.47 15.47 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 113.18 -4.08 . . . . 25.0 114.729 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.07 69.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.083 -0.508 . . . . 25.0 109.994 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.0 t -76.62 -20.43 56.74 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.564 0.697 . . . . 25.0 110.544 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -67.27 -16.79 64.49 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.828 -0.624 . . . . 25.0 111.635 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -71.86 105.02 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.205 0.526 . . . . 25.0 111.992 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.48 -21.24 28.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.944 -0.571 . . . . 25.0 109.726 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.1 t -95.28 138.54 32.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.929 -0.397 . . . . 25.0 109.929 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -141.7 151.15 42.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.279 -0.419 . . . . 25.0 111.925 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -101.35 133.83 45.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.818 -0.628 . . . . 25.0 109.948 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.0 mm -131.86 132.61 61.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.78 136.8 32.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.606 -0.516 . . . . 25.0 109.606 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.05 134.18 20.48 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.37 144.15 84.87 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 117.17 -1.42 . . . . 25.0 113.886 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -96.8 -7.56 33.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.449 -0.796 . . . . 25.0 110.095 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -112.42 -3.15 14.54 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.164 1.542 . . . . 25.0 115.164 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -136.54 156.63 48.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.6 mp -127.85 152.48 47.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.006 -0.997 . . . . 25.0 108.888 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.67 154.49 6.15 Favored Glycine 0 C--O 1.237 0.308 0 CA-C-O 121.671 0.595 . . . . 25.0 113.933 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.5 p90 -86.97 148.9 25.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.643 0.735 . . . . 25.0 111.859 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -139.04 149.05 44.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.525 -1.657 . . . . 25.0 106.525 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.5 t -103.4 131.6 51.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.343 -2.095 . . . . 25.0 105.343 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.7 mt -95.92 123.51 48.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.233 -2.136 . . . . 25.0 105.233 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 mp -99.99 127.9 46.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 103.683 -2.71 . . . . 25.0 103.683 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.72 144.08 35.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.819 0.736 . . . . 25.0 111.762 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.56 132.94 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.141 -0.936 . . . . 25.0 109.215 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -124.31 112.63 17.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -97.26 121.65 39.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.008 -0.542 . . . . 25.0 111.784 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.43 115.84 39.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 108.892 -0.781 . . . . 25.0 108.892 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.74 63.44 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.43 -0.77 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.751 0.649 . . . . 25.0 112.751 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.2 t -154.83 166.27 34.02 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.35 -2.66 46.38 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 109.957 -0.386 . . . . 25.0 109.957 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.47 152.99 20.49 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.698 -0.626 . . . . 25.0 109.775 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.36 171.91 13.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.452 -0.573 . . . . 25.0 109.452 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.59 128.33 47.9 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.818 -0.808 . . . . 25.0 108.818 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -126.07 126.55 44.41 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 103.876 -2.639 . . . . 25.0 103.876 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -143.59 155.78 44.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.376 0.535 . . . . 25.0 111.318 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.49 136.7 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.893 -1.521 . . . . 25.0 106.893 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.4 mt -137.69 122.15 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.745 0.307 . . . . 25.0 110.822 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -77.72 130.94 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.168 0.509 . . . . 25.0 112.065 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.83 156.02 41.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 19.5 t0 -123.24 113.84 19.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.884 -2.265 . . . . 25.0 104.884 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.7 mt -108.4 121.59 45.24 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 32.7 m -127.97 170.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.055 0.455 . . . . 25.0 111.505 -174.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -70.38 176.61 3.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.363 -0.835 . . . . 25.0 111.524 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.8 pttt . . . . . 0 C--O 1.244 0.789 0 CA-C-O 117.511 -1.233 . . . . 25.0 111.23 177.755 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 0.086 0 CA-C-O 119.065 -0.853 . . . . 25.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -144.18 166.79 24.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.296 0.548 . . . . 25.0 109.976 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.1 120.99 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.415 -1.698 . . . . 25.0 106.415 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -87.01 -40.2 14.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.893 0.378 . . . . 25.0 111.542 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -145.52 153.7 51.75 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 116.271 -0.422 . . . . 25.0 109.876 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.24 130.98 21.52 Favored 'Cis proline' 0 C--N 1.351 0.709 0 C-N-CA 129.625 1.094 . . . . 25.0 113.432 -3.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.95 -172.55 40.11 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 110.493 -1.043 . . . . 25.0 110.493 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -141.74 134.76 28.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -68.32 -21.15 64.77 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.563 -0.29 . . . . 25.0 111.46 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.68 72.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.81 0.338 . . . . 25.0 111.332 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -29.4 68.75 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 116.538 -0.301 . . . . 25.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 mt -88.25 -26.53 22.28 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.118 0.485 . . . . 25.0 110.263 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.051 -0.977 . . . . 25.0 110.991 -178.361 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.951 0.405 . . . . 25.0 111.744 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -11.17 23.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.841 1.793 . . . . 25.0 115.841 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -73.69 -36.61 65.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.542 0.61 . . . . 25.0 112.516 -173.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.94 59.09 2.19 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.6 -11.59 28.24 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.437 -1.242 . . . . 25.0 113.809 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -97.48 7.16 47.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 25.0 111.013 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -100.3 89.0 3.83 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 120.794 -1.191 . . . . 25.0 109.847 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.64 129.04 49.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.157 -0.683 . . . . 25.0 109.157 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.99 148.97 51.9 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.467 -0.568 . . . . 25.0 109.467 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.22 127.7 34.31 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.3 tttt . . . . . 0 C--N 1.324 -0.518 0 N-CA-C 107.647 -1.242 . . . . 25.0 107.647 176.452 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.486 0 N-CA-C 107.871 -2.092 . . . . 25.0 107.871 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.92 -11.04 15.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.804 0.842 . . . . 25.0 112.26 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -52.04 -33.63 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.005 0.743 . . . . 25.0 113.005 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.8 -29.59 59.06 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 119.835 -1.174 . . . . 25.0 112.805 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.29 0.71 87.34 Favored Glycine 0 C--O 1.219 -0.801 0 N-CA-C 116.124 1.21 . . . . 25.0 116.124 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.2 mm -54.6 -34.57 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 118.463 1.132 . . . . 25.0 112.846 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.08 -31.8 72.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.687 -0.633 . . . . 25.0 112.212 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.83 -12.13 57.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.587 0.708 . . . . 25.0 112.218 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -71.59 8.37 1.14 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -63.33 85.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.86 1.059 . . . . 25.0 113.86 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t -151.85 -170.97 3.8 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.486 -2.413 . . . . 25.0 104.486 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -62.92 -25.14 68.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.593 . . . . 25.0 110.547 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -89.26 19.31 4.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.322 0.86 . . . . 25.0 113.322 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -66.64 165.42 14.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.689 -0.856 . . . . 25.0 108.689 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -84.56 151.2 24.7 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.532 -1.284 . . . . 25.0 107.532 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.54 126.59 27.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.791 -0.64 . . . . 25.0 109.917 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -133.95 128.35 34.29 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.084 -0.962 . . . . 25.0 110.554 -175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -123.07 149.96 43.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.929 -0.308 . . . . 25.0 111.213 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -94.04 134.96 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.8 ttt -150.38 163.41 38.42 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.238 -1.393 . . . . 25.0 107.238 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.7 p -94.98 168.09 10.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.28 177.87 23.81 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.301 -0.476 . . . . 25.0 112.563 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.09 -174.1 15.14 Favored Glycine 0 N--CA 1.459 0.182 0 N-CA-C 109.573 -1.411 . . . . 25.0 109.573 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -77.16 141.78 39.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.577 1.188 . . . . 25.0 109.259 178.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -123.03 134.61 54.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.627 -1.62 . . . . 25.0 106.627 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -108.96 118.9 38.01 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -108.42 139.39 43.22 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.5 m -133.07 123.33 25.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.056 -1.461 . . . . 25.0 107.056 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -111.99 140.06 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 104.512 -2.403 . . . . 25.0 104.512 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 140.86 51.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.003 0.906 . . . . 25.0 113.131 -173.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -125.87 148.34 49.21 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.96 -2.978 . . . . 25.0 102.96 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -71.47 -18.93 62.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.344 0.52 . . . . 25.0 112.333 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.29 152.15 63.41 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.9 157.09 61.28 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 116.817 -1.656 . . . . 25.0 110.335 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -130.98 149.42 52.61 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.55 141.09 53.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.596 -1.631 . . . . 25.0 106.596 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.0 m -150.92 146.58 26.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 m -109.62 -41.87 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.669 0.271 . . . . 25.0 110.633 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.9 153.32 26.07 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.429 -0.582 . . . . 25.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -145.83 148.55 33.01 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.402 -0.962 . . . . 25.0 108.402 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.37 159.17 43.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 25.0 111.079 -172.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -130.52 142.5 50.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -132.88 164.44 26.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.714 -1.587 . . . . 25.0 106.714 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.1 pt -129.19 145.77 35.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.983 -1.488 . . . . 25.0 106.983 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.7 p -83.54 136.18 34.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.458 -1.312 . . . . 25.0 107.458 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -80.79 116.98 21.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.602 -0.888 . . . . 25.0 108.602 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -76.0 125.29 28.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.88 19.91 49.18 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 119.183 -1.484 . . . . 25.0 114.208 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -51.31 149.89 3.77 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 117.95 0.875 . . . . 25.0 112.029 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -70.93 129.59 89.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.081 -0.509 . . . . 25.0 111.135 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.98 -15.26 26.23 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 117.314 -1.324 . . . . 25.0 111.877 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.11 -14.99 61.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.159 0.984 . . . . 25.0 111.462 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -110.15 155.51 41.67 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.135 -1.061 . . . . 25.0 108.135 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.78 113.45 1.72 Allowed 'Trans proline' 0 C--O 1.24 0.593 0 N-CA-C 113.519 0.546 . . . . 25.0 113.519 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 2.5 0.63 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 118.404 2.742 . . . . 25.0 118.404 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.12 2.75 7.93 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.103 -0.373 . . . . 25.0 111.695 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -105.96 -54.71 2.44 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 116.166 -0.47 . . . . 25.0 112.027 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.0 0.51 55.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.688 0.996 . . . . 25.0 113.688 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -80.65 -21.6 41.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.096 0.406 . . . . 25.0 112.096 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -126.19 152.02 46.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -128.15 141.47 51.47 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.2 tp -77.09 118.62 19.81 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.022 -0.733 . . . . 25.0 109.022 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.03 -8.34 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.652 0.739 . . . . 25.0 110.253 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.36 155.8 9.81 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.638 -0.792 . . . . 25.0 113.289 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.57 147.07 29.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.223 -1.029 . . . . 25.0 108.223 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.62 104.48 14.47 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.97 160.99 30.19 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 115.372 -2.619 . . . . 25.0 110.884 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.04 120.96 42.2 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.161 -1.052 . . . . 25.0 108.161 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -140.25 -96.79 0.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.087 -2.19 . . . . 25.0 105.087 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.23 -144.16 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -118.3 70.54 8.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.492 0.923 . . . . 25.0 113.492 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.44 171.76 17.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 118.106 -0.796 . . . . 25.0 111.255 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.33 68.44 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.906 -0.496 . . . . 25.0 111.175 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.7 p -73.21 -2.39 21.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -64.37 -22.35 66.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.716 -0.846 . . . . 25.0 108.716 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -62.43 131.55 49.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.398 -0.593 . . . . 25.0 109.398 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.45 -10.2 56.98 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.348 0.659 . . . . 25.0 112.692 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.2 t -97.21 120.4 37.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -125.66 135.19 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 25.0 111.482 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -90.93 136.67 32.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.7 mp -132.12 119.85 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 106.197 -1.779 . . . . 25.0 106.197 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 86.9 t80 -85.26 126.88 34.06 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -125.86 101.73 29.22 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 109.964 -0.384 . . . . 25.0 109.964 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.0 145.6 40.13 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 114.447 -3.236 . . . . 25.0 108.273 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.76 96.71 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.576 0.703 . . . . 25.0 109.476 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.86 10.29 31.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.386 -0.824 . . . . 25.0 108.974 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -130.1 -179.47 5.25 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.451 -0.795 . . . . 25.0 109.991 -170.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.8 mp -132.11 128.48 38.24 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 151.16 164.21 11.92 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-O 122.285 0.936 . . . . 25.0 115.042 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -94.77 144.94 25.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.207 1.558 . . . . 25.0 115.207 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -148.93 158.34 44.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.249 -1.76 . . . . 25.0 106.249 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.07 139.73 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 25.0 110.704 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.7 mt -96.25 128.16 47.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.855 -2.276 . . . . 25.0 104.855 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.09 144.46 35.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.079 -1.452 . . . . 25.0 107.079 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.04 135.51 41.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.607 -0.516 . . . . 25.0 109.607 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.3 t -128.95 131.12 68.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 25.0 107.897 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -126.58 109.49 12.18 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.867 -0.79 . . . . 25.0 108.867 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.04 131.98 43.99 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.756 0.789 . . . . 25.0 111.976 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.1 t -128.65 122.45 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.673 -1.602 . . . . 25.0 106.673 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.0 -33.25 67.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.598 0.713 . . . . 25.0 109.404 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -7.08 28.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 115.343 1.609 . . . . 25.0 115.343 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.1 p -130.33 156.32 44.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.69 -21.49 60.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.744 0.783 . . . . 25.0 111.068 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -109.82 165.11 11.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.549 -0.751 . . . . 25.0 109.762 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 159.77 26.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -109.29 137.01 47.81 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -139.0 154.09 48.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.251 -0.281 . . . . 25.0 110.62 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -145.86 155.15 42.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.252 -0.647 . . . . 25.0 109.252 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.3 140.51 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.329 -0.989 . . . . 25.0 108.329 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.85 122.04 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.028 -1.101 . . . . 25.0 108.028 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -85.1 134.23 34.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.98 -1.119 . . . . 25.0 107.98 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.88 125.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.469 -0.567 . . . . 25.0 109.469 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -93.84 107.94 19.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.403 -2.073 . . . . 25.0 105.403 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.5 mt -109.55 133.14 53.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.188 0.518 . . . . 25.0 109.674 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.71 159.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.123 -0.944 . . . . 25.0 110.712 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -76.06 155.93 34.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 105.285 -2.117 . . . . 25.0 105.285 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-O 117.413 -1.279 . . . . 25.0 110.931 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.18 0 N-CA-C 104.336 -3.506 . . . . 25.0 104.336 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -154.18 169.66 23.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.085 1.942 . . . . 25.0 113.015 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.456 HG22 ' H ' ' A' ' 6' ' ' LYS . 30.3 mm -93.52 127.1 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.515 -0.766 . . . . 25.0 108.975 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -87.63 13.16 10.89 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.818 0.673 . . . . 25.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' H ' HG22 ' A' ' 4' ' ' ILE . 53.5 mttt 80.92 156.57 0.13 Allowed Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 126.142 1.777 . . . . 25.0 107.348 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.79 151.37 75.15 Favored 'Cis proline' 0 C--N 1.346 0.401 0 C-N-CA 129.311 0.963 . . . . 25.0 112.502 -4.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.08 9.34 63.78 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 116.297 1.279 . . . . 25.0 116.297 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -62.05 132.4 52.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 25.0 111.751 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -70.53 -26.44 63.57 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.069 -0.514 . . . . 25.0 111.298 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.15 70.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.503 -0.317 . . . . 25.0 111.629 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.39 75.81 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 120.798 0.332 . . . . 25.0 110.675 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.91 -8.04 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.353 -0.385 . . . . 25.0 111.308 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 t . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 120.739 0.304 . . . . 25.0 110.449 -177.271 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 113.09 0.774 . . . . 25.0 113.09 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.9 ptm -56.32 -10.98 1.02 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.499 1.666 . . . . 25.0 115.499 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -76.43 -35.98 58.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.9 0.381 . . . . 25.0 110.779 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -147.14 50.22 0.91 Allowed Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.824 1.046 . . . . 25.0 113.824 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.58 -17.15 23.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 115.114 -2.791 . . . . 25.0 114.634 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.07 4.99 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.073 0.768 . . . . 25.0 113.073 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 94.06 4.85 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 113.067 0.766 . . . . 25.0 113.067 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.98 132.78 51.97 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 105.602 -1.999 . . . . 25.0 105.602 168.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -129.94 149.06 51.83 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.265 0.839 . . . . 25.0 113.265 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.68 49.32 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt . . . . . 0 C--N 1.324 -0.502 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 178.208 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.557 0 CA-C-O 120.195 -0.225 . . . . 25.0 113.494 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.38 -36.97 85.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.779 0.799 . . . . 25.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -71.18 -12.7 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.549 -0.751 . . . . 25.0 111.745 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.38 -23.2 53.22 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 121.325 -0.464 . . . . 25.0 113.524 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.12 73.71 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 117.961 0.88 . . . . 25.0 112.49 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.62 -38.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.61 -29.12 69.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 25.0 110.087 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.69 -7.81 36.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.646 0.61 . . . . 25.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -68.93 -41.04 78.65 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -159.89 110.19 1.88 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 120.848 0.356 . . . . 25.0 110.646 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.91 163.55 39.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -72.47 -26.41 61.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.165 -0.309 . . . . 25.0 110.165 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.01 20.5 15.42 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.76 0.281 . . . . 25.0 111.76 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -54.81 147.56 14.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.861 -0.608 . . . . 25.0 110.624 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -90.84 151.69 21.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -77.51 136.15 38.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -106.12 144.81 32.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.133 -0.485 . . . . 25.0 110.105 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.05 142.25 48.02 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -100.71 136.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.76 151.57 45.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.288 0.477 . . . . 25.0 112.288 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p -96.14 172.05 8.22 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 106.863 -1.532 . . . . 25.0 106.863 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.46 -172.69 15.37 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 117.814 1.886 . . . . 25.0 117.814 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.86 172.04 25.46 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 113.799 -1.2 . . . . 25.0 111.622 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.06 139.23 41.31 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.935 -1.135 . . . . 25.0 107.935 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -137.3 157.12 47.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.1 m -125.61 127.33 46.16 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -115.03 140.77 48.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -127.2 133.07 50.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.357 -0.609 . . . . 25.0 109.357 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.97 150.06 45.24 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.041 -2.207 . . . . 25.0 105.041 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 161.95 37.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.755 0.707 . . . . 25.0 111.121 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.1 151.83 39.4 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -71.85 -14.3 61.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.612 0.597 . . . . 25.0 112.612 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.88 160.4 58.6 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 104.094 -2.558 . . . . 25.0 104.094 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.84 145.89 94.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 115.479 -2.547 . . . . 25.0 111.092 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -108.16 118.18 36.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.222 -0.445 . . . . 25.0 110.735 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.03 129.56 41.45 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.598 -1.63 . . . . 25.0 106.598 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.2 m -145.64 133.58 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.745 -0.207 . . . . 25.0 110.834 -170.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -104.92 -33.62 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.438 -0.579 . . . . 25.0 109.438 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -163.02 148.55 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -142.69 139.07 31.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.868 -0.79 . . . . 25.0 108.868 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.05 159.05 44.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 25.0 110.817 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.57 145.34 33.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.699 0.762 . . . . 25.0 111.286 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -127.52 167.45 16.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.794 -1.093 . . . . 25.0 109.211 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.56 156.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.396 -0.964 . . . . 25.0 108.396 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 p -95.48 145.44 25.18 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.862 -0.422 . . . . 25.0 109.862 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -88.68 113.59 24.41 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.275 -0.57 . . . . 25.0 111.563 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -77.2 147.93 36.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.669 -1.975 . . . . 25.0 105.669 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.97 59.79 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 118.076 1.991 . . . . 25.0 118.076 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -54.89 147.13 15.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.68 1.24 . . . . 25.0 113.409 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 146.69 72.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.051 -0.722 . . . . 25.0 109.051 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.65 -18.4 25.39 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 118.031 -0.846 . . . . 25.0 113.917 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.05 -22.29 62.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.183 0.992 . . . . 25.0 110.915 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.84 147.11 32.98 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.624 -0.716 . . . . 25.0 109.733 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 93.94 0.65 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 118.463 -0.558 . . . . 25.0 111.799 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -52.99 -41.31 64.49 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 114.36 1.244 . . . . 25.0 114.36 -173.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -70.66 -16.41 62.81 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.057 0.762 . . . . 25.0 113.057 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -85.69 -41.38 15.2 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.356 0.598 . . . . 25.0 109.622 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.79 7.85 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.654 -1.157 . . . . 25.0 111.943 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.2 -29.03 70.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.917 0.71 . . . . 25.0 112.917 -169.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -126.04 144.98 50.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.018 0.748 . . . . 25.0 113.018 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -127.96 144.64 51.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.697 -0.853 . . . . 25.0 108.697 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -82.58 113.69 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.521 -0.918 . . . . 25.0 108.521 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -97.34 -8.62 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.345 0.593 . . . . 25.0 110.275 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.93 149.94 8.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.198 -1.001 . . . . 25.0 114.061 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.59 146.86 28.44 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.417 -0.957 . . . . 25.0 108.417 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.1 90.11 6.89 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-O 121.23 0.538 . . . . 25.0 110.299 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.39 162.59 38.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 117.751 -1.033 . . . . 25.0 109.752 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -96.9 91.98 5.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.334 -1.728 . . . . 25.0 106.334 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -100.38 2.75 42.68 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 113.976 -1.465 . . . . 25.0 109.167 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.17 -11.42 65.33 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.068 -1.213 . . . . 25.0 110.068 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.4 t -59.34 141.1 87.8 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.659 -0.497 . . . . 25.0 109.659 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.05 -6.63 19.49 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 C-N-CA 116.94 -1.573 . . . . 25.0 115.295 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.17 83.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.182 -0.917 . . . . 25.0 109.657 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.2 t -85.57 -27.87 25.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 25.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -69.4 -35.15 75.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.465 -0.568 . . . . 25.0 109.465 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.36 111.23 12.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.027 -0.533 . . . . 25.0 110.058 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.25 -13.06 60.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.507 -0.77 . . . . 25.0 112.906 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -96.98 121.31 38.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -133.05 149.42 52.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.461 . . . . 25.0 111.925 -172.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -84.78 135.17 34.23 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.839 -0.619 . . . . 25.0 109.917 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 73.2 mt -134.51 120.62 33.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 106.783 -1.562 . . . . 25.0 106.783 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -73.39 140.99 46.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.643 0.259 . . . . 25.0 110.724 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.04 129.89 25.15 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 106.731 -1.581 . . . . 25.0 106.731 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.1 148.78 63.62 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 117.355 -1.297 . . . . 25.0 113.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -100.82 -9.4 21.71 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.654 0.74 . . . . 25.0 109.217 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.09 10.56 20.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.862 1.06 . . . . 25.0 113.862 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -132.15 141.61 49.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 110.072 -0.344 . . . . 25.0 110.072 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.4 mp -113.13 153.87 27.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 25.0 109.307 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 116.74 154.21 10.06 Favored Glycine 0 C--O 1.24 0.5 0 CA-C-O 122.192 0.885 . . . . 25.0 114.97 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 42.4 p90 -87.01 146.27 26.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.226 0.824 . . . . 25.0 113.226 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -148.95 158.96 44.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.965 -1.495 . . . . 25.0 106.965 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 166' ' ' ASP . 2.0 t -98.03 143.61 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.901 0.381 . . . . 25.0 111.81 -175.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.93 131.26 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.601 -2.0 . . . . 25.0 105.601 172.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.45 140.22 49.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.216 -1.401 . . . . 25.0 107.216 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -130.09 133.82 46.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.9 130.29 68.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.73 -1.211 . . . . 25.0 107.73 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -117.85 116.27 26.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.55 -0.75 . . . . 25.0 110.584 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.63 131.9 42.81 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 122.123 0.963 . . . . 25.0 110.484 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.12 124.2 65.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.03 -31.31 64.36 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.192 0.52 . . . . 25.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -67.41 -14.93 63.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -129.2 160.42 32.96 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 122.098 -0.376 . . . . 25.0 110.747 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.46 -12.2 59.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.148 0.499 . . . . 25.0 110.591 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -110.2 160.59 16.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.741 0.781 . . . . 25.0 111.121 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -121.94 156.54 33.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 103.355 -2.831 . . . . 25.0 103.355 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -123.81 143.91 50.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.806 -0.813 . . . . 25.0 108.806 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.01 153.97 48.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.056 0.455 . . . . 25.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -134.75 143.68 47.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.322 -1.733 . . . . 25.0 106.322 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.04 129.14 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.603 -0.518 . . . . 25.0 109.603 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.2 mt -140.21 125.74 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.088 -1.078 . . . . 25.0 108.088 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 147' ' ' VAL . 11.7 t70 -87.73 141.63 28.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.605 -0.887 . . . . 25.0 108.605 173.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.45 143.75 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.098 0.475 . . . . 25.0 109.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 11.0 t0 -97.94 122.15 40.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.1 mt -115.71 119.4 35.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.878 -1.897 . . . . 25.0 105.878 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.7 m -134.17 162.19 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.685 0.994 . . . . 25.0 113.685 -170.446 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.64 161.22 30.53 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.443 -1.688 . . . . 25.0 106.443 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt . . . . . 0 C--O 1.246 0.909 0 CA-C-O 117.841 -1.076 . . . . 25.0 109.214 172.544 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.479 1 N-CA-C 101.837 -4.505 . . . . 25.0 101.837 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -158.2 163.65 37.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.374 1.587 . . . . 25.0 111.046 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -92.36 114.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 105.569 -2.011 . . . . 25.0 105.569 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -72.81 -40.92 65.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -153.35 131.59 6.44 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.152 -0.476 . . . . 25.0 109.744 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.47 140.81 46.59 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 118.62 0.543 . . . . 25.0 112.476 0.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 154.51 18.29 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 116.019 -0.537 . . . . 25.0 113.767 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p -61.91 152.88 30.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.598 0.713 . . . . 25.0 112.744 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -65.1 -17.08 64.16 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.964 -0.562 . . . . 25.0 112.078 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.34 68.14 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 122.617 0.367 . . . . 25.0 111.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.3 77.84 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.972 0.415 . . . . 25.0 111.275 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.02 -4.04 55.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 25.0 110.941 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t . . . . . 0 C--N 1.325 -0.457 0 N-CA-C 108.369 -0.975 . . . . 25.0 108.369 179.334 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 112.658 0.614 . . . . 25.0 112.658 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm -65.31 -19.94 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.419 0.896 . . . . 25.0 113.419 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -75.53 -45.77 36.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.239 0.472 . . . . 25.0 111.018 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -154.97 89.79 3.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 113.1 0.778 . . . . 25.0 113.1 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.61 1.46 4.97 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 N-CA-C 113.22 0.431 . . . . 25.0 113.22 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -7.87 24.32 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.252 1.205 . . . . 25.0 114.252 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -132.99 129.94 38.84 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.924 1.824 . . . . 25.0 115.924 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -120.62 140.47 51.5 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.069 -2.197 . . . . 25.0 105.069 161.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -84.03 118.33 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.555 0.616 . . . . 25.0 109.858 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.86 158.1 43.95 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 107.75 -1.204 . . . . 25.0 107.75 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tttt . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.4 0.619 . . . . 25.0 110.223 178.056 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.531 0 N-CA-C 115.611 1.005 . . . . 25.0 115.611 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.37 -26.94 68.69 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.234 1.017 . . . . 25.0 112.099 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.19 -23.69 67.4 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.536 -0.466 . . . . 25.0 111.262 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.18 -26.05 71.67 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.771 -0.728 . . . . 25.0 111.852 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.7 73.48 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 121.025 -0.607 . . . . 25.0 112.008 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.25 -28.22 41.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -88.05 -38.6 15.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.725 -0.472 . . . . 25.0 109.725 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.64 -38.27 84.26 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.91 0.386 . . . . 25.0 112.005 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -64.68 -0.19 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.052 1.13 . . . . 25.0 114.052 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -143.65 34.85 1.28 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.766 0.426 . . . . 25.0 110.157 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 t -115.94 172.29 7.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.979 0.418 . . . . 25.0 111.804 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.46 -38.35 74.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.555 0.693 . . . . 25.0 110.557 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -79.99 5.44 14.03 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.751 0.649 . . . . 25.0 112.751 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -52.74 149.87 5.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.044 1.128 . . . . 25.0 114.044 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -70.28 158.51 35.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 25.0 110.92 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -84.33 151.51 24.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.825 -0.547 . . . . 25.0 111.155 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -120.52 143.29 48.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.313 -0.403 . . . . 25.0 111.2 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -121.1 150.97 40.41 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 106.612 -1.625 . . . . 25.0 106.612 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -96.2 143.0 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.178 -2.156 . . . . 25.0 105.178 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.6 ttt -150.7 164.31 36.45 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 110.421 -0.215 . . . . 25.0 110.421 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 p -110.2 172.48 6.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.775 -1.935 . . . . 25.0 105.775 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.97 -168.67 6.9 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.318 1.287 . . . . 25.0 116.318 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.68 -179.14 26.45 Favored Glycine 0 CA--C 1.521 0.417 0 O-C-N 122.519 -0.401 . . . . 25.0 113.371 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -73.08 133.65 44.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.748 -0.854 . . . . 25.0 109.615 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -125.77 137.79 53.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 25.0 110.047 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.7 m -102.56 125.54 49.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.492 -0.559 . . . . 25.0 109.492 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -112.83 130.12 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -137.98 135.1 35.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.78 -0.191 . . . . 25.0 110.565 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -122.42 150.08 42.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.47 -1.678 . . . . 25.0 106.47 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -144.96 158.58 43.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.644 -0.872 . . . . 25.0 108.644 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.66 151.04 47.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.656 -0.868 . . . . 25.0 108.656 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -72.4 -16.87 61.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.992 0.425 . . . . 25.0 111.347 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.87 141.1 23.13 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 174.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.07 146.88 47.65 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 117.167 -1.422 . . . . 25.0 112.896 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -131.12 157.08 44.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.185 -0.672 . . . . 25.0 109.185 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -76.99 144.67 38.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.312 -0.625 . . . . 25.0 109.312 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -128.28 130.11 47.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.415 -0.957 . . . . 25.0 108.415 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 t -89.75 -44.29 10.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.681 0.753 . . . . 25.0 109.771 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -158.13 155.69 29.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -146.86 141.23 26.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 168.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -148.4 159.75 43.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 25.0 111.368 -170.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -130.1 141.0 50.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.7 0.625 . . . . 25.0 110.444 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -126.68 162.87 24.76 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 pt -132.4 139.43 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.271 -0.27 . . . . 25.0 110.271 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -85.01 130.75 34.57 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 120.903 0.382 . . . . 25.0 110.339 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -88.08 125.02 34.35 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.817 0.673 . . . . 25.0 112.817 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -75.1 140.21 43.29 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.21 21.32 55.22 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.06 1.184 . . . . 25.0 116.06 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -57.09 154.18 10.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.226 1.013 . . . . 25.0 111.777 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.08 119.24 65.82 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.94 -15.84 18.52 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 117.163 -1.425 . . . . 25.0 113.51 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -75.72 -15.62 60.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.393 1.092 . . . . 25.0 110.744 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -105.01 153.79 39.17 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 106.606 -1.627 . . . . 25.0 106.606 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.98 128.44 21.87 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 115.058 -2.828 . . . . 25.0 112.215 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 tt -53.67 -38.01 63.73 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.402 -0.817 . . . . 25.0 111.895 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -58.18 -18.81 28.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.036 1.125 . . . . 25.0 114.036 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -101.61 -42.99 6.02 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 122.098 -0.376 . . . . 25.0 111.735 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.04 59.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.92 1.082 . . . . 25.0 113.92 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.95 -38.69 83.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.848 1.425 . . . . 25.0 114.848 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -130.46 161.97 30.22 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 116.413 2.005 . . . . 25.0 116.413 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -128.51 149.68 50.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.0 tp -85.56 112.93 21.4 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.169 -1.419 . . . . 25.0 107.169 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.16 -12.07 9.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.204 0.526 . . . . 25.0 110.327 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.22 158.72 12.61 Favored Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.832 -1.175 . . . . 25.0 114.707 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.93 146.58 31.11 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.496 -1.298 . . . . 25.0 107.496 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.26 107.75 4.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.619 -0.512 . . . . 25.0 109.619 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -86.64 177.26 4.32 Favored 'Trans proline' 0 C--O 1.24 0.575 0 N-CA-C 114.066 0.756 . . . . 25.0 114.066 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -104.08 91.53 3.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.812 -2.292 . . . . 25.0 104.812 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -156.44 71.42 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.062 0.458 . . . . 25.0 110.675 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.76 13.35 39.09 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.037 -0.529 . . . . 25.0 114.204 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.97 145.73 97.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.568 -0.372 . . . . 25.0 111.135 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.55 -175.63 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.784 1.656 . . . . 25.0 113.897 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.47 -26.2 12.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -57.36 -8.9 0.86 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.145 1.165 . . . . 25.0 114.145 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -76.27 3.63 10.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.729 -0.607 . . . . 25.0 111.707 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.7 150.45 23.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.949 -0.76 . . . . 25.0 108.949 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.95 -7.02 19.18 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.687 0.995 . . . . 25.0 113.687 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.3 t -97.94 122.65 41.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.141 -1.8 . . . . 25.0 106.141 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.4 151.06 51.88 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.207 0.527 . . . . 25.0 110.958 -175.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -105.92 138.51 41.97 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.67 -1.233 . . . . 25.0 107.67 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.5 mm -127.01 123.0 61.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.29 -2.115 . . . . 25.0 105.29 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.56 133.98 35.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.694 -1.224 . . . . 25.0 107.694 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.9 mm -125.88 118.6 24.06 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.03 155.29 61.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 115.736 -2.376 . . . . 25.0 110.715 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -104.79 55.03 0.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.73 -36.31 21.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.743 -0.662 . . . . 25.0 112.367 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -151.7 159.21 44.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.259 0.552 . . . . 25.0 110.786 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.5 pt? -91.62 143.87 26.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.987 -1.006 . . . . 25.0 110.25 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.31 152.0 6.04 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-O 121.839 0.688 . . . . 25.0 113.739 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 35.0 p90 -80.04 146.3 32.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.597 0.713 . . . . 25.0 111.984 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -136.27 128.52 29.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.766 -1.939 . . . . 25.0 105.766 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.01 125.57 47.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 105.675 -1.972 . . . . 25.0 105.675 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 76.7 mt -96.21 119.73 44.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.98 109.01 20.61 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.549 -1.648 . . . . 25.0 106.549 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -113.04 146.77 38.54 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.03 -0.419 . . . . 25.0 110.507 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.14 134.25 65.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.955 -0.566 . . . . 25.0 109.652 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -121.24 106.42 11.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.01 88.04 7.61 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.71 138.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.286 -1.376 . . . . 25.0 107.286 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -94.53 -13.69 25.82 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 122.068 -0.395 . . . . 25.0 111.274 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -77.26 -12.24 59.92 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.385 0.883 . . . . 25.0 113.385 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.0 p -140.18 170.59 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.89 0.7 . . . . 25.0 112.89 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -85.04 13.49 6.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.567 0.747 . . . . 25.0 110.317 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -109.91 163.51 13.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.95 139.35 32.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 100.376 -3.935 . . . . 25.0 100.376 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -117.99 152.01 36.33 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.276 0.56 . . . . 25.0 110.921 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.68 140.81 51.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.565 -1.198 . . . . 25.0 108.381 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -128.23 126.2 40.46 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.651 -2.351 . . . . 25.0 104.651 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.13 131.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.38 123.73 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.41 138.65 31.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.517 -1.29 . . . . 25.0 107.517 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.87 126.07 46.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 2.1 t0 -93.29 95.84 9.6 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.46 124.75 31.01 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.0 158.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 112.68 0.622 . . . . 25.0 112.68 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.92 161.72 14.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.773 -1.565 . . . . 25.0 106.773 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.35 -0.833 . . . . 25.0 109.138 172.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.119 0 N-CA-C 110.699 -0.96 . . . . 25.0 110.699 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -166.32 164.17 17.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.127 0.571 . . . . 25.0 110.427 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.91 128.12 45.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.284 -2.117 . . . . 25.0 105.284 170.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -94.6 -46.56 6.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.086 0.47 . . . . 25.0 110.238 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -145.97 157.1 51.02 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.909 -0.587 . . . . 25.0 109.5 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.53 132.38 26.12 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 130.312 1.38 . . . . 25.0 115.647 -0.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.51 -172.19 35.74 Favored Glycine 0 C--O 1.221 -0.695 0 CA-C-N 115.636 -0.711 . . . . 25.0 113.713 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -150.92 150.34 30.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.931 -1.137 . . . . 25.0 107.931 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.74 -21.02 59.58 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 111.907 0.336 . . . . 25.0 111.907 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.3 -31.17 68.89 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 113.043 0.757 . . . . 25.0 113.043 -173.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -27.81 68.95 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.634 0.605 . . . . 25.0 112.634 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.82 -10.5 39.61 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 120.809 0.338 . . . . 25.0 111.273 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.515 0.674 . . . . 25.0 110.044 -177.95 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 114.394 1.257 . . . . 25.0 114.394 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -72.15 -27.42 62.59 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.43 -0.794 . . . . 25.0 110.691 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -92.51 -36.18 13.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 25.0 109.976 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -118.88 72.39 11.33 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 121.427 0.632 . . . . 25.0 111.375 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.98 -26.87 21.37 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.159 -2.094 . . . . 25.0 115.021 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -8.76 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.798 1.777 . . . . 25.0 115.798 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 t -86.36 94.05 9.26 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 121.543 -0.723 . . . . 25.0 111.06 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mp -117.1 80.02 1.42 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.492 -0.322 . . . . 25.0 111.365 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -142.38 126.55 17.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.796 -0.446 . . . . 25.0 109.796 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 134.59 38.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.657 -0.498 . . . . 25.0 109.657 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt . . . . . 0 C--N 1.325 -0.494 0 O-C-N 121.448 -0.782 . . . . 25.0 109.232 177.652 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.404 0 CA-C-O 121.295 0.386 . . . . 25.0 113.254 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.03 -28.3 68.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.958 0.409 . . . . 25.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -68.46 -24.0 64.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.218 -0.301 . . . . 25.0 111.538 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -30.26 59.93 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 110.205 -1.158 . . . . 25.0 110.205 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.69 -20.63 74.26 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 121.272 -0.489 . . . . 25.0 112.409 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -66.13 -42.86 92.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.192 -1.04 . . . . 25.0 108.192 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.64 -32.05 63.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 25.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.37 -26.89 68.96 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.802 -0.359 . . . . 25.0 111.785 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -64.16 -7.59 9.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -132.07 27.22 4.54 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.055 0.455 . . . . 25.0 110.606 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.7 t -87.99 157.85 18.8 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.119 0.485 . . . . 25.0 111.748 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.97 -41.71 95.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 25.0 110.012 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -102.73 24.39 10.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.671 0.748 . . . . 25.0 111.161 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -55.08 154.57 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.655 -1.157 . . . . 25.0 110.053 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -80.11 156.15 27.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.826 0.822 . . . . 25.0 109.961 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -62.1 141.0 58.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.664 -0.698 . . . . 25.0 111.412 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -112.93 134.59 54.37 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.022 -0.536 . . . . 25.0 110.69 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.23 149.36 50.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.55 137.58 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.2 ttt -150.97 167.0 28.95 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.7 p -101.45 170.86 7.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.39 -166.08 11.0 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.066 -0.588 . . . . 25.0 113.321 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.94 179.47 25.39 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 112.16 -0.376 . . . . 25.0 112.16 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 16.9 tt0 -73.79 133.03 43.19 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.759 -0.848 . . . . 25.0 109.365 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -125.33 155.2 40.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -106.25 125.23 50.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.106 -1.072 . . . . 25.0 108.106 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -105.68 122.14 45.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.219 -2.141 . . . . 25.0 105.219 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -126.07 109.24 12.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.73 -0.47 . . . . 25.0 109.73 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -122.93 140.85 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.767 -3.049 . . . . 25.0 102.767 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 123.58 12.44 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -126.69 118.99 25.88 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.747 -0.835 . . . . 25.0 108.747 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -88.36 -6.37 57.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.821 -1.081 . . . . 25.0 111.922 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.73 130.7 54.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.87 119.61 6.45 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 115.903 -2.265 . . . . 25.0 112.794 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.04 136.06 48.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 25.0 109.821 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -84.24 149.93 25.78 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.317 -2.105 . . . . 25.0 105.317 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 m -137.11 152.55 50.12 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 104.645 -2.354 . . . . 25.0 104.645 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.6 p -93.03 -41.57 9.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -167.57 169.3 12.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.518 -0.31 . . . . 25.0 110.44 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.4 p90 -144.85 146.99 32.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.121 -1.437 . . . . 25.0 107.121 163.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.08 159.2 44.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 25.0 109.267 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.46 151.35 47.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.533 0.683 . . . . 25.0 112.604 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.35 163.95 27.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.883 -1.053 . . . . 25.0 108.533 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.52 152.43 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.6 p -80.84 126.13 30.95 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 120.906 0.384 . . . . 25.0 110.403 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -87.99 115.73 25.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.755 -1.202 . . . . 25.0 107.755 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -81.28 154.03 26.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.33 10.98 34.84 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 116.863 1.505 . . . . 25.0 116.863 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -62.56 155.02 27.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.263 1.031 . . . . 25.0 109.717 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -127.79 158.46 70.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 104.185 -2.524 . . . . 25.0 104.185 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.21 -14.9 35.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 117.646 -1.102 . . . . 25.0 113.508 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -65.58 -29.22 69.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.866 1.317 . . . . 25.0 108.801 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -96.03 145.25 29.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 106.797 -1.557 . . . . 25.0 106.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.37 104.6 1.11 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.325 -1.983 . . . . 25.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.99 -42.62 65.75 Favored 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 113.386 0.884 . . . . 25.0 113.386 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -59.88 -35.28 74.49 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -77.19 -38.75 50.91 Favored 'General case' 0 C--O 1.213 -0.865 0 O-C-N 122.074 -0.391 . . . . 25.0 111.25 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.6 -8.69 58.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.842 1.053 . . . . 25.0 113.842 -172.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.83 -36.79 75.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.959 1.096 . . . . 25.0 113.959 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -128.73 162.06 28.28 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.171 1.174 . . . . 25.0 114.171 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -130.07 146.38 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 172.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.8 115.14 20.14 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.916 -1.513 . . . . 25.0 106.916 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -95.12 -6.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.498 0.666 . . . . 25.0 109.966 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.82 159.53 11.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.771 . . . . 25.0 113.568 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.17 143.76 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.0 t -134.27 98.78 13.76 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 108.061 -1.088 . . . . 25.0 108.061 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.25 159.99 39.82 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 115.45 -2.567 . . . . 25.0 110.475 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -104.05 91.2 3.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.574 -2.38 . . . . 25.0 104.574 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -104.49 -25.01 12.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.245 -0.889 . . . . 25.0 109.827 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.17 -151.24 20.21 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 107.709 -2.157 . . . . 25.0 107.709 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.6 m 61.71 168.44 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.873 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.71 0.18 8.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 114.288 -3.341 . . . . 25.0 114.262 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.46 87.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.405 -0.816 . . . . 25.0 108.892 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.1 t -67.58 -26.42 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.917 -0.583 . . . . 25.0 112.022 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -68.43 -27.22 66.0 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.889 0.376 . . . . 25.0 110.517 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.38 104.84 11.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.03 -28.41 17.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.578 0.704 . . . . 25.0 109.941 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.0 t -93.2 139.46 30.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.802 -1.185 . . . . 25.0 107.802 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -139.93 150.9 45.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.028 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.53 132.49 36.78 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.297 -2.112 . . . . 25.0 105.297 172.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.97 128.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.636 -1.987 . . . . 25.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 91.1 t80 -78.5 125.01 28.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.923 -1.14 . . . . 25.0 107.923 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.61 108.73 59.81 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.701 -0.851 . . . . 25.0 108.701 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.89 163.92 34.53 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 117.09 -1.473 . . . . 25.0 111.496 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.88 113.05 13.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.604 -2.369 . . . . 25.0 104.604 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -90.19 -33.27 16.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 25.0 110.139 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -155.08 162.04 41.14 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 104.206 -2.516 . . . . 25.0 104.206 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.4 pt? -85.92 136.42 33.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.452 -1.314 . . . . 25.0 107.452 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.76 -176.83 25.45 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-O 121.593 0.551 . . . . 25.0 111.727 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -82.82 137.08 34.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.564 1.173 . . . . 25.0 111.901 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -133.33 158.99 41.59 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.294 -3.224 . . . . 25.0 102.294 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.64 137.35 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.791 -1.189 . . . . 25.0 107.791 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.92 129.08 59.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.409 -2.441 . . . . 25.0 104.409 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.02 134.23 55.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.905 -1.146 . . . . 25.0 107.905 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.11 48.83 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.3 t -129.03 132.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.076 -0.713 . . . . 25.0 109.076 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -116.38 111.67 20.39 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 92.49 5.77 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.821 0.343 . . . . 25.0 111.208 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.98 144.2 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -102.95 -21.7 13.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.309 0.485 . . . . 25.0 112.309 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -73.7 -21.67 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.336 0.495 . . . . 25.0 112.336 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.0 p -135.92 168.57 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 25.0 110.724 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -79.3 13.61 1.84 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.979 0.895 . . . . 25.0 110.734 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -110.03 157.8 18.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 25.0 111.294 -172.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.93 171.9 18.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -141.01 143.45 34.45 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.52 -0.872 . . . . 25.0 111.849 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.55 119.93 37.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.386 -2.45 . . . . 25.0 104.386 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -122.69 132.41 54.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.022 -1.844 . . . . 25.0 106.022 -173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.33 147.48 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 25.0 110.275 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.53 120.68 48.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.43 125.04 28.7 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.624 -1.25 . . . . 25.0 107.624 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.33 126.02 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.951 0.881 . . . . 25.0 108.682 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -89.02 96.09 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 103.474 -2.787 . . . . 25.0 103.474 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.11 119.63 31.4 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.339 -1.726 . . . . 25.0 106.339 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.18 161.91 39.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 O-C-N 123.592 0.558 . . . . 25.0 111.788 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -79.35 159.08 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.314 -1.365 . . . . 25.0 107.314 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.863 -1.065 . . . . 25.0 109.84 178.589 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.141 0 CA-C-O 120.197 -0.224 . . . . 25.0 113.566 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -135.62 139.74 44.03 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 6' ' ' LYS . 84.3 mt -96.67 111.96 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.337 -0.616 . . . . 25.0 109.337 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -93.56 39.95 1.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.321 0.649 . . . . 25.0 110.326 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' H ' HG22 ' A' ' 4' ' ' ILE . 74.5 mttt 79.81 156.35 0.13 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 126.317 1.847 . . . . 25.0 111.629 171.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.89 147.86 90.62 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 129.622 1.093 . . . . 25.0 113.928 -0.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.58 152.14 29.03 Favored Glycine 0 C--O 1.223 -0.55 0 CA-C-N 114.964 -1.016 . . . . 25.0 113.854 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -161.63 142.94 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.91 -1.515 . . . . 25.0 106.91 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -77.97 -28.92 49.51 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.477 -0.489 . . . . 25.0 110.081 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.2 71.85 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.713 0.292 . . . . 25.0 111.013 -177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.44 89.57 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.596 -0.275 . . . . 25.0 111.135 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.08 -16.52 35.32 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 120.679 0.276 . . . . 25.0 111.183 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.976 -0.556 . . . . 25.0 110.906 179.563 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 113.693 0.997 . . . . 25.0 113.693 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -16.81 23.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.668 1.359 . . . . 25.0 114.668 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -73.04 -36.49 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.997 0.74 . . . . 25.0 112.997 -173.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.05 45.61 0.42 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 118.69 2.848 . . . . 25.0 118.69 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.28 -22.68 33.92 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 113.778 -3.681 . . . . 25.0 112.582 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -77.76 3.23 14.68 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.841 0.682 . . . . 25.0 112.841 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -110.87 66.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.103 -0.702 . . . . 25.0 109.103 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 tt -118.96 111.28 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.438 -0.801 . . . . 25.0 109.414 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -130.03 142.24 50.64 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.317 -1.735 . . . . 25.0 106.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.99 144.84 51.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.9 tttt . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.103 0.478 . . . . 25.0 110.972 -178.421 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.591 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.26 -30.07 68.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.502 -0.411 . . . . 25.0 111.584 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -66.31 -22.44 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.863 -0.335 . . . . 25.0 111.36 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.07 -22.52 77.27 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.775 -0.726 . . . . 25.0 111.48 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.73 -18.02 71.77 Favored Glycine 0 C--O 1.223 -0.555 0 C-N-CA 121.332 -0.461 . . . . 25.0 112.815 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.09 -38.18 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.461 -0.94 . . . . 25.0 108.461 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.53 -38.05 62.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 25.0 109.794 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -64.21 -41.86 96.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.378 0.608 . . . . 25.0 111.505 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -78.64 -1.82 36.1 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.723 -0.611 . . . . 25.0 112.268 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -134.15 55.08 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.862 0.839 . . . . 25.0 110.177 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -135.79 163.91 29.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 25.0 108.687 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -68.84 -27.71 66.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.245 -1.021 . . . . 25.0 108.245 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -96.49 22.82 7.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.3 -0.864 . . . . 25.0 110.933 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -56.91 145.62 29.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 25.0 108.552 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -81.63 160.2 23.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 25.0 109.908 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -61.71 149.27 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.326 -0.852 . . . . 25.0 111.798 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -121.65 143.24 49.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -124.85 140.01 53.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 25.0 109.846 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.15 131.55 34.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.566 -2.012 . . . . 25.0 105.566 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.0 mtp -138.74 167.88 21.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -101.33 174.53 5.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.798 -0.183 . . . . 25.0 110.647 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.76 -170.99 13.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.488 -1.445 . . . . 25.0 109.488 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.51 -176.13 44.58 Favored Glycine 0 C--O 1.236 0.236 0 N-CA-C 111.702 -0.559 . . . . 25.0 111.702 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -87.75 144.9 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.981 -0.717 . . . . 25.0 111.508 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -136.21 161.46 35.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.576 -2.009 . . . . 25.0 105.576 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.5 m -122.85 125.45 45.42 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -108.93 137.96 46.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 m -124.1 123.35 40.13 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -123.91 149.96 45.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 103.698 -2.705 . . . . 25.0 103.698 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.7 p -138.12 159.86 40.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.186 0.517 . . . . 25.0 110.507 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -133.13 123.92 26.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 103.571 -2.752 . . . . 25.0 103.571 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -84.21 -20.76 31.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.448 0.536 . . . . 25.0 112.448 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.19 127.26 69.67 Favored Pre-proline 0 C--O 1.244 0.78 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -67.0 129.89 21.71 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.782 -1.012 . . . . 25.0 113.067 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -136.07 158.93 43.22 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.649 -0.705 . . . . 25.0 110.395 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.18 86.98 6.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.081 -1.451 . . . . 25.0 107.081 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -76.99 129.28 35.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.04 -0.527 . . . . 25.0 110.002 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.9 m -92.73 -42.71 9.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.588 0.588 . . . . 25.0 112.588 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -166.85 173.66 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.897 0.379 . . . . 25.0 111.222 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -147.76 145.62 28.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 165.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -147.93 154.1 39.91 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.716 -0.846 . . . . 25.0 108.716 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -149.84 148.93 29.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.142 0.496 . . . . 25.0 110.537 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.94 156.97 44.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.79 161.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 110.252 -0.277 . . . . 25.0 110.252 -176.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 p -70.61 140.09 51.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.042 0.448 . . . . 25.0 110.938 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -87.94 120.49 29.33 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.921 0.712 . . . . 25.0 112.921 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -77.04 133.16 39.19 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.95 62.12 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 119.47 -1.347 . . . . 25.0 115.109 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.08 142.59 24.83 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.437 1.118 . . . . 25.0 113.173 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.47 128.04 92.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.405 -1.271 . . . . 25.0 109.338 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.44 -13.18 27.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 117.875 -0.95 . . . . 25.0 112.839 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -66.08 -29.48 69.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.884 0.85 . . . . 25.0 110.886 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -96.01 141.03 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.056 -0.72 . . . . 25.0 109.056 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.62 128.57 18.32 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 115.085 -2.81 . . . . 25.0 111.53 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -25.41 60.35 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.997 -0.547 . . . . 25.0 111.993 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.37 -34.26 46.98 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.63 -0.714 . . . . 25.0 111.963 176.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.5 mpt_? -96.81 -42.92 7.73 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.195 -0.457 . . . . 25.0 110.96 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.08 1.99 11.79 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.48 2.03 . . . . 25.0 116.48 -170.08 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.69 -34.95 79.52 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.059 -0.719 . . . . 25.0 109.059 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -127.16 146.6 50.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.081 0.552 . . . . 25.0 109.985 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.58 144.67 50.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.418 -0.586 . . . . 25.0 109.418 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.74 124.83 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.526 . . . . 25.0 109.905 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.7 tt -111.49 -12.17 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.291 0.567 . . . . 25.0 109.986 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.39 147.76 8.41 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.489 -1.339 . . . . 25.0 116.092 174.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.82 131.03 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.104 -2.184 . . . . 25.0 105.104 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.99 129.71 9.08 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 118.089 0.404 . . . . 25.0 109.99 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -86.62 177.08 4.41 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 117.289 -1.341 . . . . 25.0 114.718 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -137.73 120.95 16.86 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 106.598 -1.63 . . . . 25.0 106.598 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.45 7.12 10.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 25.0 112.005 -176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.14 -99.43 0.21 Allowed Glycine 0 N--CA 1.454 -0.104 0 N-CA-C 111.469 -0.652 . . . . 25.0 111.469 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -124.45 53.56 7.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.751 1.389 . . . . 25.0 114.751 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.07 -177.18 3.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 117.563 -1.158 . . . . 25.0 110.479 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.15 -30.69 70.54 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.56 -0.713 . . . . 25.0 109.662 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 78.3 p -80.19 8.02 8.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.509 0.929 . . . . 25.0 113.509 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -60.35 -23.59 64.38 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.514 -0.741 . . . . 25.0 111.965 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -81.3 129.85 34.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 25.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.67 -9.29 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.411 0.624 . . . . 25.0 112.145 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.8 t -82.26 137.98 34.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.126 -1.064 . . . . 25.0 108.126 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -144.01 143.18 31.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.427 0.529 . . . . 25.0 112.427 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -77.63 139.51 39.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.153 -1.425 . . . . 25.0 107.153 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -131.88 120.73 45.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -98.62 136.07 39.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.312 -0.255 . . . . 25.0 110.312 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.4 mm -117.32 123.78 29.65 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.135 -1.432 . . . . 25.0 107.135 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.78 143.09 49.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 115.549 -2.501 . . . . 25.0 112.012 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.72 12.18 30.83 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.134 -0.939 . . . . 25.0 112.602 -171.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -58.85 -38.33 78.49 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.854 1.057 . . . . 25.0 113.854 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -151.82 157.24 41.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.817 0.342 . . . . 25.0 110.938 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.6 pt? -88.45 152.74 21.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 25.0 109.067 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.88 154.94 8.99 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 115.497 0.959 . . . . 25.0 115.497 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -78.82 145.03 34.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.21 159.0 43.09 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.117 -0.492 . . . . 25.0 110.004 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.3 t -118.7 133.65 64.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 104.942 -2.244 . . . . 25.0 104.942 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.4 mt -114.65 127.83 71.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.404 -1.702 . . . . 25.0 106.404 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.0 tp -124.65 120.85 33.06 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.52 42.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 25.0 109.424 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.01 140.05 50.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.465 -0.939 . . . . 25.0 108.465 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -126.96 113.92 17.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 25.0 107.709 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -105.85 131.99 52.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.843 -0.617 . . . . 25.0 111.317 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.04 136.13 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.34 54.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 115.083 1.512 . . . . 25.0 115.083 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -87.18 10.77 15.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.405 1.261 . . . . 25.0 114.405 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.3 t -145.28 161.77 38.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.231 0.538 . . . . 25.0 110.879 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -88.33 0.92 55.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.347 0.594 . . . . 25.0 110.264 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -110.08 160.84 16.11 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.914 -0.585 . . . . 25.0 110.216 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.03 154.45 41.27 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.559 -1.645 . . . . 25.0 106.559 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -105.08 137.05 43.45 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.493 -0.928 . . . . 25.0 108.493 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.67 150.1 50.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.991 -1.114 . . . . 25.0 107.991 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -146.06 129.7 17.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 173.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.96 137.94 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.295 -1.372 . . . . 25.0 107.295 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.0 mt -138.41 120.46 17.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.38 -0.97 . . . . 25.0 108.38 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.87 134.07 35.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.47 166.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.263 0.554 . . . . 25.0 110.419 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -124.54 106.69 10.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.2 103.96 14.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.07 160.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.831 1.419 . . . . 25.0 114.831 -172.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -95.11 162.2 13.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.323 -2.102 . . . . 25.0 105.323 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt . . . . . 0 C--O 1.244 0.779 0 N-CA-C 107.456 -1.313 . . . . 25.0 107.456 173.231 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 CA-C-O 120.341 -0.144 . . . . 25.0 112.948 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -112.4 158.22 20.09 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.758 0.779 . . . . 25.0 112.273 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.4 mt -103.86 121.3 55.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.561 -1.274 . . . . 25.0 107.561 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -91.34 -36.61 13.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.352 0.596 . . . . 25.0 111.441 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -140.47 146.04 43.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.18 109.27 1.35 Allowed 'Cis proline' 0 CA--C 1.539 0.749 0 C-N-CA 130.874 1.614 . . . . 25.0 115.562 -0.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.47 173.23 9.91 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 115.562 0.985 . . . . 25.0 115.562 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -86.67 131.48 34.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.619 -0.342 . . . . 25.0 111.033 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -69.76 -37.32 76.36 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.417 -0.586 . . . . 25.0 109.417 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.85 72.55 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 112.592 0.59 . . . . 25.0 112.592 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.73 85.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 25.0 110.904 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.76 -10.31 51.41 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.036 0.446 . . . . 25.0 111.558 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 178.954 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.194 0.521 . . . . 25.0 111.814 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -66.66 -12.4 58.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -78.35 -37.44 44.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.543 0.61 . . . . 25.0 111.507 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -149.43 70.05 9.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.656 0.741 . . . . 25.0 112.964 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.61 -6.75 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 N-CA-C 113.792 0.651 . . . . 25.0 113.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -87.28 -7.61 57.66 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.102 0.779 . . . . 25.0 113.102 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 t -108.58 95.43 5.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.861 1.06 . . . . 25.0 113.861 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 tt -125.21 81.38 1.96 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.101 0.477 . . . . 25.0 110.06 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -100.22 137.63 38.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.384 0.513 . . . . 25.0 112.384 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.77 114.96 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.075 -0.343 . . . . 25.0 110.075 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 112.7 0.63 . . . . 25.0 112.7 -176.682 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.542 0 N-CA-C 114.552 0.581 . . . . 25.0 114.552 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.3 pt? -67.31 -27.79 67.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.419 0.526 . . . . 25.0 112.419 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -71.45 -21.68 61.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.246 0.462 . . . . 25.0 112.246 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.03 90.83 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.904 -0.665 . . . . 25.0 112.473 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.28 68.22 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.784 -0.722 . . . . 25.0 113.541 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.58 -46.22 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.084 0.469 . . . . 25.0 109.989 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.16 -24.08 62.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.933 1.086 . . . . 25.0 113.933 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.41 -25.68 59.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 25.0 114.254 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -57.16 -21.6 34.17 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.532 0.938 . . . . 25.0 113.532 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -138.87 38.84 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.41 0.624 . . . . 25.0 109.788 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.5 t -85.98 146.75 26.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 25.0 110.715 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -63.26 -25.11 68.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.135 0.969 . . . . 25.0 109.881 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -118.77 28.19 8.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.993 -1.003 . . . . 25.0 108.733 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -47.65 140.78 5.88 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.245 -0.889 . . . . 25.0 112.982 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -79.05 146.15 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.968 0.889 . . . . 25.0 109.65 -171.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -68.82 134.68 50.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.361 -0.836 . . . . 25.0 109.388 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -121.01 139.99 52.54 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 113.453 0.908 . . . . 25.0 113.453 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -119.42 143.21 47.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.69 -1.226 . . . . 25.0 107.69 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.9 mt -94.06 128.27 45.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 102.928 -2.99 . . . . 25.0 102.928 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 89.8 mtp -140.88 164.29 30.63 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 107.554 -1.276 . . . . 25.0 107.554 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.0 p -92.44 174.06 7.48 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 104.494 -2.409 . . . . 25.0 104.494 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.401 ' H ' ' HG3' ' A' ' 140' ' ' GLU . . . -74.52 -162.27 8.9 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.846 -0.902 . . . . 25.0 110.846 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.6 -178.13 27.33 Favored Glycine 0 C--N 1.323 -0.173 0 CA-C-O 121.452 0.473 . . . . 25.0 112.392 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.4 131.35 43.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.948 -0.736 . . . . 25.0 109.222 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.12 158.55 37.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.853 -1.166 . . . . 25.0 107.853 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 m -120.38 126.68 51.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.11 0.481 . . . . 25.0 109.73 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.62 135.77 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.526 -2.027 . . . . 25.0 105.526 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.1 m -138.07 128.52 26.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.036 0.384 . . . . 25.0 112.036 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -117.96 149.98 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.5 t -137.85 160.12 40.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.9 143.87 38.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 p -80.78 -16.82 52.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.0 151.81 63.4 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.83 144.99 61.08 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 116.54 -1.84 . . . . 25.0 111.521 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -131.16 148.58 52.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 25.0 109.262 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.08 157.34 33.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.9 m -160.07 148.31 16.94 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 104.093 -2.558 . . . . 25.0 104.093 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -92.1 -51.63 5.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' H ' ' HB3' ' A' ' 153' ' ' ASP . 16.4 pt20 -156.12 170.61 21.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.309 -0.626 . . . . 25.0 109.309 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -149.56 142.52 24.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.915 -1.143 . . . . 25.0 107.915 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -148.04 154.55 40.4 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.226 -0.296 . . . . 25.0 111.162 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -120.02 133.81 55.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.368 -0.833 . . . . 25.0 109.391 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -121.62 163.67 18.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.383 -1.71 . . . . 25.0 106.383 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.37 165.18 29.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 t -126.12 135.71 52.02 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-O 121.435 0.636 . . . . 25.0 111.452 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -109.06 118.78 37.67 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.838 -0.619 . . . . 25.0 112.323 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -75.98 156.02 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.416 -1.327 . . . . 25.0 107.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.97 10.55 15.76 Favored Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.955 -0.64 . . . . 25.0 114.24 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -60.69 162.88 6.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.306 0.574 . . . . 25.0 112.439 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.55 144.98 92.16 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.785 -1.561 . . . . 25.0 106.785 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.7 -23.11 14.81 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 116.638 -1.774 . . . . 25.0 115.001 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -104.64 24.93 10.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.093 0.949 . . . . 25.0 112.721 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -122.97 160.47 49.29 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 105.752 -1.944 . . . . 25.0 105.752 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.64 83.46 1.74 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 116.14 -2.107 . . . . 25.0 112.868 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.27 -39.19 72.24 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 121.511 0.672 . . . . 25.0 110.019 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -16.61 6.58 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.475 1.287 . . . . 25.0 114.475 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -93.81 -46.76 7.07 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 112.447 0.536 . . . . 25.0 112.447 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.97 -17.17 41.44 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.898 1.814 . . . . 25.0 115.898 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.93 -26.32 65.91 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.325 1.232 . . . . 25.0 114.325 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -103.32 125.17 49.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.464 0.65 . . . . 25.0 111.257 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.74 141.0 52.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.782 -0.644 . . . . 25.0 109.695 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.41 128.15 32.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.513 -0.551 . . . . 25.0 109.513 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.6 tt -111.0 -3.65 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.609 0.719 . . . . 25.0 110.33 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.26 150.96 6.68 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.749 -0.739 . . . . 25.0 113.42 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.54 140.68 31.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.958 -0.756 . . . . 25.0 108.958 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.38 112.36 8.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 123.326 0.391 . . . . 25.0 109.989 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.73 158.86 28.18 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 114.877 -2.949 . . . . 25.0 111.326 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -105.83 91.9 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 103.154 -2.906 . . . . 25.0 103.154 175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -156.6 56.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.663 0.744 . . . . 25.0 110.973 -172.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.62 12.97 43.35 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.062 -0.589 . . . . 25.0 113.839 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.27 156.85 7.22 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.271 1.212 . . . . 25.0 114.271 -173.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.08 -163.8 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.369 1.379 . . . . 25.0 112.146 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.07 -25.57 0.6 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 117.21 2.3 . . . . 25.0 117.21 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.8 t -62.39 -18.34 61.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.616 0.598 . . . . 25.0 112.616 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -58.88 -25.13 63.07 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.249 1.02 . . . . 25.0 112.547 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -59.0 135.61 57.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.882 0.697 . . . . 25.0 112.882 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.57 -7.78 51.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.124 -0.944 . . . . 25.0 111.527 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -100.0 120.02 39.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.123 -2.547 . . . . 25.0 104.123 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.5 136.26 39.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 -171.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -83.27 136.75 34.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.31 -1.737 . . . . 25.0 106.31 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.0 mm -131.96 131.19 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 105.971 -1.862 . . . . 25.0 105.971 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -93.34 130.87 38.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.603 -0.518 . . . . 25.0 109.603 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.6 mt -126.1 136.47 28.56 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.047 -1.464 . . . . 25.0 107.047 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.3 168.1 24.37 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 117.22 -1.386 . . . . 25.0 113.015 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 77' ' ' GLY . 28.0 tt0 -127.24 35.98 4.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -86.18 -31.4 21.8 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.986 1.106 . . . . 25.0 113.986 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -146.22 169.66 18.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.114 -0.328 . . . . 25.0 110.114 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.3 pt? -107.68 152.02 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.874 0.694 . . . . 25.0 112.874 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.29 157.75 7.33 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.721 -0.672 . . . . 25.0 112.078 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 15.8 p90 -84.03 144.94 28.77 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.732 0.777 . . . . 25.0 113.042 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -138.06 135.01 35.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.7 t -98.0 134.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.263 -1.754 . . . . 25.0 106.263 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.02 125.31 61.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -104.69 109.68 21.7 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.401 -1.333 . . . . 25.0 107.401 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -108.09 123.8 49.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.63 133.1 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.663 -0.865 . . . . 25.0 108.663 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -121.25 107.58 12.72 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.537 -1.283 . . . . 25.0 107.537 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 52.2 t0 -82.67 90.69 6.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 25.0 109.98 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.59 119.32 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.043 -1.095 . . . . 25.0 108.043 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.32 11.89 22.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 25.0 112.101 -174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.96 -2.97 30.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.046 0.387 . . . . 25.0 112.046 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.7 p -143.83 168.5 19.8 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.671 0.272 . . . . 25.0 111.512 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.26 1.07 34.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.957 0.884 . . . . 25.0 109.371 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.14 155.04 18.69 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 150.86 41.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 103.197 -2.89 . . . . 25.0 103.197 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.33 138.57 47.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.593 -0.521 . . . . 25.0 109.593 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -138.97 154.02 48.25 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.135 -1.061 . . . . 25.0 108.135 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.16 152.3 45.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.467 -1.679 . . . . 25.0 106.467 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.97 145.46 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.538 -0.542 . . . . 25.0 109.538 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.2 mt -136.24 125.19 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.086 -2.561 . . . . 25.0 104.086 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -111.15 130.63 55.57 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.31 -1.367 . . . . 25.0 107.31 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.73 134.93 58.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 1.0 OUTLIER -93.17 100.52 12.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.55 -2.018 . . . . 25.0 105.55 176.288 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.0 mt -92.88 130.21 38.54 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.915 -1.513 . . . . 25.0 106.915 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 10.1 m -127.04 158.01 38.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 113.871 1.063 . . . . 25.0 113.871 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -93.82 161.47 14.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.299 -1.371 . . . . 25.0 107.299 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt . . . . . 0 C--O 1.243 0.723 0 CA-C-O 118.472 -0.775 . . . . 25.0 109.409 175.293 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.32 0 N-CA-C 107.906 -2.078 . . . . 25.0 107.906 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -134.06 161.7 34.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.015 0.908 . . . . 25.0 108.907 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.98 121.77 66.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.938 -1.505 . . . . 25.0 106.938 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -12.27 60.58 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.95 1.092 . . . . 25.0 113.95 -174.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt 79.68 149.69 0.12 Allowed Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 126.195 1.798 . . . . 25.0 108.161 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.31 156.72 91.42 Favored 'Cis proline' 0 C--N 1.346 0.425 0 CA-C-O 121.181 0.409 . . . . 25.0 112.371 -0.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.7 10.53 30.63 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 116.262 1.265 . . . . 25.0 116.262 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -64.5 126.93 29.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.945 0.872 . . . . 25.0 111.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -77.95 -19.12 55.16 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 116.345 -0.389 . . . . 25.0 110.231 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.79 69.64 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.75 -0.205 . . . . 25.0 111.191 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -25.12 65.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 25.0 110.811 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.28 0.56 51.03 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 122.915 0.486 . . . . 25.0 110.567 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 111.997 0.369 . . . . 25.0 111.997 -176.775 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 121.021 0.439 . . . . 25.0 110.559 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.6 ptm -60.32 -10.44 4.72 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.53 -46.61 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.576 0.625 . . . . 25.0 109.983 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.02 69.41 5.61 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 113.185 0.809 . . . . 25.0 113.185 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.32 3.12 6.06 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 N-CA-C 113.71 0.619 . . . . 25.0 113.71 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -101.32 -2.44 31.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.497 0.555 . . . . 25.0 112.497 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.94 97.4 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.662 0.986 . . . . 25.0 113.662 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.96 112.29 24.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.504 -1.665 . . . . 25.0 106.504 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -89.03 110.19 20.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.977 0.732 . . . . 25.0 112.977 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.55 152.42 20.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.084 -1.821 . . . . 25.0 106.084 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.1 tttt . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 112.171 0.434 . . . . 25.0 112.171 -179.192 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.523 0 N-CA-C 112.305 -0.318 . . . . 25.0 112.305 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.3 mt -72.26 -25.97 61.81 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.704 . . . . 25.0 110.291 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.561 -0.533 . . . . 25.0 109.561 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -24.99 69.5 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.926 -0.869 . . . . 25.0 110.926 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.86 -16.9 68.81 Favored Glycine 0 C--O 1.228 -0.26 0 O-C-N 122.774 -0.251 . . . . 25.0 112.536 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mm -66.16 -40.1 86.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mp -75.81 -26.89 57.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 25.0 111.15 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.78 -22.01 66.7 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.149 0.5 . . . . 25.0 111.589 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.73 -5.93 18.48 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.865 -0.522 . . . . 25.0 112.156 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -130.65 35.15 4.04 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -106.62 156.54 18.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 25.0 111.101 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -68.66 -31.02 69.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.811 -0.811 . . . . 25.0 108.811 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -97.48 21.39 10.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.564 -0.744 . . . . 25.0 110.409 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -52.31 136.1 31.51 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.057 0.456 . . . . 25.0 111.5 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 146.03 46.44 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 122.686 1.231 . . . . 25.0 112.33 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -75.7 148.78 38.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.383 -1.28 . . . . 25.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -103.03 126.87 50.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -100.1 108.79 21.03 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.182 -0.607 . . . . 25.0 109.658 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.55 138.6 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.67 -0.863 . . . . 25.0 108.67 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.4 tpt -151.04 154.09 36.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.202 -0.666 . . . . 25.0 109.202 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.2 p -91.16 -179.48 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.838 -1.171 . . . . 25.0 107.838 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.45 -168.88 31.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 116.445 1.338 . . . . 25.0 116.445 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.92 170.72 36.92 Favored Glycine 0 C--N 1.329 0.162 0 N-CA-C 108.864 -1.694 . . . . 25.0 108.864 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.77 148.3 28.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 119.309 1.555 . . . . 25.0 108.477 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -134.19 157.96 44.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.611 -1.255 . . . . 25.0 107.611 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -124.95 125.74 44.39 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.46 140.89 48.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.189 -1.041 . . . . 25.0 108.189 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -132.58 132.42 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.608 0.568 . . . . 25.0 111.993 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -118.47 150.06 40.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.0 p -133.84 161.71 34.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.99 158.11 42.32 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.867 -1.531 . . . . 25.0 106.867 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 t -69.83 -27.02 64.51 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.347 0.499 . . . . 25.0 112.347 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.13 61.17 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 106.684 -1.598 . . . . 25.0 106.684 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.39 152.03 65.82 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 115.956 -2.229 . . . . 25.0 110.038 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.15 147.57 52.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -61.03 137.01 58.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 m -146.16 144.66 30.09 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.9 t -91.56 -48.03 7.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.487 -0.56 . . . . 25.0 109.487 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -166.2 169.65 14.11 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.298 -0.251 . . . . 25.0 111.369 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -141.9 141.0 32.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 166.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.8 156.42 42.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.605 -0.27 . . . . 25.0 110.84 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -130.67 142.94 50.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.809 -0.632 . . . . 25.0 111.535 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -132.3 164.96 25.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.9 pt -130.31 157.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.9 p -96.71 133.63 41.0 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-O 121.148 0.499 . . . . 25.0 111.273 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -92.22 99.57 12.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.627 0.727 . . . . 25.0 111.98 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -76.16 148.14 38.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.407 -1.331 . . . . 25.0 107.407 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 22.19 40.32 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 115.579 0.992 . . . . 25.0 115.579 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -56.93 148.74 20.31 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.686 0.743 . . . . 25.0 111.705 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.96 138.79 46.2 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.204 -1.036 . . . . 25.0 108.204 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.98 -15.91 29.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 117.617 -1.122 . . . . 25.0 112.261 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.15 -22.06 64.88 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.023 0.929 . . . . 25.0 111.577 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -113.75 153.79 45.89 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.944 -0.571 . . . . 25.0 109.55 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.08 107.03 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 117.987 -0.876 . . . . 25.0 113.633 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -52.72 -46.87 67.57 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.193 -0.912 . . . . 25.0 112.742 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -54.35 -38.48 66.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.184 -0.462 . . . . 25.0 112.094 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.71 -44.28 23.88 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.894 -0.594 . . . . 25.0 111.944 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.43 -24.69 62.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.765 1.394 . . . . 25.0 114.765 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -68.07 -23.81 65.0 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.812 1.412 . . . . 25.0 114.812 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -123.02 135.18 54.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.003 -1.061 . . . . 25.0 112.508 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -128.15 133.11 48.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.464 -0.939 . . . . 25.0 108.464 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.11 120.56 23.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.708 -0.849 . . . . 25.0 108.708 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.2 tt -96.3 -10.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.478 0.656 . . . . 25.0 110.094 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.05 160.27 13.1 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.323 -0.942 . . . . 25.0 113.935 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.69 146.71 29.38 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.096 -1.075 . . . . 25.0 108.096 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -135.25 106.84 10.23 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.09 160.57 39.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 114.902 -2.932 . . . . 25.0 110.743 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -118.51 94.19 4.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.395 1.093 . . . . 25.0 108.804 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.17 -94.71 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.033 -2.951 . . . . 25.0 103.033 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.26 128.54 9.6 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.3 t -163.49 145.07 7.44 Favored Pre-proline 0 C--O 1.242 0.708 0 CA-C-N 117.159 0.48 . . . . 25.0 109.959 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -76.08 -154.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.516 1.477 . . . . 25.0 110.744 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -18.84 4.47 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.129 1.529 . . . . 25.0 115.129 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.6 t -66.87 -6.73 17.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.825 0.676 . . . . 25.0 112.825 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.92 -14.87 63.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.423 0.689 . . . . 25.0 110.807 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -66.59 150.66 48.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.495 0.664 . . . . 25.0 112.205 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.06 -12.51 60.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.182 -0.917 . . . . 25.0 110.209 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -89.68 120.81 31.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.231 -1.766 . . . . 25.0 106.231 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -135.07 134.15 40.05 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.277 0.473 . . . . 25.0 112.277 -173.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -82.28 139.31 34.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.812 -0.631 . . . . 25.0 109.973 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.19 121.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 106.395 -1.706 . . . . 25.0 106.395 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -80.65 135.36 36.02 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.036 -0.728 . . . . 25.0 109.036 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.0 mm -122.94 117.85 28.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.47 158.05 51.85 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 115.947 -2.235 . . . . 25.0 110.577 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -112.35 51.65 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.948 -1.501 . . . . 25.0 106.948 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.29 -26.01 16.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.039 -0.982 . . . . 25.0 111.731 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -158.09 160.13 37.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.301 . . . . 25.0 110.782 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 pt? -100.13 137.54 38.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 172.26 144.53 4.57 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 122.348 0.971 . . . . 25.0 115.453 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -95.72 144.96 25.67 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 112.664 0.616 . . . . 25.0 112.664 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -148.95 163.57 37.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.369 -0.974 . . . . 25.0 108.369 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.1 t -93.43 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.384 -0.969 . . . . 25.0 108.384 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.04 129.22 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 105.893 -1.892 . . . . 25.0 105.893 171.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.32 141.86 45.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.001 -1.852 . . . . 25.0 106.001 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.36 143.99 40.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.716 -0.475 . . . . 25.0 109.716 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.07 135.11 62.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.442 -0.948 . . . . 25.0 108.442 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -126.08 118.5 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -111.76 134.62 53.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.949 0.351 . . . . 25.0 111.949 -173.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.28 128.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.781 -1.563 . . . . 25.0 106.781 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -31.17 65.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 25.0 111.533 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -75.26 -2.03 26.19 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.0 p -123.01 155.01 37.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.748 0.785 . . . . 25.0 112.699 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -83.24 -6.36 59.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.124 -0.695 . . . . 25.0 109.124 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -109.25 153.83 23.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.2 -0.909 . . . . 25.0 109.544 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.86 150.63 51.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -119.66 135.81 54.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.037 0.446 . . . . 25.0 111.239 -168.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -127.09 153.88 45.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -146.19 156.18 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.69 138.78 48.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.585 . . . . 25.0 109.422 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.5 mt -140.04 121.43 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.66 140.52 29.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.703 -0.851 . . . . 25.0 108.703 174.561 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.78 157.56 42.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -128.81 118.58 23.0 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 104.293 -2.484 . . . . 25.0 104.293 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.7 mt -108.25 121.91 45.86 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 104.627 -2.36 . . . . 25.0 104.627 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 18.7 m -130.86 160.4 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.12 1.155 . . . . 25.0 114.12 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -95.13 157.51 15.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.307 -1.738 . . . . 25.0 106.307 174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.9 tptt . . . . . 0 C--O 1.251 1.139 0 O-C-N 124.297 0.998 . . . . 25.0 110.83 174.601 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.853 0 CA-C-O 119.632 -0.538 . . . . 25.0 113.911 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -150.96 170.96 18.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.173 0.589 . . . . 25.0 109.431 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 tt -106.86 131.86 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.074 0.464 . . . . 25.0 110.245 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -85.15 -47.94 9.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.266 1.031 . . . . 25.0 111.054 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.21 149.69 56.04 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.771 -1.104 . . . . 25.0 108.552 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.17 98.59 0.23 Allowed 'Cis proline' 0 CA--C 1.545 1.041 0 C-N-CA 131.498 1.874 . . . . 25.0 114.52 -1.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.9 138.82 7.26 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 121.657 0.587 . . . . 25.0 113.593 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 t -68.21 145.53 54.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.612 0.72 . . . . 25.0 112.71 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.385 -0.825 . . . . 25.0 110.248 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -26.43 68.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.291 0.848 . . . . 25.0 113.291 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.76 88.71 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 112.079 0.4 . . . . 25.0 112.079 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.92 -3.92 55.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.579 0.704 . . . . 25.0 111.605 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.218 -0.597 0 CA-C-N 115.335 -0.848 . . . . 25.0 109.84 179.479 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.943 0.401 . . . . 25.0 110.695 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.33 -14.21 10.82 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 115.3 1.593 . . . . 25.0 115.3 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -71.47 -37.72 71.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.427 0.558 . . . . 25.0 110.111 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.81 68.26 10.62 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 121.64 0.733 . . . . 25.0 111.797 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.91 -8.97 23.14 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 117.541 -1.173 . . . . 25.0 112.829 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -83.77 -9.9 58.47 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.718 -0.475 . . . . 25.0 109.718 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 t -81.37 104.15 11.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.462 0.649 . . . . 25.0 110.037 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.6 mt -122.91 74.02 1.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.494 -0.775 . . . . 25.0 109.325 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -142.02 135.68 29.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.664 0.386 . . . . 25.0 111.142 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.51 32.54 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt . . . . . 0 C--N 1.322 -0.609 0 O-C-N 122.047 -0.408 . . . . 25.0 109.954 -178.874 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.663 0 N-CA-C 114.092 0.397 . . . . 25.0 114.092 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.13 -37.99 13.03 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.137 -0.625 . . . . 25.0 111.897 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -84.77 -13.72 50.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.692 0.997 . . . . 25.0 113.692 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.4 -15.92 64.32 Favored Glycine 0 C--O 1.216 -1.024 0 C-N-CA 121.496 -0.383 . . . . 25.0 112.87 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.15 -24.34 68.71 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.654 -0.784 . . . . 25.0 112.843 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -66.67 -41.54 88.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -72.15 -29.37 63.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.041 -0.527 . . . . 25.0 110.537 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.44 -19.78 65.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.282 0.475 . . . . 25.0 112.282 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -66.29 -11.8 52.68 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.046 -0.409 . . . . 25.0 111.082 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -137.86 64.91 1.5 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.582 -1.266 . . . . 25.0 107.582 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.5 t -135.75 159.58 41.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.318 -0.401 . . . . 25.0 110.742 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.75 -32.33 72.86 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.984 0.897 . . . . 25.0 109.488 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -96.88 22.04 8.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.438 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -49.59 134.5 19.68 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.946 0.879 . . . . 25.0 112.916 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.12 154.81 38.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.906 -1.043 . . . . 25.0 112.678 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -80.49 129.53 34.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.792 -0.818 . . . . 25.0 108.792 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 152.79 21.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.929 0.395 . . . . 25.0 111.746 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.78 100.35 6.14 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.534 0.334 . . . . 25.0 110.694 174.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.9 mt -78.52 131.02 35.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.149 -1.056 . . . . 25.0 108.149 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.3 mtm -143.32 163.81 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.263 0.625 . . . . 25.0 110.309 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.3 p -93.14 -179.46 5.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.958 -1.867 . . . . 25.0 105.958 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.9 30.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.778 -0.725 . . . . 25.0 111.319 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.73 -160.76 16.99 Favored Glycine 0 CA--C 1.517 0.171 0 O-C-N 122.269 -0.548 . . . . 25.0 114.053 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.59 137.56 38.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.946 0.403 . . . . 25.0 111.425 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -132.6 139.95 48.02 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.013 -0.736 . . . . 25.0 109.013 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.2 m -120.35 111.43 17.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -93.15 116.37 28.97 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.0 m -119.28 93.47 4.09 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.149 -0.686 . . . . 25.0 109.149 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -89.06 133.59 34.3 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.884 -1.525 . . . . 25.0 106.884 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -123.77 136.62 54.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -126.4 148.57 49.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 120.985 0.422 . . . . 25.0 110.308 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -120.64 31.35 6.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.623 -1.992 . . . . 25.0 105.623 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.66 125.08 91.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 114.619 -1.173 . . . . 25.0 109.43 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.08 26.39 0.65 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 120.227 0.618 . . . . 25.0 112.615 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -130.9 149.48 52.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 25.0 111.495 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -69.78 156.42 39.05 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.21 -0.663 . . . . 25.0 109.21 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -123.03 149.53 44.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.049 -1.834 . . . . 25.0 106.049 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -93.95 -56.85 2.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.074 0.464 . . . . 25.0 110.501 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -161.63 173.77 14.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.815 -0.439 . . . . 25.0 109.815 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.32 152.69 39.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.735 -0.666 . . . . 25.0 109.698 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -146.73 141.82 27.17 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -140.83 149.12 41.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.836 0.827 . . . . 25.0 112.53 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.07 160.51 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.617 -1.174 . . . . 25.0 109.397 -172.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.5 158.88 42.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.314 -0.995 . . . . 25.0 108.314 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.419 ' CG2' ' H ' ' A' ' 147' ' ' VAL . 1.1 t -96.86 126.96 42.38 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 113.227 0.825 . . . . 25.0 113.227 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -99.47 103.33 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.644 -1.243 . . . . 25.0 107.644 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -70.91 152.36 43.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.13 10.08 24.8 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.731 -0.483 . . . . 25.0 113.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -62.02 153.81 28.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.76 0.79 . . . . 25.0 109.817 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.54 151.29 85.03 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.03 -11.35 27.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 113.499 0.538 . . . . 25.0 113.499 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -74.46 -6.16 46.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.544 0.687 . . . . 25.0 111.511 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -105.07 135.82 19.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 121.812 -0.555 . . . . 25.0 111.161 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.89 123.21 10.42 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.588 -1.141 . . . . 25.0 113.002 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -52.62 -49.41 65.16 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 114.415 1.265 . . . . 25.0 114.415 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -64.72 -11.05 31.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.746 1.017 . . . . 25.0 113.746 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -104.69 -48.96 3.64 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 112.231 0.456 . . . . 25.0 112.231 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.81 -22.46 58.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 -170.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.16 -28.77 67.58 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.535 -0.466 . . . . 25.0 111.895 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -124.6 144.89 49.91 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -126.7 144.29 50.97 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.998 0.428 . . . . 25.0 110.516 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.39 126.79 30.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.6 tp -115.21 1.82 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 121.997 0.904 . . . . 25.0 109.027 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.55 156.08 9.03 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 115.838 1.095 . . . . 25.0 115.838 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.62 128.04 16.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.1 t -140.5 123.09 9.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.568 0.347 . . . . 25.0 110.336 -170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.7 168.58 20.9 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 117.191 -1.406 . . . . 25.0 111.973 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -82.65 121.0 26.28 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.891 -0.723 . . . . 25.0 111.987 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.77 33.14 22.86 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.92 1.822 . . . . 25.0 115.92 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.43 165.12 44.11 Favored Glycine 0 C--O 1.219 -0.84 0 N-CA-C 110.968 -0.853 . . . . 25.0 110.968 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.3 t -54.9 -47.41 98.42 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 117.3 2.333 . . . . 25.0 117.3 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.08 159.82 49.03 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 114.17 -3.42 . . . . 25.0 114.648 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.75 -14.23 20.02 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.817 1.043 . . . . 25.0 113.817 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.7 p -68.88 -10.47 57.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.802 0.297 . . . . 25.0 111.802 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.64 -16.89 29.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.424 1.268 . . . . 25.0 114.424 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.55 141.51 58.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.334 0.587 . . . . 25.0 111.625 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 tp -72.21 -25.42 61.64 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.439 -0.948 . . . . 25.0 108.439 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.9 t -89.23 134.04 34.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -138.86 150.92 46.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.619 0.723 . . . . 25.0 112.658 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -92.53 132.89 36.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.239 -1.022 . . . . 25.0 108.239 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.1 mm -132.62 119.15 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.242 -1.021 . . . . 25.0 108.242 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -82.27 139.47 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.253 -1.017 . . . . 25.0 108.253 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -125.93 128.22 24.58 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.64 167.33 26.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 CA-C-N 118.566 0.524 . . . . 25.0 111.592 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -122.91 30.51 6.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.655 0.741 . . . . 25.0 111.523 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -78.37 -20.72 50.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.993 -0.548 . . . . 25.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -143.35 169.84 16.91 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.665 -0.495 . . . . 25.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 150.41 47.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.832 -0.622 . . . . 25.0 109.545 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.08 165.5 12.62 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.469 0.547 . . . . 25.0 114.469 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 40.2 p90 -86.94 147.21 25.86 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.744 1.016 . . . . 25.0 113.744 -176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -139.65 158.92 43.31 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.525 -1.216 . . . . 25.0 108.001 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.419 ' H ' ' CG2' ' A' ' 100' ' ' THR . 52.8 t -116.41 136.54 53.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.3 mt -106.49 129.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.001 -1.851 . . . . 25.0 106.001 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.25 135.58 50.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.926 -0.398 . . . . 25.0 109.926 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.0 130.18 31.07 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.614 -0.266 . . . . 25.0 110.721 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.79 128.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 106.299 -1.741 . . . . 25.0 106.299 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -125.64 108.67 11.78 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -96.17 107.72 20.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.978 -0.556 . . . . 25.0 112.327 -171.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.47 135.46 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.514 -1.291 . . . . 25.0 107.514 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.01 -32.23 27.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 25.0 111.849 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -79.28 -12.68 59.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.733 1.383 . . . . 25.0 114.733 -170.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.0 p -139.21 165.8 26.22 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.166 0.802 . . . . 25.0 113.166 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.61 5.2 16.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.546 0.689 . . . . 25.0 110.756 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -102.79 150.08 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.908 -1.145 . . . . 25.0 107.908 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.23 170.55 21.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 102.544 -3.132 . . . . 25.0 102.544 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.444 ' HB3' HE22 ' A' ' 163' ' ' GLN . 23.7 t80 -143.48 151.83 40.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.765 1.166 . . . . 25.0 113.411 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.93 120.5 41.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.444 HE22 ' HB3' ' A' ' 161' ' ' PHE . 19.9 mm-40 -94.53 130.82 40.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.99 -2.226 . . . . 25.0 104.99 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.5 p -133.11 133.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.824 -0.806 . . . . 25.0 108.824 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.35 128.69 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -85.3 133.03 34.17 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.789 -0.819 . . . . 25.0 108.789 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 149.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 36.3 t0 -120.41 111.11 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.625 -1.991 . . . . 25.0 105.625 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.0 mt -109.18 104.63 13.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.72 168.02 19.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.129 -0.487 . . . . 25.0 111.92 -173.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -80.78 135.97 36.05 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.9 pttm . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.344 -1.313 . . . . 25.0 111.287 176.112 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.294 0 N-CA-C 110.529 -1.029 . . . . 25.0 110.529 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -98.24 149.77 22.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.798 -0.816 . . . . 25.0 108.798 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -102.32 126.77 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 122.427 0.291 . . . . 25.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -103.47 -34.3 8.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.684 0.754 . . . . 25.0 111.054 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.27 143.01 16.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.0 137.63 50.79 Favored 'Cis proline' 0 C--N 1.352 0.736 0 N-CA-C 117.863 2.216 . . . . 25.0 117.863 2.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 137.12 2.94 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 117.388 1.715 . . . . 25.0 117.388 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -76.17 147.98 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.116 0.484 . . . . 25.0 111.249 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -68.22 -37.96 81.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.669 . . . . 25.0 111.602 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.83 66.42 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.67 -28.02 69.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.255 0.465 . . . . 25.0 112.255 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.94 -9.16 44.11 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 111.85 0.315 . . . . 25.0 111.85 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 C--O 1.217 -0.641 0 CA-C-O 121.251 0.548 . . . . 25.0 110.839 -177.033 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 113.749 1.018 . . . . 25.0 113.749 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -68.63 -14.26 62.9 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.156 -0.965 . . . . 25.0 112.957 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.64 -37.64 49.58 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.87 -0.332 . . . . 25.0 111.68 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -149.63 63.58 6.54 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.115 1.154 . . . . 25.0 114.115 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.28 -9.15 25.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 118.096 -0.803 . . . . 25.0 114.083 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -97.82 -0.19 45.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.241 0.46 . . . . 25.0 112.241 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -87.3 94.13 9.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.764 -1.199 . . . . 25.0 107.764 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -129.78 133.43 46.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -125.9 131.89 52.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.444 0.566 . . . . 25.0 109.731 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.01 163.53 32.45 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.98 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.8 mttt . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 112.973 0.731 . . . . 25.0 112.973 -176.567 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.535 0 CA-C-O 120.139 -0.256 . . . . 25.0 113.588 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -62.1 -45.9 91.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.925 0.869 . . . . 25.0 109.534 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -84.87 -13.19 51.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.49 -0.777 . . . . 25.0 110.598 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.34 86.18 Favored Glycine 0 C--O 1.216 -0.989 0 CA-C-N 116.072 -0.513 . . . . 25.0 112.475 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.64 77.63 Favored Glycine 0 C--O 1.222 -0.607 0 C-N-CA 120.358 -0.925 . . . . 25.0 112.493 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.51 -43.82 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.54 -34.42 75.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.722 -0.672 . . . . 25.0 110.689 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.42 -30.66 70.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -68.04 -6.05 20.62 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.604 -0.685 . . . . 25.0 111.921 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -130.3 37.5 3.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.34 -0.615 . . . . 25.0 109.34 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -120.42 169.54 10.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 25.0 109.794 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.99 -28.1 68.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.495 0.664 . . . . 25.0 109.983 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -96.18 19.99 10.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.621 -0.718 . . . . 25.0 111.438 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -49.75 135.58 18.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.602 0.715 . . . . 25.0 111.536 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -87.76 154.75 20.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.057 0.932 . . . . 25.0 110.428 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -66.41 147.14 53.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 25.0 110.152 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -116.22 132.32 56.7 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.468 -0.938 . . . . 25.0 108.468 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -119.9 135.89 54.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.99 136.29 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.29 -1.745 . . . . 25.0 106.29 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.1 ttt -150.59 168.14 25.17 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.236 -1.765 . . . . 25.0 106.236 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.8 p -90.52 166.7 13.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.79 -1.93 . . . . 25.0 105.79 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.25 -164.28 10.65 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 117.925 0.33 . . . . 25.0 113.667 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.06 -175.77 31.24 Favored Glycine 0 N--CA 1.458 0.114 0 O-C-N 122.348 -0.501 . . . . 25.0 112.2 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 15.0 tt0 -69.73 134.65 48.86 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.754 -0.85 . . . . 25.0 109.444 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -125.59 158.23 35.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.561 -0.903 . . . . 25.0 108.561 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.0 m -117.63 116.28 26.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.898 -1.89 . . . . 25.0 105.898 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -93.01 136.87 32.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 105.901 -1.889 . . . . 25.0 105.901 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -127.62 115.53 18.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 25.0 110.469 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -122.3 145.2 48.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.387 -2.449 . . . . 25.0 104.387 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -145.02 156.74 44.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 25.0 109.622 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -139.82 154.45 47.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -71.42 -13.25 61.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.398 0.888 . . . . 25.0 113.398 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.12 158.34 64.72 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.275 -1.009 . . . . 25.0 108.275 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.16 150.86 72.36 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 114.581 -3.146 . . . . 25.0 109.594 170.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -130.98 132.81 45.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.361 -0.978 . . . . 25.0 108.361 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -66.05 144.89 56.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 25.0 109.689 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -162.92 152.07 15.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.368 -3.197 . . . . 25.0 102.368 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 -40.13 10.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.715 0.769 . . . . 25.0 108.946 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -156.1 148.96 24.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.799 -0.815 . . . . 25.0 108.799 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.59 142.31 39.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.32 -1.363 . . . . 25.0 107.32 170.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 156.33 42.69 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.394 -0.191 . . . . 25.0 110.723 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -130.52 144.94 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.642 0.589 . . . . 25.0 111.3 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -131.96 159.7 37.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.021 -1.844 . . . . 25.0 106.021 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.447 HD12 ' HB ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -135.96 158.1 38.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.423 -0.954 . . . . 25.0 108.423 175.065 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.9 p -103.23 138.69 39.69 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.489 0.661 . . . . 25.0 110.942 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.0 117.72 27.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.98 128.36 34.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 102.575 -3.121 . . . . 25.0 102.575 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.67 30.67 12.75 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 118.856 -1.64 . . . . 25.0 113.611 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -51.77 148.16 5.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.688 0.744 . . . . 25.0 110.172 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -68.97 129.43 92.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.998 -0.547 . . . . 25.0 110.22 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.22 -14.03 25.7 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 118.484 -0.544 . . . . 25.0 113.451 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.5 -10.23 59.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.778 0.799 . . . . 25.0 110.808 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -116.55 148.99 43.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.558 -0.534 . . . . 25.0 109.558 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.2 125.93 15.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 116.616 -1.79 . . . . 25.0 112.059 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 tt -52.99 -50.43 64.16 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.079 -0.964 . . . . 25.0 113.158 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -68.55 -2.96 10.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.748 1.388 . . . . 25.0 114.748 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.86 -49.33 3.53 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.138 0.494 . . . . 25.0 111.703 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.06 50.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.186 1.55 . . . . 25.0 115.186 -170.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -77.63 -29.05 51.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.479 0.548 . . . . 25.0 112.479 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -126.01 151.12 47.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.694 0.628 . . . . 25.0 112.694 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.11 154.66 47.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.71 128.04 33.98 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.098 -0.704 . . . . 25.0 109.098 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.447 ' HB ' HD12 ' A' ' 99' ' ' ILE . 10.0 tt -104.25 -9.47 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.297 0.57 . . . . 25.0 111.609 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.92 160.12 21.62 Favored Glycine 0 CA--C 1.511 -0.197 0 C-N-CA 119.86 -1.162 . . . . 25.0 114.33 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.55 142.03 25.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.779 -1.193 . . . . 25.0 107.779 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.32 111.62 10.84 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.78 163.96 25.85 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 116.013 -2.192 . . . . 25.0 111.299 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -138.45 113.88 9.6 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.219 1.009 . . . . 25.0 109.276 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -172.44 -107.2 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 99.111 -4.403 . . . . 25.0 99.111 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.53 54.19 4.9 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.377 -1.089 . . . . 25.0 110.377 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 t -81.99 132.88 52.57 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 122.382 -0.481 . . . . 25.0 110.245 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.08 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 121.691 1.594 . . . . 25.0 111.423 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -21.06 8.42 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.9 t -64.71 -8.0 12.99 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -62.56 -14.16 39.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.282 1.215 . . . . 25.0 114.282 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.17 137.8 58.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -20.33 63.75 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -99.97 132.99 44.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -137.43 149.82 47.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -81.66 133.31 35.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.408 -1.701 . . . . 25.0 106.408 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.98 118.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.552 -2.018 . . . . 25.0 105.552 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 49.6 t80 -84.57 125.67 32.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.14 104.28 25.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 120.508 0.194 . . . . 25.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.63 150.9 51.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 116.027 -2.182 . . . . 25.0 109.486 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.2 102.75 3.26 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.496 -0.557 . . . . 25.0 109.496 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -91.73 -17.93 24.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.489 0.552 . . . . 25.0 112.489 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -140.93 169.91 16.74 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.41 128.97 36.64 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.751 -1.203 . . . . 25.0 107.751 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -179.36 163.37 30.77 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.202 2.041 . . . . 25.0 118.202 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 19.6 p90 -87.09 147.04 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.64 -1.28 . . . . 25.0 110.384 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -134.94 150.41 50.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.06 127.97 67.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.038 -2.208 . . . . 25.0 105.038 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.96 116.85 53.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.487 -1.672 . . . . 25.0 106.487 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.1 tt -99.09 133.63 43.08 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.665 -1.235 . . . . 25.0 107.665 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -122.85 145.77 48.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.89 0.376 . . . . 25.0 110.069 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.7 t -126.57 134.05 67.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.013 -1.106 . . . . 25.0 108.013 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -129.18 99.0 5.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.419 -1.326 . . . . 25.0 107.419 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.83 106.79 17.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.084 -0.507 . . . . 25.0 111.891 -173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.4 t -92.48 126.69 44.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.14 -2.17 . . . . 25.0 105.14 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.35 -13.52 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.419 -0.956 . . . . 25.0 108.419 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.43 -1.39 29.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.288 -1.324 . . . . 25.0 112.035 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.9 t -152.95 165.87 34.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.13 -25.02 67.58 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.764 1.024 . . . . 25.0 113.764 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -110.07 159.1 17.62 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.183 0.809 . . . . 25.0 113.183 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 163.86 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 104.639 -2.356 . . . . 25.0 104.639 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -108.94 127.93 54.49 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.774 -0.37 . . . . 25.0 111.047 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.95 137.76 53.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -148.96 166.05 29.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.74 -0.467 . . . . 25.0 109.74 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.97 150.98 31.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.339 -0.986 . . . . 25.0 108.339 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.09 118.44 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.905 -1.887 . . . . 25.0 105.905 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -92.21 134.2 35.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.473 0.654 . . . . 25.0 110.577 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.58 157.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -127.25 119.21 25.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.234 -2.136 . . . . 25.0 105.234 174.979 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.7 mt -119.86 132.38 55.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.097 0.475 . . . . 25.0 110.208 -170.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.91 163.57 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.904 -0.589 . . . . 25.0 110.969 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -78.08 158.28 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.325 -1.361 . . . . 25.0 107.325 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 116.609 -1.662 . . . . 25.0 107.799 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.261 1 N-CA-C 102.497 -4.241 . . . . 25.0 102.497 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.46 149.15 35.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 120.093 1.946 . . . . 25.0 113.103 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -94.84 120.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.143 -0.935 . . . . 25.0 109.996 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.92 -13.09 20.14 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.527 0.566 . . . . 25.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -162.7 142.81 7.29 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.84 126.61 12.95 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 130.373 1.406 . . . . 25.0 113.999 -1.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.81 51.21 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 111.276 -0.73 . . . . 25.0 111.276 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.2 t -141.29 136.47 31.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.634 -1.246 . . . . 25.0 107.634 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -67.28 -21.12 65.72 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.43 0.53 . . . . 25.0 112.43 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.14 80.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.132 0.492 . . . . 25.0 110.641 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.56 65.07 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 120.876 0.37 . . . . 25.0 110.639 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.92 -4.25 59.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.219 -0.446 . . . . 25.0 110.825 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 25.0 110.078 -176.554 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.329 0.862 . . . . 25.0 113.329 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -50.35 -22.05 1.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 117.742 2.497 . . . . 25.0 117.742 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -79.91 -35.96 37.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.459 -0.776 . . . . 25.0 112.045 -172.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.88 63.31 5.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.173 0.805 . . . . 25.0 113.173 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.28 -6.46 18.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 117.411 -1.26 . . . . 25.0 112.296 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -93.68 4.97 53.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 25.0 112.115 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -92.34 93.94 8.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.219 -1.03 . . . . 25.0 108.219 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.0 mt -116.47 104.95 11.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.686 -0.857 . . . . 25.0 108.686 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -129.9 146.17 51.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.947 0.404 . . . . 25.0 110.628 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.5 145.53 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.995 -0.743 . . . . 25.0 108.995 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.686 0.279 . . . . 25.0 110.417 179.693 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.47 0 CA-C-O 120.222 -0.21 . . . . 25.0 113.085 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.81 -43.89 94.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.532 0.682 . . . . 25.0 109.948 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -69.51 -25.52 64.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.626 -0.715 . . . . 25.0 111.468 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -31.83 72.64 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.836 -0.697 . . . . 25.0 111.52 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.53 72.17 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 120.952 -0.642 . . . . 25.0 112.891 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.95 -38.21 71.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.25 -43.89 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.997 0.427 . . . . 25.0 111.308 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.73 -4.44 37.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.863 1.06 . . . . 25.0 113.863 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -62.1 -13.4 26.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -133.88 82.8 2.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 171.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.4 t -145.74 152.22 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.344 -0.614 . . . . 25.0 109.344 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.03 -25.76 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.392 0.615 . . . . 25.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -97.18 7.34 46.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.973 -0.558 . . . . 25.0 111.424 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ARG . . . . . 0.438 ' HG2' ' H ' ' A' ' 70' ' ' TRP . 44.7 ttp180 -65.43 169.37 6.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.471 1.129 . . . . 25.0 110.219 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TRP . . . . . 0.438 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 20.7 p90 -91.37 165.94 13.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.103 -1.443 . . . . 25.0 107.103 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -76.12 151.87 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -121.14 123.21 41.75 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 106.078 -1.823 . . . . 25.0 106.078 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -118.82 126.09 51.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.315 0.487 . . . . 25.0 112.315 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.5 132.2 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.682 -0.858 . . . . 25.0 108.682 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttp -150.69 157.56 43.11 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 107.809 -1.182 . . . . 25.0 107.809 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.0 p -95.01 163.79 13.16 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.081 -0.387 . . . . 25.0 110.143 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.23 172.23 50.25 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.937 -0.649 . . . . 25.0 112.815 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.57 -166.2 12.36 Favored Glycine 0 C--O 1.228 -0.258 0 O-C-N 122.516 -0.402 . . . . 25.0 112.367 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -76.84 140.54 40.67 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.058 -0.672 . . . . 25.0 111.417 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -136.02 158.54 44.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.8 m -126.07 123.77 39.12 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -116.23 139.58 50.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.003 -1.11 . . . . 25.0 108.003 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 t -137.96 145.99 42.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.3 -1.37 . . . . 25.0 107.3 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -121.42 145.18 48.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.777 -1.564 . . . . 25.0 106.777 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -131.47 161.96 31.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.41 153.65 48.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.597 -1.26 . . . . 25.0 107.597 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.1 p -81.02 -11.89 59.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.934 0.346 . . . . 25.0 111.934 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.92 20.75 Favored Pre-proline 0 C--O 1.25 1.112 0 N-CA-C 110.371 -0.233 . . . . 25.0 110.371 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.07 129.54 14.29 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.725 -1.05 . . . . 25.0 110.959 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -131.14 158.69 39.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.97 -0.382 . . . . 25.0 109.97 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -81.74 157.48 24.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.039 -1.097 . . . . 25.0 108.039 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.3 m -139.31 140.17 37.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.1 t -88.5 -48.64 7.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.238 -1.393 . . . . 25.0 107.238 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.23 166.36 18.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.265 -0.642 . . . . 25.0 109.265 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -146.79 138.68 24.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.456 -1.683 . . . . 25.0 106.456 167.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.84 148.91 31.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 25.0 109.297 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -145.32 148.25 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.23 1.014 . . . . 25.0 113.289 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.77 168.94 17.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.384 -1.28 . . . . 25.0 107.734 -170.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.54 159.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 166.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -95.35 135.86 36.43 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -87.7 124.9 34.05 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.336 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -88.6 153.94 20.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.49 15.17 58.91 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.147 -1.502 . . . . 25.0 113.059 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -52.75 153.47 3.22 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.597 0.962 . . . . 25.0 113.597 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -75.79 130.59 78.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.78 -0.646 . . . . 25.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.92 -15.7 29.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 117.174 -1.417 . . . . 25.0 111.777 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.61 -21.77 65.39 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.309 1.043 . . . . 25.0 111.718 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -120.2 141.97 32.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 O-C-N 121.978 -0.451 . . . . 25.0 110.444 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.55 134.42 30.61 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 115.34 -2.64 . . . . 25.0 112.554 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.5 mt -57.81 -33.84 69.01 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.39 -0.823 . . . . 25.0 111.939 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -53.2 -39.23 63.55 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.609 -0.723 . . . . 25.0 111.286 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.28 -51.8 7.56 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.738 0.644 . . . . 25.0 112.738 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.87 -27.45 61.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 116.855 2.169 . . . . 25.0 116.855 -166.056 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -71.1 -17.3 62.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.784 1.402 . . . . 25.0 114.784 -170.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -96.74 121.39 38.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -118.65 112.03 19.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.422 -0.585 . . . . 25.0 109.422 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.8 124.24 23.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.866 -1.531 . . . . 25.0 106.866 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.0 tt -115.8 1.82 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.919 0.866 . . . . 25.0 109.834 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.51 145.8 4.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 25.0 114.004 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.73 137.91 31.99 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.723 -1.584 . . . . 25.0 106.723 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 t -132.48 89.27 36.75 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 108.636 -0.876 . . . . 25.0 108.636 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.41 163.49 37.6 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 116.073 -2.151 . . . . 25.0 110.54 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -128.22 120.99 28.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.434 0.635 . . . . 25.0 109.578 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -127.07 -76.7 0.57 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.002 -2.592 . . . . 25.0 104.002 172.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -147.97 -150.09 5.12 Favored Glycine 0 C--O 1.242 0.603 0 N-CA-C 108.6 -1.8 . . . . 25.0 108.6 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.2 m 62.59 157.17 0.12 Allowed Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 114.474 1.287 . . . . 25.0 114.474 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.11 0.15 9.3 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 115.781 -2.346 . . . . 25.0 114.799 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.42 91.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.443 -0.799 . . . . 25.0 109.486 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.3 p -79.74 -11.24 59.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.117 0.484 . . . . 25.0 111.626 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -76.97 -21.0 55.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.191 -0.459 . . . . 25.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -74.34 104.93 5.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.885 0.374 . . . . 25.0 111.172 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -16.06 24.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.019 0.748 . . . . 25.0 113.019 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -100.22 126.51 46.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.301 -1.37 . . . . 25.0 107.301 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -131.07 150.5 52.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.559 0.695 . . . . 25.0 111.826 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -94.73 136.08 35.45 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 105.602 -1.999 . . . . 25.0 105.602 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.0 118.97 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -80.61 130.58 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.169 -2.16 . . . . 25.0 105.169 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.7 mt -122.43 111.57 31.64 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 107.265 -1.383 . . . . 25.0 107.265 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.74 162.0 40.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 116.949 -1.567 . . . . 25.0 112.406 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -111.24 91.03 3.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.517 -2.401 . . . . 25.0 104.517 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -79.42 -29.77 42.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.155 -0.683 . . . . 25.0 109.155 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mtt-85 -155.27 170.0 22.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 103.535 -2.765 . . . . 25.0 103.535 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.89 112.68 24.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.987 -2.968 . . . . 25.0 102.987 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 168.27 166.7 27.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.229 -0.51 . . . . 25.0 112.497 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 49.9 p90 -87.08 142.35 27.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.778 1.399 . . . . 25.0 114.778 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -129.4 136.85 50.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.182 -1.784 . . . . 25.0 106.182 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.91 133.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.89 -1.152 . . . . 25.0 107.89 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.8 mt -96.08 126.27 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.6 mt -111.6 127.05 55.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.038 -1.467 . . . . 25.0 107.038 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.34 145.84 52.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.51 0.596 . . . . 25.0 111.022 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.07 138.15 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -129.19 120.63 26.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.783 -0.821 . . . . 25.0 108.783 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -101.45 97.0 7.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.327 0.585 . . . . 25.0 109.955 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.62 123.03 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.218 -1.03 . . . . 25.0 108.218 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.17 -22.97 59.19 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.95 -7.61 55.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.578 0.955 . . . . 25.0 113.578 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -132.16 158.03 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.24 13.07 3.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.628 -1.169 . . . . 25.0 109.285 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -109.92 162.21 14.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 25.0 109.93 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.88 150.28 50.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.381 -2.452 . . . . 25.0 104.381 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -122.65 143.11 49.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.794 -1.188 . . . . 25.0 107.794 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -138.93 156.38 47.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.384 -0.599 . . . . 25.0 109.384 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.71 149.67 36.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.35 141.98 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.72 -0.474 . . . . 25.0 109.72 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.4 mt -139.02 128.53 30.6 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 105.396 -2.076 . . . . 25.0 105.396 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -112.15 126.9 55.7 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.4 m -125.52 126.12 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.576 0.703 . . . . 25.0 109.92 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 42.2 t0 -87.58 96.05 10.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.196 -1.779 . . . . 25.0 106.196 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.2 112.14 22.42 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.356 -0.838 . . . . 25.0 109.86 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.6 m -136.32 173.75 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.171 -0.468 . . . . 25.0 111.245 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -63.05 159.37 17.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.695 0.76 . . . . 25.0 112.678 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.59 -1.187 . . . . 25.0 110.861 178.144 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.163 0 N-CA-C 107.801 -2.119 . . . . 25.0 107.801 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.24 165.76 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.824 1.312 . . . . 25.0 110.57 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.445 HG22 ' H ' ' A' ' 6' ' ' LYS . 30.1 mm -93.98 124.55 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 25.0 109.78 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -87.9 22.11 2.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.386 0.675 . . . . 25.0 111.7 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.445 ' H ' HG22 ' A' ' 4' ' ' ILE . 42.3 mttt 77.05 153.27 0.14 Allowed Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 125.975 1.71 . . . . 25.0 111.955 175.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.97 151.98 68.7 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 129.031 0.846 . . . . 25.0 111.158 -7.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.91 21.73 15.21 Favored Glycine 0 C--O 1.211 -1.288 0 N-CA-C 117.714 1.846 . . . . 25.0 117.714 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -76.5 128.37 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 119.23 1.515 . . . . 25.0 110.041 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -73.33 -27.13 61.34 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.988 -0.375 . . . . 25.0 109.988 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.22 -33.63 69.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.526 0.565 . . . . 25.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.21 69.6 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 120.826 0.346 . . . . 25.0 111.55 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.95 -8.33 46.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.583 0.706 . . . . 25.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.8 t . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.133 -0.939 . . . . 25.0 113.24 -171.729 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.551 0.983 0 N-CA-C 112.592 0.59 . . . . 25.0 112.592 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.3 ptm -56.46 -10.92 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 116.678 2.103 . . . . 25.0 116.678 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.19 -35.9 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 118.163 0.438 . . . . 25.0 111.985 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.05 46.02 0.39 Allowed Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 117.042 2.238 . . . . 25.0 117.042 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.45 -14.28 36.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 115.797 -2.335 . . . . 25.0 114.648 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.06 5.01 49.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.367 0.506 . . . . 25.0 112.367 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.4 t -106.39 89.69 3.12 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.588 -1.264 . . . . 25.0 107.588 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.36 124.68 45.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.0 -1.852 . . . . 25.0 106.0 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -127.45 145.82 50.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 25.0 110.883 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 158.02 45.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.902 -1.888 . . . . 25.0 105.902 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 tttt . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 178.406 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.427 0 N-CA-C 114.839 0.695 . . . . 25.0 114.839 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.62 -25.41 66.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 25.0 111.14 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -84.9 0.57 50.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.817 0.342 . . . . 25.0 111.77 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.68 -19.49 58.33 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 121.129 -0.558 . . . . 25.0 112.98 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.97 -20.75 67.08 Favored Glycine 0 C--O 1.222 -0.617 0 C-N-CA 121.079 -0.582 . . . . 25.0 113.228 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.59 -39.4 80.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.415 -0.957 . . . . 25.0 108.415 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.03 -26.86 61.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.52 7.56 4.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.485 0.66 . . . . 25.0 112.221 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.49 -28.02 15.1 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.45 -0.781 . . . . 25.0 109.037 171.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -150.72 96.73 2.4 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.836 0.351 . . . . 25.0 111.394 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.6 t -152.87 154.37 34.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -69.55 -32.8 71.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.177 0.989 . . . . 25.0 109.802 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.32 28.13 8.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.2 -0.909 . . . . 25.0 110.037 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -53.68 154.31 3.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.273 -0.876 . . . . 25.0 109.992 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -84.78 165.26 17.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.28 -1.378 . . . . 25.0 107.28 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -74.8 139.02 42.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -127.5 133.98 49.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -119.63 146.94 45.1 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.366 -1.346 . . . . 25.0 107.366 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -96.7 133.03 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 25.0 108.199 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 93.7 mtp -135.06 158.42 44.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -104.47 172.04 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.14 -175.93 7.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 114.495 0.558 . . . . 25.0 114.495 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.14 -173.37 20.56 Favored Glycine 0 CA--C 1.518 0.221 0 O-C-N 122.525 -0.397 . . . . 25.0 112.755 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.14 141.13 33.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -141.91 160.75 39.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.349 -0.612 . . . . 25.0 109.349 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -126.75 129.49 48.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.39 -1.708 . . . . 25.0 106.39 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.43 139.05 49.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -130.82 133.41 45.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.495 0.497 . . . . 25.0 110.16 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -124.08 151.71 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.839 -1.911 . . . . 25.0 105.839 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -138.07 161.95 35.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 119.037 0.835 . . . . 25.0 110.656 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.14 150.65 39.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.488 -1.671 . . . . 25.0 106.488 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -68.63 -22.39 64.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.384 0.513 . . . . 25.0 112.384 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.04 151.97 63.72 Favored Pre-proline 0 C--O 1.242 0.693 0 N-CA-C 105.719 -1.956 . . . . 25.0 105.719 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.38 145.93 73.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 115.587 -2.475 . . . . 25.0 109.515 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -130.88 140.49 50.22 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.994 -0.441 . . . . 25.0 111.491 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.62 141.52 57.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 m -150.02 151.9 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.746 -1.946 . . . . 25.0 105.746 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.0 p -108.01 -34.05 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 118.256 0.48 . . . . 25.0 110.618 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.76 145.29 18.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.971 -0.456 . . . . 25.0 109.835 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -141.2 139.43 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.035 -0.666 . . . . 25.0 109.543 163.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -148.09 159.64 43.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.89 -0.596 . . . . 25.0 109.532 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -145.04 150.24 36.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.915 1.08 . . . . 25.0 113.915 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.74 164.6 17.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.035 -1.438 . . . . 25.0 107.522 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.66 155.73 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.6 p -96.02 144.19 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.424 -0.584 . . . . 25.0 109.424 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -87.99 129.82 35.14 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 110.163 -0.31 . . . . 25.0 110.163 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -81.53 156.21 25.36 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.054 0.542 . . . . 25.0 109.671 172.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.8 10.12 73.2 Favored Glycine 0 N--CA 1.462 0.419 0 N-CA-C 118.59 2.196 . . . . 25.0 118.59 166.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -59.26 161.35 5.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.032 1.123 . . . . 25.0 114.032 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.24 156.02 36.28 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 106.646 -1.613 . . . . 25.0 106.646 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.45 -8.62 18.48 Favored 'Trans proline' 0 C--N 1.345 0.389 0 N-CA-C 116.663 1.755 . . . . 25.0 116.663 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -82.33 0.72 40.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.912 0.863 . . . . 25.0 111.77 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -95.97 148.43 34.53 Favored Pre-proline 0 C--N 1.322 -0.616 0 O-C-N 121.734 -0.604 . . . . 25.0 110.412 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.04 83.4 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 N-CA-C 110.329 -0.681 . . . . 25.0 110.329 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.7 mt -53.15 -39.53 63.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.912 1.449 . . . . 25.0 114.912 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -63.07 -21.98 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.797 0.666 . . . . 25.0 112.797 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -94.76 -48.55 5.99 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 112.344 0.498 . . . . 25.0 112.344 169.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.79 64.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 115.708 1.744 . . . . 25.0 115.708 -166.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -69.31 -28.88 66.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.247 -0.581 . . . . 25.0 111.633 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -97.66 113.92 25.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.116 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -121.86 136.67 54.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.235 0.541 . . . . 25.0 111.469 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.4 tp -75.61 123.93 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.459 -1.682 . . . . 25.0 106.459 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.2 tp -121.75 -5.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.564 0.697 . . . . 25.0 111.185 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -161.21 140.15 6.47 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.395 -0.907 . . . . 25.0 112.243 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 134.21 16.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.401 -1.333 . . . . 25.0 107.401 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.74 103.2 7.65 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.92 148.73 76.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 116.013 -2.191 . . . . 25.0 109.69 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -106.14 92.2 4.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.364 -1.346 . . . . 25.0 107.364 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -119.17 1.15 11.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.373 -1.739 . . . . 25.0 109.782 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.62 -18.75 9.93 Favored Glycine 0 C--O 1.236 0.24 0 CA-C-N 115.303 -0.862 . . . . 25.0 111.905 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.6 t -54.71 136.99 63.89 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 117.116 0.458 . . . . 25.0 110.465 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.75 -11.67 28.03 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 117.029 -1.514 . . . . 25.0 114.753 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.78 -34.67 78.89 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.375 -1.284 . . . . 25.0 109.143 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -84.4 -10.05 57.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.202 0.525 . . . . 25.0 112.044 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -86.48 -22.78 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.643 -1.243 . . . . 25.0 107.643 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.04 104.84 17.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 25.0 110.402 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.65 -10.87 59.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.667 -0.697 . . . . 25.0 112.321 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -91.31 121.98 33.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.928 -1.138 . . . . 25.0 107.928 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -137.26 147.83 46.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 25.0 111.426 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -79.23 137.89 37.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.726 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.0 mt -132.68 106.02 9.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.744 -1.206 . . . . 25.0 107.744 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -78.12 140.85 39.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.574 -0.899 . . . . 25.0 108.574 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.9 mm -124.63 123.36 25.72 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.61 158.44 53.59 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 117.289 -1.341 . . . . 25.0 111.52 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -106.97 52.83 0.71 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.512 1.149 . . . . 25.0 110.037 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.75 -37.5 24.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 115.477 1.658 . . . . 25.0 115.477 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -152.87 172.23 17.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.19 0.596 . . . . 25.0 109.738 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.0 mp -99.95 142.77 30.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.678 -2.342 . . . . 25.0 104.678 167.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.41 150.07 5.88 Favored Glycine 0 C--O 1.234 0.117 0 C-N-CA 120.588 -0.815 . . . . 25.0 114.078 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 27.4 p90 -86.01 145.11 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 25.0 110.049 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 153.02 40.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.842 -0.617 . . . . 25.0 110.184 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.65 143.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.046 -0.524 . . . . 25.0 110.644 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.08 128.85 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.341 -2.466 . . . . 25.0 104.341 172.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.72 137.43 53.93 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.842 -1.54 . . . . 25.0 106.842 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.82 151.15 42.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 118.958 0.799 . . . . 25.0 110.971 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.04 134.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.124 -1.435 . . . . 25.0 107.124 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -124.78 98.98 5.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.586 -1.265 . . . . 25.0 107.586 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -84.79 117.81 24.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.037 0.446 . . . . 25.0 110.554 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.03 133.75 28.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.76 -42.47 58.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.119 0.485 . . . . 25.0 111.194 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.66 -24.07 64.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.812 1.782 . . . . 25.0 115.812 -168.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 66.3 p -135.62 162.55 32.39 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 122.381 -0.199 . . . . 25.0 110.701 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 11.32 2.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 25.0 112.587 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.11 160.0 16.85 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.168 -1.419 . . . . 25.0 107.168 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.52 170.7 15.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.04 -2.207 . . . . 25.0 105.04 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -120.32 158.37 27.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.1 -1.074 . . . . 25.0 108.1 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -138.7 154.63 48.6 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -132.7 142.06 48.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.11 129.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.3 mt -140.66 126.56 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.47 137.09 37.66 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.624 -0.51 . . . . 25.0 109.624 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.58 137.51 43.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 51.8 t0 -82.03 136.14 35.26 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.687 -1.598 . . . . 25.0 106.687 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.14 104.24 9.94 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 34.1 m -113.03 166.95 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.239 0.543 . . . . 25.0 111.824 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.21 158.7 32.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.535 -1.654 . . . . 25.0 106.535 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 117.285 -1.34 . . . . 25.0 110.365 178.975 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 CA-C-O 118.428 -1.207 . . . . 25.0 110.714 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -156.64 164.73 37.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.226 1.013 . . . . 25.0 112.864 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.4 mt -90.73 122.74 42.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -77.72 -41.38 38.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.382 0.61 . . . . 25.0 109.537 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.32 117.08 8.73 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.182 -0.463 . . . . 25.0 109.836 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.36 122.61 7.83 Favored 'Cis proline' 0 C--N 1.357 1.002 0 C-N-CA 130.412 1.422 . . . . 25.0 113.454 -3.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.1 -22.58 57.07 Favored Glycine 0 CA--C 1.508 -0.36 0 N-CA-C 116.051 1.18 . . . . 25.0 116.051 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 t -91.18 97.18 10.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.601 -0.941 . . . . 25.0 110.73 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -83.96 -32.34 25.08 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.727 -0.471 . . . . 25.0 109.727 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -36.67 71.13 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.203 1.186 . . . . 25.0 114.203 -173.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.81 -32.43 71.8 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.282 0.364 . . . . 25.0 110.957 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.9 mp -92.93 -19.93 21.14 Favored 'General case' 0 C--O 1.211 -0.931 0 N-CA-C 112.708 0.632 . . . . 25.0 112.708 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.7 t . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 109.303 -0.628 . . . . 25.0 109.303 179.046 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.546 0.812 0 CA-C-O 121.597 0.713 . . . . 25.0 111.024 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -26.26 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 117.933 2.568 . . . . 25.0 117.933 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -75.97 -43.4 44.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.882 0.764 . . . . 25.0 112.816 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.9 71.93 19.03 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 122.009 0.909 . . . . 25.0 112.928 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.66 2.0 5.09 Favored 'Trans proline' 0 C--O 1.221 -0.346 0 N-CA-C 114.606 0.964 . . . . 25.0 114.606 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 3.17 33.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.654 -0.498 . . . . 25.0 109.654 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -134.15 84.03 2.08 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 115.771 1.767 . . . . 25.0 115.771 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.0 131.19 55.31 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 103.525 -2.769 . . . . 25.0 103.525 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -114.37 143.54 44.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.191 1.182 . . . . 25.0 114.191 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.28 155.97 49.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.456 -2.424 . . . . 25.0 104.456 167.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.7 tttt . . . . . 0 C--N 1.327 -0.392 0 O-C-N 121.572 -0.705 . . . . 25.0 110.483 -178.306 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.561 0 N-CA-C 113.495 0.158 . . . . 25.0 113.495 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 mt -59.32 -10.68 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.606 1.706 . . . . 25.0 115.606 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -61.04 -19.96 61.98 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.21 -16.15 77.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.35 -0.844 . . . . 25.0 111.709 177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.71 -4.58 66.49 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 115.421 0.928 . . . . 25.0 115.421 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.48 -32.76 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.352 1.076 . . . . 25.0 110.077 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.52 -25.37 65.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.513 -0.312 . . . . 25.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -106.15 15.44 26.32 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.783 0.801 . . . . 25.0 110.041 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -70.59 14.75 0.12 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.37 1.248 . . . . 25.0 114.37 -174.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.51 52.91 1.69 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -131.91 178.69 6.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -64.64 -21.15 66.65 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.805 -0.559 . . . . 25.0 112.413 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -95.57 14.38 23.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.555 0.693 . . . . 25.0 112.098 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 ttt85 -58.18 128.32 36.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.867 -0.606 . . . . 25.0 111.129 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -106.14 168.18 9.31 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.921 0.867 . . . . 25.0 112.203 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -63.86 149.58 46.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.613 -0.721 . . . . 25.0 112.123 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -130.5 146.5 52.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.74 -1.207 . . . . 25.0 107.74 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -113.34 138.49 49.97 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.38 129.19 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 94.3 mmm -137.88 166.51 23.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.3 p -107.46 -173.72 2.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.256 -2.128 . . . . 25.0 105.256 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -161.54 21.56 Favored Glycine 0 C--O 1.242 0.605 0 CA-C-O 121.676 0.598 . . . . 25.0 113.744 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.79 176.61 42.65 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.73 -0.948 . . . . 25.0 110.73 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -83.29 141.48 31.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.139 1.469 . . . . 25.0 109.849 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -129.39 139.16 51.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.714 -0.847 . . . . 25.0 108.714 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -85.57 128.84 34.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 25.0 109.946 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.03 127.43 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.962 -1.866 . . . . 25.0 105.962 174.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -128.85 120.47 26.33 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.1 -0.333 . . . . 25.0 110.1 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -124.08 150.1 45.4 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.45 -1.685 . . . . 25.0 106.45 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.1 t -145.21 158.78 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.465 -0.569 . . . . 25.0 109.465 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.01 133.45 52.97 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 108.997 -0.742 . . . . 25.0 108.997 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -77.03 -6.63 53.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.686 0.625 . . . . 25.0 112.686 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.95 145.04 37.65 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 106.907 -1.516 . . . . 25.0 106.907 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.32 142.87 38.1 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 117.239 -1.374 . . . . 25.0 111.804 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -136.27 140.22 43.27 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.935 -0.765 . . . . 25.0 108.935 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -81.51 152.97 27.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.1 m -138.79 148.49 43.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 105.855 -1.905 . . . . 25.0 105.855 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 t -102.71 -43.36 5.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 25.0 110.59 173.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.82 143.46 20.67 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.947 -0.76 . . . . 25.0 108.947 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -144.5 134.8 24.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.78 0.324 . . . . 25.0 110.192 170.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -154.18 162.22 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.407 0.521 . . . . 25.0 112.407 -172.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.25 146.01 51.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.458 0.647 . . . . 25.0 112.107 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -124.0 163.79 20.66 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -131.34 152.98 38.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.6 p -80.48 144.69 32.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.884 -1.154 . . . . 25.0 107.884 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -88.42 124.77 34.28 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 25.0 110.295 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -73.51 126.22 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.007 -1.109 . . . . 25.0 108.007 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.63 35.82 31.23 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 119.041 -1.552 . . . . 25.0 113.931 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -54.9 149.19 11.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.241 1.02 . . . . 25.0 110.713 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -75.6 139.68 71.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.44 -22.47 16.11 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 118.549 -0.5 . . . . 25.0 113.179 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.8 -27.55 64.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.877 0.846 . . . . 25.0 111.956 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -91.67 143.86 28.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.19 115.67 3.28 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 117.555 -1.163 . . . . 25.0 112.019 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tt -52.36 -54.35 32.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.851 1.426 . . . . 25.0 114.851 -166.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -69.57 -4.03 17.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.114 1.153 . . . . 25.0 114.114 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.63 -46.58 5.96 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.503 -0.748 . . . . 25.0 109.483 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.5 -19.99 51.79 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.545 1.313 . . . . 25.0 114.545 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -72.67 -33.69 66.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.08 1.141 . . . . 25.0 114.08 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -91.7 100.01 12.8 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.623 -0.831 . . . . 25.0 112.593 -173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -97.37 125.06 41.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 25.0 110.011 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 tp -71.4 116.98 12.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.976 -0.749 . . . . 25.0 108.976 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -96.88 -4.46 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.876 0.846 . . . . 25.0 109.898 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.35 159.72 11.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.602 -0.808 . . . . 25.0 113.016 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.0 147.07 28.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.769 -0.826 . . . . 25.0 108.769 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -133.67 111.8 12.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.223 -1.028 . . . . 25.0 108.223 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.72 168.92 18.89 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 115.796 -2.336 . . . . 25.0 111.071 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -145.18 120.04 9.94 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 120.568 -0.453 . . . . 25.0 110.505 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -91.57 -39.94 11.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.953 0.882 . . . . 25.0 110.04 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.08 -26.04 0.42 Allowed Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.125 -1.99 . . . . 25.0 108.125 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 t -51.76 141.42 26.55 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.771 0.656 . . . . 25.0 112.771 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.29 23.77 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.805 1.67 . . . . 25.0 114.343 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.28 -25.91 66.07 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.282 -0.886 . . . . 25.0 110.688 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 54.6 p -71.71 0.95 7.58 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.955 0.724 . . . . 25.0 112.955 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -62.1 -35.28 78.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.373 -0.973 . . . . 25.0 108.373 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -94.41 82.82 4.08 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.003 -1.851 . . . . 25.0 106.003 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.87 -19.84 58.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.345 -0.843 . . . . 25.0 111.653 -175.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 t -72.65 138.69 46.85 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.623 -0.673 . . . . 25.0 109.858 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -135.57 143.16 45.51 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.711 -0.477 . . . . 25.0 109.711 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -96.29 139.39 32.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.431 -1.692 . . . . 25.0 106.431 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.9 mm -133.28 130.19 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 39.4 t80 -80.71 132.17 35.53 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.0 mm -112.06 126.39 28.54 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.604 -0.888 . . . . 25.0 108.604 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.85 169.49 22.48 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 118.19 -0.74 . . . . 25.0 111.758 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -130.18 51.26 2.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.084 -1.45 . . . . 25.0 107.084 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -78.52 -32.03 47.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.123 1.157 . . . . 25.0 114.123 -172.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -152.2 165.83 33.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.975 -1.491 . . . . 25.0 106.975 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.4 mp -92.89 142.91 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.271 -2.492 . . . . 25.0 104.271 167.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.29 165.39 10.27 Favored Glycine 0 C--O 1.237 0.318 0 N-CA-C 114.24 0.456 . . . . 25.0 114.24 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 3.9 p90 -81.45 149.69 28.66 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.086 0.772 . . . . 25.0 113.086 -176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.86 159.39 43.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.137 -1.801 . . . . 25.0 106.137 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.1 149.68 11.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 118.517 0.599 . . . . 25.0 111.158 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.7 128.44 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.94 139.21 52.04 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.362 -0.977 . . . . 25.0 108.362 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.69 144.32 41.73 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.87 -0.419 . . . . 25.0 109.87 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.85 135.28 61.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.417 -0.957 . . . . 25.0 108.417 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -128.38 112.14 14.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.261 0.624 . . . . 25.0 111.466 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -88.7 88.42 7.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.42 126.81 33.66 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 105.267 -2.123 . . . . 25.0 105.267 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.09 -23.52 54.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.261 0.553 . . . . 25.0 110.222 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.5 -11.85 61.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.686 -0.688 . . . . 25.0 112.481 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -127.61 161.4 28.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.952 0.406 . . . . 25.0 110.641 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -88.38 3.27 50.49 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.635 1.207 . . . . 25.0 108.054 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -108.83 157.34 18.68 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.702 -1.136 . . . . 25.0 108.945 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.69 141.77 49.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.785 -2.672 . . . . 25.0 103.785 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.03 144.69 32.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.066 -0.516 . . . . 25.0 111.14 -172.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -124.57 145.84 49.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.402 -0.817 . . . . 25.0 109.282 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -138.77 129.5 26.29 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.048 -1.834 . . . . 25.0 106.048 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.14 130.4 34.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.615 -0.883 . . . . 25.0 108.615 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.5 mt -140.37 130.87 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 120.486 0.184 . . . . 25.0 110.645 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.18 138.61 39.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.807 0.813 . . . . 25.0 111.282 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.61 160.81 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 25.0 109.07 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 54.1 t0 -117.29 132.1 56.68 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.216 -1.772 . . . . 25.0 106.216 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.07 121.99 40.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 33.8 m -130.54 167.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 123.532 0.52 . . . . 25.0 110.059 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -77.58 158.1 29.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 117.317 -1.325 . . . . 25.0 110.466 176.541 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.344 0 N-CA-C 108.548 -1.821 . . . . 25.0 108.548 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -80.27 136.33 36.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.11 106.85 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -77.26 -41.13 42.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.794 0.807 . . . . 25.0 110.94 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -152.84 143.76 15.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.036 -0.506 . . . . 25.0 109.669 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 137.39 47.96 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 118.99 0.675 . . . . 25.0 112.126 -5.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.68 168.06 38.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.817 -1.182 . . . . 25.0 113.665 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -161.93 121.36 2.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.339 -2.467 . . . . 25.0 104.339 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -83.4 -38.54 21.82 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 112.149 0.426 . . . . 25.0 112.149 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.21 74.14 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 25.0 112.559 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.77 70.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 112.08 0.4 . . . . 25.0 112.08 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 mt -92.0 -35.39 13.99 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 121.363 0.601 . . . . 25.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-N 114.809 -1.087 . . . . 25.0 110.917 -174.985 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.202 0.815 . . . . 25.0 113.202 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -67.08 -10.4 49.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.24 -41.09 70.57 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.888 1.07 . . . . 25.0 113.888 -171.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -142.59 43.28 0.47 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 117.377 2.362 . . . . 25.0 117.377 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.95 -21.1 28.4 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 113.236 -4.042 . . . . 25.0 112.259 176.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -79.03 -18.74 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 25.0 111.599 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -132.87 78.99 1.82 Allowed 'General case' 0 C--O 1.206 -1.229 0 N-CA-C 113.039 0.755 . . . . 25.0 113.039 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.2 mt -104.33 141.57 36.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.23 -0.656 . . . . 25.0 109.23 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -105.43 141.67 36.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 25.0 109.495 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 167.37 21.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 25.0 110.766 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 113.286 0.847 . . . . 25.0 113.286 -179.011 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.842 0 N-CA-C 111.79 -0.524 . . . . 25.0 111.79 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.95 -61.24 1.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.461 0.648 . . . . 25.0 111.309 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -85.02 -13.03 51.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.31 0.856 . . . . 25.0 113.31 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.38 72.26 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.804 -0.713 . . . . 25.0 113.058 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.89 -31.49 80.99 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 120.495 -0.86 . . . . 25.0 111.948 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mm -65.5 -37.36 79.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.385 0.612 . . . . 25.0 109.527 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.14 -33.63 59.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.531 . . . . 25.0 110.33 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -67.39 -31.74 72.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.451 0.643 . . . . 25.0 111.231 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.96 -5.06 23.67 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -130.11 41.94 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 25.0 109.044 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -125.16 167.63 14.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.25 -26.11 67.2 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -88.08 12.67 12.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.601 -0.727 . . . . 25.0 112.203 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -53.42 139.66 29.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.563 0.697 . . . . 25.0 109.702 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -81.93 142.32 32.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.52 1.153 . . . . 25.0 111.577 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -71.14 152.13 43.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.939 -1.482 . . . . 25.0 112.01 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -110.9 140.97 44.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.793 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -119.01 133.43 55.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.98 131.0 41.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.4 ttt -151.03 168.18 25.38 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 106.862 -1.533 . . . . 25.0 106.862 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.7 p -88.21 165.97 14.68 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.805 -1.924 . . . . 25.0 105.805 173.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.8 -158.2 5.23 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.396 -0.431 . . . . 25.0 112.583 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.52 -163.89 25.23 Favored Glycine 0 CA--C 1.512 -0.099 0 O-C-N 122.347 -0.502 . . . . 25.0 112.908 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 2.7 tt0 -74.71 129.14 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.008 -0.701 . . . . 25.0 110.906 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -122.5 136.21 54.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.218 -1.03 . . . . 25.0 108.218 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.5 m -99.94 118.15 35.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.896 -1.52 . . . . 25.0 106.896 175.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.65 134.78 42.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.131 -1.433 . . . . 25.0 107.131 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -133.11 130.91 39.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -114.61 150.04 35.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.558 -0.905 . . . . 25.0 108.558 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -143.31 154.92 44.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.164 -0.68 . . . . 25.0 109.164 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -140.13 159.07 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -67.48 -30.55 70.28 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.84 151.18 62.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.65 134.32 27.93 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 115.475 -2.55 . . . . 25.0 111.217 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -131.0 154.47 48.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.129 -0.693 . . . . 25.0 109.129 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -68.54 160.34 30.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.842 0.83 . . . . 25.0 109.717 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -154.46 161.64 41.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.692 -3.818 . . . . 25.0 100.692 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 p -110.7 -39.13 4.96 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.997 -0.742 . . . . 25.0 108.997 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -159.75 143.59 14.53 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.557 -0.905 . . . . 25.0 108.557 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.81 138.47 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.18 -1.415 . . . . 25.0 107.18 169.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -140.83 152.81 45.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.399 . . . . 25.0 111.527 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -117.28 139.11 51.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.934 -1.03 . . . . 25.0 109.081 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.99 165.77 25.23 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.168 -1.419 . . . . 25.0 107.168 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.97 153.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.1 p -85.78 147.87 26.11 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.169 -0.678 . . . . 25.0 109.169 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -86.45 100.85 12.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.996 0.903 . . . . 25.0 110.095 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -76.08 126.72 31.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.761 -1.2 . . . . 25.0 107.761 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 20.92 34.75 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 119.701 -1.238 . . . . 25.0 114.053 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.06 141.1 19.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.492 0.663 . . . . 25.0 111.837 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.85 134.86 81.0 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.8 -16.73 23.35 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 117.703 -1.065 . . . . 25.0 113.344 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.44 -29.32 68.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.061 0.934 . . . . 25.0 110.339 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -100.76 152.31 37.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 107.973 -1.121 . . . . 25.0 107.973 -174.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.52 105.99 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 117.449 -1.234 . . . . 25.0 113.885 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.14 -42.18 69.26 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.459 -0.792 . . . . 25.0 112.075 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.74 -6.55 27.12 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.267 1.21 . . . . 25.0 114.267 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.3 -44.02 6.07 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.535 0.683 . . . . 25.0 111.281 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.45 28.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.333 -1.303 . . . . 25.0 114.489 -170.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -69.13 -29.09 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.9 1.074 . . . . 25.0 113.9 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -127.36 159.15 35.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.332 0.514 . . . . 25.0 112.228 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -133.48 147.68 51.67 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.203 -1.406 . . . . 25.0 107.203 173.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 tt -87.02 133.79 33.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.893 -0.504 . . . . 25.0 110.277 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 tt -121.34 1.87 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.847 0.832 . . . . 25.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.81 156.91 14.17 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.175 -1.012 . . . . 25.0 113.408 172.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.92 139.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.989 -1.115 . . . . 25.0 107.989 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.76 102.13 13.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.3 169.77 16.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 117.353 -1.298 . . . . 25.0 112.044 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -132.24 113.49 13.31 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.721 -1.215 . . . . 25.0 107.721 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -164.59 -104.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 102.009 -3.33 . . . . 25.0 102.009 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.7 40.4 2.93 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 111.152 -0.779 . . . . 25.0 111.152 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -76.28 132.73 72.63 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 122.244 -0.562 . . . . 25.0 111.597 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.2 -178.45 3.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 O-C-N 121.719 0.326 . . . . 25.0 111.955 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -13.9 6.35 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.396 1.258 . . . . 25.0 114.396 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -59.66 -13.24 8.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.583 0.957 . . . . 25.0 113.583 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -67.0 16.24 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.63 1.715 . . . . 25.0 115.63 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -58.09 143.13 44.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.553 0.692 . . . . 25.0 110.679 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.49 -10.79 60.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.139 -0.937 . . . . 25.0 112.21 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.5 t -100.06 122.67 43.29 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 106.936 -1.505 . . . . 25.0 106.936 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -133.83 141.31 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.08 0.467 . . . . 25.0 110.326 -175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -91.97 132.88 36.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -131.92 129.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.903 -1.888 . . . . 25.0 105.903 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 35.3 t80 -96.73 132.08 42.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.008 -1.108 . . . . 25.0 108.008 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.16 106.31 36.17 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.42 151.13 65.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 116.145 -2.103 . . . . 25.0 109.242 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -139.04 95.31 2.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.64 0.733 . . . . 25.0 111.028 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.87 4.68 53.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.933 -1.03 . . . . 25.0 110.721 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -140.8 -179.34 6.0 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.57 130.48 51.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 104.432 -2.433 . . . . 25.0 104.432 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.01 -177.36 24.42 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-O 122.848 1.249 . . . . 25.0 115.973 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.9 p90 -79.02 146.54 33.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.354 1.242 . . . . 25.0 114.354 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -136.39 158.81 43.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.376 -2.453 . . . . 25.0 104.376 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.88 132.91 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.681 -0.859 . . . . 25.0 108.681 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.6 mt -108.51 134.85 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 tt -118.4 137.82 52.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.428 -0.953 . . . . 25.0 108.428 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.48 144.52 51.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.532 0.682 . . . . 25.0 110.9 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.98 133.64 68.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -129.43 100.79 5.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 25.0 108.952 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.1 131.97 34.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.006 -0.543 . . . . 25.0 109.562 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -89.05 160.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.957 -1.127 . . . . 25.0 107.957 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.99 -27.65 12.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.984 -0.747 . . . . 25.0 108.984 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.65 -2.42 58.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.4 t -152.95 162.78 40.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 25.0 111.469 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -67.74 -26.17 66.01 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.496 1.119 . . . . 25.0 111.855 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.74 167.31 14.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 25.0 110.592 -173.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.43 -179.56 5.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -128.36 140.46 51.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.538 -0.912 . . . . 25.0 108.538 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -131.76 137.83 48.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.688 -1.227 . . . . 25.0 107.688 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -149.18 155.36 40.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.6 151.0 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.5 mm -134.58 113.01 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.993 -1.114 . . . . 25.0 107.993 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.8 141.27 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.783 -1.192 . . . . 25.0 107.783 175.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.0 m -135.51 161.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 1.0 OUTLIER -126.71 117.59 23.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.955 -1.868 . . . . 25.0 105.955 176.492 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.97 135.12 55.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.868 -0.606 . . . . 25.0 110.937 -169.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.35 165.83 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.525 -0.762 . . . . 25.0 109.774 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -91.47 157.71 16.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.198 -1.779 . . . . 25.0 106.198 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.593 -1.194 . . . . 25.0 108.602 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.569 0 N-CA-C 104.769 -3.333 . . . . 25.0 104.769 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.54 161.38 41.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.587 2.193 . . . . 25.0 113.244 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 mt -93.97 126.47 46.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.432 -1.321 . . . . 25.0 107.432 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.27 -47.59 14.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.189 -0.671 . . . . 25.0 109.189 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -163.15 165.59 14.38 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.076 -1.083 . . . . 25.0 108.076 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -70.32 124.78 8.18 Favored 'Cis proline' 0 C--N 1.353 0.805 0 C-N-CA 131.392 1.83 . . . . 25.0 114.987 1.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.07 175.4 39.14 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.484 -0.78 . . . . 25.0 112.731 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -139.61 152.83 47.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.407 -0.96 . . . . 25.0 108.407 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -75.29 -21.01 58.81 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.815 -0.439 . . . . 25.0 109.815 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -33.58 66.57 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.006 0.373 . . . . 25.0 112.006 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.51 70.76 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 112.446 0.536 . . . . 25.0 112.446 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.04 -32.07 15.33 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.254 0.549 . . . . 25.0 109.86 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 25.0 111.526 -176.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 112.955 0.724 . . . . 25.0 112.955 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -22.6 15.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 116.539 2.051 . . . . 25.0 116.539 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.67 -37.88 62.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.582 0.628 . . . . 25.0 111.777 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.74 68.29 8.23 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 115.358 1.614 . . . . 25.0 115.358 174.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.8 -6.49 19.11 Favored 'Trans proline' 0 C--O 1.222 -0.309 0 N-CA-C 113.14 0.4 . . . . 25.0 113.14 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -97.92 4.85 49.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.855 0.687 . . . . 25.0 112.855 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -107.81 88.08 2.65 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.666 -0.813 . . . . 25.0 110.603 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.95 140.18 42.79 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 103.891 -2.633 . . . . 25.0 103.891 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -107.51 144.05 35.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.666 0.746 . . . . 25.0 112.198 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 162.78 31.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.606 -1.998 . . . . 25.0 105.606 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 tttt . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 118.228 0.467 . . . . 25.0 109.816 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 112.527 -0.229 . . . . 25.0 112.527 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.73 -10.88 6.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.262 0.838 . . . . 25.0 113.262 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -57.86 -21.22 41.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.364 0.876 . . . . 25.0 113.364 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.86 -26.32 72.16 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.252 -0.975 . . . . 25.0 111.136 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.44 -14.7 72.22 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-O 119.589 -0.562 . . . . 25.0 114.028 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.86 -33.08 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.072 0.936 . . . . 25.0 110.146 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.5 -39.51 91.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 25.0 110.65 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -88.82 -2.97 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.996 0.903 . . . . 25.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.57 23.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.438 1.273 . . . . 25.0 114.438 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -70.57 74.33 0.56 Allowed 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.615 -0.678 . . . . 25.0 111.882 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t -151.59 171.2 17.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.877 -1.898 . . . . 25.0 105.877 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -64.76 -17.03 63.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.885 0.874 . . . . 25.0 112.025 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -74.26 -9.96 59.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -71.04 160.38 33.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.407 0.622 . . . . 25.0 110.216 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -85.06 163.65 18.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -62.73 146.78 51.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.938 0.875 . . . . 25.0 112.525 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -114.4 143.59 44.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.188 -1.412 . . . . 25.0 107.188 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -118.89 118.16 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.392 -0.596 . . . . 25.0 109.392 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.7 mt -76.13 135.87 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.89 165.97 30.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 p -108.49 170.19 8.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.926 -1.879 . . . . 25.0 105.926 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.54 179.21 26.36 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 115.076 0.791 . . . . 25.0 115.076 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.13 172.99 21.04 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.593 -1.003 . . . . 25.0 110.593 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 144.99 54.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.786 -0.832 . . . . 25.0 109.345 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -133.32 157.18 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.389 -0.597 . . . . 25.0 109.389 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.3 m -115.91 127.89 55.35 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.517 -0.549 . . . . 25.0 109.517 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.18 132.77 53.29 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.3 m -137.84 130.05 29.06 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -124.07 155.74 37.81 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.686 -1.598 . . . . 25.0 106.686 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.9 t -142.24 162.01 36.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.466 -0.568 . . . . 25.0 109.466 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -125.42 142.8 51.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.703 -1.221 . . . . 25.0 107.703 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -83.52 -0.56 50.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.27 0.557 . . . . 25.0 111.617 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 160.4 58.42 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.18 147.82 94.33 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.286 -2.01 . . . . 25.0 110.411 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -130.74 109.5 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.081 0.771 . . . . 25.0 113.081 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.29 144.5 53.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.062 -0.972 . . . . 25.0 108.85 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.4 m -133.34 132.81 41.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 25.0 109.976 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -106.54 -47.28 3.8 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.693 -1.225 . . . . 25.0 107.693 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -162.47 145.32 11.2 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.582 -1.636 . . . . 25.0 106.582 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -137.96 136.16 36.71 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -148.06 158.58 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.49 154.89 46.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.163 0.506 . . . . 25.0 111.878 -175.65 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -135.44 163.2 30.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.255 -0.884 . . . . 25.0 109.936 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.7 pt -129.36 152.56 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 168.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.6 p -84.87 141.92 30.09 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -74.22 114.82 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.809 0.814 . . . . 25.0 110.605 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -76.22 122.76 24.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 105.598 -2.001 . . . . 25.0 105.598 172.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.28 44.92 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.885 -1.15 . . . . 25.0 115.416 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.02 150.41 17.04 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.898 0.849 . . . . 25.0 112.552 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.83 118.63 72.41 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.099 -0.5 . . . . 25.0 110.789 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.27 -15.95 22.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 N-CA-C 114.725 1.01 . . . . 25.0 114.725 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.77 -3.85 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.174 0.987 . . . . 25.0 111.071 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -113.79 159.26 36.49 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 105.358 -2.09 . . . . 25.0 105.358 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.28 99.32 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 117.454 -1.23 . . . . 25.0 112.829 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.08 -36.57 60.8 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 113.634 0.975 . . . . 25.0 113.634 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.46 -15.27 6.42 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -85.99 -43.62 13.02 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.238 0.472 . . . . 25.0 111.439 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.82 -3.89 59.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.78 1.03 . . . . 25.0 113.78 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -67.87 -31.46 71.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.103 -0.239 . . . . 25.0 110.862 -174.28 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -127.15 132.41 50.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.772 0.656 . . . . 25.0 112.772 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -118.35 124.8 48.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.148 -1.056 . . . . 25.0 108.148 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.29 119.98 15.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -103.13 -2.13 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.913 0.863 . . . . 25.0 109.668 -176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.97 160.54 11.06 Favored Glycine 0 CA--C 1.512 -0.143 0 C-N-CA 120.769 -0.729 . . . . 25.0 113.242 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.2 144.84 26.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.678 -0.86 . . . . 25.0 108.678 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.6 104.76 10.0 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 107.159 -1.423 . . . . 25.0 107.159 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.52 172.21 12.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 116.902 -1.599 . . . . 25.0 112.662 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -134.65 91.45 2.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.303 -2.48 . . . . 25.0 104.303 170.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -106.14 29.95 6.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.166 0.984 . . . . 25.0 108.997 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.72 -37.29 3.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 109.336 -1.506 . . . . 25.0 109.336 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.3 t -59.38 138.1 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.1 46.78 2.05 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.991 1.794 . . . . 25.0 114.496 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.85 -21.79 61.42 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.828 0.677 . . . . 25.0 112.828 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.0 m -61.84 -13.16 21.65 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 113.834 1.05 . . . . 25.0 113.834 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -61.14 -35.92 78.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.884 0.374 . . . . 25.0 110.394 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -106.56 105.02 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 25.0 110.425 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.12 -13.81 30.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.274 0.842 . . . . 25.0 113.274 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.4 t -100.03 140.95 33.51 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.184 -0.323 . . . . 25.0 110.748 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -139.15 139.52 37.63 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.019 0.437 . . . . 25.0 111.904 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -86.75 137.53 32.36 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.013 -0.736 . . . . 25.0 109.013 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.14 124.97 53.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.289 -1.375 . . . . 25.0 107.289 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -77.0 135.56 38.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.016 -0.735 . . . . 25.0 109.016 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.9 mm -126.08 129.21 24.31 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.78 172.64 14.89 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 117.941 -0.906 . . . . 25.0 112.87 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -129.83 45.58 2.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.45 -37.72 15.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.657 -1.156 . . . . 25.0 113.364 -174.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -147.77 156.95 43.28 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 110.175 -0.306 . . . . 25.0 110.175 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.0 mp -95.56 145.73 25.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.199 0.6 . . . . 25.0 110.431 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.55 163.85 9.82 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 114.558 0.583 . . . . 25.0 114.558 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -94.37 145.75 24.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.895 1.443 . . . . 25.0 114.895 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -148.99 163.32 37.84 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.04 149.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.14 0.495 . . . . 25.0 112.029 -175.466 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.8 mt -120.59 133.22 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.426 -2.065 . . . . 25.0 105.426 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 mp -121.52 149.06 43.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -136.68 144.13 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.91 131.14 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -122.33 101.84 7.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.362 0.601 . . . . 25.0 109.959 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -79.97 131.87 35.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.369 -0.975 . . . . 25.0 108.369 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.58 128.96 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.218 -1.771 . . . . 25.0 106.218 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.99 44.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.94 0.4 . . . . 25.0 109.99 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -24.95 66.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 115.6 1.704 . . . . 25.0 115.6 -175.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 p -123.27 161.69 24.1 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.241 -0.287 . . . . 25.0 110.331 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.67 -19.12 62.12 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.181 0.991 . . . . 25.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -108.92 161.81 14.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.886 -1.052 . . . . 25.0 111.249 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.18 16.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.73 -2.693 . . . . 25.0 103.73 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -114.97 144.36 43.71 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.036 0.446 . . . . 25.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -113.28 146.53 39.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -133.55 141.17 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 104.813 -2.291 . . . . 25.0 104.813 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.07 136.61 47.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.3 mt -137.89 125.39 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.88 142.89 27.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.16 142.51 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.947 -0.471 . . . . 25.0 109.967 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -109.67 120.88 43.86 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.935 -2.246 . . . . 25.0 104.935 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 mt -120.02 128.22 53.32 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.713 -0.477 . . . . 25.0 109.713 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.73 170.06 18.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.774 -0.454 . . . . 25.0 109.774 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -77.56 157.94 30.08 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.898 -0.778 . . . . 25.0 108.898 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.6 mttt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 117.793 -1.098 . . . . 25.0 109.787 178.353 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.332 0 N-CA-C 106.26 -2.736 . . . . 25.0 106.26 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -125.77 156.72 39.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.642 1.221 . . . . 25.0 111.372 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.6 mt -97.66 119.44 45.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.637 -2.727 . . . . 25.0 103.637 170.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -77.5 5.67 8.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.654 0.613 . . . . 25.0 112.654 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttt 79.26 152.43 0.13 Allowed Pre-proline 0 N--CA 1.489 1.509 0 C-N-CA 126.021 1.729 . . . . 25.0 108.322 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 152.4 90.71 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 128.547 0.645 . . . . 25.0 112.023 -2.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.15 26.01 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 118.177 2.031 . . . . 25.0 118.177 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -65.04 131.29 46.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.896 1.348 . . . . 25.0 111.762 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -78.84 -15.93 57.75 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 113.459 0.911 . . . . 25.0 113.459 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.78 74.78 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 112.222 0.453 . . . . 25.0 112.222 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.73 -23.66 62.48 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.841 -0.537 . . . . 25.0 110.908 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.18 -4.03 54.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.279 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.219 -0.515 0 N-CA-C 108.822 -0.806 . . . . 25.0 108.822 179.384 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 113.071 0.767 . . . . 25.0 113.071 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.3 ptm -57.83 -11.09 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 118.121 2.637 . . . . 25.0 118.121 -174.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -69.94 -38.7 76.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.521 0.601 . . . . 25.0 110.462 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.95 63.74 3.16 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.174 1.176 . . . . 25.0 114.174 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.97 -8.12 22.35 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.122 -0.785 . . . . 25.0 113.856 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -97.19 5.12 50.66 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 122.056 -0.403 . . . . 25.0 111.878 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -121.21 130.4 53.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.739 0.644 . . . . 25.0 112.739 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.0 137.3 52.23 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.947 -1.501 . . . . 25.0 106.947 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -110.36 140.52 44.49 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.932 0.145 . . . . 25.0 111.132 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.93 158.08 45.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.396 -0.594 . . . . 25.0 109.396 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 tttt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 112.939 0.718 . . . . 25.0 112.939 179.812 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.463 0 N-CA-C 114.24 0.456 . . . . 25.0 114.24 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.68 -24.53 67.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.319 0.56 . . . . 25.0 111.151 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -66.49 -19.39 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.955 0.354 . . . . 25.0 111.955 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.76 -26.85 74.28 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.46 -1.056 . . . . 25.0 110.46 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.64 78.35 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.235 -0.507 . . . . 25.0 112.189 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.38 -42.59 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.377 -1.342 . . . . 25.0 107.377 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.39 -32.57 72.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.526 . . . . 25.0 109.914 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.11 -23.21 66.4 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.628 0.603 . . . . 25.0 112.628 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.94 -7.27 33.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.439 -0.788 . . . . 25.0 112.171 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -131.0 40.79 3.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -112.43 158.29 20.03 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.19 -30.78 63.79 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.582 -0.895 . . . . 25.0 108.582 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -96.64 21.26 9.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.329 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -50.24 148.29 3.63 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.127 -0.942 . . . . 25.0 111.64 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -67.37 138.15 56.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.766 1.269 . . . . 25.0 110.03 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -82.06 140.08 34.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.911 -1.495 . . . . 25.0 109.551 -172.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -108.72 138.68 44.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 25.0 111.485 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -124.39 135.25 53.15 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.835 -0.431 . . . . 25.0 109.835 168.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -79.66 138.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.1 tpt -139.51 156.11 47.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.349 -1.352 . . . . 25.0 107.349 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.9 p -101.43 -179.34 4.0 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.6 -178.77 30.3 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.275 -0.488 . . . . 25.0 112.355 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.26 -177.89 32.64 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 122.439 -0.448 . . . . 25.0 113.575 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -85.2 142.31 29.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -139.62 158.5 44.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.14 0.495 . . . . 25.0 110.206 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m -110.18 129.15 55.76 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.393 -0.966 . . . . 25.0 108.393 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.6 138.21 53.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.518 -1.289 . . . . 25.0 107.518 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -136.38 144.07 44.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.903 0.382 . . . . 25.0 111.113 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -121.02 149.98 41.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.83 156.44 48.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.296 0.57 . . . . 25.0 110.282 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -139.03 145.56 39.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.544 -2.021 . . . . 25.0 105.544 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -75.03 -14.15 60.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.495 0.554 . . . . 25.0 112.495 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.98 149.25 55.32 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.588 -1.264 . . . . 25.0 107.588 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -71.05 153.15 63.06 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 117.267 -1.356 . . . . 25.0 111.062 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -131.0 140.18 50.09 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.729 -0.471 . . . . 25.0 109.729 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.74 145.81 51.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 174.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.8 m -152.11 142.65 22.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.1 p -101.88 -37.37 8.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -165.13 167.11 18.51 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.239 -0.288 . . . . 25.0 111.119 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -141.25 141.17 34.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.625 -0.88 . . . . 25.0 108.625 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -147.94 155.68 41.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.377 -0.374 . . . . 25.0 110.265 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 150.03 46.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.39 0.614 . . . . 25.0 111.918 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -131.5 165.06 24.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.435 -1.32 . . . . 25.0 107.435 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -132.47 148.91 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 106.839 -1.541 . . . . 25.0 106.839 173.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 p -83.93 121.78 27.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -99.88 104.29 15.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.686 0.755 . . . . 25.0 109.06 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -75.99 153.96 36.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.61 23.95 17.24 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 119.779 -1.201 . . . . 25.0 114.606 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -66.7 161.62 23.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.667 0.734 . . . . 25.0 109.546 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.83 155.7 47.58 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.73 -14.54 33.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.777 -1.015 . . . . 25.0 113.261 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.07 -20.6 64.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.703 0.801 . . . . 25.0 111.468 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -96.04 147.16 32.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.494 -0.558 . . . . 25.0 109.494 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -61.82 119.71 6.96 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.285 -0.677 . . . . 25.0 111.609 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.58 -49.97 61.06 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 115.533 1.679 . . . . 25.0 115.533 -167.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.91 -36.67 36.09 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.902 0.858 . . . . 25.0 111.797 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -75.85 -32.67 59.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.492 -0.776 . . . . 25.0 112.983 -172.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.62 1.9 47.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.624 -0.262 . . . . 25.0 111.157 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.91 -29.59 68.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.195 -0.202 . . . . 25.0 111.135 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -125.88 150.14 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.91 0.708 . . . . 25.0 112.91 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -127.75 145.76 50.8 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.073 -1.084 . . . . 25.0 108.073 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.12 124.68 28.34 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.257 -0.645 . . . . 25.0 109.257 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.1 tt -98.36 -12.21 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.375 0.607 . . . . 25.0 110.137 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.46 160.19 14.42 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.311 -0.947 . . . . 25.0 114.206 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.54 139.06 23.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.706 -1.591 . . . . 25.0 106.706 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.0 t -137.09 116.49 10.4 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.85 167.53 22.09 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 115.329 -2.648 . . . . 25.0 111.904 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -126.64 96.25 4.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.348 1.071 . . . . 25.0 108.554 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -165.72 -98.15 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 100.527 -3.879 . . . . 25.0 100.527 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -93.69 134.93 12.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 105.843 -2.903 . . . . 25.0 105.843 168.103 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 t -164.58 146.2 6.76 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 117.48 0.64 . . . . 25.0 109.442 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.2 -162.43 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 120.747 0.964 . . . . 25.0 110.184 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.76 -14.07 2.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.381 1.252 . . . . 25.0 114.381 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.5 m -60.48 -16.05 32.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.079 0.77 . . . . 25.0 113.079 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -67.36 -10.44 51.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.467 0.544 . . . . 25.0 112.467 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -65.97 147.7 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 25.0 109.935 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.57 -9.7 58.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.568 0.699 . . . . 25.0 111.258 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.0 t -100.03 121.04 40.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.313 -1.736 . . . . 25.0 106.313 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -124.61 132.28 53.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 25.0 110.49 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -87.21 137.03 32.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.019 -0.537 . . . . 25.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.03 124.6 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.315 -0.994 . . . . 25.0 108.315 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 82.3 t80 -90.87 140.97 29.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -122.3 128.93 25.29 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 107.587 -1.264 . . . . 25.0 107.587 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.27 166.45 29.48 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 117.892 -0.939 . . . . 25.0 112.444 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -111.02 14.27 21.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.617 0.722 . . . . 25.0 111.076 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.34 -18.18 46.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.938 1.458 . . . . 25.0 114.938 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -155.18 170.01 22.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.19 0.811 . . . . 25.0 113.19 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.8 144.81 51.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.994 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.29 151.67 5.47 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.138 0.815 . . . . 25.0 115.138 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.03 146.89 25.94 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 114.943 1.46 . . . . 25.0 114.943 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -149.01 163.54 37.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -96.96 150.03 4.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.592 -0.522 . . . . 25.0 109.592 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.49 132.58 62.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.9 mt -119.05 139.84 51.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.876 -1.898 . . . . 25.0 105.876 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.79 151.52 47.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.114 0.87 . . . . 25.0 110.31 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.0 133.61 65.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.995 -1.002 . . . . 25.0 109.035 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -117.39 113.73 22.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.801 -1.185 . . . . 25.0 107.801 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -103.25 133.54 48.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.401 0.62 . . . . 25.0 111.358 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.86 132.26 70.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.73 -43.61 30.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 25.0 110.925 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 10.14 3.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.502 2.038 . . . . 25.0 116.502 -169.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -131.55 155.02 48.21 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.915 -0.49 . . . . 25.0 110.867 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -73.7 -7.85 53.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 25.0 110.959 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -115.22 163.83 15.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 25.0 112.14 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.88 163.22 33.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 103.453 -2.795 . . . . 25.0 103.453 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -130.45 152.39 49.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 -172.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -130.96 157.58 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.5 154.62 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.862 -0.792 . . . . 25.0 108.862 171.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.1 137.22 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.934 0.397 . . . . 25.0 110.853 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 60.6 mt -141.71 135.0 29.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.55 141.74 37.34 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.242 1.383 . . . . 25.0 108.961 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.41 134.52 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.447 0.641 . . . . 25.0 109.657 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -101.73 96.02 6.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.782 . . . . 25.0 106.187 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.66 105.86 17.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.04 158.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -99.66 164.99 11.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.632 -1.167 . . . . 25.0 107.897 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 C--O 1.253 1.264 0 CA-C-O 116.544 -1.693 . . . . 25.0 113.051 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.137 0 N-CA-C 111.423 -0.671 . . . . 25.0 111.423 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -108.88 135.99 49.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.38 0.272 . . . . 25.0 111.247 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.6 mt -93.98 114.38 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.27 -1.381 . . . . 25.0 107.27 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.12 -43.37 9.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.86 -0.792 . . . . 25.0 108.86 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -137.47 149.4 65.18 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 107.763 -1.199 . . . . 25.0 107.763 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.81 105.07 0.64 Allowed 'Cis proline' 0 CA--C 1.539 0.757 0 C-N-CA 131.102 1.709 . . . . 25.0 113.143 -3.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.71 -166.41 46.52 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.776 -0.726 . . . . 25.0 111.873 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 t -139.95 154.54 47.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.565 -0.531 . . . . 25.0 109.565 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.1 -20.85 57.3 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 116.391 -0.368 . . . . 25.0 111.701 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.52 66.53 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.914 0.709 . . . . 25.0 112.914 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.33 70.63 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.96 -11.36 39.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.036 0.446 . . . . 25.0 110.615 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.8 t . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 120.884 0.373 . . . . 25.0 111.373 -177.921 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 121.045 0.45 . . . . 25.0 110.772 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.5 ptm -62.69 -27.01 68.95 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.391 -0.818 . . . . 25.0 111.31 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.21 -28.87 31.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.542 0.687 . . . . 25.0 110.03 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -115.95 61.51 1.97 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.749 -0.659 . . . . 25.0 112.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.61 -38.62 3.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 114.169 -3.421 . . . . 25.0 113.335 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -105.69 -32.55 8.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.391 0.885 . . . . 25.0 113.391 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 m -102.14 78.26 1.75 Allowed 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 109.133 -0.692 . . . . 25.0 109.133 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -107.58 109.97 21.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.913 0.708 . . . . 25.0 112.913 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.35 103.91 4.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.565 0.58 . . . . 25.0 112.565 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.65 0 N-CA-C 113.478 0.151 . . . . 25.0 113.478 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.04 -21.46 66.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.522 0.329 . . . . 25.0 111.712 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -63.98 -13.0 42.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.117 0.414 . . . . 25.0 112.117 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.89 -14.64 56.25 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.432 -0.413 . . . . 25.0 113.732 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.86 -21.72 65.73 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 117.773 0.787 . . . . 25.0 112.796 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -66.44 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.39 -31.71 58.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 25.0 111.061 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.79 -49.89 76.01 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.32 0.581 . . . . 25.0 110.4 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -75.27 2.11 11.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -119.92 19.15 12.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.91 0.862 . . . . 25.0 109.61 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.0 t -107.47 177.18 4.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 25.0 110.614 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -80.95 -18.05 48.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -95.38 14.84 21.18 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.166 -0.925 . . . . 25.0 109.651 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.86 146.05 33.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -80.69 140.84 35.41 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.55 -0.907 . . . . 25.0 108.55 -176.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -58.33 142.45 48.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 25.0 112.645 -171.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -126.23 147.89 49.58 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.365 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -126.28 151.04 48.02 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.153 -0.684 . . . . 25.0 109.153 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -94.76 143.01 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.841 -1.911 . . . . 25.0 105.841 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.6 ttp -151.0 166.89 29.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.205 -0.295 . . . . 25.0 110.205 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.1 p -103.96 171.96 7.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.38 -2.081 . . . . 25.0 105.38 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.04 -169.41 7.52 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.361 0.423 . . . . 25.0 114.117 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.92 -172.74 20.21 Favored Glycine 0 N--CA 1.459 0.222 0 O-C-N 122.405 -0.467 . . . . 25.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 18.0 tt0 -75.82 135.66 40.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.952 -0.734 . . . . 25.0 109.424 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -129.24 152.11 49.17 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.8 m -117.7 134.84 54.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.455 . . . . 25.0 110.136 -174.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.73 111.99 23.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.781 -1.933 . . . . 25.0 105.781 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.4 m -120.37 110.78 16.93 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.99 141.38 52.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 104.699 -2.334 . . . . 25.0 104.699 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.6 t -145.01 161.97 38.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.553 0.216 . . . . 25.0 110.657 -173.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -125.43 150.73 47.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -72.39 -17.41 61.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 159.69 61.09 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.0 140.49 60.49 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 114.553 -3.165 . . . . 25.0 110.355 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -130.91 147.17 52.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.547 -1.279 . . . . 25.0 107.547 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -68.01 146.9 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.455 -1.313 . . . . 25.0 107.455 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.4 p -140.37 146.71 38.76 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.322 -1.362 . . . . 25.0 107.322 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -110.23 -50.16 2.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.905 0.383 . . . . 25.0 110.082 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -158.95 147.59 18.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.03 -0.419 . . . . 25.0 109.927 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -135.18 144.29 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 166.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -148.04 159.13 44.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.472 -0.566 . . . . 25.0 109.472 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.35 149.91 47.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.653 0.74 . . . . 25.0 112.08 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.74 165.95 20.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.051 -1.463 . . . . 25.0 107.051 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 pt -130.03 159.1 42.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.598 -0.89 . . . . 25.0 108.598 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 114' ' ' ASP . 58.9 m -111.72 115.95 29.94 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -89.99 112.02 23.29 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -76.11 153.96 35.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.014 -1.106 . . . . 25.0 108.014 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.33 31.95 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 116.011 1.164 . . . . 25.0 116.011 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -60.2 153.74 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.765 0.783 . . . . 25.0 110.102 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.52 147.1 98.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 25.0 107.767 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.91 -20.0 34.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 117.828 -0.982 . . . . 25.0 114.468 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.11 -23.71 63.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.027 0.918 . . . . 25.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -96.04 136.19 22.29 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.49 126.56 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 116.726 -1.716 . . . . 25.0 114.372 -172.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 tt -52.76 -39.44 62.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.421 -1.263 . . . . 25.0 111.726 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.04 -16.06 63.04 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -83.06 -41.72 18.29 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.965 -0.459 . . . . 25.0 110.831 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.84 60.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 100' ' ' THR . 0.4 OUTLIER -67.87 -31.51 71.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.164 -0.471 . . . . 25.0 112.041 -176.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -125.98 111.67 15.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.784 0.661 . . . . 25.0 112.784 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -128.18 121.14 28.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.52 124.26 23.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.227 -0.296 . . . . 25.0 110.746 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -14.96 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.985 -0.746 . . . . 25.0 108.985 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.51 154.43 10.22 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.298 -0.953 . . . . 25.0 113.965 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.66 137.25 36.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.88 87.47 48.98 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.0 157.65 46.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.275 -1.35 . . . . 25.0 111.339 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -112.21 99.11 7.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.195 -1.039 . . . . 25.0 108.195 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.29 4.21 9.15 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.552 -1.647 . . . . 25.0 106.552 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.52 -179.1 45.13 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 103.401 -3.88 . . . . 25.0 103.401 -175.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -139.51 65.58 33.76 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 116.12 1.896 . . . . 25.0 116.12 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 175.71 9.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 116.884 -1.611 . . . . 25.0 109.565 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.87 56.2 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.045 0.757 . . . . 25.0 113.045 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.3 t -60.36 -24.55 65.17 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.193 0.52 . . . . 25.0 112.28 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.97 7.1 47.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.384 0.673 . . . . 25.0 112.532 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -58.37 141.28 51.78 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.542 -1.651 . . . . 25.0 106.542 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -35.6 80.81 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.376 0.534 . . . . 25.0 111.883 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.4 t -86.09 124.84 32.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.769 -0.826 . . . . 25.0 108.769 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -120.58 149.76 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.735 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -112.35 131.72 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.2 mm -132.0 128.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 63.0 t80 -79.79 132.81 36.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.954 -1.128 . . . . 25.0 107.954 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.6 mm -119.42 123.07 28.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.09 162.97 39.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 117.355 -1.296 . . . . 25.0 112.523 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.91 28.71 8.18 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.919 -1.511 . . . . 25.0 106.919 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.15 -18.63 63.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.852 -1.067 . . . . 25.0 113.566 -172.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -156.81 150.29 24.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.258 0.552 . . . . 25.0 109.959 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.83 154.18 19.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.898 -1.046 . . . . 25.0 108.718 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.27 -176.33 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 121.509 0.505 . . . . 25.0 112.105 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 55.2 p90 -80.74 145.02 31.74 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.78 0.659 . . . . 25.0 112.78 -174.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -132.66 116.05 16.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 t -93.28 138.12 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 120.69 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 mp -104.51 141.08 37.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.804 -1.184 . . . . 25.0 107.804 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.67 132.92 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.827 0.739 . . . . 25.0 112.206 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.33 137.41 57.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -120.65 112.54 19.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.763 -1.569 . . . . 25.0 106.763 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.78 133.1 34.36 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.553 -1.203 . . . . 25.0 109.444 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 156' ' ' ASP . 58.1 t -117.24 121.96 68.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.542 -0.91 . . . . 25.0 108.542 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -13.6 61.58 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.747 0.647 . . . . 25.0 112.747 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.438 ' H ' HG12 ' A' ' 154' ' ' VAL . 25.5 m-20 -81.31 -13.64 58.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.702 0.63 . . . . 25.0 112.702 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.3 p -144.31 159.77 42.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.33 0.863 . . . . 25.0 113.33 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -79.45 3.82 17.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 25.0 110.722 171.143 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -110.13 171.04 7.69 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.742 -0.836 . . . . 25.0 108.742 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.47 161.29 40.06 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.421 0.629 . . . . 25.0 109.925 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -96.45 130.39 43.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -132.31 139.13 48.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.694 0.627 . . . . 25.0 112.694 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.71 154.24 39.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.119 -0.697 . . . . 25.0 109.119 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.2 p -136.98 137.25 47.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.374 -2.454 . . . . 25.0 104.374 171.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.6 mt -132.2 130.73 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -111.97 139.12 47.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.65 -1.241 . . . . 25.0 107.65 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.81 126.91 60.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.442 0.639 . . . . 25.0 109.921 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 42.3 t0 -85.97 102.04 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.778 -1.564 . . . . 25.0 106.778 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.21 117.33 33.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.537 -0.912 . . . . 25.0 108.537 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 25.7 m -136.45 163.19 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.017 -0.538 . . . . 25.0 111.023 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -89.99 155.27 19.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.007 -1.849 . . . . 25.0 106.007 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.991 -1.004 . . . . 25.0 110.095 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.267 0 N-CA-C 106.147 -2.781 . . . . 25.0 106.147 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.19 148.12 36.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.441 1.121 . . . . 25.0 111.021 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.23 112.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 104.025 -2.583 . . . . 25.0 104.025 170.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.48 2.69 13.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.709 0.633 . . . . 25.0 112.709 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 74.15 151.66 0.14 Allowed Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 125.752 1.621 . . . . 25.0 110.003 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.53 153.78 89.52 Favored 'Cis proline' 0 C--O 1.222 -0.283 0 CA-C-O 121.733 0.639 . . . . 25.0 112.203 -1.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.56 14.8 13.37 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 117.081 1.592 . . . . 25.0 117.081 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -65.86 125.36 25.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.632 1.216 . . . . 25.0 111.431 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -78.51 -19.64 52.54 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.441 0.534 . . . . 25.0 112.441 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.66 67.93 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.146 0.278 . . . . 25.0 111.091 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.02 -31.52 72.67 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 120.693 0.283 . . . . 25.0 111.315 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.98 -3.88 55.3 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 116.43 -0.35 . . . . 25.0 111.164 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.487 . . . . 25.0 109.684 179.464 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 120.861 0.362 . . . . 25.0 111.167 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.7 ptm -58.6 -10.88 2.5 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 117.77 2.507 . . . . 25.0 117.77 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -69.4 -39.84 77.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.43 0.559 . . . . 25.0 110.85 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.37 64.59 2.52 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 113.571 0.952 . . . . 25.0 113.571 173.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.37 -8.87 24.63 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 118.185 -0.743 . . . . 25.0 113.754 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 pm0 -97.85 4.37 49.68 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.823 0.675 . . . . 25.0 112.823 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -100.74 98.73 9.23 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 118.573 0.624 . . . . 25.0 111.16 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.7 mt -90.47 117.7 29.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.978 -2.23 . . . . 25.0 104.978 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -84.21 141.31 31.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.725 0.297 . . . . 25.0 110.632 -175.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.96 157.71 46.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.012 -1.477 . . . . 25.0 107.012 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttm . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.498 0.666 . . . . 25.0 111.703 178.379 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.4 0 N-CA-C 112.35 -0.3 . . . . 25.0 112.35 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.24 -24.94 63.17 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.401 -0.47 . . . . 25.0 111.493 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.01 -26.64 67.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.91 0.386 . . . . 25.0 111.349 175.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.25 -25.68 75.05 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 110.673 -0.971 . . . . 25.0 110.673 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.49 71.62 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 121.25 -0.5 . . . . 25.0 112.846 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.42 -42.61 84.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.929 -1.137 . . . . 25.0 107.929 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.06 -26.42 56.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 25.0 111.227 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -21.65 64.87 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.425 0.631 . . . . 25.0 111.674 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -68.84 -3.78 13.79 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.816 -0.553 . . . . 25.0 112.41 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -132.69 55.68 1.88 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -135.71 157.8 45.98 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.979 -0.378 . . . . 25.0 109.979 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -71.95 -25.11 61.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.688 0.756 . . . . 25.0 109.138 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -97.55 18.84 14.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.711 . . . . 25.0 110.492 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -52.71 142.22 19.13 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.564 0.697 . . . . 25.0 111.634 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -69.02 143.82 54.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.555 1.169 . . . . 25.0 109.778 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -75.36 131.29 40.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.587 -0.733 . . . . 25.0 111.562 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -91.62 146.34 23.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.813 -0.63 . . . . 25.0 111.121 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -131.76 114.32 14.59 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.173 -0.306 . . . . 25.0 110.173 168.095 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -73.47 135.54 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.063 -2.199 . . . . 25.0 105.063 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.1 tpt -150.42 154.15 37.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 p -93.0 -177.17 4.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.189 -1.411 . . . . 25.0 107.189 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -166.53 31.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.87 -0.492 . . . . 25.0 111.87 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.78 -178.94 30.05 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 112.16 -0.376 . . . . 25.0 112.16 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 1.7 tp10 -79.99 133.89 36.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -126.03 121.81 34.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.414 0.626 . . . . 25.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.3 m -91.75 126.92 37.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.982 -1.118 . . . . 25.0 107.982 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -119.06 125.91 50.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -123.54 130.76 53.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 25.0 111.347 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.1 m0 -123.66 147.91 46.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.628 -2.73 . . . . 25.0 103.628 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -136.54 161.06 36.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.16 0.505 . . . . 25.0 109.723 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.05 137.88 47.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.7 t -79.32 -9.13 59.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.93 60.85 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 106.268 -1.752 . . . . 25.0 106.268 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.26 144.75 47.0 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 116.203 -2.065 . . . . 25.0 111.92 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -131.07 139.74 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.197 -1.409 . . . . 25.0 107.197 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -71.26 148.39 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -149.95 141.89 23.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.7 t -92.44 -47.26 7.25 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.756 0.422 . . . . 25.0 109.998 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -165.61 168.65 16.15 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.162 -0.336 . . . . 25.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -139.58 140.19 36.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 167.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -145.86 156.37 43.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.389 -0.369 . . . . 25.0 110.748 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -133.14 144.78 50.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.874 -0.603 . . . . 25.0 111.02 -167.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -137.12 165.53 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 28.2 pt -134.74 152.2 32.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.686 -1.227 . . . . 25.0 107.686 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 p -85.13 141.95 29.84 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -88.33 121.31 30.58 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 113.255 0.835 . . . . 25.0 113.255 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -86.5 150.78 24.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.443 -1.317 . . . . 25.0 107.443 169.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.29 64.1 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.072 1.589 . . . . 25.0 117.072 173.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -61.19 154.32 23.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.678 1.239 . . . . 25.0 110.735 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.63 154.43 44.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 25.0 109.907 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.62 -7.39 16.7 Favored 'Trans proline' 0 C--N 1.351 0.707 0 N-CA-C 116.084 1.532 . . . . 25.0 116.084 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.16 -8.1 55.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.141 0.972 . . . . 25.0 110.096 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -123.74 150.14 61.12 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.192 -0.67 . . . . 25.0 109.192 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.7 111.36 1.88 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 117.321 -1.319 . . . . 25.0 111.797 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.84 -44.06 66.48 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.226 -0.897 . . . . 25.0 113.23 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.68 -27.22 68.54 Favored 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.92 -41.78 50.79 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.337 0.589 . . . . 25.0 110.209 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.46 6.37 23.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.943 -1.026 . . . . 25.0 112.953 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.07 -38.83 82.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.848 0.684 . . . . 25.0 112.848 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -133.62 156.77 47.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.957 -0.464 . . . . 25.0 111.605 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -133.53 146.31 50.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.033 -0.728 . . . . 25.0 109.033 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.4 tp -77.59 127.18 32.07 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 tt -106.08 -3.37 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.693 0.759 . . . . 25.0 110.984 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.23 156.12 8.29 Favored Glycine 0 C--O 1.229 -0.175 0 C-N-CA 120.469 -0.872 . . . . 25.0 113.948 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.35 137.18 22.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.681 -1.229 . . . . 25.0 107.681 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.19 109.45 10.55 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.69 161.7 36.38 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 116.228 -2.048 . . . . 25.0 111.965 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -122.96 92.66 3.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -175.62 -94.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 N-CA-C 99.897 -4.112 . . . . 25.0 99.897 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -97.87 143.27 16.59 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 105.32 -3.112 . . . . 25.0 105.32 167.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.6 155.82 13.35 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.67 -167.3 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 O-C-N 122.265 0.613 . . . . 25.0 111.017 174.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.75 24.2 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.662 0.616 . . . . 25.0 112.662 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.8 1.07 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.927 1.454 . . . . 25.0 114.927 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -58.66 -13.84 6.91 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.421 1.267 . . . . 25.0 114.421 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -59.12 144.12 46.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.686 0.755 . . . . 25.0 112.714 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.6 tp -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.983 -1.008 . . . . 25.0 112.395 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.6 t -94.45 123.37 37.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -103.99 133.72 48.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 25.0 110.742 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -99.82 134.1 43.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 25.0 109.563 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.9 mt -132.95 119.67 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 87.9 t80 -85.82 138.01 32.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.785 -0.45 . . . . 25.0 109.785 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.45 124.87 26.21 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.46 153.57 50.02 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 116.381 -1.946 . . . . 25.0 111.403 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -108.1 51.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.66 1.219 . . . . 25.0 109.302 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -103.72 -6.2 21.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.639 -1.164 . . . . 25.0 111.2 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -161.0 157.74 26.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.283 0.563 . . . . 25.0 112.41 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.3 pt? -116.72 153.87 31.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.584 -0.735 . . . . 25.0 110.334 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 133.31 140.26 4.35 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 113.851 0.3 . . . . 25.0 113.851 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -85.83 145.95 26.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 116.272 1.953 . . . . 25.0 116.272 -173.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -149.55 167.05 27.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -98.06 150.51 4.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.894 0.854 . . . . 25.0 111.965 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.7 mt -106.94 131.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.311 -2.848 . . . . 25.0 103.311 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.0 mt -110.12 143.97 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 163' ' ' GLN . . . -142.63 148.49 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.612 -0.885 . . . . 25.0 108.612 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.14 139.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.563 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -126.5 103.23 7.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.596 -0.89 . . . . 25.0 108.596 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -94.15 138.19 32.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.238 -0.289 . . . . 25.0 110.8 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.5 t -117.6 132.01 68.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.056 -1.461 . . . . 25.0 107.056 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.54 -41.42 46.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 25.0 110.524 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -10.92 60.37 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.12 1.896 . . . . 25.0 116.12 -170.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.8 p -126.37 158.25 36.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.966 -0.459 . . . . 25.0 110.519 -176.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -74.44 -10.17 59.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 25.0 111.588 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -103.76 158.67 16.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.412 0.625 . . . . 25.0 110.451 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.83 162.92 34.2 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.465 -3.161 . . . . 25.0 102.465 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.31 150.59 45.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.516 0.562 . . . . 25.0 112.516 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.65 153.92 41.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.29 -1.374 . . . . 25.0 107.29 174.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -145.95 154.21 41.67 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.83 141.86 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.886 0.374 . . . . 25.0 110.324 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 62.9 mt -133.58 122.6 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.28 -1.378 . . . . 25.0 107.28 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -87.81 131.6 34.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.549 -1.649 . . . . 25.0 106.549 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.38 132.59 70.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.827 -0.805 . . . . 25.0 108.827 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.9 95.76 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 104.929 -2.248 . . . . 25.0 104.929 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.58 121.8 32.12 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.254 -1.758 . . . . 25.0 106.254 -173.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 20.0 m -135.19 166.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 123.231 0.332 . . . . 25.0 111.448 -175.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.38 141.11 28.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.8 tptt . . . . . 0 C--O 1.246 0.917 0 N-CA-C 115.564 1.69 . . . . 25.0 115.564 177.38 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.555 0 N-CA-C 117.364 1.706 . . . . 25.0 117.364 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -128.02 153.0 47.26 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.602 0.761 . . . . 25.0 111.956 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 93.7 mt -93.83 119.34 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 103.665 -2.717 . . . . 25.0 103.665 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -90.08 -43.33 10.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.535 -0.543 . . . . 25.0 109.535 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -138.79 149.68 62.9 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 109.8 1.48 Allowed 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 132.306 2.211 . . . . 25.0 115.299 -1.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.38 -176.76 26.81 Favored Glycine 0 C--O 1.226 -0.405 0 N-CA-C 114.631 0.612 . . . . 25.0 114.631 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 t -82.97 134.77 35.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.485 -0.421 . . . . 25.0 111.065 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -78.11 -26.32 47.94 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.919 0.39 . . . . 25.0 111.051 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.34 65.92 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.873 0.694 . . . . 25.0 112.873 -172.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.07 71.9 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 120.785 0.326 . . . . 25.0 111.184 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.47 -4.38 55.6 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.054 -0.521 . . . . 25.0 111.743 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 25.0 111.577 -175.325 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.843 0.354 . . . . 25.0 110.36 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -63.94 -11.06 24.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -79.04 -35.98 41.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.659 -0.496 . . . . 25.0 109.659 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.66 79.25 9.56 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 175.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.53 -15.89 46.01 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 115.938 -2.241 . . . . 25.0 112.44 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -85.4 -22.08 28.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.718 -0.658 . . . . 25.0 112.437 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -132.99 94.02 3.29 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 114.732 1.382 . . . . 25.0 114.732 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.15 114.79 28.82 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -114.5 142.21 46.7 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.427 0.454 . . . . 25.0 110.358 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 104.16 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.475 -0.565 . . . . 25.0 109.475 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.969 0.89 . . . . 25.0 112.933 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.687 0 N-CA-C 113.833 0.293 . . . . 25.0 113.833 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.2 mt -61.89 -23.28 66.21 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 112.585 0.587 . . . . 25.0 112.585 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -71.06 -13.12 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.205 -0.309 . . . . 25.0 111.692 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.25 -16.65 60.53 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.114 0.805 . . . . 25.0 115.114 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.3 -26.14 69.12 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-N 118.121 0.961 . . . . 25.0 112.389 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.2 mm -68.03 -33.91 63.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.112 -0.64 . . . . 25.0 110.007 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -77.53 -19.3 55.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.206 -0.309 . . . . 25.0 111.256 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.96 -21.56 64.91 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.625 0.602 . . . . 25.0 112.625 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -56.03 -21.4 21.36 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.678 0.622 . . . . 25.0 112.678 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -138.75 51.73 1.81 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.174 0.511 . . . . 25.0 109.751 177.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 t -118.78 162.83 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 25.0 111.255 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.87 -32.48 74.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.827 0.822 . . . . 25.0 110.283 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -94.48 16.43 15.34 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.659 -0.701 . . . . 25.0 112.633 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -61.07 150.25 34.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -97.02 156.4 16.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.042 -1.096 . . . . 25.0 108.042 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.06 121.93 3.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -76.24 108.08 8.92 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.799 -0.445 . . . . 25.0 109.799 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 105.93 16.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.362 0.601 . . . . 25.0 112.117 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -64.18 142.86 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.028 -0.731 . . . . 25.0 109.028 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 tpt -146.82 151.87 37.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.849 -1.167 . . . . 25.0 107.849 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -101.95 171.99 7.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.455 -1.313 . . . . 25.0 107.455 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.08 177.57 19.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.81 0.684 . . . . 25.0 114.81 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.16 177.1 31.79 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 112.399 -0.281 . . . . 25.0 112.399 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER -92.06 132.73 36.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.942 -0.74 . . . . 25.0 109.733 179.358 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -135.33 141.78 45.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.888 0.375 . . . . 25.0 110.448 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.9 m -84.34 118.75 24.42 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -93.03 111.92 23.71 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.443 -2.058 . . . . 25.0 105.443 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -90.67 118.74 30.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.93 -0.577 . . . . 25.0 111.192 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -122.92 139.49 53.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.757 -2.312 . . . . 25.0 104.757 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -145.01 161.84 38.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 25.0 111.95 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.87 136.87 52.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.076 -2.564 . . . . 25.0 104.076 173.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.7 t -72.82 -15.91 61.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.382 0.882 . . . . 25.0 113.382 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 153.81 67.74 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 104.752 -2.314 . . . . 25.0 104.752 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 130.73 25.24 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 115.525 -2.517 . . . . 25.0 111.574 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -130.93 153.34 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 156' ' ' ASP . 11.8 t-20 -65.08 143.2 58.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.563 -1.643 . . . . 25.0 106.563 171.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -144.78 147.26 32.69 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.378 -2.453 . . . . 25.0 104.378 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -116.99 -47.15 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.099 0.777 . . . . 25.0 113.099 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -159.12 153.29 23.7 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.518 -0.739 . . . . 25.0 112.388 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.39 132.34 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.161 0.505 . . . . 25.0 109.73 167.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -136.89 142.57 42.75 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.85 151.52 39.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.774 0.797 . . . . 25.0 111.614 -166.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.48 168.94 18.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.61 -1.177 . . . . 25.0 109.064 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.78 149.11 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.115 -0.328 . . . . 25.0 110.115 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.5 m -88.5 117.19 27.28 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.192 -0.458 . . . . 25.0 110.025 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.18 125.16 34.47 Favored 'General case' 0 C--O 1.209 -1.057 0 O-C-N 121.334 -0.854 . . . . 25.0 110.949 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -76.86 154.08 34.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 106.531 -1.655 . . . . 25.0 106.531 168.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.01 10.21 56.45 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 119.349 2.499 . . . . 25.0 119.349 170.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -61.02 153.33 25.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.958 1.379 . . . . 25.0 110.699 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.51 152.05 95.46 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.337 -1.357 . . . . 25.0 107.337 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 -19.8 47.3 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 117.646 -1.102 . . . . 25.0 114.868 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.18 -18.62 62.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.822 0.82 . . . . 25.0 111.67 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -96.13 128.86 35.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.483 -0.761 . . . . 25.0 109.866 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.14 126.28 16.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.588 -1.141 . . . . 25.0 114.223 -173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.12 -42.94 66.51 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.525 -1.216 . . . . 25.0 113.213 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -69.01 -17.35 63.9 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 113.046 0.758 . . . . 25.0 113.046 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -77.15 -45.63 26.12 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.64 67.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.364 0.602 . . . . 25.0 112.216 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -71.04 -29.03 64.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 25.0 110.538 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.46 92.12 3.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.259 0.552 . . . . 25.0 109.712 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -99.75 110.13 22.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -62.82 117.25 6.09 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.857 -0.423 . . . . 25.0 109.857 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -2.53 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 107.382 -1.34 . . . . 25.0 107.382 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.22 151.05 6.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.778 . . . . 25.0 114.639 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -143.04 122.66 13.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.057 -1.831 . . . . 25.0 106.057 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.09 117.95 11.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.35 175.38 11.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 115.962 -2.225 . . . . 25.0 110.259 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -128.56 92.36 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.253 -2.128 . . . . 25.0 105.253 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.0 -19.94 13.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.681 -1.6 . . . . 25.0 107.711 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.76 -179.35 30.78 Favored Glycine 0 N--CA 1.445 -0.764 1 N-CA-C 103.013 -4.035 . . . . 25.0 103.013 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -116.65 36.75 0.22 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 117.16 2.281 . . . . 25.0 117.16 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.88 170.57 18.5 Favored 'Trans proline' 0 C--N 1.355 0.876 1 C-N-CA 113.225 -4.05 . . . . 25.0 110.333 171.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.11 55.43 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.294 1.22 . . . . 25.0 114.294 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.8 p -70.51 -19.81 62.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.1 mmt-85 -100.96 10.72 40.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.274 0.63 . . . . 25.0 112.478 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -58.05 156.8 8.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.028 1.862 . . . . 25.0 116.028 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.73 -22.4 59.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.344 -1.298 . . . . 25.0 111.662 176.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 65.1 m -100.04 140.55 34.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -129.57 136.86 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.339 0.866 . . . . 25.0 113.339 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -79.37 126.8 31.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.543 -1.651 . . . . 25.0 106.543 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -131.91 125.81 55.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.705 -1.221 . . . . 25.0 107.705 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 90.6 t80 -85.85 133.33 33.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -108.84 129.67 23.65 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.844 -1.539 . . . . 25.0 106.844 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -66.27 146.58 81.47 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 117.127 -1.449 . . . . 25.0 111.92 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -110.57 -12.54 14.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.055 0.931 . . . . 25.0 110.857 -173.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.0 4.22 45.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.839 1.052 . . . . 25.0 113.839 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -151.78 151.65 31.65 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 121.844 -0.535 . . . . 25.0 112.145 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.32 141.57 47.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.286 -0.87 . . . . 25.0 109.49 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.74 163.49 10.49 Favored Glycine 0 CA--C 1.517 0.178 0 N-CA-C 115.11 0.804 . . . . 25.0 115.11 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 11.4 p90 -86.92 145.04 26.69 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.504 0.927 . . . . 25.0 113.504 -176.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -144.5 159.09 43.35 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 105.861 -1.904 . . . . 25.0 105.861 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.83 136.31 50.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 106.894 -1.521 . . . . 25.0 106.894 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.7 mt -96.04 120.16 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.155 -2.535 . . . . 25.0 104.155 174.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.5 mt -105.5 137.48 43.26 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.31 146.64 32.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.101 0.864 . . . . 25.0 112.321 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.03 135.43 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.64 -1.615 . . . . 25.0 106.64 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -130.06 117.45 20.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.606 0.717 . . . . 25.0 110.01 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.7 132.0 38.49 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.865 -1.061 . . . . 25.0 109.998 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.0 t -135.18 134.74 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.0 -10.04 19.29 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.204 1.557 . . . . 25.0 115.204 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ASP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 91' ' ' ASN . 41.9 p-10 -102.29 18.22 21.52 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 25.0 110.457 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.2 p -133.0 151.16 52.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -70.22 -18.13 63.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.665 0.269 . . . . 25.0 111.656 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.16 171.93 7.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.061 -0.518 . . . . 25.0 111.87 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 159.53 26.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.683 -1.969 . . . . 25.0 105.683 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -111.35 145.59 38.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.302 1.223 . . . . 25.0 114.302 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -123.5 139.7 53.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.204 -0.907 . . . . 25.0 108.734 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -149.57 142.1 24.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.417 -1.327 . . . . 25.0 107.417 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 m -135.59 151.06 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.305 -1.369 . . . . 25.0 107.305 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.08 110.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.006 -1.479 . . . . 25.0 107.006 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -77.53 131.74 38.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.321 -1.733 . . . . 25.0 106.321 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.0 157.93 41.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.789 -0.569 . . . . 25.0 110.605 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 43.7 t0 -123.58 108.29 12.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.344 -1.724 . . . . 25.0 106.344 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.77 103.99 16.0 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.81 -1.552 . . . . 25.0 106.81 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.45 171.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.825 0.345 . . . . 25.0 111.319 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.02 152.67 32.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.9 -1.148 . . . . 25.0 107.9 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.896 0 CA-C-O 117.844 -1.074 . . . . 25.0 109.599 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.285 0 N-CA-C 110.559 -1.016 . . . . 25.0 110.559 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.08 133.24 36.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.995 0.398 . . . . 25.0 110.347 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.68 112.32 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 106.498 -1.668 . . . . 25.0 106.498 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.61 -43.5 10.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.95 -0.568 . . . . 25.0 110.798 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -140.55 158.09 66.71 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 107.862 -1.162 . . . . 25.0 107.862 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.14 116.57 4.53 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 131.672 1.947 . . . . 25.0 113.955 -2.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.23 -149.48 45.27 Favored Glycine 0 C--O 1.226 -0.367 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -131.43 110.77 11.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.239 0.542 . . . . 25.0 110.553 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -20.73 65.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.994 -0.548 . . . . 25.0 111.004 176.425 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -24.13 67.7 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.104 0.253 . . . . 25.0 111.577 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.65 93.89 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 120.852 -0.339 . . . . 25.0 110.281 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.53 -16.8 61.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.269 0.557 . . . . 25.0 111.147 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.547 -0.751 . . . . 25.0 110.099 -177.693 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 t . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 112.482 0.549 . . . . 25.0 112.482 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -70.34 -27.95 64.76 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.763 -0.586 . . . . 25.0 112.542 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.17 -16.28 25.03 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.378 1.085 . . . . 25.0 108.541 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.66 60.09 0.84 Allowed Pre-proline 0 C--O 1.245 0.86 0 CA-C-N 115.176 -0.92 . . . . 25.0 111.733 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.71 -39.86 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 113.558 -3.828 . . . . 25.0 114.348 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -104.24 -23.44 13.24 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.476 1.288 . . . . 25.0 114.476 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.49 114.16 21.86 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 104.567 -2.383 . . . . 25.0 104.567 173.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -133.38 105.05 6.72 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 106.487 -1.671 . . . . 25.0 106.487 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -128.62 141.01 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.22 0.533 . . . . 25.0 112.18 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.07 102.86 5.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm . . . . . 0 C--N 1.327 -0.401 0 N-CA-C 105.037 -2.208 . . . . 25.0 105.037 -174.312 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.709 0 N-CA-C 115.079 0.791 . . . . 25.0 115.079 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -59.84 -35.94 75.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.573 0.953 . . . . 25.0 113.573 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -65.03 -11.82 43.54 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.841 0.682 . . . . 25.0 112.841 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.94 48.34 Favored Glycine 0 C--O 1.22 -0.74 0 CA-C-O 119.713 -0.493 . . . . 25.0 113.663 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.55 -22.9 73.56 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 117.962 0.881 . . . . 25.0 112.673 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -86.31 -36.98 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.31 -10.86 60.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 25.0 111.9 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -30.57 64.55 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 111.654 0.242 . . . . 25.0 111.654 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.92 -8.64 11.84 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.259 1.207 . . . . 25.0 114.259 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -127.8 24.25 6.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.418 0.628 . . . . 25.0 109.867 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 t -98.5 164.96 12.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.244 -0.435 . . . . 25.0 110.983 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.67 -33.38 74.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.61 0.719 . . . . 25.0 109.148 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -94.89 19.03 10.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.002 -0.545 . . . . 25.0 112.053 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -47.63 136.37 10.41 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.345 0.869 . . . . 25.0 113.345 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -89.68 159.06 17.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.788 . . . . 25.0 109.227 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -65.52 132.91 50.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -80.78 143.24 33.01 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.47 -0.787 . . . . 25.0 109.717 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 96.57 4.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.898 0.703 . . . . 25.0 112.898 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -69.25 138.43 22.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.152 -2.536 . . . . 25.0 104.152 168.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.5 tpt -145.42 146.55 31.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.23 -0.655 . . . . 25.0 109.23 -176.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p -95.0 172.04 8.39 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.81 -174.97 5.48 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 116.648 1.419 . . . . 25.0 116.648 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.84 177.08 35.18 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 115.035 -0.583 . . . . 25.0 113.031 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.97 132.63 34.17 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.034 -0.686 . . . . 25.0 110.86 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -132.61 137.92 47.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 25.0 109.515 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 m -101.97 137.49 40.19 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.596 0.961 . . . . 25.0 113.596 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.29 129.73 55.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.901 -1.518 . . . . 25.0 106.901 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -137.77 129.56 28.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.993 -0.373 . . . . 25.0 109.993 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -124.01 143.36 50.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -145.01 156.92 44.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.7 0.286 . . . . 25.0 111.168 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -139.78 163.98 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -71.28 -19.38 62.35 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.501 0.926 . . . . 25.0 113.501 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.77 147.34 48.11 Favored Pre-proline 0 C--O 1.238 0.468 0 O-C-N 121.943 -0.473 . . . . 25.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.86 149.71 37.79 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 117.689 -1.074 . . . . 25.0 111.734 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -130.94 161.65 31.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 25.0 109.199 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -65.86 131.09 45.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.563 -1.273 . . . . 25.0 107.563 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.4 p -143.63 152.22 41.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.256 -1.387 . . . . 25.0 107.256 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.2 t -103.3 -56.84 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.494 0.924 . . . . 25.0 113.494 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -159.01 150.43 20.45 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.849 -0.532 . . . . 25.0 110.644 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 131.12 52.4 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.008 -1.478 . . . . 25.0 107.008 169.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -147.84 158.96 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.528 -0.305 . . . . 25.0 110.729 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -145.32 150.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.705 0.764 . . . . 25.0 112.239 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -128.36 154.8 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.606 -1.179 . . . . 25.0 108.12 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.01 149.36 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.907 0.706 . . . . 25.0 112.907 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.1 m -86.79 121.82 29.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -108.05 125.53 51.67 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 121.74 -0.6 . . . . 25.0 111.759 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -75.9 148.29 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.202 -1.777 . . . . 25.0 106.202 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.58 9.91 34.47 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 117.229 1.652 . . . . 25.0 117.229 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' TRP . . . . . 0.401 ' CH2' ' HA ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -83.05 161.5 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.615 1.208 . . . . 25.0 110.56 175.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.63 140.35 78.38 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.26 -13.51 20.87 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 114.492 0.92 . . . . 25.0 114.492 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.44 -13.97 61.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.114 0.959 . . . . 25.0 111.621 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.22 148.21 52.47 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.102 -1.814 . . . . 25.0 106.102 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.96 93.82 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-O 121.55 0.562 . . . . 25.0 112.717 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -36.35 61.13 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 114.367 1.247 . . . . 25.0 114.367 -174.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -61.39 -28.04 68.96 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.186 -0.606 . . . . 25.0 112.305 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -84.65 -46.02 11.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.043 0.449 . . . . 25.0 110.946 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.38 57.54 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 115.705 1.743 . . . . 25.0 115.705 -169.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HA ' ' CH2' ' A' ' 104' ' ' TRP . 42.7 t0 -64.99 -30.71 71.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 25.0 111.335 -172.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -126.15 108.88 11.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.787 -0.82 . . . . 25.0 108.787 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -103.1 132.19 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.525 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.51 127.94 33.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.92 0.74 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.944 0.878 . . . . 25.0 110.031 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.46 140.8 4.72 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.363 -0.922 . . . . 25.0 112.863 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 132.86 15.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.67 109.6 12.14 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.069 -1.086 . . . . 25.0 108.069 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.0 164.69 22.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.482 -1.879 . . . . 25.0 111.72 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -103.84 106.86 17.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.025 -1.472 . . . . 25.0 107.025 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -114.53 -22.7 9.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.578 -1.192 . . . . 25.0 109.515 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -173.86 -161.58 24.19 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 103.78 -3.728 . . . . 25.0 103.78 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.3 t -123.7 50.44 3.36 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.301 1.593 . . . . 25.0 115.301 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.77 170.55 17.52 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 114.047 -3.502 . . . . 25.0 109.769 170.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.62 58.67 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.077 1.14 . . . . 25.0 114.077 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 53.3 p -70.87 -16.0 62.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.892 0.701 . . . . 25.0 112.892 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -99.16 7.01 46.19 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.742 0.275 . . . . 25.0 111.742 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -61.19 152.29 29.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.885 -1.154 . . . . 25.0 107.885 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -11.49 60.77 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.618 0.599 . . . . 25.0 112.618 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.2 t -90.98 124.47 35.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -128.86 140.39 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.049 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -100.83 137.22 39.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.235 -1.024 . . . . 25.0 108.235 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.3 mm -130.85 123.74 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -93.35 134.34 35.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.649 -0.5 . . . . 25.0 109.649 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.72 129.86 23.45 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.7 150.0 73.91 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 117.951 -0.9 . . . . 25.0 112.275 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.36 -4.93 11.3 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 122.115 0.96 . . . . 25.0 110.663 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.87 6.61 27.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.698 -0.683 . . . . 25.0 112.796 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -155.95 170.09 22.93 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.991 -0.443 . . . . 25.0 111.852 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.82 153.56 45.47 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 105.766 -1.939 . . . . 25.0 105.766 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 153.02 144.87 4.01 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-O 122.075 0.819 . . . . 25.0 115.091 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 4.8 p90 -81.48 146.12 30.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.439 -0.88 . . . . 25.0 112.425 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -146.33 158.95 43.94 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 105.512 -2.033 . . . . 25.0 105.512 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.6 t -121.36 130.26 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.05 -2.574 . . . . 25.0 104.05 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.48 119.34 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.204 -1.036 . . . . 25.0 108.204 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.48 131.43 54.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.419 -1.697 . . . . 25.0 106.419 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.49 133.82 45.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.2 t -129.01 132.92 66.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -119.47 108.31 14.39 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.29 132.0 34.06 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.872 -1.058 . . . . 25.0 111.259 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.28 129.5 66.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.559 -2.015 . . . . 25.0 105.559 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.94 -28.3 63.37 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 -167.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -110.0 22.66 15.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -172.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.6 p -137.98 153.1 49.46 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.867 0.365 . . . . 25.0 111.685 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -78.8 -7.81 58.19 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.601 0.715 . . . . 25.0 110.333 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -110.11 161.31 15.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.02 -0.991 . . . . 25.0 109.081 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.11 39.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.785 -2.302 . . . . 25.0 104.785 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -90.86 131.25 36.61 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.836 -1.172 . . . . 25.0 107.836 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -128.73 134.47 48.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.149 -0.478 . . . . 25.0 110.216 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.97 140.15 26.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 176.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.02 139.82 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.9 mt -135.31 118.55 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -80.16 131.42 35.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.96 -1.866 . . . . 25.0 105.96 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.12 162.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.345 0.593 . . . . 25.0 111.767 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 63.0 t0 -129.58 120.99 26.22 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.242 -2.873 . . . . 25.0 103.242 170.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.74 111.41 24.12 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.75 166.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 114.48 1.289 . . . . 25.0 114.48 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -72.08 154.35 41.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 173.293 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.659 0 CA-C-O 118.255 -0.879 . . . . 25.0 110.106 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.017 -0.364 . . . . 25.0 110.017 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.9 -177.02 47.93 Favored Glycine 0 C--O 1.24 0.479 0 N-CA-C 108.905 -1.678 . . . . 25.0 108.905 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.31 166.08 34.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.953 0.877 . . . . 25.0 112.696 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.65 122.08 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.752 -1.573 . . . . 25.0 106.752 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -85.75 -42.54 14.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.233 -0.44 . . . . 25.0 111.024 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -143.23 158.6 57.87 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.53 116.13 3.93 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 131.403 1.835 . . . . 25.0 116.823 2.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.2 148.64 7.12 Favored Glycine 0 C--O 1.221 -0.682 0 CA-C-N 114.947 -1.024 . . . . 25.0 113.039 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -94.13 119.87 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.514 . . . . 25.0 109.611 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -21.18 64.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.436 -0.347 . . . . 25.0 111.481 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.38 72.39 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.031 0.382 . . . . 25.0 112.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.59 -27.57 69.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.985 0.422 . . . . 25.0 111.075 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 mt -94.69 -4.09 48.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 25.0 110.901 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.6 t -90.94 -36.49 14.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.849 -0.614 . . . . 25.0 109.478 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -60.05 142.86 53.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.67 -0.695 . . . . 25.0 111.442 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -68.17 -14.97 63.38 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 116.465 -0.334 . . . . 25.0 110.606 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.92 -13.0 29.1 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.003 0.372 . . . . 25.0 112.003 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -83.02 -5.05 58.95 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.311 0.485 . . . . 25.0 112.311 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.68 -29.97 0.1 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 116.904 1.522 . . . . 25.0 116.904 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 t80 63.66 -59.51 0.18 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.602 1.961 . . . . 25.0 114.805 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.55 -20.82 62.77 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.844 -1.169 . . . . 25.0 107.844 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -134.3 117.0 15.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.959 -1.018 . . . . 25.0 108.721 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.94 157.0 43.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.794 -1.928 . . . . 25.0 105.794 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -149.78 77.9 1.34 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.878 0.371 . . . . 25.0 110.028 -173.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.9 t -132.12 -74.7 0.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.713 -0.676 . . . . 25.0 112.794 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.59 177.8 42.08 Favored Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.48 -0.867 . . . . 25.0 112.883 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.7 t -75.18 -16.72 60.49 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.996 0.739 . . . . 25.0 112.996 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.92 -12.5 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.674 0.75 . . . . 25.0 111.112 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -15.23 61.96 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.92 1.452 . . . . 25.0 114.92 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -76.19 -30.17 57.94 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.745 1.017 . . . . 25.0 113.745 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.98 44.75 0.46 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 116.805 2.15 . . . . 25.0 116.805 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.06 -22.58 25.99 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 114.543 -3.171 . . . . 25.0 113.786 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -83.68 -34.85 24.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.177 0.513 . . . . 25.0 109.896 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.7 m -111.39 69.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.645 -0.422 . . . . 25.0 111.645 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 tp -81.85 123.34 28.73 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 104.979 -2.23 . . . . 25.0 104.979 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -83.95 132.2 34.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.335 . . . . 25.0 110.868 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.64 28.65 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.82 -1.178 . . . . 25.0 107.82 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -139.7 143.63 37.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.855 -0.424 . . . . 25.0 109.855 -173.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -69.96 142.52 52.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.139 -1.06 . . . . 25.0 108.139 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.76 -152.37 47.4 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.252 -0.975 . . . . 25.0 114.744 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -104.69 153.9 38.91 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.18 150.46 88.72 Favored 'Cis proline' 0 C--N 1.349 0.594 0 C-N-CA 128.856 0.773 . . . . 25.0 112.64 -1.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -68.69 -46.17 69.76 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.287 -0.635 . . . . 25.0 109.287 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t 64.6 -46.27 0.32 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.012 1.856 . . . . 25.0 116.012 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.34 -155.31 31.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.581 -0.608 . . . . 25.0 111.581 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.52 173.72 9.42 Favored 'Trans proline' 0 C--O 1.237 0.452 0 CA-C-N 118.541 1.171 . . . . 25.0 113.741 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 105.06 2.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.586 . . . . 25.0 110.941 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -143.78 173.97 11.22 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.233 -1.025 . . . . 25.0 108.233 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 11.0 81.32 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 108.437 -1.865 . . . . 25.0 108.437 -172.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -126.75 35.47 4.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.619 0.368 . . . . 25.0 111.273 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.8 mt -67.83 -42.66 86.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.099 0.476 . . . . 25.0 110.16 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.04 82.78 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.431 0.53 . . . . 25.0 112.431 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 p -90.41 -4.67 56.87 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.192 -0.458 . . . . 25.0 110.681 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.79 19.83 4.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.904 1.282 . . . . 25.0 114.286 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.47 -36.08 92.12 Favored Glycine 0 CA--C 1.512 -0.125 0 N-CA-C 109.375 -1.49 . . . . 25.0 109.375 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.2 -36.33 24.6 Favored Glycine 0 C--O 1.216 -1.011 0 N-CA-C 111.366 -0.693 . . . . 25.0 111.366 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.6 -48.18 73.18 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.174 -0.603 . . . . 25.0 110.98 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -73.68 -22.24 60.0 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.781 -0.575 . . . . 25.0 109.494 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -20.64 74.93 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 121.059 -0.591 . . . . 25.0 111.883 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.25 -21.35 70.11 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-N 117.786 0.793 . . . . 25.0 112.409 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.79 -39.17 77.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.343 -0.984 . . . . 25.0 108.343 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.57 -25.78 45.43 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.029 -0.532 . . . . 25.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -67.74 -27.32 66.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.789 0.804 . . . . 25.0 109.852 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -73.1 2.28 7.45 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.847 -0.533 . . . . 25.0 111.534 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -129.61 18.58 5.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.197 0.599 . . . . 25.0 110.036 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.7 t -86.18 156.13 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 25.0 111.897 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -66.75 -31.46 72.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.642 0.734 . . . . 25.0 109.057 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -88.07 1.9 53.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 25.0 112.658 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -56.87 134.95 55.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.39 165.79 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.666 0.746 . . . . 25.0 109.969 -174.028 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -79.56 106.13 11.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.088 0.47 . . . . 25.0 110.561 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -65.22 146.8 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.93 -1.106 . . . . 25.0 111.133 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.91 130.06 55.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 25.0 110.906 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.2 135.63 24.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.701 -0.681 . . . . 25.0 109.677 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.1 mtp -134.19 142.27 47.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.626 -1.25 . . . . 25.0 107.626 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -89.47 172.96 8.62 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.09 -177.4 6.1 Favored Glycine 0 C--O 1.24 0.531 0 N-CA-C 115.801 1.08 . . . . 25.0 115.801 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.63 -178.72 36.78 Favored Glycine 0 CA--C 1.517 0.181 0 N-CA-C 110.833 -0.907 . . . . 25.0 110.833 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 147.04 34.84 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.452 -1.028 . . . . 25.0 108.596 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -141.86 153.82 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.9 m -117.03 128.26 54.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.303 -0.408 . . . . 25.0 110.241 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -104.11 136.14 44.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.38 0.672 . . . . 25.0 109.285 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.1 m -132.59 130.01 39.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -122.05 152.6 39.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.698 -1.593 . . . . 25.0 106.698 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -143.47 153.17 42.35 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.762 -1.199 . . . . 25.0 107.762 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -121.64 138.49 54.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.742 0.306 . . . . 25.0 110.746 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -92.71 0.41 57.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 25.0 110.526 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.41 129.82 41.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.109 -0.7 . . . . 25.0 109.109 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.11 1.3 9.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 O-C-N 121.983 0.464 . . . . 25.0 112.98 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -73.73 149.36 41.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 25.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.14 155.81 39.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 25.0 112.19 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.2 m -123.48 130.32 52.52 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -90.76 -43.8 9.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 25.0 111.654 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -160.9 152.48 19.41 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 110.259 -0.275 . . . . 25.0 110.259 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -147.32 144.05 28.49 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 25.0 109.132 169.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -152.73 156.71 39.65 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.17 -0.307 . . . . 25.0 110.17 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -149.69 152.97 36.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.116 0.784 . . . . 25.0 113.116 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -134.38 167.43 20.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 pt -133.14 152.22 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.5 p -89.87 145.75 24.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 112.472 0.545 . . . . 25.0 112.472 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -117.49 115.26 24.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.836 0.827 . . . . 25.0 109.966 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -76.23 146.9 38.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.279 -1.748 . . . . 25.0 106.279 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.68 18.47 9.48 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 120.608 -0.806 . . . . 25.0 114.46 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -58.62 149.15 26.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.365 0.582 . . . . 25.0 111.105 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -76.13 146.77 79.04 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 107.472 -1.307 . . . . 25.0 107.472 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.79 -19.97 26.77 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 117.288 -1.341 . . . . 25.0 112.896 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.78 -22.59 61.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.816 0.817 . . . . 25.0 111.756 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -95.92 146.41 31.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.94 -0.475 . . . . 25.0 110.091 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.39 111.52 2.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 117.377 -1.282 . . . . 25.0 113.091 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -38.59 63.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.398 0.679 . . . . 25.0 112.741 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -54.57 -33.03 59.59 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -92.73 -45.06 8.22 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.496 0.554 . . . . 25.0 112.496 175.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.96 -17.19 64.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.67 -39.64 84.5 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.175 1.176 . . . . 25.0 114.175 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.47 155.08 49.19 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 114.231 1.197 . . . . 25.0 114.231 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -129.29 147.0 51.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.97 0.508 . . . . 25.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.5 tp -78.26 128.69 34.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.092 -0.336 . . . . 25.0 110.092 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.0 pt -119.85 1.93 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.95 0.405 . . . . 25.0 111.53 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.64 141.08 3.32 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.179 -1.01 . . . . 25.0 114.513 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.4 131.17 24.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.91 94.88 23.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.206 0.526 . . . . 25.0 110.126 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.17 162.98 37.64 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 116.235 -2.043 . . . . 25.0 110.733 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -103.17 115.67 31.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -127.42 -97.81 0.4 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.498 -1.668 . . . . 25.0 106.498 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -159.35 -167.06 19.49 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.161 -0.776 . . . . 25.0 111.161 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 p 61.41 169.71 0.08 OUTLIER Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 124.365 1.066 . . . . 25.0 111.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.36 -4.47 15.47 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 113.18 -4.08 . . . . 25.0 114.729 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.07 69.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.083 -0.508 . . . . 25.0 109.994 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.0 t -76.62 -20.43 56.74 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.564 0.697 . . . . 25.0 110.544 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -67.27 -16.79 64.49 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.828 -0.624 . . . . 25.0 111.635 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -71.86 105.02 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.205 0.526 . . . . 25.0 111.992 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.48 -21.24 28.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.944 -0.571 . . . . 25.0 109.726 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.1 t -95.28 138.54 32.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.929 -0.397 . . . . 25.0 109.929 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -141.7 151.15 42.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.279 -0.419 . . . . 25.0 111.925 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -101.35 133.83 45.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.818 -0.628 . . . . 25.0 109.948 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.0 mm -131.86 132.61 61.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.78 136.8 32.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.606 -0.516 . . . . 25.0 109.606 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.05 134.18 20.48 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.37 144.15 84.87 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 117.17 -1.42 . . . . 25.0 113.886 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -96.8 -7.56 33.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.449 -0.796 . . . . 25.0 110.095 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -112.42 -3.15 14.54 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.164 1.542 . . . . 25.0 115.164 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -136.54 156.63 48.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.6 mp -127.85 152.48 47.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.006 -0.997 . . . . 25.0 108.888 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.67 154.49 6.15 Favored Glycine 0 C--O 1.237 0.308 0 CA-C-O 121.671 0.595 . . . . 25.0 113.933 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.5 p90 -86.97 148.9 25.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.643 0.735 . . . . 25.0 111.859 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -139.04 149.05 44.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.525 -1.657 . . . . 25.0 106.525 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.5 t -103.4 131.6 51.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.343 -2.095 . . . . 25.0 105.343 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.7 mt -95.92 123.51 48.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.233 -2.136 . . . . 25.0 105.233 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 mp -99.99 127.9 46.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 103.683 -2.71 . . . . 25.0 103.683 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.72 144.08 35.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.819 0.736 . . . . 25.0 111.762 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.56 132.94 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.141 -0.936 . . . . 25.0 109.215 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -124.31 112.63 17.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -97.26 121.65 39.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.008 -0.542 . . . . 25.0 111.784 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.43 115.84 39.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 108.892 -0.781 . . . . 25.0 108.892 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.74 63.44 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.43 -0.77 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.751 0.649 . . . . 25.0 112.751 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.2 t -154.83 166.27 34.02 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.35 -2.66 46.38 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 109.957 -0.386 . . . . 25.0 109.957 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.47 152.99 20.49 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.698 -0.626 . . . . 25.0 109.775 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.36 171.91 13.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.452 -0.573 . . . . 25.0 109.452 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.59 128.33 47.9 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.818 -0.808 . . . . 25.0 108.818 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -126.07 126.55 44.41 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 103.876 -2.639 . . . . 25.0 103.876 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.6 pm0 -143.59 155.78 44.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.376 0.535 . . . . 25.0 111.318 -175.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.49 136.7 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.893 -1.521 . . . . 25.0 106.893 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.4 mt -137.69 122.15 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.745 0.307 . . . . 25.0 110.822 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -77.72 130.94 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.168 0.509 . . . . 25.0 112.065 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.83 156.02 41.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 19.5 t0 -123.24 113.84 19.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.884 -2.265 . . . . 25.0 104.884 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.7 mt -108.4 121.59 45.24 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 32.7 m -127.97 170.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.055 0.455 . . . . 25.0 111.505 -174.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -70.38 176.61 3.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.363 -0.835 . . . . 25.0 111.524 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.8 pttt . . . . . 0 C--O 1.244 0.789 0 CA-C-O 117.511 -1.233 . . . . 25.0 111.23 177.755 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 110.811 -0.07 . . . . 25.0 110.811 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.74 -173.66 52.65 Favored Glycine 0 C--N 1.329 0.175 0 CA-C-O 119.065 -0.853 . . . . 25.0 111.206 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -144.18 166.79 24.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.296 0.548 . . . . 25.0 109.976 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.1 120.99 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.415 -1.698 . . . . 25.0 106.415 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -87.01 -40.2 14.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.893 0.378 . . . . 25.0 111.542 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -145.52 153.7 51.75 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 116.271 -0.422 . . . . 25.0 109.876 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.24 130.98 21.52 Favored 'Cis proline' 0 C--N 1.351 0.709 0 C-N-CA 129.625 1.094 . . . . 25.0 113.432 -3.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.95 -172.55 40.11 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 110.493 -1.043 . . . . 25.0 110.493 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -141.74 134.76 28.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -68.32 -21.15 64.77 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.563 -0.29 . . . . 25.0 111.46 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.68 72.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.81 0.338 . . . . 25.0 111.332 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -29.4 68.75 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 116.538 -0.301 . . . . 25.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 mt -88.25 -26.53 22.28 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.118 0.485 . . . . 25.0 110.263 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.44 -42.59 92.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.051 -0.977 . . . . 25.0 110.991 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.7 t -69.05 142.11 54.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.691 -0.686 . . . . 25.0 112.064 -176.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -64.42 -16.32 62.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.465 -0.789 . . . . 25.0 110.321 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.3 -12.92 15.51 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.398 0.518 . . . . 25.0 112.398 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -83.01 -2.01 54.14 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.043 0.386 . . . . 25.0 112.043 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.77 -31.26 0.05 OUTLIER Glycine 0 C--O 1.223 -0.553 0 N-CA-C 116.591 1.396 . . . . 25.0 116.591 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.9 t80 61.13 1.77 0.52 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.882 1.808 . . . . 25.0 115.882 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.65 -24.63 45.08 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.6 -0.687 . . . . 25.0 110.188 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -164.98 164.82 20.56 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.179 -1.415 . . . . 25.0 107.179 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.2 154.69 37.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.922 -1.51 . . . . 25.0 106.922 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -142.33 48.97 1.54 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.55 0.944 . . . . 25.0 113.55 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -151.57 -44.65 0.11 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.119 1.526 . . . . 25.0 115.119 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.73 170.86 35.86 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.072 -0.585 . . . . 25.0 112.926 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -70.93 -14.02 62.22 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.05 -0.676 . . . . 25.0 112.657 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -10.09 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.951 0.405 . . . . 25.0 111.744 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -11.17 23.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.841 1.793 . . . . 25.0 115.841 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -73.69 -36.61 65.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.542 0.61 . . . . 25.0 112.516 -173.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.94 59.09 2.19 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.6 -11.59 28.24 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.437 -1.242 . . . . 25.0 113.809 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -97.48 7.16 47.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 25.0 111.013 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -100.3 89.0 3.83 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 120.794 -1.191 . . . . 25.0 109.847 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.64 129.04 49.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.157 -0.683 . . . . 25.0 109.157 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.99 148.97 51.9 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.467 -0.568 . . . . 25.0 109.467 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.22 127.7 34.31 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -64.95 142.04 58.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.647 -1.242 . . . . 25.0 107.647 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.03 129.5 41.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.024 -0.732 . . . . 25.0 109.024 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.22 68.27 2.91 Favored Glycine 0 C--O 1.227 -0.297 0 N-CA-C 116.597 1.399 . . . . 25.0 116.597 -171.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -102.76 118.43 58.42 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 109.035 -0.728 . . . . 25.0 109.035 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.32 155.51 99.87 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 131.499 1.875 . . . . 25.0 112.292 -2.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.79 -34.53 78.1 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 113.835 1.05 . . . . 25.0 113.835 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.0 t 53.34 -107.3 0.35 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 122.641 0.376 . . . . 25.0 111.772 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.75 157.47 50.68 Favored Glycine 0 C--O 1.219 -0.805 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.69 -28.05 12.08 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 116.711 -1.726 . . . . 25.0 116.397 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.19 121.11 17.78 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.684 0.624 . . . . 25.0 112.684 -174.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.47 142.33 58.43 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.213 0.82 . . . . 25.0 113.213 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.0 -31.64 1.77 Allowed Glycine 0 N--CA 1.461 0.327 0 CA-C-N 115.759 -0.655 . . . . 25.0 114.359 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -69.5 -10.22 57.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.273 0.842 . . . . 25.0 113.273 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 51' ' ' ILE . 5.3 mp -62.71 -54.31 35.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.461 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.84 -25.22 26.39 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.737 0.643 . . . . 25.0 112.737 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.5 p -86.58 4.93 38.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.408 0.522 . . . . 25.0 112.408 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.65 45.8 27.31 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.814 0.816 . . . . 25.0 109.774 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 22.05 0.49 Allowed Glycine 0 C--O 1.225 -0.464 0 N-CA-C 117.705 1.842 . . . . 25.0 117.705 -174.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.26 -17.85 79.01 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 107.871 -2.092 . . . . 25.0 107.871 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.92 -11.04 15.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.804 0.842 . . . . 25.0 112.26 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -52.04 -33.63 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.005 0.743 . . . . 25.0 113.005 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.8 -29.59 59.06 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 119.835 -1.174 . . . . 25.0 112.805 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.29 0.71 87.34 Favored Glycine 0 C--O 1.219 -0.801 0 N-CA-C 116.124 1.21 . . . . 25.0 116.124 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.2 mm -54.6 -34.57 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 118.463 1.132 . . . . 25.0 112.846 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.08 -31.8 72.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.687 -0.633 . . . . 25.0 112.212 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.83 -12.13 57.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.587 0.708 . . . . 25.0 112.218 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -71.59 8.37 1.14 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -63.33 85.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.86 1.059 . . . . 25.0 113.86 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t -151.85 -170.97 3.8 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.486 -2.413 . . . . 25.0 104.486 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -62.92 -25.14 68.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.593 . . . . 25.0 110.547 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -89.26 19.31 4.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.322 0.86 . . . . 25.0 113.322 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -66.64 165.42 14.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.689 -0.856 . . . . 25.0 108.689 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -84.56 151.2 24.7 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.532 -1.284 . . . . 25.0 107.532 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.54 126.59 27.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.791 -0.64 . . . . 25.0 109.917 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -133.95 128.35 34.29 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.084 -0.962 . . . . 25.0 110.554 -175.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -123.07 149.96 43.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.929 -0.308 . . . . 25.0 111.213 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -94.04 134.96 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.8 ttt -150.38 163.41 38.42 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.238 -1.393 . . . . 25.0 107.238 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.7 p -94.98 168.09 10.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.28 177.87 23.81 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.301 -0.476 . . . . 25.0 112.563 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.09 -174.1 15.14 Favored Glycine 0 N--CA 1.459 0.182 0 N-CA-C 109.573 -1.411 . . . . 25.0 109.573 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -77.16 141.78 39.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.577 1.188 . . . . 25.0 109.259 178.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -123.03 134.61 54.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.627 -1.62 . . . . 25.0 106.627 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -108.96 118.9 38.01 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -108.42 139.39 43.22 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.5 m -133.07 123.33 25.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.056 -1.461 . . . . 25.0 107.056 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -111.99 140.06 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 104.512 -2.403 . . . . 25.0 104.512 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 140.86 51.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.003 0.906 . . . . 25.0 113.131 -173.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -125.87 148.34 49.21 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.96 -2.978 . . . . 25.0 102.96 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -71.47 -18.93 62.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.344 0.52 . . . . 25.0 112.333 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.29 152.15 63.41 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.9 157.09 61.28 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 116.817 -1.656 . . . . 25.0 110.335 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -130.98 149.42 52.61 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.55 141.09 53.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.596 -1.631 . . . . 25.0 106.596 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.0 m -150.92 146.58 26.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 m -109.62 -41.87 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.669 0.271 . . . . 25.0 110.633 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.9 153.32 26.07 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.429 -0.582 . . . . 25.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -145.83 148.55 33.01 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.402 -0.962 . . . . 25.0 108.402 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.37 159.17 43.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 25.0 111.079 -172.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -130.52 142.5 50.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -132.88 164.44 26.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.714 -1.587 . . . . 25.0 106.714 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.1 pt -129.19 145.77 35.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.983 -1.488 . . . . 25.0 106.983 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.7 p -83.54 136.18 34.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.458 -1.312 . . . . 25.0 107.458 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -80.79 116.98 21.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.602 -0.888 . . . . 25.0 108.602 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -76.0 125.29 28.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.88 19.91 49.18 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 119.183 -1.484 . . . . 25.0 114.208 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -51.31 149.89 3.77 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 117.95 0.875 . . . . 25.0 112.029 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -70.93 129.59 89.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.081 -0.509 . . . . 25.0 111.135 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.98 -15.26 26.23 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 117.314 -1.324 . . . . 25.0 111.877 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.11 -14.99 61.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.159 0.984 . . . . 25.0 111.462 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -110.15 155.51 41.67 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.135 -1.061 . . . . 25.0 108.135 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.78 113.45 1.72 Allowed 'Trans proline' 0 C--O 1.24 0.593 0 N-CA-C 113.519 0.546 . . . . 25.0 113.519 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 2.5 0.63 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 118.404 2.742 . . . . 25.0 118.404 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.12 2.75 7.93 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.103 -0.373 . . . . 25.0 111.695 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -105.96 -54.71 2.44 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 116.166 -0.47 . . . . 25.0 112.027 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.0 0.51 55.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.688 0.996 . . . . 25.0 113.688 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -80.65 -21.6 41.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.096 0.406 . . . . 25.0 112.096 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -126.19 152.02 46.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -128.15 141.47 51.47 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.2 tp -77.09 118.62 19.81 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.022 -0.733 . . . . 25.0 109.022 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.03 -8.34 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.652 0.739 . . . . 25.0 110.253 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.36 155.8 9.81 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.638 -0.792 . . . . 25.0 113.289 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.57 147.07 29.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.223 -1.029 . . . . 25.0 108.223 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.62 104.48 14.47 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.97 160.99 30.19 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 115.372 -2.619 . . . . 25.0 110.884 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.04 120.96 42.2 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.161 -1.052 . . . . 25.0 108.161 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -140.25 -96.79 0.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.087 -2.19 . . . . 25.0 105.087 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.23 -144.16 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -118.3 70.54 8.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.492 0.923 . . . . 25.0 113.492 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.44 171.76 17.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 118.106 -0.796 . . . . 25.0 111.255 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.33 68.44 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.906 -0.496 . . . . 25.0 111.175 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.7 p -73.21 -2.39 21.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -64.37 -22.35 66.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.716 -0.846 . . . . 25.0 108.716 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -62.43 131.55 49.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.398 -0.593 . . . . 25.0 109.398 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.45 -10.2 56.98 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.348 0.659 . . . . 25.0 112.692 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.2 t -97.21 120.4 37.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -125.66 135.19 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 25.0 111.482 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -90.93 136.67 32.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.7 mp -132.12 119.85 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 106.197 -1.779 . . . . 25.0 106.197 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 86.9 t80 -85.26 126.88 34.06 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -125.86 101.73 29.22 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 109.964 -0.384 . . . . 25.0 109.964 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.0 145.6 40.13 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 114.447 -3.236 . . . . 25.0 108.273 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.76 96.71 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.576 0.703 . . . . 25.0 109.476 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.86 10.29 31.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.386 -0.824 . . . . 25.0 108.974 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -130.1 -179.47 5.25 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.451 -0.795 . . . . 25.0 109.991 -170.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.8 mp -132.11 128.48 38.24 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 151.16 164.21 11.92 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-O 122.285 0.936 . . . . 25.0 115.042 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -94.77 144.94 25.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.207 1.558 . . . . 25.0 115.207 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 29.3 p80 -148.93 158.34 44.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.249 -1.76 . . . . 25.0 106.249 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.07 139.73 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 25.0 110.704 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.7 mt -96.25 128.16 47.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.855 -2.276 . . . . 25.0 104.855 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.09 144.46 35.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.079 -1.452 . . . . 25.0 107.079 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.04 135.51 41.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.607 -0.516 . . . . 25.0 109.607 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.3 t -128.95 131.12 68.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 25.0 107.897 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -126.58 109.49 12.18 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.867 -0.79 . . . . 25.0 108.867 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.04 131.98 43.99 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.756 0.789 . . . . 25.0 111.976 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.1 t -128.65 122.45 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.673 -1.602 . . . . 25.0 106.673 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.0 -33.25 67.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.598 0.713 . . . . 25.0 109.404 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -7.08 28.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 115.343 1.609 . . . . 25.0 115.343 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.1 p -130.33 156.32 44.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.69 -21.49 60.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.744 0.783 . . . . 25.0 111.068 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -109.82 165.11 11.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.549 -0.751 . . . . 25.0 109.762 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 159.77 26.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -109.29 137.01 47.81 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -139.0 154.09 48.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.251 -0.281 . . . . 25.0 110.62 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -145.86 155.15 42.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.252 -0.647 . . . . 25.0 109.252 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.3 140.51 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.329 -0.989 . . . . 25.0 108.329 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.85 122.04 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.028 -1.101 . . . . 25.0 108.028 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -85.1 134.23 34.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.98 -1.119 . . . . 25.0 107.98 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.88 125.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.469 -0.567 . . . . 25.0 109.469 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -93.84 107.94 19.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.403 -2.073 . . . . 25.0 105.403 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.5 mt -109.55 133.14 53.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.188 0.518 . . . . 25.0 109.674 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.71 159.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.123 -0.944 . . . . 25.0 110.712 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -76.06 155.93 34.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 105.285 -2.117 . . . . 25.0 105.285 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-O 117.413 -1.279 . . . . 25.0 110.931 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.88 0.371 . . . . 25.0 110.991 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.43 173.88 46.59 Favored Glycine 0 C--O 1.235 0.18 0 N-CA-C 104.336 -3.506 . . . . 25.0 104.336 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -154.18 169.66 23.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.085 1.942 . . . . 25.0 113.015 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.456 HG22 ' H ' ' A' ' 6' ' ' LYS . 30.3 mm -93.52 127.1 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.515 -0.766 . . . . 25.0 108.975 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -87.63 13.16 10.89 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.818 0.673 . . . . 25.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' H ' HG22 ' A' ' 4' ' ' ILE . 53.5 mttt 80.92 156.57 0.13 Allowed Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 126.142 1.777 . . . . 25.0 107.348 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.79 151.37 75.15 Favored 'Cis proline' 0 C--N 1.346 0.401 0 C-N-CA 129.311 0.963 . . . . 25.0 112.502 -4.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.08 9.34 63.78 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 116.297 1.279 . . . . 25.0 116.297 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -62.05 132.4 52.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 25.0 111.751 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -70.53 -26.44 63.57 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.069 -0.514 . . . . 25.0 111.298 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.15 70.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.503 -0.317 . . . . 25.0 111.629 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.39 75.81 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 120.798 0.332 . . . . 25.0 110.675 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.91 -8.04 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.353 -0.385 . . . . 25.0 111.308 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 t -81.16 -14.21 57.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.739 0.304 . . . . 25.0 110.449 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.5 t -99.97 139.69 35.27 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.643 -0.502 . . . . 25.0 109.643 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.07 -16.87 63.79 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 120.901 0.381 . . . . 25.0 110.144 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.53 -12.85 17.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -79.9 -10.89 59.82 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.245 -0.284 . . . . 25.0 111.596 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.21 -12.81 0.02 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 117.588 1.795 . . . . 25.0 117.588 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.9 t80 64.02 -32.47 0.13 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.368 2.359 . . . . 25.0 117.368 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.68 -25.66 65.81 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.931 -0.481 . . . . 25.0 111.112 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -167.72 171.99 9.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.27 150.68 44.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.769 -1.937 . . . . 25.0 105.769 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -129.28 47.87 2.43 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.556 0.947 . . . . 25.0 113.556 -170.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -66.92 -61.97 1.67 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 120.684 -0.406 . . . . 25.0 111.895 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.1 147.11 18.84 Favored Glycine 0 C--O 1.219 -0.825 0 CA-C-N 116.463 -0.335 . . . . 25.0 113.704 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -63.71 -29.9 71.06 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.062 1.134 . . . . 25.0 114.062 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.28 0.39 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 113.09 0.774 . . . . 25.0 113.09 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.9 ptm -56.32 -10.98 1.02 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.499 1.666 . . . . 25.0 115.499 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -76.43 -35.98 58.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.9 0.381 . . . . 25.0 110.779 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -147.14 50.22 0.91 Allowed Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.824 1.046 . . . . 25.0 113.824 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.58 -17.15 23.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 115.114 -2.791 . . . . 25.0 114.634 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.07 4.99 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.073 0.768 . . . . 25.0 113.073 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 94.06 4.85 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 113.067 0.766 . . . . 25.0 113.067 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.98 132.78 51.97 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 105.602 -1.999 . . . . 25.0 105.602 168.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -129.94 149.06 51.83 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.265 0.839 . . . . 25.0 113.265 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.68 49.32 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -80.9 138.15 36.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -65.51 136.75 56.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.939 0.4 . . . . 25.0 110.077 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.34 179.72 48.84 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 109.567 -1.413 . . . . 25.0 109.567 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.96 145.27 32.82 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.978 -0.749 . . . . 25.0 108.978 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.59 163.76 83.28 Favored 'Cis proline' 0 C--N 1.348 0.517 0 C-N-CA 130.666 1.527 . . . . 25.0 111.664 -5.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -146.52 27.75 1.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.908 0.707 . . . . 25.0 112.908 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.8 t -89.93 -25.69 20.81 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.868 0.692 . . . . 25.0 112.868 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -114.01 172.44 14.34 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 110.338 -1.105 . . . . 25.0 110.338 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.81 -17.71 10.8 Favored 'Trans proline' 0 C--N 1.346 0.444 0 CA-C-N 119.329 1.564 . . . . 25.0 114.429 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.82 129.53 38.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.733 -0.84 . . . . 25.0 108.733 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -148.07 170.13 18.45 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.865 -1.532 . . . . 25.0 106.865 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.44 -32.02 1.17 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 116.253 1.261 . . . . 25.0 116.253 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -124.91 44.04 2.88 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.049 -0.677 . . . . 25.0 109.766 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.2 mm -58.14 -45.09 88.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.131 -0.486 . . . . 25.0 112.216 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.74 -36.86 83.44 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.874 1.064 . . . . 25.0 113.874 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.1 p -96.79 -20.88 17.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.914 0.709 . . . . 25.0 112.914 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.08 28.33 10.71 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.666 0.786 . . . . 25.0 109.877 -170.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -20.08 76.15 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-N 116.009 -0.541 . . . . 25.0 114.304 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.98 -21.14 67.49 Favored Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.867 -0.682 . . . . 25.0 113.494 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.38 -36.97 85.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.779 0.799 . . . . 25.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -71.18 -12.7 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.549 -0.751 . . . . 25.0 111.745 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.38 -23.2 53.22 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 121.325 -0.464 . . . . 25.0 113.524 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.12 73.71 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 117.961 0.88 . . . . 25.0 112.49 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.62 -38.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.61 -29.12 69.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 25.0 110.087 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.69 -7.81 36.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.646 0.61 . . . . 25.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -68.93 -41.04 78.65 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -159.89 110.19 1.88 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 120.848 0.356 . . . . 25.0 110.646 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.91 163.55 39.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -72.47 -26.41 61.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.165 -0.309 . . . . 25.0 110.165 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.01 20.5 15.42 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.76 0.281 . . . . 25.0 111.76 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -54.81 147.56 14.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.861 -0.608 . . . . 25.0 110.624 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -90.84 151.69 21.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -77.51 136.15 38.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -106.12 144.81 32.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.133 -0.485 . . . . 25.0 110.105 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.05 142.25 48.02 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -100.71 136.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.76 151.57 45.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.288 0.477 . . . . 25.0 112.288 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p -96.14 172.05 8.22 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 106.863 -1.532 . . . . 25.0 106.863 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.46 -172.69 15.37 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 117.814 1.886 . . . . 25.0 117.814 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.86 172.04 25.46 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 113.799 -1.2 . . . . 25.0 111.622 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.06 139.23 41.31 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.935 -1.135 . . . . 25.0 107.935 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -137.3 157.12 47.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.1 m -125.61 127.33 46.16 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -115.03 140.77 48.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -127.2 133.07 50.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.357 -0.609 . . . . 25.0 109.357 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.97 150.06 45.24 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.041 -2.207 . . . . 25.0 105.041 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 161.95 37.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.755 0.707 . . . . 25.0 111.121 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.1 151.83 39.4 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -71.85 -14.3 61.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.612 0.597 . . . . 25.0 112.612 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.88 160.4 58.6 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 104.094 -2.558 . . . . 25.0 104.094 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.84 145.89 94.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 115.479 -2.547 . . . . 25.0 111.092 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -108.16 118.18 36.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.222 -0.445 . . . . 25.0 110.735 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.03 129.56 41.45 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.598 -1.63 . . . . 25.0 106.598 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.2 m -145.64 133.58 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.745 -0.207 . . . . 25.0 110.834 -170.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -104.92 -33.62 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.438 -0.579 . . . . 25.0 109.438 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -163.02 148.55 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -142.69 139.07 31.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.868 -0.79 . . . . 25.0 108.868 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -148.05 159.05 44.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 25.0 110.817 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.57 145.34 33.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.699 0.762 . . . . 25.0 111.286 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -127.52 167.45 16.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.794 -1.093 . . . . 25.0 109.211 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.56 156.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.396 -0.964 . . . . 25.0 108.396 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 p -95.48 145.44 25.18 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.862 -0.422 . . . . 25.0 109.862 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -88.68 113.59 24.41 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.275 -0.57 . . . . 25.0 111.563 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -77.2 147.93 36.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.669 -1.975 . . . . 25.0 105.669 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.97 59.79 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 118.076 1.991 . . . . 25.0 118.076 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -54.89 147.13 15.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.68 1.24 . . . . 25.0 113.409 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 146.69 72.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.051 -0.722 . . . . 25.0 109.051 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.65 -18.4 25.39 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 118.031 -0.846 . . . . 25.0 113.917 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.05 -22.29 62.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.183 0.992 . . . . 25.0 110.915 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.84 147.11 32.98 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.624 -0.716 . . . . 25.0 109.733 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 93.94 0.65 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 118.463 -0.558 . . . . 25.0 111.799 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -52.99 -41.31 64.49 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 114.36 1.244 . . . . 25.0 114.36 -173.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -70.66 -16.41 62.81 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.057 0.762 . . . . 25.0 113.057 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -85.69 -41.38 15.2 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.356 0.598 . . . . 25.0 109.622 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.79 7.85 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.654 -1.157 . . . . 25.0 111.943 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.2 -29.03 70.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.917 0.71 . . . . 25.0 112.917 -169.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -126.04 144.98 50.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.018 0.748 . . . . 25.0 113.018 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -127.96 144.64 51.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.697 -0.853 . . . . 25.0 108.697 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -82.58 113.69 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.521 -0.918 . . . . 25.0 108.521 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -97.34 -8.62 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.345 0.593 . . . . 25.0 110.275 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.93 149.94 8.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.198 -1.001 . . . . 25.0 114.061 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.59 146.86 28.44 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.417 -0.957 . . . . 25.0 108.417 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.1 90.11 6.89 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-O 121.23 0.538 . . . . 25.0 110.299 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.39 162.59 38.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 117.751 -1.033 . . . . 25.0 109.752 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -96.9 91.98 5.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.334 -1.728 . . . . 25.0 106.334 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -100.38 2.75 42.68 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 113.976 -1.465 . . . . 25.0 109.167 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.17 -11.42 65.33 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.068 -1.213 . . . . 25.0 110.068 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.4 t -59.34 141.1 87.8 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.659 -0.497 . . . . 25.0 109.659 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.05 -6.63 19.49 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 C-N-CA 116.94 -1.573 . . . . 25.0 115.295 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.17 83.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.182 -0.917 . . . . 25.0 109.657 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.2 t -85.57 -27.87 25.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 25.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -69.4 -35.15 75.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.465 -0.568 . . . . 25.0 109.465 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.36 111.23 12.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.027 -0.533 . . . . 25.0 110.058 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.25 -13.06 60.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.507 -0.77 . . . . 25.0 112.906 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -96.98 121.31 38.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -133.05 149.42 52.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.461 . . . . 25.0 111.925 -172.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -84.78 135.17 34.23 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.839 -0.619 . . . . 25.0 109.917 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 73.2 mt -134.51 120.62 33.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 106.783 -1.562 . . . . 25.0 106.783 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -73.39 140.99 46.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.643 0.259 . . . . 25.0 110.724 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.04 129.89 25.15 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 106.731 -1.581 . . . . 25.0 106.731 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.1 148.78 63.62 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 117.355 -1.297 . . . . 25.0 113.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -100.82 -9.4 21.71 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.654 0.74 . . . . 25.0 109.217 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.09 10.56 20.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.862 1.06 . . . . 25.0 113.862 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -132.15 141.61 49.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 110.072 -0.344 . . . . 25.0 110.072 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.4 mp -113.13 153.87 27.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 25.0 109.307 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 116.74 154.21 10.06 Favored Glycine 0 C--O 1.24 0.5 0 CA-C-O 122.192 0.885 . . . . 25.0 114.97 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 42.4 p90 -87.01 146.27 26.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.226 0.824 . . . . 25.0 113.226 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -148.95 158.96 44.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.965 -1.495 . . . . 25.0 106.965 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 166' ' ' ASP . 2.0 t -98.03 143.61 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.901 0.381 . . . . 25.0 111.81 -175.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.93 131.26 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.601 -2.0 . . . . 25.0 105.601 172.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.45 140.22 49.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.216 -1.401 . . . . 25.0 107.216 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -130.09 133.82 46.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.9 130.29 68.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.73 -1.211 . . . . 25.0 107.73 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -117.85 116.27 26.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.55 -0.75 . . . . 25.0 110.584 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.63 131.9 42.81 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 122.123 0.963 . . . . 25.0 110.484 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.12 124.2 65.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.03 -31.31 64.36 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.192 0.52 . . . . 25.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -67.41 -14.93 63.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -129.2 160.42 32.96 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 122.098 -0.376 . . . . 25.0 110.747 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.46 -12.2 59.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.148 0.499 . . . . 25.0 110.591 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -110.2 160.59 16.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.741 0.781 . . . . 25.0 111.121 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -121.94 156.54 33.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 103.355 -2.831 . . . . 25.0 103.355 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -123.81 143.91 50.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.806 -0.813 . . . . 25.0 108.806 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.01 153.97 48.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.056 0.455 . . . . 25.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -134.75 143.68 47.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.322 -1.733 . . . . 25.0 106.322 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.04 129.14 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.603 -0.518 . . . . 25.0 109.603 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.2 mt -140.21 125.74 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.088 -1.078 . . . . 25.0 108.088 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 147' ' ' VAL . 11.7 t70 -87.73 141.63 28.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.605 -0.887 . . . . 25.0 108.605 173.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.45 143.75 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.098 0.475 . . . . 25.0 109.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 11.0 t0 -97.94 122.15 40.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.1 mt -115.71 119.4 35.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.878 -1.897 . . . . 25.0 105.878 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.7 m -134.17 162.19 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.685 0.994 . . . . 25.0 113.685 -170.446 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.64 161.22 30.53 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.443 -1.688 . . . . 25.0 106.443 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt . . . . . 0 C--O 1.246 0.909 0 CA-C-O 117.841 -1.076 . . . . 25.0 109.214 172.544 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 28.4 m170 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.576 0.227 . . . . 25.0 110.493 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.68 -165.96 37.53 Favored Glycine 0 CA--C 1.506 -0.479 1 N-CA-C 101.837 -4.505 . . . . 25.0 101.837 -175.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -158.2 163.65 37.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.374 1.587 . . . . 25.0 111.046 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -92.36 114.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 105.569 -2.011 . . . . 25.0 105.569 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -72.81 -40.92 65.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -153.35 131.59 6.44 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.152 -0.476 . . . . 25.0 109.744 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.47 140.81 46.59 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 118.62 0.543 . . . . 25.0 112.476 0.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 154.51 18.29 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 116.019 -0.537 . . . . 25.0 113.767 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p -61.91 152.88 30.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.598 0.713 . . . . 25.0 112.744 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -65.1 -17.08 64.16 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.964 -0.562 . . . . 25.0 112.078 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.34 68.14 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 122.617 0.367 . . . . 25.0 111.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.3 77.84 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.972 0.415 . . . . 25.0 111.275 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.02 -4.04 55.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 25.0 110.941 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -91.8 -16.03 27.4 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.369 -0.975 . . . . 25.0 108.369 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 t -63.87 145.52 55.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.861 -0.609 . . . . 25.0 109.695 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mp0 -63.79 -19.48 65.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.599 . . . . 25.0 110.251 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.46 -22.19 63.2 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.798 -0.564 . . . . 25.0 111.759 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -91.96 -1.73 57.12 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.619 0.97 . . . . 25.0 113.619 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.3 -30.11 0.05 OUTLIER Glycine 0 N--CA 1.461 0.326 0 N-CA-C 116.286 1.274 . . . . 25.0 116.286 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 65.35 -45.16 0.36 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 118.027 2.603 . . . . 25.0 118.027 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 87.1 mt -78.01 -21.12 51.28 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.898 -0.502 . . . . 25.0 112.347 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -149.06 153.17 37.45 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.822 -0.807 . . . . 25.0 108.822 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.07 156.95 42.58 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.953 -1.128 . . . . 25.0 107.953 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -153.37 83.07 1.18 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.743 0.782 . . . . 25.0 110.68 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 m -75.76 -39.08 57.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.456 -0.793 . . . . 25.0 112.608 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.28 172.65 8.79 Favored Glycine 0 C--O 1.221 -0.715 0 C-N-CA 121.611 -0.328 . . . . 25.0 112.927 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 t -63.69 -27.96 69.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.259 1.028 . . . . 25.0 110.704 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 t -60.16 -13.03 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 114.748 -1.115 . . . . 25.0 112.658 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm -65.31 -19.94 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.419 0.896 . . . . 25.0 113.419 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -75.53 -45.77 36.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.239 0.472 . . . . 25.0 111.018 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -154.97 89.79 3.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 113.1 0.778 . . . . 25.0 113.1 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.61 1.46 4.97 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 N-CA-C 113.22 0.431 . . . . 25.0 113.22 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.14 -7.87 24.32 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.252 1.205 . . . . 25.0 114.252 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -132.99 129.94 38.84 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.924 1.824 . . . . 25.0 115.924 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -120.62 140.47 51.5 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.069 -2.197 . . . . 25.0 105.069 161.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -84.03 118.33 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.555 0.616 . . . . 25.0 109.858 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.86 158.1 43.95 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 107.75 -1.204 . . . . 25.0 107.75 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -130.53 169.01 16.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.4 0.619 . . . . 25.0 110.223 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -73.9 164.08 27.09 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 104.023 -2.584 . . . . 25.0 104.023 172.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.95 23.77 0.7 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 116.664 1.426 . . . . 25.0 116.664 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -107.58 134.23 20.1 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 109.07 -0.715 . . . . 25.0 109.07 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -79.58 145.09 73.05 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 129.731 1.138 . . . . 25.0 112.472 -4.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -74.16 2.8 8.22 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.651 0.612 . . . . 25.0 112.651 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -92.27 -9.5 41.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.881 -0.6 . . . . 25.0 111.543 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.32 -164.37 32.08 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 109.834 -1.306 . . . . 25.0 109.834 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -69.21 165.53 30.02 Favored 'Trans proline' 0 C--N 1.345 0.368 0 CA-C-N 118.959 1.379 . . . . 25.0 110.804 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 131.59 46.86 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.731 -0.387 . . . . 25.0 110.665 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -145.03 157.2 44.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 104.574 -2.38 . . . . 25.0 104.574 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.83 10.12 54.55 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.68 -0.295 . . . . 25.0 113.528 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -68.49 -8.96 45.68 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.106 0.78 . . . . 25.0 113.106 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -66.81 -29.52 46.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 175.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.26 69.57 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.982 -0.449 . . . . 25.0 111.847 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.0 p -101.09 12.51 37.49 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.291 0.567 . . . . 25.0 109.953 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.14 15.99 3.61 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.592 1.557 . . . . 25.0 114.095 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.29 -37.21 42.67 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 120.62 -0.8 . . . . 25.0 111.921 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.32 -2.8 68.57 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 115.611 1.005 . . . . 25.0 115.611 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.37 -26.94 68.69 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.234 1.017 . . . . 25.0 112.099 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.19 -23.69 67.4 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.536 -0.466 . . . . 25.0 111.262 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.18 -26.05 71.67 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.771 -0.728 . . . . 25.0 111.852 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.7 73.48 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 121.025 -0.607 . . . . 25.0 112.008 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.25 -28.22 41.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -88.05 -38.6 15.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.725 -0.472 . . . . 25.0 109.725 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.64 -38.27 84.26 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.91 0.386 . . . . 25.0 112.005 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -64.68 -0.19 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.052 1.13 . . . . 25.0 114.052 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -143.65 34.85 1.28 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.766 0.426 . . . . 25.0 110.157 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 t -115.94 172.29 7.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.979 0.418 . . . . 25.0 111.804 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.46 -38.35 74.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.555 0.693 . . . . 25.0 110.557 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -79.99 5.44 14.03 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.751 0.649 . . . . 25.0 112.751 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -52.74 149.87 5.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.044 1.128 . . . . 25.0 114.044 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -70.28 158.51 35.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 25.0 110.92 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -84.33 151.51 24.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.825 -0.547 . . . . 25.0 111.155 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -120.52 143.29 48.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.313 -0.403 . . . . 25.0 111.2 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -121.1 150.97 40.41 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 106.612 -1.625 . . . . 25.0 106.612 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -96.2 143.0 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.178 -2.156 . . . . 25.0 105.178 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.6 ttt -150.7 164.31 36.45 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 110.421 -0.215 . . . . 25.0 110.421 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 p -110.2 172.48 6.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.775 -1.935 . . . . 25.0 105.775 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.97 -168.67 6.9 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.318 1.287 . . . . 25.0 116.318 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.68 -179.14 26.45 Favored Glycine 0 CA--C 1.521 0.417 0 O-C-N 122.519 -0.401 . . . . 25.0 113.371 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -73.08 133.65 44.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.748 -0.854 . . . . 25.0 109.615 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -125.77 137.79 53.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 25.0 110.047 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.7 m -102.56 125.54 49.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.492 -0.559 . . . . 25.0 109.492 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -112.83 130.12 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -137.98 135.1 35.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.78 -0.191 . . . . 25.0 110.565 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -122.42 150.08 42.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.47 -1.678 . . . . 25.0 106.47 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -144.96 158.58 43.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.644 -0.872 . . . . 25.0 108.644 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.66 151.04 47.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.656 -0.868 . . . . 25.0 108.656 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -72.4 -16.87 61.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.992 0.425 . . . . 25.0 111.347 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.87 141.1 23.13 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 174.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.07 146.88 47.65 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 117.167 -1.422 . . . . 25.0 112.896 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -131.12 157.08 44.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.185 -0.672 . . . . 25.0 109.185 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -76.99 144.67 38.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.312 -0.625 . . . . 25.0 109.312 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -128.28 130.11 47.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.415 -0.957 . . . . 25.0 108.415 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 t -89.75 -44.29 10.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.681 0.753 . . . . 25.0 109.771 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -158.13 155.69 29.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -146.86 141.23 26.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 168.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -148.4 159.75 43.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 25.0 111.368 -170.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -130.1 141.0 50.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.7 0.625 . . . . 25.0 110.444 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -126.68 162.87 24.76 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 pt -132.4 139.43 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.271 -0.27 . . . . 25.0 110.271 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -85.01 130.75 34.57 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 120.903 0.382 . . . . 25.0 110.339 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -88.08 125.02 34.35 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.817 0.673 . . . . 25.0 112.817 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -75.1 140.21 43.29 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.21 21.32 55.22 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.06 1.184 . . . . 25.0 116.06 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -57.09 154.18 10.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.226 1.013 . . . . 25.0 111.777 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.08 119.24 65.82 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.94 -15.84 18.52 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 117.163 -1.425 . . . . 25.0 113.51 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -75.72 -15.62 60.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.393 1.092 . . . . 25.0 110.744 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -105.01 153.79 39.17 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 106.606 -1.627 . . . . 25.0 106.606 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.98 128.44 21.87 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 115.058 -2.828 . . . . 25.0 112.215 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 tt -53.67 -38.01 63.73 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.402 -0.817 . . . . 25.0 111.895 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -58.18 -18.81 28.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.036 1.125 . . . . 25.0 114.036 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -101.61 -42.99 6.02 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 122.098 -0.376 . . . . 25.0 111.735 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.04 59.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.92 1.082 . . . . 25.0 113.92 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.95 -38.69 83.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.848 1.425 . . . . 25.0 114.848 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -130.46 161.97 30.22 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 116.413 2.005 . . . . 25.0 116.413 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -128.51 149.68 50.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.0 tp -85.56 112.93 21.4 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.169 -1.419 . . . . 25.0 107.169 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.16 -12.07 9.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.204 0.526 . . . . 25.0 110.327 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.22 158.72 12.61 Favored Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.832 -1.175 . . . . 25.0 114.707 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.93 146.58 31.11 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.496 -1.298 . . . . 25.0 107.496 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.26 107.75 4.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.619 -0.512 . . . . 25.0 109.619 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -86.64 177.26 4.32 Favored 'Trans proline' 0 C--O 1.24 0.575 0 N-CA-C 114.066 0.756 . . . . 25.0 114.066 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -104.08 91.53 3.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.812 -2.292 . . . . 25.0 104.812 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -156.44 71.42 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.062 0.458 . . . . 25.0 110.675 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.76 13.35 39.09 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.037 -0.529 . . . . 25.0 114.204 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.97 145.73 97.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.568 -0.372 . . . . 25.0 111.135 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.55 -175.63 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.784 1.656 . . . . 25.0 113.897 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.47 -26.2 12.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -57.36 -8.9 0.86 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.145 1.165 . . . . 25.0 114.145 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -76.27 3.63 10.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.729 -0.607 . . . . 25.0 111.707 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -58.7 150.45 23.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.949 -0.76 . . . . 25.0 108.949 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.95 -7.02 19.18 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.687 0.995 . . . . 25.0 113.687 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.3 t -97.94 122.65 41.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.141 -1.8 . . . . 25.0 106.141 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.4 151.06 51.88 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.207 0.527 . . . . 25.0 110.958 -175.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -105.92 138.51 41.97 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.67 -1.233 . . . . 25.0 107.67 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.5 mm -127.01 123.0 61.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.29 -2.115 . . . . 25.0 105.29 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.56 133.98 35.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.694 -1.224 . . . . 25.0 107.694 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.9 mm -125.88 118.6 24.06 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.03 155.29 61.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 115.736 -2.376 . . . . 25.0 110.715 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -104.79 55.03 0.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.73 -36.31 21.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.743 -0.662 . . . . 25.0 112.367 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -151.7 159.21 44.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.259 0.552 . . . . 25.0 110.786 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.5 pt? -91.62 143.87 26.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.987 -1.006 . . . . 25.0 110.25 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.31 152.0 6.04 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-O 121.839 0.688 . . . . 25.0 113.739 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 35.0 p90 -80.04 146.3 32.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.597 0.713 . . . . 25.0 111.984 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -136.27 128.52 29.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.766 -1.939 . . . . 25.0 105.766 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.01 125.57 47.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 105.675 -1.972 . . . . 25.0 105.675 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 76.7 mt -96.21 119.73 44.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.98 109.01 20.61 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.549 -1.648 . . . . 25.0 106.549 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -113.04 146.77 38.54 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.03 -0.419 . . . . 25.0 110.507 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.14 134.25 65.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.955 -0.566 . . . . 25.0 109.652 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -121.24 106.42 11.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.01 88.04 7.61 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.71 138.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.286 -1.376 . . . . 25.0 107.286 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -94.53 -13.69 25.82 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 122.068 -0.395 . . . . 25.0 111.274 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -77.26 -12.24 59.92 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.385 0.883 . . . . 25.0 113.385 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.0 p -140.18 170.59 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.89 0.7 . . . . 25.0 112.89 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -85.04 13.49 6.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.567 0.747 . . . . 25.0 110.317 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -109.91 163.51 13.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.95 139.35 32.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 100.376 -3.935 . . . . 25.0 100.376 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -117.99 152.01 36.33 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.276 0.56 . . . . 25.0 110.921 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.68 140.81 51.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.565 -1.198 . . . . 25.0 108.381 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 19.8 mp0 -128.23 126.2 40.46 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.651 -2.351 . . . . 25.0 104.651 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.13 131.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.38 123.73 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.41 138.65 31.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.517 -1.29 . . . . 25.0 107.517 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.87 126.07 46.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 2.1 t0 -93.29 95.84 9.6 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.46 124.75 31.01 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.0 158.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 112.68 0.622 . . . . 25.0 112.68 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.92 161.72 14.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.773 -1.565 . . . . 25.0 106.773 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.35 -0.833 . . . . 25.0 109.138 172.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 110.249 -0.278 . . . . 25.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.67 157.33 33.14 Favored Glycine 0 C--O 1.234 0.119 0 N-CA-C 110.699 -0.96 . . . . 25.0 110.699 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -166.32 164.17 17.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.127 0.571 . . . . 25.0 110.427 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.91 128.12 45.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.284 -2.117 . . . . 25.0 105.284 170.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -94.6 -46.56 6.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.086 0.47 . . . . 25.0 110.238 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -145.97 157.1 51.02 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.909 -0.587 . . . . 25.0 109.5 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.53 132.38 26.12 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 130.312 1.38 . . . . 25.0 115.647 -0.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.51 -172.19 35.74 Favored Glycine 0 C--O 1.221 -0.695 0 CA-C-N 115.636 -0.711 . . . . 25.0 113.713 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -150.92 150.34 30.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.931 -1.137 . . . . 25.0 107.931 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.74 -21.02 59.58 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 111.907 0.336 . . . . 25.0 111.907 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.3 -31.17 68.89 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 113.043 0.757 . . . . 25.0 113.043 -173.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -27.81 68.95 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.634 0.605 . . . . 25.0 112.634 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.82 -10.5 39.61 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 120.809 0.338 . . . . 25.0 111.273 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t -99.2 -11.49 21.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.515 0.674 . . . . 25.0 110.044 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.4 t -67.79 151.95 46.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.329 0.585 . . . . 25.0 110.553 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 16' ' ' GLU . 37.6 mp0 -63.74 -28.45 69.89 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.19 -12.98 59.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.578 -0.737 . . . . 25.0 112.655 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -83.03 2.1 36.71 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.918 0.34 . . . . 25.0 111.918 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.52 5.7 1.07 Allowed Glycine 0 N--CA 1.463 0.497 0 N-CA-C 116.033 1.173 . . . . 25.0 116.033 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 t80 55.87 25.61 8.75 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.123 1.157 . . . . 25.0 114.123 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.96 -39.47 79.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.738 -1.208 . . . . 25.0 107.738 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 57.84 25.16 11.67 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.658 -1.156 . . . . 25.0 113.636 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.25 157.0 46.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.7 -0.682 . . . . 25.0 110.239 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.9 t30 51.3 77.01 0.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.602 2.075 . . . . 25.0 116.602 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.6 m -92.19 17.67 9.28 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.513 -0.767 . . . . 25.0 110.877 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.71 161.09 11.56 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.305 -0.407 . . . . 25.0 113.595 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.6 t -57.55 -29.01 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.361 0.6 . . . . 25.0 110.756 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -12.08 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 114.394 1.257 . . . . 25.0 114.394 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -72.15 -27.42 62.59 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.43 -0.794 . . . . 25.0 110.691 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -92.51 -36.18 13.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 25.0 109.976 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -118.88 72.39 11.33 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 121.427 0.632 . . . . 25.0 111.375 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.98 -26.87 21.37 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.159 -2.094 . . . . 25.0 115.021 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -8.76 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.798 1.777 . . . . 25.0 115.798 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 t -86.36 94.05 9.26 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 121.543 -0.723 . . . . 25.0 111.06 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mp -117.1 80.02 1.42 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.492 -0.322 . . . . 25.0 111.365 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -142.38 126.55 17.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.796 -0.446 . . . . 25.0 109.796 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 134.59 38.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.657 -0.498 . . . . 25.0 109.657 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -63.79 137.09 57.91 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.448 -0.782 . . . . 25.0 109.232 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.53 135.51 54.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.267 -0.424 . . . . 25.0 110.451 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.21 157.85 22.99 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 117.618 1.807 . . . . 25.0 117.618 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -94.67 156.52 38.24 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.42 147.99 85.05 Favored 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 130.39 1.412 . . . . 25.0 112.624 1.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -144.56 12.09 1.49 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.994 0.739 . . . . 25.0 112.994 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.63 -54.06 0.55 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.216 1.406 . . . . 25.0 112.196 -173.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.19 -176.62 51.06 Favored Glycine 0 C--O 1.243 0.714 0 N-CA-C 110.147 -1.181 . . . . 25.0 110.147 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.86 159.38 54.06 Favored 'Trans proline' 0 C--N 1.344 0.33 0 CA-C-N 118.503 1.152 . . . . 25.0 112.895 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.89 120.12 21.59 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.912 -0.773 . . . . 25.0 108.912 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 41.5 t0 -135.82 -179.41 5.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.648 -0.501 . . . . 25.0 109.648 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 48' ' ' ASP . . . 89.94 -9.52 76.99 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 108.602 -1.799 . . . . 25.0 108.602 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -86.59 42.79 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.647 0.779 . . . . 25.0 110.267 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.8 mt -65.28 -39.71 86.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.591 -0.731 . . . . 25.0 109.232 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.0 -31.22 72.3 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.055 0.455 . . . . 25.0 111.758 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 m -91.11 -3.51 57.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.466 -0.334 . . . . 25.0 110.881 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.76 37.52 24.05 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.31 1.044 . . . . 25.0 111.414 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.31 -42.07 2.1 Favored Glycine 0 C--O 1.223 -0.554 0 CA-C-N 115.804 -0.634 . . . . 25.0 113.458 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.17 -15.82 80.92 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.942 -0.647 . . . . 25.0 113.254 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.03 -28.3 68.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.958 0.409 . . . . 25.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -68.46 -24.0 64.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.218 -0.301 . . . . 25.0 111.538 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -30.26 59.93 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 110.205 -1.158 . . . . 25.0 110.205 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.69 -20.63 74.26 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 121.272 -0.489 . . . . 25.0 112.409 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -66.13 -42.86 92.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.192 -1.04 . . . . 25.0 108.192 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.64 -32.05 63.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 25.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.37 -26.89 68.96 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.802 -0.359 . . . . 25.0 111.785 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -64.16 -7.59 9.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -132.07 27.22 4.54 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.055 0.455 . . . . 25.0 110.606 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.7 t -87.99 157.85 18.8 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.119 0.485 . . . . 25.0 111.748 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.97 -41.71 95.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 25.0 110.012 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -102.73 24.39 10.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.671 0.748 . . . . 25.0 111.161 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -55.08 154.57 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.655 -1.157 . . . . 25.0 110.053 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -80.11 156.15 27.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.826 0.822 . . . . 25.0 109.961 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -62.1 141.0 58.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.664 -0.698 . . . . 25.0 111.412 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -112.93 134.59 54.37 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.022 -0.536 . . . . 25.0 110.69 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.23 149.36 50.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.55 137.58 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.2 ttt -150.97 167.0 28.95 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.7 p -101.45 170.86 7.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.39 -166.08 11.0 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.066 -0.588 . . . . 25.0 113.321 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.94 179.47 25.39 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 112.16 -0.376 . . . . 25.0 112.16 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 16.9 tt0 -73.79 133.03 43.19 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.759 -0.848 . . . . 25.0 109.365 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -125.33 155.2 40.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -106.25 125.23 50.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.106 -1.072 . . . . 25.0 108.106 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -105.68 122.14 45.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.219 -2.141 . . . . 25.0 105.219 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -126.07 109.24 12.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.73 -0.47 . . . . 25.0 109.73 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -122.93 140.85 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.767 -3.049 . . . . 25.0 102.767 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 123.58 12.44 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -126.69 118.99 25.88 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.747 -0.835 . . . . 25.0 108.747 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -88.36 -6.37 57.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.821 -1.081 . . . . 25.0 111.922 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.73 130.7 54.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.87 119.61 6.45 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 115.903 -2.265 . . . . 25.0 112.794 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.04 136.06 48.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 25.0 109.821 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -84.24 149.93 25.78 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.317 -2.105 . . . . 25.0 105.317 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 m -137.11 152.55 50.12 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 104.645 -2.354 . . . . 25.0 104.645 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.6 p -93.03 -41.57 9.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -167.57 169.3 12.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.518 -0.31 . . . . 25.0 110.44 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.4 p90 -144.85 146.99 32.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.121 -1.437 . . . . 25.0 107.121 163.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.08 159.2 44.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 25.0 109.267 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.46 151.35 47.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.533 0.683 . . . . 25.0 112.604 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.35 163.95 27.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.883 -1.053 . . . . 25.0 108.533 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.52 152.43 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.6 p -80.84 126.13 30.95 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 120.906 0.384 . . . . 25.0 110.403 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -87.99 115.73 25.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.755 -1.202 . . . . 25.0 107.755 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -81.28 154.03 26.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.33 10.98 34.84 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 116.863 1.505 . . . . 25.0 116.863 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -62.56 155.02 27.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.263 1.031 . . . . 25.0 109.717 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -127.79 158.46 70.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 104.185 -2.524 . . . . 25.0 104.185 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.21 -14.9 35.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 117.646 -1.102 . . . . 25.0 113.508 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -65.58 -29.22 69.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.866 1.317 . . . . 25.0 108.801 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -96.03 145.25 29.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 106.797 -1.557 . . . . 25.0 106.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.37 104.6 1.11 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.325 -1.983 . . . . 25.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.99 -42.62 65.75 Favored 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 113.386 0.884 . . . . 25.0 113.386 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -59.88 -35.28 74.49 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -77.19 -38.75 50.91 Favored 'General case' 0 C--O 1.213 -0.865 0 O-C-N 122.074 -0.391 . . . . 25.0 111.25 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.6 -8.69 58.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.842 1.053 . . . . 25.0 113.842 -172.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.83 -36.79 75.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.959 1.096 . . . . 25.0 113.959 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -128.73 162.06 28.28 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.171 1.174 . . . . 25.0 114.171 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -130.07 146.38 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 172.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.8 115.14 20.14 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.916 -1.513 . . . . 25.0 106.916 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -95.12 -6.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.498 0.666 . . . . 25.0 109.966 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.82 159.53 11.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.771 . . . . 25.0 113.568 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.17 143.76 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.0 t -134.27 98.78 13.76 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 108.061 -1.088 . . . . 25.0 108.061 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.25 159.99 39.82 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 115.45 -2.567 . . . . 25.0 110.475 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -104.05 91.2 3.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.574 -2.38 . . . . 25.0 104.574 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -104.49 -25.01 12.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.245 -0.889 . . . . 25.0 109.827 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.17 -151.24 20.21 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 107.709 -2.157 . . . . 25.0 107.709 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.6 m 61.71 168.44 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.873 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.71 0.18 8.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 114.288 -3.341 . . . . 25.0 114.262 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.46 87.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.405 -0.816 . . . . 25.0 108.892 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.1 t -67.58 -26.42 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.917 -0.583 . . . . 25.0 112.022 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -68.43 -27.22 66.0 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.889 0.376 . . . . 25.0 110.517 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.38 104.84 11.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.03 -28.41 17.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.578 0.704 . . . . 25.0 109.941 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.0 t -93.2 139.46 30.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.802 -1.185 . . . . 25.0 107.802 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -139.93 150.9 45.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.028 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.53 132.49 36.78 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.297 -2.112 . . . . 25.0 105.297 172.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.97 128.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.636 -1.987 . . . . 25.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 91.1 t80 -78.5 125.01 28.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.923 -1.14 . . . . 25.0 107.923 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.61 108.73 59.81 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.701 -0.851 . . . . 25.0 108.701 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.89 163.92 34.53 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 117.09 -1.473 . . . . 25.0 111.496 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.88 113.05 13.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.604 -2.369 . . . . 25.0 104.604 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -90.19 -33.27 16.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 25.0 110.139 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -155.08 162.04 41.14 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 104.206 -2.516 . . . . 25.0 104.206 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.4 pt? -85.92 136.42 33.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.452 -1.314 . . . . 25.0 107.452 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.76 -176.83 25.45 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-O 121.593 0.551 . . . . 25.0 111.727 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -82.82 137.08 34.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.564 1.173 . . . . 25.0 111.901 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -133.33 158.99 41.59 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.294 -3.224 . . . . 25.0 102.294 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.64 137.35 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.791 -1.189 . . . . 25.0 107.791 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.92 129.08 59.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.409 -2.441 . . . . 25.0 104.409 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.02 134.23 55.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.905 -1.146 . . . . 25.0 107.905 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.11 48.83 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.3 t -129.03 132.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.076 -0.713 . . . . 25.0 109.076 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -116.38 111.67 20.39 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 92.49 5.77 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.821 0.343 . . . . 25.0 111.208 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.98 144.2 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -102.95 -21.7 13.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.309 0.485 . . . . 25.0 112.309 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -73.7 -21.67 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.336 0.495 . . . . 25.0 112.336 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.0 p -135.92 168.57 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 25.0 110.724 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -79.3 13.61 1.84 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.979 0.895 . . . . 25.0 110.734 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -110.03 157.8 18.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 25.0 111.294 -172.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.93 171.9 18.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -141.01 143.45 34.45 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.52 -0.872 . . . . 25.0 111.849 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.55 119.93 37.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.386 -2.45 . . . . 25.0 104.386 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -122.69 132.41 54.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.022 -1.844 . . . . 25.0 106.022 -173.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.33 147.48 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 25.0 110.275 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.53 120.68 48.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.43 125.04 28.7 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.624 -1.25 . . . . 25.0 107.624 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.33 126.02 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.951 0.881 . . . . 25.0 108.682 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -89.02 96.09 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 103.474 -2.787 . . . . 25.0 103.474 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.11 119.63 31.4 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.339 -1.726 . . . . 25.0 106.339 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.18 161.91 39.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 O-C-N 123.592 0.558 . . . . 25.0 111.788 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -79.35 159.08 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.314 -1.365 . . . . 25.0 107.314 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.863 -1.065 . . . . 25.0 109.84 178.589 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.8 m170 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 118.864 -0.589 . . . . 25.0 109.762 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.6 168.91 32.25 Favored Glycine 0 C--O 1.23 -0.141 0 C-N-CA 121.251 -0.5 . . . . 25.0 113.566 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -135.62 139.74 44.03 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 6' ' ' LYS . 84.3 mt -96.67 111.96 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.337 -0.616 . . . . 25.0 109.337 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -93.56 39.95 1.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.321 0.649 . . . . 25.0 110.326 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' H ' HG22 ' A' ' 4' ' ' ILE . 74.5 mttt 79.81 156.35 0.13 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 126.317 1.847 . . . . 25.0 111.629 171.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.89 147.86 90.62 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 129.622 1.093 . . . . 25.0 113.928 -0.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.58 152.14 29.03 Favored Glycine 0 C--O 1.223 -0.55 0 CA-C-N 114.964 -1.016 . . . . 25.0 113.854 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -161.63 142.94 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.91 -1.515 . . . . 25.0 106.91 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -77.97 -28.92 49.51 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.477 -0.489 . . . . 25.0 110.081 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.2 71.85 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.713 0.292 . . . . 25.0 111.013 -177.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.44 89.57 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.596 -0.275 . . . . 25.0 111.135 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.08 -16.52 35.32 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 120.679 0.276 . . . . 25.0 111.183 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t -73.28 -17.97 61.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.976 -0.556 . . . . 25.0 110.906 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.2 t -66.19 140.63 58.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.965 -0.561 . . . . 25.0 111.822 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -64.35 -13.38 50.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.406 -0.815 . . . . 25.0 111.152 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.62 -27.52 64.79 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.978 -0.451 . . . . 25.0 110.247 172.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -111.28 -13.08 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 25.0 110.47 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.47 52.63 0.62 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 108.954 -1.658 . . . . 25.0 108.954 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -69.41 -27.0 64.91 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.321 1.23 . . . . 25.0 114.321 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.6 mt -100.93 -24.7 14.3 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.85 0.357 . . . . 25.0 111.848 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -161.21 155.87 23.4 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.444 -2.428 . . . . 25.0 104.444 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.89 121.68 22.25 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.731 -1.211 . . . . 25.0 107.731 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -101.89 11.26 38.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.792 -1.095 . . . . 25.0 112.682 -170.984 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -67.45 -28.61 68.02 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.195 0.813 . . . . 25.0 113.195 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.94 164.88 24.92 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 121.591 -0.338 . . . . 25.0 112.602 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -79.07 -35.79 41.9 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.76 -0.847 . . . . 25.0 111.027 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.66 -15.93 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.693 0.997 . . . . 25.0 113.693 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -16.81 23.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.668 1.359 . . . . 25.0 114.668 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -73.04 -36.49 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.997 0.74 . . . . 25.0 112.997 -173.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.05 45.61 0.42 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 118.69 2.848 . . . . 25.0 118.69 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.28 -22.68 33.92 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 113.778 -3.681 . . . . 25.0 112.582 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -77.76 3.23 14.68 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.841 0.682 . . . . 25.0 112.841 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -110.87 66.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.103 -0.702 . . . . 25.0 109.103 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 tt -118.96 111.28 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.438 -0.801 . . . . 25.0 109.414 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -130.03 142.24 50.64 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.317 -1.735 . . . . 25.0 106.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.99 144.84 51.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -106.8 136.94 45.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.103 0.478 . . . . 25.0 110.972 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -71.71 134.69 46.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.51 -144.57 25.67 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.44 -0.886 . . . . 25.0 113.754 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -109.75 154.62 42.41 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.134 0.574 . . . . 25.0 111.059 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.44 137.34 34.08 Favored 'Cis proline' 0 C--N 1.354 0.847 0 C-N-CA 129.403 1.001 . . . . 25.0 110.789 -0.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -80.14 -47.67 14.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.551 1.315 . . . . 25.0 114.551 -168.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.8 t 62.11 -63.48 0.1 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 117.855 2.539 . . . . 25.0 117.855 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.64 -154.98 30.46 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 117.416 1.726 . . . . 25.0 117.416 -171.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.05 -177.97 2.58 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.973 2.449 . . . . 25.0 111.221 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.79 86.47 1.71 Allowed 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.354 -0.841 . . . . 25.0 111.362 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -74.7 146.7 42.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.04 -0.982 . . . . 25.0 109.765 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.08 -31.98 1.53 Allowed Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.664 -0.698 . . . . 25.0 113.472 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -85.49 38.79 0.75 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.715 0.769 . . . . 25.0 110.024 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.2 mm -59.06 -32.79 48.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.435 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.74 -11.37 35.61 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.293 1.22 . . . . 25.0 114.293 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -91.51 -10.09 42.04 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.006 -0.434 . . . . 25.0 110.382 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.47 13.76 1.97 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.321 1.448 . . . . 25.0 113.243 -171.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.0 -42.57 99.64 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 121.087 -0.578 . . . . 25.0 111.97 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.75 -29.07 61.82 Favored Glycine 0 C--O 1.223 -0.591 0 C-N-CA 120.574 -0.822 . . . . 25.0 111.483 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.26 -30.07 68.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.502 -0.411 . . . . 25.0 111.584 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -66.31 -22.44 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.863 -0.335 . . . . 25.0 111.36 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.07 -22.52 77.27 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.775 -0.726 . . . . 25.0 111.48 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.73 -18.02 71.77 Favored Glycine 0 C--O 1.223 -0.555 0 C-N-CA 121.332 -0.461 . . . . 25.0 112.815 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.09 -38.18 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.461 -0.94 . . . . 25.0 108.461 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.53 -38.05 62.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 25.0 109.794 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -64.21 -41.86 96.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.378 0.608 . . . . 25.0 111.505 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -78.64 -1.82 36.1 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.723 -0.611 . . . . 25.0 112.268 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -134.15 55.08 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.862 0.839 . . . . 25.0 110.177 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -135.79 163.91 29.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 25.0 108.687 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -68.84 -27.71 66.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.245 -1.021 . . . . 25.0 108.245 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -96.49 22.82 7.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.3 -0.864 . . . . 25.0 110.933 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -56.91 145.62 29.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 25.0 108.552 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -81.63 160.2 23.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 25.0 109.908 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -61.71 149.27 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.326 -0.852 . . . . 25.0 111.798 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -121.65 143.24 49.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -124.85 140.01 53.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 25.0 109.846 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.15 131.55 34.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.566 -2.012 . . . . 25.0 105.566 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.0 mtp -138.74 167.88 21.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -101.33 174.53 5.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.798 -0.183 . . . . 25.0 110.647 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.76 -170.99 13.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.488 -1.445 . . . . 25.0 109.488 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.51 -176.13 44.58 Favored Glycine 0 C--O 1.236 0.236 0 N-CA-C 111.702 -0.559 . . . . 25.0 111.702 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -87.75 144.9 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.981 -0.717 . . . . 25.0 111.508 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -136.21 161.46 35.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.576 -2.009 . . . . 25.0 105.576 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.5 m -122.85 125.45 45.42 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -108.93 137.96 46.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 m -124.1 123.35 40.13 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -123.91 149.96 45.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 103.698 -2.705 . . . . 25.0 103.698 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.7 p -138.12 159.86 40.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.186 0.517 . . . . 25.0 110.507 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -133.13 123.92 26.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 103.571 -2.752 . . . . 25.0 103.571 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -84.21 -20.76 31.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.448 0.536 . . . . 25.0 112.448 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.19 127.26 69.67 Favored Pre-proline 0 C--O 1.244 0.78 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -67.0 129.89 21.71 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.782 -1.012 . . . . 25.0 113.067 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -136.07 158.93 43.22 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.649 -0.705 . . . . 25.0 110.395 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.18 86.98 6.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.081 -1.451 . . . . 25.0 107.081 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -76.99 129.28 35.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.04 -0.527 . . . . 25.0 110.002 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.9 m -92.73 -42.71 9.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.588 0.588 . . . . 25.0 112.588 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -166.85 173.66 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.897 0.379 . . . . 25.0 111.222 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -147.76 145.62 28.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 165.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -147.93 154.1 39.91 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.716 -0.846 . . . . 25.0 108.716 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -149.84 148.93 29.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.142 0.496 . . . . 25.0 110.537 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.94 156.97 44.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.79 161.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 110.252 -0.277 . . . . 25.0 110.252 -176.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 p -70.61 140.09 51.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.042 0.448 . . . . 25.0 110.938 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -87.94 120.49 29.33 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.921 0.712 . . . . 25.0 112.921 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -77.04 133.16 39.19 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.95 62.12 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 119.47 -1.347 . . . . 25.0 115.109 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.08 142.59 24.83 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.437 1.118 . . . . 25.0 113.173 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.47 128.04 92.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.405 -1.271 . . . . 25.0 109.338 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.44 -13.18 27.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 117.875 -0.95 . . . . 25.0 112.839 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -66.08 -29.48 69.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.884 0.85 . . . . 25.0 110.886 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -96.01 141.03 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.056 -0.72 . . . . 25.0 109.056 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.62 128.57 18.32 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 115.085 -2.81 . . . . 25.0 111.53 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -25.41 60.35 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.997 -0.547 . . . . 25.0 111.993 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.37 -34.26 46.98 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.63 -0.714 . . . . 25.0 111.963 176.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.5 mpt_? -96.81 -42.92 7.73 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.195 -0.457 . . . . 25.0 110.96 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.08 1.99 11.79 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.48 2.03 . . . . 25.0 116.48 -170.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.69 -34.95 79.52 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.059 -0.719 . . . . 25.0 109.059 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -127.16 146.6 50.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.081 0.552 . . . . 25.0 109.985 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.58 144.67 50.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.418 -0.586 . . . . 25.0 109.418 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.74 124.83 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.526 . . . . 25.0 109.905 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.7 tt -111.49 -12.17 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.291 0.567 . . . . 25.0 109.986 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.39 147.76 8.41 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.489 -1.339 . . . . 25.0 116.092 174.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.82 131.03 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.104 -2.184 . . . . 25.0 105.104 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.99 129.71 9.08 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 118.089 0.404 . . . . 25.0 109.99 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -86.62 177.08 4.41 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 117.289 -1.341 . . . . 25.0 114.718 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -137.73 120.95 16.86 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 106.598 -1.63 . . . . 25.0 106.598 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.45 7.12 10.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 25.0 112.005 -176.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.14 -99.43 0.21 Allowed Glycine 0 N--CA 1.454 -0.104 0 N-CA-C 111.469 -0.652 . . . . 25.0 111.469 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -124.45 53.56 7.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.751 1.389 . . . . 25.0 114.751 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.07 -177.18 3.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 117.563 -1.158 . . . . 25.0 110.479 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.15 -30.69 70.54 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.56 -0.713 . . . . 25.0 109.662 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 78.3 p -80.19 8.02 8.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.509 0.929 . . . . 25.0 113.509 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -60.35 -23.59 64.38 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.514 -0.741 . . . . 25.0 111.965 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -81.3 129.85 34.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 25.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.67 -9.29 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.411 0.624 . . . . 25.0 112.145 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.8 t -82.26 137.98 34.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.126 -1.064 . . . . 25.0 108.126 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -144.01 143.18 31.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.427 0.529 . . . . 25.0 112.427 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -77.63 139.51 39.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.153 -1.425 . . . . 25.0 107.153 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -131.88 120.73 45.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -98.62 136.07 39.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.312 -0.255 . . . . 25.0 110.312 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.4 mm -117.32 123.78 29.65 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.135 -1.432 . . . . 25.0 107.135 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.78 143.09 49.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 115.549 -2.501 . . . . 25.0 112.012 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.72 12.18 30.83 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.134 -0.939 . . . . 25.0 112.602 -171.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -58.85 -38.33 78.49 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.854 1.057 . . . . 25.0 113.854 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -151.82 157.24 41.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.817 0.342 . . . . 25.0 110.938 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.6 pt? -88.45 152.74 21.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 25.0 109.067 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.88 154.94 8.99 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 115.497 0.959 . . . . 25.0 115.497 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -78.82 145.03 34.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.21 159.0 43.09 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.117 -0.492 . . . . 25.0 110.004 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.3 t -118.7 133.65 64.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 104.942 -2.244 . . . . 25.0 104.942 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.4 mt -114.65 127.83 71.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.404 -1.702 . . . . 25.0 106.404 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.0 tp -124.65 120.85 33.06 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.52 42.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 25.0 109.424 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.01 140.05 50.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.465 -0.939 . . . . 25.0 108.465 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -126.96 113.92 17.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 25.0 107.709 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -105.85 131.99 52.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.843 -0.617 . . . . 25.0 111.317 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.04 136.13 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.34 54.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 115.083 1.512 . . . . 25.0 115.083 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -87.18 10.77 15.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.405 1.261 . . . . 25.0 114.405 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.3 t -145.28 161.77 38.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.231 0.538 . . . . 25.0 110.879 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -88.33 0.92 55.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.347 0.594 . . . . 25.0 110.264 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -110.08 160.84 16.11 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.914 -0.585 . . . . 25.0 110.216 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.03 154.45 41.27 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.559 -1.645 . . . . 25.0 106.559 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -105.08 137.05 43.45 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.493 -0.928 . . . . 25.0 108.493 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.67 150.1 50.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.991 -1.114 . . . . 25.0 107.991 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -146.06 129.7 17.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 173.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.96 137.94 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.295 -1.372 . . . . 25.0 107.295 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.0 mt -138.41 120.46 17.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.38 -0.97 . . . . 25.0 108.38 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.87 134.07 35.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.47 166.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.263 0.554 . . . . 25.0 110.419 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -124.54 106.69 10.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.2 103.96 14.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.07 160.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.831 1.419 . . . . 25.0 114.831 -172.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -95.11 162.2 13.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.323 -2.102 . . . . 25.0 105.323 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt . . . . . 0 C--O 1.244 0.779 0 N-CA-C 107.456 -1.313 . . . . 25.0 107.456 173.231 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 119.209 -0.424 . . . . 25.0 110.439 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.42 -138.61 4.02 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 118.046 0.384 . . . . 25.0 112.948 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -112.4 158.22 20.09 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.758 0.779 . . . . 25.0 112.273 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.4 mt -103.86 121.3 55.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.561 -1.274 . . . . 25.0 107.561 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -91.34 -36.61 13.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.352 0.596 . . . . 25.0 111.441 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -140.47 146.04 43.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.18 109.27 1.35 Allowed 'Cis proline' 0 CA--C 1.539 0.749 0 C-N-CA 130.874 1.614 . . . . 25.0 115.562 -0.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.47 173.23 9.91 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 115.562 0.985 . . . . 25.0 115.562 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -86.67 131.48 34.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.619 -0.342 . . . . 25.0 111.033 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -69.76 -37.32 76.36 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.417 -0.586 . . . . 25.0 109.417 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.85 72.55 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 112.592 0.59 . . . . 25.0 112.592 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.73 85.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 25.0 110.904 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.76 -10.31 51.41 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.036 0.446 . . . . 25.0 111.558 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t -84.54 -23.26 29.81 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -72.75 146.71 46.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.314 0.578 . . . . 25.0 111.714 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -67.79 -16.63 64.2 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.847 -0.615 . . . . 25.0 110.674 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.84 -18.68 57.26 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.71 0.263 . . . . 25.0 111.71 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -83.08 -1.19 52.15 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.42 0.896 . . . . 25.0 113.42 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.92 -34.68 0.08 OUTLIER Glycine 0 CA--C 1.522 0.522 0 N-CA-C 117.384 1.713 . . . . 25.0 117.384 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.3 t80 62.14 -40.35 0.15 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 118.392 2.738 . . . . 25.0 118.392 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.92 -20.09 66.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.772 -0.58 . . . . 25.0 112.304 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -146.26 151.14 37.08 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.283 -1.747 . . . . 25.0 106.283 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.14 138.24 25.15 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -130.6 44.14 3.01 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.035 -0.728 . . . . 25.0 109.035 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.73 10.72 1.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.219 0.822 . . . . 25.0 113.219 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.49 -61.7 7.11 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 115.673 1.029 . . . . 25.0 115.673 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.4 t -78.98 -14.1 59.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.807 0.803 . . . . 25.0 111.281 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.1 t -75.95 -33.39 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 25.0 111.814 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -66.66 -12.4 58.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -78.35 -37.44 44.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.543 0.61 . . . . 25.0 111.507 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -149.43 70.05 9.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.656 0.741 . . . . 25.0 112.964 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.61 -6.75 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 N-CA-C 113.792 0.651 . . . . 25.0 113.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -87.28 -7.61 57.66 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.102 0.779 . . . . 25.0 113.102 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 t -108.58 95.43 5.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.861 1.06 . . . . 25.0 113.861 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 tt -125.21 81.38 1.96 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.101 0.477 . . . . 25.0 110.06 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -100.22 137.63 38.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.384 0.513 . . . . 25.0 112.384 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.77 114.96 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.075 -0.343 . . . . 25.0 110.075 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -76.54 140.33 41.08 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.7 0.63 . . . . 25.0 112.7 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -69.15 153.61 43.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.631 -0.713 . . . . 25.0 111.673 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.43 -167.72 47.23 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 115.108 0.803 . . . . 25.0 115.108 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -98.09 153.69 38.02 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.359 -0.608 . . . . 25.0 109.359 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.66 159.11 98.37 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 129.406 1.003 . . . . 25.0 111.839 -3.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -65.6 -23.96 66.95 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.946 -0.301 . . . . 25.0 111.31 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t 60.59 -89.42 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.25 1.02 . . . . 25.0 113.305 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.3 -176.99 39.8 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.403 -0.427 . . . . 25.0 112.938 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.47 171.02 18.57 Favored 'Trans proline' 0 C--O 1.235 0.371 0 CA-C-N 118.591 1.195 . . . . 25.0 112.867 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.79 113.33 25.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.863 -1.532 . . . . 25.0 106.863 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 50' ' ' GLN . 44.3 t0 -150.81 144.73 25.25 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.51 -1.293 . . . . 25.0 107.51 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.14 -13.8 3.24 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 122.69 1.161 . . . . 25.0 112.291 -173.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 48' ' ' ASP . 29.3 mt-30 -89.68 46.76 1.39 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.805 1.242 . . . . 25.0 109.31 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.8 mt -60.79 -39.54 82.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.717 -1.129 . . . . 25.0 108.078 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . . . -64.73 -23.07 67.13 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.5 t -89.84 7.27 37.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.001 -0.37 . . . . 25.0 110.001 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.86 23.98 11.93 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.418 1.087 . . . . 25.0 113.817 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.55 -34.96 0.72 Allowed Glycine 0 C--O 1.22 -0.734 0 C-N-CA 121.361 -0.447 . . . . 25.0 113.466 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.0 15.74 60.21 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 114.552 0.581 . . . . 25.0 114.552 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.3 pt? -67.31 -27.79 67.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.419 0.526 . . . . 25.0 112.419 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -71.45 -21.68 61.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.246 0.462 . . . . 25.0 112.246 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.03 90.83 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.904 -0.665 . . . . 25.0 112.473 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.28 68.22 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.784 -0.722 . . . . 25.0 113.541 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.58 -46.22 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.084 0.469 . . . . 25.0 109.989 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.16 -24.08 62.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.933 1.086 . . . . 25.0 113.933 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.41 -25.68 59.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 25.0 114.254 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -57.16 -21.6 34.17 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.532 0.938 . . . . 25.0 113.532 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -138.87 38.84 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.41 0.624 . . . . 25.0 109.788 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.5 t -85.98 146.75 26.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 25.0 110.715 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -63.26 -25.11 68.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.135 0.969 . . . . 25.0 109.881 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -118.77 28.19 8.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.993 -1.003 . . . . 25.0 108.733 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -47.65 140.78 5.88 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.245 -0.889 . . . . 25.0 112.982 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -79.05 146.15 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.968 0.889 . . . . 25.0 109.65 -171.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -68.82 134.68 50.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.361 -0.836 . . . . 25.0 109.388 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -121.01 139.99 52.54 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 113.453 0.908 . . . . 25.0 113.453 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -119.42 143.21 47.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.69 -1.226 . . . . 25.0 107.69 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.9 mt -94.06 128.27 45.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 102.928 -2.99 . . . . 25.0 102.928 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 89.8 mtp -140.88 164.29 30.63 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 107.554 -1.276 . . . . 25.0 107.554 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.0 p -92.44 174.06 7.48 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 104.494 -2.409 . . . . 25.0 104.494 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.401 ' H ' ' HG3' ' A' ' 140' ' ' GLU . . . -74.52 -162.27 8.9 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.846 -0.902 . . . . 25.0 110.846 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.6 -178.13 27.33 Favored Glycine 0 C--N 1.323 -0.173 0 CA-C-O 121.452 0.473 . . . . 25.0 112.392 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.4 131.35 43.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.948 -0.736 . . . . 25.0 109.222 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.12 158.55 37.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.853 -1.166 . . . . 25.0 107.853 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 m -120.38 126.68 51.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.11 0.481 . . . . 25.0 109.73 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.62 135.77 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.526 -2.027 . . . . 25.0 105.526 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.1 m -138.07 128.52 26.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.036 0.384 . . . . 25.0 112.036 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -117.96 149.98 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.5 t -137.85 160.12 40.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.9 143.87 38.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 p -80.78 -16.82 52.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.0 151.81 63.4 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.83 144.99 61.08 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 116.54 -1.84 . . . . 25.0 111.521 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -131.16 148.58 52.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 25.0 109.262 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.08 157.34 33.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.9 m -160.07 148.31 16.94 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 104.093 -2.558 . . . . 25.0 104.093 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -92.1 -51.63 5.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' H ' ' HB3' ' A' ' 153' ' ' ASP . 16.4 pt20 -156.12 170.61 21.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.309 -0.626 . . . . 25.0 109.309 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -149.56 142.52 24.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.915 -1.143 . . . . 25.0 107.915 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -148.04 154.55 40.4 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.226 -0.296 . . . . 25.0 111.162 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -120.02 133.81 55.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.368 -0.833 . . . . 25.0 109.391 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -121.62 163.67 18.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.383 -1.71 . . . . 25.0 106.383 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.37 165.18 29.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 t -126.12 135.71 52.02 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-O 121.435 0.636 . . . . 25.0 111.452 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -109.06 118.78 37.67 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.838 -0.619 . . . . 25.0 112.323 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -75.98 156.02 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.416 -1.327 . . . . 25.0 107.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.97 10.55 15.76 Favored Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.955 -0.64 . . . . 25.0 114.24 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -60.69 162.88 6.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.306 0.574 . . . . 25.0 112.439 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.55 144.98 92.16 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.785 -1.561 . . . . 25.0 106.785 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.7 -23.11 14.81 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 116.638 -1.774 . . . . 25.0 115.001 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -104.64 24.93 10.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.093 0.949 . . . . 25.0 112.721 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -122.97 160.47 49.29 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 105.752 -1.944 . . . . 25.0 105.752 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.64 83.46 1.74 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 116.14 -2.107 . . . . 25.0 112.868 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.27 -39.19 72.24 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 121.511 0.672 . . . . 25.0 110.019 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -16.61 6.58 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.475 1.287 . . . . 25.0 114.475 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -93.81 -46.76 7.07 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 112.447 0.536 . . . . 25.0 112.447 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.97 -17.17 41.44 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.898 1.814 . . . . 25.0 115.898 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.93 -26.32 65.91 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.325 1.232 . . . . 25.0 114.325 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 52' ' ' ALA . 43.3 p90 -103.32 125.17 49.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.464 0.65 . . . . 25.0 111.257 -175.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.74 141.0 52.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.782 -0.644 . . . . 25.0 109.695 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.41 128.15 32.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.513 -0.551 . . . . 25.0 109.513 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.6 tt -111.0 -3.65 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.609 0.719 . . . . 25.0 110.33 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.26 150.96 6.68 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.749 -0.739 . . . . 25.0 113.42 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.54 140.68 31.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.958 -0.756 . . . . 25.0 108.958 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.38 112.36 8.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 123.326 0.391 . . . . 25.0 109.989 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.73 158.86 28.18 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 114.877 -2.949 . . . . 25.0 111.326 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -105.83 91.9 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 103.154 -2.906 . . . . 25.0 103.154 175.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -156.6 56.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.663 0.744 . . . . 25.0 110.973 -172.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.62 12.97 43.35 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.062 -0.589 . . . . 25.0 113.839 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.27 156.85 7.22 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.271 1.212 . . . . 25.0 114.271 -173.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.08 -163.8 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.369 1.379 . . . . 25.0 112.146 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.07 -25.57 0.6 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 117.21 2.3 . . . . 25.0 117.21 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.8 t -62.39 -18.34 61.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.616 0.598 . . . . 25.0 112.616 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -58.88 -25.13 63.07 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.249 1.02 . . . . 25.0 112.547 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -59.0 135.61 57.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.882 0.697 . . . . 25.0 112.882 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.57 -7.78 51.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.124 -0.944 . . . . 25.0 111.527 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -100.0 120.02 39.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.123 -2.547 . . . . 25.0 104.123 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.5 136.26 39.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 -171.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -83.27 136.75 34.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.31 -1.737 . . . . 25.0 106.31 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.0 mm -131.96 131.19 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 105.971 -1.862 . . . . 25.0 105.971 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -93.34 130.87 38.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.603 -0.518 . . . . 25.0 109.603 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.6 mt -126.1 136.47 28.56 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.047 -1.464 . . . . 25.0 107.047 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.3 168.1 24.37 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 117.22 -1.386 . . . . 25.0 113.015 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 77' ' ' GLY . 28.0 tt0 -127.24 35.98 4.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -86.18 -31.4 21.8 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.986 1.106 . . . . 25.0 113.986 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -146.22 169.66 18.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.114 -0.328 . . . . 25.0 110.114 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.3 pt? -107.68 152.02 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.874 0.694 . . . . 25.0 112.874 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.29 157.75 7.33 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.721 -0.672 . . . . 25.0 112.078 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 15.8 p90 -84.03 144.94 28.77 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.732 0.777 . . . . 25.0 113.042 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -138.06 135.01 35.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.7 t -98.0 134.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.263 -1.754 . . . . 25.0 106.263 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.02 125.31 61.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -104.69 109.68 21.7 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.401 -1.333 . . . . 25.0 107.401 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -108.09 123.8 49.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.63 133.1 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.663 -0.865 . . . . 25.0 108.663 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -121.25 107.58 12.72 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.537 -1.283 . . . . 25.0 107.537 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 52.2 t0 -82.67 90.69 6.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 25.0 109.98 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.59 119.32 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.043 -1.095 . . . . 25.0 108.043 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.32 11.89 22.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 25.0 112.101 -174.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.96 -2.97 30.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.046 0.387 . . . . 25.0 112.046 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.7 p -143.83 168.5 19.8 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.671 0.272 . . . . 25.0 111.512 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.26 1.07 34.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.957 0.884 . . . . 25.0 109.371 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.14 155.04 18.69 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 150.86 41.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 103.197 -2.89 . . . . 25.0 103.197 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.33 138.57 47.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.593 -0.521 . . . . 25.0 109.593 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -138.97 154.02 48.25 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.135 -1.061 . . . . 25.0 108.135 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.16 152.3 45.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.467 -1.679 . . . . 25.0 106.467 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.97 145.46 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.538 -0.542 . . . . 25.0 109.538 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.2 mt -136.24 125.19 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.086 -2.561 . . . . 25.0 104.086 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -111.15 130.63 55.57 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.31 -1.367 . . . . 25.0 107.31 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.73 134.93 58.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 1.0 OUTLIER -93.17 100.52 12.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.55 -2.018 . . . . 25.0 105.55 176.288 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.0 mt -92.88 130.21 38.54 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.915 -1.513 . . . . 25.0 106.915 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 10.1 m -127.04 158.01 38.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 113.871 1.063 . . . . 25.0 113.871 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -93.82 161.47 14.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.299 -1.371 . . . . 25.0 107.299 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt . . . . . 0 C--O 1.243 0.723 0 CA-C-O 118.472 -0.775 . . . . 25.0 109.409 175.293 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 110.299 -0.26 . . . . 25.0 110.299 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.96 179.75 29.15 Favored Glycine 0 CA--C 1.509 -0.32 0 N-CA-C 107.906 -2.078 . . . . 25.0 107.906 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -134.06 161.7 34.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.015 0.908 . . . . 25.0 108.907 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.98 121.77 66.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.938 -1.505 . . . . 25.0 106.938 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -12.27 60.58 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.95 1.092 . . . . 25.0 113.95 -174.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt 79.68 149.69 0.12 Allowed Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 126.195 1.798 . . . . 25.0 108.161 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.31 156.72 91.42 Favored 'Cis proline' 0 C--N 1.346 0.425 0 CA-C-O 121.181 0.409 . . . . 25.0 112.371 -0.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.7 10.53 30.63 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 116.262 1.265 . . . . 25.0 116.262 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -64.5 126.93 29.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.945 0.872 . . . . 25.0 111.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -77.95 -19.12 55.16 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 116.345 -0.389 . . . . 25.0 110.231 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.79 69.64 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.75 -0.205 . . . . 25.0 111.191 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -25.12 65.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 25.0 110.811 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.28 0.56 51.03 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 122.915 0.486 . . . . 25.0 110.567 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 t -80.12 -8.7 59.53 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.997 0.369 . . . . 25.0 111.997 -176.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.5 t -56.99 143.69 37.08 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.487 0.921 . . . . 25.0 113.487 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -17.19 54.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.625 -1.17 . . . . 25.0 112.026 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.89 -12.96 8.8 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.069 0.766 . . . . 25.0 113.069 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -75.22 -12.97 60.4 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.024 0.379 . . . . 25.0 112.024 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.43 -8.02 0.03 OUTLIER Glycine 0 N--CA 1.464 0.519 0 N-CA-C 118.037 1.975 . . . . 25.0 118.037 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.5 t80 57.2 27.83 14.15 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.727 1.38 . . . . 25.0 114.727 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.0 mt -101.05 -2.94 30.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.337 0.589 . . . . 25.0 109.438 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -133.53 167.58 20.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.624 -0.716 . . . . 25.0 110.432 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mp -74.9 164.26 26.75 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.835 -1.913 . . . . 25.0 105.835 172.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -45.67 -20.06 0.07 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.888 2.181 . . . . 25.0 116.888 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.9 t -164.27 -16.55 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.708 0.766 . . . . 25.0 109.966 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.07 167.72 38.46 Favored Glycine 0 C--O 1.222 -0.644 0 C-N-CA 121.251 -0.499 . . . . 25.0 113.08 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.3 t -76.47 -13.97 60.07 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.869 -0.783 . . . . 25.0 111.441 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -69.84 -11.92 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 122.801 0.441 . . . . 25.0 110.559 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.6 ptm -60.32 -10.44 4.72 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.53 -46.61 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.576 0.625 . . . . 25.0 109.983 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.02 69.41 5.61 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 113.185 0.809 . . . . 25.0 113.185 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.32 3.12 6.06 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 N-CA-C 113.71 0.619 . . . . 25.0 113.71 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -101.32 -2.44 31.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.497 0.555 . . . . 25.0 112.497 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.94 97.4 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.662 0.986 . . . . 25.0 113.662 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.96 112.29 24.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.504 -1.665 . . . . 25.0 106.504 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -89.03 110.19 20.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.977 0.732 . . . . 25.0 112.977 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.55 152.42 20.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.084 -1.821 . . . . 25.0 106.084 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -141.49 149.37 40.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.171 0.434 . . . . 25.0 112.171 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -66.01 146.24 54.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.37 -1.344 . . . . 25.0 107.37 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.58 108.95 0.56 Allowed Glycine 0 C--O 1.219 -0.803 0 C-N-CA 120.691 -0.766 . . . . 25.0 114.462 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.35 152.54 38.0 Favored Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 122.286 -0.537 . . . . 25.0 111.4 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.05 -17.65 16.92 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 128.824 0.76 . . . . 25.0 113.188 -1.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -162.27 -33.1 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 116.238 -0.437 . . . . 25.0 111.537 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 t 59.51 -85.69 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.073 0.949 . . . . 25.0 111.829 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.62 -154.99 19.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.449 -0.661 . . . . 25.0 111.449 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.21 167.1 26.0 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.19 1.495 . . . . 25.0 111.583 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.02 115.83 16.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.491 -0.559 . . . . 25.0 109.491 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -146.58 179.47 7.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 105.857 -1.905 . . . . 25.0 105.857 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.74 -2.09 69.96 Favored Glycine 0 C--N 1.324 -0.135 0 CA-C-O 121.951 0.75 . . . . 25.0 111.252 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -73.54 -1.93 20.64 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.158 0.504 . . . . 25.0 111.885 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.92 -38.61 82.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.243 -1.021 . . . . 25.0 108.243 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.67 -23.96 60.96 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.604 0.594 . . . . 25.0 112.604 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.7 p -95.39 2.48 54.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.612 0.244 . . . . 25.0 111.062 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.18 -0.56 0.84 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.238 1.415 . . . . 25.0 113.336 -173.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.33 -31.54 71.57 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 121.06 -0.591 . . . . 25.0 111.724 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.5 -17.2 80.23 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 121.047 -0.597 . . . . 25.0 112.305 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.3 mt -72.26 -25.97 61.81 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.704 . . . . 25.0 110.291 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.561 -0.533 . . . . 25.0 109.561 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -24.99 69.5 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.926 -0.869 . . . . 25.0 110.926 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.86 -16.9 68.81 Favored Glycine 0 C--O 1.228 -0.26 0 O-C-N 122.774 -0.251 . . . . 25.0 112.536 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mm -66.16 -40.1 86.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mp -75.81 -26.89 57.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 25.0 111.15 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.78 -22.01 66.7 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.149 0.5 . . . . 25.0 111.589 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.73 -5.93 18.48 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.865 -0.522 . . . . 25.0 112.156 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -130.65 35.15 4.04 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -106.62 156.54 18.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 25.0 111.101 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -68.66 -31.02 69.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.811 -0.811 . . . . 25.0 108.811 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -97.48 21.39 10.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.564 -0.744 . . . . 25.0 110.409 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -52.31 136.1 31.51 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.057 0.456 . . . . 25.0 111.5 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 146.03 46.44 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 122.686 1.231 . . . . 25.0 112.33 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -75.7 148.78 38.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.383 -1.28 . . . . 25.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -103.03 126.87 50.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -100.1 108.79 21.03 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.182 -0.607 . . . . 25.0 109.658 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.55 138.6 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.67 -0.863 . . . . 25.0 108.67 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.4 tpt -151.04 154.09 36.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.202 -0.666 . . . . 25.0 109.202 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.2 p -91.16 -179.48 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.838 -1.171 . . . . 25.0 107.838 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.45 -168.88 31.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 116.445 1.338 . . . . 25.0 116.445 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.92 170.72 36.92 Favored Glycine 0 C--N 1.329 0.162 0 N-CA-C 108.864 -1.694 . . . . 25.0 108.864 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.77 148.3 28.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 119.309 1.555 . . . . 25.0 108.477 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -134.19 157.96 44.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.611 -1.255 . . . . 25.0 107.611 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -124.95 125.74 44.39 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.46 140.89 48.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.189 -1.041 . . . . 25.0 108.189 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -132.58 132.42 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.608 0.568 . . . . 25.0 111.993 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -118.47 150.06 40.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.0 p -133.84 161.71 34.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.99 158.11 42.32 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.867 -1.531 . . . . 25.0 106.867 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 t -69.83 -27.02 64.51 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.347 0.499 . . . . 25.0 112.347 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.13 61.17 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 106.684 -1.598 . . . . 25.0 106.684 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.39 152.03 65.82 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 115.956 -2.229 . . . . 25.0 110.038 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.15 147.57 52.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -61.03 137.01 58.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 m -146.16 144.66 30.09 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.9 t -91.56 -48.03 7.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.487 -0.56 . . . . 25.0 109.487 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -166.2 169.65 14.11 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.298 -0.251 . . . . 25.0 111.369 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -141.9 141.0 32.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 166.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.8 156.42 42.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.605 -0.27 . . . . 25.0 110.84 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -130.67 142.94 50.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.809 -0.632 . . . . 25.0 111.535 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -132.3 164.96 25.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.9 pt -130.31 157.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.9 p -96.71 133.63 41.0 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-O 121.148 0.499 . . . . 25.0 111.273 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -92.22 99.57 12.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.627 0.727 . . . . 25.0 111.98 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -76.16 148.14 38.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.407 -1.331 . . . . 25.0 107.407 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 22.19 40.32 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 115.579 0.992 . . . . 25.0 115.579 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -56.93 148.74 20.31 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.686 0.743 . . . . 25.0 111.705 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.96 138.79 46.2 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.204 -1.036 . . . . 25.0 108.204 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.98 -15.91 29.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 117.617 -1.122 . . . . 25.0 112.261 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.15 -22.06 64.88 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.023 0.929 . . . . 25.0 111.577 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -113.75 153.79 45.89 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.944 -0.571 . . . . 25.0 109.55 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.08 107.03 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 117.987 -0.876 . . . . 25.0 113.633 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -52.72 -46.87 67.57 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.193 -0.912 . . . . 25.0 112.742 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -54.35 -38.48 66.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.184 -0.462 . . . . 25.0 112.094 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.71 -44.28 23.88 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.894 -0.594 . . . . 25.0 111.944 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.43 -24.69 62.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.765 1.394 . . . . 25.0 114.765 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -68.07 -23.81 65.0 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.812 1.412 . . . . 25.0 114.812 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -123.02 135.18 54.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.003 -1.061 . . . . 25.0 112.508 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -128.15 133.11 48.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.464 -0.939 . . . . 25.0 108.464 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.11 120.56 23.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.708 -0.849 . . . . 25.0 108.708 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.2 tt -96.3 -10.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.478 0.656 . . . . 25.0 110.094 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.05 160.27 13.1 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.323 -0.942 . . . . 25.0 113.935 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.69 146.71 29.38 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.096 -1.075 . . . . 25.0 108.096 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -135.25 106.84 10.23 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.09 160.57 39.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 114.902 -2.932 . . . . 25.0 110.743 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -118.51 94.19 4.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.395 1.093 . . . . 25.0 108.804 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.17 -94.71 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.033 -2.951 . . . . 25.0 103.033 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.26 128.54 9.6 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.3 t -163.49 145.07 7.44 Favored Pre-proline 0 C--O 1.242 0.708 0 CA-C-N 117.159 0.48 . . . . 25.0 109.959 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -76.08 -154.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.516 1.477 . . . . 25.0 110.744 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -18.84 4.47 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.129 1.529 . . . . 25.0 115.129 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.6 t -66.87 -6.73 17.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.825 0.676 . . . . 25.0 112.825 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.92 -14.87 63.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.423 0.689 . . . . 25.0 110.807 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -66.59 150.66 48.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.495 0.664 . . . . 25.0 112.205 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.06 -12.51 60.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.182 -0.917 . . . . 25.0 110.209 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -89.68 120.81 31.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.231 -1.766 . . . . 25.0 106.231 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -135.07 134.15 40.05 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.277 0.473 . . . . 25.0 112.277 -173.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -82.28 139.31 34.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.812 -0.631 . . . . 25.0 109.973 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.19 121.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 106.395 -1.706 . . . . 25.0 106.395 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -80.65 135.36 36.02 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.036 -0.728 . . . . 25.0 109.036 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.0 mm -122.94 117.85 28.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.47 158.05 51.85 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 115.947 -2.235 . . . . 25.0 110.577 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -112.35 51.65 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.948 -1.501 . . . . 25.0 106.948 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.29 -26.01 16.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.039 -0.982 . . . . 25.0 111.731 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -158.09 160.13 37.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.301 . . . . 25.0 110.782 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 pt? -100.13 137.54 38.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 172.26 144.53 4.57 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 122.348 0.971 . . . . 25.0 115.453 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -95.72 144.96 25.67 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 112.664 0.616 . . . . 25.0 112.664 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -148.95 163.57 37.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.369 -0.974 . . . . 25.0 108.369 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.1 t -93.43 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.384 -0.969 . . . . 25.0 108.384 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.04 129.22 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 105.893 -1.892 . . . . 25.0 105.893 171.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.32 141.86 45.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.001 -1.852 . . . . 25.0 106.001 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.36 143.99 40.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.716 -0.475 . . . . 25.0 109.716 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.07 135.11 62.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.442 -0.948 . . . . 25.0 108.442 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -126.08 118.5 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -111.76 134.62 53.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.949 0.351 . . . . 25.0 111.949 -173.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.28 128.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.781 -1.563 . . . . 25.0 106.781 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -31.17 65.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 25.0 111.533 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -75.26 -2.03 26.19 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.0 p -123.01 155.01 37.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.748 0.785 . . . . 25.0 112.699 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -83.24 -6.36 59.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.124 -0.695 . . . . 25.0 109.124 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -109.25 153.83 23.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.2 -0.909 . . . . 25.0 109.544 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.86 150.63 51.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -119.66 135.81 54.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.037 0.446 . . . . 25.0 111.239 -168.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -127.09 153.88 45.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -146.19 156.18 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.69 138.78 48.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.585 . . . . 25.0 109.422 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.5 mt -140.04 121.43 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.66 140.52 29.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.703 -0.851 . . . . 25.0 108.703 174.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.78 157.56 42.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -128.81 118.58 23.0 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 104.293 -2.484 . . . . 25.0 104.293 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.7 mt -108.25 121.91 45.86 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 104.627 -2.36 . . . . 25.0 104.627 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 18.7 m -130.86 160.4 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.12 1.155 . . . . 25.0 114.12 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -95.13 157.51 15.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.307 -1.738 . . . . 25.0 106.307 174.461 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.9 tptt . . . . . 0 C--O 1.251 1.139 0 O-C-N 124.297 0.998 . . . . 25.0 110.83 174.601 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 82.4 m-70 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 119.605 -0.236 . . . . 25.0 110.894 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.83 -169.28 40.08 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.13 -0.557 . . . . 25.0 113.911 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -150.96 170.96 18.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.173 0.589 . . . . 25.0 109.431 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 tt -106.86 131.86 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.074 0.464 . . . . 25.0 110.245 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -85.15 -47.94 9.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.266 1.031 . . . . 25.0 111.054 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.21 149.69 56.04 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.771 -1.104 . . . . 25.0 108.552 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.17 98.59 0.23 Allowed 'Cis proline' 0 CA--C 1.545 1.041 0 C-N-CA 131.498 1.874 . . . . 25.0 114.52 -1.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.9 138.82 7.26 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 121.657 0.587 . . . . 25.0 113.593 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 t -68.21 145.53 54.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.612 0.72 . . . . 25.0 112.71 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.385 -0.825 . . . . 25.0 110.248 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -26.43 68.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.291 0.848 . . . . 25.0 113.291 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.76 88.71 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 112.079 0.4 . . . . 25.0 112.079 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.92 -3.92 55.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.579 0.704 . . . . 25.0 111.605 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 t -87.31 -21.69 25.58 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.335 -0.848 . . . . 25.0 109.84 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.2 t -73.47 133.0 43.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.669 -0.493 . . . . 25.0 109.669 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -65.48 -30.15 70.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.379 0.609 . . . . 25.0 110.432 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.48 -17.39 63.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.005 -0.543 . . . . 25.0 112.179 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -79.95 -15.84 56.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.776 -0.577 . . . . 25.0 110.935 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.51 7.34 10.45 Favored Glycine 0 C--N 1.328 0.102 0 N-CA-C 110.02 -1.232 . . . . 25.0 110.02 174.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.0 t80 61.96 -60.95 0.11 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.775 2.03 . . . . 25.0 114.803 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.9 mt -108.5 -4.22 17.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.691 0.396 . . . . 25.0 111.582 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -137.57 159.46 41.91 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.236 0.458 . . . . 25.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.1 157.62 45.64 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.517 -1.66 . . . . 25.0 106.517 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.41 26.53 9.53 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.125 0.488 . . . . 25.0 111.02 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.99 -21.23 31.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.694 0.628 . . . . 25.0 112.694 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.86 -179.59 30.74 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.747 -0.66 . . . . 25.0 112.636 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 p -66.24 -14.01 61.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.301 0.572 . . . . 25.0 110.919 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t -61.17 -18.44 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.286 0.634 . . . . 25.0 110.695 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.33 -14.21 10.82 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 115.3 1.593 . . . . 25.0 115.3 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -71.47 -37.72 71.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.427 0.558 . . . . 25.0 110.111 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.81 68.26 10.62 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 121.64 0.733 . . . . 25.0 111.797 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.91 -8.97 23.14 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 117.541 -1.173 . . . . 25.0 112.829 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -83.77 -9.9 58.47 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.718 -0.475 . . . . 25.0 109.718 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 t -81.37 104.15 11.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.462 0.649 . . . . 25.0 110.037 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.6 mt -122.91 74.02 1.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.494 -0.775 . . . . 25.0 109.325 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -142.02 135.68 29.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.664 0.386 . . . . 25.0 111.142 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.51 32.54 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -103.53 147.37 27.26 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.047 -0.408 . . . . 25.0 109.954 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -60.25 153.43 22.38 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.876 0.369 . . . . 25.0 111.791 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.79 -158.03 9.06 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.707 -0.957 . . . . 25.0 110.707 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -88.53 144.18 33.26 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -96.37 -2.37 34.39 Favored 'Cis proline' 0 CA--C 1.534 0.498 0 C-N-CA 130.681 1.534 . . . . 25.0 115.264 -0.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.4 t60 67.1 -32.59 0.19 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.807 1.643 . . . . 25.0 114.188 -172.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.7 m -83.6 -14.13 52.76 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.515 1.302 . . . . 25.0 114.515 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.2 165.62 12.85 Favored Glycine 0 N--CA 1.46 0.254 0 C-N-CA 121.161 -0.543 . . . . 25.0 112.427 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.41 -27.11 13.59 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 118.737 1.268 . . . . 25.0 113.262 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.9 132.83 42.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.367 -1.716 . . . . 25.0 106.367 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -135.86 142.17 44.74 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.19 -1.041 . . . . 25.0 108.19 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.45 -32.38 3.11 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.911 1.125 . . . . 25.0 115.911 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -105.16 34.16 3.34 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.787 1.294 . . . . 25.0 112.726 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mm -63.39 -36.9 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.666 0.617 . . . . 25.0 112.666 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.03 -38.27 72.92 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.32 0.859 . . . . 25.0 113.32 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.9 p -102.47 -8.54 20.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.432 -0.168 . . . . 25.0 110.963 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.27 19.98 3.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.622 1.169 . . . . 25.0 112.107 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.8 1.93 84.8 Favored Glycine 0 C--O 1.217 -0.934 0 N-CA-C 115.745 1.058 . . . . 25.0 115.745 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.68 -35.13 84.99 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 117.92 0.86 . . . . 25.0 114.092 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.13 -37.99 13.03 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.137 -0.625 . . . . 25.0 111.897 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -84.77 -13.72 50.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.692 0.997 . . . . 25.0 113.692 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.4 -15.92 64.32 Favored Glycine 0 C--O 1.216 -1.024 0 C-N-CA 121.496 -0.383 . . . . 25.0 112.87 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.15 -24.34 68.71 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.654 -0.784 . . . . 25.0 112.843 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -66.67 -41.54 88.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -72.15 -29.37 63.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.041 -0.527 . . . . 25.0 110.537 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.44 -19.78 65.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.282 0.475 . . . . 25.0 112.282 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -66.29 -11.8 52.68 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.046 -0.409 . . . . 25.0 111.082 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -137.86 64.91 1.5 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.582 -1.266 . . . . 25.0 107.582 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.5 t -135.75 159.58 41.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.318 -0.401 . . . . 25.0 110.742 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.75 -32.33 72.86 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.984 0.897 . . . . 25.0 109.488 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -96.88 22.04 8.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.438 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -49.59 134.5 19.68 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.946 0.879 . . . . 25.0 112.916 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.12 154.81 38.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.906 -1.043 . . . . 25.0 112.678 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -80.49 129.53 34.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.792 -0.818 . . . . 25.0 108.792 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 152.79 21.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.929 0.395 . . . . 25.0 111.746 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.78 100.35 6.14 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.534 0.334 . . . . 25.0 110.694 174.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.9 mt -78.52 131.02 35.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.149 -1.056 . . . . 25.0 108.149 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.3 mtm -143.32 163.81 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.263 0.625 . . . . 25.0 110.309 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.3 p -93.14 -179.46 5.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.958 -1.867 . . . . 25.0 105.958 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.9 30.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.778 -0.725 . . . . 25.0 111.319 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.73 -160.76 16.99 Favored Glycine 0 CA--C 1.517 0.171 0 O-C-N 122.269 -0.548 . . . . 25.0 114.053 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.59 137.56 38.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.946 0.403 . . . . 25.0 111.425 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -132.6 139.95 48.02 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.013 -0.736 . . . . 25.0 109.013 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.2 m -120.35 111.43 17.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -93.15 116.37 28.97 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.0 m -119.28 93.47 4.09 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.149 -0.686 . . . . 25.0 109.149 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -89.06 133.59 34.3 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.884 -1.525 . . . . 25.0 106.884 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -123.77 136.62 54.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -126.4 148.57 49.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 120.985 0.422 . . . . 25.0 110.308 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -120.64 31.35 6.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.623 -1.992 . . . . 25.0 105.623 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.66 125.08 91.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 114.619 -1.173 . . . . 25.0 109.43 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.08 26.39 0.65 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 120.227 0.618 . . . . 25.0 112.615 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -130.9 149.48 52.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 25.0 111.495 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -69.78 156.42 39.05 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.21 -0.663 . . . . 25.0 109.21 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -123.03 149.53 44.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.049 -1.834 . . . . 25.0 106.049 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -93.95 -56.85 2.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.074 0.464 . . . . 25.0 110.501 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -161.63 173.77 14.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.815 -0.439 . . . . 25.0 109.815 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.32 152.69 39.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.735 -0.666 . . . . 25.0 109.698 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -146.73 141.82 27.17 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -140.83 149.12 41.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.836 0.827 . . . . 25.0 112.53 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.07 160.51 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.617 -1.174 . . . . 25.0 109.397 -172.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.5 158.88 42.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.314 -0.995 . . . . 25.0 108.314 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.419 ' CG2' ' H ' ' A' ' 147' ' ' VAL . 1.1 t -96.86 126.96 42.38 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 113.227 0.825 . . . . 25.0 113.227 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -99.47 103.33 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.644 -1.243 . . . . 25.0 107.644 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -70.91 152.36 43.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.13 10.08 24.8 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.731 -0.483 . . . . 25.0 113.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -62.02 153.81 28.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.76 0.79 . . . . 25.0 109.817 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.54 151.29 85.03 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.03 -11.35 27.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 113.499 0.538 . . . . 25.0 113.499 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -74.46 -6.16 46.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.544 0.687 . . . . 25.0 111.511 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -105.07 135.82 19.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 121.812 -0.555 . . . . 25.0 111.161 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.89 123.21 10.42 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.588 -1.141 . . . . 25.0 113.002 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -52.62 -49.41 65.16 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 114.415 1.265 . . . . 25.0 114.415 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -64.72 -11.05 31.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.746 1.017 . . . . 25.0 113.746 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -104.69 -48.96 3.64 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 112.231 0.456 . . . . 25.0 112.231 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.81 -22.46 58.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 -170.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.16 -28.77 67.58 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.535 -0.466 . . . . 25.0 111.895 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -124.6 144.89 49.91 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -126.7 144.29 50.97 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.998 0.428 . . . . 25.0 110.516 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.39 126.79 30.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.6 tp -115.21 1.82 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 121.997 0.904 . . . . 25.0 109.027 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.55 156.08 9.03 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 115.838 1.095 . . . . 25.0 115.838 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.62 128.04 16.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.1 t -140.5 123.09 9.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.568 0.347 . . . . 25.0 110.336 -170.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.7 168.58 20.9 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 117.191 -1.406 . . . . 25.0 111.973 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -82.65 121.0 26.28 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.891 -0.723 . . . . 25.0 111.987 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.77 33.14 22.86 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.92 1.822 . . . . 25.0 115.92 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.43 165.12 44.11 Favored Glycine 0 C--O 1.219 -0.84 0 N-CA-C 110.968 -0.853 . . . . 25.0 110.968 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.3 t -54.9 -47.41 98.42 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 117.3 2.333 . . . . 25.0 117.3 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.08 159.82 49.03 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 114.17 -3.42 . . . . 25.0 114.648 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.75 -14.23 20.02 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.817 1.043 . . . . 25.0 113.817 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.7 p -68.88 -10.47 57.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.802 0.297 . . . . 25.0 111.802 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.64 -16.89 29.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.424 1.268 . . . . 25.0 114.424 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.55 141.51 58.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.334 0.587 . . . . 25.0 111.625 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 tp -72.21 -25.42 61.64 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.439 -0.948 . . . . 25.0 108.439 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.9 t -89.23 134.04 34.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -138.86 150.92 46.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.619 0.723 . . . . 25.0 112.658 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -92.53 132.89 36.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.239 -1.022 . . . . 25.0 108.239 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.1 mm -132.62 119.15 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.242 -1.021 . . . . 25.0 108.242 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -82.27 139.47 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.253 -1.017 . . . . 25.0 108.253 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -125.93 128.22 24.58 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.64 167.33 26.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 CA-C-N 118.566 0.524 . . . . 25.0 111.592 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -122.91 30.51 6.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.655 0.741 . . . . 25.0 111.523 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -78.37 -20.72 50.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.993 -0.548 . . . . 25.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -143.35 169.84 16.91 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.665 -0.495 . . . . 25.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 150.41 47.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.832 -0.622 . . . . 25.0 109.545 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.08 165.5 12.62 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.469 0.547 . . . . 25.0 114.469 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 40.2 p90 -86.94 147.21 25.86 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.744 1.016 . . . . 25.0 113.744 -176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -139.65 158.92 43.31 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.525 -1.216 . . . . 25.0 108.001 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.419 ' H ' ' CG2' ' A' ' 100' ' ' THR . 52.8 t -116.41 136.54 53.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.3 mt -106.49 129.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.001 -1.851 . . . . 25.0 106.001 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.25 135.58 50.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.926 -0.398 . . . . 25.0 109.926 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.0 130.18 31.07 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.614 -0.266 . . . . 25.0 110.721 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.79 128.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 106.299 -1.741 . . . . 25.0 106.299 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -125.64 108.67 11.78 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -96.17 107.72 20.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.978 -0.556 . . . . 25.0 112.327 -171.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.47 135.46 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.514 -1.291 . . . . 25.0 107.514 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.01 -32.23 27.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 25.0 111.849 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -79.28 -12.68 59.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.733 1.383 . . . . 25.0 114.733 -170.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.0 p -139.21 165.8 26.22 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.166 0.802 . . . . 25.0 113.166 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.61 5.2 16.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.546 0.689 . . . . 25.0 110.756 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -102.79 150.08 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.908 -1.145 . . . . 25.0 107.908 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.23 170.55 21.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 102.544 -3.132 . . . . 25.0 102.544 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.444 ' HB3' HE22 ' A' ' 163' ' ' GLN . 23.7 t80 -143.48 151.83 40.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.765 1.166 . . . . 25.0 113.411 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.93 120.5 41.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.444 HE22 ' HB3' ' A' ' 161' ' ' PHE . 19.9 mm-40 -94.53 130.82 40.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.99 -2.226 . . . . 25.0 104.99 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.5 p -133.11 133.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.824 -0.806 . . . . 25.0 108.824 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.35 128.69 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -85.3 133.03 34.17 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.789 -0.819 . . . . 25.0 108.789 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 149.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 36.3 t0 -120.41 111.11 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.625 -1.991 . . . . 25.0 105.625 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.0 mt -109.18 104.63 13.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.72 168.02 19.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.129 -0.487 . . . . 25.0 111.92 -173.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -80.78 135.97 36.05 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.9 pttm . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.344 -1.313 . . . . 25.0 111.287 176.112 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 119.225 -0.417 . . . . 25.0 111.031 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.33 -163.36 15.72 Favored Glycine 0 N--CA 1.46 0.294 0 N-CA-C 110.529 -1.029 . . . . 25.0 110.529 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -98.24 149.77 22.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.798 -0.816 . . . . 25.0 108.798 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -102.32 126.77 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 122.427 0.291 . . . . 25.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -103.47 -34.3 8.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.684 0.754 . . . . 25.0 111.054 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.27 143.01 16.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.0 137.63 50.79 Favored 'Cis proline' 0 C--N 1.352 0.736 0 N-CA-C 117.863 2.216 . . . . 25.0 117.863 2.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 137.12 2.94 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 117.388 1.715 . . . . 25.0 117.388 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -76.17 147.98 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.116 0.484 . . . . 25.0 111.249 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -68.22 -37.96 81.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.669 . . . . 25.0 111.602 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.83 66.42 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.67 -28.02 69.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.255 0.465 . . . . 25.0 112.255 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.94 -9.16 44.11 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 111.85 0.315 . . . . 25.0 111.85 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.4 t -78.84 -16.15 57.45 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.251 0.548 . . . . 25.0 110.839 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.0 t -77.74 144.29 37.33 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 121.885 -0.509 . . . . 25.0 109.916 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -64.1 -20.3 65.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.188 0.518 . . . . 25.0 109.738 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.5 -13.11 18.33 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.475 0.546 . . . . 25.0 112.475 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -78.62 -8.94 59.16 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.225 -0.297 . . . . 25.0 111.157 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.36 -4.8 0.02 OUTLIER Glycine 0 CA--C 1.521 0.423 0 N-CA-C 120.067 2.787 . . . . 25.0 120.067 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.6 t80 64.11 -40.64 0.24 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 117.558 2.429 . . . . 25.0 117.558 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.3 mt -103.77 0.61 30.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.254 0.55 . . . . 25.0 111.002 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -80.91 177.23 9.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.757 -0.656 . . . . 25.0 109.419 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.04 155.56 37.13 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.512 -1.662 . . . . 25.0 106.512 175.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.14 15.45 0.07 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.725 1.75 . . . . 25.0 115.725 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.3 t -176.63 -34.21 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.081 0.952 . . . . 25.0 110.019 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.1 132.37 7.38 Favored Glycine 0 C--O 1.221 -0.659 0 CA-C-N 115.444 -0.798 . . . . 25.0 112.514 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.6 t -67.73 -28.65 67.83 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.403 0.62 . . . . 25.0 112.484 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -57.54 -15.38 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.749 1.018 . . . . 25.0 113.749 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -68.63 -14.26 62.9 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.156 -0.965 . . . . 25.0 112.957 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.64 -37.64 49.58 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.87 -0.332 . . . . 25.0 111.68 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -149.63 63.58 6.54 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.115 1.154 . . . . 25.0 114.115 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.28 -9.15 25.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 118.096 -0.803 . . . . 25.0 114.083 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -97.82 -0.19 45.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.241 0.46 . . . . 25.0 112.241 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -87.3 94.13 9.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.764 -1.199 . . . . 25.0 107.764 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -129.78 133.43 46.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -125.9 131.89 52.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.444 0.566 . . . . 25.0 109.731 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.01 163.53 32.45 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.98 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -73.95 175.14 7.64 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.973 0.731 . . . . 25.0 112.973 -176.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.92 141.34 22.18 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.99 0.737 . . . . 25.0 112.99 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.59 18.66 15.03 Favored Glycine 0 C--O 1.225 -0.451 0 CA-C-N 115.651 -0.704 . . . . 25.0 113.539 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -89.93 132.29 36.78 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.599 -0.889 . . . . 25.0 108.599 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.99 143.48 73.54 Favored 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 130.825 1.594 . . . . 25.0 113.747 -2.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -68.09 -14.24 62.83 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.891 1.071 . . . . 25.0 113.891 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -80.99 -12.28 59.41 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.131 -0.486 . . . . 25.0 111.222 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.35 179.0 43.37 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 120.885 -0.674 . . . . 25.0 114.48 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.11 -173.38 1.76 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.726 2.284 . . . . 25.0 110.29 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.18 123.58 19.0 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.737 -0.385 . . . . 25.0 110.24 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -100.05 -178.85 3.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.14 0.495 . . . . 25.0 111.011 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.82 3.04 87.27 Favored Glycine 0 C--N 1.328 0.108 0 CA-C-O 121.122 0.29 . . . . 25.0 112.636 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -142.71 4.51 1.52 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.367 0.506 . . . . 25.0 112.367 -173.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.01 -36.01 59.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.968 0.729 . . . . 25.0 112.968 -170.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.3 -39.71 64.21 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.878 1.066 . . . . 25.0 113.878 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 m -112.88 -16.65 12.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.675 0.991 . . . . 25.0 113.675 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 54.86 36.04 25.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.627 0.771 . . . . 25.0 109.864 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.06 -16.67 80.51 Favored Glycine 0 C--O 1.222 -0.632 0 N-CA-C 115.526 0.971 . . . . 25.0 115.526 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.45 -21.14 70.34 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 118.014 0.907 . . . . 25.0 113.588 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -62.1 -45.9 91.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.925 0.869 . . . . 25.0 109.534 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -84.87 -13.19 51.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.49 -0.777 . . . . 25.0 110.598 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.34 86.18 Favored Glycine 0 C--O 1.216 -0.989 0 CA-C-N 116.072 -0.513 . . . . 25.0 112.475 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.64 77.63 Favored Glycine 0 C--O 1.222 -0.607 0 C-N-CA 120.358 -0.925 . . . . 25.0 112.493 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.51 -43.82 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.54 -34.42 75.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.722 -0.672 . . . . 25.0 110.689 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.42 -30.66 70.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -68.04 -6.05 20.62 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.604 -0.685 . . . . 25.0 111.921 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -130.3 37.5 3.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.34 -0.615 . . . . 25.0 109.34 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -120.42 169.54 10.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 25.0 109.794 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.99 -28.1 68.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.495 0.664 . . . . 25.0 109.983 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -96.18 19.99 10.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.621 -0.718 . . . . 25.0 111.438 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -49.75 135.58 18.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.602 0.715 . . . . 25.0 111.536 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -87.76 154.75 20.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.057 0.932 . . . . 25.0 110.428 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -66.41 147.14 53.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 25.0 110.152 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -116.22 132.32 56.7 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.468 -0.938 . . . . 25.0 108.468 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -119.9 135.89 54.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.99 136.29 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.29 -1.745 . . . . 25.0 106.29 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.1 ttt -150.59 168.14 25.17 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.236 -1.765 . . . . 25.0 106.236 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.8 p -90.52 166.7 13.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.79 -1.93 . . . . 25.0 105.79 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.25 -164.28 10.65 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 117.925 0.33 . . . . 25.0 113.667 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.06 -175.77 31.24 Favored Glycine 0 N--CA 1.458 0.114 0 O-C-N 122.348 -0.501 . . . . 25.0 112.2 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 15.0 tt0 -69.73 134.65 48.86 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.754 -0.85 . . . . 25.0 109.444 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -125.59 158.23 35.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.561 -0.903 . . . . 25.0 108.561 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.0 m -117.63 116.28 26.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.898 -1.89 . . . . 25.0 105.898 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -93.01 136.87 32.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 105.901 -1.889 . . . . 25.0 105.901 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -127.62 115.53 18.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 25.0 110.469 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -122.3 145.2 48.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.387 -2.449 . . . . 25.0 104.387 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -145.02 156.74 44.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 25.0 109.622 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -139.82 154.45 47.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -71.42 -13.25 61.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.398 0.888 . . . . 25.0 113.398 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.12 158.34 64.72 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.275 -1.009 . . . . 25.0 108.275 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.16 150.86 72.36 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 114.581 -3.146 . . . . 25.0 109.594 170.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -130.98 132.81 45.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.361 -0.978 . . . . 25.0 108.361 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -66.05 144.89 56.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 25.0 109.689 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -162.92 152.07 15.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.368 -3.197 . . . . 25.0 102.368 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 -40.13 10.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.715 0.769 . . . . 25.0 108.946 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -156.1 148.96 24.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.799 -0.815 . . . . 25.0 108.799 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.59 142.31 39.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.32 -1.363 . . . . 25.0 107.32 170.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 156.33 42.69 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.394 -0.191 . . . . 25.0 110.723 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -130.52 144.94 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.642 0.589 . . . . 25.0 111.3 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -131.96 159.7 37.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.021 -1.844 . . . . 25.0 106.021 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.447 HD12 ' HB ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -135.96 158.1 38.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.423 -0.954 . . . . 25.0 108.423 175.065 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.9 p -103.23 138.69 39.69 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.489 0.661 . . . . 25.0 110.942 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.0 117.72 27.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.98 128.36 34.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 102.575 -3.121 . . . . 25.0 102.575 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.67 30.67 12.75 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 118.856 -1.64 . . . . 25.0 113.611 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -51.77 148.16 5.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.688 0.744 . . . . 25.0 110.172 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -68.97 129.43 92.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.998 -0.547 . . . . 25.0 110.22 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.22 -14.03 25.7 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 118.484 -0.544 . . . . 25.0 113.451 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.5 -10.23 59.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.778 0.799 . . . . 25.0 110.808 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -116.55 148.99 43.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.558 -0.534 . . . . 25.0 109.558 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.2 125.93 15.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 116.616 -1.79 . . . . 25.0 112.059 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 tt -52.99 -50.43 64.16 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.079 -0.964 . . . . 25.0 113.158 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -68.55 -2.96 10.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.748 1.388 . . . . 25.0 114.748 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.86 -49.33 3.53 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.138 0.494 . . . . 25.0 111.703 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.06 50.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.186 1.55 . . . . 25.0 115.186 -170.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -77.63 -29.05 51.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.479 0.548 . . . . 25.0 112.479 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -126.01 151.12 47.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.694 0.628 . . . . 25.0 112.694 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.11 154.66 47.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.71 128.04 33.98 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.098 -0.704 . . . . 25.0 109.098 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.447 ' HB ' HD12 ' A' ' 99' ' ' ILE . 10.0 tt -104.25 -9.47 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.297 0.57 . . . . 25.0 111.609 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.92 160.12 21.62 Favored Glycine 0 CA--C 1.511 -0.197 0 C-N-CA 119.86 -1.162 . . . . 25.0 114.33 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.55 142.03 25.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.779 -1.193 . . . . 25.0 107.779 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.32 111.62 10.84 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.78 163.96 25.85 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 116.013 -2.192 . . . . 25.0 111.299 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -138.45 113.88 9.6 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.219 1.009 . . . . 25.0 109.276 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -172.44 -107.2 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 99.111 -4.403 . . . . 25.0 99.111 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.53 54.19 4.9 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.377 -1.089 . . . . 25.0 110.377 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 t -81.99 132.88 52.57 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 122.382 -0.481 . . . . 25.0 110.245 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.08 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 121.691 1.594 . . . . 25.0 111.423 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -21.06 8.42 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.9 t -64.71 -8.0 12.99 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -62.56 -14.16 39.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.282 1.215 . . . . 25.0 114.282 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.17 137.8 58.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -20.33 63.75 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -99.97 132.99 44.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -137.43 149.82 47.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -81.66 133.31 35.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.408 -1.701 . . . . 25.0 106.408 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.98 118.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.552 -2.018 . . . . 25.0 105.552 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 49.6 t80 -84.57 125.67 32.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.14 104.28 25.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 120.508 0.194 . . . . 25.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.63 150.9 51.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 116.027 -2.182 . . . . 25.0 109.486 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.2 102.75 3.26 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.496 -0.557 . . . . 25.0 109.496 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -91.73 -17.93 24.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.489 0.552 . . . . 25.0 112.489 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -140.93 169.91 16.74 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.41 128.97 36.64 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.751 -1.203 . . . . 25.0 107.751 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -179.36 163.37 30.77 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.202 2.041 . . . . 25.0 118.202 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 19.6 p90 -87.09 147.04 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.64 -1.28 . . . . 25.0 110.384 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -134.94 150.41 50.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.06 127.97 67.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.038 -2.208 . . . . 25.0 105.038 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.96 116.85 53.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.487 -1.672 . . . . 25.0 106.487 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.1 tt -99.09 133.63 43.08 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.665 -1.235 . . . . 25.0 107.665 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -122.85 145.77 48.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.89 0.376 . . . . 25.0 110.069 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.7 t -126.57 134.05 67.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.013 -1.106 . . . . 25.0 108.013 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -129.18 99.0 5.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.419 -1.326 . . . . 25.0 107.419 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.83 106.79 17.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.084 -0.507 . . . . 25.0 111.891 -173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.4 t -92.48 126.69 44.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.14 -2.17 . . . . 25.0 105.14 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.35 -13.52 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.419 -0.956 . . . . 25.0 108.419 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.43 -1.39 29.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.288 -1.324 . . . . 25.0 112.035 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.9 t -152.95 165.87 34.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.13 -25.02 67.58 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.764 1.024 . . . . 25.0 113.764 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -110.07 159.1 17.62 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.183 0.809 . . . . 25.0 113.183 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 163.86 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 104.639 -2.356 . . . . 25.0 104.639 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -108.94 127.93 54.49 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.774 -0.37 . . . . 25.0 111.047 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.95 137.76 53.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -148.96 166.05 29.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.74 -0.467 . . . . 25.0 109.74 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.97 150.98 31.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.339 -0.986 . . . . 25.0 108.339 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.09 118.44 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.905 -1.887 . . . . 25.0 105.905 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -92.21 134.2 35.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.473 0.654 . . . . 25.0 110.577 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.58 157.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -127.25 119.21 25.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.234 -2.136 . . . . 25.0 105.234 174.979 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.7 mt -119.86 132.38 55.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.097 0.475 . . . . 25.0 110.208 -170.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.91 163.57 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.904 -0.589 . . . . 25.0 110.969 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -78.08 158.28 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.325 -1.361 . . . . 25.0 107.325 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 116.609 -1.662 . . . . 25.0 107.799 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 121.559 0.695 . . . . 25.0 112.081 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.71 -179.0 27.91 Favored Glycine 0 C--O 1.236 0.261 1 N-CA-C 102.497 -4.241 . . . . 25.0 102.497 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.46 149.15 35.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 120.093 1.946 . . . . 25.0 113.103 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -94.84 120.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.143 -0.935 . . . . 25.0 109.996 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.92 -13.09 20.14 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.527 0.566 . . . . 25.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -162.7 142.81 7.29 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.84 126.61 12.95 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 130.373 1.406 . . . . 25.0 113.999 -1.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.81 51.21 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 111.276 -0.73 . . . . 25.0 111.276 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.2 t -141.29 136.47 31.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.634 -1.246 . . . . 25.0 107.634 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -67.28 -21.12 65.72 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.43 0.53 . . . . 25.0 112.43 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.14 80.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.132 0.492 . . . . 25.0 110.641 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.56 65.07 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 120.876 0.37 . . . . 25.0 110.639 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.92 -4.25 59.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.219 -0.446 . . . . 25.0 110.825 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -111.75 -11.52 13.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 25.0 110.078 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -77.42 134.98 38.27 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -78.55 -74.08 0.29 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 120.033 -0.667 . . . . 25.0 111.958 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.49 -53.02 2.45 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.554 1.687 . . . . 25.0 115.554 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -110.99 26.03 11.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.772 -1.104 . . . . 25.0 113.449 -166.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.76 34.5 9.06 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.022 -1.085 . . . . 25.0 111.231 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 t80 63.45 38.32 10.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.162 1.541 . . . . 25.0 115.162 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.14 -16.32 63.08 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.774 -0.825 . . . . 25.0 108.774 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -120.62 137.76 54.26 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.548 -1.649 . . . . 25.0 106.548 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.21 111.24 19.65 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.1 0.407 . . . . 25.0 112.1 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -148.45 46.59 1.05 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.487 -0.779 . . . . 25.0 111.931 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.8 t -145.32 7.03 1.14 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.475 0.655 . . . . 25.0 112.671 -175.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.29 172.49 37.56 Favored Glycine 0 C--O 1.217 -0.92 0 C-N-CA 120.95 -0.643 . . . . 25.0 113.082 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -78.99 -33.5 44.96 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -9.94 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 113.329 0.862 . . . . 25.0 113.329 -174.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -50.35 -22.05 1.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 117.742 2.497 . . . . 25.0 117.742 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -79.91 -35.96 37.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.459 -0.776 . . . . 25.0 112.045 -172.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.88 63.31 5.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.173 0.805 . . . . 25.0 113.173 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.28 -6.46 18.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 117.411 -1.26 . . . . 25.0 112.296 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -93.68 4.97 53.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 25.0 112.115 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -92.34 93.94 8.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.219 -1.03 . . . . 25.0 108.219 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.0 mt -116.47 104.95 11.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.686 -0.857 . . . . 25.0 108.686 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -129.9 146.17 51.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.947 0.404 . . . . 25.0 110.628 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.5 145.53 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.995 -0.743 . . . . 25.0 108.995 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -93.02 142.21 27.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.686 0.279 . . . . 25.0 110.417 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -71.47 135.51 47.19 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.246 -1.02 . . . . 25.0 108.246 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.73 143.4 3.72 Favored Glycine 0 C--O 1.225 -0.462 0 C-N-CA 121.065 -0.588 . . . . 25.0 112.987 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -90.05 151.92 45.6 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 122.573 -0.369 . . . . 25.0 110.574 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.88 -27.86 7.6 Favored 'Cis proline' 0 C--N 1.352 0.749 0 N-CA-C 113.463 0.524 . . . . 25.0 113.463 -1.179 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.3 p80 160.85 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 127.117 2.167 . . . . 25.0 106.759 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 m 64.65 -42.77 0.3 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.529 2.048 . . . . 25.0 116.529 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.01 -154.89 17.37 Favored Glycine 0 C--O 1.239 0.414 0 N-CA-C 109.192 -1.563 . . . . 25.0 109.192 172.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -67.18 -177.29 1.01 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 CA-C-N 119.787 1.793 . . . . 25.0 110.751 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.98 101.44 8.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.169 -1.789 . . . . 25.0 106.169 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -99.06 158.84 15.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.663 -0.698 . . . . 25.0 109.596 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.52 61.93 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.772 -0.728 . . . . 25.0 114.005 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -66.94 -9.36 37.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.0 -39.4 83.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 172.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.74 -32.26 67.55 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.166 0.508 . . . . 25.0 110.038 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -74.03 -6.39 47.18 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.089 -0.505 . . . . 25.0 110.597 175.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.51 20.0 7.12 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.202 1.401 . . . . 25.0 112.546 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.04 -24.71 28.84 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 109.771 -1.331 . . . . 25.0 109.771 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.52 -14.01 68.97 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 121.272 -0.49 . . . . 25.0 113.085 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.81 -43.89 94.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.532 0.682 . . . . 25.0 109.948 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -69.51 -25.52 64.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.626 -0.715 . . . . 25.0 111.468 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -31.83 72.64 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.836 -0.697 . . . . 25.0 111.52 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.53 72.17 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 120.952 -0.642 . . . . 25.0 112.891 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.95 -38.21 71.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.25 -43.89 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.997 0.427 . . . . 25.0 111.308 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.73 -4.44 37.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.863 1.06 . . . . 25.0 113.863 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -62.1 -13.4 26.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -133.88 82.8 2.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 171.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.4 t -145.74 152.22 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.344 -0.614 . . . . 25.0 109.344 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.03 -25.76 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.392 0.615 . . . . 25.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -97.18 7.34 46.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.973 -0.558 . . . . 25.0 111.424 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ARG . . . . . 0.438 ' HG2' ' H ' ' A' ' 70' ' ' TRP . 44.7 ttp180 -65.43 169.37 6.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.471 1.129 . . . . 25.0 110.219 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TRP . . . . . 0.438 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 20.7 p90 -91.37 165.94 13.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.103 -1.443 . . . . 25.0 107.103 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -76.12 151.87 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -121.14 123.21 41.75 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 106.078 -1.823 . . . . 25.0 106.078 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -118.82 126.09 51.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.315 0.487 . . . . 25.0 112.315 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.5 132.2 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.682 -0.858 . . . . 25.0 108.682 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttp -150.69 157.56 43.11 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 107.809 -1.182 . . . . 25.0 107.809 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.0 p -95.01 163.79 13.16 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.081 -0.387 . . . . 25.0 110.143 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.23 172.23 50.25 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.937 -0.649 . . . . 25.0 112.815 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.57 -166.2 12.36 Favored Glycine 0 C--O 1.228 -0.258 0 O-C-N 122.516 -0.402 . . . . 25.0 112.367 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -76.84 140.54 40.67 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.058 -0.672 . . . . 25.0 111.417 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -136.02 158.54 44.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.8 m -126.07 123.77 39.12 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -116.23 139.58 50.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.003 -1.11 . . . . 25.0 108.003 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 t -137.96 145.99 42.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.3 -1.37 . . . . 25.0 107.3 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -121.42 145.18 48.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.777 -1.564 . . . . 25.0 106.777 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -131.47 161.96 31.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.41 153.65 48.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.597 -1.26 . . . . 25.0 107.597 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.1 p -81.02 -11.89 59.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.934 0.346 . . . . 25.0 111.934 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.92 20.75 Favored Pre-proline 0 C--O 1.25 1.112 0 N-CA-C 110.371 -0.233 . . . . 25.0 110.371 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.07 129.54 14.29 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.725 -1.05 . . . . 25.0 110.959 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 23.5 p80 -131.14 158.69 39.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.97 -0.382 . . . . 25.0 109.97 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -81.74 157.48 24.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.039 -1.097 . . . . 25.0 108.039 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.3 m -139.31 140.17 37.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.1 t -88.5 -48.64 7.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.238 -1.393 . . . . 25.0 107.238 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.23 166.36 18.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.265 -0.642 . . . . 25.0 109.265 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -146.79 138.68 24.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.456 -1.683 . . . . 25.0 106.456 167.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.84 148.91 31.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 25.0 109.297 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -145.32 148.25 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.23 1.014 . . . . 25.0 113.289 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.77 168.94 17.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.384 -1.28 . . . . 25.0 107.734 -170.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.54 159.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 166.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -95.35 135.86 36.43 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -87.7 124.9 34.05 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.336 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -88.6 153.94 20.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.49 15.17 58.91 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.147 -1.502 . . . . 25.0 113.059 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -52.75 153.47 3.22 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.597 0.962 . . . . 25.0 113.597 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -75.79 130.59 78.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.78 -0.646 . . . . 25.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.92 -15.7 29.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 117.174 -1.417 . . . . 25.0 111.777 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.61 -21.77 65.39 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.309 1.043 . . . . 25.0 111.718 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -120.2 141.97 32.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 O-C-N 121.978 -0.451 . . . . 25.0 110.444 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.55 134.42 30.61 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 115.34 -2.64 . . . . 25.0 112.554 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.5 mt -57.81 -33.84 69.01 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.39 -0.823 . . . . 25.0 111.939 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -53.2 -39.23 63.55 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.609 -0.723 . . . . 25.0 111.286 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.28 -51.8 7.56 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.738 0.644 . . . . 25.0 112.738 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.87 -27.45 61.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 116.855 2.169 . . . . 25.0 116.855 -166.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -71.1 -17.3 62.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.784 1.402 . . . . 25.0 114.784 -170.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -96.74 121.39 38.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -118.65 112.03 19.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.422 -0.585 . . . . 25.0 109.422 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.8 124.24 23.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.866 -1.531 . . . . 25.0 106.866 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.0 tt -115.8 1.82 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.919 0.866 . . . . 25.0 109.834 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.51 145.8 4.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 25.0 114.004 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.73 137.91 31.99 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.723 -1.584 . . . . 25.0 106.723 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 t -132.48 89.27 36.75 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 108.636 -0.876 . . . . 25.0 108.636 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.41 163.49 37.6 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 116.073 -2.151 . . . . 25.0 110.54 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -128.22 120.99 28.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.434 0.635 . . . . 25.0 109.578 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -127.07 -76.7 0.57 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.002 -2.592 . . . . 25.0 104.002 172.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -147.97 -150.09 5.12 Favored Glycine 0 C--O 1.242 0.603 0 N-CA-C 108.6 -1.8 . . . . 25.0 108.6 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.2 m 62.59 157.17 0.12 Allowed Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 114.474 1.287 . . . . 25.0 114.474 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.11 0.15 9.3 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 115.781 -2.346 . . . . 25.0 114.799 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.42 91.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.443 -0.799 . . . . 25.0 109.486 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.3 p -79.74 -11.24 59.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.117 0.484 . . . . 25.0 111.626 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -76.97 -21.0 55.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.191 -0.459 . . . . 25.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -74.34 104.93 5.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.885 0.374 . . . . 25.0 111.172 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -16.06 24.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.019 0.748 . . . . 25.0 113.019 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -100.22 126.51 46.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.301 -1.37 . . . . 25.0 107.301 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -131.07 150.5 52.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.559 0.695 . . . . 25.0 111.826 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -94.73 136.08 35.45 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 105.602 -1.999 . . . . 25.0 105.602 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.0 118.97 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -80.61 130.58 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.169 -2.16 . . . . 25.0 105.169 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.7 mt -122.43 111.57 31.64 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 107.265 -1.383 . . . . 25.0 107.265 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.74 162.0 40.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 116.949 -1.567 . . . . 25.0 112.406 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -111.24 91.03 3.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.517 -2.401 . . . . 25.0 104.517 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -79.42 -29.77 42.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.155 -0.683 . . . . 25.0 109.155 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mtt-85 -155.27 170.0 22.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 103.535 -2.765 . . . . 25.0 103.535 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.89 112.68 24.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.987 -2.968 . . . . 25.0 102.987 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 168.27 166.7 27.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.229 -0.51 . . . . 25.0 112.497 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 49.9 p90 -87.08 142.35 27.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.778 1.399 . . . . 25.0 114.778 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -129.4 136.85 50.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.182 -1.784 . . . . 25.0 106.182 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.91 133.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.89 -1.152 . . . . 25.0 107.89 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.8 mt -96.08 126.27 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.6 mt -111.6 127.05 55.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.038 -1.467 . . . . 25.0 107.038 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.34 145.84 52.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.51 0.596 . . . . 25.0 111.022 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.07 138.15 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -129.19 120.63 26.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.783 -0.821 . . . . 25.0 108.783 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -101.45 97.0 7.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.327 0.585 . . . . 25.0 109.955 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.62 123.03 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.218 -1.03 . . . . 25.0 108.218 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.17 -22.97 59.19 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.95 -7.61 55.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.578 0.955 . . . . 25.0 113.578 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -132.16 158.03 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.24 13.07 3.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.628 -1.169 . . . . 25.0 109.285 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -109.92 162.21 14.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 25.0 109.93 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.88 150.28 50.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.381 -2.452 . . . . 25.0 104.381 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -122.65 143.11 49.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.794 -1.188 . . . . 25.0 107.794 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -138.93 156.38 47.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.384 -0.599 . . . . 25.0 109.384 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.71 149.67 36.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.35 141.98 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.72 -0.474 . . . . 25.0 109.72 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.4 mt -139.02 128.53 30.6 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 105.396 -2.076 . . . . 25.0 105.396 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -112.15 126.9 55.7 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.4 m -125.52 126.12 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.576 0.703 . . . . 25.0 109.92 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 42.2 t0 -87.58 96.05 10.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.196 -1.779 . . . . 25.0 106.196 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.2 112.14 22.42 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.356 -0.838 . . . . 25.0 109.86 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.6 m -136.32 173.75 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.171 -0.468 . . . . 25.0 111.245 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -63.05 159.37 17.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.695 0.76 . . . . 25.0 112.678 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.59 -1.187 . . . . 25.0 110.861 178.144 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 110.43 -0.211 . . . . 25.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.69 -158.84 22.92 Favored Glycine 0 CA--C 1.511 -0.163 0 N-CA-C 107.801 -2.119 . . . . 25.0 107.801 -177.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.24 165.76 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.824 1.312 . . . . 25.0 110.57 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.445 HG22 ' H ' ' A' ' 6' ' ' LYS . 30.1 mm -93.98 124.55 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 25.0 109.78 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -87.9 22.11 2.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.386 0.675 . . . . 25.0 111.7 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' H ' HG22 ' A' ' 4' ' ' ILE . 42.3 mttt 77.05 153.27 0.14 Allowed Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 125.975 1.71 . . . . 25.0 111.955 175.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.97 151.98 68.7 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 129.031 0.846 . . . . 25.0 111.158 -7.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.91 21.73 15.21 Favored Glycine 0 C--O 1.211 -1.288 0 N-CA-C 117.714 1.846 . . . . 25.0 117.714 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -76.5 128.37 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 119.23 1.515 . . . . 25.0 110.041 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -73.33 -27.13 61.34 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.988 -0.375 . . . . 25.0 109.988 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.22 -33.63 69.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.526 0.565 . . . . 25.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.21 69.6 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 120.826 0.346 . . . . 25.0 111.55 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.95 -8.33 46.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.583 0.706 . . . . 25.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.8 t -89.73 -44.3 10.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.133 -0.939 . . . . 25.0 113.24 -171.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.8 t -67.36 129.06 38.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.992 0.425 . . . . 25.0 110.854 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.53 -23.66 63.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.666 . . . . 25.0 110.203 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.63 -20.31 66.2 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.039 -0.413 . . . . 25.0 111.68 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -83.06 -13.21 56.25 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.373 0.508 . . . . 25.0 112.373 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.47 -8.23 2.91 Favored Glycine 0 N--CA 1.46 0.269 0 N-CA-C 115.003 0.761 . . . . 25.0 115.003 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 61.96 -59.91 0.11 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.775 2.03 . . . . 25.0 114.85 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.9 mt -103.97 -3.17 25.02 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.705 0.402 . . . . 25.0 110.695 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -134.35 137.38 44.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.397 0.888 . . . . 25.0 113.397 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.95 157.06 42.78 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.237 -2.135 . . . . 25.0 105.237 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -138.86 33.06 2.19 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.682 0.753 . . . . 25.0 111.063 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.7 t -62.73 -50.31 71.59 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.264 1.209 . . . . 25.0 114.264 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.89 154.38 10.63 Favored Glycine 0 C--O 1.217 -0.908 0 N-CA-C 112.504 -0.238 . . . . 25.0 112.504 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 t -65.64 -25.41 67.35 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.638 0.719 . . . . 25.0 112.278 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -61.03 -10.05 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.701 0.8 . . . . 25.0 112.592 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.3 ptm -56.46 -10.92 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 116.678 2.103 . . . . 25.0 116.678 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.19 -35.9 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 118.163 0.438 . . . . 25.0 111.985 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.05 46.02 0.39 Allowed Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 117.042 2.238 . . . . 25.0 117.042 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.45 -14.28 36.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 115.797 -2.335 . . . . 25.0 114.648 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.06 5.01 49.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.367 0.506 . . . . 25.0 112.367 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.4 t -106.39 89.69 3.12 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.588 -1.264 . . . . 25.0 107.588 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.36 124.68 45.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.0 -1.852 . . . . 25.0 106.0 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -127.45 145.82 50.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 25.0 110.883 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 158.02 45.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.902 -1.888 . . . . 25.0 105.902 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -100.14 141.71 32.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -69.94 135.21 49.21 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.192 -0.67 . . . . 25.0 109.192 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.83 163.03 28.87 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 107.024 -2.43 . . . . 25.0 107.024 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -92.28 146.92 33.53 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 117.641 0.721 . . . . 25.0 110.32 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.4 149.64 91.76 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 129.321 0.967 . . . . 25.0 113.048 -2.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.38 16.06 1.85 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.324 0.861 . . . . 25.0 113.324 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -88.77 -33.8 17.33 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.391 0.515 . . . . 25.0 112.391 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.76 175.35 38.59 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-O 119.463 -0.631 . . . . 25.0 111.873 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.79 -14.8 21.59 Favored 'Trans proline' 0 C--N 1.346 0.422 0 CA-C-N 118.858 1.329 . . . . 25.0 114.167 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.82 126.8 32.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.041 -0.725 . . . . 25.0 109.041 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -149.34 157.45 43.33 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.853 -1.536 . . . . 25.0 106.853 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.76 -31.86 0.38 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 118.148 2.019 . . . . 25.0 118.148 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -115.6 35.07 4.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.958 0.879 . . . . 25.0 109.989 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.4 mm -61.22 -38.36 79.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.559 -0.746 . . . . 25.0 110.468 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.3 87.9 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.9 p -93.86 -21.08 19.48 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.181 -0.324 . . . . 25.0 111.344 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.23 19.98 1.7 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.264 1.026 . . . . 25.0 112.726 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.33 -6.07 45.25 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 114.653 0.621 . . . . 25.0 114.653 -174.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.33 -24.67 61.66 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 114.839 0.695 . . . . 25.0 114.839 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.62 -25.41 66.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 25.0 111.14 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -84.9 0.57 50.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.817 0.342 . . . . 25.0 111.77 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.68 -19.49 58.33 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 121.129 -0.558 . . . . 25.0 112.98 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.97 -20.75 67.08 Favored Glycine 0 C--O 1.222 -0.617 0 C-N-CA 121.079 -0.582 . . . . 25.0 113.228 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.59 -39.4 80.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.415 -0.957 . . . . 25.0 108.415 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.03 -26.86 61.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.52 7.56 4.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.485 0.66 . . . . 25.0 112.221 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.49 -28.02 15.1 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.45 -0.781 . . . . 25.0 109.037 171.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -150.72 96.73 2.4 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.836 0.351 . . . . 25.0 111.394 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.6 t -152.87 154.37 34.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -69.55 -32.8 71.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.177 0.989 . . . . 25.0 109.802 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.32 28.13 8.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.2 -0.909 . . . . 25.0 110.037 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -53.68 154.31 3.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.273 -0.876 . . . . 25.0 109.992 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -84.78 165.26 17.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.28 -1.378 . . . . 25.0 107.28 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -74.8 139.02 42.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -127.5 133.98 49.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -119.63 146.94 45.1 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.366 -1.346 . . . . 25.0 107.366 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -96.7 133.03 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 25.0 108.199 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 93.7 mtp -135.06 158.42 44.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -104.47 172.04 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.14 -175.93 7.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 114.495 0.558 . . . . 25.0 114.495 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.14 -173.37 20.56 Favored Glycine 0 CA--C 1.518 0.221 0 O-C-N 122.525 -0.397 . . . . 25.0 112.755 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.14 141.13 33.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -141.91 160.75 39.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.349 -0.612 . . . . 25.0 109.349 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -126.75 129.49 48.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.39 -1.708 . . . . 25.0 106.39 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.43 139.05 49.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -130.82 133.41 45.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.495 0.497 . . . . 25.0 110.16 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -124.08 151.71 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.839 -1.911 . . . . 25.0 105.839 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -138.07 161.95 35.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 119.037 0.835 . . . . 25.0 110.656 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.14 150.65 39.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.488 -1.671 . . . . 25.0 106.488 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -68.63 -22.39 64.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.384 0.513 . . . . 25.0 112.384 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.04 151.97 63.72 Favored Pre-proline 0 C--O 1.242 0.693 0 N-CA-C 105.719 -1.956 . . . . 25.0 105.719 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.38 145.93 73.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 115.587 -2.475 . . . . 25.0 109.515 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -130.88 140.49 50.22 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.994 -0.441 . . . . 25.0 111.491 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.62 141.52 57.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 m -150.02 151.9 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.746 -1.946 . . . . 25.0 105.746 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.0 p -108.01 -34.05 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 118.256 0.48 . . . . 25.0 110.618 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.76 145.29 18.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.971 -0.456 . . . . 25.0 109.835 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -141.2 139.43 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.035 -0.666 . . . . 25.0 109.543 163.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -148.09 159.64 43.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.89 -0.596 . . . . 25.0 109.532 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -145.04 150.24 36.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.915 1.08 . . . . 25.0 113.915 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.74 164.6 17.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.035 -1.438 . . . . 25.0 107.522 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.66 155.73 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.6 p -96.02 144.19 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.424 -0.584 . . . . 25.0 109.424 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -87.99 129.82 35.14 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 110.163 -0.31 . . . . 25.0 110.163 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -81.53 156.21 25.36 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.054 0.542 . . . . 25.0 109.671 172.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.8 10.12 73.2 Favored Glycine 0 N--CA 1.462 0.419 0 N-CA-C 118.59 2.196 . . . . 25.0 118.59 166.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -59.26 161.35 5.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.032 1.123 . . . . 25.0 114.032 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.24 156.02 36.28 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 106.646 -1.613 . . . . 25.0 106.646 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.45 -8.62 18.48 Favored 'Trans proline' 0 C--N 1.345 0.389 0 N-CA-C 116.663 1.755 . . . . 25.0 116.663 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -82.33 0.72 40.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.912 0.863 . . . . 25.0 111.77 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -95.97 148.43 34.53 Favored Pre-proline 0 C--N 1.322 -0.616 0 O-C-N 121.734 -0.604 . . . . 25.0 110.412 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.04 83.4 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 N-CA-C 110.329 -0.681 . . . . 25.0 110.329 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.7 mt -53.15 -39.53 63.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.912 1.449 . . . . 25.0 114.912 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -63.07 -21.98 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.797 0.666 . . . . 25.0 112.797 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -94.76 -48.55 5.99 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 112.344 0.498 . . . . 25.0 112.344 169.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.79 64.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 115.708 1.744 . . . . 25.0 115.708 -166.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -69.31 -28.88 66.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.247 -0.581 . . . . 25.0 111.633 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -97.66 113.92 25.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.116 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -121.86 136.67 54.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.235 0.541 . . . . 25.0 111.469 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.4 tp -75.61 123.93 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.459 -1.682 . . . . 25.0 106.459 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.2 tp -121.75 -5.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.564 0.697 . . . . 25.0 111.185 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -161.21 140.15 6.47 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.395 -0.907 . . . . 25.0 112.243 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 134.21 16.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.401 -1.333 . . . . 25.0 107.401 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.74 103.2 7.65 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.92 148.73 76.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 116.013 -2.191 . . . . 25.0 109.69 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -106.14 92.2 4.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.364 -1.346 . . . . 25.0 107.364 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -119.17 1.15 11.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.373 -1.739 . . . . 25.0 109.782 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.62 -18.75 9.93 Favored Glycine 0 C--O 1.236 0.24 0 CA-C-N 115.303 -0.862 . . . . 25.0 111.905 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.6 t -54.71 136.99 63.89 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 117.116 0.458 . . . . 25.0 110.465 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.75 -11.67 28.03 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 117.029 -1.514 . . . . 25.0 114.753 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.78 -34.67 78.89 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.375 -1.284 . . . . 25.0 109.143 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -84.4 -10.05 57.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.202 0.525 . . . . 25.0 112.044 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -86.48 -22.78 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.643 -1.243 . . . . 25.0 107.643 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.04 104.84 17.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 25.0 110.402 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.65 -10.87 59.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.667 -0.697 . . . . 25.0 112.321 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -91.31 121.98 33.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.928 -1.138 . . . . 25.0 107.928 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -137.26 147.83 46.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 25.0 111.426 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -79.23 137.89 37.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.726 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.0 mt -132.68 106.02 9.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.744 -1.206 . . . . 25.0 107.744 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -78.12 140.85 39.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.574 -0.899 . . . . 25.0 108.574 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.9 mm -124.63 123.36 25.72 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.61 158.44 53.59 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 117.289 -1.341 . . . . 25.0 111.52 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -106.97 52.83 0.71 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.512 1.149 . . . . 25.0 110.037 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.75 -37.5 24.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 115.477 1.658 . . . . 25.0 115.477 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -152.87 172.23 17.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.19 0.596 . . . . 25.0 109.738 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.0 mp -99.95 142.77 30.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.678 -2.342 . . . . 25.0 104.678 167.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.41 150.07 5.88 Favored Glycine 0 C--O 1.234 0.117 0 C-N-CA 120.588 -0.815 . . . . 25.0 114.078 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 27.4 p90 -86.01 145.11 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 25.0 110.049 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 153.02 40.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.842 -0.617 . . . . 25.0 110.184 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.65 143.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.046 -0.524 . . . . 25.0 110.644 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.08 128.85 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.341 -2.466 . . . . 25.0 104.341 172.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.72 137.43 53.93 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.842 -1.54 . . . . 25.0 106.842 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.82 151.15 42.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 118.958 0.799 . . . . 25.0 110.971 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.04 134.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.124 -1.435 . . . . 25.0 107.124 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -124.78 98.98 5.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.586 -1.265 . . . . 25.0 107.586 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -84.79 117.81 24.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.037 0.446 . . . . 25.0 110.554 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.03 133.75 28.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.76 -42.47 58.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.119 0.485 . . . . 25.0 111.194 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.66 -24.07 64.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.812 1.782 . . . . 25.0 115.812 -168.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 66.3 p -135.62 162.55 32.39 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 122.381 -0.199 . . . . 25.0 110.701 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 11.32 2.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 25.0 112.587 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.11 160.0 16.85 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.168 -1.419 . . . . 25.0 107.168 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.52 170.7 15.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.04 -2.207 . . . . 25.0 105.04 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -120.32 158.37 27.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.1 -1.074 . . . . 25.0 108.1 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -138.7 154.63 48.6 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -132.7 142.06 48.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.11 129.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.3 mt -140.66 126.56 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.47 137.09 37.66 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.624 -0.51 . . . . 25.0 109.624 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.58 137.51 43.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 51.8 t0 -82.03 136.14 35.26 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.687 -1.598 . . . . 25.0 106.687 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.14 104.24 9.94 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 34.1 m -113.03 166.95 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.239 0.543 . . . . 25.0 111.824 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.21 158.7 32.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.535 -1.654 . . . . 25.0 106.535 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 117.285 -1.34 . . . . 25.0 110.365 178.975 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.1 m80 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 119.77 -0.157 . . . . 25.0 111.041 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.48 -177.83 51.53 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-O 118.428 -1.207 . . . . 25.0 110.714 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -156.64 164.73 37.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.226 1.013 . . . . 25.0 112.864 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.4 mt -90.73 122.74 42.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -77.72 -41.38 38.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.382 0.61 . . . . 25.0 109.537 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.32 117.08 8.73 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.182 -0.463 . . . . 25.0 109.836 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.36 122.61 7.83 Favored 'Cis proline' 0 C--N 1.357 1.002 0 C-N-CA 130.412 1.422 . . . . 25.0 113.454 -3.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.1 -22.58 57.07 Favored Glycine 0 CA--C 1.508 -0.36 0 N-CA-C 116.051 1.18 . . . . 25.0 116.051 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 t -91.18 97.18 10.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.601 -0.941 . . . . 25.0 110.73 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -83.96 -32.34 25.08 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.727 -0.471 . . . . 25.0 109.727 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -36.67 71.13 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.203 1.186 . . . . 25.0 114.203 -173.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.81 -32.43 71.8 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.282 0.364 . . . . 25.0 110.957 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.9 mp -92.93 -19.93 21.14 Favored 'General case' 0 C--O 1.211 -0.931 0 N-CA-C 112.708 0.632 . . . . 25.0 112.708 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.7 t -70.16 -30.47 67.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.303 -0.628 . . . . 25.0 109.303 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.2 t -55.88 138.47 48.38 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.93 1.085 . . . . 25.0 113.93 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -69.33 -11.05 60.48 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 114.217 -1.356 . . . . 25.0 110.36 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.83 -10.94 0.34 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.035 1.124 . . . . 25.0 114.035 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -68.71 -14.01 62.75 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.843 -0.536 . . . . 25.0 110.97 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.31 -24.1 0.02 OUTLIER Glycine 0 C--O 1.222 -0.64 0 C-N-CA 120.197 -1.001 . . . . 25.0 115.454 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 t80 65.56 -21.86 0.09 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.881 1.808 . . . . 25.0 115.881 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.34 -15.85 59.2 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.968 -0.457 . . . . 25.0 110.533 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -154.64 163.39 40.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.894 0.378 . . . . 25.0 110.481 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.86 155.06 35.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 25.0 111.72 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -127.17 11.75 7.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.131 0.967 . . . . 25.0 111.229 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.3 t -110.73 -35.46 5.98 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 115.384 1.624 . . . . 25.0 115.384 -172.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.42 150.98 6.06 Favored Glycine 0 CA--C 1.517 0.182 0 CA-C-O 121.252 0.362 . . . . 25.0 112.82 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.6 t -66.39 -14.32 61.96 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.583 -0.951 . . . . 25.0 112.817 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.69 0.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.597 0.713 . . . . 25.0 111.024 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -26.26 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 117.933 2.568 . . . . 25.0 117.933 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -75.97 -43.4 44.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.882 0.764 . . . . 25.0 112.816 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.9 71.93 19.03 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 122.009 0.909 . . . . 25.0 112.928 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.66 2.0 5.09 Favored 'Trans proline' 0 C--O 1.221 -0.346 0 N-CA-C 114.606 0.964 . . . . 25.0 114.606 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 3.17 33.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.654 -0.498 . . . . 25.0 109.654 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -134.15 84.03 2.08 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 115.771 1.767 . . . . 25.0 115.771 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.0 131.19 55.31 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 103.525 -2.769 . . . . 25.0 103.525 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -114.37 143.54 44.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.191 1.182 . . . . 25.0 114.191 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.28 155.97 49.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.456 -2.424 . . . . 25.0 104.456 167.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -83.42 146.4 28.45 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.572 -0.705 . . . . 25.0 110.483 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -70.84 145.73 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.548 -0.538 . . . . 25.0 109.548 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.96 -177.65 44.59 Favored Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 103.527 -3.829 . . . . 25.0 103.527 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -112.93 147.56 37.48 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 107.006 -1.479 . . . . 25.0 107.006 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.84 148.65 75.82 Favored 'Cis proline' 0 C--O 1.212 -0.793 0 C-N-CA 129.556 1.065 . . . . 25.0 113.329 0.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -138.54 -48.51 0.52 Allowed 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.657 -0.701 . . . . 25.0 111.051 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 t -91.84 1.83 56.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.138 0.971 . . . . 25.0 108.746 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.9 -154.65 30.16 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 113.625 -1.625 . . . . 25.0 109.492 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.28 154.45 73.53 Favored 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 118.712 1.256 . . . . 25.0 112.291 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.14 106.98 10.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.276 -0.875 . . . . 25.0 111.915 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -114.99 158.88 21.45 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 104.159 -2.534 . . . . 25.0 104.159 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.45 -31.94 3.17 Favored Glycine 0 C--O 1.215 -1.09 0 C-N-CA 120.611 -0.804 . . . . 25.0 112.733 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.18 -21.96 62.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.962 1.468 . . . . 25.0 114.962 -176.67 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.3 mt -69.29 -42.42 81.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 N-CA-C 108.768 -0.827 . . . . 25.0 108.768 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.72 -31.12 66.38 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 112.094 0.405 . . . . 25.0 112.094 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -85.85 2.95 43.82 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.205 0.817 . . . . 25.0 113.205 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.16 24.35 11.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.832 0.853 . . . . 25.0 112.001 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.9 -13.89 75.69 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 110.33 -1.108 . . . . 25.0 110.33 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.46 17.94 31.69 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.755 -0.223 . . . . 25.0 113.495 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 mt -59.32 -10.68 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.606 1.706 . . . . 25.0 115.606 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -61.04 -19.96 61.98 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.21 -16.15 77.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.35 -0.844 . . . . 25.0 111.709 177.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.71 -4.58 66.49 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 115.421 0.928 . . . . 25.0 115.421 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.48 -32.76 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.352 1.076 . . . . 25.0 110.077 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.52 -25.37 65.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.513 -0.312 . . . . 25.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -106.15 15.44 26.32 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.783 0.801 . . . . 25.0 110.041 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -70.59 14.75 0.12 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.37 1.248 . . . . 25.0 114.37 -174.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.51 52.91 1.69 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -131.91 178.69 6.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -64.64 -21.15 66.65 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.805 -0.559 . . . . 25.0 112.413 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -95.57 14.38 23.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.555 0.693 . . . . 25.0 112.098 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 ttt85 -58.18 128.32 36.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.867 -0.606 . . . . 25.0 111.129 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -106.14 168.18 9.31 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.921 0.867 . . . . 25.0 112.203 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -63.86 149.58 46.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.613 -0.721 . . . . 25.0 112.123 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -130.5 146.5 52.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.74 -1.207 . . . . 25.0 107.74 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -113.34 138.49 49.97 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.38 129.19 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 94.3 mmm -137.88 166.51 23.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.3 p -107.46 -173.72 2.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.256 -2.128 . . . . 25.0 105.256 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -161.54 21.56 Favored Glycine 0 C--O 1.242 0.605 0 CA-C-O 121.676 0.598 . . . . 25.0 113.744 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.79 176.61 42.65 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.73 -0.948 . . . . 25.0 110.73 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -83.29 141.48 31.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.139 1.469 . . . . 25.0 109.849 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -129.39 139.16 51.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.714 -0.847 . . . . 25.0 108.714 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -85.57 128.84 34.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 25.0 109.946 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.03 127.43 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.962 -1.866 . . . . 25.0 105.962 174.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -128.85 120.47 26.33 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.1 -0.333 . . . . 25.0 110.1 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -124.08 150.1 45.4 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.45 -1.685 . . . . 25.0 106.45 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.1 t -145.21 158.78 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.465 -0.569 . . . . 25.0 109.465 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.01 133.45 52.97 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 108.997 -0.742 . . . . 25.0 108.997 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -77.03 -6.63 53.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.686 0.625 . . . . 25.0 112.686 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.95 145.04 37.65 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 106.907 -1.516 . . . . 25.0 106.907 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.32 142.87 38.1 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 117.239 -1.374 . . . . 25.0 111.804 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -136.27 140.22 43.27 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.935 -0.765 . . . . 25.0 108.935 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -81.51 152.97 27.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.1 m -138.79 148.49 43.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 105.855 -1.905 . . . . 25.0 105.855 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 t -102.71 -43.36 5.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 25.0 110.59 173.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.82 143.46 20.67 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.947 -0.76 . . . . 25.0 108.947 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -144.5 134.8 24.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.78 0.324 . . . . 25.0 110.192 170.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -154.18 162.22 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.407 0.521 . . . . 25.0 112.407 -172.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.25 146.01 51.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.458 0.647 . . . . 25.0 112.107 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -124.0 163.79 20.66 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -131.34 152.98 38.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.6 p -80.48 144.69 32.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.884 -1.154 . . . . 25.0 107.884 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -88.42 124.77 34.28 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 25.0 110.295 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -73.51 126.22 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.007 -1.109 . . . . 25.0 108.007 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.63 35.82 31.23 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 119.041 -1.552 . . . . 25.0 113.931 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -54.9 149.19 11.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.241 1.02 . . . . 25.0 110.713 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -75.6 139.68 71.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.44 -22.47 16.11 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 118.549 -0.5 . . . . 25.0 113.179 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.8 -27.55 64.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.877 0.846 . . . . 25.0 111.956 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -91.67 143.86 28.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.19 115.67 3.28 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 117.555 -1.163 . . . . 25.0 112.019 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tt -52.36 -54.35 32.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.851 1.426 . . . . 25.0 114.851 -166.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -69.57 -4.03 17.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.114 1.153 . . . . 25.0 114.114 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.63 -46.58 5.96 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.503 -0.748 . . . . 25.0 109.483 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.5 -19.99 51.79 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.545 1.313 . . . . 25.0 114.545 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -72.67 -33.69 66.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.08 1.141 . . . . 25.0 114.08 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -91.7 100.01 12.8 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.623 -0.831 . . . . 25.0 112.593 -173.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -97.37 125.06 41.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 25.0 110.011 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 tp -71.4 116.98 12.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.976 -0.749 . . . . 25.0 108.976 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -96.88 -4.46 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.876 0.846 . . . . 25.0 109.898 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.35 159.72 11.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.602 -0.808 . . . . 25.0 113.016 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.0 147.07 28.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.769 -0.826 . . . . 25.0 108.769 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -133.67 111.8 12.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.223 -1.028 . . . . 25.0 108.223 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.72 168.92 18.89 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 115.796 -2.336 . . . . 25.0 111.071 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -145.18 120.04 9.94 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 120.568 -0.453 . . . . 25.0 110.505 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -91.57 -39.94 11.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.953 0.882 . . . . 25.0 110.04 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.08 -26.04 0.42 Allowed Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.125 -1.99 . . . . 25.0 108.125 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 t -51.76 141.42 26.55 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.771 0.656 . . . . 25.0 112.771 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.29 23.77 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.805 1.67 . . . . 25.0 114.343 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.28 -25.91 66.07 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.282 -0.886 . . . . 25.0 110.688 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 54.6 p -71.71 0.95 7.58 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.955 0.724 . . . . 25.0 112.955 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -62.1 -35.28 78.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.373 -0.973 . . . . 25.0 108.373 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -94.41 82.82 4.08 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.003 -1.851 . . . . 25.0 106.003 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.87 -19.84 58.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.345 -0.843 . . . . 25.0 111.653 -175.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 t -72.65 138.69 46.85 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.623 -0.673 . . . . 25.0 109.858 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -135.57 143.16 45.51 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.711 -0.477 . . . . 25.0 109.711 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -96.29 139.39 32.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.431 -1.692 . . . . 25.0 106.431 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.9 mm -133.28 130.19 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 39.4 t80 -80.71 132.17 35.53 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.0 mm -112.06 126.39 28.54 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.604 -0.888 . . . . 25.0 108.604 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.85 169.49 22.48 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 118.19 -0.74 . . . . 25.0 111.758 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -130.18 51.26 2.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.084 -1.45 . . . . 25.0 107.084 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -78.52 -32.03 47.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.123 1.157 . . . . 25.0 114.123 -172.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -152.2 165.83 33.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.975 -1.491 . . . . 25.0 106.975 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.4 mp -92.89 142.91 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.271 -2.492 . . . . 25.0 104.271 167.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.29 165.39 10.27 Favored Glycine 0 C--O 1.237 0.318 0 N-CA-C 114.24 0.456 . . . . 25.0 114.24 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 3.9 p90 -81.45 149.69 28.66 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.086 0.772 . . . . 25.0 113.086 -176.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.86 159.39 43.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.137 -1.801 . . . . 25.0 106.137 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.1 149.68 11.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 118.517 0.599 . . . . 25.0 111.158 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.7 128.44 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.94 139.21 52.04 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.362 -0.977 . . . . 25.0 108.362 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.69 144.32 41.73 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.87 -0.419 . . . . 25.0 109.87 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.85 135.28 61.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.417 -0.957 . . . . 25.0 108.417 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -128.38 112.14 14.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.261 0.624 . . . . 25.0 111.466 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -88.7 88.42 7.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.42 126.81 33.66 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 105.267 -2.123 . . . . 25.0 105.267 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.09 -23.52 54.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.261 0.553 . . . . 25.0 110.222 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.5 -11.85 61.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.686 -0.688 . . . . 25.0 112.481 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -127.61 161.4 28.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.952 0.406 . . . . 25.0 110.641 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -88.38 3.27 50.49 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.635 1.207 . . . . 25.0 108.054 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -108.83 157.34 18.68 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.702 -1.136 . . . . 25.0 108.945 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.69 141.77 49.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.785 -2.672 . . . . 25.0 103.785 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.03 144.69 32.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.066 -0.516 . . . . 25.0 111.14 -172.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -124.57 145.84 49.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.402 -0.817 . . . . 25.0 109.282 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -138.77 129.5 26.29 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.048 -1.834 . . . . 25.0 106.048 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.14 130.4 34.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.615 -0.883 . . . . 25.0 108.615 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.5 mt -140.37 130.87 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 120.486 0.184 . . . . 25.0 110.645 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.18 138.61 39.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.807 0.813 . . . . 25.0 111.282 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.61 160.81 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 25.0 109.07 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 54.1 t0 -117.29 132.1 56.68 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.216 -1.772 . . . . 25.0 106.216 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.07 121.99 40.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 33.8 m -130.54 167.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 123.532 0.52 . . . . 25.0 110.059 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -77.58 158.1 29.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 117.317 -1.325 . . . . 25.0 110.466 176.541 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.85 179.58 48.79 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 108.548 -1.821 . . . . 25.0 108.548 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -80.27 136.33 36.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.11 106.85 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -77.26 -41.13 42.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.794 0.807 . . . . 25.0 110.94 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -152.84 143.76 15.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.036 -0.506 . . . . 25.0 109.669 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 137.39 47.96 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 118.99 0.675 . . . . 25.0 112.126 -5.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.68 168.06 38.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.817 -1.182 . . . . 25.0 113.665 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -161.93 121.36 2.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.339 -2.467 . . . . 25.0 104.339 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -83.4 -38.54 21.82 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 112.149 0.426 . . . . 25.0 112.149 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.21 74.14 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 25.0 112.559 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.77 70.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 112.08 0.4 . . . . 25.0 112.08 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 mt -92.0 -35.39 13.99 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 121.363 0.601 . . . . 25.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.7 t -66.07 -39.95 90.49 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 114.809 -1.087 . . . . 25.0 110.917 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.7 t -61.47 134.16 56.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.076 0.465 . . . . 25.0 110.147 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -64.57 -15.01 60.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.171 -0.468 . . . . 25.0 110.959 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.19 -12.91 14.58 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 122.055 -0.403 . . . . 25.0 111.831 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.73 -3.82 54.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.834 0.309 . . . . 25.0 111.834 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.58 -9.64 0.03 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 119.604 2.602 . . . . 25.0 119.604 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 63.68 -41.6 0.23 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.704 2.113 . . . . 25.0 116.704 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 80.0 mt -80.08 -3.01 46.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.594 0.711 . . . . 25.0 109.241 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -73.85 153.9 39.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.341 -0.845 . . . . 25.0 109.398 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 mp -75.08 163.82 27.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 105.722 -1.955 . . . . 25.0 105.722 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -49.82 -10.1 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.778 2.14 . . . . 25.0 116.778 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -163.9 -17.85 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.024 0.53 . . . . 25.0 112.158 171.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.68 142.79 13.38 Favored Glycine 0 C--O 1.222 -0.64 0 N-CA-C 112.187 -0.365 . . . . 25.0 112.187 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 m -76.24 -30.8 58.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.816 0.808 . . . . 25.0 112.953 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.28 -12.27 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.202 0.815 . . . . 25.0 113.202 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -67.08 -10.4 49.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.24 -41.09 70.57 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.888 1.07 . . . . 25.0 113.888 -171.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -142.59 43.28 0.47 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 117.377 2.362 . . . . 25.0 117.377 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.95 -21.1 28.4 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 113.236 -4.042 . . . . 25.0 112.259 176.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -79.03 -18.74 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 25.0 111.599 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -132.87 78.99 1.82 Allowed 'General case' 0 C--O 1.206 -1.229 0 N-CA-C 113.039 0.755 . . . . 25.0 113.039 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.2 mt -104.33 141.57 36.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.23 -0.656 . . . . 25.0 109.23 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -105.43 141.67 36.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 25.0 109.495 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 167.37 21.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 25.0 110.766 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -63.15 -178.15 0.22 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.286 0.847 . . . . 25.0 113.286 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 14.4 pttp -53.32 138.71 31.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.833 -1.076 . . . . 25.0 112.302 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.34 -7.37 32.58 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 115.097 -0.956 . . . . 25.0 114.833 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -73.27 133.34 81.08 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 118.259 1.03 . . . . 25.0 108.526 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.1 116.35 4.16 Favored 'Cis proline' 0 CA--C 1.545 1.053 0 C-N-CA 130.748 1.562 . . . . 25.0 115.077 -0.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -60.32 -19.79 56.71 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.808 1.41 . . . . 25.0 114.808 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 t -69.94 -28.29 65.45 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.135 -0.353 . . . . 25.0 111.461 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.32 -159.61 31.14 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 114.914 0.726 . . . . 25.0 114.914 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.3 -178.82 4.71 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.637 1.558 . . . . 25.0 111.511 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.79 133.01 55.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.37 -0.377 . . . . 25.0 111.169 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -104.79 175.14 5.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.116 0.484 . . . . 25.0 111.212 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.81 0.93 57.53 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 114.528 0.571 . . . . 25.0 114.528 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -144.49 -31.12 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 116.067 1.877 . . . . 25.0 116.067 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.5 mm -68.18 -33.83 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 118.489 0.586 . . . . 25.0 109.671 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.6 -28.61 70.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.87 0.367 . . . . 25.0 111.478 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.7 m -94.26 3.09 55.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.268 -0.424 . . . . 25.0 110.77 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.64 15.07 1.97 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.441 1.497 . . . . 25.0 113.627 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.96 -29.75 50.11 Favored Glycine 0 C--O 1.215 -1.09 0 N-CA-C 110.446 -1.062 . . . . 25.0 110.446 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.41 -16.7 77.4 Favored Glycine 0 C--O 1.219 -0.842 0 C-N-CA 120.38 -0.914 . . . . 25.0 111.79 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.95 -61.24 1.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.461 0.648 . . . . 25.0 111.309 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -85.02 -13.03 51.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.31 0.856 . . . . 25.0 113.31 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.38 72.26 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.804 -0.713 . . . . 25.0 113.058 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.89 -31.49 80.99 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 120.495 -0.86 . . . . 25.0 111.948 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mm -65.5 -37.36 79.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.385 0.612 . . . . 25.0 109.527 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.14 -33.63 59.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.531 . . . . 25.0 110.33 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -67.39 -31.74 72.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.451 0.643 . . . . 25.0 111.231 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.96 -5.06 23.67 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -130.11 41.94 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 25.0 109.044 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -125.16 167.63 14.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.25 -26.11 67.2 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -88.08 12.67 12.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.601 -0.727 . . . . 25.0 112.203 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -53.42 139.66 29.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.563 0.697 . . . . 25.0 109.702 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -81.93 142.32 32.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.52 1.153 . . . . 25.0 111.577 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -71.14 152.13 43.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.939 -1.482 . . . . 25.0 112.01 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -110.9 140.97 44.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.793 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -119.01 133.43 55.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.98 131.0 41.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.4 ttt -151.03 168.18 25.38 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 106.862 -1.533 . . . . 25.0 106.862 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.7 p -88.21 165.97 14.68 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.805 -1.924 . . . . 25.0 105.805 173.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.8 -158.2 5.23 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.396 -0.431 . . . . 25.0 112.583 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.52 -163.89 25.23 Favored Glycine 0 CA--C 1.512 -0.099 0 O-C-N 122.347 -0.502 . . . . 25.0 112.908 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 2.7 tt0 -74.71 129.14 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.008 -0.701 . . . . 25.0 110.906 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -122.5 136.21 54.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.218 -1.03 . . . . 25.0 108.218 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.5 m -99.94 118.15 35.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.896 -1.52 . . . . 25.0 106.896 175.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.65 134.78 42.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.131 -1.433 . . . . 25.0 107.131 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -133.11 130.91 39.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -114.61 150.04 35.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.558 -0.905 . . . . 25.0 108.558 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -143.31 154.92 44.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.164 -0.68 . . . . 25.0 109.164 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -140.13 159.07 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -67.48 -30.55 70.28 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.84 151.18 62.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.65 134.32 27.93 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 115.475 -2.55 . . . . 25.0 111.217 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -131.0 154.47 48.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.129 -0.693 . . . . 25.0 109.129 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -68.54 160.34 30.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.842 0.83 . . . . 25.0 109.717 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -154.46 161.64 41.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.692 -3.818 . . . . 25.0 100.692 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 p -110.7 -39.13 4.96 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.997 -0.742 . . . . 25.0 108.997 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -159.75 143.59 14.53 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.557 -0.905 . . . . 25.0 108.557 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.81 138.47 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.18 -1.415 . . . . 25.0 107.18 169.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -140.83 152.81 45.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.399 . . . . 25.0 111.527 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -117.28 139.11 51.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.934 -1.03 . . . . 25.0 109.081 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.99 165.77 25.23 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.168 -1.419 . . . . 25.0 107.168 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.97 153.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.1 p -85.78 147.87 26.11 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.169 -0.678 . . . . 25.0 109.169 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -86.45 100.85 12.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.996 0.903 . . . . 25.0 110.095 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -76.08 126.72 31.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.761 -1.2 . . . . 25.0 107.761 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 20.92 34.75 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 119.701 -1.238 . . . . 25.0 114.053 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.06 141.1 19.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.492 0.663 . . . . 25.0 111.837 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.85 134.86 81.0 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.8 -16.73 23.35 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 117.703 -1.065 . . . . 25.0 113.344 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.44 -29.32 68.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.061 0.934 . . . . 25.0 110.339 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -100.76 152.31 37.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 107.973 -1.121 . . . . 25.0 107.973 -174.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.52 105.99 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 117.449 -1.234 . . . . 25.0 113.885 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.14 -42.18 69.26 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.459 -0.792 . . . . 25.0 112.075 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.74 -6.55 27.12 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.267 1.21 . . . . 25.0 114.267 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.3 -44.02 6.07 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.535 0.683 . . . . 25.0 111.281 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.45 28.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.333 -1.303 . . . . 25.0 114.489 -170.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -69.13 -29.09 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.9 1.074 . . . . 25.0 113.9 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -127.36 159.15 35.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.332 0.514 . . . . 25.0 112.228 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -133.48 147.68 51.67 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.203 -1.406 . . . . 25.0 107.203 173.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 tt -87.02 133.79 33.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.893 -0.504 . . . . 25.0 110.277 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 tt -121.34 1.87 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.847 0.832 . . . . 25.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.81 156.91 14.17 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.175 -1.012 . . . . 25.0 113.408 172.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.92 139.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.989 -1.115 . . . . 25.0 107.989 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.76 102.13 13.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.3 169.77 16.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 117.353 -1.298 . . . . 25.0 112.044 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -132.24 113.49 13.31 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.721 -1.215 . . . . 25.0 107.721 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -164.59 -104.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 102.009 -3.33 . . . . 25.0 102.009 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.7 40.4 2.93 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 111.152 -0.779 . . . . 25.0 111.152 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -76.28 132.73 72.63 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 122.244 -0.562 . . . . 25.0 111.597 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.2 -178.45 3.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 O-C-N 121.719 0.326 . . . . 25.0 111.955 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -13.9 6.35 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.396 1.258 . . . . 25.0 114.396 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -59.66 -13.24 8.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.583 0.957 . . . . 25.0 113.583 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -67.0 16.24 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.63 1.715 . . . . 25.0 115.63 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -58.09 143.13 44.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.553 0.692 . . . . 25.0 110.679 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.49 -10.79 60.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.139 -0.937 . . . . 25.0 112.21 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.5 t -100.06 122.67 43.29 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 106.936 -1.505 . . . . 25.0 106.936 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -133.83 141.31 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.08 0.467 . . . . 25.0 110.326 -175.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -91.97 132.88 36.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -131.92 129.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.903 -1.888 . . . . 25.0 105.903 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 35.3 t80 -96.73 132.08 42.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.008 -1.108 . . . . 25.0 108.008 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.16 106.31 36.17 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.42 151.13 65.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 116.145 -2.103 . . . . 25.0 109.242 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -139.04 95.31 2.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.64 0.733 . . . . 25.0 111.028 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.87 4.68 53.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.933 -1.03 . . . . 25.0 110.721 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -140.8 -179.34 6.0 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.57 130.48 51.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 104.432 -2.433 . . . . 25.0 104.432 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.01 -177.36 24.42 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-O 122.848 1.249 . . . . 25.0 115.973 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.9 p90 -79.02 146.54 33.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.354 1.242 . . . . 25.0 114.354 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -136.39 158.81 43.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.376 -2.453 . . . . 25.0 104.376 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.88 132.91 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.681 -0.859 . . . . 25.0 108.681 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.6 mt -108.51 134.85 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 tt -118.4 137.82 52.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.428 -0.953 . . . . 25.0 108.428 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.48 144.52 51.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.532 0.682 . . . . 25.0 110.9 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.98 133.64 68.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -129.43 100.79 5.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 25.0 108.952 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.1 131.97 34.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.006 -0.543 . . . . 25.0 109.562 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -89.05 160.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.957 -1.127 . . . . 25.0 107.957 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.99 -27.65 12.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.984 -0.747 . . . . 25.0 108.984 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.65 -2.42 58.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.4 t -152.95 162.78 40.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 25.0 111.469 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -67.74 -26.17 66.01 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.496 1.119 . . . . 25.0 111.855 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 86.2 m-20 -86.74 167.31 14.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 25.0 110.592 -173.391 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.43 -179.56 5.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -128.36 140.46 51.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.538 -0.912 . . . . 25.0 108.538 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -131.76 137.83 48.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.688 -1.227 . . . . 25.0 107.688 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -149.18 155.36 40.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.6 151.0 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.5 mm -134.58 113.01 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.993 -1.114 . . . . 25.0 107.993 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.8 141.27 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.783 -1.192 . . . . 25.0 107.783 175.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.0 m -135.51 161.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 1.0 OUTLIER -126.71 117.59 23.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.955 -1.868 . . . . 25.0 105.955 176.492 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.97 135.12 55.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.868 -0.606 . . . . 25.0 110.937 -169.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.35 165.83 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.525 -0.762 . . . . 25.0 109.774 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -91.47 157.71 16.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.198 -1.779 . . . . 25.0 106.198 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.593 -1.194 . . . . 25.0 108.602 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 109.999 -0.371 . . . . 25.0 109.999 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.68 -168.17 21.25 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 104.769 -3.333 . . . . 25.0 104.769 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.54 161.38 41.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.587 2.193 . . . . 25.0 113.244 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 mt -93.97 126.47 46.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.432 -1.321 . . . . 25.0 107.432 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.27 -47.59 14.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.189 -0.671 . . . . 25.0 109.189 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -163.15 165.59 14.38 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.076 -1.083 . . . . 25.0 108.076 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -70.32 124.78 8.18 Favored 'Cis proline' 0 C--N 1.353 0.805 0 C-N-CA 131.392 1.83 . . . . 25.0 114.987 1.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.07 175.4 39.14 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.484 -0.78 . . . . 25.0 112.731 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -139.61 152.83 47.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.407 -0.96 . . . . 25.0 108.407 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -75.29 -21.01 58.81 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.815 -0.439 . . . . 25.0 109.815 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -33.58 66.57 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.006 0.373 . . . . 25.0 112.006 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.51 70.76 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 112.446 0.536 . . . . 25.0 112.446 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.04 -32.07 15.33 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.254 0.549 . . . . 25.0 109.86 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -39.71 75.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 25.0 111.526 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.2 t -63.37 129.04 38.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.191 0.811 . . . . 25.0 113.191 -174.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -65.6 -15.01 62.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.763 -1.108 . . . . 25.0 111.747 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 -13.01 8.63 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.431 0.53 . . . . 25.0 112.431 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -77.83 -7.17 56.27 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 111.983 0.364 . . . . 25.0 111.983 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.47 -29.89 0.05 OUTLIER Glycine 0 C--O 1.223 -0.573 0 N-CA-C 115.999 1.16 . . . . 25.0 115.999 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 61.5 3.26 0.78 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.094 1.887 . . . . 25.0 116.094 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.5 mt -71.6 -27.53 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.977 -0.452 . . . . 25.0 111.162 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -160.9 161.94 31.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.1 138.83 38.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.958 -1.127 . . . . 25.0 107.958 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -125.45 -3.28 7.36 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.043 1.127 . . . . 25.0 114.043 -174.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 t -66.08 -45.1 82.45 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.215 1.191 . . . . 25.0 114.215 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.85 156.32 6.12 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 114.766 0.667 . . . . 25.0 114.766 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 t -66.25 -33.46 75.8 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.595 0.961 . . . . 25.0 113.595 -176.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.21 -10.01 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.955 0.724 . . . . 25.0 112.955 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -22.6 15.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 116.539 2.051 . . . . 25.0 116.539 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.67 -37.88 62.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.582 0.628 . . . . 25.0 111.777 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.74 68.29 8.23 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 115.358 1.614 . . . . 25.0 115.358 174.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.8 -6.49 19.11 Favored 'Trans proline' 0 C--O 1.222 -0.309 0 N-CA-C 113.14 0.4 . . . . 25.0 113.14 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -97.92 4.85 49.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.855 0.687 . . . . 25.0 112.855 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -107.81 88.08 2.65 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.666 -0.813 . . . . 25.0 110.603 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.95 140.18 42.79 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 103.891 -2.633 . . . . 25.0 103.891 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -107.51 144.05 35.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.666 0.746 . . . . 25.0 112.198 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 162.78 31.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.606 -1.998 . . . . 25.0 105.606 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -109.4 154.0 23.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.228 0.467 . . . . 25.0 109.816 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -61.54 142.1 57.3 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.57 93.28 0.09 OUTLIER Glycine 0 C--O 1.22 -0.719 0 N-CA-C 110.111 -1.196 . . . . 25.0 110.111 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.94 148.65 94.67 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.278 -1.008 . . . . 25.0 108.278 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.9 153.03 93.17 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 129.937 1.224 . . . . 25.0 114.024 0.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 -36.19 0.67 Allowed 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 114.24 1.2 . . . . 25.0 114.24 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 t -83.14 -12.97 56.5 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.831 0.741 . . . . 25.0 109.765 173.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.08 -148.52 18.28 Favored Glycine 0 C--O 1.236 0.258 0 N-CA-C 108.51 -1.836 . . . . 25.0 108.51 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -61.96 156.24 50.47 Favored 'Trans proline' 0 C--N 1.346 0.396 0 CA-C-N 119.113 1.457 . . . . 25.0 111.321 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.86 123.85 20.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.033 -0.53 . . . . 25.0 111.167 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -146.36 174.88 10.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.797 -2.668 . . . . 25.0 103.797 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.5 -32.02 4.33 Favored Glycine 0 C--O 1.223 -0.579 0 CA-C-N 118.309 0.504 . . . . 25.0 112.73 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -100.72 12.47 37.4 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.426 -0.455 . . . . 25.0 111.676 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.11 -40.01 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.12 -24.59 66.71 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.492 0.552 . . . . 25.0 112.492 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.0 p -101.18 23.18 11.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.305 0.242 . . . . 25.0 110.886 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.32 46.22 26.84 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.996 0.739 . . . . 25.0 112.996 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 -10.18 9.63 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 116.166 1.226 . . . . 25.0 116.166 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.84 -7.32 58.7 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 117.783 0.792 . . . . 25.0 112.527 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.73 -10.88 6.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.262 0.838 . . . . 25.0 113.262 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -57.86 -21.22 41.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.364 0.876 . . . . 25.0 113.364 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.86 -26.32 72.16 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.252 -0.975 . . . . 25.0 111.136 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.44 -14.7 72.22 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-O 119.589 -0.562 . . . . 25.0 114.028 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.86 -33.08 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.072 0.936 . . . . 25.0 110.146 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.5 -39.51 91.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 25.0 110.65 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -88.82 -2.97 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.996 0.903 . . . . 25.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.57 23.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.438 1.273 . . . . 25.0 114.438 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -70.57 74.33 0.56 Allowed 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.615 -0.678 . . . . 25.0 111.882 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t -151.59 171.2 17.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.877 -1.898 . . . . 25.0 105.877 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -64.76 -17.03 63.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.885 0.874 . . . . 25.0 112.025 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -74.26 -9.96 59.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -71.04 160.38 33.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.407 0.622 . . . . 25.0 110.216 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -85.06 163.65 18.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -62.73 146.78 51.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.938 0.875 . . . . 25.0 112.525 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -114.4 143.59 44.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.188 -1.412 . . . . 25.0 107.188 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -118.89 118.16 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.392 -0.596 . . . . 25.0 109.392 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.7 mt -76.13 135.87 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.89 165.97 30.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 p -108.49 170.19 8.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.926 -1.879 . . . . 25.0 105.926 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.54 179.21 26.36 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 115.076 0.791 . . . . 25.0 115.076 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.13 172.99 21.04 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.593 -1.003 . . . . 25.0 110.593 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 144.99 54.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.786 -0.832 . . . . 25.0 109.345 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -133.32 157.18 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.389 -0.597 . . . . 25.0 109.389 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.3 m -115.91 127.89 55.35 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.517 -0.549 . . . . 25.0 109.517 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.18 132.77 53.29 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.3 m -137.84 130.05 29.06 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -124.07 155.74 37.81 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.686 -1.598 . . . . 25.0 106.686 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.9 t -142.24 162.01 36.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.466 -0.568 . . . . 25.0 109.466 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -125.42 142.8 51.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.703 -1.221 . . . . 25.0 107.703 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -83.52 -0.56 50.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.27 0.557 . . . . 25.0 111.617 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 160.4 58.42 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.18 147.82 94.33 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.286 -2.01 . . . . 25.0 110.411 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -130.74 109.5 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.081 0.771 . . . . 25.0 113.081 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.29 144.5 53.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.062 -0.972 . . . . 25.0 108.85 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.4 m -133.34 132.81 41.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 25.0 109.976 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -106.54 -47.28 3.8 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.693 -1.225 . . . . 25.0 107.693 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -162.47 145.32 11.2 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.582 -1.636 . . . . 25.0 106.582 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -137.96 136.16 36.71 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -148.06 158.58 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.49 154.89 46.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.163 0.506 . . . . 25.0 111.878 -175.65 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -135.44 163.2 30.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.255 -0.884 . . . . 25.0 109.936 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.7 pt -129.36 152.56 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 168.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.6 p -84.87 141.92 30.09 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -74.22 114.82 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.809 0.814 . . . . 25.0 110.605 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -76.22 122.76 24.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 105.598 -2.001 . . . . 25.0 105.598 172.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.28 44.92 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.885 -1.15 . . . . 25.0 115.416 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.02 150.41 17.04 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.898 0.849 . . . . 25.0 112.552 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.83 118.63 72.41 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.099 -0.5 . . . . 25.0 110.789 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.27 -15.95 22.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 N-CA-C 114.725 1.01 . . . . 25.0 114.725 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.77 -3.85 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.174 0.987 . . . . 25.0 111.071 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -113.79 159.26 36.49 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 105.358 -2.09 . . . . 25.0 105.358 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.28 99.32 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 117.454 -1.23 . . . . 25.0 112.829 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.08 -36.57 60.8 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 113.634 0.975 . . . . 25.0 113.634 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.46 -15.27 6.42 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -85.99 -43.62 13.02 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.238 0.472 . . . . 25.0 111.439 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.82 -3.89 59.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.78 1.03 . . . . 25.0 113.78 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -67.87 -31.46 71.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.103 -0.239 . . . . 25.0 110.862 -174.28 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -127.15 132.41 50.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.772 0.656 . . . . 25.0 112.772 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -118.35 124.8 48.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.148 -1.056 . . . . 25.0 108.148 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.29 119.98 15.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -103.13 -2.13 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.913 0.863 . . . . 25.0 109.668 -176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.97 160.54 11.06 Favored Glycine 0 CA--C 1.512 -0.143 0 C-N-CA 120.769 -0.729 . . . . 25.0 113.242 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.2 144.84 26.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.678 -0.86 . . . . 25.0 108.678 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.6 104.76 10.0 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 107.159 -1.423 . . . . 25.0 107.159 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.52 172.21 12.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 116.902 -1.599 . . . . 25.0 112.662 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -134.65 91.45 2.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.303 -2.48 . . . . 25.0 104.303 170.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -106.14 29.95 6.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.166 0.984 . . . . 25.0 108.997 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.72 -37.29 3.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 109.336 -1.506 . . . . 25.0 109.336 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.3 t -59.38 138.1 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.1 46.78 2.05 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.991 1.794 . . . . 25.0 114.496 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.85 -21.79 61.42 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.828 0.677 . . . . 25.0 112.828 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.0 m -61.84 -13.16 21.65 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 113.834 1.05 . . . . 25.0 113.834 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -61.14 -35.92 78.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.884 0.374 . . . . 25.0 110.394 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -106.56 105.02 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 25.0 110.425 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.12 -13.81 30.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.274 0.842 . . . . 25.0 113.274 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.4 t -100.03 140.95 33.51 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.184 -0.323 . . . . 25.0 110.748 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -139.15 139.52 37.63 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.019 0.437 . . . . 25.0 111.904 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -86.75 137.53 32.36 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.013 -0.736 . . . . 25.0 109.013 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.14 124.97 53.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.289 -1.375 . . . . 25.0 107.289 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -77.0 135.56 38.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.016 -0.735 . . . . 25.0 109.016 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.9 mm -126.08 129.21 24.31 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.78 172.64 14.89 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 117.941 -0.906 . . . . 25.0 112.87 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -129.83 45.58 2.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.45 -37.72 15.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.657 -1.156 . . . . 25.0 113.364 -174.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -147.77 156.95 43.28 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 110.175 -0.306 . . . . 25.0 110.175 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.0 mp -95.56 145.73 25.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.199 0.6 . . . . 25.0 110.431 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.55 163.85 9.82 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 114.558 0.583 . . . . 25.0 114.558 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -94.37 145.75 24.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.895 1.443 . . . . 25.0 114.895 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -148.99 163.32 37.84 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.04 149.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.14 0.495 . . . . 25.0 112.029 -175.466 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.8 mt -120.59 133.22 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.426 -2.065 . . . . 25.0 105.426 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 mp -121.52 149.06 43.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -136.68 144.13 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.91 131.14 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -122.33 101.84 7.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.362 0.601 . . . . 25.0 109.959 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -79.97 131.87 35.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.369 -0.975 . . . . 25.0 108.369 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.58 128.96 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.218 -1.771 . . . . 25.0 106.218 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.99 44.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.94 0.4 . . . . 25.0 109.99 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -24.95 66.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 115.6 1.704 . . . . 25.0 115.6 -175.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 p -123.27 161.69 24.1 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.241 -0.287 . . . . 25.0 110.331 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.67 -19.12 62.12 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.181 0.991 . . . . 25.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -108.92 161.81 14.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.886 -1.052 . . . . 25.0 111.249 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.18 16.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.73 -2.693 . . . . 25.0 103.73 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -114.97 144.36 43.71 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.036 0.446 . . . . 25.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -113.28 146.53 39.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -133.55 141.17 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 104.813 -2.291 . . . . 25.0 104.813 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.07 136.61 47.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.3 mt -137.89 125.39 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.88 142.89 27.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.16 142.51 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.947 -0.471 . . . . 25.0 109.967 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -109.67 120.88 43.86 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.935 -2.246 . . . . 25.0 104.935 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 mt -120.02 128.22 53.32 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.713 -0.477 . . . . 25.0 109.713 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.73 170.06 18.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.774 -0.454 . . . . 25.0 109.774 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -77.56 157.94 30.08 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.898 -0.778 . . . . 25.0 108.898 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.6 mttt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 117.793 -1.098 . . . . 25.0 109.787 178.353 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 110.582 -0.155 . . . . 25.0 110.582 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.03 178.28 47.52 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 106.26 -2.736 . . . . 25.0 106.26 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -125.77 156.72 39.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.642 1.221 . . . . 25.0 111.372 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.6 mt -97.66 119.44 45.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.637 -2.727 . . . . 25.0 103.637 170.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -77.5 5.67 8.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.654 0.613 . . . . 25.0 112.654 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttt 79.26 152.43 0.13 Allowed Pre-proline 0 N--CA 1.489 1.509 0 C-N-CA 126.021 1.729 . . . . 25.0 108.322 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 152.4 90.71 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 128.547 0.645 . . . . 25.0 112.023 -2.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.15 26.01 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 118.177 2.031 . . . . 25.0 118.177 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -65.04 131.29 46.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.896 1.348 . . . . 25.0 111.762 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -78.84 -15.93 57.75 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 113.459 0.911 . . . . 25.0 113.459 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.78 74.78 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 112.222 0.453 . . . . 25.0 112.222 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.73 -23.66 62.48 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.841 -0.537 . . . . 25.0 110.908 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.18 -4.03 54.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.279 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 t -88.02 -15.33 36.67 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.822 -0.806 . . . . 25.0 108.822 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.89 162.06 3.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.391 0.886 . . . . 25.0 113.391 -176.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -18.79 7.05 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.125 0.97 . . . . 25.0 113.282 176.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.4 -12.93 2.87 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.731 0.813 . . . . 25.0 112.737 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -71.44 -11.2 60.76 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.175 0.59 . . . . 25.0 111.196 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.41 -0.56 0.58 Allowed Glycine 0 C--O 1.223 -0.573 0 N-CA-C 116.785 1.474 . . . . 25.0 116.785 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 56.49 22.59 6.66 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.472 1.286 . . . . 25.0 114.472 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.8 mt -84.58 -7.87 59.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.586 0.708 . . . . 25.0 109.541 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -135.39 -174.89 3.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.009 -0.996 . . . . 25.0 110.461 -172.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 mp -74.89 168.56 19.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.977 -1.49 . . . . 25.0 106.977 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -42.15 -24.48 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.404 2.002 . . . . 25.0 116.404 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.19 -13.05 0.26 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.48 0.657 . . . . 25.0 111.763 171.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.44 167.5 42.8 Favored Glycine 0 CA--C 1.524 0.62 0 O-C-N 121.628 -0.67 . . . . 25.0 112.875 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -65.72 -30.24 70.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.473 0.654 . . . . 25.0 112.545 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p -66.84 -10.27 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.071 0.767 . . . . 25.0 113.071 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.3 ptm -57.83 -11.09 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 118.121 2.637 . . . . 25.0 118.121 -174.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -69.94 -38.7 76.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.521 0.601 . . . . 25.0 110.462 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.95 63.74 3.16 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.174 1.176 . . . . 25.0 114.174 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.97 -8.12 22.35 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.122 -0.785 . . . . 25.0 113.856 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -97.19 5.12 50.66 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 122.056 -0.403 . . . . 25.0 111.878 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -121.21 130.4 53.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.739 0.644 . . . . 25.0 112.739 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.0 137.3 52.23 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.947 -1.501 . . . . 25.0 106.947 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -110.36 140.52 44.49 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.932 0.145 . . . . 25.0 111.132 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.93 158.08 45.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.396 -0.594 . . . . 25.0 109.396 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -127.22 159.25 34.89 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.939 0.718 . . . . 25.0 112.939 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.03 169.53 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.395 1.078 . . . . 25.0 109.521 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.94 108.5 2.55 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 116.405 -0.361 . . . . 25.0 112.509 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -62.13 147.12 91.29 Favored Pre-proline 0 CA--C 1.539 0.528 0 O-C-N 122.014 -0.698 . . . . 25.0 110.871 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.48 -16.98 16.46 Favored 'Cis proline' 0 C--N 1.349 0.597 0 N-CA-C 114.83 1.05 . . . . 25.0 114.83 1.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -177.31 -34.71 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.697 0.799 . . . . 25.0 110.652 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.9 t 68.7 -37.88 0.37 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.11 1.364 . . . . 25.0 114.434 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.8 -146.61 21.02 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 108.294 -1.922 . . . . 25.0 108.294 173.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -67.85 -163.27 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.831 0 CA-C-N 119.557 1.679 . . . . 25.0 110.067 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.08 88.72 1.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.853 -1.154 . . . . 25.0 108.912 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -88.79 162.62 16.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.011 -0.995 . . . . 25.0 111.533 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.07 -6.96 31.87 Favored Glycine 0 C--O 1.227 -0.296 0 N-CA-C 114.958 0.743 . . . . 25.0 114.958 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -68.21 -25.48 65.24 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.947 -0.737 . . . . 25.0 112.176 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.46 -39.46 78.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.611 -0.885 . . . . 25.0 108.611 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.04 -31.99 69.89 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.907 0.336 . . . . 25.0 111.907 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.5 p -81.62 -0.71 43.69 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.873 0.368 . . . . 25.0 110.215 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.29 19.9 9.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.933 1.293 . . . . 25.0 112.678 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.93 -32.27 10.12 Favored Glycine 0 C--O 1.226 -0.397 0 N-CA-C 111.02 -0.832 . . . . 25.0 111.02 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.71 -5.32 88.37 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 114.24 0.456 . . . . 25.0 114.24 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.68 -24.53 67.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.319 0.56 . . . . 25.0 111.151 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -66.49 -19.39 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.955 0.354 . . . . 25.0 111.955 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.76 -26.85 74.28 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.46 -1.056 . . . . 25.0 110.46 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.64 78.35 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.235 -0.507 . . . . 25.0 112.189 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.38 -42.59 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.377 -1.342 . . . . 25.0 107.377 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.39 -32.57 72.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.526 . . . . 25.0 109.914 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.11 -23.21 66.4 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.628 0.603 . . . . 25.0 112.628 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -68.94 -7.27 33.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.439 -0.788 . . . . 25.0 112.171 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -131.0 40.79 3.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -112.43 158.29 20.03 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.19 -30.78 63.79 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.582 -0.895 . . . . 25.0 108.582 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -96.64 21.26 9.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.329 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -50.24 148.29 3.63 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.127 -0.942 . . . . 25.0 111.64 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -67.37 138.15 56.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.766 1.269 . . . . 25.0 110.03 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -82.06 140.08 34.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.911 -1.495 . . . . 25.0 109.551 -172.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -108.72 138.68 44.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 25.0 111.485 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -124.39 135.25 53.15 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.835 -0.431 . . . . 25.0 109.835 168.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -79.66 138.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.1 tpt -139.51 156.11 47.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.349 -1.352 . . . . 25.0 107.349 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.9 p -101.43 -179.34 4.0 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.6 -178.77 30.3 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.275 -0.488 . . . . 25.0 112.355 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.26 -177.89 32.64 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 122.439 -0.448 . . . . 25.0 113.575 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -85.2 142.31 29.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -139.62 158.5 44.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.14 0.495 . . . . 25.0 110.206 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m -110.18 129.15 55.76 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.393 -0.966 . . . . 25.0 108.393 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.6 138.21 53.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.518 -1.289 . . . . 25.0 107.518 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -136.38 144.07 44.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.903 0.382 . . . . 25.0 111.113 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -121.02 149.98 41.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.83 156.44 48.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.296 0.57 . . . . 25.0 110.282 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -139.03 145.56 39.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.544 -2.021 . . . . 25.0 105.544 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -75.03 -14.15 60.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.495 0.554 . . . . 25.0 112.495 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.98 149.25 55.32 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.588 -1.264 . . . . 25.0 107.588 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -71.05 153.15 63.06 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 117.267 -1.356 . . . . 25.0 111.062 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -131.0 140.18 50.09 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.729 -0.471 . . . . 25.0 109.729 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.74 145.81 51.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 174.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.8 m -152.11 142.65 22.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.1 p -101.88 -37.37 8.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -165.13 167.11 18.51 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.239 -0.288 . . . . 25.0 111.119 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -141.25 141.17 34.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.625 -0.88 . . . . 25.0 108.625 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -147.94 155.68 41.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.377 -0.374 . . . . 25.0 110.265 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 150.03 46.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.39 0.614 . . . . 25.0 111.918 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -131.5 165.06 24.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.435 -1.32 . . . . 25.0 107.435 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -132.47 148.91 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 106.839 -1.541 . . . . 25.0 106.839 173.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 p -83.93 121.78 27.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -99.88 104.29 15.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.686 0.755 . . . . 25.0 109.06 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -75.99 153.96 36.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.61 23.95 17.24 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 119.779 -1.201 . . . . 25.0 114.606 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -66.7 161.62 23.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.667 0.734 . . . . 25.0 109.546 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.83 155.7 47.58 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.73 -14.54 33.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.777 -1.015 . . . . 25.0 113.261 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.07 -20.6 64.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.703 0.801 . . . . 25.0 111.468 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -96.04 147.16 32.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.494 -0.558 . . . . 25.0 109.494 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -61.82 119.71 6.96 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.285 -0.677 . . . . 25.0 111.609 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.58 -49.97 61.06 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 115.533 1.679 . . . . 25.0 115.533 -167.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.91 -36.67 36.09 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.902 0.858 . . . . 25.0 111.797 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -75.85 -32.67 59.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.492 -0.776 . . . . 25.0 112.983 -172.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.62 1.9 47.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.624 -0.262 . . . . 25.0 111.157 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.91 -29.59 68.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.195 -0.202 . . . . 25.0 111.135 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -125.88 150.14 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.91 0.708 . . . . 25.0 112.91 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -127.75 145.76 50.8 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.073 -1.084 . . . . 25.0 108.073 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.12 124.68 28.34 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.257 -0.645 . . . . 25.0 109.257 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.1 tt -98.36 -12.21 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.375 0.607 . . . . 25.0 110.137 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.46 160.19 14.42 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.311 -0.947 . . . . 25.0 114.206 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.54 139.06 23.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.706 -1.591 . . . . 25.0 106.706 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.0 t -137.09 116.49 10.4 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.85 167.53 22.09 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 115.329 -2.648 . . . . 25.0 111.904 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -126.64 96.25 4.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.348 1.071 . . . . 25.0 108.554 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -165.72 -98.15 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 100.527 -3.879 . . . . 25.0 100.527 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -93.69 134.93 12.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 105.843 -2.903 . . . . 25.0 105.843 168.103 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 t -164.58 146.2 6.76 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 117.48 0.64 . . . . 25.0 109.442 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.2 -162.43 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 120.747 0.964 . . . . 25.0 110.184 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.76 -14.07 2.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.381 1.252 . . . . 25.0 114.381 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.5 m -60.48 -16.05 32.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.079 0.77 . . . . 25.0 113.079 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -67.36 -10.44 51.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.467 0.544 . . . . 25.0 112.467 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -65.97 147.7 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 25.0 109.935 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.57 -9.7 58.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.568 0.699 . . . . 25.0 111.258 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.0 t -100.03 121.04 40.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.313 -1.736 . . . . 25.0 106.313 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -124.61 132.28 53.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 25.0 110.49 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -87.21 137.03 32.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.019 -0.537 . . . . 25.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.03 124.6 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.315 -0.994 . . . . 25.0 108.315 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 82.3 t80 -90.87 140.97 29.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -122.3 128.93 25.29 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 107.587 -1.264 . . . . 25.0 107.587 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.27 166.45 29.48 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 117.892 -0.939 . . . . 25.0 112.444 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -111.02 14.27 21.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.617 0.722 . . . . 25.0 111.076 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.34 -18.18 46.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.938 1.458 . . . . 25.0 114.938 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -155.18 170.01 22.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.19 0.811 . . . . 25.0 113.19 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.8 144.81 51.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.994 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.29 151.67 5.47 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.138 0.815 . . . . 25.0 115.138 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.03 146.89 25.94 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 114.943 1.46 . . . . 25.0 114.943 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -149.01 163.54 37.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -96.96 150.03 4.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.592 -0.522 . . . . 25.0 109.592 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.49 132.58 62.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.9 mt -119.05 139.84 51.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.876 -1.898 . . . . 25.0 105.876 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.79 151.52 47.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.114 0.87 . . . . 25.0 110.31 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.0 133.61 65.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.995 -1.002 . . . . 25.0 109.035 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -117.39 113.73 22.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.801 -1.185 . . . . 25.0 107.801 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -103.25 133.54 48.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.401 0.62 . . . . 25.0 111.358 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.86 132.26 70.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.73 -43.61 30.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 25.0 110.925 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 10.14 3.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.502 2.038 . . . . 25.0 116.502 -169.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -131.55 155.02 48.21 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.915 -0.49 . . . . 25.0 110.867 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -73.7 -7.85 53.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 25.0 110.959 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -115.22 163.83 15.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 25.0 112.14 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.88 163.22 33.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 103.453 -2.795 . . . . 25.0 103.453 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -130.45 152.39 49.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 -172.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -130.96 157.58 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.5 154.62 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.862 -0.792 . . . . 25.0 108.862 171.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.1 137.22 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.934 0.397 . . . . 25.0 110.853 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 60.6 mt -141.71 135.0 29.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.55 141.74 37.34 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.242 1.383 . . . . 25.0 108.961 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.41 134.52 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.447 0.641 . . . . 25.0 109.657 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -101.73 96.02 6.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.782 . . . . 25.0 106.187 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.66 105.86 17.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.04 158.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -99.66 164.99 11.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.632 -1.167 . . . . 25.0 107.897 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 C--O 1.253 1.264 0 CA-C-O 116.544 -1.693 . . . . 25.0 113.051 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 119.512 -0.28 . . . . 25.0 111.524 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.92 -159.87 34.75 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.184 -1.008 . . . . 25.0 111.423 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -108.88 135.99 49.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.38 0.272 . . . . 25.0 111.247 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.6 mt -93.98 114.38 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.27 -1.381 . . . . 25.0 107.27 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.12 -43.37 9.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.86 -0.792 . . . . 25.0 108.86 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -137.47 149.4 65.18 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 107.763 -1.199 . . . . 25.0 107.763 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.81 105.07 0.64 Allowed 'Cis proline' 0 CA--C 1.539 0.757 0 C-N-CA 131.102 1.709 . . . . 25.0 113.143 -3.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.71 -166.41 46.52 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.776 -0.726 . . . . 25.0 111.873 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 t -139.95 154.54 47.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.565 -0.531 . . . . 25.0 109.565 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.1 -20.85 57.3 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 116.391 -0.368 . . . . 25.0 111.701 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.52 66.53 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.914 0.709 . . . . 25.0 112.914 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.33 70.63 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.96 -11.36 39.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.036 0.446 . . . . 25.0 110.615 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.8 t -80.13 -43.4 21.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.884 0.373 . . . . 25.0 111.373 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -71.89 129.53 38.81 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.203 0.445 . . . . 25.0 112.203 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.9 -24.05 67.64 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.262 0.553 . . . . 25.0 110.041 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.08 -13.09 2.54 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.496 0.924 . . . . 25.0 113.496 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -78.67 -10.83 59.89 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.231 0.212 . . . . 25.0 111.431 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.96 -14.84 0.04 OUTLIER Glycine 0 C--O 1.222 -0.603 0 N-CA-C 117.461 1.744 . . . . 25.0 117.461 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.9 t80 62.12 -7.95 0.11 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 116.773 2.138 . . . . 25.0 116.773 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.78 -38.62 83.63 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.757 -0.589 . . . . 25.0 109.895 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -169.31 177.26 4.8 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -136.81 157.04 47.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.587 -1.264 . . . . 25.0 107.587 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.87 54.94 1.67 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.745 -1.205 . . . . 25.0 107.745 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.5 t -91.21 -48.29 7.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.383 -0.527 . . . . 25.0 110.566 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.74 -176.78 35.43 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 116.182 -0.463 . . . . 25.0 112.894 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 t -64.94 -13.96 58.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.679 0.752 . . . . 25.0 110.886 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 28' ' ' VAL . 2.3 t -62.51 -9.75 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.665 -0.698 . . . . 25.0 110.772 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.5 ptm -62.69 -27.01 68.95 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.391 -0.818 . . . . 25.0 111.31 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.21 -28.87 31.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.542 0.687 . . . . 25.0 110.03 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -115.95 61.51 1.97 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.749 -0.659 . . . . 25.0 112.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.61 -38.62 3.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 114.169 -3.421 . . . . 25.0 113.335 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -105.69 -32.55 8.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.391 0.885 . . . . 25.0 113.391 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 m -102.14 78.26 1.75 Allowed 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 109.133 -0.692 . . . . 25.0 109.133 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -107.58 109.97 21.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.913 0.708 . . . . 25.0 112.913 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.35 103.91 4.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.565 0.58 . . . . 25.0 112.565 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.95 -164.8 0.17 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -60.63 151.28 29.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.302 0.641 . . . . 25.0 111.146 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.87 140.19 3.51 Favored Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 109.255 -1.538 . . . . 25.0 109.255 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -112.26 125.46 30.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 117.288 0.544 . . . . 25.0 110.264 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.0 152.56 98.43 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 129.72 1.134 . . . . 25.0 111.041 -3.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -98.15 -42.85 7.26 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 112.696 0.628 . . . . 25.0 112.696 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t 63.67 -52.51 0.23 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.143 1.534 . . . . 25.0 115.143 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.37 172.42 53.67 Favored Glycine 0 C--O 1.244 0.736 0 N-CA-C 111.37 -0.692 . . . . 25.0 111.37 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -74.51 -170.57 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.8 2.333 . . . . 25.0 113.684 -177.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.35 141.63 19.08 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.819 0.674 . . . . 25.0 112.819 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -55.51 113.68 1.53 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.769 -0.65 . . . . 25.0 112.534 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.52 17.19 25.24 Favored Glycine 0 C--O 1.222 -0.601 0 CA-C-N 115.503 -0.771 . . . . 25.0 114.242 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 57.2 13.86 1.83 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.837 0.855 . . . . 25.0 113.234 -174.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.09 -39.21 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 25.0 110.096 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.19 -27.26 69.24 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.287 0.847 . . . . 25.0 113.287 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.3 p -94.16 -19.47 20.75 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.64 -0.424 . . . . 25.0 110.715 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.19 -0.54 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 116.324 1.972 . . . . 25.0 116.324 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 -23.62 4.37 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 112.016 -0.434 . . . . 25.0 112.016 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.64 2.89 65.81 Favored Glycine 0 C--O 1.222 -0.65 0 C-N-CA 120.912 -0.661 . . . . 25.0 113.478 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.04 -21.46 66.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.522 0.329 . . . . 25.0 111.712 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -63.98 -13.0 42.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.117 0.414 . . . . 25.0 112.117 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.89 -14.64 56.25 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.432 -0.413 . . . . 25.0 113.732 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.86 -21.72 65.73 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 117.773 0.787 . . . . 25.0 112.796 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -66.44 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.39 -31.71 58.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 25.0 111.061 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.79 -49.89 76.01 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.32 0.581 . . . . 25.0 110.4 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -75.27 2.11 11.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -119.92 19.15 12.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.91 0.862 . . . . 25.0 109.61 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.0 t -107.47 177.18 4.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 25.0 110.614 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -80.95 -18.05 48.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -95.38 14.84 21.18 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.166 -0.925 . . . . 25.0 109.651 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.86 146.05 33.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -80.69 140.84 35.41 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.55 -0.907 . . . . 25.0 108.55 -176.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -58.33 142.45 48.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 25.0 112.645 -171.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -126.23 147.89 49.58 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.365 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -126.28 151.04 48.02 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.153 -0.684 . . . . 25.0 109.153 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -94.76 143.01 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.841 -1.911 . . . . 25.0 105.841 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.6 ttp -151.0 166.89 29.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.205 -0.295 . . . . 25.0 110.205 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.1 p -103.96 171.96 7.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.38 -2.081 . . . . 25.0 105.38 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.04 -169.41 7.52 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.361 0.423 . . . . 25.0 114.117 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.92 -172.74 20.21 Favored Glycine 0 N--CA 1.459 0.222 0 O-C-N 122.405 -0.467 . . . . 25.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 18.0 tt0 -75.82 135.66 40.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.952 -0.734 . . . . 25.0 109.424 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -129.24 152.11 49.17 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.8 m -117.7 134.84 54.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.455 . . . . 25.0 110.136 -174.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.73 111.99 23.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.781 -1.933 . . . . 25.0 105.781 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.4 m -120.37 110.78 16.93 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.99 141.38 52.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 104.699 -2.334 . . . . 25.0 104.699 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.6 t -145.01 161.97 38.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.553 0.216 . . . . 25.0 110.657 -173.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -125.43 150.73 47.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -72.39 -17.41 61.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 159.69 61.09 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.0 140.49 60.49 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 114.553 -3.165 . . . . 25.0 110.355 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -130.91 147.17 52.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.547 -1.279 . . . . 25.0 107.547 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -68.01 146.9 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.455 -1.313 . . . . 25.0 107.455 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.4 p -140.37 146.71 38.76 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.322 -1.362 . . . . 25.0 107.322 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -110.23 -50.16 2.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.905 0.383 . . . . 25.0 110.082 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -158.95 147.59 18.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.03 -0.419 . . . . 25.0 109.927 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -135.18 144.29 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 166.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -148.04 159.13 44.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.472 -0.566 . . . . 25.0 109.472 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.35 149.91 47.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.653 0.74 . . . . 25.0 112.08 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.74 165.95 20.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.051 -1.463 . . . . 25.0 107.051 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 pt -130.03 159.1 42.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.598 -0.89 . . . . 25.0 108.598 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 114' ' ' ASP . 58.9 m -111.72 115.95 29.94 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -89.99 112.02 23.29 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -76.11 153.96 35.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.014 -1.106 . . . . 25.0 108.014 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.33 31.95 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 116.011 1.164 . . . . 25.0 116.011 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -60.2 153.74 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.765 0.783 . . . . 25.0 110.102 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.52 147.1 98.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 25.0 107.767 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.91 -20.0 34.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 117.828 -0.982 . . . . 25.0 114.468 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.11 -23.71 63.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.027 0.918 . . . . 25.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -96.04 136.19 22.29 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.49 126.56 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 116.726 -1.716 . . . . 25.0 114.372 -172.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 tt -52.76 -39.44 62.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.421 -1.263 . . . . 25.0 111.726 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.04 -16.06 63.04 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -83.06 -41.72 18.29 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.965 -0.459 . . . . 25.0 110.831 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.84 60.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 100' ' ' THR . 0.4 OUTLIER -67.87 -31.51 71.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.164 -0.471 . . . . 25.0 112.041 -176.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -125.98 111.67 15.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.784 0.661 . . . . 25.0 112.784 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -128.18 121.14 28.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.52 124.26 23.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.227 -0.296 . . . . 25.0 110.746 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -14.96 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.985 -0.746 . . . . 25.0 108.985 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.51 154.43 10.22 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.298 -0.953 . . . . 25.0 113.965 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.66 137.25 36.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.88 87.47 48.98 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.0 157.65 46.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.275 -1.35 . . . . 25.0 111.339 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -112.21 99.11 7.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.195 -1.039 . . . . 25.0 108.195 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.29 4.21 9.15 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.552 -1.647 . . . . 25.0 106.552 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.52 -179.1 45.13 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 103.401 -3.88 . . . . 25.0 103.401 -175.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -139.51 65.58 33.76 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 116.12 1.896 . . . . 25.0 116.12 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 175.71 9.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 116.884 -1.611 . . . . 25.0 109.565 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.87 56.2 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.045 0.757 . . . . 25.0 113.045 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.3 t -60.36 -24.55 65.17 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.193 0.52 . . . . 25.0 112.28 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.97 7.1 47.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.384 0.673 . . . . 25.0 112.532 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -58.37 141.28 51.78 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.542 -1.651 . . . . 25.0 106.542 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -35.6 80.81 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.376 0.534 . . . . 25.0 111.883 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.4 t -86.09 124.84 32.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.769 -0.826 . . . . 25.0 108.769 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -120.58 149.76 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.735 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -112.35 131.72 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.2 mm -132.0 128.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 63.0 t80 -79.79 132.81 36.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.954 -1.128 . . . . 25.0 107.954 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.6 mm -119.42 123.07 28.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.09 162.97 39.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 117.355 -1.296 . . . . 25.0 112.523 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.91 28.71 8.18 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.919 -1.511 . . . . 25.0 106.919 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.15 -18.63 63.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.852 -1.067 . . . . 25.0 113.566 -172.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -156.81 150.29 24.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.258 0.552 . . . . 25.0 109.959 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.83 154.18 19.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.898 -1.046 . . . . 25.0 108.718 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.27 -176.33 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 121.509 0.505 . . . . 25.0 112.105 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 55.2 p90 -80.74 145.02 31.74 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.78 0.659 . . . . 25.0 112.78 -174.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 33.8 m80 -132.66 116.05 16.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 t -93.28 138.12 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 120.69 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 mp -104.51 141.08 37.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.804 -1.184 . . . . 25.0 107.804 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.67 132.92 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.827 0.739 . . . . 25.0 112.206 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.33 137.41 57.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -120.65 112.54 19.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.763 -1.569 . . . . 25.0 106.763 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.78 133.1 34.36 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.553 -1.203 . . . . 25.0 109.444 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 156' ' ' ASP . 58.1 t -117.24 121.96 68.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.542 -0.91 . . . . 25.0 108.542 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -13.6 61.58 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.747 0.647 . . . . 25.0 112.747 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.438 ' H ' HG12 ' A' ' 154' ' ' VAL . 25.5 m-20 -81.31 -13.64 58.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.702 0.63 . . . . 25.0 112.702 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.3 p -144.31 159.77 42.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.33 0.863 . . . . 25.0 113.33 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -79.45 3.82 17.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 25.0 110.722 171.143 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -110.13 171.04 7.69 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.742 -0.836 . . . . 25.0 108.742 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.47 161.29 40.06 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.421 0.629 . . . . 25.0 109.925 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -96.45 130.39 43.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -132.31 139.13 48.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.694 0.627 . . . . 25.0 112.694 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.71 154.24 39.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.119 -0.697 . . . . 25.0 109.119 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.2 p -136.98 137.25 47.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.374 -2.454 . . . . 25.0 104.374 171.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.6 mt -132.2 130.73 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -111.97 139.12 47.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.65 -1.241 . . . . 25.0 107.65 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.81 126.91 60.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.442 0.639 . . . . 25.0 109.921 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 42.3 t0 -85.97 102.04 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.778 -1.564 . . . . 25.0 106.778 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.21 117.33 33.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.537 -0.912 . . . . 25.0 108.537 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 25.7 m -136.45 163.19 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.017 -0.538 . . . . 25.0 111.023 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -89.99 155.27 19.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.007 -1.849 . . . . 25.0 106.007 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.991 -1.004 . . . . 25.0 110.095 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 109.896 -0.409 . . . . 25.0 109.896 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.89 -175.84 47.79 Favored Glycine 0 CA--C 1.51 -0.267 0 N-CA-C 106.147 -2.781 . . . . 25.0 106.147 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.19 148.12 36.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.441 1.121 . . . . 25.0 111.021 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.23 112.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 104.025 -2.583 . . . . 25.0 104.025 170.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.48 2.69 13.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.709 0.633 . . . . 25.0 112.709 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 74.15 151.66 0.14 Allowed Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 125.752 1.621 . . . . 25.0 110.003 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.53 153.78 89.52 Favored 'Cis proline' 0 C--O 1.222 -0.283 0 CA-C-O 121.733 0.639 . . . . 25.0 112.203 -1.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.56 14.8 13.37 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 117.081 1.592 . . . . 25.0 117.081 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -65.86 125.36 25.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.632 1.216 . . . . 25.0 111.431 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -78.51 -19.64 52.54 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.441 0.534 . . . . 25.0 112.441 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.66 67.93 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.146 0.278 . . . . 25.0 111.091 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.02 -31.52 72.67 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 120.693 0.283 . . . . 25.0 111.315 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.98 -3.88 55.3 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 116.43 -0.35 . . . . 25.0 111.164 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -80.88 -6.27 58.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.487 . . . . 25.0 109.684 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -56.56 160.37 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.013 -0.994 . . . . 25.0 111.212 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -55.46 -17.26 4.81 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.959 0.904 . . . . 25.0 113.1 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.96 -20.99 57.67 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 121.83 -0.544 . . . . 25.0 112.378 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -83.09 -1.98 54.21 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.347 0.869 . . . . 25.0 113.347 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.5 -31.28 0.06 OUTLIER Glycine 0 C--O 1.222 -0.644 0 N-CA-C 117.191 1.637 . . . . 25.0 117.191 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 63.54 -27.86 0.08 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 118.545 2.795 . . . . 25.0 118.545 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.5 mt -80.02 -3.02 46.7 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.815 -0.553 . . . . 25.0 111.792 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -119.21 -178.21 3.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.91 -0.586 . . . . 25.0 110.503 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.03 158.17 33.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.168 -1.79 . . . . 25.0 106.168 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -63.1 12.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.779 2.14 . . . . 25.0 116.779 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.7 t 178.91 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.089 1.756 . . . . 25.0 108.236 170.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.29 177.65 51.16 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 121.196 -0.526 . . . . 25.0 113.584 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.6 t -70.02 -14.19 62.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.894 0.702 . . . . 25.0 112.894 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -70.33 -12.82 16.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.861 0.362 . . . . 25.0 111.167 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.7 ptm -58.6 -10.88 2.5 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 117.77 2.507 . . . . 25.0 117.77 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -69.4 -39.84 77.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.43 0.559 . . . . 25.0 110.85 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.37 64.59 2.52 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 113.571 0.952 . . . . 25.0 113.571 173.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.37 -8.87 24.63 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 118.185 -0.743 . . . . 25.0 113.754 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 pm0 -97.85 4.37 49.68 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.823 0.675 . . . . 25.0 112.823 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -100.74 98.73 9.23 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 118.573 0.624 . . . . 25.0 111.16 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.7 mt -90.47 117.7 29.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.978 -2.23 . . . . 25.0 104.978 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -84.21 141.31 31.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.725 0.297 . . . . 25.0 110.632 -175.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.96 157.71 46.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.012 -1.477 . . . . 25.0 107.012 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -127.47 143.52 51.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.498 0.666 . . . . 25.0 111.703 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -71.36 155.47 40.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.685 -0.689 . . . . 25.0 110.421 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.64 154.82 27.62 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 116.261 1.264 . . . . 25.0 116.261 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -90.42 153.88 46.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.247 -0.476 . . . . 25.0 110.046 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.6 -26.17 8.0 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 128.618 0.674 . . . . 25.0 112.787 0.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.8 p80 163.56 -46.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.933 2.093 . . . . 25.0 106.588 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 m 64.0 -39.94 0.22 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.723 1.609 . . . . 25.0 115.169 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.45 -146.53 6.89 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.815 -1.714 . . . . 25.0 108.815 171.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -67.65 -178.97 1.75 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 CA-C-N 119.998 1.899 . . . . 25.0 111.3 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 100.54 3.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.096 -1.075 . . . . 25.0 108.096 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -93.73 165.24 12.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.41 -0.814 . . . . 25.0 112.07 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.53 -3.64 58.78 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.468 -0.787 . . . . 25.0 113.736 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -70.41 -18.23 63.03 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.129 -0.63 . . . . 25.0 112.399 -176.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -71.27 -40.49 74.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.148 -1.056 . . . . 25.0 108.148 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.81 -30.51 68.05 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.026 0.38 . . . . 25.0 112.026 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -87.83 -2.88 58.9 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.375 -0.375 . . . . 25.0 110.731 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.23 17.28 3.51 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 125.243 1.417 . . . . 25.0 113.144 -173.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.94 -33.14 46.89 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.641 -0.984 . . . . 25.0 110.641 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.37 -18.7 65.98 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.6 -0.81 . . . . 25.0 112.35 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.24 -24.94 63.17 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.401 -0.47 . . . . 25.0 111.493 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.01 -26.64 67.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.91 0.386 . . . . 25.0 111.349 175.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.25 -25.68 75.05 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 110.673 -0.971 . . . . 25.0 110.673 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.49 71.62 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 121.25 -0.5 . . . . 25.0 112.846 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.42 -42.61 84.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.929 -1.137 . . . . 25.0 107.929 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.06 -26.42 56.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 25.0 111.227 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -21.65 64.87 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.425 0.631 . . . . 25.0 111.674 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -68.84 -3.78 13.79 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.816 -0.553 . . . . 25.0 112.41 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -132.69 55.68 1.88 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -135.71 157.8 45.98 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.979 -0.378 . . . . 25.0 109.979 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -71.95 -25.11 61.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.688 0.756 . . . . 25.0 109.138 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -97.55 18.84 14.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.711 . . . . 25.0 110.492 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -52.71 142.22 19.13 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.564 0.697 . . . . 25.0 111.634 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -69.02 143.82 54.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.555 1.169 . . . . 25.0 109.778 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -75.36 131.29 40.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.587 -0.733 . . . . 25.0 111.562 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -91.62 146.34 23.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.813 -0.63 . . . . 25.0 111.121 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -131.76 114.32 14.59 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.173 -0.306 . . . . 25.0 110.173 168.095 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -73.47 135.54 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.063 -2.199 . . . . 25.0 105.063 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.1 tpt -150.42 154.15 37.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 p -93.0 -177.17 4.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.189 -1.411 . . . . 25.0 107.189 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -166.53 31.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.87 -0.492 . . . . 25.0 111.87 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.78 -178.94 30.05 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 112.16 -0.376 . . . . 25.0 112.16 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 1.7 tp10 -79.99 133.89 36.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -126.03 121.81 34.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.414 0.626 . . . . 25.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.3 m -91.75 126.92 37.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.982 -1.118 . . . . 25.0 107.982 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -119.06 125.91 50.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -123.54 130.76 53.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 25.0 111.347 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.1 m0 -123.66 147.91 46.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.628 -2.73 . . . . 25.0 103.628 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -136.54 161.06 36.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.16 0.505 . . . . 25.0 109.723 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.05 137.88 47.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.7 t -79.32 -9.13 59.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.93 60.85 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 106.268 -1.752 . . . . 25.0 106.268 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.26 144.75 47.0 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 116.203 -2.065 . . . . 25.0 111.92 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -131.07 139.74 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.197 -1.409 . . . . 25.0 107.197 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -71.26 148.39 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -149.95 141.89 23.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.7 t -92.44 -47.26 7.25 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.756 0.422 . . . . 25.0 109.998 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -165.61 168.65 16.15 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.162 -0.336 . . . . 25.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -139.58 140.19 36.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 167.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -145.86 156.37 43.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.389 -0.369 . . . . 25.0 110.748 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -133.14 144.78 50.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.874 -0.603 . . . . 25.0 111.02 -167.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -137.12 165.53 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 28.2 pt -134.74 152.2 32.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.686 -1.227 . . . . 25.0 107.686 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 p -85.13 141.95 29.84 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -88.33 121.31 30.58 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 113.255 0.835 . . . . 25.0 113.255 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -86.5 150.78 24.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.443 -1.317 . . . . 25.0 107.443 169.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.29 64.1 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.072 1.589 . . . . 25.0 117.072 173.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -61.19 154.32 23.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.678 1.239 . . . . 25.0 110.735 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.63 154.43 44.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 25.0 109.907 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.62 -7.39 16.7 Favored 'Trans proline' 0 C--N 1.351 0.707 0 N-CA-C 116.084 1.532 . . . . 25.0 116.084 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.16 -8.1 55.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.141 0.972 . . . . 25.0 110.096 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -123.74 150.14 61.12 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.192 -0.67 . . . . 25.0 109.192 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.7 111.36 1.88 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 117.321 -1.319 . . . . 25.0 111.797 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.84 -44.06 66.48 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.226 -0.897 . . . . 25.0 113.23 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.68 -27.22 68.54 Favored 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.92 -41.78 50.79 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.337 0.589 . . . . 25.0 110.209 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.46 6.37 23.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.943 -1.026 . . . . 25.0 112.953 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.07 -38.83 82.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.848 0.684 . . . . 25.0 112.848 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -133.62 156.77 47.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.957 -0.464 . . . . 25.0 111.605 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -133.53 146.31 50.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.033 -0.728 . . . . 25.0 109.033 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.4 tp -77.59 127.18 32.07 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 tt -106.08 -3.37 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.693 0.759 . . . . 25.0 110.984 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.23 156.12 8.29 Favored Glycine 0 C--O 1.229 -0.175 0 C-N-CA 120.469 -0.872 . . . . 25.0 113.948 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.35 137.18 22.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.681 -1.229 . . . . 25.0 107.681 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.19 109.45 10.55 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.69 161.7 36.38 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 116.228 -2.048 . . . . 25.0 111.965 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -122.96 92.66 3.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -175.62 -94.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 N-CA-C 99.897 -4.112 . . . . 25.0 99.897 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -97.87 143.27 16.59 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 105.32 -3.112 . . . . 25.0 105.32 167.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.6 155.82 13.35 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.67 -167.3 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 O-C-N 122.265 0.613 . . . . 25.0 111.017 174.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.75 24.2 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.662 0.616 . . . . 25.0 112.662 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.8 1.07 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.927 1.454 . . . . 25.0 114.927 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -58.66 -13.84 6.91 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.421 1.267 . . . . 25.0 114.421 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -59.12 144.12 46.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.686 0.755 . . . . 25.0 112.714 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.6 tp -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.983 -1.008 . . . . 25.0 112.395 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.6 t -94.45 123.37 37.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -103.99 133.72 48.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 25.0 110.742 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -99.82 134.1 43.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 25.0 109.563 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.9 mt -132.95 119.67 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 87.9 t80 -85.82 138.01 32.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.785 -0.45 . . . . 25.0 109.785 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.45 124.87 26.21 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.46 153.57 50.02 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 116.381 -1.946 . . . . 25.0 111.403 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -108.1 51.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.66 1.219 . . . . 25.0 109.302 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -103.72 -6.2 21.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.639 -1.164 . . . . 25.0 111.2 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -161.0 157.74 26.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.283 0.563 . . . . 25.0 112.41 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.3 pt? -116.72 153.87 31.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.584 -0.735 . . . . 25.0 110.334 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 133.31 140.26 4.35 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 113.851 0.3 . . . . 25.0 113.851 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -85.83 145.95 26.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 116.272 1.953 . . . . 25.0 116.272 -173.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -149.55 167.05 27.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -98.06 150.51 4.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.894 0.854 . . . . 25.0 111.965 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.7 mt -106.94 131.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.311 -2.848 . . . . 25.0 103.311 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.0 mt -110.12 143.97 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 163' ' ' GLN . . . -142.63 148.49 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.612 -0.885 . . . . 25.0 108.612 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.14 139.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.563 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -126.5 103.23 7.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.596 -0.89 . . . . 25.0 108.596 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -94.15 138.19 32.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.238 -0.289 . . . . 25.0 110.8 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.5 t -117.6 132.01 68.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.056 -1.461 . . . . 25.0 107.056 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.54 -41.42 46.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 25.0 110.524 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -10.92 60.37 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.12 1.896 . . . . 25.0 116.12 -170.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.8 p -126.37 158.25 36.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.966 -0.459 . . . . 25.0 110.519 -176.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -74.44 -10.17 59.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 25.0 111.588 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -103.76 158.67 16.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.412 0.625 . . . . 25.0 110.451 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.83 162.92 34.2 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.465 -3.161 . . . . 25.0 102.465 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.31 150.59 45.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.516 0.562 . . . . 25.0 112.516 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.65 153.92 41.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.29 -1.374 . . . . 25.0 107.29 174.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 150' ' ' ALA . 0.5 OUTLIER -145.95 154.21 41.67 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.83 141.86 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.886 0.374 . . . . 25.0 110.324 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 62.9 mt -133.58 122.6 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.28 -1.378 . . . . 25.0 107.28 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -87.81 131.6 34.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.549 -1.649 . . . . 25.0 106.549 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.38 132.59 70.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.827 -0.805 . . . . 25.0 108.827 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.9 95.76 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 104.929 -2.248 . . . . 25.0 104.929 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.58 121.8 32.12 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.254 -1.758 . . . . 25.0 106.254 -173.795 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 20.0 m -135.19 166.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 123.231 0.332 . . . . 25.0 111.448 -175.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.38 141.11 28.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.8 tptt . . . . . 0 C--O 1.246 0.917 0 N-CA-C 115.564 1.69 . . . . 25.0 115.564 177.38 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 112.149 0.426 . . . . 25.0 112.149 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.24 -153.37 27.23 Favored Glycine 0 C--O 1.241 0.555 0 N-CA-C 117.364 1.706 . . . . 25.0 117.364 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -128.02 153.0 47.26 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.602 0.761 . . . . 25.0 111.956 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 93.7 mt -93.83 119.34 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 103.665 -2.717 . . . . 25.0 103.665 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -90.08 -43.33 10.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.535 -0.543 . . . . 25.0 109.535 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -138.79 149.68 62.9 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 109.8 1.48 Allowed 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 132.306 2.211 . . . . 25.0 115.299 -1.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.38 -176.76 26.81 Favored Glycine 0 C--O 1.226 -0.405 0 N-CA-C 114.631 0.612 . . . . 25.0 114.631 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 t -82.97 134.77 35.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.485 -0.421 . . . . 25.0 111.065 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -78.11 -26.32 47.94 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.919 0.39 . . . . 25.0 111.051 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.34 65.92 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.873 0.694 . . . . 25.0 112.873 -172.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.07 71.9 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 120.785 0.326 . . . . 25.0 111.184 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.47 -4.38 55.6 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.054 -0.521 . . . . 25.0 111.743 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.93 -33.04 24.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 25.0 111.577 -175.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -71.6 153.85 41.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.014 0.746 . . . . 25.0 113.014 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.04 -31.49 67.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.629 -0.714 . . . . 25.0 110.679 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.17 -29.23 65.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.468 0.544 . . . . 25.0 112.468 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -83.28 -13.26 55.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.066 0.395 . . . . 25.0 112.066 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.99 -6.28 26.32 Favored Glycine 0 CA--C 1.513 -0.086 0 N-CA-C 111.411 -0.675 . . . . 25.0 111.411 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.6 t80 63.69 -46.66 0.26 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.448 1.899 . . . . 25.0 115.528 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -103.89 -22.15 13.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.768 0.655 . . . . 25.0 112.768 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -151.91 159.8 43.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.559 0.219 . . . . 25.0 111.173 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -81.32 156.95 25.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.495 . . . . 25.0 109.752 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.84 59.38 0.99 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 176.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.21 -36.63 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.95 -154.44 51.18 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.158 -1.177 . . . . 25.0 110.158 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.3 t -61.2 -13.86 21.23 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.334 1.235 . . . . 25.0 114.334 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.2 t -62.54 -20.99 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.868 -0.52 . . . . 25.0 110.36 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -63.94 -11.06 24.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -79.04 -35.98 41.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.659 -0.496 . . . . 25.0 109.659 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.66 79.25 9.56 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 175.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.53 -15.89 46.01 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 115.938 -2.241 . . . . 25.0 112.44 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -85.4 -22.08 28.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.718 -0.658 . . . . 25.0 112.437 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -132.99 94.02 3.29 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 114.732 1.382 . . . . 25.0 114.732 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.15 114.79 28.82 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -114.5 142.21 46.7 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.427 0.454 . . . . 25.0 110.358 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 104.16 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.475 -0.565 . . . . 25.0 109.475 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.0 -72.28 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.969 0.89 . . . . 25.0 112.933 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -112.27 -163.99 0.89 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 106.558 -1.645 . . . . 25.0 106.558 -176.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.8 53.09 0.67 Allowed Glycine 0 C--O 1.218 -0.888 0 C-N-CA 121.277 -0.487 . . . . 25.0 111.946 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -89.97 138.36 27.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.58 -0.896 . . . . 25.0 108.58 177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.21 128.13 15.41 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 128.957 0.815 . . . . 25.0 112.346 -3.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -67.91 -36.25 79.85 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.561 -0.456 . . . . 25.0 110.693 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m 64.25 -38.32 0.21 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.636 2.088 . . . . 25.0 116.636 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.19 -155.06 28.73 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.654 -0.578 . . . . 25.0 111.654 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.26 161.46 40.36 Favored 'Trans proline' 0 C--N 1.346 0.437 0 CA-C-N 118.668 1.234 . . . . 25.0 114.181 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.58 13.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.081 -0.963 . . . . 25.0 112.451 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.62 134.55 56.51 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.025 -1.102 . . . . 25.0 108.025 173.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.11 6.99 35.2 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.347 -0.454 . . . . 25.0 113.476 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 57.7 20.78 6.68 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.259 1.024 . . . . 25.0 113.438 -176.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.6 mt -50.87 -37.92 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 114.338 1.236 . . . . 25.0 114.338 -171.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.62 -45.44 89.21 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.257 1.206 . . . . 25.0 114.257 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 m -120.47 -20.86 7.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 117.006 2.224 . . . . 25.0 117.006 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.01 19.87 0.52 Allowed 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 115.281 1.586 . . . . 25.0 115.281 -171.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -108.99 -25.8 5.49 Favored Glycine 0 C--O 1.221 -0.682 0 O-C-N 122.221 -0.3 . . . . 25.0 113.362 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.87 -6.08 42.61 Favored Glycine 0 C--O 1.221 -0.687 0 O-C-N 122.45 -0.441 . . . . 25.0 113.833 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.2 mt -61.89 -23.28 66.21 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 112.585 0.587 . . . . 25.0 112.585 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -71.06 -13.12 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.205 -0.309 . . . . 25.0 111.692 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.25 -16.65 60.53 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.114 0.805 . . . . 25.0 115.114 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.3 -26.14 69.12 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-N 118.121 0.961 . . . . 25.0 112.389 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.2 mm -68.03 -33.91 63.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.112 -0.64 . . . . 25.0 110.007 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -77.53 -19.3 55.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.206 -0.309 . . . . 25.0 111.256 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.96 -21.56 64.91 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.625 0.602 . . . . 25.0 112.625 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -56.03 -21.4 21.36 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.678 0.622 . . . . 25.0 112.678 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -138.75 51.73 1.81 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.174 0.511 . . . . 25.0 109.751 177.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 t -118.78 162.83 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 25.0 111.255 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.87 -32.48 74.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.827 0.822 . . . . 25.0 110.283 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -94.48 16.43 15.34 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.659 -0.701 . . . . 25.0 112.633 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -61.07 150.25 34.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -97.02 156.4 16.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.042 -1.096 . . . . 25.0 108.042 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.06 121.93 3.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -76.24 108.08 8.92 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.799 -0.445 . . . . 25.0 109.799 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 105.93 16.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.362 0.601 . . . . 25.0 112.117 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -64.18 142.86 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.028 -0.731 . . . . 25.0 109.028 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 tpt -146.82 151.87 37.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.849 -1.167 . . . . 25.0 107.849 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -101.95 171.99 7.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.455 -1.313 . . . . 25.0 107.455 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.08 177.57 19.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.81 0.684 . . . . 25.0 114.81 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.16 177.1 31.79 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 112.399 -0.281 . . . . 25.0 112.399 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER -92.06 132.73 36.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.942 -0.74 . . . . 25.0 109.733 179.358 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -135.33 141.78 45.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.888 0.375 . . . . 25.0 110.448 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.9 m -84.34 118.75 24.42 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -93.03 111.92 23.71 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.443 -2.058 . . . . 25.0 105.443 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -90.67 118.74 30.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.93 -0.577 . . . . 25.0 111.192 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -122.92 139.49 53.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.757 -2.312 . . . . 25.0 104.757 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -145.01 161.84 38.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 25.0 111.95 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.87 136.87 52.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.076 -2.564 . . . . 25.0 104.076 173.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.7 t -72.82 -15.91 61.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.382 0.882 . . . . 25.0 113.382 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 153.81 67.74 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 104.752 -2.314 . . . . 25.0 104.752 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 130.73 25.24 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 115.525 -2.517 . . . . 25.0 111.574 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -130.93 153.34 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 156' ' ' ASP . 11.8 t-20 -65.08 143.2 58.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.563 -1.643 . . . . 25.0 106.563 171.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -144.78 147.26 32.69 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.378 -2.453 . . . . 25.0 104.378 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -116.99 -47.15 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.099 0.777 . . . . 25.0 113.099 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -159.12 153.29 23.7 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.518 -0.739 . . . . 25.0 112.388 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.39 132.34 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.161 0.505 . . . . 25.0 109.73 167.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -136.89 142.57 42.75 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.85 151.52 39.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.774 0.797 . . . . 25.0 111.614 -166.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.48 168.94 18.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.61 -1.177 . . . . 25.0 109.064 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.78 149.11 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.115 -0.328 . . . . 25.0 110.115 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.5 m -88.5 117.19 27.28 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.192 -0.458 . . . . 25.0 110.025 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.18 125.16 34.47 Favored 'General case' 0 C--O 1.209 -1.057 0 O-C-N 121.334 -0.854 . . . . 25.0 110.949 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -76.86 154.08 34.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 106.531 -1.655 . . . . 25.0 106.531 168.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.01 10.21 56.45 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 119.349 2.499 . . . . 25.0 119.349 170.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -61.02 153.33 25.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.958 1.379 . . . . 25.0 110.699 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.51 152.05 95.46 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.337 -1.357 . . . . 25.0 107.337 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 -19.8 47.3 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 117.646 -1.102 . . . . 25.0 114.868 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.18 -18.62 62.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.822 0.82 . . . . 25.0 111.67 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -96.13 128.86 35.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.483 -0.761 . . . . 25.0 109.866 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.14 126.28 16.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.588 -1.141 . . . . 25.0 114.223 -173.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.12 -42.94 66.51 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.525 -1.216 . . . . 25.0 113.213 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -69.01 -17.35 63.9 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 113.046 0.758 . . . . 25.0 113.046 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -77.15 -45.63 26.12 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.64 67.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.364 0.602 . . . . 25.0 112.216 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -71.04 -29.03 64.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 25.0 110.538 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.46 92.12 3.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.259 0.552 . . . . 25.0 109.712 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -99.75 110.13 22.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -62.82 117.25 6.09 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.857 -0.423 . . . . 25.0 109.857 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -2.53 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 107.382 -1.34 . . . . 25.0 107.382 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.22 151.05 6.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.778 . . . . 25.0 114.639 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -143.04 122.66 13.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.057 -1.831 . . . . 25.0 106.057 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.09 117.95 11.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.35 175.38 11.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 115.962 -2.225 . . . . 25.0 110.259 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -128.56 92.36 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.253 -2.128 . . . . 25.0 105.253 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.0 -19.94 13.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.681 -1.6 . . . . 25.0 107.711 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.76 -179.35 30.78 Favored Glycine 0 N--CA 1.445 -0.764 1 N-CA-C 103.013 -4.035 . . . . 25.0 103.013 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -116.65 36.75 0.22 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 117.16 2.281 . . . . 25.0 117.16 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.88 170.57 18.5 Favored 'Trans proline' 0 C--N 1.355 0.876 1 C-N-CA 113.225 -4.05 . . . . 25.0 110.333 171.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.11 55.43 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.294 1.22 . . . . 25.0 114.294 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.8 p -70.51 -19.81 62.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.1 mmt-85 -100.96 10.72 40.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.274 0.63 . . . . 25.0 112.478 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -58.05 156.8 8.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.028 1.862 . . . . 25.0 116.028 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.73 -22.4 59.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.344 -1.298 . . . . 25.0 111.662 176.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 65.1 m -100.04 140.55 34.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -129.57 136.86 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.339 0.866 . . . . 25.0 113.339 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -79.37 126.8 31.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.543 -1.651 . . . . 25.0 106.543 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -131.91 125.81 55.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.705 -1.221 . . . . 25.0 107.705 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 90.6 t80 -85.85 133.33 33.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -108.84 129.67 23.65 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.844 -1.539 . . . . 25.0 106.844 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -66.27 146.58 81.47 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 117.127 -1.449 . . . . 25.0 111.92 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -110.57 -12.54 14.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.055 0.931 . . . . 25.0 110.857 -173.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.0 4.22 45.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.839 1.052 . . . . 25.0 113.839 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -151.78 151.65 31.65 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 121.844 -0.535 . . . . 25.0 112.145 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.32 141.57 47.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.286 -0.87 . . . . 25.0 109.49 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.74 163.49 10.49 Favored Glycine 0 CA--C 1.517 0.178 0 N-CA-C 115.11 0.804 . . . . 25.0 115.11 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 11.4 p90 -86.92 145.04 26.69 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.504 0.927 . . . . 25.0 113.504 -176.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -144.5 159.09 43.35 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 105.861 -1.904 . . . . 25.0 105.861 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.83 136.31 50.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 106.894 -1.521 . . . . 25.0 106.894 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.7 mt -96.04 120.16 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.155 -2.535 . . . . 25.0 104.155 174.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.5 mt -105.5 137.48 43.26 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.31 146.64 32.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.101 0.864 . . . . 25.0 112.321 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.03 135.43 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.64 -1.615 . . . . 25.0 106.64 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -130.06 117.45 20.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.606 0.717 . . . . 25.0 110.01 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.7 132.0 38.49 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.865 -1.061 . . . . 25.0 109.998 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.0 t -135.18 134.74 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.0 -10.04 19.29 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.204 1.557 . . . . 25.0 115.204 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ASP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 91' ' ' ASN . 41.9 p-10 -102.29 18.22 21.52 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 25.0 110.457 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.2 p -133.0 151.16 52.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -70.22 -18.13 63.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.665 0.269 . . . . 25.0 111.656 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.16 171.93 7.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.061 -0.518 . . . . 25.0 111.87 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 159.53 26.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.683 -1.969 . . . . 25.0 105.683 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -111.35 145.59 38.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.302 1.223 . . . . 25.0 114.302 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -123.5 139.7 53.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.204 -0.907 . . . . 25.0 108.734 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -149.57 142.1 24.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.417 -1.327 . . . . 25.0 107.417 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 m -135.59 151.06 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.305 -1.369 . . . . 25.0 107.305 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.08 110.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.006 -1.479 . . . . 25.0 107.006 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -77.53 131.74 38.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.321 -1.733 . . . . 25.0 106.321 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.0 157.93 41.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.789 -0.569 . . . . 25.0 110.605 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 43.7 t0 -123.58 108.29 12.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.344 -1.724 . . . . 25.0 106.344 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.77 103.99 16.0 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.81 -1.552 . . . . 25.0 106.81 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.45 171.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.825 0.345 . . . . 25.0 111.319 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.02 152.67 32.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.9 -1.148 . . . . 25.0 107.9 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.896 0 CA-C-O 117.844 -1.074 . . . . 25.0 109.599 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 112.374 0.509 . . . . 25.0 112.374 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.42 -156.75 48.79 Favored Glycine 0 C--O 1.227 -0.285 0 C-N-CA 119.731 -1.223 . . . . 25.0 110.559 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.08 133.24 36.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.995 0.398 . . . . 25.0 110.347 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.68 112.32 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 106.498 -1.668 . . . . 25.0 106.498 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.61 -43.5 10.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.95 -0.568 . . . . 25.0 110.798 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -140.55 158.09 66.71 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 107.862 -1.162 . . . . 25.0 107.862 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.14 116.57 4.53 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 131.672 1.947 . . . . 25.0 113.955 -2.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.23 -149.48 45.27 Favored Glycine 0 C--O 1.226 -0.367 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -131.43 110.77 11.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.239 0.542 . . . . 25.0 110.553 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -20.73 65.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.994 -0.548 . . . . 25.0 111.004 176.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -24.13 67.7 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.104 0.253 . . . . 25.0 111.577 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.65 93.89 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 120.852 -0.339 . . . . 25.0 110.281 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.53 -16.8 61.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.269 0.557 . . . . 25.0 111.147 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 t -83.49 -20.44 33.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.547 -0.751 . . . . 25.0 110.099 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.3 p -96.21 157.25 15.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.976 -0.556 . . . . 25.0 111.282 -177.29 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.29 -16.23 64.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.225 -0.443 . . . . 25.0 111.318 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.45 -13.47 30.38 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.184 0.438 . . . . 25.0 112.184 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -83.28 2.22 37.07 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.429 0.9 . . . . 25.0 113.429 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.81 -29.38 0.17 Allowed Glycine 0 C--O 1.224 -0.503 0 N-CA-C 116.317 1.287 . . . . 25.0 116.317 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.76 4.16 0.73 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.34 1.978 . . . . 25.0 116.34 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.19 -30.74 38.8 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.761 -0.587 . . . . 25.0 110.459 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -169.0 157.21 7.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.423 -1.695 . . . . 25.0 106.423 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.08 144.4 40.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.307 -1.738 . . . . 25.0 106.307 170.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.26 63.33 0.49 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.5 t -92.33 -10.34 38.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.247 0.546 . . . . 25.0 111.314 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.83 -160.66 53.94 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.733 -1.347 . . . . 25.0 109.733 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -64.9 -13.86 58.01 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.614 0.598 . . . . 25.0 112.614 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 t -58.09 -23.73 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.482 0.549 . . . . 25.0 112.482 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -70.34 -27.95 64.76 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.763 -0.586 . . . . 25.0 112.542 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.17 -16.28 25.03 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.378 1.085 . . . . 25.0 108.541 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.66 60.09 0.84 Allowed Pre-proline 0 C--O 1.245 0.86 0 CA-C-N 115.176 -0.92 . . . . 25.0 111.733 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.71 -39.86 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 113.558 -3.828 . . . . 25.0 114.348 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -104.24 -23.44 13.24 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.476 1.288 . . . . 25.0 114.476 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.49 114.16 21.86 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 104.567 -2.383 . . . . 25.0 104.567 173.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -133.38 105.05 6.72 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 106.487 -1.671 . . . . 25.0 106.487 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -128.62 141.01 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.22 0.533 . . . . 25.0 112.18 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.07 102.86 5.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -170.94 -168.42 0.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.037 -2.208 . . . . 25.0 105.037 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.58 122.21 23.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.663 0.986 . . . . 25.0 113.663 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.63 156.68 15.42 Favored Glycine 0 C--N 1.322 -0.198 0 N-CA-C 104.026 -3.629 . . . . 25.0 104.026 164.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -112.08 125.78 29.59 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 118.749 1.274 . . . . 25.0 111.061 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.1 149.99 92.66 Favored 'Cis proline' 0 C--N 1.353 0.785 0 C-N-CA 130.461 1.442 . . . . 25.0 110.983 -3.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -68.72 -47.41 66.41 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 -172.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.6 t 61.31 -62.98 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.415 2.006 . . . . 25.0 116.415 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.15 -179.18 29.51 Favored Glycine 0 C--O 1.242 0.599 0 N-CA-C 116.015 1.166 . . . . 25.0 116.015 -175.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.68 170.29 16.83 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.261 2.64 . . . . 25.0 113.758 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.99 132.66 47.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.541 0.571 . . . . 25.0 112.541 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.12 125.22 24.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.047 -0.723 . . . . 25.0 109.047 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.22 9.51 42.48 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.175 -0.535 . . . . 25.0 111.885 -176.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 55.96 19.21 3.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.713 1.205 . . . . 25.0 112.68 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.3 -44.84 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.62 -26.7 68.51 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.419 1.266 . . . . 25.0 114.419 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -112.95 -21.11 11.29 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.79 0.663 . . . . 25.0 112.79 -178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 48.19 26.62 1.09 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.719 1.378 . . . . 25.0 114.719 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.95 -41.28 1.2 Allowed Glycine 0 C--O 1.221 -0.69 0 C-N-CA 121.306 -0.473 . . . . 25.0 113.485 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.46 18.38 33.78 Favored Glycine 0 C--O 1.221 -0.709 0 N-CA-C 115.079 0.791 . . . . 25.0 115.079 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -59.84 -35.94 75.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.573 0.953 . . . . 25.0 113.573 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -65.03 -11.82 43.54 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.841 0.682 . . . . 25.0 112.841 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.94 48.34 Favored Glycine 0 C--O 1.22 -0.74 0 CA-C-O 119.713 -0.493 . . . . 25.0 113.663 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.55 -22.9 73.56 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 117.962 0.881 . . . . 25.0 112.673 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -86.31 -36.98 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.31 -10.86 60.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 25.0 111.9 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -30.57 64.55 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 111.654 0.242 . . . . 25.0 111.654 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.92 -8.64 11.84 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.259 1.207 . . . . 25.0 114.259 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -127.8 24.25 6.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.418 0.628 . . . . 25.0 109.867 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 t -98.5 164.96 12.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.244 -0.435 . . . . 25.0 110.983 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.67 -33.38 74.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.61 0.719 . . . . 25.0 109.148 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -94.89 19.03 10.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.002 -0.545 . . . . 25.0 112.053 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -47.63 136.37 10.41 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.345 0.869 . . . . 25.0 113.345 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -89.68 159.06 17.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.788 . . . . 25.0 109.227 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -65.52 132.91 50.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -80.78 143.24 33.01 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.47 -0.787 . . . . 25.0 109.717 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 96.57 4.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.898 0.703 . . . . 25.0 112.898 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -69.25 138.43 22.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.152 -2.536 . . . . 25.0 104.152 168.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.5 tpt -145.42 146.55 31.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.23 -0.655 . . . . 25.0 109.23 -176.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p -95.0 172.04 8.39 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.81 -174.97 5.48 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 116.648 1.419 . . . . 25.0 116.648 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.84 177.08 35.18 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 115.035 -0.583 . . . . 25.0 113.031 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.97 132.63 34.17 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.034 -0.686 . . . . 25.0 110.86 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -132.61 137.92 47.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 25.0 109.515 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 m -101.97 137.49 40.19 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.596 0.961 . . . . 25.0 113.596 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.29 129.73 55.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.901 -1.518 . . . . 25.0 106.901 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -137.77 129.56 28.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.993 -0.373 . . . . 25.0 109.993 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -124.01 143.36 50.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -145.01 156.92 44.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.7 0.286 . . . . 25.0 111.168 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -139.78 163.98 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -71.28 -19.38 62.35 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.501 0.926 . . . . 25.0 113.501 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.77 147.34 48.11 Favored Pre-proline 0 C--O 1.238 0.468 0 O-C-N 121.943 -0.473 . . . . 25.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.86 149.71 37.79 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 117.689 -1.074 . . . . 25.0 111.734 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 30.7 t60 -130.94 161.65 31.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 25.0 109.199 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -65.86 131.09 45.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.563 -1.273 . . . . 25.0 107.563 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.4 p -143.63 152.22 41.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.256 -1.387 . . . . 25.0 107.256 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.2 t -103.3 -56.84 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.494 0.924 . . . . 25.0 113.494 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -159.01 150.43 20.45 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.849 -0.532 . . . . 25.0 110.644 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 131.12 52.4 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.008 -1.478 . . . . 25.0 107.008 169.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -147.84 158.96 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.528 -0.305 . . . . 25.0 110.729 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -145.32 150.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.705 0.764 . . . . 25.0 112.239 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -128.36 154.8 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.606 -1.179 . . . . 25.0 108.12 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.01 149.36 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.907 0.706 . . . . 25.0 112.907 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.1 m -86.79 121.82 29.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -108.05 125.53 51.67 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 121.74 -0.6 . . . . 25.0 111.759 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -75.9 148.29 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.202 -1.777 . . . . 25.0 106.202 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.58 9.91 34.47 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 117.229 1.652 . . . . 25.0 117.229 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TRP . . . . . 0.401 ' CH2' ' HA ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -83.05 161.5 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.615 1.208 . . . . 25.0 110.56 175.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.63 140.35 78.38 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.26 -13.51 20.87 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 114.492 0.92 . . . . 25.0 114.492 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.44 -13.97 61.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.114 0.959 . . . . 25.0 111.621 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.22 148.21 52.47 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.102 -1.814 . . . . 25.0 106.102 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.96 93.82 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-O 121.55 0.562 . . . . 25.0 112.717 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -36.35 61.13 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 114.367 1.247 . . . . 25.0 114.367 -174.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -61.39 -28.04 68.96 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.186 -0.606 . . . . 25.0 112.305 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -84.65 -46.02 11.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.043 0.449 . . . . 25.0 110.946 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.38 57.54 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 115.705 1.743 . . . . 25.0 115.705 -169.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HA ' ' CH2' ' A' ' 104' ' ' TRP . 42.7 t0 -64.99 -30.71 71.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 25.0 111.335 -172.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -126.15 108.88 11.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.787 -0.82 . . . . 25.0 108.787 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -103.1 132.19 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.525 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.51 127.94 33.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.92 0.74 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.944 0.878 . . . . 25.0 110.031 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.46 140.8 4.72 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.363 -0.922 . . . . 25.0 112.863 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 132.86 15.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.67 109.6 12.14 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.069 -1.086 . . . . 25.0 108.069 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.0 164.69 22.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.482 -1.879 . . . . 25.0 111.72 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -103.84 106.86 17.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.025 -1.472 . . . . 25.0 107.025 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -114.53 -22.7 9.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.578 -1.192 . . . . 25.0 109.515 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -173.86 -161.58 24.19 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 103.78 -3.728 . . . . 25.0 103.78 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.3 t -123.7 50.44 3.36 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.301 1.593 . . . . 25.0 115.301 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.77 170.55 17.52 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 114.047 -3.502 . . . . 25.0 109.769 170.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.62 58.67 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.077 1.14 . . . . 25.0 114.077 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 53.3 p -70.87 -16.0 62.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.892 0.701 . . . . 25.0 112.892 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -99.16 7.01 46.19 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.742 0.275 . . . . 25.0 111.742 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -61.19 152.29 29.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.885 -1.154 . . . . 25.0 107.885 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -11.49 60.77 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.618 0.599 . . . . 25.0 112.618 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.2 t -90.98 124.47 35.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -128.86 140.39 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.049 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -100.83 137.22 39.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.235 -1.024 . . . . 25.0 108.235 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.3 mm -130.85 123.74 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -93.35 134.34 35.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.649 -0.5 . . . . 25.0 109.649 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.72 129.86 23.45 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.7 150.0 73.91 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 117.951 -0.9 . . . . 25.0 112.275 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.36 -4.93 11.3 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 122.115 0.96 . . . . 25.0 110.663 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.87 6.61 27.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.698 -0.683 . . . . 25.0 112.796 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -155.95 170.09 22.93 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.991 -0.443 . . . . 25.0 111.852 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.82 153.56 45.47 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 105.766 -1.939 . . . . 25.0 105.766 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 153.02 144.87 4.01 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-O 122.075 0.819 . . . . 25.0 115.091 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 4.8 p90 -81.48 146.12 30.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.439 -0.88 . . . . 25.0 112.425 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -146.33 158.95 43.94 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 105.512 -2.033 . . . . 25.0 105.512 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.6 t -121.36 130.26 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.05 -2.574 . . . . 25.0 104.05 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.48 119.34 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.204 -1.036 . . . . 25.0 108.204 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.48 131.43 54.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.419 -1.697 . . . . 25.0 106.419 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.49 133.82 45.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.2 t -129.01 132.92 66.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -119.47 108.31 14.39 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.29 132.0 34.06 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.872 -1.058 . . . . 25.0 111.259 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.28 129.5 66.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.559 -2.015 . . . . 25.0 105.559 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.94 -28.3 63.37 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 -167.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -110.0 22.66 15.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -172.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.6 p -137.98 153.1 49.46 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.867 0.365 . . . . 25.0 111.685 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -78.8 -7.81 58.19 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.601 0.715 . . . . 25.0 110.333 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -110.11 161.31 15.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.02 -0.991 . . . . 25.0 109.081 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.11 39.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.785 -2.302 . . . . 25.0 104.785 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -90.86 131.25 36.61 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.836 -1.172 . . . . 25.0 107.836 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -128.73 134.47 48.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.149 -0.478 . . . . 25.0 110.216 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.97 140.15 26.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 176.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.02 139.82 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.9 mt -135.31 118.55 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -80.16 131.42 35.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.96 -1.866 . . . . 25.0 105.96 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.12 162.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.345 0.593 . . . . 25.0 111.767 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 63.0 t0 -129.58 120.99 26.22 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.242 -2.873 . . . . 25.0 103.242 170.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.74 111.41 24.12 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.75 166.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 114.48 1.289 . . . . 25.0 114.48 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -72.08 154.35 41.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 173.293 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.659 0 CA-C-O 118.255 -0.879 . . . . 25.0 110.106 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . 0.641 ' N ' ' HG ' ' A' ' 34' ' ' SER . . . . . . . . 0 C--O 1.24 0.479 0 N-CA-C 108.905 -1.678 . . . . 25.0 108.905 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.31 166.08 34.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.953 0.877 . . . . 25.0 112.696 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.65 122.08 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.752 -1.573 . . . . 25.0 106.752 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -85.75 -42.54 14.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.233 -0.44 . . . . 25.0 111.024 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -143.23 158.6 57.87 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.53 116.13 3.93 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 131.403 1.835 . . . . 25.0 116.823 2.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.2 148.64 7.12 Favored Glycine 0 C--O 1.221 -0.682 0 CA-C-N 114.947 -1.024 . . . . 25.0 113.039 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -94.13 119.87 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.514 . . . . 25.0 109.611 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -21.18 64.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.436 -0.347 . . . . 25.0 111.481 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.38 72.39 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.031 0.382 . . . . 25.0 112.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.59 -27.57 69.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.985 0.422 . . . . 25.0 111.075 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 mt -94.69 -4.09 48.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 25.0 110.901 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.6 t . . . . . 0 C--N 1.322 -0.609 0 CA-C-N 115.849 -0.614 . . . . 25.0 109.478 -177.192 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 N--CA 1.474 0.728 0 CA-C-O 121.674 0.75 . . . . 25.0 111.112 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -15.23 61.96 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.92 1.452 . . . . 25.0 114.92 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -76.19 -30.17 57.94 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.745 1.017 . . . . 25.0 113.745 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.98 44.75 0.46 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 116.805 2.15 . . . . 25.0 116.805 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.06 -22.58 25.99 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 114.543 -3.171 . . . . 25.0 113.786 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -83.68 -34.85 24.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.177 0.513 . . . . 25.0 109.896 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.641 ' HG ' ' N ' ' A' ' 2' ' ' GLY . 60.7 m -111.39 69.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.645 -0.422 . . . . 25.0 111.645 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 tp -81.85 123.34 28.73 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 104.979 -2.23 . . . . 25.0 104.979 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -83.95 132.2 34.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.335 . . . . 25.0 110.868 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.64 28.65 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.82 -1.178 . . . . 25.0 107.82 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? . . . . . 0 C--N 1.325 -0.482 0 N-CA-C 109.855 -0.424 . . . . 25.0 109.855 -173.107 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.216 -1.011 0 N-CA-C 111.366 -0.693 . . . . 25.0 111.366 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.6 -48.18 73.18 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.174 -0.603 . . . . 25.0 110.98 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -73.68 -22.24 60.0 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.781 -0.575 . . . . 25.0 109.494 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -20.64 74.93 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 121.059 -0.591 . . . . 25.0 111.883 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.25 -21.35 70.11 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-N 117.786 0.793 . . . . 25.0 112.409 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.79 -39.17 77.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.343 -0.984 . . . . 25.0 108.343 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.57 -25.78 45.43 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.029 -0.532 . . . . 25.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -67.74 -27.32 66.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.789 0.804 . . . . 25.0 109.852 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -73.1 2.28 7.45 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.847 -0.533 . . . . 25.0 111.534 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -129.61 18.58 5.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.197 0.599 . . . . 25.0 110.036 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.7 t -86.18 156.13 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 25.0 111.897 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -66.75 -31.46 72.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.642 0.734 . . . . 25.0 109.057 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -88.07 1.9 53.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 25.0 112.658 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -56.87 134.95 55.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.39 165.79 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.666 0.746 . . . . 25.0 109.969 -174.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -79.56 106.13 11.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.088 0.47 . . . . 25.0 110.561 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -65.22 146.8 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.93 -1.106 . . . . 25.0 111.133 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.91 130.06 55.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 25.0 110.906 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.2 135.63 24.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.701 -0.681 . . . . 25.0 109.677 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.1 mtp -134.19 142.27 47.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.626 -1.25 . . . . 25.0 107.626 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -89.47 172.96 8.62 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.09 -177.4 6.1 Favored Glycine 0 C--O 1.24 0.531 0 N-CA-C 115.801 1.08 . . . . 25.0 115.801 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.63 -178.72 36.78 Favored Glycine 0 CA--C 1.517 0.181 0 N-CA-C 110.833 -0.907 . . . . 25.0 110.833 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 147.04 34.84 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.452 -1.028 . . . . 25.0 108.596 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -141.86 153.82 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.9 m -117.03 128.26 54.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.303 -0.408 . . . . 25.0 110.241 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -104.11 136.14 44.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.38 0.672 . . . . 25.0 109.285 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.1 m -132.59 130.01 39.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -122.05 152.6 39.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.698 -1.593 . . . . 25.0 106.698 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -143.47 153.17 42.35 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.762 -1.199 . . . . 25.0 107.762 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -121.64 138.49 54.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.742 0.306 . . . . 25.0 110.746 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -92.71 0.41 57.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 25.0 110.526 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.41 129.82 41.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.109 -0.7 . . . . 25.0 109.109 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.11 1.3 9.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 O-C-N 121.983 0.464 . . . . 25.0 112.98 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -73.73 149.36 41.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 25.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.14 155.81 39.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 25.0 112.19 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.2 m -123.48 130.32 52.52 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -90.76 -43.8 9.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 25.0 111.654 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -160.9 152.48 19.41 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 110.259 -0.275 . . . . 25.0 110.259 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -147.32 144.05 28.49 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 25.0 109.132 169.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -152.73 156.71 39.65 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.17 -0.307 . . . . 25.0 110.17 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -149.69 152.97 36.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.116 0.784 . . . . 25.0 113.116 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -134.38 167.43 20.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 pt -133.14 152.22 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.5 p -89.87 145.75 24.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 112.472 0.545 . . . . 25.0 112.472 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -117.49 115.26 24.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.836 0.827 . . . . 25.0 109.966 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -76.23 146.9 38.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.279 -1.748 . . . . 25.0 106.279 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.68 18.47 9.48 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 120.608 -0.806 . . . . 25.0 114.46 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -58.62 149.15 26.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.365 0.582 . . . . 25.0 111.105 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -76.13 146.77 79.04 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 107.472 -1.307 . . . . 25.0 107.472 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.79 -19.97 26.77 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 117.288 -1.341 . . . . 25.0 112.896 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.78 -22.59 61.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.816 0.817 . . . . 25.0 111.756 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -95.92 146.41 31.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.94 -0.475 . . . . 25.0 110.091 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.39 111.52 2.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 117.377 -1.282 . . . . 25.0 113.091 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -38.59 63.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.398 0.679 . . . . 25.0 112.741 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -54.57 -33.03 59.59 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -92.73 -45.06 8.22 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.496 0.554 . . . . 25.0 112.496 175.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.96 -17.19 64.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.67 -39.64 84.5 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.175 1.176 . . . . 25.0 114.175 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.47 155.08 49.19 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 114.231 1.197 . . . . 25.0 114.231 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -129.29 147.0 51.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.97 0.508 . . . . 25.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.5 tp -78.26 128.69 34.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.092 -0.336 . . . . 25.0 110.092 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.0 pt -119.85 1.93 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.95 0.405 . . . . 25.0 111.53 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.64 141.08 3.32 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.179 -1.01 . . . . 25.0 114.513 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.4 131.17 24.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.91 94.88 23.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.206 0.526 . . . . 25.0 110.126 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.17 162.98 37.64 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 116.235 -2.043 . . . . 25.0 110.733 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -103.17 115.67 31.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -127.42 -97.81 0.4 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.498 -1.668 . . . . 25.0 106.498 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -159.35 -167.06 19.49 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.161 -0.776 . . . . 25.0 111.161 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 p 61.41 169.71 0.08 OUTLIER Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 124.365 1.066 . . . . 25.0 111.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.36 -4.47 15.47 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 113.18 -4.08 . . . . 25.0 114.729 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.07 69.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.083 -0.508 . . . . 25.0 109.994 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.0 t -76.62 -20.43 56.74 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.564 0.697 . . . . 25.0 110.544 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -67.27 -16.79 64.49 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.828 -0.624 . . . . 25.0 111.635 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -71.86 105.02 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.205 0.526 . . . . 25.0 111.992 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.48 -21.24 28.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.944 -0.571 . . . . 25.0 109.726 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.1 t -95.28 138.54 32.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.929 -0.397 . . . . 25.0 109.929 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -141.7 151.15 42.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.279 -0.419 . . . . 25.0 111.925 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -101.35 133.83 45.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.818 -0.628 . . . . 25.0 109.948 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.0 mm -131.86 132.61 61.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.78 136.8 32.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.606 -0.516 . . . . 25.0 109.606 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.05 134.18 20.48 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.37 144.15 84.87 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 117.17 -1.42 . . . . 25.0 113.886 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -96.8 -7.56 33.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.449 -0.796 . . . . 25.0 110.095 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -112.42 -3.15 14.54 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.164 1.542 . . . . 25.0 115.164 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -136.54 156.63 48.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.6 mp -127.85 152.48 47.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.006 -0.997 . . . . 25.0 108.888 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.67 154.49 6.15 Favored Glycine 0 C--O 1.237 0.308 0 CA-C-O 121.671 0.595 . . . . 25.0 113.933 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.5 p90 -86.97 148.9 25.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.643 0.735 . . . . 25.0 111.859 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -139.04 149.05 44.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.525 -1.657 . . . . 25.0 106.525 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.5 t -103.4 131.6 51.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.343 -2.095 . . . . 25.0 105.343 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.7 mt -95.92 123.51 48.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.233 -2.136 . . . . 25.0 105.233 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 mp -99.99 127.9 46.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 103.683 -2.71 . . . . 25.0 103.683 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.72 144.08 35.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.819 0.736 . . . . 25.0 111.762 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.56 132.94 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.141 -0.936 . . . . 25.0 109.215 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -124.31 112.63 17.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -97.26 121.65 39.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.008 -0.542 . . . . 25.0 111.784 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.43 115.84 39.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 108.892 -0.781 . . . . 25.0 108.892 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.74 63.44 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.43 -0.77 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.751 0.649 . . . . 25.0 112.751 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.2 t -154.83 166.27 34.02 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.35 -2.66 46.38 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 109.957 -0.386 . . . . 25.0 109.957 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.47 152.99 20.49 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.698 -0.626 . . . . 25.0 109.775 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.36 171.91 13.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.452 -0.573 . . . . 25.0 109.452 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.59 128.33 47.9 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.818 -0.808 . . . . 25.0 108.818 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -126.07 126.55 44.41 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 103.876 -2.639 . . . . 25.0 103.876 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.59 155.78 44.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.376 0.535 . . . . 25.0 111.318 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.49 136.7 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.893 -1.521 . . . . 25.0 106.893 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.4 mt -137.69 122.15 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.745 0.307 . . . . 25.0 110.822 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -77.72 130.94 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.168 0.509 . . . . 25.0 112.065 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.83 156.02 41.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 19.5 t0 -123.24 113.84 19.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.884 -2.265 . . . . 25.0 104.884 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.7 mt -108.4 121.59 45.24 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 32.7 m -127.97 170.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.055 0.455 . . . . 25.0 111.505 -174.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -70.38 176.61 3.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.363 -0.835 . . . . 25.0 111.524 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.8 pttt . . . . . 0 C--O 1.244 0.789 0 CA-C-O 117.511 -1.233 . . . . 25.0 111.23 177.755 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 0.086 0 CA-C-O 119.065 -0.853 . . . . 25.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -144.18 166.79 24.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.296 0.548 . . . . 25.0 109.976 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.1 120.99 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.415 -1.698 . . . . 25.0 106.415 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -87.01 -40.2 14.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.893 0.378 . . . . 25.0 111.542 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -145.52 153.7 51.75 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 116.271 -0.422 . . . . 25.0 109.876 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.24 130.98 21.52 Favored 'Cis proline' 0 C--N 1.351 0.709 0 C-N-CA 129.625 1.094 . . . . 25.0 113.432 -3.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.95 -172.55 40.11 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 110.493 -1.043 . . . . 25.0 110.493 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -141.74 134.76 28.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -68.32 -21.15 64.77 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.563 -0.29 . . . . 25.0 111.46 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.68 72.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.81 0.338 . . . . 25.0 111.332 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -29.4 68.75 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 116.538 -0.301 . . . . 25.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 mt -88.25 -26.53 22.28 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.118 0.485 . . . . 25.0 110.263 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.4 t . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 115.051 -0.977 . . . . 25.0 110.991 -178.361 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.469 0.497 0 CA-C-O 120.951 0.405 . . . . 25.0 111.744 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -11.17 23.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.841 1.793 . . . . 25.0 115.841 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -73.69 -36.61 65.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.542 0.61 . . . . 25.0 112.516 -173.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.94 59.09 2.19 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.6 -11.59 28.24 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.437 -1.242 . . . . 25.0 113.809 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -97.48 7.16 47.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 25.0 111.013 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -100.3 89.0 3.83 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 120.794 -1.191 . . . . 25.0 109.847 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.64 129.04 49.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.157 -0.683 . . . . 25.0 109.157 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.99 148.97 51.9 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.467 -0.568 . . . . 25.0 109.467 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.22 127.7 34.31 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.3 tttt . . . . . 0 C--N 1.324 -0.518 0 N-CA-C 107.647 -1.242 . . . . 25.0 107.647 176.452 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.486 0 N-CA-C 107.871 -2.092 . . . . 25.0 107.871 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.92 -11.04 15.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.804 0.842 . . . . 25.0 112.26 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -52.04 -33.63 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.005 0.743 . . . . 25.0 113.005 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.8 -29.59 59.06 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 119.835 -1.174 . . . . 25.0 112.805 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.29 0.71 87.34 Favored Glycine 0 C--O 1.219 -0.801 0 N-CA-C 116.124 1.21 . . . . 25.0 116.124 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.2 mm -54.6 -34.57 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 118.463 1.132 . . . . 25.0 112.846 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.08 -31.8 72.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.687 -0.633 . . . . 25.0 112.212 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.83 -12.13 57.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.587 0.708 . . . . 25.0 112.218 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -71.59 8.37 1.14 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -63.33 85.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.86 1.059 . . . . 25.0 113.86 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t -151.85 -170.97 3.8 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.486 -2.413 . . . . 25.0 104.486 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -62.92 -25.14 68.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.593 . . . . 25.0 110.547 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -89.26 19.31 4.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.322 0.86 . . . . 25.0 113.322 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -66.64 165.42 14.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.689 -0.856 . . . . 25.0 108.689 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -84.56 151.2 24.7 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.532 -1.284 . . . . 25.0 107.532 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.54 126.59 27.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.791 -0.64 . . . . 25.0 109.917 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -133.95 128.35 34.29 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.084 -0.962 . . . . 25.0 110.554 -175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -123.07 149.96 43.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.929 -0.308 . . . . 25.0 111.213 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -94.04 134.96 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.8 ttt -150.38 163.41 38.42 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.238 -1.393 . . . . 25.0 107.238 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.7 p -94.98 168.09 10.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.28 177.87 23.81 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.301 -0.476 . . . . 25.0 112.563 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.09 -174.1 15.14 Favored Glycine 0 N--CA 1.459 0.182 0 N-CA-C 109.573 -1.411 . . . . 25.0 109.573 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -77.16 141.78 39.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.577 1.188 . . . . 25.0 109.259 178.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -123.03 134.61 54.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.627 -1.62 . . . . 25.0 106.627 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -108.96 118.9 38.01 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -108.42 139.39 43.22 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.5 m -133.07 123.33 25.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.056 -1.461 . . . . 25.0 107.056 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -111.99 140.06 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 104.512 -2.403 . . . . 25.0 104.512 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 140.86 51.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.003 0.906 . . . . 25.0 113.131 -173.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -125.87 148.34 49.21 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.96 -2.978 . . . . 25.0 102.96 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -71.47 -18.93 62.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.344 0.52 . . . . 25.0 112.333 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.29 152.15 63.41 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.9 157.09 61.28 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 116.817 -1.656 . . . . 25.0 110.335 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -130.98 149.42 52.61 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.55 141.09 53.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.596 -1.631 . . . . 25.0 106.596 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.0 m -150.92 146.58 26.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 m -109.62 -41.87 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.669 0.271 . . . . 25.0 110.633 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.9 153.32 26.07 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.429 -0.582 . . . . 25.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -145.83 148.55 33.01 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.402 -0.962 . . . . 25.0 108.402 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.37 159.17 43.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 25.0 111.079 -172.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -130.52 142.5 50.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -132.88 164.44 26.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.714 -1.587 . . . . 25.0 106.714 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.1 pt -129.19 145.77 35.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.983 -1.488 . . . . 25.0 106.983 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.7 p -83.54 136.18 34.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.458 -1.312 . . . . 25.0 107.458 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -80.79 116.98 21.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.602 -0.888 . . . . 25.0 108.602 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -76.0 125.29 28.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.88 19.91 49.18 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 119.183 -1.484 . . . . 25.0 114.208 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -51.31 149.89 3.77 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 117.95 0.875 . . . . 25.0 112.029 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -70.93 129.59 89.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.081 -0.509 . . . . 25.0 111.135 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.98 -15.26 26.23 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 117.314 -1.324 . . . . 25.0 111.877 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.11 -14.99 61.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.159 0.984 . . . . 25.0 111.462 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -110.15 155.51 41.67 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.135 -1.061 . . . . 25.0 108.135 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.78 113.45 1.72 Allowed 'Trans proline' 0 C--O 1.24 0.593 0 N-CA-C 113.519 0.546 . . . . 25.0 113.519 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 2.5 0.63 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 118.404 2.742 . . . . 25.0 118.404 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.12 2.75 7.93 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.103 -0.373 . . . . 25.0 111.695 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -105.96 -54.71 2.44 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 116.166 -0.47 . . . . 25.0 112.027 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.0 0.51 55.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.688 0.996 . . . . 25.0 113.688 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -80.65 -21.6 41.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.096 0.406 . . . . 25.0 112.096 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -126.19 152.02 46.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -128.15 141.47 51.47 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.2 tp -77.09 118.62 19.81 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.022 -0.733 . . . . 25.0 109.022 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.03 -8.34 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.652 0.739 . . . . 25.0 110.253 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.36 155.8 9.81 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.638 -0.792 . . . . 25.0 113.289 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.57 147.07 29.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.223 -1.029 . . . . 25.0 108.223 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.62 104.48 14.47 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.97 160.99 30.19 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 115.372 -2.619 . . . . 25.0 110.884 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.04 120.96 42.2 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.161 -1.052 . . . . 25.0 108.161 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -140.25 -96.79 0.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.087 -2.19 . . . . 25.0 105.087 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.23 -144.16 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -118.3 70.54 8.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.492 0.923 . . . . 25.0 113.492 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.44 171.76 17.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 118.106 -0.796 . . . . 25.0 111.255 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.33 68.44 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.906 -0.496 . . . . 25.0 111.175 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.7 p -73.21 -2.39 21.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -64.37 -22.35 66.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.716 -0.846 . . . . 25.0 108.716 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -62.43 131.55 49.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.398 -0.593 . . . . 25.0 109.398 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.45 -10.2 56.98 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.348 0.659 . . . . 25.0 112.692 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.2 t -97.21 120.4 37.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -125.66 135.19 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 25.0 111.482 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -90.93 136.67 32.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.7 mp -132.12 119.85 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 106.197 -1.779 . . . . 25.0 106.197 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 86.9 t80 -85.26 126.88 34.06 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -125.86 101.73 29.22 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 109.964 -0.384 . . . . 25.0 109.964 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.0 145.6 40.13 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 114.447 -3.236 . . . . 25.0 108.273 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.76 96.71 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.576 0.703 . . . . 25.0 109.476 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.86 10.29 31.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.386 -0.824 . . . . 25.0 108.974 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -130.1 -179.47 5.25 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.451 -0.795 . . . . 25.0 109.991 -170.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.8 mp -132.11 128.48 38.24 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 151.16 164.21 11.92 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-O 122.285 0.936 . . . . 25.0 115.042 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -94.77 144.94 25.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.207 1.558 . . . . 25.0 115.207 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -148.93 158.34 44.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.249 -1.76 . . . . 25.0 106.249 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.07 139.73 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 25.0 110.704 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.7 mt -96.25 128.16 47.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.855 -2.276 . . . . 25.0 104.855 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.09 144.46 35.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.079 -1.452 . . . . 25.0 107.079 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.04 135.51 41.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.607 -0.516 . . . . 25.0 109.607 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.3 t -128.95 131.12 68.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 25.0 107.897 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -126.58 109.49 12.18 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.867 -0.79 . . . . 25.0 108.867 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.04 131.98 43.99 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.756 0.789 . . . . 25.0 111.976 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.1 t -128.65 122.45 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.673 -1.602 . . . . 25.0 106.673 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.0 -33.25 67.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.598 0.713 . . . . 25.0 109.404 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -7.08 28.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 115.343 1.609 . . . . 25.0 115.343 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.1 p -130.33 156.32 44.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.69 -21.49 60.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.744 0.783 . . . . 25.0 111.068 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -109.82 165.11 11.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.549 -0.751 . . . . 25.0 109.762 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 159.77 26.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -109.29 137.01 47.81 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -139.0 154.09 48.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.251 -0.281 . . . . 25.0 110.62 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -145.86 155.15 42.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.252 -0.647 . . . . 25.0 109.252 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.3 140.51 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.329 -0.989 . . . . 25.0 108.329 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.85 122.04 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.028 -1.101 . . . . 25.0 108.028 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -85.1 134.23 34.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.98 -1.119 . . . . 25.0 107.98 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.88 125.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.469 -0.567 . . . . 25.0 109.469 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -93.84 107.94 19.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.403 -2.073 . . . . 25.0 105.403 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.5 mt -109.55 133.14 53.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.188 0.518 . . . . 25.0 109.674 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.71 159.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.123 -0.944 . . . . 25.0 110.712 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -76.06 155.93 34.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 105.285 -2.117 . . . . 25.0 105.285 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-O 117.413 -1.279 . . . . 25.0 110.931 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.18 0 N-CA-C 104.336 -3.506 . . . . 25.0 104.336 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -154.18 169.66 23.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.085 1.942 . . . . 25.0 113.015 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.456 HG22 ' H ' ' A' ' 6' ' ' LYS . 30.3 mm -93.52 127.1 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.515 -0.766 . . . . 25.0 108.975 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -87.63 13.16 10.89 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.818 0.673 . . . . 25.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.456 ' H ' HG22 ' A' ' 4' ' ' ILE . 53.5 mttt 80.92 156.57 0.13 Allowed Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 126.142 1.777 . . . . 25.0 107.348 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.79 151.37 75.15 Favored 'Cis proline' 0 C--N 1.346 0.401 0 C-N-CA 129.311 0.963 . . . . 25.0 112.502 -4.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.08 9.34 63.78 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 116.297 1.279 . . . . 25.0 116.297 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -62.05 132.4 52.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 25.0 111.751 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -70.53 -26.44 63.57 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.069 -0.514 . . . . 25.0 111.298 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.15 70.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.503 -0.317 . . . . 25.0 111.629 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.39 75.81 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 120.798 0.332 . . . . 25.0 110.675 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.91 -8.04 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.353 -0.385 . . . . 25.0 111.308 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 t . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 120.739 0.304 . . . . 25.0 110.449 -177.271 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 p . . . . . 0 CA--C 1.547 0.829 0 N-CA-C 113.09 0.774 . . . . 25.0 113.09 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.9 ptm -56.32 -10.98 1.02 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.499 1.666 . . . . 25.0 115.499 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -76.43 -35.98 58.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.9 0.381 . . . . 25.0 110.779 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -147.14 50.22 0.91 Allowed Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.824 1.046 . . . . 25.0 113.824 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.58 -17.15 23.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 115.114 -2.791 . . . . 25.0 114.634 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.07 4.99 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.073 0.768 . . . . 25.0 113.073 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 94.06 4.85 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 113.067 0.766 . . . . 25.0 113.067 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.98 132.78 51.97 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 105.602 -1.999 . . . . 25.0 105.602 168.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -129.94 149.06 51.83 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.265 0.839 . . . . 25.0 113.265 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.68 49.32 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt . . . . . 0 C--N 1.324 -0.502 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 178.208 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.557 0 CA-C-O 120.195 -0.225 . . . . 25.0 113.494 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.38 -36.97 85.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.779 0.799 . . . . 25.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -71.18 -12.7 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.549 -0.751 . . . . 25.0 111.745 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.38 -23.2 53.22 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 121.325 -0.464 . . . . 25.0 113.524 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.12 73.71 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 117.961 0.88 . . . . 25.0 112.49 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.62 -38.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.61 -29.12 69.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 25.0 110.087 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.69 -7.81 36.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.646 0.61 . . . . 25.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -68.93 -41.04 78.65 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -159.89 110.19 1.88 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 120.848 0.356 . . . . 25.0 110.646 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.91 163.55 39.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -72.47 -26.41 61.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.165 -0.309 . . . . 25.0 110.165 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.01 20.5 15.42 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.76 0.281 . . . . 25.0 111.76 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -54.81 147.56 14.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.861 -0.608 . . . . 25.0 110.624 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -90.84 151.69 21.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -77.51 136.15 38.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -106.12 144.81 32.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.133 -0.485 . . . . 25.0 110.105 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.05 142.25 48.02 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -100.71 136.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.76 151.57 45.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.288 0.477 . . . . 25.0 112.288 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p -96.14 172.05 8.22 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 106.863 -1.532 . . . . 25.0 106.863 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.46 -172.69 15.37 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 117.814 1.886 . . . . 25.0 117.814 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.86 172.04 25.46 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 113.799 -1.2 . . . . 25.0 111.622 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.06 139.23 41.31 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.935 -1.135 . . . . 25.0 107.935 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -137.3 157.12 47.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.1 m -125.61 127.33 46.16 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -115.03 140.77 48.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -127.2 133.07 50.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.357 -0.609 . . . . 25.0 109.357 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.97 150.06 45.24 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.041 -2.207 . . . . 25.0 105.041 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 161.95 37.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.755 0.707 . . . . 25.0 111.121 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.1 151.83 39.4 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -71.85 -14.3 61.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.612 0.597 . . . . 25.0 112.612 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.88 160.4 58.6 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 104.094 -2.558 . . . . 25.0 104.094 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.84 145.89 94.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 115.479 -2.547 . . . . 25.0 111.092 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -108.16 118.18 36.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.222 -0.445 . . . . 25.0 110.735 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.03 129.56 41.45 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.598 -1.63 . . . . 25.0 106.598 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.2 m -145.64 133.58 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.745 -0.207 . . . . 25.0 110.834 -170.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -104.92 -33.62 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.438 -0.579 . . . . 25.0 109.438 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -163.02 148.55 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -142.69 139.07 31.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.868 -0.79 . . . . 25.0 108.868 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.05 159.05 44.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 25.0 110.817 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.57 145.34 33.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.699 0.762 . . . . 25.0 111.286 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -127.52 167.45 16.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.794 -1.093 . . . . 25.0 109.211 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.56 156.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.396 -0.964 . . . . 25.0 108.396 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 p -95.48 145.44 25.18 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.862 -0.422 . . . . 25.0 109.862 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -88.68 113.59 24.41 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.275 -0.57 . . . . 25.0 111.563 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -77.2 147.93 36.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.669 -1.975 . . . . 25.0 105.669 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.97 59.79 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 118.076 1.991 . . . . 25.0 118.076 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -54.89 147.13 15.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.68 1.24 . . . . 25.0 113.409 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 146.69 72.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.051 -0.722 . . . . 25.0 109.051 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.65 -18.4 25.39 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 118.031 -0.846 . . . . 25.0 113.917 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.05 -22.29 62.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.183 0.992 . . . . 25.0 110.915 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.84 147.11 32.98 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.624 -0.716 . . . . 25.0 109.733 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 93.94 0.65 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 118.463 -0.558 . . . . 25.0 111.799 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -52.99 -41.31 64.49 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 114.36 1.244 . . . . 25.0 114.36 -173.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -70.66 -16.41 62.81 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.057 0.762 . . . . 25.0 113.057 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -85.69 -41.38 15.2 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.356 0.598 . . . . 25.0 109.622 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.79 7.85 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.654 -1.157 . . . . 25.0 111.943 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.2 -29.03 70.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.917 0.71 . . . . 25.0 112.917 -169.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -126.04 144.98 50.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.018 0.748 . . . . 25.0 113.018 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -127.96 144.64 51.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.697 -0.853 . . . . 25.0 108.697 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -82.58 113.69 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.521 -0.918 . . . . 25.0 108.521 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -97.34 -8.62 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.345 0.593 . . . . 25.0 110.275 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.93 149.94 8.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.198 -1.001 . . . . 25.0 114.061 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.59 146.86 28.44 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.417 -0.957 . . . . 25.0 108.417 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.1 90.11 6.89 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-O 121.23 0.538 . . . . 25.0 110.299 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.39 162.59 38.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 117.751 -1.033 . . . . 25.0 109.752 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -96.9 91.98 5.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.334 -1.728 . . . . 25.0 106.334 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -100.38 2.75 42.68 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 113.976 -1.465 . . . . 25.0 109.167 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.17 -11.42 65.33 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.068 -1.213 . . . . 25.0 110.068 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.4 t -59.34 141.1 87.8 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.659 -0.497 . . . . 25.0 109.659 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.05 -6.63 19.49 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 C-N-CA 116.94 -1.573 . . . . 25.0 115.295 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.17 83.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.182 -0.917 . . . . 25.0 109.657 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.2 t -85.57 -27.87 25.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 25.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -69.4 -35.15 75.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.465 -0.568 . . . . 25.0 109.465 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.36 111.23 12.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.027 -0.533 . . . . 25.0 110.058 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.25 -13.06 60.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.507 -0.77 . . . . 25.0 112.906 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -96.98 121.31 38.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -133.05 149.42 52.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.461 . . . . 25.0 111.925 -172.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -84.78 135.17 34.23 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.839 -0.619 . . . . 25.0 109.917 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 73.2 mt -134.51 120.62 33.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 106.783 -1.562 . . . . 25.0 106.783 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -73.39 140.99 46.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.643 0.259 . . . . 25.0 110.724 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.04 129.89 25.15 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 106.731 -1.581 . . . . 25.0 106.731 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.1 148.78 63.62 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 117.355 -1.297 . . . . 25.0 113.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -100.82 -9.4 21.71 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.654 0.74 . . . . 25.0 109.217 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.09 10.56 20.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.862 1.06 . . . . 25.0 113.862 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -132.15 141.61 49.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 110.072 -0.344 . . . . 25.0 110.072 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.4 mp -113.13 153.87 27.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 25.0 109.307 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 116.74 154.21 10.06 Favored Glycine 0 C--O 1.24 0.5 0 CA-C-O 122.192 0.885 . . . . 25.0 114.97 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 42.4 p90 -87.01 146.27 26.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.226 0.824 . . . . 25.0 113.226 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -148.95 158.96 44.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.965 -1.495 . . . . 25.0 106.965 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 166' ' ' ASP . 2.0 t -98.03 143.61 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.901 0.381 . . . . 25.0 111.81 -175.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.93 131.26 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.601 -2.0 . . . . 25.0 105.601 172.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.45 140.22 49.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.216 -1.401 . . . . 25.0 107.216 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -130.09 133.82 46.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.9 130.29 68.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.73 -1.211 . . . . 25.0 107.73 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -117.85 116.27 26.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.55 -0.75 . . . . 25.0 110.584 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.63 131.9 42.81 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 122.123 0.963 . . . . 25.0 110.484 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.12 124.2 65.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.03 -31.31 64.36 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.192 0.52 . . . . 25.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -67.41 -14.93 63.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -129.2 160.42 32.96 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 122.098 -0.376 . . . . 25.0 110.747 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.46 -12.2 59.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.148 0.499 . . . . 25.0 110.591 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -110.2 160.59 16.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.741 0.781 . . . . 25.0 111.121 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -121.94 156.54 33.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 103.355 -2.831 . . . . 25.0 103.355 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -123.81 143.91 50.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.806 -0.813 . . . . 25.0 108.806 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.01 153.97 48.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.056 0.455 . . . . 25.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -134.75 143.68 47.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.322 -1.733 . . . . 25.0 106.322 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.04 129.14 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.603 -0.518 . . . . 25.0 109.603 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.2 mt -140.21 125.74 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.088 -1.078 . . . . 25.0 108.088 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 147' ' ' VAL . 11.7 t70 -87.73 141.63 28.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.605 -0.887 . . . . 25.0 108.605 173.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.45 143.75 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.098 0.475 . . . . 25.0 109.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 11.0 t0 -97.94 122.15 40.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.1 mt -115.71 119.4 35.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.878 -1.897 . . . . 25.0 105.878 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.7 m -134.17 162.19 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.685 0.994 . . . . 25.0 113.685 -170.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.64 161.22 30.53 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.443 -1.688 . . . . 25.0 106.443 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt . . . . . 0 C--O 1.246 0.909 0 CA-C-O 117.841 -1.076 . . . . 25.0 109.214 172.544 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.506 -0.479 1 N-CA-C 101.837 -4.505 . . . . 25.0 101.837 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -158.2 163.65 37.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.374 1.587 . . . . 25.0 111.046 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -92.36 114.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 105.569 -2.011 . . . . 25.0 105.569 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -72.81 -40.92 65.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -153.35 131.59 6.44 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.152 -0.476 . . . . 25.0 109.744 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.47 140.81 46.59 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 118.62 0.543 . . . . 25.0 112.476 0.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 154.51 18.29 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 116.019 -0.537 . . . . 25.0 113.767 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p -61.91 152.88 30.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.598 0.713 . . . . 25.0 112.744 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -65.1 -17.08 64.16 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.964 -0.562 . . . . 25.0 112.078 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.34 68.14 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 122.617 0.367 . . . . 25.0 111.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.3 77.84 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.972 0.415 . . . . 25.0 111.275 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.02 -4.04 55.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 25.0 110.941 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t . . . . . 0 C--N 1.325 -0.457 0 N-CA-C 108.369 -0.975 . . . . 25.0 108.369 179.334 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 CA--C 1.546 0.813 0 N-CA-C 112.658 0.614 . . . . 25.0 112.658 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm -65.31 -19.94 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.419 0.896 . . . . 25.0 113.419 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -75.53 -45.77 36.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.239 0.472 . . . . 25.0 111.018 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -154.97 89.79 3.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 113.1 0.778 . . . . 25.0 113.1 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.61 1.46 4.97 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 N-CA-C 113.22 0.431 . . . . 25.0 113.22 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.14 -7.87 24.32 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.252 1.205 . . . . 25.0 114.252 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -132.99 129.94 38.84 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.924 1.824 . . . . 25.0 115.924 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -120.62 140.47 51.5 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.069 -2.197 . . . . 25.0 105.069 161.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -84.03 118.33 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.555 0.616 . . . . 25.0 109.858 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.86 158.1 43.95 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 107.75 -1.204 . . . . 25.0 107.75 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tttt . . . . . 0 C--N 1.326 -0.436 0 CA-C-O 121.4 0.619 . . . . 25.0 110.223 178.056 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.531 0 N-CA-C 115.611 1.005 . . . . 25.0 115.611 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.37 -26.94 68.69 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.234 1.017 . . . . 25.0 112.099 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.19 -23.69 67.4 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.536 -0.466 . . . . 25.0 111.262 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.18 -26.05 71.67 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.771 -0.728 . . . . 25.0 111.852 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.7 73.48 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 121.025 -0.607 . . . . 25.0 112.008 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.25 -28.22 41.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -88.05 -38.6 15.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.725 -0.472 . . . . 25.0 109.725 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.64 -38.27 84.26 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.91 0.386 . . . . 25.0 112.005 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -64.68 -0.19 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.052 1.13 . . . . 25.0 114.052 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -143.65 34.85 1.28 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.766 0.426 . . . . 25.0 110.157 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 t -115.94 172.29 7.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.979 0.418 . . . . 25.0 111.804 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.46 -38.35 74.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.555 0.693 . . . . 25.0 110.557 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -79.99 5.44 14.03 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.751 0.649 . . . . 25.0 112.751 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -52.74 149.87 5.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.044 1.128 . . . . 25.0 114.044 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -70.28 158.51 35.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 25.0 110.92 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -84.33 151.51 24.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.825 -0.547 . . . . 25.0 111.155 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -120.52 143.29 48.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.313 -0.403 . . . . 25.0 111.2 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -121.1 150.97 40.41 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 106.612 -1.625 . . . . 25.0 106.612 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -96.2 143.0 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.178 -2.156 . . . . 25.0 105.178 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.6 ttt -150.7 164.31 36.45 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 110.421 -0.215 . . . . 25.0 110.421 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 p -110.2 172.48 6.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.775 -1.935 . . . . 25.0 105.775 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.97 -168.67 6.9 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.318 1.287 . . . . 25.0 116.318 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.68 -179.14 26.45 Favored Glycine 0 CA--C 1.521 0.417 0 O-C-N 122.519 -0.401 . . . . 25.0 113.371 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -73.08 133.65 44.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.748 -0.854 . . . . 25.0 109.615 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -125.77 137.79 53.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 25.0 110.047 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.7 m -102.56 125.54 49.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.492 -0.559 . . . . 25.0 109.492 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -112.83 130.12 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -137.98 135.1 35.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.78 -0.191 . . . . 25.0 110.565 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -122.42 150.08 42.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.47 -1.678 . . . . 25.0 106.47 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -144.96 158.58 43.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.644 -0.872 . . . . 25.0 108.644 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.66 151.04 47.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.656 -0.868 . . . . 25.0 108.656 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -72.4 -16.87 61.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.992 0.425 . . . . 25.0 111.347 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.87 141.1 23.13 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 174.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.07 146.88 47.65 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 117.167 -1.422 . . . . 25.0 112.896 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -131.12 157.08 44.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.185 -0.672 . . . . 25.0 109.185 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -76.99 144.67 38.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.312 -0.625 . . . . 25.0 109.312 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -128.28 130.11 47.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.415 -0.957 . . . . 25.0 108.415 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 t -89.75 -44.29 10.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.681 0.753 . . . . 25.0 109.771 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -158.13 155.69 29.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -146.86 141.23 26.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 168.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -148.4 159.75 43.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 25.0 111.368 -170.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -130.1 141.0 50.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.7 0.625 . . . . 25.0 110.444 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -126.68 162.87 24.76 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 pt -132.4 139.43 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.271 -0.27 . . . . 25.0 110.271 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -85.01 130.75 34.57 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 120.903 0.382 . . . . 25.0 110.339 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -88.08 125.02 34.35 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.817 0.673 . . . . 25.0 112.817 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -75.1 140.21 43.29 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.21 21.32 55.22 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.06 1.184 . . . . 25.0 116.06 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -57.09 154.18 10.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.226 1.013 . . . . 25.0 111.777 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.08 119.24 65.82 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.94 -15.84 18.52 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 117.163 -1.425 . . . . 25.0 113.51 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -75.72 -15.62 60.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.393 1.092 . . . . 25.0 110.744 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -105.01 153.79 39.17 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 106.606 -1.627 . . . . 25.0 106.606 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.98 128.44 21.87 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 115.058 -2.828 . . . . 25.0 112.215 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 tt -53.67 -38.01 63.73 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.402 -0.817 . . . . 25.0 111.895 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -58.18 -18.81 28.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.036 1.125 . . . . 25.0 114.036 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -101.61 -42.99 6.02 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 122.098 -0.376 . . . . 25.0 111.735 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.04 59.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.92 1.082 . . . . 25.0 113.92 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.95 -38.69 83.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.848 1.425 . . . . 25.0 114.848 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -130.46 161.97 30.22 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 116.413 2.005 . . . . 25.0 116.413 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -128.51 149.68 50.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.0 tp -85.56 112.93 21.4 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.169 -1.419 . . . . 25.0 107.169 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.16 -12.07 9.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.204 0.526 . . . . 25.0 110.327 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.22 158.72 12.61 Favored Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.832 -1.175 . . . . 25.0 114.707 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.93 146.58 31.11 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.496 -1.298 . . . . 25.0 107.496 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.26 107.75 4.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.619 -0.512 . . . . 25.0 109.619 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -86.64 177.26 4.32 Favored 'Trans proline' 0 C--O 1.24 0.575 0 N-CA-C 114.066 0.756 . . . . 25.0 114.066 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -104.08 91.53 3.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.812 -2.292 . . . . 25.0 104.812 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -156.44 71.42 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.062 0.458 . . . . 25.0 110.675 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.76 13.35 39.09 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.037 -0.529 . . . . 25.0 114.204 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.97 145.73 97.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.568 -0.372 . . . . 25.0 111.135 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.55 -175.63 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.784 1.656 . . . . 25.0 113.897 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.47 -26.2 12.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -57.36 -8.9 0.86 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.145 1.165 . . . . 25.0 114.145 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -76.27 3.63 10.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.729 -0.607 . . . . 25.0 111.707 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -58.7 150.45 23.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.949 -0.76 . . . . 25.0 108.949 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.95 -7.02 19.18 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.687 0.995 . . . . 25.0 113.687 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.3 t -97.94 122.65 41.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.141 -1.8 . . . . 25.0 106.141 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.4 151.06 51.88 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.207 0.527 . . . . 25.0 110.958 -175.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -105.92 138.51 41.97 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.67 -1.233 . . . . 25.0 107.67 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.5 mm -127.01 123.0 61.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.29 -2.115 . . . . 25.0 105.29 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.56 133.98 35.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.694 -1.224 . . . . 25.0 107.694 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.9 mm -125.88 118.6 24.06 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.03 155.29 61.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 115.736 -2.376 . . . . 25.0 110.715 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -104.79 55.03 0.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.73 -36.31 21.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.743 -0.662 . . . . 25.0 112.367 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -151.7 159.21 44.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.259 0.552 . . . . 25.0 110.786 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.5 pt? -91.62 143.87 26.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.987 -1.006 . . . . 25.0 110.25 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.31 152.0 6.04 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-O 121.839 0.688 . . . . 25.0 113.739 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 35.0 p90 -80.04 146.3 32.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.597 0.713 . . . . 25.0 111.984 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -136.27 128.52 29.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.766 -1.939 . . . . 25.0 105.766 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.01 125.57 47.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 105.675 -1.972 . . . . 25.0 105.675 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 76.7 mt -96.21 119.73 44.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.98 109.01 20.61 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.549 -1.648 . . . . 25.0 106.549 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -113.04 146.77 38.54 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.03 -0.419 . . . . 25.0 110.507 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.14 134.25 65.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.955 -0.566 . . . . 25.0 109.652 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -121.24 106.42 11.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.01 88.04 7.61 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.71 138.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.286 -1.376 . . . . 25.0 107.286 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -94.53 -13.69 25.82 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 122.068 -0.395 . . . . 25.0 111.274 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -77.26 -12.24 59.92 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.385 0.883 . . . . 25.0 113.385 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.0 p -140.18 170.59 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.89 0.7 . . . . 25.0 112.89 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -85.04 13.49 6.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.567 0.747 . . . . 25.0 110.317 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -109.91 163.51 13.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.95 139.35 32.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 100.376 -3.935 . . . . 25.0 100.376 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -117.99 152.01 36.33 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.276 0.56 . . . . 25.0 110.921 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.68 140.81 51.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.565 -1.198 . . . . 25.0 108.381 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -128.23 126.2 40.46 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.651 -2.351 . . . . 25.0 104.651 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.13 131.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.38 123.73 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.41 138.65 31.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.517 -1.29 . . . . 25.0 107.517 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.87 126.07 46.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 2.1 t0 -93.29 95.84 9.6 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.46 124.75 31.01 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.0 158.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 112.68 0.622 . . . . 25.0 112.68 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.92 161.72 14.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.773 -1.565 . . . . 25.0 106.773 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.35 -0.833 . . . . 25.0 109.138 172.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.119 0 N-CA-C 110.699 -0.96 . . . . 25.0 110.699 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -166.32 164.17 17.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.127 0.571 . . . . 25.0 110.427 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.91 128.12 45.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.284 -2.117 . . . . 25.0 105.284 170.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -94.6 -46.56 6.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.086 0.47 . . . . 25.0 110.238 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -145.97 157.1 51.02 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.909 -0.587 . . . . 25.0 109.5 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.53 132.38 26.12 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 130.312 1.38 . . . . 25.0 115.647 -0.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.51 -172.19 35.74 Favored Glycine 0 C--O 1.221 -0.695 0 CA-C-N 115.636 -0.711 . . . . 25.0 113.713 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -150.92 150.34 30.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.931 -1.137 . . . . 25.0 107.931 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.74 -21.02 59.58 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 111.907 0.336 . . . . 25.0 111.907 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.3 -31.17 68.89 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 113.043 0.757 . . . . 25.0 113.043 -173.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -27.81 68.95 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.634 0.605 . . . . 25.0 112.634 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.82 -10.5 39.61 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 120.809 0.338 . . . . 25.0 111.273 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.515 0.674 . . . . 25.0 110.044 -177.95 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 114.394 1.257 . . . . 25.0 114.394 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -72.15 -27.42 62.59 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.43 -0.794 . . . . 25.0 110.691 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -92.51 -36.18 13.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 25.0 109.976 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -118.88 72.39 11.33 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 121.427 0.632 . . . . 25.0 111.375 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.98 -26.87 21.37 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.159 -2.094 . . . . 25.0 115.021 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -8.76 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.798 1.777 . . . . 25.0 115.798 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 t -86.36 94.05 9.26 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 121.543 -0.723 . . . . 25.0 111.06 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mp -117.1 80.02 1.42 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.492 -0.322 . . . . 25.0 111.365 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -142.38 126.55 17.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.796 -0.446 . . . . 25.0 109.796 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 134.59 38.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.657 -0.498 . . . . 25.0 109.657 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt . . . . . 0 C--N 1.325 -0.494 0 O-C-N 121.448 -0.782 . . . . 25.0 109.232 177.652 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.404 0 CA-C-O 121.295 0.386 . . . . 25.0 113.254 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.03 -28.3 68.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.958 0.409 . . . . 25.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -68.46 -24.0 64.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.218 -0.301 . . . . 25.0 111.538 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -30.26 59.93 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 110.205 -1.158 . . . . 25.0 110.205 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.69 -20.63 74.26 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 121.272 -0.489 . . . . 25.0 112.409 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -66.13 -42.86 92.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.192 -1.04 . . . . 25.0 108.192 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.64 -32.05 63.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 25.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.37 -26.89 68.96 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.802 -0.359 . . . . 25.0 111.785 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -64.16 -7.59 9.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -132.07 27.22 4.54 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.055 0.455 . . . . 25.0 110.606 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.7 t -87.99 157.85 18.8 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.119 0.485 . . . . 25.0 111.748 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.97 -41.71 95.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 25.0 110.012 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -102.73 24.39 10.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.671 0.748 . . . . 25.0 111.161 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -55.08 154.57 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.655 -1.157 . . . . 25.0 110.053 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -80.11 156.15 27.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.826 0.822 . . . . 25.0 109.961 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -62.1 141.0 58.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.664 -0.698 . . . . 25.0 111.412 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -112.93 134.59 54.37 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.022 -0.536 . . . . 25.0 110.69 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.23 149.36 50.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.55 137.58 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.2 ttt -150.97 167.0 28.95 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.7 p -101.45 170.86 7.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.39 -166.08 11.0 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.066 -0.588 . . . . 25.0 113.321 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.94 179.47 25.39 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 112.16 -0.376 . . . . 25.0 112.16 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 16.9 tt0 -73.79 133.03 43.19 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.759 -0.848 . . . . 25.0 109.365 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -125.33 155.2 40.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -106.25 125.23 50.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.106 -1.072 . . . . 25.0 108.106 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -105.68 122.14 45.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.219 -2.141 . . . . 25.0 105.219 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -126.07 109.24 12.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.73 -0.47 . . . . 25.0 109.73 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -122.93 140.85 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.767 -3.049 . . . . 25.0 102.767 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 123.58 12.44 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -126.69 118.99 25.88 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.747 -0.835 . . . . 25.0 108.747 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -88.36 -6.37 57.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.821 -1.081 . . . . 25.0 111.922 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.73 130.7 54.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.87 119.61 6.45 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 115.903 -2.265 . . . . 25.0 112.794 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.04 136.06 48.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 25.0 109.821 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -84.24 149.93 25.78 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.317 -2.105 . . . . 25.0 105.317 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 m -137.11 152.55 50.12 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 104.645 -2.354 . . . . 25.0 104.645 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.6 p -93.03 -41.57 9.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -167.57 169.3 12.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.518 -0.31 . . . . 25.0 110.44 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.4 p90 -144.85 146.99 32.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.121 -1.437 . . . . 25.0 107.121 163.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.08 159.2 44.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 25.0 109.267 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.46 151.35 47.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.533 0.683 . . . . 25.0 112.604 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.35 163.95 27.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.883 -1.053 . . . . 25.0 108.533 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.52 152.43 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.6 p -80.84 126.13 30.95 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 120.906 0.384 . . . . 25.0 110.403 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -87.99 115.73 25.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.755 -1.202 . . . . 25.0 107.755 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -81.28 154.03 26.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.33 10.98 34.84 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 116.863 1.505 . . . . 25.0 116.863 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -62.56 155.02 27.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.263 1.031 . . . . 25.0 109.717 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -127.79 158.46 70.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 104.185 -2.524 . . . . 25.0 104.185 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.21 -14.9 35.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 117.646 -1.102 . . . . 25.0 113.508 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -65.58 -29.22 69.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.866 1.317 . . . . 25.0 108.801 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -96.03 145.25 29.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 106.797 -1.557 . . . . 25.0 106.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.37 104.6 1.11 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.325 -1.983 . . . . 25.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.99 -42.62 65.75 Favored 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 113.386 0.884 . . . . 25.0 113.386 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -59.88 -35.28 74.49 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -77.19 -38.75 50.91 Favored 'General case' 0 C--O 1.213 -0.865 0 O-C-N 122.074 -0.391 . . . . 25.0 111.25 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.6 -8.69 58.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.842 1.053 . . . . 25.0 113.842 -172.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.83 -36.79 75.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.959 1.096 . . . . 25.0 113.959 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -128.73 162.06 28.28 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.171 1.174 . . . . 25.0 114.171 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -130.07 146.38 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 172.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.8 115.14 20.14 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.916 -1.513 . . . . 25.0 106.916 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -95.12 -6.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.498 0.666 . . . . 25.0 109.966 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.82 159.53 11.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.771 . . . . 25.0 113.568 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.17 143.76 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.0 t -134.27 98.78 13.76 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 108.061 -1.088 . . . . 25.0 108.061 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.25 159.99 39.82 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 115.45 -2.567 . . . . 25.0 110.475 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -104.05 91.2 3.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.574 -2.38 . . . . 25.0 104.574 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -104.49 -25.01 12.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.245 -0.889 . . . . 25.0 109.827 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.17 -151.24 20.21 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 107.709 -2.157 . . . . 25.0 107.709 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.6 m 61.71 168.44 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.873 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.71 0.18 8.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 114.288 -3.341 . . . . 25.0 114.262 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.46 87.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.405 -0.816 . . . . 25.0 108.892 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.1 t -67.58 -26.42 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.917 -0.583 . . . . 25.0 112.022 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -68.43 -27.22 66.0 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.889 0.376 . . . . 25.0 110.517 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.38 104.84 11.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.03 -28.41 17.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.578 0.704 . . . . 25.0 109.941 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.0 t -93.2 139.46 30.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.802 -1.185 . . . . 25.0 107.802 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -139.93 150.9 45.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.028 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.53 132.49 36.78 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.297 -2.112 . . . . 25.0 105.297 172.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.97 128.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.636 -1.987 . . . . 25.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 91.1 t80 -78.5 125.01 28.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.923 -1.14 . . . . 25.0 107.923 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.61 108.73 59.81 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.701 -0.851 . . . . 25.0 108.701 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.89 163.92 34.53 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 117.09 -1.473 . . . . 25.0 111.496 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.88 113.05 13.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.604 -2.369 . . . . 25.0 104.604 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -90.19 -33.27 16.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 25.0 110.139 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -155.08 162.04 41.14 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 104.206 -2.516 . . . . 25.0 104.206 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.4 pt? -85.92 136.42 33.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.452 -1.314 . . . . 25.0 107.452 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.76 -176.83 25.45 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-O 121.593 0.551 . . . . 25.0 111.727 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -82.82 137.08 34.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.564 1.173 . . . . 25.0 111.901 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -133.33 158.99 41.59 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.294 -3.224 . . . . 25.0 102.294 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.64 137.35 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.791 -1.189 . . . . 25.0 107.791 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.92 129.08 59.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.409 -2.441 . . . . 25.0 104.409 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.02 134.23 55.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.905 -1.146 . . . . 25.0 107.905 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.11 48.83 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.3 t -129.03 132.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.076 -0.713 . . . . 25.0 109.076 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -116.38 111.67 20.39 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 92.49 5.77 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.821 0.343 . . . . 25.0 111.208 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.98 144.2 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -102.95 -21.7 13.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.309 0.485 . . . . 25.0 112.309 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -73.7 -21.67 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.336 0.495 . . . . 25.0 112.336 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.0 p -135.92 168.57 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 25.0 110.724 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -79.3 13.61 1.84 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.979 0.895 . . . . 25.0 110.734 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -110.03 157.8 18.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 25.0 111.294 -172.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.93 171.9 18.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -141.01 143.45 34.45 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.52 -0.872 . . . . 25.0 111.849 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.55 119.93 37.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.386 -2.45 . . . . 25.0 104.386 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -122.69 132.41 54.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.022 -1.844 . . . . 25.0 106.022 -173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.33 147.48 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 25.0 110.275 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.53 120.68 48.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.43 125.04 28.7 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.624 -1.25 . . . . 25.0 107.624 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.33 126.02 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.951 0.881 . . . . 25.0 108.682 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -89.02 96.09 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 103.474 -2.787 . . . . 25.0 103.474 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.11 119.63 31.4 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.339 -1.726 . . . . 25.0 106.339 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.18 161.91 39.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 O-C-N 123.592 0.558 . . . . 25.0 111.788 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -79.35 159.08 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.314 -1.365 . . . . 25.0 107.314 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.863 -1.065 . . . . 25.0 109.84 178.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.141 0 CA-C-O 120.197 -0.224 . . . . 25.0 113.566 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -135.62 139.74 44.03 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 6' ' ' LYS . 84.3 mt -96.67 111.96 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.337 -0.616 . . . . 25.0 109.337 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -93.56 39.95 1.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.321 0.649 . . . . 25.0 110.326 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.443 ' H ' HG22 ' A' ' 4' ' ' ILE . 74.5 mttt 79.81 156.35 0.13 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 126.317 1.847 . . . . 25.0 111.629 171.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.89 147.86 90.62 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 129.622 1.093 . . . . 25.0 113.928 -0.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.58 152.14 29.03 Favored Glycine 0 C--O 1.223 -0.55 0 CA-C-N 114.964 -1.016 . . . . 25.0 113.854 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -161.63 142.94 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.91 -1.515 . . . . 25.0 106.91 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -77.97 -28.92 49.51 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.477 -0.489 . . . . 25.0 110.081 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.2 71.85 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.713 0.292 . . . . 25.0 111.013 -177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.44 89.57 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.596 -0.275 . . . . 25.0 111.135 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.08 -16.52 35.32 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 120.679 0.276 . . . . 25.0 111.183 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 115.976 -0.556 . . . . 25.0 110.906 179.563 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.471 0.604 0 N-CA-C 113.693 0.997 . . . . 25.0 113.693 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -16.81 23.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.668 1.359 . . . . 25.0 114.668 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -73.04 -36.49 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.997 0.74 . . . . 25.0 112.997 -173.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.05 45.61 0.42 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 118.69 2.848 . . . . 25.0 118.69 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.28 -22.68 33.92 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 113.778 -3.681 . . . . 25.0 112.582 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -77.76 3.23 14.68 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.841 0.682 . . . . 25.0 112.841 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -110.87 66.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.103 -0.702 . . . . 25.0 109.103 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 tt -118.96 111.28 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.438 -0.801 . . . . 25.0 109.414 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -130.03 142.24 50.64 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.317 -1.735 . . . . 25.0 106.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.99 144.84 51.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.9 tttt . . . . . 0 C--N 1.326 -0.42 0 CA-C-O 121.103 0.478 . . . . 25.0 110.972 -178.421 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.591 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.26 -30.07 68.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.502 -0.411 . . . . 25.0 111.584 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -66.31 -22.44 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.863 -0.335 . . . . 25.0 111.36 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.07 -22.52 77.27 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.775 -0.726 . . . . 25.0 111.48 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.73 -18.02 71.77 Favored Glycine 0 C--O 1.223 -0.555 0 C-N-CA 121.332 -0.461 . . . . 25.0 112.815 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.09 -38.18 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.461 -0.94 . . . . 25.0 108.461 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.53 -38.05 62.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 25.0 109.794 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -64.21 -41.86 96.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.378 0.608 . . . . 25.0 111.505 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -78.64 -1.82 36.1 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.723 -0.611 . . . . 25.0 112.268 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -134.15 55.08 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.862 0.839 . . . . 25.0 110.177 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -135.79 163.91 29.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 25.0 108.687 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -68.84 -27.71 66.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.245 -1.021 . . . . 25.0 108.245 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -96.49 22.82 7.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.3 -0.864 . . . . 25.0 110.933 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -56.91 145.62 29.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 25.0 108.552 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -81.63 160.2 23.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 25.0 109.908 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -61.71 149.27 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.326 -0.852 . . . . 25.0 111.798 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -121.65 143.24 49.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -124.85 140.01 53.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 25.0 109.846 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.15 131.55 34.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.566 -2.012 . . . . 25.0 105.566 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.0 mtp -138.74 167.88 21.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -101.33 174.53 5.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.798 -0.183 . . . . 25.0 110.647 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.76 -170.99 13.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.488 -1.445 . . . . 25.0 109.488 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.51 -176.13 44.58 Favored Glycine 0 C--O 1.236 0.236 0 N-CA-C 111.702 -0.559 . . . . 25.0 111.702 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -87.75 144.9 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.981 -0.717 . . . . 25.0 111.508 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -136.21 161.46 35.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.576 -2.009 . . . . 25.0 105.576 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.5 m -122.85 125.45 45.42 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -108.93 137.96 46.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 m -124.1 123.35 40.13 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -123.91 149.96 45.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 103.698 -2.705 . . . . 25.0 103.698 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.7 p -138.12 159.86 40.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.186 0.517 . . . . 25.0 110.507 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -133.13 123.92 26.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 103.571 -2.752 . . . . 25.0 103.571 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -84.21 -20.76 31.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.448 0.536 . . . . 25.0 112.448 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.19 127.26 69.67 Favored Pre-proline 0 C--O 1.244 0.78 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -67.0 129.89 21.71 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.782 -1.012 . . . . 25.0 113.067 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -136.07 158.93 43.22 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.649 -0.705 . . . . 25.0 110.395 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.18 86.98 6.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.081 -1.451 . . . . 25.0 107.081 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -76.99 129.28 35.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.04 -0.527 . . . . 25.0 110.002 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.9 m -92.73 -42.71 9.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.588 0.588 . . . . 25.0 112.588 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -166.85 173.66 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.897 0.379 . . . . 25.0 111.222 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -147.76 145.62 28.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 165.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -147.93 154.1 39.91 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.716 -0.846 . . . . 25.0 108.716 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -149.84 148.93 29.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.142 0.496 . . . . 25.0 110.537 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.94 156.97 44.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.79 161.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 110.252 -0.277 . . . . 25.0 110.252 -176.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 p -70.61 140.09 51.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.042 0.448 . . . . 25.0 110.938 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -87.94 120.49 29.33 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.921 0.712 . . . . 25.0 112.921 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -77.04 133.16 39.19 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.95 62.12 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 119.47 -1.347 . . . . 25.0 115.109 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.08 142.59 24.83 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.437 1.118 . . . . 25.0 113.173 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.47 128.04 92.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.405 -1.271 . . . . 25.0 109.338 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.44 -13.18 27.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 117.875 -0.95 . . . . 25.0 112.839 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -66.08 -29.48 69.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.884 0.85 . . . . 25.0 110.886 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -96.01 141.03 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.056 -0.72 . . . . 25.0 109.056 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.62 128.57 18.32 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 115.085 -2.81 . . . . 25.0 111.53 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -25.41 60.35 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.997 -0.547 . . . . 25.0 111.993 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.37 -34.26 46.98 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.63 -0.714 . . . . 25.0 111.963 176.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.5 mpt_? -96.81 -42.92 7.73 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.195 -0.457 . . . . 25.0 110.96 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.08 1.99 11.79 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.48 2.03 . . . . 25.0 116.48 -170.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.69 -34.95 79.52 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.059 -0.719 . . . . 25.0 109.059 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -127.16 146.6 50.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.081 0.552 . . . . 25.0 109.985 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.58 144.67 50.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.418 -0.586 . . . . 25.0 109.418 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.74 124.83 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.526 . . . . 25.0 109.905 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.7 tt -111.49 -12.17 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.291 0.567 . . . . 25.0 109.986 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.39 147.76 8.41 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.489 -1.339 . . . . 25.0 116.092 174.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.82 131.03 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.104 -2.184 . . . . 25.0 105.104 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.99 129.71 9.08 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 118.089 0.404 . . . . 25.0 109.99 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -86.62 177.08 4.41 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 117.289 -1.341 . . . . 25.0 114.718 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -137.73 120.95 16.86 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 106.598 -1.63 . . . . 25.0 106.598 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.45 7.12 10.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 25.0 112.005 -176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.14 -99.43 0.21 Allowed Glycine 0 N--CA 1.454 -0.104 0 N-CA-C 111.469 -0.652 . . . . 25.0 111.469 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -124.45 53.56 7.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.751 1.389 . . . . 25.0 114.751 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.07 -177.18 3.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 117.563 -1.158 . . . . 25.0 110.479 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.15 -30.69 70.54 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.56 -0.713 . . . . 25.0 109.662 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 78.3 p -80.19 8.02 8.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.509 0.929 . . . . 25.0 113.509 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -60.35 -23.59 64.38 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.514 -0.741 . . . . 25.0 111.965 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -81.3 129.85 34.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 25.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.67 -9.29 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.411 0.624 . . . . 25.0 112.145 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.8 t -82.26 137.98 34.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.126 -1.064 . . . . 25.0 108.126 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -144.01 143.18 31.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.427 0.529 . . . . 25.0 112.427 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -77.63 139.51 39.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.153 -1.425 . . . . 25.0 107.153 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -131.88 120.73 45.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -98.62 136.07 39.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.312 -0.255 . . . . 25.0 110.312 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.4 mm -117.32 123.78 29.65 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.135 -1.432 . . . . 25.0 107.135 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.78 143.09 49.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 115.549 -2.501 . . . . 25.0 112.012 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.72 12.18 30.83 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.134 -0.939 . . . . 25.0 112.602 -171.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -58.85 -38.33 78.49 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.854 1.057 . . . . 25.0 113.854 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -151.82 157.24 41.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.817 0.342 . . . . 25.0 110.938 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.6 pt? -88.45 152.74 21.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 25.0 109.067 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.88 154.94 8.99 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 115.497 0.959 . . . . 25.0 115.497 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -78.82 145.03 34.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.21 159.0 43.09 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.117 -0.492 . . . . 25.0 110.004 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.3 t -118.7 133.65 64.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 104.942 -2.244 . . . . 25.0 104.942 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.4 mt -114.65 127.83 71.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.404 -1.702 . . . . 25.0 106.404 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.0 tp -124.65 120.85 33.06 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.52 42.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 25.0 109.424 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.01 140.05 50.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.465 -0.939 . . . . 25.0 108.465 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -126.96 113.92 17.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 25.0 107.709 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -105.85 131.99 52.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.843 -0.617 . . . . 25.0 111.317 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.04 136.13 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.34 54.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 115.083 1.512 . . . . 25.0 115.083 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -87.18 10.77 15.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.405 1.261 . . . . 25.0 114.405 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.3 t -145.28 161.77 38.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.231 0.538 . . . . 25.0 110.879 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -88.33 0.92 55.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.347 0.594 . . . . 25.0 110.264 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -110.08 160.84 16.11 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.914 -0.585 . . . . 25.0 110.216 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.03 154.45 41.27 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.559 -1.645 . . . . 25.0 106.559 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -105.08 137.05 43.45 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.493 -0.928 . . . . 25.0 108.493 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.67 150.1 50.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.991 -1.114 . . . . 25.0 107.991 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.442 ' HA ' HE21 ' A' ' 163' ' ' GLN . 0.0 OUTLIER -146.06 129.7 17.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 173.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.96 137.94 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.295 -1.372 . . . . 25.0 107.295 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.0 mt -138.41 120.46 17.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.38 -0.97 . . . . 25.0 108.38 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.87 134.07 35.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.47 166.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.263 0.554 . . . . 25.0 110.419 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -124.54 106.69 10.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.2 103.96 14.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.07 160.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.831 1.419 . . . . 25.0 114.831 -172.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -95.11 162.2 13.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.323 -2.102 . . . . 25.0 105.323 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt . . . . . 0 C--O 1.244 0.779 0 N-CA-C 107.456 -1.313 . . . . 25.0 107.456 173.231 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.512 0 CA-C-O 120.341 -0.144 . . . . 25.0 112.948 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -112.4 158.22 20.09 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.758 0.779 . . . . 25.0 112.273 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.4 mt -103.86 121.3 55.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.561 -1.274 . . . . 25.0 107.561 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -91.34 -36.61 13.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.352 0.596 . . . . 25.0 111.441 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -140.47 146.04 43.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.18 109.27 1.35 Allowed 'Cis proline' 0 CA--C 1.539 0.749 0 C-N-CA 130.874 1.614 . . . . 25.0 115.562 -0.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.47 173.23 9.91 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 115.562 0.985 . . . . 25.0 115.562 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -86.67 131.48 34.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.619 -0.342 . . . . 25.0 111.033 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -69.76 -37.32 76.36 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.417 -0.586 . . . . 25.0 109.417 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.85 72.55 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 112.592 0.59 . . . . 25.0 112.592 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.73 85.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 25.0 110.904 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.76 -10.31 51.41 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.036 0.446 . . . . 25.0 111.558 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 178.954 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.1 t . . . . . 0 N--CA 1.463 0.223 0 CA-C-O 121.194 0.521 . . . . 25.0 111.814 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -66.66 -12.4 58.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -78.35 -37.44 44.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.543 0.61 . . . . 25.0 111.507 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -149.43 70.05 9.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.656 0.741 . . . . 25.0 112.964 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.61 -6.75 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 N-CA-C 113.792 0.651 . . . . 25.0 113.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -87.28 -7.61 57.66 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.102 0.779 . . . . 25.0 113.102 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 t -108.58 95.43 5.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.861 1.06 . . . . 25.0 113.861 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 tt -125.21 81.38 1.96 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.101 0.477 . . . . 25.0 110.06 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -100.22 137.63 38.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.384 0.513 . . . . 25.0 112.384 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.77 114.96 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.075 -0.343 . . . . 25.0 110.075 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt . . . . . 0 N--CA 1.472 0.633 0 N-CA-C 112.7 0.63 . . . . 25.0 112.7 -176.682 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.542 0 N-CA-C 114.552 0.581 . . . . 25.0 114.552 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.3 pt? -67.31 -27.79 67.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.419 0.526 . . . . 25.0 112.419 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -71.45 -21.68 61.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.246 0.462 . . . . 25.0 112.246 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.03 90.83 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.904 -0.665 . . . . 25.0 112.473 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.28 68.22 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.784 -0.722 . . . . 25.0 113.541 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.58 -46.22 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.084 0.469 . . . . 25.0 109.989 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.16 -24.08 62.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.933 1.086 . . . . 25.0 113.933 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.41 -25.68 59.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 25.0 114.254 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -57.16 -21.6 34.17 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.532 0.938 . . . . 25.0 113.532 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -138.87 38.84 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.41 0.624 . . . . 25.0 109.788 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.5 t -85.98 146.75 26.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 25.0 110.715 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -63.26 -25.11 68.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.135 0.969 . . . . 25.0 109.881 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -118.77 28.19 8.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.993 -1.003 . . . . 25.0 108.733 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -47.65 140.78 5.88 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.245 -0.889 . . . . 25.0 112.982 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -79.05 146.15 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.968 0.889 . . . . 25.0 109.65 -171.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -68.82 134.68 50.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.361 -0.836 . . . . 25.0 109.388 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -121.01 139.99 52.54 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 113.453 0.908 . . . . 25.0 113.453 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -119.42 143.21 47.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.69 -1.226 . . . . 25.0 107.69 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.9 mt -94.06 128.27 45.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 102.928 -2.99 . . . . 25.0 102.928 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 89.8 mtp -140.88 164.29 30.63 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 107.554 -1.276 . . . . 25.0 107.554 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.0 p -92.44 174.06 7.48 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 104.494 -2.409 . . . . 25.0 104.494 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.401 ' H ' ' HG3' ' A' ' 140' ' ' GLU . . . -74.52 -162.27 8.9 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.846 -0.902 . . . . 25.0 110.846 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.6 -178.13 27.33 Favored Glycine 0 C--N 1.323 -0.173 0 CA-C-O 121.452 0.473 . . . . 25.0 112.392 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.4 131.35 43.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.948 -0.736 . . . . 25.0 109.222 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.12 158.55 37.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.853 -1.166 . . . . 25.0 107.853 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 m -120.38 126.68 51.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.11 0.481 . . . . 25.0 109.73 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.62 135.77 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.526 -2.027 . . . . 25.0 105.526 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.1 m -138.07 128.52 26.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.036 0.384 . . . . 25.0 112.036 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -117.96 149.98 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.5 t -137.85 160.12 40.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.9 143.87 38.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 p -80.78 -16.82 52.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.0 151.81 63.4 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.83 144.99 61.08 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 116.54 -1.84 . . . . 25.0 111.521 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -131.16 148.58 52.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 25.0 109.262 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.08 157.34 33.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.9 m -160.07 148.31 16.94 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 104.093 -2.558 . . . . 25.0 104.093 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -92.1 -51.63 5.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.431 ' H ' ' HB3' ' A' ' 153' ' ' ASP . 16.4 pt20 -156.12 170.61 21.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.309 -0.626 . . . . 25.0 109.309 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -149.56 142.52 24.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.915 -1.143 . . . . 25.0 107.915 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -148.04 154.55 40.4 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.226 -0.296 . . . . 25.0 111.162 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -120.02 133.81 55.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.368 -0.833 . . . . 25.0 109.391 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -121.62 163.67 18.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.383 -1.71 . . . . 25.0 106.383 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.37 165.18 29.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 t -126.12 135.71 52.02 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-O 121.435 0.636 . . . . 25.0 111.452 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -109.06 118.78 37.67 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.838 -0.619 . . . . 25.0 112.323 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -75.98 156.02 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.416 -1.327 . . . . 25.0 107.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.97 10.55 15.76 Favored Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.955 -0.64 . . . . 25.0 114.24 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -60.69 162.88 6.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.306 0.574 . . . . 25.0 112.439 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.55 144.98 92.16 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.785 -1.561 . . . . 25.0 106.785 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.7 -23.11 14.81 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 116.638 -1.774 . . . . 25.0 115.001 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -104.64 24.93 10.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.093 0.949 . . . . 25.0 112.721 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -122.97 160.47 49.29 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 105.752 -1.944 . . . . 25.0 105.752 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.64 83.46 1.74 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 116.14 -2.107 . . . . 25.0 112.868 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.27 -39.19 72.24 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 121.511 0.672 . . . . 25.0 110.019 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -16.61 6.58 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.475 1.287 . . . . 25.0 114.475 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -93.81 -46.76 7.07 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 112.447 0.536 . . . . 25.0 112.447 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.97 -17.17 41.44 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.898 1.814 . . . . 25.0 115.898 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.93 -26.32 65.91 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.325 1.232 . . . . 25.0 114.325 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 43.3 p90 -103.32 125.17 49.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.464 0.65 . . . . 25.0 111.257 -175.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.74 141.0 52.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.782 -0.644 . . . . 25.0 109.695 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.41 128.15 32.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.513 -0.551 . . . . 25.0 109.513 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.6 tt -111.0 -3.65 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.609 0.719 . . . . 25.0 110.33 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.26 150.96 6.68 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.749 -0.739 . . . . 25.0 113.42 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.54 140.68 31.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.958 -0.756 . . . . 25.0 108.958 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.38 112.36 8.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 123.326 0.391 . . . . 25.0 109.989 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.73 158.86 28.18 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 114.877 -2.949 . . . . 25.0 111.326 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -105.83 91.9 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 103.154 -2.906 . . . . 25.0 103.154 175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -156.6 56.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.663 0.744 . . . . 25.0 110.973 -172.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.62 12.97 43.35 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.062 -0.589 . . . . 25.0 113.839 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.27 156.85 7.22 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.271 1.212 . . . . 25.0 114.271 -173.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.08 -163.8 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.369 1.379 . . . . 25.0 112.146 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.07 -25.57 0.6 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 117.21 2.3 . . . . 25.0 117.21 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.8 t -62.39 -18.34 61.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.616 0.598 . . . . 25.0 112.616 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -58.88 -25.13 63.07 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.249 1.02 . . . . 25.0 112.547 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -59.0 135.61 57.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.882 0.697 . . . . 25.0 112.882 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.57 -7.78 51.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.124 -0.944 . . . . 25.0 111.527 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -100.0 120.02 39.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.123 -2.547 . . . . 25.0 104.123 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.5 136.26 39.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 -171.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -83.27 136.75 34.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.31 -1.737 . . . . 25.0 106.31 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.0 mm -131.96 131.19 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 105.971 -1.862 . . . . 25.0 105.971 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -93.34 130.87 38.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.603 -0.518 . . . . 25.0 109.603 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.6 mt -126.1 136.47 28.56 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.047 -1.464 . . . . 25.0 107.047 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.3 168.1 24.37 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 117.22 -1.386 . . . . 25.0 113.015 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 77' ' ' GLY . 28.0 tt0 -127.24 35.98 4.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -86.18 -31.4 21.8 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.986 1.106 . . . . 25.0 113.986 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -146.22 169.66 18.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.114 -0.328 . . . . 25.0 110.114 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.3 pt? -107.68 152.02 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.874 0.694 . . . . 25.0 112.874 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.29 157.75 7.33 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.721 -0.672 . . . . 25.0 112.078 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 15.8 p90 -84.03 144.94 28.77 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.732 0.777 . . . . 25.0 113.042 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -138.06 135.01 35.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.7 t -98.0 134.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.263 -1.754 . . . . 25.0 106.263 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.02 125.31 61.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -104.69 109.68 21.7 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.401 -1.333 . . . . 25.0 107.401 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -108.09 123.8 49.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.63 133.1 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.663 -0.865 . . . . 25.0 108.663 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -121.25 107.58 12.72 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.537 -1.283 . . . . 25.0 107.537 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 52.2 t0 -82.67 90.69 6.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 25.0 109.98 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.59 119.32 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.043 -1.095 . . . . 25.0 108.043 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.32 11.89 22.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 25.0 112.101 -174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.96 -2.97 30.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.046 0.387 . . . . 25.0 112.046 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.7 p -143.83 168.5 19.8 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.671 0.272 . . . . 25.0 111.512 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.26 1.07 34.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.957 0.884 . . . . 25.0 109.371 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.14 155.04 18.69 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 150.86 41.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 103.197 -2.89 . . . . 25.0 103.197 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.33 138.57 47.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.593 -0.521 . . . . 25.0 109.593 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -138.97 154.02 48.25 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.135 -1.061 . . . . 25.0 108.135 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.16 152.3 45.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.467 -1.679 . . . . 25.0 106.467 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.97 145.46 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.538 -0.542 . . . . 25.0 109.538 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.2 mt -136.24 125.19 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.086 -2.561 . . . . 25.0 104.086 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -111.15 130.63 55.57 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.31 -1.367 . . . . 25.0 107.31 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.73 134.93 58.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 1.0 OUTLIER -93.17 100.52 12.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.55 -2.018 . . . . 25.0 105.55 176.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.0 mt -92.88 130.21 38.54 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.915 -1.513 . . . . 25.0 106.915 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 10.1 m -127.04 158.01 38.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 113.871 1.063 . . . . 25.0 113.871 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -93.82 161.47 14.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.299 -1.371 . . . . 25.0 107.299 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt . . . . . 0 C--O 1.243 0.723 0 CA-C-O 118.472 -0.775 . . . . 25.0 109.409 175.293 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.32 0 N-CA-C 107.906 -2.078 . . . . 25.0 107.906 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -134.06 161.7 34.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.015 0.908 . . . . 25.0 108.907 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.98 121.77 66.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.938 -1.505 . . . . 25.0 106.938 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -12.27 60.58 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.95 1.092 . . . . 25.0 113.95 -174.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt 79.68 149.69 0.12 Allowed Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 126.195 1.798 . . . . 25.0 108.161 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.31 156.72 91.42 Favored 'Cis proline' 0 C--N 1.346 0.425 0 CA-C-O 121.181 0.409 . . . . 25.0 112.371 -0.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.7 10.53 30.63 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 116.262 1.265 . . . . 25.0 116.262 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -64.5 126.93 29.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.945 0.872 . . . . 25.0 111.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -77.95 -19.12 55.16 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 116.345 -0.389 . . . . 25.0 110.231 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.79 69.64 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.75 -0.205 . . . . 25.0 111.191 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -25.12 65.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 25.0 110.811 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.28 0.56 51.03 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 122.915 0.486 . . . . 25.0 110.567 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 t . . . . . 0 N--CA 1.47 0.529 0 N-CA-C 111.997 0.369 . . . . 25.0 111.997 -176.775 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p . . . . . 0 CA--C 1.536 0.422 0 CA-C-O 121.021 0.439 . . . . 25.0 110.559 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.6 ptm -60.32 -10.44 4.72 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.53 -46.61 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.576 0.625 . . . . 25.0 109.983 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.02 69.41 5.61 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 113.185 0.809 . . . . 25.0 113.185 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.32 3.12 6.06 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 N-CA-C 113.71 0.619 . . . . 25.0 113.71 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -101.32 -2.44 31.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.497 0.555 . . . . 25.0 112.497 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.94 97.4 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.662 0.986 . . . . 25.0 113.662 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.96 112.29 24.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.504 -1.665 . . . . 25.0 106.504 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -89.03 110.19 20.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.977 0.732 . . . . 25.0 112.977 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.55 152.42 20.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.084 -1.821 . . . . 25.0 106.084 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.1 tttt . . . . . 0 C--N 1.325 -0.494 0 N-CA-C 112.171 0.434 . . . . 25.0 112.171 -179.192 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.523 0 N-CA-C 112.305 -0.318 . . . . 25.0 112.305 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.3 mt -72.26 -25.97 61.81 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.704 . . . . 25.0 110.291 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.561 -0.533 . . . . 25.0 109.561 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -24.99 69.5 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.926 -0.869 . . . . 25.0 110.926 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.86 -16.9 68.81 Favored Glycine 0 C--O 1.228 -0.26 0 O-C-N 122.774 -0.251 . . . . 25.0 112.536 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mm -66.16 -40.1 86.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mp -75.81 -26.89 57.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 25.0 111.15 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.78 -22.01 66.7 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.149 0.5 . . . . 25.0 111.589 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.73 -5.93 18.48 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.865 -0.522 . . . . 25.0 112.156 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -130.65 35.15 4.04 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -106.62 156.54 18.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 25.0 111.101 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -68.66 -31.02 69.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.811 -0.811 . . . . 25.0 108.811 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -97.48 21.39 10.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.564 -0.744 . . . . 25.0 110.409 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -52.31 136.1 31.51 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.057 0.456 . . . . 25.0 111.5 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 146.03 46.44 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 122.686 1.231 . . . . 25.0 112.33 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -75.7 148.78 38.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.383 -1.28 . . . . 25.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -103.03 126.87 50.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -100.1 108.79 21.03 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.182 -0.607 . . . . 25.0 109.658 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.55 138.6 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.67 -0.863 . . . . 25.0 108.67 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.4 tpt -151.04 154.09 36.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.202 -0.666 . . . . 25.0 109.202 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.2 p -91.16 -179.48 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.838 -1.171 . . . . 25.0 107.838 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.45 -168.88 31.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 116.445 1.338 . . . . 25.0 116.445 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.92 170.72 36.92 Favored Glycine 0 C--N 1.329 0.162 0 N-CA-C 108.864 -1.694 . . . . 25.0 108.864 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.77 148.3 28.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 119.309 1.555 . . . . 25.0 108.477 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -134.19 157.96 44.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.611 -1.255 . . . . 25.0 107.611 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -124.95 125.74 44.39 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.46 140.89 48.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.189 -1.041 . . . . 25.0 108.189 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -132.58 132.42 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.608 0.568 . . . . 25.0 111.993 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -118.47 150.06 40.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.0 p -133.84 161.71 34.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.99 158.11 42.32 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.867 -1.531 . . . . 25.0 106.867 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 t -69.83 -27.02 64.51 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.347 0.499 . . . . 25.0 112.347 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.13 61.17 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 106.684 -1.598 . . . . 25.0 106.684 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.39 152.03 65.82 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 115.956 -2.229 . . . . 25.0 110.038 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.15 147.57 52.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -61.03 137.01 58.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 m -146.16 144.66 30.09 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.9 t -91.56 -48.03 7.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.487 -0.56 . . . . 25.0 109.487 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -166.2 169.65 14.11 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.298 -0.251 . . . . 25.0 111.369 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -141.9 141.0 32.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 166.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.8 156.42 42.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.605 -0.27 . . . . 25.0 110.84 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -130.67 142.94 50.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.809 -0.632 . . . . 25.0 111.535 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -132.3 164.96 25.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.9 pt -130.31 157.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.9 p -96.71 133.63 41.0 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-O 121.148 0.499 . . . . 25.0 111.273 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -92.22 99.57 12.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.627 0.727 . . . . 25.0 111.98 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -76.16 148.14 38.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.407 -1.331 . . . . 25.0 107.407 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 22.19 40.32 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 115.579 0.992 . . . . 25.0 115.579 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -56.93 148.74 20.31 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.686 0.743 . . . . 25.0 111.705 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.96 138.79 46.2 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.204 -1.036 . . . . 25.0 108.204 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.98 -15.91 29.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 117.617 -1.122 . . . . 25.0 112.261 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.15 -22.06 64.88 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.023 0.929 . . . . 25.0 111.577 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -113.75 153.79 45.89 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.944 -0.571 . . . . 25.0 109.55 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.08 107.03 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 117.987 -0.876 . . . . 25.0 113.633 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -52.72 -46.87 67.57 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.193 -0.912 . . . . 25.0 112.742 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -54.35 -38.48 66.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.184 -0.462 . . . . 25.0 112.094 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.71 -44.28 23.88 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.894 -0.594 . . . . 25.0 111.944 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.43 -24.69 62.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.765 1.394 . . . . 25.0 114.765 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -68.07 -23.81 65.0 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.812 1.412 . . . . 25.0 114.812 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -123.02 135.18 54.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.003 -1.061 . . . . 25.0 112.508 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -128.15 133.11 48.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.464 -0.939 . . . . 25.0 108.464 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.11 120.56 23.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.708 -0.849 . . . . 25.0 108.708 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.2 tt -96.3 -10.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.478 0.656 . . . . 25.0 110.094 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.05 160.27 13.1 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.323 -0.942 . . . . 25.0 113.935 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.69 146.71 29.38 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.096 -1.075 . . . . 25.0 108.096 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -135.25 106.84 10.23 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.09 160.57 39.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 114.902 -2.932 . . . . 25.0 110.743 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -118.51 94.19 4.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.395 1.093 . . . . 25.0 108.804 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.17 -94.71 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.033 -2.951 . . . . 25.0 103.033 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.26 128.54 9.6 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.3 t -163.49 145.07 7.44 Favored Pre-proline 0 C--O 1.242 0.708 0 CA-C-N 117.159 0.48 . . . . 25.0 109.959 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -76.08 -154.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.516 1.477 . . . . 25.0 110.744 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -18.84 4.47 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.129 1.529 . . . . 25.0 115.129 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.6 t -66.87 -6.73 17.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.825 0.676 . . . . 25.0 112.825 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.92 -14.87 63.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.423 0.689 . . . . 25.0 110.807 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -66.59 150.66 48.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.495 0.664 . . . . 25.0 112.205 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.06 -12.51 60.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.182 -0.917 . . . . 25.0 110.209 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -89.68 120.81 31.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.231 -1.766 . . . . 25.0 106.231 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -135.07 134.15 40.05 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.277 0.473 . . . . 25.0 112.277 -173.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -82.28 139.31 34.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.812 -0.631 . . . . 25.0 109.973 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.19 121.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 106.395 -1.706 . . . . 25.0 106.395 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -80.65 135.36 36.02 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.036 -0.728 . . . . 25.0 109.036 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.0 mm -122.94 117.85 28.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.47 158.05 51.85 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 115.947 -2.235 . . . . 25.0 110.577 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -112.35 51.65 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.948 -1.501 . . . . 25.0 106.948 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.29 -26.01 16.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.039 -0.982 . . . . 25.0 111.731 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -158.09 160.13 37.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.301 . . . . 25.0 110.782 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 pt? -100.13 137.54 38.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 172.26 144.53 4.57 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 122.348 0.971 . . . . 25.0 115.453 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -95.72 144.96 25.67 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 112.664 0.616 . . . . 25.0 112.664 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -148.95 163.57 37.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.369 -0.974 . . . . 25.0 108.369 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.1 t -93.43 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.384 -0.969 . . . . 25.0 108.384 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.04 129.22 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 105.893 -1.892 . . . . 25.0 105.893 171.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.32 141.86 45.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.001 -1.852 . . . . 25.0 106.001 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.36 143.99 40.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.716 -0.475 . . . . 25.0 109.716 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.07 135.11 62.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.442 -0.948 . . . . 25.0 108.442 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -126.08 118.5 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -111.76 134.62 53.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.949 0.351 . . . . 25.0 111.949 -173.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.28 128.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.781 -1.563 . . . . 25.0 106.781 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -31.17 65.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 25.0 111.533 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -75.26 -2.03 26.19 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.0 p -123.01 155.01 37.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.748 0.785 . . . . 25.0 112.699 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -83.24 -6.36 59.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.124 -0.695 . . . . 25.0 109.124 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -109.25 153.83 23.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.2 -0.909 . . . . 25.0 109.544 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.86 150.63 51.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -119.66 135.81 54.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.037 0.446 . . . . 25.0 111.239 -168.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -127.09 153.88 45.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -146.19 156.18 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.69 138.78 48.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.585 . . . . 25.0 109.422 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.5 mt -140.04 121.43 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.66 140.52 29.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.703 -0.851 . . . . 25.0 108.703 174.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.78 157.56 42.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -128.81 118.58 23.0 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 104.293 -2.484 . . . . 25.0 104.293 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.7 mt -108.25 121.91 45.86 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 104.627 -2.36 . . . . 25.0 104.627 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 18.7 m -130.86 160.4 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.12 1.155 . . . . 25.0 114.12 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -95.13 157.51 15.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.307 -1.738 . . . . 25.0 106.307 174.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.9 tptt . . . . . 0 C--O 1.251 1.139 0 O-C-N 124.297 0.998 . . . . 25.0 110.83 174.601 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.528 0.853 0 CA-C-O 119.632 -0.538 . . . . 25.0 113.911 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -150.96 170.96 18.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.173 0.589 . . . . 25.0 109.431 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 tt -106.86 131.86 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.074 0.464 . . . . 25.0 110.245 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -85.15 -47.94 9.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.266 1.031 . . . . 25.0 111.054 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.21 149.69 56.04 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.771 -1.104 . . . . 25.0 108.552 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.17 98.59 0.23 Allowed 'Cis proline' 0 CA--C 1.545 1.041 0 C-N-CA 131.498 1.874 . . . . 25.0 114.52 -1.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.9 138.82 7.26 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 121.657 0.587 . . . . 25.0 113.593 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 t -68.21 145.53 54.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.612 0.72 . . . . 25.0 112.71 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.385 -0.825 . . . . 25.0 110.248 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -26.43 68.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.291 0.848 . . . . 25.0 113.291 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.76 88.71 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 112.079 0.4 . . . . 25.0 112.079 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.92 -3.92 55.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.579 0.704 . . . . 25.0 111.605 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 t . . . . . 0 C--O 1.218 -0.597 0 CA-C-N 115.335 -0.848 . . . . 25.0 109.84 179.479 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 120.943 0.401 . . . . 25.0 110.695 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.33 -14.21 10.82 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 115.3 1.593 . . . . 25.0 115.3 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -71.47 -37.72 71.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.427 0.558 . . . . 25.0 110.111 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.81 68.26 10.62 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 121.64 0.733 . . . . 25.0 111.797 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.91 -8.97 23.14 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 117.541 -1.173 . . . . 25.0 112.829 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -83.77 -9.9 58.47 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.718 -0.475 . . . . 25.0 109.718 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 t -81.37 104.15 11.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.462 0.649 . . . . 25.0 110.037 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.6 mt -122.91 74.02 1.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.494 -0.775 . . . . 25.0 109.325 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -142.02 135.68 29.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.664 0.386 . . . . 25.0 111.142 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.51 32.54 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt . . . . . 0 C--N 1.322 -0.609 0 O-C-N 122.047 -0.408 . . . . 25.0 109.954 -178.874 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.663 0 N-CA-C 114.092 0.397 . . . . 25.0 114.092 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.13 -37.99 13.03 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.137 -0.625 . . . . 25.0 111.897 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -84.77 -13.72 50.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.692 0.997 . . . . 25.0 113.692 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.4 -15.92 64.32 Favored Glycine 0 C--O 1.216 -1.024 0 C-N-CA 121.496 -0.383 . . . . 25.0 112.87 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.15 -24.34 68.71 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.654 -0.784 . . . . 25.0 112.843 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -66.67 -41.54 88.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -72.15 -29.37 63.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.041 -0.527 . . . . 25.0 110.537 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.44 -19.78 65.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.282 0.475 . . . . 25.0 112.282 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -66.29 -11.8 52.68 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.046 -0.409 . . . . 25.0 111.082 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -137.86 64.91 1.5 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.582 -1.266 . . . . 25.0 107.582 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.5 t -135.75 159.58 41.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.318 -0.401 . . . . 25.0 110.742 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.75 -32.33 72.86 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.984 0.897 . . . . 25.0 109.488 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -96.88 22.04 8.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.438 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -49.59 134.5 19.68 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.946 0.879 . . . . 25.0 112.916 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.12 154.81 38.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.906 -1.043 . . . . 25.0 112.678 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -80.49 129.53 34.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.792 -0.818 . . . . 25.0 108.792 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 152.79 21.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.929 0.395 . . . . 25.0 111.746 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.78 100.35 6.14 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.534 0.334 . . . . 25.0 110.694 174.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.9 mt -78.52 131.02 35.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.149 -1.056 . . . . 25.0 108.149 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.3 mtm -143.32 163.81 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.263 0.625 . . . . 25.0 110.309 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.3 p -93.14 -179.46 5.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.958 -1.867 . . . . 25.0 105.958 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.9 30.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.778 -0.725 . . . . 25.0 111.319 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.73 -160.76 16.99 Favored Glycine 0 CA--C 1.517 0.171 0 O-C-N 122.269 -0.548 . . . . 25.0 114.053 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.59 137.56 38.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.946 0.403 . . . . 25.0 111.425 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -132.6 139.95 48.02 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.013 -0.736 . . . . 25.0 109.013 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.2 m -120.35 111.43 17.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -93.15 116.37 28.97 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.0 m -119.28 93.47 4.09 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.149 -0.686 . . . . 25.0 109.149 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -89.06 133.59 34.3 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.884 -1.525 . . . . 25.0 106.884 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -123.77 136.62 54.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -126.4 148.57 49.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 120.985 0.422 . . . . 25.0 110.308 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -120.64 31.35 6.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.623 -1.992 . . . . 25.0 105.623 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.66 125.08 91.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 114.619 -1.173 . . . . 25.0 109.43 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.08 26.39 0.65 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 120.227 0.618 . . . . 25.0 112.615 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -130.9 149.48 52.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 25.0 111.495 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -69.78 156.42 39.05 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.21 -0.663 . . . . 25.0 109.21 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -123.03 149.53 44.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.049 -1.834 . . . . 25.0 106.049 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -93.95 -56.85 2.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.074 0.464 . . . . 25.0 110.501 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -161.63 173.77 14.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.815 -0.439 . . . . 25.0 109.815 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.32 152.69 39.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.735 -0.666 . . . . 25.0 109.698 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -146.73 141.82 27.17 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -140.83 149.12 41.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.836 0.827 . . . . 25.0 112.53 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.07 160.51 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.617 -1.174 . . . . 25.0 109.397 -172.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.5 158.88 42.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.314 -0.995 . . . . 25.0 108.314 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.419 ' CG2' ' H ' ' A' ' 147' ' ' VAL . 1.1 t -96.86 126.96 42.38 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 113.227 0.825 . . . . 25.0 113.227 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -99.47 103.33 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.644 -1.243 . . . . 25.0 107.644 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -70.91 152.36 43.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.13 10.08 24.8 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.731 -0.483 . . . . 25.0 113.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -62.02 153.81 28.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.76 0.79 . . . . 25.0 109.817 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.54 151.29 85.03 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.03 -11.35 27.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 113.499 0.538 . . . . 25.0 113.499 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -74.46 -6.16 46.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.544 0.687 . . . . 25.0 111.511 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -105.07 135.82 19.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 121.812 -0.555 . . . . 25.0 111.161 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.89 123.21 10.42 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.588 -1.141 . . . . 25.0 113.002 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -52.62 -49.41 65.16 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 114.415 1.265 . . . . 25.0 114.415 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -64.72 -11.05 31.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.746 1.017 . . . . 25.0 113.746 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -104.69 -48.96 3.64 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 112.231 0.456 . . . . 25.0 112.231 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.81 -22.46 58.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 -170.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.16 -28.77 67.58 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.535 -0.466 . . . . 25.0 111.895 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -124.6 144.89 49.91 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -126.7 144.29 50.97 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.998 0.428 . . . . 25.0 110.516 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.39 126.79 30.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.6 tp -115.21 1.82 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 121.997 0.904 . . . . 25.0 109.027 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.55 156.08 9.03 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 115.838 1.095 . . . . 25.0 115.838 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.62 128.04 16.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.1 t -140.5 123.09 9.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.568 0.347 . . . . 25.0 110.336 -170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.7 168.58 20.9 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 117.191 -1.406 . . . . 25.0 111.973 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -82.65 121.0 26.28 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.891 -0.723 . . . . 25.0 111.987 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.77 33.14 22.86 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.92 1.822 . . . . 25.0 115.92 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.43 165.12 44.11 Favored Glycine 0 C--O 1.219 -0.84 0 N-CA-C 110.968 -0.853 . . . . 25.0 110.968 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.3 t -54.9 -47.41 98.42 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 117.3 2.333 . . . . 25.0 117.3 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.08 159.82 49.03 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 114.17 -3.42 . . . . 25.0 114.648 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.75 -14.23 20.02 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.817 1.043 . . . . 25.0 113.817 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.7 p -68.88 -10.47 57.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.802 0.297 . . . . 25.0 111.802 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.64 -16.89 29.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.424 1.268 . . . . 25.0 114.424 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.55 141.51 58.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.334 0.587 . . . . 25.0 111.625 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 tp -72.21 -25.42 61.64 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.439 -0.948 . . . . 25.0 108.439 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.9 t -89.23 134.04 34.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -138.86 150.92 46.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.619 0.723 . . . . 25.0 112.658 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -92.53 132.89 36.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.239 -1.022 . . . . 25.0 108.239 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.1 mm -132.62 119.15 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.242 -1.021 . . . . 25.0 108.242 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -82.27 139.47 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.253 -1.017 . . . . 25.0 108.253 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -125.93 128.22 24.58 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.64 167.33 26.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 CA-C-N 118.566 0.524 . . . . 25.0 111.592 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -122.91 30.51 6.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.655 0.741 . . . . 25.0 111.523 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -78.37 -20.72 50.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.993 -0.548 . . . . 25.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -143.35 169.84 16.91 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.665 -0.495 . . . . 25.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 150.41 47.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.832 -0.622 . . . . 25.0 109.545 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.08 165.5 12.62 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.469 0.547 . . . . 25.0 114.469 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 40.2 p90 -86.94 147.21 25.86 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.744 1.016 . . . . 25.0 113.744 -176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -139.65 158.92 43.31 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.525 -1.216 . . . . 25.0 108.001 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.419 ' H ' ' CG2' ' A' ' 100' ' ' THR . 52.8 t -116.41 136.54 53.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.3 mt -106.49 129.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.001 -1.851 . . . . 25.0 106.001 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.25 135.58 50.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.926 -0.398 . . . . 25.0 109.926 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.0 130.18 31.07 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.614 -0.266 . . . . 25.0 110.721 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.79 128.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 106.299 -1.741 . . . . 25.0 106.299 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -125.64 108.67 11.78 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -96.17 107.72 20.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.978 -0.556 . . . . 25.0 112.327 -171.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.47 135.46 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.514 -1.291 . . . . 25.0 107.514 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.01 -32.23 27.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 25.0 111.849 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -79.28 -12.68 59.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.733 1.383 . . . . 25.0 114.733 -170.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.0 p -139.21 165.8 26.22 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.166 0.802 . . . . 25.0 113.166 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.61 5.2 16.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.546 0.689 . . . . 25.0 110.756 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -102.79 150.08 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.908 -1.145 . . . . 25.0 107.908 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.23 170.55 21.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 102.544 -3.132 . . . . 25.0 102.544 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.444 ' HB3' HE22 ' A' ' 163' ' ' GLN . 23.7 t80 -143.48 151.83 40.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.765 1.166 . . . . 25.0 113.411 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.93 120.5 41.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.444 HE22 ' HB3' ' A' ' 161' ' ' PHE . 19.9 mm-40 -94.53 130.82 40.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.99 -2.226 . . . . 25.0 104.99 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.5 p -133.11 133.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.824 -0.806 . . . . 25.0 108.824 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.35 128.69 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -85.3 133.03 34.17 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.789 -0.819 . . . . 25.0 108.789 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 149.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 36.3 t0 -120.41 111.11 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.625 -1.991 . . . . 25.0 105.625 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.0 mt -109.18 104.63 13.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.72 168.02 19.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.129 -0.487 . . . . 25.0 111.92 -173.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -80.78 135.97 36.05 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.9 pttm . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.344 -1.313 . . . . 25.0 111.287 176.112 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.294 0 N-CA-C 110.529 -1.029 . . . . 25.0 110.529 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -98.24 149.77 22.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.798 -0.816 . . . . 25.0 108.798 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -102.32 126.77 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 122.427 0.291 . . . . 25.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -103.47 -34.3 8.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.684 0.754 . . . . 25.0 111.054 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.27 143.01 16.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.0 137.63 50.79 Favored 'Cis proline' 0 C--N 1.352 0.736 0 N-CA-C 117.863 2.216 . . . . 25.0 117.863 2.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 137.12 2.94 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 117.388 1.715 . . . . 25.0 117.388 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -76.17 147.98 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.116 0.484 . . . . 25.0 111.249 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -68.22 -37.96 81.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.669 . . . . 25.0 111.602 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.83 66.42 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.67 -28.02 69.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.255 0.465 . . . . 25.0 112.255 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.94 -9.16 44.11 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 111.85 0.315 . . . . 25.0 111.85 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.4 t . . . . . 0 C--O 1.217 -0.641 0 CA-C-O 121.251 0.548 . . . . 25.0 110.839 -177.033 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p . . . . . 0 CA--C 1.542 0.649 0 N-CA-C 113.749 1.018 . . . . 25.0 113.749 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -68.63 -14.26 62.9 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.156 -0.965 . . . . 25.0 112.957 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.64 -37.64 49.58 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.87 -0.332 . . . . 25.0 111.68 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -149.63 63.58 6.54 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.115 1.154 . . . . 25.0 114.115 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.28 -9.15 25.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 118.096 -0.803 . . . . 25.0 114.083 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -97.82 -0.19 45.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.241 0.46 . . . . 25.0 112.241 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -87.3 94.13 9.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.764 -1.199 . . . . 25.0 107.764 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -129.78 133.43 46.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -125.9 131.89 52.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.444 0.566 . . . . 25.0 109.731 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.01 163.53 32.45 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.98 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.8 mttt . . . . . 0 CA--C 1.54 0.594 0 N-CA-C 112.973 0.731 . . . . 25.0 112.973 -176.567 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.535 0 CA-C-O 120.139 -0.256 . . . . 25.0 113.588 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -62.1 -45.9 91.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.925 0.869 . . . . 25.0 109.534 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -84.87 -13.19 51.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.49 -0.777 . . . . 25.0 110.598 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.34 86.18 Favored Glycine 0 C--O 1.216 -0.989 0 CA-C-N 116.072 -0.513 . . . . 25.0 112.475 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.64 77.63 Favored Glycine 0 C--O 1.222 -0.607 0 C-N-CA 120.358 -0.925 . . . . 25.0 112.493 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.51 -43.82 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.54 -34.42 75.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.722 -0.672 . . . . 25.0 110.689 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.42 -30.66 70.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -68.04 -6.05 20.62 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.604 -0.685 . . . . 25.0 111.921 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -130.3 37.5 3.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.34 -0.615 . . . . 25.0 109.34 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -120.42 169.54 10.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 25.0 109.794 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.99 -28.1 68.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.495 0.664 . . . . 25.0 109.983 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -96.18 19.99 10.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.621 -0.718 . . . . 25.0 111.438 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -49.75 135.58 18.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.602 0.715 . . . . 25.0 111.536 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -87.76 154.75 20.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.057 0.932 . . . . 25.0 110.428 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -66.41 147.14 53.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 25.0 110.152 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -116.22 132.32 56.7 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.468 -0.938 . . . . 25.0 108.468 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -119.9 135.89 54.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.99 136.29 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.29 -1.745 . . . . 25.0 106.29 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.1 ttt -150.59 168.14 25.17 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.236 -1.765 . . . . 25.0 106.236 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.8 p -90.52 166.7 13.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.79 -1.93 . . . . 25.0 105.79 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.25 -164.28 10.65 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 117.925 0.33 . . . . 25.0 113.667 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.06 -175.77 31.24 Favored Glycine 0 N--CA 1.458 0.114 0 O-C-N 122.348 -0.501 . . . . 25.0 112.2 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 15.0 tt0 -69.73 134.65 48.86 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.754 -0.85 . . . . 25.0 109.444 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -125.59 158.23 35.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.561 -0.903 . . . . 25.0 108.561 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.0 m -117.63 116.28 26.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.898 -1.89 . . . . 25.0 105.898 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -93.01 136.87 32.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 105.901 -1.889 . . . . 25.0 105.901 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -127.62 115.53 18.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 25.0 110.469 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -122.3 145.2 48.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.387 -2.449 . . . . 25.0 104.387 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -145.02 156.74 44.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 25.0 109.622 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -139.82 154.45 47.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -71.42 -13.25 61.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.398 0.888 . . . . 25.0 113.398 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.12 158.34 64.72 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.275 -1.009 . . . . 25.0 108.275 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.16 150.86 72.36 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 114.581 -3.146 . . . . 25.0 109.594 170.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -130.98 132.81 45.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.361 -0.978 . . . . 25.0 108.361 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -66.05 144.89 56.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 25.0 109.689 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -162.92 152.07 15.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.368 -3.197 . . . . 25.0 102.368 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 -40.13 10.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.715 0.769 . . . . 25.0 108.946 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -156.1 148.96 24.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.799 -0.815 . . . . 25.0 108.799 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.59 142.31 39.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.32 -1.363 . . . . 25.0 107.32 170.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 156.33 42.69 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.394 -0.191 . . . . 25.0 110.723 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -130.52 144.94 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.642 0.589 . . . . 25.0 111.3 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -131.96 159.7 37.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.021 -1.844 . . . . 25.0 106.021 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.447 HD12 ' HB ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -135.96 158.1 38.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.423 -0.954 . . . . 25.0 108.423 175.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.9 p -103.23 138.69 39.69 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.489 0.661 . . . . 25.0 110.942 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.0 117.72 27.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.98 128.36 34.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 102.575 -3.121 . . . . 25.0 102.575 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.67 30.67 12.75 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 118.856 -1.64 . . . . 25.0 113.611 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -51.77 148.16 5.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.688 0.744 . . . . 25.0 110.172 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -68.97 129.43 92.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.998 -0.547 . . . . 25.0 110.22 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.22 -14.03 25.7 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 118.484 -0.544 . . . . 25.0 113.451 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.5 -10.23 59.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.778 0.799 . . . . 25.0 110.808 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -116.55 148.99 43.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.558 -0.534 . . . . 25.0 109.558 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.2 125.93 15.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 116.616 -1.79 . . . . 25.0 112.059 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 tt -52.99 -50.43 64.16 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.079 -0.964 . . . . 25.0 113.158 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -68.55 -2.96 10.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.748 1.388 . . . . 25.0 114.748 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.86 -49.33 3.53 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.138 0.494 . . . . 25.0 111.703 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.06 50.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.186 1.55 . . . . 25.0 115.186 -170.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -77.63 -29.05 51.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.479 0.548 . . . . 25.0 112.479 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -126.01 151.12 47.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.694 0.628 . . . . 25.0 112.694 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.11 154.66 47.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.71 128.04 33.98 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.098 -0.704 . . . . 25.0 109.098 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.447 ' HB ' HD12 ' A' ' 99' ' ' ILE . 10.0 tt -104.25 -9.47 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.297 0.57 . . . . 25.0 111.609 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.92 160.12 21.62 Favored Glycine 0 CA--C 1.511 -0.197 0 C-N-CA 119.86 -1.162 . . . . 25.0 114.33 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.55 142.03 25.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.779 -1.193 . . . . 25.0 107.779 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.32 111.62 10.84 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.78 163.96 25.85 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 116.013 -2.192 . . . . 25.0 111.299 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -138.45 113.88 9.6 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.219 1.009 . . . . 25.0 109.276 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -172.44 -107.2 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 99.111 -4.403 . . . . 25.0 99.111 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.53 54.19 4.9 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.377 -1.089 . . . . 25.0 110.377 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 t -81.99 132.88 52.57 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 122.382 -0.481 . . . . 25.0 110.245 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.08 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 121.691 1.594 . . . . 25.0 111.423 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -21.06 8.42 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.9 t -64.71 -8.0 12.99 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -62.56 -14.16 39.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.282 1.215 . . . . 25.0 114.282 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.17 137.8 58.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -20.33 63.75 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -99.97 132.99 44.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -137.43 149.82 47.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -81.66 133.31 35.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.408 -1.701 . . . . 25.0 106.408 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.98 118.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.552 -2.018 . . . . 25.0 105.552 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 49.6 t80 -84.57 125.67 32.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.14 104.28 25.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 120.508 0.194 . . . . 25.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.63 150.9 51.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 116.027 -2.182 . . . . 25.0 109.486 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.2 102.75 3.26 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.496 -0.557 . . . . 25.0 109.496 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -91.73 -17.93 24.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.489 0.552 . . . . 25.0 112.489 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -140.93 169.91 16.74 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.41 128.97 36.64 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.751 -1.203 . . . . 25.0 107.751 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -179.36 163.37 30.77 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.202 2.041 . . . . 25.0 118.202 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 19.6 p90 -87.09 147.04 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.64 -1.28 . . . . 25.0 110.384 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -134.94 150.41 50.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.06 127.97 67.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.038 -2.208 . . . . 25.0 105.038 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.96 116.85 53.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.487 -1.672 . . . . 25.0 106.487 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.1 tt -99.09 133.63 43.08 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.665 -1.235 . . . . 25.0 107.665 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -122.85 145.77 48.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.89 0.376 . . . . 25.0 110.069 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.7 t -126.57 134.05 67.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.013 -1.106 . . . . 25.0 108.013 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -129.18 99.0 5.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.419 -1.326 . . . . 25.0 107.419 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.83 106.79 17.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.084 -0.507 . . . . 25.0 111.891 -173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.4 t -92.48 126.69 44.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.14 -2.17 . . . . 25.0 105.14 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.35 -13.52 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.419 -0.956 . . . . 25.0 108.419 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.43 -1.39 29.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.288 -1.324 . . . . 25.0 112.035 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.9 t -152.95 165.87 34.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.13 -25.02 67.58 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.764 1.024 . . . . 25.0 113.764 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -110.07 159.1 17.62 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.183 0.809 . . . . 25.0 113.183 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 163.86 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 104.639 -2.356 . . . . 25.0 104.639 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -108.94 127.93 54.49 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.774 -0.37 . . . . 25.0 111.047 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.95 137.76 53.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -148.96 166.05 29.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.74 -0.467 . . . . 25.0 109.74 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.97 150.98 31.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.339 -0.986 . . . . 25.0 108.339 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.09 118.44 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.905 -1.887 . . . . 25.0 105.905 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -92.21 134.2 35.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.473 0.654 . . . . 25.0 110.577 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.58 157.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -127.25 119.21 25.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.234 -2.136 . . . . 25.0 105.234 174.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.7 mt -119.86 132.38 55.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.097 0.475 . . . . 25.0 110.208 -170.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.91 163.57 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.904 -0.589 . . . . 25.0 110.969 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -78.08 158.28 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.325 -1.361 . . . . 25.0 107.325 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 116.609 -1.662 . . . . 25.0 107.799 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.236 0.261 1 N-CA-C 102.497 -4.241 . . . . 25.0 102.497 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.46 149.15 35.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 120.093 1.946 . . . . 25.0 113.103 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -94.84 120.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.143 -0.935 . . . . 25.0 109.996 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.92 -13.09 20.14 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.527 0.566 . . . . 25.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -162.7 142.81 7.29 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.84 126.61 12.95 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 130.373 1.406 . . . . 25.0 113.999 -1.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.81 51.21 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 111.276 -0.73 . . . . 25.0 111.276 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.2 t -141.29 136.47 31.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.634 -1.246 . . . . 25.0 107.634 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -67.28 -21.12 65.72 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.43 0.53 . . . . 25.0 112.43 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.14 80.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.132 0.492 . . . . 25.0 110.641 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.56 65.07 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 120.876 0.37 . . . . 25.0 110.639 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.92 -4.25 59.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.219 -0.446 . . . . 25.0 110.825 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t . . . . . 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 25.0 110.078 -176.554 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.472 0.674 0 N-CA-C 113.329 0.862 . . . . 25.0 113.329 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -50.35 -22.05 1.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 117.742 2.497 . . . . 25.0 117.742 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -79.91 -35.96 37.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.459 -0.776 . . . . 25.0 112.045 -172.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.88 63.31 5.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.173 0.805 . . . . 25.0 113.173 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.28 -6.46 18.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 117.411 -1.26 . . . . 25.0 112.296 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -93.68 4.97 53.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 25.0 112.115 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -92.34 93.94 8.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.219 -1.03 . . . . 25.0 108.219 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.0 mt -116.47 104.95 11.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.686 -0.857 . . . . 25.0 108.686 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -129.9 146.17 51.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.947 0.404 . . . . 25.0 110.628 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.5 145.53 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.995 -0.743 . . . . 25.0 108.995 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 tttt . . . . . 0 C--N 1.324 -0.513 0 CA-C-O 120.686 0.279 . . . . 25.0 110.417 179.693 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.224 -0.47 0 CA-C-O 120.222 -0.21 . . . . 25.0 113.085 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.81 -43.89 94.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.532 0.682 . . . . 25.0 109.948 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -69.51 -25.52 64.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.626 -0.715 . . . . 25.0 111.468 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -31.83 72.64 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.836 -0.697 . . . . 25.0 111.52 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.53 72.17 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 120.952 -0.642 . . . . 25.0 112.891 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.95 -38.21 71.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.25 -43.89 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.997 0.427 . . . . 25.0 111.308 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.73 -4.44 37.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.863 1.06 . . . . 25.0 113.863 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -62.1 -13.4 26.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -133.88 82.8 2.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 171.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.4 t -145.74 152.22 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.344 -0.614 . . . . 25.0 109.344 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.03 -25.76 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.392 0.615 . . . . 25.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -97.18 7.34 46.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.973 -0.558 . . . . 25.0 111.424 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . 0.438 ' HG2' ' H ' ' A' ' 70' ' ' TRP . 44.7 ttp180 -65.43 169.37 6.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.471 1.129 . . . . 25.0 110.219 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . 0.438 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 20.7 p90 -91.37 165.94 13.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.103 -1.443 . . . . 25.0 107.103 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -76.12 151.87 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -121.14 123.21 41.75 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 106.078 -1.823 . . . . 25.0 106.078 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -118.82 126.09 51.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.315 0.487 . . . . 25.0 112.315 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.5 132.2 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.682 -0.858 . . . . 25.0 108.682 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttp -150.69 157.56 43.11 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 107.809 -1.182 . . . . 25.0 107.809 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.0 p -95.01 163.79 13.16 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.081 -0.387 . . . . 25.0 110.143 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.23 172.23 50.25 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.937 -0.649 . . . . 25.0 112.815 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.57 -166.2 12.36 Favored Glycine 0 C--O 1.228 -0.258 0 O-C-N 122.516 -0.402 . . . . 25.0 112.367 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -76.84 140.54 40.67 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.058 -0.672 . . . . 25.0 111.417 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -136.02 158.54 44.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.8 m -126.07 123.77 39.12 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -116.23 139.58 50.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.003 -1.11 . . . . 25.0 108.003 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 t -137.96 145.99 42.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.3 -1.37 . . . . 25.0 107.3 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -121.42 145.18 48.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.777 -1.564 . . . . 25.0 106.777 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -131.47 161.96 31.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.41 153.65 48.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.597 -1.26 . . . . 25.0 107.597 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.1 p -81.02 -11.89 59.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.934 0.346 . . . . 25.0 111.934 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.92 20.75 Favored Pre-proline 0 C--O 1.25 1.112 0 N-CA-C 110.371 -0.233 . . . . 25.0 110.371 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.07 129.54 14.29 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.725 -1.05 . . . . 25.0 110.959 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -131.14 158.69 39.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.97 -0.382 . . . . 25.0 109.97 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -81.74 157.48 24.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.039 -1.097 . . . . 25.0 108.039 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.3 m -139.31 140.17 37.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.1 t -88.5 -48.64 7.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.238 -1.393 . . . . 25.0 107.238 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.23 166.36 18.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.265 -0.642 . . . . 25.0 109.265 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -146.79 138.68 24.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.456 -1.683 . . . . 25.0 106.456 167.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.84 148.91 31.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 25.0 109.297 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -145.32 148.25 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.23 1.014 . . . . 25.0 113.289 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.77 168.94 17.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.384 -1.28 . . . . 25.0 107.734 -170.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.54 159.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 166.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -95.35 135.86 36.43 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -87.7 124.9 34.05 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.336 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -88.6 153.94 20.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.49 15.17 58.91 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.147 -1.502 . . . . 25.0 113.059 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -52.75 153.47 3.22 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.597 0.962 . . . . 25.0 113.597 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -75.79 130.59 78.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.78 -0.646 . . . . 25.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.92 -15.7 29.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 117.174 -1.417 . . . . 25.0 111.777 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.61 -21.77 65.39 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.309 1.043 . . . . 25.0 111.718 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -120.2 141.97 32.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 O-C-N 121.978 -0.451 . . . . 25.0 110.444 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.55 134.42 30.61 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 115.34 -2.64 . . . . 25.0 112.554 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.5 mt -57.81 -33.84 69.01 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.39 -0.823 . . . . 25.0 111.939 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -53.2 -39.23 63.55 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.609 -0.723 . . . . 25.0 111.286 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.28 -51.8 7.56 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.738 0.644 . . . . 25.0 112.738 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.87 -27.45 61.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 116.855 2.169 . . . . 25.0 116.855 -166.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -71.1 -17.3 62.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.784 1.402 . . . . 25.0 114.784 -170.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -96.74 121.39 38.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -118.65 112.03 19.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.422 -0.585 . . . . 25.0 109.422 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.8 124.24 23.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.866 -1.531 . . . . 25.0 106.866 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.0 tt -115.8 1.82 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.919 0.866 . . . . 25.0 109.834 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.51 145.8 4.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 25.0 114.004 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.73 137.91 31.99 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.723 -1.584 . . . . 25.0 106.723 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 t -132.48 89.27 36.75 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 108.636 -0.876 . . . . 25.0 108.636 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.41 163.49 37.6 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 116.073 -2.151 . . . . 25.0 110.54 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -128.22 120.99 28.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.434 0.635 . . . . 25.0 109.578 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -127.07 -76.7 0.57 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.002 -2.592 . . . . 25.0 104.002 172.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -147.97 -150.09 5.12 Favored Glycine 0 C--O 1.242 0.603 0 N-CA-C 108.6 -1.8 . . . . 25.0 108.6 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.2 m 62.59 157.17 0.12 Allowed Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 114.474 1.287 . . . . 25.0 114.474 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.11 0.15 9.3 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 115.781 -2.346 . . . . 25.0 114.799 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.42 91.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.443 -0.799 . . . . 25.0 109.486 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.3 p -79.74 -11.24 59.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.117 0.484 . . . . 25.0 111.626 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -76.97 -21.0 55.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.191 -0.459 . . . . 25.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -74.34 104.93 5.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.885 0.374 . . . . 25.0 111.172 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -16.06 24.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.019 0.748 . . . . 25.0 113.019 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -100.22 126.51 46.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.301 -1.37 . . . . 25.0 107.301 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -131.07 150.5 52.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.559 0.695 . . . . 25.0 111.826 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -94.73 136.08 35.45 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 105.602 -1.999 . . . . 25.0 105.602 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.0 118.97 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -80.61 130.58 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.169 -2.16 . . . . 25.0 105.169 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.7 mt -122.43 111.57 31.64 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 107.265 -1.383 . . . . 25.0 107.265 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.74 162.0 40.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 116.949 -1.567 . . . . 25.0 112.406 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -111.24 91.03 3.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.517 -2.401 . . . . 25.0 104.517 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -79.42 -29.77 42.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.155 -0.683 . . . . 25.0 109.155 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mtt-85 -155.27 170.0 22.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 103.535 -2.765 . . . . 25.0 103.535 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.89 112.68 24.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.987 -2.968 . . . . 25.0 102.987 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 168.27 166.7 27.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.229 -0.51 . . . . 25.0 112.497 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 49.9 p90 -87.08 142.35 27.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.778 1.399 . . . . 25.0 114.778 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -129.4 136.85 50.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.182 -1.784 . . . . 25.0 106.182 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.91 133.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.89 -1.152 . . . . 25.0 107.89 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.8 mt -96.08 126.27 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.6 mt -111.6 127.05 55.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.038 -1.467 . . . . 25.0 107.038 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.34 145.84 52.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.51 0.596 . . . . 25.0 111.022 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.07 138.15 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -129.19 120.63 26.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.783 -0.821 . . . . 25.0 108.783 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -101.45 97.0 7.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.327 0.585 . . . . 25.0 109.955 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.62 123.03 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.218 -1.03 . . . . 25.0 108.218 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.17 -22.97 59.19 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.95 -7.61 55.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.578 0.955 . . . . 25.0 113.578 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -132.16 158.03 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.24 13.07 3.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.628 -1.169 . . . . 25.0 109.285 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -109.92 162.21 14.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 25.0 109.93 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.88 150.28 50.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.381 -2.452 . . . . 25.0 104.381 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -122.65 143.11 49.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.794 -1.188 . . . . 25.0 107.794 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -138.93 156.38 47.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.384 -0.599 . . . . 25.0 109.384 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.71 149.67 36.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.35 141.98 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.72 -0.474 . . . . 25.0 109.72 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.4 mt -139.02 128.53 30.6 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 105.396 -2.076 . . . . 25.0 105.396 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -112.15 126.9 55.7 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.4 m -125.52 126.12 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.576 0.703 . . . . 25.0 109.92 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 42.2 t0 -87.58 96.05 10.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.196 -1.779 . . . . 25.0 106.196 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.2 112.14 22.42 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.356 -0.838 . . . . 25.0 109.86 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.6 m -136.32 173.75 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.171 -0.468 . . . . 25.0 111.245 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -63.05 159.37 17.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.695 0.76 . . . . 25.0 112.678 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.59 -1.187 . . . . 25.0 110.861 178.144 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.163 0 N-CA-C 107.801 -2.119 . . . . 25.0 107.801 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.24 165.76 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.824 1.312 . . . . 25.0 110.57 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.445 HG22 ' H ' ' A' ' 6' ' ' LYS . 30.1 mm -93.98 124.55 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 25.0 109.78 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -87.9 22.11 2.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.386 0.675 . . . . 25.0 111.7 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.445 ' H ' HG22 ' A' ' 4' ' ' ILE . 42.3 mttt 77.05 153.27 0.14 Allowed Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 125.975 1.71 . . . . 25.0 111.955 175.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.97 151.98 68.7 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 129.031 0.846 . . . . 25.0 111.158 -7.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.91 21.73 15.21 Favored Glycine 0 C--O 1.211 -1.288 0 N-CA-C 117.714 1.846 . . . . 25.0 117.714 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -76.5 128.37 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 119.23 1.515 . . . . 25.0 110.041 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -73.33 -27.13 61.34 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.988 -0.375 . . . . 25.0 109.988 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.22 -33.63 69.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.526 0.565 . . . . 25.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.21 69.6 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 120.826 0.346 . . . . 25.0 111.55 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.95 -8.33 46.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.583 0.706 . . . . 25.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.8 t . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.133 -0.939 . . . . 25.0 113.24 -171.729 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p . . . . . 0 CA--C 1.551 0.983 0 N-CA-C 112.592 0.59 . . . . 25.0 112.592 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.3 ptm -56.46 -10.92 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 116.678 2.103 . . . . 25.0 116.678 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.19 -35.9 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 118.163 0.438 . . . . 25.0 111.985 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.05 46.02 0.39 Allowed Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 117.042 2.238 . . . . 25.0 117.042 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.45 -14.28 36.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 115.797 -2.335 . . . . 25.0 114.648 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.06 5.01 49.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.367 0.506 . . . . 25.0 112.367 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.4 t -106.39 89.69 3.12 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.588 -1.264 . . . . 25.0 107.588 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.36 124.68 45.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.0 -1.852 . . . . 25.0 106.0 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -127.45 145.82 50.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 25.0 110.883 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 158.02 45.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.902 -1.888 . . . . 25.0 105.902 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 tttt . . . . . 0 C--N 1.323 -0.575 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 178.406 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.427 0 N-CA-C 114.839 0.695 . . . . 25.0 114.839 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.62 -25.41 66.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 25.0 111.14 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -84.9 0.57 50.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.817 0.342 . . . . 25.0 111.77 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.68 -19.49 58.33 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 121.129 -0.558 . . . . 25.0 112.98 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.97 -20.75 67.08 Favored Glycine 0 C--O 1.222 -0.617 0 C-N-CA 121.079 -0.582 . . . . 25.0 113.228 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.59 -39.4 80.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.415 -0.957 . . . . 25.0 108.415 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.03 -26.86 61.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.52 7.56 4.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.485 0.66 . . . . 25.0 112.221 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.49 -28.02 15.1 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.45 -0.781 . . . . 25.0 109.037 171.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -150.72 96.73 2.4 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.836 0.351 . . . . 25.0 111.394 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.6 t -152.87 154.37 34.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -69.55 -32.8 71.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.177 0.989 . . . . 25.0 109.802 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.32 28.13 8.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.2 -0.909 . . . . 25.0 110.037 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -53.68 154.31 3.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.273 -0.876 . . . . 25.0 109.992 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -84.78 165.26 17.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.28 -1.378 . . . . 25.0 107.28 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -74.8 139.02 42.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -127.5 133.98 49.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -119.63 146.94 45.1 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.366 -1.346 . . . . 25.0 107.366 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -96.7 133.03 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 25.0 108.199 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 93.7 mtp -135.06 158.42 44.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -104.47 172.04 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.14 -175.93 7.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 114.495 0.558 . . . . 25.0 114.495 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.14 -173.37 20.56 Favored Glycine 0 CA--C 1.518 0.221 0 O-C-N 122.525 -0.397 . . . . 25.0 112.755 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.14 141.13 33.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -141.91 160.75 39.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.349 -0.612 . . . . 25.0 109.349 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -126.75 129.49 48.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.39 -1.708 . . . . 25.0 106.39 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.43 139.05 49.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -130.82 133.41 45.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.495 0.497 . . . . 25.0 110.16 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -124.08 151.71 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.839 -1.911 . . . . 25.0 105.839 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -138.07 161.95 35.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 119.037 0.835 . . . . 25.0 110.656 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.14 150.65 39.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.488 -1.671 . . . . 25.0 106.488 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -68.63 -22.39 64.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.384 0.513 . . . . 25.0 112.384 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.04 151.97 63.72 Favored Pre-proline 0 C--O 1.242 0.693 0 N-CA-C 105.719 -1.956 . . . . 25.0 105.719 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.38 145.93 73.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 115.587 -2.475 . . . . 25.0 109.515 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -130.88 140.49 50.22 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.994 -0.441 . . . . 25.0 111.491 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.62 141.52 57.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 m -150.02 151.9 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.746 -1.946 . . . . 25.0 105.746 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.0 p -108.01 -34.05 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 118.256 0.48 . . . . 25.0 110.618 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.76 145.29 18.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.971 -0.456 . . . . 25.0 109.835 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -141.2 139.43 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.035 -0.666 . . . . 25.0 109.543 163.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -148.09 159.64 43.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.89 -0.596 . . . . 25.0 109.532 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -145.04 150.24 36.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.915 1.08 . . . . 25.0 113.915 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.74 164.6 17.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.035 -1.438 . . . . 25.0 107.522 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.66 155.73 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.6 p -96.02 144.19 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.424 -0.584 . . . . 25.0 109.424 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -87.99 129.82 35.14 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 110.163 -0.31 . . . . 25.0 110.163 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -81.53 156.21 25.36 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.054 0.542 . . . . 25.0 109.671 172.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.8 10.12 73.2 Favored Glycine 0 N--CA 1.462 0.419 0 N-CA-C 118.59 2.196 . . . . 25.0 118.59 166.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -59.26 161.35 5.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.032 1.123 . . . . 25.0 114.032 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.24 156.02 36.28 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 106.646 -1.613 . . . . 25.0 106.646 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.45 -8.62 18.48 Favored 'Trans proline' 0 C--N 1.345 0.389 0 N-CA-C 116.663 1.755 . . . . 25.0 116.663 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -82.33 0.72 40.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.912 0.863 . . . . 25.0 111.77 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -95.97 148.43 34.53 Favored Pre-proline 0 C--N 1.322 -0.616 0 O-C-N 121.734 -0.604 . . . . 25.0 110.412 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.04 83.4 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 N-CA-C 110.329 -0.681 . . . . 25.0 110.329 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.7 mt -53.15 -39.53 63.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.912 1.449 . . . . 25.0 114.912 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -63.07 -21.98 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.797 0.666 . . . . 25.0 112.797 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -94.76 -48.55 5.99 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 112.344 0.498 . . . . 25.0 112.344 169.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.79 64.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 115.708 1.744 . . . . 25.0 115.708 -166.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -69.31 -28.88 66.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.247 -0.581 . . . . 25.0 111.633 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -97.66 113.92 25.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.116 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -121.86 136.67 54.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.235 0.541 . . . . 25.0 111.469 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.4 tp -75.61 123.93 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.459 -1.682 . . . . 25.0 106.459 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.2 tp -121.75 -5.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.564 0.697 . . . . 25.0 111.185 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -161.21 140.15 6.47 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.395 -0.907 . . . . 25.0 112.243 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 134.21 16.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.401 -1.333 . . . . 25.0 107.401 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.74 103.2 7.65 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.92 148.73 76.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 116.013 -2.191 . . . . 25.0 109.69 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -106.14 92.2 4.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.364 -1.346 . . . . 25.0 107.364 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -119.17 1.15 11.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.373 -1.739 . . . . 25.0 109.782 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.62 -18.75 9.93 Favored Glycine 0 C--O 1.236 0.24 0 CA-C-N 115.303 -0.862 . . . . 25.0 111.905 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.6 t -54.71 136.99 63.89 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 117.116 0.458 . . . . 25.0 110.465 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.75 -11.67 28.03 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 117.029 -1.514 . . . . 25.0 114.753 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.78 -34.67 78.89 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.375 -1.284 . . . . 25.0 109.143 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -84.4 -10.05 57.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.202 0.525 . . . . 25.0 112.044 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -86.48 -22.78 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.643 -1.243 . . . . 25.0 107.643 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.04 104.84 17.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 25.0 110.402 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.65 -10.87 59.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.667 -0.697 . . . . 25.0 112.321 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -91.31 121.98 33.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.928 -1.138 . . . . 25.0 107.928 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -137.26 147.83 46.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 25.0 111.426 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -79.23 137.89 37.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.726 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.0 mt -132.68 106.02 9.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.744 -1.206 . . . . 25.0 107.744 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -78.12 140.85 39.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.574 -0.899 . . . . 25.0 108.574 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.9 mm -124.63 123.36 25.72 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.61 158.44 53.59 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 117.289 -1.341 . . . . 25.0 111.52 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -106.97 52.83 0.71 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.512 1.149 . . . . 25.0 110.037 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.75 -37.5 24.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 115.477 1.658 . . . . 25.0 115.477 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -152.87 172.23 17.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.19 0.596 . . . . 25.0 109.738 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.0 mp -99.95 142.77 30.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.678 -2.342 . . . . 25.0 104.678 167.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.41 150.07 5.88 Favored Glycine 0 C--O 1.234 0.117 0 C-N-CA 120.588 -0.815 . . . . 25.0 114.078 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 27.4 p90 -86.01 145.11 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 25.0 110.049 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 153.02 40.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.842 -0.617 . . . . 25.0 110.184 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.65 143.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.046 -0.524 . . . . 25.0 110.644 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.08 128.85 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.341 -2.466 . . . . 25.0 104.341 172.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.72 137.43 53.93 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.842 -1.54 . . . . 25.0 106.842 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.82 151.15 42.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 118.958 0.799 . . . . 25.0 110.971 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.04 134.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.124 -1.435 . . . . 25.0 107.124 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -124.78 98.98 5.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.586 -1.265 . . . . 25.0 107.586 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -84.79 117.81 24.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.037 0.446 . . . . 25.0 110.554 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.03 133.75 28.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.76 -42.47 58.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.119 0.485 . . . . 25.0 111.194 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.66 -24.07 64.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.812 1.782 . . . . 25.0 115.812 -168.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 66.3 p -135.62 162.55 32.39 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 122.381 -0.199 . . . . 25.0 110.701 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 11.32 2.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 25.0 112.587 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.11 160.0 16.85 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.168 -1.419 . . . . 25.0 107.168 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.52 170.7 15.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.04 -2.207 . . . . 25.0 105.04 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -120.32 158.37 27.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.1 -1.074 . . . . 25.0 108.1 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -138.7 154.63 48.6 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -132.7 142.06 48.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.11 129.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.3 mt -140.66 126.56 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.47 137.09 37.66 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.624 -0.51 . . . . 25.0 109.624 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.58 137.51 43.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 51.8 t0 -82.03 136.14 35.26 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.687 -1.598 . . . . 25.0 106.687 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.14 104.24 9.94 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 34.1 m -113.03 166.95 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.239 0.543 . . . . 25.0 111.824 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.21 158.7 32.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.535 -1.654 . . . . 25.0 106.535 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 117.285 -1.34 . . . . 25.0 110.365 178.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.678 0 CA-C-O 118.428 -1.207 . . . . 25.0 110.714 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -156.64 164.73 37.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.226 1.013 . . . . 25.0 112.864 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.4 mt -90.73 122.74 42.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -77.72 -41.38 38.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.382 0.61 . . . . 25.0 109.537 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.32 117.08 8.73 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.182 -0.463 . . . . 25.0 109.836 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.36 122.61 7.83 Favored 'Cis proline' 0 C--N 1.357 1.002 0 C-N-CA 130.412 1.422 . . . . 25.0 113.454 -3.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.1 -22.58 57.07 Favored Glycine 0 CA--C 1.508 -0.36 0 N-CA-C 116.051 1.18 . . . . 25.0 116.051 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 t -91.18 97.18 10.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.601 -0.941 . . . . 25.0 110.73 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -83.96 -32.34 25.08 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.727 -0.471 . . . . 25.0 109.727 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -36.67 71.13 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.203 1.186 . . . . 25.0 114.203 -173.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.81 -32.43 71.8 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.282 0.364 . . . . 25.0 110.957 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.9 mp -92.93 -19.93 21.14 Favored 'General case' 0 C--O 1.211 -0.931 0 N-CA-C 112.708 0.632 . . . . 25.0 112.708 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.7 t . . . . . 0 C--N 1.324 -0.517 0 N-CA-C 109.303 -0.628 . . . . 25.0 109.303 179.046 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 CA--C 1.546 0.812 0 CA-C-O 121.597 0.713 . . . . 25.0 111.024 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -26.26 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 117.933 2.568 . . . . 25.0 117.933 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -75.97 -43.4 44.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.882 0.764 . . . . 25.0 112.816 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.9 71.93 19.03 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 122.009 0.909 . . . . 25.0 112.928 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.66 2.0 5.09 Favored 'Trans proline' 0 C--O 1.221 -0.346 0 N-CA-C 114.606 0.964 . . . . 25.0 114.606 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 3.17 33.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.654 -0.498 . . . . 25.0 109.654 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -134.15 84.03 2.08 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 115.771 1.767 . . . . 25.0 115.771 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.0 131.19 55.31 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 103.525 -2.769 . . . . 25.0 103.525 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -114.37 143.54 44.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.191 1.182 . . . . 25.0 114.191 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.28 155.97 49.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.456 -2.424 . . . . 25.0 104.456 167.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.7 tttt . . . . . 0 C--N 1.327 -0.392 0 O-C-N 121.572 -0.705 . . . . 25.0 110.483 -178.306 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.561 0 N-CA-C 113.495 0.158 . . . . 25.0 113.495 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 mt -59.32 -10.68 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.606 1.706 . . . . 25.0 115.606 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -61.04 -19.96 61.98 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.21 -16.15 77.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.35 -0.844 . . . . 25.0 111.709 177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.71 -4.58 66.49 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 115.421 0.928 . . . . 25.0 115.421 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.48 -32.76 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.352 1.076 . . . . 25.0 110.077 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.52 -25.37 65.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.513 -0.312 . . . . 25.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -106.15 15.44 26.32 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.783 0.801 . . . . 25.0 110.041 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -70.59 14.75 0.12 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.37 1.248 . . . . 25.0 114.37 -174.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.51 52.91 1.69 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -131.91 178.69 6.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -64.64 -21.15 66.65 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.805 -0.559 . . . . 25.0 112.413 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -95.57 14.38 23.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.555 0.693 . . . . 25.0 112.098 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 ttt85 -58.18 128.32 36.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.867 -0.606 . . . . 25.0 111.129 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -106.14 168.18 9.31 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.921 0.867 . . . . 25.0 112.203 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -63.86 149.58 46.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.613 -0.721 . . . . 25.0 112.123 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -130.5 146.5 52.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.74 -1.207 . . . . 25.0 107.74 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -113.34 138.49 49.97 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.38 129.19 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 94.3 mmm -137.88 166.51 23.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.3 p -107.46 -173.72 2.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.256 -2.128 . . . . 25.0 105.256 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -161.54 21.56 Favored Glycine 0 C--O 1.242 0.605 0 CA-C-O 121.676 0.598 . . . . 25.0 113.744 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.79 176.61 42.65 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.73 -0.948 . . . . 25.0 110.73 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -83.29 141.48 31.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.139 1.469 . . . . 25.0 109.849 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -129.39 139.16 51.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.714 -0.847 . . . . 25.0 108.714 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -85.57 128.84 34.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 25.0 109.946 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.03 127.43 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.962 -1.866 . . . . 25.0 105.962 174.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -128.85 120.47 26.33 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.1 -0.333 . . . . 25.0 110.1 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -124.08 150.1 45.4 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.45 -1.685 . . . . 25.0 106.45 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.1 t -145.21 158.78 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.465 -0.569 . . . . 25.0 109.465 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.01 133.45 52.97 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 108.997 -0.742 . . . . 25.0 108.997 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -77.03 -6.63 53.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.686 0.625 . . . . 25.0 112.686 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.95 145.04 37.65 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 106.907 -1.516 . . . . 25.0 106.907 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.32 142.87 38.1 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 117.239 -1.374 . . . . 25.0 111.804 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -136.27 140.22 43.27 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.935 -0.765 . . . . 25.0 108.935 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -81.51 152.97 27.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.1 m -138.79 148.49 43.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 105.855 -1.905 . . . . 25.0 105.855 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 t -102.71 -43.36 5.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 25.0 110.59 173.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.82 143.46 20.67 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.947 -0.76 . . . . 25.0 108.947 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -144.5 134.8 24.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.78 0.324 . . . . 25.0 110.192 170.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -154.18 162.22 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.407 0.521 . . . . 25.0 112.407 -172.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.25 146.01 51.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.458 0.647 . . . . 25.0 112.107 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -124.0 163.79 20.66 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -131.34 152.98 38.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.6 p -80.48 144.69 32.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.884 -1.154 . . . . 25.0 107.884 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -88.42 124.77 34.28 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 25.0 110.295 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -73.51 126.22 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.007 -1.109 . . . . 25.0 108.007 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.63 35.82 31.23 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 119.041 -1.552 . . . . 25.0 113.931 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -54.9 149.19 11.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.241 1.02 . . . . 25.0 110.713 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -75.6 139.68 71.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.44 -22.47 16.11 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 118.549 -0.5 . . . . 25.0 113.179 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.8 -27.55 64.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.877 0.846 . . . . 25.0 111.956 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -91.67 143.86 28.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.19 115.67 3.28 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 117.555 -1.163 . . . . 25.0 112.019 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tt -52.36 -54.35 32.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.851 1.426 . . . . 25.0 114.851 -166.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -69.57 -4.03 17.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.114 1.153 . . . . 25.0 114.114 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.63 -46.58 5.96 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.503 -0.748 . . . . 25.0 109.483 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.5 -19.99 51.79 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.545 1.313 . . . . 25.0 114.545 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -72.67 -33.69 66.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.08 1.141 . . . . 25.0 114.08 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -91.7 100.01 12.8 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.623 -0.831 . . . . 25.0 112.593 -173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -97.37 125.06 41.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 25.0 110.011 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 tp -71.4 116.98 12.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.976 -0.749 . . . . 25.0 108.976 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -96.88 -4.46 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.876 0.846 . . . . 25.0 109.898 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.35 159.72 11.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.602 -0.808 . . . . 25.0 113.016 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.0 147.07 28.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.769 -0.826 . . . . 25.0 108.769 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -133.67 111.8 12.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.223 -1.028 . . . . 25.0 108.223 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.72 168.92 18.89 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 115.796 -2.336 . . . . 25.0 111.071 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -145.18 120.04 9.94 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 120.568 -0.453 . . . . 25.0 110.505 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -91.57 -39.94 11.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.953 0.882 . . . . 25.0 110.04 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.08 -26.04 0.42 Allowed Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.125 -1.99 . . . . 25.0 108.125 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 t -51.76 141.42 26.55 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.771 0.656 . . . . 25.0 112.771 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.29 23.77 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.805 1.67 . . . . 25.0 114.343 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.28 -25.91 66.07 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.282 -0.886 . . . . 25.0 110.688 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 54.6 p -71.71 0.95 7.58 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.955 0.724 . . . . 25.0 112.955 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -62.1 -35.28 78.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.373 -0.973 . . . . 25.0 108.373 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -94.41 82.82 4.08 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.003 -1.851 . . . . 25.0 106.003 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.87 -19.84 58.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.345 -0.843 . . . . 25.0 111.653 -175.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 t -72.65 138.69 46.85 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.623 -0.673 . . . . 25.0 109.858 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -135.57 143.16 45.51 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.711 -0.477 . . . . 25.0 109.711 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -96.29 139.39 32.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.431 -1.692 . . . . 25.0 106.431 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.9 mm -133.28 130.19 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 39.4 t80 -80.71 132.17 35.53 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.0 mm -112.06 126.39 28.54 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.604 -0.888 . . . . 25.0 108.604 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.85 169.49 22.48 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 118.19 -0.74 . . . . 25.0 111.758 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -130.18 51.26 2.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.084 -1.45 . . . . 25.0 107.084 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -78.52 -32.03 47.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.123 1.157 . . . . 25.0 114.123 -172.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -152.2 165.83 33.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.975 -1.491 . . . . 25.0 106.975 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.4 mp -92.89 142.91 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.271 -2.492 . . . . 25.0 104.271 167.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.29 165.39 10.27 Favored Glycine 0 C--O 1.237 0.318 0 N-CA-C 114.24 0.456 . . . . 25.0 114.24 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 3.9 p90 -81.45 149.69 28.66 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.086 0.772 . . . . 25.0 113.086 -176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.86 159.39 43.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.137 -1.801 . . . . 25.0 106.137 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.1 149.68 11.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 118.517 0.599 . . . . 25.0 111.158 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.7 128.44 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.94 139.21 52.04 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.362 -0.977 . . . . 25.0 108.362 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.69 144.32 41.73 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.87 -0.419 . . . . 25.0 109.87 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.85 135.28 61.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.417 -0.957 . . . . 25.0 108.417 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -128.38 112.14 14.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.261 0.624 . . . . 25.0 111.466 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -88.7 88.42 7.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.42 126.81 33.66 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 105.267 -2.123 . . . . 25.0 105.267 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.09 -23.52 54.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.261 0.553 . . . . 25.0 110.222 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.5 -11.85 61.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.686 -0.688 . . . . 25.0 112.481 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -127.61 161.4 28.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.952 0.406 . . . . 25.0 110.641 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -88.38 3.27 50.49 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.635 1.207 . . . . 25.0 108.054 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -108.83 157.34 18.68 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.702 -1.136 . . . . 25.0 108.945 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.69 141.77 49.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.785 -2.672 . . . . 25.0 103.785 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.03 144.69 32.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.066 -0.516 . . . . 25.0 111.14 -172.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -124.57 145.84 49.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.402 -0.817 . . . . 25.0 109.282 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -138.77 129.5 26.29 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.048 -1.834 . . . . 25.0 106.048 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.14 130.4 34.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.615 -0.883 . . . . 25.0 108.615 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.5 mt -140.37 130.87 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 120.486 0.184 . . . . 25.0 110.645 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.18 138.61 39.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.807 0.813 . . . . 25.0 111.282 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.61 160.81 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 25.0 109.07 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 54.1 t0 -117.29 132.1 56.68 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.216 -1.772 . . . . 25.0 106.216 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.07 121.99 40.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 33.8 m -130.54 167.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 123.532 0.52 . . . . 25.0 110.059 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -77.58 158.1 29.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 117.317 -1.325 . . . . 25.0 110.466 176.541 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.344 0 N-CA-C 108.548 -1.821 . . . . 25.0 108.548 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -80.27 136.33 36.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.11 106.85 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -77.26 -41.13 42.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.794 0.807 . . . . 25.0 110.94 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -152.84 143.76 15.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.036 -0.506 . . . . 25.0 109.669 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 137.39 47.96 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 118.99 0.675 . . . . 25.0 112.126 -5.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.68 168.06 38.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.817 -1.182 . . . . 25.0 113.665 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -161.93 121.36 2.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.339 -2.467 . . . . 25.0 104.339 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -83.4 -38.54 21.82 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 112.149 0.426 . . . . 25.0 112.149 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.21 74.14 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 25.0 112.559 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.77 70.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 112.08 0.4 . . . . 25.0 112.08 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 mt -92.0 -35.39 13.99 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 121.363 0.601 . . . . 25.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.7 t . . . . . 0 C--O 1.219 -0.503 0 CA-C-N 114.809 -1.087 . . . . 25.0 110.917 -174.985 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 113.202 0.815 . . . . 25.0 113.202 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -67.08 -10.4 49.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.24 -41.09 70.57 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.888 1.07 . . . . 25.0 113.888 -171.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -142.59 43.28 0.47 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 117.377 2.362 . . . . 25.0 117.377 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.95 -21.1 28.4 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 113.236 -4.042 . . . . 25.0 112.259 176.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -79.03 -18.74 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 25.0 111.599 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -132.87 78.99 1.82 Allowed 'General case' 0 C--O 1.206 -1.229 0 N-CA-C 113.039 0.755 . . . . 25.0 113.039 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.2 mt -104.33 141.57 36.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.23 -0.656 . . . . 25.0 109.23 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -105.43 141.67 36.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 25.0 109.495 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 167.37 21.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 25.0 110.766 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 94.5 mttt . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 113.286 0.847 . . . . 25.0 113.286 -179.011 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.842 0 N-CA-C 111.79 -0.524 . . . . 25.0 111.79 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.95 -61.24 1.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.461 0.648 . . . . 25.0 111.309 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -85.02 -13.03 51.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.31 0.856 . . . . 25.0 113.31 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.38 72.26 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.804 -0.713 . . . . 25.0 113.058 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.89 -31.49 80.99 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 120.495 -0.86 . . . . 25.0 111.948 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mm -65.5 -37.36 79.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.385 0.612 . . . . 25.0 109.527 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.14 -33.63 59.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.531 . . . . 25.0 110.33 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -67.39 -31.74 72.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.451 0.643 . . . . 25.0 111.231 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.96 -5.06 23.67 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -130.11 41.94 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 25.0 109.044 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -125.16 167.63 14.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.25 -26.11 67.2 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -88.08 12.67 12.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.601 -0.727 . . . . 25.0 112.203 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -53.42 139.66 29.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.563 0.697 . . . . 25.0 109.702 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -81.93 142.32 32.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.52 1.153 . . . . 25.0 111.577 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -71.14 152.13 43.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.939 -1.482 . . . . 25.0 112.01 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -110.9 140.97 44.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.793 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -119.01 133.43 55.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.98 131.0 41.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.4 ttt -151.03 168.18 25.38 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 106.862 -1.533 . . . . 25.0 106.862 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.7 p -88.21 165.97 14.68 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.805 -1.924 . . . . 25.0 105.805 173.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.8 -158.2 5.23 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.396 -0.431 . . . . 25.0 112.583 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.52 -163.89 25.23 Favored Glycine 0 CA--C 1.512 -0.099 0 O-C-N 122.347 -0.502 . . . . 25.0 112.908 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 2.7 tt0 -74.71 129.14 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.008 -0.701 . . . . 25.0 110.906 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -122.5 136.21 54.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.218 -1.03 . . . . 25.0 108.218 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.5 m -99.94 118.15 35.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.896 -1.52 . . . . 25.0 106.896 175.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.65 134.78 42.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.131 -1.433 . . . . 25.0 107.131 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -133.11 130.91 39.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -114.61 150.04 35.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.558 -0.905 . . . . 25.0 108.558 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -143.31 154.92 44.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.164 -0.68 . . . . 25.0 109.164 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -140.13 159.07 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -67.48 -30.55 70.28 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.84 151.18 62.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.65 134.32 27.93 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 115.475 -2.55 . . . . 25.0 111.217 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -131.0 154.47 48.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.129 -0.693 . . . . 25.0 109.129 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -68.54 160.34 30.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.842 0.83 . . . . 25.0 109.717 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -154.46 161.64 41.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.692 -3.818 . . . . 25.0 100.692 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 p -110.7 -39.13 4.96 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.997 -0.742 . . . . 25.0 108.997 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -159.75 143.59 14.53 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.557 -0.905 . . . . 25.0 108.557 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.81 138.47 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.18 -1.415 . . . . 25.0 107.18 169.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -140.83 152.81 45.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.399 . . . . 25.0 111.527 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -117.28 139.11 51.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.934 -1.03 . . . . 25.0 109.081 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.99 165.77 25.23 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.168 -1.419 . . . . 25.0 107.168 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.97 153.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.1 p -85.78 147.87 26.11 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.169 -0.678 . . . . 25.0 109.169 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -86.45 100.85 12.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.996 0.903 . . . . 25.0 110.095 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -76.08 126.72 31.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.761 -1.2 . . . . 25.0 107.761 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 20.92 34.75 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 119.701 -1.238 . . . . 25.0 114.053 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.06 141.1 19.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.492 0.663 . . . . 25.0 111.837 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.85 134.86 81.0 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.8 -16.73 23.35 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 117.703 -1.065 . . . . 25.0 113.344 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.44 -29.32 68.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.061 0.934 . . . . 25.0 110.339 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -100.76 152.31 37.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 107.973 -1.121 . . . . 25.0 107.973 -174.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.52 105.99 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 117.449 -1.234 . . . . 25.0 113.885 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.14 -42.18 69.26 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.459 -0.792 . . . . 25.0 112.075 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.74 -6.55 27.12 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.267 1.21 . . . . 25.0 114.267 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.3 -44.02 6.07 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.535 0.683 . . . . 25.0 111.281 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.45 28.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.333 -1.303 . . . . 25.0 114.489 -170.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -69.13 -29.09 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.9 1.074 . . . . 25.0 113.9 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -127.36 159.15 35.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.332 0.514 . . . . 25.0 112.228 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -133.48 147.68 51.67 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.203 -1.406 . . . . 25.0 107.203 173.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 tt -87.02 133.79 33.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.893 -0.504 . . . . 25.0 110.277 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 tt -121.34 1.87 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.847 0.832 . . . . 25.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.81 156.91 14.17 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.175 -1.012 . . . . 25.0 113.408 172.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.92 139.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.989 -1.115 . . . . 25.0 107.989 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.76 102.13 13.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.3 169.77 16.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 117.353 -1.298 . . . . 25.0 112.044 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -132.24 113.49 13.31 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.721 -1.215 . . . . 25.0 107.721 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -164.59 -104.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 102.009 -3.33 . . . . 25.0 102.009 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.7 40.4 2.93 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 111.152 -0.779 . . . . 25.0 111.152 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -76.28 132.73 72.63 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 122.244 -0.562 . . . . 25.0 111.597 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.2 -178.45 3.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 O-C-N 121.719 0.326 . . . . 25.0 111.955 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -13.9 6.35 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.396 1.258 . . . . 25.0 114.396 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -59.66 -13.24 8.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.583 0.957 . . . . 25.0 113.583 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -67.0 16.24 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.63 1.715 . . . . 25.0 115.63 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -58.09 143.13 44.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.553 0.692 . . . . 25.0 110.679 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.49 -10.79 60.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.139 -0.937 . . . . 25.0 112.21 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.5 t -100.06 122.67 43.29 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 106.936 -1.505 . . . . 25.0 106.936 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -133.83 141.31 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.08 0.467 . . . . 25.0 110.326 -175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -91.97 132.88 36.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -131.92 129.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.903 -1.888 . . . . 25.0 105.903 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 35.3 t80 -96.73 132.08 42.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.008 -1.108 . . . . 25.0 108.008 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.16 106.31 36.17 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.42 151.13 65.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 116.145 -2.103 . . . . 25.0 109.242 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -139.04 95.31 2.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.64 0.733 . . . . 25.0 111.028 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.87 4.68 53.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.933 -1.03 . . . . 25.0 110.721 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -140.8 -179.34 6.0 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.57 130.48 51.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 104.432 -2.433 . . . . 25.0 104.432 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.01 -177.36 24.42 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-O 122.848 1.249 . . . . 25.0 115.973 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.9 p90 -79.02 146.54 33.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.354 1.242 . . . . 25.0 114.354 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -136.39 158.81 43.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.376 -2.453 . . . . 25.0 104.376 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.88 132.91 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.681 -0.859 . . . . 25.0 108.681 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.6 mt -108.51 134.85 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 tt -118.4 137.82 52.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.428 -0.953 . . . . 25.0 108.428 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.48 144.52 51.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.532 0.682 . . . . 25.0 110.9 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.98 133.64 68.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -129.43 100.79 5.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 25.0 108.952 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.1 131.97 34.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.006 -0.543 . . . . 25.0 109.562 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -89.05 160.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.957 -1.127 . . . . 25.0 107.957 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.99 -27.65 12.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.984 -0.747 . . . . 25.0 108.984 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.65 -2.42 58.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.4 t -152.95 162.78 40.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 25.0 111.469 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -67.74 -26.17 66.01 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.496 1.119 . . . . 25.0 111.855 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -86.74 167.31 14.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 25.0 110.592 -173.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.43 -179.56 5.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -128.36 140.46 51.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.538 -0.912 . . . . 25.0 108.538 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -131.76 137.83 48.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.688 -1.227 . . . . 25.0 107.688 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -149.18 155.36 40.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.6 151.0 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.5 mm -134.58 113.01 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.993 -1.114 . . . . 25.0 107.993 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.8 141.27 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.783 -1.192 . . . . 25.0 107.783 175.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.0 m -135.51 161.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 1.0 OUTLIER -126.71 117.59 23.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.955 -1.868 . . . . 25.0 105.955 176.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.97 135.12 55.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.868 -0.606 . . . . 25.0 110.937 -169.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.35 165.83 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.525 -0.762 . . . . 25.0 109.774 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -91.47 157.71 16.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.198 -1.779 . . . . 25.0 106.198 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.593 -1.194 . . . . 25.0 108.602 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.223 -0.569 0 N-CA-C 104.769 -3.333 . . . . 25.0 104.769 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.54 161.38 41.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.587 2.193 . . . . 25.0 113.244 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 mt -93.97 126.47 46.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.432 -1.321 . . . . 25.0 107.432 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.27 -47.59 14.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.189 -0.671 . . . . 25.0 109.189 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -163.15 165.59 14.38 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.076 -1.083 . . . . 25.0 108.076 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -70.32 124.78 8.18 Favored 'Cis proline' 0 C--N 1.353 0.805 0 C-N-CA 131.392 1.83 . . . . 25.0 114.987 1.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.07 175.4 39.14 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.484 -0.78 . . . . 25.0 112.731 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -139.61 152.83 47.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.407 -0.96 . . . . 25.0 108.407 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -75.29 -21.01 58.81 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.815 -0.439 . . . . 25.0 109.815 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -33.58 66.57 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.006 0.373 . . . . 25.0 112.006 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.51 70.76 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 112.446 0.536 . . . . 25.0 112.446 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.04 -32.07 15.33 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.254 0.549 . . . . 25.0 109.86 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 25.0 111.526 -176.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 p . . . . . 0 CA--C 1.544 0.735 0 N-CA-C 112.955 0.724 . . . . 25.0 112.955 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -22.6 15.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 116.539 2.051 . . . . 25.0 116.539 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.67 -37.88 62.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.582 0.628 . . . . 25.0 111.777 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.74 68.29 8.23 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 115.358 1.614 . . . . 25.0 115.358 174.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.8 -6.49 19.11 Favored 'Trans proline' 0 C--O 1.222 -0.309 0 N-CA-C 113.14 0.4 . . . . 25.0 113.14 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -97.92 4.85 49.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.855 0.687 . . . . 25.0 112.855 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -107.81 88.08 2.65 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.666 -0.813 . . . . 25.0 110.603 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.95 140.18 42.79 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 103.891 -2.633 . . . . 25.0 103.891 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -107.51 144.05 35.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.666 0.746 . . . . 25.0 112.198 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 162.78 31.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.606 -1.998 . . . . 25.0 105.606 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 tttt . . . . . 0 C--N 1.322 -0.597 0 CA-C-N 118.228 0.467 . . . . 25.0 109.816 -179.85 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.726 0 N-CA-C 112.527 -0.229 . . . . 25.0 112.527 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.73 -10.88 6.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.262 0.838 . . . . 25.0 113.262 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -57.86 -21.22 41.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.364 0.876 . . . . 25.0 113.364 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.86 -26.32 72.16 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.252 -0.975 . . . . 25.0 111.136 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.44 -14.7 72.22 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-O 119.589 -0.562 . . . . 25.0 114.028 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.86 -33.08 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.072 0.936 . . . . 25.0 110.146 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.5 -39.51 91.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 25.0 110.65 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -88.82 -2.97 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.996 0.903 . . . . 25.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.57 23.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.438 1.273 . . . . 25.0 114.438 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -70.57 74.33 0.56 Allowed 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.615 -0.678 . . . . 25.0 111.882 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t -151.59 171.2 17.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.877 -1.898 . . . . 25.0 105.877 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -64.76 -17.03 63.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.885 0.874 . . . . 25.0 112.025 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -74.26 -9.96 59.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -71.04 160.38 33.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.407 0.622 . . . . 25.0 110.216 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -85.06 163.65 18.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -62.73 146.78 51.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.938 0.875 . . . . 25.0 112.525 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -114.4 143.59 44.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.188 -1.412 . . . . 25.0 107.188 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -118.89 118.16 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.392 -0.596 . . . . 25.0 109.392 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.7 mt -76.13 135.87 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.89 165.97 30.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 p -108.49 170.19 8.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.926 -1.879 . . . . 25.0 105.926 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.54 179.21 26.36 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 115.076 0.791 . . . . 25.0 115.076 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.13 172.99 21.04 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.593 -1.003 . . . . 25.0 110.593 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 144.99 54.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.786 -0.832 . . . . 25.0 109.345 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -133.32 157.18 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.389 -0.597 . . . . 25.0 109.389 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.3 m -115.91 127.89 55.35 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.517 -0.549 . . . . 25.0 109.517 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.18 132.77 53.29 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.3 m -137.84 130.05 29.06 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -124.07 155.74 37.81 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.686 -1.598 . . . . 25.0 106.686 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.9 t -142.24 162.01 36.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.466 -0.568 . . . . 25.0 109.466 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -125.42 142.8 51.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.703 -1.221 . . . . 25.0 107.703 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -83.52 -0.56 50.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.27 0.557 . . . . 25.0 111.617 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 160.4 58.42 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.18 147.82 94.33 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.286 -2.01 . . . . 25.0 110.411 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -130.74 109.5 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.081 0.771 . . . . 25.0 113.081 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.29 144.5 53.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.062 -0.972 . . . . 25.0 108.85 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.4 m -133.34 132.81 41.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 25.0 109.976 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -106.54 -47.28 3.8 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.693 -1.225 . . . . 25.0 107.693 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -162.47 145.32 11.2 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.582 -1.636 . . . . 25.0 106.582 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -137.96 136.16 36.71 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -148.06 158.58 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.49 154.89 46.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.163 0.506 . . . . 25.0 111.878 -175.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -135.44 163.2 30.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.255 -0.884 . . . . 25.0 109.936 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.7 pt -129.36 152.56 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 168.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.6 p -84.87 141.92 30.09 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -74.22 114.82 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.809 0.814 . . . . 25.0 110.605 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -76.22 122.76 24.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 105.598 -2.001 . . . . 25.0 105.598 172.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.28 44.92 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.885 -1.15 . . . . 25.0 115.416 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.02 150.41 17.04 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.898 0.849 . . . . 25.0 112.552 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.83 118.63 72.41 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.099 -0.5 . . . . 25.0 110.789 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.27 -15.95 22.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 N-CA-C 114.725 1.01 . . . . 25.0 114.725 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.77 -3.85 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.174 0.987 . . . . 25.0 111.071 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -113.79 159.26 36.49 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 105.358 -2.09 . . . . 25.0 105.358 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.28 99.32 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 117.454 -1.23 . . . . 25.0 112.829 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.08 -36.57 60.8 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 113.634 0.975 . . . . 25.0 113.634 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.46 -15.27 6.42 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -85.99 -43.62 13.02 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.238 0.472 . . . . 25.0 111.439 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.82 -3.89 59.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.78 1.03 . . . . 25.0 113.78 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -67.87 -31.46 71.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.103 -0.239 . . . . 25.0 110.862 -174.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -127.15 132.41 50.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.772 0.656 . . . . 25.0 112.772 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -118.35 124.8 48.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.148 -1.056 . . . . 25.0 108.148 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.29 119.98 15.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -103.13 -2.13 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.913 0.863 . . . . 25.0 109.668 -176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.97 160.54 11.06 Favored Glycine 0 CA--C 1.512 -0.143 0 C-N-CA 120.769 -0.729 . . . . 25.0 113.242 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.2 144.84 26.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.678 -0.86 . . . . 25.0 108.678 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.6 104.76 10.0 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 107.159 -1.423 . . . . 25.0 107.159 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.52 172.21 12.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 116.902 -1.599 . . . . 25.0 112.662 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -134.65 91.45 2.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.303 -2.48 . . . . 25.0 104.303 170.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -106.14 29.95 6.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.166 0.984 . . . . 25.0 108.997 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.72 -37.29 3.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 109.336 -1.506 . . . . 25.0 109.336 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.3 t -59.38 138.1 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.1 46.78 2.05 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.991 1.794 . . . . 25.0 114.496 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.85 -21.79 61.42 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.828 0.677 . . . . 25.0 112.828 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.0 m -61.84 -13.16 21.65 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 113.834 1.05 . . . . 25.0 113.834 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -61.14 -35.92 78.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.884 0.374 . . . . 25.0 110.394 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -106.56 105.02 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 25.0 110.425 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.12 -13.81 30.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.274 0.842 . . . . 25.0 113.274 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.4 t -100.03 140.95 33.51 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.184 -0.323 . . . . 25.0 110.748 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -139.15 139.52 37.63 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.019 0.437 . . . . 25.0 111.904 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -86.75 137.53 32.36 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.013 -0.736 . . . . 25.0 109.013 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.14 124.97 53.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.289 -1.375 . . . . 25.0 107.289 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -77.0 135.56 38.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.016 -0.735 . . . . 25.0 109.016 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.9 mm -126.08 129.21 24.31 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.78 172.64 14.89 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 117.941 -0.906 . . . . 25.0 112.87 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -129.83 45.58 2.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.45 -37.72 15.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.657 -1.156 . . . . 25.0 113.364 -174.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -147.77 156.95 43.28 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 110.175 -0.306 . . . . 25.0 110.175 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.0 mp -95.56 145.73 25.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.199 0.6 . . . . 25.0 110.431 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.55 163.85 9.82 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 114.558 0.583 . . . . 25.0 114.558 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -94.37 145.75 24.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.895 1.443 . . . . 25.0 114.895 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -148.99 163.32 37.84 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.04 149.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.14 0.495 . . . . 25.0 112.029 -175.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.8 mt -120.59 133.22 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.426 -2.065 . . . . 25.0 105.426 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 mp -121.52 149.06 43.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -136.68 144.13 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.91 131.14 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -122.33 101.84 7.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.362 0.601 . . . . 25.0 109.959 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -79.97 131.87 35.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.369 -0.975 . . . . 25.0 108.369 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.58 128.96 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.218 -1.771 . . . . 25.0 106.218 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.99 44.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.94 0.4 . . . . 25.0 109.99 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -24.95 66.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 115.6 1.704 . . . . 25.0 115.6 -175.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 p -123.27 161.69 24.1 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.241 -0.287 . . . . 25.0 110.331 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.67 -19.12 62.12 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.181 0.991 . . . . 25.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -108.92 161.81 14.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.886 -1.052 . . . . 25.0 111.249 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.18 16.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.73 -2.693 . . . . 25.0 103.73 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -114.97 144.36 43.71 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.036 0.446 . . . . 25.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -113.28 146.53 39.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -133.55 141.17 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 104.813 -2.291 . . . . 25.0 104.813 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.07 136.61 47.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.3 mt -137.89 125.39 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.88 142.89 27.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.16 142.51 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.947 -0.471 . . . . 25.0 109.967 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -109.67 120.88 43.86 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.935 -2.246 . . . . 25.0 104.935 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 mt -120.02 128.22 53.32 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.713 -0.477 . . . . 25.0 109.713 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.73 170.06 18.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.774 -0.454 . . . . 25.0 109.774 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -77.56 157.94 30.08 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.898 -0.778 . . . . 25.0 108.898 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.6 mttt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 117.793 -1.098 . . . . 25.0 109.787 178.353 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.509 -0.332 0 N-CA-C 106.26 -2.736 . . . . 25.0 106.26 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -125.77 156.72 39.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.642 1.221 . . . . 25.0 111.372 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.6 mt -97.66 119.44 45.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.637 -2.727 . . . . 25.0 103.637 170.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -77.5 5.67 8.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.654 0.613 . . . . 25.0 112.654 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttt 79.26 152.43 0.13 Allowed Pre-proline 0 N--CA 1.489 1.509 0 C-N-CA 126.021 1.729 . . . . 25.0 108.322 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 152.4 90.71 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 128.547 0.645 . . . . 25.0 112.023 -2.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.15 26.01 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 118.177 2.031 . . . . 25.0 118.177 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -65.04 131.29 46.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.896 1.348 . . . . 25.0 111.762 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -78.84 -15.93 57.75 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 113.459 0.911 . . . . 25.0 113.459 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.78 74.78 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 112.222 0.453 . . . . 25.0 112.222 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.73 -23.66 62.48 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.841 -0.537 . . . . 25.0 110.908 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.18 -4.03 54.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.279 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 t . . . . . 0 C--O 1.219 -0.515 0 N-CA-C 108.822 -0.806 . . . . 25.0 108.822 179.384 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p . . . . . 0 CA--C 1.544 0.712 0 N-CA-C 113.071 0.767 . . . . 25.0 113.071 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.3 ptm -57.83 -11.09 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 118.121 2.637 . . . . 25.0 118.121 -174.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -69.94 -38.7 76.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.521 0.601 . . . . 25.0 110.462 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.95 63.74 3.16 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.174 1.176 . . . . 25.0 114.174 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.97 -8.12 22.35 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.122 -0.785 . . . . 25.0 113.856 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -97.19 5.12 50.66 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 122.056 -0.403 . . . . 25.0 111.878 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -121.21 130.4 53.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.739 0.644 . . . . 25.0 112.739 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.0 137.3 52.23 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.947 -1.501 . . . . 25.0 106.947 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -110.36 140.52 44.49 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.932 0.145 . . . . 25.0 111.132 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.93 158.08 45.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.396 -0.594 . . . . 25.0 109.396 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 tttt . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 112.939 0.718 . . . . 25.0 112.939 179.812 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.225 -0.463 0 N-CA-C 114.24 0.456 . . . . 25.0 114.24 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.68 -24.53 67.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.319 0.56 . . . . 25.0 111.151 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -66.49 -19.39 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.955 0.354 . . . . 25.0 111.955 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.76 -26.85 74.28 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.46 -1.056 . . . . 25.0 110.46 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.64 78.35 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.235 -0.507 . . . . 25.0 112.189 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.38 -42.59 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.377 -1.342 . . . . 25.0 107.377 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.39 -32.57 72.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.526 . . . . 25.0 109.914 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.11 -23.21 66.4 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.628 0.603 . . . . 25.0 112.628 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -68.94 -7.27 33.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.439 -0.788 . . . . 25.0 112.171 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -131.0 40.79 3.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -112.43 158.29 20.03 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.19 -30.78 63.79 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.582 -0.895 . . . . 25.0 108.582 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -96.64 21.26 9.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.329 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -50.24 148.29 3.63 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.127 -0.942 . . . . 25.0 111.64 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -67.37 138.15 56.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.766 1.269 . . . . 25.0 110.03 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -82.06 140.08 34.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.911 -1.495 . . . . 25.0 109.551 -172.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -108.72 138.68 44.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 25.0 111.485 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -124.39 135.25 53.15 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.835 -0.431 . . . . 25.0 109.835 168.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -79.66 138.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.1 tpt -139.51 156.11 47.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.349 -1.352 . . . . 25.0 107.349 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.9 p -101.43 -179.34 4.0 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.6 -178.77 30.3 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.275 -0.488 . . . . 25.0 112.355 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.26 -177.89 32.64 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 122.439 -0.448 . . . . 25.0 113.575 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -85.2 142.31 29.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -139.62 158.5 44.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.14 0.495 . . . . 25.0 110.206 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m -110.18 129.15 55.76 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.393 -0.966 . . . . 25.0 108.393 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.6 138.21 53.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.518 -1.289 . . . . 25.0 107.518 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -136.38 144.07 44.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.903 0.382 . . . . 25.0 111.113 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -121.02 149.98 41.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.83 156.44 48.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.296 0.57 . . . . 25.0 110.282 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -139.03 145.56 39.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.544 -2.021 . . . . 25.0 105.544 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -75.03 -14.15 60.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.495 0.554 . . . . 25.0 112.495 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.98 149.25 55.32 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.588 -1.264 . . . . 25.0 107.588 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -71.05 153.15 63.06 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 117.267 -1.356 . . . . 25.0 111.062 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -131.0 140.18 50.09 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.729 -0.471 . . . . 25.0 109.729 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.74 145.81 51.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 174.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.8 m -152.11 142.65 22.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.1 p -101.88 -37.37 8.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -165.13 167.11 18.51 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.239 -0.288 . . . . 25.0 111.119 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -141.25 141.17 34.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.625 -0.88 . . . . 25.0 108.625 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -147.94 155.68 41.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.377 -0.374 . . . . 25.0 110.265 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 150.03 46.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.39 0.614 . . . . 25.0 111.918 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -131.5 165.06 24.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.435 -1.32 . . . . 25.0 107.435 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -132.47 148.91 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 106.839 -1.541 . . . . 25.0 106.839 173.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 p -83.93 121.78 27.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -99.88 104.29 15.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.686 0.755 . . . . 25.0 109.06 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -75.99 153.96 36.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.61 23.95 17.24 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 119.779 -1.201 . . . . 25.0 114.606 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -66.7 161.62 23.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.667 0.734 . . . . 25.0 109.546 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.83 155.7 47.58 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.73 -14.54 33.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.777 -1.015 . . . . 25.0 113.261 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.07 -20.6 64.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.703 0.801 . . . . 25.0 111.468 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -96.04 147.16 32.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.494 -0.558 . . . . 25.0 109.494 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -61.82 119.71 6.96 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.285 -0.677 . . . . 25.0 111.609 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.58 -49.97 61.06 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 115.533 1.679 . . . . 25.0 115.533 -167.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.91 -36.67 36.09 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.902 0.858 . . . . 25.0 111.797 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -75.85 -32.67 59.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.492 -0.776 . . . . 25.0 112.983 -172.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.62 1.9 47.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.624 -0.262 . . . . 25.0 111.157 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.91 -29.59 68.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.195 -0.202 . . . . 25.0 111.135 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -125.88 150.14 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.91 0.708 . . . . 25.0 112.91 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -127.75 145.76 50.8 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.073 -1.084 . . . . 25.0 108.073 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.12 124.68 28.34 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.257 -0.645 . . . . 25.0 109.257 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.1 tt -98.36 -12.21 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.375 0.607 . . . . 25.0 110.137 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.46 160.19 14.42 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.311 -0.947 . . . . 25.0 114.206 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.54 139.06 23.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.706 -1.591 . . . . 25.0 106.706 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.0 t -137.09 116.49 10.4 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.85 167.53 22.09 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 115.329 -2.648 . . . . 25.0 111.904 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -126.64 96.25 4.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.348 1.071 . . . . 25.0 108.554 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -165.72 -98.15 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 100.527 -3.879 . . . . 25.0 100.527 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -93.69 134.93 12.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 105.843 -2.903 . . . . 25.0 105.843 168.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 t -164.58 146.2 6.76 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 117.48 0.64 . . . . 25.0 109.442 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.2 -162.43 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 120.747 0.964 . . . . 25.0 110.184 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.76 -14.07 2.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.381 1.252 . . . . 25.0 114.381 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.5 m -60.48 -16.05 32.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.079 0.77 . . . . 25.0 113.079 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -67.36 -10.44 51.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.467 0.544 . . . . 25.0 112.467 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -65.97 147.7 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 25.0 109.935 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.57 -9.7 58.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.568 0.699 . . . . 25.0 111.258 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.0 t -100.03 121.04 40.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.313 -1.736 . . . . 25.0 106.313 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -124.61 132.28 53.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 25.0 110.49 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -87.21 137.03 32.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.019 -0.537 . . . . 25.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.03 124.6 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.315 -0.994 . . . . 25.0 108.315 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 82.3 t80 -90.87 140.97 29.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -122.3 128.93 25.29 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 107.587 -1.264 . . . . 25.0 107.587 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.27 166.45 29.48 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 117.892 -0.939 . . . . 25.0 112.444 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -111.02 14.27 21.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.617 0.722 . . . . 25.0 111.076 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.34 -18.18 46.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.938 1.458 . . . . 25.0 114.938 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -155.18 170.01 22.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.19 0.811 . . . . 25.0 113.19 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.8 144.81 51.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.994 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.29 151.67 5.47 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.138 0.815 . . . . 25.0 115.138 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.03 146.89 25.94 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 114.943 1.46 . . . . 25.0 114.943 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -149.01 163.54 37.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -96.96 150.03 4.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.592 -0.522 . . . . 25.0 109.592 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.49 132.58 62.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.9 mt -119.05 139.84 51.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.876 -1.898 . . . . 25.0 105.876 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.79 151.52 47.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.114 0.87 . . . . 25.0 110.31 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.0 133.61 65.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.995 -1.002 . . . . 25.0 109.035 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -117.39 113.73 22.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.801 -1.185 . . . . 25.0 107.801 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -103.25 133.54 48.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.401 0.62 . . . . 25.0 111.358 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.86 132.26 70.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.73 -43.61 30.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 25.0 110.925 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 10.14 3.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.502 2.038 . . . . 25.0 116.502 -169.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -131.55 155.02 48.21 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.915 -0.49 . . . . 25.0 110.867 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -73.7 -7.85 53.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 25.0 110.959 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -115.22 163.83 15.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 25.0 112.14 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.88 163.22 33.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 103.453 -2.795 . . . . 25.0 103.453 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -130.45 152.39 49.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 -172.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -130.96 157.58 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.5 154.62 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.862 -0.792 . . . . 25.0 108.862 171.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.1 137.22 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.934 0.397 . . . . 25.0 110.853 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 60.6 mt -141.71 135.0 29.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.55 141.74 37.34 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.242 1.383 . . . . 25.0 108.961 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.41 134.52 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.447 0.641 . . . . 25.0 109.657 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -101.73 96.02 6.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.782 . . . . 25.0 106.187 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.66 105.86 17.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.04 158.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -99.66 164.99 11.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.632 -1.167 . . . . 25.0 107.897 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 C--O 1.253 1.264 0 CA-C-O 116.544 -1.693 . . . . 25.0 113.051 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.137 0 N-CA-C 111.423 -0.671 . . . . 25.0 111.423 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -108.88 135.99 49.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.38 0.272 . . . . 25.0 111.247 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.6 mt -93.98 114.38 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.27 -1.381 . . . . 25.0 107.27 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.12 -43.37 9.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.86 -0.792 . . . . 25.0 108.86 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -137.47 149.4 65.18 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 107.763 -1.199 . . . . 25.0 107.763 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.81 105.07 0.64 Allowed 'Cis proline' 0 CA--C 1.539 0.757 0 C-N-CA 131.102 1.709 . . . . 25.0 113.143 -3.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.71 -166.41 46.52 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.776 -0.726 . . . . 25.0 111.873 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 t -139.95 154.54 47.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.565 -0.531 . . . . 25.0 109.565 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.1 -20.85 57.3 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 116.391 -0.368 . . . . 25.0 111.701 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.52 66.53 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.914 0.709 . . . . 25.0 112.914 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.33 70.63 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.96 -11.36 39.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.036 0.446 . . . . 25.0 110.615 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.8 t . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 120.884 0.373 . . . . 25.0 111.373 -177.921 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.549 0.918 0 CA-C-O 121.045 0.45 . . . . 25.0 110.772 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.5 ptm -62.69 -27.01 68.95 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.391 -0.818 . . . . 25.0 111.31 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.21 -28.87 31.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.542 0.687 . . . . 25.0 110.03 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -115.95 61.51 1.97 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.749 -0.659 . . . . 25.0 112.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.61 -38.62 3.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 114.169 -3.421 . . . . 25.0 113.335 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -105.69 -32.55 8.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.391 0.885 . . . . 25.0 113.391 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 m -102.14 78.26 1.75 Allowed 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 109.133 -0.692 . . . . 25.0 109.133 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -107.58 109.97 21.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.913 0.708 . . . . 25.0 112.913 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.35 103.91 4.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.565 0.58 . . . . 25.0 112.565 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 176.075 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.222 -0.65 0 N-CA-C 113.478 0.151 . . . . 25.0 113.478 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.04 -21.46 66.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.522 0.329 . . . . 25.0 111.712 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -63.98 -13.0 42.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.117 0.414 . . . . 25.0 112.117 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.89 -14.64 56.25 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.432 -0.413 . . . . 25.0 113.732 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.86 -21.72 65.73 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 117.773 0.787 . . . . 25.0 112.796 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -66.44 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.39 -31.71 58.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 25.0 111.061 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.79 -49.89 76.01 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.32 0.581 . . . . 25.0 110.4 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -75.27 2.11 11.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -119.92 19.15 12.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.91 0.862 . . . . 25.0 109.61 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.0 t -107.47 177.18 4.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 25.0 110.614 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -80.95 -18.05 48.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -95.38 14.84 21.18 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.166 -0.925 . . . . 25.0 109.651 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.86 146.05 33.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -80.69 140.84 35.41 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.55 -0.907 . . . . 25.0 108.55 -176.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -58.33 142.45 48.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 25.0 112.645 -171.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -126.23 147.89 49.58 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.365 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -126.28 151.04 48.02 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.153 -0.684 . . . . 25.0 109.153 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -94.76 143.01 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.841 -1.911 . . . . 25.0 105.841 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.6 ttp -151.0 166.89 29.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.205 -0.295 . . . . 25.0 110.205 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.1 p -103.96 171.96 7.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.38 -2.081 . . . . 25.0 105.38 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.04 -169.41 7.52 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.361 0.423 . . . . 25.0 114.117 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.92 -172.74 20.21 Favored Glycine 0 N--CA 1.459 0.222 0 O-C-N 122.405 -0.467 . . . . 25.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 18.0 tt0 -75.82 135.66 40.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.952 -0.734 . . . . 25.0 109.424 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -129.24 152.11 49.17 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.8 m -117.7 134.84 54.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.455 . . . . 25.0 110.136 -174.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.73 111.99 23.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.781 -1.933 . . . . 25.0 105.781 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.4 m -120.37 110.78 16.93 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.99 141.38 52.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 104.699 -2.334 . . . . 25.0 104.699 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.6 t -145.01 161.97 38.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.553 0.216 . . . . 25.0 110.657 -173.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -125.43 150.73 47.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -72.39 -17.41 61.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 159.69 61.09 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.0 140.49 60.49 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 114.553 -3.165 . . . . 25.0 110.355 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -130.91 147.17 52.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.547 -1.279 . . . . 25.0 107.547 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -68.01 146.9 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.455 -1.313 . . . . 25.0 107.455 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.4 p -140.37 146.71 38.76 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.322 -1.362 . . . . 25.0 107.322 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -110.23 -50.16 2.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.905 0.383 . . . . 25.0 110.082 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -158.95 147.59 18.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.03 -0.419 . . . . 25.0 109.927 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -135.18 144.29 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 166.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -148.04 159.13 44.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.472 -0.566 . . . . 25.0 109.472 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.35 149.91 47.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.653 0.74 . . . . 25.0 112.08 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.74 165.95 20.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.051 -1.463 . . . . 25.0 107.051 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 pt -130.03 159.1 42.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.598 -0.89 . . . . 25.0 108.598 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 114' ' ' ASP . 58.9 m -111.72 115.95 29.94 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -89.99 112.02 23.29 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -76.11 153.96 35.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.014 -1.106 . . . . 25.0 108.014 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.33 31.95 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 116.011 1.164 . . . . 25.0 116.011 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -60.2 153.74 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.765 0.783 . . . . 25.0 110.102 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.52 147.1 98.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 25.0 107.767 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.91 -20.0 34.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 117.828 -0.982 . . . . 25.0 114.468 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.11 -23.71 63.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.027 0.918 . . . . 25.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -96.04 136.19 22.29 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.49 126.56 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 116.726 -1.716 . . . . 25.0 114.372 -172.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 tt -52.76 -39.44 62.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.421 -1.263 . . . . 25.0 111.726 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.04 -16.06 63.04 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -83.06 -41.72 18.29 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.965 -0.459 . . . . 25.0 110.831 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.84 60.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 100' ' ' THR . 0.4 OUTLIER -67.87 -31.51 71.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.164 -0.471 . . . . 25.0 112.041 -176.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -125.98 111.67 15.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.784 0.661 . . . . 25.0 112.784 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -128.18 121.14 28.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.52 124.26 23.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.227 -0.296 . . . . 25.0 110.746 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -14.96 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.985 -0.746 . . . . 25.0 108.985 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.51 154.43 10.22 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.298 -0.953 . . . . 25.0 113.965 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.66 137.25 36.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.88 87.47 48.98 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.0 157.65 46.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.275 -1.35 . . . . 25.0 111.339 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -112.21 99.11 7.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.195 -1.039 . . . . 25.0 108.195 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.29 4.21 9.15 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.552 -1.647 . . . . 25.0 106.552 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.52 -179.1 45.13 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 103.401 -3.88 . . . . 25.0 103.401 -175.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -139.51 65.58 33.76 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 116.12 1.896 . . . . 25.0 116.12 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 175.71 9.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 116.884 -1.611 . . . . 25.0 109.565 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.87 56.2 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.045 0.757 . . . . 25.0 113.045 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.3 t -60.36 -24.55 65.17 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.193 0.52 . . . . 25.0 112.28 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.97 7.1 47.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.384 0.673 . . . . 25.0 112.532 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -58.37 141.28 51.78 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.542 -1.651 . . . . 25.0 106.542 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -35.6 80.81 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.376 0.534 . . . . 25.0 111.883 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.4 t -86.09 124.84 32.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.769 -0.826 . . . . 25.0 108.769 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -120.58 149.76 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.735 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -112.35 131.72 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.2 mm -132.0 128.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 63.0 t80 -79.79 132.81 36.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.954 -1.128 . . . . 25.0 107.954 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.6 mm -119.42 123.07 28.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.09 162.97 39.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 117.355 -1.296 . . . . 25.0 112.523 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.91 28.71 8.18 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.919 -1.511 . . . . 25.0 106.919 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.15 -18.63 63.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.852 -1.067 . . . . 25.0 113.566 -172.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -156.81 150.29 24.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.258 0.552 . . . . 25.0 109.959 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.83 154.18 19.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.898 -1.046 . . . . 25.0 108.718 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.27 -176.33 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 121.509 0.505 . . . . 25.0 112.105 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 55.2 p90 -80.74 145.02 31.74 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.78 0.659 . . . . 25.0 112.78 -174.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -132.66 116.05 16.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 t -93.28 138.12 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 120.69 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 mp -104.51 141.08 37.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.804 -1.184 . . . . 25.0 107.804 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.67 132.92 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.827 0.739 . . . . 25.0 112.206 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.33 137.41 57.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -120.65 112.54 19.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.763 -1.569 . . . . 25.0 106.763 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.78 133.1 34.36 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.553 -1.203 . . . . 25.0 109.444 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 156' ' ' ASP . 58.1 t -117.24 121.96 68.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.542 -0.91 . . . . 25.0 108.542 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -13.6 61.58 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.747 0.647 . . . . 25.0 112.747 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.438 ' H ' HG12 ' A' ' 154' ' ' VAL . 25.5 m-20 -81.31 -13.64 58.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.702 0.63 . . . . 25.0 112.702 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.3 p -144.31 159.77 42.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.33 0.863 . . . . 25.0 113.33 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -79.45 3.82 17.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 25.0 110.722 171.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -110.13 171.04 7.69 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.742 -0.836 . . . . 25.0 108.742 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.47 161.29 40.06 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.421 0.629 . . . . 25.0 109.925 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -96.45 130.39 43.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -132.31 139.13 48.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.694 0.627 . . . . 25.0 112.694 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.71 154.24 39.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.119 -0.697 . . . . 25.0 109.119 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.2 p -136.98 137.25 47.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.374 -2.454 . . . . 25.0 104.374 171.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.6 mt -132.2 130.73 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -111.97 139.12 47.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.65 -1.241 . . . . 25.0 107.65 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.81 126.91 60.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.442 0.639 . . . . 25.0 109.921 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 42.3 t0 -85.97 102.04 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.778 -1.564 . . . . 25.0 106.778 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.21 117.33 33.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.537 -0.912 . . . . 25.0 108.537 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 25.7 m -136.45 163.19 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.017 -0.538 . . . . 25.0 111.023 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -89.99 155.27 19.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.007 -1.849 . . . . 25.0 106.007 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.991 -1.004 . . . . 25.0 110.095 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.267 0 N-CA-C 106.147 -2.781 . . . . 25.0 106.147 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.19 148.12 36.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.441 1.121 . . . . 25.0 111.021 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.23 112.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 104.025 -2.583 . . . . 25.0 104.025 170.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.48 2.69 13.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.709 0.633 . . . . 25.0 112.709 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 74.15 151.66 0.14 Allowed Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 125.752 1.621 . . . . 25.0 110.003 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.53 153.78 89.52 Favored 'Cis proline' 0 C--O 1.222 -0.283 0 CA-C-O 121.733 0.639 . . . . 25.0 112.203 -1.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.56 14.8 13.37 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 117.081 1.592 . . . . 25.0 117.081 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -65.86 125.36 25.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.632 1.216 . . . . 25.0 111.431 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -78.51 -19.64 52.54 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.441 0.534 . . . . 25.0 112.441 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.66 67.93 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.146 0.278 . . . . 25.0 111.091 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.02 -31.52 72.67 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 120.693 0.283 . . . . 25.0 111.315 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.98 -3.88 55.3 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 116.43 -0.35 . . . . 25.0 111.164 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.487 . . . . 25.0 109.684 179.464 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p . . . . . 0 CA--C 1.536 0.435 0 CA-C-O 120.861 0.362 . . . . 25.0 111.167 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.7 ptm -58.6 -10.88 2.5 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 117.77 2.507 . . . . 25.0 117.77 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -69.4 -39.84 77.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.43 0.559 . . . . 25.0 110.85 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.37 64.59 2.52 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 113.571 0.952 . . . . 25.0 113.571 173.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.37 -8.87 24.63 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 118.185 -0.743 . . . . 25.0 113.754 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 pm0 -97.85 4.37 49.68 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.823 0.675 . . . . 25.0 112.823 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -100.74 98.73 9.23 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 118.573 0.624 . . . . 25.0 111.16 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.7 mt -90.47 117.7 29.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.978 -2.23 . . . . 25.0 104.978 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -84.21 141.31 31.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.725 0.297 . . . . 25.0 110.632 -175.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.96 157.71 46.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.012 -1.477 . . . . 25.0 107.012 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttm . . . . . 0 N--CA 1.465 0.311 0 CA-C-O 121.498 0.666 . . . . 25.0 111.703 178.379 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.4 0 N-CA-C 112.35 -0.3 . . . . 25.0 112.35 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.24 -24.94 63.17 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.401 -0.47 . . . . 25.0 111.493 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.01 -26.64 67.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.91 0.386 . . . . 25.0 111.349 175.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.25 -25.68 75.05 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 110.673 -0.971 . . . . 25.0 110.673 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.49 71.62 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 121.25 -0.5 . . . . 25.0 112.846 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.42 -42.61 84.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.929 -1.137 . . . . 25.0 107.929 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.06 -26.42 56.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 25.0 111.227 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -21.65 64.87 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.425 0.631 . . . . 25.0 111.674 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -68.84 -3.78 13.79 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.816 -0.553 . . . . 25.0 112.41 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -132.69 55.68 1.88 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -135.71 157.8 45.98 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.979 -0.378 . . . . 25.0 109.979 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -71.95 -25.11 61.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.688 0.756 . . . . 25.0 109.138 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -97.55 18.84 14.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.711 . . . . 25.0 110.492 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -52.71 142.22 19.13 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.564 0.697 . . . . 25.0 111.634 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -69.02 143.82 54.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.555 1.169 . . . . 25.0 109.778 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -75.36 131.29 40.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.587 -0.733 . . . . 25.0 111.562 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -91.62 146.34 23.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.813 -0.63 . . . . 25.0 111.121 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -131.76 114.32 14.59 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.173 -0.306 . . . . 25.0 110.173 168.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -73.47 135.54 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.063 -2.199 . . . . 25.0 105.063 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.1 tpt -150.42 154.15 37.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 p -93.0 -177.17 4.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.189 -1.411 . . . . 25.0 107.189 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -166.53 31.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.87 -0.492 . . . . 25.0 111.87 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.78 -178.94 30.05 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 112.16 -0.376 . . . . 25.0 112.16 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 1.7 tp10 -79.99 133.89 36.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -126.03 121.81 34.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.414 0.626 . . . . 25.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.3 m -91.75 126.92 37.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.982 -1.118 . . . . 25.0 107.982 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -119.06 125.91 50.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -123.54 130.76 53.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 25.0 111.347 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.1 m0 -123.66 147.91 46.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.628 -2.73 . . . . 25.0 103.628 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -136.54 161.06 36.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.16 0.505 . . . . 25.0 109.723 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.05 137.88 47.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.7 t -79.32 -9.13 59.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.93 60.85 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 106.268 -1.752 . . . . 25.0 106.268 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.26 144.75 47.0 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 116.203 -2.065 . . . . 25.0 111.92 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -131.07 139.74 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.197 -1.409 . . . . 25.0 107.197 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -71.26 148.39 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -149.95 141.89 23.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.7 t -92.44 -47.26 7.25 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.756 0.422 . . . . 25.0 109.998 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -165.61 168.65 16.15 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.162 -0.336 . . . . 25.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -139.58 140.19 36.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 167.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -145.86 156.37 43.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.389 -0.369 . . . . 25.0 110.748 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -133.14 144.78 50.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.874 -0.603 . . . . 25.0 111.02 -167.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -137.12 165.53 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 28.2 pt -134.74 152.2 32.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.686 -1.227 . . . . 25.0 107.686 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 p -85.13 141.95 29.84 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -88.33 121.31 30.58 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 113.255 0.835 . . . . 25.0 113.255 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -86.5 150.78 24.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.443 -1.317 . . . . 25.0 107.443 169.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.29 64.1 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.072 1.589 . . . . 25.0 117.072 173.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -61.19 154.32 23.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.678 1.239 . . . . 25.0 110.735 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.63 154.43 44.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 25.0 109.907 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.62 -7.39 16.7 Favored 'Trans proline' 0 C--N 1.351 0.707 0 N-CA-C 116.084 1.532 . . . . 25.0 116.084 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.16 -8.1 55.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.141 0.972 . . . . 25.0 110.096 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -123.74 150.14 61.12 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.192 -0.67 . . . . 25.0 109.192 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.7 111.36 1.88 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 117.321 -1.319 . . . . 25.0 111.797 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.84 -44.06 66.48 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.226 -0.897 . . . . 25.0 113.23 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.68 -27.22 68.54 Favored 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.92 -41.78 50.79 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.337 0.589 . . . . 25.0 110.209 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.46 6.37 23.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.943 -1.026 . . . . 25.0 112.953 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.07 -38.83 82.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.848 0.684 . . . . 25.0 112.848 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -133.62 156.77 47.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.957 -0.464 . . . . 25.0 111.605 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -133.53 146.31 50.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.033 -0.728 . . . . 25.0 109.033 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.4 tp -77.59 127.18 32.07 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 tt -106.08 -3.37 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.693 0.759 . . . . 25.0 110.984 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.23 156.12 8.29 Favored Glycine 0 C--O 1.229 -0.175 0 C-N-CA 120.469 -0.872 . . . . 25.0 113.948 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.35 137.18 22.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.681 -1.229 . . . . 25.0 107.681 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.19 109.45 10.55 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.69 161.7 36.38 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 116.228 -2.048 . . . . 25.0 111.965 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -122.96 92.66 3.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -175.62 -94.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 N-CA-C 99.897 -4.112 . . . . 25.0 99.897 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -97.87 143.27 16.59 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 105.32 -3.112 . . . . 25.0 105.32 167.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.6 155.82 13.35 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.67 -167.3 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 O-C-N 122.265 0.613 . . . . 25.0 111.017 174.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.75 24.2 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.662 0.616 . . . . 25.0 112.662 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.8 1.07 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.927 1.454 . . . . 25.0 114.927 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -58.66 -13.84 6.91 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.421 1.267 . . . . 25.0 114.421 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -59.12 144.12 46.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.686 0.755 . . . . 25.0 112.714 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.6 tp -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.983 -1.008 . . . . 25.0 112.395 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.6 t -94.45 123.37 37.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -103.99 133.72 48.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 25.0 110.742 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -99.82 134.1 43.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 25.0 109.563 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.9 mt -132.95 119.67 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 87.9 t80 -85.82 138.01 32.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.785 -0.45 . . . . 25.0 109.785 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.45 124.87 26.21 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.46 153.57 50.02 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 116.381 -1.946 . . . . 25.0 111.403 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -108.1 51.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.66 1.219 . . . . 25.0 109.302 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -103.72 -6.2 21.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.639 -1.164 . . . . 25.0 111.2 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -161.0 157.74 26.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.283 0.563 . . . . 25.0 112.41 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.3 pt? -116.72 153.87 31.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.584 -0.735 . . . . 25.0 110.334 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 133.31 140.26 4.35 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 113.851 0.3 . . . . 25.0 113.851 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -85.83 145.95 26.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 116.272 1.953 . . . . 25.0 116.272 -173.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -149.55 167.05 27.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -98.06 150.51 4.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.894 0.854 . . . . 25.0 111.965 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.7 mt -106.94 131.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.311 -2.848 . . . . 25.0 103.311 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.0 mt -110.12 143.97 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 163' ' ' GLN . . . -142.63 148.49 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.612 -0.885 . . . . 25.0 108.612 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.14 139.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.563 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -126.5 103.23 7.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.596 -0.89 . . . . 25.0 108.596 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -94.15 138.19 32.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.238 -0.289 . . . . 25.0 110.8 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.5 t -117.6 132.01 68.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.056 -1.461 . . . . 25.0 107.056 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.54 -41.42 46.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 25.0 110.524 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -10.92 60.37 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.12 1.896 . . . . 25.0 116.12 -170.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.8 p -126.37 158.25 36.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.966 -0.459 . . . . 25.0 110.519 -176.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -74.44 -10.17 59.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 25.0 111.588 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -103.76 158.67 16.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.412 0.625 . . . . 25.0 110.451 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.83 162.92 34.2 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.465 -3.161 . . . . 25.0 102.465 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.31 150.59 45.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.516 0.562 . . . . 25.0 112.516 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.65 153.92 41.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.29 -1.374 . . . . 25.0 107.29 174.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -145.95 154.21 41.67 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.83 141.86 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.886 0.374 . . . . 25.0 110.324 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 62.9 mt -133.58 122.6 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.28 -1.378 . . . . 25.0 107.28 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -87.81 131.6 34.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.549 -1.649 . . . . 25.0 106.549 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.38 132.59 70.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.827 -0.805 . . . . 25.0 108.827 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.9 95.76 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 104.929 -2.248 . . . . 25.0 104.929 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.58 121.8 32.12 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.254 -1.758 . . . . 25.0 106.254 -173.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 20.0 m -135.19 166.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 123.231 0.332 . . . . 25.0 111.448 -175.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.38 141.11 28.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.8 tptt . . . . . 0 C--O 1.246 0.917 0 N-CA-C 115.564 1.69 . . . . 25.0 115.564 177.38 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.555 0 N-CA-C 117.364 1.706 . . . . 25.0 117.364 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -128.02 153.0 47.26 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.602 0.761 . . . . 25.0 111.956 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 93.7 mt -93.83 119.34 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 103.665 -2.717 . . . . 25.0 103.665 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -90.08 -43.33 10.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.535 -0.543 . . . . 25.0 109.535 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -138.79 149.68 62.9 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 109.8 1.48 Allowed 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 132.306 2.211 . . . . 25.0 115.299 -1.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.38 -176.76 26.81 Favored Glycine 0 C--O 1.226 -0.405 0 N-CA-C 114.631 0.612 . . . . 25.0 114.631 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 t -82.97 134.77 35.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.485 -0.421 . . . . 25.0 111.065 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -78.11 -26.32 47.94 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.919 0.39 . . . . 25.0 111.051 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.34 65.92 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.873 0.694 . . . . 25.0 112.873 -172.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.07 71.9 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 120.785 0.326 . . . . 25.0 111.184 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.47 -4.38 55.6 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.054 -0.521 . . . . 25.0 111.743 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t . . . . . 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 25.0 111.577 -175.325 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.2 t . . . . . 0 CA--C 1.537 0.465 0 CA-C-O 120.843 0.354 . . . . 25.0 110.36 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -63.94 -11.06 24.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -79.04 -35.98 41.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.659 -0.496 . . . . 25.0 109.659 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.66 79.25 9.56 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 175.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.53 -15.89 46.01 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 115.938 -2.241 . . . . 25.0 112.44 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -85.4 -22.08 28.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.718 -0.658 . . . . 25.0 112.437 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -132.99 94.02 3.29 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 114.732 1.382 . . . . 25.0 114.732 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.15 114.79 28.82 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -114.5 142.21 46.7 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.427 0.454 . . . . 25.0 110.358 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 104.16 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.475 -0.565 . . . . 25.0 109.475 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.48 1.037 0 CA-C-O 121.969 0.89 . . . . 25.0 112.933 179.367 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.687 0 N-CA-C 113.833 0.293 . . . . 25.0 113.833 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.2 mt -61.89 -23.28 66.21 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 112.585 0.587 . . . . 25.0 112.585 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -71.06 -13.12 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.205 -0.309 . . . . 25.0 111.692 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.25 -16.65 60.53 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.114 0.805 . . . . 25.0 115.114 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.3 -26.14 69.12 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-N 118.121 0.961 . . . . 25.0 112.389 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.2 mm -68.03 -33.91 63.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.112 -0.64 . . . . 25.0 110.007 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -77.53 -19.3 55.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.206 -0.309 . . . . 25.0 111.256 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.96 -21.56 64.91 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.625 0.602 . . . . 25.0 112.625 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -56.03 -21.4 21.36 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.678 0.622 . . . . 25.0 112.678 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -138.75 51.73 1.81 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.174 0.511 . . . . 25.0 109.751 177.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 t -118.78 162.83 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 25.0 111.255 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.87 -32.48 74.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.827 0.822 . . . . 25.0 110.283 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -94.48 16.43 15.34 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.659 -0.701 . . . . 25.0 112.633 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -61.07 150.25 34.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -97.02 156.4 16.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.042 -1.096 . . . . 25.0 108.042 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.06 121.93 3.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -76.24 108.08 8.92 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.799 -0.445 . . . . 25.0 109.799 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 105.93 16.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.362 0.601 . . . . 25.0 112.117 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -64.18 142.86 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.028 -0.731 . . . . 25.0 109.028 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 tpt -146.82 151.87 37.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.849 -1.167 . . . . 25.0 107.849 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -101.95 171.99 7.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.455 -1.313 . . . . 25.0 107.455 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.08 177.57 19.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.81 0.684 . . . . 25.0 114.81 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.16 177.1 31.79 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 112.399 -0.281 . . . . 25.0 112.399 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER -92.06 132.73 36.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.942 -0.74 . . . . 25.0 109.733 179.358 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -135.33 141.78 45.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.888 0.375 . . . . 25.0 110.448 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.9 m -84.34 118.75 24.42 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -93.03 111.92 23.71 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.443 -2.058 . . . . 25.0 105.443 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -90.67 118.74 30.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.93 -0.577 . . . . 25.0 111.192 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -122.92 139.49 53.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.757 -2.312 . . . . 25.0 104.757 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -145.01 161.84 38.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 25.0 111.95 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.87 136.87 52.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.076 -2.564 . . . . 25.0 104.076 173.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.7 t -72.82 -15.91 61.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.382 0.882 . . . . 25.0 113.382 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 153.81 67.74 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 104.752 -2.314 . . . . 25.0 104.752 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 130.73 25.24 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 115.525 -2.517 . . . . 25.0 111.574 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -130.93 153.34 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 156' ' ' ASP . 11.8 t-20 -65.08 143.2 58.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.563 -1.643 . . . . 25.0 106.563 171.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -144.78 147.26 32.69 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.378 -2.453 . . . . 25.0 104.378 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -116.99 -47.15 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.099 0.777 . . . . 25.0 113.099 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -159.12 153.29 23.7 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.518 -0.739 . . . . 25.0 112.388 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.39 132.34 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.161 0.505 . . . . 25.0 109.73 167.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -136.89 142.57 42.75 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.85 151.52 39.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.774 0.797 . . . . 25.0 111.614 -166.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.48 168.94 18.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.61 -1.177 . . . . 25.0 109.064 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.78 149.11 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.115 -0.328 . . . . 25.0 110.115 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.5 m -88.5 117.19 27.28 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.192 -0.458 . . . . 25.0 110.025 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.18 125.16 34.47 Favored 'General case' 0 C--O 1.209 -1.057 0 O-C-N 121.334 -0.854 . . . . 25.0 110.949 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -76.86 154.08 34.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 106.531 -1.655 . . . . 25.0 106.531 168.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.01 10.21 56.45 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 119.349 2.499 . . . . 25.0 119.349 170.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -61.02 153.33 25.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.958 1.379 . . . . 25.0 110.699 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.51 152.05 95.46 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.337 -1.357 . . . . 25.0 107.337 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 -19.8 47.3 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 117.646 -1.102 . . . . 25.0 114.868 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.18 -18.62 62.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.822 0.82 . . . . 25.0 111.67 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -96.13 128.86 35.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.483 -0.761 . . . . 25.0 109.866 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.14 126.28 16.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.588 -1.141 . . . . 25.0 114.223 -173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.12 -42.94 66.51 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.525 -1.216 . . . . 25.0 113.213 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -69.01 -17.35 63.9 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 113.046 0.758 . . . . 25.0 113.046 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -77.15 -45.63 26.12 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.64 67.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.364 0.602 . . . . 25.0 112.216 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -71.04 -29.03 64.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 25.0 110.538 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.46 92.12 3.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.259 0.552 . . . . 25.0 109.712 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -99.75 110.13 22.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -62.82 117.25 6.09 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.857 -0.423 . . . . 25.0 109.857 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -2.53 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 107.382 -1.34 . . . . 25.0 107.382 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.22 151.05 6.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.778 . . . . 25.0 114.639 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -143.04 122.66 13.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.057 -1.831 . . . . 25.0 106.057 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.09 117.95 11.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.35 175.38 11.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 115.962 -2.225 . . . . 25.0 110.259 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -128.56 92.36 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.253 -2.128 . . . . 25.0 105.253 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.0 -19.94 13.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.681 -1.6 . . . . 25.0 107.711 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.76 -179.35 30.78 Favored Glycine 0 N--CA 1.445 -0.764 1 N-CA-C 103.013 -4.035 . . . . 25.0 103.013 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -116.65 36.75 0.22 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 117.16 2.281 . . . . 25.0 117.16 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.88 170.57 18.5 Favored 'Trans proline' 0 C--N 1.355 0.876 1 C-N-CA 113.225 -4.05 . . . . 25.0 110.333 171.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.11 55.43 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.294 1.22 . . . . 25.0 114.294 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.8 p -70.51 -19.81 62.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.1 mmt-85 -100.96 10.72 40.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.274 0.63 . . . . 25.0 112.478 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -58.05 156.8 8.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.028 1.862 . . . . 25.0 116.028 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.73 -22.4 59.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.344 -1.298 . . . . 25.0 111.662 176.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 65.1 m -100.04 140.55 34.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -129.57 136.86 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.339 0.866 . . . . 25.0 113.339 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -79.37 126.8 31.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.543 -1.651 . . . . 25.0 106.543 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -131.91 125.81 55.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.705 -1.221 . . . . 25.0 107.705 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 90.6 t80 -85.85 133.33 33.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -108.84 129.67 23.65 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.844 -1.539 . . . . 25.0 106.844 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -66.27 146.58 81.47 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 117.127 -1.449 . . . . 25.0 111.92 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -110.57 -12.54 14.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.055 0.931 . . . . 25.0 110.857 -173.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.0 4.22 45.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.839 1.052 . . . . 25.0 113.839 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -151.78 151.65 31.65 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 121.844 -0.535 . . . . 25.0 112.145 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.32 141.57 47.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.286 -0.87 . . . . 25.0 109.49 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.74 163.49 10.49 Favored Glycine 0 CA--C 1.517 0.178 0 N-CA-C 115.11 0.804 . . . . 25.0 115.11 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 11.4 p90 -86.92 145.04 26.69 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.504 0.927 . . . . 25.0 113.504 -176.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -144.5 159.09 43.35 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 105.861 -1.904 . . . . 25.0 105.861 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.83 136.31 50.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 106.894 -1.521 . . . . 25.0 106.894 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.7 mt -96.04 120.16 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.155 -2.535 . . . . 25.0 104.155 174.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.5 mt -105.5 137.48 43.26 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.31 146.64 32.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.101 0.864 . . . . 25.0 112.321 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.03 135.43 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.64 -1.615 . . . . 25.0 106.64 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -130.06 117.45 20.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.606 0.717 . . . . 25.0 110.01 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.7 132.0 38.49 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.865 -1.061 . . . . 25.0 109.998 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.0 t -135.18 134.74 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.0 -10.04 19.29 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.204 1.557 . . . . 25.0 115.204 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 91' ' ' ASN . 41.9 p-10 -102.29 18.22 21.52 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 25.0 110.457 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.2 p -133.0 151.16 52.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -70.22 -18.13 63.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.665 0.269 . . . . 25.0 111.656 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.16 171.93 7.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.061 -0.518 . . . . 25.0 111.87 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 159.53 26.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.683 -1.969 . . . . 25.0 105.683 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -111.35 145.59 38.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.302 1.223 . . . . 25.0 114.302 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -123.5 139.7 53.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.204 -0.907 . . . . 25.0 108.734 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -149.57 142.1 24.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.417 -1.327 . . . . 25.0 107.417 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 m -135.59 151.06 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.305 -1.369 . . . . 25.0 107.305 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.08 110.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.006 -1.479 . . . . 25.0 107.006 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -77.53 131.74 38.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.321 -1.733 . . . . 25.0 106.321 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.0 157.93 41.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.789 -0.569 . . . . 25.0 110.605 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 43.7 t0 -123.58 108.29 12.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.344 -1.724 . . . . 25.0 106.344 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.77 103.99 16.0 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.81 -1.552 . . . . 25.0 106.81 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.45 171.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.825 0.345 . . . . 25.0 111.319 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.02 152.67 32.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.9 -1.148 . . . . 25.0 107.9 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.896 0 CA-C-O 117.844 -1.074 . . . . 25.0 109.599 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.285 0 N-CA-C 110.559 -1.016 . . . . 25.0 110.559 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.08 133.24 36.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.995 0.398 . . . . 25.0 110.347 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.68 112.32 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 106.498 -1.668 . . . . 25.0 106.498 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.61 -43.5 10.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.95 -0.568 . . . . 25.0 110.798 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -140.55 158.09 66.71 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 107.862 -1.162 . . . . 25.0 107.862 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.14 116.57 4.53 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 131.672 1.947 . . . . 25.0 113.955 -2.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.23 -149.48 45.27 Favored Glycine 0 C--O 1.226 -0.367 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -131.43 110.77 11.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.239 0.542 . . . . 25.0 110.553 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -20.73 65.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.994 -0.548 . . . . 25.0 111.004 176.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -24.13 67.7 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.104 0.253 . . . . 25.0 111.577 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.65 93.89 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 120.852 -0.339 . . . . 25.0 110.281 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.53 -16.8 61.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.269 0.557 . . . . 25.0 111.147 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 t . . . . . 0 C--N 1.319 -0.745 0 CA-C-N 115.547 -0.751 . . . . 25.0 110.099 -177.693 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 t . . . . . 0 CA--C 1.545 0.768 0 N-CA-C 112.482 0.549 . . . . 25.0 112.482 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -70.34 -27.95 64.76 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.763 -0.586 . . . . 25.0 112.542 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.17 -16.28 25.03 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.378 1.085 . . . . 25.0 108.541 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.66 60.09 0.84 Allowed Pre-proline 0 C--O 1.245 0.86 0 CA-C-N 115.176 -0.92 . . . . 25.0 111.733 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.71 -39.86 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 113.558 -3.828 . . . . 25.0 114.348 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -104.24 -23.44 13.24 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.476 1.288 . . . . 25.0 114.476 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.49 114.16 21.86 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 104.567 -2.383 . . . . 25.0 104.567 173.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -133.38 105.05 6.72 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 106.487 -1.671 . . . . 25.0 106.487 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -128.62 141.01 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.22 0.533 . . . . 25.0 112.18 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.07 102.86 5.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm . . . . . 0 C--N 1.327 -0.401 0 N-CA-C 105.037 -2.208 . . . . 25.0 105.037 -174.312 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.709 0 N-CA-C 115.079 0.791 . . . . 25.0 115.079 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -59.84 -35.94 75.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.573 0.953 . . . . 25.0 113.573 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -65.03 -11.82 43.54 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.841 0.682 . . . . 25.0 112.841 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.94 48.34 Favored Glycine 0 C--O 1.22 -0.74 0 CA-C-O 119.713 -0.493 . . . . 25.0 113.663 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.55 -22.9 73.56 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 117.962 0.881 . . . . 25.0 112.673 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -86.31 -36.98 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.31 -10.86 60.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 25.0 111.9 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -30.57 64.55 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 111.654 0.242 . . . . 25.0 111.654 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.92 -8.64 11.84 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.259 1.207 . . . . 25.0 114.259 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -127.8 24.25 6.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.418 0.628 . . . . 25.0 109.867 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 t -98.5 164.96 12.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.244 -0.435 . . . . 25.0 110.983 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.67 -33.38 74.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.61 0.719 . . . . 25.0 109.148 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -94.89 19.03 10.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.002 -0.545 . . . . 25.0 112.053 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -47.63 136.37 10.41 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.345 0.869 . . . . 25.0 113.345 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -89.68 159.06 17.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.788 . . . . 25.0 109.227 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -65.52 132.91 50.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -80.78 143.24 33.01 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.47 -0.787 . . . . 25.0 109.717 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 96.57 4.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.898 0.703 . . . . 25.0 112.898 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -69.25 138.43 22.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.152 -2.536 . . . . 25.0 104.152 168.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.5 tpt -145.42 146.55 31.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.23 -0.655 . . . . 25.0 109.23 -176.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p -95.0 172.04 8.39 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.81 -174.97 5.48 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 116.648 1.419 . . . . 25.0 116.648 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.84 177.08 35.18 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 115.035 -0.583 . . . . 25.0 113.031 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.97 132.63 34.17 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.034 -0.686 . . . . 25.0 110.86 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -132.61 137.92 47.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 25.0 109.515 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 m -101.97 137.49 40.19 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.596 0.961 . . . . 25.0 113.596 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.29 129.73 55.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.901 -1.518 . . . . 25.0 106.901 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -137.77 129.56 28.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.993 -0.373 . . . . 25.0 109.993 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -124.01 143.36 50.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -145.01 156.92 44.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.7 0.286 . . . . 25.0 111.168 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -139.78 163.98 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -71.28 -19.38 62.35 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.501 0.926 . . . . 25.0 113.501 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.77 147.34 48.11 Favored Pre-proline 0 C--O 1.238 0.468 0 O-C-N 121.943 -0.473 . . . . 25.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.86 149.71 37.79 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 117.689 -1.074 . . . . 25.0 111.734 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -130.94 161.65 31.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 25.0 109.199 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -65.86 131.09 45.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.563 -1.273 . . . . 25.0 107.563 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.4 p -143.63 152.22 41.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.256 -1.387 . . . . 25.0 107.256 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.2 t -103.3 -56.84 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.494 0.924 . . . . 25.0 113.494 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -159.01 150.43 20.45 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.849 -0.532 . . . . 25.0 110.644 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 131.12 52.4 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.008 -1.478 . . . . 25.0 107.008 169.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -147.84 158.96 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.528 -0.305 . . . . 25.0 110.729 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -145.32 150.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.705 0.764 . . . . 25.0 112.239 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -128.36 154.8 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.606 -1.179 . . . . 25.0 108.12 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.01 149.36 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.907 0.706 . . . . 25.0 112.907 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.1 m -86.79 121.82 29.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -108.05 125.53 51.67 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 121.74 -0.6 . . . . 25.0 111.759 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -75.9 148.29 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.202 -1.777 . . . . 25.0 106.202 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.58 9.91 34.47 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 117.229 1.652 . . . . 25.0 117.229 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' TRP . . . . . 0.401 ' CH2' ' HA ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -83.05 161.5 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.615 1.208 . . . . 25.0 110.56 175.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.63 140.35 78.38 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.26 -13.51 20.87 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 114.492 0.92 . . . . 25.0 114.492 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.44 -13.97 61.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.114 0.959 . . . . 25.0 111.621 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.22 148.21 52.47 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.102 -1.814 . . . . 25.0 106.102 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.96 93.82 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-O 121.55 0.562 . . . . 25.0 112.717 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -36.35 61.13 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 114.367 1.247 . . . . 25.0 114.367 -174.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -61.39 -28.04 68.96 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.186 -0.606 . . . . 25.0 112.305 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -84.65 -46.02 11.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.043 0.449 . . . . 25.0 110.946 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.38 57.54 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 115.705 1.743 . . . . 25.0 115.705 -169.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HA ' ' CH2' ' A' ' 104' ' ' TRP . 42.7 t0 -64.99 -30.71 71.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 25.0 111.335 -172.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -126.15 108.88 11.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.787 -0.82 . . . . 25.0 108.787 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -103.1 132.19 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.525 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.51 127.94 33.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.92 0.74 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.944 0.878 . . . . 25.0 110.031 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.46 140.8 4.72 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.363 -0.922 . . . . 25.0 112.863 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 132.86 15.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.67 109.6 12.14 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.069 -1.086 . . . . 25.0 108.069 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.0 164.69 22.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.482 -1.879 . . . . 25.0 111.72 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -103.84 106.86 17.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.025 -1.472 . . . . 25.0 107.025 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -114.53 -22.7 9.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.578 -1.192 . . . . 25.0 109.515 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -173.86 -161.58 24.19 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 103.78 -3.728 . . . . 25.0 103.78 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.3 t -123.7 50.44 3.36 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.301 1.593 . . . . 25.0 115.301 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.77 170.55 17.52 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 114.047 -3.502 . . . . 25.0 109.769 170.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.62 58.67 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.077 1.14 . . . . 25.0 114.077 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 53.3 p -70.87 -16.0 62.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.892 0.701 . . . . 25.0 112.892 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -99.16 7.01 46.19 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.742 0.275 . . . . 25.0 111.742 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -61.19 152.29 29.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.885 -1.154 . . . . 25.0 107.885 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -11.49 60.77 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.618 0.599 . . . . 25.0 112.618 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.2 t -90.98 124.47 35.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -128.86 140.39 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.049 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -100.83 137.22 39.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.235 -1.024 . . . . 25.0 108.235 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.3 mm -130.85 123.74 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -93.35 134.34 35.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.649 -0.5 . . . . 25.0 109.649 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.72 129.86 23.45 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.7 150.0 73.91 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 117.951 -0.9 . . . . 25.0 112.275 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.36 -4.93 11.3 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 122.115 0.96 . . . . 25.0 110.663 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.87 6.61 27.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.698 -0.683 . . . . 25.0 112.796 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -155.95 170.09 22.93 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.991 -0.443 . . . . 25.0 111.852 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.82 153.56 45.47 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 105.766 -1.939 . . . . 25.0 105.766 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 153.02 144.87 4.01 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-O 122.075 0.819 . . . . 25.0 115.091 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 4.8 p90 -81.48 146.12 30.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.439 -0.88 . . . . 25.0 112.425 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -146.33 158.95 43.94 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 105.512 -2.033 . . . . 25.0 105.512 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.6 t -121.36 130.26 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.05 -2.574 . . . . 25.0 104.05 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.48 119.34 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.204 -1.036 . . . . 25.0 108.204 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.48 131.43 54.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.419 -1.697 . . . . 25.0 106.419 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.49 133.82 45.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.2 t -129.01 132.92 66.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -119.47 108.31 14.39 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.29 132.0 34.06 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.872 -1.058 . . . . 25.0 111.259 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.28 129.5 66.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.559 -2.015 . . . . 25.0 105.559 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.94 -28.3 63.37 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 -167.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -110.0 22.66 15.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -172.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.6 p -137.98 153.1 49.46 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.867 0.365 . . . . 25.0 111.685 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -78.8 -7.81 58.19 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.601 0.715 . . . . 25.0 110.333 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -110.11 161.31 15.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.02 -0.991 . . . . 25.0 109.081 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.11 39.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.785 -2.302 . . . . 25.0 104.785 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -90.86 131.25 36.61 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.836 -1.172 . . . . 25.0 107.836 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -128.73 134.47 48.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.149 -0.478 . . . . 25.0 110.216 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.97 140.15 26.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 176.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.02 139.82 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.9 mt -135.31 118.55 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -80.16 131.42 35.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.96 -1.866 . . . . 25.0 105.96 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.12 162.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.345 0.593 . . . . 25.0 111.767 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 63.0 t0 -129.58 120.99 26.22 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.242 -2.873 . . . . 25.0 103.242 170.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.74 111.41 24.12 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.75 166.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 114.48 1.289 . . . . 25.0 114.48 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -72.08 154.35 41.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 173.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.659 0 CA-C-O 118.255 -0.879 . . . . 25.0 110.106 177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 59.0 m80 . . . . . 0 N--CA 1.482 1.138 0 N-CA-C 110.017 -0.364 . . . . 25.0 110.017 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -87.9 -177.02 47.93 Favored Glycine 0 C--O 1.24 0.479 0 N-CA-C 108.905 -1.678 . . . . 25.0 108.905 177.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -154.31 166.08 34.31 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 117.953 0.877 . . . . 25.0 112.696 -179.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 78.3 mt -91.65 122.08 42.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 106.752 -1.573 . . . . 25.0 106.752 177.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -85.75 -42.54 14.13 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.233 -0.44 . . . . 25.0 111.024 -177.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -143.23 158.6 57.87 Favored Pre-proline 0 N--CA 1.473 0.711 0 N-CA-C 109.315 -0.624 . . . . 25.0 109.315 -174.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.53 116.13 3.93 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 131.403 1.835 . . . . 25.0 116.823 2.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.2 148.64 7.12 Favored Glycine 0 C--O 1.221 -0.682 0 CA-C-N 114.947 -1.024 . . . . 25.0 113.039 176.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -94.13 119.87 33.57 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.611 -0.514 . . . . 25.0 109.611 179.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.09 -21.18 64.98 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.436 -0.347 . . . . 25.0 111.481 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.47 -32.38 72.39 Favored 'General case' 0 CA--C 1.538 0.493 0 N-CA-C 112.031 0.382 . . . . 25.0 112.031 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.59 -27.57 69.04 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.985 0.422 . . . . 25.0 111.075 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 55.0 mt -94.69 -4.09 48.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.718 -0.674 . . . . 25.0 110.901 -179.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 51.6 t -90.94 -36.49 14.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.849 -0.614 . . . . 25.0 109.478 -177.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 19.3 m -60.05 142.86 53.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.67 -0.695 . . . . 25.0 111.442 -179.17 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -68.17 -14.97 63.38 Favored 'General case' 0 C--O 1.211 -0.925 0 CA-C-N 116.465 -0.334 . . . . 25.0 110.606 178.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.92 -13.0 29.1 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.003 0.372 . . . . 25.0 112.003 175.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 22.8 t80 -83.02 -5.05 58.95 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.311 0.485 . . . . 25.0 112.311 178.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 172.68 -29.97 0.1 Allowed Glycine 0 C--N 1.331 0.301 0 N-CA-C 116.904 1.522 . . . . 25.0 116.904 178.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.8 t80 63.66 -59.51 0.18 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 126.602 1.961 . . . . 25.0 114.805 179.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 75.5 mt -70.55 -20.82 62.77 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 107.844 -1.169 . . . . 25.0 107.844 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -134.3 117.0 15.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.959 -1.018 . . . . 25.0 108.721 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -148.94 157.0 43.09 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 105.794 -1.928 . . . . 25.0 105.794 175.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -149.78 77.9 1.34 Allowed 'General case' 0 C--O 1.234 0.265 0 CA-C-O 120.878 0.371 . . . . 25.0 110.028 -173.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 9.9 t -132.12 -74.7 0.51 Allowed 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.713 -0.676 . . . . 25.0 112.794 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.59 177.8 42.08 Favored Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.48 -0.867 . . . . 25.0 112.883 178.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 19.7 t -75.18 -16.72 60.49 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.996 0.739 . . . . 25.0 112.996 -175.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.2 p -66.92 -12.5 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 CA-C-O 121.674 0.75 . . . . 25.0 111.112 -177.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -15.23 61.96 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 114.92 1.452 . . . . 25.0 114.92 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 50.5 t80 -76.19 -30.17 57.94 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 113.745 1.017 . . . . 25.0 113.745 -173.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -144.98 44.75 0.46 Allowed Pre-proline 0 CA--C 1.548 0.878 0 N-CA-C 116.805 2.15 . . . . 25.0 116.805 -177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -71.06 -22.58 25.99 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 114.543 -3.171 . . . . 25.0 113.786 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -83.68 -34.85 24.88 Favored 'General case' 0 C--O 1.216 -0.693 0 CA-C-O 121.177 0.513 . . . . 25.0 109.896 177.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 60.7 m -111.39 69.15 0.68 Allowed 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.645 -0.422 . . . . 25.0 111.645 -175.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.4 tp -81.85 123.34 28.73 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 104.979 -2.23 . . . . 25.0 104.979 170.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 86.4 mt-10 -83.95 132.2 34.78 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.462 -0.335 . . . . 25.0 110.868 -173.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -120.2 157.64 28.65 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.82 -1.178 . . . . 25.0 107.82 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 4.4 ttmp? -139.7 143.63 37.17 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.855 -0.424 . . . . 25.0 109.855 -173.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 62.0 mmtt -69.96 142.52 52.86 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 108.139 -1.06 . . . . 25.0 108.139 177.48 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 72.76 -152.37 47.4 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.252 -0.975 . . . . 25.0 114.744 175.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -104.69 153.9 38.91 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 109.247 -0.649 . . . . 25.0 109.247 178.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_endo -78.18 150.46 88.72 Favored 'Cis proline' 0 C--N 1.349 0.594 0 C-N-CA 128.856 0.773 . . . . 25.0 112.64 -1.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 47.4 m-70 -68.69 -46.17 69.76 Favored 'General case' 0 C--O 1.224 -0.256 0 N-CA-C 109.287 -0.635 . . . . 25.0 109.287 176.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 t 64.6 -46.27 0.32 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 116.012 1.856 . . . . 25.0 116.012 178.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -92.34 -155.31 31.77 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 111.581 -0.608 . . . . 25.0 111.581 178.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -68.52 173.72 9.42 Favored 'Trans proline' 0 C--O 1.237 0.452 0 CA-C-N 118.541 1.171 . . . . 25.0 113.741 -179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -70.35 105.06 2.88 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.912 -0.586 . . . . 25.0 110.941 -177.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 45.0 t0 -143.78 173.97 11.22 Favored 'General case' 0 C--O 1.241 0.619 0 N-CA-C 108.233 -1.025 . . . . 25.0 108.233 177.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.34 11.0 81.32 Favored Glycine 0 C--O 1.225 -0.441 0 N-CA-C 108.437 -1.865 . . . . 25.0 108.437 -172.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -126.75 35.47 4.61 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 122.619 0.368 . . . . 25.0 111.273 -172.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 76.8 mt -67.83 -42.66 86.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.099 0.476 . . . . 25.0 110.16 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.19 -36.04 82.78 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 112.431 0.53 . . . . 25.0 112.431 -177.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 35.4 p -90.41 -4.67 56.87 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.192 -0.458 . . . . 25.0 110.681 179.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.79 19.83 4.71 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.904 1.282 . . . . 25.0 114.286 -175.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -65.47 -36.08 92.12 Favored Glycine 0 CA--C 1.512 -0.125 0 N-CA-C 109.375 -1.49 . . . . 25.0 109.375 175.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.2 -36.33 24.6 Favored Glycine 0 C--O 1.216 -1.011 0 N-CA-C 111.366 -0.693 . . . . 25.0 111.366 178.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.5 mt -65.6 -48.18 73.18 Favored 'General case' 0 C--N 1.327 -0.382 0 O-C-N 122.174 -0.603 . . . . 25.0 110.98 -178.126 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 19.5 m-85 -73.68 -22.24 60.0 Favored 'General case' 0 C--N 1.323 -0.558 0 O-C-N 121.781 -0.575 . . . . 25.0 109.494 179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -20.64 74.93 Favored Glycine 0 C--O 1.224 -0.494 0 C-N-CA 121.059 -0.591 . . . . 25.0 111.883 174.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -66.25 -21.35 70.11 Favored Glycine 0 C--O 1.224 -0.485 0 CA-C-N 117.786 0.793 . . . . 25.0 112.409 178.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.1 mm -69.79 -39.17 77.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 108.343 -0.984 . . . . 25.0 108.343 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -78.57 -25.78 45.43 Favored 'General case' 0 C--O 1.216 -0.687 0 CA-C-N 116.029 -0.532 . . . . 25.0 110.461 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -67.74 -27.32 66.69 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.789 0.804 . . . . 25.0 109.852 178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 56.9 mt-30 -73.1 2.28 7.45 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.847 -0.533 . . . . 25.0 111.534 174.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 81.6 mm-40 -129.61 18.58 5.74 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 123.197 0.599 . . . . 25.0 110.036 174.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.7 t -86.18 156.13 20.46 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.86 -0.609 . . . . 25.0 111.897 -173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 75.7 tt0 -66.75 -31.46 72.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.642 0.734 . . . . 25.0 109.057 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -88.07 1.9 53.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.413 -0.812 . . . . 25.0 112.658 -178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -56.87 134.95 55.8 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -178.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -84.39 165.79 17.9 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.666 0.746 . . . . 25.0 109.969 -174.028 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -79.56 106.13 11.36 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.088 0.47 . . . . 25.0 110.561 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.4 pttm -65.22 146.8 54.48 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 120.93 -1.106 . . . . 25.0 111.133 -175.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -118.91 130.06 55.52 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.579 -0.737 . . . . 25.0 110.906 -176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 57.8 mt -85.2 135.63 24.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.701 -0.681 . . . . 25.0 109.677 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 74.1 mtp -134.19 142.27 47.35 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.626 -1.25 . . . . 25.0 107.626 174.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 21.4 p -89.47 172.96 8.62 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 109.015 -0.735 . . . . 25.0 109.015 -179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.09 -177.4 6.1 Favored Glycine 0 C--O 1.24 0.531 0 N-CA-C 115.801 1.08 . . . . 25.0 115.801 -178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.63 -178.72 36.78 Favored Glycine 0 CA--C 1.517 0.181 0 N-CA-C 110.833 -0.907 . . . . 25.0 110.833 -179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -78.1 147.04 34.84 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 121.452 -1.028 . . . . 25.0 108.596 178.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 84.2 m-70 -141.86 153.82 44.72 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 29.9 m -117.03 128.26 54.98 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.303 -0.408 . . . . 25.0 110.241 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -104.11 136.14 44.28 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 123.38 0.672 . . . . 25.0 109.285 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.1 m -132.59 130.01 39.7 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.1 m0 -122.05 152.6 39.64 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.698 -1.593 . . . . 25.0 106.698 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.3 t -143.47 153.17 42.35 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 107.762 -1.199 . . . . 25.0 107.762 175.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 21.1 m-85 -121.64 138.49 54.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.742 0.306 . . . . 25.0 110.746 -175.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 66.3 p -92.71 0.41 57.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.158 0.504 . . . . 25.0 110.526 179.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -91.41 129.82 41.74 Favored Pre-proline 0 C--N 1.324 -0.526 0 N-CA-C 109.109 -0.7 . . . . 25.0 109.109 -177.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -79.11 1.3 9.29 Favored 'Trans proline' 0 C--N 1.349 0.59 0 O-C-N 121.983 0.464 . . . . 25.0 112.98 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 26.0 m80 -73.73 149.36 41.87 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.173 -0.467 . . . . 25.0 111.623 -178.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 72.2 m-80 -69.14 155.81 39.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.795 -0.639 . . . . 25.0 112.19 -177.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.2 m -123.48 130.32 52.52 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.631 -1.248 . . . . 25.0 107.631 178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.9 p -90.76 -43.8 9.86 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.051 0.453 . . . . 25.0 111.654 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 22.4 tt0 -160.9 152.48 19.41 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 110.259 -0.275 . . . . 25.0 110.259 -175.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -147.32 144.05 28.49 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 25.0 109.132 169.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -152.73 156.71 39.65 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 110.17 -0.307 . . . . 25.0 110.17 -172.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -149.69 152.97 36.22 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.116 0.784 . . . . 25.0 113.116 -174.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -134.38 167.43 20.76 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 107.617 -1.253 . . . . 25.0 107.617 -173.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 49.2 pt -133.14 152.22 35.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 170.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 68.5 p -89.87 145.75 24.92 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 112.472 0.545 . . . . 25.0 112.472 178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 54.0 pttt -117.49 115.26 24.8 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-O 121.836 0.827 . . . . 25.0 109.966 172.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 82.5 tttt -76.23 146.9 38.71 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 106.279 -1.748 . . . . 25.0 106.279 174.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 108.68 18.47 9.48 Favored Glycine 0 N--CA 1.464 0.523 0 C-N-CA 120.608 -0.806 . . . . 25.0 114.46 177.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 32.4 p90 -58.62 149.15 26.57 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 117.365 0.582 . . . . 25.0 111.105 177.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -76.13 146.77 79.04 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 107.472 -1.307 . . . . 25.0 107.472 174.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -71.79 -19.97 26.77 Favored 'Trans proline' 0 CA--C 1.531 0.349 0 C-N-CA 117.288 -1.341 . . . . 25.0 112.896 178.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 37.9 t70 -71.78 -22.59 61.56 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.816 0.817 . . . . 25.0 111.756 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -95.92 146.41 31.27 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.94 -0.475 . . . . 25.0 110.091 -175.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -66.39 111.52 2.09 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 117.377 -1.282 . . . . 25.0 113.091 -177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -53.2 -38.59 63.0 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.398 0.679 . . . . 25.0 112.741 -176.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -54.57 -33.03 59.59 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 70.5 mtp180 -92.73 -45.06 8.22 Favored 'General case' 0 C--O 1.209 -1.059 0 N-CA-C 112.496 0.554 . . . . 25.0 112.496 175.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -66.96 -17.19 64.8 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 114.391 1.256 . . . . 25.0 114.391 -172.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -67.67 -39.64 84.5 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 114.175 1.176 . . . . 25.0 114.175 -178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 49.1 p90 -132.47 155.08 49.19 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 114.231 1.197 . . . . 25.0 114.231 -177.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -129.29 147.0 51.08 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 122.97 0.508 . . . . 25.0 110.87 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 30.5 tp -78.26 128.69 34.1 Favored 'General case' 0 N--CA 1.47 0.528 0 N-CA-C 110.092 -0.336 . . . . 25.0 110.092 178.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.0 pt -119.85 1.93 7.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-O 120.95 0.405 . . . . 25.0 111.53 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.64 141.08 3.32 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.179 -1.01 . . . . 25.0 114.513 175.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.4 131.17 24.25 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.15 -2.167 . . . . 25.0 105.15 177.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 23.4 t -131.91 94.88 23.59 Favored Pre-proline 0 C--N 1.321 -0.646 0 CA-C-O 121.206 0.526 . . . . 25.0 110.126 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -74.17 162.98 37.64 Favored 'Trans proline' 0 C--O 1.239 0.542 0 C-N-CA 116.235 -2.043 . . . . 25.0 110.733 175.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 23.1 t-80 -103.17 115.67 31.02 Favored 'General case' 0 CA--C 1.502 -0.879 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 175.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -127.42 -97.81 0.4 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 106.498 -1.668 . . . . 25.0 106.498 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -159.35 -167.06 19.49 Favored Glycine 0 C--O 1.243 0.688 0 N-CA-C 111.161 -0.776 . . . . 25.0 111.161 -177.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 p 61.41 169.71 0.08 OUTLIER Pre-proline 0 N--CA 1.48 1.07 0 C-N-CA 124.365 1.066 . . . . 25.0 111.887 -177.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -74.36 -4.47 15.47 Favored 'Trans proline' 0 C--N 1.348 0.545 1 C-N-CA 113.18 -4.08 . . . . 25.0 114.729 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -68.75 -46.07 69.81 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 116.083 -0.508 . . . . 25.0 109.994 178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 29.0 t -76.62 -20.43 56.74 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 121.564 0.697 . . . . 25.0 110.544 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 5.6 ttm-85 -67.27 -16.79 64.49 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.828 -0.624 . . . . 25.0 111.635 178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 74.0 m-20 -71.86 105.02 3.65 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.205 0.526 . . . . 25.0 111.992 -177.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -85.48 -21.24 28.77 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.944 -0.571 . . . . 25.0 109.726 175.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.1 t -95.28 138.54 32.83 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.929 -0.397 . . . . 25.0 109.929 -176.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 78.6 m80 -141.7 151.15 42.71 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.279 -0.419 . . . . 25.0 111.925 -174.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -101.35 133.83 45.36 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 115.818 -0.628 . . . . 25.0 109.948 -178.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 42.0 mm -131.86 132.61 61.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 106.807 -1.553 . . . . 25.0 106.807 178.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 88.3 t80 -87.78 136.8 32.8 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.606 -0.516 . . . . 25.0 109.606 176.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.05 134.18 20.48 Favored Pre-proline 0 C--N 1.321 -0.638 0 N-CA-C 105.663 -1.977 . . . . 25.0 105.663 179.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -64.37 144.15 84.87 Favored 'Trans proline' 0 C--N 1.35 0.618 0 C-N-CA 117.17 -1.42 . . . . 25.0 113.886 -175.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -96.8 -7.56 33.36 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.449 -0.796 . . . . 25.0 110.095 -178.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -112.42 -3.15 14.54 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 115.164 1.542 . . . . 25.0 115.164 -174.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.3 mtt180 -136.54 156.63 48.31 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.635 0.605 . . . . 25.0 112.635 -173.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.6 mp -127.85 152.48 47.77 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.006 -0.997 . . . . 25.0 108.888 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.67 154.49 6.15 Favored Glycine 0 C--O 1.237 0.308 0 CA-C-O 121.671 0.595 . . . . 25.0 113.933 174.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.5 p90 -86.97 148.9 25.13 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.643 0.735 . . . . 25.0 111.859 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -139.04 149.05 44.18 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 106.525 -1.657 . . . . 25.0 106.525 -178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 38.5 t -103.4 131.6 51.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 N-CA-C 105.343 -2.095 . . . . 25.0 105.343 175.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.7 mt -95.92 123.51 48.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 N-CA-C 105.233 -2.136 . . . . 25.0 105.233 177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 mp -99.99 127.9 46.14 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 103.683 -2.71 . . . . 25.0 103.683 176.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -140.72 144.08 35.38 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 118.819 0.736 . . . . 25.0 111.762 -177.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 59.1 t -129.56 132.94 65.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.141 -0.936 . . . . 25.0 109.215 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -124.31 112.63 17.21 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -97.26 121.65 39.4 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.008 -0.542 . . . . 25.0 111.784 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 99.5 t -98.43 115.84 39.73 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.667 0 N-CA-C 108.892 -0.781 . . . . 25.0 108.892 -176.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -69.62 -16.74 63.44 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 114.078 1.14 . . . . 25.0 114.078 -172.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -83.43 -0.77 51.5 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 112.751 0.649 . . . . 25.0 112.751 -175.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 6.2 t -154.83 166.27 34.02 Favored 'General case' 0 C--O 1.213 -0.829 0 N-CA-C 108.809 -0.811 . . . . 25.0 108.809 -178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -80.35 -2.66 46.38 Favored 'General case' 0 C--O 1.217 -0.648 0 N-CA-C 109.957 -0.386 . . . . 25.0 109.957 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -102.47 152.99 20.49 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.698 -0.626 . . . . 25.0 109.775 -175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.36 171.91 13.92 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.452 -0.573 . . . . 25.0 109.452 -172.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -101.59 128.33 47.9 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.818 -0.808 . . . . 25.0 108.818 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -126.07 126.55 44.41 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 103.876 -2.639 . . . . 25.0 103.876 177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.59 155.78 44.39 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 118.376 0.535 . . . . 25.0 111.318 -175.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 13.0 m -128.49 136.7 59.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 106.893 -1.521 . . . . 25.0 106.893 175.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 50.4 mt -137.69 122.15 23.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 CA-C-O 120.745 0.307 . . . . 25.0 110.822 -175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -77.72 130.94 37.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.168 0.509 . . . . 25.0 112.065 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -128.83 156.02 41.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 106.856 -1.535 . . . . 25.0 106.856 171.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.412 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 19.5 t0 -123.24 113.84 19.46 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 104.884 -2.265 . . . . 25.0 104.884 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 64.7 mt -108.4 121.59 45.24 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 107.333 -1.358 . . . . 25.0 107.333 -171.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.436 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 32.7 m -127.97 170.66 17.36 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.055 0.455 . . . . 25.0 111.505 -174.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.8 p-10 -70.38 176.61 3.87 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.363 -0.835 . . . . 25.0 111.524 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 29.8 pttt . . . . . 0 C--O 1.244 0.789 0 CA-C-O 117.511 -1.233 . . . . 25.0 111.23 177.755 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 110.811 -0.07 . . . . 25.0 110.811 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.74 -173.66 52.65 Favored Glycine 0 C--N 1.329 0.175 0 CA-C-O 119.065 -0.853 . . . . 25.0 111.206 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.3 p90 -144.18 166.79 24.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 117.296 0.548 . . . . 25.0 109.976 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 45.5 mm -94.1 120.99 44.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 106.415 -1.698 . . . . 25.0 106.415 175.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -87.01 -40.2 14.95 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.893 0.378 . . . . 25.0 111.542 -178.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -145.52 153.7 51.75 Favored Pre-proline 0 N--CA 1.473 0.713 0 CA-C-N 116.271 -0.422 . . . . 25.0 109.876 -175.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -79.24 130.98 21.52 Favored 'Cis proline' 0 C--N 1.351 0.709 0 C-N-CA 129.625 1.094 . . . . 25.0 113.432 -3.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.95 -172.55 40.11 Favored Glycine 0 C--O 1.222 -0.603 0 N-CA-C 110.493 -1.043 . . . . 25.0 110.493 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.9 t -141.74 134.76 28.97 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 178.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -68.32 -21.15 64.77 Favored 'General case' 0 C--O 1.216 -0.659 0 CA-C-N 116.563 -0.29 . . . . 25.0 111.46 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.01 -31.68 72.96 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.81 0.338 . . . . 25.0 111.332 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.58 -29.4 68.75 Favored 'General case' 0 C--O 1.216 -0.66 0 CA-C-N 116.538 -0.301 . . . . 25.0 111.086 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 54.0 mt -88.25 -26.53 22.28 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.118 0.485 . . . . 25.0 110.263 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.4 t -65.44 -42.59 92.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.051 -0.977 . . . . 25.0 110.991 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.7 t -69.05 142.11 54.63 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.691 -0.686 . . . . 25.0 112.064 -176.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 22.2 mp0 -64.42 -16.32 62.15 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.465 -0.789 . . . . 25.0 110.321 176.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.3 -12.92 15.51 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 112.398 0.518 . . . . 25.0 112.398 176.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -83.01 -2.01 54.14 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 112.043 0.386 . . . . 25.0 112.043 -179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.77 -31.26 0.05 OUTLIER Glycine 0 C--O 1.223 -0.553 0 N-CA-C 116.591 1.396 . . . . 25.0 116.591 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 9.9 t80 61.13 1.77 0.52 Allowed 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 115.882 1.808 . . . . 25.0 115.882 178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 91.1 mt -78.65 -24.63 45.08 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 121.6 -0.687 . . . . 25.0 110.188 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -164.98 164.82 20.56 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 107.179 -1.415 . . . . 25.0 107.179 178.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.7 mp -75.2 154.69 37.49 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 106.922 -1.51 . . . . 25.0 106.922 173.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.9 t30 -142.33 48.97 1.54 Allowed 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 113.55 0.944 . . . . 25.0 113.55 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -151.57 -44.65 0.11 Allowed 'General case' 0 N--CA 1.469 0.485 0 N-CA-C 115.119 1.526 . . . . 25.0 115.119 -178.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.73 170.86 35.86 Favored Glycine 0 CA--C 1.521 0.414 0 C-N-CA 121.072 -0.585 . . . . 25.0 112.926 -179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 8.4 t -70.93 -14.02 62.22 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 122.05 -0.676 . . . . 25.0 112.657 -176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.85 -10.09 10.96 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-O 120.951 0.405 . . . . 25.0 111.744 -178.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.72 -11.17 23.87 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 115.841 1.793 . . . . 25.0 115.841 -178.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 87.7 t80 -73.69 -36.61 65.3 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 118.542 0.61 . . . . 25.0 112.516 -173.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -154.94 59.09 2.19 Favored Pre-proline 0 CA--C 1.548 0.868 0 N-CA-C 113.288 0.848 . . . . 25.0 113.288 171.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -71.6 -11.59 28.24 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.437 -1.242 . . . . 25.0 113.809 -175.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -97.48 7.16 47.02 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.27 -0.423 . . . . 25.0 111.013 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.8 t -100.3 89.0 3.83 Favored 'General case' 0 C--O 1.219 -0.523 0 O-C-N 120.794 -1.191 . . . . 25.0 109.847 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.7 mt -124.64 129.04 49.8 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.157 -0.683 . . . . 25.0 109.157 173.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.99 148.97 51.9 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.467 -0.568 . . . . 25.0 109.467 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -133.22 127.7 34.31 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 107.848 -1.167 . . . . 25.0 107.848 177.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 43.3 tttt -64.95 142.04 58.57 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.647 -1.242 . . . . 25.0 107.647 176.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -57.03 129.5 41.99 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.024 -0.732 . . . . 25.0 109.024 -178.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -78.22 68.27 2.91 Favored Glycine 0 C--O 1.227 -0.297 0 N-CA-C 116.597 1.399 . . . . 25.0 116.597 -171.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -102.76 118.43 58.42 Favored Pre-proline 0 CA--C 1.54 0.589 0 N-CA-C 109.035 -0.728 . . . . 25.0 109.035 170.125 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -74.32 155.51 99.87 Favored 'Cis proline' 0 C--N 1.352 0.714 0 C-N-CA 131.499 1.875 . . . . 25.0 112.292 -2.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.5 t60 -63.79 -34.53 78.1 Favored 'General case' 0 C--O 1.212 -0.91 0 N-CA-C 113.835 1.05 . . . . 25.0 113.835 -174.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.0 t 53.34 -107.3 0.35 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 122.641 0.376 . . . . 25.0 111.772 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -66.75 157.47 50.68 Favored Glycine 0 C--O 1.219 -0.805 0 N-CA-C 111.483 -0.647 . . . . 25.0 111.483 178.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.69 -28.05 12.08 Favored 'Trans proline' 0 CA--C 1.534 0.487 0 C-N-CA 116.711 -1.726 . . . . 25.0 116.397 -173.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -71.19 121.11 17.78 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 112.684 0.624 . . . . 25.0 112.684 -174.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.3 m-20 -63.47 142.33 58.43 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 113.213 0.82 . . . . 25.0 113.213 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.0 -31.64 1.77 Allowed Glycine 0 N--CA 1.461 0.327 0 CA-C-N 115.759 -0.655 . . . . 25.0 114.359 179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.5 mm-40 -69.5 -10.22 57.16 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.273 0.842 . . . . 25.0 113.273 -173.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.495 HD12 ' H ' ' A' ' 51' ' ' ILE . 5.3 mp -62.71 -54.31 35.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.461 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -85.84 -25.22 26.39 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 112.737 0.643 . . . . 25.0 112.737 -175.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 90.5 p -86.58 4.93 38.09 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.408 0.522 . . . . 25.0 112.408 -177.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.65 45.8 27.31 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-O 121.814 0.816 . . . . 25.0 109.774 -177.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 22.05 0.49 Allowed Glycine 0 C--O 1.225 -0.464 0 N-CA-C 117.705 1.842 . . . . 25.0 117.705 -174.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -73.26 -17.85 79.01 Favored Glycine 0 CA--C 1.522 0.486 0 N-CA-C 107.871 -2.092 . . . . 25.0 107.871 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 82.6 mt -62.92 -11.04 15.86 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.804 0.842 . . . . 25.0 112.26 175.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 71.1 t80 -52.04 -33.63 39.62 Favored 'General case' 0 CA--C 1.539 0.558 0 N-CA-C 113.005 0.743 . . . . 25.0 113.005 176.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.8 -29.59 59.06 Favored Glycine 0 CA--C 1.522 0.506 0 C-N-CA 119.835 -1.174 . . . . 25.0 112.805 178.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.29 0.71 87.34 Favored Glycine 0 C--O 1.219 -0.801 0 N-CA-C 116.124 1.21 . . . . 25.0 116.124 -176.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.2 mm -54.6 -34.57 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 CA-C-N 118.463 1.132 . . . . 25.0 112.846 -174.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.4 mp -66.08 -31.8 72.88 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.687 -0.633 . . . . 25.0 112.212 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -82.83 -12.13 57.69 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.587 0.708 . . . . 25.0 112.218 -176.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -71.59 8.37 1.14 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -63.33 85.35 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 113.86 1.059 . . . . 25.0 113.86 179.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 25.6 t -151.85 -170.97 3.8 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.486 -2.413 . . . . 25.0 104.486 -178.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 mt-10 -62.92 -25.14 68.18 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.344 0.593 . . . . 25.0 110.547 176.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 21.1 m120 -89.26 19.31 4.42 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 113.322 0.86 . . . . 25.0 113.322 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 32.9 ttt180 -66.64 165.42 14.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.689 -0.856 . . . . 25.0 108.689 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 96.6 m95 -84.56 151.2 24.7 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.532 -1.284 . . . . 25.0 107.532 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -57.54 126.59 27.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.791 -0.64 . . . . 25.0 109.917 -176.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 29.1 tttt -133.95 128.35 34.29 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-N 115.084 -0.962 . . . . 25.0 110.554 -175.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 20.3 t60 -123.07 149.96 43.75 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.929 -0.308 . . . . 25.0 111.213 173.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 69.6 mt -94.04 134.96 29.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 106.42 -1.696 . . . . 25.0 106.42 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 24.8 ttt -150.38 163.41 38.42 Favored 'General case' 0 C--O 1.216 -0.658 0 N-CA-C 107.238 -1.393 . . . . 25.0 107.238 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 49.7 p -94.98 168.09 10.99 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.499 -0.556 . . . . 25.0 109.499 -179.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -68.28 177.87 23.81 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 121.301 -0.476 . . . . 25.0 112.563 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 115.09 -174.1 15.14 Favored Glycine 0 N--CA 1.459 0.182 0 N-CA-C 109.573 -1.411 . . . . 25.0 109.573 -177.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -77.16 141.78 39.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 118.577 1.188 . . . . 25.0 109.259 178.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.0 m170 -123.03 134.61 54.29 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.627 -1.62 . . . . 25.0 106.627 -178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 57.8 m -108.96 118.9 38.01 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 107.509 -1.293 . . . . 25.0 107.509 175.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -108.42 139.39 43.22 Favored 'General case' 0 CA--C 1.509 -0.599 0 N-CA-C 107.34 -1.356 . . . . 25.0 107.34 179.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.5 m -133.07 123.33 25.57 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 107.056 -1.461 . . . . 25.0 107.056 176.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 13.2 m0 -111.99 140.06 46.98 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 104.512 -2.403 . . . . 25.0 104.512 -177.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.56 140.86 51.58 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 122.003 0.906 . . . . 25.0 113.131 -173.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 63.5 m-85 -125.87 148.34 49.21 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 102.96 -2.978 . . . . 25.0 102.96 174.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.5 t -71.47 -18.93 62.27 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-N 118.344 0.52 . . . . 25.0 112.333 -176.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.29 152.15 63.41 Favored Pre-proline 0 C--O 1.239 0.532 0 N-CA-C 106.717 -1.586 . . . . 25.0 106.717 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -69.9 157.09 61.28 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 116.817 -1.656 . . . . 25.0 110.335 174.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 41.6 t-80 -130.98 149.42 52.61 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.526 -0.546 . . . . 25.0 109.526 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -58.55 141.09 53.08 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.596 -1.631 . . . . 25.0 106.596 175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 95.0 m -150.92 146.58 26.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 -172.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 17.0 m -109.62 -41.87 4.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.669 0.271 . . . . 25.0 110.633 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -157.9 153.32 26.07 Favored 'General case' 0 C--O 1.216 -0.701 0 N-CA-C 109.429 -0.582 . . . . 25.0 109.429 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 1.1 p-90 -145.83 148.55 33.01 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 108.402 -0.962 . . . . 25.0 108.402 169.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.37 159.17 43.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.494 -0.321 . . . . 25.0 111.079 -172.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -130.52 142.5 50.48 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.128 -1.064 . . . . 25.0 108.128 175.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -132.88 164.44 26.89 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.714 -1.587 . . . . 25.0 106.714 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.1 pt -129.19 145.77 35.26 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 106.983 -1.488 . . . . 25.0 106.983 171.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 76.7 p -83.54 136.18 34.36 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.458 -1.312 . . . . 25.0 107.458 176.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 63.5 tttt -80.79 116.98 21.06 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.602 -0.888 . . . . 25.0 108.602 -178.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.3 tttm -76.0 125.29 28.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.449 -1.685 . . . . 25.0 106.449 178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.88 19.91 49.18 Favored Glycine 0 C--O 1.224 -0.48 0 C-N-CA 119.183 -1.484 . . . . 25.0 114.208 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.6 p90 -51.31 149.89 3.77 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 117.95 0.875 . . . . 25.0 112.029 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -70.93 129.59 89.38 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.081 -0.509 . . . . 25.0 111.135 -178.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -72.98 -15.26 26.23 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 117.314 -1.324 . . . . 25.0 111.877 173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -72.11 -14.99 61.98 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.159 0.984 . . . . 25.0 111.462 177.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.4 mptt -110.15 155.51 41.67 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 108.135 -1.061 . . . . 25.0 108.135 -176.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -60.78 113.45 1.72 Allowed 'Trans proline' 0 C--O 1.24 0.593 0 N-CA-C 113.519 0.546 . . . . 25.0 113.519 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.55 2.5 0.63 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 118.404 2.742 . . . . 25.0 118.404 -172.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.12 2.75 7.93 Favored 'General case' 0 N--CA 1.469 0.521 0 O-C-N 122.103 -0.373 . . . . 25.0 111.695 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 79.4 mtp85 -105.96 -54.71 2.44 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-N 116.166 -0.47 . . . . 25.0 112.027 169.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -88.0 0.51 55.84 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.688 0.996 . . . . 25.0 113.688 -172.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.6 p-10 -80.65 -21.6 41.27 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 112.096 0.406 . . . . 25.0 112.096 -176.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -126.19 152.02 46.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 174.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 91.9 mt-10 -128.15 141.47 51.47 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.427 -0.953 . . . . 25.0 108.427 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.2 tp -77.09 118.62 19.81 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 109.022 -0.733 . . . . 25.0 109.022 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.9 tp -99.03 -8.34 9.05 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-O 121.652 0.739 . . . . 25.0 110.253 -178.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.36 155.8 9.81 Favored Glycine 0 C--O 1.226 -0.348 0 C-N-CA 120.638 -0.792 . . . . 25.0 113.289 174.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.57 147.07 29.7 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 108.223 -1.029 . . . . 25.0 108.223 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.5 t -131.62 104.48 14.47 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 177.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -77.97 160.99 30.19 Favored 'Trans proline' 0 N--CA 1.464 -0.23 0 C-N-CA 115.372 -2.619 . . . . 25.0 110.884 175.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 18.1 t-80 -104.04 120.96 42.2 Favored 'General case' 0 CA--C 1.508 -0.669 0 N-CA-C 108.161 -1.052 . . . . 25.0 108.161 173.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -140.25 -96.79 0.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 105.087 -2.19 . . . . 25.0 105.087 174.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -86.23 -144.16 7.77 Favored Glycine 0 N--CA 1.451 -0.341 0 N-CA-C 111.608 -0.597 . . . . 25.0 111.608 174.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.8 t -118.3 70.54 8.53 Favored Pre-proline 0 CA--C 1.537 0.479 0 N-CA-C 113.492 0.923 . . . . 25.0 113.492 -179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -74.44 171.76 17.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 118.106 -0.796 . . . . 25.0 111.255 176.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.37 -27.33 68.44 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.906 -0.496 . . . . 25.0 111.175 177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 20.7 p -73.21 -2.39 21.57 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.238 0.829 . . . . 25.0 113.238 179.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 80.2 ttt180 -64.37 -22.35 66.93 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 108.716 -0.846 . . . . 25.0 108.716 173.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 38.5 t-20 -62.43 131.55 49.59 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.398 -0.593 . . . . 25.0 109.398 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.7 mm? -69.45 -10.2 56.98 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 123.348 0.659 . . . . 25.0 112.692 179.564 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.2 t -97.21 120.4 37.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 107.522 -1.288 . . . . 25.0 107.522 179.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 17.1 t-80 -125.66 135.19 51.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.658 -0.701 . . . . 25.0 111.482 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 63.2 m-70 -90.93 136.67 32.92 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 107.722 -1.214 . . . . 25.0 107.722 175.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.7 mp -132.12 119.85 41.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 106.197 -1.779 . . . . 25.0 106.197 174.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.455 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 86.9 t80 -85.26 126.88 34.06 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 177.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.8 mt -125.86 101.73 29.22 Favored Pre-proline 0 C--O 1.24 0.584 0 N-CA-C 109.964 -0.384 . . . . 25.0 109.964 178.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.0 145.6 40.13 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 114.447 -3.236 . . . . 25.0 108.273 171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -147.76 96.71 2.71 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.576 0.703 . . . . 25.0 109.476 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -92.86 10.29 31.7 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.386 -0.824 . . . . 25.0 108.974 179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.7 mtt-85 -130.1 -179.47 5.25 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.451 -0.795 . . . . 25.0 109.991 -170.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 5.8 mp -132.11 128.48 38.24 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 107.348 -1.353 . . . . 25.0 107.348 177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 151.16 164.21 11.92 Favored Glycine 0 N--CA 1.45 -0.367 0 CA-C-O 122.285 0.936 . . . . 25.0 115.042 176.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -94.77 144.94 25.23 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 115.207 1.558 . . . . 25.0 115.207 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -148.93 158.34 44.1 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 106.249 -1.76 . . . . 25.0 106.249 171.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 21.2 t -98.07 139.73 19.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.867 0.365 . . . . 25.0 110.704 -173.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 86.7 mt -96.25 128.16 47.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 104.855 -2.276 . . . . 25.0 104.855 171.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 29.0 mt -108.09 144.46 35.42 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 107.079 -1.452 . . . . 25.0 107.079 -179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -135.04 135.51 41.35 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.607 -0.516 . . . . 25.0 109.607 177.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 87.3 t -128.95 131.12 68.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 107.897 -1.149 . . . . 25.0 107.897 179.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 7.9 t-105 -126.58 109.49 12.18 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 108.867 -0.79 . . . . 25.0 108.867 -177.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -98.04 131.98 43.99 Favored 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.756 0.789 . . . . 25.0 111.976 -174.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 86.1 t -128.65 122.45 57.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 106.673 -1.602 . . . . 25.0 106.673 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.0 -33.25 67.94 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.598 0.713 . . . . 25.0 109.404 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -68.41 -7.08 28.46 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 115.343 1.609 . . . . 25.0 115.343 -173.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.1 p -130.33 156.32 44.88 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -73.69 -21.49 60.23 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.744 0.783 . . . . 25.0 111.068 -178.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -109.82 165.11 11.96 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.549 -0.751 . . . . 25.0 109.762 -176.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 159.77 26.31 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 105.116 -2.179 . . . . 25.0 105.116 174.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 82.4 t80 -109.29 137.01 47.81 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.032 -0.729 . . . . 25.0 109.032 -175.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.1 p90 -139.0 154.09 48.22 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 122.251 -0.281 . . . . 25.0 110.62 -179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 62.5 mm-40 -145.86 155.15 42.7 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.252 -0.647 . . . . 25.0 109.252 178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 27.4 m -136.3 140.51 43.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 108.329 -0.989 . . . . 25.0 108.329 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 71.1 mt -138.85 122.04 18.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 N-CA-C 108.028 -1.101 . . . . 25.0 108.028 179.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -85.1 134.23 34.2 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.98 -1.119 . . . . 25.0 107.98 177.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 18.4 m -129.88 125.98 61.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.469 -0.567 . . . . 25.0 109.469 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -93.84 107.94 19.78 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 105.403 -2.073 . . . . 25.0 105.403 177.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 33.5 mt -109.55 133.14 53.44 Favored 'General case' 0 CA--C 1.507 -0.697 0 CA-C-O 121.188 0.518 . . . . 25.0 109.674 -174.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.8 m -131.71 159.73 42.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-N 115.123 -0.944 . . . . 25.0 110.712 -175.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -76.06 155.93 34.37 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 105.285 -2.117 . . . . 25.0 105.285 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.767 0 CA-C-O 117.413 -1.279 . . . . 25.0 110.931 -177.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.88 0.371 . . . . 25.0 110.991 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.43 173.88 46.59 Favored Glycine 0 C--O 1.235 0.18 0 N-CA-C 104.336 -3.506 . . . . 25.0 104.336 179.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 50.0 p90 -154.18 169.66 23.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 120.085 1.942 . . . . 25.0 113.015 -177.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.456 HG22 ' H ' ' A' ' 6' ' ' LYS . 30.3 mm -93.52 127.1 45.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.515 -0.766 . . . . 25.0 108.975 -176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -87.63 13.16 10.89 Favored 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 112.818 0.673 . . . . 25.0 112.818 -176.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.456 ' H ' HG22 ' A' ' 4' ' ' ILE . 53.5 mttt 80.92 156.57 0.13 Allowed Pre-proline 0 N--CA 1.492 1.652 0 C-N-CA 126.142 1.777 . . . . 25.0 107.348 -177.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -64.79 151.37 75.15 Favored 'Cis proline' 0 C--N 1.346 0.401 0 C-N-CA 129.311 0.963 . . . . 25.0 112.502 -4.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 91.08 9.34 63.78 Favored Glycine 0 C--O 1.227 -0.287 0 N-CA-C 116.297 1.279 . . . . 25.0 116.297 171.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 22.7 t -62.05 132.4 52.77 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 117.409 0.604 . . . . 25.0 111.751 -178.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -70.53 -26.44 63.57 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-N 116.069 -0.514 . . . . 25.0 111.298 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.39 -30.15 70.37 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.503 -0.317 . . . . 25.0 111.629 -179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.63 -33.39 75.81 Favored 'General case' 0 C--O 1.22 -0.449 0 CA-C-O 120.798 0.332 . . . . 25.0 110.675 178.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 71.4 mt -83.91 -8.04 59.28 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.353 -0.385 . . . . 25.0 111.308 -178.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.8 t -81.16 -14.21 57.86 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.739 0.304 . . . . 25.0 110.449 -177.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 43.5 t -99.97 139.69 35.27 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.643 -0.502 . . . . 25.0 109.643 179.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -69.07 -16.87 63.79 Favored 'General case' 0 C--O 1.218 -0.571 0 CA-C-O 120.901 0.381 . . . . 25.0 110.144 176.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.53 -12.85 17.03 Favored 'General case' 0 CA--C 1.539 0.539 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -79.9 -10.89 59.82 Favored 'General case' 0 CA--C 1.537 0.476 0 O-C-N 122.245 -0.284 . . . . 25.0 111.596 -177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.21 -12.81 0.02 OUTLIER Glycine 0 CA--C 1.52 0.404 0 N-CA-C 117.588 1.795 . . . . 25.0 117.588 178.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 8.9 t80 64.02 -32.47 0.13 Allowed 'General case' 0 N--CA 1.479 1.005 0 N-CA-C 117.368 2.359 . . . . 25.0 117.368 178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.8 mt -67.68 -25.66 65.81 Favored 'General case' 0 C--N 1.323 -0.566 0 O-C-N 121.931 -0.481 . . . . 25.0 111.112 178.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -167.72 171.99 9.62 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 108.607 -0.886 . . . . 25.0 108.607 179.203 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -140.27 150.68 44.37 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 105.769 -1.937 . . . . 25.0 105.769 173.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.4 m120 -129.28 47.87 2.43 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.556 0.947 . . . . 25.0 113.556 -170.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.9 t -66.92 -61.97 1.67 Allowed 'General case' 0 CA--C 1.546 0.798 0 C-N-CA 120.684 -0.406 . . . . 25.0 111.895 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 91.1 147.11 18.84 Favored Glycine 0 C--O 1.219 -0.825 0 CA-C-N 116.463 -0.335 . . . . 25.0 113.704 179.323 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.2 t -63.71 -29.9 71.06 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.062 1.134 . . . . 25.0 114.062 -175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.2 p -66.28 0.39 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 113.09 0.774 . . . . 25.0 113.09 -178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.9 ptm -56.32 -10.98 1.02 Allowed 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.499 1.666 . . . . 25.0 115.499 178.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.2 t80 -76.43 -35.98 58.23 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 120.9 0.381 . . . . 25.0 110.779 179.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.3 pt-20 -147.14 50.22 0.91 Allowed Pre-proline 0 CA--C 1.55 0.972 0 N-CA-C 113.824 1.046 . . . . 25.0 113.824 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.58 -17.15 23.68 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 115.114 -2.791 . . . . 25.0 114.634 -172.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 -98.07 4.99 49.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.073 0.768 . . . . 25.0 113.073 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.8 94.06 4.85 Favored 'General case' 0 C--O 1.219 -0.519 0 N-CA-C 113.067 0.766 . . . . 25.0 113.067 -175.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 mt -125.98 132.78 51.97 Favored 'General case' 0 C--O 1.241 0.658 0 N-CA-C 105.602 -1.999 . . . . 25.0 105.602 168.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -129.94 149.06 51.83 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 113.265 0.839 . . . . 25.0 113.265 -174.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.0 150.68 49.32 Favored 'General case' 0 C--O 1.222 -0.376 0 N-CA-C 106.356 -1.72 . . . . 25.0 106.356 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 85.2 tttt -80.9 138.15 36.15 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.089 -0.708 . . . . 25.0 109.089 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 45.3 mtpt -65.51 136.75 56.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.939 0.4 . . . . 25.0 110.077 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -179.34 179.72 48.84 Favored Glycine 0 N--CA 1.449 -0.433 0 N-CA-C 109.567 -1.413 . . . . 25.0 109.567 178.317 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.96 145.27 32.82 Favored Pre-proline 0 C--N 1.324 -0.515 0 N-CA-C 108.978 -0.749 . . . . 25.0 108.978 176.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.59 163.76 83.28 Favored 'Cis proline' 0 C--N 1.348 0.517 0 C-N-CA 130.666 1.527 . . . . 25.0 111.664 -5.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 8.1 t60 -146.52 27.75 1.1 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 112.908 0.707 . . . . 25.0 112.908 -178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 18.8 t -89.93 -25.69 20.81 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.868 0.692 . . . . 25.0 112.868 -177.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -114.01 172.44 14.34 Favored Glycine 0 C--O 1.227 -0.288 0 N-CA-C 110.338 -1.105 . . . . 25.0 110.338 -179.305 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -79.81 -17.71 10.8 Favored 'Trans proline' 0 C--N 1.346 0.444 0 CA-C-N 119.329 1.564 . . . . 25.0 114.429 -179.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.82 129.53 38.1 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 108.733 -0.84 . . . . 25.0 108.733 -179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -148.07 170.13 18.45 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 106.865 -1.532 . . . . 25.0 106.865 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.44 -32.02 1.17 Allowed Glycine 0 CA--C 1.524 0.636 0 N-CA-C 116.253 1.261 . . . . 25.0 116.253 179.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -124.91 44.04 2.88 Favored 'General case' 0 N--CA 1.469 0.519 0 O-C-N 122.049 -0.677 . . . . 25.0 109.766 179.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 50.2 mm -58.14 -45.09 88.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-N 116.131 -0.486 . . . . 25.0 112.216 -176.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.74 -36.86 83.44 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 113.874 1.064 . . . . 25.0 113.874 -174.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 78.1 p -96.79 -20.88 17.88 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.914 0.709 . . . . 25.0 112.914 -175.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.08 28.33 10.71 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.666 0.786 . . . . 25.0 109.877 -170.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -70.11 -20.08 76.15 Favored Glycine 0 C--O 1.225 -0.423 0 CA-C-N 116.009 -0.541 . . . . 25.0 114.304 -174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -64.98 -21.14 67.49 Favored Glycine 0 C--O 1.223 -0.557 0 C-N-CA 120.867 -0.682 . . . . 25.0 113.494 -179.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.2 mt -65.38 -36.97 85.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.779 0.799 . . . . 25.0 110.621 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -71.18 -12.7 61.62 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.549 -0.751 . . . . 25.0 111.745 -178.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.38 -23.2 53.22 Favored Glycine 0 C--O 1.221 -0.678 0 C-N-CA 121.325 -0.464 . . . . 25.0 113.524 178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.36 -25.12 73.71 Favored Glycine 0 CA--C 1.523 0.547 0 CA-C-N 117.961 0.88 . . . . 25.0 112.49 176.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.1 mm -78.62 -38.21 21.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 177.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -66.61 -29.12 69.09 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.126 -0.488 . . . . 25.0 110.087 179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -68.69 -7.81 36.79 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.646 0.61 . . . . 25.0 112.646 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -68.93 -41.04 78.65 Favored 'General case' 0 CA--C 1.536 0.411 0 N-CA-C 107.922 -1.14 . . . . 25.0 107.922 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 2.5 tm0? -159.89 110.19 1.88 Allowed 'General case' 0 C--O 1.221 -0.423 0 CA-C-O 120.848 0.356 . . . . 25.0 110.646 173.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 47.4 t -152.91 163.55 39.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 105.801 -1.926 . . . . 25.0 105.801 174.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 13.7 mp0 -72.47 -26.41 61.8 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.165 -0.309 . . . . 25.0 110.165 179.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -101.01 20.5 15.42 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 111.76 0.281 . . . . 25.0 111.76 178.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -54.81 147.56 14.75 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 115.861 -0.608 . . . . 25.0 110.624 178.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 6.4 m0 -90.84 151.69 21.05 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.215 -0.661 . . . . 25.0 109.215 -174.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 1.8 p90 -77.51 136.15 38.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 107.699 -1.223 . . . . 25.0 107.699 -179.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -106.12 144.81 32.3 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.133 -0.485 . . . . 25.0 110.105 -173.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -119.05 142.25 48.02 Favored 'General case' 0 C--O 1.218 -0.581 0 N-CA-C 107.962 -1.125 . . . . 25.0 107.962 172.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.1 mt -100.71 136.81 30.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 N-CA-C 107.396 -1.335 . . . . 25.0 107.396 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -139.76 151.57 45.91 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.288 0.477 . . . . 25.0 112.288 177.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.6 p -96.14 172.05 8.22 Favored 'General case' 0 C--O 1.242 0.678 0 N-CA-C 106.863 -1.532 . . . . 25.0 106.863 173.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.46 -172.69 15.37 Favored Glycine 0 C--O 1.24 0.502 0 N-CA-C 117.814 1.886 . . . . 25.0 117.814 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.86 172.04 25.46 Favored Glycine 0 N--CA 1.449 -0.444 0 CA-C-N 113.799 -1.2 . . . . 25.0 111.622 -179.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -76.06 139.23 41.31 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.935 -1.135 . . . . 25.0 107.935 176.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 68.3 m80 -137.3 157.12 47.31 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 178.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.1 m -125.61 127.33 46.16 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 106.347 -1.723 . . . . 25.0 106.347 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -115.03 140.77 48.78 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.898 -0.779 . . . . 25.0 108.898 -175.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.8 m -127.2 133.07 50.33 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.357 -0.609 . . . . 25.0 109.357 -178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.97 150.06 45.24 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.041 -2.207 . . . . 25.0 105.041 178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.5 t -144.43 161.95 37.73 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 118.755 0.707 . . . . 25.0 111.121 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 -121.1 151.83 39.4 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 107.793 -1.188 . . . . 25.0 107.793 178.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -71.85 -14.3 61.92 Favored 'General case' 0 N--CA 1.469 0.478 0 N-CA-C 112.612 0.597 . . . . 25.0 112.612 -177.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.88 160.4 58.6 Favored Pre-proline 0 C--N 1.323 -0.559 0 N-CA-C 104.094 -2.558 . . . . 25.0 104.094 177.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.84 145.89 94.82 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 115.479 -2.547 . . . . 25.0 111.092 176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 33.2 t-80 -108.16 118.18 36.1 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.222 -0.445 . . . . 25.0 110.735 -173.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -62.03 129.56 41.45 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 106.598 -1.63 . . . . 25.0 106.598 175.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 62.2 m -145.64 133.58 21.34 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.745 -0.207 . . . . 25.0 110.834 -170.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.6 p -104.92 -33.62 8.31 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.438 -0.579 . . . . 25.0 109.438 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -163.02 148.55 11.85 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.089 -1.078 . . . . 25.0 108.089 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 14.2 p-90 -142.69 139.07 31.02 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.868 -0.79 . . . . 25.0 108.868 169.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -148.05 159.05 44.32 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.196 -0.456 . . . . 25.0 110.817 -175.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -142.57 145.34 33.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.699 0.762 . . . . 25.0 111.286 -174.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.3 m-85 -127.52 167.45 16.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.794 -1.093 . . . . 25.0 109.211 -171.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.6 pt -133.56 156.84 42.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 108.396 -0.964 . . . . 25.0 108.396 173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 73.5 p -95.48 145.44 25.18 Favored 'General case' 0 C--O 1.243 0.733 0 N-CA-C 109.862 -0.422 . . . . 25.0 109.862 173.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -88.68 113.59 24.41 Favored 'General case' 0 C--O 1.219 -0.51 0 C-N-CA 120.275 -0.57 . . . . 25.0 111.563 176.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 52.0 pttt -77.2 147.93 36.15 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 105.669 -1.975 . . . . 25.0 105.669 166.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.25 15.97 59.79 Favored Glycine 0 C--O 1.222 -0.618 0 N-CA-C 118.076 1.991 . . . . 25.0 118.076 172.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -54.89 147.13 15.87 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 118.68 1.24 . . . . 25.0 113.409 -177.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -77.96 146.69 72.34 Favored Pre-proline 0 C--N 1.324 -0.53 0 N-CA-C 109.051 -0.722 . . . . 25.0 109.051 179.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -72.65 -18.4 25.39 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 118.031 -0.846 . . . . 25.0 113.917 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -71.05 -22.29 62.15 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.183 0.992 . . . . 25.0 110.915 178.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -99.84 147.11 32.98 Favored Pre-proline 0 C--N 1.323 -0.58 0 CA-C-N 115.624 -0.716 . . . . 25.0 109.733 -174.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.2 93.94 0.65 Allowed 'Trans proline' 0 CA--C 1.534 0.486 0 C-N-CA 118.463 -0.558 . . . . 25.0 111.799 178.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . 0.511 HD23 ' H ' ' A' ' 110' ' ' LEU . 0.9 OUTLIER -52.99 -41.31 64.49 Favored 'General case' 0 C--O 1.214 -0.792 0 N-CA-C 114.36 1.244 . . . . 25.0 114.36 -173.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -70.66 -16.41 62.81 Favored 'General case' 0 N--CA 1.465 0.312 0 N-CA-C 113.057 0.762 . . . . 25.0 113.057 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 33.7 ttm180 -85.69 -41.38 15.2 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.356 0.598 . . . . 25.0 109.622 173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -80.79 7.85 9.46 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.654 -1.157 . . . . 25.0 111.943 -176.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.2 -29.03 70.16 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 112.917 0.71 . . . . 25.0 112.917 -169.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.0 m-85 -126.04 144.98 50.51 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 113.018 0.748 . . . . 25.0 113.018 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -127.96 144.64 51.1 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 108.697 -0.853 . . . . 25.0 108.697 167.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.8 tp -82.58 113.69 20.46 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 108.521 -0.918 . . . . 25.0 108.521 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -97.34 -8.62 9.18 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 CA-C-O 121.345 0.593 . . . . 25.0 110.275 -177.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 178.93 149.94 8.57 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.198 -1.001 . . . . 25.0 114.061 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.59 146.86 28.44 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.417 -0.957 . . . . 25.0 108.417 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.1 90.11 6.89 Favored Pre-proline 0 C--O 1.244 0.791 0 CA-C-O 121.23 0.538 . . . . 25.0 110.299 177.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -67.39 162.59 38.15 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 117.751 -1.033 . . . . 25.0 109.752 174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -96.9 91.98 5.89 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.334 -1.728 . . . . 25.0 106.334 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -100.38 2.75 42.68 Favored 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 113.976 -1.465 . . . . 25.0 109.167 -178.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 87.17 -11.42 65.33 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 110.068 -1.213 . . . . 25.0 110.068 -171.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 30.4 t -59.34 141.1 87.8 Favored Pre-proline 0 C--O 1.244 0.792 0 N-CA-C 109.659 -0.497 . . . . 25.0 109.659 176.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.05 -6.63 19.49 Favored 'Trans proline' 0 CA--C 1.51 -0.711 0 C-N-CA 116.94 -1.573 . . . . 25.0 115.295 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.32 -36.17 83.23 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.182 -0.917 . . . . 25.0 109.657 175.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 23.2 t -85.57 -27.87 25.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.97 -0.559 . . . . 25.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 74.1 mtt-85 -69.4 -35.15 75.49 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 109.465 -0.568 . . . . 25.0 109.465 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -77.36 111.23 12.82 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.027 -0.533 . . . . 25.0 110.058 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.25 -13.06 60.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.507 -0.77 . . . . 25.0 112.906 179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.7 t -96.98 121.31 38.72 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.846 -0.798 . . . . 25.0 108.846 -176.012 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 7.4 m170 -133.05 149.42 52.18 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 116.185 -0.461 . . . . 25.0 111.925 -172.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 73.5 m-70 -84.78 135.17 34.23 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-N 115.839 -0.619 . . . . 25.0 109.917 179.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 73.2 mt -134.51 120.62 33.37 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 N-CA-C 106.783 -1.562 . . . . 25.0 106.783 172.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.0 t80 -73.39 140.99 46.99 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.643 0.259 . . . . 25.0 110.724 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.5 mm -119.04 129.89 25.15 Favored Pre-proline 0 CA--C 1.538 0.513 0 N-CA-C 106.731 -1.581 . . . . 25.0 106.731 175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -70.1 148.78 63.62 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 117.355 -1.297 . . . . 25.0 113.227 -179.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.2 tp10 -100.82 -9.4 21.71 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-O 121.654 0.74 . . . . 25.0 109.217 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -112.09 10.56 20.35 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.862 1.06 . . . . 25.0 113.862 -171.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 4.5 mmt180 -132.15 141.61 49.18 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 110.072 -0.344 . . . . 25.0 110.072 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.474 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.4 mp -113.13 153.87 27.54 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.691 -0.686 . . . . 25.0 109.307 176.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 116.74 154.21 10.06 Favored Glycine 0 C--O 1.24 0.5 0 CA-C-O 122.192 0.885 . . . . 25.0 114.97 175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.492 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 42.4 p90 -87.01 146.27 26.18 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.226 0.824 . . . . 25.0 113.226 -177.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 1.7 p-80 -148.95 158.96 44.57 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.965 -1.495 . . . . 25.0 106.965 178.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 166' ' ' ASP . 2.0 t -98.03 143.61 12.58 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-O 120.901 0.381 . . . . 25.0 111.81 -175.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 80.5 mt -111.93 131.26 63.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 105.601 -2.0 . . . . 25.0 105.601 172.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -116.45 140.22 49.6 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 107.216 -1.401 . . . . 25.0 107.216 -178.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -130.09 133.82 46.93 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 107.22 -1.4 . . . . 25.0 107.22 175.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 61.3 t -128.9 130.29 68.45 Favored 'Isoleucine or valine' 0 C--O 1.24 0.571 0 N-CA-C 107.73 -1.211 . . . . 25.0 107.73 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 6.2 t-105 -117.85 116.27 26.64 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.55 -0.75 . . . . 25.0 110.584 -175.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -96.63 131.9 42.81 Favored 'General case' 0 C--O 1.244 0.814 0 CA-C-O 122.123 0.963 . . . . 25.0 110.484 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 61.3 t -126.12 124.2 65.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 106.937 -1.505 . . . . 25.0 106.937 -177.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -73.03 -31.31 64.36 Favored 'General case' 0 C--O 1.219 -0.542 0 CA-C-O 121.192 0.52 . . . . 25.0 109.617 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -67.41 -14.93 63.37 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 116.557 2.058 . . . . 25.0 116.557 -173.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.6 p -129.2 160.42 32.96 Favored 'General case' 0 N--CA 1.467 0.395 0 O-C-N 122.098 -0.376 . . . . 25.0 110.747 -175.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -77.46 -12.2 59.93 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.148 0.499 . . . . 25.0 110.591 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 81.0 m-20 -110.2 160.59 16.37 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.741 0.781 . . . . 25.0 111.121 -176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -121.94 156.54 33.17 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 103.355 -2.831 . . . . 25.0 103.355 175.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -123.81 143.91 50.03 Favored 'General case' 0 C--N 1.318 -0.777 0 N-CA-C 108.806 -0.813 . . . . 25.0 108.806 -169.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -139.01 153.97 48.19 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.056 0.455 . . . . 25.0 111.724 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 25.0 mp0 -134.75 143.68 47.28 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 106.322 -1.733 . . . . 25.0 106.322 178.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.04 129.14 43.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 109.603 -0.518 . . . . 25.0 109.603 -177.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.2 mt -140.21 125.74 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 N-CA-C 108.088 -1.078 . . . . 25.0 108.088 179.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.47 ' HA ' ' HA ' ' A' ' 147' ' ' VAL . 11.7 t70 -87.73 141.63 28.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.605 -0.887 . . . . 25.0 108.605 173.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.6 m -135.45 143.75 35.92 Favored 'Isoleucine or valine' 0 C--O 1.24 0.599 0 CA-C-O 121.098 0.475 . . . . 25.0 109.901 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.492 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 11.0 t0 -97.94 122.15 40.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.032 -1.47 . . . . 25.0 107.032 179.263 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 65.1 mt -115.71 119.4 35.95 Favored 'General case' 0 CA--C 1.507 -0.699 0 N-CA-C 105.878 -1.897 . . . . 25.0 105.878 -175.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.474 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 27.7 m -134.17 162.19 39.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 113.685 0.994 . . . . 25.0 113.685 -170.446 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -73.64 161.22 30.53 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 106.443 -1.688 . . . . 25.0 106.443 172.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 57.9 mtpt . . . . . 0 C--O 1.246 0.909 0 CA-C-O 117.841 -1.076 . . . . 25.0 109.214 172.544 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 28.4 m170 . . . . . 0 N--CA 1.488 1.436 0 CA-C-O 120.576 0.227 . . . . 25.0 110.493 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 174.68 -165.96 37.53 Favored Glycine 0 CA--C 1.506 -0.479 1 N-CA-C 101.837 -4.505 . . . . 25.0 101.837 -175.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -158.2 163.65 37.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 119.374 1.587 . . . . 25.0 111.046 177.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 40.9 mm -92.36 114.19 28.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 N-CA-C 105.569 -2.011 . . . . 25.0 105.569 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -72.81 -40.92 65.44 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.533 -0.914 . . . . 25.0 108.533 -178.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -153.35 131.59 6.44 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.152 -0.476 . . . . 25.0 109.744 177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -65.47 140.81 46.59 Favored 'Cis proline' 0 C--N 1.352 0.724 0 CA-C-N 118.62 0.543 . . . . 25.0 112.476 0.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -56.93 154.51 18.29 Favored Glycine 0 C--O 1.242 0.625 0 CA-C-N 116.019 -0.537 . . . . 25.0 113.767 -177.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 95.6 p -61.91 152.88 30.72 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.598 0.713 . . . . 25.0 112.744 -175.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -65.1 -17.08 64.16 Favored 'General case' 0 C--O 1.215 -0.736 0 CA-C-N 115.964 -0.562 . . . . 25.0 112.078 178.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.18 -32.34 68.14 Favored 'General case' 0 C--O 1.219 -0.542 0 C-N-CA 122.617 0.367 . . . . 25.0 111.849 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.84 -35.3 77.84 Favored 'General case' 0 CA--C 1.537 0.481 0 CA-C-O 120.972 0.415 . . . . 25.0 111.275 178.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.8 mp -92.02 -4.04 55.02 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.982 0.42 . . . . 25.0 110.941 -178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 52.2 t -91.8 -16.03 27.4 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.369 -0.975 . . . . 25.0 108.369 179.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 41.0 t -63.87 145.52 55.67 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.861 -0.609 . . . . 25.0 109.695 178.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 38.6 mp0 -63.79 -19.48 65.04 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.881 -0.599 . . . . 25.0 110.251 179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.46 -22.19 63.2 Favored 'General case' 0 CA--C 1.539 0.556 0 O-C-N 121.798 -0.564 . . . . 25.0 111.759 175.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -91.96 -1.73 57.12 Favored 'General case' 0 CA--C 1.545 0.758 0 N-CA-C 113.619 0.97 . . . . 25.0 113.619 -177.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -179.3 -30.11 0.05 OUTLIER Glycine 0 N--CA 1.461 0.326 0 N-CA-C 116.286 1.274 . . . . 25.0 116.286 -178.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 65.35 -45.16 0.36 Allowed 'General case' 0 N--CA 1.483 1.189 0 N-CA-C 118.027 2.603 . . . . 25.0 118.027 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 87.1 mt -78.01 -21.12 51.28 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 121.898 -0.502 . . . . 25.0 112.347 -176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 59.1 m-80 -149.06 153.17 37.45 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.822 -0.807 . . . . 25.0 108.822 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.07 156.95 42.58 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 107.953 -1.128 . . . . 25.0 107.953 175.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -153.37 83.07 1.18 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.743 0.782 . . . . 25.0 110.68 -178.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.1 m -75.76 -39.08 57.72 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.456 -0.793 . . . . 25.0 112.608 177.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 69.28 172.65 8.79 Favored Glycine 0 C--O 1.221 -0.715 0 C-N-CA 121.611 -0.328 . . . . 25.0 112.927 -178.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 39.1 t -63.69 -27.96 69.57 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-O 122.259 1.028 . . . . 25.0 110.704 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.2 t -60.16 -13.03 4.99 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-N 114.748 -1.115 . . . . 25.0 112.658 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.4 ptm -65.31 -19.94 66.18 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.419 0.896 . . . . 25.0 113.419 177.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 70.0 t80 -75.53 -45.77 36.1 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 118.239 0.472 . . . . 25.0 111.018 -173.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -154.97 89.79 3.08 Favored Pre-proline 0 C--N 1.325 -0.467 0 N-CA-C 113.1 0.778 . . . . 25.0 113.1 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_endo -70.61 1.46 4.97 Favored 'Trans proline' 0 CA--C 1.537 0.649 0 N-CA-C 113.22 0.431 . . . . 25.0 113.22 178.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -100.14 -7.87 24.32 Favored 'General case' 0 CA--C 1.543 0.687 0 N-CA-C 114.252 1.205 . . . . 25.0 114.252 178.276 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 6.9 t -132.99 129.94 38.84 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.924 1.824 . . . . 25.0 115.924 -175.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 94.8 mt -120.62 140.47 51.5 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.069 -2.197 . . . . 25.0 105.069 161.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -84.03 118.33 23.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 118.555 0.616 . . . . 25.0 109.858 179.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -142.86 158.1 43.95 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 107.75 -1.204 . . . . 25.0 107.75 177.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 11.8 tttt -130.53 169.01 16.13 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.4 0.619 . . . . 25.0 110.223 178.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 58.6 mttp -73.9 164.08 27.09 Favored 'General case' 0 C--O 1.221 -0.436 0 N-CA-C 104.023 -2.584 . . . . 25.0 104.023 172.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -71.95 23.77 0.7 Allowed Glycine 0 CA--C 1.528 0.874 0 N-CA-C 116.664 1.426 . . . . 25.0 116.664 -176.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 41.1 m-85 -107.58 134.23 20.1 Favored Pre-proline 0 CA--C 1.539 0.556 0 N-CA-C 109.07 -0.715 . . . . 25.0 109.07 177.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -79.58 145.09 73.05 Favored 'Cis proline' 0 C--N 1.346 0.416 0 C-N-CA 129.731 1.138 . . . . 25.0 112.472 -4.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -74.16 2.8 8.22 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 112.651 0.612 . . . . 25.0 112.651 179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.2 t -92.27 -9.5 41.84 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.881 -0.6 . . . . 25.0 111.543 -177.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.32 -164.37 32.08 Favored Glycine 0 N--CA 1.453 -0.215 0 N-CA-C 109.834 -1.306 . . . . 25.0 109.834 178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -69.21 165.53 30.02 Favored 'Trans proline' 0 C--N 1.345 0.368 0 CA-C-N 118.959 1.379 . . . . 25.0 110.804 175.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -65.35 131.59 46.86 Favored 'General case' 0 C--N 1.322 -0.609 0 C-N-CA 120.731 -0.387 . . . . 25.0 110.665 -178.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -145.03 157.2 44.19 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 104.574 -2.38 . . . . 25.0 104.574 175.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.83 10.12 54.55 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 121.68 -0.295 . . . . 25.0 113.528 -175.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -68.49 -8.96 45.68 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 113.106 0.78 . . . . 25.0 113.106 -174.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 71.7 mt -66.81 -29.52 46.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 175.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.38 -28.26 69.57 Favored 'General case' 0 CA--C 1.542 0.653 0 O-C-N 121.982 -0.449 . . . . 25.0 111.847 178.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 64.0 p -101.09 12.51 37.49 Favored 'General case' 0 C--O 1.243 0.755 0 CA-C-O 121.291 0.567 . . . . 25.0 109.953 177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.14 15.99 3.61 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.592 1.557 . . . . 25.0 114.095 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.29 -37.21 42.67 Favored Glycine 0 C--O 1.227 -0.291 0 C-N-CA 120.62 -0.8 . . . . 25.0 111.921 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.32 -2.8 68.57 Favored Glycine 0 C--O 1.224 -0.531 0 N-CA-C 115.611 1.005 . . . . 25.0 115.611 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.37 -26.94 68.69 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-N 118.234 1.017 . . . . 25.0 112.099 -177.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -64.19 -23.69 67.4 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.536 -0.466 . . . . 25.0 111.262 177.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -73.18 -26.05 71.67 Favored Glycine 0 C--O 1.223 -0.547 0 C-N-CA 120.771 -0.728 . . . . 25.0 111.852 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.38 -23.7 73.48 Favored Glycine 0 C--O 1.227 -0.287 0 C-N-CA 121.025 -0.607 . . . . 25.0 112.008 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.1 mm -67.25 -28.22 41.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 178.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.3 mp -88.05 -38.6 15.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.725 -0.472 . . . . 25.0 109.725 175.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -60.64 -38.27 84.26 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 120.91 0.386 . . . . 25.0 112.005 -176.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.8 pt20 -64.68 -0.19 1.34 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 114.052 1.13 . . . . 25.0 114.052 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 22.6 pt20 -143.65 34.85 1.28 Allowed 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 122.766 0.426 . . . . 25.0 110.157 176.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.2 t -115.94 172.29 7.24 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-O 120.979 0.418 . . . . 25.0 111.804 -177.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 18.4 tp10 -70.46 -38.35 74.43 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.555 0.693 . . . . 25.0 110.557 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -79.99 5.44 14.03 Favored 'General case' 0 N--CA 1.468 0.444 0 N-CA-C 112.751 0.649 . . . . 25.0 112.751 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 53.2 ttp180 -52.74 149.87 5.76 Favored 'General case' 0 N--CA 1.466 0.338 0 N-CA-C 114.044 1.128 . . . . 25.0 114.044 -175.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 2.5 p90 -70.28 158.51 35.75 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 114.635 -1.166 . . . . 25.0 110.92 -178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.5 p90 -84.33 151.51 24.69 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 121.825 -0.547 . . . . 25.0 111.155 -176.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.9 ttpt -120.52 143.29 48.64 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.313 -0.403 . . . . 25.0 111.2 178.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -121.1 150.97 40.41 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 106.612 -1.625 . . . . 25.0 106.612 171.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -96.2 143.0 12.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 105.178 -2.156 . . . . 25.0 105.178 176.49 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.6 ttt -150.7 164.31 36.45 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 110.421 -0.215 . . . . 25.0 110.421 -176.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.2 p -110.2 172.48 6.84 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 105.775 -1.935 . . . . 25.0 105.775 174.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.97 -168.67 6.9 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 116.318 1.287 . . . . 25.0 116.318 -177.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.68 -179.14 26.45 Favored Glycine 0 CA--C 1.521 0.417 0 O-C-N 122.519 -0.401 . . . . 25.0 113.371 -179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 65.6 mt-10 -73.08 133.65 44.25 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.748 -0.854 . . . . 25.0 109.615 176.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.4 m170 -125.77 137.79 53.82 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 110.047 -0.353 . . . . 25.0 110.047 -178.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.7 m -102.56 125.54 49.33 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.492 -0.559 . . . . 25.0 109.492 -178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -112.83 130.12 56.2 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 107.01 -1.478 . . . . 25.0 107.01 178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.5 m -137.98 135.1 35.66 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.78 -0.191 . . . . 25.0 110.565 -176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.3 m0 -122.42 150.08 42.96 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 106.47 -1.678 . . . . 25.0 106.47 175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.4 t -144.96 158.58 43.76 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.644 -0.872 . . . . 25.0 108.644 174.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -125.66 151.04 47.07 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.656 -0.868 . . . . 25.0 108.656 -178.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 75.2 p -72.4 -16.87 61.84 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.992 0.425 . . . . 25.0 111.347 -176.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.87 141.1 23.13 Favored Pre-proline 0 C--O 1.24 0.556 0 N-CA-C 105.654 -1.98 . . . . 25.0 105.654 174.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -72.07 146.88 47.65 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 117.167 -1.422 . . . . 25.0 112.896 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -131.12 157.08 44.09 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.185 -0.672 . . . . 25.0 109.185 177.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -76.99 144.67 38.56 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.312 -0.625 . . . . 25.0 109.312 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 33.0 m -128.28 130.11 47.37 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.415 -0.957 . . . . 25.0 108.415 -177.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.5 t -89.75 -44.29 10.1 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.681 0.753 . . . . 25.0 109.771 177.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 11.7 tt0 -158.13 155.69 29.59 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.418 -0.956 . . . . 25.0 108.418 -177.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.0 p-90 -146.86 141.23 26.38 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 107.701 -1.222 . . . . 25.0 107.701 168.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.1 p80 -148.4 159.75 43.71 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.391 -0.368 . . . . 25.0 111.368 -170.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 91.2 m-85 -130.1 141.0 50.74 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.7 0.625 . . . . 25.0 110.444 -177.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -126.68 162.87 24.76 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 16.5 pt -132.4 139.43 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 N-CA-C 110.271 -0.27 . . . . 25.0 110.271 175.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 41.8 m -85.01 130.75 34.57 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-O 120.903 0.382 . . . . 25.0 110.339 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 30.8 mtpt -88.08 125.02 34.35 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.817 0.673 . . . . 25.0 112.817 -178.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -75.1 140.21 43.29 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 166.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 85.21 21.32 55.22 Favored Glycine 0 C--O 1.221 -0.666 0 N-CA-C 116.06 1.184 . . . . 25.0 116.06 173.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -57.09 154.18 10.35 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 118.226 1.013 . . . . 25.0 111.777 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 37.8 m-20 -68.08 119.24 65.82 Favored Pre-proline 0 CA--C 1.534 0.357 0 N-CA-C 109.566 -0.531 . . . . 25.0 109.566 178.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -75.94 -15.84 18.52 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 117.163 -1.425 . . . . 25.0 113.51 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -75.72 -15.62 60.27 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 122.393 1.092 . . . . 25.0 110.744 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -105.01 153.79 39.17 Favored Pre-proline 0 C--N 1.325 -0.497 0 N-CA-C 106.606 -1.627 . . . . 25.0 106.606 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -63.98 128.44 21.87 Favored 'Trans proline' 0 C--O 1.235 0.373 0 C-N-CA 115.058 -2.828 . . . . 25.0 112.215 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 9.3 tt -53.67 -38.01 63.73 Favored 'General case' 0 C--O 1.216 -0.704 0 CA-C-N 115.402 -0.817 . . . . 25.0 111.895 -176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -58.18 -18.81 28.41 Favored 'General case' 0 N--CA 1.471 0.625 0 N-CA-C 114.036 1.125 . . . . 25.0 114.036 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 7.5 mpt_? -101.61 -42.99 6.02 Favored 'General case' 0 C--O 1.217 -0.654 0 O-C-N 122.098 -0.376 . . . . 25.0 111.735 174.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -76.27 -16.04 59.88 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.92 1.082 . . . . 25.0 113.92 -171.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.95 -38.69 83.13 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 114.848 1.425 . . . . 25.0 114.848 -174.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -130.46 161.97 30.22 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 116.413 2.005 . . . . 25.0 116.413 -174.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -128.51 149.68 50.49 Favored 'General case' 0 N--CA 1.467 0.407 0 N-CA-C 107.507 -1.294 . . . . 25.0 107.507 172.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.0 tp -85.56 112.93 21.4 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 107.169 -1.419 . . . . 25.0 107.169 173.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.0 tt -91.16 -12.07 9.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-O 121.204 0.526 . . . . 25.0 110.327 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 168.22 158.72 12.61 Favored Glycine 0 CA--C 1.509 -0.287 0 C-N-CA 119.832 -1.175 . . . . 25.0 114.707 173.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -145.93 146.58 31.11 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.496 -1.298 . . . . 25.0 107.496 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -144.26 107.75 4.87 Favored Pre-proline 0 CA--C 1.551 0.986 0 N-CA-C 109.619 -0.512 . . . . 25.0 109.619 179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -86.64 177.26 4.32 Favored 'Trans proline' 0 C--O 1.24 0.575 0 N-CA-C 114.066 0.756 . . . . 25.0 114.066 -178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -104.08 91.53 3.99 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 104.812 -2.292 . . . . 25.0 104.812 171.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -156.44 71.42 0.7 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.062 0.458 . . . . 25.0 110.675 -174.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 61.76 13.35 39.09 Favored Glycine 0 CA--C 1.521 0.438 0 CA-C-N 116.037 -0.529 . . . . 25.0 114.204 -176.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.97 145.73 97.66 Favored Pre-proline 0 C--N 1.322 -0.604 0 O-C-N 122.568 -0.372 . . . . 25.0 111.135 -174.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -69.55 -175.63 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 121.784 1.656 . . . . 25.0 113.897 -176.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -52.47 -26.2 12.23 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 113.02 0.748 . . . . 25.0 113.02 -179.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.1 m -57.36 -8.9 0.86 Allowed 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 114.145 1.165 . . . . 25.0 114.145 174.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 44.3 ttp85 -76.27 3.63 10.45 Favored 'General case' 0 N--CA 1.47 0.564 0 O-C-N 121.729 -0.607 . . . . 25.0 111.707 175.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -58.7 150.45 23.44 Favored 'General case' 0 N--CA 1.471 0.589 0 N-CA-C 108.949 -0.76 . . . . 25.0 108.949 177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -66.95 -7.02 19.18 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 113.687 0.995 . . . . 25.0 113.687 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.3 t -97.94 122.65 41.32 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.141 -1.8 . . . . 25.0 106.141 175.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -131.4 151.06 51.88 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-O 121.207 0.527 . . . . 25.0 110.958 -175.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 87.9 m-70 -105.92 138.51 41.97 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 107.67 -1.233 . . . . 25.0 107.67 179.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.5 mm -127.01 123.0 61.52 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 N-CA-C 105.29 -2.115 . . . . 25.0 105.29 176.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -80.56 133.98 35.86 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 107.694 -1.224 . . . . 25.0 107.694 176.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 31.9 mm -125.88 118.6 24.06 Favored Pre-proline 0 C--O 1.239 0.509 0 N-CA-C 108.14 -1.059 . . . . 25.0 108.14 175.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -71.03 155.29 61.95 Favored 'Trans proline' 0 C--N 1.345 0.384 0 C-N-CA 115.736 -2.376 . . . . 25.0 110.715 175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -104.79 55.03 0.71 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 107.463 -1.31 . . . . 25.0 107.463 178.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -84.73 -36.31 21.88 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.743 -0.662 . . . . 25.0 112.367 -175.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 49.5 mtm180 -151.7 159.21 44.08 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 121.259 0.552 . . . . 25.0 110.786 -177.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.5 pt? -91.62 143.87 26.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 114.987 -1.006 . . . . 25.0 110.25 178.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 155.31 152.0 6.04 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-O 121.839 0.688 . . . . 25.0 113.739 178.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.517 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 35.0 p90 -80.04 146.3 32.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.597 0.713 . . . . 25.0 111.984 -179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -136.27 128.52 29.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 105.766 -1.939 . . . . 25.0 105.766 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 42.6 t -95.01 125.57 47.62 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 105.675 -1.972 . . . . 25.0 105.675 178.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 76.7 mt -96.21 119.73 44.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 56.7 mt -103.98 109.01 20.61 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 106.549 -1.648 . . . . 25.0 106.549 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -113.04 146.77 38.54 Favored 'General case' 0 C--N 1.319 -0.748 0 O-C-N 122.03 -0.419 . . . . 25.0 110.507 -175.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 57.5 t -128.14 134.25 65.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.955 -0.566 . . . . 25.0 109.652 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.2 t90 -121.24 106.42 11.49 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.34 -0.985 . . . . 25.0 108.34 177.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -87.01 88.04 7.61 Favored 'General case' 0 C--O 1.245 0.823 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 7.4 p -68.71 138.37 22.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 107.286 -1.376 . . . . 25.0 107.286 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -94.53 -13.69 25.82 Favored 'General case' 0 C--O 1.218 -0.558 0 O-C-N 122.068 -0.395 . . . . 25.0 111.274 -176.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -77.26 -12.24 59.92 Favored 'General case' 0 N--CA 1.47 0.539 0 N-CA-C 113.385 0.883 . . . . 25.0 113.385 -176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 47.0 p -140.18 170.59 15.55 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 112.89 0.7 . . . . 25.0 112.89 -175.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 12.3 tt0 -85.04 13.49 6.05 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.567 0.747 . . . . 25.0 110.317 176.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -109.91 163.51 13.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -141.95 139.35 32.46 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 100.376 -3.935 . . . . 25.0 100.376 174.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -117.99 152.01 36.33 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.276 0.56 . . . . 25.0 110.921 -172.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -121.68 140.81 51.82 Favored 'General case' 0 N--CA 1.446 -0.64 0 CA-C-N 114.565 -1.198 . . . . 25.0 108.381 -176.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 3.0 mp0 -128.23 126.2 40.46 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 104.651 -2.351 . . . . 25.0 104.651 178.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.0 m -124.13 131.4 72.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.485 -0.561 . . . . 25.0 109.485 -175.411 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 67.6 mt -138.38 123.73 23.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.971 -1.122 . . . . 25.0 107.971 -177.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.9 t0 -92.41 138.65 31.33 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.517 -1.29 . . . . 25.0 107.517 176.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.87 126.07 46.68 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 N-CA-C 108.829 -0.804 . . . . 25.0 108.829 177.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 2.1 t0 -93.29 95.84 9.6 Favored 'General case' 0 CA--C 1.509 -0.604 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 -179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -83.46 124.75 31.01 Favored 'General case' 0 CA--C 1.499 -1.012 0 N-CA-C 107.291 -1.374 . . . . 25.0 107.291 -178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.2 m -134.0 158.41 42.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 N-CA-C 112.68 0.622 . . . . 25.0 112.68 179.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.8 m120 -94.92 161.72 14.03 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 106.773 -1.565 . . . . 25.0 106.773 174.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.244 0.815 0 CA-C-O 118.35 -0.833 . . . . 25.0 109.138 172.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 . . . . . 0 N--CA 1.491 1.592 0 N-CA-C 110.249 -0.278 . . . . 25.0 110.249 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.67 157.33 33.14 Favored Glycine 0 C--O 1.234 0.119 0 N-CA-C 110.699 -0.96 . . . . 25.0 110.699 -176.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -166.32 164.17 17.56 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.127 0.571 . . . . 25.0 110.427 -175.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.0 mt -93.91 128.12 45.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 105.284 -2.117 . . . . 25.0 105.284 170.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -94.6 -46.56 6.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.086 0.47 . . . . 25.0 110.238 179.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -145.97 157.1 51.02 Favored Pre-proline 0 N--CA 1.471 0.617 0 CA-C-N 115.909 -0.587 . . . . 25.0 109.5 -175.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -78.53 132.38 26.12 Favored 'Cis proline' 0 CA--C 1.535 0.549 0 C-N-CA 130.312 1.38 . . . . 25.0 115.647 -0.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.51 -172.19 35.74 Favored Glycine 0 C--O 1.221 -0.695 0 CA-C-N 115.636 -0.711 . . . . 25.0 113.713 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.0 t -150.92 150.34 30.72 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.931 -1.137 . . . . 25.0 107.931 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 55.4 ptt85 -74.74 -21.02 59.58 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 111.907 0.336 . . . . 25.0 111.907 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.3 -31.17 68.89 Favored 'General case' 0 C--O 1.22 -0.479 0 N-CA-C 113.043 0.757 . . . . 25.0 113.043 -173.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.68 -27.81 68.95 Favored 'General case' 0 C--O 1.218 -0.563 0 N-CA-C 112.634 0.605 . . . . 25.0 112.634 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.1 mp -91.82 -10.5 39.61 Favored 'General case' 0 C--O 1.22 -0.495 0 CA-C-O 120.809 0.338 . . . . 25.0 111.273 -178.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 48.3 t -99.2 -11.49 21.29 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.515 0.674 . . . . 25.0 110.044 -177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.4 t -67.79 151.95 46.37 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.329 0.585 . . . . 25.0 110.553 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.414 ' H ' ' CD ' ' A' ' 16' ' ' GLU . 37.6 mp0 -63.74 -28.45 69.89 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 108.529 -0.915 . . . . 25.0 108.529 177.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.19 -12.98 59.41 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.578 -0.737 . . . . 25.0 112.655 178.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -83.03 2.1 36.71 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 111.918 0.34 . . . . 25.0 111.918 -178.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.52 5.7 1.07 Allowed Glycine 0 N--CA 1.463 0.497 0 N-CA-C 116.033 1.173 . . . . 25.0 116.033 176.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.8 t80 55.87 25.61 8.75 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 114.123 1.157 . . . . 25.0 114.123 178.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.8 mt -68.96 -39.47 79.45 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 107.738 -1.208 . . . . 25.0 107.738 176.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 57.84 25.16 11.67 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 114.658 -1.156 . . . . 25.0 113.636 175.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.25 157.0 46.26 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.7 -0.682 . . . . 25.0 110.239 178.134 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.9 t30 51.3 77.01 0.14 Allowed 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 116.602 2.075 . . . . 25.0 116.602 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 99.6 m -92.19 17.67 9.28 Favored 'General case' 0 C--O 1.242 0.681 0 CA-C-N 115.513 -0.767 . . . . 25.0 110.877 169.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 76.71 161.09 11.56 Favored Glycine 0 CA--C 1.52 0.404 0 CA-C-N 116.305 -0.407 . . . . 25.0 113.595 -178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.6 t -57.55 -29.01 64.05 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 121.361 0.6 . . . . 25.0 110.756 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -57.73 -12.08 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 114.394 1.257 . . . . 25.0 114.394 178.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 23.6 ptt? -72.15 -27.42 62.59 Favored 'General case' 0 C--N 1.328 -0.34 0 O-C-N 121.43 -0.794 . . . . 25.0 110.691 174.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 57.9 t80 -92.51 -36.18 13.2 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.366 0.603 . . . . 25.0 109.976 178.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.1 pt-20 -118.88 72.39 11.33 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-O 121.427 0.632 . . . . 25.0 111.375 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -70.98 -26.87 21.37 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 116.159 -2.094 . . . . 25.0 115.021 -176.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.21 -8.76 12.93 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 115.798 1.777 . . . . 25.0 115.798 -177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 32.6 t -86.36 94.05 9.26 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 121.543 -0.723 . . . . 25.0 111.06 -169.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 9.4 mp -117.1 80.02 1.42 Allowed 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 116.492 -0.322 . . . . 25.0 111.365 178.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -142.38 126.55 17.47 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 109.796 -0.446 . . . . 25.0 109.796 169.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 134.59 38.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.657 -0.498 . . . . 25.0 109.657 176.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt -63.79 137.09 57.91 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.448 -0.782 . . . . 25.0 109.232 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -66.53 135.51 54.3 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.267 -0.424 . . . . 25.0 110.451 -178.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.21 157.85 22.99 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 117.618 1.807 . . . . 25.0 117.618 173.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 53.0 p90 -94.67 156.52 38.24 Favored Pre-proline 0 CA--C 1.543 0.691 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 174.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.42 147.99 85.05 Favored 'Cis proline' 0 C--N 1.35 0.657 0 C-N-CA 130.39 1.412 . . . . 25.0 112.624 1.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -144.56 12.09 1.49 Allowed 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.994 0.739 . . . . 25.0 112.994 -175.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 68.63 -54.06 0.55 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.216 1.406 . . . . 25.0 112.196 -173.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -81.19 -176.62 51.06 Favored Glycine 0 C--O 1.243 0.714 0 N-CA-C 110.147 -1.181 . . . . 25.0 110.147 172.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -68.86 159.38 54.06 Favored 'Trans proline' 0 C--N 1.344 0.33 0 CA-C-N 118.503 1.152 . . . . 25.0 112.895 -179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.89 120.12 21.59 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.912 -0.773 . . . . 25.0 108.912 178.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.403 ' CG ' ' H ' ' A' ' 49' ' ' GLY . 41.5 t0 -135.82 -179.41 5.63 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.648 -0.501 . . . . 25.0 109.648 178.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.403 ' H ' ' CG ' ' A' ' 48' ' ' ASP . . . 89.94 -9.52 76.99 Favored Glycine 0 C--O 1.228 -0.233 0 N-CA-C 108.602 -1.799 . . . . 25.0 108.602 -173.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.0 mm-40 -86.59 42.79 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.647 0.779 . . . . 25.0 110.267 -178.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 88.8 mt -65.28 -39.71 86.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.591 -0.731 . . . . 25.0 109.232 -179.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.0 -31.22 72.3 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.055 0.455 . . . . 25.0 111.758 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 13.7 m -91.11 -3.51 57.05 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.466 -0.334 . . . . 25.0 110.881 178.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 52.76 37.52 24.05 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.31 1.044 . . . . 25.0 111.414 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.31 -42.07 2.1 Favored Glycine 0 C--O 1.223 -0.554 0 CA-C-N 115.804 -0.634 . . . . 25.0 113.458 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.17 -15.82 80.92 Favored Glycine 0 C--O 1.226 -0.404 0 C-N-CA 120.942 -0.647 . . . . 25.0 113.254 -177.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -61.03 -28.3 68.95 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.958 0.409 . . . . 25.0 111.935 -178.065 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -68.46 -24.0 64.66 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 122.218 -0.301 . . . . 25.0 111.538 178.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -74.78 -30.26 59.93 Favored Glycine 0 C--O 1.226 -0.351 0 N-CA-C 110.205 -1.158 . . . . 25.0 110.205 175.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.69 -20.63 74.26 Favored Glycine 0 C--O 1.224 -0.489 0 C-N-CA 121.272 -0.489 . . . . 25.0 112.409 178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -66.13 -42.86 92.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 108.192 -1.04 . . . . 25.0 108.192 176.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -73.64 -32.05 63.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.028 -0.533 . . . . 25.0 110.878 -179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -63.37 -26.89 68.96 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.802 -0.359 . . . . 25.0 111.785 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -64.16 -7.59 9.54 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 113.455 0.909 . . . . 25.0 113.455 -179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -132.07 27.22 4.54 Favored 'General case' 0 CA--C 1.548 0.886 0 CA-C-O 121.055 0.455 . . . . 25.0 110.606 172.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.7 t -87.99 157.85 18.8 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.119 0.485 . . . . 25.0 111.748 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -64.97 -41.71 95.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.938 -0.573 . . . . 25.0 110.012 175.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.0 m-80 -102.73 24.39 10.64 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.671 0.748 . . . . 25.0 111.161 -175.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.3 ttp180 -55.08 154.57 5.41 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.655 -1.157 . . . . 25.0 110.053 175.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 85.8 m95 -80.11 156.15 27.17 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.826 0.822 . . . . 25.0 109.961 -177.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -62.1 141.0 58.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.664 -0.698 . . . . 25.0 111.412 -174.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 21.9 mtmt -112.93 134.59 54.37 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.022 -0.536 . . . . 25.0 110.69 -177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 -127.23 149.36 50.03 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 111.8 0.296 . . . . 25.0 111.8 172.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.2 tt -92.55 137.58 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 173.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.2 ttt -150.97 167.0 28.95 Favored 'General case' 0 C--O 1.216 -0.676 0 N-CA-C 108.389 -0.967 . . . . 25.0 108.389 -177.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 47.7 p -101.45 170.86 7.93 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 106.77 -1.567 . . . . 25.0 106.77 172.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.39 -166.08 11.0 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.066 -0.588 . . . . 25.0 113.321 176.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 103.94 179.47 25.39 Favored Glycine 0 N--CA 1.46 0.255 0 N-CA-C 112.16 -0.376 . . . . 25.0 112.16 179.187 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.545 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 16.9 tt0 -73.79 133.03 43.19 Favored 'General case' 0 C--N 1.324 -0.542 0 O-C-N 121.759 -0.848 . . . . 25.0 109.365 178.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.6 m170 -125.33 155.2 40.64 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 31.3 m -106.25 125.23 50.74 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.106 -1.072 . . . . 25.0 108.106 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 19.2 m-85 -105.68 122.14 45.43 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.219 -2.141 . . . . 25.0 105.219 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -126.07 109.24 12.17 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.73 -0.47 . . . . 25.0 109.73 -173.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 22.0 m0 -122.93 140.85 52.56 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 102.767 -3.049 . . . . 25.0 102.767 177.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -145.04 123.58 12.44 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.65 -0.5 . . . . 25.0 109.65 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 71.9 m-85 -126.69 118.99 25.88 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 108.747 -0.835 . . . . 25.0 108.747 -179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.3 t -88.36 -6.37 57.75 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.821 -1.081 . . . . 25.0 111.922 -174.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.73 130.7 54.56 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 177.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.87 119.61 6.45 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 115.903 -2.265 . . . . 25.0 112.794 -178.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.04 136.06 48.13 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.81 -0.632 . . . . 25.0 109.821 174.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 67.6 m-20 -84.24 149.93 25.78 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 105.317 -2.105 . . . . 25.0 105.317 169.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.3 m -137.11 152.55 50.12 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 104.645 -2.354 . . . . 25.0 104.645 -176.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 50.6 p -93.03 -41.57 9.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.847 -1.168 . . . . 25.0 107.847 173.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.0 pt20 -167.57 169.3 12.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.518 -0.31 . . . . 25.0 110.44 178.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 13.4 p90 -144.85 146.99 32.32 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 107.121 -1.437 . . . . 25.0 107.121 163.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 -148.08 159.2 44.16 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 109.267 -0.642 . . . . 25.0 109.267 -175.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -138.46 151.35 47.33 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.533 0.683 . . . . 25.0 112.604 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 24.2 m-85 -132.35 163.95 27.54 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 114.883 -1.053 . . . . 25.0 108.533 -176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.4 pt -132.52 152.43 36.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 N-CA-C 107.685 -1.228 . . . . 25.0 107.685 171.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 35.6 p -80.84 126.13 30.95 Favored 'General case' 0 C--O 1.242 0.676 0 CA-C-O 120.906 0.384 . . . . 25.0 110.403 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -87.99 115.73 25.66 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 107.755 -1.202 . . . . 25.0 107.755 177.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.2 mmmt -81.28 154.03 26.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 107.311 -1.366 . . . . 25.0 107.311 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 103.33 10.98 34.84 Favored Glycine 0 N--CA 1.459 0.192 0 N-CA-C 116.863 1.505 . . . . 25.0 116.863 174.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.4 p90 -62.56 155.02 27.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 118.263 1.031 . . . . 25.0 109.717 176.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -127.79 158.46 70.3 Favored Pre-proline 0 C--N 1.321 -0.632 0 N-CA-C 104.185 -2.524 . . . . 25.0 104.185 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_endo -70.21 -14.9 35.19 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 117.646 -1.102 . . . . 25.0 113.508 178.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -65.58 -29.22 69.8 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 122.866 1.317 . . . . 25.0 108.801 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.5 mttt -96.03 145.25 29.22 Favored Pre-proline 0 C--N 1.322 -0.589 0 N-CA-C 106.797 -1.557 . . . . 25.0 106.797 -179.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -68.37 104.6 1.11 Allowed 'Trans proline' 0 CA--C 1.534 0.508 0 C-N-CA 116.325 -1.983 . . . . 25.0 110.814 175.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.9 tt -52.99 -42.62 65.75 Favored 'General case' 0 C--O 1.213 -0.832 0 N-CA-C 113.386 0.884 . . . . 25.0 113.386 -170.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -59.88 -35.28 74.49 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.95 0.722 . . . . 25.0 112.95 -179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.1 mpp_? -77.19 -38.75 50.91 Favored 'General case' 0 C--O 1.213 -0.865 0 O-C-N 122.074 -0.391 . . . . 25.0 111.25 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -77.6 -8.69 58.23 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.842 1.053 . . . . 25.0 113.842 -172.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.3 t70 -69.83 -36.79 75.87 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.959 1.096 . . . . 25.0 113.959 -175.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -128.73 162.06 28.28 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 114.171 1.174 . . . . 25.0 114.171 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 45.0 mm-40 -130.07 146.38 51.73 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.015 -1.105 . . . . 25.0 108.015 172.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.0 tp -80.8 115.14 20.14 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 106.916 -1.513 . . . . 25.0 106.916 175.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.1 tp -95.12 -6.99 9.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.498 0.666 . . . . 25.0 109.966 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.82 159.53 11.34 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.68 -0.771 . . . . 25.0 113.568 173.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.17 143.76 28.46 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.781 -1.192 . . . . 25.0 107.781 179.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 47.0 t -134.27 98.78 13.76 Favored Pre-proline 0 C--O 1.242 0.662 0 N-CA-C 108.061 -1.088 . . . . 25.0 108.061 178.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -75.25 159.99 39.82 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 115.45 -2.567 . . . . 25.0 110.475 176.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 30.4 t-80 -104.05 91.2 3.85 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 104.574 -2.38 . . . . 25.0 104.574 179.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -104.49 -25.01 12.95 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.245 -0.889 . . . . 25.0 109.827 -177.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 134.17 -151.24 20.21 Favored Glycine 0 C--O 1.241 0.57 0 N-CA-C 107.709 -2.157 . . . . 25.0 107.709 -175.194 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 15.6 m 61.71 168.44 0.09 OUTLIER Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.852 0.861 . . . . 25.0 112.873 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -73.71 0.18 8.54 Favored 'Trans proline' 0 C--N 1.354 0.866 0 C-N-CA 114.288 -3.341 . . . . 25.0 114.262 179.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.82 -37.46 87.7 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 115.405 -0.816 . . . . 25.0 108.892 175.068 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.1 t -67.58 -26.42 66.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.917 -0.583 . . . . 25.0 112.022 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -68.43 -27.22 66.0 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 120.889 0.376 . . . . 25.0 110.517 179.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -80.38 104.84 11.2 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.329 -0.619 . . . . 25.0 109.329 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -91.03 -28.41 17.99 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.578 0.704 . . . . 25.0 109.941 176.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.0 t -93.2 139.46 30.58 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 107.802 -1.185 . . . . 25.0 107.802 -177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 62.1 m80 -139.93 150.9 45.09 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.572 -0.74 . . . . 25.0 112.028 -171.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.6 m-70 -92.53 132.49 36.78 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 105.297 -2.112 . . . . 25.0 105.297 172.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 3.8 mp -131.97 128.89 60.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.636 -1.987 . . . . 25.0 105.636 176.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.545 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 91.1 t80 -78.5 125.01 28.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.923 -1.14 . . . . 25.0 107.923 174.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.6 mm -109.61 108.73 59.81 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.701 -0.851 . . . . 25.0 108.701 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -74.89 163.92 34.53 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 117.09 -1.473 . . . . 25.0 111.496 177.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -131.88 113.05 13.0 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.604 -2.369 . . . . 25.0 104.604 172.573 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -90.19 -33.27 16.26 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.213 0.53 . . . . 25.0 110.139 -178.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 96.2 mtt180 -155.08 162.04 41.14 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 104.206 -2.516 . . . . 25.0 104.206 -177.05 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.522 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.4 pt? -85.92 136.42 33.29 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.452 -1.314 . . . . 25.0 107.452 177.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.76 -176.83 25.45 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-O 121.593 0.551 . . . . 25.0 111.727 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -82.82 137.08 34.44 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 122.564 1.173 . . . . 25.0 111.901 -173.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -133.33 158.99 41.59 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 102.294 -3.224 . . . . 25.0 102.294 -179.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.64 137.35 57.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.791 -1.189 . . . . 25.0 107.791 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 57.9 mt -105.92 129.08 59.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 104.409 -2.441 . . . . 25.0 104.409 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 4.7 mp -116.02 134.23 55.18 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.905 -1.146 . . . . 25.0 107.905 -176.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -132.79 142.11 48.83 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.948 -0.76 . . . . 25.0 108.948 178.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 49.3 t -129.03 132.47 67.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.076 -0.713 . . . . 25.0 109.076 179.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 24.1 t90 -116.38 111.67 20.39 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.6 -0.889 . . . . 25.0 108.6 -179.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 16.3 m-20 -98.14 92.49 5.77 Favored 'General case' 0 C--O 1.24 0.588 0 CA-C-O 120.821 0.343 . . . . 25.0 111.208 -176.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 35.6 t -63.98 144.2 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 N-CA-C 109.29 -0.633 . . . . 25.0 109.29 179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -102.95 -21.7 13.93 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.309 0.485 . . . . 25.0 112.309 -179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -73.7 -21.67 60.16 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.336 0.495 . . . . 25.0 112.336 -178.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 68.0 p -135.92 168.57 19.08 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.292 0.568 . . . . 25.0 110.724 -172.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -79.3 13.61 1.84 Allowed 'General case' 0 C--O 1.24 0.584 0 CA-C-O 121.979 0.895 . . . . 25.0 110.734 177.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 69.0 m-20 -110.03 157.8 18.93 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.281 -0.872 . . . . 25.0 111.294 -172.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -153.93 171.9 18.28 Favored 'General case' 0 C--N 1.317 -0.812 0 N-CA-C 104.485 -2.413 . . . . 25.0 104.485 175.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 11.2 t80 -141.01 143.45 34.45 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 119.52 -0.872 . . . . 25.0 111.849 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -115.55 119.93 37.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 104.386 -2.45 . . . . 25.0 104.386 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 10.7 tm0? -122.69 132.41 54.25 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.022 -1.844 . . . . 25.0 106.022 -173.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 32.7 m -126.33 147.48 31.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.848 0.356 . . . . 25.0 110.275 -178.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 69.3 mt -130.53 120.68 48.95 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 108.06 -1.089 . . . . 25.0 108.06 179.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -77.43 125.04 28.7 Favored 'General case' 0 C--O 1.244 0.771 0 N-CA-C 107.624 -1.25 . . . . 25.0 107.624 175.097 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 3.7 m -125.33 126.02 70.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.951 0.881 . . . . 25.0 108.682 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 44.5 t0 -89.02 96.09 10.59 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 103.474 -2.787 . . . . 25.0 103.474 175.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 96.0 mt -91.11 119.63 31.4 Favored 'General case' 0 CA--C 1.5 -0.963 0 N-CA-C 106.339 -1.726 . . . . 25.0 106.339 -175.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 18.2 m -134.18 161.91 39.99 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 O-C-N 123.592 0.558 . . . . 25.0 111.788 -175.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -79.35 159.08 27.29 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.314 -1.365 . . . . 25.0 107.314 174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 65.0 pttt . . . . . 0 C--O 1.249 1.074 0 CA-C-O 117.863 -1.065 . . . . 25.0 109.84 178.589 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 39.8 m170 . . . . . 0 N--CA 1.484 1.264 0 CA-C-O 118.864 -0.589 . . . . 25.0 109.762 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -91.6 168.91 32.25 Favored Glycine 0 C--O 1.23 -0.141 0 C-N-CA 121.251 -0.5 . . . . 25.0 113.566 -175.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -135.62 139.74 44.03 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 108.158 -1.053 . . . . 25.0 108.158 177.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.443 HG22 ' H ' ' A' ' 6' ' ' LYS . 84.3 mt -96.67 111.96 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.462 0 N-CA-C 109.337 -0.616 . . . . 25.0 109.337 179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 71.7 mm-40 -93.56 39.95 1.07 Allowed 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.321 0.649 . . . . 25.0 110.326 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.443 ' H ' HG22 ' A' ' 4' ' ' ILE . 74.5 mttt 79.81 156.35 0.13 Allowed Pre-proline 0 N--CA 1.486 1.348 0 C-N-CA 126.317 1.847 . . . . 25.0 111.629 171.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -72.89 147.86 90.62 Favored 'Cis proline' 0 C--N 1.352 0.742 0 C-N-CA 129.622 1.093 . . . . 25.0 113.928 -0.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 94.58 152.14 29.03 Favored Glycine 0 C--O 1.223 -0.55 0 CA-C-N 114.964 -1.016 . . . . 25.0 113.854 176.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 26.8 t -161.63 142.94 11.21 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 106.91 -1.515 . . . . 25.0 106.91 178.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -77.97 -28.92 49.51 Favored 'General case' 0 C--O 1.217 -0.607 0 C-N-CA 120.477 -0.489 . . . . 25.0 110.081 175.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -66.32 -31.2 71.85 Favored 'General case' 0 C--O 1.22 -0.468 0 CA-C-O 120.713 0.292 . . . . 25.0 111.013 -177.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.37 -38.44 89.57 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 116.596 -0.275 . . . . 25.0 111.135 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 7.6 mp -87.08 -16.52 35.32 Favored 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 120.679 0.276 . . . . 25.0 111.183 -177.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.8 t -73.28 -17.97 61.26 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.976 -0.556 . . . . 25.0 110.906 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.2 t -66.19 140.63 58.19 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.965 -0.561 . . . . 25.0 111.822 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 30.5 mp0 -64.35 -13.38 50.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.406 -0.815 . . . . 25.0 111.152 176.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.62 -27.52 64.79 Favored 'General case' 0 CA--C 1.545 0.76 0 O-C-N 121.978 -0.451 . . . . 25.0 110.247 172.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -111.28 -13.08 14.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.211 0.529 . . . . 25.0 110.47 177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -111.47 52.63 0.62 Allowed Glycine 0 C--O 1.225 -0.445 0 N-CA-C 108.954 -1.658 . . . . 25.0 108.954 176.19 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -69.41 -27.0 64.91 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 114.321 1.23 . . . . 25.0 114.321 -171.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 85.6 mt -100.93 -24.7 14.3 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-O 120.85 0.357 . . . . 25.0 111.848 -176.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -161.21 155.87 23.4 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 104.444 -2.428 . . . . 25.0 104.444 177.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.89 121.68 22.25 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 107.731 -1.211 . . . . 25.0 107.731 -178.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 20.5 p-10 -101.89 11.26 38.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 114.792 -1.095 . . . . 25.0 112.682 -170.984 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.0 t -67.45 -28.61 68.02 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 113.195 0.813 . . . . 25.0 113.195 -174.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.94 164.88 24.92 Favored Glycine 0 C--O 1.222 -0.597 0 C-N-CA 121.591 -0.338 . . . . 25.0 112.602 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.3 t -79.07 -35.79 41.9 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.76 -0.847 . . . . 25.0 111.027 179.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -59.66 -15.93 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.604 0 N-CA-C 113.693 0.997 . . . . 25.0 113.693 -176.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.27 -16.81 23.77 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 114.668 1.359 . . . . 25.0 114.668 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 64.4 t80 -73.04 -36.49 66.93 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.997 0.74 . . . . 25.0 112.997 -173.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.05 45.61 0.42 Allowed Pre-proline 0 CA--C 1.547 0.836 0 N-CA-C 118.69 2.848 . . . . 25.0 118.69 -176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -69.28 -22.68 33.92 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 113.778 -3.681 . . . . 25.0 112.582 177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -77.76 3.23 14.68 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 112.841 0.682 . . . . 25.0 112.841 177.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.0 t -110.87 66.99 0.63 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.103 -0.702 . . . . 25.0 109.103 178.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.0 tt -118.96 111.28 18.14 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.438 -0.801 . . . . 25.0 109.414 176.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.3 mt-10 -130.03 142.24 50.64 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.317 -1.735 . . . . 25.0 106.317 176.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -127.99 144.84 51.11 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.302 -1.37 . . . . 25.0 107.302 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -106.8 136.94 45.76 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.103 0.478 . . . . 25.0 110.972 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 31.1 pttt -71.71 134.69 46.43 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 172.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 80.51 -144.57 25.67 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 120.44 -0.886 . . . . 25.0 113.754 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -109.75 154.62 42.41 Favored Pre-proline 0 CA--C 1.55 0.945 0 C-N-CA 123.134 0.574 . . . . 25.0 111.059 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -66.44 137.34 34.08 Favored 'Cis proline' 0 C--N 1.354 0.847 0 C-N-CA 129.403 1.001 . . . . 25.0 110.789 -0.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 79.6 t60 -80.14 -47.67 14.39 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 114.551 1.315 . . . . 25.0 114.551 -168.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.8 t 62.11 -63.48 0.1 Allowed 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 117.855 2.539 . . . . 25.0 117.855 178.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.64 -154.98 30.46 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 117.416 1.726 . . . . 25.0 117.416 -171.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.05 -177.97 2.58 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.973 2.449 . . . . 25.0 111.221 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.79 86.47 1.71 Allowed 'General case' 0 CA--C 1.541 0.619 0 O-C-N 121.354 -0.841 . . . . 25.0 111.362 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -74.7 146.7 42.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.04 -0.982 . . . . 25.0 109.765 177.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.08 -31.98 1.53 Allowed Glycine 0 CA--C 1.521 0.416 0 CA-C-N 115.664 -0.698 . . . . 25.0 113.472 -178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -85.49 38.79 0.75 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.715 0.769 . . . . 25.0 110.024 179.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 45.2 mm -59.06 -32.79 48.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.756 -0.656 . . . . 25.0 111.435 -174.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.74 -11.37 35.61 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 114.293 1.22 . . . . 25.0 114.293 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 89.6 p -91.51 -10.09 42.04 Favored 'General case' 0 N--CA 1.468 0.443 0 O-C-N 122.006 -0.434 . . . . 25.0 110.382 177.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.47 13.76 1.97 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.321 1.448 . . . . 25.0 113.243 -171.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.0 -42.57 99.64 Favored Glycine 0 C--O 1.223 -0.539 0 C-N-CA 121.087 -0.578 . . . . 25.0 111.97 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -74.75 -29.07 61.82 Favored Glycine 0 C--O 1.223 -0.591 0 C-N-CA 120.574 -0.822 . . . . 25.0 111.483 177.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 85.4 mt -69.26 -30.07 68.11 Favored 'General case' 0 N--CA 1.466 0.346 0 O-C-N 122.502 -0.411 . . . . 25.0 111.584 -177.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 -66.31 -22.44 66.28 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 120.863 -0.335 . . . . 25.0 111.36 176.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -70.07 -22.52 77.27 Favored Glycine 0 C--O 1.227 -0.34 0 C-N-CA 120.775 -0.726 . . . . 25.0 111.48 176.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.73 -18.02 71.77 Favored Glycine 0 C--O 1.223 -0.555 0 C-N-CA 121.332 -0.461 . . . . 25.0 112.815 179.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -67.09 -38.18 80.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.461 -0.94 . . . . 25.0 108.461 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 7.8 mp -74.53 -38.05 62.88 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.186 -0.461 . . . . 25.0 109.794 179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.5 t0 -64.21 -41.86 96.87 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 121.378 0.608 . . . . 25.0 111.505 -177.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -78.64 -1.82 36.1 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 121.723 -0.611 . . . . 25.0 112.268 179.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.6 tt0 -134.15 55.08 1.91 Allowed 'General case' 0 CA--C 1.537 0.464 0 CA-C-O 121.862 0.839 . . . . 25.0 110.177 -179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 41.2 t -135.79 163.91 29.12 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.307 -0.861 . . . . 25.0 108.687 -178.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.3 tp10 -68.84 -27.71 66.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.245 -1.021 . . . . 25.0 108.245 174.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 70.2 m-20 -96.49 22.82 7.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.3 -0.864 . . . . 25.0 110.933 179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 51.7 ttp180 -56.91 145.62 29.35 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 108.552 -0.907 . . . . 25.0 108.552 174.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -81.63 160.2 23.83 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 122.019 0.914 . . . . 25.0 109.908 -176.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -61.71 149.27 40.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.326 -0.852 . . . . 25.0 111.798 -176.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.1 mtpt -121.65 143.24 49.44 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 175.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 75.3 m-70 -124.85 140.01 53.32 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.239 -0.437 . . . . 25.0 109.846 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.9 mt -87.15 131.55 34.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 105.566 -2.012 . . . . 25.0 105.566 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 95.0 mtp -138.74 167.88 21.01 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 -179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 80.6 p -101.33 174.53 5.94 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.798 -0.183 . . . . 25.0 110.647 -178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.76 -170.99 13.9 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 109.488 -1.445 . . . . 25.0 109.488 167.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 88.51 -176.13 44.58 Favored Glycine 0 C--O 1.236 0.236 0 N-CA-C 111.702 -0.559 . . . . 25.0 111.702 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -87.75 144.9 26.38 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 121.981 -0.717 . . . . 25.0 111.508 -179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -136.21 161.46 35.68 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 105.576 -2.009 . . . . 25.0 105.576 175.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 44.5 m -122.85 125.45 45.42 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 106.589 -1.634 . . . . 25.0 106.589 177.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 39.4 m-85 -108.93 137.96 46.03 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -177.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 59.7 m -124.1 123.35 40.13 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.092 -1.077 . . . . 25.0 108.092 176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 40.8 m0 -123.91 149.96 45.25 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 103.698 -2.705 . . . . 25.0 103.698 176.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 47.7 p -138.12 159.86 40.93 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.186 0.517 . . . . 25.0 110.507 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -133.13 123.92 26.57 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 103.571 -2.752 . . . . 25.0 103.571 170.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 6.4 t -84.21 -20.76 31.78 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 112.448 0.536 . . . . 25.0 112.448 -175.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -83.19 127.26 69.67 Favored Pre-proline 0 C--O 1.244 0.78 0 N-CA-C 108.785 -0.82 . . . . 25.0 108.785 179.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -67.0 129.89 21.71 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 117.782 -1.012 . . . . 25.0 113.067 -178.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -136.07 158.93 43.22 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 115.649 -0.705 . . . . 25.0 110.395 178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 50.2 t-20 -89.18 86.98 6.99 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 107.081 -1.451 . . . . 25.0 107.081 171.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.1 m -76.99 129.28 35.9 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.04 -0.527 . . . . 25.0 110.002 -177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 9.9 m -92.73 -42.71 9.44 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 112.588 0.588 . . . . 25.0 112.588 -178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -166.85 173.66 9.24 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.897 0.379 . . . . 25.0 111.222 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 30.3 p90 -147.76 145.62 28.88 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.507 -0.923 . . . . 25.0 108.507 165.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -147.93 154.1 39.91 Favored 'General case' 0 CA--C 1.509 -0.612 0 N-CA-C 108.716 -0.846 . . . . 25.0 108.716 -175.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 19.0 p90 -149.84 148.93 29.75 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.142 0.496 . . . . 25.0 110.537 -173.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -143.94 156.97 44.62 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.435 -0.95 . . . . 25.0 108.435 -176.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -134.79 161.05 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 110.252 -0.277 . . . . 25.0 110.252 -176.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 26.4 p -70.61 140.09 51.56 Favored 'General case' 0 C--O 1.239 0.543 0 CA-C-O 121.042 0.448 . . . . 25.0 110.938 178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -87.94 120.49 29.33 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.921 0.712 . . . . 25.0 112.921 -177.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -77.04 133.16 39.19 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 105.549 -2.019 . . . . 25.0 105.549 169.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.4 24.95 62.12 Favored Glycine 0 C--O 1.224 -0.53 0 C-N-CA 119.47 -1.347 . . . . 25.0 115.109 176.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -54.08 142.59 24.83 Favored 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 118.437 1.118 . . . . 25.0 113.173 -178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.47 128.04 92.46 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 114.405 -1.271 . . . . 25.0 109.338 -175.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -72.44 -13.18 27.7 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 117.875 -0.95 . . . . 25.0 112.839 179.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -66.08 -29.48 69.82 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.884 0.85 . . . . 25.0 110.886 175.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.3 mttt -96.01 141.03 22.58 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.056 -0.72 . . . . 25.0 109.056 -174.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -67.62 128.57 18.32 Favored 'Trans proline' 0 C--O 1.236 0.403 0 C-N-CA 115.085 -2.81 . . . . 25.0 111.53 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.73 -25.41 60.35 Favored 'General case' 0 C--O 1.214 -0.796 0 CA-C-N 115.997 -0.547 . . . . 25.0 111.993 -179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.37 -34.26 46.98 Favored 'General case' 0 C--O 1.221 -0.4 0 CA-C-N 115.63 -0.714 . . . . 25.0 111.963 176.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 12.5 mpt_? -96.81 -42.92 7.73 Favored 'General case' 0 C--O 1.218 -0.598 0 CA-C-N 116.195 -0.457 . . . . 25.0 110.96 173.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.08 1.99 11.79 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 116.48 2.03 . . . . 25.0 116.48 -170.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -64.69 -34.95 79.52 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.059 -0.719 . . . . 25.0 109.059 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 27.4 m-85 -127.16 146.6 50.34 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 123.081 0.552 . . . . 25.0 109.985 173.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 57.2 mt-10 -125.58 144.67 50.47 Favored 'General case' 0 N--CA 1.47 0.572 0 N-CA-C 109.418 -0.586 . . . . 25.0 109.418 170.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.9 tp -76.74 124.83 28.27 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.044 -0.526 . . . . 25.0 109.905 -178.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 17.7 tt -111.49 -12.17 11.57 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.291 0.567 . . . . 25.0 109.986 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -177.39 147.76 8.41 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 119.489 -1.339 . . . . 25.0 116.092 174.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -151.82 131.03 12.75 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 105.104 -2.184 . . . . 25.0 105.104 178.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 14.4 p -144.99 129.71 9.08 Favored Pre-proline 0 C--O 1.243 0.728 0 CA-C-N 118.089 0.404 . . . . 25.0 109.99 179.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -86.62 177.08 4.41 Favored 'Trans proline' 0 C--O 1.242 0.675 0 C-N-CA 117.289 -1.341 . . . . 25.0 114.718 -178.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -137.73 120.95 16.86 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 106.598 -1.63 . . . . 25.0 106.598 178.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 27.7 p-10 -121.45 7.12 10.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.283 0.563 . . . . 25.0 112.005 -176.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 146.14 -99.43 0.21 Allowed Glycine 0 N--CA 1.454 -0.104 0 N-CA-C 111.469 -0.652 . . . . 25.0 111.469 -178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 22.9 t -124.45 53.56 7.22 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 114.751 1.389 . . . . 25.0 114.751 178.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -80.07 -177.18 3.63 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 117.563 -1.158 . . . . 25.0 110.479 175.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -61.15 -30.69 70.54 Favored 'General case' 0 CA--C 1.545 0.755 0 O-C-N 121.56 -0.713 . . . . 25.0 109.662 173.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 78.3 p -80.19 8.02 8.17 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.509 0.929 . . . . 25.0 113.509 178.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 33.2 ptt180 -60.35 -23.59 64.38 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 121.514 -0.741 . . . . 25.0 111.965 -178.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -81.3 129.85 34.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.808 0.337 . . . . 25.0 110.219 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 13.6 tp -71.67 -9.29 58.04 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 121.411 0.624 . . . . 25.0 112.145 178.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 40.8 t -82.26 137.98 34.72 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.126 -1.064 . . . . 25.0 108.126 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 5.3 t-80 -144.01 143.18 31.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.427 0.529 . . . . 25.0 112.427 -175.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -77.63 139.51 39.5 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 107.153 -1.425 . . . . 25.0 107.153 173.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 32.5 mm -131.88 120.73 45.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -98.62 136.07 39.23 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 110.312 -0.255 . . . . 25.0 110.312 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 50.4 mm -117.32 123.78 29.65 Favored Pre-proline 0 C--N 1.323 -0.57 0 N-CA-C 107.135 -1.432 . . . . 25.0 107.135 176.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -69.78 143.09 49.66 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 115.549 -2.501 . . . . 25.0 112.012 179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -95.72 12.18 30.83 Favored 'General case' 0 C--O 1.218 -0.558 0 CA-C-N 115.134 -0.939 . . . . 25.0 112.602 -171.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -58.85 -38.33 78.49 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 113.854 1.057 . . . . 25.0 113.854 -177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 69.8 mtp180 -151.82 157.24 41.66 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.817 0.342 . . . . 25.0 110.938 -176.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.416 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.6 pt? -88.45 152.74 21.69 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.055 -0.975 . . . . 25.0 109.067 176.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 167.88 154.94 8.99 Favored Glycine 0 CA--C 1.521 0.449 0 N-CA-C 115.497 0.959 . . . . 25.0 115.497 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 4.2 p90 -78.82 145.03 34.51 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 179.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 54.3 m80 -142.21 159.0 43.09 Favored 'General case' 0 CA--C 1.509 -0.624 0 CA-C-N 116.117 -0.492 . . . . 25.0 110.004 -174.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 15.3 t -118.7 133.65 64.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 N-CA-C 104.942 -2.244 . . . . 25.0 104.942 174.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.4 mt -114.65 127.83 71.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 106.404 -1.702 . . . . 25.0 106.404 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.0 tp -124.65 120.85 33.06 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 108.387 -0.968 . . . . 25.0 108.387 178.725 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -117.53 147.52 42.71 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.64 -0.709 . . . . 25.0 109.424 -178.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 10.6 t -129.01 140.05 50.28 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 N-CA-C 108.465 -0.939 . . . . 25.0 108.465 -178.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 62.1 t90 -126.96 113.92 17.14 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 107.709 -1.219 . . . . 25.0 107.709 -178.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -105.85 131.99 52.5 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-N 115.843 -0.617 . . . . 25.0 111.317 -172.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.04 136.13 53.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 -176.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -79.62 -17.34 54.03 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 115.083 1.512 . . . . 25.0 115.083 -172.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -87.18 10.77 15.85 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.405 1.261 . . . . 25.0 114.405 -174.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 5.3 t -145.28 161.77 38.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.231 0.538 . . . . 25.0 110.879 179.137 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -88.33 0.92 55.64 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.347 0.594 . . . . 25.0 110.264 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -110.08 160.84 16.11 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.914 -0.585 . . . . 25.0 110.216 -176.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -125.03 154.45 41.27 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.559 -1.645 . . . . 25.0 106.559 173.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -105.08 137.05 43.45 Favored 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 108.493 -0.928 . . . . 25.0 108.493 -178.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -128.67 150.1 50.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.991 -1.114 . . . . 25.0 107.991 178.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.442 ' HA ' HE21 ' A' ' 163' ' ' GLN . 0.0 OUTLIER -146.06 129.7 17.04 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.357 -0.979 . . . . 25.0 108.357 173.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 14.7 p -114.96 137.94 46.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 107.295 -1.372 . . . . 25.0 107.295 -179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.0 mt -138.41 120.46 17.91 Favored 'Isoleucine or valine' 0 C--O 1.239 0.531 0 N-CA-C 108.38 -0.97 . . . . 25.0 108.38 177.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -81.87 134.07 35.37 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 108.354 -0.98 . . . . 25.0 108.354 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.0 m -136.47 166.02 27.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.263 0.554 . . . . 25.0 110.419 -177.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 38.9 t0 -124.54 106.69 10.35 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 106.435 -1.691 . . . . 25.0 106.435 173.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 35.9 mt -103.2 103.96 14.05 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 107.851 -1.166 . . . . 25.0 107.851 -174.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.07 160.26 42.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 N-CA-C 114.831 1.419 . . . . 25.0 114.831 -172.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -95.11 162.2 13.81 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 105.323 -2.102 . . . . 25.0 105.323 174.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt . . . . . 0 C--O 1.244 0.779 0 N-CA-C 107.456 -1.313 . . . . 25.0 107.456 173.231 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.5 2.052 0 CA-C-O 119.209 -0.424 . . . . 25.0 110.439 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -84.42 -138.61 4.02 Favored Glycine 0 CA--C 1.522 0.512 0 CA-C-N 118.046 0.384 . . . . 25.0 112.948 177.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -112.4 158.22 20.09 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 117.758 0.779 . . . . 25.0 112.273 -177.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.4 mt -103.86 121.3 55.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 N-CA-C 107.561 -1.274 . . . . 25.0 107.561 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -91.34 -36.61 13.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.352 0.596 . . . . 25.0 111.441 179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -140.47 146.04 43.44 Favored Pre-proline 0 C--N 1.328 -0.329 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 -175.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -77.18 109.27 1.35 Allowed 'Cis proline' 0 CA--C 1.539 0.749 0 C-N-CA 130.874 1.614 . . . . 25.0 115.562 -0.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 69.47 173.23 9.91 Favored Glycine 0 C--O 1.223 -0.536 0 N-CA-C 115.562 0.985 . . . . 25.0 115.562 175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.7 t -86.67 131.48 34.14 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 122.619 -0.342 . . . . 25.0 111.033 178.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 79.2 ttt180 -69.76 -37.32 76.36 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.417 -0.586 . . . . 25.0 109.417 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.36 -31.85 72.55 Favored 'General case' 0 C--O 1.221 -0.395 0 N-CA-C 112.592 0.59 . . . . 25.0 112.592 -176.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.85 -37.73 85.59 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.824 0.345 . . . . 25.0 110.904 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 87.8 mt -87.76 -10.31 51.41 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-O 121.036 0.446 . . . . 25.0 111.558 -178.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 49.2 t -84.54 -23.26 29.81 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 178.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 59.5 p -72.75 146.71 46.21 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.314 0.578 . . . . 25.0 111.714 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 59.2 mt-10 -67.79 -16.63 64.2 Favored 'General case' 0 C--O 1.219 -0.526 0 CA-C-N 115.847 -0.615 . . . . 25.0 110.674 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -60.84 -18.68 57.26 Favored 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 111.71 0.263 . . . . 25.0 111.71 178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 5.3 t80 -83.08 -1.19 52.15 Favored 'General case' 0 CA--C 1.543 0.694 0 N-CA-C 113.42 0.896 . . . . 25.0 113.42 179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 177.92 -34.68 0.08 OUTLIER Glycine 0 CA--C 1.522 0.522 0 N-CA-C 117.384 1.713 . . . . 25.0 117.384 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.3 t80 62.14 -40.35 0.15 Allowed 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 118.392 2.738 . . . . 25.0 118.392 178.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.0 mt -65.92 -20.09 66.09 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 121.772 -0.58 . . . . 25.0 112.304 -177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 63.2 m-80 -146.26 151.14 37.08 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 106.283 -1.747 . . . . 25.0 106.283 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -146.14 138.24 25.15 Favored 'General case' 0 C--O 1.22 -0.47 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 175.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 -130.6 44.14 3.01 Favored 'General case' 0 N--CA 1.47 0.527 0 N-CA-C 109.035 -0.728 . . . . 25.0 109.035 -177.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -145.73 10.72 1.22 Allowed 'General case' 0 CA--C 1.536 0.424 0 N-CA-C 113.219 0.822 . . . . 25.0 113.219 -174.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -55.49 -61.7 7.11 Favored Glycine 0 C--O 1.222 -0.635 0 N-CA-C 115.673 1.029 . . . . 25.0 115.673 -173.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.4 t -78.98 -14.1 59.4 Favored 'General case' 0 N--CA 1.47 0.558 0 CA-C-N 117.807 0.803 . . . . 25.0 111.281 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 33.1 t -75.95 -33.39 25.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.984 -0.553 . . . . 25.0 111.814 -174.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -66.66 -12.4 58.1 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 116.074 1.879 . . . . 25.0 116.074 -171.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -78.35 -37.44 44.35 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 118.543 0.61 . . . . 25.0 111.507 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -149.43 70.05 9.69 Favored Pre-proline 0 CA--C 1.539 0.54 0 CA-C-O 121.656 0.741 . . . . 25.0 112.964 174.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -67.61 -6.75 17.42 Favored 'Trans proline' 0 CA--C 1.534 0.519 0 N-CA-C 113.792 0.651 . . . . 25.0 113.792 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.2 pm0 -87.28 -7.61 57.66 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 113.102 0.779 . . . . 25.0 113.102 176.071 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.8 t -108.58 95.43 5.65 Favored 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 113.861 1.06 . . . . 25.0 113.861 -174.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.6 tt -125.21 81.38 1.96 Allowed 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.101 0.477 . . . . 25.0 110.06 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 67.2 mm-40 -100.22 137.63 38.38 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 112.384 0.513 . . . . 25.0 112.384 -173.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -131.77 114.96 15.36 Favored 'General case' 0 CA--C 1.536 0.414 0 N-CA-C 110.075 -0.343 . . . . 25.0 110.075 176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 24.2 ttmt -76.54 140.33 41.08 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 112.7 0.63 . . . . 25.0 112.7 -176.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -69.15 153.61 43.43 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.631 -0.713 . . . . 25.0 111.673 177.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.43 -167.72 47.23 Favored Glycine 0 C--O 1.226 -0.403 0 N-CA-C 115.108 0.803 . . . . 25.0 115.108 173.515 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 55.6 m-85 -98.09 153.69 38.02 Favored Pre-proline 0 C--N 1.325 -0.477 0 N-CA-C 109.359 -0.608 . . . . 25.0 109.359 177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.66 159.11 98.37 Favored 'Cis proline' 0 C--N 1.349 0.568 0 C-N-CA 129.406 1.003 . . . . 25.0 111.839 -3.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -65.6 -23.96 66.95 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.946 -0.301 . . . . 25.0 111.31 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 23.1 t 60.59 -89.42 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.25 1.02 . . . . 25.0 113.305 178.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.3 -176.99 39.8 Favored Glycine 0 CA--C 1.521 0.442 0 C-N-CA 121.403 -0.427 . . . . 25.0 112.938 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -73.47 171.02 18.57 Favored 'Trans proline' 0 C--O 1.235 0.371 0 CA-C-N 118.591 1.195 . . . . 25.0 112.867 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -90.79 113.33 25.44 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 106.863 -1.532 . . . . 25.0 106.863 173.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.436 ' C ' ' H ' ' A' ' 50' ' ' GLN . 44.3 t0 -150.81 144.73 25.25 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.51 -1.293 . . . . 25.0 107.51 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.14 -13.8 3.24 Favored Glycine 0 CA--C 1.523 0.552 0 CA-C-O 122.69 1.161 . . . . 25.0 112.291 -173.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.436 ' H ' ' C ' ' A' ' 48' ' ' ASP . 29.3 mt-30 -89.68 46.76 1.39 Allowed 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 124.805 1.242 . . . . 25.0 109.31 -175.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.8 mt -60.79 -39.54 82.13 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.717 -1.129 . . . . 25.0 108.078 178.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 115' ' ' PHE . . . -64.73 -23.07 67.13 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.416 0.895 . . . . 25.0 113.416 179.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 18.5 t -89.84 7.27 37.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.001 -0.37 . . . . 25.0 110.001 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.86 23.98 11.93 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.418 1.087 . . . . 25.0 113.817 -179.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -123.55 -34.96 0.72 Allowed Glycine 0 C--O 1.22 -0.734 0 C-N-CA 121.361 -0.447 . . . . 25.0 113.466 178.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -91.0 15.74 60.21 Favored Glycine 0 C--O 1.223 -0.542 0 N-CA-C 114.552 0.581 . . . . 25.0 114.552 -176.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.47 ' H ' HD23 ' A' ' 57' ' ' LEU . 1.3 pt? -67.31 -27.79 67.45 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.419 0.526 . . . . 25.0 112.419 -178.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 49.8 m-85 -71.45 -21.68 61.93 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.246 0.462 . . . . 25.0 112.246 -175.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -62.01 -35.03 90.83 Favored Glycine 0 C--O 1.22 -0.78 0 C-N-CA 120.904 -0.665 . . . . 25.0 112.473 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.79 -20.28 68.22 Favored Glycine 0 CA--C 1.52 0.354 0 C-N-CA 120.784 -0.722 . . . . 25.0 113.541 179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.4 mm -90.58 -46.22 14.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.084 0.469 . . . . 25.0 109.989 175.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.1 mp -71.16 -24.08 62.18 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.933 1.086 . . . . 25.0 113.933 -173.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -57.41 -25.68 59.93 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 114.254 1.205 . . . . 25.0 114.254 -176.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -57.16 -21.6 34.17 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.532 0.938 . . . . 25.0 113.532 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 29.1 tt0 -138.87 38.84 2.17 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.41 0.624 . . . . 25.0 109.788 177.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.5 t -85.98 146.75 26.53 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.084 0.469 . . . . 25.0 110.715 -178.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -63.26 -25.11 68.17 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 122.135 0.969 . . . . 25.0 109.881 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -118.77 28.19 8.45 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.993 -1.003 . . . . 25.0 108.733 -176.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 43.8 ttt180 -47.65 140.78 5.88 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 115.245 -0.889 . . . . 25.0 112.982 -174.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -79.05 146.15 33.45 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.968 0.889 . . . . 25.0 109.65 -171.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -68.82 134.68 50.04 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.361 -0.836 . . . . 25.0 109.388 -175.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 18.8 mtpt -121.01 139.99 52.54 Favored 'General case' 0 CA--C 1.508 -0.641 0 N-CA-C 113.453 0.908 . . . . 25.0 113.453 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 95.1 m-70 -119.42 143.21 47.61 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.69 -1.226 . . . . 25.0 107.69 169.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 86.9 mt -94.06 128.27 45.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 102.928 -2.99 . . . . 25.0 102.928 171.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 89.8 mtp -140.88 164.29 30.63 Favored 'General case' 0 C--O 1.215 -0.755 0 N-CA-C 107.554 -1.276 . . . . 25.0 107.554 -175.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 42.0 p -92.44 174.06 7.48 Favored 'General case' 0 C--N 1.317 -0.81 0 N-CA-C 104.494 -2.409 . . . . 25.0 104.494 173.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.401 ' H ' ' HG3' ' A' ' 140' ' ' GLU . . . -74.52 -162.27 8.9 Favored Glycine 0 CA--C 1.524 0.611 0 N-CA-C 110.846 -0.902 . . . . 25.0 110.846 173.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 101.6 -178.13 27.33 Favored Glycine 0 C--N 1.323 -0.173 0 CA-C-O 121.452 0.473 . . . . 25.0 112.392 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.4 131.35 43.24 Favored 'General case' 0 C--N 1.323 -0.546 0 O-C-N 121.948 -0.736 . . . . 25.0 109.222 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.2 m-70 -128.12 158.55 37.72 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 107.853 -1.166 . . . . 25.0 107.853 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 62.1 m -120.38 126.68 51.1 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.11 0.481 . . . . 25.0 109.73 179.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -109.62 135.77 50.05 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 105.526 -2.027 . . . . 25.0 105.526 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 34.1 m -138.07 128.52 26.33 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.036 0.384 . . . . 25.0 112.036 -174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -117.96 149.98 40.02 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 106.023 -1.843 . . . . 25.0 106.023 173.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.5 t -137.85 160.12 40.15 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.9 143.87 38.88 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 23.7 p -80.78 -16.82 52.79 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.339 0.496 . . . . 25.0 112.339 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.0 151.81 63.4 Favored Pre-proline 0 C--O 1.237 0.432 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.83 144.99 61.08 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 116.54 -1.84 . . . . 25.0 111.521 178.273 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -131.16 148.58 52.73 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.262 -0.644 . . . . 25.0 109.262 179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 -76.08 157.34 33.01 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 173.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 24.9 m -160.07 148.31 16.94 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 104.093 -2.558 . . . . 25.0 104.093 -178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 29.2 t -92.1 -51.63 5.09 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.431 ' H ' ' HB3' ' A' ' 153' ' ' ASP . 16.4 pt20 -156.12 170.61 21.8 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.309 -0.626 . . . . 25.0 109.309 178.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 40.7 p-90 -149.56 142.52 24.83 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 107.915 -1.143 . . . . 25.0 107.915 167.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -148.04 154.55 40.4 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 122.226 -0.296 . . . . 25.0 111.162 -175.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -120.02 133.81 55.43 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.368 -0.833 . . . . 25.0 109.391 -175.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -121.62 163.67 18.57 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 106.383 -1.71 . . . . 25.0 106.383 174.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.5 pt -129.37 165.18 29.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 106.045 -1.835 . . . . 25.0 106.045 172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 13.2 t -126.12 135.71 52.02 Favored 'General case' 0 C--O 1.247 0.947 0 CA-C-O 121.435 0.636 . . . . 25.0 111.452 173.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 41.3 mtpt -109.06 118.78 37.67 Favored 'General case' 0 C--O 1.218 -0.559 0 CA-C-N 115.838 -0.619 . . . . 25.0 112.323 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 61.6 pttt -75.98 156.02 34.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.416 -1.327 . . . . 25.0 107.416 169.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 112.97 10.55 15.76 Favored Glycine 0 C--O 1.223 -0.572 0 C-N-CA 120.955 -0.64 . . . . 25.0 114.24 -179.067 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 13.8 p90 -60.69 162.88 6.06 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.306 0.574 . . . . 25.0 112.439 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -70.55 144.98 92.16 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 106.785 -1.561 . . . . 25.0 106.785 169.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -74.7 -23.11 14.81 Favored 'Trans proline' 0 CA--C 1.538 0.724 0 C-N-CA 116.638 -1.774 . . . . 25.0 115.001 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -104.64 24.93 10.96 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 122.093 0.949 . . . . 25.0 112.721 -174.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.8 mmtp -122.97 160.47 49.29 Favored Pre-proline 0 C--N 1.322 -0.601 0 N-CA-C 105.752 -1.944 . . . . 25.0 105.752 178.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -74.64 83.46 1.74 Allowed 'Trans proline' 0 CA--C 1.535 0.571 0 C-N-CA 116.14 -2.107 . . . . 25.0 112.868 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -56.27 -39.19 72.24 Favored 'General case' 0 C--O 1.213 -0.866 0 CA-C-O 121.511 0.672 . . . . 25.0 110.019 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.65 -16.61 6.58 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.475 1.287 . . . . 25.0 114.475 176.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 37.5 mmt180 -93.81 -46.76 7.07 Favored 'General case' 0 C--O 1.216 -0.682 0 N-CA-C 112.447 0.536 . . . . 25.0 112.447 171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -83.97 -17.17 41.44 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 115.898 1.814 . . . . 25.0 115.898 -171.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 97.0 m-20 -67.93 -26.32 65.91 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 114.325 1.232 . . . . 25.0 114.325 -169.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.46 ' CE1' ' HA ' ' A' ' 52' ' ' ALA . 43.3 p90 -103.32 125.17 49.81 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.464 0.65 . . . . 25.0 111.257 -175.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -124.74 141.0 52.41 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.782 -0.644 . . . . 25.0 109.695 -178.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.3 tp -79.41 128.15 32.99 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.513 -0.551 . . . . 25.0 109.513 -178.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.6 tt -111.0 -3.65 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-O 121.609 0.719 . . . . 25.0 110.33 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.26 150.96 6.68 Favored Glycine 0 C--O 1.229 -0.158 0 C-N-CA 120.749 -0.739 . . . . 25.0 113.42 174.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -142.54 140.68 31.87 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 108.958 -0.756 . . . . 25.0 108.958 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.0 t -138.38 112.36 8.57 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 123.326 0.391 . . . . 25.0 109.989 -178.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -78.73 158.86 28.18 Favored 'Trans proline' 0 C--O 1.238 0.506 0 C-N-CA 114.877 -2.949 . . . . 25.0 111.326 175.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -105.83 91.9 3.94 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 103.154 -2.906 . . . . 25.0 103.154 175.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -156.6 56.75 0.55 Allowed 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.663 0.744 . . . . 25.0 110.973 -172.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 62.62 12.97 43.35 Favored Glycine 0 CA--C 1.523 0.574 0 C-N-CA 121.062 -0.589 . . . . 25.0 113.839 -177.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -55.27 156.85 7.22 Favored Pre-proline 0 CA--C 1.539 0.554 0 N-CA-C 114.271 1.212 . . . . 25.0 114.271 -173.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -69.08 -163.8 0.1 Allowed 'Trans proline' 0 C--N 1.353 0.764 0 C-N-CA 121.369 1.379 . . . . 25.0 112.146 178.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -46.07 -25.57 0.6 Allowed 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 117.21 2.3 . . . . 25.0 117.21 -175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.8 t -62.39 -18.34 61.35 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 112.616 0.598 . . . . 25.0 112.616 176.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -58.88 -25.13 63.07 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 124.249 1.02 . . . . 25.0 112.547 179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 50.6 m-20 -59.0 135.61 57.68 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 112.882 0.697 . . . . 25.0 112.882 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -72.57 -7.78 51.87 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 115.124 -0.944 . . . . 25.0 111.527 179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 27.2 t -100.0 120.02 39.17 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 104.123 -2.547 . . . . 25.0 104.123 172.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -136.5 136.26 39.25 Favored 'General case' 0 CA--C 1.512 -0.516 0 N-CA-C 113.065 0.765 . . . . 25.0 113.065 -171.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 -83.27 136.75 34.27 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 106.31 -1.737 . . . . 25.0 106.31 173.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 37.0 mm -131.96 131.19 61.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 N-CA-C 105.971 -1.862 . . . . 25.0 105.971 179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.8 t80 -93.34 130.87 38.95 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.603 -0.518 . . . . 25.0 109.603 177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 82.6 mt -126.1 136.47 28.56 Favored Pre-proline 0 CA--C 1.54 0.595 0 N-CA-C 107.047 -1.464 . . . . 25.0 107.047 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -71.3 168.1 24.37 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 117.22 -1.386 . . . . 25.0 113.015 178.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 77' ' ' GLY . 28.0 tt0 -127.24 35.98 4.48 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 107.854 -1.165 . . . . 25.0 107.854 -178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -86.18 -31.4 21.8 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 113.986 1.106 . . . . 25.0 113.986 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -146.22 169.66 18.31 Favored 'General case' 0 N--CA 1.473 0.691 0 N-CA-C 110.114 -0.328 . . . . 25.0 110.114 -176.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 2.3 pt? -107.68 152.02 24.88 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.874 0.694 . . . . 25.0 112.874 178.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 144.29 157.75 7.33 Favored Glycine 0 CA--C 1.517 0.208 0 CA-C-N 115.721 -0.672 . . . . 25.0 112.078 175.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.45 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 15.8 p90 -84.03 144.94 28.77 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-O 121.732 0.777 . . . . 25.0 113.042 -175.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 95.2 m-70 -138.06 135.01 35.44 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.331 -1.359 . . . . 25.0 107.331 -179.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 36.7 t -98.0 134.13 37.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 106.263 -1.754 . . . . 25.0 106.263 -179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 69.3 mt -106.02 125.31 61.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 -178.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -104.69 109.68 21.7 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 107.401 -1.333 . . . . 25.0 107.401 -175.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -108.09 123.8 49.24 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 -179.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 46.8 t -116.63 133.1 64.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 108.663 -0.865 . . . . 25.0 108.663 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t90 -121.25 107.58 12.72 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.537 -1.283 . . . . 25.0 107.537 -176.784 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . 0.431 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 52.2 t0 -82.67 90.69 6.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.693 -0.685 . . . . 25.0 109.98 -174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.59 119.32 34.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 108.043 -1.095 . . . . 25.0 108.043 -178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -91.32 11.89 22.17 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.864 -0.607 . . . . 25.0 112.101 -174.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -100.96 -2.97 30.43 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.046 0.387 . . . . 25.0 112.046 -174.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 12.7 p -143.83 168.5 19.8 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 120.671 0.272 . . . . 25.0 111.512 -173.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 24.8 mp0 -81.26 1.07 34.0 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.957 0.884 . . . . 25.0 109.371 172.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -103.14 155.04 18.69 Favored 'General case' 0 C--N 1.316 -0.878 0 N-CA-C 107.843 -1.169 . . . . 25.0 107.843 -177.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.01 150.86 41.48 Favored 'General case' 0 C--N 1.318 -0.782 0 N-CA-C 103.197 -2.89 . . . . 25.0 103.197 172.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -111.33 138.57 47.65 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.593 -0.521 . . . . 25.0 109.593 -176.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -138.97 154.02 48.25 Favored 'General case' 0 C--O 1.216 -0.698 0 N-CA-C 108.135 -1.061 . . . . 25.0 108.135 172.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.16 152.3 45.96 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 106.467 -1.679 . . . . 25.0 106.467 178.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 31.4 m -123.97 145.46 31.03 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 109.538 -0.542 . . . . 25.0 109.538 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 81.2 mt -136.24 125.19 37.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 104.086 -2.561 . . . . 25.0 104.086 179.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 63.1 t0 -111.15 130.63 55.57 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.31 -1.367 . . . . 25.0 107.31 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 2.9 m -132.73 134.93 58.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 -178.328 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.45 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 1.0 OUTLIER -93.17 100.52 12.89 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 105.55 -2.018 . . . . 25.0 105.55 176.288 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 21.0 mt -92.88 130.21 38.54 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 106.915 -1.513 . . . . 25.0 106.915 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 10.1 m -127.04 158.01 38.19 Favored 'Isoleucine or valine' 0 C--O 1.238 0.453 0 N-CA-C 113.871 1.063 . . . . 25.0 113.871 -176.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -93.82 161.47 14.31 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 107.299 -1.371 . . . . 25.0 107.299 172.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt . . . . . 0 C--O 1.243 0.723 0 CA-C-O 118.472 -0.775 . . . . 25.0 109.409 175.293 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 45.2 p-80 . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 110.299 -0.26 . . . . 25.0 110.299 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.96 179.75 29.15 Favored Glycine 0 CA--C 1.509 -0.32 0 N-CA-C 107.906 -2.078 . . . . 25.0 107.906 179.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -134.06 161.7 34.11 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 118.015 0.908 . . . . 25.0 108.907 -178.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.98 121.77 66.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 106.938 -1.505 . . . . 25.0 106.938 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.0 -12.27 60.58 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.95 1.092 . . . . 25.0 113.95 -174.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 35.5 mtmt 79.68 149.69 0.12 Allowed Pre-proline 0 N--CA 1.492 1.659 0 C-N-CA 126.195 1.798 . . . . 25.0 108.161 -176.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -69.31 156.72 91.42 Favored 'Cis proline' 0 C--N 1.346 0.425 0 CA-C-O 121.181 0.409 . . . . 25.0 112.371 -0.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 105.7 10.53 30.63 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 116.262 1.265 . . . . 25.0 116.262 173.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 46.8 t -64.5 126.93 29.42 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 117.945 0.872 . . . . 25.0 111.476 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -77.95 -19.12 55.16 Favored 'General case' 0 C--O 1.213 -0.836 0 CA-C-N 116.345 -0.389 . . . . 25.0 110.231 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.05 -27.79 69.64 Favored 'General case' 0 C--O 1.217 -0.65 0 CA-C-N 116.75 -0.205 . . . . 25.0 111.191 -179.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -67.33 -25.12 65.85 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-O 121.031 0.443 . . . . 25.0 110.811 178.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.7 mp -96.28 0.56 51.03 Favored 'General case' 0 C--O 1.218 -0.56 0 C-N-CA 122.915 0.486 . . . . 25.0 110.567 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 4.0 t -80.12 -8.7 59.53 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 111.997 0.369 . . . . 25.0 111.997 -176.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.5 t -56.99 143.69 37.08 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 113.487 0.921 . . . . 25.0 113.487 -174.295 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.73 -17.19 54.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.625 -1.17 . . . . 25.0 112.026 176.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.89 -12.96 8.8 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 113.069 0.766 . . . . 25.0 113.069 177.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -75.22 -12.97 60.4 Favored 'General case' 0 CA--C 1.544 0.732 0 N-CA-C 112.024 0.379 . . . . 25.0 112.024 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 174.43 -8.02 0.03 OUTLIER Glycine 0 N--CA 1.464 0.519 0 N-CA-C 118.037 1.975 . . . . 25.0 118.037 177.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.5 t80 57.2 27.83 14.15 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.727 1.38 . . . . 25.0 114.727 179.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.0 mt -101.05 -2.94 30.3 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.337 0.589 . . . . 25.0 109.438 175.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -133.53 167.58 20.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.624 -0.716 . . . . 25.0 110.432 -174.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.0 mp -74.9 164.26 26.75 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 105.835 -1.913 . . . . 25.0 105.835 172.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -45.67 -20.06 0.07 Allowed 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.888 2.181 . . . . 25.0 116.888 -175.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 19.9 t -164.27 -16.55 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 CA-C-O 121.708 0.766 . . . . 25.0 109.966 169.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 81.07 167.72 38.46 Favored Glycine 0 C--O 1.222 -0.644 0 C-N-CA 121.251 -0.499 . . . . 25.0 113.08 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.3 t -76.47 -13.97 60.07 Favored 'General case' 0 N--CA 1.471 0.607 0 O-C-N 121.869 -0.783 . . . . 25.0 111.441 -178.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.4 p -69.84 -11.92 15.46 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 122.801 0.441 . . . . 25.0 110.559 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.6 ptm -60.32 -10.44 4.72 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 115.714 1.746 . . . . 25.0 115.714 -177.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 80.9 t80 -65.53 -46.61 78.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 118.576 0.625 . . . . 25.0 109.983 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -155.02 69.41 5.61 Favored Pre-proline 0 N--CA 1.476 0.863 0 N-CA-C 113.185 0.809 . . . . 25.0 113.185 172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -75.32 3.12 6.06 Favored 'Trans proline' 0 CA--C 1.532 0.415 0 N-CA-C 113.71 0.619 . . . . 25.0 113.71 -177.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -101.32 -2.44 31.02 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.497 0.555 . . . . 25.0 112.497 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.94 97.4 11.17 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 113.662 0.986 . . . . 25.0 113.662 -172.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 62.1 mt -96.96 112.29 24.12 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 106.504 -1.665 . . . . 25.0 106.504 173.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 80.2 mm-40 -89.03 110.19 20.93 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.977 0.732 . . . . 25.0 112.977 -173.516 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -100.55 152.42 20.43 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 106.084 -1.821 . . . . 25.0 106.084 171.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -141.49 149.37 40.82 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 112.171 0.434 . . . . 25.0 112.171 -179.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -66.01 146.24 54.93 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.37 -1.344 . . . . 25.0 107.37 174.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 146.58 108.95 0.56 Allowed Glycine 0 C--O 1.219 -0.803 0 C-N-CA 120.691 -0.766 . . . . 25.0 114.462 176.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -101.35 152.54 38.0 Favored Pre-proline 0 C--N 1.321 -0.633 0 O-C-N 122.286 -0.537 . . . . 25.0 111.4 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -73.05 -17.65 16.92 Favored 'Cis proline' 0 C--N 1.353 0.794 0 C-N-CA 128.824 0.76 . . . . 25.0 113.188 -1.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 26.3 p80 -162.27 -33.1 0.04 OUTLIER 'General case' 0 C--O 1.218 -0.592 0 CA-C-N 116.238 -0.437 . . . . 25.0 111.537 174.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.2 t 59.51 -85.69 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.073 0.949 . . . . 25.0 111.829 -174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.62 -154.99 19.31 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.449 -0.661 . . . . 25.0 111.449 176.414 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -70.21 167.1 26.0 Favored 'Trans proline' 0 C--N 1.35 0.609 0 CA-C-N 119.19 1.495 . . . . 25.0 111.583 178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -76.02 115.83 16.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.491 -0.559 . . . . 25.0 109.491 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -146.58 179.47 7.53 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 105.857 -1.905 . . . . 25.0 105.857 175.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.74 -2.09 69.96 Favored Glycine 0 C--N 1.324 -0.135 0 CA-C-O 121.951 0.75 . . . . 25.0 111.252 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 98.7 mm-40 -73.54 -1.93 20.64 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.158 0.504 . . . . 25.0 111.885 -176.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.0 mt -63.92 -38.61 82.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.243 -1.021 . . . . 25.0 108.243 174.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.67 -23.96 60.96 Favored 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 112.604 0.594 . . . . 25.0 112.604 -179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.7 p -95.39 2.48 54.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.612 0.244 . . . . 25.0 111.062 -178.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.18 -0.56 0.84 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 125.238 1.415 . . . . 25.0 113.336 -173.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -69.33 -31.54 71.57 Favored Glycine 0 C--O 1.226 -0.398 0 C-N-CA 121.06 -0.591 . . . . 25.0 111.724 179.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -75.5 -17.2 80.23 Favored Glycine 0 C--O 1.224 -0.523 0 C-N-CA 121.047 -0.597 . . . . 25.0 112.305 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 84.3 mt -72.26 -25.97 61.81 Favored 'General case' 0 N--CA 1.465 0.313 0 O-C-N 122.004 -0.704 . . . . 25.0 110.291 -177.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.561 -0.533 . . . . 25.0 109.561 174.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -75.29 -24.99 69.5 Favored Glycine 0 CA--C 1.518 0.246 0 N-CA-C 110.926 -0.869 . . . . 25.0 110.926 176.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.86 -16.9 68.81 Favored Glycine 0 C--O 1.228 -0.26 0 O-C-N 122.774 -0.251 . . . . 25.0 112.536 178.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.4 mm -66.16 -40.1 86.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 107.943 -1.132 . . . . 25.0 107.943 176.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.2 mp -75.81 -26.89 57.67 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.406 -0.361 . . . . 25.0 111.15 -178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -63.78 -22.01 66.7 Favored 'General case' 0 C--O 1.217 -0.63 0 CA-C-O 121.149 0.5 . . . . 25.0 111.589 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 72.4 mt-30 -67.73 -5.93 18.48 Favored 'General case' 0 C--N 1.32 -0.69 0 O-C-N 121.865 -0.522 . . . . 25.0 112.156 177.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 59.5 mt-30 -130.65 35.15 4.04 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 109.064 -0.717 . . . . 25.0 109.064 174.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 43.6 t -106.62 156.54 18.5 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.931 0.396 . . . . 25.0 111.101 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -68.66 -31.02 69.85 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 108.811 -0.811 . . . . 25.0 108.811 173.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.0 m-80 -97.48 21.39 10.27 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.564 -0.744 . . . . 25.0 110.409 -179.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -52.31 136.1 31.51 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-O 121.057 0.456 . . . . 25.0 111.5 -177.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -72.89 146.03 46.44 Favored 'General case' 0 C--O 1.241 0.612 0 CA-C-O 122.686 1.231 . . . . 25.0 112.33 -174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -75.7 148.78 38.36 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 114.383 -1.28 . . . . 25.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.6 mtpt -103.03 126.87 50.39 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.1 t60 -100.1 108.79 21.03 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.182 -0.607 . . . . 25.0 109.658 174.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 63.5 mt -78.55 138.6 19.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.67 -0.863 . . . . 25.0 108.67 -179.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 11.4 tpt -151.04 154.09 36.37 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 109.202 -0.666 . . . . 25.0 109.202 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.2 p -91.16 -179.48 5.44 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.838 -1.171 . . . . 25.0 107.838 177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -77.45 -168.88 31.51 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 116.445 1.338 . . . . 25.0 116.445 -177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.92 170.72 36.92 Favored Glycine 0 C--N 1.329 0.162 0 N-CA-C 108.864 -1.694 . . . . 25.0 108.864 -176.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -81.77 148.3 28.97 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 119.309 1.555 . . . . 25.0 108.477 176.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.1 m80 -134.19 157.96 44.91 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 107.611 -1.255 . . . . 25.0 107.611 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 37.2 m -124.95 125.74 44.39 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 106.331 -1.729 . . . . 25.0 106.331 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -114.46 140.89 48.34 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.189 -1.041 . . . . 25.0 108.189 -178.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 23.0 m -132.58 132.42 42.52 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 123.608 0.568 . . . . 25.0 111.993 -174.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 33.6 m95 -118.47 150.06 40.24 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.714 -1.217 . . . . 25.0 107.714 175.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 38.0 p -133.84 161.71 34.0 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.207 -1.034 . . . . 25.0 108.207 177.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -131.99 158.11 42.32 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.867 -1.531 . . . . 25.0 106.867 179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 10.9 t -69.83 -27.02 64.51 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 112.347 0.499 . . . . 25.0 112.347 -176.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -143.06 154.13 61.17 Favored Pre-proline 0 C--O 1.24 0.598 0 N-CA-C 106.684 -1.598 . . . . 25.0 106.684 176.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -70.39 152.03 65.82 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 115.956 -2.229 . . . . 25.0 110.038 170.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 37.1 t-80 -131.15 147.57 52.62 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.268 -0.641 . . . . 25.0 109.268 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -61.03 137.01 58.25 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.277 -1.749 . . . . 25.0 106.277 173.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.1 m -146.16 144.66 30.09 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 107.868 -1.16 . . . . 25.0 107.868 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.9 t -91.56 -48.03 7.08 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.487 -0.56 . . . . 25.0 109.487 176.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 25.4 pt20 -166.2 169.65 14.11 Favored 'General case' 0 N--CA 1.466 0.351 0 O-C-N 122.298 -0.251 . . . . 25.0 111.369 178.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 37.6 p90 -141.9 141.0 32.99 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.623 -0.88 . . . . 25.0 108.623 166.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.8 156.42 42.71 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.605 -0.27 . . . . 25.0 110.84 -173.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -130.67 142.94 50.44 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.809 -0.632 . . . . 25.0 111.535 -170.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -132.3 164.96 25.27 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 108.622 -0.881 . . . . 25.0 108.622 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 40.9 pt -130.31 157.42 42.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 106.704 -1.591 . . . . 25.0 106.704 173.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 40.9 p -96.71 133.63 41.0 Favored 'General case' 0 C--O 1.246 0.917 0 CA-C-O 121.148 0.499 . . . . 25.0 111.273 -179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 68.5 tttt -92.22 99.57 12.33 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.627 0.727 . . . . 25.0 111.98 -178.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 18.1 ptmt -76.16 148.14 38.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 107.407 -1.331 . . . . 25.0 107.407 175.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.78 22.19 40.32 Favored Glycine 0 C--O 1.226 -0.386 0 N-CA-C 115.579 0.992 . . . . 25.0 115.579 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 4.5 p90 -56.93 148.74 20.31 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 117.686 0.743 . . . . 25.0 111.705 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 39.9 m-20 -81.96 138.79 46.2 Favored Pre-proline 0 C--N 1.328 -0.363 0 N-CA-C 108.204 -1.036 . . . . 25.0 108.204 177.068 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -71.98 -15.91 29.22 Favored 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 117.617 -1.122 . . . . 25.0 112.261 176.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -68.15 -22.06 64.88 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 124.023 0.929 . . . . 25.0 111.577 176.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 79.8 mttt -113.75 153.79 45.89 Favored Pre-proline 0 C--N 1.324 -0.541 0 CA-C-N 115.944 -0.571 . . . . 25.0 109.55 -172.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -66.08 107.03 1.07 Allowed 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 117.987 -0.876 . . . . 25.0 113.633 -177.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.9 tt -52.72 -46.87 67.57 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 115.193 -0.912 . . . . 25.0 112.742 -177.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -54.35 -38.48 66.11 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 116.184 -0.462 . . . . 25.0 112.094 -176.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -78.71 -44.28 23.88 Favored 'General case' 0 C--O 1.214 -0.798 0 CA-C-N 115.894 -0.594 . . . . 25.0 111.944 178.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -70.43 -24.69 62.95 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 114.765 1.394 . . . . 25.0 114.765 -174.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 30.2 t0 -68.07 -23.81 65.0 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.812 1.412 . . . . 25.0 114.812 -171.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -123.02 135.18 54.35 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 121.003 -1.061 . . . . 25.0 112.508 -178.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 54.1 mt-10 -128.15 133.11 48.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.464 -0.939 . . . . 25.0 108.464 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.5 tp -78.11 120.56 23.11 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 108.708 -0.849 . . . . 25.0 108.708 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.2 tt -96.3 -10.84 8.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 CA-C-O 121.478 0.656 . . . . 25.0 110.094 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 166.05 160.27 13.1 Favored Glycine 0 N--CA 1.452 -0.244 0 C-N-CA 120.323 -0.942 . . . . 25.0 113.935 175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.69 146.71 29.38 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.096 -1.075 . . . . 25.0 108.096 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 86.4 t -135.25 106.84 10.23 Favored Pre-proline 0 C--O 1.238 0.492 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 175.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -75.09 160.57 39.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 114.902 -2.932 . . . . 25.0 110.743 176.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 46.2 t-80 -118.51 94.19 4.39 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-O 122.395 1.093 . . . . 25.0 108.804 -179.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -159.17 -94.71 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 103.033 -2.951 . . . . 25.0 103.033 174.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -98.26 128.54 9.6 Favored Glycine 0 C--O 1.224 -0.513 0 N-CA-C 109.115 -1.594 . . . . 25.0 109.115 171.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.3 t -163.49 145.07 7.44 Favored Pre-proline 0 C--O 1.242 0.708 0 CA-C-N 117.159 0.48 . . . . 25.0 109.959 -179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -76.08 -154.13 0.04 OUTLIER 'Trans proline' 0 C--N 1.353 0.78 0 C-N-CA 121.516 1.477 . . . . 25.0 110.744 174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -18.84 4.47 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 115.129 1.529 . . . . 25.0 115.129 -179.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 21.6 t -66.87 -6.73 17.55 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 112.825 0.676 . . . . 25.0 112.825 176.001 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 18.8 ttm180 -66.92 -14.87 63.24 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.423 0.689 . . . . 25.0 110.807 177.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 -66.59 150.66 48.69 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.495 0.664 . . . . 25.0 112.205 -178.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -75.06 -12.51 60.34 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.182 -0.917 . . . . 25.0 110.209 175.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.0 t -89.68 120.81 31.28 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.231 -1.766 . . . . 25.0 106.231 177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -135.07 134.15 40.05 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.277 0.473 . . . . 25.0 112.277 -173.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 16.8 m-70 -82.28 139.31 34.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.812 -0.631 . . . . 25.0 109.973 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 69.2 mt -132.19 121.38 46.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 106.395 -1.706 . . . . 25.0 106.395 172.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.9 t80 -80.65 135.36 36.02 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.036 -0.728 . . . . 25.0 109.036 176.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 43.0 mm -122.94 117.85 28.4 Favored Pre-proline 0 C--N 1.326 -0.453 0 N-CA-C 107.882 -1.155 . . . . 25.0 107.882 176.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -72.47 158.05 51.85 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 115.947 -2.235 . . . . 25.0 110.577 174.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -112.35 51.65 0.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 106.948 -1.501 . . . . 25.0 106.948 177.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -94.29 -26.01 16.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.039 -0.982 . . . . 25.0 111.731 -177.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 34.9 ptt-85 -158.09 160.13 37.0 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.301 . . . . 25.0 110.782 -176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.448 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 1.1 pt? -100.13 137.54 38.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.178 -1.045 . . . . 25.0 108.178 175.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 172.26 144.53 4.57 Favored Glycine 0 CA--C 1.523 0.573 0 CA-C-O 122.348 0.971 . . . . 25.0 115.453 179.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -95.72 144.96 25.67 Favored 'General case' 0 C--O 1.242 0.685 0 N-CA-C 112.664 0.616 . . . . 25.0 112.664 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 22.8 p80 -148.95 163.57 37.07 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.369 -0.974 . . . . 25.0 108.369 174.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 18.1 t -93.43 143.08 12.25 Favored 'Isoleucine or valine' 0 C--O 1.245 0.845 0 N-CA-C 108.384 -0.969 . . . . 25.0 108.384 -179.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 85.1 mt -111.04 129.22 66.71 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.542 0 N-CA-C 105.893 -1.892 . . . . 25.0 105.893 171.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 35.3 mt -112.32 141.86 45.52 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 106.001 -1.852 . . . . 25.0 106.001 179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.36 143.99 40.11 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.716 -0.475 . . . . 25.0 109.716 177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 21.0 t -129.07 135.11 62.82 Favored 'Isoleucine or valine' 0 C--O 1.241 0.649 0 N-CA-C 108.442 -0.948 . . . . 25.0 108.442 -177.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -126.08 118.5 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -111.76 134.62 53.21 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.949 0.351 . . . . 25.0 111.949 -173.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.2 t -127.28 128.78 70.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 N-CA-C 106.781 -1.563 . . . . 25.0 106.781 178.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -31.17 65.63 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.053 0.454 . . . . 25.0 111.533 -176.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 30.6 m-20 -75.26 -2.03 26.19 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 113.901 1.074 . . . . 25.0 113.901 -172.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 27.0 p -123.01 155.01 37.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.748 0.785 . . . . 25.0 112.699 -173.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 43.4 mm-40 -83.24 -6.36 59.45 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.124 -0.695 . . . . 25.0 109.124 174.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -109.25 153.83 23.29 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.2 -0.909 . . . . 25.0 109.544 -176.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -129.86 150.63 51.08 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 103.365 -2.828 . . . . 25.0 103.365 174.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 27.3 m-85 -119.66 135.81 54.66 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.037 0.446 . . . . 25.0 111.239 -168.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 31.6 m-85 -127.09 153.88 45.42 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 108.753 -0.832 . . . . 25.0 108.753 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -146.19 156.18 43.23 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.8 p -134.69 138.78 48.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.585 . . . . 25.0 109.422 -177.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.5 mt -140.04 121.43 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.66 140.52 29.74 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.703 -0.851 . . . . 25.0 108.703 174.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 28.7 m -133.78 157.56 42.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 108.973 -0.751 . . . . 25.0 108.973 177.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -128.81 118.58 23.0 Favored 'General case' 0 CA--C 1.507 -0.673 0 N-CA-C 104.293 -2.484 . . . . 25.0 104.293 175.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.7 mt -108.25 121.91 45.86 Favored 'General case' 0 CA--C 1.506 -0.731 0 N-CA-C 104.627 -2.36 . . . . 25.0 104.627 -174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 18.7 m -130.86 160.4 42.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 114.12 1.155 . . . . 25.0 114.12 -171.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 10.3 m-20 -95.13 157.51 15.86 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.307 -1.738 . . . . 25.0 106.307 174.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 42.9 tptt . . . . . 0 C--O 1.251 1.139 0 O-C-N 124.297 0.998 . . . . 25.0 110.83 174.601 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 51.6 m80 . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 119.605 -0.236 . . . . 25.0 110.894 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.83 -169.28 40.08 Favored Glycine 0 CA--C 1.528 0.853 0 C-N-CA 121.13 -0.557 . . . . 25.0 113.911 -177.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 21.4 p90 -150.96 170.96 18.08 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 123.173 0.589 . . . . 25.0 109.431 -179.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 14.2 tt -106.86 131.86 55.67 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.888 0 CA-C-O 121.074 0.464 . . . . 25.0 110.245 176.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -85.15 -47.94 9.65 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 122.266 1.031 . . . . 25.0 111.054 178.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -141.21 149.69 56.04 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 114.771 -1.104 . . . . 25.0 108.552 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -80.17 98.59 0.23 Allowed 'Cis proline' 0 CA--C 1.545 1.041 0 C-N-CA 131.498 1.874 . . . . 25.0 114.52 -1.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 89.9 138.82 7.26 Favored Glycine 0 C--O 1.239 0.44 0 CA-C-O 121.657 0.587 . . . . 25.0 113.593 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.2 t -68.21 145.53 54.22 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.612 0.72 . . . . 25.0 112.71 -176.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.9 ttp180 -66.27 -37.46 85.51 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.385 -0.825 . . . . 25.0 110.248 174.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.94 -26.43 68.3 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.291 0.848 . . . . 25.0 113.291 -175.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -59.06 -41.76 88.71 Favored 'General case' 0 C--O 1.215 -0.74 0 N-CA-C 112.079 0.4 . . . . 25.0 112.079 -177.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.6 mp -91.92 -3.92 55.34 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.579 0.704 . . . . 25.0 111.605 -178.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 7.7 t -87.31 -21.69 25.58 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 115.335 -0.848 . . . . 25.0 109.84 179.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 46.2 t -73.47 133.0 43.56 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.669 -0.493 . . . . 25.0 109.669 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.7 mt-10 -65.48 -30.15 70.89 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.379 0.609 . . . . 25.0 110.432 179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.48 -17.39 63.82 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.005 -0.543 . . . . 25.0 112.179 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 43.6 t80 -79.95 -15.84 56.45 Favored 'General case' 0 CA--C 1.533 0.289 0 O-C-N 121.776 -0.577 . . . . 25.0 110.935 -178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -121.51 7.34 10.45 Favored Glycine 0 C--N 1.328 0.102 0 N-CA-C 110.02 -1.232 . . . . 25.0 110.02 174.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.0 t80 61.96 -60.95 0.11 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 126.775 2.03 . . . . 25.0 114.803 -175.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.9 mt -108.5 -4.22 17.44 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.691 0.396 . . . . 25.0 111.582 178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 34.4 m120 -137.57 159.46 41.91 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 112.236 0.458 . . . . 25.0 112.236 -173.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -139.1 157.62 45.64 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 106.517 -1.66 . . . . 25.0 106.517 175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -118.41 26.53 9.53 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.125 0.488 . . . . 25.0 111.02 178.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.99 -21.23 31.78 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 112.694 0.628 . . . . 25.0 112.694 -178.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.86 -179.59 30.74 Favored Glycine 0 CA--C 1.521 0.451 0 CA-C-N 115.747 -0.66 . . . . 25.0 112.636 -178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.6 p -66.24 -14.01 61.26 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.301 0.572 . . . . 25.0 110.919 176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.4 t -61.17 -18.44 18.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.286 0.634 . . . . 25.0 110.695 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -59.33 -14.21 10.82 Favored 'General case' 0 N--CA 1.467 0.38 0 N-CA-C 115.3 1.593 . . . . 25.0 115.3 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 90.2 t80 -71.47 -37.72 71.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 118.427 0.558 . . . . 25.0 110.111 178.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -147.81 68.26 10.62 Favored Pre-proline 0 CA--C 1.541 0.604 0 CA-C-O 121.64 0.733 . . . . 25.0 111.797 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -72.91 -8.97 23.14 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 117.541 -1.173 . . . . 25.0 112.829 -177.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 21.9 tt0 -83.77 -9.9 58.47 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.718 -0.475 . . . . 25.0 109.718 176.04 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.4 t -81.37 104.15 11.62 Favored 'General case' 0 C--O 1.215 -0.744 0 CA-C-O 121.462 0.649 . . . . 25.0 110.037 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 58.6 mt -122.91 74.02 1.18 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.494 -0.775 . . . . 25.0 109.325 -177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -142.02 135.68 29.49 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 122.664 0.386 . . . . 25.0 111.142 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.15 163.51 32.54 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 106.737 -1.579 . . . . 25.0 106.737 176.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 37.6 ttmt -103.53 147.37 27.26 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.047 -0.408 . . . . 25.0 109.954 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 65.1 pttt -60.25 153.43 22.38 Favored 'General case' 0 N--CA 1.47 0.566 0 CA-C-O 120.876 0.369 . . . . 25.0 111.791 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -160.79 -158.03 9.06 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 110.707 -0.957 . . . . 25.0 110.707 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -88.53 144.18 33.26 Favored Pre-proline 0 C--N 1.326 -0.419 0 N-CA-C 109.455 -0.572 . . . . 25.0 109.455 178.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -96.37 -2.37 34.39 Favored 'Cis proline' 0 CA--C 1.534 0.498 0 C-N-CA 130.681 1.534 . . . . 25.0 115.264 -0.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 80.4 t60 67.1 -32.59 0.19 Allowed 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 125.807 1.643 . . . . 25.0 114.188 -172.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.7 m -83.6 -14.13 52.76 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 114.515 1.302 . . . . 25.0 114.515 -177.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -108.2 165.62 12.85 Favored Glycine 0 N--CA 1.46 0.254 0 C-N-CA 121.161 -0.543 . . . . 25.0 112.427 -176.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -73.41 -27.11 13.59 Favored 'Trans proline' 0 C--N 1.35 0.629 0 CA-C-N 118.737 1.268 . . . . 25.0 113.262 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -96.9 132.83 42.27 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 106.367 -1.716 . . . . 25.0 106.367 175.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -135.86 142.17 44.74 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 108.19 -1.041 . . . . 25.0 108.19 -178.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.45 -32.38 3.11 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 115.911 1.125 . . . . 25.0 115.911 -178.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.9 mp0 -105.16 34.16 3.34 Favored 'General case' 0 N--CA 1.479 0.981 0 CA-C-N 118.787 1.294 . . . . 25.0 112.726 -179.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 24.6 mm -63.39 -36.9 77.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 112.666 0.617 . . . . 25.0 112.666 -177.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.03 -38.27 72.92 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 113.32 0.859 . . . . 25.0 113.32 -177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 77.9 p -102.47 -8.54 20.99 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.432 -0.168 . . . . 25.0 110.963 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 55.27 19.98 3.25 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 124.622 1.169 . . . . 25.0 112.107 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.8 1.93 84.8 Favored Glycine 0 C--O 1.217 -0.934 0 N-CA-C 115.745 1.058 . . . . 25.0 115.745 -173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -59.68 -35.13 84.99 Favored Glycine 0 C--O 1.221 -0.663 0 CA-C-N 117.92 0.86 . . . . 25.0 114.092 -177.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 97.9 mt -91.13 -37.99 13.03 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 122.137 -0.625 . . . . 25.0 111.897 177.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -84.77 -13.72 50.37 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 113.692 0.997 . . . . 25.0 113.692 -171.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.4 -15.92 64.32 Favored Glycine 0 C--O 1.216 -1.024 0 C-N-CA 121.496 -0.383 . . . . 25.0 112.87 -179.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.15 -24.34 68.71 Favored Glycine 0 C--O 1.219 -0.83 0 C-N-CA 120.654 -0.784 . . . . 25.0 112.843 178.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -66.67 -41.54 88.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 108.904 -0.776 . . . . 25.0 108.904 176.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 76.7 mt -72.15 -29.37 63.96 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.041 -0.527 . . . . 25.0 110.537 -178.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -67.44 -19.78 65.41 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 112.282 0.475 . . . . 25.0 112.282 -177.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 69.3 mt-30 -66.29 -11.8 52.68 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 122.046 -0.409 . . . . 25.0 111.082 176.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 68.4 tp60 -137.86 64.91 1.5 Allowed 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 107.582 -1.266 . . . . 25.0 107.582 174.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.5 t -135.75 159.58 41.19 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.318 -0.401 . . . . 25.0 110.742 -174.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -67.75 -32.33 72.86 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-O 121.984 0.897 . . . . 25.0 109.488 175.512 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 64.2 m-80 -96.88 22.04 8.83 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.762 -0.654 . . . . 25.0 110.438 -178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 74.4 ttt180 -49.59 134.5 19.68 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.946 0.879 . . . . 25.0 112.916 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -74.12 154.81 38.98 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.906 -1.043 . . . . 25.0 112.678 -178.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.3 p90 -80.49 129.53 34.57 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.792 -0.818 . . . . 25.0 108.792 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.97 152.79 21.79 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 120.929 0.395 . . . . 25.0 111.746 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -126.78 100.35 6.14 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.534 0.334 . . . . 25.0 110.694 174.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 64.9 mt -78.52 131.02 35.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 108.149 -1.056 . . . . 25.0 108.149 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 76.3 mtm -143.32 163.81 31.98 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 123.263 0.625 . . . . 25.0 110.309 -178.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 61.3 p -93.14 -179.46 5.09 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 105.958 -1.867 . . . . 25.0 105.958 174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.85 -172.9 30.52 Favored Glycine 0 CA--C 1.52 0.356 0 C-N-CA 120.778 -0.725 . . . . 25.0 111.319 174.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 102.73 -160.76 16.99 Favored Glycine 0 CA--C 1.517 0.171 0 O-C-N 122.269 -0.548 . . . . 25.0 114.053 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 -77.59 137.56 38.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.946 0.403 . . . . 25.0 111.425 178.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -132.6 139.95 48.02 Favored 'General case' 0 C--O 1.216 -0.673 0 N-CA-C 109.013 -0.736 . . . . 25.0 109.013 178.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 59.2 m -120.35 111.43 17.75 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 108.153 -1.054 . . . . 25.0 108.153 176.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -93.15 116.37 28.97 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 33.0 m -119.28 93.47 4.09 Favored 'General case' 0 CA--C 1.509 -0.608 0 N-CA-C 109.149 -0.686 . . . . 25.0 109.149 -173.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 3.2 m-90 -89.06 133.59 34.3 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 106.884 -1.525 . . . . 25.0 106.884 174.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.7 p -123.77 136.62 54.53 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 107.736 -1.209 . . . . 25.0 107.736 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -126.4 148.57 49.59 Favored 'General case' 0 CA--C 1.51 -0.577 0 CA-C-O 120.985 0.422 . . . . 25.0 110.308 -175.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 5.1 t -120.64 31.35 6.48 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 105.623 -1.992 . . . . 25.0 105.623 177.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -68.66 125.08 91.43 Favored Pre-proline 0 CA--C 1.543 0.704 0 CA-C-N 114.619 -1.173 . . . . 25.0 109.43 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.08 26.39 0.65 Allowed 'Trans proline' 0 CA--C 1.54 0.803 0 C-N-CA 120.227 0.618 . . . . 25.0 112.615 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 55.0 m-70 -130.9 149.48 52.51 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.344 -0.389 . . . . 25.0 111.495 -176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -69.78 156.42 39.05 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.21 -0.663 . . . . 25.0 109.21 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 17.0 m -123.03 149.53 44.24 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.049 -1.834 . . . . 25.0 106.049 -179.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.3 t -93.95 -56.85 2.72 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.074 0.464 . . . . 25.0 110.501 179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -161.63 173.77 14.27 Favored 'General case' 0 CA--C 1.515 -0.388 0 N-CA-C 109.815 -0.439 . . . . 25.0 109.815 176.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 28.6 p90 -146.32 152.69 39.54 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.735 -0.666 . . . . 25.0 109.698 170.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -146.73 141.82 27.17 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.335 -1.357 . . . . 25.0 107.335 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 13.6 p90 -140.83 149.12 41.6 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.836 0.827 . . . . 25.0 112.53 -168.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.5 p90 -144.07 160.51 40.77 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.617 -1.174 . . . . 25.0 109.397 -172.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.9 pt -134.5 158.88 42.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 108.314 -0.995 . . . . 25.0 108.314 -178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.419 ' CG2' ' H ' ' A' ' 147' ' ' VAL . 1.1 t -96.86 126.96 42.38 Favored 'General case' 0 C--O 1.244 0.805 0 N-CA-C 113.227 0.825 . . . . 25.0 113.227 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 20.1 ttmm -99.47 103.33 15.08 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 107.644 -1.243 . . . . 25.0 107.644 173.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -70.91 152.36 43.74 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 107.489 -1.3 . . . . 25.0 107.489 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 109.13 10.08 24.8 Favored Glycine 0 C--O 1.225 -0.434 0 CA-C-O 119.731 -0.483 . . . . 25.0 113.082 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 22.3 p90 -62.02 153.81 28.51 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.76 0.79 . . . . 25.0 109.817 177.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -75.54 151.29 85.03 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 177.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -72.03 -11.35 27.19 Favored 'Trans proline' 0 C--N 1.349 0.569 0 N-CA-C 113.499 0.538 . . . . 25.0 113.499 -178.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -74.46 -6.16 46.73 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.544 0.687 . . . . 25.0 111.511 178.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -105.07 135.82 19.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 121.812 -0.555 . . . . 25.0 111.161 -173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -67.89 123.21 10.42 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 117.588 -1.141 . . . . 25.0 113.002 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -52.62 -49.41 65.16 Favored 'General case' 0 C--O 1.217 -0.62 0 N-CA-C 114.415 1.265 . . . . 25.0 114.415 -172.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -64.72 -11.05 31.93 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.746 1.017 . . . . 25.0 113.746 -175.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 73.4 mtp180 -104.69 -48.96 3.64 Favored 'General case' 0 C--O 1.216 -0.667 0 N-CA-C 112.231 0.456 . . . . 25.0 112.231 173.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.81 -22.46 58.72 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 115.326 1.602 . . . . 25.0 115.326 -170.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 35.6 m-20 -68.16 -28.77 67.58 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.535 -0.466 . . . . 25.0 111.895 -172.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -124.6 144.89 49.91 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 112.406 0.521 . . . . 25.0 112.406 -178.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 23.7 pt-20 -126.7 144.29 50.97 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 120.998 0.428 . . . . 25.0 110.516 177.526 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.5 tp -71.39 126.79 30.57 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.074 -0.713 . . . . 25.0 109.074 -178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.6 tp -115.21 1.82 8.19 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 121.997 0.904 . . . . 25.0 109.027 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 165.55 156.08 9.03 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 115.838 1.095 . . . . 25.0 115.838 170.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -144.62 128.04 16.92 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 105.239 -2.134 . . . . 25.0 105.239 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 96.1 t -140.5 123.09 9.85 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 122.568 0.347 . . . . 25.0 110.336 -170.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -78.7 168.58 20.9 Favored 'Trans proline' 0 C--N 1.348 0.544 0 C-N-CA 117.191 -1.406 . . . . 25.0 111.973 176.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -82.65 121.0 26.28 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 119.891 -0.723 . . . . 25.0 111.987 -176.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.6 t0 58.77 33.14 22.86 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 115.92 1.822 . . . . 25.0 115.92 170.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -67.43 165.12 44.11 Favored Glycine 0 C--O 1.219 -0.84 0 N-CA-C 110.968 -0.853 . . . . 25.0 110.968 175.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 38.3 t -54.9 -47.41 98.42 Favored Pre-proline 0 CA--C 1.554 1.116 0 N-CA-C 117.3 2.333 . . . . 25.0 117.3 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -72.08 159.82 49.03 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 114.17 -3.42 . . . . 25.0 114.648 -175.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.75 -14.23 20.02 Favored 'General case' 0 CA--C 1.548 0.868 0 N-CA-C 113.817 1.043 . . . . 25.0 113.817 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 37.7 p -68.88 -10.47 57.22 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 111.802 0.297 . . . . 25.0 111.802 176.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 35.3 ptt180 -59.64 -16.89 29.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.424 1.268 . . . . 25.0 114.424 178.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.55 141.51 58.74 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.334 0.587 . . . . 25.0 111.625 -173.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 8.3 tp -72.21 -25.42 61.64 Favored 'General case' 0 C--O 1.217 -0.626 0 N-CA-C 108.439 -0.948 . . . . 25.0 108.439 175.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 28.9 t -89.23 134.04 34.2 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.438 -0.949 . . . . 25.0 108.438 177.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -138.86 150.92 46.54 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.619 0.723 . . . . 25.0 112.658 -176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 67.9 m-70 -92.53 132.89 36.46 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 108.239 -1.022 . . . . 25.0 108.239 176.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.1 mm -132.62 119.15 37.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 108.242 -1.021 . . . . 25.0 108.242 178.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 83.7 t80 -82.27 139.47 34.18 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.253 -1.017 . . . . 25.0 108.253 174.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 33.1 mm -125.93 128.22 24.58 Favored Pre-proline 0 CA--C 1.54 0.593 0 N-CA-C 108.237 -1.023 . . . . 25.0 108.237 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -71.64 167.33 26.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 CA-C-N 118.566 0.524 . . . . 25.0 111.592 177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.1 tt0 -122.91 30.51 6.38 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.655 0.741 . . . . 25.0 111.523 -175.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 13.2 p-10 -78.37 -20.72 50.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.993 -0.548 . . . . 25.0 111.986 -178.423 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -143.35 169.84 16.91 Favored 'General case' 0 CA--C 1.514 -0.434 0 N-CA-C 109.665 -0.495 . . . . 25.0 109.665 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -125.9 150.41 47.96 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.832 -0.622 . . . . 25.0 109.545 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 150.08 165.5 12.62 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.469 0.547 . . . . 25.0 114.469 176.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 40.2 p90 -86.94 147.21 25.86 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 113.744 1.016 . . . . 25.0 113.744 -176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 63.7 m-70 -139.65 158.92 43.31 Favored 'General case' 0 C--O 1.214 -0.764 0 CA-C-N 114.525 -1.216 . . . . 25.0 108.001 -176.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.419 ' H ' ' CG2' ' A' ' 100' ' ' THR . 52.8 t -116.41 136.54 53.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 N-CA-C 108.045 -1.094 . . . . 25.0 108.045 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 77.3 mt -106.49 129.51 59.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 N-CA-C 106.001 -1.851 . . . . 25.0 106.001 175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 3.6 mt -127.25 135.58 50.81 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.926 -0.398 . . . . 25.0 109.926 179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.0 130.18 31.07 Favored 'General case' 0 C--O 1.216 -0.666 0 CA-C-N 116.614 -0.266 . . . . 25.0 110.721 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 96.4 t -96.79 128.82 47.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 106.299 -1.741 . . . . 25.0 106.299 175.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 46.0 t90 -125.64 108.67 11.78 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 -174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -96.17 107.72 20.09 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-N 115.978 -0.556 . . . . 25.0 112.327 -171.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.47 135.46 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 107.514 -1.291 . . . . 25.0 107.514 177.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.01 -32.23 27.03 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.014 0.435 . . . . 25.0 111.849 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 -79.28 -12.68 59.94 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 114.733 1.383 . . . . 25.0 114.733 -170.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 71.0 p -139.21 165.8 26.22 Favored 'General case' 0 C--O 1.221 -0.429 0 N-CA-C 113.166 0.802 . . . . 25.0 113.166 -171.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.61 5.2 16.17 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.546 0.689 . . . . 25.0 110.756 172.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -102.79 150.08 23.84 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 107.908 -1.145 . . . . 25.0 107.908 -179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -155.23 170.55 21.59 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 102.544 -3.132 . . . . 25.0 102.544 -178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.444 ' HB3' HE22 ' A' ' 163' ' ' GLN . 23.7 t80 -143.48 151.83 40.77 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 119.765 1.166 . . . . 25.0 113.411 178.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -104.93 120.5 41.58 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 106.681 -1.6 . . . . 25.0 106.681 175.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.444 HE22 ' HB3' ' A' ' 161' ' ' PHE . 19.9 mm-40 -94.53 130.82 40.79 Favored 'General case' 0 C--N 1.319 -0.719 0 N-CA-C 104.99 -2.226 . . . . 25.0 104.99 -178.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 12.5 p -133.11 133.49 58.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 108.824 -0.806 . . . . 25.0 108.824 -178.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.0 mt -139.35 128.69 29.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 -178.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -85.3 133.03 34.17 Favored 'General case' 0 C--O 1.241 0.635 0 N-CA-C 108.789 -0.819 . . . . 25.0 108.789 175.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.37 149.14 30.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 N-CA-C 108.416 -0.957 . . . . 25.0 108.416 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.445 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 36.3 t0 -120.41 111.11 17.32 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 105.625 -1.991 . . . . 25.0 105.625 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 25.0 mt -109.18 104.63 13.82 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 107.037 -1.468 . . . . 25.0 107.037 -171.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 17.7 m -125.72 168.02 19.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.129 -0.487 . . . . 25.0 111.92 -173.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -80.78 135.97 36.05 Favored 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 108.878 -0.786 . . . . 25.0 108.878 175.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 14.9 pttm . . . . . 0 C--O 1.246 0.869 0 CA-C-O 117.344 -1.313 . . . . 25.0 111.287 176.112 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 . . . . . 0 N--CA 1.486 1.335 0 CA-C-O 119.225 -0.417 . . . . 25.0 111.031 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.33 -163.36 15.72 Favored Glycine 0 N--CA 1.46 0.294 0 N-CA-C 110.529 -1.029 . . . . 25.0 110.529 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 13.2 m-85 -98.24 149.77 22.22 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.798 -0.816 . . . . 25.0 108.798 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.2 mt -102.32 126.77 56.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 C-N-CA 122.427 0.291 . . . . 25.0 110.307 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 19.9 tp10 -103.47 -34.3 8.75 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.684 0.754 . . . . 25.0 111.054 179.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -148.27 143.01 16.98 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 -176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.0 137.63 50.79 Favored 'Cis proline' 0 C--N 1.352 0.736 0 N-CA-C 117.863 2.216 . . . . 25.0 117.863 2.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 83.21 137.12 2.94 Favored Glycine 0 C--O 1.221 -0.711 0 N-CA-C 117.388 1.715 . . . . 25.0 117.388 169.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -76.17 147.98 38.09 Favored 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.116 0.484 . . . . 25.0 111.249 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 83.5 mtp180 -68.22 -37.96 81.4 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.729 -0.669 . . . . 25.0 111.602 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.37 -22.83 66.42 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 113.52 0.933 . . . . 25.0 113.52 -174.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.67 -28.02 69.09 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.255 0.465 . . . . 25.0 112.255 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.94 -9.16 44.11 Favored 'General case' 0 C--O 1.22 -0.5 0 N-CA-C 111.85 0.315 . . . . 25.0 111.85 -177.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 37.4 t -78.84 -16.15 57.45 Favored 'General case' 0 C--O 1.217 -0.641 0 CA-C-O 121.251 0.548 . . . . 25.0 110.839 -177.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 45.0 t -77.74 144.29 37.33 Favored 'General case' 0 C--N 1.321 -0.637 0 O-C-N 121.885 -0.509 . . . . 25.0 109.916 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 57.1 mt-10 -64.1 -20.3 65.86 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.188 0.518 . . . . 25.0 109.738 176.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.5 -13.11 18.33 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.475 0.546 . . . . 25.0 112.475 176.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 69.1 t80 -78.62 -8.94 59.16 Favored 'General case' 0 CA--C 1.539 0.548 0 O-C-N 122.225 -0.297 . . . . 25.0 111.157 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -177.36 -4.8 0.02 OUTLIER Glycine 0 CA--C 1.521 0.423 0 N-CA-C 120.067 2.787 . . . . 25.0 120.067 175.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 57.6 t80 64.11 -40.64 0.24 Allowed 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 117.558 2.429 . . . . 25.0 117.558 177.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 79.3 mt -103.77 0.61 30.65 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.254 0.55 . . . . 25.0 111.002 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -80.91 177.23 9.18 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.757 -0.656 . . . . 25.0 109.419 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.6 mp -75.04 155.56 37.13 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.512 -1.662 . . . . 25.0 106.512 175.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -69.14 15.45 0.07 Allowed 'General case' 0 N--CA 1.478 0.93 0 N-CA-C 115.725 1.75 . . . . 25.0 115.725 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.3 t -176.63 -34.21 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 124.081 0.952 . . . . 25.0 110.019 173.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 97.1 132.37 7.38 Favored Glycine 0 C--O 1.221 -0.659 0 CA-C-N 115.444 -0.798 . . . . 25.0 112.514 -178.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 20.6 t -67.73 -28.65 67.83 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.403 0.62 . . . . 25.0 112.484 -176.526 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.2 p -57.54 -15.38 3.87 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.649 0 N-CA-C 113.749 1.018 . . . . 25.0 113.749 -177.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 19.8 ptt? -68.63 -14.26 62.9 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 121.156 -0.965 . . . . 25.0 112.957 178.011 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.5 t80 -77.64 -37.64 49.58 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.87 -0.332 . . . . 25.0 111.68 -174.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -149.63 63.58 6.54 Favored Pre-proline 0 CA--C 1.544 0.739 0 N-CA-C 114.115 1.154 . . . . 25.0 114.115 177.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -70.28 -9.15 25.29 Favored 'Trans proline' 0 C--N 1.349 0.599 0 C-N-CA 118.096 -0.803 . . . . 25.0 114.083 -178.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 -97.82 -0.19 45.63 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 112.241 0.46 . . . . 25.0 112.241 177.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 23.2 t -87.3 94.13 9.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 107.764 -1.199 . . . . 25.0 107.764 -179.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.0 mt -129.78 133.43 46.99 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.042 -1.095 . . . . 25.0 108.042 -176.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -125.9 131.89 52.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.444 0.566 . . . . 25.0 109.731 175.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.01 163.53 32.45 Favored 'General case' 0 C--O 1.219 -0.524 0 CA-C-N 115.609 -0.723 . . . . 25.0 109.98 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -73.95 175.14 7.64 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 112.973 0.731 . . . . 25.0 112.973 -176.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -52.92 141.34 22.18 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.99 0.737 . . . . 25.0 112.99 179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.59 18.66 15.03 Favored Glycine 0 C--O 1.225 -0.451 0 CA-C-N 115.651 -0.704 . . . . 25.0 113.539 -179.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 76.2 m-85 -89.93 132.29 36.78 Favored Pre-proline 0 C--N 1.32 -0.702 0 N-CA-C 108.599 -0.889 . . . . 25.0 108.599 179.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -77.99 143.48 73.54 Favored 'Cis proline' 0 C--N 1.351 0.671 0 C-N-CA 130.825 1.594 . . . . 25.0 113.747 -2.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -68.09 -14.24 62.83 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 113.891 1.071 . . . . 25.0 113.891 -175.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.7 t -80.99 -12.28 59.41 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 116.131 -0.486 . . . . 25.0 111.222 179.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.35 179.0 43.37 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 120.885 -0.674 . . . . 25.0 114.48 -176.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -77.11 -173.38 1.76 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.726 2.284 . . . . 25.0 110.29 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.18 123.58 19.0 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 120.737 -0.385 . . . . 25.0 110.24 177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -100.05 -178.85 3.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.14 0.495 . . . . 25.0 111.011 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.82 3.04 87.27 Favored Glycine 0 C--N 1.328 0.108 0 CA-C-O 121.122 0.29 . . . . 25.0 112.636 179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -142.71 4.51 1.52 Allowed 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.367 0.506 . . . . 25.0 112.367 -173.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 46.3 mm -59.01 -36.01 59.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.968 0.729 . . . . 25.0 112.968 -170.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -53.3 -39.71 64.21 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 113.878 1.066 . . . . 25.0 113.878 -177.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 11.2 m -112.88 -16.65 12.67 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 113.675 0.991 . . . . 25.0 113.675 -178.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 54.86 36.04 25.68 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.627 0.771 . . . . 25.0 109.864 -172.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.06 -16.67 80.51 Favored Glycine 0 C--O 1.222 -0.632 0 N-CA-C 115.526 0.971 . . . . 25.0 115.526 -173.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.45 -21.14 70.34 Favored Glycine 0 C--O 1.223 -0.535 0 CA-C-N 118.014 0.907 . . . . 25.0 113.588 -177.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 67.7 mt -62.1 -45.9 91.45 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.925 0.869 . . . . 25.0 109.534 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 64.3 m-85 -84.87 -13.19 51.68 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.49 -0.777 . . . . 25.0 110.598 179.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -60.71 -34.34 86.18 Favored Glycine 0 C--O 1.216 -0.989 0 CA-C-N 116.072 -0.513 . . . . 25.0 112.475 -178.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -65.82 -30.64 77.63 Favored Glycine 0 C--O 1.222 -0.607 0 C-N-CA 120.358 -0.925 . . . . 25.0 112.493 178.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.3 mm -69.51 -43.82 80.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.286 -1.005 . . . . 25.0 108.286 179.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.5 mp -68.54 -34.42 75.82 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.722 -0.672 . . . . 25.0 110.689 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -67.42 -30.66 70.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.394 0.516 . . . . 25.0 112.394 -177.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -68.04 -6.05 20.62 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 121.604 -0.685 . . . . 25.0 111.921 177.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -130.3 37.5 3.87 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 109.34 -0.615 . . . . 25.0 109.34 173.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.3 t -120.42 169.54 10.22 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.943 -0.571 . . . . 25.0 109.794 -178.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -65.99 -28.1 68.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.495 0.664 . . . . 25.0 109.983 176.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -96.18 19.99 10.97 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.621 -0.718 . . . . 25.0 111.438 -177.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -49.75 135.58 18.97 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.602 0.715 . . . . 25.0 111.536 -178.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 25.2 m95 -87.76 154.75 20.31 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 122.057 0.932 . . . . 25.0 110.428 -179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -66.41 147.14 53.72 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.083 -0.962 . . . . 25.0 110.152 -178.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -116.22 132.32 56.7 Favored 'General case' 0 CA--C 1.508 -0.659 0 N-CA-C 108.468 -0.938 . . . . 25.0 108.468 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -119.9 135.89 54.72 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 171.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 72.4 mt -92.99 136.29 25.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 106.29 -1.745 . . . . 25.0 106.29 178.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 23.1 ttt -150.59 168.14 25.17 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 106.236 -1.765 . . . . 25.0 106.236 -178.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 16.8 p -90.52 166.7 13.08 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 105.79 -1.93 . . . . 25.0 105.79 175.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.25 -164.28 10.65 Favored Glycine 0 CA--C 1.521 0.414 0 CA-C-N 117.925 0.33 . . . . 25.0 113.667 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.06 -175.77 31.24 Favored Glycine 0 N--CA 1.458 0.114 0 O-C-N 122.348 -0.501 . . . . 25.0 112.2 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 15.0 tt0 -69.73 134.65 48.86 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 121.754 -0.85 . . . . 25.0 109.444 178.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.4 m170 -125.59 158.23 35.16 Favored 'General case' 0 CA--C 1.508 -0.661 0 N-CA-C 108.561 -0.903 . . . . 25.0 108.561 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 33.0 m -117.63 116.28 26.75 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 105.898 -1.89 . . . . 25.0 105.898 176.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -93.01 136.87 32.88 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 105.901 -1.889 . . . . 25.0 105.901 -176.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.7 m -127.62 115.53 18.92 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 25.0 110.469 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -122.3 145.2 48.47 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 104.387 -2.449 . . . . 25.0 104.387 177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.1 t -145.02 156.74 44.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.622 -0.51 . . . . 25.0 109.622 -179.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.4 t80 -139.82 154.45 47.35 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 173.497 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -71.42 -13.25 61.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.398 0.888 . . . . 25.0 113.398 -175.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.12 158.34 64.72 Favored Pre-proline 0 C--N 1.325 -0.485 0 N-CA-C 108.275 -1.009 . . . . 25.0 108.275 -179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.16 150.86 72.36 Favored 'Trans proline' 0 CA--C 1.534 0.521 0 C-N-CA 114.581 -3.146 . . . . 25.0 109.594 170.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -130.98 132.81 45.26 Favored 'General case' 0 CA--C 1.511 -0.538 0 N-CA-C 108.361 -0.978 . . . . 25.0 108.361 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 74.9 m-20 -66.05 144.89 56.43 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.247 0.546 . . . . 25.0 109.689 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.5 t -162.92 152.07 15.01 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 102.368 -3.197 . . . . 25.0 102.368 177.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 28.5 t -94.5 -40.13 10.04 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.715 0.769 . . . . 25.0 108.946 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -156.1 148.96 24.09 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.799 -0.815 . . . . 25.0 108.799 -175.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -138.59 142.31 39.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 107.32 -1.363 . . . . 25.0 107.32 170.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -147.61 156.33 42.69 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 122.394 -0.191 . . . . 25.0 110.723 -172.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -130.52 144.94 51.74 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 123.642 0.589 . . . . 25.0 111.3 -174.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 43.1 m-85 -131.96 159.7 37.96 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 106.021 -1.844 . . . . 25.0 106.021 178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.447 HD12 ' HB ' ' A' ' 118' ' ' ILE . 0.1 OUTLIER -135.96 158.1 38.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 108.423 -0.954 . . . . 25.0 108.423 175.065 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 55.9 p -103.23 138.69 39.69 Favored 'General case' 0 C--O 1.249 1.032 0 CA-C-O 121.489 0.661 . . . . 25.0 110.942 178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -88.0 117.72 27.07 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.732 -0.84 . . . . 25.0 108.732 178.039 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -75.98 128.36 34.89 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 102.575 -3.121 . . . . 25.0 102.575 170.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.67 30.67 12.75 Favored Glycine 0 C--O 1.227 -0.293 0 C-N-CA 118.856 -1.64 . . . . 25.0 113.611 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 5.0 p90 -51.77 148.16 5.94 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 117.688 0.744 . . . . 25.0 110.172 177.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 48.5 m-20 -68.97 129.43 92.26 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.998 -0.547 . . . . 25.0 110.22 -173.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -73.22 -14.03 25.7 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 118.484 -0.544 . . . . 25.0 113.451 -178.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -75.5 -10.23 59.27 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.778 0.799 . . . . 25.0 110.808 178.266 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.8 mttt -116.55 148.99 43.02 Favored Pre-proline 0 C--N 1.327 -0.391 0 N-CA-C 109.558 -0.534 . . . . 25.0 109.558 -175.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -65.2 125.93 15.46 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 116.616 -1.79 . . . . 25.0 112.059 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.0 tt -52.99 -50.43 64.16 Favored 'General case' 0 C--O 1.207 -1.152 0 CA-C-N 115.079 -0.964 . . . . 25.0 113.158 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 39.2 mtmt -68.55 -2.96 10.02 Favored 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 114.748 1.388 . . . . 25.0 114.748 -174.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.86 -49.33 3.53 Favored 'General case' 0 C--O 1.217 -0.621 0 CA-C-O 121.138 0.494 . . . . 25.0 111.703 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.01 2.06 50.8 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 115.186 1.55 . . . . 25.0 115.186 -170.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 15.1 p-10 -77.63 -29.05 51.56 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.479 0.548 . . . . 25.0 112.479 -177.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -126.01 151.12 47.51 Favored 'General case' 0 N--CA 1.468 0.433 0 N-CA-C 112.694 0.628 . . . . 25.0 112.694 178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -140.11 154.66 47.08 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 109.179 -0.674 . . . . 25.0 109.179 178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -82.71 128.04 33.98 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 109.098 -0.704 . . . . 25.0 109.098 177.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.447 ' HB ' HD12 ' A' ' 99' ' ' ILE . 10.0 tt -104.25 -9.47 9.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.515 0 CA-C-O 121.297 0.57 . . . . 25.0 111.609 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.92 160.12 21.62 Favored Glycine 0 CA--C 1.511 -0.197 0 C-N-CA 119.86 -1.162 . . . . 25.0 114.33 176.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -148.55 142.03 25.33 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.779 -1.193 . . . . 25.0 107.779 178.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 42.3 t -135.32 111.62 10.84 Favored Pre-proline 0 C--N 1.324 -0.5 0 N-CA-C 108.957 -0.757 . . . . 25.0 108.957 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.78 163.96 25.85 Favored 'Trans proline' 0 C--O 1.241 0.666 0 C-N-CA 116.013 -2.192 . . . . 25.0 111.299 176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 63.9 t60 -138.45 113.88 9.6 Favored 'General case' 0 CA--C 1.501 -0.936 0 CA-C-O 122.219 1.009 . . . . 25.0 109.276 173.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 19.2 t0 -172.44 -107.2 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.928 1 N-CA-C 99.111 -4.403 . . . . 25.0 99.111 -178.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -84.53 54.19 4.9 Favored Glycine 0 C--O 1.225 -0.455 0 N-CA-C 110.377 -1.089 . . . . 25.0 110.377 171.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 14.1 t -81.99 132.88 52.57 Favored Pre-proline 0 C--N 1.322 -0.597 0 O-C-N 122.382 -0.481 . . . . 25.0 110.245 -174.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.3 Cg_endo -75.08 -157.22 0.06 OUTLIER 'Trans proline' 0 C--N 1.354 0.844 0 C-N-CA 121.691 1.594 . . . . 25.0 111.423 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -54.33 -21.06 8.42 Favored 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 32.9 t -64.71 -8.0 12.99 Favored 'General case' 0 CA--C 1.543 0.688 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 175.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -62.56 -14.16 39.21 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 114.282 1.215 . . . . 25.0 114.282 178.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -62.17 137.8 58.31 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.512 -0.551 . . . . 25.0 109.512 -179.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -69.46 -20.33 63.75 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 114.153 1.168 . . . . 25.0 114.153 -175.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.6 t -99.97 132.99 44.99 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 -178.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -137.43 149.82 47.16 Favored 'General case' 0 CA--C 1.514 -0.408 0 N-CA-C 113.028 0.751 . . . . 25.0 113.028 -172.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.4 m-70 -81.66 133.31 35.35 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.408 -1.701 . . . . 25.0 106.408 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 33.2 mm -131.98 118.36 37.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 105.552 -2.018 . . . . 25.0 105.552 177.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 49.6 t80 -84.57 125.67 32.64 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 108.842 -0.799 . . . . 25.0 108.842 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 55.5 mt -126.14 104.28 25.94 Favored Pre-proline 0 C--O 1.236 0.39 0 CA-C-O 120.508 0.194 . . . . 25.0 110.516 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -72.63 150.9 51.68 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 116.027 -2.182 . . . . 25.0 109.486 173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -149.2 102.75 3.26 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.496 -0.557 . . . . 25.0 109.496 -177.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -91.73 -17.93 24.68 Favored 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 112.489 0.552 . . . . 25.0 112.489 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 26.8 mtt180 -140.93 169.91 16.74 Favored 'General case' 0 C--O 1.209 -1.076 0 N-CA-C 107.62 -1.252 . . . . 25.0 107.62 -176.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.8 mp -90.41 128.97 36.64 Favored 'General case' 0 C--O 1.243 0.743 0 N-CA-C 107.751 -1.203 . . . . 25.0 107.751 -176.476 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . -179.36 163.37 30.77 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 118.202 2.041 . . . . 25.0 118.202 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 19.6 p90 -87.09 147.04 25.83 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 113.64 -1.28 . . . . 25.0 110.384 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -134.94 150.41 50.39 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 106.712 -1.588 . . . . 25.0 106.712 176.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 47.9 t -111.06 127.97 67.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 N-CA-C 105.038 -2.208 . . . . 25.0 105.038 176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.0 mt -108.96 116.85 53.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 106.487 -1.672 . . . . 25.0 106.487 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.1 tt -99.09 133.63 43.08 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.665 -1.235 . . . . 25.0 107.665 -178.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -122.85 145.77 48.15 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.89 0.376 . . . . 25.0 110.069 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 22.7 t -126.57 134.05 67.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.013 -1.106 . . . . 25.0 108.013 179.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 52.2 t-105 -129.18 99.0 5.08 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 107.419 -1.326 . . . . 25.0 107.419 179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -85.83 106.79 17.31 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.084 -0.507 . . . . 25.0 111.891 -173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 87.4 t -92.48 126.69 44.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.709 0 N-CA-C 105.14 -2.17 . . . . 25.0 105.14 174.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -93.35 -13.52 28.01 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 108.419 -0.956 . . . . 25.0 108.419 -178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -77.43 -1.39 29.99 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.288 -1.324 . . . . 25.0 112.035 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 9.9 t -152.95 165.87 34.16 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.927 -0.768 . . . . 25.0 108.927 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -65.13 -25.02 67.58 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 113.764 1.024 . . . . 25.0 113.764 -176.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -110.07 159.1 17.62 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 113.183 0.809 . . . . 25.0 113.183 -173.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 163.86 18.68 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 104.639 -2.356 . . . . 25.0 104.639 176.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -108.94 127.93 54.49 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 120.774 -0.37 . . . . 25.0 111.047 -177.318 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 85.0 m-85 -119.95 137.76 53.86 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 178.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -148.96 166.05 29.76 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.74 -0.467 . . . . 25.0 109.74 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 23.4 m -125.97 150.98 31.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.339 -0.986 . . . . 25.0 108.339 175.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 43.3 mm -130.09 118.44 43.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 105.905 -1.887 . . . . 25.0 105.905 178.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.2 m-20 -92.21 134.2 35.1 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.473 0.654 . . . . 25.0 110.577 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 30.1 m -134.58 157.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 107.966 -1.124 . . . . 25.0 107.966 178.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 0.7 OUTLIER -127.25 119.21 25.82 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 105.234 -2.136 . . . . 25.0 105.234 174.979 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 91.7 mt -119.86 132.38 55.55 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.097 0.475 . . . . 25.0 110.208 -170.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.0 m -127.91 163.57 31.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.904 -0.589 . . . . 25.0 110.969 -175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -78.08 158.28 29.21 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 107.325 -1.361 . . . . 25.0 107.325 174.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 116.609 -1.662 . . . . 25.0 107.799 178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 . . . . . 0 N--CA 1.499 1.987 0 CA-C-O 121.559 0.695 . . . . 25.0 112.081 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -152.71 -179.0 27.91 Favored Glycine 0 C--O 1.236 0.261 1 N-CA-C 102.497 -4.241 . . . . 25.0 102.497 173.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 7.1 p90 -144.46 149.15 35.52 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 120.093 1.946 . . . . 25.0 113.103 179.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.9 mm -94.84 120.4 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 CA-C-N 115.143 -0.935 . . . . 25.0 109.996 -177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -98.92 -13.09 20.14 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 112.527 0.566 . . . . 25.0 112.527 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.0 ttmt -162.7 142.81 7.29 Favored Pre-proline 0 C--O 1.236 0.375 0 N-CA-C 108.937 -0.764 . . . . 25.0 108.937 -178.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.84 126.61 12.95 Favored 'Cis proline' 0 C--N 1.349 0.564 0 C-N-CA 130.373 1.406 . . . . 25.0 113.999 -1.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 71.14 -167.81 51.21 Favored Glycine 0 C--O 1.226 -0.352 0 N-CA-C 111.276 -0.73 . . . . 25.0 111.276 -178.868 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.2 t -141.29 136.47 31.61 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 107.634 -1.246 . . . . 25.0 107.634 177.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 50.2 ptt85 -67.28 -21.12 65.72 Favored 'General case' 0 C--O 1.215 -0.75 0 N-CA-C 112.43 0.53 . . . . 25.0 112.43 -178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -65.25 -35.14 80.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.132 0.492 . . . . 25.0 110.641 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -69.73 -27.56 65.07 Favored 'General case' 0 C--O 1.216 -0.681 0 CA-C-O 120.876 0.37 . . . . 25.0 110.639 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 78.7 mt -85.92 -4.25 59.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.219 -0.446 . . . . 25.0 110.825 -179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 42.9 t -111.75 -11.52 13.95 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.661 -0.7 . . . . 25.0 110.078 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 49.9 m -77.42 134.98 38.27 Favored 'General case' 0 C--O 1.219 -0.527 0 N-CA-C 108.124 -1.065 . . . . 25.0 108.124 177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 14.7 tt0 -78.55 -74.08 0.29 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 120.033 -0.667 . . . . 25.0 111.958 -176.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.49 -53.02 2.45 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 115.554 1.687 . . . . 25.0 115.554 176.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 68.4 m-85 -110.99 26.03 11.15 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 114.772 -1.104 . . . . 25.0 113.449 -166.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 88.76 34.5 9.06 Favored Glycine 0 C--O 1.222 -0.612 0 C-N-CA 120.022 -1.085 . . . . 25.0 111.231 -176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.3 t80 63.45 38.32 10.03 Favored 'General case' 0 N--CA 1.471 0.613 0 N-CA-C 115.162 1.541 . . . . 25.0 115.162 175.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 93.6 mt -70.14 -16.32 63.08 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 108.774 -0.825 . . . . 25.0 108.774 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -120.62 137.76 54.26 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 106.548 -1.649 . . . . 25.0 106.548 178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.5 mp -85.21 111.24 19.65 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.1 0.407 . . . . 25.0 112.1 -177.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.0 t-20 -148.45 46.59 1.05 Allowed 'General case' 0 CA--C 1.545 0.769 0 CA-C-N 115.487 -0.779 . . . . 25.0 111.931 -179.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.8 t -145.32 7.03 1.14 Allowed 'General case' 0 N--CA 1.479 0.991 0 CA-C-O 121.475 0.655 . . . . 25.0 112.671 -175.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 77.29 172.49 37.56 Favored Glycine 0 C--O 1.217 -0.92 0 C-N-CA 120.95 -0.643 . . . . 25.0 113.082 -179.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.0 t -78.99 -33.5 44.96 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.037 0.754 . . . . 25.0 113.037 -177.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.63 -9.94 10.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 113.329 0.862 . . . . 25.0 113.329 -174.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 18.6 ptt? -50.35 -22.05 1.67 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 117.742 2.497 . . . . 25.0 117.742 -176.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -79.91 -35.96 37.11 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 121.459 -0.776 . . . . 25.0 112.045 -172.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -151.88 63.31 5.22 Favored Pre-proline 0 CA--C 1.541 0.611 0 N-CA-C 113.173 0.805 . . . . 25.0 113.173 175.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -74.28 -6.46 18.43 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 117.411 -1.26 . . . . 25.0 112.296 -179.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 17.3 pt20 -93.68 4.97 53.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.557 -0.747 . . . . 25.0 112.115 179.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.7 t -92.34 93.94 8.88 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.219 -1.03 . . . . 25.0 108.219 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.0 mt -116.47 104.95 11.95 Favored 'General case' 0 C--O 1.238 0.454 0 N-CA-C 108.686 -0.857 . . . . 25.0 108.686 175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -129.9 146.17 51.61 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.947 0.404 . . . . 25.0 110.628 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -134.5 145.53 48.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.995 -0.743 . . . . 25.0 108.995 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -93.02 142.21 27.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.686 0.279 . . . . 25.0 110.417 179.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 48.8 mttp -71.47 135.51 47.19 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.246 -1.02 . . . . 25.0 108.246 175.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 150.73 143.4 3.72 Favored Glycine 0 C--O 1.225 -0.462 0 C-N-CA 121.065 -0.588 . . . . 25.0 112.987 177.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -90.05 151.92 45.6 Favored Pre-proline 0 C--N 1.324 -0.52 0 O-C-N 122.573 -0.369 . . . . 25.0 110.574 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -72.88 -27.86 7.6 Favored 'Cis proline' 0 C--N 1.352 0.749 0 N-CA-C 113.463 0.524 . . . . 25.0 113.463 -1.179 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 12.3 p80 160.85 -39.8 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 127.117 2.167 . . . . 25.0 106.759 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.1 m 64.65 -42.77 0.3 Allowed 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 116.529 2.048 . . . . 25.0 116.529 177.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.01 -154.89 17.37 Favored Glycine 0 C--O 1.239 0.414 0 N-CA-C 109.192 -1.563 . . . . 25.0 109.192 172.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -67.18 -177.29 1.01 Allowed 'Trans proline' 0 CA--C 1.536 0.607 0 CA-C-N 119.787 1.793 . . . . 25.0 110.751 175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -79.98 101.44 8.65 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.169 -1.789 . . . . 25.0 106.169 176.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -99.06 158.84 15.39 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.663 -0.698 . . . . 25.0 109.596 -177.424 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 75.28 0.52 61.93 Favored Glycine 0 C--O 1.226 -0.365 0 C-N-CA 120.772 -0.728 . . . . 25.0 114.005 177.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -66.94 -9.36 37.53 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.957 0.725 . . . . 25.0 112.957 -178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 43.9 mm -67.0 -39.4 83.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 108.358 -0.979 . . . . 25.0 108.358 172.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.74 -32.26 67.55 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-O 121.166 0.508 . . . . 25.0 110.038 179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 2.3 m -74.03 -6.39 47.18 Favored 'General case' 0 C--O 1.24 0.56 0 CA-C-N 116.089 -0.505 . . . . 25.0 110.597 175.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.51 20.0 7.12 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 125.202 1.401 . . . . 25.0 112.546 -176.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.04 -24.71 28.84 Favored Glycine 0 C--O 1.224 -0.496 0 N-CA-C 109.771 -1.331 . . . . 25.0 109.771 177.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.52 -14.01 68.97 Favored Glycine 0 C--O 1.224 -0.47 0 C-N-CA 121.272 -0.49 . . . . 25.0 113.085 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 91.3 mt -59.81 -43.89 94.26 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.532 0.682 . . . . 25.0 109.948 178.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -69.51 -25.52 64.09 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.626 -0.715 . . . . 25.0 111.468 -177.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -69.04 -31.83 72.64 Favored Glycine 0 C--O 1.225 -0.448 0 C-N-CA 120.836 -0.697 . . . . 25.0 111.52 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.67 -20.53 72.17 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 120.952 -0.642 . . . . 25.0 112.891 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 46.9 mm -70.95 -38.21 71.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 N-CA-C 108.731 -0.84 . . . . 25.0 108.731 178.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.8 mp -81.25 -43.89 18.55 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.997 0.427 . . . . 25.0 111.308 -178.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -74.73 -4.44 37.51 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.863 1.06 . . . . 25.0 113.863 -173.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 22.7 pt20 -62.1 -13.4 26.36 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 113.335 0.865 . . . . 25.0 113.335 -177.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -133.88 82.8 2.0 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 107.669 -1.234 . . . . 25.0 107.669 171.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.4 t -145.74 152.22 39.23 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.344 -0.614 . . . . 25.0 109.344 -174.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -72.03 -25.76 61.93 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.392 0.615 . . . . 25.0 110.959 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 -97.18 7.34 46.79 Favored 'General case' 0 N--CA 1.468 0.474 0 CA-C-N 115.973 -0.558 . . . . 25.0 111.424 -177.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . 0.438 ' HG2' ' H ' ' A' ' 70' ' ' TRP . 44.7 ttp180 -65.43 169.37 6.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 122.471 1.129 . . . . 25.0 110.219 -178.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . 0.438 ' H ' ' HG2' ' A' ' 69' ' ' ARG . 20.7 p90 -91.37 165.94 13.15 Favored 'General case' 0 C--N 1.314 -0.96 0 N-CA-C 107.103 -1.443 . . . . 25.0 107.103 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -76.12 151.87 36.9 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.273 -0.64 . . . . 25.0 109.273 -178.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -121.14 123.21 41.75 Favored 'General case' 0 CA--C 1.513 -0.477 0 N-CA-C 106.078 -1.823 . . . . 25.0 106.078 176.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 50.9 t60 -118.82 126.09 51.04 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.315 0.487 . . . . 25.0 112.315 -177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 71.3 mt -69.5 132.2 33.32 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 108.682 -0.858 . . . . 25.0 108.682 177.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 36.2 ttp -150.69 157.56 43.11 Favored 'General case' 0 C--O 1.215 -0.758 0 N-CA-C 107.809 -1.182 . . . . 25.0 107.809 -178.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 32.0 p -95.01 163.79 13.16 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.081 -0.387 . . . . 25.0 110.143 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.23 172.23 50.25 Favored Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.937 -0.649 . . . . 25.0 112.815 178.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 116.57 -166.2 12.36 Favored Glycine 0 C--O 1.228 -0.258 0 O-C-N 122.516 -0.402 . . . . 25.0 112.367 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -76.84 140.54 40.67 Favored 'General case' 0 C--N 1.324 -0.522 0 O-C-N 122.058 -0.672 . . . . 25.0 111.417 178.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -136.02 158.54 44.16 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.391 -1.337 . . . . 25.0 107.391 176.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 40.8 m -126.07 123.77 39.12 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.234 -1.024 . . . . 25.0 108.234 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -116.23 139.58 50.21 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.003 -1.11 . . . . 25.0 108.003 -178.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 12.6 t -137.96 145.99 42.64 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.3 -1.37 . . . . 25.0 107.3 173.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.5 m0 -121.42 145.18 48.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 106.777 -1.564 . . . . 25.0 106.777 -179.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.7 p -131.47 161.96 31.31 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.338 -1.356 . . . . 25.0 107.338 177.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -138.41 153.65 48.89 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 107.597 -1.26 . . . . 25.0 107.597 -178.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 58.1 p -81.02 -11.89 59.46 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 111.934 0.346 . . . . 25.0 111.934 -178.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.82 139.92 20.75 Favored Pre-proline 0 C--O 1.25 1.112 0 N-CA-C 110.371 -0.233 . . . . 25.0 110.371 178.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -73.07 129.54 14.29 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.725 -1.05 . . . . 25.0 110.959 176.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 46.9 p-80 -131.14 158.69 39.79 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.97 -0.382 . . . . 25.0 109.97 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -81.74 157.48 24.53 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.039 -1.097 . . . . 25.0 108.039 173.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 90.3 m -139.31 140.17 37.51 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.543 -0.91 . . . . 25.0 108.543 -174.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 33.1 t -88.5 -48.64 7.45 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 107.238 -1.393 . . . . 25.0 107.238 172.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 24.8 pt20 -165.23 166.36 18.92 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.265 -0.642 . . . . 25.0 109.265 177.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 5.2 p-90 -146.79 138.68 24.55 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 106.456 -1.683 . . . . 25.0 106.456 167.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -147.84 148.91 31.4 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.297 -0.631 . . . . 25.0 109.297 -169.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 23.4 p90 -145.32 148.25 33.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 122.23 1.014 . . . . 25.0 113.289 -174.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -133.77 168.94 17.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.384 -1.28 . . . . 25.0 107.734 -170.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.5 pt -126.54 159.51 35.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 166.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 5.9 t -95.35 135.86 36.43 Favored 'General case' 0 C--O 1.252 1.209 0 N-CA-C 108.796 -0.816 . . . . 25.0 108.796 174.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 44.9 tttp -87.7 124.9 34.05 Favored 'General case' 0 C--O 1.219 -0.519 0 CA-C-N 116.109 -0.496 . . . . 25.0 110.336 -177.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 29.9 mmmt -88.6 153.94 20.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.021 -1.474 . . . . 25.0 107.021 172.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 89.49 15.17 58.91 Favored Glycine 0 C--O 1.225 -0.447 0 C-N-CA 119.147 -1.502 . . . . 25.0 113.059 177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -52.75 153.47 3.22 Favored 'General case' 0 CA--C 1.539 0.555 0 N-CA-C 113.597 0.962 . . . . 25.0 113.597 -178.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -75.79 130.59 78.4 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.78 -0.646 . . . . 25.0 109.52 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -71.92 -15.7 29.44 Favored 'Trans proline' 0 C--N 1.349 0.588 0 C-N-CA 117.174 -1.417 . . . . 25.0 111.777 174.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.61 -21.77 65.39 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 124.309 1.043 . . . . 25.0 111.718 177.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -120.2 141.97 32.74 Favored Pre-proline 0 C--N 1.327 -0.375 0 O-C-N 121.978 -0.451 . . . . 25.0 110.444 -172.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -68.55 134.42 30.61 Favored 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 115.34 -2.64 . . . . 25.0 112.554 -177.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 31.5 mt -57.81 -33.84 69.01 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-N 115.39 -0.823 . . . . 25.0 111.939 -177.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.1 mmmt -53.2 -39.23 63.55 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.609 -0.723 . . . . 25.0 111.286 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -82.28 -51.8 7.56 Favored 'General case' 0 C--O 1.22 -0.469 0 N-CA-C 112.738 0.644 . . . . 25.0 112.738 175.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -73.87 -27.45 61.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 116.855 2.169 . . . . 25.0 116.855 -166.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -71.1 -17.3 62.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.784 1.402 . . . . 25.0 114.784 -170.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -96.74 121.39 38.54 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 114.786 1.402 . . . . 25.0 114.786 -173.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -118.65 112.03 19.3 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.422 -0.585 . . . . 25.0 109.422 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 28.4 tp -70.8 124.24 23.84 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.866 -1.531 . . . . 25.0 106.866 176.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 11.0 tt -115.8 1.82 8.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.919 0.866 . . . . 25.0 109.834 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 169.51 145.8 4.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.761 -0.733 . . . . 25.0 114.004 172.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -141.73 137.91 31.99 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 106.723 -1.584 . . . . 25.0 106.723 177.903 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 13.7 t -132.48 89.27 36.75 Favored Pre-proline 0 C--O 1.24 0.579 0 N-CA-C 108.636 -0.876 . . . . 25.0 108.636 -177.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -73.41 163.49 37.6 Favored 'Trans proline' 0 C--O 1.235 0.327 0 C-N-CA 116.073 -2.151 . . . . 25.0 110.54 177.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 21.8 t-80 -128.22 120.99 28.32 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.434 0.635 . . . . 25.0 109.578 176.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -127.07 -76.7 0.57 Allowed 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 104.002 -2.592 . . . . 25.0 104.002 172.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -147.97 -150.09 5.12 Favored Glycine 0 C--O 1.242 0.603 0 N-CA-C 108.6 -1.8 . . . . 25.0 108.6 173.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 20.2 m 62.59 157.17 0.12 Allowed Pre-proline 0 N--CA 1.477 0.877 0 N-CA-C 114.474 1.287 . . . . 25.0 114.474 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -75.11 0.15 9.3 Favored 'Trans proline' 0 C--N 1.349 0.605 0 C-N-CA 115.781 -2.346 . . . . 25.0 114.799 -177.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -65.88 -41.42 91.59 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 115.443 -0.799 . . . . 25.0 109.486 177.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 90.3 p -79.74 -11.24 59.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.117 0.484 . . . . 25.0 111.626 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 72.3 ttt180 -76.97 -21.0 55.41 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.191 -0.459 . . . . 25.0 110.636 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -74.34 104.93 5.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.885 0.374 . . . . 25.0 111.172 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -93.64 -16.06 24.71 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.019 0.748 . . . . 25.0 113.019 -179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 42.5 t -100.22 126.51 46.52 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.301 -1.37 . . . . 25.0 107.301 179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -131.07 150.5 52.12 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-O 121.559 0.695 . . . . 25.0 111.826 -176.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 -94.73 136.08 35.45 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 105.602 -1.999 . . . . 25.0 105.602 174.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 4.2 mp -132.0 118.97 39.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 106.008 -1.849 . . . . 25.0 106.008 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -80.61 130.58 35.2 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 105.169 -2.16 . . . . 25.0 105.169 172.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 60.7 mt -122.43 111.57 31.64 Favored Pre-proline 0 C--N 1.322 -0.621 0 N-CA-C 107.265 -1.383 . . . . 25.0 107.265 -179.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -73.74 162.0 40.52 Favored 'Trans proline' 0 C--N 1.344 0.307 0 C-N-CA 116.949 -1.567 . . . . 25.0 112.406 -179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 46.1 tt0 -111.24 91.03 3.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 104.517 -2.401 . . . . 25.0 104.517 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.1 p-10 -79.42 -29.77 42.06 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.155 -0.683 . . . . 25.0 109.155 -177.55 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 mtt-85 -155.27 170.0 22.89 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 103.535 -2.765 . . . . 25.0 103.535 -176.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 9.0 mp -93.89 112.68 24.57 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 102.987 -2.968 . . . . 25.0 102.987 173.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 168.27 166.7 27.78 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 121.229 -0.51 . . . . 25.0 112.497 -176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.419 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 49.9 p90 -87.08 142.35 27.99 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 114.778 1.399 . . . . 25.0 114.778 -172.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -129.4 136.85 50.48 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 106.182 -1.784 . . . . 25.0 106.182 178.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 25.1 t -97.91 133.85 38.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.89 -1.152 . . . . 25.0 107.89 178.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 67.8 mt -96.08 126.27 48.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 104.602 -2.37 . . . . 25.0 104.602 176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 50.6 mt -111.6 127.05 55.62 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 107.038 -1.467 . . . . 25.0 107.038 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.34 145.84 52.02 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 118.51 0.596 . . . . 25.0 111.022 -178.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 62.5 t -129.07 138.15 55.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 107.668 -1.234 . . . . 25.0 107.668 177.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t-105 -129.19 120.63 26.12 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.783 -0.821 . . . . 25.0 108.783 177.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -101.45 97.0 7.52 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.327 0.585 . . . . 25.0 109.955 -177.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 94.2 t -78.62 123.03 34.94 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 N-CA-C 108.218 -1.03 . . . . 25.0 108.218 179.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.17 -22.97 59.19 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 113.05 0.759 . . . . 25.0 113.05 -173.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 52.7 m-20 -75.95 -7.61 55.01 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.578 0.955 . . . . 25.0 113.578 -175.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 81.6 p -132.16 158.03 42.75 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 115.522 1.675 . . . . 25.0 115.522 -169.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -82.24 13.07 3.73 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.628 -1.169 . . . . 25.0 109.285 173.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 70.9 m-20 -109.92 162.21 14.73 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.618 -0.719 . . . . 25.0 109.93 -177.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -128.88 150.28 50.41 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 104.381 -2.452 . . . . 25.0 104.381 173.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -122.65 143.11 49.98 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.794 -1.188 . . . . 25.0 107.794 -174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 52.4 p90 -138.93 156.38 47.31 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.384 -0.599 . . . . 25.0 109.384 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.71 149.67 36.0 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.88 -0.415 . . . . 25.0 109.88 -179.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.3 m -130.35 141.98 44.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.72 -0.474 . . . . 25.0 109.72 177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 75.4 mt -139.02 128.53 30.6 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.742 0 N-CA-C 105.396 -2.076 . . . . 25.0 105.396 177.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -112.15 126.9 55.7 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 4.4 m -125.52 126.12 69.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.576 0.703 . . . . 25.0 109.92 -177.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.419 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 42.2 t0 -87.58 96.05 10.27 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 106.196 -1.779 . . . . 25.0 106.196 178.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.3 mt -88.2 112.14 22.42 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-N 115.356 -0.838 . . . . 25.0 109.86 -171.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 23.6 m -136.32 173.75 13.31 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 116.171 -0.468 . . . . 25.0 111.245 -175.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -63.05 159.37 17.36 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.695 0.76 . . . . 25.0 112.678 -179.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 89.1 mttt . . . . . 0 C--O 1.246 0.904 0 CA-C-N 114.59 -1.187 . . . . 25.0 110.861 178.144 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 84.4 m-70 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 110.43 -0.211 . . . . 25.0 110.43 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.69 -158.84 22.92 Favored Glycine 0 CA--C 1.511 -0.163 0 N-CA-C 107.801 -2.119 . . . . 25.0 107.801 -177.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 51.7 p90 -152.24 165.76 33.89 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 118.824 1.312 . . . . 25.0 110.57 176.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.445 HG22 ' H ' ' A' ' 6' ' ' LYS . 30.1 mm -93.98 124.55 46.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.92 -0.582 . . . . 25.0 109.78 -174.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 20.0 mm-40 -87.9 22.11 2.45 Favored 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 123.386 0.675 . . . . 25.0 111.7 -178.408 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' H ' HG22 ' A' ' 4' ' ' ILE . 42.3 mttt 77.05 153.27 0.14 Allowed Pre-proline 0 N--CA 1.481 1.116 0 C-N-CA 125.975 1.71 . . . . 25.0 111.955 175.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -62.97 151.98 68.7 Favored 'Cis proline' 0 C--N 1.348 0.545 0 C-N-CA 129.031 0.846 . . . . 25.0 111.158 -7.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.91 21.73 15.21 Favored Glycine 0 C--O 1.211 -1.288 0 N-CA-C 117.714 1.846 . . . . 25.0 117.714 175.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.8 t -76.5 128.37 34.64 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 119.23 1.515 . . . . 25.0 110.041 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 -73.33 -27.13 61.34 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 109.988 -0.375 . . . . 25.0 109.988 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.22 -33.63 69.52 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 112.526 0.565 . . . . 25.0 112.526 -177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.91 -29.21 69.6 Favored 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 120.826 0.346 . . . . 25.0 111.55 179.302 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 86.9 mt -91.95 -8.33 46.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.583 0.706 . . . . 25.0 110.738 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 28.8 t -89.73 -44.3 10.1 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.133 -0.939 . . . . 25.0 113.24 -171.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 38.8 t -67.36 129.06 38.71 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.992 0.425 . . . . 25.0 110.854 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -69.53 -23.66 63.63 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.666 . . . . 25.0 110.203 177.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.63 -20.31 66.2 Favored 'General case' 0 C--N 1.326 -0.421 0 O-C-N 122.039 -0.413 . . . . 25.0 111.68 179.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 62.1 t80 -83.06 -13.21 56.25 Favored 'General case' 0 CA--C 1.537 0.449 0 N-CA-C 112.373 0.508 . . . . 25.0 112.373 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.47 -8.23 2.91 Favored Glycine 0 N--CA 1.46 0.269 0 N-CA-C 115.003 0.761 . . . . 25.0 115.003 -179.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 22.9 t80 61.96 -59.91 0.11 Allowed 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 126.775 2.03 . . . . 25.0 114.85 -177.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 82.9 mt -103.97 -3.17 25.02 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 122.705 0.402 . . . . 25.0 110.695 178.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 67.8 m-80 -134.35 137.38 44.11 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 113.397 0.888 . . . . 25.0 113.397 -173.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -149.95 157.06 42.78 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.237 -2.135 . . . . 25.0 105.237 171.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -138.86 33.06 2.19 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-O 121.682 0.753 . . . . 25.0 111.063 179.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.7 t -62.73 -50.31 71.59 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 114.264 1.209 . . . . 25.0 114.264 -177.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.89 154.38 10.63 Favored Glycine 0 C--O 1.217 -0.908 0 N-CA-C 112.504 -0.238 . . . . 25.0 112.504 -178.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 17.3 t -65.64 -25.41 67.35 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 117.638 0.719 . . . . 25.0 112.278 -177.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.4 p -61.03 -10.05 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.983 0 C-N-CA 123.701 0.8 . . . . 25.0 112.592 178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.3 ptm -56.46 -10.92 1.06 Allowed 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 116.678 2.103 . . . . 25.0 116.678 178.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 89.8 t80 -71.19 -35.9 71.73 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 118.163 0.438 . . . . 25.0 111.985 -172.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -150.05 46.02 0.39 Allowed Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 117.042 2.238 . . . . 25.0 117.042 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.45 -14.28 36.83 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 115.797 -2.335 . . . . 25.0 114.648 -177.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -98.06 5.01 49.18 Favored 'General case' 0 C--O 1.241 0.624 0 N-CA-C 112.367 0.506 . . . . 25.0 112.367 175.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 34.4 t -106.39 89.69 3.12 Favored 'General case' 0 C--O 1.217 -0.639 0 N-CA-C 107.588 -1.264 . . . . 25.0 107.588 175.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.0 mt -121.36 124.68 45.13 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.0 -1.852 . . . . 25.0 106.0 175.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 27.7 mt-10 -127.45 145.82 50.7 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.199 0.523 . . . . 25.0 110.883 -177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 158.02 45.43 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 105.902 -1.888 . . . . 25.0 105.902 179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 46.6 tttt -100.14 141.71 32.61 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.805 -0.813 . . . . 25.0 108.805 178.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 41.5 mtpt -69.94 135.21 49.21 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.192 -0.67 . . . . 25.0 109.192 -179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 177.83 163.03 28.87 Favored Glycine 0 N--CA 1.449 -0.492 0 N-CA-C 107.024 -2.43 . . . . 25.0 107.024 178.65 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -92.28 146.92 33.53 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 117.641 0.721 . . . . 25.0 110.32 178.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -76.4 149.64 91.76 Favored 'Cis proline' 0 C--N 1.349 0.603 0 C-N-CA 129.321 0.967 . . . . 25.0 113.048 -2.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.38 16.06 1.85 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 113.324 0.861 . . . . 25.0 113.324 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -88.77 -33.8 17.33 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 112.391 0.515 . . . . 25.0 112.391 -177.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.76 175.35 38.59 Favored Glycine 0 C--O 1.227 -0.303 0 CA-C-O 119.463 -0.631 . . . . 25.0 111.873 -178.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -74.79 -14.8 21.59 Favored 'Trans proline' 0 C--N 1.346 0.422 0 CA-C-N 118.858 1.329 . . . . 25.0 114.167 179.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -81.82 126.8 32.29 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.041 -0.725 . . . . 25.0 109.041 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -149.34 157.45 43.33 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.853 -1.536 . . . . 25.0 106.853 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.76 -31.86 0.38 Allowed Glycine 0 CA--C 1.526 0.732 0 N-CA-C 118.148 2.019 . . . . 25.0 118.148 177.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -115.6 35.07 4.58 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.958 0.879 . . . . 25.0 109.989 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 48.4 mm -61.22 -38.36 79.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.559 -0.746 . . . . 25.0 110.468 -177.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.93 -38.3 87.9 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.71 1.004 . . . . 25.0 113.71 -176.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 87.9 p -93.86 -21.08 19.48 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 122.181 -0.324 . . . . 25.0 111.344 -178.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.23 19.98 1.7 Allowed 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.264 1.026 . . . . 25.0 112.726 -175.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -103.33 -6.07 45.25 Favored Glycine 0 C--O 1.224 -0.517 0 N-CA-C 114.653 0.621 . . . . 25.0 114.653 -174.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -60.33 -24.67 61.66 Favored Glycine 0 C--O 1.225 -0.427 0 N-CA-C 114.839 0.695 . . . . 25.0 114.839 -176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 75.3 mt -66.62 -25.41 66.58 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.087 0.47 . . . . 25.0 111.14 179.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -84.9 0.57 50.63 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.817 0.342 . . . . 25.0 111.77 -179.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -61.68 -19.49 58.33 Favored Glycine 0 C--O 1.226 -0.382 0 C-N-CA 121.129 -0.558 . . . . 25.0 112.98 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.97 -20.75 67.08 Favored Glycine 0 C--O 1.222 -0.617 0 C-N-CA 121.079 -0.582 . . . . 25.0 113.228 177.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.3 mm -68.59 -39.4 80.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 N-CA-C 108.415 -0.957 . . . . 25.0 108.415 177.189 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.2 mp -73.03 -26.86 61.45 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 179.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -76.52 7.56 4.37 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 121.485 0.66 . . . . 25.0 112.221 177.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -95.49 -28.02 15.1 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 121.45 -0.781 . . . . 25.0 109.037 171.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.5 tt0 -150.72 96.73 2.4 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 120.836 0.351 . . . . 25.0 111.394 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.6 t -152.87 154.37 34.95 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 108.421 -0.955 . . . . 25.0 108.421 177.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -69.55 -32.8 71.81 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 122.177 0.989 . . . . 25.0 109.802 177.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 68.8 m-20 -107.32 28.13 8.4 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 115.2 -0.909 . . . . 25.0 110.037 -178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -53.68 154.31 3.84 Favored 'General case' 0 C--O 1.245 0.831 0 CA-C-N 115.273 -0.876 . . . . 25.0 109.992 178.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 26.7 m0 -84.78 165.26 17.93 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.28 -1.378 . . . . 25.0 107.28 -176.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -74.8 139.02 42.99 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 -178.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 19.0 mtpp -127.5 133.98 49.83 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 106.798 -1.556 . . . . 25.0 106.798 -177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -119.63 146.94 45.1 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 107.366 -1.346 . . . . 25.0 107.366 178.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 68.5 mt -96.7 133.03 39.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.199 -1.037 . . . . 25.0 108.199 178.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 93.7 mtp -135.06 158.42 44.39 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.65 -0.87 . . . . 25.0 108.65 179.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 19.2 p -104.47 172.04 7.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 108.094 -1.076 . . . . 25.0 108.094 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.14 -175.93 7.9 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 114.495 0.558 . . . . 25.0 114.495 179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 105.14 -173.37 20.56 Favored Glycine 0 CA--C 1.518 0.221 0 O-C-N 122.525 -0.397 . . . . 25.0 112.755 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -82.14 141.13 33.35 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 109.082 -0.71 . . . . 25.0 109.082 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -141.91 160.75 39.56 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.349 -0.612 . . . . 25.0 109.349 178.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.0 m -126.75 129.49 48.47 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 106.39 -1.708 . . . . 25.0 106.39 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -114.43 139.05 49.83 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 108.08 -1.081 . . . . 25.0 108.08 -179.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -130.82 133.41 45.93 Favored 'General case' 0 C--N 1.328 -0.363 0 O-C-N 123.495 0.497 . . . . 25.0 110.16 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 45.8 m0 -124.08 151.71 43.53 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 105.839 -1.911 . . . . 25.0 105.839 178.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -138.07 161.95 35.44 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 119.037 0.835 . . . . 25.0 110.656 175.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -118.14 150.65 39.01 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.488 -1.671 . . . . 25.0 106.488 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.6 t -68.63 -22.39 64.43 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.384 0.513 . . . . 25.0 112.384 -174.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.04 151.97 63.72 Favored Pre-proline 0 C--O 1.242 0.693 0 N-CA-C 105.719 -1.956 . . . . 25.0 105.719 174.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -67.38 145.93 73.2 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 115.587 -2.475 . . . . 25.0 109.515 173.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -130.88 140.49 50.22 Favored 'General case' 0 CA--C 1.514 -0.429 0 O-C-N 121.994 -0.441 . . . . 25.0 111.491 -177.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -66.62 141.52 57.78 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 107.406 -1.331 . . . . 25.0 107.406 174.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.8 m -150.02 151.9 34.02 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.746 -1.946 . . . . 25.0 105.746 -169.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 34.0 p -108.01 -34.05 7.01 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 118.256 0.48 . . . . 25.0 110.618 175.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -157.76 145.29 18.49 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 121.971 -0.456 . . . . 25.0 109.835 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 63.0 p-90 -141.2 139.43 33.82 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.035 -0.666 . . . . 25.0 109.543 163.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -148.09 159.64 43.71 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.89 -0.596 . . . . 25.0 109.532 -177.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -145.04 150.24 36.51 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 113.915 1.08 . . . . 25.0 113.915 -178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -121.74 164.6 17.15 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 114.035 -1.438 . . . . 25.0 107.522 -175.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 39.1 pt -135.66 155.73 36.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 107.462 -1.31 . . . . 25.0 107.462 171.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 69.6 p -96.02 144.19 26.52 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.424 -0.584 . . . . 25.0 109.424 175.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 35.4 mmtp -87.99 129.82 35.14 Favored 'General case' 0 C--O 1.206 -1.231 0 N-CA-C 110.163 -0.31 . . . . 25.0 110.163 176.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 60.6 pttt -81.53 156.21 25.36 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.054 0.542 . . . . 25.0 109.671 172.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 86.8 10.12 73.2 Favored Glycine 0 N--CA 1.462 0.419 0 N-CA-C 118.59 2.196 . . . . 25.0 118.59 166.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 10.1 p90 -59.26 161.35 5.54 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 114.032 1.123 . . . . 25.0 114.032 -177.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -98.24 156.02 36.28 Favored Pre-proline 0 C--N 1.323 -0.581 0 N-CA-C 106.646 -1.613 . . . . 25.0 106.646 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -76.45 -8.62 18.48 Favored 'Trans proline' 0 C--N 1.345 0.389 0 N-CA-C 116.663 1.755 . . . . 25.0 116.663 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 17.3 t0 -82.33 0.72 40.4 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-O 121.912 0.863 . . . . 25.0 111.77 -176.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.2 mttp -95.97 148.43 34.53 Favored Pre-proline 0 C--N 1.322 -0.616 0 O-C-N 121.734 -0.604 . . . . 25.0 110.412 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -75.04 83.4 1.83 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 N-CA-C 110.329 -0.681 . . . . 25.0 110.329 174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 63.7 mt -53.15 -39.53 63.59 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 114.912 1.449 . . . . 25.0 114.912 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -63.07 -21.98 66.54 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.797 0.666 . . . . 25.0 112.797 -179.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -94.76 -48.55 5.99 Favored 'General case' 0 C--O 1.216 -0.686 0 N-CA-C 112.344 0.498 . . . . 25.0 112.344 169.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -74.13 -34.79 64.0 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 115.708 1.744 . . . . 25.0 115.708 -166.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 -69.31 -28.88 66.65 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.247 -0.581 . . . . 25.0 111.633 -172.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -97.66 113.92 25.77 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.116 -173.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -121.86 136.67 54.94 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.235 0.541 . . . . 25.0 111.469 178.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 22.4 tp -75.61 123.93 26.36 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 106.459 -1.682 . . . . 25.0 106.459 176.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 6.2 tp -121.75 -5.76 9.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.564 0.697 . . . . 25.0 111.185 -175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -161.21 140.15 6.47 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.395 -0.907 . . . . 25.0 112.243 174.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 134.21 16.83 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 107.401 -1.333 . . . . 25.0 107.401 177.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.74 103.2 7.65 Favored Pre-proline 0 C--O 1.241 0.617 0 N-CA-C 108.214 -1.032 . . . . 25.0 108.214 177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -67.92 148.73 76.93 Favored 'Trans proline' 0 C--N 1.349 0.574 0 C-N-CA 116.013 -2.191 . . . . 25.0 109.69 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -106.14 92.2 4.04 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 107.364 -1.346 . . . . 25.0 107.364 -178.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 51.8 p30 -119.17 1.15 11.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 113.373 -1.739 . . . . 25.0 109.782 -176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 119.62 -18.75 9.93 Favored Glycine 0 C--O 1.236 0.24 0 CA-C-N 115.303 -0.862 . . . . 25.0 111.905 -177.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 29.6 t -54.71 136.99 63.89 Favored Pre-proline 0 C--O 1.242 0.665 0 CA-C-N 117.116 0.458 . . . . 25.0 110.465 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -71.75 -11.67 28.03 Favored 'Trans proline' 0 CA--C 1.506 -0.92 0 C-N-CA 117.029 -1.514 . . . . 25.0 114.753 -177.034 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -64.78 -34.67 78.89 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.375 -1.284 . . . . 25.0 109.143 176.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.2 t -84.4 -10.05 57.88 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.202 0.525 . . . . 25.0 112.044 -178.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 66.1 mtt-85 -86.48 -22.78 26.25 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 107.643 -1.243 . . . . 25.0 107.643 177.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -88.04 104.84 17.03 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.763 -0.653 . . . . 25.0 110.402 178.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -74.65 -10.87 59.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.667 -0.697 . . . . 25.0 112.321 177.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.1 t -91.31 121.98 33.52 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.928 -1.138 . . . . 25.0 107.928 -175.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 12.2 t-80 -137.26 147.83 46.0 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.059 -0.519 . . . . 25.0 111.426 -175.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -79.23 137.89 37.58 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.726 177.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 52.0 mt -132.68 106.02 9.76 Favored 'Isoleucine or valine' 0 C--O 1.24 0.602 0 N-CA-C 107.744 -1.206 . . . . 25.0 107.744 173.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -78.12 140.85 39.04 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.574 -0.899 . . . . 25.0 108.574 174.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 41.9 mm -124.63 123.36 25.72 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.756 -0.831 . . . . 25.0 108.756 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -71.61 158.44 53.59 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 117.289 -1.341 . . . . 25.0 111.52 175.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -106.97 52.83 0.71 Allowed 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 122.512 1.149 . . . . 25.0 110.037 -177.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -82.75 -37.5 24.53 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 115.477 1.658 . . . . 25.0 115.477 -174.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 39.1 mmt180 -152.87 172.23 17.08 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.19 0.596 . . . . 25.0 109.738 -170.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.0 mp -99.95 142.77 30.98 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 104.678 -2.342 . . . . 25.0 104.678 167.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 162.41 150.07 5.88 Favored Glycine 0 C--O 1.234 0.117 0 C-N-CA 120.588 -0.815 . . . . 25.0 114.078 178.05 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.566 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 27.4 p90 -86.01 145.11 27.24 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.153 0.501 . . . . 25.0 110.049 -177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.89 153.02 40.38 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.842 -0.617 . . . . 25.0 110.184 -176.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 4.0 t -108.65 143.83 18.26 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.046 -0.524 . . . . 25.0 110.644 -176.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 71.3 mt -107.08 128.85 61.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 104.341 -2.466 . . . . 25.0 104.341 172.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -119.72 137.43 53.93 Favored 'General case' 0 C--O 1.213 -0.816 0 N-CA-C 106.842 -1.54 . . . . 25.0 106.842 -178.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -141.82 151.15 42.53 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 118.958 0.799 . . . . 25.0 110.971 177.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 58.1 t -129.04 134.18 64.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 107.124 -1.435 . . . . 25.0 107.124 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 36.5 t-105 -124.78 98.98 5.94 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.586 -1.265 . . . . 25.0 107.586 -178.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 57.3 m-20 -84.79 117.81 24.08 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.037 0.446 . . . . 25.0 110.554 -175.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 97.6 t -82.03 133.75 28.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.331 -0.989 . . . . 25.0 108.331 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -74.76 -42.47 58.14 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.119 0.485 . . . . 25.0 111.194 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -68.66 -24.07 64.48 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 115.812 1.782 . . . . 25.0 115.812 -168.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 66.3 p -135.62 162.55 32.39 Favored 'General case' 0 CA--C 1.506 -0.714 0 O-C-N 122.381 -0.199 . . . . 25.0 110.701 -171.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -79.04 11.32 2.8 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.587 0.588 . . . . 25.0 112.587 176.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -110.11 160.0 16.85 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 107.168 -1.419 . . . . 25.0 107.168 176.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -144.52 170.7 15.54 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 105.04 -2.207 . . . . 25.0 105.04 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 19.3 m-85 -120.32 158.37 27.24 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 108.1 -1.074 . . . . 25.0 108.1 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -138.7 154.63 48.6 Favored 'General case' 0 C--N 1.319 -0.717 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 174.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 -132.7 142.06 48.88 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.304 -0.999 . . . . 25.0 108.304 -178.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.6 p -137.11 129.32 43.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.73 -0.841 . . . . 25.0 108.73 178.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 74.3 mt -140.66 126.56 20.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.485 0 N-CA-C 108.854 -0.795 . . . . 25.0 108.854 179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -98.47 137.09 37.66 Favored 'General case' 0 C--O 1.242 0.66 0 N-CA-C 109.624 -0.51 . . . . 25.0 109.624 174.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 22.8 m -138.58 137.51 43.24 Favored 'Isoleucine or valine' 0 C--O 1.244 0.77 0 N-CA-C 107.883 -1.155 . . . . 25.0 107.883 171.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 51.8 t0 -82.03 136.14 35.26 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.687 -1.598 . . . . 25.0 106.687 179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.2 mt -120.14 104.24 9.94 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 108.489 -0.93 . . . . 25.0 108.489 -176.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 34.1 m -113.03 166.95 6.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.239 0.543 . . . . 25.0 111.824 -176.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -75.21 158.7 32.56 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 106.535 -1.654 . . . . 25.0 106.535 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt . . . . . 0 C--O 1.249 1.056 0 CA-C-O 117.285 -1.34 . . . . 25.0 110.365 178.975 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 52.1 m80 . . . . . 0 N--CA 1.494 1.758 0 CA-C-O 119.77 -0.157 . . . . 25.0 111.041 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.48 -177.83 51.53 Favored Glycine 0 N--CA 1.466 0.678 0 CA-C-O 118.428 -1.207 . . . . 25.0 110.714 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -156.64 164.73 37.83 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 118.226 1.013 . . . . 25.0 112.864 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.4 mt -90.73 122.74 42.43 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.56 0 N-CA-C 108.266 -1.013 . . . . 25.0 108.266 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -77.72 -41.38 38.02 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.382 0.61 . . . . 25.0 109.537 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -139.32 117.08 8.73 Favored Pre-proline 0 C--N 1.32 -0.696 0 CA-C-N 116.182 -0.463 . . . . 25.0 109.836 179.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -73.36 122.61 7.83 Favored 'Cis proline' 0 C--N 1.357 1.002 0 C-N-CA 130.412 1.422 . . . . 25.0 113.454 -3.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -83.1 -22.58 57.07 Favored Glycine 0 CA--C 1.508 -0.36 0 N-CA-C 116.051 1.18 . . . . 25.0 116.051 -176.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.4 t -91.18 97.18 10.98 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 121.601 -0.941 . . . . 25.0 110.73 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 77.7 ttt-85 -83.96 -32.34 25.08 Favored 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 109.727 -0.471 . . . . 25.0 109.727 173.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.2 -36.67 71.13 Favored 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 114.203 1.186 . . . . 25.0 114.203 -173.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.81 -32.43 71.8 Favored 'General case' 0 CA--C 1.538 0.483 0 O-C-N 123.282 0.364 . . . . 25.0 110.957 -179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.9 mp -92.93 -19.93 21.14 Favored 'General case' 0 C--O 1.211 -0.931 0 N-CA-C 112.708 0.632 . . . . 25.0 112.708 -179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 30.7 t -70.16 -30.47 67.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.303 -0.628 . . . . 25.0 109.303 179.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 24.2 t -55.88 138.47 48.38 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 113.93 1.085 . . . . 25.0 113.93 -175.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 53.2 mp0 -69.33 -11.05 60.48 Favored 'General case' 0 C--O 1.216 -0.691 0 CA-C-N 114.217 -1.356 . . . . 25.0 110.36 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.83 -10.94 0.34 Allowed 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 114.035 1.124 . . . . 25.0 114.035 179.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -68.71 -14.01 62.75 Favored 'General case' 0 CA--C 1.548 0.868 0 O-C-N 121.843 -0.536 . . . . 25.0 110.97 175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -174.31 -24.1 0.02 OUTLIER Glycine 0 C--O 1.222 -0.64 0 C-N-CA 120.197 -1.001 . . . . 25.0 115.454 177.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.1 t80 65.56 -21.86 0.09 Allowed 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 115.881 1.808 . . . . 25.0 115.881 178.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 88.0 mt -77.34 -15.85 59.2 Favored 'General case' 0 C--N 1.322 -0.623 0 O-C-N 121.968 -0.457 . . . . 25.0 110.533 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -154.64 163.39 40.29 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.894 0.378 . . . . 25.0 110.481 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -75.86 155.06 35.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.082 -0.508 . . . . 25.0 111.72 -178.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -127.17 11.75 7.03 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 122.131 0.967 . . . . 25.0 111.229 -178.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.3 t -110.73 -35.46 5.98 Favored 'General case' 0 C--O 1.245 0.858 0 N-CA-C 115.384 1.624 . . . . 25.0 115.384 -172.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 79.42 150.98 6.06 Favored Glycine 0 CA--C 1.517 0.182 0 CA-C-O 121.252 0.362 . . . . 25.0 112.82 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 28.6 t -66.39 -14.32 61.96 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.583 -0.951 . . . . 25.0 112.817 -179.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.1 p -73.69 0.33 1.89 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 CA-C-O 121.597 0.713 . . . . 25.0 111.024 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -52.16 -26.26 11.0 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 117.933 2.568 . . . . 25.0 117.933 -174.23 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -75.97 -43.4 44.76 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 118.882 0.764 . . . . 25.0 112.816 -175.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -142.9 71.93 19.03 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-O 122.009 0.909 . . . . 25.0 112.928 175.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -71.66 2.0 5.09 Favored 'Trans proline' 0 C--O 1.221 -0.346 0 N-CA-C 114.606 0.964 . . . . 25.0 114.606 -179.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.97 3.17 33.2 Favored 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 109.654 -0.498 . . . . 25.0 109.654 176.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.3 t -134.15 84.03 2.08 Favored 'General case' 0 C--O 1.21 -1.02 0 N-CA-C 115.771 1.767 . . . . 25.0 115.771 -176.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 10.0 mp -109.0 131.19 55.31 Favored 'General case' 0 C--O 1.222 -0.394 0 N-CA-C 103.525 -2.769 . . . . 25.0 103.525 170.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 75.2 mt-10 -114.37 143.54 44.74 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 114.191 1.182 . . . . 25.0 114.191 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.28 155.97 49.74 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 104.456 -2.424 . . . . 25.0 104.456 167.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -83.42 146.4 28.45 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 121.572 -0.705 . . . . 25.0 110.483 -178.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -70.84 145.73 50.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.548 -0.538 . . . . 25.0 109.548 174.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 171.96 -177.65 44.59 Favored Glycine 0 CA--C 1.502 -0.762 0 N-CA-C 103.527 -3.829 . . . . 25.0 103.527 178.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 52.7 p90 -112.93 147.56 37.48 Favored Pre-proline 0 CA--C 1.539 0.521 0 N-CA-C 107.006 -1.479 . . . . 25.0 107.006 173.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -65.84 148.65 75.82 Favored 'Cis proline' 0 C--O 1.212 -0.793 0 C-N-CA 129.556 1.065 . . . . 25.0 113.329 0.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -138.54 -48.51 0.52 Allowed 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 115.657 -0.701 . . . . 25.0 111.051 179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.5 t -91.84 1.83 56.91 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-O 122.138 0.971 . . . . 25.0 108.746 173.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.9 -154.65 30.16 Favored Glycine 0 N--CA 1.448 -0.519 0 CA-C-N 113.625 -1.625 . . . . 25.0 109.492 -179.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -65.28 154.45 73.53 Favored 'Trans proline' 0 C--N 1.347 0.469 0 CA-C-N 118.712 1.256 . . . . 25.0 112.291 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -78.14 106.98 10.39 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.276 -0.875 . . . . 25.0 111.915 -177.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -114.99 158.88 21.45 Favored 'General case' 0 C--O 1.218 -0.575 0 N-CA-C 104.159 -2.534 . . . . 25.0 104.159 171.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 83.45 -31.94 3.17 Favored Glycine 0 C--O 1.215 -1.09 0 C-N-CA 120.611 -0.804 . . . . 25.0 112.733 -177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -60.18 -21.96 62.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 114.962 1.468 . . . . 25.0 114.962 -176.67 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 87.3 mt -69.29 -42.42 81.35 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.36 0 N-CA-C 108.768 -0.827 . . . . 25.0 108.768 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.72 -31.12 66.38 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 112.094 0.405 . . . . 25.0 112.094 -178.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 98.7 p -85.85 2.95 43.82 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.205 0.817 . . . . 25.0 113.205 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 58.16 24.35 11.23 Favored 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 123.832 0.853 . . . . 25.0 112.001 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -71.9 -13.89 75.69 Favored Glycine 0 C--O 1.223 -0.554 0 N-CA-C 110.33 -1.108 . . . . 25.0 110.33 176.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -85.46 17.94 31.69 Favored Glycine 0 CA--C 1.523 0.561 0 CA-C-N 115.755 -0.223 . . . . 25.0 113.495 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 2.7 mt -59.32 -10.68 3.26 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 115.606 1.706 . . . . 25.0 115.606 -177.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -61.04 -19.96 61.98 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 174.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -80.21 -16.15 77.05 Favored Glycine 0 CA--C 1.525 0.712 0 O-C-N 121.35 -0.844 . . . . 25.0 111.709 177.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -73.71 -4.58 66.49 Favored Glycine 0 C--O 1.218 -0.872 0 N-CA-C 115.421 0.928 . . . . 25.0 115.421 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.8 mt -58.48 -32.76 46.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 118.352 1.076 . . . . 25.0 110.077 -178.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.52 -25.37 65.8 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 116.513 -0.312 . . . . 25.0 111.747 -178.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.1 t0 -106.15 15.44 26.32 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-O 121.783 0.801 . . . . 25.0 110.041 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -70.59 14.75 0.12 Allowed 'General case' 0 CA--C 1.547 0.837 0 N-CA-C 114.37 1.248 . . . . 25.0 114.37 -174.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 38.6 mt-30 -126.51 52.91 1.69 Allowed 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 107.277 -1.379 . . . . 25.0 107.277 174.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.5 t -131.91 178.69 6.58 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 107.327 -1.36 . . . . 25.0 107.327 -176.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -64.64 -21.15 66.65 Favored 'General case' 0 N--CA 1.476 0.867 0 O-C-N 121.805 -0.559 . . . . 25.0 112.413 -177.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 62.5 m-80 -95.57 14.38 23.07 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.555 0.693 . . . . 25.0 112.098 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 48.6 ttt85 -58.18 128.32 36.52 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.867 -0.606 . . . . 25.0 111.129 179.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -106.14 168.18 9.31 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.921 0.867 . . . . 25.0 112.203 178.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -63.86 149.58 46.72 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.613 -0.721 . . . . 25.0 112.123 -178.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 34.7 ttpt -130.5 146.5 52.05 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.74 -1.207 . . . . 25.0 107.74 176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -113.34 138.49 49.97 Favored 'General case' 0 C--O 1.216 -0.704 0 N-CA-C 107.739 -1.208 . . . . 25.0 107.739 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 61.6 mt -104.38 129.19 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.519 0 N-CA-C 107.538 -1.282 . . . . 25.0 107.538 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 94.3 mmm -137.88 166.51 23.85 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.521 -0.548 . . . . 25.0 109.521 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.3 p -107.46 -173.72 2.36 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 105.256 -2.128 . . . . 25.0 105.256 171.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -161.54 21.56 Favored Glycine 0 C--O 1.242 0.605 0 CA-C-O 121.676 0.598 . . . . 25.0 113.744 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 91.79 176.61 42.65 Favored Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.73 -0.948 . . . . 25.0 110.73 -178.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -83.29 141.48 31.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 119.139 1.469 . . . . 25.0 109.849 -179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -129.39 139.16 51.77 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 108.714 -0.847 . . . . 25.0 108.714 -178.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.5 m -85.57 128.84 34.88 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 25.0 109.946 176.699 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -114.03 127.43 55.94 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 105.962 -1.866 . . . . 25.0 105.962 174.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.9 m -128.85 120.47 26.33 Favored 'General case' 0 N--CA 1.467 0.419 0 N-CA-C 110.1 -0.333 . . . . 25.0 110.1 -178.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 5.2 m0 -124.08 150.1 45.4 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.45 -1.685 . . . . 25.0 106.45 178.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 8.1 t -145.21 158.78 43.74 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.465 -0.569 . . . . 25.0 109.465 -178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -125.01 133.45 52.97 Favored 'General case' 0 C--O 1.214 -0.791 0 N-CA-C 108.997 -0.742 . . . . 25.0 108.997 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 15.2 t -77.03 -6.63 53.42 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 112.686 0.625 . . . . 25.0 112.686 -177.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.95 145.04 37.65 Favored Pre-proline 0 C--O 1.241 0.614 0 N-CA-C 106.907 -1.516 . . . . 25.0 106.907 178.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.32 142.87 38.1 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 117.239 -1.374 . . . . 25.0 111.804 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 -136.27 140.22 43.27 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.935 -0.765 . . . . 25.0 108.935 175.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 46.0 t30 -81.51 152.97 27.05 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 106.097 -1.816 . . . . 25.0 106.097 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 57.1 m -138.79 148.49 43.88 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 105.855 -1.905 . . . . 25.0 105.855 -171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 48.4 t -102.71 -43.36 5.61 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.605 0.717 . . . . 25.0 110.59 173.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 33.0 tt0 -154.82 143.46 20.67 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 108.947 -0.76 . . . . 25.0 108.947 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 17.1 p-90 -144.5 134.8 24.35 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.78 0.324 . . . . 25.0 110.192 170.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -154.18 162.22 41.33 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.407 0.521 . . . . 25.0 112.407 -172.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -130.25 146.01 51.81 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 121.458 0.647 . . . . 25.0 112.107 -178.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.9 m-85 -124.0 163.79 20.66 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 107.539 -1.282 . . . . 25.0 107.539 177.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 37.2 pt -131.34 152.98 38.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 172.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 51.6 p -80.48 144.69 32.36 Favored 'General case' 0 C--O 1.246 0.905 0 N-CA-C 107.884 -1.154 . . . . 25.0 107.884 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttpt -88.42 124.77 34.28 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.33 0.586 . . . . 25.0 110.295 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.0 mttt -73.51 126.22 29.73 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.007 -1.109 . . . . 25.0 108.007 178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 78.63 35.82 31.23 Favored Glycine 0 C--O 1.223 -0.542 0 C-N-CA 119.041 -1.552 . . . . 25.0 113.931 175.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 8.0 p90 -54.9 149.19 11.91 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-N 118.241 1.02 . . . . 25.0 110.713 -178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 22.4 m-20 -75.6 139.68 71.04 Favored Pre-proline 0 C--N 1.321 -0.666 0 N-CA-C 109.13 -0.693 . . . . 25.0 109.13 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.44 -22.47 16.11 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 118.549 -0.5 . . . . 25.0 113.179 178.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -69.8 -27.55 64.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.877 0.846 . . . . 25.0 111.956 -179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -91.67 143.86 28.6 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 107.934 -1.136 . . . . 25.0 107.934 -174.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -64.19 115.67 3.28 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 117.555 -1.163 . . . . 25.0 112.019 -178.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 4.4 tt -52.36 -54.35 32.88 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 114.851 1.426 . . . . 25.0 114.851 -166.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -69.57 -4.03 17.4 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 114.114 1.153 . . . . 25.0 114.114 -176.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -97.63 -46.58 5.96 Favored 'General case' 0 C--O 1.216 -0.674 0 O-C-N 121.503 -0.748 . . . . 25.0 109.483 173.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.5 -19.99 51.79 Favored 'General case' 0 C--O 1.217 -0.649 0 N-CA-C 114.545 1.313 . . . . 25.0 114.545 -171.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 25.5 t0 -72.67 -33.69 66.71 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 114.08 1.141 . . . . 25.0 114.08 -175.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -91.7 100.01 12.8 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 119.623 -0.831 . . . . 25.0 112.593 -173.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 46.9 mm-40 -97.37 125.06 41.75 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.18 0.514 . . . . 25.0 110.011 178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.3 tp -71.4 116.98 12.36 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.976 -0.749 . . . . 25.0 108.976 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -96.88 -4.46 9.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-O 121.876 0.846 . . . . 25.0 109.898 -177.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 164.35 159.72 11.32 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.602 -0.808 . . . . 25.0 113.016 175.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.0 147.07 28.13 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.769 -0.826 . . . . 25.0 108.769 -179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 56.3 t -133.67 111.8 12.56 Favored Pre-proline 0 C--N 1.321 -0.659 0 N-CA-C 108.223 -1.028 . . . . 25.0 108.223 175.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -79.72 168.92 18.89 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 115.796 -2.336 . . . . 25.0 111.071 178.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 62.5 t-80 -145.18 120.04 9.94 Favored 'General case' 0 C--O 1.213 -0.844 0 C-N-CA 120.568 -0.453 . . . . 25.0 110.505 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -91.57 -39.94 11.62 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 121.953 0.882 . . . . 25.0 110.04 178.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 158.08 -26.04 0.42 Allowed Glycine 0 N--CA 1.46 0.249 0 N-CA-C 108.125 -1.99 . . . . 25.0 108.125 -174.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 39.9 t -51.76 141.42 26.55 Favored Pre-proline 0 CA--C 1.548 0.893 0 N-CA-C 112.771 0.656 . . . . 25.0 112.771 176.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_endo -76.29 23.77 0.46 Allowed 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 121.805 1.67 . . . . 25.0 114.343 -177.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.28 -25.91 66.07 Favored 'General case' 0 N--CA 1.473 0.688 0 O-C-N 121.282 -0.886 . . . . 25.0 110.688 175.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 54.6 p -71.71 0.95 7.58 Favored 'General case' 0 CA--C 1.535 0.402 0 N-CA-C 112.955 0.724 . . . . 25.0 112.955 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 64.1 ttt180 -62.1 -35.28 78.23 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 108.373 -0.973 . . . . 25.0 108.373 175.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -94.41 82.82 4.08 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.003 -1.851 . . . . 25.0 106.003 175.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -75.87 -19.84 58.55 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.345 -0.843 . . . . 25.0 111.653 -175.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 32.6 t -72.65 138.69 46.85 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 121.623 -0.673 . . . . 25.0 109.858 -173.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 8.8 t-80 -135.57 143.16 45.51 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.711 -0.477 . . . . 25.0 109.711 -178.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -96.29 139.39 32.5 Favored 'General case' 0 C--N 1.317 -0.84 0 N-CA-C 106.431 -1.692 . . . . 25.0 106.431 176.665 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 27.9 mm -133.28 130.19 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 106.453 -1.684 . . . . 25.0 106.453 179.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 39.4 t80 -80.71 132.17 35.53 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 175.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 48.0 mm -112.06 126.39 28.54 Favored Pre-proline 0 C--N 1.32 -0.693 0 N-CA-C 108.604 -0.888 . . . . 25.0 108.604 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.85 169.49 22.48 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 118.19 -0.74 . . . . 25.0 111.758 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 -130.18 51.26 2.11 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 107.084 -1.45 . . . . 25.0 107.084 -178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -78.52 -32.03 47.87 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 114.123 1.157 . . . . 25.0 114.123 -172.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 82.9 mtt85 -152.2 165.83 33.63 Favored 'General case' 0 CA--C 1.505 -0.76 0 N-CA-C 106.975 -1.491 . . . . 25.0 106.975 -175.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 170' ' ' VAL . 5.4 mp -92.89 142.91 26.79 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 104.271 -2.492 . . . . 25.0 104.271 167.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 140.29 165.39 10.27 Favored Glycine 0 C--O 1.237 0.318 0 N-CA-C 114.24 0.456 . . . . 25.0 114.24 178.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.442 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 3.9 p90 -81.45 149.69 28.66 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 113.086 0.772 . . . . 25.0 113.086 -176.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -152.86 159.39 43.02 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 106.137 -1.801 . . . . 25.0 106.137 173.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 2.1 t -108.1 149.68 11.26 Favored 'Isoleucine or valine' 0 C--O 1.244 0.768 0 CA-C-N 118.517 0.599 . . . . 25.0 111.158 -177.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 84.5 mt -110.7 128.44 67.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 104.581 -2.377 . . . . 25.0 104.581 173.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 1.6 mt -118.94 139.21 52.04 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.362 -0.977 . . . . 25.0 108.362 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -137.69 144.32 41.73 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.87 -0.419 . . . . 25.0 109.87 179.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 20.9 t -129.85 135.28 61.54 Favored 'Isoleucine or valine' 0 C--O 1.24 0.59 0 N-CA-C 108.417 -0.957 . . . . 25.0 108.417 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -128.38 112.14 14.08 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 123.261 0.624 . . . . 25.0 111.466 -177.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -88.7 88.42 7.6 Favored 'General case' 0 C--O 1.243 0.713 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 175.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 69.7 t -72.42 126.81 33.66 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.661 0 N-CA-C 105.267 -2.123 . . . . 25.0 105.267 175.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.09 -23.52 54.97 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.261 0.553 . . . . 25.0 110.222 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.5 -11.85 61.17 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-N 115.686 -0.688 . . . . 25.0 112.481 -175.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 31.7 p -127.61 161.4 28.94 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.952 0.406 . . . . 25.0 110.641 -172.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -88.38 3.27 50.49 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-O 122.635 1.207 . . . . 25.0 108.054 174.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -108.83 157.34 18.68 Favored 'General case' 0 C--O 1.244 0.776 0 CA-C-N 114.702 -1.136 . . . . 25.0 108.945 -175.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -119.69 141.77 49.09 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 103.785 -2.672 . . . . 25.0 103.785 174.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -106.03 144.69 32.39 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.066 -0.516 . . . . 25.0 111.14 -172.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 80.4 m-85 -124.57 145.84 49.37 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.402 -0.817 . . . . 25.0 109.282 -178.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 86.5 mt-30 -138.77 129.5 26.29 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.048 -1.834 . . . . 25.0 106.048 177.38 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 3.6 p -139.14 130.4 34.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 N-CA-C 108.615 -0.883 . . . . 25.0 108.615 -176.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 80.5 mt -140.37 130.87 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-O 120.486 0.184 . . . . 25.0 110.645 -177.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 72.7 m-20 -77.18 138.61 39.56 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-O 121.807 0.813 . . . . 25.0 111.282 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 26.9 m -137.61 160.81 34.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 115.469 -0.787 . . . . 25.0 109.07 172.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.442 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 54.1 t0 -117.29 132.1 56.68 Favored 'General case' 0 CA--C 1.5 -0.965 0 N-CA-C 106.216 -1.772 . . . . 25.0 106.216 179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.0 mt -120.07 121.99 40.1 Favored 'General case' 0 CA--C 1.501 -0.938 0 N-CA-C 106.833 -1.543 . . . . 25.0 106.833 -176.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 33.8 m -130.54 167.12 26.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 123.532 0.52 . . . . 25.0 110.059 -177.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 6.7 m120 -77.58 158.1 29.99 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.839 -0.8 . . . . 25.0 108.839 177.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 88.1 mttt . . . . . 0 C--O 1.252 1.213 0 CA-C-O 117.317 -1.325 . . . . 25.0 110.466 176.541 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 . . . . . 0 N--CA 1.478 0.931 0 N-CA-C 109.538 -0.541 . . . . 25.0 109.538 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 179.85 179.58 48.79 Favored Glycine 0 C--O 1.226 -0.344 0 N-CA-C 108.548 -1.821 . . . . 25.0 108.548 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -80.27 136.33 36.42 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.865 -0.791 . . . . 25.0 108.865 179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 74.3 mt -94.11 106.85 18.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 104.679 -2.341 . . . . 25.0 104.679 171.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -77.26 -41.13 42.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.794 0.807 . . . . 25.0 110.94 -173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -152.84 143.76 15.87 Favored Pre-proline 0 C--N 1.325 -0.465 0 CA-C-O 119.036 -0.506 . . . . 25.0 109.669 -174.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.03 137.39 47.96 Favored 'Cis proline' 0 C--N 1.351 0.701 0 CA-C-N 118.99 0.675 . . . . 25.0 112.126 -5.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -178.68 168.06 38.84 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 119.817 -1.182 . . . . 25.0 113.665 177.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.0 t -161.93 121.36 2.42 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 104.339 -2.467 . . . . 25.0 104.339 176.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.2 mtp180 -83.4 -38.54 21.82 Favored 'General case' 0 C--O 1.217 -0.632 0 N-CA-C 112.149 0.426 . . . . 25.0 112.149 -179.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.78 -34.21 74.14 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.559 0.577 . . . . 25.0 112.559 -175.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.95 -28.77 70.3 Favored 'General case' 0 C--O 1.217 -0.634 0 N-CA-C 112.08 0.4 . . . . 25.0 112.08 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 51.5 mt -92.0 -35.39 13.99 Favored 'General case' 0 C--O 1.219 -0.551 0 CA-C-O 121.363 0.601 . . . . 25.0 110.966 -179.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 25.7 t -66.07 -39.95 90.49 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 114.809 -1.087 . . . . 25.0 110.917 -174.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 35.7 t -61.47 134.16 56.56 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.076 0.465 . . . . 25.0 110.147 -179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -64.57 -15.01 60.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.171 -0.468 . . . . 25.0 110.959 178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.19 -12.91 14.58 Favored 'General case' 0 CA--C 1.546 0.825 0 O-C-N 122.055 -0.403 . . . . 25.0 111.831 174.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.5 t80 -81.73 -3.82 54.7 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 111.834 0.309 . . . . 25.0 111.834 179.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.58 -9.64 0.03 OUTLIER Glycine 0 CA--C 1.525 0.674 0 N-CA-C 119.604 2.602 . . . . 25.0 119.604 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.2 t80 63.68 -41.6 0.23 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.704 2.113 . . . . 25.0 116.704 -178.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 80.0 mt -80.08 -3.01 46.9 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.594 0.711 . . . . 25.0 109.241 176.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -73.85 153.9 39.7 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.341 -0.845 . . . . 25.0 109.398 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.8 mp -75.08 163.82 27.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 105.722 -1.955 . . . . 25.0 105.722 170.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -49.82 -10.1 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.778 2.14 . . . . 25.0 116.778 178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -163.9 -17.85 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 123.024 0.53 . . . . 25.0 112.158 171.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 95.68 142.79 13.38 Favored Glycine 0 C--O 1.222 -0.64 0 N-CA-C 112.187 -0.365 . . . . 25.0 112.187 -179.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 2.2 m -76.24 -30.8 58.04 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 117.816 0.808 . . . . 25.0 112.953 -176.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.7 p -61.28 -12.27 5.92 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 N-CA-C 113.202 0.815 . . . . 25.0 113.202 -176.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 20.4 ptt? -67.08 -10.4 49.58 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 114.384 1.253 . . . . 25.0 114.384 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -71.24 -41.09 70.57 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 113.888 1.07 . . . . 25.0 113.888 -171.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -142.59 43.28 0.47 Allowed Pre-proline 0 N--CA 1.475 0.799 0 N-CA-C 117.377 2.362 . . . . 25.0 117.377 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -70.95 -21.1 28.4 Favored 'Trans proline' 0 C--N 1.349 0.602 1 C-N-CA 113.236 -4.042 . . . . 25.0 112.259 176.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 7.1 pm0 -79.03 -18.74 53.02 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.25 -0.432 . . . . 25.0 111.599 176.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.3 t -132.87 78.99 1.82 Allowed 'General case' 0 C--O 1.206 -1.229 0 N-CA-C 113.039 0.755 . . . . 25.0 113.039 -179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 97.2 mt -104.33 141.57 36.08 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.23 -0.656 . . . . 25.0 109.23 172.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.5 mm-40 -105.43 141.67 36.52 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.495 -0.557 . . . . 25.0 109.495 178.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.08 167.37 21.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.96 0.41 . . . . 25.0 110.766 178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -63.15 -178.15 0.22 Allowed 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 113.286 0.847 . . . . 25.0 113.286 -179.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . 0.526 ' HA ' ' HA ' ' A' ' 159' ' ' ASN . 14.4 pttp -53.32 138.71 31.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.833 -1.076 . . . . 25.0 112.302 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -107.34 -7.37 32.58 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 115.097 -0.956 . . . . 25.0 114.833 -176.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -73.27 133.34 81.08 Favored Pre-proline 0 C--N 1.322 -0.588 0 CA-C-N 118.259 1.03 . . . . 25.0 108.526 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -76.1 116.35 4.16 Favored 'Cis proline' 0 CA--C 1.545 1.053 0 C-N-CA 130.748 1.562 . . . . 25.0 115.077 -0.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 46.2 m170 -60.32 -19.79 56.71 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.808 1.41 . . . . 25.0 114.808 -177.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 39.0 t -69.94 -28.29 65.45 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 122.135 -0.353 . . . . 25.0 111.461 179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -97.32 -159.61 31.14 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 114.914 0.726 . . . . 25.0 114.914 -174.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -76.3 -178.82 4.71 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 121.637 1.558 . . . . 25.0 111.511 177.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -59.79 133.01 55.7 Favored 'General case' 0 CA--C 1.536 0.438 0 CA-C-N 116.37 -0.377 . . . . 25.0 111.169 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -104.79 175.14 5.59 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.116 0.484 . . . . 25.0 111.212 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.81 0.93 57.53 Favored Glycine 0 CA--C 1.517 0.215 0 N-CA-C 114.528 0.571 . . . . 25.0 114.528 179.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -144.49 -31.12 0.45 Allowed 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 116.067 1.877 . . . . 25.0 116.067 -173.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 33.5 mm -68.18 -33.83 63.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 CA-C-N 118.489 0.586 . . . . 25.0 109.671 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.6 -28.61 70.04 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-O 120.87 0.367 . . . . 25.0 111.478 177.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 10.7 m -94.26 3.09 55.71 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.268 -0.424 . . . . 25.0 110.77 178.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.64 15.07 1.97 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.441 1.497 . . . . 25.0 113.627 -174.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -78.96 -29.75 50.11 Favored Glycine 0 C--O 1.215 -1.09 0 N-CA-C 110.446 -1.062 . . . . 25.0 110.446 179.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -72.41 -16.7 77.4 Favored Glycine 0 C--O 1.219 -0.842 0 C-N-CA 120.38 -0.914 . . . . 25.0 111.79 177.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.1 mt -93.95 -61.24 1.57 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.461 0.648 . . . . 25.0 111.309 -179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 58.8 m-85 -85.02 -13.03 51.84 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.31 0.856 . . . . 25.0 113.31 -173.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -66.43 -24.38 72.26 Favored Glycine 0 C--O 1.224 -0.52 0 C-N-CA 120.804 -0.713 . . . . 25.0 113.058 -177.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.89 -31.49 80.99 Favored Glycine 0 C--O 1.218 -0.862 0 C-N-CA 120.495 -0.86 . . . . 25.0 111.948 178.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 43.8 mm -65.5 -37.36 79.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.385 0.612 . . . . 25.0 109.527 179.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.5 mp -76.14 -33.63 59.4 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.033 -0.531 . . . . 25.0 110.33 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -67.39 -31.74 72.16 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.451 0.643 . . . . 25.0 111.231 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -69.96 -5.06 23.67 Favored 'General case' 0 CA--C 1.539 0.544 0 N-CA-C 112.377 0.51 . . . . 25.0 112.377 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 14.5 pt20 -130.11 41.94 3.34 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.044 -0.724 . . . . 25.0 109.044 176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.1 t -125.16 167.63 14.55 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 108.646 -0.872 . . . . 25.0 108.646 -179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.1 tp10 -66.25 -26.11 67.2 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 174.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -88.08 12.67 12.95 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.601 -0.727 . . . . 25.0 112.203 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 21.0 ttm180 -53.42 139.66 29.94 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.563 0.697 . . . . 25.0 109.702 179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 86.8 m95 -81.93 142.32 32.55 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 122.52 1.153 . . . . 25.0 111.577 -176.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 23.1 p90 -71.14 152.13 43.73 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 113.939 -1.482 . . . . 25.0 112.01 -178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 55.6 mtpt -110.9 140.97 44.92 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.691 -0.686 . . . . 25.0 110.793 178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 58.1 m80 -119.01 133.43 55.83 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.596 -0.52 . . . . 25.0 109.596 170.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 67.4 mt -92.98 131.0 41.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 106.756 -1.572 . . . . 25.0 106.756 178.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 18.4 ttt -151.03 168.18 25.38 Favored 'General case' 0 C--O 1.217 -0.619 0 N-CA-C 106.862 -1.533 . . . . 25.0 106.862 -178.355 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 29.7 p -88.21 165.97 14.68 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 105.805 -1.924 . . . . 25.0 105.805 173.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -73.8 -158.2 5.23 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 121.396 -0.431 . . . . 25.0 112.583 178.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.52 -163.89 25.23 Favored Glycine 0 CA--C 1.512 -0.099 0 O-C-N 122.347 -0.502 . . . . 25.0 112.908 178.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 2.7 tt0 -74.71 129.14 37.17 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 122.008 -0.701 . . . . 25.0 110.906 -179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 54.0 m170 -122.5 136.21 54.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.218 -1.03 . . . . 25.0 108.218 177.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 89.5 m -99.94 118.15 35.75 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.896 -1.52 . . . . 25.0 106.896 175.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 81.7 m-85 -99.65 134.78 42.05 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 107.131 -1.433 . . . . 25.0 107.131 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 52.7 m -133.11 130.91 39.9 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.6 -0.519 . . . . 25.0 109.6 -179.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 53.5 m0 -114.61 150.04 35.67 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.558 -0.905 . . . . 25.0 108.558 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 15.0 t -143.31 154.92 44.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.164 -0.68 . . . . 25.0 109.164 175.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -140.13 159.07 43.0 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 106.906 -1.516 . . . . 25.0 106.906 178.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 9.5 t -67.48 -30.55 70.28 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.791 1.034 . . . . 25.0 113.791 -174.199 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.84 151.18 62.08 Favored Pre-proline 0 C--N 1.327 -0.375 0 N-CA-C 108.471 -0.937 . . . . 25.0 108.471 178.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -69.65 134.32 27.93 Favored 'Trans proline' 0 CA--C 1.533 0.467 0 C-N-CA 115.475 -2.55 . . . . 25.0 111.217 175.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 35.8 t-80 -131.0 154.47 48.14 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.129 -0.693 . . . . 25.0 109.129 179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -68.54 160.34 30.1 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.842 0.83 . . . . 25.0 109.717 174.535 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.2 t -154.46 161.64 41.58 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 100.692 -3.818 . . . . 25.0 100.692 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.0 p -110.7 -39.13 4.96 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.997 -0.742 . . . . 25.0 108.997 177.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 41.5 tt0 -159.75 143.59 14.53 Favored 'General case' 0 C--O 1.217 -0.636 0 N-CA-C 108.557 -0.905 . . . . 25.0 108.557 177.218 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -134.81 138.47 44.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 107.18 -1.415 . . . . 25.0 107.18 169.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . 0.421 ' CD2' ' N ' ' A' ' 96' ' ' HIS . 0.0 OUTLIER -140.83 152.81 45.44 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.937 0.399 . . . . 25.0 111.527 -171.31 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 62.5 m-85 -117.28 139.11 51.24 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.934 -1.03 . . . . 25.0 109.081 -176.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -136.99 165.77 25.23 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 107.168 -1.419 . . . . 25.0 107.168 176.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -133.97 153.71 36.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 105.353 -2.092 . . . . 25.0 105.353 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 72.1 p -85.78 147.87 26.11 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.169 -0.678 . . . . 25.0 109.169 -179.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.2 tttt -86.45 100.85 12.65 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.996 0.903 . . . . 25.0 110.095 -178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -76.08 126.72 31.53 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 107.761 -1.2 . . . . 25.0 107.761 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.0 20.92 34.75 Favored Glycine 0 C--O 1.225 -0.453 0 C-N-CA 119.701 -1.238 . . . . 25.0 114.053 178.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -52.06 141.1 19.04 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-O 121.492 0.663 . . . . 25.0 111.837 178.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -72.85 134.86 81.0 Favored Pre-proline 0 C--N 1.324 -0.519 0 N-CA-C 109.38 -0.6 . . . . 25.0 109.38 -178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.8 -16.73 23.35 Favored 'Trans proline' 0 CA--C 1.536 0.58 0 C-N-CA 117.703 -1.065 . . . . 25.0 113.344 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -67.44 -29.32 68.77 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 122.061 0.934 . . . . 25.0 110.339 177.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 68.2 mttt -100.76 152.31 37.81 Favored Pre-proline 0 C--N 1.322 -0.598 0 N-CA-C 107.973 -1.121 . . . . 25.0 107.973 -174.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -66.52 105.99 0.99 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 117.449 -1.234 . . . . 25.0 113.885 -176.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.6 tt -54.14 -42.18 69.26 Favored 'General case' 0 C--O 1.212 -0.881 0 CA-C-N 115.459 -0.792 . . . . 25.0 112.075 -178.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -68.74 -6.55 27.12 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 114.267 1.21 . . . . 25.0 114.267 -178.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -100.3 -44.02 6.07 Favored 'General case' 0 C--O 1.216 -0.703 0 CA-C-O 121.535 0.683 . . . . 25.0 111.281 170.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -87.38 7.45 28.92 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.333 -1.303 . . . . 25.0 114.489 -170.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -69.13 -29.09 67.07 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.9 1.074 . . . . 25.0 113.9 -172.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 38.4 p90 -127.36 159.15 35.31 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 118.332 0.514 . . . . 25.0 112.228 173.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 77.3 mt-10 -133.48 147.68 51.67 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 107.203 -1.406 . . . . 25.0 107.203 173.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 4.9 tt -87.02 133.79 33.55 Favored 'General case' 0 N--CA 1.476 0.831 0 O-C-N 121.893 -0.504 . . . . 25.0 110.277 -177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 14.6 tt -121.34 1.87 6.72 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 CA-C-O 121.847 0.832 . . . . 25.0 111.209 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 173.81 156.91 14.17 Favored Glycine 0 C--O 1.223 -0.562 0 C-N-CA 120.175 -1.012 . . . . 25.0 113.408 172.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -152.92 139.43 18.69 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.989 -1.115 . . . . 25.0 107.989 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.5 t -132.76 102.13 13.79 Favored Pre-proline 0 CA--C 1.539 0.55 0 N-CA-C 107.658 -1.238 . . . . 25.0 107.658 177.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -80.3 169.77 16.95 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 117.353 -1.298 . . . . 25.0 112.044 179.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -132.24 113.49 13.31 Favored 'General case' 0 CA--C 1.496 -1.132 0 N-CA-C 107.721 -1.215 . . . . 25.0 107.721 176.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -164.59 -104.44 0.01 OUTLIER 'General case' 0 C--N 1.312 -1.046 0 N-CA-C 102.009 -3.33 . . . . 25.0 102.009 174.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -91.7 40.4 2.93 Favored Glycine 0 C--N 1.318 -0.451 0 N-CA-C 111.152 -0.779 . . . . 25.0 111.152 176.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -76.28 132.73 72.63 Favored Pre-proline 0 C--O 1.24 0.573 0 O-C-N 122.244 -0.562 . . . . 25.0 111.597 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -72.2 -178.45 3.26 Favored 'Trans proline' 0 C--N 1.35 0.646 0 O-C-N 121.719 0.326 . . . . 25.0 111.955 176.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.37 -13.9 6.35 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 114.396 1.258 . . . . 25.0 114.396 -178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.2 m -59.66 -13.24 8.94 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 113.583 0.957 . . . . 25.0 113.583 176.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 52.1 ptt85 -67.0 16.24 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.63 1.715 . . . . 25.0 115.63 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 73.4 m-20 -58.09 143.13 44.77 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.553 0.692 . . . . 25.0 110.679 -177.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -70.49 -10.79 60.09 Favored 'General case' 0 N--CA 1.468 0.467 0 CA-C-N 115.139 -0.937 . . . . 25.0 112.21 -177.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 22.5 t -100.06 122.67 43.29 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 106.936 -1.505 . . . . 25.0 106.936 175.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -133.83 141.31 47.38 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.08 0.467 . . . . 25.0 110.326 -175.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 -91.97 132.88 36.19 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 107.932 -1.136 . . . . 25.0 107.932 179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 30.8 mm -131.92 129.07 60.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 105.903 -1.888 . . . . 25.0 105.903 177.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.47 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 35.3 t80 -96.73 132.08 42.78 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.008 -1.108 . . . . 25.0 108.008 176.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 65.4 mt -122.16 106.31 36.17 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 108.364 -0.976 . . . . 25.0 108.364 178.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -70.42 151.13 65.11 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 116.145 -2.103 . . . . 25.0 109.242 175.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -139.04 95.31 2.93 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.64 0.733 . . . . 25.0 111.028 -176.368 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -94.87 4.68 53.54 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.933 -1.03 . . . . 25.0 110.721 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 67.5 mtt180 -140.8 -179.34 6.0 Favored 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 109.046 -0.724 . . . . 25.0 109.046 -172.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.1 mp -125.57 130.48 51.77 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 104.432 -2.433 . . . . 25.0 104.432 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.01 -177.36 24.42 Favored Glycine 0 CA--C 1.516 0.152 0 CA-C-O 122.848 1.249 . . . . 25.0 115.973 177.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.493 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 31.9 p90 -79.02 146.54 33.26 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 114.354 1.242 . . . . 25.0 114.354 -173.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 61.7 m-70 -136.39 158.81 43.54 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.376 -2.453 . . . . 25.0 104.376 177.248 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 41.0 t -123.88 132.91 70.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.501 0 N-CA-C 108.681 -0.859 . . . . 25.0 108.681 177.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.6 mt -108.51 134.85 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 10.0 tt -118.4 137.82 52.87 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.428 -0.953 . . . . 25.0 108.428 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -128.48 144.52 51.16 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.532 0.682 . . . . 25.0 110.9 -178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 94.0 t -125.98 133.64 68.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 108.012 -1.107 . . . . 25.0 108.012 179.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.1 t-105 -129.43 100.79 5.69 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.952 -0.759 . . . . 25.0 108.952 176.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -88.1 131.97 34.48 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.006 -0.543 . . . . 25.0 109.562 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -89.05 160.97 2.75 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.957 -1.127 . . . . 25.0 107.957 179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -101.99 -27.65 12.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 108.984 -0.747 . . . . 25.0 108.984 177.564 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.65 -2.42 58.16 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 113.729 1.011 . . . . 25.0 113.729 -171.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 11.4 t -152.95 162.78 40.9 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.246 0.546 . . . . 25.0 111.469 -179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 38.3 tp10 -67.74 -26.17 66.01 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.496 1.119 . . . . 25.0 111.855 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . 0.526 ' HA ' ' HA ' ' A' ' 39' ' ' LYS . 86.2 m-20 -86.74 167.31 14.56 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.338 0.59 . . . . 25.0 110.592 -173.391 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -139.43 -179.56 5.96 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 105.665 -1.976 . . . . 25.0 105.665 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -128.36 140.46 51.85 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.538 -0.912 . . . . 25.0 108.538 178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -131.76 137.83 48.35 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 107.688 -1.227 . . . . 25.0 107.688 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -149.18 155.36 40.53 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.527 -0.545 . . . . 25.0 109.527 178.751 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 28.6 m -128.6 151.0 34.78 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 108.699 -0.852 . . . . 25.0 108.699 178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 31.5 mm -134.58 113.01 16.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.993 -1.114 . . . . 25.0 107.993 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -79.8 141.27 36.4 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 107.783 -1.192 . . . . 25.0 107.783 175.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 23.0 m -135.51 161.57 38.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 106.747 -1.575 . . . . 25.0 106.747 177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.493 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 1.0 OUTLIER -126.71 117.59 23.01 Favored 'General case' 0 C--N 1.318 -0.784 0 N-CA-C 105.955 -1.868 . . . . 25.0 105.955 176.492 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 90.5 mt -119.97 135.12 55.03 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.868 -0.606 . . . . 25.0 110.937 -169.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 34.7 m -134.35 165.83 30.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.525 -0.762 . . . . 25.0 109.774 -179.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -91.47 157.71 16.9 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 106.198 -1.779 . . . . 25.0 106.198 171.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.593 -1.194 . . . . 25.0 108.602 175.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 40.0 m80 . . . . . 0 N--CA 1.487 1.412 0 N-CA-C 109.999 -0.371 . . . . 25.0 109.999 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 129.68 -168.17 21.25 Favored Glycine 0 C--O 1.223 -0.569 0 N-CA-C 104.769 -3.333 . . . . 25.0 104.769 -174.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -154.54 161.38 41.66 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 120.587 2.193 . . . . 25.0 113.244 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.2 mt -93.97 126.47 46.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 107.432 -1.321 . . . . 25.0 107.432 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -80.27 -47.59 14.35 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.189 -0.671 . . . . 25.0 109.189 178.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 47.5 pttt -163.15 165.59 14.38 Favored Pre-proline 0 CA--C 1.539 0.528 0 N-CA-C 108.076 -1.083 . . . . 25.0 108.076 -176.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_endo -70.32 124.78 8.18 Favored 'Cis proline' 0 C--N 1.353 0.805 0 C-N-CA 131.392 1.83 . . . . 25.0 114.987 1.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.07 175.4 39.14 Favored Glycine 0 C--O 1.222 -0.634 0 CA-C-N 115.484 -0.78 . . . . 25.0 112.731 177.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 28.9 t -139.61 152.83 47.13 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 108.407 -0.96 . . . . 25.0 108.407 -179.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -75.29 -21.01 58.81 Favored 'General case' 0 C--O 1.219 -0.51 0 N-CA-C 109.815 -0.439 . . . . 25.0 109.815 178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.69 -33.58 66.57 Favored 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 112.006 0.373 . . . . 25.0 112.006 -178.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.56 -29.51 70.76 Favored 'General case' 0 C--O 1.217 -0.644 0 N-CA-C 112.446 0.536 . . . . 25.0 112.446 179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.8 mp -92.04 -32.07 15.33 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-O 121.254 0.549 . . . . 25.0 109.86 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -70.11 -39.71 75.33 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.709 -0.678 . . . . 25.0 111.526 -176.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 33.2 t -63.37 129.04 38.56 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 113.191 0.811 . . . . 25.0 113.191 -174.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -65.6 -15.01 62.32 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.763 -1.108 . . . . 25.0 111.747 176.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -59.82 -13.01 8.63 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 112.431 0.53 . . . . 25.0 112.431 177.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -77.83 -7.17 56.27 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 111.983 0.364 . . . . 25.0 111.983 -179.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -178.47 -29.89 0.05 OUTLIER Glycine 0 C--O 1.223 -0.573 0 N-CA-C 115.999 1.16 . . . . 25.0 115.999 178.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.3 t80 61.5 3.26 0.78 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 116.094 1.887 . . . . 25.0 116.094 177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.5 mt -71.6 -27.53 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 121.977 -0.452 . . . . 25.0 111.162 178.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -160.9 161.94 31.91 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 107.418 -1.327 . . . . 25.0 107.418 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.8 mp -78.1 138.83 38.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 107.958 -1.127 . . . . 25.0 107.958 175.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -125.45 -3.28 7.36 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 114.043 1.127 . . . . 25.0 114.043 -174.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.2 t -66.08 -45.1 82.45 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 114.215 1.191 . . . . 25.0 114.215 -175.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 75.85 156.32 6.12 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 114.766 0.667 . . . . 25.0 114.766 178.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 32.0 t -66.25 -33.46 75.8 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 113.595 0.961 . . . . 25.0 113.595 -176.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.4 p -64.21 -10.01 7.21 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.955 0.724 . . . . 25.0 112.955 -177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -54.88 -22.6 15.26 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 116.539 2.051 . . . . 25.0 116.539 -176.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -74.67 -37.88 62.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 118.582 0.628 . . . . 25.0 111.777 -174.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -150.74 68.29 8.23 Favored Pre-proline 0 C--N 1.324 -0.524 0 N-CA-C 115.358 1.614 . . . . 25.0 115.358 174.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -72.8 -6.49 19.11 Favored 'Trans proline' 0 C--O 1.222 -0.309 0 N-CA-C 113.14 0.4 . . . . 25.0 113.14 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 1.5 pp0? -97.92 4.85 49.47 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.855 0.687 . . . . 25.0 112.855 177.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.7 t -107.81 88.08 2.65 Favored 'General case' 0 C--O 1.221 -0.437 0 C-N-CA 119.666 -0.813 . . . . 25.0 110.603 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 7.0 mp -108.95 140.18 42.79 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 103.891 -2.633 . . . . 25.0 103.891 172.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -107.51 144.05 35.03 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.666 0.746 . . . . 25.0 112.198 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.98 162.78 31.92 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.606 -1.998 . . . . 25.0 105.606 179.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -109.4 154.0 23.19 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 118.228 0.467 . . . . 25.0 109.816 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 76.2 mttt -61.54 142.1 57.3 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.223 -0.658 . . . . 25.0 109.223 175.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 168.57 93.28 0.09 OUTLIER Glycine 0 C--O 1.22 -0.719 0 N-CA-C 110.111 -1.196 . . . . 25.0 110.111 178.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -70.94 148.65 94.67 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.278 -1.008 . . . . 25.0 108.278 -179.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.9 153.03 93.17 Favored 'Cis proline' 0 C--N 1.349 0.563 0 C-N-CA 129.937 1.224 . . . . 25.0 114.024 0.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -137.23 -36.19 0.67 Allowed 'General case' 0 C--O 1.214 -0.797 0 N-CA-C 114.24 1.2 . . . . 25.0 114.24 179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.8 t -83.14 -12.97 56.5 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 118.831 0.741 . . . . 25.0 109.765 173.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -89.08 -148.52 18.28 Favored Glycine 0 C--O 1.236 0.258 0 N-CA-C 108.51 -1.836 . . . . 25.0 108.51 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -61.96 156.24 50.47 Favored 'Trans proline' 0 C--N 1.346 0.396 0 CA-C-N 119.113 1.457 . . . . 25.0 111.321 176.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -64.86 123.85 20.47 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.033 -0.53 . . . . 25.0 111.167 -177.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -146.36 174.88 10.97 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 103.797 -2.668 . . . . 25.0 103.797 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 87.5 -32.02 4.33 Favored Glycine 0 C--O 1.223 -0.579 0 CA-C-N 118.309 0.504 . . . . 25.0 112.73 -176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 3.8 mp0 -100.72 12.47 37.4 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 122.426 -0.455 . . . . 25.0 111.676 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 81.8 mt -64.11 -40.01 87.51 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 108.386 -0.968 . . . . 25.0 108.386 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.12 -24.59 66.71 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.492 0.552 . . . . 25.0 112.492 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 80.0 p -101.18 23.18 11.24 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 122.305 0.242 . . . . 25.0 110.886 -179.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 53.32 46.22 26.84 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 112.996 0.739 . . . . 25.0 112.996 179.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -59.23 -10.18 9.63 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 116.166 1.226 . . . . 25.0 116.166 -179.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -69.84 -7.32 58.7 Favored Glycine 0 CA--C 1.526 0.726 0 CA-C-N 117.783 0.792 . . . . 25.0 112.527 175.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 25.9 mt -60.73 -10.88 6.0 Favored 'General case' 0 N--CA 1.469 0.493 0 N-CA-C 113.262 0.838 . . . . 25.0 113.262 176.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 13.2 p90 -57.86 -21.22 41.69 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.364 0.876 . . . . 25.0 113.364 178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -65.86 -26.32 72.16 Favored Glycine 0 CA--C 1.522 0.473 0 C-N-CA 120.252 -0.975 . . . . 25.0 111.136 176.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -70.44 -14.7 72.22 Favored Glycine 0 C--O 1.217 -0.949 0 CA-C-O 119.589 -0.562 . . . . 25.0 114.028 178.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 95.4 mt -60.86 -33.08 53.98 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-N 118.072 0.936 . . . . 25.0 110.146 -178.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.5 -39.51 91.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.249 -0.432 . . . . 25.0 110.65 -179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -88.82 -2.97 58.86 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.996 0.903 . . . . 25.0 111.935 -176.34 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -74.57 23.23 0.09 Allowed 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 114.438 1.273 . . . . 25.0 114.438 -175.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -70.57 74.33 0.56 Allowed 'General case' 0 CA--C 1.547 0.853 0 O-C-N 121.615 -0.678 . . . . 25.0 111.882 -177.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 30.6 t -151.59 171.2 17.98 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 105.877 -1.898 . . . . 25.0 105.877 -176.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.6 mp0 -64.76 -17.03 63.8 Favored 'General case' 0 C--N 1.322 -0.604 0 C-N-CA 123.885 0.874 . . . . 25.0 112.025 -179.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -74.26 -9.96 59.12 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 178.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 1.3 ttp85 -71.04 160.38 33.02 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.407 0.622 . . . . 25.0 110.216 -178.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.4 p90 -85.06 163.65 18.7 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.328 -0.99 . . . . 25.0 108.328 178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.5 p90 -62.73 146.78 51.56 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.938 0.875 . . . . 25.0 112.525 -172.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -114.4 143.59 44.67 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.188 -1.412 . . . . 25.0 107.188 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -118.89 118.16 30.79 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.392 -0.596 . . . . 25.0 109.392 176.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.7 mt -76.13 135.87 25.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 N-CA-C 105.754 -1.943 . . . . 25.0 105.754 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -149.89 165.97 30.96 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 106.995 -1.483 . . . . 25.0 106.995 -178.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 24.0 p -108.49 170.19 8.18 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 105.926 -1.879 . . . . 25.0 105.926 173.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.54 179.21 26.36 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 115.076 0.791 . . . . 25.0 115.076 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 109.13 172.99 21.04 Favored Glycine 0 C--O 1.228 -0.258 0 N-CA-C 110.593 -1.003 . . . . 25.0 110.593 -177.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.62 144.99 54.32 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 121.786 -0.832 . . . . 25.0 109.345 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 28.8 m170 -133.32 157.18 46.13 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.389 -0.597 . . . . 25.0 109.389 178.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.3 m -115.91 127.89 55.35 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.517 -0.549 . . . . 25.0 109.517 -179.386 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -108.18 132.77 53.29 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.188 -1.041 . . . . 25.0 108.188 -179.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 46.3 m -137.84 130.05 29.06 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.612 -0.514 . . . . 25.0 109.612 178.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 4.3 m0 -124.07 155.74 37.81 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 106.686 -1.598 . . . . 25.0 106.686 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.9 t -142.24 162.01 36.56 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.466 -0.568 . . . . 25.0 109.466 176.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -125.42 142.8 51.3 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 107.703 -1.221 . . . . 25.0 107.703 -178.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.9 t -83.52 -0.56 50.77 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 121.27 0.557 . . . . 25.0 111.617 -177.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 160.4 58.42 Favored Pre-proline 0 C--O 1.241 0.657 0 N-CA-C 105.473 -2.047 . . . . 25.0 105.473 -179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -62.18 147.82 94.33 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 116.286 -2.01 . . . . 25.0 110.411 175.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -130.74 109.5 10.65 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 113.081 0.771 . . . . 25.0 113.081 -171.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 16.4 t-20 -61.29 144.5 53.77 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.062 -0.972 . . . . 25.0 108.85 176.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.4 m -133.34 132.81 41.72 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.362 -0.381 . . . . 25.0 109.976 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 22.1 t -106.54 -47.28 3.8 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 107.693 -1.225 . . . . 25.0 107.693 171.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 45.1 tt0 -162.47 145.32 11.2 Favored 'General case' 0 C--O 1.218 -0.577 0 N-CA-C 106.582 -1.636 . . . . 25.0 106.582 179.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 3.9 p-90 -137.96 136.16 36.71 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.591 -0.892 . . . . 25.0 108.591 171.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -148.06 158.58 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.741 -0.837 . . . . 25.0 108.741 -169.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.49 154.89 46.76 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.163 0.506 . . . . 25.0 111.878 -175.65 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 60.5 m-85 -135.44 163.2 30.58 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.255 -0.884 . . . . 25.0 109.936 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 46.7 pt -129.36 152.56 37.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 106.17 -1.789 . . . . 25.0 106.17 168.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 42.6 p -84.87 141.92 30.09 Favored 'General case' 0 C--O 1.243 0.739 0 N-CA-C 107.234 -1.395 . . . . 25.0 107.234 174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 6.6 tppt? -74.22 114.82 13.02 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.809 0.814 . . . . 25.0 110.605 -177.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 65.6 tttm -76.22 122.76 24.83 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 105.598 -2.001 . . . . 25.0 105.598 172.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 92.85 17.28 44.92 Favored Glycine 0 C--O 1.221 -0.708 0 C-N-CA 119.885 -1.15 . . . . 25.0 115.416 179.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -57.02 150.41 17.04 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 117.898 0.849 . . . . 25.0 112.552 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -82.83 118.63 72.41 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 116.099 -0.5 . . . . 25.0 110.789 -179.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.27 -15.95 22.44 Favored 'Trans proline' 0 C--N 1.349 0.563 0 N-CA-C 114.725 1.01 . . . . 25.0 114.725 -179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -80.77 -3.85 52.41 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 122.174 0.987 . . . . 25.0 111.071 -179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -113.79 159.26 36.49 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 105.358 -2.09 . . . . 25.0 105.358 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -66.28 99.32 0.42 Allowed 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 117.454 -1.23 . . . . 25.0 112.829 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 3.0 tp -53.08 -36.57 60.8 Favored 'General case' 0 C--O 1.209 -1.065 0 N-CA-C 113.634 0.975 . . . . 25.0 113.634 -173.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 17.9 ptpt -57.46 -15.27 6.42 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 114.634 1.346 . . . . 25.0 114.634 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -85.99 -43.62 13.02 Favored 'General case' 0 C--O 1.218 -0.603 0 CA-C-N 118.238 0.472 . . . . 25.0 111.439 170.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -86.82 -3.89 59.11 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 113.78 1.03 . . . . 25.0 113.78 -172.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -67.87 -31.46 71.28 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 121.103 -0.239 . . . . 25.0 110.862 -174.28 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -127.15 132.41 50.55 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.772 0.656 . . . . 25.0 112.772 178.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -118.35 124.8 48.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.148 -1.056 . . . . 25.0 108.148 178.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.6 tp -70.29 119.98 15.28 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 108.208 -1.034 . . . . 25.0 108.208 178.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -103.13 -2.13 9.73 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.913 0.863 . . . . 25.0 109.668 -176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 161.97 160.54 11.06 Favored Glycine 0 CA--C 1.512 -0.143 0 C-N-CA 120.769 -0.729 . . . . 25.0 113.242 173.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -149.2 144.84 26.82 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.678 -0.86 . . . . 25.0 108.678 179.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 57.7 t -135.6 104.76 10.0 Favored Pre-proline 0 C--O 1.239 0.54 0 N-CA-C 107.159 -1.423 . . . . 25.0 107.159 177.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.52 172.21 12.69 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 116.902 -1.599 . . . . 25.0 112.662 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 31.7 t-80 -134.65 91.45 2.78 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.303 -2.48 . . . . 25.0 104.303 170.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -106.14 29.95 6.32 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 122.166 0.984 . . . . 25.0 108.997 -175.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 117.72 -37.29 3.34 Favored Glycine 0 C--O 1.228 -0.245 0 N-CA-C 109.336 -1.506 . . . . 25.0 109.336 -176.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 41.3 t -59.38 138.1 88.92 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 109.527 -0.546 . . . . 25.0 109.527 176.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -77.1 46.78 2.05 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 121.991 1.794 . . . . 25.0 114.496 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.85 -21.79 61.42 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.828 0.677 . . . . 25.0 112.828 -179.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 15.0 m -61.84 -13.16 21.65 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 113.834 1.05 . . . . 25.0 113.834 178.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -61.14 -35.92 78.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-O 120.884 0.374 . . . . 25.0 110.394 175.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -106.56 105.02 14.86 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.01 0.433 . . . . 25.0 110.425 -174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.12 -13.81 30.16 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 113.274 0.842 . . . . 25.0 113.274 -178.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 26.4 t -100.03 140.95 33.51 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 122.184 -0.323 . . . . 25.0 110.748 -175.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.9 t-80 -139.15 139.52 37.63 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.019 0.437 . . . . 25.0 111.904 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 76.9 m-70 -86.75 137.53 32.36 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.013 -0.736 . . . . 25.0 109.013 176.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 31.6 mm -132.14 124.97 53.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 107.289 -1.375 . . . . 25.0 107.289 177.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 78.7 t80 -77.0 135.56 38.68 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.016 -0.735 . . . . 25.0 109.016 175.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 37.9 mm -126.08 129.21 24.31 Favored Pre-proline 0 C--N 1.323 -0.565 0 N-CA-C 106.482 -1.673 . . . . 25.0 106.482 176.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.9 Cg_endo -72.78 172.64 14.89 Favored 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 117.941 -0.906 . . . . 25.0 112.87 179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -129.83 45.58 2.78 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 107.271 -1.381 . . . . 25.0 107.271 178.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -88.45 -37.72 15.6 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.657 -1.156 . . . . 25.0 113.364 -174.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 81.9 mtt85 -147.77 156.95 43.28 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 110.175 -0.306 . . . . 25.0 110.175 -173.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.0 mp -95.56 145.73 25.0 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.199 0.6 . . . . 25.0 110.431 -177.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 137.55 163.85 9.82 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 114.558 0.583 . . . . 25.0 114.558 173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 43.1 p90 -94.37 145.75 24.54 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 114.895 1.443 . . . . 25.0 114.895 -176.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 17.7 p-80 -148.99 163.32 37.84 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 107.541 -1.281 . . . . 25.0 107.541 174.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -98.04 149.91 5.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.14 0.495 . . . . 25.0 112.029 -175.466 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 62.8 mt -120.59 133.22 67.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 105.426 -2.065 . . . . 25.0 105.426 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.7 mp -121.52 149.06 43.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -136.68 144.13 43.78 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 175.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 40.9 t -128.91 131.14 68.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.951 -1.129 . . . . 25.0 107.951 -178.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.6 t-105 -122.33 101.84 7.75 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.362 0.601 . . . . 25.0 109.959 179.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -79.97 131.87 35.91 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.369 -0.975 . . . . 25.0 108.369 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.58 128.96 75.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 106.218 -1.771 . . . . 25.0 106.218 -176.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.81 -28.99 44.59 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.94 0.4 . . . . 25.0 109.99 -177.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.68 -24.95 66.33 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 115.6 1.704 . . . . 25.0 115.6 -175.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.5 p -123.27 161.69 24.1 Favored 'General case' 0 C--O 1.219 -0.527 0 O-C-N 122.241 -0.287 . . . . 25.0 110.331 -173.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -71.67 -19.12 62.12 Favored 'General case' 0 C--O 1.24 0.585 0 CA-C-O 122.181 0.991 . . . . 25.0 109.909 178.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 8.8 m120 -108.92 161.81 14.79 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 114.886 -1.052 . . . . 25.0 111.249 -174.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.41 165.18 16.73 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 103.73 -2.693 . . . . 25.0 103.73 176.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -114.97 144.36 43.71 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.036 0.446 . . . . 25.0 110.971 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -113.28 146.53 39.21 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 106.416 -1.698 . . . . 25.0 106.416 174.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 72.8 mt-30 -133.55 141.17 47.59 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 104.813 -2.291 . . . . 25.0 104.813 174.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.07 136.61 47.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.502 -0.555 . . . . 25.0 109.502 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 66.3 mt -137.89 125.39 29.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 N-CA-C 107.357 -1.349 . . . . 25.0 107.357 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -90.88 142.89 27.29 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 107.533 -1.284 . . . . 25.0 107.533 175.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 31.2 m -132.16 142.51 42.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 O-C-N 121.947 -0.471 . . . . 25.0 109.967 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -109.67 120.88 43.86 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 104.935 -2.246 . . . . 25.0 104.935 176.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 34.5 mt -120.02 128.22 53.32 Favored 'General case' 0 CA--C 1.497 -1.058 0 N-CA-C 109.713 -0.477 . . . . 25.0 109.713 -172.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 28.6 m -136.73 170.06 18.94 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.774 -0.454 . . . . 25.0 109.774 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -77.56 157.94 30.08 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.898 -0.778 . . . . 25.0 108.898 177.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 27.6 mttt . . . . . 0 C--O 1.247 0.965 0 CA-C-O 117.793 -1.098 . . . . 25.0 109.787 178.353 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.9 p-80 . . . . . 0 N--CA 1.497 1.917 0 N-CA-C 110.582 -0.155 . . . . 25.0 110.582 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -176.03 178.28 47.52 Favored Glycine 0 CA--C 1.509 -0.332 0 N-CA-C 106.26 -2.736 . . . . 25.0 106.26 179.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -125.77 156.72 39.02 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 118.642 1.221 . . . . 25.0 111.372 -177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 70.6 mt -97.66 119.44 45.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 103.637 -2.727 . . . . 25.0 103.637 170.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 29.1 tp10 -77.5 5.67 8.5 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 112.654 0.613 . . . . 25.0 112.654 -172.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 56.7 mttt 79.26 152.43 0.13 Allowed Pre-proline 0 N--CA 1.489 1.509 0 C-N-CA 126.021 1.729 . . . . 25.0 108.322 -179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -69.13 152.4 90.71 Favored 'Cis proline' 0 C--N 1.346 0.415 0 C-N-CA 128.547 0.645 . . . . 25.0 112.023 -2.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 98.8 18.15 26.01 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 118.177 2.031 . . . . 25.0 118.177 173.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -65.04 131.29 46.18 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 118.896 1.348 . . . . 25.0 111.762 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -78.84 -15.93 57.75 Favored 'General case' 0 C--O 1.213 -0.851 0 N-CA-C 113.459 0.911 . . . . 25.0 113.459 178.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.7 -36.78 74.78 Favored 'General case' 0 C--O 1.214 -0.802 0 N-CA-C 112.222 0.453 . . . . 25.0 112.222 -175.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.73 -23.66 62.48 Favored 'General case' 0 C--O 1.216 -0.669 0 O-C-N 121.841 -0.537 . . . . 25.0 110.908 178.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 10.6 mp -92.18 -4.03 54.77 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.05 -0.523 . . . . 25.0 110.279 -178.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 11.1 t -88.02 -15.33 36.67 Favored 'General case' 0 C--O 1.219 -0.515 0 N-CA-C 108.822 -0.806 . . . . 25.0 108.822 179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -57.89 162.06 3.5 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 113.391 0.886 . . . . 25.0 113.391 -176.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -55.32 -18.79 7.05 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.125 0.97 . . . . 25.0 113.282 176.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.4 -12.93 2.87 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 123.731 0.813 . . . . 25.0 112.737 173.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -71.44 -11.2 60.76 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.175 0.59 . . . . 25.0 111.196 178.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 148.41 -0.56 0.58 Allowed Glycine 0 C--O 1.223 -0.573 0 N-CA-C 116.785 1.474 . . . . 25.0 116.785 174.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER 56.49 22.59 6.66 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 114.472 1.286 . . . . 25.0 114.472 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.8 mt -84.58 -7.87 59.1 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.586 0.708 . . . . 25.0 109.541 176.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -135.39 -174.89 3.76 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.009 -0.996 . . . . 25.0 110.461 -172.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.0 mp -74.89 168.56 19.68 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 106.977 -1.49 . . . . 25.0 106.977 175.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m-20 -42.15 -24.48 0.05 OUTLIER 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 116.404 2.002 . . . . 25.0 116.404 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.19 -13.05 0.26 Allowed 'General case' 0 CA--C 1.546 0.793 0 CA-C-O 121.48 0.657 . . . . 25.0 111.763 171.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 84.44 167.5 42.8 Favored Glycine 0 CA--C 1.524 0.62 0 O-C-N 121.628 -0.67 . . . . 25.0 112.875 -178.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -65.72 -30.24 70.88 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.473 0.654 . . . . 25.0 112.545 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.6 p -66.84 -10.27 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 N-CA-C 113.071 0.767 . . . . 25.0 113.071 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.3 ptm -57.83 -11.09 2.02 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 118.121 2.637 . . . . 25.0 118.121 -174.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 92.7 t80 -69.94 -38.7 76.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 118.521 0.601 . . . . 25.0 110.462 -177.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -156.95 63.74 3.16 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 114.174 1.176 . . . . 25.0 114.174 173.056 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -71.97 -8.12 22.35 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.122 -0.785 . . . . 25.0 113.856 -177.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 2.6 pm0 -97.19 5.12 50.66 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 122.056 -0.403 . . . . 25.0 111.878 178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 1.4 t -121.21 130.4 53.68 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.739 0.644 . . . . 25.0 112.739 -175.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 92.4 mt -116.0 137.3 52.23 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 106.947 -1.501 . . . . 25.0 106.947 172.47 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -110.36 140.52 44.49 Favored 'General case' 0 CA--C 1.537 0.479 0 O-C-N 122.932 0.145 . . . . 25.0 111.132 -174.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.93 158.08 45.28 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 109.396 -0.594 . . . . 25.0 109.396 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -127.22 159.25 34.89 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.939 0.718 . . . . 25.0 112.939 179.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -97.03 169.53 9.76 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 124.395 1.078 . . . . 25.0 109.521 179.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.94 108.5 2.55 Favored Glycine 0 C--O 1.224 -0.528 0 CA-C-N 116.405 -0.361 . . . . 25.0 112.509 176.313 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -62.13 147.12 91.29 Favored Pre-proline 0 CA--C 1.539 0.528 0 O-C-N 122.014 -0.698 . . . . 25.0 110.871 -177.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -72.48 -16.98 16.46 Favored 'Cis proline' 0 C--N 1.349 0.597 0 N-CA-C 114.83 1.05 . . . . 25.0 114.83 1.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.3 p80 -177.31 -34.71 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 123.697 0.799 . . . . 25.0 110.652 175.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 7.9 t 68.7 -37.88 0.37 Allowed 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.11 1.364 . . . . 25.0 114.434 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -94.8 -146.61 21.02 Favored Glycine 0 C--O 1.243 0.66 0 N-CA-C 108.294 -1.922 . . . . 25.0 108.294 173.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -67.85 -163.27 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.831 0 CA-C-N 119.557 1.679 . . . . 25.0 110.067 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.08 88.72 1.43 Allowed 'General case' 0 CA--C 1.543 0.693 0 O-C-N 120.853 -1.154 . . . . 25.0 108.912 178.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 68.9 m-20 -88.79 162.62 16.1 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.011 -0.995 . . . . 25.0 111.533 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.07 -6.96 31.87 Favored Glycine 0 C--O 1.227 -0.296 0 N-CA-C 114.958 0.743 . . . . 25.0 114.958 176.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 92.8 mm-40 -68.21 -25.48 65.24 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 121.947 -0.737 . . . . 25.0 112.176 -175.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.2 mt -69.46 -39.46 78.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 108.611 -0.885 . . . . 25.0 108.611 175.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.04 -31.99 69.89 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 111.907 0.336 . . . . 25.0 111.907 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 95.5 p -81.62 -0.71 43.69 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 120.873 0.368 . . . . 25.0 110.215 176.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.29 19.9 9.38 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.933 1.293 . . . . 25.0 112.678 -178.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -89.93 -32.27 10.12 Favored Glycine 0 C--O 1.226 -0.397 0 N-CA-C 111.02 -0.832 . . . . 25.0 111.02 177.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.71 -5.32 88.37 Favored Glycine 0 C--O 1.225 -0.463 0 N-CA-C 114.24 0.456 . . . . 25.0 114.24 -177.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 88.8 mt -63.68 -24.53 67.82 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 117.319 0.56 . . . . 25.0 111.151 -178.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -66.49 -19.39 65.78 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 111.955 0.354 . . . . 25.0 111.955 178.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -68.76 -26.85 74.28 Favored Glycine 0 C--O 1.22 -0.743 0 N-CA-C 110.46 -1.056 . . . . 25.0 110.46 174.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.9 -19.64 78.35 Favored Glycine 0 C--O 1.219 -0.829 0 C-N-CA 121.235 -0.507 . . . . 25.0 112.189 178.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.8 mm -71.38 -42.59 73.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 107.377 -1.342 . . . . 25.0 107.377 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 11.0 mp -68.39 -32.57 72.74 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.044 -0.526 . . . . 25.0 109.914 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.0 t70 -62.11 -23.21 66.4 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 112.628 0.603 . . . . 25.0 112.628 -179.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 65.7 mt-30 -68.94 -7.27 33.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 121.439 -0.788 . . . . 25.0 112.171 178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 79.6 mt-30 -131.0 40.79 3.43 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.835 -0.802 . . . . 25.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 44.8 t -112.43 158.29 20.03 Favored 'General case' 0 C--O 1.223 -0.316 0 N-CA-C 109.744 -0.465 . . . . 25.0 109.744 -177.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -73.19 -30.78 63.79 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.582 -0.895 . . . . 25.0 108.582 174.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -96.64 21.26 9.6 Favored 'General case' 0 N--CA 1.468 0.438 0 CA-C-N 115.416 -0.811 . . . . 25.0 110.329 -179.341 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 57.6 ttt180 -50.24 148.29 3.63 Favored 'General case' 0 C--O 1.242 0.69 0 CA-C-N 115.127 -0.942 . . . . 25.0 111.64 -179.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -67.37 138.15 56.52 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.766 1.269 . . . . 25.0 110.03 -175.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.5 p90 -82.06 140.08 34.09 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 113.911 -1.495 . . . . 25.0 109.551 -172.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.6 mtpt -108.72 138.68 44.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.346 -0.388 . . . . 25.0 111.485 -176.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -124.39 135.25 53.15 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 109.835 -0.431 . . . . 25.0 109.835 168.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 76.5 mt -79.66 138.38 20.03 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 107.821 -1.177 . . . . 25.0 107.821 177.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 5.1 tpt -139.51 156.11 47.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.349 -1.352 . . . . 25.0 107.349 176.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 35.9 p -101.43 -179.34 4.0 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.309 -0.997 . . . . 25.0 108.309 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -71.6 -178.77 30.3 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 121.275 -0.488 . . . . 25.0 112.355 175.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 97.26 -177.89 32.64 Favored Glycine 0 CA--C 1.519 0.285 0 O-C-N 122.439 -0.448 . . . . 25.0 113.575 179.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.402 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.0 OUTLIER -85.2 142.31 29.53 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 108.313 -0.995 . . . . 25.0 108.313 178.586 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 18.9 m80 -139.62 158.5 44.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.14 0.495 . . . . 25.0 110.206 177.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.8 m -110.18 129.15 55.76 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.393 -0.966 . . . . 25.0 108.393 179.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -125.6 138.21 53.92 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.518 -1.289 . . . . 25.0 107.518 176.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 24.5 m -136.38 144.07 44.36 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.903 0.382 . . . . 25.0 111.113 -174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 7.2 m95 -121.02 149.98 41.85 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.634 -1.617 . . . . 25.0 106.634 174.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -135.83 156.44 48.79 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.296 0.57 . . . . 25.0 110.282 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -139.03 145.56 39.76 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 105.544 -2.021 . . . . 25.0 105.544 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.8 t -75.03 -14.15 60.57 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.495 0.554 . . . . 25.0 112.495 -176.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.98 149.25 55.32 Favored Pre-proline 0 C--O 1.243 0.753 0 N-CA-C 107.588 -1.264 . . . . 25.0 107.588 178.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_endo -71.05 153.15 63.06 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 117.267 -1.356 . . . . 25.0 111.062 176.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -131.0 140.18 50.09 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.729 -0.471 . . . . 25.0 109.729 178.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 5.7 m-20 -61.74 145.81 51.28 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 106.51 -1.663 . . . . 25.0 106.51 174.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 42.8 m -152.11 142.65 22.69 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 108.348 -0.982 . . . . 25.0 108.348 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 51.1 p -101.88 -37.37 8.29 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.477 -0.564 . . . . 25.0 109.477 174.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -165.13 167.11 18.51 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 122.239 -0.288 . . . . 25.0 111.119 174.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -141.25 141.17 34.01 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 108.625 -0.88 . . . . 25.0 108.625 167.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 3.8 p80 -147.94 155.68 41.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.377 -0.374 . . . . 25.0 110.265 -175.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -137.9 150.03 46.74 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.39 0.614 . . . . 25.0 111.918 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 52.3 m-85 -131.5 165.06 24.4 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 107.435 -1.32 . . . . 25.0 107.435 -177.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 38.5 pt -132.47 148.91 31.77 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 106.839 -1.541 . . . . 25.0 106.839 173.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 45.0 p -83.93 121.78 27.83 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 175.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -99.88 104.29 15.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.686 0.755 . . . . 25.0 109.06 178.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 56.2 pttt -75.99 153.96 36.15 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 106.745 -1.576 . . . . 25.0 106.745 173.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 95.61 23.95 17.24 Favored Glycine 0 C--O 1.226 -0.36 0 C-N-CA 119.779 -1.201 . . . . 25.0 114.606 178.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.5 p90 -66.7 161.62 23.06 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 117.667 0.734 . . . . 25.0 109.546 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -89.83 155.7 47.58 Favored Pre-proline 0 C--N 1.319 -0.735 0 N-CA-C 107.485 -1.302 . . . . 25.0 107.485 177.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.73 -14.54 33.08 Favored 'Trans proline' 0 C--N 1.35 0.628 0 C-N-CA 117.777 -1.015 . . . . 25.0 113.261 178.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -69.07 -20.6 64.09 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 123.703 0.801 . . . . 25.0 111.468 175.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -96.04 147.16 32.55 Favored Pre-proline 0 C--N 1.323 -0.555 0 N-CA-C 109.494 -0.558 . . . . 25.0 109.494 -173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -61.82 119.71 6.96 Favored 'Trans proline' 0 C--N 1.348 0.525 0 C-N-CA 118.285 -0.677 . . . . 25.0 111.609 -178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 58.2 tp -51.58 -49.97 61.06 Favored 'General case' 0 C--O 1.218 -0.582 0 N-CA-C 115.533 1.679 . . . . 25.0 115.533 -167.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 84.6 mttt -79.91 -36.67 36.09 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.902 0.858 . . . . 25.0 111.797 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 51.0 ttt180 -75.85 -32.67 59.85 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.492 -0.776 . . . . 25.0 112.983 -172.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -85.62 1.9 47.33 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.624 -0.262 . . . . 25.0 111.157 -179.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -67.91 -29.59 68.72 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 121.195 -0.202 . . . . 25.0 111.135 -177.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 54.7 p90 -125.88 150.14 48.13 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 112.91 0.708 . . . . 25.0 112.91 177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -127.75 145.76 50.8 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 108.073 -1.084 . . . . 25.0 108.073 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 14.4 tp -78.12 124.68 28.34 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 109.257 -0.645 . . . . 25.0 109.257 179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 16.1 tt -98.36 -12.21 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 CA-C-O 121.375 0.607 . . . . 25.0 110.137 178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.46 160.19 14.42 Favored Glycine 0 CA--C 1.51 -0.268 0 C-N-CA 120.311 -0.947 . . . . 25.0 114.206 174.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.54 139.06 23.88 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 106.706 -1.591 . . . . 25.0 106.706 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 61.0 t -137.09 116.49 10.4 Favored Pre-proline 0 C--O 1.242 0.664 0 N-CA-C 107.393 -1.336 . . . . 25.0 107.393 177.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -78.85 167.53 22.09 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 115.329 -2.648 . . . . 25.0 111.904 178.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.0 t-80 -126.64 96.25 4.6 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 122.348 1.071 . . . . 25.0 108.554 178.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 60.7 t0 -165.72 -98.15 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 100.527 -3.879 . . . . 25.0 100.527 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -93.69 134.93 12.32 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 105.843 -2.903 . . . . 25.0 105.843 168.103 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.4 t -164.58 146.2 6.76 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 117.48 0.64 . . . . 25.0 109.442 -177.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -74.2 -162.43 0.14 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 120.747 0.964 . . . . 25.0 110.184 171.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.76 -14.07 2.09 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 114.381 1.252 . . . . 25.0 114.381 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 7.5 m -60.48 -16.05 32.96 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 113.079 0.77 . . . . 25.0 113.079 174.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 8.3 ttm180 -67.36 -10.44 51.12 Favored 'General case' 0 N--CA 1.474 0.767 0 N-CA-C 112.467 0.544 . . . . 25.0 112.467 178.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -65.97 147.7 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.278 0.561 . . . . 25.0 109.935 -179.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -72.57 -9.7 58.89 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.568 0.699 . . . . 25.0 111.258 178.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.0 t -100.03 121.04 40.76 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 106.313 -1.736 . . . . 25.0 106.313 176.308 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 57.6 t-80 -124.61 132.28 53.43 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.177 0.513 . . . . 25.0 110.49 -174.262 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -87.21 137.03 32.69 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.019 -0.537 . . . . 25.0 110.284 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.3 mt -132.03 124.6 53.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 108.315 -0.994 . . . . 25.0 108.315 178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.402 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 82.3 t80 -90.87 140.97 29.31 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 109.261 -0.644 . . . . 25.0 109.261 176.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 49.2 mm -122.3 128.93 25.29 Favored Pre-proline 0 C--N 1.322 -0.63 0 N-CA-C 107.587 -1.264 . . . . 25.0 107.587 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.27 166.45 29.48 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 117.892 -0.939 . . . . 25.0 112.444 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -111.02 14.27 21.97 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 121.617 0.722 . . . . 25.0 111.076 -175.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -81.34 -18.18 46.59 Favored 'General case' 0 N--CA 1.471 0.579 0 N-CA-C 114.938 1.458 . . . . 25.0 114.938 -175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 33.8 ptt-85 -155.18 170.01 22.82 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 113.19 0.811 . . . . 25.0 113.19 -173.32 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 1.1 pp -128.8 144.81 51.27 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.709 -0.678 . . . . 25.0 109.994 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.29 151.67 5.47 Favored Glycine 0 CA--C 1.523 0.584 0 N-CA-C 115.138 0.815 . . . . 25.0 115.138 176.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 52.0 p90 -87.03 146.89 25.94 Favored 'General case' 0 C--O 1.242 0.687 0 N-CA-C 114.943 1.46 . . . . 25.0 114.943 -175.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -149.01 163.54 37.23 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 108.132 -1.062 . . . . 25.0 108.132 173.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -96.96 150.03 4.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 N-CA-C 109.592 -0.522 . . . . 25.0 109.592 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 73.6 mt -113.49 132.58 62.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 104.525 -2.398 . . . . 25.0 104.525 175.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 63.9 mt -119.05 139.84 51.06 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 105.876 -1.898 . . . . 25.0 105.876 178.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -138.79 151.52 47.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 119.114 0.87 . . . . 25.0 110.31 178.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 64.0 t -129.0 133.61 65.72 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 CA-C-N 114.995 -1.002 . . . . 25.0 109.035 -176.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -117.39 113.73 22.51 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 107.801 -1.185 . . . . 25.0 107.801 178.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -103.25 133.54 48.17 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.401 0.62 . . . . 25.0 111.358 -175.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 60.9 t -125.86 132.26 70.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 178.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -77.73 -43.61 30.41 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.97 0.414 . . . . 25.0 110.925 -177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 10.14 3.11 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 116.502 2.038 . . . . 25.0 116.502 -169.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.7 p -131.55 155.02 48.21 Favored 'General case' 0 C--N 1.323 -0.584 0 O-C-N 121.915 -0.49 . . . . 25.0 110.867 -178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 58.1 mm-40 -73.7 -7.85 53.68 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.946 0.403 . . . . 25.0 110.959 176.368 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 12.6 m120 -115.22 163.83 15.1 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.201 0.524 . . . . 25.0 112.14 -176.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -140.88 163.22 33.54 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 103.453 -2.795 . . . . 25.0 103.453 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -130.45 152.39 49.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.548 0.573 . . . . 25.0 112.548 -172.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -130.96 157.58 42.57 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.594 -0.891 . . . . 25.0 108.594 176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -145.5 154.62 42.41 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.862 -0.792 . . . . 25.0 108.862 171.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 6.7 p -135.1 137.22 50.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-O 120.934 0.397 . . . . 25.0 110.853 -173.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 60.6 mt -141.71 135.0 29.72 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.942 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 -178.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -106.55 141.74 37.34 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 120.242 1.383 . . . . 25.0 108.961 172.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.1 m -129.41 134.52 63.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.447 0.641 . . . . 25.0 109.657 179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -101.73 96.02 6.8 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.187 -1.782 . . . . 25.0 106.187 176.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -88.66 105.86 17.95 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 107.824 -1.176 . . . . 25.0 107.824 -173.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 11.4 m -136.04 158.81 39.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 114.451 1.278 . . . . 25.0 114.451 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -99.66 164.99 11.82 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 114.632 -1.167 . . . . 25.0 107.897 172.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 11.9 tptp . . . . . 0 C--O 1.253 1.264 0 CA-C-O 116.544 -1.693 . . . . 25.0 113.051 171.933 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 2.7 p80 . . . . . 0 N--CA 1.478 0.96 0 CA-C-O 119.512 -0.28 . . . . 25.0 111.524 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 84.92 -159.87 34.75 Favored Glycine 0 C--N 1.329 0.188 0 C-N-CA 120.184 -1.008 . . . . 25.0 111.423 177.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 33.6 m-85 -108.88 135.99 49.17 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 122.38 0.272 . . . . 25.0 111.247 -177.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 97.6 mt -93.98 114.38 30.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 107.27 -1.381 . . . . 25.0 107.27 174.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -92.12 -43.37 9.41 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.86 -0.792 . . . . 25.0 108.86 178.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -137.47 149.4 65.18 Favored Pre-proline 0 N--CA 1.468 0.466 0 N-CA-C 107.763 -1.199 . . . . 25.0 107.763 -179.35 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -77.81 105.07 0.64 Allowed 'Cis proline' 0 CA--C 1.539 0.757 0 C-N-CA 131.102 1.709 . . . . 25.0 113.143 -3.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.71 -166.41 46.52 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.776 -0.726 . . . . 25.0 111.873 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.6 t -139.95 154.54 47.23 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.565 -0.531 . . . . 25.0 109.565 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 5.4 ptm180 -76.1 -20.85 57.3 Favored 'General case' 0 C--O 1.217 -0.649 0 CA-C-N 116.391 -0.368 . . . . 25.0 111.701 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.85 -35.52 66.53 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.914 0.709 . . . . 25.0 112.914 -174.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.33 70.63 Favored 'General case' 0 C--O 1.216 -0.695 0 N-CA-C 112.214 0.45 . . . . 25.0 112.214 -179.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.96 -11.36 39.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.036 0.446 . . . . 25.0 110.615 -178.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 45.8 t -80.13 -43.4 21.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.884 0.373 . . . . 25.0 111.373 -177.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 20.2 p -71.89 129.53 38.81 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.203 0.445 . . . . 25.0 112.203 -176.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -62.9 -24.05 67.64 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 121.262 0.553 . . . . 25.0 110.041 174.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.08 -13.09 2.54 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 113.496 0.924 . . . . 25.0 113.496 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 38.2 t80 -78.67 -10.83 59.89 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 122.231 0.212 . . . . 25.0 111.431 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 173.96 -14.84 0.04 OUTLIER Glycine 0 C--O 1.222 -0.603 0 N-CA-C 117.461 1.744 . . . . 25.0 117.461 177.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.9 t80 62.12 -7.95 0.11 Allowed 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 116.773 2.138 . . . . 25.0 116.773 178.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 95.4 mt -67.78 -38.62 83.63 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 121.757 -0.589 . . . . 25.0 109.895 176.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 8.7 t-20 -169.31 177.26 4.8 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 106.108 -1.812 . . . . 25.0 106.108 177.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -136.81 157.04 47.66 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 107.587 -1.264 . . . . 25.0 107.587 175.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -127.87 54.94 1.67 Allowed 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 107.745 -1.205 . . . . 25.0 107.745 178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.5 t -91.21 -48.29 7.02 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.383 -0.527 . . . . 25.0 110.566 177.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.74 -176.78 35.43 Favored Glycine 0 CA--C 1.518 0.276 0 CA-C-N 116.182 -0.463 . . . . 25.0 112.894 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 16.6 t -64.94 -13.96 58.68 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 121.679 0.752 . . . . 25.0 110.886 178.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.418 HG23 ' H ' ' A' ' 28' ' ' VAL . 2.3 t -62.51 -9.75 4.34 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.918 0 CA-C-N 115.665 -0.698 . . . . 25.0 110.772 175.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 28.5 ptm -62.69 -27.01 68.95 Favored 'General case' 0 CA--C 1.537 0.46 0 O-C-N 121.391 -0.818 . . . . 25.0 111.31 171.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -82.21 -28.87 31.73 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.542 0.687 . . . . 25.0 110.03 179.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -115.95 61.51 1.97 Allowed Pre-proline 0 CA--C 1.54 0.572 0 CA-C-N 115.749 -0.659 . . . . 25.0 112.17 179.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.61 -38.62 3.15 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 114.169 -3.421 . . . . 25.0 113.335 -177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -105.69 -32.55 8.39 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 113.391 0.885 . . . . 25.0 113.391 177.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 19.2 m -102.14 78.26 1.75 Allowed 'General case' 0 C--O 1.208 -1.123 0 N-CA-C 109.133 -0.692 . . . . 25.0 109.133 -179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 42.5 tp -107.58 109.97 21.75 Favored 'General case' 0 C--O 1.249 1.049 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 66.6 mt-10 -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 112.913 0.708 . . . . 25.0 112.913 -173.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -140.35 103.91 4.67 Favored 'General case' 0 CA--C 1.54 0.58 0 N-CA-C 112.565 0.58 . . . . 25.0 112.565 176.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -174.95 -164.8 0.17 Allowed 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 107.068 -1.456 . . . . 25.0 107.068 176.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -60.63 151.28 29.42 Favored 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 123.302 0.641 . . . . 25.0 111.146 177.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 176.87 140.19 3.51 Favored Glycine 0 N--CA 1.453 -0.181 0 N-CA-C 109.255 -1.538 . . . . 25.0 109.255 174.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -112.26 125.46 30.07 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-N 117.288 0.544 . . . . 25.0 110.264 177.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -73.0 152.56 98.43 Favored 'Cis proline' 0 C--N 1.35 0.639 0 C-N-CA 129.72 1.134 . . . . 25.0 111.041 -3.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 7.5 t-80 -98.15 -42.85 7.26 Favored 'General case' 0 C--O 1.219 -0.502 0 N-CA-C 112.696 0.628 . . . . 25.0 112.696 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.8 t 63.67 -52.51 0.23 Allowed 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.143 1.534 . . . . 25.0 115.143 -176.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -75.37 172.42 53.67 Favored Glycine 0 C--O 1.244 0.736 0 N-CA-C 111.37 -0.692 . . . . 25.0 111.37 177.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.49 ' HB2' HE22 ' A' ' 50' ' ' GLN . 67.5 Cg_endo -74.51 -170.57 0.76 Allowed 'Trans proline' 0 CA--C 1.536 0.584 0 C-N-CA 122.8 2.333 . . . . 25.0 113.684 -177.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -52.35 141.63 19.08 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.819 0.674 . . . . 25.0 112.819 -178.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 75.4 m-20 -55.51 113.68 1.53 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 115.769 -0.65 . . . . 25.0 112.534 -177.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 57.52 17.19 25.24 Favored Glycine 0 C--O 1.222 -0.601 0 CA-C-N 115.503 -0.771 . . . . 25.0 114.242 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.49 HE22 ' HB2' ' A' ' 46' ' ' PRO . 1.6 mp0 57.2 13.86 1.83 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 123.837 0.855 . . . . 25.0 113.234 -174.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 78.0 mt -66.09 -39.21 83.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.889 0.376 . . . . 25.0 110.096 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -63.19 -27.26 69.24 Favored 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.287 0.847 . . . . 25.0 113.287 -177.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 99.3 p -94.16 -19.47 20.75 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.64 -0.424 . . . . 25.0 110.715 178.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 56.19 -0.54 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 116.324 1.972 . . . . 25.0 116.324 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -115.45 -23.62 4.37 Favored Glycine 0 C--O 1.221 -0.705 0 N-CA-C 112.016 -0.434 . . . . 25.0 112.016 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.64 2.89 65.81 Favored Glycine 0 C--O 1.222 -0.65 0 C-N-CA 120.912 -0.661 . . . . 25.0 113.478 -179.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 92.2 mt -63.04 -21.46 66.18 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 122.522 0.329 . . . . 25.0 111.712 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -63.98 -13.0 42.89 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.117 0.414 . . . . 25.0 112.117 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -63.89 -14.64 56.25 Favored Glycine 0 CA--C 1.52 0.404 0 C-N-CA 121.432 -0.413 . . . . 25.0 113.732 177.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.86 -21.72 65.73 Favored Glycine 0 CA--C 1.521 0.45 0 CA-C-N 117.773 0.787 . . . . 25.0 112.796 177.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 49.4 mm -66.44 -40.54 86.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 108.887 -0.783 . . . . 25.0 108.887 176.617 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 8.9 mp -76.39 -31.71 58.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.325 -0.398 . . . . 25.0 111.061 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -58.79 -49.89 76.01 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.32 0.581 . . . . 25.0 110.4 179.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 25.5 pt20 -75.27 2.11 11.93 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.993 0.738 . . . . 25.0 112.993 -178.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.9 tt0 -119.92 19.15 12.43 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.91 0.862 . . . . 25.0 109.61 179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 13.0 t -107.47 177.18 4.91 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.363 -0.835 . . . . 25.0 110.614 -177.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -80.95 -18.05 48.39 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 108.101 -1.074 . . . . 25.0 108.101 171.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -95.38 14.84 21.18 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.166 -0.925 . . . . 25.0 109.651 178.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.86 146.05 33.16 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.047 -1.094 . . . . 25.0 108.047 178.069 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 66.0 m95 -80.69 140.84 35.41 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.55 -0.907 . . . . 25.0 108.55 -176.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 42.1 p90 -58.33 142.45 48.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.275 -0.875 . . . . 25.0 112.645 -171.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.4 mttt -126.23 147.89 49.58 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-N 115.372 -0.831 . . . . 25.0 110.365 -177.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -126.28 151.04 48.02 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 109.153 -0.684 . . . . 25.0 109.153 175.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.0 tt -94.76 143.01 12.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 105.841 -1.911 . . . . 25.0 105.841 171.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 3.6 ttp -151.0 166.89 29.31 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.205 -0.295 . . . . 25.0 110.205 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 36.1 p -103.96 171.96 7.06 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 105.38 -2.081 . . . . 25.0 105.38 172.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.04 -169.41 7.52 Favored Glycine 0 CA--C 1.524 0.615 0 CA-C-O 121.361 0.423 . . . . 25.0 114.117 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 104.92 -172.74 20.21 Favored Glycine 0 N--CA 1.459 0.222 0 O-C-N 122.405 -0.467 . . . . 25.0 112.333 179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 18.0 tt0 -75.82 135.66 40.22 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.952 -0.734 . . . . 25.0 109.424 178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -129.24 152.11 49.17 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.26 -1.015 . . . . 25.0 108.26 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 61.8 m -117.7 134.84 54.48 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.2 -0.455 . . . . 25.0 110.136 -174.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -109.73 111.99 23.78 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 105.781 -1.933 . . . . 25.0 105.781 176.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 50.4 m -120.37 110.78 16.93 Favored 'General case' 0 CA--C 1.507 -0.674 0 N-CA-C 108.302 -0.999 . . . . 25.0 108.302 -177.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 20.9 m0 -123.99 141.38 52.1 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 104.699 -2.334 . . . . 25.0 104.699 179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 12.6 t -145.01 161.97 38.08 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.553 0.216 . . . . 25.0 110.657 -173.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.0 t80 -125.43 150.73 47.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.726 -1.583 . . . . 25.0 106.726 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 14.6 t -72.39 -17.41 61.82 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.914 1.079 . . . . 25.0 113.914 -175.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 159.69 61.09 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 106.861 -1.533 . . . . 25.0 106.861 -179.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -66.0 140.49 60.49 Favored 'Trans proline' 0 CA--C 1.532 0.39 0 C-N-CA 114.553 -3.165 . . . . 25.0 110.355 172.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 29.3 t-80 -130.91 147.17 52.52 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 107.547 -1.279 . . . . 25.0 107.547 -178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -68.01 146.9 53.1 Favored 'General case' 0 C--O 1.242 0.698 0 N-CA-C 107.455 -1.313 . . . . 25.0 107.455 175.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 65.4 p -140.37 146.71 38.76 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.322 -1.362 . . . . 25.0 107.322 -178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 1.5 p -110.23 -50.16 2.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.905 0.383 . . . . 25.0 110.082 176.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -158.95 147.59 18.36 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 122.03 -0.419 . . . . 25.0 109.927 -178.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 47.4 p90 -135.18 144.29 46.91 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 106.575 -1.639 . . . . 25.0 106.575 166.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -148.04 159.13 44.22 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.472 -0.566 . . . . 25.0 109.472 -175.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -137.35 149.91 47.34 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.653 0.74 . . . . 25.0 112.08 -178.235 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 40.7 m-85 -129.74 165.95 20.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 107.051 -1.463 . . . . 25.0 107.051 -176.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 44.2 pt -130.03 159.1 42.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.598 -0.89 . . . . 25.0 108.598 173.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . 0.56 HG23 ' HA ' ' A' ' 114' ' ' ASP . 58.9 m -111.72 115.95 29.94 Favored 'General case' 0 C--O 1.242 0.706 0 N-CA-C 107.264 -1.384 . . . . 25.0 107.264 173.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -89.99 112.02 23.29 Favored 'General case' 0 C--O 1.218 -0.592 0 N-CA-C 108.406 -0.961 . . . . 25.0 108.406 177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 26.3 pttm -76.11 153.96 35.89 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.014 -1.106 . . . . 25.0 108.014 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 105.26 10.33 31.95 Favored Glycine 0 C--O 1.223 -0.562 0 N-CA-C 116.011 1.164 . . . . 25.0 116.011 176.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 34.7 p90 -60.2 153.74 21.44 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 117.765 0.783 . . . . 25.0 110.102 177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.52 147.1 98.8 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.767 -1.197 . . . . 25.0 107.767 176.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -69.91 -20.0 34.7 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 117.828 -0.982 . . . . 25.0 114.468 -177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.11 -23.71 63.08 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 122.027 0.918 . . . . 25.0 111.419 176.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -96.04 136.19 22.29 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 107.901 -1.148 . . . . 25.0 107.901 -172.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -64.49 126.56 17.12 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 116.726 -1.716 . . . . 25.0 114.372 -172.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 6.9 tt -52.76 -39.44 62.2 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.421 -1.263 . . . . 25.0 111.726 179.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -65.04 -16.06 63.04 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 113.565 0.95 . . . . 25.0 113.565 -176.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -83.06 -41.72 18.29 Favored 'General case' 0 C--O 1.216 -0.685 0 O-C-N 121.965 -0.459 . . . . 25.0 110.831 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -75.85 -14.84 60.29 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.386 0.513 . . . . 25.0 112.386 -174.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.56 ' HA ' HG23 ' A' ' 100' ' ' THR . 0.4 OUTLIER -67.87 -31.51 71.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.164 -0.471 . . . . 25.0 112.041 -176.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -125.98 111.67 15.02 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 112.784 0.661 . . . . 25.0 112.784 -179.467 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -128.18 121.14 28.76 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 108.368 -0.975 . . . . 25.0 108.368 175.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.52 124.26 23.1 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 122.227 -0.296 . . . . 25.0 110.746 -176.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -104.2 -14.96 8.43 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.985 -0.746 . . . . 25.0 108.985 177.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 172.51 154.43 10.22 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.298 -0.953 . . . . 25.0 113.965 174.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -138.66 137.25 36.7 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 107.414 -1.328 . . . . 25.0 107.414 178.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 38.7 t -130.88 87.47 48.98 Favored Pre-proline 0 C--O 1.24 0.592 0 N-CA-C 109.221 -0.659 . . . . 25.0 109.221 -177.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -74.0 157.65 46.73 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 117.275 -1.35 . . . . 25.0 111.339 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 65.1 t60 -112.21 99.11 7.78 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.195 -1.039 . . . . 25.0 108.195 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -123.29 4.21 9.15 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 106.552 -1.647 . . . . 25.0 106.552 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 173.52 -179.1 45.13 Favored Glycine 0 C--O 1.24 0.485 0 N-CA-C 103.401 -3.88 . . . . 25.0 103.401 -175.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.9 t -139.51 65.58 33.76 Favored Pre-proline 0 CA--C 1.538 0.51 0 N-CA-C 116.12 1.896 . . . . 25.0 116.12 -178.394 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -71.97 175.71 9.38 Favored 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 116.884 -1.611 . . . . 25.0 109.565 169.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.87 56.2 Favored 'General case' 0 CA--C 1.546 0.805 0 N-CA-C 113.045 0.757 . . . . 25.0 113.045 179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 40.3 t -60.36 -24.55 65.17 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.193 0.52 . . . . 25.0 112.28 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 9.4 mpt_? -96.97 7.1 47.38 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.384 0.673 . . . . 25.0 112.532 -177.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 95.4 m-20 -58.37 141.28 51.78 Favored 'General case' 0 C--O 1.219 -0.543 0 N-CA-C 106.542 -1.651 . . . . 25.0 106.542 174.849 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.09 -35.6 80.81 Favored 'General case' 0 N--CA 1.471 0.618 0 CA-C-N 118.376 0.534 . . . . 25.0 111.883 -175.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 41.4 t -86.09 124.84 32.97 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 108.769 -0.826 . . . . 25.0 108.769 -177.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -120.58 149.76 41.94 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.497 -0.774 . . . . 25.0 110.735 -176.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -112.35 131.72 55.38 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 106.119 -1.808 . . . . 25.0 106.119 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 25.2 mm -132.0 128.76 59.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 107.49 -1.3 . . . . 25.0 107.49 -179.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.543 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 63.0 t80 -79.79 132.81 36.23 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 107.954 -1.128 . . . . 25.0 107.954 173.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 36.6 mm -119.42 123.07 28.92 Favored Pre-proline 0 C--N 1.322 -0.604 0 N-CA-C 107.638 -1.245 . . . . 25.0 107.638 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -73.09 162.97 39.47 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 117.355 -1.296 . . . . 25.0 112.523 179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -108.91 28.71 8.18 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.919 -1.511 . . . . 25.0 106.919 178.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -69.15 -18.63 63.96 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.852 -1.067 . . . . 25.0 113.566 -172.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 9.1 ptp180 -156.81 150.29 24.38 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.258 0.552 . . . . 25.0 109.959 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 7.8 mp -90.83 154.18 19.69 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 114.898 -1.046 . . . . 25.0 108.718 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 119.27 -176.33 16.06 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-O 121.509 0.505 . . . . 25.0 112.105 176.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.438 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 55.2 p90 -80.74 145.02 31.74 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.78 0.659 . . . . 25.0 112.78 -174.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 23.4 m-70 -132.66 116.05 16.16 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 104.427 -2.434 . . . . 25.0 104.427 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 12.4 t -93.28 138.12 20.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 108.996 -0.742 . . . . 25.0 108.996 -173.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 61.7 mt -127.18 120.69 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 108.228 -1.027 . . . . 25.0 108.228 -179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 2.6 mp -104.51 141.08 37.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 107.804 -1.184 . . . . 25.0 107.804 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -142.67 132.92 24.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 118.827 0.739 . . . . 25.0 112.206 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 1.9 t -128.33 137.41 57.51 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.012 -0.736 . . . . 25.0 109.012 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 2.9 t90 -120.65 112.54 19.01 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 106.763 -1.569 . . . . 25.0 106.763 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -84.78 133.1 34.36 Favored 'General case' 0 C--O 1.248 0.994 0 CA-C-N 114.553 -1.203 . . . . 25.0 109.444 -178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . 0.438 HG12 ' H ' ' A' ' 156' ' ' ASP . 58.1 t -117.24 121.96 68.88 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.731 0 N-CA-C 108.542 -0.91 . . . . 25.0 108.542 -174.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -72.2 -13.6 61.58 Favored 'General case' 0 C--O 1.22 -0.485 0 N-CA-C 112.747 0.647 . . . . 25.0 112.747 -176.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.438 ' H ' HG12 ' A' ' 154' ' ' VAL . 25.5 m-20 -81.31 -13.64 58.19 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.702 0.63 . . . . 25.0 112.702 -176.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 35.3 p -144.31 159.77 42.15 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 113.33 0.863 . . . . 25.0 113.33 -172.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 37.7 mp0 -79.45 3.82 17.38 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.956 0.408 . . . . 25.0 110.722 171.143 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -110.13 171.04 7.69 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.742 -0.836 . . . . 25.0 108.742 -179.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -145.47 161.29 40.06 Favored 'General case' 0 CA--C 1.509 -0.63 0 CA-C-O 121.421 0.629 . . . . 25.0 109.925 -176.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 18.4 m-85 -96.45 130.39 43.61 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.545 -0.909 . . . . 25.0 108.545 179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -132.31 139.13 48.08 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 112.694 0.627 . . . . 25.0 112.694 -173.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -148.71 154.24 39.36 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.119 -0.697 . . . . 25.0 109.119 170.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 2.2 p -136.98 137.25 47.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 N-CA-C 104.374 -2.454 . . . . 25.0 104.374 171.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 64.6 mt -132.2 130.73 60.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 106.34 -1.726 . . . . 25.0 106.34 -176.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 45.2 t0 -111.97 139.12 47.74 Favored 'General case' 0 C--N 1.318 -0.78 0 N-CA-C 107.65 -1.241 . . . . 25.0 107.65 177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -130.81 126.91 60.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.442 0.639 . . . . 25.0 109.921 -177.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.438 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 42.3 t0 -85.97 102.04 13.43 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 106.778 -1.564 . . . . 25.0 106.778 178.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.1 mt -104.21 117.33 33.97 Favored 'General case' 0 CA--C 1.506 -0.746 0 N-CA-C 108.537 -0.912 . . . . 25.0 108.537 -175.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 25.7 m -136.45 163.19 34.15 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 116.017 -0.538 . . . . 25.0 111.023 -175.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -89.99 155.27 19.21 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 106.007 -1.849 . . . . 25.0 106.007 172.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.89 0 CA-C-O 117.991 -1.004 . . . . 25.0 110.095 176.592 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 5.1 p-80 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 109.896 -0.409 . . . . 25.0 109.896 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 176.89 -175.84 47.79 Favored Glycine 0 CA--C 1.51 -0.267 0 N-CA-C 106.147 -2.781 . . . . 25.0 106.147 -176.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -113.19 148.12 36.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 118.441 1.121 . . . . 25.0 111.021 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 80.0 mt -99.23 112.0 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 N-CA-C 104.025 -2.583 . . . . 25.0 104.025 170.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -76.48 2.69 13.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.709 0.633 . . . . 25.0 112.709 -172.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 23.9 mtmt 74.15 151.66 0.14 Allowed Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 125.752 1.621 . . . . 25.0 110.003 177.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -68.53 153.78 89.52 Favored 'Cis proline' 0 C--O 1.222 -0.283 0 CA-C-O 121.733 0.639 . . . . 25.0 112.203 -1.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.56 14.8 13.37 Favored Glycine 0 C--O 1.222 -0.626 0 N-CA-C 117.081 1.592 . . . . 25.0 117.081 174.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 40.8 t -65.86 125.36 25.11 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 118.632 1.216 . . . . 25.0 111.431 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 14.9 ptm180 -78.51 -19.64 52.54 Favored 'General case' 0 C--O 1.215 -0.759 0 N-CA-C 112.441 0.534 . . . . 25.0 112.441 176.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.29 -26.66 67.93 Favored 'General case' 0 C--O 1.217 -0.646 0 O-C-N 123.146 0.278 . . . . 25.0 111.091 -177.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -63.02 -31.52 72.67 Favored 'General case' 0 C--O 1.215 -0.756 0 CA-C-O 120.693 0.283 . . . . 25.0 111.315 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.0 mp -91.98 -3.88 55.3 Favored 'General case' 0 C--O 1.21 -1.026 0 CA-C-N 116.43 -0.35 . . . . 25.0 111.164 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 t -80.88 -6.27 58.42 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.684 -0.487 . . . . 25.0 109.684 179.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 12.9 t -56.56 160.37 3.27 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.013 -0.994 . . . . 25.0 111.212 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.8 pm0 -55.46 -17.26 4.81 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 123.959 0.904 . . . . 25.0 113.1 177.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.96 -20.99 57.67 Favored 'General case' 0 CA--C 1.552 1.025 0 O-C-N 121.83 -0.544 . . . . 25.0 112.378 173.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -83.09 -1.98 54.21 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 113.347 0.869 . . . . 25.0 113.347 -178.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 179.5 -31.28 0.06 OUTLIER Glycine 0 C--O 1.222 -0.644 0 N-CA-C 117.191 1.637 . . . . 25.0 117.191 -179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 2.2 t80 63.54 -27.86 0.08 Allowed 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 118.545 2.795 . . . . 25.0 118.545 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 73.5 mt -80.02 -3.02 46.7 Favored 'General case' 0 C--N 1.323 -0.582 0 O-C-N 121.815 -0.553 . . . . 25.0 111.792 179.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 71.4 m-20 -119.21 -178.21 3.53 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.91 -0.586 . . . . 25.0 110.503 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 10.4 mp -75.03 158.17 33.65 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 106.168 -1.79 . . . . 25.0 106.168 177.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.0 m-20 -63.1 12.02 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 116.779 2.14 . . . . 25.0 116.779 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 13.7 t 178.91 -29.0 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 126.089 1.756 . . . . 25.0 108.236 170.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 80.29 177.65 51.16 Favored Glycine 0 C--O 1.223 -0.588 0 C-N-CA 121.196 -0.526 . . . . 25.0 113.584 177.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 22.6 t -70.02 -14.19 62.57 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.894 0.702 . . . . 25.0 112.894 -176.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.9 p -70.33 -12.82 16.5 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.861 0.362 . . . . 25.0 111.167 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 27.7 ptm -58.6 -10.88 2.5 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 117.77 2.507 . . . . 25.0 117.77 -175.701 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 78.4 t80 -69.4 -39.84 77.69 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.43 0.559 . . . . 25.0 110.85 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -159.37 64.59 2.52 Favored Pre-proline 0 N--CA 1.469 0.491 0 N-CA-C 113.571 0.952 . . . . 25.0 113.571 173.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 78.8 Cg_endo -70.37 -8.87 24.63 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 118.185 -0.743 . . . . 25.0 113.754 -177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 13.9 pm0 -97.85 4.37 49.68 Favored 'General case' 0 CA--C 1.535 0.404 0 N-CA-C 112.823 0.675 . . . . 25.0 112.823 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 2.8 t -100.74 98.73 9.23 Favored 'General case' 0 C--O 1.218 -0.563 0 CA-C-N 118.573 0.624 . . . . 25.0 111.16 -177.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 69.7 mt -90.47 117.7 29.37 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 104.978 -2.23 . . . . 25.0 104.978 174.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.7 mm-40 -84.21 141.31 31.11 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.725 0.297 . . . . 25.0 110.632 -175.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.96 157.71 46.17 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 107.012 -1.477 . . . . 25.0 107.012 176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -127.47 143.52 51.18 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.498 0.666 . . . . 25.0 111.703 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 93.9 mttt -71.36 155.47 40.61 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.685 -0.689 . . . . 25.0 110.421 175.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 87.64 154.82 27.62 Favored Glycine 0 C--O 1.224 -0.527 0 N-CA-C 116.261 1.264 . . . . 25.0 116.261 169.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -90.42 153.88 46.31 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.247 -0.476 . . . . 25.0 110.046 179.339 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -70.6 -26.17 8.0 Favored 'Cis proline' 0 C--N 1.35 0.655 0 C-N-CA 128.618 0.674 . . . . 25.0 112.787 0.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 10.8 p80 163.56 -46.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 126.933 2.093 . . . . 25.0 106.588 174.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 m 64.0 -39.94 0.22 Allowed 'General case' 0 N--CA 1.485 1.288 0 C-N-CA 125.723 1.609 . . . . 25.0 115.169 -178.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -83.45 -146.53 6.89 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 108.815 -1.714 . . . . 25.0 108.815 171.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -67.65 -178.97 1.75 Allowed 'Trans proline' 0 CA--C 1.535 0.535 0 CA-C-N 119.998 1.899 . . . . 25.0 111.3 176.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -73.87 100.54 3.52 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 108.096 -1.075 . . . . 25.0 108.096 178.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 -93.73 165.24 12.8 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.41 -0.814 . . . . 25.0 112.07 -175.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.53 -3.64 58.78 Favored Glycine 0 C--O 1.227 -0.321 0 CA-C-N 115.468 -0.787 . . . . 25.0 113.736 178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.0 mm-40 -70.41 -18.23 63.03 Favored 'General case' 0 C--N 1.327 -0.409 0 O-C-N 122.129 -0.63 . . . . 25.0 112.399 -176.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 96.1 mt -71.27 -40.49 74.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 108.148 -1.056 . . . . 25.0 108.148 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.81 -30.51 68.05 Favored 'General case' 0 C--O 1.22 -0.471 0 N-CA-C 112.026 0.38 . . . . 25.0 112.026 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 93.8 p -87.83 -2.88 58.9 Favored 'General case' 0 C--O 1.243 0.746 0 CA-C-N 116.375 -0.375 . . . . 25.0 110.731 178.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 57.23 17.28 3.51 Favored 'General case' 0 C--O 1.221 -0.408 0 C-N-CA 125.243 1.417 . . . . 25.0 113.144 -173.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -76.94 -33.14 46.89 Favored Glycine 0 C--O 1.224 -0.524 0 N-CA-C 110.641 -0.984 . . . . 25.0 110.641 178.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -82.37 -18.7 65.98 Favored Glycine 0 C--O 1.226 -0.4 0 C-N-CA 120.6 -0.81 . . . . 25.0 112.35 -179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 95.8 mt -70.24 -24.94 63.17 Favored 'General case' 0 C--N 1.327 -0.37 0 O-C-N 122.401 -0.47 . . . . 25.0 111.493 -177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.01 -26.64 67.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.91 0.386 . . . . 25.0 111.349 175.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -71.25 -25.68 75.05 Favored Glycine 0 C--O 1.225 -0.416 0 N-CA-C 110.673 -0.971 . . . . 25.0 110.673 178.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -68.93 -17.49 71.62 Favored Glycine 0 C--O 1.221 -0.66 0 C-N-CA 121.25 -0.5 . . . . 25.0 112.846 179.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 48.0 mm -68.42 -42.61 84.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 107.929 -1.137 . . . . 25.0 107.929 177.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.1 mp -76.06 -26.42 56.53 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.952 -0.567 . . . . 25.0 111.227 -178.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.87 -21.65 64.87 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-O 121.425 0.631 . . . . 25.0 111.674 178.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 67.5 mt-30 -68.84 -3.78 13.79 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.816 -0.553 . . . . 25.0 112.41 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -132.69 55.68 1.88 Allowed 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 108.185 -1.042 . . . . 25.0 108.185 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 38.8 t -135.71 157.8 45.98 Favored 'General case' 0 C--O 1.222 -0.377 0 N-CA-C 109.979 -0.378 . . . . 25.0 109.979 -176.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 93.9 mt-10 -71.95 -25.11 61.75 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.688 0.756 . . . . 25.0 109.138 175.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -97.55 18.84 14.53 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.635 -0.711 . . . . 25.0 110.492 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 63.4 ttt180 -52.71 142.22 19.13 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.564 0.697 . . . . 25.0 111.634 -177.458 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -69.02 143.82 54.23 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.555 1.169 . . . . 25.0 109.778 -179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 14.5 p90 -75.36 131.29 40.15 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.587 -0.733 . . . . 25.0 111.562 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp -91.62 146.34 23.86 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-N 115.813 -0.63 . . . . 25.0 111.121 179.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -131.76 114.32 14.59 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 110.173 -0.306 . . . . 25.0 110.173 168.095 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -73.47 135.54 27.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 105.063 -2.199 . . . . 25.0 105.063 174.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 13.1 tpt -150.42 154.15 37.22 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 109.253 -0.647 . . . . 25.0 109.253 -176.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 41.7 p -93.0 -177.17 4.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 107.189 -1.411 . . . . 25.0 107.189 176.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -79.19 -166.53 31.85 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 111.87 -0.492 . . . . 25.0 111.87 178.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.78 -178.94 30.05 Favored Glycine 0 C--O 1.227 -0.302 0 N-CA-C 112.16 -0.376 . . . . 25.0 112.16 -178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 1.7 tp10 -79.99 133.89 36.2 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 107.894 -1.15 . . . . 25.0 107.894 177.271 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -126.03 121.81 34.06 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.414 0.626 . . . . 25.0 110.748 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 77.3 m -91.75 126.92 37.01 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 107.982 -1.118 . . . . 25.0 107.982 177.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -119.06 125.91 50.44 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 109.172 -0.677 . . . . 25.0 109.172 178.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.1 m -123.54 130.76 53.15 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.078 0.466 . . . . 25.0 111.347 -176.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 15.1 m0 -123.66 147.91 46.97 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 103.628 -2.73 . . . . 25.0 103.628 174.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 22.5 p -136.54 161.06 36.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.16 0.505 . . . . 25.0 109.723 -177.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -132.05 137.88 47.97 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 108.361 -0.977 . . . . 25.0 108.361 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 13.7 t -79.32 -9.13 59.52 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 -175.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.01 150.93 60.85 Favored Pre-proline 0 C--O 1.243 0.714 0 N-CA-C 106.268 -1.752 . . . . 25.0 106.268 178.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.26 144.75 47.0 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 116.203 -2.065 . . . . 25.0 111.92 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -131.07 139.74 49.94 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 107.197 -1.409 . . . . 25.0 107.197 175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 23.7 m-20 -71.26 148.39 47.23 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 107.231 -1.396 . . . . 25.0 107.231 178.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 27.8 m -149.95 141.89 23.85 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 -174.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 40.7 t -92.44 -47.26 7.25 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 122.756 0.422 . . . . 25.0 109.998 175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 23.4 pt20 -165.61 168.65 16.15 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 122.162 -0.336 . . . . 25.0 110.897 -179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 6.8 p90 -139.58 140.19 36.99 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 108.939 -0.763 . . . . 25.0 108.939 167.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 2.3 p80 -145.86 156.37 43.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.389 -0.369 . . . . 25.0 110.748 -174.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -133.14 144.78 50.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.874 -0.603 . . . . 25.0 111.02 -167.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 53.5 m-85 -137.12 165.53 25.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 179.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 28.2 pt -134.74 152.2 32.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 107.686 -1.227 . . . . 25.0 107.686 171.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 19.5 p -85.13 141.95 29.84 Favored 'General case' 0 C--O 1.241 0.62 0 N-CA-C 108.232 -1.025 . . . . 25.0 108.232 174.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 60.8 tttt -88.33 121.31 30.58 Favored 'General case' 0 C--O 1.215 -0.719 0 N-CA-C 113.255 0.835 . . . . 25.0 113.255 -174.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -86.5 150.78 24.02 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 107.443 -1.317 . . . . 25.0 107.443 169.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 88.23 13.29 64.1 Favored Glycine 0 C--O 1.224 -0.47 0 N-CA-C 117.072 1.589 . . . . 25.0 117.072 173.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -61.19 154.32 23.67 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 118.678 1.239 . . . . 25.0 110.735 178.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -112.63 154.43 44.71 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-N 116.27 -0.423 . . . . 25.0 109.907 -177.727 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -77.62 -7.39 16.7 Favored 'Trans proline' 0 C--N 1.351 0.707 0 N-CA-C 116.084 1.532 . . . . 25.0 116.084 -174.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -75.16 -8.1 55.64 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 122.141 0.972 . . . . 25.0 110.096 -178.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 54.2 mttp -123.74 150.14 61.12 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 109.192 -0.67 . . . . 25.0 109.192 -177.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.7 111.36 1.88 Allowed 'Trans proline' 0 CA--C 1.535 0.555 0 C-N-CA 117.321 -1.319 . . . . 25.0 111.797 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 8.5 tt -52.84 -44.06 66.48 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 115.226 -0.897 . . . . 25.0 113.23 -172.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 48.9 mtmt -61.68 -27.22 68.54 Favored 'General case' 0 C--O 1.214 -0.783 0 N-CA-C 114.026 1.121 . . . . 25.0 114.026 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -75.92 -41.78 50.79 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-O 121.337 0.589 . . . . 25.0 110.209 177.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -84.46 6.37 23.69 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.943 -1.026 . . . . 25.0 112.953 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -68.07 -38.83 82.85 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.848 0.684 . . . . 25.0 112.848 -169.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -133.62 156.77 47.27 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.957 -0.464 . . . . 25.0 111.605 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 82.5 mt-10 -133.53 146.31 50.93 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.033 -0.728 . . . . 25.0 109.033 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 15.4 tp -77.59 127.18 32.07 Favored 'General case' 0 N--CA 1.476 0.858 0 N-CA-C 109.277 -0.638 . . . . 25.0 109.277 -178.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 12.8 tt -106.08 -3.37 9.9 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 121.693 0.759 . . . . 25.0 110.984 -179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.23 156.12 8.29 Favored Glycine 0 C--O 1.229 -0.175 0 C-N-CA 120.469 -0.872 . . . . 25.0 113.948 174.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -147.35 137.18 22.98 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.681 -1.229 . . . . 25.0 107.681 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 95.3 t -135.19 109.45 10.55 Favored Pre-proline 0 C--O 1.243 0.735 0 N-CA-C 108.349 -0.982 . . . . 25.0 108.349 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -75.69 161.7 36.38 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 116.228 -2.048 . . . . 25.0 111.965 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 -122.96 92.66 3.75 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 108.383 -0.969 . . . . 25.0 108.383 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -175.62 -94.29 0.0 OUTLIER 'General case' 0 C--N 1.318 -0.804 1 N-CA-C 99.897 -4.112 . . . . 25.0 99.897 177.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -97.87 143.27 16.59 Favored Glycine 0 CA--C 1.506 -0.516 0 N-CA-C 105.32 -3.112 . . . . 25.0 105.32 167.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.6 155.82 13.35 Favored Pre-proline 0 C--N 1.322 -0.615 0 N-CA-C 108.687 -0.857 . . . . 25.0 108.687 -176.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.67 -167.3 0.37 Allowed 'Trans proline' 0 CA--C 1.539 0.75 0 O-C-N 122.265 0.613 . . . . 25.0 111.017 174.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.84 -18.75 24.2 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 112.662 0.616 . . . . 25.0 112.662 178.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 1.3 m -67.8 1.07 2.77 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 114.927 1.454 . . . . 25.0 114.927 175.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -58.66 -13.84 6.91 Favored 'General case' 0 N--CA 1.479 1.016 0 N-CA-C 114.421 1.267 . . . . 25.0 114.421 -178.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -59.12 144.12 46.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.686 0.755 . . . . 25.0 112.714 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 22.6 tp -70.08 -18.99 63.29 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 114.983 -1.008 . . . . 25.0 112.395 -178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 39.6 t -94.45 123.37 37.82 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.282 -1.007 . . . . 25.0 108.282 -179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 11.8 t-160 -103.99 133.72 48.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.852 -0.613 . . . . 25.0 110.742 -174.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 92.5 m-70 -99.82 134.1 43.22 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.632 -0.713 . . . . 25.0 109.563 179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 70.9 mt -132.95 119.67 37.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 177.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 87.9 t80 -85.82 138.01 32.37 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.785 -0.45 . . . . 25.0 109.785 173.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.0 mm -123.45 124.87 26.21 Favored Pre-proline 0 CA--C 1.538 0.503 0 N-CA-C 108.757 -0.831 . . . . 25.0 108.757 177.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_endo -73.46 153.57 50.02 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 116.381 -1.946 . . . . 25.0 111.403 174.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -108.1 51.9 0.73 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 122.66 1.219 . . . . 25.0 109.302 179.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 14.3 p-10 -103.72 -6.2 21.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 114.639 -1.164 . . . . 25.0 111.2 -178.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 8.2 ptt180 -161.0 157.74 26.79 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.283 0.563 . . . . 25.0 112.41 -172.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . 0.463 ' H ' HD23 ' A' ' 143' ' ' LEU . 2.3 pt? -116.72 153.87 31.62 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-N 115.584 -0.735 . . . . 25.0 110.334 177.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 133.31 140.26 4.35 Favored Glycine 0 CA--C 1.522 0.474 0 N-CA-C 113.851 0.3 . . . . 25.0 113.851 177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . . . . . . . . . 45.8 p90 -85.83 145.95 26.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 116.272 1.953 . . . . 25.0 116.272 -173.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -149.55 167.05 27.4 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.523 -1.658 . . . . 25.0 106.523 172.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 27.1 m -98.06 150.51 4.75 Favored 'Isoleucine or valine' 0 C--O 1.243 0.751 0 CA-C-O 121.894 0.854 . . . . 25.0 111.965 176.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 88.7 mt -106.94 131.52 56.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 103.311 -2.848 . . . . 25.0 103.311 172.294 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 36.0 mt -110.12 143.97 39.42 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 -179.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.448 ' HB3' ' HG2' ' A' ' 163' ' ' GLN . . . -142.63 148.49 37.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.612 -0.885 . . . . 25.0 108.612 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 4.1 t -130.14 139.6 51.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.622 -0.717 . . . . 25.0 109.563 -175.584 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -126.5 103.23 7.49 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.596 -0.89 . . . . 25.0 108.596 178.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -94.15 138.19 32.48 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 122.238 -0.289 . . . . 25.0 110.8 -176.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 66.5 t -117.6 132.01 68.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.056 -1.461 . . . . 25.0 107.056 177.117 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.54 -41.42 46.69 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.481 0.658 . . . . 25.0 110.524 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.64 -10.92 60.37 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 116.12 1.896 . . . . 25.0 116.12 -170.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 43.8 p -126.37 158.25 36.38 Favored 'General case' 0 CA--C 1.509 -0.634 0 O-C-N 121.966 -0.459 . . . . 25.0 110.519 -176.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -74.44 -10.17 59.3 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.218 -0.446 . . . . 25.0 111.588 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -103.76 158.67 16.23 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.412 0.625 . . . . 25.0 110.451 -178.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -142.83 162.92 34.2 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 102.465 -3.161 . . . . 25.0 102.465 175.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -124.31 150.59 45.26 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.516 0.562 . . . . 25.0 112.516 -175.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -124.65 153.92 41.54 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.29 -1.374 . . . . 25.0 107.29 174.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . 0.448 ' HG2' ' HB3' ' A' ' 150' ' ' ALA . 0.0 OUTLIER -145.95 154.21 41.67 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.334 -1.358 . . . . 25.0 107.334 176.843 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.1 p -136.83 141.86 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.886 0.374 . . . . 25.0 110.324 -176.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 62.9 mt -133.58 122.6 44.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 107.28 -1.378 . . . . 25.0 107.28 178.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -87.81 131.6 34.47 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 106.549 -1.649 . . . . 25.0 106.549 174.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 16.4 m -126.38 132.59 70.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.827 -0.805 . . . . 25.0 108.827 177.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -103.9 95.76 6.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 104.929 -2.248 . . . . 25.0 104.929 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 mt -89.58 121.8 32.12 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 106.254 -1.758 . . . . 25.0 106.254 -173.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.419 ' HA ' ' HA ' ' A' ' 143' ' ' LEU . 20.0 m -135.19 166.67 27.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 O-C-N 123.231 0.332 . . . . 25.0 111.448 -175.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 66.5 m-20 -93.38 141.11 28.82 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 107.249 -1.389 . . . . 25.0 107.249 176.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 55.8 tptt . . . . . 0 C--O 1.246 0.917 0 N-CA-C 115.564 1.69 . . . . 25.0 115.564 177.38 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 . . . . . 0 N--CA 1.489 1.501 0 N-CA-C 112.149 0.426 . . . . 25.0 112.149 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 58.24 -153.37 27.23 Favored Glycine 0 C--O 1.241 0.555 0 N-CA-C 117.364 1.706 . . . . 25.0 117.364 170.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -128.02 153.0 47.26 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 123.602 0.761 . . . . 25.0 111.956 -174.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 93.7 mt -93.83 119.34 41.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 103.665 -2.717 . . . . 25.0 103.665 171.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -90.08 -43.33 10.56 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.535 -0.543 . . . . 25.0 109.535 -177.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -138.79 149.68 62.9 Favored Pre-proline 0 N--CA 1.468 0.436 0 N-CA-C 106.666 -1.605 . . . . 25.0 106.666 179.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -76.64 109.8 1.48 Allowed 'Cis proline' 0 CA--C 1.537 0.642 0 C-N-CA 132.306 2.211 . . . . 25.0 115.299 -1.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 68.38 -176.76 26.81 Favored Glycine 0 C--O 1.226 -0.405 0 N-CA-C 114.631 0.612 . . . . 25.0 114.631 175.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 t -82.97 134.77 35.04 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 122.485 -0.421 . . . . 25.0 111.065 -179.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 39.9 ptt180 -78.11 -26.32 47.94 Favored 'General case' 0 C--O 1.219 -0.55 0 CA-C-O 120.919 0.39 . . . . 25.0 111.051 172.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.91 -33.34 65.92 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 112.873 0.694 . . . . 25.0 112.873 -172.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.67 -31.07 71.9 Favored 'General case' 0 C--O 1.215 -0.745 0 CA-C-O 120.785 0.326 . . . . 25.0 111.184 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 9.8 mp -91.47 -4.38 55.6 Favored 'General case' 0 C--O 1.219 -0.532 0 CA-C-N 116.054 -0.521 . . . . 25.0 111.743 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 46.3 t -83.93 -33.04 24.78 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.179 0.514 . . . . 25.0 111.577 -175.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 39.0 t -71.6 153.85 41.83 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 113.014 0.746 . . . . 25.0 113.014 -175.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -58.04 -31.49 67.07 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.629 -0.714 . . . . 25.0 110.679 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.17 -29.23 65.45 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 112.468 0.544 . . . . 25.0 112.468 -179.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 17.1 t80 -83.28 -13.26 55.57 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.066 0.395 . . . . 25.0 112.066 -177.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.99 -6.28 26.32 Favored Glycine 0 CA--C 1.513 -0.086 0 N-CA-C 111.411 -0.675 . . . . 25.0 111.411 178.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 41.6 t80 63.69 -46.66 0.26 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.448 1.899 . . . . 25.0 115.528 -177.33 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 77.2 mt -103.89 -22.15 13.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 112.768 0.655 . . . . 25.0 112.768 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 52.4 m-80 -151.91 159.8 43.7 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-O 120.559 0.219 . . . . 25.0 111.173 -173.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -81.32 156.95 25.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.11 -0.495 . . . . 25.0 109.752 173.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -121.84 59.38 0.99 Allowed 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.956 -1.498 . . . . 25.0 106.956 176.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.21 -36.63 0.09 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.227 1.195 . . . . 25.0 114.227 -176.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 65.95 -154.44 51.18 Favored Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 110.158 -1.177 . . . . 25.0 110.158 -174.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 21.3 t -61.2 -13.86 21.23 Favored 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.334 1.235 . . . . 25.0 114.334 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.2 t -62.54 -20.99 26.13 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 O-C-N 121.868 -0.52 . . . . 25.0 110.36 -179.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -63.94 -11.06 24.92 Favored 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 114.431 1.271 . . . . 25.0 114.431 178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -79.04 -35.98 41.73 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.659 -0.496 . . . . 25.0 109.659 -178.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -147.66 79.25 9.56 Favored Pre-proline 0 C--N 1.324 -0.543 0 N-CA-C 108.617 -0.883 . . . . 25.0 108.617 175.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo -67.53 -15.89 46.01 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 115.938 -2.241 . . . . 25.0 112.44 179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -85.4 -22.08 28.53 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-O 118.718 -0.658 . . . . 25.0 112.437 176.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 7.7 t -132.99 94.02 3.29 Favored 'General case' 0 C--O 1.215 -0.733 0 N-CA-C 114.732 1.382 . . . . 25.0 114.732 -179.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 51.2 tp -109.15 114.79 28.82 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.165 -1.05 . . . . 25.0 108.165 166.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 73.8 mt-10 -114.5 142.21 46.7 Favored 'General case' 0 C--N 1.321 -0.664 0 O-C-N 123.427 0.454 . . . . 25.0 110.358 -178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -135.99 104.16 5.61 Favored 'General case' 0 C--O 1.237 0.439 0 N-CA-C 109.475 -0.565 . . . . 25.0 109.475 175.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -167.0 -72.28 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 121.969 0.89 . . . . 25.0 112.933 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 85.5 mttt -112.27 -163.99 0.89 Allowed 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 106.558 -1.645 . . . . 25.0 106.558 -176.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.8 53.09 0.67 Allowed Glycine 0 C--O 1.218 -0.888 0 C-N-CA 121.277 -0.487 . . . . 25.0 111.946 -178.492 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -89.97 138.36 27.71 Favored Pre-proline 0 C--N 1.323 -0.55 0 N-CA-C 108.58 -0.896 . . . . 25.0 108.58 177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -74.21 128.13 15.41 Favored 'Cis proline' 0 C--N 1.35 0.618 0 C-N-CA 128.957 0.815 . . . . 25.0 112.346 -3.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -67.91 -36.25 79.85 Favored 'General case' 0 C--O 1.221 -0.407 0 C-N-CA 120.561 -0.456 . . . . 25.0 110.693 -177.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 4.2 m 64.25 -38.32 0.21 Allowed 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 116.636 2.088 . . . . 25.0 116.636 178.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -88.19 -155.06 28.73 Favored Glycine 0 CA--C 1.521 0.415 0 N-CA-C 111.654 -0.578 . . . . 25.0 111.654 176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.26 161.46 40.36 Favored 'Trans proline' 0 C--N 1.346 0.437 0 CA-C-N 118.668 1.234 . . . . 25.0 114.181 -178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -63.03 121.58 13.92 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.081 -0.963 . . . . 25.0 112.451 -177.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -62.62 134.55 56.51 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 108.025 -1.102 . . . . 25.0 108.025 173.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.11 6.99 35.2 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.347 -0.454 . . . . 25.0 113.476 -177.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 57.7 20.78 6.68 Favored 'General case' 0 N--CA 1.465 0.282 0 C-N-CA 124.259 1.024 . . . . 25.0 113.438 -176.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 80.6 mt -50.87 -37.92 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 114.338 1.236 . . . . 25.0 114.338 -171.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.62 -45.44 89.21 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 114.257 1.206 . . . . 25.0 114.257 -177.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.9 m -120.47 -20.86 7.03 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 117.006 2.224 . . . . 25.0 117.006 -175.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 50.01 19.87 0.52 Allowed 'General case' 0 CA--C 1.554 1.132 0 N-CA-C 115.281 1.586 . . . . 25.0 115.281 -171.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -108.99 -25.8 5.49 Favored Glycine 0 C--O 1.221 -0.682 0 O-C-N 122.221 -0.3 . . . . 25.0 113.362 -179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -67.87 -6.08 42.61 Favored Glycine 0 C--O 1.221 -0.687 0 O-C-N 122.45 -0.441 . . . . 25.0 113.833 -179.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 78.2 mt -61.89 -23.28 66.21 Favored 'General case' 0 C--O 1.218 -0.584 0 N-CA-C 112.585 0.587 . . . . 25.0 112.585 -179.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -71.06 -13.12 61.87 Favored 'General case' 0 C--N 1.326 -0.427 0 O-C-N 122.205 -0.309 . . . . 25.0 111.692 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -64.25 -16.65 60.53 Favored Glycine 0 C--O 1.223 -0.543 0 N-CA-C 115.114 0.805 . . . . 25.0 115.114 -177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -63.3 -26.14 69.12 Favored Glycine 0 C--O 1.223 -0.584 0 CA-C-N 118.121 0.961 . . . . 25.0 112.389 178.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 51.2 mm -68.03 -33.91 63.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 O-C-N 122.112 -0.64 . . . . 25.0 110.007 178.272 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 9.9 mp -77.53 -19.3 55.99 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 122.206 -0.309 . . . . 25.0 111.256 -177.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -61.96 -21.56 64.91 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.625 0.602 . . . . 25.0 112.625 -176.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 18.5 pt20 -56.03 -21.4 21.36 Favored 'General case' 0 CA--C 1.539 0.528 0 N-CA-C 112.678 0.622 . . . . 25.0 112.678 178.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 45.7 tt0 -138.75 51.73 1.81 Allowed 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.174 0.511 . . . . 25.0 109.751 177.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 11.2 t -118.78 162.83 17.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.998 0.428 . . . . 25.0 111.255 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -65.87 -32.48 74.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.827 0.822 . . . . 25.0 110.283 178.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.4 p-10 -94.48 16.43 15.34 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 115.659 -0.701 . . . . 25.0 112.633 -177.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 11.6 ttm180 -61.07 150.25 34.5 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 106.961 -1.496 . . . . 25.0 106.961 175.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 14.7 m95 -97.02 156.4 16.37 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 108.042 -1.096 . . . . 25.0 108.042 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -45.06 121.93 3.07 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 113.887 1.069 . . . . 25.0 113.887 -174.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 52.7 mmtt -76.24 108.08 8.92 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 109.799 -0.445 . . . . 25.0 109.799 -179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -102.28 105.93 16.66 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.362 0.601 . . . . 25.0 112.117 177.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.8 tt -64.18 142.86 16.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 109.028 -0.731 . . . . 25.0 109.028 177.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 6.4 tpt -146.82 151.87 37.81 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 107.849 -1.167 . . . . 25.0 107.849 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 33.5 p -101.95 171.99 7.19 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 107.455 -1.313 . . . . 25.0 107.455 176.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.08 177.57 19.31 Favored Glycine 0 CA--C 1.524 0.626 0 N-CA-C 114.81 0.684 . . . . 25.0 114.81 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 99.16 177.1 31.79 Favored Glycine 0 C--O 1.227 -0.299 0 N-CA-C 112.399 -0.281 . . . . 25.0 112.399 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER -92.06 132.73 36.34 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 121.942 -0.74 . . . . 25.0 109.733 179.358 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 3.5 m80 -135.33 141.78 45.67 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.888 0.375 . . . . 25.0 110.448 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.9 m -84.34 118.75 24.42 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.038 -1.097 . . . . 25.0 108.038 174.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 34.3 m-85 -93.03 111.92 23.71 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.443 -2.058 . . . . 25.0 105.443 177.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 11.4 m -90.67 118.74 30.35 Favored 'General case' 0 C--O 1.239 0.527 0 CA-C-N 115.93 -0.577 . . . . 25.0 111.192 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 50.3 m0 -122.92 139.49 53.99 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 104.757 -2.312 . . . . 25.0 104.757 179.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 11.5 t -145.01 161.84 38.4 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.973 0.415 . . . . 25.0 111.95 -174.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -113.87 136.87 52.4 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 104.076 -2.564 . . . . 25.0 104.076 173.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 12.7 t -72.82 -15.91 61.62 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.382 0.882 . . . . 25.0 113.382 -173.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.96 153.81 67.74 Favored Pre-proline 0 C--N 1.326 -0.452 0 N-CA-C 104.752 -2.314 . . . . 25.0 104.752 176.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -65.91 130.73 25.24 Favored 'Trans proline' 0 C--N 1.347 0.473 0 C-N-CA 115.525 -2.517 . . . . 25.0 111.574 179.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 19.6 t-80 -130.93 153.34 49.29 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.02 -1.104 . . . . 25.0 108.02 -177.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.412 ' HB3' ' CG ' ' A' ' 156' ' ' ASP . 11.8 t-20 -65.08 143.2 58.06 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 106.563 -1.643 . . . . 25.0 106.563 171.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.8 p -144.78 147.26 32.69 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 104.378 -2.453 . . . . 25.0 104.378 176.063 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 13.4 t -116.99 -47.15 2.7 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 113.099 0.777 . . . . 25.0 113.099 -176.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -159.12 153.29 23.7 Favored 'General case' 0 N--CA 1.466 0.335 0 O-C-N 121.518 -0.739 . . . . 25.0 112.388 -175.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -142.39 132.34 24.4 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.161 0.505 . . . . 25.0 109.73 167.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -136.89 142.57 42.75 Favored 'General case' 0 CA--C 1.509 -0.619 0 N-CA-C 106.864 -1.532 . . . . 25.0 106.864 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -143.85 151.52 39.99 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.774 0.797 . . . . 25.0 111.614 -166.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 21.3 m-85 -137.48 168.94 18.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.61 -1.177 . . . . 25.0 109.064 -168.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 45.2 pt -132.78 149.11 31.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 110.115 -0.328 . . . . 25.0 110.115 170.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 43.5 m -88.5 117.19 27.28 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-N 116.192 -0.458 . . . . 25.0 110.025 176.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.18 125.16 34.47 Favored 'General case' 0 C--O 1.209 -1.057 0 O-C-N 121.334 -0.854 . . . . 25.0 110.949 175.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -76.86 154.08 34.16 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 106.531 -1.655 . . . . 25.0 106.531 168.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 96.01 10.21 56.45 Favored Glycine 0 C--O 1.222 -0.654 0 N-CA-C 119.349 2.499 . . . . 25.0 119.349 170.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . . . . . . . . . 23.8 p90 -61.02 153.33 25.58 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 118.958 1.379 . . . . 25.0 110.699 178.624 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -70.51 152.05 95.46 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.337 -1.357 . . . . 25.0 107.337 174.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.68 -19.8 47.3 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 117.646 -1.102 . . . . 25.0 114.868 -177.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -71.18 -18.62 62.47 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.822 0.82 . . . . 25.0 111.67 176.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 61.7 mttm -96.13 128.86 35.47 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 121.483 -0.761 . . . . 25.0 109.866 -172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -64.14 126.28 16.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 117.588 -1.141 . . . . 25.0 114.223 -173.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 7.8 tt -53.12 -42.94 66.51 Favored 'General case' 0 C--O 1.217 -0.626 0 CA-C-N 114.525 -1.216 . . . . 25.0 113.213 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -69.01 -17.35 63.9 Favored 'General case' 0 C--O 1.218 -0.554 0 N-CA-C 113.046 0.758 . . . . 25.0 113.046 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 5.3 mpt_? -77.15 -45.63 26.12 Favored 'General case' 0 C--O 1.211 -0.95 0 N-CA-C 109.335 -0.617 . . . . 25.0 109.335 169.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -65.97 -25.64 67.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.364 0.602 . . . . 25.0 112.216 -176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . . . . . . . . . 33.8 t0 -71.04 -29.03 64.84 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.72 -0.673 . . . . 25.0 110.538 177.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -121.46 92.12 3.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.259 0.552 . . . . 25.0 109.712 177.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -99.75 110.13 22.54 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 105.564 -2.013 . . . . 25.0 105.564 172.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.0 tp -62.82 117.25 6.09 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.857 -0.423 . . . . 25.0 109.857 -175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -108.17 -2.53 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 N-CA-C 107.382 -1.34 . . . . 25.0 107.382 -177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.22 151.05 6.72 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.665 -0.778 . . . . 25.0 114.639 171.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -143.04 122.66 13.27 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 106.057 -1.831 . . . . 25.0 106.057 177.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 60.6 t -136.09 117.95 11.84 Favored Pre-proline 0 C--N 1.322 -0.592 0 N-CA-C 108.572 -0.899 . . . . 25.0 108.572 -176.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -78.35 175.38 11.15 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 115.962 -2.225 . . . . 25.0 110.259 176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 43.8 t60 -128.56 92.36 3.41 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 105.253 -2.128 . . . . 25.0 105.253 166.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -105.0 -19.94 13.68 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 113.681 -1.6 . . . . 25.0 107.711 -178.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -155.76 -179.35 30.78 Favored Glycine 0 N--CA 1.445 -0.764 1 N-CA-C 103.013 -4.035 . . . . 25.0 103.013 175.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -116.65 36.75 0.22 Allowed Pre-proline 0 CA--C 1.545 0.769 0 N-CA-C 117.16 2.281 . . . . 25.0 117.16 179.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -71.88 170.57 18.5 Favored 'Trans proline' 0 C--N 1.355 0.876 1 C-N-CA 113.225 -4.05 . . . . 25.0 110.333 171.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.94 -28.11 55.43 Favored 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.294 1.22 . . . . 25.0 114.294 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.8 p -70.51 -19.81 62.89 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.452 0.538 . . . . 25.0 112.452 179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 65.1 mmt-85 -100.96 10.72 40.78 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.274 0.63 . . . . 25.0 112.478 -178.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 13.7 m-20 -58.05 156.8 8.83 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 116.028 1.862 . . . . 25.0 116.028 -173.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.73 -22.4 59.89 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.344 -1.298 . . . . 25.0 111.662 176.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 65.1 m -100.04 140.55 34.11 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 107.55 -1.278 . . . . 25.0 107.55 -176.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 27.1 m80 -129.57 136.86 50.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.339 0.866 . . . . 25.0 113.339 -168.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 49.7 m-70 -79.37 126.8 31.28 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 106.543 -1.651 . . . . 25.0 106.543 175.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 29.4 mm -131.91 125.81 55.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.705 -1.221 . . . . 25.0 107.705 -179.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' A' ' 79' ' ' GLU . 90.6 t80 -85.85 133.33 33.97 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.791 -0.818 . . . . 25.0 108.791 174.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 45.4 mm -108.84 129.67 23.65 Favored Pre-proline 0 C--N 1.322 -0.623 0 N-CA-C 106.844 -1.539 . . . . 25.0 106.844 178.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 70.3 Cg_endo -66.27 146.58 81.47 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 117.127 -1.449 . . . . 25.0 111.92 179.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 66.7 tt0 -110.57 -12.54 14.34 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.055 0.931 . . . . 25.0 110.857 -173.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -88.0 4.22 45.87 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 113.839 1.052 . . . . 25.0 113.839 -176.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 19.3 ptp180 -151.78 151.65 31.65 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 121.844 -0.535 . . . . 25.0 112.145 -175.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 8.3 mp -115.32 141.57 47.86 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-N 115.286 -0.87 . . . . 25.0 109.49 -177.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 146.74 163.49 10.49 Favored Glycine 0 CA--C 1.517 0.178 0 N-CA-C 115.11 0.804 . . . . 25.0 115.11 173.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 11.4 p90 -86.92 145.04 26.69 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 113.504 0.927 . . . . 25.0 113.504 -176.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -144.5 159.09 43.35 Favored 'General case' 0 C--O 1.214 -0.811 0 N-CA-C 105.861 -1.904 . . . . 25.0 105.861 -176.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 22.0 t -113.83 136.31 50.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 106.894 -1.521 . . . . 25.0 106.894 174.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 78.7 mt -96.04 120.16 45.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 104.155 -2.535 . . . . 25.0 104.155 174.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 42.5 mt -105.5 137.48 43.26 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 107.933 -1.136 . . . . 25.0 107.933 -176.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -144.31 146.64 32.71 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 119.101 0.864 . . . . 25.0 112.321 -179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 45.4 t -126.03 135.43 63.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 106.64 -1.615 . . . . 25.0 106.64 178.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 3.3 t90 -130.06 117.45 20.03 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.606 0.717 . . . . 25.0 110.01 -173.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -93.7 132.0 38.49 Favored 'General case' 0 C--O 1.244 0.804 0 CA-C-N 114.865 -1.061 . . . . 25.0 109.998 -179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 85.0 t -135.18 134.74 52.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 105.732 -1.951 . . . . 25.0 105.732 -177.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -103.0 -10.04 19.29 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.204 1.557 . . . . 25.0 115.204 -172.125 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . 0.412 ' CG ' ' HB3' ' A' ' 91' ' ' ASN . 41.9 p-10 -102.29 18.22 21.52 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.245 0.545 . . . . 25.0 110.457 179.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 25.2 p -133.0 151.16 52.1 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 106.988 -1.486 . . . . 25.0 106.988 175.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 35.1 mp0 -70.22 -18.13 63.15 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.665 0.269 . . . . 25.0 111.656 -179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -118.16 171.93 7.78 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.061 -0.518 . . . . 25.0 111.87 -174.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -122.03 159.53 26.85 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.683 -1.969 . . . . 25.0 105.683 177.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -111.35 145.59 38.6 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 114.302 1.223 . . . . 25.0 114.302 -170.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -123.5 139.7 53.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.204 -0.907 . . . . 25.0 108.734 176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -149.57 142.1 24.4 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 107.417 -1.327 . . . . 25.0 107.417 179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 26.5 m -135.59 151.06 29.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 107.305 -1.369 . . . . 25.0 107.305 177.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 56.8 mt -129.08 110.32 20.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 107.006 -1.479 . . . . 25.0 107.006 178.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -77.53 131.74 38.03 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 106.321 -1.733 . . . . 25.0 106.321 177.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 19.6 m -135.0 157.93 41.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 O-C-N 121.789 -0.569 . . . . 25.0 110.605 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 43.7 t0 -123.58 108.29 12.45 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 106.344 -1.724 . . . . 25.0 106.344 176.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 mt -98.77 103.99 16.0 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.81 -1.552 . . . . 25.0 106.81 -171.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 35.8 m -145.45 171.1 5.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.825 0.345 . . . . 25.0 111.319 -172.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -78.02 152.67 32.92 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 107.9 -1.148 . . . . 25.0 107.9 172.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.896 0 CA-C-O 117.844 -1.074 . . . . 25.0 109.599 177.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 112.374 0.509 . . . . 25.0 112.374 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.42 -156.75 48.79 Favored Glycine 0 C--O 1.227 -0.285 0 C-N-CA 119.731 -1.223 . . . . 25.0 110.559 -179.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -93.08 133.24 36.45 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.995 0.398 . . . . 25.0 110.347 -177.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 92.3 mt -88.68 112.32 23.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 106.498 -1.668 . . . . 25.0 106.498 177.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 17.7 tt0 -89.61 -43.5 10.72 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.95 -0.568 . . . . 25.0 110.798 -176.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 70.3 mmtt -140.55 158.09 66.71 Favored Pre-proline 0 N--CA 1.477 0.91 0 N-CA-C 107.862 -1.162 . . . . 25.0 107.862 -177.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -82.14 116.57 4.53 Favored 'Cis proline' 0 C--N 1.35 0.624 0 C-N-CA 131.672 1.947 . . . . 25.0 113.955 -2.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 61.23 -149.48 45.27 Favored Glycine 0 C--O 1.226 -0.367 0 N-CA-C 110.201 -1.16 . . . . 25.0 110.201 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 39.9 t -131.43 110.77 11.26 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.239 0.542 . . . . 25.0 110.553 176.319 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.61 -20.73 65.91 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-N 115.994 -0.548 . . . . 25.0 111.004 176.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -62.92 -24.13 67.7 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 123.104 0.253 . . . . 25.0 111.577 -178.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -61.07 -45.65 93.89 Favored 'General case' 0 C--O 1.216 -0.679 0 C-N-CA 120.852 -0.339 . . . . 25.0 110.281 177.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.4 mp -73.53 -16.8 61.26 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.269 0.557 . . . . 25.0 111.147 -179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 13.0 t -83.49 -20.44 33.97 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.547 -0.751 . . . . 25.0 110.099 -177.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 81.3 p -96.21 157.25 15.98 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.976 -0.556 . . . . 25.0 111.282 -177.29 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -67.29 -16.23 64.15 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.225 -0.443 . . . . 25.0 111.318 178.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.45 -13.47 30.38 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 112.184 0.438 . . . . 25.0 112.184 178.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -83.28 2.22 37.07 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 113.429 0.9 . . . . 25.0 113.429 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 167.81 -29.38 0.17 Allowed Glycine 0 C--O 1.224 -0.503 0 N-CA-C 116.317 1.287 . . . . 25.0 116.317 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER 60.76 4.16 0.73 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 116.34 1.978 . . . . 25.0 116.34 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 86.9 mt -80.19 -30.74 38.8 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 121.761 -0.587 . . . . 25.0 110.459 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . . . . . . . . . 24.9 t-20 -169.0 157.21 7.77 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.423 -1.695 . . . . 25.0 106.423 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -138.08 144.4 40.9 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 106.307 -1.738 . . . . 25.0 106.307 170.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -157.26 63.33 0.49 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.712 -1.218 . . . . 25.0 107.712 -179.425 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 11.5 t -92.33 -10.34 38.63 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.247 0.546 . . . . 25.0 111.314 -177.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 70.83 -160.66 53.94 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 109.733 -1.347 . . . . 25.0 109.733 -176.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 23.1 t -64.9 -13.86 58.01 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 112.614 0.598 . . . . 25.0 112.614 -179.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.8 t -58.09 -23.73 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 112.482 0.549 . . . . 25.0 112.482 -178.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -70.34 -27.95 64.76 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 121.763 -0.586 . . . . 25.0 112.542 175.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 41.0 t80 -93.17 -16.28 25.03 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.378 1.085 . . . . 25.0 108.541 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.66 60.09 0.84 Allowed Pre-proline 0 C--O 1.245 0.86 0 CA-C-N 115.176 -0.92 . . . . 25.0 111.733 -177.33 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -75.71 -39.86 0.89 Allowed 'Trans proline' 0 C--N 1.353 0.766 0 C-N-CA 113.558 -3.828 . . . . 25.0 114.348 -178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 15.4 pt20 -104.24 -23.44 13.24 Favored 'General case' 0 CA--C 1.544 0.723 0 N-CA-C 114.476 1.288 . . . . 25.0 114.476 -176.123 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.49 114.16 21.86 Favored 'General case' 0 C--O 1.203 -1.386 0 N-CA-C 104.567 -2.383 . . . . 25.0 104.567 173.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.1 tp -133.38 105.05 6.72 Favored 'General case' 0 C--O 1.251 1.149 0 N-CA-C 106.487 -1.671 . . . . 25.0 106.487 177.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -128.62 141.01 51.49 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.22 0.533 . . . . 25.0 112.18 -172.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -136.07 102.86 5.15 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.468 -1.679 . . . . 25.0 106.468 172.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mmtm -170.94 -168.42 0.66 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 105.037 -2.208 . . . . 25.0 105.037 -174.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -75.58 122.21 23.57 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.663 0.986 . . . . 25.0 113.663 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -111.63 156.68 15.42 Favored Glycine 0 C--N 1.322 -0.198 0 N-CA-C 104.026 -3.629 . . . . 25.0 104.026 164.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -112.08 125.78 29.59 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 118.749 1.274 . . . . 25.0 111.061 177.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -71.1 149.99 92.66 Favored 'Cis proline' 0 C--N 1.353 0.785 0 C-N-CA 130.461 1.442 . . . . 25.0 110.983 -3.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 41.7 t-80 -68.72 -47.41 66.41 Favored 'General case' 0 C--O 1.22 -0.461 0 N-CA-C 114.77 1.396 . . . . 25.0 114.77 -172.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.6 t 61.31 -62.98 0.08 Allowed 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.415 2.006 . . . . 25.0 116.415 -177.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -71.15 -179.18 29.51 Favored Glycine 0 C--O 1.242 0.599 0 N-CA-C 116.015 1.166 . . . . 25.0 116.015 -175.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.68 170.29 16.83 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.261 2.64 . . . . 25.0 113.758 -177.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ALA . . . . . . . . . . . . . . . -54.99 132.66 47.5 Favored 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 112.541 0.571 . . . . 25.0 112.541 -177.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -66.12 125.22 24.83 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.047 -0.723 . . . . 25.0 109.047 179.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.22 9.51 42.48 Favored Glycine 0 CA--C 1.519 0.333 0 C-N-CA 121.175 -0.535 . . . . 25.0 111.885 -176.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 27.3 mp0 55.96 19.21 3.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.713 1.205 . . . . 25.0 112.68 -177.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 69.3 mt -62.3 -44.84 99.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.404 0 N-CA-C 113.006 0.743 . . . . 25.0 113.006 -174.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.62 -26.7 68.51 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 114.419 1.266 . . . . 25.0 114.419 -173.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 28.3 t -112.95 -21.11 11.29 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.79 0.663 . . . . 25.0 112.79 -178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 48.19 26.62 1.09 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.719 1.378 . . . . 25.0 114.719 -178.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -110.95 -41.28 1.2 Allowed Glycine 0 C--O 1.221 -0.69 0 C-N-CA 121.306 -0.473 . . . . 25.0 113.485 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -86.46 18.38 33.78 Favored Glycine 0 C--O 1.221 -0.709 0 N-CA-C 115.079 0.791 . . . . 25.0 115.079 -175.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 16.2 mt -59.84 -35.94 75.8 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 113.573 0.953 . . . . 25.0 113.573 -173.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -65.03 -11.82 43.54 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 112.841 0.682 . . . . 25.0 112.841 177.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . -58.18 -21.94 48.34 Favored Glycine 0 C--O 1.22 -0.74 0 CA-C-O 119.713 -0.493 . . . . 25.0 113.663 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -67.55 -22.9 73.56 Favored Glycine 0 C--O 1.223 -0.544 0 CA-C-N 117.962 0.881 . . . . 25.0 112.673 176.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 45.5 mm -86.31 -36.98 11.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.325 -0.991 . . . . 25.0 108.325 177.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 10.6 mp -73.31 -10.86 60.19 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.797 -0.638 . . . . 25.0 111.9 -178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -57.15 -30.57 64.55 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 111.654 0.242 . . . . 25.0 111.654 179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -63.92 -8.64 11.84 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 114.259 1.207 . . . . 25.0 114.259 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -127.8 24.25 6.11 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-O 121.418 0.628 . . . . 25.0 109.867 178.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 12.5 t -98.5 164.96 12.05 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.244 -0.435 . . . . 25.0 110.983 -177.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -67.67 -33.38 74.81 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.61 0.719 . . . . 25.0 109.148 175.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -94.89 19.03 10.79 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 116.002 -0.545 . . . . 25.0 112.053 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ARG . . . . . . . . . . . . . 5.3 tmm_? -47.63 136.37 10.41 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.345 0.869 . . . . 25.0 113.345 -176.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TRP . . . . . . . . . . . . . 24.3 m95 -89.68 159.06 17.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.465 -0.788 . . . . 25.0 109.227 -178.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -65.52 132.91 50.08 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.486 0.921 . . . . 25.0 113.486 -174.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.3 mmtt -80.78 143.24 33.01 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.47 -0.787 . . . . 25.0 109.717 176.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.94 96.57 4.53 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 112.898 0.703 . . . . 25.0 112.898 173.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 17.5 tt -69.25 138.43 22.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 104.152 -2.536 . . . . 25.0 104.152 168.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' MET . . . . . . . . . . . . . 12.5 tpt -145.42 146.55 31.57 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.23 -0.655 . . . . 25.0 109.23 -176.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 22.0 p -95.0 172.04 8.39 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.684 -1.228 . . . . 25.0 107.684 179.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.81 -174.97 5.48 Favored Glycine 0 CA--C 1.524 0.599 0 N-CA-C 116.648 1.419 . . . . 25.0 116.648 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 96.84 177.08 35.18 Favored Glycine 0 CA--C 1.518 0.235 0 CA-C-N 115.035 -0.583 . . . . 25.0 113.031 179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -87.97 132.63 34.17 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.034 -0.686 . . . . 25.0 110.86 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' HIS . . . . . . . . . . . . . 10.7 m80 -132.61 137.92 47.21 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.515 -0.55 . . . . 25.0 109.515 179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.1 m -101.97 137.49 40.19 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.596 0.961 . . . . 25.0 113.596 -175.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -109.29 129.73 55.51 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.901 -1.518 . . . . 25.0 106.901 175.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 32.4 m -137.77 129.56 28.51 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.993 -0.373 . . . . 25.0 109.993 -179.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TRP . . . . . . . . . . . . . 43.8 m0 -124.01 143.36 50.46 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 106.035 -1.839 . . . . 25.0 106.035 175.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.9 t -145.01 156.92 44.22 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.7 0.286 . . . . 25.0 111.168 -177.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -139.78 163.98 31.18 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 106.835 -1.543 . . . . 25.0 106.835 173.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' THR . . . . . . . . . . . . . 11.5 t -71.28 -19.38 62.35 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 113.501 0.926 . . . . 25.0 113.501 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -140.77 147.34 48.11 Favored Pre-proline 0 C--O 1.238 0.468 0 O-C-N 121.943 -0.473 . . . . 25.0 111.026 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -74.86 149.71 37.79 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 117.689 -1.074 . . . . 25.0 111.734 175.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -130.94 161.65 31.44 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.199 -0.667 . . . . 25.0 109.199 176.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . . . . . . . . . 45.1 t-20 -65.86 131.09 45.44 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 107.563 -1.273 . . . . 25.0 107.563 174.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.4 p -143.63 152.22 41.09 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 107.256 -1.387 . . . . 25.0 107.256 -176.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 41.2 t -103.3 -56.84 2.14 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.494 0.924 . . . . 25.0 113.494 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 17.1 tt0 -159.01 150.43 20.45 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 121.849 -0.532 . . . . 25.0 110.644 -174.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -125.9 131.12 52.4 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 107.008 -1.478 . . . . 25.0 107.008 169.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -147.84 158.96 44.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.528 -0.305 . . . . 25.0 110.729 -177.65 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -145.32 150.79 37.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.705 0.764 . . . . 25.0 112.239 -175.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -128.36 154.8 45.6 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.606 -1.179 . . . . 25.0 108.12 -172.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 41.5 pt -136.01 149.36 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 N-CA-C 112.907 0.706 . . . . 25.0 112.907 174.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' THR . . . . . . . . . . . . . 50.1 m -86.79 121.82 29.81 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.442 -1.318 . . . . 25.0 107.442 171.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 ptpt -108.05 125.53 51.67 Favored 'General case' 0 C--O 1.215 -0.759 0 O-C-N 121.74 -0.6 . . . . 25.0 111.759 178.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 19.9 pttm -75.9 148.29 38.36 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 106.202 -1.777 . . . . 25.0 106.202 173.435 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . 104.58 9.91 34.47 Favored Glycine 0 CA--C 1.522 0.485 0 N-CA-C 117.229 1.652 . . . . 25.0 117.229 176.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TRP . . . . . 0.401 ' CH2' ' HA ' ' A' ' 114' ' ' ASP . 0.4 OUTLIER -83.05 161.5 21.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 118.615 1.208 . . . . 25.0 110.56 175.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -73.63 140.35 78.38 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 109.048 -0.723 . . . . 25.0 109.048 178.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.26 -13.51 20.87 Favored 'Trans proline' 0 C--N 1.348 0.502 0 N-CA-C 114.492 0.92 . . . . 25.0 114.492 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -72.44 -13.97 61.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 122.114 0.959 . . . . 25.0 111.621 179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -84.22 148.21 52.47 Favored Pre-proline 0 C--N 1.323 -0.56 0 N-CA-C 106.102 -1.814 . . . . 25.0 106.102 -175.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.96 93.82 0.39 Allowed 'Trans proline' 0 C--N 1.35 0.649 0 CA-C-O 121.55 0.562 . . . . 25.0 112.717 -175.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -53.3 -36.35 61.13 Favored 'General case' 0 C--O 1.208 -1.118 0 N-CA-C 114.367 1.247 . . . . 25.0 114.367 -174.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 46.7 mtmt -61.39 -28.04 68.96 Favored 'General case' 0 C--O 1.217 -0.63 0 C-N-CA 120.186 -0.606 . . . . 25.0 112.305 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . . . . . . . . . 2.8 mpt_? -84.65 -46.02 11.91 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-O 121.043 0.449 . . . . 25.0 110.946 172.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -78.61 -7.38 57.54 Favored 'General case' 0 C--O 1.219 -0.514 0 N-CA-C 115.705 1.743 . . . . 25.0 115.705 -169.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASP . . . . . 0.401 ' HA ' ' CH2' ' A' ' 104' ' ' TRP . 42.7 t0 -64.99 -30.71 71.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.232 0.539 . . . . 25.0 111.335 -172.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 35.0 m-85 -126.15 108.88 11.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.787 -0.82 . . . . 25.0 108.787 172.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -103.1 132.19 49.54 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.588 -0.278 . . . . 25.0 111.525 -176.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 29.2 tp -62.51 127.94 33.69 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.037 -0.727 . . . . 25.0 109.037 179.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -126.92 0.74 3.99 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.624 0 CA-C-O 121.944 0.878 . . . . 25.0 110.031 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.46 140.8 4.72 Favored Glycine 0 CA--C 1.511 -0.199 0 C-N-CA 120.363 -0.922 . . . . 25.0 112.863 173.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ALA . . . . . . . . . . . . . . . -150.32 132.86 15.72 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.619 -0.882 . . . . 25.0 108.619 179.406 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.0 t -133.67 109.6 12.14 Favored Pre-proline 0 C--N 1.321 -0.631 0 N-CA-C 108.069 -1.086 . . . . 25.0 108.069 177.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -80.0 164.69 22.34 Favored 'Trans proline' 0 C--O 1.236 0.378 0 C-N-CA 116.482 -1.879 . . . . 25.0 111.72 177.815 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 58.5 t60 -103.84 106.86 17.5 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 107.025 -1.472 . . . . 25.0 107.025 178.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 35.9 p-10 -114.53 -22.7 9.67 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.578 -1.192 . . . . 25.0 109.515 -177.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -173.86 -161.58 24.19 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 103.78 -3.728 . . . . 25.0 103.78 -178.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 6.3 t -123.7 50.44 3.36 Favored Pre-proline 0 CA--C 1.541 0.629 0 N-CA-C 115.301 1.593 . . . . 25.0 115.301 179.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -70.77 170.55 17.52 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 114.047 -3.502 . . . . 25.0 109.769 170.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.33 -29.62 58.67 Favored 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 114.077 1.14 . . . . 25.0 114.077 -177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 53.3 p -70.87 -16.0 62.67 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 112.892 0.701 . . . . 25.0 112.892 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ARG . . . . . . . . . . . . . 6.7 mpt_? -99.16 7.01 46.19 Favored 'General case' 0 N--CA 1.467 0.395 0 N-CA-C 111.742 0.275 . . . . 25.0 111.742 -179.354 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -61.19 152.29 29.12 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 107.885 -1.154 . . . . 25.0 107.885 174.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -72.1 -11.49 60.77 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 112.618 0.599 . . . . 25.0 112.618 -179.135 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.2 t -90.98 124.47 35.25 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 108.059 -1.089 . . . . 25.0 108.059 -178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 22.0 m80 -128.86 140.39 51.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.247 -0.433 . . . . 25.0 110.049 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -100.83 137.22 39.5 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.235 -1.024 . . . . 25.0 108.235 -177.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ILE . . . . . . . . . . . . . 34.3 mm -130.85 123.74 54.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 108.022 -1.103 . . . . 25.0 108.022 -177.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -93.35 134.34 35.68 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.649 -0.5 . . . . 25.0 109.649 177.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 47.4 mm -109.72 129.86 23.45 Favored Pre-proline 0 C--N 1.322 -0.608 0 N-CA-C 108.532 -0.914 . . . . 25.0 108.532 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -68.7 150.0 73.91 Favored 'Trans proline' 0 C--N 1.349 0.6 0 C-N-CA 117.951 -0.9 . . . . 25.0 112.275 179.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -117.36 -4.93 11.3 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-O 122.115 0.96 . . . . 25.0 110.663 -175.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASP . . . . . . . . . . . . . 11.0 p-10 -85.87 6.61 27.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.698 -0.683 . . . . 25.0 112.796 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ARG . . . . . . . . . . . . . 20.1 ptp180 -155.95 170.09 22.93 Favored 'General case' 0 C--O 1.22 -0.453 0 O-C-N 121.991 -0.443 . . . . 25.0 111.852 -173.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LEU . . . . . . . . . . . . . 6.2 mp -126.82 153.56 45.47 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 105.766 -1.939 . . . . 25.0 105.766 175.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 153.02 144.87 4.01 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-O 122.075 0.819 . . . . 25.0 115.091 177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TYR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 168' ' ' ASP . 4.8 p90 -81.48 146.12 30.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.439 -0.88 . . . . 25.0 112.425 -177.122 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' HIS . . . . . . . . . . . . . 88.3 m-70 -146.33 158.95 43.94 Favored 'General case' 0 C--O 1.211 -0.923 0 N-CA-C 105.512 -2.033 . . . . 25.0 105.512 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.6 t -121.36 130.26 74.82 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 104.05 -2.574 . . . . 25.0 104.05 172.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ILE . . . . . . . . . . . . . 72.1 mt -109.48 119.34 58.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 108.204 -1.036 . . . . 25.0 108.204 -177.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 7.2 mp -108.48 131.43 54.82 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 106.419 -1.697 . . . . 25.0 106.419 -179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . . . . . . . . . . . -131.49 133.82 45.52 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.564 -0.532 . . . . 25.0 109.564 178.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 8.2 t -129.01 132.92 66.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 109.246 -0.65 . . . . 25.0 109.246 -177.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' TRP . . . . . . . . . . . . . 4.6 t90 -119.47 108.31 14.39 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 106.447 -1.686 . . . . 25.0 106.447 179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -87.29 132.0 34.06 Favored 'General case' 0 C--O 1.245 0.822 0 CA-C-N 114.872 -1.058 . . . . 25.0 111.259 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' VAL . . . . . . . . . . . . . 92.0 t -111.28 129.5 66.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 105.559 -2.015 . . . . 25.0 105.559 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -71.94 -28.3 63.37 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 115.072 1.508 . . . . 25.0 115.072 -167.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ASP . . . . . . . . . . . . . 24.5 p-10 -110.0 22.66 15.34 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.929 1.085 . . . . 25.0 113.929 -172.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 40.6 p -137.98 153.1 49.46 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 120.867 0.365 . . . . 25.0 111.685 177.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 44.5 mp0 -78.8 -7.81 58.19 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 121.601 0.715 . . . . 25.0 110.333 177.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -110.11 161.31 15.67 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.02 -0.991 . . . . 25.0 109.081 -178.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ALA . . . . . . . . . . . . . . . -143.78 161.11 39.47 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 104.785 -2.302 . . . . 25.0 104.785 -179.045 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -90.86 131.25 36.61 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 107.836 -1.172 . . . . 25.0 107.836 -177.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -128.73 134.47 48.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.149 -0.478 . . . . 25.0 110.216 -176.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -145.97 140.15 26.69 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 107.36 -1.348 . . . . 25.0 107.36 176.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' VAL . . . . . . . . . . . . . 7.4 p -134.02 139.82 47.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 N-CA-C 106.79 -1.559 . . . . 25.0 106.79 178.688 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.9 mt -135.31 118.55 23.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.115 -1.068 . . . . 25.0 108.115 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -80.16 131.42 35.72 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 105.96 -1.866 . . . . 25.0 105.96 175.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.2 m -134.12 162.8 38.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 121.345 0.593 . . . . 25.0 111.767 -175.538 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 145' ' ' TYR . 63.0 t0 -129.58 120.99 26.22 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 103.242 -2.873 . . . . 25.0 103.242 170.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 74.7 mt -104.74 111.41 24.12 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 106.858 -1.534 . . . . 25.0 106.858 -172.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.75 166.6 22.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 114.48 1.289 . . . . 25.0 114.48 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 48.8 t-20 -72.08 154.35 41.16 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 107.085 -1.45 . . . . 25.0 107.085 173.293 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.659 0 CA-C-O 118.255 -0.879 . . . . 25.0 110.106 177.713 . . . . . . . . 1 1 . 1 stop_ save_